Citrus Sinensis ID: 014189

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------43
Protein Sequence
MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQCN
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccEEEccccEEEEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccccccEEcHHHHHHHHcccccccccccccccEEEEEEEcccccccccccEEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccccHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccHHHHEEEEEEEEEHHHHHEcccccEEEEccccccccccccccccccccccccccccccccccccccccHcccccccccccEEcHHHHHHHHccccHHHcccccccccEEEEEcccccccccccEEEEEEEEcccccccccHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEEcccccccHcHccccccccccccccEEEEEcccccHccHHHHHHccccHHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHHccHcccccHHHHHHHHHHHcccccccccccccEEEcccccccccccccccccc
Coil and Loop (DISEMBL)
mgncwckwepsvyivssnpksdsfvgffiLDIPFLFCKLMKKTEMKKVQSFFQFqsishckespkdespsekakkeysklpsnpeevedlrrdsaanpliaftyDELRIITANfrqdrvlggggfgcvyKGFISedlreglqpvpvavkvhdgdnsyqgHREWLAEVIFLghlshpnlVKLIGYCCEDEHRVLIYEFMARgsvennlfskvllplpwsiRMKIAFGAAKGLAFLheaekpviyrdfktsnilldtdynaklsdfglakdgpegdkshvstrimgtygyaapeyimtghltprsdvysFGVVLLEILTGrksldksrparEQNLADWALPLLKEKKKLLNIidprlegdypvkgVHKAAMLAYHClnhnpkarplMRDIVdsleplqvlpdeaptpknfvtvvtpeepkaeiqtkdsqcn
Flexible Loop (DISEMBL)
mgncwckwEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQfqsishckespkdespsekakkeysklpsnpeevedlrrdsAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDfglakdgpegdkshvstRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTgrksldksrpareqnladwalplLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLqvlpdeaptpknfVTVVTPeepkaeiqtkdsqcn
Low Complexity Region (SEG)
MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLggggfgCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAlpllkekkkllNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQCN
Disordered region (IsUnstruct)
**NCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSI***************************************NPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA**********VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR************NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL*************************************
Disordered Region (DISOPRED)
*GNC***********************FILDIPFLF***************************************************************IAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL**********************************
Disordered Region (DISEMBL)
MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISH******************************LRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPE**************
Disordered Region (DISPRO)
**NCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQS**********************************************NPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL*******************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQCN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	429	2.2.26 [Sep-21-2011]
Q9FM85	408	Probable receptor-like pr	yes	no	0.878	0.924	0.732	1e-176
Q8GXZ3	410	Serine/threonine-protein	no	no	0.743	0.778	0.684	1e-127
Q9LFP7	493	Probable receptor-like pr	no	no	0.724	0.630	0.621	1e-112
Q9SRH7	490	Receptor-like serine/thre	no	no	0.724	0.634	0.605	1e-108
P46573	412	Protein kinase APK1B, chl	no	no	0.696	0.725	0.622	1e-106
Q9CAH1	450	Putative receptor-like pr	no	no	0.752	0.717	0.567	1e-103
Q06548	410	Protein kinase APK1A, chl	no	no	0.696	0.729	0.6	1e-102
P43293	389	Probable serine/threonine	no	no	0.738	0.814	0.549	1e-102
O49840	426	Protein kinase 2B, chloro	no	no	0.692	0.697	0.588	1e-101
O48814	395	Serine/threonine-protein	no	no	0.701	0.762	0.573	1e-100

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  617 bits (1591), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 312/426 (73%), Positives = 342/426 (80%), Gaps = 49/426 (11%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNCWC++EP  + VS+N KS                                       
Sbjct: 1   MGNCWCRFEPLNHRVSANAKS--------------------------------------- 21

Query: 61  KESPKDESPS--EKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDR 118
            ESPK++SP+  +K  KE  KLPSNP+EVEDLRRDSAANPLIAFTY+EL+ IT+NFRQDR
Sbjct: 22  -ESPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANPLIAFTYEELKNITSNFRQDR 80

Query: 119 VLGGGGFGCVYKGFISEDL--REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           VLGGGGFG VYKGFI EDL  +E  +P+PVAVKVHDGDNS+QGHREWLAEVIFLG LSHP
Sbjct: 81  VLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHP 140

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
           NLVKLIGYCCED HRVLIYE+MARGSVENNLFS+VLLPL W+IRMKIAFGAAKGLAFLHE
Sbjct: 141 NLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHE 200

Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT 296
           A+KPVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDKSHVSTRIMGTYGYAAPEYIMT
Sbjct: 201 AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMT 260

Query: 297 GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE 356
           GHLTP SDVYSFGVVLLE+LTGRKSLDKSRP REQNL DWALPLLKEKKK+LNI+DP++ 
Sbjct: 261 GHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMN 320

Query: 357 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA----PTPKNFVTVV 412
            +YPVK V KAAMLAYHCLN NPKARPLMRDIVDSLEPLQ   +EA    P  K  +T++
Sbjct: 321 CEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEEEALLVPPVQKAVITII 380

Query: 413 TPEEPK 418
             E PK
Sbjct: 381 D-EMPK 385

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  454 bits (1169), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 219/320 (68%), Positives = 256/320 (80%), Gaps = 1/320 (0%)

Query: 81  PSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREG 140
           PS P   +D R   +   +I FT  EL  IT +FR D +LG GGFG VYKG+I ++LR G
Sbjct: 36  PSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVG 95

Query: 141 LQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMAR 200
           L+ +PVAVKV + +   QGHREWL EV FLG L HPNLVKLIGYCCED+HR+L+YEFM R
Sbjct: 96  LKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLR 154

Query: 201 GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 260
           GS+EN+LF K   PL WS RM IA GAAKGLAFLH AE+PVIYRDFKTSNILLD+DY AK
Sbjct: 155 GSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 214

Query: 261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK 320
           LSDFGLAK GP+GD++HVSTR+MGTYGYAAPEY+MTGHLT RSDVYSFGVVLLE+LTGRK
Sbjct: 215 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRK 274

Query: 321 SLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPK 380
           S+DK+RP++EQNL DWA P L +K+KLL IIDPRLE  Y V+   KA  LAY+CL+ NPK
Sbjct: 275 SVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPK 334

Query: 381 ARPLMRDIVDSLEPLQVLPD 400
           ARPLM D+V++LEPLQ   D
Sbjct: 335 ARPLMSDVVETLEPLQCTGD 354

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  404 bits (1039), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 197/317 (62%), Positives = 247/317 (77%), Gaps = 6/317 (1%)

Query: 99  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDN 155
           L  FT+++L++ T NFR + +LG GGFGCV+KG+I E+    ++P   + VAVK  + D 
Sbjct: 127 LRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPD- 185

Query: 156 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 215
             QGH+EWLAE+ FLG+L HPNLVKL+GYC ED+ R+L+YEFM RGS+EN+LF + L PL
Sbjct: 186 GLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PL 244

Query: 216 PWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
           PWSIRMKIA GAAKGL+FLHE A KPVIYRDFKTSNILLD DYNAKLSDFGLAKD P+  
Sbjct: 245 PWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEG 304

Query: 275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA 334
           K+HVSTR+MGTYGYAAPEY+MTGHLT +SDVYSFGVVLLE+LTGR+S+DK+RP  E NL 
Sbjct: 305 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 364

Query: 335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 394
           +WA P L +K++   ++DPRLEG + +KG  K   LA  CL+ +PK RP M D+V++L+P
Sbjct: 365 EWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKP 424

Query: 395 LQVLPDEAPTPKNFVTV 411
           L  L D A +   F T+
Sbjct: 425 LPHLKDMASSSYYFQTM 441

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  391 bits (1005), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 192/317 (60%), Positives = 243/317 (76%), Gaps = 6/317 (1%)

Query: 99  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDN 155
           L  F++ +L++ T NFR + +LG GGFGCV+KG++ E+    ++P   + VAVK  + D 
Sbjct: 121 LKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDG 180

Query: 156 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 215
             QGH+EWLAE+ +LG+L HPNLVKL+GYC ED+ R+L+YEFM RGS+EN+LF + L PL
Sbjct: 181 -LQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PL 238

Query: 216 PWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
           PWSIRMKIA GAAKGL+FLHE A KPVIYRDFKTSNILLD +YNAKLSDFGLAKD P+  
Sbjct: 239 PWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEG 298

Query: 275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA 334
           K+HVSTR+MGTYGYAAPEY+MTGHLT +SDVYSFGVVLLE+LTGR+S+DK+RP  E NL 
Sbjct: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358

Query: 335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 394
           +WA P L +K++   ++DPRLEG + VKG  K   LA  CL+ + K RP M ++V+ L+P
Sbjct: 359 EWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKP 418

Query: 395 LQVLPDEAPTPKNFVTV 411
           L  L D A     F T+
Sbjct: 419 LPHLKDMASASYYFQTM 435

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  386 bits (992), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 190/305 (62%), Positives = 230/305 (75%), Gaps = 6/305 (1%)

Query: 99  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDN 155
           L +FT+ EL+  T NFR D VLG GGFG V+KG+I E      +P   V +AVK  + D 
Sbjct: 54  LKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQD- 112

Query: 156 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLL 213
            +QGH+EWLAEV +LG  SHPNLVKLIGYC EDEHR+L+YEFM RGS+EN+LF +     
Sbjct: 113 GWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQ 172

Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
           PL W++R+K+A GAAKGLAFLH AE  VIYRDFKTSNILLD++YNAKLSDFGLAKDGP G
Sbjct: 173 PLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTG 232

Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 333
           DKSHVSTRIMGTYGYAAPEY+ TGHLT +SDVYS+GVVLLE+L+GR+++DK+RP  EQ L
Sbjct: 233 DKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKL 292

Query: 334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            +WA PLL  K+KL  +ID RL+  Y ++   K A LA  CL    K RP M ++V  LE
Sbjct: 293 VEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLE 352

Query: 394 PLQVL 398
            +Q L
Sbjct: 353 HIQTL 357

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAH1|Y1725_ARATH Putative receptor-like protein kinase At1g72540 OS=Arabidopsis thaliana GN=At1g72540 PE=2 SV=1

 Score =  374 bits (960), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 184/324 (56%), Positives = 232/324 (71%), Gaps = 1/324 (0%)

Query: 102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 161
           FTY+EL+ IT  F +   LG GGFG VYKGF+ + L+ GL+  PVAVK    +   QGHR
Sbjct: 72  FTYEELKTITQGFSKYNFLGEGGFGEVYKGFVDDSLKTGLKDQPVAVKALKREGG-QGHR 130

Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           EWLAEVI LG L HP+LV L+GYCCED+ R+L+YE+M RG++E++LF K    LPW  R+
Sbjct: 131 EWLAEVIILGQLKHPHLVNLVGYCCEDDERLLVYEYMERGNLEDHLFQKYGGALPWLTRV 190

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           KI  GAAKGL FLH+ EKPVIYRDFK SNILL +D+++KLSDFGLA DG E + S+ +  
Sbjct: 191 KILLGAAKGLEFLHKQEKPVIYRDFKPSNILLSSDFSSKLSDFGLATDGSEEEDSNFTKS 250

Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL 341
           +MGT GYAAPEYI  G+LT  SDV+SFGVVLLE+LT RK+++K R  R +NL +WA P+L
Sbjct: 251 VMGTEGYAAPEYISAGNLTTMSDVFSFGVVLLEMLTARKAVEKYRAQRGRNLVEWARPML 310

Query: 342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE 401
           K+  KL  IIDP LEG Y V+G+ KAA LAY CL+HNPK+RP M  +V +LEP+  L D 
Sbjct: 311 KDPNKLERIIDPSLEGKYSVEGIRKAAALAYQCLSHNPKSRPTMTTVVKTLEPILDLKDI 370

Query: 402 APTPKNFVTVVTPEEPKAEIQTKD 425
              P  ++  V       EI+ KD
Sbjct: 371 QNGPFVYIVPVAGVSEVHEIKCKD 394

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  374 bits (959), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 183/305 (60%), Positives = 231/305 (75%), Gaps = 6/305 (1%)

Query: 99  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDN 155
           L +F++ EL+  T NFR D VLG GGFGCV+KG+I E      +P   + +AVK  + D 
Sbjct: 53  LKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDG 112

Query: 156 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-- 213
            +QGH+EWLAEV +LG  SH +LVKLIGYC EDEHR+L+YEFM RGS+EN+LF + L   
Sbjct: 113 -WQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQ 171

Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
           PL W +R+K+A GAAKGLAFLH +E  VIYRDFKTSNILLD++YNAKLSDFGLAKDGP G
Sbjct: 172 PLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIG 231

Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 333
           DKSHVSTR+MGT+GYAAPEY+ TGHLT +SDVYSFGVVLLE+L+GR+++DK+RP+ E+NL
Sbjct: 232 DKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNL 291

Query: 334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            +WA P L  K+K+  +ID RL+  Y ++   K A L+  CL    K RP M ++V  LE
Sbjct: 292 VEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLE 351

Query: 394 PLQVL 398
            +Q L
Sbjct: 352 HIQSL 356

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  373 bits (957), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 179/326 (54%), Positives = 239/326 (73%), Gaps = 9/326 (2%)

Query: 102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDNSYQ 158
           F+  EL+  T NFR D V+G GGFGCV+KG+I E      +P   + +AVK  + +  +Q
Sbjct: 56  FSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQE-GFQ 114

Query: 159 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PLP 216
           GHREWLAE+ +LG L HPNLVKLIGYC E+EHR+L+YEFM RGS+EN+LF +     PL 
Sbjct: 115 GHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLS 174

Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
           W+ R+++A GAA+GLAFLH A+  VIYRDFK SNILLD++YNAKLSDFGLA+DGP GD S
Sbjct: 175 WNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNS 234

Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
           HVSTR+MGT GYAAPEY+ TGHL+ +SDVYSFGVVLLE+L+GR+++DK++P  E NL DW
Sbjct: 235 HVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDW 294

Query: 337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
           A P L  K++LL ++DPRL+G Y +    K A+LA  C++ + K+RP M +IV ++E L 
Sbjct: 295 ARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELH 354

Query: 397 VLPD---EAPTPKNFVTVVTPEEPKA 419
           +  +   E   P+  +  +  + P+A
Sbjct: 355 IQKEASKEQQNPQISIDNIINKSPQA 380

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  369 bits (947), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 177/301 (58%), Positives = 227/301 (75%), Gaps = 4/301 (1%)

Query: 99  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDN 155
           L AFT++EL+  T NFR D +LG GGFG V+KG+I        +P   + VAVK    + 
Sbjct: 68  LKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEG 127

Query: 156 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 215
            YQGH+EWL EV +LG LSHPNLVKL+GYC E E+R+L+YEFM +GS+EN+LF +   PL
Sbjct: 128 -YQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPL 186

Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
            W+IRMK+A GAAKGL FLH+A+  VIYRDFK +NILLD ++N+KLSDFGLAK GP GDK
Sbjct: 187 TWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDK 246

Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 335
           +HVST++MGT+GYAAPEY+ TG LT +SDVYSFGVVLLE+L+GR+++DKS+   EQ+L D
Sbjct: 247 THVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVD 306

Query: 336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
           WA P L +K+KL  I+D RL G YP KG + AA LA  CLN + K RP M +++  L+ L
Sbjct: 307 WATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQL 366

Query: 396 Q 396
           +
Sbjct: 367 E 367

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  366 bits (940), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 176/307 (57%), Positives = 230/307 (74%), Gaps = 6/307 (1%)

Query: 95  AANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVH 151
           ++ P+ +FT++EL++ T NFR D V+G GGFGCV+KG++ E      +P   + +AVK  
Sbjct: 48  SSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKL 107

Query: 152 DGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK- 210
           + +  +QGHREWL E+ +LG LSHPNLVKLIGYC EDEHR+L+YEFM +GS+EN+LF + 
Sbjct: 108 NQEG-FQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRG 166

Query: 211 -VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 269
               PLPW +R+ +A  AAKGLAFLH     VIYRD K SNILLD DYNAKLSDFGLA+D
Sbjct: 167 AYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARD 226

Query: 270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
           GP GD S+VSTR+MGTYGYAAPEY+ +GHL  RSDVYSFGV+LLEIL+G+++LD +RPA+
Sbjct: 227 GPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAK 286

Query: 330 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
           E+NL DWA P L  K+K+L I+D RL+  Y  +   + A +A  CL+  PK+RP M  +V
Sbjct: 287 EENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVV 346

Query: 390 DSLEPLQ 396
            +L+ LQ
Sbjct: 347 RALQQLQ 353

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	429
255564816	385	Protein kinase APK1B, chloroplast precur	0.890	0.992	0.776	0.0
147783438	380	hypothetical protein VITISV_020249 [Viti	0.885	1.0	0.774	0.0
225435796	380	PREDICTED: probable receptor-like protei	0.885	1.0	0.774	0.0
358248287	381	probable receptor-like protein kinase At	0.881	0.992	0.748	1e-179
255636669	381	unknown [Glycine max]	0.881	0.992	0.745	1e-179
356512582	382	PREDICTED: probable receptor-like protei	0.881	0.989	0.732	1e-176
297793143	419	hypothetical protein ARALYDRAFT_331952 [	0.881	0.902	0.734	1e-174
15241220	408	protein kinase family protein [Arabidops	0.878	0.924	0.732	1e-174
449452642	390	PREDICTED: probable receptor-like protei	0.864	0.951	0.761	1e-172
224052859	371	predicted protein [Populus trichocarpa]	0.820	0.948	0.746	1e-171

>gi|255564816|ref|XP_002523402.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223537352|gb|EEF38981.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  667 bits (1722), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/425 (77%), Positives = 357/425 (84%), Gaps = 43/425 (10%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNCWC+WEPS+Y VSSN KS                                       
Sbjct: 1   MGNCWCRWEPSIYRVSSNAKS--------------------------------------- 21

Query: 61  KESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 120
            ESPK ESPS K + +  KLPSNPEEVEDLRRDSAANPL+AFTYDEL+IIT NFRQDR+L
Sbjct: 22  -ESPKCESPSGKPRNDDRKLPSNPEEVEDLRRDSAANPLVAFTYDELKIITGNFRQDRLL 80

Query: 121 GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           GGGGFG VYKGFI+E+LREGL+P+PVAVKVHDGDNSYQGHREWLAEVIFLG LSHPNLVK
Sbjct: 81  GGGGFGSVYKGFITEELREGLEPLPVAVKVHDGDNSYQGHREWLAEVIFLGQLSHPNLVK 140

Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIGYCCEDEHRVLIYE+MARGSVENNLFS+VLLPLPW +RMKIAFGAAKGLAFLHEAEKP
Sbjct: 141 LIGYCCEDEHRVLIYEYMARGSVENNLFSRVLLPLPWYVRMKIAFGAAKGLAFLHEAEKP 200

Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
           VIYRDFKTSNILLD +YNAKLSDFGLAKDGP GDK+HVSTRIMGTYGYAAPEYIMTGHLT
Sbjct: 201 VIYRDFKTSNILLDVEYNAKLSDFGLAKDGPMGDKTHVSTRIMGTYGYAAPEYIMTGHLT 260

Query: 301 PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP 360
           PRSDVYSFGVVLLE+LTGRKSLDKS PAREQNLADWALPLLKEKKK+LNIIDPRLEGDYP
Sbjct: 261 PRSDVYSFGVVLLELLTGRKSLDKSLPAREQNLADWALPLLKEKKKILNIIDPRLEGDYP 320

Query: 361 VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAE 420
           +KGVHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQ+ P+EA   K+  TV++  +   E
Sbjct: 321 IKGVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQI-PEEASNGKSVFTVISVSD--GE 377

Query: 421 IQTKD 425
           I+ K+
Sbjct: 378 IKRKE 382

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147783438|emb|CAN77488.1| hypothetical protein VITISV_020249 [Vitis vinifera]

 Score =  661 bits (1706), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/421 (77%), Positives = 349/421 (82%), Gaps = 41/421 (9%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNCWC+W+PS+Y VSSN KS                                       
Sbjct: 1   MGNCWCRWKPSIYRVSSNAKS--------------------------------------- 21

Query: 61  KESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 120
            ESPKD+SPS K  K+  KLPSNPEEVEDLRRDSAANPLI FT++EL+ IT NFRQD VL
Sbjct: 22  -ESPKDQSPSVKPMKDIRKLPSNPEEVEDLRRDSAANPLIVFTFNELKQITGNFRQDYVL 80

Query: 121 GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           GGGGFG VYKGF++EDL EG QP+PVAVKVHDGDNS+QGHREWLAEVIFLG LSHPNLVK
Sbjct: 81  GGGGFGSVYKGFVTEDLMEGHQPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVK 140

Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIGYCCEDEHRVL+YE+MARGSVENNLFS+VLLPL W IRMKIAFGAAKGLAFLH+AEKP
Sbjct: 141 LIGYCCEDEHRVLVYEYMARGSVENNLFSRVLLPLSWYIRMKIAFGAAKGLAFLHDAEKP 200

Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
           VIYRDFKTSNILLD DYN KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL+
Sbjct: 201 VIYRDFKTSNILLDLDYNPKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLS 260

Query: 301 PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP 360
           PRSDVYSFGVVLLE+LTGRKSLDKSRPAREQNL DWALPLL+EKKKLLNIIDPRLEGDYP
Sbjct: 261 PRSDVYSFGVVLLELLTGRKSLDKSRPAREQNLTDWALPLLREKKKLLNIIDPRLEGDYP 320

Query: 361 VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAE 420
           VKGVHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQV  D +P  + F TV+T E P A 
Sbjct: 321 VKGVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQVATDVSPDKQTF-TVITNEVPNAA 379

Query: 421 I 421
           +
Sbjct: 380 V 380

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225435796|ref|XP_002285747.1| PREDICTED: probable receptor-like protein kinase At5g56460 [Vitis vinifera]

 Score =  660 bits (1704), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/421 (77%), Positives = 349/421 (82%), Gaps = 41/421 (9%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNCWC+W+PS+Y VSSN KS                                       
Sbjct: 1   MGNCWCRWKPSIYRVSSNAKS--------------------------------------- 21

Query: 61  KESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 120
            ESPKD+SPS K  K+  KLPSNPEEVEDLRRDSAANPLI FT++EL+ IT NFRQD VL
Sbjct: 22  -ESPKDQSPSVKPMKDIRKLPSNPEEVEDLRRDSAANPLIVFTFNELKQITGNFRQDYVL 80

Query: 121 GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           GGGGFG VYKGF++EDL EGLQP+PVAVKVHDGDNS+QGHREWLAEVIFLG LSHPNLVK
Sbjct: 81  GGGGFGSVYKGFVTEDLMEGLQPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVK 140

Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIGY CEDEHRVL+YE+MARGSVENNLFS+VLLPL W IRMKIAFGAAKGLAFLH+AEKP
Sbjct: 141 LIGYGCEDEHRVLVYEYMARGSVENNLFSRVLLPLSWYIRMKIAFGAAKGLAFLHDAEKP 200

Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
           VIYRDFKTSNILLD DYN KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL+
Sbjct: 201 VIYRDFKTSNILLDLDYNPKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLS 260

Query: 301 PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP 360
           PRSDVYSFGVVLLE+LTGRKSLDKSRPAREQNL DWALPLL+EKKKLLNIIDPRLEGDYP
Sbjct: 261 PRSDVYSFGVVLLELLTGRKSLDKSRPAREQNLTDWALPLLREKKKLLNIIDPRLEGDYP 320

Query: 361 VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAE 420
           VKGVHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQV  D +P  + F TV+T E P A 
Sbjct: 321 VKGVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQVATDVSPDKQTF-TVITNEVPNAA 379

Query: 421 I 421
           +
Sbjct: 380 V 380

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358248287|ref|NP_001239855.1| probable receptor-like protein kinase At5g56460-like [Glycine max] gi|223452321|gb|ACM89488.1| protein kinase [Glycine max]

 Score =  635 bits (1638), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 318/425 (74%), Positives = 342/425 (80%), Gaps = 47/425 (11%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNCWC+WE S Y VSSN KS+   G                                  
Sbjct: 1   MGNCWCRWESSEYRVSSNVKSEQNQG---------------------------------- 26

Query: 61  KESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 120
                      K + + SKLPSNPEEVEDLRRDSAANPLIAFTYDEL+IITANFRQDRVL
Sbjct: 27  ----------TKQRHDDSKLPSNPEEVEDLRRDSAANPLIAFTYDELKIITANFRQDRVL 76

Query: 121 GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           GGGGFG VYKGFISE+LREGL  + VAVKVHDGDNS+QGHREWLAEVIFLG LSHPNLVK
Sbjct: 77  GGGGFGRVYKGFISEELREGLPTLAVAVKVHDGDNSHQGHREWLAEVIFLGQLSHPNLVK 136

Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIGYCCEDEHRVLIYE+M+RGSVE+NLFSK+LLPLPWSIRMKIAFGAAKGLAFLHEAEKP
Sbjct: 137 LIGYCCEDEHRVLIYEYMSRGSVEHNLFSKILLPLPWSIRMKIAFGAAKGLAFLHEAEKP 196

Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
           VIYRDFKTSNILLD +YN+KLSDFGLAKDGP GDKSHVSTR+MGTYGYAAPEYIMTGHLT
Sbjct: 197 VIYRDFKTSNILLDQEYNSKLSDFGLAKDGPVGDKSHVSTRVMGTYGYAAPEYIMTGHLT 256

Query: 301 PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP 360
           PRSDVYSFGVVLLE+LTGRKSLDK RPAREQNLA+WALPLLKEKKK LNIIDPRL+GDYP
Sbjct: 257 PRSDVYSFGVVLLELLTGRKSLDKLRPAREQNLAEWALPLLKEKKKFLNIIDPRLDGDYP 316

Query: 361 VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAE 420
           +K VHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQ    E P  K     +  E P++ 
Sbjct: 317 IKAVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQA-HTEVPIGKTL--TIISEVPESG 373

Query: 421 IQTKD 425
           ++ KD
Sbjct: 374 LKMKD 378

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255636669|gb|ACU18671.1| unknown [Glycine max]

 Score =  632 bits (1631), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 317/425 (74%), Positives = 341/425 (80%), Gaps = 47/425 (11%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNCWC+WE S Y VSSN KS+   G                                  
Sbjct: 1   MGNCWCRWESSEYRVSSNVKSEQNQG---------------------------------- 26

Query: 61  KESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 120
                      K + + SKLPSNPEEVEDLRRDSAANPLIAFTY EL+IITANFRQDRVL
Sbjct: 27  ----------TKQRHDDSKLPSNPEEVEDLRRDSAANPLIAFTYGELKIITANFRQDRVL 76

Query: 121 GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           GGGGFG VYKGFISE+LREGL  + VAVKVHDGDNS+QGHREWLAEVIFLG LSHPNLVK
Sbjct: 77  GGGGFGRVYKGFISEELREGLPTLAVAVKVHDGDNSHQGHREWLAEVIFLGQLSHPNLVK 136

Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIGYCCEDEHRVLIYE+M+RGSVE+NLFSK+LLPLPWSIRMKIAFGAAKGLAFLHEAEKP
Sbjct: 137 LIGYCCEDEHRVLIYEYMSRGSVEHNLFSKILLPLPWSIRMKIAFGAAKGLAFLHEAEKP 196

Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
           VIYRDFKTSNILLD +YN+KLSDFGLAKDGP GDKSHVSTR+MGTYGYAAPEYIMTGHLT
Sbjct: 197 VIYRDFKTSNILLDQEYNSKLSDFGLAKDGPVGDKSHVSTRVMGTYGYAAPEYIMTGHLT 256

Query: 301 PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP 360
           PRSDVYSFGVVLLE+LTGRKSLDK RPAREQNLA+WALPLLKEKKK LNIIDPRL+GDYP
Sbjct: 257 PRSDVYSFGVVLLELLTGRKSLDKLRPAREQNLAEWALPLLKEKKKFLNIIDPRLDGDYP 316

Query: 361 VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAE 420
           +K VHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQ    E P  K     +  E P++ 
Sbjct: 317 IKAVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQA-HTEVPIGKTL--TIISEVPESG 373

Query: 421 IQTKD 425
           ++ KD
Sbjct: 374 LKMKD 378

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356512582|ref|XP_003524997.1| PREDICTED: probable receptor-like protein kinase At5g56460-like [Glycine max]

 Score =  623 bits (1606), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 312/426 (73%), Positives = 340/426 (79%), Gaps = 48/426 (11%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNCWC+W+ S Y VSSN KS+   G                                  
Sbjct: 1   MGNCWCRWKSSEYRVSSNVKSEQNQG---------------------------------- 26

Query: 61  KESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 120
                      K + + SKLPSNPEEVEDLRRD+AANPLIAFTYDEL+I+TANFR DRVL
Sbjct: 27  ----------TKQRHDDSKLPSNPEEVEDLRRDTAANPLIAFTYDELKIVTANFRPDRVL 76

Query: 121 GGGGFGCVYKGFISEDL-REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           GGGGFG VYKGFISE+L R+GL  + VAVKVHDGDNS+QGHREWLAEVIFLG LSHPNLV
Sbjct: 77  GGGGFGSVYKGFISEELIRQGLPTLAVAVKVHDGDNSHQGHREWLAEVIFLGQLSHPNLV 136

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           KLIGYCCEDEHRVLIYE+M+RGSVE+NLFSK+LLP+PWS RMKIAFGAAKGLAFLHEA+K
Sbjct: 137 KLIGYCCEDEHRVLIYEYMSRGSVEHNLFSKILLPMPWSTRMKIAFGAAKGLAFLHEADK 196

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           PVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDKSHVSTR+MGTYGYAAPEYIMTGHL
Sbjct: 197 PVIYRDFKTSNILLDQDYNAKLSDFGLAKDGPVGDKSHVSTRVMGTYGYAAPEYIMTGHL 256

Query: 300 TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDY 359
           TPRSDVYSFGVVLLE+LTGRKSLDK RPAREQNLA+WALPLLKEKKK LNIIDPRL+GDY
Sbjct: 257 TPRSDVYSFGVVLLELLTGRKSLDKLRPAREQNLAEWALPLLKEKKKFLNIIDPRLDGDY 316

Query: 360 PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKA 419
           P+K VHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQ    E P  K     +  E P++
Sbjct: 317 PIKAVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQA-HTEVPIGKTL--TIISEVPES 373

Query: 420 EIQTKD 425
            ++ KD
Sbjct: 374 GLKMKD 379

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297793143|ref|XP_002864456.1| hypothetical protein ARALYDRAFT_331952 [Arabidopsis lyrata subsp. lyrata] gi|297310291|gb|EFH40715.1| hypothetical protein ARALYDRAFT_331952 [Arabidopsis lyrata subsp. lyrata]

 Score =  619 bits (1596), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 312/425 (73%), Positives = 340/425 (80%), Gaps = 47/425 (11%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNCWC++EP  + VS+N KS                                       
Sbjct: 1   MGNCWCRFEPLNHRVSANAKS--------------------------------------- 21

Query: 61  KESPKDESPS--EKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDR 118
            ESPK++SP+  +K  KE  KLPSNP+EVEDLRRDSAANPLIAFTY+EL+ IT NFRQDR
Sbjct: 22  -ESPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANPLIAFTYEELKNITGNFRQDR 80

Query: 119 VLGGGGFGCVYKGFISEDL--REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           VLGGGGFG VYKGFI EDL  ++  QP+PVAVKVHDGDNS+QGHREWLAEVIFLG LSHP
Sbjct: 81  VLGGGGFGSVYKGFIKEDLGDQDVPQPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHP 140

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
           NLVKLIGYCCED HRVLIYE+MARGSVENNLFS+VLLPL W+IRMKIAFGAAKGLAFLHE
Sbjct: 141 NLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHE 200

Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT 296
           A+KPVIYRDFKTSNILLD +YNAKLSDFGLAKDGP GDKSHVSTRIMGTYGYAAPEYIMT
Sbjct: 201 AKKPVIYRDFKTSNILLDMEYNAKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMT 260

Query: 297 GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE 356
           GHLTP SDVYSFGVVLLE+LTGRKSLDKSRP REQNL DWALPLLKEKKK+LNI+DPR+ 
Sbjct: 261 GHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPRMN 320

Query: 357 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA---PTPKNFVTVVT 413
            +YPVK V KAAMLAYHCLN NPKARPLMRDIVDSLEPLQ   +EA   PT +  V  + 
Sbjct: 321 CEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEEEALLVPTVQKAVVTII 380

Query: 414 PEEPK 418
            E PK
Sbjct: 381 DEMPK 385

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15241220|ref|NP_200457.1| protein kinase family protein [Arabidopsis thaliana] gi|75334057|sp|Q9FM85.1|Y5564_ARATH RecName: Full=Probable receptor-like protein kinase At5g56460 gi|10177845|dbj|BAB11274.1| protein kinase-like protein [Arabidopsis thaliana] gi|22135984|gb|AAM91574.1| protein kinase-like protein [Arabidopsis thaliana] gi|30725688|gb|AAP37866.1| At5g56460 [Arabidopsis thaliana] gi|332009386|gb|AED96769.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  617 bits (1591), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 312/426 (73%), Positives = 342/426 (80%), Gaps = 49/426 (11%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNCWC++EP  + VS+N KS                                       
Sbjct: 1   MGNCWCRFEPLNHRVSANAKS--------------------------------------- 21

Query: 61  KESPKDESPS--EKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDR 118
            ESPK++SP+  +K  KE  KLPSNP+EVEDLRRDSAANPLIAFTY+EL+ IT+NFRQDR
Sbjct: 22  -ESPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANPLIAFTYEELKNITSNFRQDR 80

Query: 119 VLGGGGFGCVYKGFISEDL--REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           VLGGGGFG VYKGFI EDL  +E  +P+PVAVKVHDGDNS+QGHREWLAEVIFLG LSHP
Sbjct: 81  VLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHP 140

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
           NLVKLIGYCCED HRVLIYE+MARGSVENNLFS+VLLPL W+IRMKIAFGAAKGLAFLHE
Sbjct: 141 NLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHE 200

Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT 296
           A+KPVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDKSHVSTRIMGTYGYAAPEYIMT
Sbjct: 201 AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMT 260

Query: 297 GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE 356
           GHLTP SDVYSFGVVLLE+LTGRKSLDKSRP REQNL DWALPLLKEKKK+LNI+DP++ 
Sbjct: 261 GHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMN 320

Query: 357 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA----PTPKNFVTVV 412
            +YPVK V KAAMLAYHCLN NPKARPLMRDIVDSLEPLQ   +EA    P  K  +T++
Sbjct: 321 CEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEEEALLVPPVQKAVITII 380

Query: 413 TPEEPK 418
             E PK
Sbjct: 381 D-EMPK 385

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452642|ref|XP_004144068.1| PREDICTED: probable receptor-like protein kinase At5g56460-like [Cucumis sativus] gi|449493564|ref|XP_004159351.1| PREDICTED: probable receptor-like protein kinase At5g56460-like [Cucumis sativus]

 Score =  610 bits (1573), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 313/411 (76%), Positives = 333/411 (81%), Gaps = 40/411 (9%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNCW +WEP+V  VSSN KS                                       
Sbjct: 1   MGNCWYRWEPTVNRVSSNAKS--------------------------------------- 21

Query: 61  KESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 120
            ESPK ES S   +     LPSNP+EVEDLRRDSA NPLIAFT+DEL++IT NFRQDRVL
Sbjct: 22  -ESPKVESTSPYTRNNEHNLPSNPKEVEDLRRDSATNPLIAFTFDELKLITGNFRQDRVL 80

Query: 121 GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           GGGGFG VYKGFI+EDLREG+ P+PVAVKVHDG NSYQGHREWLAEVIFLG LSHPNLVK
Sbjct: 81  GGGGFGSVYKGFITEDLREGIVPLPVAVKVHDGFNSYQGHREWLAEVIFLGQLSHPNLVK 140

Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIGYCCEDEHRVLIYE+M RGSVENNLFS+VLLPLPWSIRMKIAFGAAKGLAFLHEAEKP
Sbjct: 141 LIGYCCEDEHRVLIYEYMPRGSVENNLFSRVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200

Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
           VIYRDFKTSNILLD+DYN KLSDFGLAKDGP GDKSHVSTRIMGTYGYAAPEYI+TGHLT
Sbjct: 201 VIYRDFKTSNILLDSDYNPKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYILTGHLT 260

Query: 301 PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP 360
           PRSDVYSFGVVLLE+LTGRKSLDK RPAREQNL DWALPLLKEKKKL+ I+DPRL G+YP
Sbjct: 261 PRSDVYSFGVVLLELLTGRKSLDKLRPAREQNLTDWALPLLKEKKKLMTIVDPRLGGEYP 320

Query: 361 VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTV 411
           VKG HKAAMLAYHCLN NPKARPLMRDIVDSLEPLQ   DEA  P    ++
Sbjct: 321 VKGFHKAAMLAYHCLNKNPKARPLMRDIVDSLEPLQETIDEAVAPSETTSL 371

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224052859|ref|XP_002297616.1| predicted protein [Populus trichocarpa] gi|222844874|gb|EEE82421.1| predicted protein [Populus trichocarpa]

 Score =  609 bits (1570), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 307/411 (74%), Positives = 328/411 (79%), Gaps = 59/411 (14%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSDSFVGFFILDIPFLFCKLMKKTEMKKVQSFFQFQSISHC 60
           MGNC C+WE SVY    N KS                                       
Sbjct: 1   MGNCCCRWELSVY----NAKS--------------------------------------- 17

Query: 61  KESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 120
             SPK++SPS +  ++  KLPSNPEEVEDLRRDSAANPLIAFT+DEL++IT NFRQD +L
Sbjct: 18  -VSPKEQSPSGRPIQDDRKLPSNPEEVEDLRRDSAANPLIAFTFDELKLITENFRQDHLL 76

Query: 121 GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           GGGGFG VYKG I++D RE LQP+ VAVKVHDGDNSYQGHREWLAEVIFLG LSHPNLVK
Sbjct: 77  GGGGFGSVYKGIIAKDSREELQPLQVAVKVHDGDNSYQGHREWLAEVIFLGQLSHPNLVK 136

Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIGYCC+DEHRVLIYE+MARGSVENNLFS+VLLPLPWSIRMKIAFGAAKGLAFLHEAEKP
Sbjct: 137 LIGYCCQDEHRVLIYEYMARGSVENNLFSRVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 196

Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---- 296
           VIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDK+HVSTRIMGTYGYAAPEYIMT    
Sbjct: 197 VIYRDFKTSNILLDQDYNAKLSDFGLAKDGPMGDKTHVSTRIMGTYGYAAPEYIMTGNKL 256

Query: 297 -----------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 345
                      GHLTPRSDVYSFGVVLLE+LTGRKSLDKSRP REQNL DWALPLLKEK+
Sbjct: 257 GLIHCLSNFHSGHLTPRSDVYSFGVVLLELLTGRKSLDKSRPGREQNLTDWALPLLKEKR 316

Query: 346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
           KLLNI+DPRLEGDYP+KG  KAAMLAYHCLN NPKARPLMRDIVDSLEPLQ
Sbjct: 317 KLLNIVDPRLEGDYPIKGFQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQ 367

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	429
TAIR|locus:2161093	408	AT5G56460 [Arabidopsis thalian	0.829	0.872	0.775	5.6e-154
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.766	0.802	0.635	5.5e-109
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.836	0.777	0.564	8.8e-102
TAIR|locus:2157101	494	AT5G35580 [Arabidopsis thalian	0.801	0.696	0.556	8.6e-100
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.731	0.693	0.593	5.8e-98
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.804	0.699	0.550	2.5e-97
TAIR|locus:2057770	424	ARSK1 "root-specific kinase 1"	0.734	0.742	0.589	8.4e-97
TAIR|locus:2060167	442	AT2G07180 [Arabidopsis thalian	0.736	0.714	0.577	1.4e-96
TAIR|locus:2200863	424	AT1G61590 [Arabidopsis thalian	0.783	0.792	0.548	3.3e-95
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.717	0.628	0.582	1.3e-93

TAIR|locus:2161093 AT5G56460 [Arabidopsis thaliana (taxid:3702)]

 Score = 1439 (511.6 bits), Expect = 5.6e-154, Sum P(2) = 5.6e-154
 Identities = 283/365 (77%), Positives = 308/365 (84%)

Query:    62 ESPKDESPSEKAK--KEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRV 119
             ESPK++SP+ + K  KE  KLPSNP+EVEDLRRDSAANPLIAFTY+EL+ IT+NFRQDRV
Sbjct:    22 ESPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANPLIAFTYEELKNITSNFRQDRV 81

Query:   120 LXXXXXXCVYKGFISEDL--REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
             L       VYKGFI EDL  +E  +P+PVAVKVHDGDNS+QGHREWLAEVIFLG LSHPN
Sbjct:    82 LGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPN 141

Query:   178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
             LVKLIGYCCED HRVLIYE+MARGSVENNLFS+VLLPL W+IRMKIAFGAAKGLAFLHEA
Sbjct:   142 LVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHEA 201

Query:   238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG 297
             +KPVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDKSHVSTRIMGTYGYAAPEYIMTG
Sbjct:   202 KKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTG 261

Query:   298 HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEG 357
             HLTP SDVYSFGVVLLE+LTGRKSLDKSRP REQNL DWA           NI+DP++  
Sbjct:   262 HLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNC 321

Query:   358 DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA----PTPKNFVTVVT 413
             +YPVK V KAAMLAYHCLN NPKARPLMRDIVDSLEPLQ   +EA    P  K  +T++ 
Sbjct:   322 EYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEEEALLVPPVQKAVITIID 381

Query:   414 PEEPK 418
              E PK
Sbjct:   382 -EMPK 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1077 (384.2 bits), Expect = 5.5e-109, P = 5.5e-109
 Identities = 211/332 (63%), Positives = 248/332 (74%)

Query:    71 EKAKKEYSKL--PSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCV 128
             +K  +  S L  PS P   +D R   +   +I FT  EL  IT +FR D +L       V
Sbjct:    24 KKHSRSVSDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTV 83

Query:   129 YKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED 188
             YKG+I ++LR GL+ +PVAVKV + +   QGHREWL EV FLG L HPNLVKLIGYCCED
Sbjct:    84 YKGYIDDNLRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED 142

Query:   189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKT 248
             +HR+L+YEFM RGS+EN+LF K   PL WS RM IA GAAKGLAFLH AE+PVIYRDFKT
Sbjct:   143 DHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKT 202

Query:   249 SNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSF 308
             SNILLD+DY AKLSDFGLAK GP+GD++HVSTR+MGTYGYAAPEY+MTGHLT RSDVYSF
Sbjct:   203 SNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSF 262

Query:   309 GVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAA 368
             GVVLLE+LTGRKS+DK+RP++EQNL DWA            IIDPRLE  Y V+   KA 
Sbjct:   263 GVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKAC 322

Query:   369 MLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD 400
              LAY+CL+ NPKARPLM D+V++LEPLQ   D
Sbjct:   323 SLAYYCLSQNPKARPLMSDVVETLEPLQCTGD 354

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1009 (360.2 bits), Expect = 8.8e-102, P = 8.8e-102
 Identities = 209/370 (56%), Positives = 243/370 (65%)

Query:    55 QSISHCKESPKDESPSEKAKKEYSKLP----SNPEE---VEDLRRDSAANPLIAFTYDEL 107
             +++    + PK ++   K +  + +L     SNP      EDL    A + L  FT  EL
Sbjct:    21 ETLMASSKKPKRKNDVIKKQSSFQRLSILDMSNPSSNTLSEDLSISLAGSDLHVFTLAEL 80

Query:   108 RIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 167
             ++IT +F     L       V+KGFI + LR GL+  PVAVK+ D +   QGHREWL EV
Sbjct:    81 KVITQSFSSTNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLEG-LQGHREWLTEV 139

Query:   168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA 227
             +FLG L H NLVKLIGYCCE+EHR L+YEFM RGS+EN LF +    LPWS RMKIA GA
Sbjct:   140 MFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQLFRRYSASLPWSTRMKIAHGA 199

Query:   228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
             A GL FLHEAE PVIYRDFK SNILLD+DY AKLSDFGLAKDGPEGD +HVSTR+MGT G
Sbjct:   200 ATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 259

Query:   288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXX 347
             YAAPEYIMTGHLT RSDVYSFGVVLLE+LTGR+S+DK R +REQNL DWA          
Sbjct:   260 YAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSSREQNLVDWARPMLNDPRKL 319

Query:   348 XNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKN 407
               I+DPRLEG Y   G  KAA LAY CL+H PK RP M  +V  L  L+   D    P  
Sbjct:   320 SRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVVSILNDLK---DYNDIPMG 376

Query:   408 FVTVVTPEEP 417
               T   P  P
Sbjct:   377 TFTYTVPNTP 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2157101 AT5G35580 [Arabidopsis thaliana (taxid:3702)]

 Score = 973 (347.6 bits), Expect = 8.6e-100, Sum P(2) = 8.6e-100
 Identities = 193/347 (55%), Positives = 238/347 (68%)

Query:    81 PSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREG 140
             PS+    EDL    A + L  FT  ELR+IT +F     L       V+KGFI + LR G
Sbjct:    43 PSSTTLSEDLSISLAGSDLHVFTQAELRVITQSFSSSNFLGEGGFGPVHKGFIDDKLRPG 102

Query:   141 LQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMAR 200
             L+  PVAVK+ D D   QGHRE++ EV+ LG L HPNLVKLIGYCCE+ HR+L+YEFM R
Sbjct:   103 LKAQPVAVKLLDLDG-LQGHREFMTEVMCLGKLKHPNLVKLIGYCCEEAHRLLVYEFMPR 161

Query:   201 GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 260
             GS+E+ LF +  LPLPW+ R+ IA+ AAKGL FLHEAEKP+IYRDFK SNILLD+DY AK
Sbjct:   162 GSLESQLFRRCSLPLPWTTRLNIAYEAAKGLQFLHEAEKPIIYRDFKASNILLDSDYTAK 221

Query:   261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK 320
             LSDFGLAKDGP+GD +HVSTR+MGT GYAAPEYIMTGHLT +SDVYSFGVVLLE+LTGRK
Sbjct:   222 LSDFGLAKDGPQGDDTHVSTRVMGTQGYAAPEYIMTGHLTAKSDVYSFGVVLLELLTGRK 281

Query:   321 SLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPK 380
             S+D +R +R++ L +WA            I+DPRLE  Y   G  KAA LAY CL + PK
Sbjct:   282 SVDIARSSRKETLVEWARPMLNDARKLGRIMDPRLEDQYSETGARKAATLAYQCLRYRPK 341

Query:   381 ARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQ 427
              RP +  +V  L+ ++   D+ P      T   P +P+ E++    Q
Sbjct:   342 TRPDISTVVSVLQDIKDYKDDIPI--GIFTYTVPTKPRREVKETSLQ 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
 Identities = 190/320 (59%), Positives = 240/320 (75%)

Query:    96 ANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQP---VPVAVKVHD 152
             ++ L  F +++L++ T NFR + +L      CV+KG+I E+    ++P   + VAVK  +
Sbjct:    85 SSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 144

Query:   153 GDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL 212
              D   QGH+EWLAE+ FLG+L HP+LVKL+GYC E++ R+L+YEFM RGS+EN+LF + L
Sbjct:   145 PDG-LQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRRTL 203

Query:   213 LPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 271
              PLPWS+RMKIA GAAKGLAFLHE AEKPVIYRDFKTSNILLD +YNAKLSDFGLAKD P
Sbjct:   204 -PLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAP 262

Query:   272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 331
             +  KSHVSTR+MGTYGYAAPEY+MTGHLT +SDVYSFGVVLLEILTGR+S+DKSRP  EQ
Sbjct:   263 DEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQ 322

Query:   332 NLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS 391
             NL +W             ++DPRLEG Y +KG  KA  +A  CLN + KARP M ++V++
Sbjct:   323 NLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEA 382

Query:   392 LEPLQVLPDEAPTPKNFVTV 411
             L+PL  L D A +  +F T+
Sbjct:   383 LKPLPNLKDFASSSSSFQTM 402

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 967 (345.5 bits), Expect = 2.5e-97, P = 2.5e-97
 Identities = 195/354 (55%), Positives = 248/354 (70%)

Query:    62 ESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLX 121
             + P  +  S           S P   E+L   + ++ L  FT+++L++ T NFR + +L 
Sbjct:    93 DQPVGQVSSTTTTSNAESSSSTPVISEEL---NISSHLRKFTFNDLKLSTRNFRPESLLG 149

Query:   122 XXXXXCVYKGFISEDLREGLQP---VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
                  CV+KG+I E+    ++P   + VAVK  + D   QGH+EWLAE+ FLG+L HPNL
Sbjct:   150 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDG-LQGHKEWLAEINFLGNLLHPNL 208

Query:   179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-A 237
             VKL+GYC ED+ R+L+YEFM RGS+EN+LF + L PLPWSIRMKIA GAAKGL+FLHE A
Sbjct:   209 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLSFLHEEA 267

Query:   238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG 297
              KPVIYRDFKTSNILLD DYNAKLSDFGLAKD P+  K+HVSTR+MGTYGYAAPEY+MTG
Sbjct:   268 LKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTG 327

Query:   298 HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEG 357
             HLT +SDVYSFGVVLLE+LTGR+S+DK+RP  E NL +WA            ++DPRLEG
Sbjct:   328 HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEG 387

Query:   358 DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTV 411
              + +KG  K   LA  CL+ +PK RP M D+V++L+PL  L D A +   F T+
Sbjct:   388 HFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTM 441

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 962 (343.7 bits), Expect = 8.4e-97, P = 8.4e-97
 Identities = 187/317 (58%), Positives = 232/317 (73%)

Query:    81 PSNPEEV-EDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLRE 139
             PS+P  V +DL     +  L  FT  ELR+IT NF +  +L       VYKGFI + ++ 
Sbjct:    54 PSSPMSVMDDLSHSFTSQKLRLFTLSELRVITHNFSRSNMLGEGGFGPVYKGFIDDKVKP 113

Query:   140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
             G++  PVAVK  D  + +QGHREWLAE++FLG LS+ +LVKLIG+CCE+E RVL+YE+M 
Sbjct:   114 GIEAQPVAVKALDL-HGHQGHREWLAEILFLGQLSNKHLVKLIGFCCEEEQRVLVYEYMP 172

Query:   200 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
             RGS+EN LF +  L + W IRMKIA GAAKGLAFLHEAEKPVIYRDFKTSNILLD+DYNA
Sbjct:   173 RGSLENQLFRRNSLAMAWGIRMKIALGAAKGLAFLHEAEKPVIYRDFKTSNILLDSDYNA 232

Query:   260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             KLSDFGLAKDGPEG+ +HV+TR+MGT GYAAPEYIMTGHLT  +DVYSFGVVLLE++TG+
Sbjct:   233 KLSDFGLAKDGPEGEHTHVTTRVMGTQGYAAPEYIMTGHLTTMNDVYSFGVVLLELITGK 292

Query:   320 KSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP 379
             +S+D +R  REQ+L +WA            IIDPRL   +  +    AA LAY CL+ +P
Sbjct:   293 RSMDNTRTRREQSLVEWARPMLRDQRKLERIIDPRLANQHKTEAAQVAASLAYKCLSQHP 352

Query:   380 KARPLMRDIVDSLEPLQ 396
             K RP M ++V  LE +Q
Sbjct:   353 KYRPTMCEVVKVLESIQ 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2060167 AT2G07180 [Arabidopsis thaliana (taxid:3702)]

 Score = 960 (343.0 bits), Expect = 1.4e-96, P = 1.4e-96
 Identities = 183/317 (57%), Positives = 229/317 (72%)

Query:    80 LPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLRE 139
             LP  P+ ++DL+ +     +  FTY+E++I T  FR D +L       VYKG I E +R 
Sbjct:    56 LPLAPKNIKDLQSNPGYENVDIFTYEEMKIATKQFRPDYILGEGGFGVVYKGVIDESVRV 115

Query:   140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
             G +   VA+K  + +  +QG REWLAEV +LG LSHPNLVKLIGYCCED+HR+L+YE+MA
Sbjct:   116 GFKSTKVAIKELNPEG-FQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMA 174

Query:   200 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
              GS+E +LF +V   L W+ RMKIA  AAKGLAFLH AE+ +IYRD KT+NILLD  YNA
Sbjct:   175 MGSLEKHLFRRVGCTLTWTKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNA 234

Query:   260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             KLSDFGLAKDGP GD++HVSTR+MGTYGYAAPEY+MTGHLT RSDVY FGV+LLE+L G+
Sbjct:   235 KLSDFGLAKDGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGK 294

Query:   320 KSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP 379
             +++DKSR  RE NL +WA            IIDPR++G Y  K + K A LAY CL+ NP
Sbjct:   295 RAMDKSRACREHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNP 354

Query:   380 KARPLMRDIVDSLEPLQ 396
             K RPLM  +V+ LE L+
Sbjct:   355 KGRPLMNHVVEVLETLK 371

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)]

 Score = 947 (338.4 bits), Expect = 3.3e-95, P = 3.3e-95
 Identities = 194/354 (54%), Positives = 244/354 (68%)

Query:    54 FQSISHCKESPKDESPSEKAKKEYSKLPSNPE-EVEDLRRDSAAN-----------PLIA 101
             F ++S C+  P   S SE +K     LPS       DL R S+A             L+ 
Sbjct:    32 FGNLSRCR--P---SRSEFSKNHLGPLPSFRRLSFADLSRSSSARINEDLAQTLGADLVD 86

Query:   102 FTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 161
             F   EL++IT +F  + +L       VYKG++ + LR+ L+  PVAVK+ D +   QGHR
Sbjct:    87 FQMCELKMITQSFSGNYLLGEGGFGKVYKGYVDDYLRQSLKAQPVAVKLLDIEG-LQGHR 145

Query:   162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
             EWL+EVIFLG L HPNLVKLIGYCCE+E RVLIYEFM RGS+EN+LF ++ L LPW+ R+
Sbjct:   146 EWLSEVIFLGQLKHPNLVKLIGYCCEEEERVLIYEFMPRGSLENHLFRRISLSLPWATRL 205

Query:   222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             KIA  AAKGLAFLH+ E P+IYRDFKTSNILLD+D+ AKLSDFGLAK GPEG KSHV+TR
Sbjct:   206 KIAVAAAKGLAFLHDLESPIIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSKSHVTTR 265

Query:   282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXX 341
             +MGTYGYAAPEY+ TGHLT +SDVYS+GVVLLE+LTGR++ +KSRP  +QN+ DW+    
Sbjct:   266 VMGTYGYAAPEYVSTGHLTTKSDVYSYGVVLLELLTGRRATEKSRPKNQQNIIDWSKPYL 325

Query:   342 XXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
                     ++DPRL G Y VK     A+LA  C++ NPK RP M  +V++LE L
Sbjct:   326 TSSRRLRCVMDPRLAGQYSVKAAKDTALLALQCVSPNPKDRPKMLAVVEALESL 379

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 932 (333.1 bits), Expect = 1.3e-93, P = 1.3e-93
 Identities = 183/314 (58%), Positives = 231/314 (73%)

Query:   102 FTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQP---VPVAVKVHDGDNSYQ 158
             F++ +L++ T NFR + +L      CV+KG++ E+    ++P   + VAVK  + D   Q
Sbjct:   124 FSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDG-LQ 182

Query:   159 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS 218
             GH+EWLAE+ +LG+L HPNLVKL+GYC ED+ R+L+YEFM RGS+EN+LF + L PLPWS
Sbjct:   183 GHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWS 241

Query:   219 IRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
             IRMKIA GAAKGL+FLHE A KPVIYRDFKTSNILLD +YNAKLSDFGLAKD P+  K+H
Sbjct:   242 IRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTH 301

Query:   278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 337
             VSTR+MGTYGYAAPEY+MTGHLT +SDVYSFGVVLLE+LTGR+S+DK+RP  E NL +WA
Sbjct:   302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361

Query:   338 XXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV 397
                         ++DPRLEG + VKG  K   LA  CL+ + K RP M ++V+ L+PL  
Sbjct:   362 RPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPH 421

Query:   398 LPDEAPTPKNFVTV 411
             L D A     F T+
Sbjct:   422 LKDMASASYYFQTM 435

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FM85	Y5564_ARATH	2, ., 7, ., 1, 1, ., 1	0.7323	0.8787	0.9240	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00024839001	SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (380 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00024519001	SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (401 aa)			•						0.412

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	429
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-51
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-49
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-33
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-26
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-22
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-22
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-21
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-20
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-20
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-20
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  172 bits (439), Expect = 3e-51
 Identities = 86/277 (31%), Positives = 131/277 (47%), Gaps = 23/277 (8%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
            + LG G FG VYKG +    +   + V VAVK    D S Q   E+L E   +  L HP
Sbjct: 4   GKKLGEGAFGEVYKGTL--KGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
           N+VKL+G C E+E  +++ E+M  G + + L       L  S  +  A   A+G+ +L  
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE- 120

Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIM 295
             K  I+RD    N L+  +   K+SDFGL++D  + D       ++     + APE + 
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177

Query: 296 TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL 355
            G  T +SDV+SFGV+L EI T  +      P    + A+  L  LK+  +L     P+ 
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYLKKGYRL-----PK- 225

Query: 356 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 392
               P     +   L   C   +P+ RP   ++V+ L
Sbjct: 226 ----PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  171 bits (435), Expect = 2e-50
 Identities = 87/277 (31%), Positives = 130/277 (46%), Gaps = 24/277 (8%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
            + LG G FG VYKG +    + G + V VAVK    D S Q   E+L E   +  L HP
Sbjct: 4   GKKLGEGAFGEVYKGKL--KGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
           N+VKL+G C E+E   ++ E+M  G + + L  K    L  S  +  A   A+G+ +L  
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE- 119

Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIM 295
             K  I+RD    N L+  +   K+SDFGL++D  + D       ++     + APE + 
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLK 176

Query: 296 TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL 355
            G  T +SDV+SFGV+L EI T  +      P    +  +  L  LK   +L     P+ 
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYLKNGYRL-----PQ- 224

Query: 356 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 392
               P     +   L   C   +P+ RP   ++V+ L
Sbjct: 225 ----PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  165 bits (419), Expect = 9e-49
 Identities = 67/198 (33%), Positives = 105/198 (53%), Gaps = 13/198 (6%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG GGFG VY     +  ++      VA+K+   ++S     E L E+  L  L+HPN+V
Sbjct: 1   LGEGGFGTVYLARDKKTGKK------VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV 54

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           KL G   ++ H  L+ E+   GS++ +L  +    L     ++I     +GL +LH    
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLK-DLLKENEGKLSEDEILRILLQILEGLEYLH--SN 111

Query: 240 PVIYRDFKTSNILLD-TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TG 297
            +I+RD K  NILLD  +   KL+DFGL+K         +   I+GT  Y APE ++  G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKG 169

Query: 298 HLTPRSDVYSFGVVLLEI 315
           + + +SD++S GV+L E+
Sbjct: 170 YYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  164 bits (417), Expect = 8e-48
 Identities = 85/289 (29%), Positives = 126/289 (43%), Gaps = 40/289 (13%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           + LG G FG VYKG +     +  +   VAVK    D S +  +++L E   +  L HPN
Sbjct: 1   KKLGEGAFGEVYKGKLK---GKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPN 57

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGS-------VENNLFSKVLLPLPWSIRMKIAFGAAKG 230
           +V+L+G C E+E   L+ E+M  G              S     L     +  A   AKG
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST------RIMG 284
           + +L    K  ++RD    N L+  D   K+SDFGL++D  + D     T      R M 
Sbjct: 118 MEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM- 174

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 344
                APE +  G  T +SDV+SFGV+L EI T   +     P    +  +  L  L++ 
Sbjct: 175 -----APESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPGLSNEE-VLEYLRKG 223

Query: 345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            +L     P    D       +   L   C   +P+ RP   ++V+ LE
Sbjct: 224 YRLPK---PEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  158 bits (403), Expect = 8e-46
 Identities = 85/285 (29%), Positives = 129/285 (45%), Gaps = 33/285 (11%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
               + LG G FG VYKG +  D         VAVK      S +   E+L E   +  L
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGD--GEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL 58

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
           SHPN+V+L+G C + E   ++ E+M  G + + L  K    L     +++A   AKG+ +
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 234 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST------RIMGTYG 287
           L    K  ++RD    N L+  +   K+SDFGL++D  E D            + M    
Sbjct: 118 LE--SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM---- 171

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 347
             APE +  G  T +SDV+SFGV+L EI T  +      P    +  +  L LL++  +L
Sbjct: 172 --APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDGYRL 223

Query: 348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 392
                PR E         +   L   C  ++P+ RP   ++V+ L
Sbjct: 224 -----PRPENCPD-----ELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  157 bits (398), Expect = 4e-45
 Identities = 92/284 (32%), Positives = 131/284 (46%), Gaps = 33/284 (11%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG-DNSYQGHREWLAEVIFLGH 172
           +   R LG G FG VYK    +    G     VAVK+        +  +    E+  L  
Sbjct: 1   YELLRKLGSGSFGTVYKA---KHKGTGKI---VAVKILKKRSEKSKKDQTARREIRILRR 54

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGAAKG 230
           LSHPN+V+LI    + +H  L+ E+   G     LF  +    PL      KIA    +G
Sbjct: 55  LSHPNIVRLIDAFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRG 110

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L +LH     +I+RD K  NILLD +   K++DFGLAK       S ++T + GT  Y A
Sbjct: 111 LEYLHS--NGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMA 166

Query: 291 PEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 349
           PE ++ G    P+ DV+S GV+L E+LTG+       P   +N+ D       + + +  
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKP------PFSGENILD-------QLQLIRR 213

Query: 350 IIDPRLEGDYPVKGVHKAAM--LAYHCLNHNPKARPLMRDIVDS 391
           I+ P LE D P           L   CLN +P  RP   +I+  
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  153 bits (389), Expect = 6e-44
 Identities = 74/272 (27%), Positives = 113/272 (41%), Gaps = 31/272 (11%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           +     LG G FG VY      D + G     VA+KV       +     L E+  L  L
Sbjct: 1   YEILEKLGEGSFGKVYLA---RDKKTGKL---VAIKVIKKKKIKKDRERILREIKILKKL 54

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
            HPN+V+L     +++   L+ E+   G + + L  +  L      R          L +
Sbjct: 55  KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSALEY 112

Query: 234 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 293
           LH   K +++RD K  NILLD D + KL+DFGLA+         ++T + GT  Y APE 
Sbjct: 113 LHS--KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEV 167

Query: 294 IMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII-D 352
           ++        D++S GV+L E+LTG+       P    +          +  +L   I  
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDD----------QLLELFKKIGK 211

Query: 353 PRLEGDYPVKGVHKAAM-LAYHCLNHNPKARP 383
           P+     P   +   A  L    L  +P+ R 
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (323), Expect = 2e-34
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 15/211 (7%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 171
            + +  +LG G FG VY      D   G     +AVK V    +S +       E+  L 
Sbjct: 1   EWTRGELLGRGSFGSVYLAL---DKDTGEL---MAVKSVELSGDSEEELEALEREIRILS 54

Query: 172 HLSHPNLVKLIGYCCEDEHRVL-IY-EFMARGSVENNLFSKVLLPLPWS-IRMKIAFGAA 228
            L HPN+V+  G   ++E   L I+ E+++ GS+ +    K    LP   IR K      
Sbjct: 55  SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS--LLKKFGKLPEPVIR-KYTRQIL 111

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           +GLA+LH     +++RD K +NIL+D+D   KL+DFG AK   + +    +  + GT  +
Sbjct: 112 EGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            APE I        +D++S G  ++E+ TG+
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  125 bits (316), Expect = 3e-33
 Identities = 76/278 (27%), Positives = 117/278 (42%), Gaps = 44/278 (15%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLG 171
           F     +G GGFG VYK       R G     VA+KV   +     +   + + E+  L 
Sbjct: 2   FEILEKIGKGGFGEVYKAR---HKRTG---KEVAIKVIKLESKEKKE---KIINEIQILK 52

Query: 172 HLSHPNLVKLIG-YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
              HPN+VK  G Y  +DE   ++ EF + GS+++ L       L  S    +     KG
Sbjct: 53  KCKHPNIVKYYGSYLKKDE-LWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKG 110

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L +LH     +I+RD K +NILL +D   KL DFGL+    +    +    ++GT  + A
Sbjct: 111 LEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMA 165

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE-----QNLADWALPLLKEKK 345
           PE I       ++D++S G+  +E+  G+    +  P +       N      P L+  +
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP----PGLRNPE 221

Query: 346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
           K  +                    L   CL  NP+ RP
Sbjct: 222 KWSDEF---------------KDFL-KKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 4e-30
 Identities = 82/287 (28%), Positives = 134/287 (46%), Gaps = 27/287 (9%)

Query: 116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH 175
             R LG G FG VY+G +++ + +G     VA+K  + + S +   E+L E   +   + 
Sbjct: 10  LIRELGQGSFGMVYEG-LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC 68

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------VLLPLPWSIRMKIAFGA 227
            ++V+L+G     +  +++ E MA+G +++ L S+         L P      +++A   
Sbjct: 69  HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           A G+A+L  A K  ++RD    N ++  D   K+ DFG+ +D  E D      + +    
Sbjct: 129 ADGMAYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 347
           + APE +  G  T +SDV+SFGVVL E+ T               LA+     L  ++ L
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQPYQGLSNEEVL 231

Query: 348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 394
             +ID     D P     K   L   C  +NPK RP   +IV SL+ 
Sbjct: 232 KFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 2e-29
 Identities = 75/233 (32%), Positives = 125/233 (53%), Gaps = 23/233 (9%)

Query: 107 LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           LRI+      + +VLG G FG VYKG    +  E ++ +PVA+KV   + S + ++E L 
Sbjct: 1   LRILKETELEKIKVLGSGAFGTVYKGVWIPEG-EKVK-IPVAIKVLREETSPKANKEILD 58

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGS----VENN---LFSKVLLPLPWS 218
           E   +  + HP++V+L+G C   + + LI + M  G     V N+   + S+ L  L W 
Sbjct: 59  EAYVMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYL--LNWC 115

Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
           +++      AKG+++L   EK +++RD    N+L+ T  + K++DFGLAK     +K + 
Sbjct: 116 VQI------AKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH 167

Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
           +        + A E I+    T +SDV+S+GV + E++T G K  +   PA E
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (288), Expect = 4e-29
 Identities = 85/298 (28%), Positives = 122/298 (40%), Gaps = 44/298 (14%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           + LG G FG V       D         VAVK  +     Q   ++  E+  L  L H N
Sbjct: 10  KQLGEGHFGKVELC--RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 178 LVKLIGYCCEDEHRV---LIYEFMARGSV-------ENNLFSKVLLPLPWSIRMKIAFGA 227
           +VK  G  CE        LI E++  GS+        + +  K LL          +   
Sbjct: 68  IVKYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL--------LFSSQI 118

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST--RIMGT 285
            KG+ +L    +  I+RD    NIL++++   K+SDFGLAK  PE    +          
Sbjct: 119 CKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKS-------LDKSRPAREQNLADWA 337
           + Y APE + T   +  SDV+SFGV L E+ T G  S       L     A+ Q +    
Sbjct: 177 FWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235

Query: 338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
           L LLKE ++L     PR     P     +   L   C    P+ RP   D++  ++ L
Sbjct: 236 LELLKEGERL-----PR-----PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 1e-27
 Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 13/202 (6%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           ++G G FG VYKG    +L  G     VA+K +       +  +  + E+  L +L HPN
Sbjct: 7   LIGRGAFGVVYKGL---NLETGDF---VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
           +VK IG     +   +I E+   GS+   +  K   P P S+     +   +GLA+LHE 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHE- 117

Query: 238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG 297
            + VI+RD K +NIL   D   KL+DFG+A      D S     ++GT  + APE I   
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 298 HLTPRSDVYSFGVVLLEILTGR 319
             +  SD++S G  ++E+LTG 
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  112 bits (279), Expect = 2e-27
 Identities = 84/292 (28%), Positives = 127/292 (43%), Gaps = 30/292 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 170
           ++R  R LG G FG VY      D +       VA+KV     ++  +    +L E+  L
Sbjct: 1   SYRILRKLGEGSFGEVYLA---RDRK------LVALKVLAKKLESKSKEVERFLREIQIL 51

Query: 171 GHLSHP-NLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAA 228
             L+HP N+VKL  +  ++    L+ E++  GS+E+ L       PL  S  + I     
Sbjct: 52  ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQIL 111

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFGLAKDGPEGDKS----HVSTRIM 283
             L +LH   K +I+RD K  NILLD D    KL DFGLAK  P+   +     + +  +
Sbjct: 112 SALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 284 GTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 340
           GT GY APE ++     + +  SD++S G+ L E+LTG    +          +      
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE------KNSSATSQT 223

Query: 341 LKEKKKL-LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS 391
           LK   +L    +   L    P      A+ L    L  +PK R      +  
Sbjct: 224 LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 6e-27
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 26/205 (12%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           +G G FG V  G          +   VAVK + D   + Q    +LAE   +  L HPNL
Sbjct: 14  IGKGEFGDVMLGD--------YRGQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNL 62

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 238
           V+L+G   +     ++ E+MA+GS+ + L S+    +  + ++  A    +G+ +L   E
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--E 120

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD---GPEGDKSHVSTRIMGTYGYAAPEYIM 295
           K  ++RD    N+L+  D  AK+SDFGLAK+   G +  K  V         + APE + 
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALR 172

Query: 296 TGHLTPRSDVYSFGVVLLEILT-GR 319
               + +SDV+SFG++L EI + GR
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 8e-27
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 24/210 (11%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSH 175
           ++V+GGG FG V +G +    +   + + VA+K +  G +  Q   ++L E   +G   H
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGK---KEIDVAIKTLKAGSSDKQ-RLDFLTEASIMGQFDH 64

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAK 229
           PN+++L G   +    ++I E+M  GS++  L      F+   L       + +  G A 
Sbjct: 65  PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-------VGMLRGIAS 117

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSHVSTRIMGTYG 287
           G+ +L  +E   ++RD    NIL++++   K+SDFGL++  +  E   +    +I     
Sbjct: 118 GMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIR 173

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           + APE I     T  SDV+SFG+V+ E+++
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  106 bits (267), Expect = 2e-26
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 12/204 (5%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           F  +R LG G FG V++G            V VA+K+   D+  +  +++  EV  L  L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNR-------VRVAIKILKSDDLLK-QQDFQKEVQALKRL 59

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
            H +L+ L   C   E   +I E M +GS+   L S     LP +  + +A   A+G+A+
Sbjct: 60  RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119

Query: 234 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 293
           L E  +  I+RD    NIL+  D   K++DFGLA+   E        +I   Y + APE 
Sbjct: 120 LEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEA 175

Query: 294 IMTGHLTPRSDVYSFGVVLLEILT 317
              G  + +SDV+SFG++L E+ T
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  105 bits (263), Expect = 7e-26
 Identities = 73/212 (34%), Positives = 106/212 (50%), Gaps = 16/212 (7%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
             LG G FG VY+G  ++ L  G  P+ VAVK      + Q  +E+L E   + + +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNL-------FSKVLLPLPWSIRMKIAFGAAKG 230
           +VKL+G C  +E + +I E M  G + + L       F   LL L     + I    AKG
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL--KELLDICLDVAKG 118

Query: 231 LAFLHEAEKPVIYRDFKTSNILL-----DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             +L +     I+RD    N L+     D D   K+ DFGLA+D  + D        +  
Sbjct: 119 CVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             + APE ++ G  T +SDV+SFGV++ EILT
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (264), Expect = 9e-26
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 17/222 (7%)

Query: 108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 167
            I  +  R    LG G FG VYKG ++    E L    VA+K    +   +  +E+  E 
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTG-PNERLSATSVAIKTLKENAEPKVQQEFRQEA 59

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------------VLL 213
             +  L HPN+V L+G C +++   +++E++A G +   L                 V  
Sbjct: 60  ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119

Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
            L  S  + IA   A G+ +L  +    ++RD    N L+      K+SDFGL++D    
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177

Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           D   V ++ +    +  PE I+ G  T  SD++SFGVVL EI
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  104 bits (261), Expect = 2e-25
 Identities = 79/290 (27%), Positives = 120/290 (41%), Gaps = 27/290 (9%)

Query: 112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
            +    R LG G FG VY+G            + VAVK      S Q   ++L E + + 
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYR-GRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS 64

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMK----IAFG 226
             +H N+V+LIG   E   R ++ E MA G +++ L  ++     P S+ MK     A  
Sbjct: 65  KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            AKG  +L   E   I+RD    N LL        AK++DFG+A+D           R M
Sbjct: 125 VAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 343
               +  PE  + G  T ++DV+SFGV+L EI +        R  +E       +  +  
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTG 236

Query: 344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
             +L          D P         +   C  H P+ RP    I++ ++
Sbjct: 237 GGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  100 bits (252), Expect = 3e-24
 Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 15/212 (7%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           R LG G FG V+ G       E  + + VAVK      S    +++  E   L +  H N
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKEL-VAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK----VLL--------PLPWSIRMKIAF 225
           +VK  G C E +  ++++E+M  G +   L S       L         L  S  ++IA 
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A G+ +L  A +  ++RD  T N L+  D   K+ DFG+++D    D   V    M  
Sbjct: 130 QIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             +  PE IM    T  SDV+SFGVVL EI T
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 19/208 (9%)

Query: 118 RVLGGGGFGCVYKG-FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           RV+G G FGCVY G  I  D ++    +  AVK  +     +   ++L E I +   SHP
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQK----IHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHP 56

Query: 177 NLVKLIGYCCEDE---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGL 231
           N++ L+G C   E     VL Y  M  G + N + S+   P   +++  I FG   AKG+
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPY--MKHGDLRNFIRSETHNP---TVKDLIGFGLQVAKGM 111

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYA 289
            +L  A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 112 EYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILT 317
           A E + T   T +SDV+SFGV+L E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 55/161 (34%), Positives = 79/161 (49%), Gaps = 16/161 (9%)

Query: 164 LAEVIFLGHLSHPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           L E   L  ++HP +VKL  +     +E   L+ E+   G + ++L  +           
Sbjct: 41  LTERNILSRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER---- 94

Query: 222 KIAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
              F AA+    L +LH     +IYRD K  NILLD D + KL+DFGLAK+      S  
Sbjct: 95  -ARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRT 150

Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           +T   GT  Y APE ++        D +S GV+L E+LTG+
Sbjct: 151 NTFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 21/217 (9%)

Query: 120 LGGGGFGCVY-------KGFISEDLREG---LQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
           LG G FG V+       + F  +   E      PV VAVKV   D S     ++L EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV---------ENNLFSKVLLPLPWSIR 220
           L  LS PN+ +L+G C  D    +I E+M  G +         E +  +     L +S  
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           + +A   A G+ +L       ++RD  T N L+  +Y  K++DFG++++    D   V  
Sbjct: 133 LYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           R      + A E ++ G  T +SDV++FGV L EILT
Sbjct: 191 RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 83/309 (26%), Positives = 126/309 (40%), Gaps = 45/309 (14%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISE-DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
           N    + LG G FG V K        R G     VAVK+   + S    R+ L+E   L 
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGY--TTVAVKMLKENASSSELRDLLSEFNLLK 58

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV----------------------ENNLFS 209
            ++HP+++KL G C +D   +LI E+   GS+                       + L +
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 210 KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 269
                L     +  A+  ++G+ +L  AE  +++RD    N+L+      K+SDFGL++D
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPA 328
             E D     ++      + A E +     T +SDV+SFGV+L EI+T G        P 
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236

Query: 329 REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
           R  N       LLK   ++          + P     +   L   C    P  RP   DI
Sbjct: 237 RLFN-------LLKTGYRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Query: 389 VDSLEPLQV 397
              LE + V
Sbjct: 280 SKELEKMMV 288

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 99.2 bits (247), Expect = 3e-22
 Identities = 89/290 (30%), Positives = 138/290 (47%), Gaps = 34/290 (11%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
           I ++ +++ V+  G  G  YKG   + ++ G+Q V   VK  +  NS        +E+  
Sbjct: 688 ILSSLKEENVISRGKKGASYKG---KSIKNGMQFV---VKEINDVNSIP-----SSEIAD 736

Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 229
           +G L HPN+VKLIG C  ++   LI+E+     +E    S+VL  L W  R KIA G AK
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEY-----IEGKNLSEVLRNLSWERRRKIAIGIAK 791

Query: 230 GLAFLHEAEKP-VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
            L FLH    P V+  +     I++D      L      +    G     +   + +  Y
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AY 844

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL 348
            APE   T  +T +SD+Y FG++L+E+LTG+   D        ++ +WA     +   L 
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSD-CHLD 902

Query: 349 NIIDPRLEGDYPVKGVHKAAM-----LAYHCLNHNPKARPLMRDIVDSLE 393
             IDP + GD     V++  +     LA HC   +P ARP   D++ +LE
Sbjct: 903 MWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 95.3 bits (237), Expect = 4e-22
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 31/229 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQP----VPVAVKVHDGDNSYQGHREWLAEVI 168
           N    R +G G FG V++         GL P      VAVK+   + S     ++  E  
Sbjct: 6   NIEYVRDIGQGAFGRVFQA-----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--------------------F 208
            +    HPN+VKL+G C   +   L++E+MA G +   L                     
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 209 SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK 268
               LPL  + ++ IA   A G+A+L  +E+  ++RD  T N L+  +   K++DFGL++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Query: 269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           +    D    S        +  PE I     T  SDV+++GVVL EI +
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 95.0 bits (236), Expect = 5e-22
 Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 31/286 (10%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           R LG G FG VY+G  + D+ +G     VAVK  +   S +   E+L E   +   +  +
Sbjct: 12  RELGQGSFGMVYEG-NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP--------LPWSIRMKIAFGA-- 227
           +V+L+G   + +  +++ E MA G +++ L  + L P         P +++  I   A  
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ +D  E D      + +    
Sbjct: 129 ADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 347
           + APE +  G  T  SD++SFGVVL EI +               LA+     L  ++ L
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 231

Query: 348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
             ++D     D P     +   L   C   NPK RP   +IV+ L+
Sbjct: 232 KFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 94.3 bits (235), Expect = 5e-22
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 40/220 (18%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVP----VAVKV--HDGDNSYQGHREWLAEV 167
                 LG G  G V K          +   P    +AVK    + + + Q  ++ L E+
Sbjct: 3   LEYLGELGAGNSGVVSK----------VLHRPTGKIMAVKTIRLEINEAIQ--KQILREL 50

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA 227
             L   + P +V   G    +    +  E+M  GS++  +  +V   +P  I  KIA   
Sbjct: 51  DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAV 109

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM---- 283
            KGL +LHE  K +I+RD K SNIL+++    KL DFG            VS +++    
Sbjct: 110 LKGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLA 156

Query: 284 ----GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
               GT  Y APE I     + +SD++S G+ L+E+ TGR
Sbjct: 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 94.3 bits (234), Expect = 6e-22
 Identities = 75/289 (25%), Positives = 135/289 (46%), Gaps = 39/289 (13%)

Query: 116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH 175
           + +V+G G FG V++G +      G + V VA+K      + +  +++L+E   +G  SH
Sbjct: 9   KQKVIGAGEFGEVFRGILK---MPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAK 229
            N+++L G   + +  ++I E+M  G+++  L      FS   L       + +  G A 
Sbjct: 66  HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-------VGMLRGIAA 118

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTY 286
           G+ +L  ++   ++RD    NIL++++   K+SDFGL++   D PEG  +    +I    
Sbjct: 119 GMKYL--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PI 174

Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK 346
            + APE I     T  SDV+SFG+V+ E+++  +     RP        W +       +
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE-----RPY-------WDM----SNHE 218

Query: 347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
           ++  I+       P+        L   C   +   RP   DIV+ L+ L
Sbjct: 219 VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 93.7 bits (233), Expect = 7e-22
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 10/201 (4%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
             +G G FG VYKG     L+   +   VAVK           R++L E   L    HPN
Sbjct: 1   EKIGKGNFGDVYKGV----LKGNTE---VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPN 53

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
           +VKLIG C + +   ++ E +  GS+   L  K    L     ++++  AA G+ +L   
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLE-- 110

Query: 238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG 297
            K  I+RD    N L+  +   K+SDFG++++   G  +           + APE +  G
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 298 HLTPRSDVYSFGVVLLEILTG 318
             T  SDV+S+G++L E  + 
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 94.1 bits (234), Expect = 9e-22
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 22/214 (10%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHP 176
           ++LG G FG V +G +S+D  +G   + VAVK    D  +Y    E+L+E   +    HP
Sbjct: 5   KILGEGEFGSVMEGQLSQD--DG-SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61

Query: 177 NLVKLIGYCCEDEHR------VLIYEFMARGSVENNLFSKVL--LP--LPWSIRMKIAFG 226
           N++KLIG C E          ++I  FM  G + + L    L  LP  LP    +K    
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRIM 283
            A G+ +L  + +  I+RD    N +L  D    ++DFGL+K    GD   +  ++   +
Sbjct: 122 IALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
               + A E +     T +SDV++FGV + EI T
Sbjct: 180 K---WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 44/282 (15%)

Query: 112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
           ++  + +VLG G  G VYK         G      A+K    D   +  ++ L E+  L 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVR---HKPTGKI---YALKKIHVDGDEEFRKQLLRELKTLR 54

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
               P +VK  G   ++    ++ E+M  GS+ + L  K +  +P  +   IA    KGL
Sbjct: 55  SCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGL 112

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGY 288
            +LH  ++ +I+RD K SN+L+++    K++DFG++K   +  +   + V     GT  Y
Sbjct: 113 DYLH-TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTY 166

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL 348
            +PE I     +  +D++S G+ LLE   G+       P        +         +L+
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGK------FPFLPPGQPSFF--------ELM 212

Query: 349 NII----DPRLEGDYPVKGVHKAAMLAY---HCLNHNPKARP 383
             I     P L  +        +         CL  +PK RP
Sbjct: 213 QAICDGPPPSLPAE------EFSPEFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 90/320 (28%), Positives = 149/320 (46%), Gaps = 57/320 (17%)

Query: 107 LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           +RI+     ++ +VLG G FG VYKG    D  E ++ +PVA+KV   + S + ++E L 
Sbjct: 1   MRILKETELKKVKVLGSGAFGTVYKGIWIPD-GENVK-IPVAIKVLRENTSPKANKEILD 58

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPWS 218
           E   +  +  P + +L+G C     + L+ + M  G +       ++ + S+ LL   W 
Sbjct: 59  EAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLN--WC 115

Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----DGPE-- 272
           +++      AKG+++L E    +++RD    N+L+ +  + K++DFGLA+    D  E  
Sbjct: 116 VQI------AKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167

Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQ 331
            D   V  + M      A E I+    T +SDV+S+GV + E++T G K  D   PARE 
Sbjct: 168 ADGGKVPIKWM------ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE- 219

Query: 332 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS 391
                 +P L EK + L           P        M+   C   + + RP  R++VD 
Sbjct: 220 ------IPDLLEKGERLP---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264

Query: 392 LEPLQVLPDEAPTPKNFVTV 411
              +      A  P  FV +
Sbjct: 265 FSRM------ARDPSRFVVI 278

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 17/203 (8%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G FG V KG     L +  + V VAVK    ++   G +E+L E   +  L HP +V
Sbjct: 3   LGHGNFGSVVKGVY---LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           +LIG  C+ E  +L+ E    G +   L  +  +P+     +  A   A G+A+L    K
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVAMGMAYLE--SK 114

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG-----YAAPEYI 294
             ++RD    N+LL   + AK+SDFG+++    G   + +T    T G     + APE I
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPECI 170

Query: 295 MTGHLTPRSDVYSFGVVLLEILT 317
             G  + +SDV+S+GV L E  +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 11/201 (5%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G FG V +G   E    G + +PVAVK    D       ++L E   +  L H NL+
Sbjct: 3   LGDGSFGVVRRG---EWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           +L G        +++ E    GS+ + L    L     S     A   A G+ +L    K
Sbjct: 60  RLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES--K 116

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST---RIMGTYGYAAPEYIMT 296
             I+RD    NILL +D   K+ DFGL +  P+ +  +V     ++   + + APE + T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRT 174

Query: 297 GHLTPRSDVYSFGVVLLEILT 317
              +  SDV+ FGV L E+ T
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 90.3 bits (225), Expect = 1e-20
 Identities = 71/297 (23%), Positives = 115/297 (38%), Gaps = 60/297 (20%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW-LAEVIFLG 171
            +   + +G G FG VY         +G       +K  D  N  +  RE  L EV  L 
Sbjct: 1   KYEIIKQIGKGSFGKVYLV---RRKSDG---KLYVLKEIDLSNMSEKEREDALNEVKILK 54

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGS----VENNLFSKVLLP----LPWSIRMKI 223
            L+HPN++K      E     ++ E+   G     ++         P    L W +++  
Sbjct: 55  KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL-- 112

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
                  L +LH   + +++RD K  NI L ++   KL DFG++K           T + 
Sbjct: 113 ----CLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV- 164

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 343
           GT  Y +PE         +SD++S G VL E+ T +       P   +NL + AL +LK 
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK------HPFEGENLLELALKILKG 218

Query: 344 K---------KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS 391
           +          +L N++                       L  +P+ RP +  I+ S
Sbjct: 219 QYPPIPSQYSSELRNLVSS--------------------LLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 28/215 (13%)

Query: 115 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLGHL 173
           R+  +LG G FG VY+G   +D       V   V + D   + Q   ++   E+  L  L
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDD--GDFFAVKE-VSLADDGQTGQEAVKQLEQEIALLSKL 59

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM---KIAFGAAKG 230
            HPN+V+ +G   E+++  +  E +  GS+   L      P P  IR+   +I      G
Sbjct: 60  QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP-VIRLYTRQIL----LG 114

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-----GT 285
           L +LH+  +  ++RD K +NIL+DT+   KL+DFG+AK         V          G+
Sbjct: 115 LEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGS 164

Query: 286 YGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
             + APE I   G     +D++S G  +LE+ TG+
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 22/217 (10%)

Query: 120 LGGGGFG----CVYKGFISEDLREGL-----QPVPVAVKVHDGDNSYQGHREWLAEVIFL 170
           LG G FG    C  +G ++E L EG      QPV VAVK+   D +     ++L E+  +
Sbjct: 13  LGEGQFGEVHLCEAEG-LAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL---------LP-LPWSIR 220
             L +PN+++L+G C  D+   +I E+M  G +   L  + +         +P +  +  
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           + +A   A G+ +L  A    ++RD  T N L+   Y  K++DFG++++   GD   +  
Sbjct: 132 LYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           R +    + A E I+ G  T  SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 27/284 (9%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           R LG G FG VY+G I++ + +      VA+K  +   S +   E+L E   +   +  +
Sbjct: 12  RELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLPWSIRMKIAFGAAK 229
           +V+L+G   + +  ++I E M RG +++ L S         V  P      +++A   A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           G+A+L+ A K  ++RD    N ++  D+  K+ DFG+ +D  E D      + +    + 
Sbjct: 131 GMAYLN-ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 349
           +PE +  G  T  SDV+SFGVVL EI T               LA+     +  ++ L  
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGMSNEQVLRF 233

Query: 350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
           +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 234 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 59/186 (31%), Positives = 80/186 (43%), Gaps = 28/186 (15%)

Query: 147 AVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY---EFMARGSV 203
           A+K    D +    ++ L E+        P +VK  G    DE    I    E+   GS+
Sbjct: 30  ALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG-AFLDESSSSIGIAMEYCEGGSL 88

Query: 204 E----------NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL 253
           +            +  KVL         KIA    KGL++LH   + +I+RD K SNILL
Sbjct: 89  DSIYKKVKKRGGRIGEKVLG--------KIAESVLKGLSYLHS--RKIIHRDIKPSNILL 138

Query: 254 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
                 KL DFG++    E   S   T   GT  Y APE I     +  SDV+S G+ LL
Sbjct: 139 TRKGQVKLCDFGVSG---ELVNSLAGT-FTGTSFYMAPERIQGKPYSITSDVWSLGLTLL 194

Query: 314 EILTGR 319
           E+   R
Sbjct: 195 EVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 72/233 (30%), Positives = 123/233 (52%), Gaps = 23/233 (9%)

Query: 107 LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           LRI+    F++ +VLG G FG VYKG    +  E ++ +PVA+K      S + ++E L 
Sbjct: 1   LRILKETEFKKIKVLGSGAFGTVYKGLWIPE-GEKVK-IPVAIKELREATSPKANKEILD 58

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPWS 218
           E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W 
Sbjct: 59  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--WC 115

Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
           +++      AKG+ +L E  + +++RD    N+L+ T  + K++DFGLAK     +K + 
Sbjct: 116 VQI------AKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
           +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 70/212 (33%), Positives = 106/212 (50%), Gaps = 23/212 (10%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGH 172
            + +R LG G FG V+ G  +           VAVK    G  S +    +L E   +  
Sbjct: 8   LKLERKLGAGQFGEVWMGTWNGT-------TKVAVKTLKPGTMSPE---AFLQEAQIMKK 57

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKG 230
           L H  LV+L   C E+E   ++ E+M++GS+ + L S     L LP  + M  A   A+G
Sbjct: 58  LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEG 115

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK--SHVSTRIMGTYGY 288
           +A+L    +  I+RD    NIL+  +   K++DFGLA+   E D+  +    +      +
Sbjct: 116 MAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKF--PIKW 170

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            APE    G  T +SDV+SFG++L EI+T GR
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 89.6 bits (222), Expect = 4e-20
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 23/219 (10%)

Query: 108 RII-TANFRQDRVLGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           RI+     R+ ++LG G FG V+KG  I E   + ++ +PVA+K     +  Q  +E   
Sbjct: 2   RILKETELRKLKLLGSGVFGTVHKGIWIPEG--DSIK-IPVAIKTIQDRSGRQTFQEITD 58

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPWS 218
            ++ +G L H  +V+L+G C     + L+ +    GS+        ++L  + LL   W 
Sbjct: 59  HMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLN--WC 115

Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
           +++      AKG+ +L E    +++R+    NILL +D   +++DFG+A      DK + 
Sbjct: 116 VQI------AKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167

Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            +       + A E I+ G  T +SDV+S+GV + E+++
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 89.2 bits (221), Expect = 4e-20
 Identities = 60/218 (27%), Positives = 112/218 (51%), Gaps = 23/218 (10%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
           I  +  + ++V+G G FG V  G +      G + +PVA+K      + +  R++L+E  
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLK---LPGKREIPVAIKTLKAGYTEKQRRDFLSEAS 57

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSIRMK 222
            +G   HPN++ L G   + +  +++ E+M  GS++  L      F+ + L       + 
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-------VG 110

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDKSHVS 279
           +  G A G+ +L  ++   ++RD    NIL++++   K+SDFGL++   D PE   +   
Sbjct: 111 MLRGIASGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            +I     + APE I     T  SDV+S+G+V+ E+++
Sbjct: 169 GKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.8 bits (220), Expect = 5e-20
 Identities = 64/221 (28%), Positives = 115/221 (52%), Gaps = 30/221 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK--------VHDGDNSYQGHREWL 164
            + + + LG G F   Y+   + D++ G     +AVK          + +   +  R+  
Sbjct: 1   EWLKGQQLGTGAFSSCYQ---ARDVKTG---TLMAVKQVTYVRNTSSEQEEVVEALRK-- 52

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E+  +  L+HP++++++G  CED H  L  E+MA GSV ++L SK       ++ +   
Sbjct: 53  -EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSK-YGAFKEAVIINYT 109

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFG----LAKDGPEGDKSHVS 279
               +GL++LHE +  +I+RD K +N+L+D T    +++DFG    LA  G    +    
Sbjct: 110 EQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQ 165

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            +++GT  + APE ++ G    RS DV+S G V++E+ T +
Sbjct: 166 GQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 89.6 bits (222), Expect = 5e-20
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 20/198 (10%)

Query: 136 DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY 195
           ++R+G +P+ VAVK+   D +     ++L EV  L  L  PN+++L+G C +++   +I 
Sbjct: 40  NVRKG-RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMIT 98

Query: 196 EFMARGSVENNLFSKVLL--------------PLP---WSIRMKIAFGAAKGLAFLHEAE 238
           E+M  G +   L S  L                LP   +S  + +A   A G+ +L  + 
Sbjct: 99  EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SS 156

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 298
              ++RD  T N L+  +   K++DFG++++   GD   +  R +    + A E I+ G 
Sbjct: 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216

Query: 299 LTPRSDVYSFGVVLLEIL 316
            T  SDV++FGV L EIL
Sbjct: 217 FTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 88.5 bits (219), Expect = 6e-20
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G FGCV KG      ++    + VA+KV   +N      E + E   +  L +P +V
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ----IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           ++IG  CE E  +L+ E MA G   N   S     +  S  +++    + G+ +L    K
Sbjct: 59  RMIG-VCEAEALMLVME-MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG--K 114

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTG 297
             ++RD    N+LL   + AK+SDFGL+K     D S+   R  G +   + APE I   
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 298 HLTPRSDVYSFGVVLLEILT-GRKSLDK 324
             + RSDV+S+G+ + E  + G+K   K
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKK 201

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.4 bits (219), Expect = 7e-20
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 10/208 (4%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           VLG G +G VY G  ++   + +    V +   +   + + + +   EV  L  L H N+
Sbjct: 7   VLGKGAYGTVYCGLTNQG--QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 238
           V+ +G C +D    +  EF+  GS+ + L      PLP  +  K       G+A+LH   
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLH--N 120

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD----GPEGDKSHVSTRIMGTYGYAAPEYI 294
             V++RD K +N++L  +   KL DFG A+     G  G  S++   + GT  + APE I
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 295 MTGHLTPRSDVYSFGVVLLEILTGRKSL 322
                  +SD++S G  + E+ TG+  L
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.4 bits (219), Expect = 8e-20
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 21/210 (10%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           + V+G G FG V +G +      G + + VA+K      + +  R++L+E   +G   HP
Sbjct: 9   EEVIGAGEFGEVCRGRLKL---PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAKG 230
           N++ L G   +    ++I EFM  G++++ L      F+ + L       + +  G A G
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-------VGMLRGIAAG 118

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG---TYG 287
           + +L  +E   ++RD    NIL++++   K+SDFGL++   +       T  +G      
Sbjct: 119 MKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           + APE I     T  SDV+S+G+V+ E+++
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.9 bits (218), Expect = 8e-20
 Identities = 69/266 (25%), Positives = 108/266 (40%), Gaps = 30/266 (11%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           +G G FG V+K     D R     V    ++     + +   E + E   L  L    ++
Sbjct: 8   IGKGSFGVVFKVVRKADKR-----VYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           +      +     ++ E+   G +   L  +   PLP     +       GLA LH   K
Sbjct: 63  RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS--K 120

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
            +++RD K+ N+ LD   N K+ D G+AK     D ++ +  I+GT  Y +PE       
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDKPY 178

Query: 300 TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDY 359
             +SDV++ GVVL E  TG+   D    A  Q     AL        +L II        
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFD----ANNQG----AL--------ILKIIRGVFP--- 219

Query: 360 PVKGVHKAAM--LAYHCLNHNPKARP 383
           PV  ++   +  L   CL  + + RP
Sbjct: 220 PVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 81/290 (27%), Positives = 131/290 (45%), Gaps = 34/290 (11%)

Query: 120 LGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPN 177
           LG G FG  V    I  D  +  +PV VAVK+   D + +   + ++E+  +  +  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNL-----------FSKVLLP---LPWSIRMKI 223
           ++ L+G C +D    ++ E+ ++G++   L           F    LP   L +   +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 140 AYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 343
               + APE +     T +SDV+SFGV+L EI T   S     P  E         LLKE
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------LFKLLKE 251

Query: 344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
             ++          D P    H+  M+   C +  P  RP  + +V+ L+
Sbjct: 252 GHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 75/252 (29%), Positives = 131/252 (51%), Gaps = 32/252 (12%)

Query: 107 LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREWL 164
           LRI+     ++ +VLG G FG VYKG     + EG    +PVA+K+ +     + + E++
Sbjct: 1   LRILKETELKRVKVLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFM 57

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E + +  + HP+LV+L+G C     + L+ + M  G +       ++N+ S++L  L W
Sbjct: 58  DEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL--LNW 114

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L   E+ +++RD    N+L+ +  + K++DFGLA+     +K +
Sbjct: 115 CVQI------AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166

Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW 336
            +        + A E I     T +SDV+S+GV + E++T G K  D   P RE      
Sbjct: 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE------ 219

Query: 337 ALPLLKEKKKLL 348
            +P L EK + L
Sbjct: 220 -IPDLLEKGERL 230

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 81/283 (28%), Positives = 116/283 (40%), Gaps = 55/283 (19%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           F     +G G FG VYK     D R       VA+KV D + +     +   E+ FL   
Sbjct: 3   FTLLECIGKGSFGEVYKAI---DKRTN---QVVAIKVIDLEEAEDEIEDIQQEIQFLSQC 56

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF---GAAKG 230
             P + K  G   +     +I E+   GS        +L P        IAF       G
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSC-----LDLLKPGKLD-ETYIAFILREVLLG 110

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYG 287
           L +LHE  K  I+RD K +NILL  + + KL+DFG++     G  +   ++    +GT  
Sbjct: 111 LEYLHEEGK--IHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPF 163

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 347
           + APE I       ++D++S G+  +E+  G           E  L+D     L   + L
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKG-----------EPPLSD-----LHPMRVL 207

Query: 348 LNIID---PRLEGDY---PVKG-VHKAAMLAYHCLNHNPKARP 383
             I     P LEG+    P K  V         CLN +PK RP
Sbjct: 208 FLIPKNNPPSLEGNKFSKPFKDFVSL-------CLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 22/208 (10%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           ++G G FG V +G   E   +      VAVK    D + Q    +L E   +  L H NL
Sbjct: 13  IIGEGEFGAVLQG---EYTGQ-----KVAVKNIKCDVTAQA---FLEETAVMTKLHHKNL 61

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 238
           V+L+G    +   +++ E M++G++ N L ++    +     ++ +   A+G+ +L    
Sbjct: 62  VRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES-- 118

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHVSTRIMGTYGYAAPEYIMTG 297
           K +++RD    NIL+  D  AK+SDFGLA+ G  G D S +  +      + APE +   
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHK 172

Query: 298 HLTPRSDVYSFGVVLLEILT-GRKSLDK 324
             + +SDV+S+GV+L E+ + GR    K
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPK 200

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 79/289 (27%), Positives = 131/289 (45%), Gaps = 31/289 (10%)

Query: 120 LGGGGFG----CVYKG---FISEDLR---EGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
           LG G FG    C  +G   F+ +D      G QPV VAVK+   D +     ++L E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP----------WSI 219
           +  L  PN+++L+  C   +   +I E+M  G + N   S+                +S 
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTISYST 131

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
            + +A   A G+ +L       ++RD  T N L+  +Y  K++DFG++++   GD   + 
Sbjct: 132 LIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP 339
            R +    + + E I+ G  T  SDV++FGV L EILT  K    S+ + EQ + +    
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG-E 248

Query: 340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
             +++ + + +  P L  D   K       L   C   N K RP  ++I
Sbjct: 249 FFRDQGRQVYLPKPALCPDSLYK-------LMLSCWRRNAKERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 85.8 bits (212), Expect = 5e-19
 Identities = 77/283 (27%), Positives = 125/283 (44%), Gaps = 47/283 (16%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           + +G G FG V  G          +   VAVK    D + Q    +LAE   +  L H N
Sbjct: 12  QTIGKGEFGDVMLG--------DYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSN 60

Query: 178 LVKLIGYCCEDEHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
           LV+L+G   E++  + I  E+MA+GS+ + L S+    L     +K +    + + +L E
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-E 119

Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTRIMGTYGYAAPEYIM 295
           A    ++RD    N+L+  D  AK+SDFGL K+     D   +  +      + APE + 
Sbjct: 120 ANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 172

Query: 296 TGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR 354
               + +SDV+SFG++L EI + GR    +             +P LK+       + PR
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPR-------------IP-LKD-------VVPR 211

Query: 355 LEGDYPVKGVHKAAMLAY----HCLNHNPKARPLMRDIVDSLE 393
           +E  Y +        + Y     C + +   RP    + + LE
Sbjct: 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 5e-19
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 22/212 (10%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGH 172
           + +   LG G +G VYK     D + G     VA+K    DN  +G     L E+  L  
Sbjct: 1   YEKLEKLGEGTYGVVYKAR---DKKTG---EIVALKKIRLDNEEEGIPSTALREISLLKE 54

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS---KVLLPLPWSIRMKIAFGAAK 229
           L HPN+VKL+     +    L++E+      + +L     K   PL  ++   I +   +
Sbjct: 55  LKHPNIVKLLDVIHTERKLYLVFEYC-----DMDLKKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           GLA+ H     +++RD K  NIL++ D   KL+DFGLA+      +++ +  ++ T  Y 
Sbjct: 110 GLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYR 165

Query: 290 APEYIMTG--HLTPRSDVYSFGVVLLEILTGR 319
           APE I+ G  H +   D++S G +  E++TG+
Sbjct: 166 APE-ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 86.1 bits (213), Expect = 6e-19
 Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 30/292 (10%)

Query: 114 FRQDRVLGGGGFGCV--YKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
            ++ RVLG G FG V  Y    + D    +    VAVK    +   Q    W  E+  L 
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEM----VAVKTLKRECGQQNTSGWKKEINILK 61

Query: 172 HLSHPNLVKLIGYCCEDEHR---VLIYEFMARGSVENNL------FSKVLLPLPWSIRMK 222
            L H N+VK  G CC ++      LI E++  GS+ + L       +++LL         
Sbjct: 62  TLYHENIVKYKG-CCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--------- 111

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH-VSTR 281
            A    +G+A+LH   +  I+RD    N+LLD D   K+ DFGLAK  PEG + + V   
Sbjct: 112 FAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169

Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL 341
                 + A E +     +  SDV+SFGV L E+LT      +S P + + +       +
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQM 228

Query: 342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
               +L+ +++  +    P     +  +L  +C     K RP  R ++  L+
Sbjct: 229 TV-VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 58/288 (20%)

Query: 116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV---HDGDNSYQGHREWLAEVIFLGH 172
           +   +GGG FG VY   ++ D  E +     AVK     D D      +E   E+  L  
Sbjct: 4   RGNKIGGGTFGKVYTA-VNLDTGELM-----AVKEIRIQDNDPK--TIKEIADEMKVLEL 55

Query: 173 LSHPNLVKLIGYCCEDEHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA--K 229
           L HPNLVK  G     E +V I+ E+ + G++E  L    +L       +   +     +
Sbjct: 56  LKHPNLVKYYGVEVHRE-KVYIFMEYCSGGTLEELLEHGRILDE----HVIRVYTLQLLE 110

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG-- 287
           GLA+LH     +++RD K +NI LD +   KL DFG A       K   +T  MG     
Sbjct: 111 GLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQS 162

Query: 288 ------YAAPEYIMTGHLTPR---SDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 338
                 Y APE I  G        +D++S G V+LE+ TG+      RP  E +  ++ +
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK------RPWSELD-NEFQI 215

Query: 339 PL---LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
                   K  + + +    EG   +            CL  +PK RP
Sbjct: 216 MFHVGAGHKPPIPDSLQLSPEGKDFLD----------RCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 73/286 (25%), Positives = 118/286 (41%), Gaps = 55/286 (19%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           LG G FG V+ G       +    + VA+K + +G  S     +++ E   +  LSHPNL
Sbjct: 12  LGSGQFGVVHLG-------KWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNL 61

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
           V+L G C +     ++ E+MA G + N L   K  L   W + M       + + +L   
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLESN 119

Query: 238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVSTRIMGTYGYAA 290
               I+RD    N L+  D   K+SDFGLA+          +G K  V         +A 
Sbjct: 120 G--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK--------WAP 169

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 350
           PE       + +SDV+SFGV++ E+ +  K                 +P   E+     +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-----------------MPY--ERFSNSEV 210

Query: 351 IDPRLEGDYPVKGVHKAAM----LAYHCLNHNPKARPLMRDIVDSL 392
           ++    G Y +     A      + Y C +  P+ RP  + ++  L
Sbjct: 211 VESVSAG-YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 28/209 (13%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNL 178
           +G G +G VYK     D   G     VA+K        +G  +  L E+  L  L+HPN+
Sbjct: 7   IGEGTYGVVYKA---RDKLTG---EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL----LPLPWSIRMKIAFGAAKGLAFL 234
           +KL+          L++EFM     + +L+ K++      LP S+     +   +GLAF 
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM-----DTDLY-KLIKDRQRGLPESLIKSYLYQLLQGLAFC 114

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSH-VSTRIMGTYGYAAP 291
           H     +++RD K  N+L++T+   KL+DFGLA+    P    +H V TR      Y AP
Sbjct: 115 HSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAP 167

Query: 292 EYIMT-GHLTPRSDVYSFGVVLLEILTGR 319
           E ++     +   D++S G +  E+L+ R
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 25/215 (11%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLA---EVI 168
           N+R+ ++LG G FG VY  +  +  RE      +AVK V    +S +  +E  A   E+ 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRE------LAVKQVPFDPDSPETKKEVNALECEIQ 56

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
            L +L H  +V+  G   +DE   +  E+M  GSV++ L  K    L  ++  K      
Sbjct: 57  LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL 114

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD------GPEGDKSHVSTRI 282
           +G+ +LH     +++RD K +NIL D+  N KL DFG +K          G KS     +
Sbjct: 115 EGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-----V 167

Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            GT  + +PE I       ++DV+S G  ++E+LT
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 21/220 (9%)

Query: 115 RQDRVL----GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 170
           R+D VL    G G FG V+       L E    + VAVK    + S    +++  E   L
Sbjct: 4   RRDIVLKWELGEGAFGKVFLAECHNLLPEQ-DKMLVAVKALK-EASESARQDFQREAELL 61

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-----KVLL--------PLPW 217
             L H ++V+  G C E    ++++E+M  G +   L S     K+L          L  
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
              + IA   A G+ +L  A    ++RD  T N L+      K+ DFG+++D    D   
Sbjct: 122 GQMLAIASQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           V  R M    +  PE I+    T  SD++SFGVVL EI T
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 76/293 (25%), Positives = 127/293 (43%), Gaps = 36/293 (12%)

Query: 117 DRVLGGGGFGCVYKG-FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-S 174
            + LG G FG V K   +  D     +   VAVK+   D + +   + ++E+  +  +  
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPN--ETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVEN--------NLFSKVLLPLPWSIRMK---- 222
           H N++ L+G C ++    ++ E+ A G++ +          ++    P P    +     
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 223 --IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
              A+  A+G+ FL  A K  I+RD    N+L+  D+  K++DFGLA+D    D    +T
Sbjct: 135 VSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 340
                  + APE +     T +SDV+SFGV+L EI T   S     P  E         L
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------LFKL 246

Query: 341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
           LKE  ++          + P     +   L   C +  P  RP  + +V+ L+
Sbjct: 247 LKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 40/214 (18%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 176
           + LG G FG V+ G+ +   +       VAVK +  G  S Q    +L E   +  L H 
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTK-------VAVKTLKPGTMSVQA---FLEEANLMKTLQHD 61

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS----KVLLPLPWSIRMKIAFGA--AKG 230
            LV+L     ++E   +I E+MA+GS+ + L S    KVLLP        I F A  A+G
Sbjct: 62  KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP------KLIDFSAQIAEG 115

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVSTRIM 283
           +A++    K  I+RD + +N+L+      K++DFGLA+          EG K  +     
Sbjct: 116 MAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK---- 169

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
               + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 170 ----WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 15/199 (7%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           +G G FG V+ G+  E  +       VA+K + +G  S +   +++ E   +  LSHP L
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-------VAIKTIREGAMSEE---DFIEEAQVMMKLSHPKL 61

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 238
           V+L G C E     L++EFM  G + + L ++          + +     +G+A+L  + 
Sbjct: 62  VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSN 120

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 298
             VI+RD    N L+  +   K+SDFG+ +   + D+   ST       +++PE      
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSK 177

Query: 299 LTPRSDVYSFGVVLLEILT 317
            + +SDV+SFGV++ E+ +
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 61/241 (25%), Positives = 110/241 (45%), Gaps = 18/241 (7%)

Query: 152 DGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV 211
              +S +  ++ L E+  +     P +V   G    + +  +  EFM  GS++     K 
Sbjct: 41  GAKSSVR--KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR--IYKK 96

Query: 212 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 271
             P+P  I  KIA    +GL +L+   + +++RD K SNIL+++    KL DFG++    
Sbjct: 97  GGPIPVEILGKIAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVS---- 151

Query: 272 EGDK-SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE 330
            G+  + ++   +GT  Y +PE I  G  T +SDV+S G+ ++E+  G+     S    +
Sbjct: 152 -GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210

Query: 331 QNLADWALPLLKEKKKLLNIIDPRL-EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                  + +L   ++++    PRL   D+P             CL  +P  RP  + + 
Sbjct: 211 GQDD--PMGILDLLQQIVQEPPPRLPSSDFP----EDLRDFVDACLLKDPTERPTPQQLC 264

Query: 390 D 390
            
Sbjct: 265 A 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 83.4 bits (206), Expect = 4e-18
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 13/209 (6%)

Query: 112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
            + + +R+LG G FG + +G +        + +PVA+       S +  R +LAE + LG
Sbjct: 5   KSIKIERILGTGRFGELCRGCLK---LPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG 61

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
              H N+V+L G        +++ E+M+ G++++ L  K    L     M +  G A G+
Sbjct: 62  QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGM 120

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG---Y 288
            +L  +E   +++      +L+++D   K+S F       E DKS      M       +
Sbjct: 121 KYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQE-DKSEAIYTTMSGKSPVLW 174

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           AAPE I   H +  SDV+SFG+V+ E+++
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.4 bits (206), Expect = 4e-18
 Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 30/209 (14%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           LG G FG V+ G+ +   +       VA+K +  G  S +    +LAE   +  L HP L
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-------VAIKSLKQGSMSPEA---FLAEANLMKQLQHPRL 63

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 238
           V+L     + E   +I E+M  GS+ + L +   + L  +  + +A   A+G+AF+    
Sbjct: 64  VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER-- 120

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVSTRIMGTYGYAAP 291
           K  I+RD + +NIL+      K++DFGLA+          EG K  +         + AP
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK--------WTAP 172

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
           E I  G  T +SDV+SFG++L EI+T GR
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 76/290 (26%), Positives = 128/290 (44%), Gaps = 34/290 (11%)

Query: 120 LGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPN 177
           LG G FG  V    I  D  +  +   VAVK+   D + +   + ++E+  +  +  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--------------MKI 223
           ++ L+G C +D    +I E+ ++G++   L ++    + +                 +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           A+  A+G+ +L  A K  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 146 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 343
               + APE +     T +SDV+SFGV+L EI T   S     P  E         LLKE
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKE 257

Query: 344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
             ++          D P    ++  M+   C +  P  RP  + +V+ L+
Sbjct: 258 GHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           +LG G FG V+KG + +         PVAVK    D   +   ++L+E   L    HPN+
Sbjct: 2   LLGKGNFGEVFKGTLKDK-------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 238
           VKLIG C + +   ++ E +  G   + L  K    L     +K A  AA G+A+L    
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE--S 111

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 298
           K  I+RD    N L+  +   K+SDFG+++   +G  S    + +    + APE +  G 
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGR 170

Query: 299 LTPRSDVYSFGVVLLEILT 317
            +  SDV+S+G++L E  +
Sbjct: 171 YSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 19/206 (9%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           R LG G FG V++G  +          PVAVK           +++LAE   +  L HP 
Sbjct: 12  RKLGAGQFGEVWEGLWNNT-------TPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPK 62

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLH 235
           L++L   C  +E   ++ E M  GS+   L       L LP  I M  A   A G+A+L 
Sbjct: 63  LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYLE 120

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRIMGTYGYAAPEYI 294
              +  I+RD    N+L+  +   K++DFGLA+   E   ++    +      + APE  
Sbjct: 121 A--QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAA 176

Query: 295 MTGHLTPRSDVYSFGVVLLEILT-GR 319
           +    + +SDV+SFG++L EI+T GR
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 82.8 bits (204), Expect = 8e-18
 Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 19/218 (8%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISE--DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 170
           N    R LG G FG   K F++E  +L      + VAVK    D S    +++  E   L
Sbjct: 6   NIVLKRELGEGAFG---KVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELL 61

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK----VLLP-------LPWSI 219
            +L H ++VK  G C E +  ++++E+M  G +   L +     VL+        L  S 
Sbjct: 62  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
            + IA   A G+ +L  A +  ++RD  T N L+  +   K+ DFG+++D    D   V 
Sbjct: 122 MLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
              M    +  PE IM    T  SDV+S GVVL EI T
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 41/218 (18%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK------VHDGDNSYQGHREWLAEVIFLG 171
             +G G  G V+K   ++D   G     VA+K      +  G        + L E+  L 
Sbjct: 6   GRIGEGAHGIVFK---AKDRETG---ETVALKKVALRRLEGG-----IPNQALREIKALQ 54

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL----PLPWSIRMKIAFGA 227
              HP +VKL+         VL+ E+M          S+VL     PLP +         
Sbjct: 55  ACQHPYVVKLLDVFPHGSGFVLVMEYMPSD------LSEVLRDEERPLPEAQVKSYMRML 108

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA---KDGPEGDKSH-VSTRIM 283
            KG+A++H     +++RD K +N+L+  D   K++DFGLA    +      SH V+TR  
Sbjct: 109 LKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-- 164

Query: 284 GTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGR 319
               Y APE ++ G     P  D+++ G +  E+L G 
Sbjct: 165 ---WYRAPE-LLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 26/218 (11%)

Query: 118 RVLGGGGFGCVYKGFISE--DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH 175
           R LG G FG   K F++E  +L      + VAVK    D +    +++  E   L +L H
Sbjct: 11  RELGEGAFG---KVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQH 66

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP----------------LPWSI 219
            ++VK  G C + +  ++++E+M  G +  N F +   P                L  S 
Sbjct: 67  EHIVKFYGVCGDGDPLIMVFEYMKHGDL--NKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
            + IA   A G+ +L  A +  ++RD  T N L+  +   K+ DFG+++D    D   V 
Sbjct: 125 MLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
              M    +  PE IM    T  SDV+SFGV+L EI T
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 120 LGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSYQGH----REWLAEVIFLGHLS 174
           LG GGFG V      S++    L+ V    K H  +   Q H    +E L E       +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVK---KRHIVETGQQEHIFSEKEILEEC------N 51

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGS-----VENNLFSKVLLPLPWSIRMKIAFGAAK 229
           HP +VKL     + ++  ++ E+   G       +  LF +      ++ R  IA     
Sbjct: 52  HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE------YTARFYIAC-VVL 104

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
              +LH   + +IYRD K  N+LLD++   KL DFG AK    G K+       GT  Y 
Sbjct: 105 AFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYV 159

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE I+        D +S G++L E+LTGR
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 22/228 (9%)

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMK 222
           +E+  L  L H N+V+ +G+   +E+  +  E++  GS+ + L  + +    L      +
Sbjct: 57  SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ 116

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +     +GLA+LH   K +++RD K  N+L+D D   K+SDFG++K   +   +  +  +
Sbjct: 117 VL----EGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 283 MGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 340
            G+  + APE I +     + + D++S G V+LE+  GR      RP  ++        L
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIAAMFKL 224

Query: 341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
             ++        P +  D  +     A      C   NP  RP  R++
Sbjct: 225 GNKRSA------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LGGG +G VY+G      +  L    VAVK    D       E+L E   +  + HPNLV
Sbjct: 14  LGGGQYGEVYEGVWK---KYSLT---VAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLV 65

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           +L+G C  +    +I EFM  G++ + L       +   + + +A   +  + +L   +K
Sbjct: 66  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KK 123

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVSTRIMGTYGYAAPE 292
             I+RD    N L+  ++  K++DFGL++           G K  +         + APE
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPE 175

Query: 293 YIMTGHLTPRSDVYSFGVVLLEILT 317
            +     + +SDV++FGV+L EI T
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 18/208 (8%)

Query: 118 RVLGGGGFGCVYK----GFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           + LG G FG V +    G    D       + VAVK+             ++E+  + HL
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSD-----AVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95

Query: 174 -SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
            +H N+V L+G C      ++I E+   G + N L  K    L     +  ++  AKG+A
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV---STRIMGTYGYA 289
           FL  A K  I+RD    N+LL      K+ DFGLA+D    D ++V   + R+     + 
Sbjct: 156 FL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVKWM 210

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILT 317
           APE I     T  SDV+S+G++L EI +
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 80.0 bits (197), Expect = 8e-17
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 21/227 (9%)

Query: 106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           EL +    F ++  LG   FG +YKG +     +  Q V  A+K     N+ Q   E+  
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLV--AIKTLKDINNPQQWGEFQQ 56

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------------- 210
           E   +  L HPN+V L+G   +++   +++E++ +G +   L  +               
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 211 VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 270
           V   L     + IA   A G+ +L  +    +++D    NIL+    + K+SD GL+++ 
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREI 174

Query: 271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
              D   V  + +    +  PE IM G  +  SD++SFGVVL EI +
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 79.7 bits (197), Expect = 8e-17
 Identities = 68/246 (27%), Positives = 104/246 (42%), Gaps = 26/246 (10%)

Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K  D +       E   EV  +   +HPN+VK        +   L+  +++ GS+ +
Sbjct: 29  VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLD 88

Query: 206 NLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
            + S      L  +I   +     KGL +LH   +  I+RD K  NILL  D + K++DF
Sbjct: 89  IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--IHRDIKAGNILLGEDGSVKIADF 146

Query: 265 G----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGR 319
           G    LA  G       V    +GT  + APE +   H    ++D++SFG+  +E+ TG 
Sbjct: 147 GVSASLADGG--DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204

Query: 320 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKA--AMLAYHCLNH 377
               K              P +K     L    P LE     K   K+   M++  CL  
Sbjct: 205 APYSK-------------YPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS-LCLQK 250

Query: 378 NPKARP 383
           +P  RP
Sbjct: 251 DPSKRP 256

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 36/241 (14%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
            +G G  G VYK       +E      VA+K        Q     + E++ +    HPN+
Sbjct: 26  KIGEGASGEVYKATDRATGKE------VAIKKMRLRK--QNKELIINEILIMKDCKHPNI 77

Query: 179 VKLIGYCCEDEHRVLIYEFMARGS----VENNLFSKVLLPLPWSIRMK---IAFGAA--- 228
           V         +   ++ E+M  GS    +  N            +RM    IA+      
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----------FVRMNEPQIAYVCREVL 126

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           +GL +LH   + VI+RD K+ NILL  D + KL+DFG A    +      S  ++GT  +
Sbjct: 127 QGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYW 182

Query: 289 AAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKK 346
            APE I       P+ D++S G++ +E+  G     +  P R   L     +P LK  +K
Sbjct: 183 MAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEK 241

Query: 347 L 347
            
Sbjct: 242 W 242

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 78/300 (26%), Positives = 123/300 (41%), Gaps = 33/300 (11%)

Query: 101 AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 160
           AF    L+ IT        LG G FG V+         EG +   V VK           
Sbjct: 1   AFPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGE-TLVLVKALQKTKDENLQ 52

Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF-----SKVLLPL 215
            E+  E+     LSH N+V+L+G C E E   +I E+   G ++  L       + L P 
Sbjct: 53  SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP 112

Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
           P S + K+A      L   H +    ++RD    N L+ +    K+S   L+KD    + 
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172

Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 335
             +   ++    + APE +     + +SDV+SFGV++ E+ T  + L     + E+ L  
Sbjct: 173 YKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE-LPFYGLSDEEVLNR 230

Query: 336 WALPLLKEKKKLLNIID--PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                L+  K  L + +  P          ++K   L   C   NPK RP   ++V +L 
Sbjct: 231 -----LQAGKLELPVPEGCP--------SRLYK---LMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 51/182 (28%), Positives = 76/182 (41%), Gaps = 28/182 (15%)

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  L+HP LV L     ++E+  L+ + +  G             L + +  K+
Sbjct: 48  LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD------------LRYHLSQKV 95

Query: 224 AFGAAK----------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
            F   +           L +LH   K +I+RD K  NILLD   +  ++DF +A      
Sbjct: 96  KFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153

Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD-KSRPAREQN 332
                +T   GT GY APE +     +   D +S GV   E L G++     SR  R+Q 
Sbjct: 154 TL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Query: 333 LA 334
            A
Sbjct: 211 RA 212

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 78/318 (24%), Positives = 140/318 (44%), Gaps = 41/318 (12%)

Query: 97  NPLIAFTYDELRIITANFRQDRVLGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDN 155
           +P   F+ D+L +        + LG G FG  V    +  D  +  + V VAVK+   D 
Sbjct: 7   DPRWEFSRDKLTL-------GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA 59

Query: 156 SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP 214
           + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++   L ++    
Sbjct: 60  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119

Query: 215 LPWSIRM--------------KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 260
           + +S  +                 +  A+G+ +L  A +  I+RD    N+L+  +   K
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMK 177

Query: 261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK 320
           ++DFGLA+D    D    +T       + APE +     T +SDV+SFGV++ EI T   
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237

Query: 321 SLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPK 380
           S     P  E         LLKE  ++          D P    ++  M+   C +  P 
Sbjct: 238 SPYPGIPVEE------LFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPS 281

Query: 381 ARPLMRDIVDSLEPLQVL 398
            RP  + +V+ L+ +  L
Sbjct: 282 HRPTFKQLVEDLDRILTL 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 33/273 (12%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           +++  ++G G +G VY+G      R       VA+K+ + D       +   EV  L  L
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGR------VVALKIINLDTPDDDVSDIQREVALLSQL 56

Query: 174 SH---PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
                PN+ K  G   +     +I E+   GSV   + +  +     S+ ++    A   
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA--- 113

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L ++H+    VI+RD K +NIL+    N KL DFG+A    +   S   +  +GT  + A
Sbjct: 114 LKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMA 169

Query: 291 PEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 349
           PE I  G     ++D++S G+ + E+ TG          R       A+ L+ + K    
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMMLIPKSKP--- 219

Query: 350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR 382
              PRLE +   K + +   +A  CL+  PK R
Sbjct: 220 ---PRLEDNGYSKLLRE--FVAA-CLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 44/286 (15%)

Query: 118 RVLGGGGFG--CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH 175
           RVLG G FG   +Y+   +ED       + V  +V+    S +  R+ L E++ L  L H
Sbjct: 6   RVLGKGAFGEATLYRR--TED-----DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL----LPLPWSIRMKIAFGAAKGL 231
           PN++    +   D++ +LI    A G     L+ K++          + +   F     +
Sbjct: 59  PNIIAYYNHF-MDDNTLLIEMEYANGG---TLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           +++H+A   +++RD KT NI L      KL DFG++K    G +  ++  ++GT  Y +P
Sbjct: 115 SYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSP 170

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 351
           E         +SD+++ G VL E+LT +++ D + P                    LN++
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------------------LNLV 210

Query: 352 DPRLEGDY-PVKGVHKAAM--LAYHCLNHNPKARPLMRDIVDSLEP 394
              ++G+Y PV  V+ + +  L +  L  +P+ RP   +++D    
Sbjct: 211 VKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 24/221 (10%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           F     LG G +G VYK    E  +       VA+KV   +   Q   E + E+  L   
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQ------VVAIKVVPVEEDLQ---EIIKEISILKQC 55

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAF---GAA 228
             P +VK  G   ++    ++ E+   GSV +   + +K L         +IA       
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL------TEEEIAAILYQTL 109

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           KGL +LH  +K  I+RD K  NILL+ +  AKL+DFG++  G   D       ++GT  +
Sbjct: 110 KGLEYLHSNKK--IHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFW 165

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
            APE I       ++D++S G+  +E+  G+       P R
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 39/290 (13%)

Query: 118 RVLGGGGFGCVYKGFISED---LREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS 174
           + LG G FG V +G +++D   L+  ++ + +A+       +     ++L+E + +    
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI------CTRSEMEDFLSEAVCMKEFD 58

Query: 175 HPNLVKLIGYCCEDEHR------VLIYEFMARGSVENNLFSKVL----LPLPWSIRMKIA 224
           HPN+++LIG C +          V+I  FM  G + + L    L      LP  + +K  
Sbjct: 59  HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
              A G+ +L  + K  I+RD    N +L+ + N  ++DFGL+K    GD          
Sbjct: 119 TDIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWALPLLKE 343
              + A E +     T +SDV+SFGV + EI T  ++     P  E + + D+    L++
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT---PYPGVENSEIYDY----LRQ 229

Query: 344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
             +L    D  L+G Y          L   C   NPK RP    +   LE
Sbjct: 230 GNRLKQPPDC-LDGLYS---------LMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 69/206 (33%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWL-AEVIFLGHLSHPN 177
           +G G  G VYK      +R       +AVK +    N  +  R  +  +V+   H   P 
Sbjct: 23  IGSGTCGQVYK------MRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDC-PY 75

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
           +VK  GY   D    +  E M+  +  + L  ++  P+P  I  K+     K L +L E 
Sbjct: 76  IVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE- 132

Query: 238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG 297
           +  VI+RD K SNILLD   N KL DFG++  G   D S   TR  G   Y APE I   
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMAPERIDPP 189

Query: 298 HLTP----RSDVYSFGVVLLEILTGR 319
              P    R+DV+S G+ L+E+ TG+
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 12/202 (5%)

Query: 117 DRVLGGGGFGCVYKG-FIS-EDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS 174
            R +G G FG VY+G ++S E+ +     + VAVK      S     ++L E   +    
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEK-----IAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL 234
           HP++VKLIG    +    ++ E    G + + L       L  +  +  ++  +  LA+L
Sbjct: 66  HPHIVKLIG-VITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYL 123

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI 294
               K  ++RD    N+L+ +    KL DFGL++   E +  + +++      + APE I
Sbjct: 124 E--SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESI 180

Query: 295 MTGHLTPRSDVYSFGVVLLEIL 316
                T  SDV+ FGV + EIL
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 76.9 bits (189), Expect = 8e-16
 Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 16/215 (7%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGH 172
           F   R+LG G FG V +  +  +         VAVK+   D  S     E+L E   +  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSF---QKVAVKMLKADIFSSSDIEEFLREAACMKE 57

Query: 173 LSHPNLVKLIGYCCEDEHR------VLIYEFMARGSVENNLFSKVL----LPLPWSIRMK 222
             HPN++KLIG       +      ++I  FM  G +   L    +      LP    ++
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
                A G+ +L  + K  I+RD    N +L+ +    ++DFGL+K    GD        
Sbjct: 118 FMIDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                + A E +     T  SDV++FGV + EI+T
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 88/307 (28%), Positives = 132/307 (42%), Gaps = 64/307 (20%)

Query: 120 LGGGGFG----CVYKGFISEDLREGLQPVPVAVK--VHDGDNSYQGHREWLAEVIFLGHL 173
           LG G FG    C Y     + L++    V VAVK   H         R++  E+  L  L
Sbjct: 12  LGKGNFGSVELCRY-----DPLQDNTGEV-VAVKKLQHSTAEHL---RDFEREIEILKSL 62

Query: 174 SHPNLVKLIGYCCEDEHR--VLIYEFMARGSV----ENN---LFSKVLLPLPWSIRMKIA 224
            H N+VK  G C     R   L+ E++  GS+    + +   L  + LL     I     
Sbjct: 63  QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI----- 117

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
               KG+ +L    K  ++RD  T NIL++++   K+ DFGL K  P+ DK +   R  G
Sbjct: 118 ---CKGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPG 171

Query: 285 ---TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR-PARE---------- 330
               + Y APE +     +  SDV+SFGVVL E+ T     DKS  P  E          
Sbjct: 172 ESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMMGNDKQ 227

Query: 331 -QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
            Q +    + LLK   +L     P   G  P + ++    +   C N++P  RP   ++ 
Sbjct: 228 GQMIVYHLIELLKNNGRL-----PAPPG-CPAE-IY---AIMKECWNNDPSQRPSFSELA 277

Query: 390 DSLEPLQ 396
             +E ++
Sbjct: 278 LQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.4 bits (188), Expect = 9e-16
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 18/211 (8%)

Query: 119 VLGGGGFGCVYKGF--ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLGHLSH 175
           ++G G FG VY G    S +L    Q    +V      +  +   + LA E+  L  L H
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSA-SSKDRKRSMLDALAREIALLKELQH 65

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
            N+V+ +G   + +H  +  E++  GSV    N +      L  +   +I     KGL +
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNY 121

Query: 234 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-----IMGTYGY 288
           LH   + +I+RD K +NIL+D     K+SDFG++K   E +     T      + G+  +
Sbjct: 122 LHN--RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSLQGSVFW 178

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            APE +     T ++D++S G +++E+LTG+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 18/151 (11%)

Query: 175 HPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK--- 229
           HP L +L  + C    +    + E++  G +  ++        P +      F AA+   
Sbjct: 55  HPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRAR-----FYAAEIVL 107

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTYGY 288
           GL FLHE  + +IYRD K  N+LLD++ + K++DFG+ K+G  G    V+T    GT  Y
Sbjct: 108 GLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDY 162

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            APE +      P  D ++ GV+L E+L G+
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 74/222 (33%), Positives = 115/222 (51%), Gaps = 35/222 (15%)

Query: 116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS- 174
           QD V+G G FG V K  I +D   GL+ +  A+K      S   HR++  E+  L  L  
Sbjct: 12  QD-VIGEGNFGQVLKARIKKD---GLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 175 HPNLVKLIGYCCEDEHRVLIY---EFMARGSVENNLF-SKVLLPLP-----------WSI 219
           HPN++ L+G C   EHR  +Y   E+   G++ + L  S+VL   P            S 
Sbjct: 67  HPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 220 RMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
           +  + F A  A+G+ +L  ++K  I+RD    NIL+  +Y AK++DFGL++    G + +
Sbjct: 124 QQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 177

Query: 278 VSTRIMGTYG--YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           V  + MG     + A E +     T  SDV+S+GV+L EI++
Sbjct: 178 VK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 76/272 (27%), Positives = 115/272 (42%), Gaps = 34/272 (12%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           +G G FG VYKG I    +E      VA+K+ D + +     +   E+  L     P + 
Sbjct: 12  IGKGSFGEVYKG-IDNRTKE-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           +  G   +     +I E++  GS  + L      PL  +    I     KGL +LH   K
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERK 122

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
             I+RD K +N+LL    + KL+DFG+A  G   D        +GT  + APE I     
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 300 TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDY 359
             ++D++S G+  +E+  G        P R   L     P             P LEG Y
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQY 225

Query: 360 --PVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
             P K   +A      CLN +P+ RP  ++++
Sbjct: 226 SKPFKEFVEA------CLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 33/213 (15%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNL 178
           +G G +G VYK     + + G     VA+K    +N  +G     + E+  L  L HPN+
Sbjct: 7   IGEGTYGQVYKA---RNKKTG---ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 179 VKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------- 229
           V+L             +++E+M     +++L + +L     S  +K      K       
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYM-----DHDL-TGLLD----SPEVKFTESQIKCYMKQLL 110

Query: 230 -GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
            GL +LH     +++RD K SNIL++ D   KL+DFGLA+       S   T  + T  Y
Sbjct: 111 EGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWY 167

Query: 289 AAPEYIMTG--HLTPRSDVYSFGVVLLEILTGR 319
             PE ++ G     P  D++S G +L E+  G+
Sbjct: 168 RPPE-LLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 74/293 (25%), Positives = 132/293 (45%), Gaps = 36/293 (12%)

Query: 120 LGGGGFGCVYK--GFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HP 176
           LG G FG V +   +  +  R   Q V VAVK+   + + +   + ++E+  +  +  H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPD-QTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNL-----------FSKVLLP---LPWSIRMK 222
           N++ L+G C ++    +I E+ A+G++   L           F    +P   L +   + 
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
            A+  A+G+ +L    +  I+RD    N+L+  D   K++DFGLA+   + D    ++  
Sbjct: 139 CAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK 342
                + APE +     T +SDV+SFG+++ EI T   S     P  E         LL+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE------LFKLLR 250

Query: 343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
           E  ++          D P    H+  ML   C +  P  RP  + +V++L+ +
Sbjct: 251 EGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 60/237 (25%), Positives = 95/237 (40%), Gaps = 49/237 (20%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG------DNSYQGHREWLAE 166
           +F+  +++G G F  V      E  +E       A+K+ D               E    
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKE------YAIKILDKRQLIKEKKVKYVKIEKEV- 54

Query: 167 VIFLGHLS-HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
              L  L+ HP ++KL  Y  +DE  +  + E+       N    + +     S+  K  
Sbjct: 55  ---LTRLNGHPGIIKLY-YTFQDEENLYFVLEY-----APNGELLQYIRKYG-SLDEKCT 104

Query: 225 -FGAA---KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS---- 276
            F AA     L +LH   K +I+RD K  NILLD D + K++DFG AK            
Sbjct: 105 RFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Query: 277 HVSTRIM--------------GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             +T I               GT  Y +PE +        SD+++ G ++ ++LTG+
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 79/278 (28%), Positives = 122/278 (43%), Gaps = 34/278 (12%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           F +   +G G FG V+KG    D R   Q V VA+K+ D + +     +   E+  L   
Sbjct: 6   FTKLEKIGKGSFGEVFKGI---DNRT--QKV-VAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
             P + K  G   +D    +I E++  GS  + L      PL  +    I     KGL +
Sbjct: 60  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDY 116

Query: 234 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 293
           LH  +K  I+RD K +N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 294 IMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP 353
           I       ++D++S G+  +E+  G     +  P +        L L+ +         P
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNP------P 219

Query: 354 RLEGDY--PVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
            LEG+Y  P+K   +A      CLN  P  RP  ++++
Sbjct: 220 TLEGNYSKPLKEFVEA------CLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.0 bits (192), Expect = 3e-15
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 39/254 (15%)

Query: 146 VAVKVHDGDNSYQGHR--EWLAEVIFLGHLSHPNLVKLIGY-CCEDEHRVLIYEFMARGS 202
           VA+K+   D   + H+   +  E      L HPN+V L+            ++E++   +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 203 VENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNA 259
           +   L +   LP   + R+ +       LA  H     +++RD K  NI++       +A
Sbjct: 66  LREVLAADGALPAGETGRLMLQ--VLDALACAHNQG--IVHRDLKPQNIMVSQTGVRPHA 121

Query: 260 KLSDFGLAKDGP---EGDKSHVS--TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 314
           K+ DFG+    P   + D + ++  T ++GT  Y APE +    +TP SD+Y++G++ LE
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181

Query: 315 ILTGRKSLDKSRPAR--EQNLA--DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAML 370
            LTG++ +  +  A    Q L+  D +LP             P + G       H    +
Sbjct: 182 CLTGQRVVQGASVAEILYQQLSPVDVSLP-------------PWIAG-------HPLGQV 221

Query: 371 AYHCLNHNPKARPL 384
               LN +P+ R  
Sbjct: 222 LRKALNKDPRQRAA 235

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 73/210 (34%), Positives = 108/210 (51%), Gaps = 26/210 (12%)

Query: 118 RVLGGGGFGCVY--KGFISEDLREGLQPVPV----AVKVHDGDNSYQGHREWLAEVIFLG 171
           +VLG G FG V+  +     D  + L  + V     +KV D   + +  R+ LAEV    
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQ-LYAMKVLKKATLKVRDRVRT-KMERDILAEV---- 55

Query: 172 HLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 229
             +HP +VKL  Y  + E ++ LI +F+  G +   L  +V+          + F  A+ 
Sbjct: 56  --NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-----TEEDVKFYLAEL 107

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            LA  H     +IYRD K  NILLD + + KL+DFGL+K+  + +K   S    GT  Y 
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165

Query: 290 APEYI-MTGHLTPRSDVYSFGVVLLEILTG 318
           APE +   GH T  +D +SFGV++ E+LTG
Sbjct: 166 APEVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 25/204 (12%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR-EWLAEVIFLGHLSHPNL 178
           LG G FG V KG     +++  + V  AVK+   DN+    + E L E   +  L +P +
Sbjct: 3   LGSGNFGTVKKGMYK--MKKSEKTV--AVKILKNDNNDPALKDELLREANVMQQLDNPYI 58

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVEN------NLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           V++IG  CE E  +L+ E    G +        ++  K +  L   + M        G+ 
Sbjct: 59  VRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMK 109

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAA 290
           +L E     ++RD    N+LL T + AK+SDFGL+K     D+++   +  G +   + A
Sbjct: 110 YLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYA 166

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLE 314
           PE +     + +SDV+SFGV++ E
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 8e-15
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G FG VYK   ++    GL      +++   +       +++ E+  L    HPN+V
Sbjct: 13  LGDGAFGKVYK---AQHKETGLFAAAKIIQIESEEEL----EDFMVEIDILSECKHPNIV 65

Query: 180 KLI-GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 238
            L   Y  E++  +LI EF   G++++ +  ++   L       +     + L FLH   
Sbjct: 66  GLYEAYFYENKLWILI-EFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHS-- 121

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYAAPEYIM-- 295
             VI+RD K  NILL  D + KL+DFG+ AK+     K       +GT  + APE +   
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACE 178

Query: 296 TGHLTP---RSDVYSFGVVLLEILTGR 319
           T    P   ++D++S G+ L+E+    
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.5 bits (184), Expect = 9e-15
 Identities = 58/176 (32%), Positives = 86/176 (48%), Gaps = 43/176 (24%)

Query: 166 EVIFLGHLS-HPNLVKLIGYCCEDEHRV-------LIYEFMARGSVENNLFSKVLLPLPW 217
           E++FL  L  HPN+VKL+     +  +        L++E+M     E +L   V      
Sbjct: 56  EIMFLQELGDHPNIVKLL-----NVIKAENDKDIYLVFEYM-----ETDL-HAV------ 98

Query: 218 SIRMK---------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK 268
            IR           I +   K L ++H     VI+RD K SNILL++D   KL+DFGLA+
Sbjct: 99  -IRANILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR 155

Query: 269 ---DGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGR 319
              +  E  ++ V T  + T  Y APE I+ G    T   D++S G +L E+L G+
Sbjct: 156 SLSELEENPENPVLTDYVATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.4 bits (181), Expect = 9e-15
 Identities = 57/218 (26%), Positives = 85/218 (38%), Gaps = 34/218 (15%)

Query: 119 VLGGGGFGCVYK------GFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-AEVIFLG 171
            +G G FG V K      G I            +  K  D  N  +  ++ L +EV  L 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKI------------LVWKEIDYGNMTEKEKQQLVSEVNILR 54

Query: 172 HLSHPNLVKLIGYCC-EDEHRVLIY-EFMARGSVENNL--FSKVLLPLPWSIRMKIAFGA 227
            L HPN+V+            + I  E+   G +   +    K    +      +I    
Sbjct: 55  ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 228 AKGLAFLHEAEKP---VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTR 281
              L   H    P   V++RD K +NI LD + N KL DFGLAK         K++V   
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV--- 171

Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             GT  Y +PE +       +SD++S G ++ E+    
Sbjct: 172 --GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 67/219 (30%), Positives = 113/219 (51%), Gaps = 34/219 (15%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPN 177
           V+G G FG V +  I +D   GL+ +  A+K+     S   HR++  E+  L  L  HPN
Sbjct: 9   VIGEGNFGQVIRAMIKKD---GLK-MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 178 LVKLIGYCCEDEHRVLIY---EFMARGSVENNLF-SKVLLPLPWSIR------------- 220
           ++ L+G C   E+R  +Y   E+   G++ + L  S+VL   P   +             
Sbjct: 65  IINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           ++ A   A G+ +L  +EK  I+RD    N+L+  +  +K++DFGL++    G++ +V  
Sbjct: 122 LQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK- 174

Query: 281 RIMGTYG--YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           + MG     + A E +     T +SDV+SFGV+L EI++
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 11/199 (5%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           +G G FG V+ G +  D        PVAVK            ++L E   L   SHPN+V
Sbjct: 3   IGRGNFGEVFSGRLRAD------NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSK-VLLPLPWSIRMKIAFGAAKGLAFLHEAE 238
           +LIG C + +   ++ E +  G     L ++   L +   I+M     AA G+ +L    
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM--VENAAAGMEYLE--S 112

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 298
           K  I+RD    N L+      K+SDFG++++  +G  +           + APE +  G 
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 299 LTPRSDVYSFGVVLLEILT 317
            +  SDV+SFG++L E  +
Sbjct: 173 YSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 35/276 (12%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           +LG G  G VYK +     R       +AVKV   D + +  ++ ++E+  L     P +
Sbjct: 8   ILGHGNGGTVYKAYHLLTRR------ILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 238
           +   G    +    +  EFM  GS++      V   +P  +  +IA    KGL +L   +
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLD------VYRKIPEHVLGRIAVAVVKGLTYLWSLK 115

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 298
             +++RD K SN+L++T    KL DFG++        + ++   +GT  Y APE I    
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ----LVNSIAKTYVGTNAYMAPERISGEQ 169

Query: 299 LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGD 358
               SDV+S G+  +E+  GR       P  ++N     +PL     +LL  I   ++ D
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPY----PQIQKNQGS-LMPL-----QLLQCI---VDED 216

Query: 359 YPVKGVHKAAMLAYH----CLNHNPKARPLMRDIVD 390
            PV  V + +    H    C+   PK RP   +++D
Sbjct: 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 28/216 (12%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PN 177
           V+G G FG V K  I +D   GL+ +  A+K      S   HR++  E+  L  L H PN
Sbjct: 2   VIGEGNFGQVLKARIKKD---GLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLF-SKVLLPLPWSIR-------------MKI 223
           ++ L+G C    +  L  E+   G++ + L  S+VL   P                 +  
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           A   A+G+ +L  ++K  I+RD    NIL+  +Y AK++DFGL++    G + +V  + M
Sbjct: 118 AADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTM 170

Query: 284 GTYG--YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           G     + A E +     T  SDV+S+GV+L EI++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 21/202 (10%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           LG G FG V  G       +      VA+K + +G  S     E++ E   +  LSH  L
Sbjct: 12  LGTGQFGVVKYG-------KWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKL 61

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 238
           V+L G C +     ++ E+M+ G + N L        P  + +++     +G+A+L    
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLE--S 118

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIM 295
           K  I+RD    N L+D     K+SDFGL++     D  + S+  +G+     ++ PE ++
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPPEVLL 174

Query: 296 TGHLTPRSDVYSFGVVLLEILT 317
               + +SDV++FGV++ E+ +
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 76/304 (25%), Positives = 104/304 (34%), Gaps = 73/304 (24%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVK----VHDGDNSYQGHREWLAEVIFLGHLS 174
           V+G G +G V K       R       VA+K      D ++     +  L EV  L  L 
Sbjct: 8   VVGEGAYGVVLK------CRNKATGEIVAIKKFKESEDDEDV---KKTALREVKVLRQLR 58

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP-----LPWSIRMKIAFGAAK 229
           H N+V L           L++E+     VE  L    LL      LP        +   +
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEY-----VERTLLE--LLEASPGGLPPDAVRSYIWQLLQ 111

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH----VSTRIMGT 285
            +A+ H     +I+RD K  NIL+      KL DFG A+       S     V+TR    
Sbjct: 112 AIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR---- 165

Query: 286 YGYAAPE----YIMTGHLTPRSDVYSFGVVLLEILTGR----------------KSLDKS 325
             Y APE        G      DV++ G ++ E+L G                 K L   
Sbjct: 166 -WYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221

Query: 326 RPA------REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP 379
            P+           A  A P   +        +  LE  YP K    A      CL  +P
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQ-------PES-LERRYPGKVSSPALDFLKACLRMDP 273

Query: 380 KARP 383
           K R 
Sbjct: 274 KERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 59/217 (27%), Positives = 88/217 (40%), Gaps = 43/217 (19%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-------------QGHREWLAE 166
           LG GGFG V                  A +V      Y             +G +  L E
Sbjct: 1   LGKGGFGEVC-----------------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNE 43

Query: 167 VIFLGHLSHPNLVKLIGYCCED-EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
              L  +S   +V L  Y  E  +   L+   M  G ++ ++++      P +   +  F
Sbjct: 44  KKILEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA---RAIF 99

Query: 226 GAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
            AA+   GL  LH+  + ++YRD K  N+LLD   N ++SD GLA +   G K       
Sbjct: 100 YAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA-- 155

Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT GY APE +         D ++ G  L E++ GR
Sbjct: 156 -GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 13/213 (6%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
            + + RV+G G FG V+      D +   ++ +PV     D   + Q       E   L 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN------ECQVLK 54

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            LSHPN+++      ED+  +++ E+   G++   +  +    L     +   F     L
Sbjct: 55  LLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILH--FFVQILL 112

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           A  H   K +++RD KT NILLD      K+ DFG++K      KS   T ++GT  Y +
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYIS 169

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
           PE         +SD+++ G VL E+ + +++ +
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.8 bits (176), Expect = 4e-14
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 29/212 (13%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           VLG G +G VY      DL   ++     +   D       H E    +    +L H N+
Sbjct: 15  VLGKGTYGIVYAA---RDLSTQVRIAIKEIPERDSRYVQPLHEE----IALHSYLKHRNI 67

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA--KGLAFLHE 236
           V+ +G   E+    +  E +  GS+   L SK   PL  + +  I +     +GL +LH+
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 237 AEKPVIYRDFKTSNILLDTDYNA--KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAA 290
            +  +++RD K  N+L++T Y+   K+SDFG    LA   P       +    GT  Y A
Sbjct: 127 NQ--IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMA 177

Query: 291 PEYI---MTGHLTPRSDVYSFGVVLLEILTGR 319
           PE I     G+  P +D++S G  ++E+ TG+
Sbjct: 178 PEVIDKGPRGYGAP-ADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 54/150 (36%), Positives = 77/150 (51%), Gaps = 16/150 (10%)

Query: 175 HPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK--- 229
           HP L  L  YC     E+   + E++  G +  ++ S     LP     +  F AA+   
Sbjct: 55  HPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP-----RATFYAAEIIC 107

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           GL FLH   K ++YRD K  NILLDTD + K++DFG+ K+   GD    +    GT  Y 
Sbjct: 108 GLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYI 163

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE ++        D +SFGV+L E+L G+
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 71.5 bits (176), Expect = 7e-14
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 27/217 (12%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK---VHDGDNSYQG-HREWLAEVI 168
            + + + LG G +  VYK    E  R       VA+K   + +   +  G +   L E+ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGR------IVAIKKIKLGERKEAKDGINFTALREIK 54

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKIAFG 226
            L  L HPN++ L+       +  L++EFM    +E  +  K ++  P  I+  M +   
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL- 112

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDK--SHVSTRIM 283
             +GL +LH     +++RD K +N+L+ +D   KL+DFGLA+  G    K    V TR  
Sbjct: 113 --RGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW- 167

Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
               Y APE +    H     D++S G +  E+L   
Sbjct: 168 ----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 80/261 (30%), Positives = 116/261 (44%), Gaps = 44/261 (16%)

Query: 133 ISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLIG-YCCEDEH 190
           I+ D   G Q   VAVK  D     Q  RE L  EV+ +    HPN+V++   Y   DE 
Sbjct: 37  IATDKSTGRQ---VAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL 91

Query: 191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYR 244
            V++ EF+  G+         L  +    RM       +     K L+FLH   + VI+R
Sbjct: 92  WVVM-EFLEGGA---------LTDIVTHTRMNEEQIATVCLAVLKALSFLHA--QGVIHR 139

Query: 245 DFKTSNILLDTDYNAKLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
           D K+ +ILL +D   KLSDFG    ++K+ P   KS V     GT  + APE I      
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLV-----GTPYWMAPEVISRLPYG 193

Query: 301 PRSDVYSFGVVLLEILTGRKSLDKSRPARE-QNLADWALPLLKEKKKLLNIIDPRLEG-- 357
              D++S G++++E++ G        P +  + + D   P LK   K    + PRL    
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK----VSPRLRSFL 249

Query: 358 -DYPVKGVHKAAMLAYHCLNH 377
               V+   + A  A   LNH
Sbjct: 250 DRMLVRDPAQRAT-AAELLNH 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.9 bits (173), Expect = 8e-14
 Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 17/214 (7%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA---EVIF 169
           N+R+ ++LG G FG VY  +  +  RE       A +V     S +  +E  A   E+  
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRE-----LAAKQVQFDPESPETSKEVSALECEIQL 57

Query: 170 LGHLSHPNLVKLIGYCCED--EHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           L +L H  +V+  G C  D  E  + I+ E+M  GSV++ L  K    L  S+  K    
Sbjct: 58  LKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQ 114

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-IMGT 285
             +G+++LH     +++RD K +NIL D+  N KL DFG +K       S    R + GT
Sbjct: 115 ILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             + +PE I       ++DV+S G  ++E+LT +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 69/233 (29%), Positives = 95/233 (40%), Gaps = 42/233 (18%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPN 177
           V+G G +G VYK       + G     VA+K+ D     +   E   E   L   S HPN
Sbjct: 13  VIGEGTYGKVYKA---RHKKTGQL---VAIKIMDIIEDEE--EEIKEEYNILRKYSNHPN 64

Query: 178 LVKLIG-------YCCEDEHRVLIYEFMARGS----VENNLFSKVLLPLPWSIRMKIAF- 225
           +    G          +D+   L+ E    GS    V+        L   W     IA+ 
Sbjct: 65  IATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYI 118

Query: 226 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
                +GLA+LHE    VI+RD K  NILL  +   KL DFG++        S +  R  
Sbjct: 119 LRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DSTLGRRNT 172

Query: 282 IMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
            +GT  + APE I            RSDV+S G+  +E+  G+  L    P R
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 80/254 (31%), Positives = 119/254 (46%), Gaps = 47/254 (18%)

Query: 174 SHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK--- 229
           +HP LV L   C + E R+  + EF++ G +  ++  +  LP          F +A+   
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLP-----EEHARFYSAEISL 107

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIMGTYGY 288
            L FLHE  + +IYRD K  N+LLD + + KL+D+G+ K+G   GD    ++   GT  Y
Sbjct: 108 ALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNY 162

Query: 289 AAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWALPLLKEKK 345
            APE I+ G     S D ++ GV++ E++ GR   D        +QN  D+   ++ EK+
Sbjct: 163 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ 221

Query: 346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PLMRDI-V 389
               I  PR      V    KA+ +    LN +PK R               P  R+I  
Sbjct: 222 ----IRIPR---SLSV----KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270

Query: 390 DSLEPLQVLPDEAP 403
           D LE  QVLP   P
Sbjct: 271 DLLEQKQVLPPYKP 284

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G FG VYK    E        V  A KV D   S +   +++ E+  L    HPN+V
Sbjct: 13  LGDGAFGKVYKAQNKE------TGVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIV 65

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           KL+     + +  ++ EF A G+V+  +  ++  PL       +     + L +LHE + 
Sbjct: 66  KLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLHENK- 123

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TG 297
            +I+RD K  NIL   D + KL+DFG++       +   S   +GT  + APE +M  T 
Sbjct: 124 -IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETS 180

Query: 298 HLTP---RSDVYSFGVVLLEI 315
              P   ++DV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 46/220 (20%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA--EVIFLGHL-S 174
           + LG G FG VY     E          VA+K       +    E +   EV  L  L  
Sbjct: 5   KQLGDGTFGSVYLARNKETGEL------VAIKKMK--KKFYSWEECMNLREVKSLRKLNE 56

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF----SKVLLPLPWSIRMKIAFGAAKG 230
           HPN+VKL     E++    ++E+M     E NL+     +   P   S+   I +   +G
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD----GPEGDKSHVSTRIMGTY 286
           LA +H+      +RD K  N+L+      K++DFGLA++     P  D  +VSTR     
Sbjct: 112 LAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR----- 162

Query: 287 GYAAPEYIMTGHLTPRSDVYS-------FGVVLLEILTGR 319
            Y APE ++      RS  YS        G ++ E+ T R
Sbjct: 163 WYRAPEILL------RSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 47/254 (18%)

Query: 174 SHPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFSKVLLPLP----WSIRMKIAFGAA 228
           +HP LV L   C + E R+  + E++  G +  ++  +  LP      +S  + +A    
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA---- 108

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTRIMGTYG 287
             L +LHE  + +IYRD K  N+LLD++ + KL+D+G+ K+G   GD    ++   GT  
Sbjct: 109 --LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPN 161

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWALPLLKEKK 345
           Y APE +         D ++ GV++ E++ GR   D   S    +QN  D+   ++ EK+
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 221

Query: 346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PLMRDI-V 389
             +           P     KAA +    LN +PK R               P  R++  
Sbjct: 222 IRI-----------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270

Query: 390 DSLEPLQVLPDEAP 403
           D +E  QV+P   P
Sbjct: 271 DLMEQKQVVPPFKP 284

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 49/215 (22%)

Query: 120 LGGGGFGCVYKG--FISEDLREGLQPVPVAVKV---HDGDN--SYQGHREWLAEVIFLGH 172
           +G G +G VYK     + +L        VA+KV     GD+    Q       E+  L  
Sbjct: 11  IGSGTYGDVYKARDIATGEL--------VAIKVIKLEPGDDFEIIQQ------EISMLKE 56

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
             HPN+V   G     +   ++ E+   GS+++ ++     PL       +     KGLA
Sbjct: 57  CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLA 115

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI---------- 282
           +LHE  K  I+RD K +NILL  D + KL+DFG            VS ++          
Sbjct: 116 YLHETGK--IHRDIKGANILLTEDGDVKLADFG------------VSAQLTATIAKRKSF 161

Query: 283 MGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLE 314
           +GT  + APE       G    + D+++ G+  +E
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 29/217 (13%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEV 167
           I   + + ++ LG G FG V+    ++  +       VAVK +  G  S +    +LAE 
Sbjct: 3   IPRESLKLEKKLGAGQFGEVWMATYNKHTK-------VAVKTMKPGSMSVEA---FLAEA 52

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA 227
             +  L H  LVKL     + E   +I EFMA+GS+ + L S      P    +  +   
Sbjct: 53  NVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 111

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVST 280
           A+G+AF+ +  +  I+RD + +NIL+      K++DFGLA+          EG K  +  
Sbjct: 112 AEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK- 168

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                  + APE I  G  T +SDV+SFG++L+EI+T
Sbjct: 169 -------WTAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           F   R +G G FG VY    + D+R   + V +    + G  S +  ++ + EV FL  +
Sbjct: 27  FTDLREIGHGSFGAVY---FARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI 82

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
            HPN ++  G C   EH   +      GS  ++L      PL       I  GA +GLA+
Sbjct: 83  KHPNSIEYKG-CYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAY 140

Query: 234 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 293
           LH     +I+RD K  NILL      KL+DFG A        +  +   +GT  + APE 
Sbjct: 141 LHSHN--MIHRDIKAGNILLTEPGQVKLADFGSAS------IASPANSFVGTPYWMAPEV 192

Query: 294 IMT---GHLTPRSDVYSFGVVLLEI 315
           I+    G    + DV+S G+  +E+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 33/161 (20%)

Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFS---KV-LLPLPWSIRMKIA 224
           L  + HP LV L G   +D+  + L+ E++  G     LFS   K    P P +      
Sbjct: 55  LQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGG----ELFSHLRKSGRFPEPVA-----R 104

Query: 225 FGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           F AA+    L +LH  +  ++YRD K  N+LLD+D   K++DFG AK         V  R
Sbjct: 105 FYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGR 154

Query: 282 IM---GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 318
                GT  Y APE I+  G+     D ++ G+++ E+L G
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 49/120 (40%), Positives = 61/120 (50%), Gaps = 7/120 (5%)

Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
           +P  I  KIA    K L +L E  K +I+RD K SNILLD + N KL DFG++  G   D
Sbjct: 104 IPEEILGKIAVATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVD 160

Query: 275 KSHVSTRIMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGRKSLDKSRPAREQ 331
            S   TR  G   Y APE I          RSDV+S G+ L E+ TG+    K     +Q
Sbjct: 161 -SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ 219

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           F   R +G G FG VY    + D+R   + V +    + G  S +  ++ + EV FL  L
Sbjct: 17  FSDLREIGHGSFGAVY---FARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
            HPN ++  G C   EH   +      GS  ++L      PL       +  GA +GLA+
Sbjct: 73  RHPNTIQYRG-CYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 234 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 293
           LH     +I+RD K  NILL      KL DFG A      +        +GT  + APE 
Sbjct: 131 LHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEV 182

Query: 294 IMT---GHLTPRSDVYSFGVVLLEI 315
           I+    G    + DV+S G+  +E+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 45/132 (34%), Positives = 63/132 (47%), Gaps = 11/132 (8%)

Query: 207 LFSKVLLP---LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + KV      +P  I  KIA    K L +LH     VI+RD K SN+L++ +   KL D
Sbjct: 89  FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCD 147

Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI----MTGHLTPRSDVYSFGVVLLEILTGR 319
           FG++  G   D S   T   G   Y APE I           +SDV+S G+ ++E+ TGR
Sbjct: 148 FGIS--GYLVD-SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Query: 320 KSLDKSRPAREQ 331
              D  +   +Q
Sbjct: 205 FPYDSWKTPFQQ 216

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 37/90 (41%), Positives = 53/90 (58%), Gaps = 4/90 (4%)

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           GL FLH+  K +IYRD K  N+LLD D + K++DFG+ K+   G+    ++   GT  Y 
Sbjct: 108 GLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYI 163

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE +         D +SFGV+L E+L G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           +G G FG VY  F +       + V V    + G  + +  ++ + EV FL  L HPN +
Sbjct: 29  IGHGSFGAVY--FATNSHTN--EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           +  G   ++    L+ E+   GS  ++L      PL       I  GA +GLA+LH    
Sbjct: 85  EYKGCYLKEHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--- 296
             I+RD K  NILL      KL+DFG A       KS  +   +GT  + APE I+    
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDE 194

Query: 297 GHLTPRSDVYSFGVVLLEI 315
           G    + DV+S G+  +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 68.7 bits (169), Expect = 7e-13
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 67/234 (28%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK--------VHDGDNSYQGHREWLAEVIF 169
           + +G G +G V       D R G +   VA+K        + D        +  L E+  
Sbjct: 6   KPIGSGAYGVVCSAV---DKRTGRK---VAIKKISNVFDDLIDA-------KRILREIKL 52

Query: 170 LGHLSHPNLVKLI------GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           L HL H N++ L+          ED + V ++ E M     E +L  KV       I+  
Sbjct: 53  LRHLRHENIIGLLDILRPPSP--EDFNDVYIVTELM-----ETDL-HKV-------IKSP 97

Query: 223 ----------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-DGP 271
                       +   +GL +LH A   VI+RD K SNIL++++ + K+ DFGLA+   P
Sbjct: 98  QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155

Query: 272 EGDKS-----HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           + D+      +V TR      Y APE +++    T   D++S G +  E+LT +
Sbjct: 156 DEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 69/213 (32%), Positives = 99/213 (46%), Gaps = 33/213 (15%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH--REWLAE--VIFLGHL 173
           RVLG G FG V    + E  R        AVKV   D   Q       + E  ++ L   
Sbjct: 1   RVLGKGSFGKVMLARLKESGR------LYAVKVLKKDVILQDDDVECTMTEKRILSLAR- 53

Query: 174 SHPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM---KIAFGAA 228
           +HP L +L  YCC    +    + EF+  G +        +  +  S R    +  F AA
Sbjct: 54  NHPFLTQL--YCCFQTPDRLFFVMEFVNGGDL--------MFHIQKSRRFDEARARFYAA 103

Query: 229 K---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
           +    L FLH+  K +IYRD K  N+LLD + + KL+DFG+ K+G    K+  ++   GT
Sbjct: 104 EITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGT 159

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             Y APE +      P  D ++ GV+L E+L G
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 51/154 (33%), Positives = 75/154 (48%), Gaps = 25/154 (16%)

Query: 174 SHPNLVKLIGYCC--EDEHRVLIYEFMARGS----VENNLFSKVLLPLPWSIRMKIAFGA 227
            HP LV L  + C   ++H   + E+ A G     +  ++FS+           +  F A
Sbjct: 60  RHPFLVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP----------RAVFYA 107

Query: 228 AK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
           A    GL +LHE    ++YRD K  N+LLDT+   K++DFGL K+G  G     ST   G
Sbjct: 108 ACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FCG 163

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + APE +     T   D +  GV++ E+L G
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 73/210 (34%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           R +G G FG VY    + D+R   + V +    + G  S +  ++ + EV FL  L HPN
Sbjct: 21  REIGHGSFGAVY---FARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 178 LVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLL-PLPWSIRMKIAFGAAKGLAFLH 235
            ++  G C   EH   L+ E+   GS  + L  +V   PL       I  GA +GLA+LH
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS--TRIMGTYGYAAPEY 293
             E+  I+RD K  NILL      KL+DFG A        S VS     +GT  + APE 
Sbjct: 133 SHER--IHRDIKAGNILLTEPGTVKLADFGSA--------SLVSPANSFVGTPYWMAPEV 182

Query: 294 IMT---GHLTPRSDVYSFGVVLLEILTGRK 320
           I+    G    + DV+S G+  +E L  RK
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE-LAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 14/212 (6%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +G G +G VYK   + +   G     VA+K    D   +G     + E+  L 
Sbjct: 1   NFQKVEKIGEGTYGVVYK---ARNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLK 54

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 55  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 114 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 169

Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGRKSL 322
           E ++   + +   D++S G +  E++T R++L
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 75/290 (25%), Positives = 121/290 (41%), Gaps = 51/290 (17%)

Query: 120 LGGGGFGCVYKGFI----SEDLREGLQPVPVAVKVHDGDNSYQGHREWLA--EVI-FLGH 172
           LG G F  +YKG +      D+    Q V V +KV         HR+ LA  E    +  
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-----SDHRDSLAFFETASLMSQ 57

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGL 231
           LSH +LVKL G C  DE+ +++ E++  G ++  L   K  + L W  ++ +A   A  L
Sbjct: 58  LSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASAL 114

Query: 232 AFLHEAEKPVIYRDFKTSNILL-----DTDYN--AKLSDFGLAKDGPEGDKSHVSTRIMG 284
            +L   +K +++ +    NIL+     +  Y    KLSD G+        +     RI  
Sbjct: 115 HYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI-- 168

Query: 285 TYGYAAPEYIMTGHLTPRS--DVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK 342
              + APE I  G  +     D +SFG  LLEI +  +    +  + E+          +
Sbjct: 169 --PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK----------E 216

Query: 343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 392
              +  + +        P+    + A L   C  ++P  RP  R I+  L
Sbjct: 217 RFYQDQHRL--------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 19/226 (8%)

Query: 106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           E+ + T  F ++  LG   FG VYKG +      G Q   VA+K            E+  
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLF-GTAPGEQTQAVAIKTLKDKAEGPLREEFKH 57

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------------V 211
           E +    L HPN+V L+G   +++   +I+ + +   +   L  +              V
Sbjct: 58  EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 212 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 271
              L  +  + I    A G+ FL  +   V+++D  T N+L+    N K+SD GL ++  
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             D   +    +    + +PE IM G  +  SD++S+GVVL E+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 51/148 (34%), Positives = 74/148 (50%), Gaps = 12/148 (8%)

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---GL 231
           +P L  L       EH   + EF+  G +  ++  K    L      +  F AA+   GL
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGL 109

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            FLH   K +IYRD K  N++LD D + K++DFG+ K+   GD    ++   GT  Y AP
Sbjct: 110 QFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAP 165

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           E +     T   D +SFGV+L E+L G+
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 55/239 (23%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
             +G G  G VYK      +         A+KV  G++     R+   E+  L  ++HPN
Sbjct: 80  NRIGSGAGGTVYK------VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPN 133

Query: 178 LVKLIGYCCED------EHRVLIYEFMARGSVEN-NLFSKVLLPLPWSIRMKIAFGAAKG 230
           +VK     C D      E +VL+ EFM  GS+E  ++  +  L         +A     G
Sbjct: 134 VVK-----CHDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLA-------DVARQILSG 180

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM------- 283
           +A+LH   + +++RD K SN+L+++  N K++DFG+         S +  + M       
Sbjct: 181 IAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGV---------SRILAQTMDPCNSSV 229

Query: 284 GTYGYAAPEYIMTGHLTPR-----SDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 337
           GT  Y +PE I T            D++S GV +LE   GR      R        DWA
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ------GDWA 282

Length = 353

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 42/104 (40%), Positives = 58/104 (55%), Gaps = 9/104 (8%)

Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+   GL FLH   K +IYRD K  N++LD + + K++DFG+ K+   G K   +T
Sbjct: 104 VFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TT 158

Query: 281 RIM-GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
           R   GT  Y APE I         D ++FGV+L E+L G+   D
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 23/226 (10%)

Query: 114 FRQDRVLGGGGFG--CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
           FRQ RVLG GGFG  C  +   +  +    +     +K   G++     ++ L +V    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV---- 57

Query: 172 HLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 229
              +   V  + Y  E +  + L+   M  G ++ ++++   +  P     +  F AA+ 
Sbjct: 58  ---NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEI 111

Query: 230 --GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
             GL  LH   +  +YRD K  NILLD   + ++SD GLA   PEG+   +  R+ GT G
Sbjct: 112 LCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVG 166

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL--DKSRPAREQ 331
           Y APE +     T   D +  G ++ E++ G+      K +  RE+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 56/185 (30%), Positives = 91/185 (49%), Gaps = 12/185 (6%)

Query: 166 EVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
           E++ +    HPN+V  L  Y   DE  V++ E++A GS+ + +    +          + 
Sbjct: 66  EILVMRENKHPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDE---GQIAAVC 121

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIM 283
               + L FLH  +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++
Sbjct: 122 RECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMV 176

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLK 342
           GT  + APE +      P+ D++S G++ +E++ G        P R   L A    P L+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ 236

Query: 343 EKKKL 347
             +KL
Sbjct: 237 NPEKL 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)

Query: 174 SHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK--- 229
           S+P LV L   C +   R+ L+ E++  G +  ++  +  LP          F AA+   
Sbjct: 54  SNPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLP-----EEHARFYAAEICI 107

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIMGTYGY 288
            L FLHE  + +IYRD K  N+LLD D + KL+D+G+ K+G   GD    ++   GT  Y
Sbjct: 108 ALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNY 162

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL 348
            APE +         D ++ GV++ E++ GR   D      + N  D+   ++ EK    
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--- 219

Query: 349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR 382
            I  PR           KA+ +    LN +PK R
Sbjct: 220 -IRIPRFLS-------VKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 81/294 (27%), Positives = 126/294 (42%), Gaps = 36/294 (12%)

Query: 118 RVLGGGGFG----CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           R LG G FG    C Y     E    G Q   VAVK    ++      +   E+  L +L
Sbjct: 10  RDLGEGHFGKVELCRYD---PEGDNTGEQ---VAVKSLKPESGGNHIADLKKEIEILRNL 63

Query: 174 SHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            H N+VK  G C ED      LI EF+  GS++  L  +    +    ++K A    KG+
Sbjct: 64  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGM 122

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR--IMGTYGYA 289
            +L    +  ++RD    N+L+++++  K+ DFGL K   E DK + + +  +     + 
Sbjct: 123 DYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWY 179

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKS--------LDKSRPAREQNLADWALPLL 341
           APE ++       SDV+SFGV L E+LT   S        L    P   Q      + +L
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239

Query: 342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
           +E K+L     PR     P     +   L   C    P  R   +++++  E +
Sbjct: 240 EEGKRL-----PR-----PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 44/124 (35%), Positives = 70/124 (56%), Gaps = 7/124 (5%)

Query: 196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           E M  GS++  L  K    +P +I  KI+    +GL +L E  K +++RD K SNIL+++
Sbjct: 79  EHMDGGSLDQVL--KKAGRIPENILGKISIAVLRGLTYLREKHK-IMHRDVKPSNILVNS 135

Query: 256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
               KL DFG++  G   D   ++   +GT  Y +PE +   H T +SD++S G+ L+E+
Sbjct: 136 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Query: 316 LTGR 319
             GR
Sbjct: 192 AIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 18/209 (8%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           +G G FG V  G    +   G+    V VK      +      +L EV     L+HPN++
Sbjct: 3   IGNGWFGKVLLG----EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLH 235
           + +G C E    +L+ EF   G ++N L S       +     +  ++A   A GL +LH
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLH 117

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY-- 293
           +A+   I+ D    N  L  D + K+ D+GLA +    D             + APE   
Sbjct: 118 QAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 294 -----IMTGHLTPRSDVYSFGVVLLEILT 317
                ++    T +S+++S GV + E+ T
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 68/285 (23%), Positives = 121/285 (42%), Gaps = 49/285 (17%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 176
           + LG G FG V+ G       +    + VA+K +++G  S     +++ E   +  LSHP
Sbjct: 10  KELGSGQFGVVHLG-------KWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHP 59

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAKG 230
            LV+L G C + +   ++ EFM  G + N L       SK +L       + +     +G
Sbjct: 60  KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-------LSMCQDVCEG 112

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           + +L       I+RD    N L+ +    K+SDFG+ +   + D+   S+       ++ 
Sbjct: 113 MEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSP 169

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 350
           PE       + +SDV+SFGV++ E+ T  K                 +P   EKK    +
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGK-----------------MPF--EKKSNYEV 210

Query: 351 IDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 392
           ++    G     P         + Y C +  P+ RP   +++ ++
Sbjct: 211 VEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 15/210 (7%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-WLAEVIFLG 171
           +F+  + LG G +G VYK     D +        A+K  D  +  Q  RE  + E+  L 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQF------YALKEVDLGSMSQKEREDAVNEIRILA 54

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGAAK 229
            ++HPN++       +     ++ E+   G +   +  +      +P     +I     +
Sbjct: 55  SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           GL  LHE +  +++RD K++NILL  +   K+ D G++K      K +++   +GT  Y 
Sbjct: 115 GLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYM 168

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE       + +SD++S G +L E+ T  
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 30/270 (11%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           +G G FG V+KG    D R   Q V VA+K+ D + +     +   E+  L     P + 
Sbjct: 12  IGKGSFGEVFKGI---DNRT--QQV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
           K  G   +     +I E++  GS  + L +        +  +K      KGL +LH  +K
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK 122

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
             I+RD K +N+LL    + KL+DFG+A  G   D        +GT  + APE I     
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178

Query: 300 TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDY 359
             ++D++S G+  +E+  G        P R        L L+ +         P L G++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMR-------VLFLIPKNNP------PTLTGEF 225

Query: 360 PVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                         CLN +P  RP  ++++
Sbjct: 226 ----SKPFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 29/218 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLA---EVI 168
           N+R  ++LG G FG VY  + ++  RE  ++ VP      D D S +  +E  A   E+ 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPF-----DPD-SQETSKEVNALECEIQ 56

Query: 169 FLGHLSHPNLVKLIGYCCED--EHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
            L +L H  +V+  G C  D  E ++ I+ E+M  GS+++ L  K    L  ++  +   
Sbjct: 57  LLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTR 113

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD------GPEGDKSHVS 279
              +G+++LH     +++RD K +NIL D+  N KL DFG +K          G KS   
Sbjct: 114 QILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--- 168

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             + GT  + +PE I       ++DV+S    ++E+LT
Sbjct: 169 --VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 29/259 (11%)

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  K++ 
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSI 110

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
              +GLA+L E  + +++RD K SNIL+++    KL DFG++  G   D   ++   +GT
Sbjct: 111 AVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 165

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 345
             Y +PE +   H + +SD++S G+ L+E+  GR  +    P  ++  A +  P++  ++
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIFGRPVVDGEE 223

Query: 346 KLLNIIDPRLE-GDYPVKGVHKAAMLAYHCLNHNPKARPLMR--DIVDSL--EPLQVLPD 400
              + I PR      PV G             H   +RP M   +++D +  EP   LP+
Sbjct: 224 GEPHSISPRPRPPGRPVSG-------------HGMDSRPAMAIFELLDYIVNEPPPKLPN 270

Query: 401 EAPTP--KNFVTVVTPEEP 417
              TP  + FV     + P
Sbjct: 271 GVFTPDFQEFVNKCLIKNP 289

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 30/213 (14%)

Query: 120 LGGGGFGCVY--KGFISEDLREGLQPVPVAVKVHDGDNSYQGHR--EWLAEVIFLGHLSH 175
           +  G +G V+  K   + D+         A+KV    +  + ++  + L E   L     
Sbjct: 1   ISKGAYGRVFLAKKKSTGDI--------YAIKVIKKADMIRKNQVDQVLTERDILSQAQS 52

Query: 176 PNLVKLIGYCCEDEHRV-LIYEFMARG---SVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
           P +VKL  Y  + +  + L+ E++  G   S+  N+ S     L   +           L
Sbjct: 53  PYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGS-----LDEDVARIYIAEIVLAL 106

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS------TRIMGT 285
            +LH     +I+RD K  NIL+D++ + KL+DFGL+K G    + +++       RI+GT
Sbjct: 107 EYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             Y APE I+    +   D +S G +L E L G
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 27/219 (12%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLA---EVI 168
           N+R  ++LG G FG VY  + ++  RE      +AVK V     S +  +E  A   E+ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRE------LAVKQVQFDPESPETSKEVNALECEIQ 56

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
            L +L H  +V+  G   +   R L    E M  GS+++ L  K    L  ++  K    
Sbjct: 57  LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQ 114

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD------GPEGDKSHVST 280
             +G+++LH     +++RD K +NIL D+  N KL DFG +K          G KS    
Sbjct: 115 ILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS---- 168

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            + GT  + +PE I       ++D++S G  ++E+LT +
Sbjct: 169 -VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           NF+Q   LG G +  VYKG      R       VA+K    D         + E+  +  
Sbjct: 1   NFKQLEKLGEGTYATVYKG------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKE 54

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL-----FSKVLLPLPWSIRMKIAFGA 227
           L H N+V+L      +   +L++E+M     + +L        V   L  +      +  
Sbjct: 55  LKHENIVRLHDVIHTENKLMLVFEYM-----DKDLKKYMDTHGVRGALDPNTVKSFTYQL 109

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
            KG+AF HE    V++RD K  N+L++     KL+DFGLA+    G   +  +  + T  
Sbjct: 110 LKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLAR--AFGIPVNTFSNEVVTLW 165

Query: 288 YAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
           Y AP+ ++       S D++S G ++ E++TGR
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH 235
           P + KL       ++  L+ E++  G   + +  K L  LP     +       G+  LH
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM 295
           +  + +I+RD K  N+L+D   + KL+DFGL+++G        + + +GT  Y APE I+
Sbjct: 115 Q--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETIL 166

Query: 296 TGHLTPRSDVYSFGVVLLEILTG 318
                  SD +S G V+ E L G
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 17/159 (10%)

Query: 164 LAEVIFLGHLSHPNLVKLI-GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM 221
             E   L  LSHP +V ++  +  +DE+RV  + EF+  G +  +L      P       
Sbjct: 66  AQEKSILMELSHPFIVNMMCSF--QDENRVYFLLEFVVGGELFTHLRKAGRFP------N 117

Query: 222 KIA--FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
            +A  + A   LAF +   K +IYRD K  N+LLD   + K++DFG AK  P+      +
Sbjct: 118 DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----T 172

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             + GT  Y APE I +       D ++ GV+L E + G
Sbjct: 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 7/99 (7%)

Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+    L FLH     VIYRD K  NILLD + + KL+DFG+ K+G        +T
Sbjct: 99  RFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
              GT  Y APE +      P  D ++ GV++ E++ G+
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 70/244 (28%), Positives = 117/244 (47%), Gaps = 25/244 (10%)

Query: 166 EVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
           E++ +  L +PN+V  +  +   DE  V++ E++A GS+ + +    +     +    + 
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVM-EYLAGGSLTDVVTETCMDEAQIA---AVC 121

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIM 283
               + L FLH  +  VI+RD K+ N+LL  D + KL+DFG  A+  PE  K    + ++
Sbjct: 122 RECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMV 176

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLK 342
           GT  + APE +      P+ D++S G++ +E++ G        P R   L A    P L+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ 236

Query: 343 EKKKLLNI----IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             +KL  I    ++  LE D   +G  K  +L +  L     A+PL      SL PL + 
Sbjct: 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAK-ELLQHPFLK---LAKPL-----SSLTPLILA 287

Query: 399 PDEA 402
             EA
Sbjct: 288 AKEA 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 7/154 (4%)

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  K++ 
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 110

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
              KGL +L E  K +++RD K SNIL+++    KL DFG++  G   D   ++   +GT
Sbjct: 111 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 165

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 7/92 (7%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGY 288
           LA  H  +  +IYRD K  NILLD++ +  L+DFGL+K+    E ++++      GT  Y
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEY 172

Query: 289 AAPEYIMTGHLTPRS--DVYSFGVVLLEILTG 318
            APE I  G        D +S GV+  E+LTG
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           +L  G FG ++ G + ++     + V V   V D  +  Q     L E   L  LSH N+
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKT-VKDHASEIQVTL-LLQESCLLYGLSHQNI 70

Query: 179 VKLIGYCCED-EHRVLIYEFMARGSVENNLFSKVLLPL--PWSIRMK----IAFGAAKGL 231
           + ++  C ED E   ++Y +M  G+++  L    L     P ++  +    +A   A G+
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE-----GDKSHVSTRIMGT 285
           ++LH+    VI++D    N ++D +   K++D  L++D  P      GD  +   + M  
Sbjct: 131 SYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM-- 186

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
               A E ++    +  SDV+SFGV+L E++T
Sbjct: 187 ----ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G FG VYK    E           A KV +  +  +   +++ E+  L   +HP +V
Sbjct: 20  LGDGAFGKVYKAKNKE------TGALAAAKVIETKSEEE-LEDYMVEIEILATCNHPYIV 72

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR----MKIAFGAAKGLAFLH 235
           KL+G    D    ++ EF   G+V+      ++L L   +       I     + L +LH
Sbjct: 73  KLLGAFYWDGKLWIMIEFCPGGAVD-----AIMLELDRGLTEPQIQVICRQMLEALQYLH 127

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM 295
                +I+RD K  N+LL  D + KL+DFG++    +  +   S   +GT  + APE +M
Sbjct: 128 S--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVM 183

Query: 296 --TGHLTP---RSDVYSFGVVLLEI 315
             T   TP   ++D++S G+ L+E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.0 bits (155), Expect = 2e-11
 Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 21/235 (8%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLGHLSHPNL 178
           +G G  G VY      D+  G +     V +   +   Q  +E +  E++ +    +PN+
Sbjct: 28  IGQGASGTVYTAM---DVATGQE-----VAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 179 VK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
           V  L  Y   DE  V++ E++A GS+ + +    +     +    +     + L FLH  
Sbjct: 80  VNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSN 135

Query: 238 EKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT 296
           +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE +  
Sbjct: 136 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190

Query: 297 GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKKLLNI 350
               P+ D++S G++ +E++ G        P R   L A    P L+  +KL  I
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 34/211 (16%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           LG G FG V+ G  + + +       VAVK +  G  S +    +L E   +  L H  L
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-------VAVKTLKPGTMSPES---FLEEAQIMKKLRHDKL 63

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLF--SKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
           V+L     E E   ++ E+M++GS+ + L       L LP  + M  A   A G+A++  
Sbjct: 64  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYIER 120

Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVSTRIMGTYGYA 289
                I+RD +++NIL+      K++DFGLA+          +G K  +         + 
Sbjct: 121 MN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK--------WT 170

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
           APE  + G  T +SDV+SFG++L E++T GR
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)

Query: 114 FRQDRVLGGGGFG--CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
           FRQ RVLG GGFG  C  +   +  +    +     +K   G++     ++ L +V    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV---- 57

Query: 172 HLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 229
              +   V  + Y  E +  + L+   M  G ++ +++             +  F AA+ 
Sbjct: 58  ---NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFYAAEI 111

Query: 230 --GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
             GL  LH+    ++YRD K  NILLD   + ++SD GLA   PEG    +  R+ GT G
Sbjct: 112 CCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVG 166

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQ 331
           Y APE +     T   D ++ G +L E++ G+      K +  RE+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 45/220 (20%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK--------VHDGDNSYQGHREWLAEVIF 169
             +G G +G V   F ++  R+      VA+K              +Y+       E+  
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRK------VAIKKLSRPFQSAIHAKRTYR-------ELRL 67

Query: 170 LGHLSHPNLVKLIGYCCEDEHR------VLIYEFMARGSVENNLFSKVLLPLPWS---IR 220
           L H+ H N++ L+                L+   M    + N +  + L     S   I+
Sbjct: 68  LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKL-----SDDHIQ 121

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
             + +   +GL ++H A   +I+RD K SNI ++ D   K+ DFGLA+   +    +V+T
Sbjct: 122 F-LVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVAT 178

Query: 281 RIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 319
           R      Y APE ++   H     D++S G ++ E+LTG+
Sbjct: 179 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 19/208 (9%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 171
           + R +  LG G FG V+ G  +   R       VA+K +  G  S +    +L E   + 
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTWNGTTR-------VAIKTLKPGTMSPEA---FLQEAQVMK 56

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAK 229
            L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + M  A   A 
Sbjct: 57  KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQIAS 113

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++            + 
Sbjct: 114 GMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWT 170

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILT 317
           APE  + G  T +SDV+SFG++L E+ T
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 62/293 (21%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPV----AVKVH------DGDNSYQGHREWLAEVIF 169
           LG G FGCVYK      +R+      +     + VH      D     +   + ++EV  
Sbjct: 8   LGSGAFGCVYK------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 170 LG-HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------------KVLLPLP 216
           +   L HPN+V+      E+  R+ I   +  G+     F+            ++     
Sbjct: 62  IKEQLRHPNIVRYYKTFLEN-DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI----- 115

Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
           W+I +++       L +LH+ EK +++RD   +NI+L  D    ++DFGLAK      K 
Sbjct: 116 WNIFVQMVLA----LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK- 169

Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
              T ++GT  Y+ PE +       ++DV++FG +L ++ T         P    N+   
Sbjct: 170 --LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSL 221

Query: 337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
           A  +++         +P  EG Y          +   CL  + +ARP   DI+
Sbjct: 222 ATKIVEAV------YEPLPEGMYS----EDVTDVITSCLTPDAEARP---DII 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 38/281 (13%)

Query: 112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK---VHDGDNSYQGHREWLAEVI 168
           ANFR ++ +G G F  VY+          L  VPVA+K   + D  ++ +   + + E+ 
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCL------LDGVPVALKKVQIFDLMDA-KARADCIKEID 54

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKIAFG 226
            L  L+HPN++K      ED    ++ E    G +   +  F K    +P     K    
Sbjct: 55  LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
               L  +H   + V++RD K +N+ +      KL D GL +      K+  +  ++GT 
Sbjct: 115 LCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTP 170

Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK 346
            Y +PE I       +SD++S G +L E                  +A    P   +K  
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMN 212

Query: 347 LLNIIDPRLEGDY-PVKGVHKAA---MLAYHCLNHNPKARP 383
           L ++     + DY P+   H +     L   C+N +P+ RP
Sbjct: 213 LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 80/291 (27%), Positives = 133/291 (45%), Gaps = 34/291 (11%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLGHLSHPNL 178
           +G G  G VY      D+  G +     V +   +   Q  +E +  E++ +    +PN+
Sbjct: 27  IGQGASGTVYTAI---DIATGQE-----VAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 179 VK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
           V  L  Y   DE  V++ E++A GS+ + +    +     +    +     + L FLH  
Sbjct: 79  VNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALDFLHSN 134

Query: 238 EKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT 296
           +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE +  
Sbjct: 135 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 189

Query: 297 GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKKL----LNII 351
               P+ D++S G++ +E++ G        P R   L A    P L+  ++L     + +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249

Query: 352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA 402
           +  LE D   +G  K  +L +  L     A+PL      SL PL +   EA
Sbjct: 250 NRCLEMDVDRRGSAK-ELLQHPFLK---LAKPL-----SSLTPLIIAAKEA 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 35/93 (37%), Positives = 57/93 (61%), Gaps = 4/93 (4%)

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-DGPEGDKSHVSTRIMGTYG 287
           +GL ++H A   V++RD K SN+LL+T+ + K+ DFGLA+   PE D +   T  + T  
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 288 YAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
           Y APE ++      ++ D++S G +L E+L+ R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 18/208 (8%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           +G G FG V  G    ++  G  P  V VK      S Q   ++L E      L H NL+
Sbjct: 3   IGNGWFGKVILG----EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFS----KVLLPLPWSIRMKIAFGAAKGLAFLH 235
           + +G C E    +L+ EF   G ++  L S    +++ P P +++ ++A   A GL  LH
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLLHLH 117

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM 295
           +     I+ D    N LL  D   K+ D+GL+ +  + D      ++     + APE + 
Sbjct: 118 KNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 296 TGH-------LTPRSDVYSFGVVLLEIL 316
             H        T  S+V+S GV + E+ 
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 19/208 (9%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 171
           + R D  LG G FG V+ G  +   +       VA+K +  G    +    +L E   + 
Sbjct: 7   SLRLDVKLGQGCFGEVWMGTWNGTTK-------VAIKTLKPGTMMPEA---FLQEAQIMK 56

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAK 229
            L H  LV L     E E   ++ EFM +GS+ + L       L LP  + M  A   A 
Sbjct: 57  KLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM--AAQIAD 113

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           G+A++       I+RD + +NIL+  +   K++DFGLA+   E ++            + 
Sbjct: 114 GMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWT 170

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILT 317
           APE  + G  T +SDV+SFG++L E++T
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 69/285 (24%), Positives = 117/285 (41%), Gaps = 44/285 (15%)

Query: 111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHRE-WLAEVI 168
             NF+ ++ +G G F  VYK      L +G     VA+K V   +      R+  L E+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKA---ICLLDGR---VVALKKVQIFEMMDAKARQDCLKEID 54

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLP----WSIRMK 222
            L  L HPN++K +    E+    ++ E    G +   +  F K    +P    W   ++
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +       L  +H   K +++RD K +N+ +      KL D GL +      K+  +  +
Sbjct: 115 LC----SALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSL 166

Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK 342
           +GT  Y +PE I       +SD++S G +L E                  +A    P   
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYG 208

Query: 343 EKKKLLNIIDPRLEGDY-PVKGVHKAAML---AYHCLNHNPKARP 383
           +K  L ++     + DY P+   H +  L      C+N +P+ RP
Sbjct: 209 DKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 7/162 (4%)

Query: 159 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-HRVLIYEFMARGSVENNLFSKVLLPLPW 217
           G +  L E   L  ++ P +V L  Y  E + H  L+   M  G ++ ++++     L  
Sbjct: 36  GEKMALLEKEILEKVNSPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-- 92

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +   I + A      LH     ++YRD K  N+LLD   N +LSD GLA +  +G    
Sbjct: 93  EMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-- 150

Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             T+  GT GY APE +     +   D ++ G  + E++ GR
Sbjct: 151 -ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)

Query: 146 VAVKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+ D     Q  RE L  EV+ +    H N+V++       E   ++ EF+  G++ 
Sbjct: 49  VAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL- 105

Query: 205 NNLFSKVLLPLPWSIRMKIAF---GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
            ++ S+  L        +IA       + L +LH   + VI+RD K+ +ILL  D   KL
Sbjct: 106 TDIVSQTRLN-----EEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKL 158

Query: 262 SDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           SDFG    ++KD P+         ++GT  + APE I         D++S G++++E++ 
Sbjct: 159 SDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212

Query: 318 GRKSLDKSRPARE-QNLADWALPLLKEKKKLLNIIDPRLE 356
           G        P +  + L D   P LK   K+  ++   LE
Sbjct: 213 GEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 55/160 (34%), Positives = 78/160 (48%), Gaps = 15/160 (9%)

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E+  L  L HPNLV LI          L++E+    +V N L  K    +P  +  KI
Sbjct: 48  LREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNEL-EKNPRGVPEHLIKKI 105

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKS-HVST 280
            +   + + F H+     I+RD K  NIL+      KL DFG A+   GP  D + +V+T
Sbjct: 106 IWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT 163

Query: 281 RIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTG 318
           R      Y APE ++  T +  P  DV++ G V  E+LTG
Sbjct: 164 R-----WYRAPELLVGDTQYGPP-VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 17/153 (11%)

Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA-- 227
           L  +SHP +++L     +     ++ E++  G     LFS +     +S    + + +  
Sbjct: 55  LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGE----LFSYLRNSGRFSNSTGLFYASEI 110

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTY 286
              L +LH   K ++YRD K  NILLD + + KL+DFG AK      K    T  + GT 
Sbjct: 111 VCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTP 162

Query: 287 GYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 318
            Y APE I   GH     D ++ G+++ E+L G
Sbjct: 163 EYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 6/97 (6%)

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTY 286
           + GL FLH   + +IYRD K  N++LD++ + K++DFG+ K   E     V+TR   GT 
Sbjct: 111 SVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTP 165

Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
            Y APE I         D +++GV+L E+L G+   D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 36/91 (39%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           A  L +LH     +IYRD K  NILLD+  +  L+DFGL K+G E  K+  ++   GT  
Sbjct: 106 ASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPE 161

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 41/105 (39%), Positives = 58/105 (55%), Gaps = 15/105 (14%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIMGTYGYA 289
           LA  H  ++ +IYRD K  NILLD   + KL+DFGL K+   EG  +H      GT  Y 
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYM 167

Query: 290 APEYIM-TGHLTPRSDVYSFGVVLLEILTG---------RKSLDK 324
           APE +M +GH     D +S G ++ ++LTG         +K++DK
Sbjct: 168 APEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 48/228 (21%)

Query: 112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFL 170
             F +   +G G +G VY+     D   G     VA+K    DN   G     L E+  L
Sbjct: 7   TEFEKLNRIGEGTYGIVYRA---RDTTSGEI---VALKKVRMDNERDGIPISSLREITLL 60

Query: 171 GHLSHPNLVKL---------------IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 215
            +L HPN+V+L               + YC +D   +L          +N        P 
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL----------DNM-------PT 103

Query: 216 PWSI-RMK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
           P+S  ++K +     +GL +LHE    +I+RD K SN+LL      K++DFGLA+    G
Sbjct: 104 PFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYG 159

Query: 274 DKSHVSTRIMGTYGYAAPEYI--MTGHLTPRSDVYSFGVVLLEILTGR 319
             +   T  + T  Y APE +   T + T   D+++ G +L E+L  +
Sbjct: 160 LPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 36/93 (38%), Positives = 49/93 (52%), Gaps = 10/93 (10%)

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA---KDGPEGDKSHVSTRIMGTY 286
           GL  LH+  + +IYRD K  N+LLD D N ++SD GLA   KDG    K +      GT 
Sbjct: 109 GLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTP 161

Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           G+ APE +         D ++ GV L E++  R
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--QGHREWLAEVIFLGHLSHPN 177
           +G G +G VYK   + D   G      +V+V   ++       RE +A +  L    HPN
Sbjct: 8   IGVGAYGTVYK---ARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPN 63

Query: 178 LVKLIGYCC----EDEHRV-LIYEFMARGSVENNL---FSKVLLP-LPWSIRMKIAFGAA 228
           +V+L+  C     + E +V L++E      V+ +L     KV  P LP      +     
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFE-----HVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS-TRIMGTYG 287
           +GL FLH     +++RD K  NIL+ +    KL+DFGLA+         ++ T ++ T  
Sbjct: 119 RGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLW 172

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 322
           Y APE ++        D++S G +  E+   RK L
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 3/90 (3%)

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH +EK V+YRD K  N++LD D + K++DFGL K+G + D + + T   GT  Y 
Sbjct: 107 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-FCGTPEYL 163

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE +         D +  GVV+ E++ GR
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 67/284 (23%), Positives = 115/284 (40%), Gaps = 44/284 (15%)

Query: 112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK------VHDGDNSYQGHREWLA 165
           ANF+ ++ +G G F  VY+     D +      PVA+K      + D     +  ++ + 
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRK------PVALKKVQIFEMMDA----KARQDCVK 51

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKI 223
           E+  L  L+HPN++K +    ED    ++ E    G +   +  F K    +P     K 
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
                  +  +H   + V++RD K +N+ +      KL D GL +      K+  +  ++
Sbjct: 112 FVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 167

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 343
           GT  Y +PE I       +SD++S G +L E                  +A    P   +
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGD 209

Query: 344 KKKLLNIIDPRLEGDY-PVKGVH---KAAMLAYHCLNHNPKARP 383
           K  L ++     + DY P+   H   K   L   C+  +P  RP
Sbjct: 210 KMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 21/219 (9%)

Query: 114 FRQDRVLGGGGFG--CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
           FR  RVLG GGFG  C  +   +  +    +     +K   G+      +  L +V    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV---- 57

Query: 172 HLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 229
              +   V  + Y  E +  + L+   M  G ++ ++++   +  P     +  F AA+ 
Sbjct: 58  ---NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN---MGNPGFDEQRAIFYAAEL 111

Query: 230 --GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
             GL  L      ++YRD K  NILLD   + ++SD GLA   PEG+   V  R+ GT G
Sbjct: 112 CCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVG 166

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR 326
           Y APE I     T   D +  G ++ E++ G+    K +
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 69/269 (25%), Positives = 105/269 (39%), Gaps = 71/269 (26%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
            R  +VLG G FG V +      + +      VAVK+     +   H+  ++E+  L H+
Sbjct: 9   LRLGKVLGHGAFGKVVEASAF-GIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHI 67

Query: 174 -SHPNLVKLIGYCCEDEHRVL-IYEF---------------------------------- 197
            +H N+V L+G C +    ++ I EF                                  
Sbjct: 68  GNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAM 127

Query: 198 --------MARGSVENNLFSKVLL------------------PLPWSIRMKIAFGAAKGL 231
                          + LFS+                     PL     +  +F  A+G+
Sbjct: 128 VEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGM 187

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV---STRIMGTYGY 288
            FL  A +  I+RD    NILL  +   K+ DFGLA+D  + D  +V   S R+     +
Sbjct: 188 EFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARL--PLKW 242

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            APE I     T +SDV+SFGV+L EI +
Sbjct: 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 36/89 (40%), Positives = 50/89 (56%), Gaps = 5/89 (5%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +GT+GY A
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYMA 163

Query: 291 PEYIMTGHLTPRS-DVYSFGVVLLEILTG 318
           PE +  G     S D +S G +L ++L G
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 36/218 (16%)

Query: 121 GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQG-HREWLAEVIFLGHLSHPNL 178
           G G +G VYK       + G      A+K   GD   Y G  +    E+  L  L H N+
Sbjct: 9   GRGTYGRVYKA----KRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENV 64

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLF-------SKVLLPLPWSIRMKIAFGAAKGL 231
           V L+    E   + +   ++     E++L+           + +P S+   + +    G+
Sbjct: 65  VSLVEVFLEHADKSV---YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNA----KLSDFGLAK--DGP-----EGDKSHVST 280
            +LH     V++RD K +NIL+  +       K+ D GLA+  + P     + D   V  
Sbjct: 122 HYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV-- 177

Query: 281 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT 317
               T  Y APE ++   H T   D+++ G +  E+LT
Sbjct: 178 ----TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 30/210 (14%)

Query: 118 RVLGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           RV+G G FG  +    ++ D +  ++ + +       ++S +       E + L  + HP
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-------EAVLLAKMKHP 58

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPWSIRMKIAFGAAK 229
           N+V        D H  ++ E+   G +          LF +  + L W ++M        
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQM-------- 109

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSHVSTRIMGTYG 287
            L   H  EK V++RD K+ NI L  +   KL DFG A+    P    ++  T + GT  
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYV-GTPY 165

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           Y  PE         +SD++S G +L E+ T
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 40/113 (35%), Positives = 60/113 (53%), Gaps = 8/113 (7%)

Query: 212 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 271
             PL     ++ +   A+G+ FL  A K  I+RD    N+LL     AK+ DFGLA+D  
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD-I 262

Query: 272 EGDKSHV---STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 321
             D ++V   + R+     + APE I     T +SDV+S+G++L EI +  KS
Sbjct: 263 MNDSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 68/284 (23%), Positives = 117/284 (41%), Gaps = 52/284 (18%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           +G G FG   K  + +   +G Q V   + +       +   E   EV  L ++ HPN+V
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSP--KEREESRKEVAVLSNMKHPNIV 62

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSK------VLLP----LPWSIRMKIAFGAAK 229
           +      E+ +  ++ ++   G    +L+ K      VL P    L W +++        
Sbjct: 63  QYQESFEENGNLYIVMDYCEGG----DLYKKINAQRGVLFPEDQILDWFVQI-------- 110

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            LA  H  ++ +++RD K+ NI L  D   KL DFG+A+         ++   +GT  Y 
Sbjct: 111 CLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYL 168

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 349
           +PE         +SD+++ G VL E+ T + + +        N+          K  +L 
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG------NM----------KNLVLK 212

Query: 350 IIDPRLEGDYPVKGVHKAA---MLAYHCLNHNPKARPLMRDIVD 390
           II     G YP    H +     L       NP+ RP +  I++
Sbjct: 213 II----RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 38/97 (39%), Positives = 55/97 (56%), Gaps = 6/97 (6%)

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTY 286
           A GL FLH   K +IYRD K  N++LD++ + K++DFG+ K   E     V+T+   GT 
Sbjct: 111 AIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTP 165

Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
            Y APE I         D ++FGV+L E+L G+   +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 33/222 (14%)

Query: 148 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 205
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G+   
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGA--- 103

Query: 206 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
                 L  +    RM       +     K L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 104 ------LTDIVTHTRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRV 155

Query: 260 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 156 KLSDFGFCAQVSKEVPR------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209

Query: 316 LTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG 357
           + G        P +   +    LP    K K L+ + P L+G
Sbjct: 210 VDGEPPYFNEPPLKAMKMIRDNLP---PKLKNLHKVSPSLKG 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 39/106 (36%), Positives = 54/106 (50%), Gaps = 11/106 (10%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +GT+GY A
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYMA 163

Query: 291 PEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 335
           PE +  G     S D +S G +L ++L G        P R+    D
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHS------PFRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           LA  H  +  ++YRD K  NILLD++ +  L+DFGL+K+    +K    +   GT  Y A
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMA 174

Query: 291 PEYI--MTGHLTPRSDVYSFGVVLLEILTG 318
           PE I    GH     D +S G+++ E+LTG
Sbjct: 175 PEIIRGKGGH-GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 183

Query: 289 AAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 9/159 (5%)

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKI 223
           E+  L  +SH  ++ LI       +R      M     + +LF+ V    PLP    + I
Sbjct: 136 EIDILKTISHRAIINLI-----HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
                + LA+LH   + +I+RD KT NI LD   NA L DFG A        +       
Sbjct: 191 QRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 322
           GT    +PE +       ++D++S G+VL E+     +L
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 36/91 (39%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           LA  H  +  +IYRD K  NILLD++ +  L+DFGL+K+  E D+   +    GT  Y A
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMA 174

Query: 291 PEYIM---TGHLTPRSDVYSFGVVLLEILTG 318
           P+ +     GH     D +S GV++ E+LTG
Sbjct: 175 PDIVRGGDGGH-DKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 64/235 (27%), Positives = 101/235 (42%), Gaps = 43/235 (18%)

Query: 111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK---VHDGDNSYQGHREWLAEV 167
             ++     LG G FG VYK      ++ G     VA+K   +H+  + +      L E+
Sbjct: 7   LRDYEILGKLGEGTFGEVYKA---RQIKTGRV---VALKKILMHNEKDGF--PITALREI 58

Query: 168 IFLGHLSHPNLVKLIGYCCE--DEHR------VLIYEFMAR---GSVENNLFSKVLLPLP 216
             L  L HPN+V LI    E  D+ +       ++  +M     G +EN     V L   
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTES 115

Query: 217 WSIR--MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK------ 268
             I+  M       +G+ +LHE    +++RD K +NIL+D     K++DFGLA+      
Sbjct: 116 -QIKCYMLQLL---EGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169

Query: 269 ---DGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
               G  G  +   T ++ T  Y  PE ++     T   D++  G V  E+ T R
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 22/211 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR--EWLAEVIFL 170
           +F   R LG G FG V    I    +    P PVA+K  +     +  +     +E   L
Sbjct: 31  DFNFIRTLGTGSFGRV----ILATYKNEDFP-PVAIKRFEKSKIIKQKQVDHVFSERKIL 85

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
            +++HP  V L G   ++ +  L+ EF+  G     L      P      +   + A   
Sbjct: 86  NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP----NDVGCFYAAQIV 141

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYG 287
           L F +     ++YRD K  N+LLD D   K++DFG AK         V TR   + GT  
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPE 193

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           Y APE ++       +D ++ G+ + EIL G
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 6/151 (3%)

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA 227
           + L ++ HP LV L       E    + +F+  G +  +L  +   P P + R   A   
Sbjct: 48  VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EI 105

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           A  L +LH     ++YRD K  NILLD+  +  L+DFGL K+G    +S  +T   GT  
Sbjct: 106 ASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPE 161

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           Y APE I         D +  G VL E+L G
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 70/229 (30%), Positives = 100/229 (43%), Gaps = 37/229 (16%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNL 178
           +G G +G VYK     + ++G      AVK+ D  +      E  AE   L  L  HPN+
Sbjct: 30  IGKGTYGKVYK---VTNKKDGSL---AAVKILDPISDVDEEIE--AEYNILQSLPNHPNV 81

Query: 179 VKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLL---PLPWSIRMKIAFGAAKG 230
           VK  G   + +  V     L+ E    GSV   L   +L+    L  ++   I +GA  G
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAMISYILYGALLG 140

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI-----MGT 285
           L  LH     +I+RD K +NILL T+   KL DFG++           STR+     +GT
Sbjct: 141 LQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVS-------AQLTSTRLRRNTSVGT 191

Query: 286 YGYAAPEYIMTGH-----LTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
             + APE I            R DV+S G+  +E+  G   L    P +
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 34/93 (36%), Positives = 50/93 (53%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           LA  H   K +I+RD K++NILL ++   KL DFG +K         V     GT  Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
           PE       + ++D++S GV+L E+LT ++  D
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 114 FRQDRVLGGGGFG--CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA--EVIF 169
           FR  RVLG GGFG  C  +   +  +         A K  +     +   E +A  E   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKM--------YACKKLEKKRIKKRKGEAMALNEKQI 53

Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
           L  ++   +V L  Y  E +  + L+   M  G ++ ++++   +  P     +  F AA
Sbjct: 54  LEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAA 109

Query: 229 K---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
           +   GL  LH     ++YRD K  NILLD   + ++SD GLA + PEG+   +  R+ GT
Sbjct: 110 EITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GT 164

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GY APE +     T   D +  G ++ E++ G+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 38/97 (39%), Positives = 54/97 (55%), Gaps = 8/97 (8%)

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV---ST 280
           +F  A+G+ FL  A +  I+RD    NILL  +   K+ DFGLA+D  + D  +V     
Sbjct: 179 SFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDA 235

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           R+     + APE I     T +SDV+SFGV+L EI +
Sbjct: 236 RL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 20/208 (9%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G +G VYK             V +A+K    +       + + E+  L     P +V
Sbjct: 9   LGKGNYGSVYKVLHRP------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIV 62

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLF--SKVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
              G    +    +  E+M  GS++  L+        +P  +  +I +   KGL FL E 
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE- 120

Query: 238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG 297
           E  +I+RD K +N+L++ +   KL DFG++ +      S   T I G   Y APE I +G
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN---LVASLAKTNI-GCQSYMAPERIKSG 176

Query: 298 HLTPR------SDVYSFGVVLLEILTGR 319
                      SDV+S G+ +LE+  GR
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 26/209 (12%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNL 178
           +G G +G VYKG      R       VA+K    ++  +G     + E+  L  L HPN+
Sbjct: 8   IGEGTYGVVYKG------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA------FGAAKGLA 232
           V L     ++    LI+EF++          K L  LP    M         +   +G+ 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMD------LKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 292
           F H   + V++RD K  N+L+D     KL+DFGLA+    G    V T  + T  Y APE
Sbjct: 116 FCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPE 171

Query: 293 YIM--TGHLTPRSDVYSFGVVLLEILTGR 319
            ++    + TP  D++S G +  E+ T +
Sbjct: 172 VLLGSPRYSTP-VDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 50/178 (28%), Positives = 72/178 (40%), Gaps = 22/178 (12%)

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           +   +  A+G+ FL  A K  ++RD    N+LL      K+ DFGLA+D    D ++VS 
Sbjct: 240 LSFTYQVARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH-DSNYVSK 296

Query: 281 -RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP 339
                   + APE I     T  SDV+S+G++L EI +               L     P
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS---------------LGGTPYP 341

Query: 340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR---DIVDSLEP 394
            +       N I        P     +   +   C N  P+ RP      DIV+SL P
Sbjct: 342 GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 40/172 (23%)

Query: 164 LAEVIFLGHLS-HPNLVKLIGYCCEDEHRVL----------IYEFMARGSVENNLFSKVL 212
           L E+  L  LS HPN+++LI    + +   L          +YE + +G           
Sbjct: 45  LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELI-KGRKR-------- 95

Query: 213 LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE 272
            PLP        +   K L  +H     + +RD K  NIL+  D   KL+DFG  +    
Sbjct: 96  -PLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIK-DDILKLADFGSCR---- 147

Query: 273 GDKSH------VSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILT 317
           G  S       +STR      Y APE ++T G+  P+ D+++ G V  EIL+
Sbjct: 148 GIYSKPPYTEYISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 54/183 (29%), Positives = 73/183 (39%), Gaps = 35/183 (19%)

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           AE   L     P +VKL  Y  +DE  + L+ E+M  G + N L  K + P         
Sbjct: 50  AERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-----A 103

Query: 224 AFGAAKGLAFLHEAEK-PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS------ 276
            F  A+ +  L    K   I+RD K  NIL+D D + KL+DFGL K   +          
Sbjct: 104 RFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163

Query: 277 ----------HVSTR-----------IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
                      V  R            +GT  Y APE +         D +S GV+L E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223

Query: 316 LTG 318
           L G
Sbjct: 224 LYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 28/217 (12%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-----VHDGDNSYQGHREWL 164
           IT  +   + +G G FG V         R+ L    VA+K           + + +RE  
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSA------RDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-- 59

Query: 165 AEVIFLGHLSHPNLVKLIG-YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
             +  L HL H N++ L   +    E    + E +    +   L S+   PL        
Sbjct: 60  --LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSR---PLEKQFIQYF 113

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            +   +GL ++H A   V++RD K SNIL++ + + K+ DFGLA+        +VSTR  
Sbjct: 114 LYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY- 170

Query: 284 GTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGR 319
               Y APE ++T        D++S G +  E+L G+
Sbjct: 171 ----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 51/157 (32%), Positives = 76/157 (48%), Gaps = 13/157 (8%)

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+  L  L H NLV LI      +   L++EF+   +V ++L  K    L  S   K  F
Sbjct: 50  EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDL-EKYPNGLDESRVRKYLF 107

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGP-EGDKSHVSTRI 282
              +G+ F H     +I+RD K  NIL+      KL DFG A+    P E    +V+TR 
Sbjct: 108 QILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR- 164

Query: 283 MGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTG 318
                Y APE ++      R+ D+++ G ++ E+LTG
Sbjct: 165 ----WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 5/90 (5%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           LA  H  +  ++YRD K  NILLD   +  L DFGL+K       +  +    GT  Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLA 164

Query: 291 PEYIM--TGHLTPRSDVYSFGVVLLEILTG 318
           PE ++   G+ T   D +S GV++ E+  G
Sbjct: 165 PEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 6/90 (6%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIMGTYGYA 289
           L +LH  +  V+YRD K  N++LD D + K++DFGL K+G  +G          GT  Y 
Sbjct: 108 LGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYL 162

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE +         D +  GVV+ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 4/89 (4%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L +LH   + V+YRD K  N++LD D + K++DFGL K+G   D + + T   GT  Y A
Sbjct: 108 LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEYLA 163

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           PE +         D +  GVV+ E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.5 bits (137), Expect = 7e-09
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 33/171 (19%)

Query: 164 LAEVIFLGHLSHPNLVKL----IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           L E+  L  L HPN+V +    +G    +  ++    +M    VE++L  K L+      
Sbjct: 52  LREINILLKLQHPNIVTVKEVVVG---SNLDKI----YMVMEYVEHDL--KSLME----- 97

Query: 220 RMKIAFGAAK----------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 269
            MK  F  ++          G+A LH+    +++RD KTSN+LL+     K+ DFGLA+ 
Sbjct: 98  TMKQPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAR- 154

Query: 270 GPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
              G      T+++ T  Y APE ++     +   D++S G +  E+LT +
Sbjct: 155 -EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 8/97 (8%)

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV---ST 280
           +F  AKG+ FL  A +  I+RD    NILL  +   K+ DFGLA+D  + D  +V     
Sbjct: 185 SFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDA 241

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           R+     + APE I     T +SDV+SFGV+L EI +
Sbjct: 242 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 37/107 (34%), Positives = 60/107 (56%), Gaps = 6/107 (5%)

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           +GL +LH A   +++RD K  N+L++++   K+ DFGLA+   E D+S   T+ + T  Y
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYY 170

Query: 289 AAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 333
            APE I+ G  H T   D++S G +  E+L  R       P ++ +L
Sbjct: 171 RAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)

Query: 148 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 205
           V V   D   Q  RE L  EV+ +    H N+V +   Y   DE  V++ EF+  G+   
Sbjct: 50  VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM-EFLEGGA--- 105

Query: 206 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
                 L  +    RM       +     + L++LH   + VI+RD K+ +ILL +D   
Sbjct: 106 ------LTDIVTHTRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRI 157

Query: 260 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           KLSDFG    ++K+ P+         ++GT  + APE I         D++S G++++E+
Sbjct: 158 KLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211

Query: 316 LTGRKSLDKSRPARE-QNLADWALPLLKEKKKLLNII 351
           + G        P +  + + D   P +K+  K+ +++
Sbjct: 212 IDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVL 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 19/160 (11%)

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF------MARGSVENN-LFSKVLLPLPWS 218
           EVI L  + HPN+V       E+    ++ E+      M R + +   LFS+  + L W 
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-LSWF 107

Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGPEGDKSH 277
           +++ +      GL  +H+  + +++RD K+ NI L  +   AKL DFG+A+     D   
Sbjct: 108 VQISL------GLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157

Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           ++   +GT  Y +PE         ++D++S G VL E+ T
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 47/173 (27%), Positives = 69/173 (39%), Gaps = 17/173 (9%)

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           +  ++  AKG++FL  A K  I+RD    NILL      K+ DFGLA+D        V  
Sbjct: 217 LSFSYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 340
                  + APE I     T  SDV+S+G++L EI +               L     P 
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPG 319

Query: 341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
           +    K   +I        P     +   +   C + +P  RP  + IV  +E
Sbjct: 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           +GL ++H A   V++RD K SN+LL+ + + K+ DFGLA+     +K    T  + T  Y
Sbjct: 119 RGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWY 174

Query: 289 AAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSL 322
            APE ++     T   DV+S G +  E+L GRK L
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 8/156 (5%)

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+  L  L+HPN+V+L+     +    L++EF+    ++  + S  L  L   +     +
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
              +G+A+ H     V++RD K  N+L+D +   KL+DFGLA+    G      T  + T
Sbjct: 107 QLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVT 162

Query: 286 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGR 319
             Y APE ++      TP  D++S G +  E++  R
Sbjct: 163 LWYRAPEILLGSRQYSTP-VDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+        +V TR      Y
Sbjct: 129 KGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WY 181

Query: 289 AAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
            APE I+   H T   D++S G ++ E+LTG+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 23/221 (10%)

Query: 105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REW 163
           D    +   ++Q + +G G  G V   F      + +  + VAVK        Q H +  
Sbjct: 14  DSTFTVLKRYQQLKPIGSGAQGIVCAAF------DTVLGINVAVKKLSRPFQNQTHAKRA 67

Query: 164 LAEVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPW 217
             E++ L  ++H N++ L+          E +   L+ E M     + NL   + + L  
Sbjct: 68  YRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIHMELDH 122

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
                + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       + 
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNF 177

Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           + T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 99/409 (24%), Positives = 171/409 (41%), Gaps = 80/409 (19%)

Query: 67  ESPSEKAKKEYS-KLPSNPEEVEDLRRDSAANPLIAFTYDELRII--------TANFRQD 117
           E  + KA K  S K   N +++++  R    N       DE ++I          +++  
Sbjct: 14  EEKNHKANKGGSGKFEMNDKKLDEEERSHNNNA--GEDEDEEKMIDNDINRSPNKSYKLG 71

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
            ++G G FG VY+  I  D  E      VA+K    D  Y+       E++ + +L+H N
Sbjct: 72  NIIGNGSFGVVYEA-ICIDTSE-----KVAIKKVLQDPQYKNR-----ELLIMKNLNHIN 120

Query: 178 LVKLIGYCCEDEHRV--------LIYEFMARGSVENNL--FSKVLLPLPWSIRMKIAFGA 227
           ++ L  Y   +  +         ++ EF+ + +V   +  +++    LP  +    ++  
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL 179

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGPEGDK--SHVSTRIMG 284
            + LA++H   K + +RD K  N+L+D + +  KL DFG AK+   G +  S++ +R   
Sbjct: 180 CRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-- 235

Query: 285 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLE------ILTGRKSLDK--------SRPAR 329
              Y APE ++   + T   D++S G ++ E      I +G+ S+D+          P  
Sbjct: 236 ---YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292

Query: 330 EQ------NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNH-NP--- 379
           +Q      N AD   P +K K   L  + P+   D  +  + +   L Y  L   NP   
Sbjct: 293 DQLKEMNPNYADIKFPDVKPKD--LKKVFPKGTPDDAINFISQ--FLKYEPLKRLNPIEA 348

Query: 380 KARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQC 428
            A P   D+ D    L    D+ P   NF          AEI+     C
Sbjct: 349 LADPFFDDLRDPCIKLPKYIDKLPDLFNFC--------DAEIKEMSDAC 389

Length = 440

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH  +  ++YRD K  N++LD D + K++DFGL K+G   D + + T   GT  Y 
Sbjct: 107 ALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKT-FCGTPEYL 162

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE +         D +  GVV+ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 4/91 (4%)

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           A  + +LH     +IYRD K  NILLD+  +  L+DFGL K+G E +++  ++   GT  
Sbjct: 106 ASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPE 161

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 9/104 (8%)

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
            GL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+        +V TR      Y
Sbjct: 128 CGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WY 180

Query: 289 AAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 331
            APE I+   H     D++S G ++ E+LTG K+L K +   +Q
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ 223

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 49/226 (21%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR-EWLAEVIFLGHLSHPN 177
            +G G +G VYK       R+      VA+K    DN  +G     + E+  L  L+H N
Sbjct: 14  QIGEGTYGQVYKA------RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67

Query: 178 LVKLIGYCCEDEHRV----------LIYEFMAR---GSVENNL----------FSKVLLP 214
           +V L     + +  +          L++E+M     G +E+ L          F K LL 
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL- 126

Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
                         +GL + H+  K  ++RD K SNILL+     KL+DFGLA+     +
Sbjct: 127 --------------EGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 275 KSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
               + +++ T  Y  PE ++      P  DV+S G +L E+ T +
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 37/89 (41%), Positives = 49/89 (55%), Gaps = 6/89 (6%)

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-DGPEGDKSHVSTRIMGTYGYA 289
           L  LH+    VIYRD K  NILLD   +  L DFGL K +  + DK++      GT  Y 
Sbjct: 106 LENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYL 160

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           APE ++    T   D ++ GV+L E+LTG
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 36/236 (15%)

Query: 110 ITANFRQ-DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW----- 163
           I+  + Q    LG G +G V K   + D   G       VK+ +  N     R+      
Sbjct: 6   ISERYIQKGAHLGEGTYGKVEK---AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 164 -----LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW- 217
                L E+  +  + H N++ L+    E +   L+ + MA   ++  +  K+ L     
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQV 121

Query: 218 -SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------- 268
             I ++I      GL  LH+     ++RD   +NI +++    K++DFGLA+        
Sbjct: 122 KCILLQIL----NGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175

Query: 269 DGPEGDKSHVSTRIMG----TYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
           D    D++      M     T  Y APE +M       + D++S G +  E+LTG+
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 68/277 (24%), Positives = 115/277 (41%), Gaps = 35/277 (12%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           +F   + +G G +G VYK   + ++  G       +K+  G++     +E    +I +  
Sbjct: 10  DFELIQRIGSGTYGDVYK---ARNVNTGELAAIKVIKLEPGEDFAVVQQE----IIMMKD 62

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
             H N+V   G     +   +  EF   GS+++     V  PL  S    ++    +GL 
Sbjct: 63  CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAYVSRETLQGLY 120

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 292
           +LH   K  ++RD K +NILL  + + KL+DFG++           S   +GT  + APE
Sbjct: 121 YLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPE 176

Query: 293 YIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL---ADWALPLLKEKKK 346
                  G      D+++ G+  +E+   +  +    P R   L   +++  P LK+K K
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236

Query: 347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
             N               H    +A   L  NPK RP
Sbjct: 237 WSN-------------SFHHFVKMA---LTKNPKKRP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 18/208 (8%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVA-VKVHDGDNSYQGHREWLAEVIFLGHLS---H 175
           +G G +G V+K   + DL+ G + V +  V+V  G+         + EV  L HL    H
Sbjct: 9   IGEGAYGKVFK---ARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLETFEH 63

Query: 176 PNLVKLIGYCC---EDEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGL 231
           PN+V+L   C     D    L   F            KV  P +P      + F   +GL
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            FLH     V++RD K  NIL+ +    KL+DFGLA+           T ++ T  Y AP
Sbjct: 124 DFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAP 178

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           E ++        D++S G +  E+   +
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 73/293 (24%), Positives = 123/293 (41%), Gaps = 60/293 (20%)

Query: 120 LGGGGFGCVYKGFI------SEDLREGLQPVPVAVKVHDGDNSYQGHRE----WLAEVIF 169
           LG G    +Y G +       +D     + + V +KV D       HR+    +      
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLD-----PSHRDISLAFFETASM 57

Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAA 228
           +  +SH ++V L G C  D   +++ EF+  G ++  +  K  +L  PW  + K+A   A
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLA 115

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILL-----DTDYNA--KLSDFGLAKDGPEGDKSHVSTR 281
             L++L +  K +++ +  T NILL     D +     KLSD G+           V +R
Sbjct: 116 SALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT--------VLSR 165

Query: 282 --IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEI-LTGRKSL-DKSRPAREQNLADW 336
              +    + APE +  + +L+  +D +SFG  L EI   G   L DK+   +E+     
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ 225

Query: 337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
            + +    K+L                    A L  HC+N++P  RP  R I+
Sbjct: 226 CMLVTPSCKEL--------------------ADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 22/180 (12%)

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP----WSIRMKIAFGAAKGL 231
           PN+V L  Y   ++   L+ +    G + +++   + +P      W+  M +A  A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDKSHVSTRIMGTYGYAA 290
             LH   + ++ RD   +NILLD   + +L+ F    +     D   V         Y A
Sbjct: 101 --LHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--LLKEKKKLL 348
           PE       T   D +S G +L E+LTG K+L +  P+         +P  + +E + LL
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEEARSLL 209

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 74/281 (26%), Positives = 123/281 (43%), Gaps = 34/281 (12%)

Query: 120 LGGGGFGCVYKGFISEDLREG--LQPVPVAVKVHDGDNSYQGHREWLAEVI-FLGHLSHP 176
           LG G F  ++KG I  ++ +   L    V +KV D   S++ + E   E    +  LSH 
Sbjct: 3   LGQGTFTKIFKG-IRREVGDYGELHKTEVLLKVLD--KSHRNYSESFFEAASMMSQLSHK 59

Query: 177 NLVKLIGYC-CEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAAKGLAFL 234
           +LV   G C C DE  +++ E++  GS++  L  +K L+ + W  ++++A   A  L FL
Sbjct: 60  HLVLNYGVCVCGDES-IMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFL 116

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT--YGYAAPE 292
              +K + + +    N+LL  + + K  +    K    G    V  + +      +  PE
Sbjct: 117 E--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174

Query: 293 YIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 351
            I    +L+  +D +SFG  L EI +G                D  L  L  +KKL    
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG---------------GDKPLSALDSQKKLQ-FY 218

Query: 352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 392
           + R +   P     + A L   C+++ P  RP  R I+  L
Sbjct: 219 EDRHQ--LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 36/129 (27%), Positives = 73/129 (56%), Gaps = 9/129 (6%)

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAK--DGPEGDKSHVSTRIMGT 285
           +GL ++H A   V++RD K +N+ ++T D   K+ DFGLA+  D     K ++S  ++  
Sbjct: 125 RGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 286 YGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE- 343
           + Y +P  +++  + T   D+++ G +  E+LTG+     +    +  L   ++P+++E 
Sbjct: 183 W-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241

Query: 344 -KKKLLNII 351
            + +LLN+I
Sbjct: 242 DRNELLNVI 250

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 79/273 (28%), Positives = 111/273 (40%), Gaps = 34/273 (12%)

Query: 107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE 166
           LR     F    V+G G +G VYKG      R        A+KV D     +   E   E
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTEDEE--EEIKLE 62

Query: 167 VIFLGHLSH-PNLVKLIGYCCE------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           +  L   SH  N+    G   +      D+   L+ EF   GSV + + +     L    
Sbjct: 63  INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSH 277
              I     +GLA LH  +  VI+RD K  N+LL  +   KL DFG++   D   G ++ 
Sbjct: 123 IAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN- 179

Query: 278 VSTRIMGTYGYAAPEYIMTGHLTP------RSDVYSFGVVLLEILTGRKSLDKSRPAREQ 331
                +GT  + APE I      P      RSD++S G+  +E+  G   L    P R  
Sbjct: 180 ---TFIGTPYWMAPEVIACDE-NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235

Query: 332 NLADW-ALPLLKEK---KKLLNIIDPRLEGDYP 360
            L      P LK K   KK ++ I+  L  +Y 
Sbjct: 236 FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYL 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 15/99 (15%)

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----DGPEGD--KSHVSTRI 282
           + L ++H A   V +RD K  NIL + D   K+ DFGLA+    D P       +V+TR 
Sbjct: 114 RALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR- 170

Query: 283 MGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGR 319
                Y APE   +     TP  D++S G +  E+LTG+
Sbjct: 171 ----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 53.0 bits (128), Expect = 8e-08
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHL---SH 175
           +G G +G VYK     DL  G     VA+K      S +G     L E+  L  L    H
Sbjct: 7   IGEGAYGTVYKA---RDLNTGRF---VALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 176 PNLVKLIGYC--CEDEHRV---LIYEFMARGSVENNL---FSKVL---LPLPWSIRMKIA 224
           PN+V+L+  C     +  +   L++E      V+ +L    SK     LP P +I+  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLP-PETIK-DLM 113

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS-TRIM 283
               +G+ FLH     +++RD K  NIL+ +D   K++DFGLA+         ++ T ++
Sbjct: 114 RQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVV 167

Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEI 315
            T  Y APE ++ + + TP  D++S G +  E+
Sbjct: 168 VTLWYRAPEVLLQSSYATP-VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 69/228 (30%), Positives = 99/228 (43%), Gaps = 35/228 (15%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNL 178
           +G G +G V+K    ++  +    V +   +HD D   +      AE   L  LS HPN+
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKA--AVKILDPIHDIDEEIE------AEYNILKALSDHPNV 77

Query: 179 VKLIG-YCCED----EHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKIAFGAAKGL 231
           VK  G Y  +D    +   L+ E    GSV + +  F K    +   I   I   A  GL
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI-----MGTY 286
             LH  +   I+RD K +NILL T+   KL DFG++           STR+     +GT 
Sbjct: 138 QHLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGVS-------AQLTSTRLRRNTSVGTP 188

Query: 287 GYAAPEYI-----MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
            + APE I     +      R DV+S G+  +E+  G   L    P R
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 39/107 (36%), Positives = 58/107 (54%), Gaps = 10/107 (9%)

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTY 286
           GL ++H A   V++RD K  N+L++ D   K+ DFGLA+   + P  +   + T  + T 
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATR 173

Query: 287 GYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 331
            Y APE IM      T   DV+S G +L E+L GRK + K +   +Q
Sbjct: 174 WYRAPE-IMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQ 218

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           +GL ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   +    +V+TR      Y
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181

Query: 289 AAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
            APE ++   H     D++S G ++ E+L G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G +  V+KG      R  L    VA+K    ++        + EV  L +L H N+V
Sbjct: 13  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 180 KLIGYCCEDEHRVLIYEFM---ARGSVEN--NLFS----KVLLPLPWSIRMKIAFGAAKG 230
            L      +    L++E++    +  ++N  NL S    K+ +           F   +G
Sbjct: 67  TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM-----------FQLLRG 115

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L++ H+  + +++RD K  N+L++     KL+DFGLA+      K++ +  +  T  Y  
Sbjct: 116 LSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRP 171

Query: 291 PEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 333
           P+ ++  T + TP  D++  G +L E+ TGR     S    E +L
Sbjct: 172 PDVLLGSTEYSTP-IDMWGVGCILYEMATGRPMFPGSTVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G +  V+KG      R  L    VA+K    ++        + EV  L  L H N+V
Sbjct: 14  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 180 KLIGYCCEDEHRVLIYEFMAR---------GSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
            L      D+   L++E++ +         G++ +    K+ L           +   +G
Sbjct: 68  TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL-----------YQILRG 116

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           LA+ H   + V++RD K  N+L++     KL+DFGLA+      K++ +  +  T  Y  
Sbjct: 117 LAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRP 172

Query: 291 PEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           P+ ++ +   + + D++  G +  E+ +GR
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 4/95 (4%)

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST-RI 282
           ++  A G+ FL  A K  ++RD    N+L+      K+ DFGLA+D    D +++S    
Sbjct: 245 SYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGST 301

Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                + APE I     T  SDV+SFG++L EI T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 18/151 (11%)

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAFGAAKGL 231
           P +V+L     +D++  ++ E+M  G + N L S   +P  W    +  + +A  A   +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
             +H        RD K  N+LLD   + KL+DFG      E       T + GT  Y +P
Sbjct: 162 GLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISP 212

Query: 292 EYIMT----GHLTPRSDVYSFGVVLLEILTG 318
           E + +    G+     D +S GV L E+L G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 45/199 (22%), Positives = 86/199 (43%), Gaps = 31/199 (15%)

Query: 138 REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-------- 189
           + G QP PV +K+     +       L E + L +++HP+++++                
Sbjct: 87  KPG-QPDPVVLKIGQKGTT-------LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138

Query: 190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
           +   +Y ++ + S           PLP    + I     +GL +LH     +I+RD KT 
Sbjct: 139 YSSDLYTYLTKRSR----------PLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTE 186

Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NI ++      + D G A+  P    + +   + GT    APE +       ++D++S G
Sbjct: 187 NIFINDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAG 243

Query: 310 VVLLEILTGRKSLDKSRPA 328
           +VL E+L    ++ +  P+
Sbjct: 244 IVLFEMLAYPSTIFEDPPS 262

Length = 357

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 18/186 (9%)

Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           V V++ D +N  + H + L   + L H   HPN++             +I  FMA GS  
Sbjct: 28  VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87

Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD- 263
           + L +     +  ++   I FGA +GL +LH+     I+R+ K S+IL+  D    LS  
Sbjct: 88  SLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGL 145

Query: 264 ---FGLAKDGPEG----DKSHVSTRIMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLL 313
              + L ++G +     D    ST ++    + +PE +   + G+   +SD+YS G+   
Sbjct: 146 SHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKSDIYSVGITAC 201

Query: 314 EILTGR 319
           E+ TGR
Sbjct: 202 ELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           A  L +LH     ++YRD K  NILLD+  +  L+DFGL K+  E + +  ++   GT  
Sbjct: 106 ASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPE 161

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 16/102 (15%)

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDK----SHVSTR 281
           +GL ++H A   VI+RD K SN+L++ D   ++ DFG+A+     P   K     +V+TR
Sbjct: 118 RGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 282 IMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSL 322
                 Y APE +++    T   D++S G +  E+L GR+ L
Sbjct: 176 -----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 42/162 (25%), Positives = 66/162 (40%), Gaps = 11/162 (6%)

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E+I    L HPN++  +     D    ++   MA GS E+ L +     LP      I 
Sbjct: 48  QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFIL 107

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF----GLAKDGPEGDKSHVST 280
                 L ++H   K  I+R  K S+ILL  D    LS       + K G      H   
Sbjct: 108 KDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165

Query: 281 R-IMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTG 318
           +  +    + +PE +   + G+   +SD+YS G+   E+  G
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 25/236 (10%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           +G G +G VYK   + +L  G       +K+  GD+     +E    +  +    H N+V
Sbjct: 17  VGSGTYGDVYK---ARNLHTGELAAVKIIKLEPGDDFSLIQQE----IFMVKECKHCNIV 69

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF---GAAKGLAFLHE 236
              G     E   +  E+   GS+++     V  PL     ++IA+      +GLA+LH 
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLS---ELQIAYVCRETLQGLAYLHS 124

Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM- 295
             K  ++RD K +NILL  + + KL+DFG+A           S   +GT  + APE    
Sbjct: 125 KGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAV 180

Query: 296 --TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL---ADWALPLLKEKKK 346
              G      D+++ G+  +E+   +  +    P R   L   +++  P LK+K K
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 34/215 (15%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNL 178
           +G G +G V+K   + +  E      VA+K    D+  +G     L E+  L  L H N+
Sbjct: 8   IGEGTYGTVFKA-KNRETHE-----IVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 179 VKLIGYCCEDEHRVLIYEFM----------ARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
           V+L      D+   L++E+             G ++  +    +  L             
Sbjct: 62  VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------------L 109

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           KGLAF H     V++RD K  N+L++ +   KL+DFGLA+    G      +  + T  Y
Sbjct: 110 KGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWY 165

Query: 289 AAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSL 322
             P+ +    L   S D++S G +  E+    + L
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 36/228 (15%)

Query: 106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-------VHDGDNSYQ 158
           +LR+   +F   +V+G G FG V      + +R        A+K       +   D+++ 
Sbjct: 37  KLRMKAEDFDVIKVIGRGAFGEV------QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF- 89

Query: 159 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS 218
               +  E   + H +   +V+L     +D++  ++ E+M  G + N L S   +P  W+
Sbjct: 90  ----FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWA 144

Query: 219 I----RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
                 + +A  A   + F+H        RD K  N+LLD   + KL+DFG         
Sbjct: 145 RFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196

Query: 275 KSHVSTRIMGTYGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTG 318
                T + GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 64/244 (26%), Positives = 94/244 (38%), Gaps = 55/244 (22%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD-----GDNSYQGHREWLAEVI 168
           F++ ++LG G  G V+   +      G      A+KV D       N  +       E+ 
Sbjct: 3   FKKIKLLGKGDVGRVF---LVRLKGTGK---LFALKVLDKKEMIKRNKVK-RVLTEQEI- 54

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS-IRMKIA-FG 226
            L  L HP L  L      + +  L+ ++   G     LF  +L   P   +  ++A F 
Sbjct: 55  -LATLDHPFLPTLYASFQTETYLCLVMDYCPGG----ELFR-LLQRQPGKCLSEEVARFY 108

Query: 227 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--------------D 269
           AA+    L +LH     ++YRD K  NILL    +  LSDF L+K               
Sbjct: 109 AAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166

Query: 270 GPEGDKSH----------VSTRIM---GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEI 315
           G      +           S R     GT  Y APE I   GH     D ++ G++L E+
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEM 225

Query: 316 LTGR 319
           L G 
Sbjct: 226 LYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 21/168 (12%)

Query: 164 LAEVIFLGHLSHPNLVKLIGYC-----CEDEHR---VLIYEFMAR--GSVENNLFSKVLL 213
           L E+  L  L H N+V LI  C       + ++    L++EF       + +N   K  L
Sbjct: 59  LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL 118

Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGP 271
                + MK+      GL ++H  +  +++RD K +NIL+  D   KL+DFGLA+     
Sbjct: 119 SEIKKV-MKMLL---NGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILT 317
           +  K +  T  + T  Y  PE ++ G     P  D++  G ++ E+ T
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPE-LLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G +  VYKG      R  L    VA+K    ++        + EV  L  L H N+V
Sbjct: 14  LGEGTYATVYKG------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 180 KLIGYCCEDEHRVLIYEFMAR---------GSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
            L      ++   L++E++ +         G+  N    K+ L           F   +G
Sbjct: 68  TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFL-----------FQLLRG 116

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L + H   + V++RD K  N+L++     KL+DFGLA+      K++ +  +  T  Y  
Sbjct: 117 LNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRP 172

Query: 291 PEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           P+ ++ +   + + D++  G +  E+ TGR
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 28/222 (12%)

Query: 177 NLVKLIGY---CCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           N++K+ G+     +D  R+ LI E+  RG +   L  +    L +  ++ +A    KGL 
Sbjct: 79  NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLY 136

Query: 233 FLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            L++   KP  Y++  + + L+  +Y  K+   GL K        +V+   M  + Y   
Sbjct: 137 NLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF--MVYFSYKML 192

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 351
             I + + T + D+YS GVVL EI TG+   +        +L      ++ +   L    
Sbjct: 193 NDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL------IINKNNSL---- 241

Query: 352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
             +L  D P     +   +   C +H+   RP +++I+ +L 
Sbjct: 242 --KLPLDCP----LEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)

Query: 166 EVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
           E   L  L HPN+V     +  ED    ++  F   G + + L  +    LP +  ++  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
              A  L +LHE  K +++RD KT N+ L      K+ D G+A+     ++  +++ ++G
Sbjct: 109 VQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLIG 164

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 344
           T  Y +PE         +SDV++ G  + E+ T + + +    A++ N    +L     +
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN----AKDMN----SLVYRIIE 216

Query: 345 KKLLNIIDPRLEGDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
            KL     P +  DY P  G   A M     L+  P+ RP ++ I+
Sbjct: 217 GKL-----PPMPKDYSPELGELIATM-----LSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 18/205 (8%)

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           V+G G +G V K       R       VA+K   D + + +     L E+  L  L   N
Sbjct: 8   VVGEGAYGVVLK------CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP---LPWSIRMKIAFGAAKGLAFL 234
           +V+L           L++E++ +  +E  L  +  +P    P  +R  I +   K + + 
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLE--LLEE--MPNGVPPEKVRSYI-YQLIKAIHWC 116

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI 294
           H+ +  +++RD K  N+L+  +   KL DFG A++  EG  ++  T  + T  Y +PE +
Sbjct: 117 HKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELL 173

Query: 295 MTGHLTPRSDVYSFGVVLLEILTGR 319
           +        D++S G +L E+  G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 74/257 (28%), Positives = 105/257 (40%), Gaps = 35/257 (13%)

Query: 107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD--GDNSYQGHREWL 164
           LR     F    ++G G +G VYKG      R        A+KV D  GD       E  
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTGDE----EEEIK 50

Query: 165 AEVIFLGHLSH-PNLVKLIGYCCE------DEHRVLIYEFMARGSVENNLFSKVLLPLPW 217
            E+  L   SH  N+    G   +      D+   L+ EF   GSV + + +     L  
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDK 275
                I     +GL+ LH+ +  VI+RD K  N+LL  +   KL DFG++   D   G +
Sbjct: 111 EWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 168

Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTP------RSDVYSFGVVLLEILTGRKSLDKSRPAR 329
           +      +GT  + APE I      P      +SD++S G+  +E+  G   L    P R
Sbjct: 169 N----TFIGTPYWMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223

Query: 330 EQNLADW-ALPLLKEKK 345
              L      P LK KK
Sbjct: 224 ALFLIPRNPAPRLKSKK 240

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 7/156 (4%)

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+  L  + H N+V+L      ++   L++E++     ++   S      P  I+  + +
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL-Y 109

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMG 284
              +G+A+ H     V++RD K  N+L+D   NA KL+DFGLA+    G      T  + 
Sbjct: 110 QILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVV 165

Query: 285 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           T  Y APE ++ + H +   D++S G +  E++  +
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 17/222 (7%)

Query: 120 LGGGGFGCVYKGF--ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           LG G +  VYKG   I+  L        VA+KV             + E   L  L H N
Sbjct: 13  LGEGSYATVYKGISRINGQL--------VALKVISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
           +V L       E    ++E+M     +  +     L  P+++R+   F   +GLA++H  
Sbjct: 65  IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH-PYNVRL-FMFQLLRGLAYIHG- 121

Query: 238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-T 296
            + +++RD K  N+L+      KL+DFGLA+      +++ S  +  T  Y  P+ ++  
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGA 178

Query: 297 GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 338
              +   D++  G + +E+L G+ +        EQ    W +
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 32/96 (33%), Positives = 44/96 (45%), Gaps = 6/96 (6%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           I+RD K  N L+D   + KL+DFGL+K       S     ++G+  Y APE +       
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGKGYDF 177

Query: 302 RSDVYSFGVVLLEILTGRKSLDKSRPARE-QNLADW 336
             D +S G +L E L G      S P    +NL  W
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 41/153 (26%), Positives = 70/153 (45%)

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
           +E+  L    H  +VK       D+  +LI E+ + G +   +  ++   LP+       
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
                 LA      + +++RD K++NI L      KL DFG +K   +     V++   G
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           T  Y APE       + ++D++S GV+L E+LT
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.2 bits (114), Expect = 4e-06
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 22/178 (12%)

Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMELDHER 120

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 121 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE------ILTGRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E      +  GR  +D+     EQ
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 23/152 (15%)

Query: 184 YCCED--EHRVLIYEFMARGSVENNLFSKVLLPLPWSI-RMKIAFGAAKGLAFLHEAEKP 240
           +C  +   H  ++ E++  G     L  K +  LP  + RM  A      L +LH     
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFA-ETVLALEYLHNYG-- 121

Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDG--------PEGD-----KSHVSTRIMGTYG 287
           +++RD K  N+L+ +  + KL+DFGL+K G         EG      +  +  ++ GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 288 YAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 318
           Y APE I+  G+  P  D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKP-VDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 18/151 (11%)

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAFGAAKGL 231
           P +V+L     +D +  ++ E+M  G + N L S   +P  W    +  + +A  A   +
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            F+H        RD K  N+LLD   + KL+DFG      +       T + GT  Y +P
Sbjct: 162 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 212

Query: 292 EYIMT----GHLTPRSDVYSFGVVLLEILTG 318
           E + +    G+     D +S GV L E+L G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+    G    ++  ++  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE I+        D++S G ++ E++ G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 6/157 (3%)

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E   L  ++HP++++L G    ++   LI   + R   +   +      +     + I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
              + + +LHE    +I+RD K  NI ++   +  L DFG A   P    ++      GT
Sbjct: 190 SVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGT 246

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 322
               APE +      P  D++S G+VL E+ T   SL
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 9/92 (9%)

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRIMGTYG 287
           G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+          +V TR    Y 
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR----Y- 182

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           Y APE I+        D++S G ++ E++ G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 21/158 (13%)

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR-------MKIAF 225
           L HPN+++ +G C E    +L++E+   G +++ L  +      W  R        ++A 
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMAC 106

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A G+  +H+     ++ D    N  L +D   K+ D+G+     + D           
Sbjct: 107 EIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164

Query: 286 YGYAAPEYI-------MTGHLTPRSDVYSFGVVLLEIL 316
             + APE +       +T   T  S+V++ GV L E+ 
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 31/209 (14%)

Query: 120 LGGGGFGCVY-----KGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS 174
           LG G FG VY     K    E L+  L+ +PV      G+ +     +   E   L  L 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPV------GELNPNETVQANQEAQLLSKLD 60

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL----FSKVLLPLP----WSIRMKIAFG 226
           HP +VK      E +   +I E+     ++  L     +   L       W I++ +   
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL--- 117

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
              G+ ++H+  + +++RD K  NI L  +   K+ DFG+++         ++T   GT 
Sbjct: 118 ---GVHYMHQ--RRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLATTFTGTP 169

Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
            Y +PE +       +SD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 61/262 (23%), Positives = 95/262 (36%), Gaps = 78/262 (29%)

Query: 118 RVLGGGGFGCVYKGF------------ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           R++G GG G VY  +            I EDL                +N     + +L 
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDL---------------SENPLL-KKRFLR 51

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA----------------RGSVENNLFS 209
           E      L HP +V +   C + +    +Y  M                 + S+   L  
Sbjct: 52  EAKIAADLIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE 108

Query: 210 KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-- 267
           K  +    SI  KI       + ++H   K V++RD K  NILL       + D+G A  
Sbjct: 109 KTSVGAFLSIFHKIC----ATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162

Query: 268 KDGPEGDKSHVST--------------RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
           K   E D   +                +I+GT  Y APE ++    +  +D+Y+ GV+L 
Sbjct: 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILY 222

Query: 314 EILT---------GRKSLDKSR 326
           ++LT         GRK   +  
Sbjct: 223 QMLTLSFPYRRKKGRKISYRDV 244

Length = 932

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 6/107 (5%)

Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPE 272
           PLP        +   KG+A  H+    V++RD K  N+L+D      K++D GL +    
Sbjct: 106 PLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163

Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 318
             KS+  T  + T  Y APE ++   H +   D++S G +  E+   
Sbjct: 164 PVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 39/234 (16%)

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF-SKVLLPLPWSIRMKIAFGA 227
            +  +SH +L  + G C      +++ EF+  G ++  L   K  +P+ W  ++ +A   
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILL-------DTDYNAKLSDFGLAKDGPEGDKSHVST 280
           A  L++L +  K +++ +    NILL        T    KLSD G++       +     
Sbjct: 127 ASALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS--REERVE 182

Query: 281 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEI-LTGRKSLDKSRPAREQNLADWAL 338
           RI     + APE +  G  L+  +D +SFG  LLEI   G   L +  P+ ++       
Sbjct: 183 RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY---- 234

Query: 339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 392
               EKK  L           P     + A L   CL + P  RP  R I+  L
Sbjct: 235 ----EKKHRL-----------PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 21/162 (12%)

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL--------LPLPW 217
           E++ LG L+H N++K+     E+  R     +M     + +L+S +          PL  
Sbjct: 213 EILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267

Query: 218 SIR--MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
             R  MK    A   + ++H+  K +I+RD K  NI L+ D    L DFG A    E ++
Sbjct: 268 QTRAIMKQLLCA---VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKER 321

Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                  +GT    +PE +        +D++S G++LL++L+
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 39/227 (17%)

Query: 119 VLGGGGFGCVYKGF--ISEDLREGLQPVPVAVKV----HDGDNSYQGHREWLAEVIFLGH 172
            LG G +  VYKG   ++  L        VA+K     H+    +   RE       L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQL--------VALKEIRLEHEEGAPFTAIRE----ASLLKD 59

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK----IAFGAA 228
           L H N+V L       +   L++E++           + +      + M       F   
Sbjct: 60  LKHANIVTLHDIIHTKKTLTLVFEYLDTD------LKQYMDDCGGGLSMHNVRLFLFQLL 113

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL--AKDGPEGDKSHVSTRIMGTY 286
           +GLA+ H+  + V++RD K  N+L+      KL+DFGL  AK  P    S+       T 
Sbjct: 114 RGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----TL 167

Query: 287 GYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 331
            Y  P+ ++  T + T   D++  G +  E+ TGR     S    +Q
Sbjct: 168 WYRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 31/97 (31%), Positives = 44/97 (45%), Gaps = 6/97 (6%)

Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
           +I+RD KT N+L++   +  L DFG A        +     I GT    APE +     T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340

Query: 301 PRSDVYSFGVVLLEILTGRKSL------DKSRPAREQ 331
           P  D++S G+V+ E      SL      D+ RP   Q
Sbjct: 341 PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ 377

Length = 461

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 33/117 (28%), Positives = 43/117 (36%), Gaps = 44/117 (37%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHVST-------------------- 280
           I+RD K  N+LLD   + KLSDFGL      G  KSH +                     
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHRTEFYRILSHALPSNFLDFISKP 178

Query: 281 --------------RIM-----GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
                         R +     GT  Y APE  +        D +S GV++ E+L G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 39/132 (29%), Positives = 53/132 (40%), Gaps = 43/132 (32%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFGL---------AKDGPEGDKSHVS------------- 279
           I+RD K  NIL+D D + KL+DFGL         +K   +GD                  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 280 --------------TRIM-----GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
                          R +     GT  Y APE ++ TG+ T   D +S GV+L E+L G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQ 241

Query: 320 KSLDKSRPAREQ 331
                  PA  Q
Sbjct: 242 PPFLADTPAETQ 253

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 44.3 bits (104), Expect = 6e-05
 Identities = 50/214 (23%), Positives = 97/214 (45%), Gaps = 15/214 (7%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 179
           LG G +  VYKG      +  +    VA+KV             + E   L  L H N+V
Sbjct: 13  LGEGSYATVYKG------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-PWSIRMKIAFGAAKGLAFLHEAE 238
            L       E   L++E++     +     K    L P ++++ + F   +GL+++H+  
Sbjct: 67  LLHDIIHTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ-- 121

Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TG 297
           + +++RD K  N+L+      KL+DFGLA+   +   SH  +  + T  Y  P+ ++ + 
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGST 179

Query: 298 HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 331
             +   D++  G + +E++ G  +    +  ++Q
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 14/86 (16%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT- 296
           ++RD K  N+LLD + + +L+DFG    + +DG     +  S+  +GT  Y +PE +   
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPEILQAM 178

Query: 297 ----GHLTPRSDVYSFGVVLLEILTG 318
               G   P  D +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 14/86 (16%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-- 295
           ++RD K  N+LLD + + +L+DFG    L  DG     +  S   +GT  Y +PE +   
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-----TVQSNVAVGTPDYISPEILQAM 178

Query: 296 ---TGHLTPRSDVYSFGVVLLEILTG 318
               G   P  D +S GV + E+L G
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 14/86 (16%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT- 296
           ++RD K  NIL+D + + +L+DFG    L +DG     +  S+  +GT  Y +PE +   
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPDYISPEILQAM 178

Query: 297 ----GHLTPRSDVYSFGVVLLEILTG 318
               G   P  D +S GV + E+L G
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 65/262 (24%), Positives = 109/262 (41%), Gaps = 55/262 (20%)

Query: 156 SYQGHRE-----WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLF 208
           SY+G +E      + EV  +  L H N+V+ I       ++ L  + EF   G +  N+ 
Sbjct: 47  SYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ 106

Query: 209 S--KVLLPLPWSIRMKIAFGAAKGLAFLHEAE-----KPVIYRDFKTSNILLDTDYN--- 258
              K+   +     + I       LA+ H  +     + V++RD K  NI L T      
Sbjct: 107 KCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166

Query: 259 --------------AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPR 302
                         AK+ DFGL+K+      +H     +GT  Y +PE ++  T     +
Sbjct: 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDK 223

Query: 303 SDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVK 362
           SD+++ G ++ E+ +G+    K+      N +     L+ E K+      P    D P+K
Sbjct: 224 SDMWALGCIIYELCSGKTPFHKA-----NNFSQ----LISELKR-----GP----DLPIK 265

Query: 363 GVHKAA-MLAYHCLNHNPKARP 383
           G  K   +L  + LN + K RP
Sbjct: 266 GKSKELNILIKNLLNLSAKERP 287

Length = 1021

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 7/84 (8%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT----- 296
           ++RD K  N+L+D   + KL+DFG A      +K   S   +GT  Y APE + T     
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 297 -GHLTPRSDVYSFGVVLLEILTGR 319
            G      D +S GV+  E++ GR
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 38/135 (28%), Positives = 53/135 (39%), Gaps = 45/135 (33%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFGLA-------------------KDGPE---------- 272
           I+RD K  NIL+D D + KL+DFGL                    +D  E          
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 273 ---GD----------KSH---VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 316
              GD          K H   ++  ++GT  Y APE ++    T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 317 TGRKSLDKSRPAREQ 331
            G+       P   Q
Sbjct: 243 VGQPPFLAPTPTETQ 257

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 35/135 (25%), Positives = 48/135 (35%), Gaps = 45/135 (33%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFGL--------------AKDGPEGDKSHVSTR------ 281
           I+RD K  NIL+D D + KL+DFGL              + D    D    S        
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 282 -------------------------IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 316
                                    ++GT  Y APE ++    T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 317 TGRKSLDKSRPAREQ 331
            G+       P   Q
Sbjct: 243 VGQPPFLAQTPLETQ 257

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 35/218 (16%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNL 178
           +G G +G VYK       ++G      A+K  +G   S    RE    +  L  L HPN+
Sbjct: 9   VGRGTYGHVYKA----KRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNV 60

Query: 179 VKL--IGYCCEDEHRVLIYEF----------MARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           + L  +     D    L++++            R S  N    K  + LP S+   + + 
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPMQLPRSMVKSLLYQ 116

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAKLSDFGLAK--DGPEGDKSHVST 280
              G+ +LH     V++RD K +NIL+  +       K++D G A+  + P    + +  
Sbjct: 117 ILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 281 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT 317
            ++ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 175 VVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 53/233 (22%), Positives = 82/233 (35%), Gaps = 53/233 (22%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFGL------------------------------AKDGP 271
           I+RD K  N+LLD+  + KLSDFGL                              +K   
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 272 EG---DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA 328
           E    ++  ++   +GT  Y APE  M        D +S GV++ E+L G        P 
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 329 RE-QNLADWALPL-------LKEKKKLLNIIDPRLEGDYPV--KGVHKAAMLA------Y 372
              + + +W   L       + EK K L I+    E ++ +   GV +           +
Sbjct: 243 ETYKKVMNWKETLIFPPEVPISEKAKDL-ILRFCCEWEHRIGAPGVEEIKTNPFFEGVDW 301

Query: 373 HCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKD 425
             +   P A P+    +D        PD         T   PE    + + KD
Sbjct: 302 EHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPE---TDYKNKD 351

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 31/110 (28%), Positives = 42/110 (38%), Gaps = 33/110 (30%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFGLA---------------KDGPEGD------------ 274
           I+RD K  N+LLD   + KLSDFGL                   P  D            
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 275 ------KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
                 +  ++   +GT  Y APE  M        D +S GV++ E+L G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNL 178
           +G G +G VYK       ++G      A+K  +G   S    RE    +  L  L HPN+
Sbjct: 9   VGRGTYGHVYKA----KRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNV 60

Query: 179 VKL--IGYCCEDEHRVLIYEF----------MARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           + L  +     D    L++++            R S  N    K  + LP  +   + + 
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQ 116

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTD----YNAKLSDFGLAK--DGPEGDKSHVST 280
              G+ +LH     V++RD K +NIL+  +       K++D G A+  + P    + +  
Sbjct: 117 ILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 281 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT 317
            ++ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 175 VVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 32/123 (26%), Positives = 42/123 (34%), Gaps = 47/123 (38%)

Query: 242 IYRDFKTSNILLDTDYNAKLSDFGL---------------------AKDGPEGDKSHV-- 278
           I+RD K  NIL+D   + KLSDFGL                      K+  +   S    
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 279 -----------------STRIM-----GTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEI 315
                            + R+M     GT  Y APE I          D +S G ++ E 
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAIMFEC 241

Query: 316 LTG 318
           L G
Sbjct: 242 LIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	429
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
smart00090	237	RIO RIO-like kinase.	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.36
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.36
KOG1243	690	consensus Protein kinase [General function predict	99.32
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG3087	229	consensus Serine/threonine protein kinase [General	99.18
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.01
COG4248	637	Uncharacterized protein with protein kinase and he	98.94
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.89
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.8
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.76
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.71
PRK09902	216	hypothetical protein; Provisional	98.62
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.41
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.41
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.38
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.32
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.3
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.28
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.21
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.21
PLN02876	822	acyl-CoA dehydrogenase	98.17
PF01636	239	APH: Phosphotransferase enzyme family This family	98.16
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.1
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.94
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.93
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.9
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.9
PRK10593	297	hypothetical protein; Provisional	97.82
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.66
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.6
PRK05231	319	homoserine kinase; Provisional	97.56
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.47
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.39
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.38
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.2
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.18
PLN02236	344	choline kinase	96.72
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.57
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.37
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.31
KOG2270	520	consensus Serine/threonine protein kinase involved	96.21
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.11
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.1
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.1
PRK12396	409	5-methylribose kinase; Reviewed	95.92
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.88
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.77
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.77
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.72
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.62
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.6
PTZ00384	383	choline kinase; Provisional	95.55
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.07
PRK06148	1013	hypothetical protein; Provisional	94.97
PLN02756	418	S-methyl-5-thioribose kinase	94.47
COG2334	331	Putative homoserine kinase type II (protein kinase	94.18
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	93.74

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-56  Score=425.06  Aligned_cols=291  Identities=58%  Similarity=0.969  Sum_probs=251.8

Q ss_pred             CccccChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCc
Q 014189           98 PLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN  177 (429)
Q Consensus        98 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n  177 (429)
                      +...|++.++..+|++|....+||+|+||.||+|.+.++       ..||||.+....... ..+|.+|+.++.+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-------~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~N  132 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-------TVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPN  132 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-------CEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcC
Confidence            566799999999999999999999999999999988764       239999887654432 566999999999999999


Q ss_pred             eeeeeeEEEeCC-eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceeCCCCCCcEEEcC
Q 014189          178 LVKLIGYCCEDE-HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDT  255 (429)
Q Consensus       178 iv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivH~Dlkp~NIll~~  255 (429)
                      +|+|+|||.+.+ ..+||||||++|+|.++|+.....+++|.+|++||.++|.||+|||... ++||||||||+|||||+
T Consensus       133 lv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~  212 (361)
T KOG1187|consen  133 LVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE  212 (361)
T ss_pred             cccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence            999999999988 5999999999999999998765547999999999999999999999854 47999999999999999


Q ss_pred             CCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 014189          256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~  335 (429)
                      ++++||+|||+|+..+.. .....+...||.+|+|||+...+..+.|+||||||++|+||+||+.+.+...+.....+.+
T Consensus       213 ~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~  291 (361)
T KOG1187|consen  213 DFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE  291 (361)
T ss_pred             CCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence            999999999999765541 1111111189999999999999999999999999999999999999988766555666889


Q ss_pred             hHhhHHHhhhhhhhhcCCCCC-CCCCh-HHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          336 WALPLLKEKKKLLNIIDPRLE-GDYPV-KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      |..+.+.+. .+.+++|+.+. ...+. .....+..++..|++.+|.+||+|.+|++.|+.+...
T Consensus       292 w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  292 WAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            987777665 78999999987 55554 5788899999999999999999999999999766554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-52  Score=381.94  Aligned_cols=253  Identities=27%  Similarity=0.380  Sum_probs=212.9

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC-eE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-HR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~  191 (429)
                      +++..+.||+|..|+||++.|+.+.      ..+|+|++.........++..+|+++++.++||+||.++|+|..++ ..
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~------~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTG------KIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCC------eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            4555688999999999999887664      4599999977767777888999999999999999999999999988 59


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +|+||||++|||.+.+...  +.+++.....|+.++++||.|||. ++  ||||||||+|||++..|+|||||||.+...
T Consensus       154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            9999999999999988665  369999999999999999999996 55  999999999999999999999999999887


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .+.    ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+...    .|+       .-+..+
T Consensus       230 vnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~----~~~-------~Ll~~I  294 (364)
T KOG0581|consen  230 VNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL----DIF-------ELLCAI  294 (364)
T ss_pred             hhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC----CHH-------HHHHHH
Confidence            653    35668999999999999999999999999999999999999999986522111    111       011222


Q ss_pred             cCCCCCCCCCh-HHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 IDPRLEGDYPV-KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ++.. ....|. .++.++.+++..||++||.+|||++|+++|
T Consensus       295 v~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  295 VDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             hcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            2211 112233 488999999999999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-51  Score=394.02  Aligned_cols=250  Identities=26%  Similarity=0.390  Sum_probs=213.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..|...++||+|||+.||.+++.++++.      ||+|++.+..  .....+...+||+|.+.|+|||||+++++|++.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~------~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEV------VAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcE------EEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            4699999999999999999987665444      9999998742  3345566779999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      +.|||.|+|.+|+|..++.+  ++++++.+++.++.||+.||.|||+++  |+|||||..|++|+++.+|||+|||||..
T Consensus        92 nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             ceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeee
Confidence            99999999999999998863  458999999999999999999999988  99999999999999999999999999998


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      +.....  ...+.||||.|+|||++....++..+||||+||+||.||+|++||+...-.      +-.....        
T Consensus       168 le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------ety~~Ik--------  231 (592)
T KOG0575|consen  168 LEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------ETYNKIK--------  231 (592)
T ss_pred             ecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------HHHHHHH--------
Confidence            875432  245689999999999999999999999999999999999999999865321      1111111        


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .-    .-..|...+.++.+||.++|+.||.+|||+.+|+.+
T Consensus       232 ~~----~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  232 LN----EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             hc----CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00    112344678899999999999999999999999976

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9e-51  Score=387.83  Aligned_cols=259  Identities=32%  Similarity=0.539  Sum_probs=214.9

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC-eE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-HR  191 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~  191 (429)
                      +...+.||+|+||+||+|.+.....       ||+|++.... .......|.+|+.+|++++|||||+++|+|.+.. .+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~-------vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDV-------VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCcee-------EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence            3344669999999999998865422       8999988653 2233678999999999999999999999999887 79


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-cEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~  270 (429)
                      ++|||||++|+|..+++......+++..++.++.|||+||.|||+.++ ||||||||+|||++.++ ++||+|||+++..
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceee
Confidence            999999999999999988545579999999999999999999998665 99999999999999998 9999999999875


Q ss_pred             CCCCCccccccccCCcccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ....  ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||...... ..               ..
T Consensus       195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~---------------~~  256 (362)
T KOG0192|consen  195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QV---------------AS  256 (362)
T ss_pred             cccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HH---------------HH
Confidence            4321  2234478999999999999  569999999999999999999999999977641 11               01


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      .......+...+..+...+..|+..||..||+.||++.+|+..|+.+...
T Consensus       257 ~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  257 AVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            11112223344455788899999999999999999999999999887663

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-52  Score=380.27  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=207.4

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh------hHHHHHHHHHHHhccCCCceeeeee
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ------GHREWLAEVIFLGHLSHPNLVKLIG  183 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~  183 (429)
                      ..+.|.+.+.||+|+||.|-+|..+.+.+      .||||++.+.....      ......+|+++|++|+|||||++++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk------~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d  243 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGK------QVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD  243 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCc------EEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee
Confidence            45668899999999999999998766654      49999998753222      1223468999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC---CcEE
Q 014189          184 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAK  260 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~---~~~k  260 (429)
                      +|...+..||||||++||+|.+.+..+.  .+.+..-..+++|++.|+.|||+.|  |+||||||+|||+..+   ..+|
T Consensus       244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  244 FFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             eeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEE
Confidence            9999999999999999999999998765  4667777899999999999999988  9999999999999876   7899


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCC---CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL---TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~  337 (429)
                      |+|||+|+....   ...+.+.|||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||.......  .+.   
T Consensus       320 ItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~---  391 (475)
T KOG0615|consen  320 ITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK---  391 (475)
T ss_pred             ecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH---
Confidence            999999998653   345677999999999999986543   348899999999999999999998654321  010   


Q ss_pred             hhHHHhhhhhhhhcCCCCC--CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          338 LPLLKEKKKLLNIIDPRLE--GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                .++...+..  .......+.+..+|+.+||..||++|||+.|+++|
T Consensus       392 ----------eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  392 ----------EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ----------HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                      111111111  12234678999999999999999999999999876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-50  Score=371.11  Aligned_cols=253  Identities=29%  Similarity=0.451  Sum_probs=208.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..+|...+.||.|+||+||+|+++.+..      .||||.+.... .....+....|+.+|+.++|||||.++++++.++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~------~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGT------EVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCc------eEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            3578888999999999999999877653      49999998765 4455566789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC------CcEEEec
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD------YNAKLSD  263 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~------~~~kl~D  263 (429)
                      .+|||||||.||+|.++++.+.  .+++..+..++.|+|.||++||+++  ||||||||.||||+..      -.+||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecc
Confidence            9999999999999999998876  6999999999999999999999977  9999999999999875      4589999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ||+|+.+..+.   ...+.||++.|||||+++...|+.|+|+||+|+++|+|++|++||+.....+...   +    .+.
T Consensus       159 FGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~---~----~~k  228 (429)
T KOG0595|consen  159 FGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL---Y----IKK  228 (429)
T ss_pred             cchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH---H----Hhc
Confidence            99999886532   3456899999999999999999999999999999999999999999766433211   1    111


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                              +..+....+...+..+.+|+...++.+|.+|.++.+...+
T Consensus       229 --------~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  229 --------GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             --------cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence                    1111122233344556677778888888888877765544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=369.12  Aligned_cols=251  Identities=27%  Similarity=0.343  Sum_probs=208.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++.++||+|+||.||.++.+++      +..+|+|++++...  ........+|..+|..++||.||+++..|++.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt------~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDT------GKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEccc------CceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            46899999999999999999976644      45599999987642  23356677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +.+|+|+||+.||.|..+|.++.  .+++..+.-++..|+.||.|||+.+  ||||||||+|||||++|+++|+||||++
T Consensus        98 ~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccch
Confidence            99999999999999999998765  6899989999999999999999977  9999999999999999999999999999


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .....  ...+.++|||+.|||||++.+..|+..+|+||||+++|||++|.+||...+....      .......     
T Consensus       174 ~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~I~~~-----  240 (357)
T KOG0598|consen  174 EDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDKILKG-----  240 (357)
T ss_pred             hcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHHHhcC-----
Confidence            65432  2235568999999999999999999999999999999999999999987653221      1111111     


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC----CHHHHHH
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP----LMRDIVD  390 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~evl~  390 (429)
                           . ....+.-.+.++.+++.++|..||++|.    ++.+|-.
T Consensus       241 -----k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  241 -----K-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             -----c-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence                 1 1112233678899999999999999996    4555443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-50  Score=384.50  Aligned_cols=261  Identities=30%  Similarity=0.431  Sum_probs=224.8

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +....+++.+.||+|.||.||.|.+....+       ||+|.+...  ....+.|.+|+++|++|+|+|||+++++|..+
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~-------vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWNGSTK-------VAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEcCCCc-------ccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            333445667899999999999999877543       899998875  23446788999999999999999999999998


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +.+|||||||+.|+|.++|....+..+...+.+.++.|||+||+||++++  +|||||..+||||+++..+||+|||||+
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccccccc
Confidence            89999999999999999998866678999999999999999999999977  9999999999999999999999999999


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ...+ +.........-+..|.|||.+..+.++.|+|||||||+||||+| |+.||.....                 ..+
T Consensus       352 ~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------------~ev  413 (468)
T KOG0197|consen  352 LIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------------EEV  413 (468)
T ss_pred             ccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------------HHH
Confidence            5433 22223333455778999999999999999999999999999999 9999987653                 234


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      .+.++...+-+.|..|+..+.+|+..||+.+|++|||++.+...|+.+...
T Consensus       414 ~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  414 LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            555666777788889999999999999999999999999999988877554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-50  Score=351.76  Aligned_cols=252  Identities=24%  Similarity=0.308  Sum_probs=204.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeee-EEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIG-YCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~  189 (429)
                      .+|++.++||+|+||+||++....++.      .+|.|.+.-+. .....+....|+.+|++|+|||||++++ .|.++.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~------l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGK------LVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcc------hhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            468888999999999999997766544      48998877554 3445567889999999999999999998 444444


Q ss_pred             -eEEEEEEecCCCChhhhhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CceeCCCCCCcEEEcCCCcEEEecc
Q 014189          190 -HRVLIYEFMARGSVENNLF--SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK--PVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       190 -~~~lv~e~~~~g~L~~~l~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                       .++||||||.+|+|...+.  .+..+.+++..+++++.|++.||+++|+.-+  .|+||||||.||+++.+|.+||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence             4899999999999999884  3445579999999999999999999998333  3999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ||++.+...  .....+.+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+-...      .       
T Consensus       173 GL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L------~-------  237 (375)
T KOG0591|consen  173 GLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL------C-------  237 (375)
T ss_pred             hhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH------H-------
Confidence            999987653  3455678999999999999999999999999999999999999999987642211      1       


Q ss_pred             hhhhhhcCCCCCCCCC-hHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014189          345 KKLLNIIDPRLEGDYP-VKGVHKAAMLAYHCLNHNPKARPLMRDI  388 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~ev  388 (429)
                      ....+   .. ..+.| ...+..+..|+..|+..||+.||+.-.+
T Consensus       238 ~KI~q---gd-~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~  278 (375)
T KOG0591|consen  238 KKIEQ---GD-YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPY  278 (375)
T ss_pred             HHHHc---CC-CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence            00111   11 12234 3568899999999999999999984333

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=370.93  Aligned_cols=257  Identities=25%  Similarity=0.327  Sum_probs=214.3

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhcc-CCCceeeeeeE
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHL-SHPNLVKLIGY  184 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~  184 (429)
                      ..-..+|.+++.||+|+|++|++|+...+.++      +|||++.+..-  .....-...|-++|.+| .||.|++|+..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~ke------YAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T  142 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKE------YAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT  142 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCce------eeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence            34457899999999999999999987776554      99999876531  11222344688899999 79999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                      |+++..+|+|+||+++|+|.++|...+  .|++.....++.+|+.||+|||++|  ||||||||+|||||.|+++||+||
T Consensus       143 FQD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  143 FQDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             eecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeec
Confidence            999999999999999999999998765  6899999999999999999999988  999999999999999999999999


Q ss_pred             CCCcCCCCCCCc---------cc--cccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH
Q 014189          265 GLAKDGPEGDKS---------HV--STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL  333 (429)
Q Consensus       265 gla~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~  333 (429)
                      |.|+.+......         ..  ..+++||..|++||++.....++.+|+|+||||||+|+.|.+||...++.--   
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli---  295 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI---  295 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH---
Confidence            999876542211         11  2458999999999999999999999999999999999999999987764311   


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                                   +.++++  +.-.++...+..+.+|+.+.|..||.+|+|.++|.+|-
T Consensus       296 -------------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 -------------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             -------------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                         111211  12345556678899999999999999999999999873

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-48  Score=389.95  Aligned_cols=267  Identities=29%  Similarity=0.446  Sum_probs=227.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+....+.||+|+||.||+|....- ........||||.++.....+...+|.+|+++|..++|||||+|+|+|.+++.+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l-~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGL-LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCC-CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            4556668899999999999975443 223456779999999988888899999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC--------C----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcE
Q 014189          192 VLIYEFMARGSVENNLFSKV--------L----LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  259 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~--------~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~  259 (429)
                      ++|+|||..|||.++|..+.        +    .+|+..+.+.||.|||.||+||-++.  .|||||..+|+||.++..|
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceEE
Confidence            99999999999999995432        1    23888999999999999999999977  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHh
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~  338 (429)
                      ||+||||++.....+.........-+.+|||||.+..+.||.++|||||||+|||+++ |+.||.+....+         
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---------  713 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---------  713 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---------
Confidence            9999999998776665555545566889999999999999999999999999999999 999998765322         


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                              +.+.+..+-..+.|..++.++.+|+..||+.+|++||++.||-..|......
T Consensus       714 --------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 --------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             --------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                    2222222222677889999999999999999999999999999999776544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.2e-48  Score=344.43  Aligned_cols=267  Identities=24%  Similarity=0.290  Sum_probs=208.5

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhh-HHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .|+.+.++|+|+||.||+++++++      ++.||||.+........ .+-.++|+++|++++|+|+|.++.+|.....+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~T------gqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrkl   76 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDT------GQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKL   76 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCc------ccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhccee
Confidence            577778999999999999987766      45599999876554333 34467999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++|+|||+.. +.+.|..... .++......+++|++.|+.|+|+++  +|||||||+|||++.+|.+||||||+|+...
T Consensus        77 hLVFE~~dhT-vL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   77 HLVFEYCDHT-VLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             EEEeeecchH-HHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhc
Confidence            9999999874 4444544333 5888999999999999999999988  9999999999999999999999999999876


Q ss_pred             CCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh--------HHH
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--------LLK  342 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~  342 (429)
                      ...  ...+..+.|.+|+|||.+.+ -.|...+||||+||++.||++|.+.|.+.+...+.-.....+.        .+.
T Consensus       153 ~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  153 APG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             CCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence            422  23456789999999999987 6899999999999999999999999998776544333222111        111


Q ss_pred             hhhhhhhhcCCCCCCC-----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKKLLNIIDPRLEGD-----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....+.-+.-|.....     ..+..+.-+.+|+.+||..||.+|++-++++.+
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            1111111111111111     112456688999999999999999999999865

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=354.52  Aligned_cols=262  Identities=29%  Similarity=0.411  Sum_probs=210.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC--
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  189 (429)
                      .++...+.||+|+||.||++.+.+++.      ..|||.+...+... .+.+.+|+.+|++++|||||+++|......  
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~------~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~   89 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGE------LMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSREND   89 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCc------ceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCe
Confidence            457777899999999999998876533      39999987664333 566789999999999999999999855444  


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC-CCcEEEeccCCCc
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAK  268 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~  268 (429)
                      .+++.|||+++|+|.+++.+..+ .+++..+..++.|+++||+|||+++  +||+||||+|||++. ++.+||+|||++.
T Consensus        90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~  166 (313)
T KOG0198|consen   90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAK  166 (313)
T ss_pred             eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccc
Confidence            68999999999999999988776 7999999999999999999999977  999999999999999 7999999999998


Q ss_pred             CCCC-CCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          269 DGPE-GDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       269 ~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      .... ...........||+.|||||++..+ ....++|||||||++.||+||++||....     ....+          
T Consensus       167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~----------  231 (313)
T KOG0198|consen  167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEA----------  231 (313)
T ss_pred             ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHH----------
Confidence            7653 1111223357899999999999963 33459999999999999999999998631     00111          


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      +..+.........+...+.++.+++.+|+..||+.|||+.+++++.-..+..
T Consensus       232 ~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  232 LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            1111111122355667889999999999999999999999999986444333

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=337.46  Aligned_cols=238  Identities=26%  Similarity=0.356  Sum_probs=205.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .+|+..+.||.|+||.|.+++.+.+      +..+|+|++.+..  ...+.+...+|..+|+.+.||+++++.+.|.+.+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~------g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHS------GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS  117 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccC------CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence            4678889999999999999977655      4459999998753  3344556778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+||||||++||.|.+++.+..  ++++..+.-++.+++.||+|||+.+  |++|||||+|||+|.+|.+||+|||+|+.
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEE
Confidence            9999999999999999997765  6899999999999999999999988  99999999999999999999999999998


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ....     +.+.||||.|+|||++....|..++|+|||||++|||+.|.+||...++..                ...+
T Consensus       194 v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----------------iY~K  252 (355)
T KOG0616|consen  194 VSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----------------IYEK  252 (355)
T ss_pred             ecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH----------------HHHH
Confidence            6542     456899999999999999999999999999999999999999998766421                1122


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCC
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR  382 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  382 (429)
                      ++...+  .+|...+.++.+|+.+.|+.|-.+|
T Consensus       253 I~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            232222  3456678899999999999999999

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-48  Score=359.24  Aligned_cols=271  Identities=24%  Similarity=0.291  Sum_probs=216.5

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  187 (429)
                      .+.++|.+.++||.|+||.||+|+....++.      ||||.++..-.....-.-++|+..|++++ |||||++++++.+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~------VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d   80 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGEL------VAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD   80 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCce------eeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence            3456899999999999999999987766544      99999887643333333468999999998 9999999999988


Q ss_pred             CC-eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          188 DE-HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       188 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      .+ .+|+|||||+ .+|++++..+ +..|++..+..|++||++||+|+|.+|  +.|||+||+|||+..+..+||+|||+
T Consensus        81 ~~~~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGL  156 (538)
T KOG0661|consen   81 NDRILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGL  156 (538)
T ss_pred             cCceEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccc
Confidence            87 9999999996 5899988777 678999999999999999999999988  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH-----
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL-----  340 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-----  340 (429)
                      ||.......   .+..+.|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++.|.+.+...+....--++..     
T Consensus       157 ARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~  233 (538)
T KOG0661|consen  157 AREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS  233 (538)
T ss_pred             ccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence            998765433   34578899999999986 578999999999999999999999999988776553322211110     


Q ss_pred             HHhhhhhhhhcCCCCCCCC-------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          341 LKEKKKLLNIIDPRLEGDY-------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      +.+...+...+.-.+....       -...+.++.+|+.+|+++||.+|||+.+++++-
T Consensus       234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            1111122222222221111       123678999999999999999999999999873

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-47  Score=355.94  Aligned_cols=270  Identities=23%  Similarity=0.257  Sum_probs=211.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCceeeeeeEEEeC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  188 (429)
                      .+.|+.+++||+|+||.||+|++..+++      .||+|.++-+... .......+||.||++|+||||++|.+...+. 
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgk------ivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGK------IVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCc------EEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            3468888999999999999998766644      4999999877533 3334456899999999999999999998876 


Q ss_pred             -CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          189 -EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       189 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                       ..+|||+|||+. +|.-++... ...|++.++..++.|++.||+|||+.+  |+|||||.+|||||.+|.+||+|||||
T Consensus       190 ~~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  190 SGSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             CceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccce
Confidence             789999999986 787776543 346999999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh-HhhHHHhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW-ALPLLKEKK  345 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~~~  345 (429)
                      +.+....... .+..+-|++|+|||.+.|. .|+.++|+||.||||.||++|++.|.+.....+....-- ......+.|
T Consensus       266 r~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  266 RFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            9776544332 4556779999999999875 799999999999999999999999998876655433211 111111122


Q ss_pred             hhhhhcCCCC---CCCC-------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRL---EGDY-------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~---~~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....+.....   ...+       -...+....+|+..+|..||.+|.|+.+++++
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            2111111000   0000       12346788999999999999999999999976

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-46  Score=361.42  Aligned_cols=269  Identities=29%  Similarity=0.396  Sum_probs=209.7

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      ..++|++.++||+|+||.||+|.+.... ....+..||+|++...........+.+|+.++..+ +||||+++++++...
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGID-KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccC-CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3467999999999999999999753221 11224459999987655555566789999999999 899999999988754


Q ss_pred             -CeEEEEEEecCCCChhhhhhcCC--------------------------------------------------------
Q 014189          189 -EHRVLIYEFMARGSVENNLFSKV--------------------------------------------------------  211 (429)
Q Consensus       189 -~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------  211 (429)
                       +.+++||||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             46889999999999999886431                                                        


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcc
Q 014189          212 ----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG  287 (429)
Q Consensus       212 ----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  287 (429)
                          ..++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...............++..
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                124778888999999999999999977  99999999999999999999999999986543222222233456788


Q ss_pred             cccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHH
Q 014189          288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHK  366 (429)
Q Consensus       288 y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (429)
                      |+|||++.+..++.++|||||||++|||++ |..||........  .   . .....         . .....+...+..
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~---~-~~~~~---------~-~~~~~~~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--F---C-QRLKD---------G-TRMRAPENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--H---H-HHHhc---------C-CCCCCCCCCCHH
Confidence            999999999999999999999999999997 9999976442111  0   0 00100         0 011123345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       367 l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      +.+|+.+||+.||++|||+.++++.|+.+..
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.4e-46  Score=354.03  Aligned_cols=256  Identities=24%  Similarity=0.293  Sum_probs=208.4

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      -.++|+++++||+|+||.||+|.-+++      +..+|+|++++..  ...+....+.|..+|....+|+||+++..|++
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~T------g~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD  212 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDT------GEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD  212 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccC------CcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence            457899999999999999999965554      4559999998764  23345667889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+++||||||++||++..+|....  .|++..+..++.+++.|++-+|.+|  +|||||||+|+|||..|++||+||||+
T Consensus       213 ~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  213 KEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLS  288 (550)
T ss_pred             CCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeecccccc
Confidence            999999999999999999998776  6888989999999999999999988  999999999999999999999999998


Q ss_pred             cCCCC----------------------CCCcc----c-------------------cccccCCcccccccccccCCCCcc
Q 014189          268 KDGPE----------------------GDKSH----V-------------------STRIMGTYGYAAPEYIMTGHLTPR  302 (429)
Q Consensus       268 ~~~~~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~  302 (429)
                      .-...                      .+...    .                   ....+|||.|+|||++.+..|+..
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~  368 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE  368 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence            52110                      00000    0                   113689999999999999999999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCCChhhhh-hHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCC
Q 014189          303 SDVYSFGVVLLEILTGRKSLDKSRPAREQ-NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA  381 (429)
Q Consensus       303 ~DvwslG~il~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~  381 (429)
                      +|+||||||+||||.|.+||....+..-- .+..|-               ..+..+....++.++.+||.+||. ||+.
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------------~~l~fP~~~~~s~eA~DLI~rll~-d~~~  432 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------------ETLKFPEEVDLSDEAKDLITRLLC-DPEN  432 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------------hhccCCCcCcccHHHHHHHHHHhc-CHHH
Confidence            99999999999999999999987764321 111111               111222223456899999999999 9999


Q ss_pred             CC---CHHHHHHh
Q 014189          382 RP---LMRDIVDS  391 (429)
Q Consensus       382 RP---s~~evl~~  391 (429)
                      |.   +++||.+|
T Consensus       433 RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  433 RLGSKGAEEIKKH  445 (550)
T ss_pred             hcCcccHHHHhcC
Confidence            97   47888776

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-46  Score=356.64  Aligned_cols=257  Identities=27%  Similarity=0.350  Sum_probs=210.0

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC----ChhhHHHHHHHHHHHhccC-CCceeeeee
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLS-HPNLVKLIG  183 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~-h~niv~l~~  183 (429)
                      ...+.|.+.+.||+|+||.|++|.+..+.      ..||+|++....    .........+|+.+++.++ ||||++++.
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~------~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTG------EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCC------CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            34568999999999999999999876654      349999877641    1122344557999999998 999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-CcEEEe
Q 014189          184 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLS  262 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~  262 (429)
                      ++.....+|+||||+.||+|.+++....  ++.+..+..++.|++.|++|||+++  |+||||||+|||++.+ +++||+
T Consensus        88 v~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   88 VFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             EEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEe
Confidence            9999999999999999999999998843  6888999999999999999999988  9999999999999999 999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-LT-PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      |||++....  .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+....      .   
T Consensus       164 DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l------~---  232 (370)
T KOG0583|consen  164 DFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL------Y---  232 (370)
T ss_pred             ccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH------H---
Confidence            999999874  1122356689999999999999877 86 789999999999999999999997432111      0   


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHH-HHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKG-VHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                             ..+...  ...++... +.++.+|+.+||..||..|+|+.+|+. -.-++
T Consensus       233 -------~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~-h~w~~  279 (370)
T KOG0583|consen  233 -------RKIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE-HPWFQ  279 (370)
T ss_pred             -------HHHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh-Chhhc
Confidence                   011111  11223344 888999999999999999999999994 44444

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-46  Score=324.68  Aligned_cols=268  Identities=24%  Similarity=0.293  Sum_probs=209.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .+|...++||+|+||.||+|++..+++.      ||||.++..+.. ......++|+..|+.++|+||+.++++|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~------VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKR------VAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcE------EEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            3577788999999999999987766544      999998765422 223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +.||+|||+. +|...+.++. ..+.......++.+++.|++|||.+.  |+||||||+|+|++++|.+||+|||+|+.+
T Consensus        76 l~lVfEfm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   76 LSLVFEFMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             eEEEEEeccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhcc
Confidence            9999999974 8988887654 46888999999999999999999988  999999999999999999999999999988


Q ss_pred             CCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH-hhh-hh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK-EKK-KL  347 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~-~~  347 (429)
                      ...+..  .+..+-|.+|+|||.+.|. .|+..+|+||.|||+.||+-|.+-|.+.++.++....-.++..-. +.| .+
T Consensus       152 ~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  152 GSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             CCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence            764432  2334789999999999864 699999999999999999999988887766554332211111000 000 01


Q ss_pred             h--------hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 L--------NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~--------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .        +.+........-..++.++.+|+.+++..||.+|+|+.|++++
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1        1111111111233456778999999999999999999999987

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.2e-47  Score=359.95  Aligned_cols=248  Identities=27%  Similarity=0.383  Sum_probs=212.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC-CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|.+.+.||+|+||.||||+-+.+      ...||+|.+.+. ..........+|++|++.++|||||.++++|++..+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t------~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYT------IQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccc------eeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            4688889999999999999965444      455999998764 345566778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +++|.||+.| +|...|....  .++++.+..++++++.||.|||+++  |+|||+||.|||++.+|.+|+||||+|+..
T Consensus        76 ~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhc
Confidence            9999999976 9999987654  6999999999999999999999988  999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ..  .....++..|||.|||||.+.+..|+..+|+||+||++|||++|++||....-.      +.+          ..+
T Consensus       151 ~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~------~Lv----------~~I  212 (808)
T KOG0597|consen  151 ST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT------QLV----------KSI  212 (808)
T ss_pred             cc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH------HHH----------HHH
Confidence            65  345667789999999999999999999999999999999999999999743321      111          111


Q ss_pred             c-CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 I-DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      . |+   ..++...+..+..++...|.+||..|.|..+++.|
T Consensus       213 ~~d~---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  213 LKDP---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             hcCC---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            1 11   12345778899999999999999999999999876

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-46  Score=343.69  Aligned_cols=265  Identities=24%  Similarity=0.326  Sum_probs=214.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ..+|++.+.||.|..++||+|+.....      ..||||++.-+........+.+|+..|+.++||||++++..|..+..
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~------e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTN------EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccC------CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            468999999999999999999876554      44999999887666667888899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +|+||.||.+||+.+.+.......+++..+..|.++++.||.|||.+|  .||||||+.||||+.+|.|||+|||.+..+
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeee
Confidence            999999999999999998777667999999999999999999999988  999999999999999999999999986554


Q ss_pred             CCCC-Ccccc-ccccCCcccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          271 PEGD-KSHVS-TRIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       271 ~~~~-~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      .... ..... ..+.||++|||||+++  ...|+.|+||||||++..||.+|..||....+....-.      .+...  
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~------tLqn~--  248 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL------TLQND--  248 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH------HhcCC--
Confidence            3322 11122 5579999999999976  35799999999999999999999999997765321100      00000  


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....-..+........+..+.+++..||.+||.+|||+++++++
T Consensus       249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            000000011112222356689999999999999999999999865

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-46  Score=362.33  Aligned_cols=249  Identities=26%  Similarity=0.380  Sum_probs=210.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      -|++++-||.|+.|.|-+|++..+      ++.+|||++.+..  .........+|+-+|+.+.|||++++++++++..+
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~T------GqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAET------GQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ceeccccccCCCCceehhhhcccc------cceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            477889999999999999976555      5559999998752  22334456689999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +|+|.||+++|.|.+++..++  ++++.++.+++.||+.|+.|+|..+  |+||||||+|+|||..+++||+|||+|..-
T Consensus        87 lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecc
Confidence            999999999999999998876  7999999999999999999999988  999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLT-PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ..+.   ...+.||++.|.|||+++|..|+ .++||||+|||||.||||+.||++.+..      ....++..       
T Consensus       163 ~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir------~LLlKV~~-------  226 (786)
T KOG0588|consen  163 VPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR------VLLLKVQR-------  226 (786)
T ss_pred             cCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH------HHHHHHHc-------
Confidence            4432   34567999999999999999984 7899999999999999999999954321      11111110       


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                           -..+.|...+.++.+|+.+||..||+.|.|++||++|-
T Consensus       227 -----G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  227 -----GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             -----CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                 01234567789999999999999999999999999983

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=360.36  Aligned_cols=270  Identities=27%  Similarity=0.424  Sum_probs=218.1

Q ss_pred             cChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceee
Q 014189          102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVK  180 (429)
Q Consensus       102 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  180 (429)
                      .+..++.+..+.+.+.+.||+|.||+||+|.|.++         ||||+++.+. ..+..+.|.+|+..+++-+|.||+-
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlL  452 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILL  452 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccccc---------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhee
Confidence            34466677777888899999999999999998876         9999998654 4556788999999999999999999


Q ss_pred             eeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEE
Q 014189          181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  260 (429)
Q Consensus       181 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  260 (429)
                      +.|+|..... .||..+|+|.+|+.+++.... .|...+.+.|+.|+|+|+.|||..+  |||||||.+||++++++.||
T Consensus       453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVk  528 (678)
T KOG0193|consen  453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVK  528 (678)
T ss_pred             eehhhcCCce-eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEE
Confidence            9999998877 999999999999999987764 5888999999999999999999966  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccCCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~  337 (429)
                      |+||||+................|...|||||+++.   .+|++.+||||||+++|||+||..||.....  ++-+.   
T Consensus       529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIif---  603 (678)
T KOG0193|consen  529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIF---  603 (678)
T ss_pred             EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEE---
Confidence            999999875433222222233568889999999984   4799999999999999999999999983321  11110   


Q ss_pred             hhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                        ++..+     ...+.+ .....+++.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus       604 --mVGrG-----~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  604 --MVGRG-----YLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --Eeccc-----ccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              00000     000000 11123678899999999999999999999999998877765

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=359.42  Aligned_cols=245  Identities=28%  Similarity=0.397  Sum_probs=206.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccC-CCceeeeeeEEE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCC  186 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  186 (429)
                      -..+|.++++||+|+||.|+++..+.+.+      .+|||+++++.  ...+.+..+.|.+|+...+ ||.++.++.+|+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e------~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ  439 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNE------YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ  439 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCc------EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc
Confidence            34689999999999999999998776644      49999999875  3344566778888887774 999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      +.+++|+||||+.||++..+.+.   ..+++..+.-+++.++.||.|||.++  |||||||.+|||||.+|++||+|||+
T Consensus       440 T~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             cCCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEeccccc
Confidence            99999999999999995444332   36999999999999999999999988  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ++......  ..++++||||.|||||++.+..|+..+|+|||||+|||||.|..||.+.+..+.                
T Consensus       515 cKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~----------------  576 (694)
T KOG0694|consen  515 CKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV----------------  576 (694)
T ss_pred             ccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------
Confidence            99865322  246779999999999999999999999999999999999999999997664221                


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM  385 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  385 (429)
                      ...++..  ...+|.-++.++..++.++|.++|++|..+
T Consensus       577 FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  577 FDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            1112111  123466788999999999999999999866

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=369.44  Aligned_cols=267  Identities=25%  Similarity=0.428  Sum_probs=231.0

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +-.+...+.++||.|.||.|++|.++...+.   ...||||.++....+....+|+.|..||.++.||||++|.|+....
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkr---e~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKR---EITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCc---ceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            3445667889999999999999998776543   5679999999998889999999999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ....||.|||++|+|..+|..+.+ .+++.+...++++||.||.||.+.+  +|||||..+|||++.+...|++||||++
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEecccccee
Confidence            999999999999999999987765 5999999999999999999999877  9999999999999999999999999999


Q ss_pred             CCCCCCCcccccccc--CCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          269 DGPEGDKSHVSTRIM--GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ..+++... ..++.-  -+.+|.|||.+....++.++||||||+++||.++ |..||=.+..                 +
T Consensus       780 vledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----------------Q  841 (996)
T KOG0196|consen  780 VLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------------Q  841 (996)
T ss_pred             ecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----------------H
Confidence            87654322 122222  2578999999999999999999999999999887 8888865442                 2


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                      ++.+-++...+.+.|.+|+..|.+|++.||++|-.+||.+.+|+.+|+++-.-|
T Consensus       842 dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  842 DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            344455556667778999999999999999999999999999999998865543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-46  Score=353.87  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=210.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      .|...++||+|+.|.||.|.-..+..      .||||.+.... ....+-.++|+.+|+..+|+|||++++.|...+.+|
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~------~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQ------EVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCc------eEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            57888999999999999997655443      39999987653 223345679999999999999999999999889999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +|||||+||+|.+.+...   .+++.+...|+++++.||+|||..+  |+|||||.+|||++.+|.+||+|||++..+..
T Consensus       347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999999999999877544   4899999999999999999999977  99999999999999999999999999988765


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      ...  ...+.+||+.|||||++....|+++.||||||++++||+.|.+||-..++....             +.+...-.
T Consensus       422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl-------------yLIa~ng~  486 (550)
T KOG0578|consen  422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------------YLIATNGT  486 (550)
T ss_pred             ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH-------------HHHhhcCC
Confidence            443  345689999999999999999999999999999999999999999865543221             11111112


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +  ....+...+..+.+|+.+||..|+++|+++.|+|+|
T Consensus       487 P--~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  487 P--KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             C--CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            2  223455778999999999999999999999999987

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-47  Score=350.60  Aligned_cols=251  Identities=27%  Similarity=0.370  Sum_probs=213.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ..|+..+.||+|+||.||+|.+..+.+.      ||+|++.-+......++..+|+.+|..++++||.++++.|..+..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~------vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKV------VAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             cccccchhccccccceeeeeeeccccce------EEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            3577778999999999999987666544      9999999887777778888999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++||||.||++.+.+....  .+.+.....|+.++..|+.|||.++  .+|||||+.|||+..+|.+||+|||.+....
T Consensus        87 wiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeee
Confidence            99999999999999886654  4577777889999999999999977  9999999999999999999999999998776


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  ...+++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+..                 +.-++
T Consensus       163 ~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----------------vlflI  223 (467)
T KOG0201|consen  163 NTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-----------------VLFLI  223 (467)
T ss_pred             chhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-----------------EEEec
Confidence            5433  2366899999999999999899999999999999999999999998766521                 11122


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+.-.......++..+.+|+..||.+||+.|||+.+++++
T Consensus       224 pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  224 PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            2222222223667889999999999999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.7e-44  Score=343.62  Aligned_cols=272  Identities=26%  Similarity=0.410  Sum_probs=210.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccc----------cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceee
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLR----------EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK  180 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  180 (429)
                      ..+|++.+.||+|+||.||+|.+.....          ....+..||+|.+...........|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999998654321          122345699999887655556678999999999999999999


Q ss_pred             eeeEEEeCCeEEEEEEecCCCChhhhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 014189          181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKV-----------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIY  243 (429)
Q Consensus       181 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH  243 (429)
                      +++++.+.+..++||||+++|+|.+++....                 ...+++.....++.|++.||.|||+.+  |+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence            9999999999999999999999999885432                 124678889999999999999999977  999


Q ss_pred             CCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh--CCCC
Q 014189          244 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT--GRKS  321 (429)
Q Consensus       244 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--G~~p  321 (429)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++  |..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986544332222334556889999999998899999999999999999987  5567


Q ss_pred             CCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          322 LDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                      |.......   ...........       .........+..++..+.+|+.+||+.||++|||+++|.+.|+.
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRD-------QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhh-------ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            76543221   11111111100       00011111233456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=377.84  Aligned_cols=267  Identities=30%  Similarity=0.454  Sum_probs=223.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+.++.+.||+|+||.||.|...+...... ...||+|.+....+.+...+|++|..+|+.++|||||+++|++.+....
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~-~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVS-PIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCcc-ceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            456677899999999999998766543333 6679999999988899999999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          192 VLIYEFMARGSVENNLFSKV-----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      +|++|||++|+|..+|....     ...++....+.++.|+|.|+.||++..  .|||||..+|+||++...|||+|||+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999997641     345888999999999999999999966  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      |+.....+.........-+..|||||.+..+.++.|+|||||||++||++| |..||...+..+-..             
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~-------------  915 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL-------------  915 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-------------
Confidence            996554333222222234578999999999999999999999999999999 889998766432111             


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                         ...... +...|..|+..+.+|+.+||+.+|++||++..|++.++.+...
T Consensus       916 ---~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  916 ---DVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ---HHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence               011111 3455778899999999999999999999999999998776543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-45  Score=347.31  Aligned_cols=265  Identities=26%  Similarity=0.426  Sum_probs=222.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .+...+.++||+|-||.|.++....       +..||+|+++.+.......+|.+|+++|.+++||||+.++|+|..++.
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg-------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP  609 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG-------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP  609 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC-------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence            3457788999999999999997654       345999999998777777899999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +++|+|||++|+|.+++..+....+.......|+.||+.||+||.+.+  +|||||.++|+|++.++++||+|||+++.+
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccc
Confidence            999999999999999998875444455666789999999999999988  999999999999999999999999999988


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT--GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ..++......+.+-+..|||||.+..++++.++|||+||+++||+++  ...||.......          ..++...+.
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----------vven~~~~~  757 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----------VVENAGEFF  757 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----------HHHhhhhhc
Confidence            77777777777778899999999999999999999999999999865  667887544221          111212222


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                      ..-........|.-++..+.+++..||.++.++|||++++...|..
T Consensus       758 ~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  758 RDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             CCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            2222223334566788999999999999999999999999988754

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-44  Score=353.82  Aligned_cols=266  Identities=26%  Similarity=0.368  Sum_probs=208.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  189 (429)
                      .++|++.+.||+|+||.||+|.+.... .......||+|++...........+.+|+.++..+ +||||+++++++...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~-~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLF-KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccc-cCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            457888999999999999999753221 12234569999987654444556788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCC----------------------------------------------------------
Q 014189          190 HRVLIYEFMARGSVENNLFSKV----------------------------------------------------------  211 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  211 (429)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999886422                                                          


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCc
Q 014189          212 ---------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  276 (429)
Q Consensus       212 ---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  276 (429)
                                     ...+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           124788899999999999999999977  999999999999999999999999999865443222


Q ss_pred             cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCC
Q 014189          277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  355 (429)
Q Consensus       277 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (429)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.......  ....    .+.          ...
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~----------~~~  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MIK----------EGY  334 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HHH----------hCc
Confidence            22223445678999999999999999999999999999998 888987543211  1111    111          111


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          356 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       356 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      ....+...+.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1111223456889999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-45  Score=337.28  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=212.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ..+|++.+.||+|+||.|-+|.....++      .||||.++++.  ..++...+.+|++||+.|+||||+.++.+|++.
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR------~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk  125 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGR------EVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK  125 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCc------EeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence            4568888999999999999997644443      49999998764  445556678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +.+.|||||..+|.|++++..+.  .+++.++..++.||..|+.|+|.++  ++|||||.+|||+|+|+++||+||||+.
T Consensus       126 dKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhh
Confidence            99999999999999999997765  6999999999999999999999988  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      .+...   ....++||++.|.+||++.|.+| .+.+|.|||||+||.|+.|..||++.+-...                +
T Consensus       202 ly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l----------------v  262 (668)
T KOG0611|consen  202 LYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL----------------V  262 (668)
T ss_pred             hhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH----------------H
Confidence            87543   34567999999999999999988 5789999999999999999999998763211                1


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      .++-....   ..++-+..+.-||.+||-.||++|.|++||..|-
T Consensus       263 rQIs~GaY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  263 RQISRGAY---REPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             HHhhcccc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            12211111   1223455677899999999999999999999885

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-44  Score=332.52  Aligned_cols=260  Identities=27%  Similarity=0.306  Sum_probs=218.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++++.||+|.-|+||++.+.+..      ..+|+|++.+..-  .........|-+||+.++||.++.|++.|+.+.
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~------~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTN------CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCC------ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            45778899999999999999877654      4599999987632  223344567999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|++||||+||+|....+++....+++..+.-++..++.||+|||..|  ||+|||||+||||.++|++.|+||.|+..
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeecccccc
Confidence            9999999999999999999999889999999999999999999999988  99999999999999999999999998753


Q ss_pred             CCC---------------------------------CCCc---------------------cccccccCCcccccccccc
Q 014189          270 GPE---------------------------------GDKS---------------------HVSTRIMGTYGYAAPEYIM  295 (429)
Q Consensus       270 ~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~  295 (429)
                      ...                                 ....                     ..+..++||-.|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            211                                 0000                     0122478999999999999


Q ss_pred             cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhh
Q 014189          296 TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCL  375 (429)
Q Consensus       296 ~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  375 (429)
                      |...+.++|+|+|||.+|||+.|..||.+.+.                +..+.+++-..+........+..+.+||.+.|
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLL  372 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence            99999999999999999999999999987653                34456666555555545577899999999999


Q ss_pred             ccCCCCCCC----HHHHHHh--cccc
Q 014189          376 NHNPKARPL----MRDIVDS--LEPL  395 (429)
Q Consensus       376 ~~dP~~RPs----~~evl~~--L~~~  395 (429)
                      .+||++|..    +.||.+|  ++++
T Consensus       373 vKdP~kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             ccChhhhhccccchHHhhcCccccCC
Confidence            999999998    8888876  4444

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.1e-44  Score=338.05  Aligned_cols=264  Identities=29%  Similarity=0.460  Sum_probs=214.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|.+..... ......+++|.+...........|.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE-RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC-CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            468888999999999999998755432 2334569999987665555667789999999999999999999999998999


Q ss_pred             EEEEEecCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVL--------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      +++|||+++|+|.+++.....              ..+++...+.++.|++.||+|||..+  ++|+||||+||++++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCCC
Confidence            999999999999999865421              35788999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHh
Q 014189          258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~  336 (429)
                      .++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||........   .  
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---~--  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---I--  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H--
Confidence            999999999986543332222334567889999999998899999999999999999998 9999976543211   1  


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                                  ..+........+..++.++.+|+.+||+.||.+||++++|+++|+.+
T Consensus       237 ------------~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         237 ------------EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             ------------HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                        01111111223446678899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-44  Score=354.16  Aligned_cols=266  Identities=26%  Similarity=0.376  Sum_probs=210.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  189 (429)
                      .++|++.+.||+|+||.||+|++..... ......||+|++...........+.+|+.+++.+ +|+||+++++++...+
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGK-EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCc-ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            4578899999999999999998654332 2234459999998665555566788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCC----------------------------------------------------------
Q 014189          190 HRVLIYEFMARGSVENNLFSKV----------------------------------------------------------  211 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  211 (429)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999885321                                                          


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcccccc
Q 014189          212 ----------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR  281 (429)
Q Consensus       212 ----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (429)
                                ..++++..+..++.|++.||+|||+.+  |+||||||+|||+++++.+||+|||+++.............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      124788889999999999999999977  99999999999999999999999999986543322222223


Q ss_pred             ccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCC
Q 014189          282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP  360 (429)
Q Consensus       282 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (429)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||........  .              ............+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~--------------~~~~~~~~~~~~~  337 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F--------------YKMVKRGYQMSRP  337 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H--------------HHHHHcccCccCC
Confidence            345678999999998899999999999999999997 9999975432111  0              0001111111122


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          361 VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       361 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      ...+.++.+++.+||+.||++|||+.+|++.|+++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            23467889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.9e-44  Score=338.84  Aligned_cols=254  Identities=26%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .|+..+.||+|+||.||+|.+..+.+      .||+|.+....  .......+.+|+.++++++|+||+++++++.+.+.
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~   74 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGK------MYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCc------eEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence            37778999999999999998765543      49999886542  12233457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            999999999999998886655556899999999999999999999977  999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .....   .....||..|+|||++.+..++.++|||||||++|||++|+.||...........  . .         ..+
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~-~---------~~~  217 (285)
T cd05631         153 PEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE--V-D---------RRV  217 (285)
T ss_pred             CCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH--H-H---------HHh
Confidence            43221   2345799999999999999999999999999999999999999986543211000  0 0         000


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                      ..  .....+...+..+.+|+.+||+.||++||+     +++++++
T Consensus       218 ~~--~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         218 KE--DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             hc--ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            00  011223345678899999999999999997     7888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-45  Score=317.19  Aligned_cols=251  Identities=27%  Similarity=0.389  Sum_probs=213.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++++.||+|.||.||+|+.+.+.      ..||+|++.+.+  ......++.+|++|-+.|+||||++++++|.++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~------~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSL------FIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCC------cEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            367999999999999999999766553      349999987654  223345678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ...|+++||..+|+|...|.......+++.....+.+|+|.|+.|+|..+  |+||||||+|+|++..+.+||+|||.+.
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCcee
Confidence            99999999999999999998777778999999999999999999999866  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ..+.    ....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||......                ....
T Consensus       173 ~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYk  232 (281)
T KOG0580|consen  173 HAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYK  232 (281)
T ss_pred             ecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHH
Confidence            7542    2345689999999999999999999999999999999999999999865421                1111


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ++..  ++..+|...+..+.+++.+|+.++|.+|.+..|++++
T Consensus       233 rI~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  233 RIRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            1111  1123345678889999999999999999999999876

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.9e-45  Score=325.51  Aligned_cols=268  Identities=21%  Similarity=0.243  Sum_probs=207.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhh-HHHHHHHHHHHhccCCCceeeeeeEEEe--C
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNLVKLIGYCCE--D  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  188 (429)
                      +.|+.+..|++|+||.||+|+++.+.+      .||+|.++-+..... -..-++||.+|.+.+|||||.+..+...  -
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~e------IVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDE------IVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcce------eEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            458888999999999999998776644      499999876542221 2345689999999999999999988763  4


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +.+|+|||||+. +|...+.... .++...++..++.|++.|++|||.+.  |+||||||+|+|++..|.+||+|||+|+
T Consensus       150 d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  150 DKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             ceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhh
Confidence            679999999986 8888876554 57999999999999999999999988  9999999999999999999999999999


Q ss_pred             CCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh-hh-
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-KK-  345 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~-  345 (429)
                      .+....  ...+..+-|.+|+|||.+.+. .|+...|+||+|||+.||+++++.|.+.....+.+..-..+..-.+ .| 
T Consensus       226 ~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  226 EYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             hhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence            987653  335567889999999999864 6999999999999999999999999887765443322111100000 00 


Q ss_pred             -----------hhhhhcCCCCCCCCChH-HHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 -----------KLLNIIDPRLEGDYPVK-GVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 -----------~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                 .+.......++..+... .+..-++|+..+|.+||.+|.|++|.+++
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                       00000000111112222 45778999999999999999999999987

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-43  Score=341.06  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=208.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||++.+..+.      ..+|+|++...........+.+|++++++++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSG------LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCC------cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            368999999999999999999876543      34899998765445556778999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||.|||+. +  |+||||||+|||++.++.+||+|||++..
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            999999999999999886543  588999999999999999999973 4  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh------
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE------  343 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------  343 (429)
                      .....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..........  .....      
T Consensus       154 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~  227 (331)
T cd06649         154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPH  227 (331)
T ss_pred             ccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCcc
Confidence            54321    2345799999999999999999999999999999999999999976543221110000  00000      


Q ss_pred             --------------------------hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          344 --------------------------KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       344 --------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                                                ......+.............+.++.+|+.+||+.||++|||+++++++-
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                      0000000000000011123567899999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.6e-44  Score=332.21  Aligned_cols=260  Identities=23%  Similarity=0.376  Sum_probs=210.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|.+....   .....||+|.+...........|.+|+.++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~---~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPS---KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCC---CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            56889999999999999999865432   235569999988765555667789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+  ++||||||+|||++.++.++++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999999887643 36899999999999999999999977  9999999999999999999999999876542


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .... .......++..|+|||.+.+..++.++|||||||++||+++ |..||........   .    .....       
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~----~~~~~-------  223 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---I----KAVED-------  223 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---H----HHHHC-------
Confidence            2111 11112345678999999999999999999999999999775 9999976543211   0    00100       


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                         ......+..++..+.+++.+||+.+|++|||+++|++.|+++
T Consensus       224 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         224 ---GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence               111122345677899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=350.87  Aligned_cols=277  Identities=28%  Similarity=0.445  Sum_probs=224.6

Q ss_pred             cChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecC--CCChhhHHHHHHHHHHHhccCCCcee
Q 014189          102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG--DNSYQGHREWLAEVIFLGHLSHPNLV  179 (429)
Q Consensus       102 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv  179 (429)
                      ...+.++...++-.+.++||+|+||.||+|.+......  ....||+|....  ........+|++|.++|+.++|||||
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~--~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV  224 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF--KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV  224 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCc--eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence            44455666667777789999999999999988764331  112289999885  34567788999999999999999999


Q ss_pred             eeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcE
Q 014189          180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  259 (429)
Q Consensus       180 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~  259 (429)
                      +++|++..+..+++|||+|.||+|.++|..... .++..++..++.+.|.||+|||+.+  ++||||..+|+|++.++.+
T Consensus       225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeE
Confidence            999999999999999999999999999987654 5899999999999999999999977  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHh
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~  338 (429)
                      ||+|||+++.........  ....-+..|+|||.+..+.|+.++|||||||++||+++ |..||.+.....-        
T Consensus       302 KISDFGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--------  371 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--------  371 (474)
T ss_pred             EeCccccccCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH--------
Confidence            999999998754211111  01235679999999999999999999999999999999 8889987764311        


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCC
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE  401 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  401 (429)
                              ...+.-...+...+...+..+..++.+|+..+|++||||.++.+.|+.+......
T Consensus       372 --------~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  372 --------KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             --------HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                    1111111223334446678888899999999999999999999999887766543

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.1e-44  Score=333.87  Aligned_cols=256  Identities=35%  Similarity=0.546  Sum_probs=203.0

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEE
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  195 (429)
                      +.+.||.|+||.||+|.+..  ........|+||.+...........|.+|++.+++++||||++++|++...+..++||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~--~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ--KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES--TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEc--ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccc
Confidence            45789999999999999874  2334466799999977656666788999999999999999999999999888899999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC
Q 014189          196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  275 (429)
Q Consensus       196 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  275 (429)
                      ||+++|+|.++|.......+++..+..|+.|++.||+|||+.+  ++|+||+++|||++.++.+||+|||++........
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence            9999999999998875567999999999999999999999977  99999999999999999999999999987633222


Q ss_pred             ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       276 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                      ........+...|+|||.+.+..++.++||||||+++|||++ |+.||.......   .   ... +..          .
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~---~~~-~~~----------~  221 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---I---IEK-LKQ----------G  221 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---H---HHH-HHT----------T
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c---ccc-ccc----------c
Confidence            222333567889999999999999999999999999999999 778987654321   1   000 011          1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      .....+..++..+.+++.+||..+|++|||++++++.|
T Consensus       222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11222345677899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-43  Score=328.70  Aligned_cols=262  Identities=25%  Similarity=0.419  Sum_probs=212.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+....+   ....||+|.+...........|.+|+.+++.++||||+++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGK---KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCC---CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            3578899999999999999998765422   2345999998776556666788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .+++|||+++|+|.+++..... .+++..+..++.|++.|++|||+.+  |+|+||||+|||+++++.++|+|||+++..
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999999999876443 6899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ....            
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~------------  221 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAV------------  221 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHH------------
Confidence            53222222223345678999999998899999999999999999998 9999865432211   0000            


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                       .. ......+...+..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus       222 -~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         222 -ED-GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -Hc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             00 011112334567889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-43  Score=334.20  Aligned_cols=269  Identities=22%  Similarity=0.262  Sum_probs=203.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..+|+|++.... .......+.+|+.+++.++||||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETK------EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCC------cEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            36899999999999999999876553      349999887543 22334567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||++++++..+...  ...+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999998766544322  236899999999999999999999977  999999999999999999999999999875


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH-hhHH-------H
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA-LPLL-------K  342 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~-~~~~-------~  342 (429)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ....       .
T Consensus       151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            432211 123357899999999999889999999999999999999999999875533221111100 0000       0


Q ss_pred             hhhhhhhhcCCCCCC------CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKKLLNIIDPRLEG------DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..........+....      ......+..+.+|+.+||+.||++|||++++++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000000      0111246779999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-43  Score=347.82  Aligned_cols=268  Identities=25%  Similarity=0.361  Sum_probs=212.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  188 (429)
                      ..++|.+.++||+|+||.||+|.+....+ ......||+|++.........+.|.+|+.+++++. ||||+++++++.+.
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSR-SQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCC-CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            35678999999999999999998643321 22244599999976655555678999999999996 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC---------------------------------------------------------
Q 014189          189 EHRVLIYEFMARGSVENNLFSKV---------------------------------------------------------  211 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  211 (429)
                      +..|+||||+++|+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999998885421                                                         


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc
Q 014189          212 -------------------------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  254 (429)
Q Consensus       212 -------------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~  254 (429)
                                                           ...+++..+..++.|++.||+|||+.+  ++|+||||+|||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~  271 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEe
Confidence                                                 124778888999999999999999977  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 014189          255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNL  333 (429)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~  333 (429)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........  .
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H
Confidence            999999999999986543322222233457788999999999899999999999999999997 9999875432110  0


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .    ...      ..    ......+...+..+.+++.+||+.+|++|||+.+|.+.|+++.
T Consensus       350 ~----~~~------~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         350 Y----NKI------KS----GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H----HHH------hc----CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            0    000      00    1111223355678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=334.44  Aligned_cols=269  Identities=25%  Similarity=0.288  Sum_probs=212.1

Q ss_pred             ChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-------------hhhHHHHHHHHHH
Q 014189          103 TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-------------YQGHREWLAEVIF  169 (429)
Q Consensus       103 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~  169 (429)
                      .-.+-....++|++.+.||+|.||.|-+|++..+.+      .||||++.+..-             ....+...+||.+
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~------l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIai  161 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGK------LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAI  161 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCc------EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHH
Confidence            333444556789999999999999999998766544      499999875321             1123466789999


Q ss_pred             HhccCCCceeeeeeEEEe--CCeEEEEEEecCCCChhhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceeCCC
Q 014189          170 LGHLSHPNLVKLIGYCCE--DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF  246 (429)
Q Consensus       170 l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dl  246 (429)
                      |++++|||||+|+.+..+  .+.+|||+|||..|.+...   ....+ +.+.+++.++.+++.||+|||.++  ||||||
T Consensus       162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDI  236 (576)
T KOG0585|consen  162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDI  236 (576)
T ss_pred             HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC--eecccc
Confidence            999999999999999875  5689999999999876532   22334 899999999999999999999988  999999


Q ss_pred             CCCcEEEcCCCcEEEeccCCCcCCCCCC---CccccccccCCcccccccccccCC----CCcccchhhHHHHHHHHHhCC
Q 014189          247 KTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRIMGTYGYAAPEYIMTGH----LTPRSDVYSFGVVLLEILTGR  319 (429)
Q Consensus       247 kp~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltG~  319 (429)
                      ||+|+||+++|++||+|||.+.....+.   .........|||.|+|||...++.    .+.+.||||+||+||.|+.|+
T Consensus       237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~  316 (576)
T KOG0585|consen  237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ  316 (576)
T ss_pred             chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence            9999999999999999999988663321   111223478999999999998743    357899999999999999999


Q ss_pred             CCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          320 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       320 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      .||......                ....+++...+..+..++....+.+|+.++|.+||+.|.++.+|..|..-.+..
T Consensus       317 ~PF~~~~~~----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  317 LPFFDDFEL----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             CCcccchHH----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            999764321                112334444444444456788899999999999999999999999887665554

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-43  Score=331.97  Aligned_cols=266  Identities=26%  Similarity=0.414  Sum_probs=209.6

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ..+++|++.+.||+|+||.||+|.+...... .....||+|.+..........+|.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCC-CceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3467899999999999999999987543221 234569999986654445566788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEE
Q 014189          189 EHRVLIYEFMARGSVENNLFSKV--------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  260 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  260 (429)
                      ...++||||+++|+|.+++....        ...+++..+..++.|++.||+|||+.+  ++|+||||+||++++++.++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEE
Confidence            99999999999999999886532        124678889999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhh
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      |+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.........   ..   
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~~---  233 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---RF---  233 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HH---
Confidence            999999876543222111222356788999999999899999999999999999999 78888755432110   00   


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                       ..         ... ....+...+..+.+++.+||+.||++|||+.|++++|++
T Consensus       234 -~~---------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 -VM---------EGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -HH---------cCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             00         000 011223456778999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.3e-44  Score=342.23  Aligned_cols=247  Identities=25%  Similarity=0.341  Sum_probs=203.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.++++++||||+++++++..++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTG------EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCC------CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            57899999999999999999876553      349999986532  2233456789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            9999999999999999987654  5888999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|..||.........                ..
T Consensus       168 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----------------~~  226 (329)
T PTZ00263        168 VPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY----------------EK  226 (329)
T ss_pred             cCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH----------------HH
Confidence            5432     12357999999999999999999999999999999999999999765432110                01


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                      +....  ...+...+..+.+|+.+||+.||.+||+     +++++.|
T Consensus       227 i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        227 ILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11111  1122334567889999999999999997     7888877

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=341.90  Aligned_cols=255  Identities=24%  Similarity=0.237  Sum_probs=205.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.++..++||||+++++++...+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTG------EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCC------CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            36899999999999999999876543      349999987542  1233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            9999999999999999986543  6889999999999999999999987  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ...     ......||+.|+|||++.+..++.++|||||||++|||++|..||............      . .   ...
T Consensus       151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i------~-~---~~~  215 (333)
T cd05600         151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL------K-Y---WKE  215 (333)
T ss_pred             ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH------H-h---ccc
Confidence            533     223467999999999999999999999999999999999999999865532211100      0 0   000


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+............+.++.+++.+||..+|.+||++++++++
T Consensus       216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            011000000012456788999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2e-43  Score=333.70  Aligned_cols=268  Identities=21%  Similarity=0.267  Sum_probs=203.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||+|....+.      ..||+|.+...........+.+|+.+++.++||||+++++++..++..
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTE------NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCC------CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            46899999999999999999866543      349999987554333445677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            99999997 48988886543 35788999999999999999999977  9999999999999999999999999987643


Q ss_pred             CCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh-HHH-------
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-LLK-------  342 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~-~~~-------  342 (429)
                      ....  ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||................. ...       
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         155 VPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             CCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            3221  1234578999999999875 5689999999999999999999999987654332211110000 000       


Q ss_pred             hhhhhhhhcCCCCCCC----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKKLLNIIDPRLEGD----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..........+.....    .....+.++.+|+.+||+.||.+|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000111111110000    011345678999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-45  Score=346.03  Aligned_cols=239  Identities=31%  Similarity=0.487  Sum_probs=202.2

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      ++-||.|+.|.||+|.+...        .||||.++.-.        ..+|+-|++|+||||+.|.|+|...-.+|||||
T Consensus       129 LeWlGSGaQGAVF~Grl~ne--------tVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME  192 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHNE--------TVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME  192 (904)
T ss_pred             hhhhccCcccceeeeeccCc--------eehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence            46799999999999987653        29999775321        157888999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCc
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  276 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  276 (429)
                      ||..|-|...|....  +++-.....|..+||.|+.|||.+.  |||||||.-||||+.+..|||+|||.++.....   
T Consensus       193 fCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---  265 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---  265 (904)
T ss_pred             ccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh---
Confidence            999999999997654  6788888999999999999999988  999999999999999999999999999876442   


Q ss_pred             cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCC
Q 014189          277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  356 (429)
Q Consensus       277 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (429)
                      ...-.++||..|||||++++.+.++|+|||||||+|||||||..||...+...    .-|            -.-.-.+.
T Consensus       266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw------------GVGsNsL~  329 (904)
T KOG4721|consen  266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW------------GVGSNSLH  329 (904)
T ss_pred             hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE------------eccCCccc
Confidence            22345899999999999999999999999999999999999999997544211    111            11122344


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          357 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       357 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                      ...|..++..+.-|+++||+..|..||||++|+.||+=
T Consensus       330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            55677888899999999999999999999999999854

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3e-43  Score=336.91  Aligned_cols=264  Identities=25%  Similarity=0.397  Sum_probs=210.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|+..+.||+|+||.||+|.+..+...  ....||+|.+..........++.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCc--cceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            5689999999999999999987543221  23458999987655555667888999999999999999999998764 56


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++++||+++|+|.+++.... ..+++...+.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccccc
Confidence            79999999999999987653 35888999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ............++..|+|||++.+..++.++||||||+++|||++ |..||........   .              ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---~--------------~~  223 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S--------------SI  223 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---H--------------HH
Confidence            4332222222345678999999999999999999999999999998 9999976432211   0              01


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      +........+..++..+.+++.+||..+|++|||+.+++..|..+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         224 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            111111122334567789999999999999999999999999776544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-43  Score=340.46  Aligned_cols=244  Identities=25%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  195 (429)
                      +.||+|+||.||+|.+..++      ..+|+|++....  .......+.+|+.++++++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREKATG------KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence            46999999999999876543      349999987532  2234456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC
Q 014189          196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  275 (429)
Q Consensus       196 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  275 (429)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...... 
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  149 (323)
T cd05571          75 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-
Confidence            9999999999887543  6899999999999999999999987  9999999999999999999999999987543221 


Q ss_pred             ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCC
Q 014189          276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  355 (429)
Q Consensus       276 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (429)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+......                .+...  
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~~~--  210 (323)
T cd05571         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----------------LILME--  210 (323)
T ss_pred             -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH----------------HHHcC--
Confidence             12234679999999999999999999999999999999999999997654321100                00000  


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          356 EGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       356 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      ....+...+.++.+|+.+||+.||++||     ++.+++++
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1122345577889999999999999999     79999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.4e-43  Score=331.10  Aligned_cols=247  Identities=21%  Similarity=0.310  Sum_probs=199.9

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEe----CCeE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE----DEHR  191 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  191 (429)
                      ..||+|++|.||+|.+.+        ..||+|.+.....  ......|.+|+.+|++++||||+++++++.+    ....
T Consensus        26 ~~i~~g~~~~v~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNN--------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             eEEeeCCceEEEEEEECC--------EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            679999999999998632        3499999876432  2224667899999999999999999999876    3578


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      ++||||+++|+|.+++....  .+++.....++.+++.||.|||.. +  ++||||||+|||+++++.+||+|||+++..
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            99999999999999987643  688999999999999999999974 6  889999999999999999999999998865


Q ss_pred             CCCCCccccccccCCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ....     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||........   ..   .         
T Consensus       174 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~---~---------  233 (283)
T PHA02988        174 SSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YD---L---------  233 (283)
T ss_pred             cccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HH---H---------
Confidence            4321     23468899999999976  6899999999999999999999999986543211   00   0         


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                       +.........+..++..+.+++.+||+.||++|||++++++.|+.++.
T Consensus       234 -i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        234 -IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence             000111112233567789999999999999999999999999987764

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=325.74  Aligned_cols=282  Identities=25%  Similarity=0.304  Sum_probs=217.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC-CChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  187 (429)
                      +...|...+.||+|+||.|+.|.++.+++      .||+|.+... ......++-.+|+.+|+.++|+||+.+.+.+.. 
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~------~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGE------KVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP   93 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCC------EeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence            44567778999999999999998877654      4999988732 234455667799999999999999999998854 


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          188 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       188 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                          -+..|+|+|+| +.+|...+..+.  .++...+..+++|+++||.|+|+.+  |+||||||+|+|++.+..+||+|
T Consensus        94 ~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             cccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEecc
Confidence                45789999999 458888876553  5899999999999999999999988  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      ||+|+...........+..+.|.+|+|||++. ...|+.+.||||.|||+.||++|++.|.+.+...+..+.......-.
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            99999875432233345678899999999886 56899999999999999999999999998876554443322221110


Q ss_pred             hh-------hhhhhhc---CCCCCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCCCCCC
Q 014189          343 EK-------KKLLNII---DPRLEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVLPDEA  402 (429)
Q Consensus       343 ~~-------~~~~~~~---~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~  402 (429)
                      +.       ......+   ...-..++   -+.....+.+|+.+||..||.+|+|++|.+.|  |.......+.|
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            00       0011111   11111111   12456789999999999999999999999988  66666665555

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=335.46  Aligned_cols=247  Identities=24%  Similarity=0.285  Sum_probs=203.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+..++      ..||+|++....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISE------HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCC------CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence            36888999999999999999876543      349999986432  2234456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  ++||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            9999999999999999986553  6889999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........      ...          
T Consensus       151 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~~~----------  209 (291)
T cd05612         151 LRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YEK----------  209 (291)
T ss_pred             ccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH----------
Confidence            5432     2235799999999999999999999999999999999999999986543211      000          


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                      +....  ...+...+..+.+|+.+||+.||.+||+     +++++++
T Consensus       210 i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         210 ILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            00000  1123344677899999999999999995     9999987

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.7e-43  Score=341.36  Aligned_cols=268  Identities=28%  Similarity=0.386  Sum_probs=209.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe-C
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE-D  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~  188 (429)
                      .++|++.+.||+|+||.||+|...+.. ...+...||+|++...........+..|+.++.++ +|+||+++++++.. +
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIE-KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccc-cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            457899999999999999999754432 12234569999987654445556778899999999 79999999998864 4


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC---------------------------------------------------------
Q 014189          189 EHRVLIYEFMARGSVENNLFSKV---------------------------------------------------------  211 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  211 (429)
                      ..++++|||+++|+|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            57889999999999999885422                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccc
Q 014189          212 --LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA  289 (429)
Q Consensus       212 --~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~  289 (429)
                        ..++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++................++..|+
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              126889999999999999999999977  9999999999999999999999999998764332222223345678899


Q ss_pred             cccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHH
Q 014189          290 APEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAA  368 (429)
Q Consensus       290 aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  368 (429)
                      |||++.+..++.++|||||||++|||++ |..||........  +.    ..+          ........+...+.++.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~----------~~~~~~~~~~~~~~~~~  306 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRL----------KEGTRMRAPEYATPEIY  306 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHH----------hccCCCCCCccCCHHHH
Confidence            9999999999999999999999999998 9999975432111  00    000          00111112234467789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          369 MLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       369 ~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      +++.+||+.+|++||++.+++++|+++..
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-44  Score=341.60  Aligned_cols=253  Identities=25%  Similarity=0.340  Sum_probs=216.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|..++++|+|+||.++++.++.+.+      .+++|.+.-.. .........+|+.++++++|||||.+.+.|..++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~------~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDK------LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCc------eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            578889999999999999987766544      38888876543 34444467789999999999999999999998887


Q ss_pred             -EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          191 -RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       191 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                       .+|||+|++||+|.+.+..+.+..+++.....++.|++.|+.|||+..  |+|||||+.||+++.++.|||+|||+|+.
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhh
Confidence             999999999999999998877778999999999999999999999866  99999999999999999999999999998


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .....  ....+..||+.||+||++.+.+|..|+|||||||++|||++-+++|...+....                 ..
T Consensus       156 l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----------------i~  216 (426)
T KOG0589|consen  156 LNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----------------IL  216 (426)
T ss_pred             cCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----------------HH
Confidence            76543  234568999999999999999999999999999999999999999987663221                 11


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      -+......+.+...+.++..++..||..+|+.||++.+++.+
T Consensus       217 ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  217 KINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            111122344566778999999999999999999999999976

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.1e-43  Score=333.02  Aligned_cols=268  Identities=25%  Similarity=0.379  Sum_probs=214.3

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      ...++|++.+.||+|+||.||+|.+..... ......+|+|.+...........+.+|+.++.++ +|+||+++++++..
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDN-PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCC-CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            344678899999999999999998754322 2234569999988765555566788999999999 79999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE
Q 014189          188 DEHRVLIYEFMARGSVENNLFSK--------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL  253 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll  253 (429)
                      ++..+++|||+++|+|..++...              ....+++..++.++.|++.||.|||+.+  ++||||||+|||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~  165 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLV  165 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEE
Confidence            99999999999999999998642              2346889999999999999999999977  9999999999999


Q ss_pred             cCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhh
Q 014189          254 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQN  332 (429)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~  332 (429)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......... 
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-  244 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-  244 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-
Confidence            9999999999999987544322222223345678999999998999999999999999999998 99998765432110 


Q ss_pred             HHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          333 LADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                                      ..+........+..++..+.+|+.+||..||++|||++++++.|+.+.
T Consensus       245 ----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 ----------------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ----------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                            001111111233455678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.4e-43  Score=329.61  Aligned_cols=263  Identities=28%  Similarity=0.398  Sum_probs=210.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|.+.+.||+|+||.||+|.+.+.. .......||+|.+...........|.+|+++++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLE-PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeecccc-CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            46788899999999999999765431 11234569999988765555667899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcE
Q 014189          192 VLIYEFMARGSVENNLFSKV------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  259 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~  259 (429)
                      ++||||+++|+|.+++....            ...+++..+..++.|++.|+.|||+++  ++||||||+||+++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCeE
Confidence            99999999999999986542            234788999999999999999999977  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHh
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~  338 (429)
                      ||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||.........   ... 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~---~~~-  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---ECI-  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH-
Confidence            9999999876433222122233456789999999999999999999999999999999 99999765432111   000 


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                                  . .......+...+..+.+++.+||+.||++|||++||++.|++
T Consensus       238 ------------~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 ------------T-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ------------H-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                        0 011111223456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.2e-43  Score=341.04  Aligned_cols=250  Identities=25%  Similarity=0.344  Sum_probs=197.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|+..+.||+|+||.||+|.+..+.      ..||+|++...........+.+|+++++.++|+||+++++++...+.+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTG------RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCC------CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            34666789999999999999876543      349999987665555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+..      ...+..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus       148 ~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        148 QVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            9999999999986532      3566778899999999999999977  9999999999999999999999999998654


Q ss_pred             CCCCccccccccCCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ...  .......||..|+|||++..     ...+.++|||||||++|||++|+.||.............           
T Consensus       220 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-----------  286 (353)
T PLN00034        220 QTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC-----------  286 (353)
T ss_pred             ccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-----------
Confidence            321  11234579999999998743     234568999999999999999999997432211100000           


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .+. .......+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       287 --~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        287 --AIC-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --HHh-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000 001112233556789999999999999999999999988

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.7e-43  Score=325.15  Aligned_cols=256  Identities=26%  Similarity=0.394  Sum_probs=208.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|.+.+.||+|+||.||+|.+.+...      .+++|....+  ......+.+|+++++.++||||+++++++..++..
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~------~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSL------TVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCc------eEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            457888999999999999998765433      3999988754  23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++|||+++|+|.+++.......+++..++.++.|++.||+|||+.+  ++||||||+||++++++.+||+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            99999999999999987665556899999999999999999999977  9999999999999999999999999998754


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .... .......++..|+|||.+.+..++.++|||||||++|||++ |..||........      .           ..
T Consensus       156 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~-----------~~  217 (263)
T cd05052         156 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------Y-----------EL  217 (263)
T ss_pred             ccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------H-----------HH
Confidence            3221 11122334678999999999999999999999999999998 9999876542211      0           00


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      +........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         218 LEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            011111223345567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-42  Score=335.55  Aligned_cols=267  Identities=23%  Similarity=0.296  Sum_probs=205.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..+|+|++...........+.+|+++++.++||||++++++|.+++.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSG------LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCC------cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence            468999999999999999999876543      34899988765445556678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .++||||+++|+|.+++....  .+++..+..++.+++.||.|||+ ++  ++|+||||+|||++.++.+||+|||++..
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence            999999999999999986543  58889999999999999999997 35  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh----------
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP----------  339 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~----------  339 (429)
                      .....    .....||..|+|||++.+..++.++|||||||++|||++|+.||.............-...          
T Consensus       154 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP  229 (333)
T ss_pred             hhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence            53321    2335789999999999988999999999999999999999999975443211110000000          


Q ss_pred             ------------------HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          340 ------------------LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       340 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                        ..........+.............+.++.+|+.+||+.||++|||+.|++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                              0000000000000000000011245678999999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.5e-43  Score=351.74  Aligned_cols=254  Identities=20%  Similarity=0.265  Sum_probs=204.5

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      .|.+.+.||+|+||.||+|....+.     ...||+|.+... .......+.+|+.+++.++||||+++++++...+..|
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~-----~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDP-----KEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCC-----CeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            4889999999999999999755431     233788876544 3344456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          193 LIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +||||+++|+|.+++...  ...++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            999999999999887542  2346889999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ............+||+.|+|||++.+..++.++|||||||++|||++|+.||........      .          ..+
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~------~----------~~~  283 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI------M----------QQV  283 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------H----------HHH
Confidence            543322234456799999999999999999999999999999999999999976542110      0          011


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..... ...+...+..+.+++.+||..||++|||+++++.+
T Consensus       284 ~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        284 LYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             HhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            10010 11233456789999999999999999999998754

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-42  Score=326.76  Aligned_cols=262  Identities=26%  Similarity=0.396  Sum_probs=208.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||+|.+.....  .....+++|.+...........|.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGM--DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCC--CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            467888999999999999997643221  124559999987655555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          192 VLIYEFMARGSVENNLFSKV---------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      +++|||+++|+|.+++....               ...+++.....++.|++.||+|||+.+  ++|+||||+|||++++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~  160 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCC
Confidence            99999999999999885321               124788899999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHH
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~  335 (429)
                      +.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||........   ..
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence            9999999999986543332222334456788999999998889999999999999999998 9999876442111   00


Q ss_pred             hHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                                    .+........+..++..+.+++.+||+.||++||++.+|+++|..
T Consensus       238 --------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 --------------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                          000111112233456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-42  Score=330.03  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=200.4

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|....+.      ..||+|++...........+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNG------KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCC------CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence            367999999999999999999876543      34999998765433334456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+. ++|.+++.... ..++...+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          78 LTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             EEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            999999995 67887776543 35888999999999999999999987  999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH----hhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK----EKK  345 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~----~~~  345 (429)
                      ....  .......||+.|+|||++.+ ..++.++|||||||++|||++|..||......... +.. ......    ..+
T Consensus       154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~-~~~~~~~~~~~~~  229 (303)
T cd07869         154 SVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ-LER-IFLVLGTPNEDTW  229 (303)
T ss_pred             cCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHH-HHHHhCCCChhhc
Confidence            3221  12234578999999999875 46899999999999999999999999865432111 100 000000    000


Q ss_pred             ----hhhhhcCCCCCCCCC---------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 ----KLLNIIDPRLEGDYP---------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ----~~~~~~~~~~~~~~~---------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          ..............+         ...+..+.+|+.+||+.||++|||++|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence                000000000000000         0123568899999999999999999999976

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-42  Score=328.60  Aligned_cols=264  Identities=29%  Similarity=0.414  Sum_probs=209.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|++.+.||+|+||.||+|........ .....+++|.+...........+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGR-AGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCC-CcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            477889999999999999986532211 1234588998876655555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 014189          193 LIYEFMARGSVENNLFSKV----------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  250 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~N  250 (429)
                      ++|||+.+|+|.+++....                      ..++++..+..++.|++.||+|||+++  ++||||||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n  157 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN  157 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence            9999999999999875321                      135789999999999999999999977  9999999999


Q ss_pred             EEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhh
Q 014189          251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAR  329 (429)
Q Consensus       251 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~  329 (429)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986543322111223456778999999988889999999999999999999 999997654321


Q ss_pred             hhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          330 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .   .              +..........+...+..+.+++.+||+.+|++||++.++++.|+.+-
T Consensus       238 ~---~--------------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 L---F--------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             H---H--------------HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            1   1              111111112223345678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-42  Score=326.57  Aligned_cols=264  Identities=28%  Similarity=0.426  Sum_probs=212.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|....... ......+|+|.............+.+|+.++..++||||+++++++.....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVK-GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCC-CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            4678899999999999999998765331 233456999998766555566778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          191 RVLIYEFMARGSVENNLFSKV--------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      .++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+.+  ++|+||||+|||++.++.+||+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEEEC
Confidence            999999999999999986432        224788899999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........   ..+    .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~----~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKF----V  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHH----H
Confidence            9999886544322222233457889999999998889999999999999999998 9999976543211   100    0


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                                ........+..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus       235 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 ----------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                      0011112233457789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-42  Score=338.87  Aligned_cols=256  Identities=24%  Similarity=0.259  Sum_probs=198.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||+||+|....+.      ..+|+|++....  .......+.+|+.++..++||||+++++.+.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTG------HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCC------CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            47889999999999999999866543      349999987532  1223456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            9999999999999999987654  6899999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------------cccccccCCcccccccccccCCCCcccchhhHHHHHHHHH
Q 014189          270 GPEGDKS---------------------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL  316 (429)
Q Consensus       270 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  316 (429)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            4321100                                 0112357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHh
Q 014189          317 TGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLN--HNPKARPLMRDIVDS  391 (429)
Q Consensus       317 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~RPs~~evl~~  391 (429)
                      +|+.||..........      ...       .. ...+........+.++.+++.+++.  .++..||+++||+++
T Consensus       231 ~G~~Pf~~~~~~~~~~------~i~-------~~-~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         231 IGYPPFCSETPQETYK------KVM-------NW-KETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             hCCCCCCCCCHHHHHH------HHH-------cC-cCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            9999998654321100      000       00 0000001111245677888887654  233346899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9e-43  Score=342.08  Aligned_cols=255  Identities=24%  Similarity=0.262  Sum_probs=199.8

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .|+.++.||+|+||.||+|.+..+.      ..+|+|++....  .......+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~------~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTH------ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            6888999999999999999876553      349999987532  23345668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||+|||..+  |+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            999999999999999987654  5888999999999999999999977  999999999999999999999999997543


Q ss_pred             CCCCC---------------------------------------------ccccccccCCcccccccccccCCCCcccch
Q 014189          271 PEGDK---------------------------------------------SHVSTRIMGTYGYAAPEYIMTGHLTPRSDV  305 (429)
Q Consensus       271 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  305 (429)
                      .....                                             .......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            11000                                             001123579999999999999899999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhh--ccCCCCCC
Q 014189          306 YSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCL--NHNPKARP  383 (429)
Q Consensus       306 wslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl--~~dP~~RP  383 (429)
                      |||||++|||++|..||..........      ...       . ....+........+.++.+|+.+|+  ..+|..||
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~------~i~-------~-~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQL------KVI-------N-WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHH------HHH-------c-cccccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            999999999999999998655322110      000       0 0001111112235678888998854  55555699


Q ss_pred             CHHHHHHh
Q 014189          384 LMRDIVDS  391 (429)
Q Consensus       384 s~~evl~~  391 (429)
                      ++++++.+
T Consensus       298 ~~~~~l~h  305 (381)
T cd05626         298 GADDIKAH  305 (381)
T ss_pred             CHHHHhcC
Confidence            99999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-42  Score=334.33  Aligned_cols=244  Identities=23%  Similarity=0.306  Sum_probs=199.1

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  195 (429)
                      +.||+|+||.||++....+.      ..||+|++....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVREKASG------KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEE
Confidence            46999999999999875543      349999987542  2234467788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC
Q 014189          196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  275 (429)
Q Consensus       196 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  275 (429)
                      ||+++|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++...... 
T Consensus        75 Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-  149 (328)
T cd05593          75 EYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-  149 (328)
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence            9999999998886543  6899999999999999999999977  9999999999999999999999999987543221 


Q ss_pred             ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCC
Q 014189          276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  355 (429)
Q Consensus       276 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (429)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......                .+...  
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~----------------~~~~~--  210 (328)
T cd05593         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----------------LILME--  210 (328)
T ss_pred             -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH----------------HhccC--
Confidence             12234679999999999999999999999999999999999999997654321100                00000  


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          356 EGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       356 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      ....+...+.++.+|+.+||..||++||     ++.+++++
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1122345567889999999999999997     89999877

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.6e-42  Score=325.51  Aligned_cols=263  Identities=28%  Similarity=0.397  Sum_probs=208.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|.+.+.||+|+||.||+|.+..... ......|++|.............|.+|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDG-DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCC-CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4578899999999999999998765211 113455999988766555556778999999999999999999999998889


Q ss_pred             EEEEEEecCCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC---cEEEe
Q 014189          191 RVLIYEFMARGSVENNLFSKVL-----LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---NAKLS  262 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~  262 (429)
                      .++||||+++|+|.+++.....     ..+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++   .+||+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEec
Confidence            9999999999999999865432     25899999999999999999999977  99999999999998765   59999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      |||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..........         
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~---------  232 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME---------  232 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---------
Confidence            9999987633221111122334578999999998999999999999999999997 999998654321100         


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                              .+........+...+..+.+++.+||+.+|++|||+.+|+++|.
T Consensus       233 --------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 --------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                    01111112223455678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.5e-42  Score=326.08  Aligned_cols=263  Identities=25%  Similarity=0.389  Sum_probs=207.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|.+..+...  ....+++|............++..|+.++++++||||+++++++. ....
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDS--IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCc--eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            4678889999999999999987544321  123478888765444444567788998999999999999999875 4557


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+|||+++++.+||+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            88999999999999987543 36899999999999999999999977  9999999999999999999999999998654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..||...........       +         
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~---------  224 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------L---------  224 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------H---------
Confidence            4332222334567789999999998899999999999999999998 9999976543221111       0         


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                       ........+..+...+.+++.+||..||++|||+.|+++.|..+..
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         225 -EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence             0001111122345677889999999999999999999999988665

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-42  Score=327.62  Aligned_cols=262  Identities=26%  Similarity=0.374  Sum_probs=208.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|++.+.||+|+||.||+|.+..+.. ......||+|++...........|.+|+.++..++||||+++++++......+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAP-GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            46667899999999999998765321 22345699999886655445567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc
Q 014189          193 LIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN  258 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~  258 (429)
                      +++||+.+++|.+++....              ...+++..+..++.|++.||.|||+++  ++||||||+|||+++++.
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCCCc
Confidence            9999999999999885321              234788889999999999999999977  999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhH
Q 014189          259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~  337 (429)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......   ...  
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~--  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIE--  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH--
Confidence            99999999886544332222233456789999999998889999999999999999998 888887654321   110  


Q ss_pred             hhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                                 .+.+.. ....+..++..+.+|+.+||+.+|++||++.+|+..|+.
T Consensus       238 -----------~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 -----------MIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----------HHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                       011111 112344567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.1e-42  Score=320.03  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=200.2

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      +.||+|+||.||+|.+..+.+      .+|+|.............|.+|+++++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNT------PVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEecCCc------eEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence            369999999999998765433      49999887655555667789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++++|.+++.... ..+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++..........
T Consensus        75 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          75 VQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             ccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence            99999999886543 35899999999999999999999977  9999999999999999999999999987644321111


Q ss_pred             ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCC
Q 014189          278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  356 (429)
Q Consensus       278 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (429)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..||.........                 ..+.....
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-----------------~~~~~~~~  214 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-----------------EAIEQGVR  214 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-----------------HHHHcCCC
Confidence            1111223567999999999899999999999999999998 88888754322110                 00111111


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          357 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       357 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      ...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2233455678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2e-42  Score=329.09  Aligned_cols=266  Identities=26%  Similarity=0.364  Sum_probs=211.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  189 (429)
                      .++|.+.+.||+|+||.||+|...... .......+|+|.+...........+.+|+.+++++ +||||+++++++...+
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLS-KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCC-CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            457889999999999999999764321 12234569999987654445556788999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..+++|||+++|+|.+++.......+++.+...++.+++.||+|||+.+  ++|+||||+|||++.++.++|+|||+++.
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCccccc
Confidence            9999999999999999987655445899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ..............++..|+|||.+.+..++.++|||||||++|||++ |..||........  .              .
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~--------------~  254 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--F--------------Y  254 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--H--------------H
Confidence            543322112223456788999999999999999999999999999998 9999876543211  0              0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      +.+........+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         255 KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            11111111112223456899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5e-43  Score=338.21  Aligned_cols=248  Identities=25%  Similarity=0.326  Sum_probs=203.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+....     ...||+|.+....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNED-----FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCC-----CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            57899999999999999999765432     2349999886432  2234456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            9999999999999999987654  6889999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.....                ..
T Consensus       181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~----------------~~  239 (340)
T PTZ00426        181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY----------------QK  239 (340)
T ss_pred             cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH----------------HH
Confidence            5321     23467999999999999989999999999999999999999999865432110                00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      +....  ...+...+..+.+++.+||+.||++|+     |+++++++
T Consensus       240 i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        240 ILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            11111  112334456788999999999999995     89999987

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-42  Score=322.30  Aligned_cols=256  Identities=25%  Similarity=0.356  Sum_probs=207.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.++||+|+||.||+|...++       ..||+|.+....  ...+.+.+|+.+++.++|+||+++++++...+.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~-------~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNS-------TKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCC-------ceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            35788999999999999999976443       238999876532  235678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .+++|||+++|+|.+++.......+++..++.++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceec
Confidence            999999999999999997765567899999999999999999999977  999999999999999999999999999875


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ..... .......++..|+|||++.+..++.++||||||+++|+|+| |..||........   ...    +      ..
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~------~~  219 (261)
T cd05072         154 EDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSA----L------QR  219 (261)
T ss_pred             CCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHH----H------Hc
Confidence            43221 11223346778999999998889999999999999999998 9999975432211   110    0      00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      ..    ........+..+.+++.+||..+|++|||++++.+.|+.+
T Consensus       220 ~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         220 GY----RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CC----CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            00    1111224567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=327.01  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=204.4

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      +|++.++||+|+||.||++.+..+      +..||+|.+....  .......+.+|+.+++.++||||+++++++..++.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRAT------GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCC------CceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            478889999999999999976544      3349999886532  12233457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+  ++||||||+||++++++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            999999999999998887655557999999999999999999999977  999999999999999999999999998865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .....   .....|++.|+|||++.+..++.++|||||||++|||++|..||.........  ...           ...
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--~~~-----------~~~  216 (285)
T cd05605         153 PEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--EEV-----------ERR  216 (285)
T ss_pred             CCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--HHH-----------HHH
Confidence            43221   22357899999999999889999999999999999999999999864432110  000           000


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      +. ......+...+..+.+|+.+||..||++||     ++++++++
T Consensus       217 ~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         217 VK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            00 011122334567889999999999999999     88899876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=332.36  Aligned_cols=242  Identities=27%  Similarity=0.296  Sum_probs=196.8

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      ||+|+||.||+|.+..+.      ..||+|++....  .......+..|+.++.+++||||+++++++...+..++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~------~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQ------RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcC
Confidence            799999999999876543      349999986532  233456678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......  .
T Consensus        75 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  148 (312)
T cd05585          75 INGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--D  148 (312)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--C
Confidence            99999999987643  6899999999999999999999977  9999999999999999999999999988543221  1


Q ss_pred             ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCC
Q 014189          278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  357 (429)
Q Consensus       278 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (429)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ...          .+...  ..
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~----------~~~~~--~~  210 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYR----------KILQE--PL  210 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHH----------HHHcC--CC
Confidence            2334679999999999999999999999999999999999999997654211      111          11111  11


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCCC---HHHHHHh
Q 014189          358 DYPVKGVHKAAMLAYHCLNHNPKARPL---MRDIVDS  391 (429)
Q Consensus       358 ~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~  391 (429)
                      ..+...+..+.+++.+||..||++||+   +.+++.+
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            223455678899999999999999985   6777765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1e-42  Score=334.10  Aligned_cols=244  Identities=24%  Similarity=0.306  Sum_probs=198.4

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  195 (429)
                      +.||+|+||.||++....++      ..||+|++....  .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVREKATG------RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence            46999999999999865543      449999987532  2234456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC
Q 014189          196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  275 (429)
Q Consensus       196 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  275 (429)
                      ||+++|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++....... 
T Consensus        75 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-  149 (323)
T cd05595          75 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-
Confidence            9999999998886543  6899999999999999999999977  9999999999999999999999999987543221 


Q ss_pred             ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCC
Q 014189          276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  355 (429)
Q Consensus       276 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (429)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+......                .+.... 
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----------------~~~~~~-  211 (323)
T cd05595         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----------------LILMEE-  211 (323)
T ss_pred             -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH----------------HHhcCC-
Confidence             11234679999999999999999999999999999999999999997654321100                000000 


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          356 EGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       356 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                       ...+...+..+.+++.+||+.||++||     ++.+++++
T Consensus       212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence             112335567889999999999999998     89998876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-42  Score=334.96  Aligned_cols=268  Identities=23%  Similarity=0.335  Sum_probs=198.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC---
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED---  188 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  188 (429)
                      +|++.+.||+|+||.||+|.+..+.      ..||+|.+.... .......+.+|+.+++.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTG------EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCC------CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            4888999999999999999876553      349999886432 223345678999999999999999999988543   


Q ss_pred             --CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          189 --EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       189 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                        ...|+||||+. ++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          75 EFKDIYVVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCcc
Confidence              35799999995 68988886543  5899999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCC-ccccccccCCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh-------
Q 014189          267 AKDGPEGDK-SHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW-------  336 (429)
Q Consensus       267 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~-------  336 (429)
                      ++....... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||..............       
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            986433221 112234579999999999875  6789999999999999999999999976553221111000       


Q ss_pred             --HhhHHHhh-hhhhhhcCCCCCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          337 --ALPLLKEK-KKLLNIIDPRLEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       337 --~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ........ ......+........   ....+..+.+++.+||+.||++|||++|++++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence              00000000 000000111100000   01235678899999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-42  Score=349.56  Aligned_cols=259  Identities=24%  Similarity=0.272  Sum_probs=207.7

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      .....+|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.++..++|+||+++++.+.
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g------~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDG------EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCC------CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            344578999999999999999999765543      349999986543 3445566789999999999999999988775


Q ss_pred             eCC--------eEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          187 EDE--------HRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       187 ~~~--------~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      ..+        .+++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN  179 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC
Confidence            332        368999999999999988643  2346899999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~  336 (429)
                      +.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~  253 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------V  253 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------H
Confidence            9999999999987544322223345689999999999999999999999999999999999999997654211      1


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...          .... .....+...+.++.+++.+||+.||.+||++.+++.+
T Consensus       254 ~~~----------~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        254 MHK----------TLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHH----------HhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            110          0100 1112334567789999999999999999999999875

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.6e-42  Score=323.42  Aligned_cols=266  Identities=25%  Similarity=0.413  Sum_probs=210.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ..+|+..++||+|+||.||+|.+..+.+.  ....||+|+............+.+|+.++..++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN--VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCc--cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            35788899999999999999987654332  13458999987665555667788999999999999999999998754 5


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+  ++||||||+|||+++++.+||+|||+++..
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence            689999999999999886543 35899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+             
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~-------------  223 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL-------------  223 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-------------
Confidence            43322111122345678999999998899999999999999999998 899987543211   1111             


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                       +........+...+..+.+++.+||..||+.||++.++++.|+.+...+
T Consensus       224 -~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         224 -LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence             1111111122345678899999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-43  Score=340.21  Aligned_cols=255  Identities=23%  Similarity=0.258  Sum_probs=202.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.++..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTG------HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            47899999999999999999876553      349999987532  1233455778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeeccccee
Confidence            9999999999999999987654  6899999999999999999999987  99999999999999999999999999875


Q ss_pred             CCCCCCc------------------------------------cccccccCCcccccccccccCCCCcccchhhHHHHHH
Q 014189          270 GPEGDKS------------------------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL  313 (429)
Q Consensus       270 ~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  313 (429)
                      .......                                    ......+||+.|+|||++.+..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            4321100                                    0011246999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 014189          314 EILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL---MRDIVD  390 (429)
Q Consensus       314 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~  390 (429)
                      ||++|..||..........      ...       .. ...+........+..+.+++.+|+. +|.+|++   +++++.
T Consensus       231 el~~G~~Pf~~~~~~~~~~------~i~-------~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYR------KII-------NW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHH------HHH-------cC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999998665322100      000       00 0011111112346778899999996 9999998   999987


Q ss_pred             h
Q 014189          391 S  391 (429)
Q Consensus       391 ~  391 (429)
                      +
T Consensus       296 h  296 (364)
T cd05599         296 H  296 (364)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-42  Score=340.39  Aligned_cols=269  Identities=24%  Similarity=0.367  Sum_probs=211.6

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEE
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCC  186 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  186 (429)
                      ....++|.+.+.||+|+||.||+|++.... .......||+|++...........+++|+.+|.++. ||||+++++++.
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLS-HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCC-CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            344567888899999999999999876431 222345699999986654445567889999999997 999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCC------------------------------------------------------
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVL------------------------------------------------------  212 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  212 (429)
                      ..+..++||||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999864321                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 014189          213 ------------------------------------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  250 (429)
Q Consensus       213 ------------------------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~N  250 (429)
                                                                ..+++.....++.|++.||+|||+.+  ++||||||+|
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~N  269 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARN  269 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcce
Confidence                                                      23677788899999999999999876  9999999999


Q ss_pred             EEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhh
Q 014189          251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAR  329 (429)
Q Consensus       251 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~  329 (429)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986533222112223467889999999998889999999999999999998 888986543211


Q ss_pred             hhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          330 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      .  .              ...+........+...+.++.+|+.+||..+|++||++++|++.|+.+
T Consensus       350 ~--~--------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 Q--F--------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             H--H--------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1  0              011111111122334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.8e-42  Score=324.68  Aligned_cols=271  Identities=28%  Similarity=0.388  Sum_probs=212.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccc----------cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeee
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLR----------EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKL  181 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~----------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  181 (429)
                      .+|++.+.||+|+||.||+|.+.....          .......||+|.+...........+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            578899999999999999998765322          1123456899998876655667788999999999999999999


Q ss_pred             eeEEEeCCeEEEEEEecCCCChhhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEE
Q 014189          182 IGYCCEDEHRVLIYEFMARGSVENNLFSKV---------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  252 (429)
Q Consensus       182 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIl  252 (429)
                      ++++..++..+++|||+++++|.+++....         ...+++..++.++.|++.||+|||+++  ++|+||||+||+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nil  162 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCL  162 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhcee
Confidence            999999999999999999999999986543         125899999999999999999999977  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCChhhh
Q 014189          253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT--GRKSLDKSRPARE  330 (429)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--G~~p~~~~~~~~~  330 (429)
                      ++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++  |..||....... 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~-  241 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ-  241 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-
Confidence            99999999999999886543332222334567789999999998889999999999999999998  667886543211 


Q ss_pred             hhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          331 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                        .........       ...........+..++.++.+++.+||+.||++|||+.+|++.|+.
T Consensus       242 --~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         242 --VIENAGHFF-------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHHhcc-------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              111111000       0001111111233456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.2e-42  Score=325.41  Aligned_cols=266  Identities=27%  Similarity=0.392  Sum_probs=210.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|.+.+.||+|+||.||++...... .......+|+|.+... .......+.+|+.++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~-~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCC-CCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            46888899999999999999754321 1223455889988654 334556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEE
Q 014189          192 VLIYEFMARGSVENNLFSKV-----------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  260 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  260 (429)
                      ++||||+++|+|.+++....           ...+++..++.++.|++.||+|||+++  ++||||||+|||+++++.+|
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEE
Confidence            99999999999999886432           134899999999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhh
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||........   ..    
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~----  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE----  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----
Confidence            999999986543322222223446788999999999999999999999999999998 8999876543211   00    


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      ....         .. ....+...+..+.+|+.+||+.||.+|||++++++.|+.+...
T Consensus       234 ~i~~---------~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 CITQ---------GR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHc---------CC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            0000         00 0111223456799999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-42  Score=320.26  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=206.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+       ..||+|.+....  ....++.+|+.++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNT-------TPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP   75 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCC-------eEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence            45788999999999999999976432       238999987543  234668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .+++|||+++++|.+++.......+++..+..++.+++.|+.|||+.+  ++|+||||+||+++.++.+||+|||+++..
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            999999999999999987665556899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ..... ........+..|+|||++.+..++.++||||||+++|||++ |+.||.........       ..+        
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~--------  217 (261)
T cd05068         154 KEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-------QQV--------  217 (261)
T ss_pred             cCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHH--------
Confidence            43211 11111233468999999999999999999999999999999 99999765422110       000        


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                        ........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       218 --~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         218 --DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence              01111122334567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-42  Score=328.75  Aligned_cols=269  Identities=25%  Similarity=0.384  Sum_probs=213.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccc-cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      ..+|.+.+.||+|+||.||+|.+..... .......+|+|.............+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            4578888999999999999997543211 12234569999987654455567788999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  254 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~  254 (429)
                      ...++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+++  ++||||||+||+++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~  171 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVT  171 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEc
Confidence            99999999999999999987542              134788899999999999999999977  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 014189          255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNL  333 (429)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~  333 (429)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||........   
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---  248 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---  248 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---
Confidence            999999999999987644322222233456778999999998899999999999999999998 7888865432111   


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                         ... ..          .......+..++..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus       249 ---~~~-~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         249 ---FKL-LK----------EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ---HHH-HH----------cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence               000 00          0111122345677899999999999999999999999999887665

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-42  Score=325.50  Aligned_cols=270  Identities=25%  Similarity=0.380  Sum_probs=207.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccc--------cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeee
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLR--------EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG  183 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~--------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  183 (429)
                      .+|++.+.||+|+||.||+|.......        .......||+|.+...........|.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578899999999999999987643211        112344589999887655555667899999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE
Q 014189          184 YCCEDEHRVLIYEFMARGSVENNLFSKV----------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL  253 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll  253 (429)
                      ++...+..++||||+++++|.+++....          ...+++..++.++.|++.||+|||+.+  ++|+||||+||++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill  162 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV  162 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEE
Confidence            9999999999999999999999885432          124688999999999999999999977  9999999999999


Q ss_pred             cCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCChhhhh
Q 014189          254 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT--GRKSLDKSRPAREQ  331 (429)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--G~~p~~~~~~~~~~  331 (429)
                      +.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++  |..||........ 
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~-  241 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV-  241 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH-
Confidence            9999999999999876543322222233456778999999998899999999999999999998  5667765442211 


Q ss_pred             hHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          332 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                        ..........       .........+...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus       242 --~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 --IENTGEFFRN-------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHHHhhhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              1100000000       0000111112234678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-42  Score=340.91  Aligned_cols=254  Identities=23%  Similarity=0.256  Sum_probs=199.3

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      +|+..++||+|+||.||+|....+.      ..+|+|++....  .......+.+|+.++++++||||+++++.+.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~------~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTK------ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCC------CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            5888999999999999999876543      349999987532  22344567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            999999999999999887653  5888999999999999999999977  999999999999999999999999997532


Q ss_pred             CCCC---------------------------------------------CccccccccCCcccccccccccCCCCcccch
Q 014189          271 PEGD---------------------------------------------KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDV  305 (429)
Q Consensus       271 ~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  305 (429)
                      ....                                             ........+||+.|+|||++.+..|+.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            1000                                             0001123579999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-
Q 014189          306 YSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-  384 (429)
Q Consensus       306 wslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-  384 (429)
                      |||||++|||++|+.||...++......             ... .............+.++.+++.+|+ .+|++|++ 
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~-------------i~~-~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  296 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQMK-------------VIN-WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK  296 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHHH-------------HHc-cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence            9999999999999999986553221100             000 0111111112245677888888875 59999997 


Q ss_pred             --HHHHHHh
Q 014189          385 --MRDIVDS  391 (429)
Q Consensus       385 --~~evl~~  391 (429)
                        +++++.|
T Consensus       297 ~~~~ei~~h  305 (382)
T cd05625         297 NGADEIKAH  305 (382)
T ss_pred             CCHHHHhcC
Confidence              8888876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.7e-42  Score=325.44  Aligned_cols=265  Identities=25%  Similarity=0.380  Sum_probs=210.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|.+.+.||+|+||.||+|.+.... .......+++|..... .......+.+|+.++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLS-PTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccC-CCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            45788899999999999999754321 1223445888887654 334446788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      ++||||+++++|.+++....              ...+++..++.++.|++.||+|||+++  ++||||||+|||++.++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence            99999999999999986532              134789999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHh
Q 014189          258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~  336 (429)
                      .++|+|||++................++..|+|||++.+..++.++||||||+++|||+| |..||.........   ..
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~  237 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---EC  237 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH
Confidence            999999999976544322222333557889999999999999999999999999999999 99998765432211   00


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                          .         .. ......+...+..+.+++.+||+.+|++|||+++|++.|+.+..
T Consensus       238 ----~---------~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         238 ----I---------TQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             ----H---------hC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence                0         00 00111123356778999999999999999999999999988854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.9e-42  Score=328.77  Aligned_cols=269  Identities=26%  Similarity=0.391  Sum_probs=211.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEcccccc-CcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      .++|.+.+.||+|+||.||+|.+....+. ......+|+|.+...........+..|++++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            46799999999999999999976442221 1123459999988654455566788899999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVL--------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  254 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~  254 (429)
                      +..++||||+++|+|.+++.....              ..+++.+++.++.|++.||+|||+++  ++||||||+||+++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~  174 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT  174 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEc
Confidence            999999999999999999975421              24889999999999999999999977  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 014189          255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNL  333 (429)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~  333 (429)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........   
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~---  251 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---  251 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---
Confidence            999999999999876543221111222334578999999999899999999999999999998 8888865432110   


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      .              ..+........+...+.++.+++.+||..+|++|||+.++++.|+++...
T Consensus       252 ~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         252 F--------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             H--------------HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            0              00001111122345567899999999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.5e-42  Score=325.14  Aligned_cols=267  Identities=27%  Similarity=0.417  Sum_probs=209.9

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ...++|++.+.||+|+||.||+|..++... ......||+|.+...........+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCC-CCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            345789999999999999999997654321 2234569999987665555556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEE
Q 014189          189 EHRVLIYEFMARGSVENNLFSKV--------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  260 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  260 (429)
                      +..++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+++  ++||||||+|||++.++.++
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999996422        234567788999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhh
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      |+|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |..||.......   ...    
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~----  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK----  232 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----
Confidence            999999886543322222222345778999999998899999999999999999998 788887543221   100    


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                               .+.+.. ....+..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus       233 ---------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 ---------FVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ---------HHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                     001110 0111234457899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-43  Score=339.58  Aligned_cols=255  Identities=27%  Similarity=0.293  Sum_probs=205.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|.+.+.||+|+||.||+|.+..+.      ..||+|++....  .......+..|+.++..++||||+++++++.+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTG------QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCC------CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            36889999999999999999876543      349999987532  1234456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            999999999999999998766  36899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCC---------------------------CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 014189          270 GPEGD---------------------------KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL  322 (429)
Q Consensus       270 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~  322 (429)
                      .....                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            54332                           001123457999999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-HHHHHHh
Q 014189          323 DKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-MRDIVDS  391 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~  391 (429)
                      ..........      ..       ... ...+........+..+.+|+.+||. ||.+||+ +++++++
T Consensus       231 ~~~~~~~~~~------~i-------~~~-~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         231 YSDTLQETYN------KI-------INW-KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCHHHHHH------HH-------hcc-CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            8765321100      00       000 0111111112257788999999997 9999999 9999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4e-42  Score=330.28  Aligned_cols=249  Identities=27%  Similarity=0.344  Sum_probs=200.1

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCC-CceeeeeeEEEeCC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCEDE  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~  189 (429)
                      +|++.+.||+|+||.||+|....+.      ..||+|++....  .......+..|..++..+.| ++|+++++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTD------ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            5888999999999999999876543      349999987532  22344567789999999976 46888999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            9999999999999999886543  5889999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||........   .             ..
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~-------------~~  212 (324)
T cd05587         151 NIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---F-------------QS  212 (324)
T ss_pred             cCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H-------------HH
Confidence            322111  22346799999999999999999999999999999999999999986543211   0             00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~  391 (429)
                      +...  ....+...+..+.+++.+||..||.+|++.     ++++++
T Consensus       213 i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         213 IMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1110  112233456788999999999999999986     677665

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.8e-42  Score=322.04  Aligned_cols=256  Identities=30%  Similarity=0.468  Sum_probs=210.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ..+|++.+.||.|+||.||+|.+.. .      ..+++|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~------~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   76 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-R------VRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP   76 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-C------CcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence            3568888999999999999998765 2      238999987653 3345568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||++++++.+||+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhc
Confidence            999999999999999998766667899999999999999999999977  999999999999999999999999999765


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .....  ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||........   ..             .
T Consensus       155 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~-------------~  216 (261)
T cd05148         155 KEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YD-------------Q  216 (261)
T ss_pred             CCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HH-------------H
Confidence            43211  1223456778999999998899999999999999999998 8999976542111   00             0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      +. .......+..++..+.+++.+||+.||++|||++++++.|+.+
T Consensus       217 ~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         217 IT-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HH-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            00 1111223445677899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.9e-42  Score=326.28  Aligned_cols=264  Identities=25%  Similarity=0.352  Sum_probs=208.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||.||+|....+..    ...+++|.+...........|.+|+.+++++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGL----KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCC----cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            478889999999999999998765432    2237888877544445566788999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      .+++|||+++|+|.+++....              ...+++..+..++.|++.||+|||+++  ++||||||+|||++++
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~  155 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGEN  155 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCC
Confidence            999999999999999986532              124888999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHH
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~  335 (429)
                      +.+||+|||++........   ......+..|+|||++.+..++.++|||||||++|||++ |..||........   ..
T Consensus       156 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~  229 (297)
T cd05089         156 LASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YE  229 (297)
T ss_pred             CeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence            9999999999864322111   111233567999999998899999999999999999997 9999976543211   00


Q ss_pred             hHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCC
Q 014189          336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE  401 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  401 (429)
                                    .+........+..++..+.+|+.+||+.+|.+|||++++++.|+.+......
T Consensus       230 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         230 --------------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             --------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                          0111111122334567889999999999999999999999999887765433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=340.25  Aligned_cols=255  Identities=22%  Similarity=0.231  Sum_probs=199.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|....+.      ..||+|++....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTG------KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCC------CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            36889999999999999999876554      349999886432  2233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999999999986543  6888999999999999999999987  99999999999999999999999999864


Q ss_pred             CCCCCCc---------------------------------------------cccccccCCcccccccccccCCCCcccc
Q 014189          270 GPEGDKS---------------------------------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSD  304 (429)
Q Consensus       270 ~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D  304 (429)
                      .......                                             ......+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            3210000                                             0001246999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCC--
Q 014189          305 VYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR--  382 (429)
Q Consensus       305 vwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R--  382 (429)
                      ||||||++|||++|..||..........      ...       .. ...+........+.++.+|+.+||. +|.+|  
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~------~i~-------~~-~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETYR------KII-------NW-RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHHH------HHH-------cc-CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            9999999999999999997654321100      000       00 0001111112346788999999998 66665  


Q ss_pred             -CCHHHHHHh
Q 014189          383 -PLMRDIVDS  391 (429)
Q Consensus       383 -Ps~~evl~~  391 (429)
                       +|+.+++.+
T Consensus       296 r~~~~~~l~h  305 (377)
T cd05629         296 RGGAHEIKSH  305 (377)
T ss_pred             CCCHHHHhcC
Confidence             699999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.4e-42  Score=317.59  Aligned_cols=251  Identities=24%  Similarity=0.424  Sum_probs=201.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||+|.+...       ..+|+|.+....  .....|.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~-------~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQ-------IKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL   74 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccC-------ceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence            4588889999999999999976543       238999876442  2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++..... .+++..+..++.+++.||+|||+++  ++|+||||+||+++.++.+||+|||+++...
T Consensus        75 ~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            999999999999998875432 5889999999999999999999977  9999999999999999999999999988654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+....   ...    ....      
T Consensus       152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~----i~~~------  217 (256)
T cd05114         152 DDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEM----ISRG------  217 (256)
T ss_pred             CCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HHCC------
Confidence            3221 11122345678999999998899999999999999999999 8999976543211   000    0000      


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                          .....+...+..+.+++.+||+.+|++|||++++++.|
T Consensus       218 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         218 ----FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                00111223456789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.2e-42  Score=330.76  Aligned_cols=247  Identities=26%  Similarity=0.336  Sum_probs=198.7

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC---ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||++....+.   ..+..||+|++....   .......+.+|+.+++.++||||+++++++..++..|+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGA---DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcccC---CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            68999999999999764321   234569999986532   122334567899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          79 LEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             EeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999999999886654  5788888999999999999999977  9999999999999999999999999987543222


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||........                ...+....
T Consensus       155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----------------~~~~~~~~  216 (323)
T cd05584         155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----------------IDKILKGK  216 (323)
T ss_pred             --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH----------------HHHHHcCC
Confidence              122346799999999999998899999999999999999999999986543211                01111111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                        ...+...+..+.+++.+||+.||++||     ++++++++
T Consensus       217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence              122334567889999999999999999     88988875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.7e-42  Score=325.16  Aligned_cols=268  Identities=23%  Similarity=0.297  Sum_probs=197.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhcc---CCCceeeeeeEEE--
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHL---SHPNLVKLIGYCC--  186 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--  186 (429)
                      +|++.+.||+|+||.||+|.+....     +..||+|.+..... ......+.+|+.+++.+   +||||+++++++.  
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~   76 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNG-----GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   76 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCC-----CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence            6889999999999999999764321     34589998765432 22233455677777665   6999999999885  


Q ss_pred             ---eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          187 ---EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       187 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                         ....+++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEcc
Confidence               3456899999996 68999887665556899999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh-HHHhHhhHHH
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWALPLLK  342 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~-~~~~~~~~~~  342 (429)
                      ||+++.....   .......||+.|+|||.+.+..++.++|||||||++|||++|.+||.......... ..........
T Consensus       154 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~  230 (290)
T cd07862         154 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  230 (290)
T ss_pred             ccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            9999765432   12334678999999999998899999999999999999999999998765432111 1000000000


Q ss_pred             hhhh-hh----hhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKK-LL----NIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~-~~----~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..+. ..    ..+.+....   ......+..+.+|+.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0000 00    000000000   0012345678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.2e-42  Score=332.08  Aligned_cols=257  Identities=26%  Similarity=0.303  Sum_probs=201.5

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      +|++.+.||+|+||.||++.....   ...+..+|+|++....   .......+..|+.++..+ +||||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTG---HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEccc---CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence            588899999999999999875432   1235569999986431   223345577899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999999987654  5889999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||.........  ......       .
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~-------~  223 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRR-------I  223 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHH-------H
Confidence            65432221 22346799999999999865 4789999999999999999999999743321110  000000       0


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      . ..+    ...+...+..+.+++.+||+.||++||     ++++++++
T Consensus       224 ~-~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         224 L-KCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             h-cCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            0 011    122334567789999999999999999     78888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.1e-42  Score=331.65  Aligned_cols=251  Identities=26%  Similarity=0.375  Sum_probs=198.1

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  194 (429)
                      ++||+|+||.||+|.+..+.      ..||+|++....  .......+..|..++..+ +||||+++++++.+.+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~------~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTR------RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence            46999999999999876553      349999987542  223345577899999888 699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          75 IEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            99999999998886543  6899999999999999999999977  9999999999999999999999999987532211


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhh--hhhHHHhHhhHHHhhhhhhhhcC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR--EQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                        .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||+......  ......+....+         ..
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~  219 (329)
T cd05588         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI---------LE  219 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---------Hc
Confidence              12334679999999999999999999999999999999999999997432111  111111111111         11


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCC------HHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL------MRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~  391 (429)
                      ..  ...+...+..+.+++.+||+.||.+|||      +++++++
T Consensus       220 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         220 KQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            11  1123345678899999999999999997      6788866

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-42  Score=338.65  Aligned_cols=254  Identities=22%  Similarity=0.229  Sum_probs=203.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..+|+|++....  .......+.+|+.+++.++||||+++++++.+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~  114 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSK------QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD  114 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            3467999999999999999999876543      349999986431  22233457789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      ++..++||||+++|+|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         115 DKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccce
Confidence            99999999999999999988653   4788888999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTG----HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ........ .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........             
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------------  255 (370)
T cd05596         190 MKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------------  255 (370)
T ss_pred             eeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-------------
Confidence            76543221 122346799999999998653    478999999999999999999999986543211             


Q ss_pred             hhhhhhhcCCC--CCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHh
Q 014189          344 KKKLLNIIDPR--LEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  391 (429)
                         ...+....  +........+..+.+|+.+||..+|.+  |||+.+++++
T Consensus       256 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         256 ---YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ---HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence               01111111  111112245788999999999999998  9999999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-42  Score=336.36  Aligned_cols=261  Identities=21%  Similarity=0.268  Sum_probs=196.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|.+.+.||+|+||.||+|.+..+.+      .||+|....       ..+.+|+.++++++||||+++++++......
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~------~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCE------HVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCC------EEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            579999999999999999998766543      499996432       2356899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++|||++. ++|..++....  .+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++....
T Consensus       159 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            99999995 68888876543  5889999999999999999999977  9999999999999999999999999997533


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhh-----hhhHHHhHhhH------
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR-----EQNLADWALPL------  340 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~-----~~~~~~~~~~~------  340 (429)
                      ... ........||+.|+|||++.+..++.++|||||||++|||++|..||.......     ...+.......      
T Consensus       234 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        234 DIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             ccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            221 112234679999999999999999999999999999999999998875432110     00000000000      


Q ss_pred             --HHhhhhhhh----hcC--CCCCCCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 --LKEKKKLLN----IID--PRLEGDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 --~~~~~~~~~----~~~--~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ......+..    ...  .......+     ...+.++.+|+.+||+.||++|||++|++++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence              000000000    000  00000000     1345678999999999999999999999975

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.8e-42  Score=321.50  Aligned_cols=274  Identities=29%  Similarity=0.391  Sum_probs=208.5

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--CCeE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DEHR  191 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  191 (429)
                      |+..+.||+|+||+||++.....  ....+..||+|.+...........|.+|+++++.++||||+++++++..  ....
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPA--NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccc--cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            38889999999999998764321  1223456999998766544556778899999999999999999998865  3468


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++|||+++|+|.+++...   .+++..+..++.|++.||+|||+.+  ++|+||||+|||+++++.+||+|||+++...
T Consensus        84 ~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccC
Confidence            8999999999999988654   4899999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCcc-ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||+||..||........ ......... .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~~~  236 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVRLIEL  236 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhhhhhh
Confidence            432211 11223456779999999988899999999999999999999999865432111 000000000 000111222


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .+.......+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2222223334456788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-42  Score=315.85  Aligned_cols=269  Identities=23%  Similarity=0.258  Sum_probs=203.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCc-eeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~  189 (429)
                      ..|...++||+|+||+||+|+...++      ..||+|.++-.... ..-....+|+.+|+.++|+| ||++++++.+.+
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g------~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~   84 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTG------KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN   84 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCC------CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence            34666678999999999999876664      44999998765432 12233468999999999999 999999998877


Q ss_pred             ------eEEEEEEecCCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          190 ------HRVLIYEFMARGSVENNLFSKVL--LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       190 ------~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                            .+++||||++. +|..++.....  ..++...+..+++|++.||+|||+++  |+||||||.||||+++|.+||
T Consensus        85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKl  161 (323)
T KOG0594|consen   85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKL  161 (323)
T ss_pred             cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEee
Confidence                  88999999964 89998876543  35777889999999999999999988  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      +|||+|+...-..  ...+..++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+.....+....-.....
T Consensus       162 aDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt  239 (323)
T KOG0594|consen  162 ADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT  239 (323)
T ss_pred             eccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence            9999999655332  224557899999999999986 7999999999999999999999999877653332111100000


Q ss_pred             HH-hhhh-hhhhcCC--CCCCCC-Ch-------HHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LK-EKKK-LLNIIDP--RLEGDY-PV-------KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~-~~~~-~~~~~~~--~~~~~~-~~-------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      -. ..|. +....+-  ...... +.       .......+++.+||+.+|.+|.|++..+.|
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            00 0000 0000000  000000 11       112478999999999999999999999987

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.3e-42  Score=330.02  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=196.7

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHH---hccCCCceeeeeeEEEeC
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFL---GHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~  188 (429)
                      |++.+.||+|+||.||+|.+..++      ..||+|++....  .......+..|+.++   +.++||||+++++++...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTG------ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            677899999999999999876543      349999987532  122334556666554   567899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..|+||||+++|+|..++...   .+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            9999999999999998877543   5899999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........      .          
T Consensus       150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~----------  211 (324)
T cd05589         150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------D----------  211 (324)
T ss_pred             cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------H----------
Confidence            543221  1223467999999999999999999999999999999999999999865432110      0          


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      .+....  ...+...+..+.+++.+||+.||++||     ++.+++++
T Consensus       212 ~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         212 SIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            011000  112334567889999999999999999     57788775

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-42  Score=340.07  Aligned_cols=255  Identities=22%  Similarity=0.240  Sum_probs=200.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.+++.++||||+++++.+.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTN------ALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCC------CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            36899999999999999999876543      449999986432  1223456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            9999999999999999986653  5888888999999999999999977  99999999999999999999999999753


Q ss_pred             CCCCC-----------------------------------------CccccccccCCcccccccccccCCCCcccchhhH
Q 014189          270 GPEGD-----------------------------------------KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSF  308 (429)
Q Consensus       270 ~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  308 (429)
                      .....                                         ........+||+.|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            21000                                         0000123579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC---CH
Q 014189          309 GVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP---LM  385 (429)
Q Consensus       309 G~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~  385 (429)
                      ||++|||++|+.||...........      ..       . .............+..+.+++.+|+ .+|.+|+   |+
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~------i~-------~-~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLK------VI-------N-WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHH------Hh-------c-cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            9999999999999987654321100      00       0 0001111112245677888888876 5999999   89


Q ss_pred             HHHHHh
Q 014189          386 RDIVDS  391 (429)
Q Consensus       386 ~evl~~  391 (429)
                      .+++++
T Consensus       296 ~ell~h  301 (376)
T cd05598         296 DEIKAH  301 (376)
T ss_pred             HHHhCC
Confidence            999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.3e-43  Score=319.63  Aligned_cols=268  Identities=24%  Similarity=0.353  Sum_probs=201.8

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC---
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE---  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  189 (429)
                      .|...+++|.|+||.||+|....+.+      .||||..-.+.....     +|+.+|+.+.|||||++..+|....   
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~------~vAIKKv~~d~r~kn-----rEl~im~~l~HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEE------EVAIKKVLQDKRYKN-----RELQIMRKLDHPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCc------eeEEEEecCCCCcCc-----HHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence            46677999999999999999877633      399999876644322     6999999999999999998886422   


Q ss_pred             --eEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-CcEEEecc
Q 014189          190 --HRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDF  264 (429)
Q Consensus       190 --~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  264 (429)
                        ...+|||||+. +|.+.+..  .....++.-.+.-+.+|+.+||+|||+++  |+||||||.|+|+|.+ |.+|||||
T Consensus        94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccC
Confidence              34589999986 88888763  23346777788889999999999999977  9999999999999977 89999999


Q ss_pred             CCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      |.|+....+...   .+..-|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.+...+....--+...-. 
T Consensus       171 GSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt-  246 (364)
T KOG0658|consen  171 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT-  246 (364)
T ss_pred             CcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC-
Confidence            999988765543   23456889999999986 5799999999999999999999999998665433222111111000 


Q ss_pred             hhhhh-------hhcCCCCCCC-----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCC
Q 014189          344 KKKLL-------NIIDPRLEGD-----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       344 ~~~~~-------~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                      ...+.       +.-.+.+...     .....+.++.+|+.++|.++|.+|.++.|++.+  +..++..
T Consensus       247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            00011       1111111111     234567899999999999999999999999866  4444443

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-41  Score=318.13  Aligned_cols=262  Identities=24%  Similarity=0.430  Sum_probs=209.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|+..+.||+|+||.||+|.+..+..   ....+++|.+...........+..|++++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGR---KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            4578888999999999999998764322   2345899998766555556778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++++|.+++.... ..+++.++..++.|++.|++|||+.+  ++|+||||+||+++.++.+||+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceec
Confidence            999999999999999886543 46899999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccc-cccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKSHV-STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.......   ..   . .+       
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~---~-~i-------  223 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VM---K-AI-------  223 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH---H-HH-------
Confidence            43221111 111233567999999998889999999999999999998 999997544211   00   0 00       


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                         ........+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       224 ---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         224 ---NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               00111122334567889999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=318.70  Aligned_cols=260  Identities=29%  Similarity=0.456  Sum_probs=204.7

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe--
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH--  190 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  190 (429)
                      |.+.+.||+|+||.||+|.+..+.   .....+|+|.+.... .......+.+|+.+++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDD---GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCC---CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            567789999999999999875432   123459999987543 33445678899999999999999999998865544  


Q ss_pred             ----EEEEEEecCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          191 ----RVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       191 ----~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                          .+++|||+++|+|..++...    ....+++..+..++.|++.||.|||+.+  ++||||||+||++++++.+||+
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEEC
Confidence                79999999999999888543    2235899999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ..++.    
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----  228 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----  228 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----
Confidence            9999986544332222222345778999999988899999999999999999999 888987544221   11100    


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                               .. ......+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       229 ---------~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 ---------RH-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---------Hc-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     00 011122345677899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.5e-42  Score=326.93  Aligned_cols=269  Identities=25%  Similarity=0.394  Sum_probs=211.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEcccccc-CcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      ..+|.+.+.||+|+||.||+|........ ......+|+|.+...........+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            35788899999999999999976432211 2234558999987655555667788999999999 599999999999998


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  254 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~  254 (429)
                      +..+++|||+++|+|.+++....              ...+++.....++.|++.||.|||+++  ++||||||+|||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~  168 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVT  168 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEc
Confidence            99999999999999999986532              135889999999999999999999977  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 014189          255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNL  333 (429)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~  333 (429)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.........  
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--  246 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF--  246 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            999999999999986543221111122234568999999999899999999999999999999 88898755422110  


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                       .    ...          .......+..++.++.+++.+||..+|++|||+.++++.|+.+...
T Consensus       247 -~----~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         247 -K----LLR----------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             -H----HHH----------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence             0    000          0111122335567888999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-41  Score=321.83  Aligned_cols=270  Identities=26%  Similarity=0.396  Sum_probs=207.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccc----------cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeee
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLR----------EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKL  181 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~----------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  181 (429)
                      ++|++.+.||+|+||.||++.......          .......+|+|+............|.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            568999999999999999986443211          1122446899998766555556788999999999999999999


Q ss_pred             eeEEEeCCeEEEEEEecCCCChhhhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEE
Q 014189          182 IGYCCEDEHRVLIYEFMARGSVENNLFSKVL---------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  252 (429)
Q Consensus       182 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIl  252 (429)
                      ++++...+..+++|||+++|+|.+++.....         ..+++..+..++.|++.||+|||+.+  ++|+||||+|||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nil  162 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCL  162 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEE
Confidence            9999999999999999999999999865431         23678889999999999999999977  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCChhhh
Q 014189          253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT--GRKSLDKSRPARE  330 (429)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--G~~p~~~~~~~~~  330 (429)
                      ++.++.++|+|||+++...............++..|++||...++.++.++|||||||++|||++  |..||........
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999986543322222223445678999999888889999999999999999998  6778865443211


Q ss_pred             hhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          331 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      .   ........       ..........+..++..+.+|+.+||+.||++|||+.+|++.|+
T Consensus       243 ~---~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         243 I---ENTGEFFR-------DQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H---HHHHHHHh-------hccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1   00000000       00001111122345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=309.78  Aligned_cols=255  Identities=22%  Similarity=0.300  Sum_probs=206.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|.|+.||++.+..++..      +|+|+++... +....+++.+|+.|.+.|+||||+++++.+.+.
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~------fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~   82 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLE------FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   82 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHH------HHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence            456788889999999999999876665443      7888765432 223556778999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCcEEEeccC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFG  265 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  265 (429)
                      ...|+|+|+|.||+|..-+..+.  -+++..+-..+.||+++|.|+|.++  |||||+||.|+|+.+   ..-+||+|||
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccc
Confidence            99999999999999987775542  4777888899999999999999988  999999999999954   3459999999


Q ss_pred             CCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      +|.....+   .......|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+....      ..+...   
T Consensus       159 vAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~~---  226 (355)
T KOG0033|consen  159 LAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIKA---  226 (355)
T ss_pred             eEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHhc---
Confidence            99987632   334567899999999999999999999999999999999999999986442211      111110   


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                           -+-..........+.++.+|+.+||..||.+|.|+.|.++|
T Consensus       227 -----g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  227 -----GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             -----cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence                 01112333445678899999999999999999999988755

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.2e-42  Score=326.39  Aligned_cols=261  Identities=26%  Similarity=0.360  Sum_probs=206.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||.||+|.+..+..    ...+++|.............+.+|++++.++ +||||+++++++..++.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCc----eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            578888999999999999998754322    2336788776544455566788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      .++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+.+  ++||||||+|||++.+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~  160 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN  160 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence            999999999999999986542              235789999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHH
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~  335 (429)
                      +.+||+|||++.......   ......++..|+|||++.+..++.++|||||||++|||+| |..||........   ..
T Consensus       161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~  234 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YE  234 (303)
T ss_pred             CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HH
Confidence            999999999986432111   1111234678999999988889999999999999999998 9999975442211   00


Q ss_pred             hHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                                    .+........+...+..+.+|+.+||+.+|++||++++++..|+.+...
T Consensus       235 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         235 --------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             --------------HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                          0001111112233566789999999999999999999999999876444

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-42  Score=332.55  Aligned_cols=244  Identities=25%  Similarity=0.324  Sum_probs=197.5

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  195 (429)
                      +.||+|+||.||++.+..+      +..||+|++....  .......+..|+.++..++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKEKAT------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEECCC------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence            4699999999999976554      3459999987532  2233456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       196 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      ||+++|+|..++....  .+++..+..++.|++.||+|||+ .+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          75 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  150 (325)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence            9999999998886543  68999999999999999999997 56  9999999999999999999999999987533221


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........                +... 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~----------------i~~~-  211 (325)
T cd05594         151 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------------ILME-  211 (325)
T ss_pred             c--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH----------------HhcC-
Confidence            1  12345799999999999999999999999999999999999999976543211000                0000 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                       ....+...+.++.+++.+||+.||++|+     ++++++++
T Consensus       212 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 -EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence             0112334567889999999999999996     89999977

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.1e-42  Score=328.85  Aligned_cols=249  Identities=25%  Similarity=0.322  Sum_probs=199.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  189 (429)
                      +|.+.+.||+|+||.||+|.+..+.      ..||+|++....  .......+..|..++..+ +|++|+++++++...+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTD------ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            5788899999999999999876543      349999987542  222334566788888777 5899999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            9999999999999998886553  5889999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........   .             ..
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~-------------~~  212 (323)
T cd05616         151 NMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F-------------QS  212 (323)
T ss_pred             cCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---H-------------HH
Confidence            43221  122346799999999999999999999999999999999999999986543211   0             01


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~  391 (429)
                      +....  ...+...+.++.+++.+||+.||++|++.     .+++++
T Consensus       213 i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         213 IMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            11111  12234556788999999999999999985     666654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5e-42  Score=330.16  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=196.8

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|.+..+.      ..+|+|++....  .......+..|+.++.++ +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTE------RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCC------CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence            46999999999999876553      349999987542  233445567888888776 799999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          75 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            99999999998876543  6899999999999999999999977  9999999999999999999999999987533211


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhh--hhhHHHhHhhHHHhhhhhhhhcC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR--EQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.....         ..
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i---------~~  219 (329)
T cd05618         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---------LE  219 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH---------hc
Confidence              12234679999999999999999999999999999999999999996322111  111111111111         11


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCC------HHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL------MRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~  391 (429)
                      .  ....+...+..+.+++.+||+.||++||+      +.+++++
T Consensus       220 ~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            1  11234455678899999999999999998      5687766

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.6e-42  Score=335.92  Aligned_cols=255  Identities=22%  Similarity=0.254  Sum_probs=202.1

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      ...++|++.+.||+|+||.||+|.+..+.+      .+|+|++....  .......+.+|+.+++.++||||+++++++.
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQK------VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ  113 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            345689999999999999999998765543      49999986421  2223455778999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      +++..|+||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         114 DDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999999988643   4788899999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG----HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      +........ .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........            
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------------  255 (370)
T cd05621         189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------------  255 (370)
T ss_pred             ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------------
Confidence            986543221 122346799999999998754    378999999999999999999999986543211            


Q ss_pred             hhhhhhhhcCCC--CCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHh
Q 014189          343 EKKKLLNIIDPR--LEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  391 (429)
                          ...+.+..  +........+..+.+++..||..++.+  |+|++|++++
T Consensus       256 ----~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         256 ----YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ----HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                01111111  111112245677889999999866654  8999999988

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.6e-42  Score=329.05  Aligned_cols=271  Identities=26%  Similarity=0.405  Sum_probs=213.8

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEcccccc-CcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      ...+|++.+.||+|+||.||+|.+....+. ......+|+|.............+.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            345789999999999999999976543222 1233458999887665555667889999999999 79999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL  253 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll  253 (429)
                      .+..+++|||+++|+|.+++....              ...+++..++.++.|++.||.|||.++  ++||||||+|||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill  167 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLV  167 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEE
Confidence            999999999999999999986532              234788999999999999999999977  9999999999999


Q ss_pred             cCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhh
Q 014189          254 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQN  332 (429)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~  332 (429)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||........  
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--  245 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--  245 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--
Confidence            9999999999999986543222111222344578999999999999999999999999999998 8888876542211  


Q ss_pred             HHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          333 LADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                          .. ..          ........+...+..+.+++.+||+.+|++|||+.++++.|+.+....
T Consensus       246 ----~~-~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         246 ----FK-LL----------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ----HH-HH----------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                00 00          001111223345678899999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-41  Score=320.30  Aligned_cols=262  Identities=26%  Similarity=0.387  Sum_probs=206.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|...+.||+|+||.||+|..... .....+..+++|.+... .......|.+|+++++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecC-CCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            4677889999999999999965332 12223456889987654 344556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc
Q 014189          192 VLIYEFMARGSVENNLFSKVL-------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN  258 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~  258 (429)
                      +++|||+++|+|.+++.....             ..+++..++.++.|++.|++|||+.+  ++|+||||+|||+++++.
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCCCC
Confidence            999999999999999865431             34789999999999999999999977  999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhH
Q 014189          259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~  337 (429)
                      +||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||...........    
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----  236 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC----  236 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH----
Confidence            99999999876543222122223445788999999999999999999999999999998 8999875443211100    


Q ss_pred             hhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                                  . ........+..++..+.+++.+||+.||++||++++|++.|+.
T Consensus       237 ------------~-~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         237 ------------I-TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ------------H-HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                        0 0001112223456778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.4e-41  Score=315.04  Aligned_cols=252  Identities=22%  Similarity=0.281  Sum_probs=206.1

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|++.+.||+|+||.||++.+..+.      ..+++|.+...........+.+|+.+++.++||||+++++.+..++..+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSD------QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCC------ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence            4788899999999999999876543      3489998865544455667888999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      ++|||+++|+|.+++.......+++.....++.|++.||.|||+++  ++|+||||+||++++++.++|+|||++.....
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            9999999999999887655556899999999999999999999977  99999999999999999999999999876543


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      ...  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+....      ...       ...   
T Consensus       153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~-------~~~---  214 (255)
T cd08219         153 PGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILK-------VCQ---  214 (255)
T ss_pred             ccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHH-------Hhc---
Confidence            221  22345789999999999988899999999999999999999999976442211      000       000   


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       ......+...+..+.+++.+||+.||++|||+.+++..
T Consensus       215 -~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         215 -GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             00111223455678899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.9e-42  Score=320.25  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=195.8

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      ||+|+||.||++....++      ..+|+|.+.....  ......+..|++++++++||||+++++++..+...++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTG------KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEccCC------cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence            799999999999876543      3499998864321  11233455799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++|+|.+++.......+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++.......   
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---  149 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---  149 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence            99999998887666567899999999999999999999977  9999999999999999999999999987654322   


Q ss_pred             ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCC
Q 014189          278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  357 (429)
Q Consensus       278 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (429)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||........  .....          ..........
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~----------~~~~~~~~~~  217 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELK----------RRTLEDEVKF  217 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHH----------HHhhcccccc
Confidence            12335789999999999988899999999999999999999999975432111  00000          1111111110


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          358 DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       358 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                       .....+.++.+|+.+||+.||++||+++|+++.+
T Consensus       218 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         218 -EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             -ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence             1123567789999999999999999997666443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.3e-42  Score=327.66  Aligned_cols=244  Identities=27%  Similarity=0.353  Sum_probs=193.2

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|.+..+.      ..||+|++....  .......+..|..++... +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTN------EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            46999999999999876543      349999987532  122334455677777654 799999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          75 MEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            99999999999886543  6889999999999999999999977  9999999999999999999999999997543322


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....      ...          +..  
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~------~~~----------i~~--  210 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL------FDS----------ILN--  210 (316)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH------HHH----------HHc--
Confidence              123346799999999999999999999999999999999999999986543211      000          000  


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH-HHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR-DIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~  391 (429)
                      .....+...+.++.+++.+||+.||++||++. +++++
T Consensus       211 ~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            01122334567788999999999999999875 56553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-41  Score=317.48  Aligned_cols=261  Identities=25%  Similarity=0.411  Sum_probs=208.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||+|.+..+.+.   ...||+|.............|..|+.+++.++||||+++++++.+++..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKR---EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCC---ceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4578889999999999999987655332   3459999987665555667899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+  ++|+||||+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccc
Confidence            99999999999999886543 36899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCcccccccc---CCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          272 EGDKSHVSTRIM---GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       272 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ............   .+..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+..         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~---------  225 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE---------  225 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH---------
Confidence            322111111111   2457999999999999999999999999999887 999997654321   111110         


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                       .    ......+.+++..+.+++.+||..+|++||++++++..|+.+
T Consensus       226 -~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 -Q----DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -c----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             0    011122334567789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-41  Score=317.55  Aligned_cols=259  Identities=28%  Similarity=0.414  Sum_probs=200.9

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC----
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED----  188 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  188 (429)
                      |.+.+.||+|+||.||+|.+.....    ...+|+|.+.... .......|.+|+.+++.++||||+++++++...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~----~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDS----ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCC----eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            3466899999999999998755432    2348999876542 344456788999999999999999999987432    


Q ss_pred             --CeEEEEEEecCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 --EHRVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 --~~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                        ...+++|||+++|+|.+++...    ....+++.....++.|++.||+|||+++  |+||||||+|||+++++.+||+
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEEC
Confidence              2568999999999999887432    2235889999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      |||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||........   ..    ..
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~----~~  227 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YD----YL  227 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HH
Confidence            9999987644322111223356778999999999999999999999999999999 8889976443211   00    01


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      ....          ....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       228 ~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQGN----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1000          0112234567789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.2e-42  Score=332.93  Aligned_cols=255  Identities=21%  Similarity=0.185  Sum_probs=203.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|.+.+.||+|+||.||+|....+.      ..+|+|++....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATG------DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            36889999999999999999876543      349999987542  2234456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeE
Confidence            9999999999999999887652 36899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIM------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ....... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........      .....  
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~--  222 (330)
T cd05601         152 LTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIM--  222 (330)
T ss_pred             CCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHH--
Confidence            5433221 223357999999999987      45678999999999999999999999976543211      00000  


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                           .. ...+........+..+.+|+.+||. +|.+|||+++++.+
T Consensus       223 -----~~-~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         223 -----NF-QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -----cC-CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                 00 0011111122456788999999998 99999999999976

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.7e-42  Score=328.52  Aligned_cols=244  Identities=27%  Similarity=0.357  Sum_probs=196.2

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|.+..+.      ..||+|++....  .......+..|..++..+ +||||+++++++...+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESG------RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCC------CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence            36999999999999876553      349999987532  223445667888888876 699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||+++  ++||||||+|||++.++.+||+|||+++......
T Consensus        75 ~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          75 MEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             EcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            99999999998886553  6899999999999999999999977  9999999999999999999999999987543221


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....   .             ..+....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~-------------~~i~~~~  212 (320)
T cd05590         151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---F-------------EAILNDE  212 (320)
T ss_pred             --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---H-------------HHHhcCC
Confidence              123346799999999999999999999999999999999999999986543211   0             0011100


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCH------HHHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLM------RDIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~  391 (429)
                        ...+...+..+.+++.+||+.||++||++      ++++.+
T Consensus       213 --~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 --VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence              11223356788999999999999999998      777765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-41  Score=313.18  Aligned_cols=252  Identities=25%  Similarity=0.346  Sum_probs=206.8

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC-CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|.+.+.||+|+||.||+|.+..+..      .+++|.+... ........+.+|+++++.++||||+++++++.+.+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKR------VYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCc------EEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            47788999999999999998765543      3899987643 2344566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++++|.+++.......+++..+..++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            99999999999999998765557899999999999999999999977  9999999999999999999999999988654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||........   ..             .+.
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~-------------~~~  214 (256)
T cd08529         153 DNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---IL-------------KII  214 (256)
T ss_pred             Cccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH-------------HHH
Confidence            3221  22345788999999999999999999999999999999999999976542110   00             000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      . ......+...+..+.+++.+||+.+|++||++.+++.+
T Consensus       215 ~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         215 R-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             c-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            0 11112222456789999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-41  Score=315.21  Aligned_cols=252  Identities=24%  Similarity=0.415  Sum_probs=202.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|.+.+.       ..+|+|.+....  .....|.+|+.++.+++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~-------~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI   74 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCC-------CcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence            4688889999999999999976442       238999887543  2345788999999999999999999999988899


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++|||+.+|+|.+++..... .+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||+++...
T Consensus        75 ~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecC
Confidence            999999999999998865433 6899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ..             .+
T Consensus       152 ~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~-------------~~  214 (256)
T cd05113         152 DDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VE-------------KV  214 (256)
T ss_pred             CCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH-------------HH
Confidence            3221 11122346678999999998889999999999999999999 9999976543211   00             00


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      .. ......+...+..+.+++.+||+.+|++|||+.+++..|+
T Consensus       215 ~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         215 SQ-GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             hc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            00 0011112234678899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=314.23  Aligned_cols=255  Identities=26%  Similarity=0.352  Sum_probs=204.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC----hhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS----YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ++|.+.+.||+|+||.||+|....+.      ..+++|.+.....    ......+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~------~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTG------RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCC------cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            57889999999999999999865543      3499998764321    1233567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      ++..++||||+++++|.+++....  .+++..+..++.|++.||+|||..+  ++|+||+|+||++++++.++|+|||++
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccc
Confidence            999999999999999999886543  5888999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCcc-ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          268 KDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       268 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      +......... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.........               
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---------------  216 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---------------  216 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---------------
Confidence            7653321111 112356888999999999988999999999999999999999999754322110               


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                       ............+...+..+.+++.+||..+|++|||+.+++++.
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         217 -FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             -HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence             011111112223445677889999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.5e-41  Score=315.46  Aligned_cols=261  Identities=21%  Similarity=0.284  Sum_probs=207.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC--CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|+...+..      .||+|.+...  ........+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRK------PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCC------EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            578999999999999999998765433      4999987542  23344567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          190 HRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      ..+++|||+++|+|.+++...  ....+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccc
Confidence            999999999999999887532  2335788999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      .......  .......|++.|+|||.+.+..++.++|+||||+++|||++|+.||.......    ..+...       +
T Consensus       154 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~-------~  220 (267)
T cd08228         154 RFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQK-------I  220 (267)
T ss_pred             eeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHH-------H
Confidence            8654322  11223568899999999998889999999999999999999999986433211    111100       0


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .....   ........+..+.+++.+||..+|++|||+.+|++.|+.++
T Consensus       221 ~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         221 EQCDY---PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             hcCCC---CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            01011   11112245677999999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=324.52  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=214.3

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +..-|.+.+-||+|.|+.|-+|+      +..++..||||++.+..- ......+..|++.|+.++|||||+++.+....
T Consensus        16 IAGLYDLekTlG~GHFAVVKLAr------HVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLAR------HVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ   89 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhh------hhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence            34568888999999999999985      445566699999987642 33345677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-CCCcEEEeccCCC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFGLA  267 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla  267 (429)
                      ..+|||+|+-++|+|++++..+.. .+.+..+.+++.||+.|+.|+|...  +|||||||+||.+. .-|-|||+|||++
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeecccc
Confidence            999999999999999999987754 5999999999999999999999988  99999999999765 5688999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT-PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ..+..+..   .++.||++.|-|||++.|..|+ +++||||||||||.|++|++||...+..+                .
T Consensus       167 Nkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------------T  227 (864)
T KOG4717|consen  167 NKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------------T  227 (864)
T ss_pred             ccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----------------h
Confidence            88776543   4568999999999999999997 67899999999999999999998766432                2


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +..++|=  ....|...+.++.+||..||..||.+|.|.++|..+
T Consensus       228 LTmImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  228 LTMIMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhhhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            2333332  223466788999999999999999999999999876

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-42  Score=329.12  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=220.8

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      ...+.++||+|.||.||+|+..+..  ......||||..+.+......+.|+.|..+|+.++|||||+++|+|.+ ...+
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~--kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W  466 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPE--KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW  466 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccc--cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence            3455688999999999999876642  234556999999998877788999999999999999999999999985 5679


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      ||||+++.|.|..+|..+.. .++......+++|++.+|+|||+..  .|||||..+|||+....-|||+|||+++...+
T Consensus       467 ivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            99999999999999987654 5888899999999999999999966  99999999999999999999999999998877


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ...... +...-+..|||||.+....++.++|||-|||.+||++. |..||.+...                 ..+.--+
T Consensus       544 ~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------sDVI~~i  605 (974)
T KOG4257|consen  544 DAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------SDVIGHI  605 (974)
T ss_pred             cchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------cceEEEe
Confidence            554333 34455778999999999999999999999999999876 9999986432                 2223334


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      ...-+.+.|+.|+..+..|+.+||+++|.+||++.++...|+.+.
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence            445566788999999999999999999999999999988886553

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-41  Score=319.54  Aligned_cols=266  Identities=24%  Similarity=0.364  Sum_probs=212.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-CC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-DE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  189 (429)
                      .++|++.+.||+|+||.||+|.+....  ......|++|.+...........+.+|+.++++++||||+++++++.. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~--~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEK--PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCC--CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            467889999999999999999876521  112345899998766566667778899999999999999999998765 56


Q ss_pred             eEEEEEEecCCCChhhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          190 HRVLIYEFMARGSVENNLFSKVL------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                      ..++++||+++|+|.+++.....      ..+++..+..++.+++.||+|||+.+  ++|+||||+||++++++.+||+|
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECC
Confidence            78999999999999999865422      45899999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      ||+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||...++..   ...+    ..
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY----LK  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH----HH
Confidence            999986644332222233456778999999998889999999999999999999 999997654321   1110    00


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                            .    ......+..++..+.+++.+||..||++|||+.++++.|+.+..
T Consensus       234 ------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 ------D----GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ------c----CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  0    01111123356778999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.9e-42  Score=328.56  Aligned_cols=251  Identities=26%  Similarity=0.343  Sum_probs=198.1

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|.+..+.      ..+|+|++....  .......+.+|+.++.++ +||||+++++++...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKND------QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence            46999999999999876553      349999987642  223345677899999888 699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          75 IEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            99999999998886543  6899999999999999999999977  9999999999999999999999999987532211


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|..||.............+......         .. 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~-  218 (327)
T cd05617         151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL---------EK-  218 (327)
T ss_pred             --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH---------hC-
Confidence              123346799999999999999999999999999999999999999975432222111111111111         11 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCH------HHHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLM------RDIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~  391 (429)
                       ....+...+..+.+++.+||+.||++|+++      ++++++
T Consensus       219 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         219 -PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence             111233456778899999999999999984      577766

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-41  Score=329.97  Aligned_cols=268  Identities=29%  Similarity=0.375  Sum_probs=206.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe-C
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE-D  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~  188 (429)
                      .++|++.+.||+|+||.||+|.+.... .......||+|++...........+.+|+.++.++ +||||+++++++.. .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGID-KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCC-ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            357999999999999999999754321 22335569999997655455556788999999999 68999999998865 4


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC---------------------------------------------------------
Q 014189          189 EHRVLIYEFMARGSVENNLFSKV---------------------------------------------------------  211 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  211 (429)
                      ...+++|||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56789999999999999886431                                                         


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcccccccc
Q 014189          212 --------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM  283 (429)
Q Consensus       212 --------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  283 (429)
                              ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++................
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    123678888999999999999999977  9999999999999999999999999988653322211122234


Q ss_pred             CCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChH
Q 014189          284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVK  362 (429)
Q Consensus       284 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (429)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||........  ..    .....          ......+..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~----------~~~~~~~~~  306 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKE----------GTRMRAPDY  306 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhc----------cCCCCCCCC
Confidence            6678999999999999999999999999999997 8999875432111  00    00000          001111222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          363 GVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       363 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      .+..+.+++..||+.+|++|||+.+|+++|+.+..
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            35678999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.2e-42  Score=328.08  Aligned_cols=244  Identities=26%  Similarity=0.338  Sum_probs=196.8

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  194 (429)
                      ++||+|+||.||+|.+..+.      ..||+|++....  .......+..|.+++..+ +||||+++++++...+..|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTD------EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECCCC------CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence            36999999999999876543      349999987542  223345567888888866 799999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          75 MEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            99999999998886543  6889999999999999999999987  9999999999999999999999999987543222


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....   .             ..+....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~-------------~~i~~~~  212 (321)
T cd05591         151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---F-------------ESILHDD  212 (321)
T ss_pred             --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---H-------------HHHHcCC
Confidence              123346799999999999999999999999999999999999999986553211   0             0011100


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARP-------LMRDIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~~  391 (429)
                        ...+...+.++.+++.+||+.||++||       ++++++++
T Consensus       213 --~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 --VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence              112223467889999999999999999       88888876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-41  Score=319.89  Aligned_cols=248  Identities=24%  Similarity=0.318  Sum_probs=196.9

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      ||+|+||+||++.+..+.      ..+|+|.+.....  ......+..|+.+++.++||||+++.+++..+...++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMRATG------KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEccCC------cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence            799999999999876543      3499999865421  22335677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC
Q 014189          198 MARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  275 (429)
Q Consensus       198 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  275 (429)
                      +++|+|..++...  ....+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            9999998877542  2346899999999999999999999977  99999999999999999999999999976543322


Q ss_pred             ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCC
Q 014189          276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  355 (429)
Q Consensus       276 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (429)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........            .......... 
T Consensus       153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~------------~~~~~~~~~~-  217 (280)
T cd05608         153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK------------ELKQRILNDS-  217 (280)
T ss_pred             --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH------------HHHHhhcccC-
Confidence              1234578999999999999999999999999999999999999997543211100            0001111111 


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          356 EGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       356 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                       ...+...+..+.+++.+||+.||++||     ++++++++
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         218 -VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             -CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence             122335677899999999999999999     67788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-41  Score=315.89  Aligned_cols=255  Identities=28%  Similarity=0.406  Sum_probs=205.5

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.++||+|+||.||+|...++       ..+|+|.+.....  ....|.+|+.++++++|+||+++++++. .+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~-------~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGH-------TKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QE   73 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCC-------ceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cC
Confidence            456799999999999999999975432       3399998876432  3457889999999999999999999874 45


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..+++|||+++|+|.+++.......+++.++..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  151 (260)
T cd05067          74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARL  151 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceee
Confidence            7899999999999999987766667899999999999999999999977  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...... .......++..|+|||++.+..++.++||||||+++|||++ |+.||..........       .+       
T Consensus       152 ~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~-------  216 (260)
T cd05067         152 IEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-------NL-------  216 (260)
T ss_pred             cCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH-------HH-------
Confidence            543221 11223456778999999998899999999999999999999 999997654321100       00       


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                         ........+...+.++.+++.+||+.+|++|||+++++..|+.
T Consensus       217 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         217 ---ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               0011112223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.3e-41  Score=318.07  Aligned_cols=253  Identities=26%  Similarity=0.356  Sum_probs=202.5

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      |+..+.||+|+||+||+|.+..+.+      .+|+|.+.....  ......+.+|+.+++.++|+||+++.+++..++..
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGK------MYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCc------EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            6777899999999999998765533      499998865421  22234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++|||+++|+|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+||++++++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999999999998887655557999999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....   .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.............            ....
T Consensus       154 ~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~------------~~~~  218 (285)
T cd05632         154 EGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD------------RRVL  218 (285)
T ss_pred             CCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------Hhhh
Confidence            3211   223578999999999998999999999999999999999999998654321111000            0000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                      ..  ....+...+..+.+|+..||+.||++||+     +.+++.+
T Consensus       219 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         219 ET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            00  01122345667889999999999999999     7788776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=327.00  Aligned_cols=252  Identities=26%  Similarity=0.302  Sum_probs=214.3

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccC-CCceeeeeeEEE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLS-HPNLVKLIGYCC  186 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  186 (429)
                      ....|.+.+.||.|.||.||+++.+.+++      .+|+|.+.+...  ........+|+.+|+++. |||||.++++|+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~------~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e  106 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGK------EVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE  106 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCc------eeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            45679999999999999999998777644      499999977543  224467789999999998 999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC----CcEEEe
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD----YNAKLS  262 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~----~~~kl~  262 (429)
                      +....++|||++.||.|.+.+...   .+++..+..++.|++.++.|||+.+  |+||||||+|+|+...    +.+|++
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEe
Confidence            999999999999999999999877   2999999999999999999999977  9999999999999643    479999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      |||++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..........          
T Consensus       182 DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----------  248 (382)
T KOG0032|consen  182 DFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----------  248 (382)
T ss_pred             eCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------
Confidence            9999998765   233566899999999999999999999999999999999999999998765432211          


Q ss_pred             hhhhhhhhc--CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKKLLNII--DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            .+.  +.....+.....+..+.+++..||..||..|+|+.++++|
T Consensus       249 ------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 ------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                  111  1123344455678999999999999999999999999997

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.2e-41  Score=317.08  Aligned_cols=252  Identities=26%  Similarity=0.371  Sum_probs=200.4

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|++.++||+|+||.||+|.+..+.      ..+|+|.+..+........+.+|++++++++||||+++++++...+..+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   75 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTR------RILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRIS   75 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCC------cEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence            5788899999999999999865543      3499999876544455567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +||||+++|+|..+.      .+++..+..++.|++.||+|||+.+  |+|+||||+|||++.++.++|+|||++.....
T Consensus        76 lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          76 ICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            999999999986542      4788888999999999999999977  99999999999999999999999999976543


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      ..    .....||..|+|||++.+..++.++|+||||+++|+|++|+.||.............   ..      ...+.+
T Consensus       148 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~------~~~~~~  214 (279)
T cd06619         148 SI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL---QL------LQCIVD  214 (279)
T ss_pred             cc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH---HH------HHHHhc
Confidence            21    234578999999999999899999999999999999999999997543221110000   00      000011


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...........+.++.+++.+||+.+|++||++++++++
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            100011112345678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.2e-41  Score=313.28  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=199.9

Q ss_pred             eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEec
Q 014189          119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM  198 (429)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  198 (429)
                      .||+|+||.||+|.+....    .+..||+|+............|.+|+.++++++||||+++++++. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~----~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRK----KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCC----CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            3899999999999764321    133499999877655555667889999999999999999999886 45779999999


Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccc
Q 014189          199 ARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV  278 (429)
Q Consensus       199 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  278 (429)
                      ++|+|.+++.... ..+++..++.++.|++.||+|||+.+  ++|+||||+|||++.++.+||+|||++...........
T Consensus        77 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          77 SGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            9999999886543 36899999999999999999999977  99999999999999999999999999986543322111


Q ss_pred             -cccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCC
Q 014189          279 -STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  356 (429)
Q Consensus       279 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (429)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |..||.........                 ..+.....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~~~~~~~  216 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-----------------SFIEQGKR  216 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-----------------HHHHCCCC
Confidence             111234678999999988889999999999999999996 99999765432110                 01111111


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          357 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       357 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      ...+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            223345678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.9e-41  Score=315.15  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=203.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+       ..+|+|.+.....  ....|.+|+.++++++|+|++++++++. ...
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-------~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGN-------TKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEP   74 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCC-------ceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence            45788899999999999999976543       2389998876433  2356889999999999999999999875 456


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .+++|||+++++|.+++.......+++..+..++.+++.||+|||+++  ++|+||||+||++++++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeec
Confidence            789999999999999987655556899999999999999999999977  999999999999999999999999999765


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ...... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||........   ...             
T Consensus       153 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~-------------  215 (260)
T cd05070         153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQ-------------  215 (260)
T ss_pred             cCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH-------------
Confidence            432211 1122345678999999988899999999999999999999 8899975442211   000             


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                       +........+...+..+.+|+.+||..+|++|||+.++.+.|+.
T Consensus       216 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         216 -VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             00111122234556789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.5e-42  Score=326.37  Aligned_cols=244  Identities=27%  Similarity=0.376  Sum_probs=193.5

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhc-cCCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGH-LSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|.+..+.      ..||+|++....  .......+..|..++.. ++||||+++++++.+.+..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTN------QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence            46999999999999876553      349999987542  12233455677888875 4899999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+++......
T Consensus        75 ~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          75 MEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            99999999999886543  5888999999999999999999977  9999999999999999999999999987533221


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...    .       ....+ 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~----i-------~~~~~-  213 (316)
T cd05619         151 A--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQS----I-------RMDNP-  213 (316)
T ss_pred             C--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HHH----H-------HhCCC-
Confidence            1  22346799999999999999999999999999999999999999986543211   000    0       00011 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH-HHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR-DIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~  391 (429)
                         ..+...+..+.+++.+||+.||++||++. +++++
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         214 ---CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             ---CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence               11223456788999999999999999997 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=314.41  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=201.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|.+...       ..+|+|++.....  ....|.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~-------~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGK-------IDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI   74 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCC-------ccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence            3577889999999999999976432       2389998865422  335688899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++++|.+++..... .+++..+..++.|++.|++|||+.+  ++||||||+||+++.++.+||+|||+++...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          75 FIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             EEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecc
Confidence            999999999999999875443 6899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........             .... 
T Consensus       152 ~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------------~~~~-  216 (256)
T cd05059         152 DDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE-------------SVSA-  216 (256)
T ss_pred             cccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH-------------HHHc-
Confidence            3211 11112234568999999999999999999999999999999 899997654321100             0011 


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                         ......+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       217 ---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 ---GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               111122334577899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=343.95  Aligned_cols=261  Identities=23%  Similarity=0.274  Sum_probs=214.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeE-EEe-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGY-CCE-  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~-  187 (429)
                      ..++++.++|.+|||+.||+|.+....      ..+|+|++-.. .....+...+||++|++|. |+|||.+++. ... 
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~------~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGG------KKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCC------ceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            346788899999999999999876653      33999988766 5677788889999999997 9999999993 221 


Q ss_pred             -----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          188 -----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       188 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                           .-..+|.||||.||.|-+++..+....|++.++++|++++++|+++||....+|||||||-+||||+.+|+.|||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence                 136689999999999999997665556999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCcCCCCCCCcccc-------ccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh
Q 014189          263 DFGLAKDGPEGDKSHVS-------TRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN  332 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~  332 (429)
                      |||.|............       -...-|+.|+|||++.   +..+++|+|||+|||+||-|+-...||+....     
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----  263 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----  263 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----
Confidence            99998754332211000       0134699999999984   67899999999999999999999999986532     


Q ss_pred             HHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          333 LADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                                     ..|++.....+..+..+..+.+||..||+.||++||++-+|+..+.+++..
T Consensus       264 ---------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 ---------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ---------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                           344444444444467899999999999999999999999999998666543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-42  Score=303.05  Aligned_cols=253  Identities=26%  Similarity=0.378  Sum_probs=208.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC----C---hhhHHHHHHHHHHHhccC-CCceeee
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----S---YQGHREWLAEVIFLGHLS-HPNLVKL  181 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~---~~~~~~~~~E~~~l~~l~-h~niv~l  181 (429)
                      .-++|...+.||.|..+.|-++.++.++++      +|+|++....    +   ..-.+.-.+|+.||+++. ||+|+.+
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e------~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l   88 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKE------FAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDL   88 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccc------eeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEe
Confidence            345677788999999999999988777655      8888875421    1   112233457999999984 9999999


Q ss_pred             eeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          182 IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       182 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                      .++|+.+..+++|+|.|+.|.|.++|....  .+++.....|+.|+..|+.|||..+  ||||||||+|||++++.++||
T Consensus        89 ~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~i  164 (411)
T KOG0599|consen   89 QDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKI  164 (411)
T ss_pred             eeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEE
Confidence            999999999999999999999999997765  6899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~  335 (429)
                      +|||+|...+.+.+   ....||||+|+|||.+..      ..|+..+|+|++|||+|.|+.|.+||-......      
T Consensus       165 sDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml------  235 (411)
T KOG0599|consen  165 SDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML------  235 (411)
T ss_pred             eccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH------
Confidence            99999999877654   456899999999999863      468899999999999999999999996432110      


Q ss_pred             hHhhHHHhhhhhhhhcCCCC--CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 WALPLLKEKKKLLNIIDPRL--EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       .         +..+.....  ..+...+.+....+|+.+||+.||..|.|++|++.|
T Consensus       236 -M---------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  236 -M---------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             -H---------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence             1         111111111  223345778899999999999999999999999987

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-41  Score=317.28  Aligned_cols=257  Identities=30%  Similarity=0.466  Sum_probs=203.5

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      +.||+|+||.||+|.+.+..........+++|.+...........|.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999876543223334568999886654445566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-----cEEEeccCCC
Q 014189          198 MARGSVENNLFSKV-----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-----NAKLSDFGLA  267 (429)
Q Consensus       198 ~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfgla  267 (429)
                      +++|+|.+++....     ...+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999996532     234788999999999999999999877  99999999999999887     8999999998


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ................++..|+|||.+.+..++.++||||||+++|||++ |..||........   ...    ..    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~----~~----  227 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQH----VT----  227 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHH----Hh----
Confidence            76543322222223456788999999999999999999999999999998 9999975443211   000    00    


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                            .......+...+..+.+++.+||..+|++||++.+|++.|+
T Consensus       228 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 ------AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ------cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                  00111223345678899999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-41  Score=316.68  Aligned_cols=263  Identities=25%  Similarity=0.425  Sum_probs=210.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|.+..+++.  ....+|+|.............+.+|+.++++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEK--VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCC--cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            5688889999999999999987654321  2345899988776555566778899999999999999999999987 788


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            999999999999999876533 5899999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ............++..|+|||.+....++.++|+||||+++||+++ |..||.......   ....              
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~--------------  223 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDL--------------  223 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHH--------------
Confidence            3322221222234678999999988899999999999999999999 999998654321   1110              


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      +........+..++..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         224 LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            00011112233455678999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3e-41  Score=315.14  Aligned_cols=261  Identities=24%  Similarity=0.412  Sum_probs=208.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|.+.....   ....+|+|.+...........|.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGK---REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCC---CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            578889999999999999997653322   23458999987655555567889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+  ++|+||||+|||++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999999987653 35899999999999999999999977  9999999999999999999999999998764


Q ss_pred             CCCCcc-ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          272 EGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       272 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ...... ......++..|+|||.+.+..++.++|+||||+++||+++ |..||........   ...    ..      +
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~----~~------~  224 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKA----IE------E  224 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHH----Hh------C
Confidence            432111 1112234568999999998899999999999999999887 9999976543211   100    00      0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      .    .....+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       225 ~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 G----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0    01112234567789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.8e-41  Score=323.18  Aligned_cols=244  Identities=27%  Similarity=0.345  Sum_probs=193.6

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|.+..++      ..||+|++.....  ......+..|..++... +||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKG------EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence            46999999999999876543      3499999875321  22334556788887754 899999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          75 MEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             ECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            99999999999886643  5889999999999999999999977  9999999999999999999999999987532221


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....   ..    ..       ....  
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~~----~~-------~~~~--  212 (316)
T cd05620         151 --NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---FE----SI-------RVDT--  212 (316)
T ss_pred             --CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH----HH-------HhCC--
Confidence              123346799999999999999999999999999999999999999976543211   00    00       0001  


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH-HHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR-DIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~  391 (429)
                        ...+...+.++.+++.+||+.||++||++. +++++
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         213 --PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence              112233567889999999999999999985 66644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.4e-41  Score=320.77  Aligned_cols=266  Identities=24%  Similarity=0.329  Sum_probs=205.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||++.+..+.      ..+|+|.+...........+.+|++++++++||||+++++++..++..
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSG------LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCC------eEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence            36889999999999999999766543      348999887654455556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+ .+  ++|+||||+|||++.++.+||+|||++...
T Consensus        75 ~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            9999999999999998765  368999999999999999999997 46  999999999999999999999999998764


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh-------
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-------  343 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------  343 (429)
                      ....    .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.................       
T Consensus       151 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         151 IDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             cccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence            3321    23457899999999998888999999999999999999999999754422111110000000000       


Q ss_pred             -------------hhhhhhhcCCCCCCCCC-hHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          344 -------------KKKLLNIIDPRLEGDYP-VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       344 -------------~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                                   ........... ....+ ...+.++.+++.+||..+|++|||+++++++-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                         00000000000 00011 12456789999999999999999999999873

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-41  Score=331.28  Aligned_cols=255  Identities=24%  Similarity=0.266  Sum_probs=199.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|+..+.||+|+||.||+|....+.      ..||+|++....  .......+.+|+.++..++||||+++++.+.+.+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTG------HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            36888999999999999999876553      349999986432  2233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            9999999999999999987654  6889999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCC---------------------------------ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHH
Q 014189          270 GPEGDK---------------------------------SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL  316 (429)
Q Consensus       270 ~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  316 (429)
                      ......                                 .......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            422110                                 00112357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC---HHHHHHh
Q 014189          317 TGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL---MRDIVDS  391 (429)
Q Consensus       317 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~  391 (429)
                      +|+.||....+.....      ...       .. ...+........+.++.+++.+|+ .||.+|++   ++++++|
T Consensus       231 tG~~Pf~~~~~~~~~~------~i~-------~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         231 IGYPPFCSETPQETYR------KVM-------NW-KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             cCCCCCCCCCHHHHHH------HHH-------cC-CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            9999998665422110      000       00 000111111124667888998876 49999984   7888877

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.5e-41  Score=319.25  Aligned_cols=264  Identities=28%  Similarity=0.401  Sum_probs=208.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+.... .......+|+|.+...........|.+|+.++++++||||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccC-CCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            357889999999999999999764311 1123456999998776555566778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 014189          191 RVLIYEFMARGSVENNLFSKV--------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  250 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~N  250 (429)
                      .+++|||+++|+|.+++....                    ...+++..++.++.|++.||+|||..+  ++||||||+|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~n  160 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRN  160 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhh
Confidence            999999999999999986421                    124788899999999999999999977  9999999999


Q ss_pred             EEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhh
Q 014189          251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAR  329 (429)
Q Consensus       251 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~  329 (429)
                      |+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875433221111222345678999999998899999999999999999998 888886544321


Q ss_pred             hhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          330 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                         ..             ..+.+... ...+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       241 ---~~-------------~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 ---VI-------------YYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HH-------------HHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               10             01111111 11233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.1e-41  Score=314.23  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=203.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ..+|++.++||+|+||.||+|.+.++.       .||+|.+.....  ....|.+|+.+++.++||||+++++++. ...
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEP   74 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-------eEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCC
Confidence            356999999999999999999765432       289999875432  3356889999999999999999999875 456


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.......+++..+..++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeec
Confidence            799999999999999997654456899999999999999999999977  999999999999999999999999999765


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ...... ......++..|+|||+..+..++.++||||||+++|||++ |..||..........                .
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----------------~  215 (262)
T cd05071         153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----------------Q  215 (262)
T ss_pred             cccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----------------H
Confidence            433221 1223456778999999998899999999999999999999 888887554221100                0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      + ........+...+..+.+++.+|++.+|++|||+.++++.|+..
T Consensus       216 ~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         216 V-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             H-hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            0 00011122335567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.2e-41  Score=319.16  Aligned_cols=254  Identities=27%  Similarity=0.382  Sum_probs=202.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .|+..+.||+|+||.||+|.+..+.+      .+|+|.+.....  ......+.+|+.++++++|+||+++++.+...+.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGK------MYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCc------eEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence            36778999999999999998766543      499998765321  2223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            999999999999999887655556899999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .....   .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.............   ....        
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~--------  218 (285)
T cd05630         153 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVK--------  218 (285)
T ss_pred             CCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhh--------
Confidence            43221   123478999999999999999999999999999999999999997643211100000   0000        


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                         ......+...+..+.+|+.+||+.||++|||     ++|++++
T Consensus       219 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         219 ---EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             ---hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence               0001122345667899999999999999999     8899875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-41  Score=311.93  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=202.0

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      +.||+|+||.||+|++.....   ....+|+|.+...........+.+|+.+++.+.||||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG---KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCC---CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            469999999999997654321   234599999887655445667889999999999999999999876 4567999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++|+|.+++....  .+++..+..++.|++.+|+|||..+  ++|+||||+|||++.++.+||+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          77 APLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999999997654  6899999999999999999999977  9999999999999999999999999998654332211


Q ss_pred             c-cccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCC
Q 014189          278 V-STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  355 (429)
Q Consensus       278 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (429)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+...   ...+..    .          ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~----------~~  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----S----------GE  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----c----------CC
Confidence            1 111234568999999998899999999999999999998 999997654321   111110    0          01


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          356 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       356 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      ....+..++..+.+++.+||..+|++|||+.++++.|+.+.
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            11223445678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=311.51  Aligned_cols=254  Identities=31%  Similarity=0.472  Sum_probs=207.2

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      +.||+|+||.||+|.+....   .....+++|.+...........+.+|+++++.++|+||+++++++......++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            46999999999999876531   123459999988765544567888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          198 MARGSVENNLFSKV-------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       198 ~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +++|+|.+++....       ...+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||.+...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999987642       346899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .............++..|+|||.+....++.++||||||+++|+|++ |..||........   ...          ...
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~----------~~~  222 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---LEY----------LRK  222 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----------HHc
Confidence            55332222334567889999999998899999999999999999999 6999986643211   000          000


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                          ......+...+.++.+++.+||..+|++|||+.+++++|+
T Consensus       223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                1112233455788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.4e-41  Score=312.22  Aligned_cols=251  Identities=26%  Similarity=0.369  Sum_probs=198.8

Q ss_pred             eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      .||+|+||.||+|.+....    .+..+|+|++.... ......++.+|+.+++.+.||||+++++++. .+..++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKK----SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecCC----CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            5899999999999754321    23459999986543 2344567889999999999999999999885 4567899999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++|+|.+++....  .+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          77 AELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            99999999986543  6889999999999999999999977  9999999999999999999999999998654332211


Q ss_pred             -ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCC
Q 014189          278 -VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  355 (429)
Q Consensus       278 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (429)
                       ......++..|+|||.+....++.++|+||||+++|||++ |..||........   ..              .+....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~--------------~i~~~~  215 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQ--------------MIESGE  215 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH--------------HHHCCC
Confidence             1122344678999999988889999999999999999998 9999986543211   10              111111


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          356 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       356 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      ....+..++.++.+++.+||+.||++||++.+|.+.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1223445677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-41  Score=325.15  Aligned_cols=244  Identities=27%  Similarity=0.375  Sum_probs=196.8

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|.+..+.      ..||+|++....  .......+..|..++..+ +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTD------ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            46999999999999876543      349999987532  223345567888898877 699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          75 MEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            99999999998886553  6899999999999999999999977  9999999999999999999999999987532221


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....   .   .          .+....
T Consensus       151 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~---~----------~i~~~~  212 (318)
T cd05570         151 V--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---F---Q----------SILEDE  212 (318)
T ss_pred             C--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---H---H----------HHHcCC
Confidence            1  12345799999999999999999999999999999999999999976542211   0   0          011111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~  391 (429)
                        ...+...+..+.+|+.+||+.||++|||+     .+++++
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         213 --VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             --CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence              11233456788999999999999999999     888875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-41  Score=322.54  Aligned_cols=268  Identities=21%  Similarity=0.294  Sum_probs=202.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|.+.+.||+|+||.||+|.+..+.      ..||+|.+...........+.+|+.++++++||||+++++++..++..
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTE------NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCC------CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            56889999999999999999865543      349999987654433445677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecC
Confidence            999999975 8888776543 35788999999999999999999977  9999999999999999999999999987643


Q ss_pred             CCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh--------hHHH
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--------PLLK  342 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~  342 (429)
                      ....  ......+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||...+............        +...
T Consensus       156 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         156 VPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             CCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            3221  1233568999999998865 568999999999999999999999998665432211111000        0000


Q ss_pred             hhhhhhhhcCCCCCC----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKKLLNIIDPRLEG----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..........+....    ......+.++.+|+.+||+.||.+|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            000000000000000    0112346678999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.8e-41  Score=331.34  Aligned_cols=258  Identities=22%  Similarity=0.235  Sum_probs=203.0

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      +....++|++.+.||+|+||.||+|.+..+.+      .+|+|++....  .......+.+|+.+++.++||||++++++
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~------~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK------VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA  111 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCc------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            34455789999999999999999998766543      49999986421  22234457789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                      +.+++..++||||+++|+|.+++...   .++...+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         112 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999999988643   4788888999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG----HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      |+++....... .......||+.|+|||++.+.    .++.++|||||||++|||++|..||...+....      .   
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~---  256 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------Y---  256 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------H---
Confidence            99986543221 122346799999999998753    378999999999999999999999986543211      0   


Q ss_pred             HHhhhhhhhhcCC--CCCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHhc
Q 014189          341 LKEKKKLLNIIDP--RLEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDSL  392 (429)
Q Consensus       341 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L  392 (429)
                             ..+...  .+........+..+.+++.+||..++.+  ||++++++++.
T Consensus       257 -------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         257 -------SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             -------HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                   111110  1111112346778899999999854443  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-41  Score=325.98  Aligned_cols=244  Identities=27%  Similarity=0.330  Sum_probs=192.8

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHH-HHhccCCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVI-FLGHLSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|.+..++      ..||+|++....  .......+..|.. +++.++||||+++++++.+.+..++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADG------KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence            46999999999999876553      349999986532  1222344555555 45788999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          75 LDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             EcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            99999999999886543  6889999999999999999999977  9999999999999999999999999987543222


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                        .......||+.|+|||++.+..++.++|||||||++|||++|..||...+....      .          ..+....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~----------~~i~~~~  212 (323)
T cd05575         151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------Y----------DNILNKP  212 (323)
T ss_pred             --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------H----------HHHHcCC
Confidence              123346799999999999999999999999999999999999999986543211      0          0111111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH----HHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR----DIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~----evl~~  391 (429)
                        ...+...+..+.+++.+||+.||.+||+++    +++++
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         213 --LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence              112234467889999999999999999984    66654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=339.33  Aligned_cols=264  Identities=21%  Similarity=0.334  Sum_probs=193.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC--
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  188 (429)
                      ..+|++.+.||+|+||.||+|.+..+.+      .||+|.+.....     ...+|+.+++.++||||+++++++...  
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~------~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSE------KVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECF  133 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCC------EEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence            4579999999999999999998765433      499998865422     223699999999999999999876432  


Q ss_pred             ------CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-cE
Q 014189          189 ------EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NA  259 (429)
Q Consensus       189 ------~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-~~  259 (429)
                            ..+++||||+++ +|.+++..  .....+++..+..++.|++.||+|||+.+  |+||||||+|||++.++ .+
T Consensus       134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~v  210 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTL  210 (440)
T ss_pred             ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCce
Confidence                  246799999975 67666642  23346899999999999999999999977  99999999999999665 69


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-HHhH
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWA  337 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~~~~  337 (429)
                      ||+|||+++.......   .....||+.|+|||++.+ ..|+.++|||||||++|||++|.+||........... ....
T Consensus       211 kL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  287 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL  287 (440)
T ss_pred             eeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9999999987643322   223578999999999875 4689999999999999999999999986653321111 0000


Q ss_pred             hhHHHhh-----hhhhhh-----cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          338 LPLLKEK-----KKLLNI-----IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       338 ~~~~~~~-----~~~~~~-----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....+.     .....+     ....+...++...+.++.+|+.+||..||.+|||+.|++.+
T Consensus       288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0000000     000000     00011111223345789999999999999999999999977

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-41  Score=332.04  Aligned_cols=266  Identities=23%  Similarity=0.249  Sum_probs=201.8

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ....+|.+.+.||+|+||.||+|...+.    .....|++|.+....      .+.+|+.++++++||||+++++++...
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~----~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~  158 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGD----EQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWK  158 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCC----ccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence            3456799999999999999999975432    224558999876542      234799999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ...+++||++. ++|.+++...  ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       159 ~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        159 STVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             CEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            99999999995 6888888433  36899999999999999999999977  9999999999999999999999999997


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh-hhHHHhHhhHHHhh---
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE-QNLADWALPLLKEK---  344 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~---  344 (429)
                      ...............||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ..+.. +...+...   
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~  312 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLE  312 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccc
Confidence            65543332233456799999999999999999999999999999999999999976543211 11110 00000000   


Q ss_pred             ----------hhhhhhcCCCCCCCCC-------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 ----------KKLLNIIDPRLEGDYP-------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ----------~~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                ..+.. ..........       ...+.++.+++.+||..||++|||+.|++.+
T Consensus       313 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        313 FPQNGSTNLCKHFKQ-YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cCCccchhHHHHHHh-hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                      00000 0000111110       1235678899999999999999999999987

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-41  Score=310.70  Aligned_cols=251  Identities=27%  Similarity=0.456  Sum_probs=206.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||.|+||.||+|...+        ..||+|.+.....  ....+.+|+.+++.++|+||+++++++...+.
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~--------~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRG--------QKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP   74 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecC--------cEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence            3578888999999999999997542        3399999876533  45678899999999999999999999998899


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++++|.+++.......+++..+..++.|++.||.|||..+  ++|+||||+||+++.++.+||+|||+++..
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccc
Confidence            999999999999999987765557899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .....     ...++..|+|||.+.+..++.++||||||+++|||++ |..||........   ..    ..        
T Consensus       153 ~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----~~--------  212 (256)
T cd05039         153 SQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----HV--------  212 (256)
T ss_pred             ccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH----HH--------
Confidence            33211     2345678999999998889999999999999999997 9999975542211   00    00        


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                        ........+...+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus       213 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         213 --EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              00111122334567889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=297.73  Aligned_cols=265  Identities=23%  Similarity=0.295  Sum_probs=208.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC-
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  188 (429)
                      -.++|++.+.||+|||+-||++....+      +..+|+|.+.-.. .++.+..++|++..++++|||+++++++...+ 
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~------~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLST------GHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCc------ccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            346799999999999999999864444      3348999887653 55667788999999999999999999876433 


Q ss_pred             ----CeEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 ----EHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 ----~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                          ...|++++|...|+|.+.+....  +..+++.+.+.|+.++++||.+||....++.||||||.|||+++.+.++|.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                35899999999999999986543  235899999999999999999999988889999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccc-------cccccCCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh
Q 014189          263 DFGLAKDGPEGDKSHV-------STRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN  332 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~  332 (429)
                      |||.+....-.-....       .....-|..|+|||.+..   ...++++|||||||+||+|+-|..||+..-.     
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----  246 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----  246 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----
Confidence            9999876432111100       112346889999999874   4578999999999999999999999974321     


Q ss_pred             HHHhHhhHHHhhhhh-hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          333 LADWALPLLKEKKKL-LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                                .+..+ ..+..+.+..+.....+..+.+++.+||+.||.+||++.+++.+++.+.
T Consensus       247 ----------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 ----------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      11111 1112222222223347889999999999999999999999999987653

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.4e-41  Score=312.83  Aligned_cols=256  Identities=25%  Similarity=0.369  Sum_probs=195.1

Q ss_pred             eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEec
Q 014189          119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM  198 (429)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  198 (429)
                      .||+|+||.||+|.+.+..    ....+++|.+...........|.+|+.++++++||||+++++++.+....++||||+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGY----TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             cccccCCceEEEEEEcCCC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence            5899999999999764321    234589998876655555567889999999999999999999999989999999999


Q ss_pred             CCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC
Q 014189          199 ARGSVENNLFSKV---LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  275 (429)
Q Consensus       199 ~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  275 (429)
                      ++|+|.+++....   ....++..+..++.|++.|++|||+.+  ++|+||||+||+++.++.+||+|||++........
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            9999999986532   224567788899999999999999977  99999999999999999999999999875433222


Q ss_pred             ccccccccCCcccccccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          276 SHVSTRIMGTYGYAAPEYIMTG-------HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       276 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ........|+..|+|||++.+.       .++.++|+||||+++|||++ |..||...........   .   .  ....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~---~---~--~~~~  227 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY---T---V--REQQ  227 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH---H---h--hccc
Confidence            2222335678899999998642       35789999999999999996 9999976543221110   0   0  0001


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      ....++.+    ....+..+.+++..|+ .+|++|||++||+..|+
T Consensus       228 ~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         228 LKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111111    1234556788999998 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=312.73  Aligned_cols=256  Identities=28%  Similarity=0.405  Sum_probs=207.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||.||+|.+.+.       ..+++|.+.....  ...++.+|+.++++++|+||+++++++....
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~-------~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGT-------TKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE   74 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCC-------ceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence            346799999999999999999976543       2389998875432  3456889999999999999999999999889


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++++|.+++.......+++..+..++.+++.|+.|||.++  ++|+||||+||+++.++.+||+|||++..
T Consensus        75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECcccccee
Confidence            9999999999999999997765557899999999999999999999977  99999999999999999999999999886


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...... .......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||........   ...            
T Consensus       153 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~------------  216 (261)
T cd05034         153 IEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQ------------  216 (261)
T ss_pred             ccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH------------
Confidence            543211 11122335678999999998899999999999999999998 9999975442211   000            


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                       + ........+...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       217 -~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         217 -V-ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -H-HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             0 0011112223346788999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-41  Score=314.27  Aligned_cols=253  Identities=27%  Similarity=0.370  Sum_probs=199.1

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      +.||+|+||.||+|.+.++..    ...+++|.............+.+|+.++.++ +||||+++++++...+..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCC----eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            368999999999998765432    2347888887554445556788999999999 79999999999999999999999


Q ss_pred             ecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          197 FMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      |+++|+|.+++....              ...+++.++..++.|++.||+|||+.+  ++|+||||+|||+++++.+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEEC
Confidence            999999999986532              124789999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      |||++.......   .......+..|+|||++.+..++.++||||||+++|||++ |..||........   .       
T Consensus       155 dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~-------  221 (270)
T cd05047         155 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y-------  221 (270)
T ss_pred             CCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH---H-------
Confidence            999986432111   1111234567999999988889999999999999999997 9999975432110   0       


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                             ..+........+...+..+.+++.+||..+|.+|||+.+++..|+++.
T Consensus       222 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         222 -------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -------HHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                   000111111122345567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.7e-41  Score=324.26  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=198.5

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDE  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  189 (429)
                      +|+..+.||+|+||.||+|.+..+++      .||+|++....  .......+..|..++..+. |++|+++++++.+.+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDE------LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            47778999999999999998765543      49999987532  2233455778888988885 577888999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccc
Confidence            9999999999999999886543  6899999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........   .             ..
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~-------------~~  212 (323)
T cd05615         151 HMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---F-------------QS  212 (323)
T ss_pred             cCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---H-------------HH
Confidence            43221  122345799999999999999999999999999999999999999986543211   0             01


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~  391 (429)
                      +....  ...+...+..+.+++.+||+.+|.+|++.     +++.++
T Consensus       213 i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         213 IMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             HHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence            11111  12233456788999999999999999984     556554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.8e-41  Score=327.14  Aligned_cols=265  Identities=25%  Similarity=0.310  Sum_probs=207.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-C-----CceeeeeeE
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-H-----PNLVKLIGY  184 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~  184 (429)
                      ..+|.+.++||+|+||.|-+|++..+.+.      ||||+++...  ....+-..|+.+|..|+ |     -|+|+++++
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~------VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~  256 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEI------VAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY  256 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcE------EEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence            34688999999999999999987776554      9999998653  23344557999999997 4     389999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC--cEEEe
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY--NAKLS  262 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~--~~kl~  262 (429)
                      |...+++|||+|.+. -+|.+++..+...+++...+..++.|++.||.+||.++  |||+||||+||||.+-+  .+||+
T Consensus       257 F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVI  333 (586)
T KOG0667|consen  257 FYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVI  333 (586)
T ss_pred             cccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEE
Confidence            999999999999995 59999999888888999999999999999999999988  99999999999997543  69999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh----
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL----  338 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~----  338 (429)
                      |||.|......-     .+...+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+...+.....-.+    
T Consensus       334 DFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp  408 (586)
T KOG0667|consen  334 DFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP  408 (586)
T ss_pred             ecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence            999998754322     24567889999999999999999999999999999999999998877655432222111    


Q ss_pred             -hHHHhhhhhhhhcCC-----------------------------CCCCCCC-----------hHHHHHHHHHHHHhhcc
Q 014189          339 -PLLKEKKKLLNIIDP-----------------------------RLEGDYP-----------VKGVHKAAMLAYHCLNH  377 (429)
Q Consensus       339 -~~~~~~~~~~~~~~~-----------------------------~~~~~~~-----------~~~~~~l~~l~~~cl~~  377 (429)
                       .++.........++.                             ......+           ......+.+++.+||.+
T Consensus       409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~  488 (586)
T KOG0667|consen  409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW  488 (586)
T ss_pred             HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence             001111111111111                             0000011           12346789999999999


Q ss_pred             CCCCCCCHHHHHHh
Q 014189          378 NPKARPLMRDIVDS  391 (429)
Q Consensus       378 dP~~RPs~~evl~~  391 (429)
                      ||.+|+|..+.++|
T Consensus       489 dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  489 DPAERITPAQALNH  502 (586)
T ss_pred             CchhcCCHHHHhcC
Confidence            99999999999987

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.9e-42  Score=326.70  Aligned_cols=247  Identities=28%  Similarity=0.321  Sum_probs=196.9

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      +.||+|+||.||++....+   ...+..+|+|++.... .......+..|++++++++||||+++++++...+..|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITG---PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEecc---CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            6799999999999875322   1235569999987532 12233456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCc
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  276 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  276 (429)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......  
T Consensus        79 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          79 FLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            999999999886543  6899999999999999999999977  9999999999999999999999999988654321  


Q ss_pred             cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCC
Q 014189          277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  356 (429)
Q Consensus       277 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (429)
                      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........                ..+....  
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~----------------~~i~~~~--  214 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM----------------TMILKAK--  214 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH----------------HHHHcCC--
Confidence            1233467999999999999888999999999999999999999999865432110                0010000  


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHh
Q 014189          357 GDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  391 (429)
Q Consensus       357 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~  391 (429)
                      ...+...+..+.+|+.+||+.||++|||+     ++++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence            12233456788999999999999999994     556544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.2e-41  Score=312.86  Aligned_cols=255  Identities=24%  Similarity=0.303  Sum_probs=201.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|....+.      ..+|+|+..... ......+.+|+.++++++||||+++++++..++..
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~------~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTG------ELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCC------eEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            57899999999999999999875543      349999986542 22344677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++....  ++++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++....
T Consensus        82 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            99999999999999886543  6899999999999999999999977  9999999999999999999999999998653


Q ss_pred             CCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ....  ......|+..|+|||.+.   ...++.++|+|||||++|||++|+.||....+......  +         ...
T Consensus       158 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--~---------~~~  224 (267)
T cd06646         158 ATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--M---------SKS  224 (267)
T ss_pred             cccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--e---------ecC
Confidence            3211  122356889999999884   44578899999999999999999999865432211000  0         000


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      ....+..  ......+..+.+++.+||..+|++|||+++++++|
T Consensus       225 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         225 NFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0001111  01123467889999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6e-41  Score=328.24  Aligned_cols=267  Identities=23%  Similarity=0.315  Sum_probs=200.5

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC--
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  189 (429)
                      +|++.+.||+|+||.||+|.+..+.      ..||+|.+.... .......+.+|+.+++.++||||+++++++...+  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDG------KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCC------CEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            4778899999999999999865443      349999886532 2334467889999999999999999999998766  


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          190 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       190 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                         ..|+||||+. ++|.+.+....  .+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccc
Confidence               7899999996 57887775443  6899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh------
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP------  339 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~------  339 (429)
                      ++....... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+.............      
T Consensus       150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            986543221 122335689999999998874 579999999999999999999999987654332211110000      


Q ss_pred             HHHhhhhhhhhc-CCCC-C------CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          340 LLKEKKKLLNII-DPRL-E------GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       340 ~~~~~~~~~~~~-~~~~-~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...........+ .... .      .......+.++.+|+.+||+.||++|||+.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000000000000 0000 0      01122346778999999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=330.30  Aligned_cols=265  Identities=26%  Similarity=0.405  Sum_probs=226.1

Q ss_pred             ChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeee
Q 014189          103 TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLI  182 (429)
Q Consensus       103 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  182 (429)
                      .+++|+....+....++||.|.||.||.|+|+...-      .||||.++.+.  ....+|+.|..+|+.++|||+|+++
T Consensus       258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkysl------TvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL------TVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             CcchhhccchheeeeeccCCCcccceeeeeeeccce------eeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHh
Confidence            446777777788888999999999999999987644      39999998763  4678999999999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          183 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       183 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      |+|..+-.+|||.|||.+|+|.++|...++..++....+.++.||+.|++||...+  .|||||..+|+|+.++..|||+
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvA  407 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVA  407 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEee
Confidence            99999999999999999999999999888888888889999999999999999866  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      ||||++.+..+. ........-+..|.|||.+....++.|+|||+|||+|||+.| |-.||.+.+...            
T Consensus       408 DFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq------------  474 (1157)
T KOG4278|consen  408 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------  474 (1157)
T ss_pred             ccchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH------------
Confidence            999999875432 212222334678999999999999999999999999999998 777888765322            


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                           +..++....+-..+..|+..+.+|++.||+++|.+||++.|+.+.||.+
T Consensus       475 -----VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  475 -----VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             -----HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence                 1223333444455678899999999999999999999999999988775

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.9e-41  Score=310.72  Aligned_cols=253  Identities=27%  Similarity=0.367  Sum_probs=202.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|.+.+.||+|+||.||+|.+....       .+|+|.+....  .....|.+|+.+++.++|||++++++++. .+..
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-------~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-------KVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI   75 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-------eEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence            56888899999999999999765432       28999876543  23456889999999999999999999875 4567


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++|||+++|+|.+++.......+++..+..++.+++.||+|||+.+  ++|+||||+||++++++.++|+|||++....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            89999999999999997665556899999999999999999999977  9999999999999999999999999997653


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........   ..+    .      .. 
T Consensus       154 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----~------~~-  218 (260)
T cd05069         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ----V------ER-  218 (260)
T ss_pred             CCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----H------Hc-
Confidence            32211 1122346778999999998899999999999999999999 8999976443211   000    0      00 


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                         ......+...+..+.+++.+||..||++||+++++++.|+.
T Consensus       219 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 ---GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               01112233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-40  Score=307.84  Aligned_cols=248  Identities=28%  Similarity=0.439  Sum_probs=199.5

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      ++||+|+||.||+|...+.       ..+|+|.+...........|.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~~~-------~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDK-------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEecCC-------cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEEC
Confidence            3689999999999975432       248999987665555556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++|+|.+++.... ..+++..++.++.+++.+|.|+|.++  ++|+||||+||+++.++.+||+|||++........ .
T Consensus        74 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  149 (250)
T cd05085          74 VPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-S  149 (250)
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceecccccc-c
Confidence            99999999886543 35889999999999999999999977  99999999999999999999999999875432211 1


Q ss_pred             ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCC
Q 014189          278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  356 (429)
Q Consensus       278 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (429)
                      ......++..|+|||++.+..++.++||||||+++|++++ |..||..........       .      ..    ....
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-------~------~~----~~~~  212 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-------Q------VE----KGYR  212 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------H------HH----cCCC
Confidence            1112344678999999998899999999999999999998 999997654321100       0      00    0111


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          357 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       357 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      ...+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            1223345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.5e-41  Score=310.05  Aligned_cols=249  Identities=27%  Similarity=0.399  Sum_probs=201.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE-eCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC-EDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~  190 (429)
                      .+|++.+.||+|+||.||+|...        +..+++|......   ....|.+|+.++++++|+|++++++++. .++.
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--------~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--------CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            46888899999999999998654        2338999886542   3456889999999999999999999764 5567


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .+++|||+++|+|.+++.......+++..++.++.|++.||+|||+++  ++||||||+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceec
Confidence            899999999999999987765556899999999999999999999977  999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ....     ....++..|+|||++.+..++.++|||||||++|||++ |+.||.......   ....             
T Consensus       153 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~-------------  211 (256)
T cd05082         153 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR-------------  211 (256)
T ss_pred             cccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------
Confidence            3321     22345678999999998899999999999999999998 999987543211   1000             


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                       +........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       212 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         212 -VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence             000111122334567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.7e-41  Score=322.63  Aligned_cols=254  Identities=19%  Similarity=0.207  Sum_probs=199.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||++.+..+.      ..+|+|++....  .......+.+|+.++..++|+||+++++++.+.+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTE------RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            47899999999999999999876543      349999986521  2223445778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceee
Confidence            9999999999999999997642 36889999999999999999999977  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ...... .......||+.|+|||++.+     +.++.++|||||||++|||++|+.||...+....      .       
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~-------  217 (331)
T cd05624         152 MNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------Y-------  217 (331)
T ss_pred             ccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------H-------
Confidence            543221 11233579999999999875     5688999999999999999999999976543211      0       


Q ss_pred             hhhhhhcCCCCCCCC---ChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDY---PVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  391 (429)
                         ..+.........   ....+..+.+++.+||..++.+  |+++++++++
T Consensus       218 ---~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         218 ---GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ---HHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence               011110000011   1234678899999999876654  5689999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.5e-41  Score=314.61  Aligned_cols=254  Identities=26%  Similarity=0.322  Sum_probs=200.8

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      +++.|++.+.||+|+||.||+|.+....      ..+|+|......  .....+..|+.++.++ +||||+++++++...
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~------~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTG------QLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCC------cEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            4567888899999999999999876543      349999986543  2345677899999998 699999999998653


Q ss_pred             ------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 ------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                            ...+++|||+++|+|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||++++++.++|+
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEc
Confidence                  46899999999999999987655557899999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~  337 (429)
                      |||++........  ......|+..|+|||++.     ...++.++|||||||++|||++|..||...........    
T Consensus       154 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----  227 (272)
T cd06637         154 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----  227 (272)
T ss_pred             cCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----
Confidence            9999886533211  223467899999999986     34688899999999999999999999975443211100    


Q ss_pred             hhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                               ......   ........+..+.+|+.+||..+|.+|||+.+++++
T Consensus       228 ---------~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         228 ---------IPRNPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ---------HhcCCC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                     000000   111122345678999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.5e-40  Score=323.82  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=198.6

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ....+|++.+.||+|+||.||+|.+..++      ..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLG------INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCC------ceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            34578999999999999999999765543      449999986542 23345667899999999999999999999864


Q ss_pred             CC------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          188 DE------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       188 ~~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                      .+      ..|+||||+++ +|...+..    .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl  164 (359)
T cd07876          92 QKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  164 (359)
T ss_pred             CCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEE
Confidence            43      57999999975 56665532    4788889999999999999999987  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-H------
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-A------  334 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~------  334 (429)
                      +|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....... .      
T Consensus       165 ~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  241 (359)
T cd07876         165 LDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP  241 (359)
T ss_pred             ecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999999764322   122345789999999999999999999999999999999999999986653221000 0      


Q ss_pred             --HhHhhHHHhhhhhhhhc--CCCCC----------------CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 --DWALPLLKEKKKLLNII--DPRLE----------------GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 --~~~~~~~~~~~~~~~~~--~~~~~----------------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .+......   ......  .+...                .......+..+.+|+.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         242 SAEFMNRLQP---TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             cHHHHHHHHH---HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence              00000000   000000  00000                00111235678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-40  Score=309.26  Aligned_cols=254  Identities=27%  Similarity=0.414  Sum_probs=203.8

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      ++||+|++|.||+|.+...   ......+|+|.+...........+.+|+.++++++||||+++++.+.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS---GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecC---CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            4689999999999987553   122335899998876554566788899999999999999999999988 889999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++|+|.+++.......+++.....++.|++.||+|||..+  ++|+||||+||+++.++.+||+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999999987654346899999999999999999999977  9999999999999999999999999998765422211


Q ss_pred             -ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCC
Q 014189          278 -VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  355 (429)
Q Consensus       278 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (429)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |..||........   ...   .       ..   ...
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~---~-------~~---~~~  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKK---I-------DK---EGE  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---H-------Hh---cCC
Confidence             1123457889999999999899999999999999999999 9999975543211   000   0       00   001


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          356 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       356 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      ....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11122345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.2e-41  Score=312.33  Aligned_cols=261  Identities=23%  Similarity=0.320  Sum_probs=207.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|....+.+      .+++|.+....  .......+.+|+.+++.++||||+++++++..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~------~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGV------PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCc------eEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            467888999999999999998655433      48999775432  2334467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          190 HRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      ..+++|||+++++|.+++..  .....+++..+..++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhh
Confidence            99999999999999998863  22346899999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........    ....       ..
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~-------~~  220 (267)
T cd08229         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCK-------KI  220 (267)
T ss_pred             hccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HHhh-------hh
Confidence            76543221  12335789999999999988899999999999999999999999965432110    0000       01


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .....+   ...+...+..+.+++.+||..+|++|||+.+|++.++++.
T Consensus       221 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         221 EQCDYP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hcCCCC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            111111   1112245678999999999999999999999999987753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-41  Score=325.19  Aligned_cols=240  Identities=25%  Similarity=0.310  Sum_probs=189.7

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHH-HHhccCCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVI-FLGHLSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|.+..+.      ..+|+|++....  .......+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEE------KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence            46999999999999876543      349999986532  1122234444544 46788999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~  150 (325)
T cd05602          75 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  150 (325)
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence            99999999999886543  5788888899999999999999987  9999999999999999999999999987543221


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                        .......||+.|+|||++.+..++.++|||||||++|||++|..||...+....      ..          .+....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~----------~i~~~~  212 (325)
T cd05602         151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YD----------NILNKP  212 (325)
T ss_pred             --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HH----------HHHhCC
Confidence              123346799999999999999999999999999999999999999986543211      00          001010


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD  387 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e  387 (429)
                        ...+...+..+.+++.+||+.||.+||++.+
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         213 --LQLKPNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             --cCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence              1122345678899999999999999998874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.6e-41  Score=316.21  Aligned_cols=267  Identities=23%  Similarity=0.282  Sum_probs=196.3

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhcc---CCCceeeeeeEEEe-
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHL---SHPNLVKLIGYCCE-  187 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-  187 (429)
                      +|++.+.||+|+||.||+|.+..+.      ..||+|.+...... .....+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSG------HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCC------cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            4788899999999999999876553      34999988753221 1223345677766655   69999999998864 


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          188 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       188 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                          ....+++|||++ ++|.+++.......+++..+..++.|++.||.|||+.+  ++||||||+|||++.++.+||+|
T Consensus        75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECc
Confidence                346799999997 58888887655556899999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh-HHHhHhhHHH
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWALPLLK  342 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~-~~~~~~~~~~  342 (429)
                      ||++.......   ......||..|+|||++.+..++.++|||||||++|+|++|.+||.......... ..........
T Consensus       152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07863         152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  228 (288)
T ss_pred             cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence            99998654322   1233578999999999998899999999999999999999999997654332111 1110000000


Q ss_pred             hhhh-hh----hhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKK-LL----NIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~-~~----~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..+. ..    ..+.+...   .......+..+.+++.+||+.||++|||+.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000 00    00000000   01112346678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-41  Score=325.00  Aligned_cols=239  Identities=28%  Similarity=0.326  Sum_probs=189.7

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHH-HHhccCCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVI-FLGHLSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|....++      ..+|+|++....  .......+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDG------KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence            46999999999999866543      349999986532  1223345556655 46778999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          75 LDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            99999999998886543  6899999999999999999999977  9999999999999999999999999987543221


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||...+....      ..          .+....
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~----------~~~~~~  212 (325)
T cd05604         151 D--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YD----------NILHKP  212 (325)
T ss_pred             C--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HH----------HHHcCC
Confidence            1  22346799999999999999999999999999999999999999986543211      00          011111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR  386 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  386 (429)
                      +  ..+...+..+.+++.+||+.+|.+||+++
T Consensus       213 ~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         213 L--VLRPGASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             c--cCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence            0  11223567788999999999999999886

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.9e-41  Score=325.38  Aligned_cols=267  Identities=20%  Similarity=0.272  Sum_probs=199.3

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ...++|++.+.||+|+||.||+|.+....      ..+|+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLD------RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCC------ceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            34578999999999999999999765443      349999887543 23344567789999999999999999998864


Q ss_pred             C------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          188 D------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       188 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                      .      ...++||||+++ +|.+.+..    .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          88 QKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             cccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEE
Confidence            3      357999999975 66666532    4788889999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH-------
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-------  334 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~-------  334 (429)
                      +|||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+........       
T Consensus       161 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             eeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999998653321   223457899999999999999999999999999999999999999866532211100       


Q ss_pred             --HhH-------hhHHHhhhhhhhhcCC-----CC---CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 --DWA-------LPLLKEKKKLLNIIDP-----RL---EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 --~~~-------~~~~~~~~~~~~~~~~-----~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .+.       ...............+     ..   ........+..+.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence              000       0000000000000000     00   001112235678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.3e-41  Score=321.09  Aligned_cols=244  Identities=27%  Similarity=0.333  Sum_probs=191.7

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHH-HHhccCCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVI-FLGHLSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      ++||+|+||.||+|.+..+.      ..+|+|++....  .......+..|.. +++.++||||+++++++.+.+..++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDG------SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCC------CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence            46999999999999876553      349999986532  1222344555554 57888999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          75 LDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            99999999998886543  5888888999999999999999977  9999999999999999999999999987532221


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                        .......||+.|+|||++.+..++.++|||||||++|||++|..||...+....      .          ..+....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~----------~~i~~~~  212 (321)
T cd05603         151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------Y----------DNILHKP  212 (321)
T ss_pred             --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------H----------HHHhcCC
Confidence              123346799999999999998999999999999999999999999976542111      0          0111111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH----HHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR----DIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~----evl~~  391 (429)
                        ...+...+..+.+++.+||+.||.+||+..    +++++
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         213 --LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence              122334567789999999999999999764    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.8e-41  Score=322.78  Aligned_cols=254  Identities=19%  Similarity=0.203  Sum_probs=198.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||++.+....      ..+|+|++.+..  .......+.+|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNAD------KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCC------CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            36889999999999999999876553      349999986421  1223345778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchhee
Confidence            9999999999999999987532 35899999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ...... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+....      ..      
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~------  218 (332)
T cd05623         152 LMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YG------  218 (332)
T ss_pred             cccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HH------
Confidence            433221 1223357999999999986     34688999999999999999999999976543211      00      


Q ss_pred             hhhhhhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  391 (429)
                          .+.......   ......+..+.+|+.+||..++++  |+++++++++
T Consensus       219 ----~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         219 ----KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ----HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                111100000   111245678899999998765554  6899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.9e-40  Score=309.34  Aligned_cols=260  Identities=22%  Similarity=0.319  Sum_probs=208.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC--CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|....++      ..+|+|.+...  ........+.+|++++++++|+||+++++++...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDG------RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCC------CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            57899999999999999999876443      34899987642  22333567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          190 HRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      ..++||||+++|+|.+++...  ....+++.++..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEecccee
Confidence            999999999999999988542  2345899999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......    ..+...         
T Consensus       154 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~---------  218 (267)
T cd08224         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK---------  218 (267)
T ss_pred             eeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh---------
Confidence            76543221  123356889999999999888999999999999999999999998644311    111000         


Q ss_pred             hhhcCCCCCCCCCh-HHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          348 LNIIDPRLEGDYPV-KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       348 ~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                        .+........+. ..+..+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus       219 --~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         219 --KIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --hhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence              000011111222 45678899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.8e-40  Score=307.66  Aligned_cols=253  Identities=24%  Similarity=0.346  Sum_probs=206.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|+..+.||.|+||.||.+....+.      ..+++|.+.... .......+.+|+.++++++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDD------SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCC------cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            5888999999999999998765543      348999876442 344556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++|||+++|+|.+++.......+++..+..++.|++.+|+|||+.+  ++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            99999999999999997664556899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  ......|++.|+|||.+.+..++.++||||||+++|||++|..||........      ..          .+.
T Consensus       153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~----------~~~  214 (256)
T cd08221         153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VV----------KIV  214 (256)
T ss_pred             cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HH----------HHH
Confidence            4321  22345789999999999988899999999999999999999999975442211      00          000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      .... ...+...+.++.+++.+||..+|++|||++++++++
T Consensus       215 ~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         215 QGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            0111 111234567889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6e-41  Score=319.08  Aligned_cols=264  Identities=24%  Similarity=0.419  Sum_probs=207.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|+..+.||+|+||.||+|.+..+...  ....+|+|.+...........+.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGET--VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCc--ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            5678889999999999999987654332  12358999887665545556788999999999999999999998754 46


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccccccccc
Confidence            78999999999999887553 35889999999999999999999977  9999999999999999999999999998764


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..||........   ..+    ...       
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~----~~~-------  226 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDL----LEK-------  226 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHC-------
Confidence            3322222223456778999999998999999999999999999997 8999975432111   111    100       


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                         ......+..++..+.+++.+||..+|++||+++++++.|+.+...
T Consensus       227 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         227 ---GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               001111223456788999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=312.57  Aligned_cols=249  Identities=27%  Similarity=0.371  Sum_probs=205.1

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|++.+.||.|+||.||+|.+..+.      ..+++|.+...........+.+|+.+++.++|+||+++++++.++...+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTN------QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLW   75 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCC------eEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEE
Confidence            6788899999999999999876543      3499999876654555567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +|+||+++++|.+++...   ++++..+..++.|++.|+.|||+.+  ++|+||+|+||++++++.++|+|||+++....
T Consensus        76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            999999999999988654   6899999999999999999999977  99999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|+|+||..||...++....      .       .......
T Consensus       151 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~-------~~~~~~~  215 (274)
T cd06609         151 TMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------F-------LIPKNNP  215 (274)
T ss_pred             ccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------H-------HhhhcCC
Confidence            321  123357888999999999888999999999999999999999999765422110      0       0001111


Q ss_pred             CCCCCCCChH-HHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVK-GVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +.+    +.. .+..+.+++.+||..+|++|||+++++++
T Consensus       216 ~~~----~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         216 PSL----EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             CCC----cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            111    112 56678999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-40  Score=314.20  Aligned_cols=276  Identities=24%  Similarity=0.342  Sum_probs=206.4

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC--Ce
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--EH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  190 (429)
                      .|++.+.||+|+||.||++.....  ....+..||+|.+...........+.+|+.+++.++||||+++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPE--GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccC--CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            478889999999999999975421  12234569999987665555567788999999999999999999998765  56


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||+++..
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCcccccc
Confidence            899999999999999886543 35899999999999999999999977  999999999999999999999999999865


Q ss_pred             CCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++++.|.................... . .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~  237 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT-V-TRLVR  237 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccccc-H-HHHHH
Confidence            432211 11223557788999999998889999999999999999999887653221100000000000000 0 00000


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      ..........+..++..+.+|+.+||+.+|++|||++++++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0111111122334678899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-40  Score=335.74  Aligned_cols=268  Identities=21%  Similarity=0.294  Sum_probs=194.1

Q ss_pred             HHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC------CCcee
Q 014189          106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS------HPNLV  179 (429)
Q Consensus       106 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv  179 (429)
                      ++.....+|++.++||+|+||.||+|.+...      +..||||+++...  .....+..|+.++..++      |++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~------~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~  194 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKR------KEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLM  194 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCC------CeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCccee
Confidence            3344567899999999999999999987554      3449999986432  12233455666666654      45688


Q ss_pred             eeeeEEEeC-CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCC
Q 014189          180 KLIGYCCED-EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       180 ~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      ++++++... .+.++|||++ +++|.+++....  .+++..+..++.|++.||+|||+ .+  ||||||||+|||++.++
T Consensus       195 ~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        195 KIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSD  269 (467)
T ss_pred             eeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCC
Confidence            999988754 5788999988 678988886653  68999999999999999999997 46  99999999999998765


Q ss_pred             ----------------cEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 014189          258 ----------------NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS  321 (429)
Q Consensus       258 ----------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p  321 (429)
                                      .+||+|||++.....     .....+||+.|+|||++.+..|+.++|||||||++|||++|+.|
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence                            499999998764322     22346899999999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhHHHhHhhHHHhh-------hhhhhhcCC--CCCCC--------------C-ChHHHHHHHHHHHHhhcc
Q 014189          322 LDKSRPAREQNLADWALPLLKEK-------KKLLNIIDP--RLEGD--------------Y-PVKGVHKAAMLAYHCLNH  377 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~--~~~~~--------------~-~~~~~~~l~~l~~~cl~~  377 (429)
                      |...+..................       .....+++.  .+...              . .......+.+|+.+||+.
T Consensus       345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  424 (467)
T PTZ00284        345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY  424 (467)
T ss_pred             CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence            98765432222111110000000       000000000  00000              0 001235678999999999


Q ss_pred             CCCCCCCHHHHHHh
Q 014189          378 NPKARPLMRDIVDS  391 (429)
Q Consensus       378 dP~~RPs~~evl~~  391 (429)
                      ||++|||++|+++|
T Consensus       425 dP~~R~ta~e~L~H  438 (467)
T PTZ00284        425 DRQKRLNARQMTTH  438 (467)
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999987

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-40  Score=309.15  Aligned_cols=255  Identities=28%  Similarity=0.397  Sum_probs=204.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||.||+|.+...       ..+++|.+...  ......|.+|+.+++.++|+||+++++++.+ .
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~-------~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~   73 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKH-------TKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E   73 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCC-------ccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence            346789999999999999999975432       23899987654  2344678899999999999999999999887 7


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..+++|||+++|+|.+++.......+++..++.++.+++.||+|||+.+  ++|+||||+||+++.++.+||+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  151 (260)
T cd05073          74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARV  151 (260)
T ss_pred             CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceee
Confidence            7899999999999999997765556889999999999999999999977  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...... .......++..|+|||++....++.++|+||||+++|++++ |..||........   ..+    ..      
T Consensus       152 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~~------  217 (260)
T cd05073         152 IEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRA----LE------  217 (260)
T ss_pred             ccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----Hh------
Confidence            543221 11222345678999999998889999999999999999999 9999976543211   000    00      


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                          .......+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       218 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         218 ----RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                001111223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.1e-41  Score=310.79  Aligned_cols=255  Identities=29%  Similarity=0.472  Sum_probs=202.5

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhH-HHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      |++.+.||+|+||+||++....+.+      .+|+|++......... .....|+.++++++||||+++++++......+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~------~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQ------KVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTE------EEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCe------EEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccc
Confidence            6778999999999999998776644      4999999876533333 23456999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +||||+++++|.+++...  ..+++..+..++.|++.||++||+.+  ++|+||||+||++++++.++|+|||.+.....
T Consensus        75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~  150 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSE  150 (260)
T ss_dssp             EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred             cccccccccccccccccc--cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc
Confidence            999999999999999733  36899999999999999999999987  99999999999999999999999999875411


Q ss_pred             CCCccccccccCCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                        .........++..|+|||++. +..++.++||||||+++|+|++|..||.................   ..  .....
T Consensus       151 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~~--~~~~~  223 (260)
T PF00069_consen  151 --NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---RP--LPSSS  223 (260)
T ss_dssp             --TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---TH--HHHHT
T ss_pred             --cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---cc--ccccc
Confidence              122334567899999999998 88899999999999999999999999987632222111111100   00  00000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            .........+.+++.+||+.||++|||+.+++++
T Consensus       224 ------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 ------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             ------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  0001123789999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-40  Score=320.99  Aligned_cols=262  Identities=20%  Similarity=0.323  Sum_probs=193.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ...+|++.+.||+|+||.||+|......      ..||+|+.....       ...|+.++++++||||+++++++....
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~  130 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQP------DPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGA  130 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCC------ceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCC
Confidence            3457999999999999999999876543      348999754432       235899999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++|||++. |+|.+++.... ..+++..+..++.|++.||.|||..+  |+||||||+|||++.++.+||+|||+++.
T Consensus       131 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        131 ITCMVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             eeEEEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccc
Confidence            9999999995 68888876543 46899999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCC-CCCChhhhhhH---HHhHhhHHHh--
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL-DKSRPAREQNL---ADWALPLLKE--  343 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~-~~~~~~~~~~~---~~~~~~~~~~--  343 (429)
                      .....   ......||..|+|||++.+..++.++|||||||++|||+++..|+ ...........   ..........  
T Consensus       207 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~  283 (357)
T PHA03209        207 PVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK  283 (357)
T ss_pred             cccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence            32211   123457999999999999999999999999999999999866554 33221111000   0000000000  


Q ss_pred             --hhh---------hhhhcCC--CCCCCC-------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 --KKK---------LLNIIDP--RLEGDY-------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 --~~~---------~~~~~~~--~~~~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ...         ....++.  ......       ....+..+.+|+.+||+.||++|||+.|+++|
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence              000         0000000  000000       01234566779999999999999999999986

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=306.15  Aligned_cols=249  Identities=28%  Similarity=0.439  Sum_probs=200.2

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      ++||+|+||.||+|.+.+ .+.      |++|.............|.+|++++++++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~------v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTE------VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCc------EEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            469999999999998655 333      9999887665444567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++++|.+++.... ..+++..++.++.+++.+|+|||+++  ++||||||+||+++.++.++|+|||++..........
T Consensus        74 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          74 VPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            99999999986543 35889999999999999999999977  9999999999999999999999999988654221111


Q ss_pred             ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCC
Q 014189          278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  356 (429)
Q Consensus       278 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (429)
                      ......++..|+|||.+.+..++.++|+||||+++|||+| |..||...........                 +.....
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-----------------~~~~~~  213 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-----------------IESGYR  213 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-----------------HhcCCC
Confidence            1112334667999999998899999999999999999999 8888876543211100                 001111


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          357 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       357 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      ...+...+..+.+++.+||..+|++|||+.|+++.|+
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1223345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-40  Score=307.44  Aligned_cols=252  Identities=23%  Similarity=0.300  Sum_probs=203.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-CCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-DEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  190 (429)
                      +|++.+.||+|++|.||++.+..+.+      .+++|.+.... .......+.+|++++++++|+|++++++.+.. +..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGK------QYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCc------EEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            48889999999999999998765433      49999886542 33445567889999999999999999998764 446


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .+++|||+++++|.+++.......+++.++..++.+++.|++|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEe
Confidence            799999999999999997655556899999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ....  .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+....      ....          
T Consensus       153 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~----------  214 (257)
T cd08223         153 ENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRI----------  214 (257)
T ss_pred             cccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHH----------
Confidence            4322  122345789999999999999999999999999999999999999975442111      0000          


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .... ....+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       215 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         215 IEGK-LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HhcC-CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000 112233456789999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.2e-40  Score=314.13  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=203.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|....+..      .+++|.+..... .....+.+|+.+++.+.||||+++++.+......
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCc------EEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence            578999999999999999998655433      499998876533 2346678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++++|.+++...   .+++.++..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            9999999999999988543   5788999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+....     .. .         ..
T Consensus       168 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-----~~-~---------~~  230 (296)
T cd06654         168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YL-I---------AT  230 (296)
T ss_pred             cccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-----HH-H---------hc
Confidence            3221  123357899999999999888999999999999999999999999765432110     00 0         00


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ........+...+..+.+++.+||..+|++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0100111233456778899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.1e-40  Score=309.68  Aligned_cols=255  Identities=25%  Similarity=0.368  Sum_probs=192.6

Q ss_pred             eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEec
Q 014189          119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM  198 (429)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  198 (429)
                      .||+|+||.||+|.....    .....+++|.+...........|.+|+.+++.++||||+++++.+......++||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecC----CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            589999999999965432    2244588898765545555667889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC
Q 014189          199 ARGSVENNLFSKVL---LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  275 (429)
Q Consensus       199 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  275 (429)
                      ++|+|.+++.....   ...++.....++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++........
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchh
Confidence            99999999865432   23467788899999999999999977  99999999999999999999999999875433221


Q ss_pred             ccccccccCCccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          276 SHVSTRIMGTYGYAAPEYIMT-------GHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       276 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ........++..|+|||++..       ..++.++|||||||++|||++ |..||........  ..    .....  ..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~~~~--~~  227 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LK----QVVRE--QD  227 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HH----HHhhc--cC
Confidence            111223456778999998753       356889999999999999999 7888875542211  00    00000  00


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      .....+    ..+...+..+.+++..|+ .||++|||+++|++.|
T Consensus       228 ~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         228 IKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            011111    122345667778888888 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.8e-41  Score=332.40  Aligned_cols=264  Identities=21%  Similarity=0.244  Sum_probs=196.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ...|.+.+.||+|+||.||+|.+....      ..||+|....       ..+.+|+++|++++|+|||++++++...+.
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~------~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~  234 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYP------QRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGL  234 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCC------CEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            347999999999999999999876553      3489995332       234579999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++|||++. ++|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       235 ~~lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        235 TCLVLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             EEEEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence            999999995 68888876543 36999999999999999999999977  999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC-hhh----hhhHHHhHhhHHHhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR-PAR----EQNLADWALPLLKEKK  345 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~-~~~----~~~~~~~~~~~~~~~~  345 (429)
                      .............||..|+|||++.+..++.++|||||||++|||++|..|+.... ...    ...+...+........
T Consensus       311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~  390 (461)
T PHA03211        311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD  390 (461)
T ss_pred             ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence            43322222334679999999999999999999999999999999999887553221 100    0111111110000000


Q ss_pred             ------------hhh----hhcCCCCCC-CCC--hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 ------------KLL----NIIDPRLEG-DYP--VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ------------~~~----~~~~~~~~~-~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                  ...    ....+.... .+.  ......+.+|+.+||+.||.+|||+.|++++
T Consensus       391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                        000    000000000 000  1234578899999999999999999999987

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-40  Score=312.95  Aligned_cols=278  Identities=23%  Similarity=0.302  Sum_probs=204.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--CC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  189 (429)
                      .+|++.+.||+|+||.||+|.....  ....+..||+|.+... .......|.+|+++++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPL--QDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCC--cCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4688889999999999999975321  1122445999998654 34445678899999999999999999998753  34


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||..+  ++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            6899999999999999986543 35899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccc-cccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHV-STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......... .....++..|+|||++.+..++.++||||||+++|||++|..++................. ......+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG-QMIVYHLI  236 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc-ccchHHHH
Confidence            654322111 1112345569999999988999999999999999999998876543221100000000000 00000011


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      +..........+...+..+.+|+.+||..+|++|||+++|++.|+.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            111111112223455678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-41  Score=321.79  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=206.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEE-EecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK-~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  189 (429)
                      ..|+++++||+||.+.||++...+..      . +|+| +.......+....|.+|+..|.+|+ |.+||.+++|-..++
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~------i-yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQ------I-YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCc------c-hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            45899999999999999998654432      2 4544 4444556777888999999999996 999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+||||||- .-+|..+|.........| .++.+..|++.++.++|.++  |||.||||.|+|+- .|.+||+|||+|..
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANA  508 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence            999999986 458998887766544445 67889999999999999988  99999999999984 57899999999998


Q ss_pred             CCCCCCccccccccCCcccccccccccCC-----------CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGH-----------LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      .............+||+.||+||.+....           .+.++||||||||||+|+.|+.||.....           
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----------  577 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----------  577 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----------
Confidence            87766666667789999999999986322           56789999999999999999999974321           


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHH-HHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKG-VHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          ....+..+.+|...-+++.-- ..++.+++..||++||++|||..++|++
T Consensus       578 ----~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  578 ----QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ----HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                123456777776544554332 2339999999999999999999999987

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-40  Score=323.42  Aligned_cols=266  Identities=19%  Similarity=0.269  Sum_probs=198.8

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ..++|++.+.||+|+||.||+|.+....      ..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILE------RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCC------cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            4578999999999999999999865543      349999987542 233445677899999999999999999987543


Q ss_pred             ------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 ------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                            ...|+||||+++ +|.+.+..    .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus        96 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875          96 KSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             ccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEE
Confidence                  357999999975 67766642    4788889999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH--------
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA--------  334 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~--------  334 (429)
                      |||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+........        
T Consensus       169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (364)
T cd07875         169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  245 (364)
T ss_pred             eCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998653321   223457899999999999999999999999999999999999999876543211100        


Q ss_pred             -HhHh-------hHHHhhhhh-----hhhcCCCC---CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 -DWAL-------PLLKEKKKL-----LNIIDPRL---EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 -~~~~-------~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       .+..       .........     ........   ...........+.+|+.+||+.||++|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             0000       000000000     00000000   000111234578999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.5e-40  Score=310.16  Aligned_cols=262  Identities=25%  Similarity=0.358  Sum_probs=208.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|+..+.||+|+||.||+|+...... ......+++|.............+.+|++++++++||||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEE-EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCc-CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            578888999999999999998765432 2334568999887654433556788999999999999999999999988999


Q ss_pred             EEEEEecCCCChhhhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          192 VLIYEFMARGSVENNLFSKVL-------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                      ++||||+++|+|.+++.....       ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++++||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999875441       25899999999999999999999987  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      |++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...        
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~--------  229 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN--------  229 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH--------
Confidence            99875432211 11223456788999999988889999999999999999999 788886543211   100        


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                           ...........+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus       230 -----~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         230 -----RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -----HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                 001111111223345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-40  Score=312.97  Aligned_cols=268  Identities=25%  Similarity=0.319  Sum_probs=208.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||+||+|.+..++      ..+|+|+............+.+|+++++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTG------TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI   78 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCC------cEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence            46778899999999999999876543      348999877654455567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      ++||||+++|+|.+++...  ..+++..+..++.+++.+|.|||+ ++  ++|+||||+||+++.++.++|+|||++...
T Consensus        79 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            9999999999999887654  368999999999999999999996 46  999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ....    .....|+..|+|||++.+..++.++|+|||||++|+|++|..||............  ......   ....+
T Consensus       155 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~--~~~~~~---~~~~~  225 (284)
T cd06620         155 INSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD--PMGILD---LLQQI  225 (284)
T ss_pred             hhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh--hhHHHH---HHHHH
Confidence            3221    22357899999999998889999999999999999999999999865432110000  000000   00111


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      .............+..+.+|+.+||+.||++|||+.|++++..-++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            111100111123567899999999999999999999999986554443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-40  Score=309.66  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=206.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ..|+..+.||.|+||.||+|.+..+.      ..+|+|.+...........+.+|+.+++.+.||||+++++++.++...
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQ------QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCC------EEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            35677789999999999999876543      349999987655555667888999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++...   ++++.....++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          78 WIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            9999999999999988643   5888999999999999999999977  9999999999999999999999999997654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  ......++..|+|||++.+..++.++|+||||+++|||++|..||....+....                 ...
T Consensus       153 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~~~  213 (277)
T cd06640         153 DTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----------------FLI  213 (277)
T ss_pred             CCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----------------hhh
Confidence            3221  123356888999999999888999999999999999999999999765432110                 000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ............+..+.+++.+||+.+|++||++++++.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1111122334567889999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.7e-40  Score=315.71  Aligned_cols=268  Identities=21%  Similarity=0.269  Sum_probs=201.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|.+.+.||+|+||.||+|.+..+.      ..||+|.+...........+.+|+.+++.++||||+++++++..++..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTD------NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCC------cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            46889999999999999999765543      349999987554333445677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+||++++++.+||+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            99999997 58888886543 35889999999999999999999977  9999999999999999999999999987643


Q ss_pred             CCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh-HHHhhh----
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-LLKEKK----  345 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~----  345 (429)
                      ....  ......+++.|+|||.+.+ ..++.++|||||||++|||++|++||...+............. .....+    
T Consensus       156 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         156 IPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            3221  1223467899999999875 4578999999999999999999999986654322111000000 000000    


Q ss_pred             ---hhhhhcCCCCCC----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 ---KLLNIIDPRLEG----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ---~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         .......+....    ......+..+.+|+.+||+.||.+|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               000000000000    0112346678999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=320.35  Aligned_cols=257  Identities=19%  Similarity=0.208  Sum_probs=198.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||++.+..+.      ..||+|++....  .......+.+|+.++..++|+||+++++++.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTG------QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCC------CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            46899999999999999999876553      349999986421  2233455788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceee
Confidence            9999999999999999986532 35889999999999999999999977  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ...... .......||+.|+|||++..     ..++.++|||||||++|||++|+.||........      ........
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~  224 (331)
T cd05597         152 LLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK  224 (331)
T ss_pred             cCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCC
Confidence            543221 11223569999999999863     4578899999999999999999999976543211      00000000


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  391 (429)
                          ...  .+ .......+..+.+++.+||..++++  ||++++++++
T Consensus       225 ----~~~--~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         225 ----EHF--QF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ----Ccc--cC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                000  00 0111235677888999988654443  7899999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-42  Score=335.80  Aligned_cols=261  Identities=26%  Similarity=0.408  Sum_probs=222.6

Q ss_pred             ccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEE
Q 014189          115 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +..++||+|+||+||+|.+.-..  ..-+.+||+|++..........+++.|..+|.++.|||+++++++|.... +-||
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Peg--e~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEG--ENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCC--ceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            33589999999999999887653  23366799999988877777889999999999999999999999998766 7889


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      ++||+.|+|.++++.+. ..+..+..+.|..|||+||.|||.+.  +|||||..+|||+.+-..+||+|||+++......
T Consensus       776 tq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999999997754 36888899999999999999999866  9999999999999999999999999999887766


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  353 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (429)
                      .........-.+.|||-|.++...|+.++|||||||++||++| |..|+++....+                 +..++..
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----------------I~dlle~  915 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----------------IPDLLEK  915 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----------------hhHHHhc
Confidence            5554444455778999999999999999999999999999999 999998765322                 2233333


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          354 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       354 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      ..+...|+.++.++..++.+||-.|+..||+++++...+.++...
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            344567888999999999999999999999999999988776554

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.3e-40  Score=308.00  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=196.6

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE-eCCeEEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC-EDEHRVLIYE  196 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e  196 (429)
                      +.||+|+||.||+|.+.+..   .....+|+|.+...........+.+|+.+++.++||||+++++++. .++..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD---GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCC---CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            36899999999999865422   2245599998865444455677889999999999999999999775 4556889999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCc
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  276 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  276 (429)
                      |+.+|+|.+++..... .+++.....++.|++.||+|||..+  ++||||||+|||++.++.+||+|||+++........
T Consensus        78 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999999999865432 4677788899999999999999977  999999999999999999999999998764332110


Q ss_pred             --cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCC
Q 014189          277 --HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG-RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  353 (429)
Q Consensus       277 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (429)
                        .......++..|+|||.+.+..++.++||||||+++|||++| .+||.......   .....          ...   
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~----------~~~---  218 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL----------LQG---  218 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----------hcC---
Confidence              111234567789999999888999999999999999999995 55665443211   11000          000   


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          354 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       354 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                       .....+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus       219 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         219 -RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             011112234567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.7e-40  Score=307.21  Aligned_cols=259  Identities=26%  Similarity=0.357  Sum_probs=208.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||.|+||+||+|....+.      ..+++|++...........+.+|+.+++.++|+||+++++.+...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNN------EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCC------cEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence            46889999999999999999865543      348999987655444667788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +++||++++++|.+++..... ..+++..+..++.|++.||+|||+.+  ++|+||+|+||++++++.++|+|||++...
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999999999876433 46899999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCc--cccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          271 PEGDKS--HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       271 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ......  .......|+..|+|||++... .++.++|+||||+++|+|++|+.||........  ....           
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~-----------  219 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLT-----------  219 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHH-----------
Confidence            543222  122335689999999998876 789999999999999999999999976543211  1000           


Q ss_pred             hhhcCCCCCCCC-ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....+.+.... ....+..+.+++.+||..||++|||+++++.+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         220 LQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             hcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000111111111 12456788999999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.4e-40  Score=309.53  Aligned_cols=261  Identities=25%  Similarity=0.357  Sum_probs=207.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|.+.+.||+|+||.||+|.+.+..   .....+++|...........+.+.+|+.+++.++||||+++++++.. ...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPE---NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCC---CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            45888899999999999999865431   12345899988766545566788999999999999999999998875 456


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++.... ..+++..+..++.+++.||+|||+.+  ++|+||||+||+++.++.+||+|||+++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeecc
Confidence            89999999999999986543 25899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..........   .    +.      +.
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~---~----~~------~~  224 (270)
T cd05056         159 DESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG---R----IE------NG  224 (270)
T ss_pred             cccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---H----HH------cC
Confidence            4321 11222345678999999988889999999999999999986 999997654321110   0    00      00


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                          .....+..++..+.+++.+|+..+|++|||+.++++.|+.+..
T Consensus       225 ----~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         225 ----ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ----CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                0111233556789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.9e-40  Score=344.73  Aligned_cols=263  Identities=22%  Similarity=0.288  Sum_probs=204.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.++||+|+||.||+|.+..+++      .||+|++....  .......|.+|+.++++++||||+++++++.+.+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~------~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSR------RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCc------EEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            478999999999999999998765533      49999987542  2334567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEE
Q 014189          190 HRVLIYEFMARGSVENNLFSKV---------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  260 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  260 (429)
                      ..+++|||++||+|.+++....         ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+|
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEE
Confidence            9999999999999999886421         123567788899999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCC----------------ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 014189          261 LSDFGLAKDGPEGDK----------------SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK  324 (429)
Q Consensus       261 l~Dfgla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~  324 (429)
                      |+|||+++.......                ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999986521110                0011235799999999999999999999999999999999999999976


Q ss_pred             CChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-CHHHHHHhcccccC
Q 014189          325 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-LMRDIVDSLEPLQV  397 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~  397 (429)
                      ....... .          .   ....++... ......+..+.+++.+||+.||++|| +++++++.|+....
T Consensus       234 ~~~~ki~-~----------~---~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        234 KKGRKIS-Y----------R---DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             cchhhhh-h----------h---hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            4321100 0          0   000111000 00124456788999999999999996 67777777766533

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=314.95  Aligned_cols=256  Identities=25%  Similarity=0.282  Sum_probs=206.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh--hhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|+..+.||+|+||.||+|....+.      ..+|+|.+......  .....+..|+++++.++||||+++++.+...+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTG------KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCC------cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            36888999999999999999876543      34999998765332  24566889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            9999999999999999987665567999999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 014189          270 GPEGDKS---------------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL  322 (429)
Q Consensus       270 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~  322 (429)
                      .......                           .......||..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4321110                           0112346899999999999888999999999999999999999999


Q ss_pred             CCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC----HHHHHHh
Q 014189          323 DKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL----MRDIVDS  391 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~~  391 (429)
                      ...+....                ..++.............+..+.+++.+||..||++|||    +++++.+
T Consensus       233 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         233 KGSNRDET----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCchHHH----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            76543211                11111111111111225788999999999999999999    8888875

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2e-40  Score=311.91  Aligned_cols=277  Identities=25%  Similarity=0.300  Sum_probs=209.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--CC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  189 (429)
                      .+|++.+.||+|+||.||+|.+....  ...+..+|+|.+...........|.+|+.+++.+.||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLG--DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCC--CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            45777899999999999999865431  223456999998866444456788999999999999999999999876  56


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..+++|||+++++|.+++..... .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            78999999999999999876533 5899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCcc-ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+.................  .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~  236 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ--MIVTRLL  236 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc--ccHHHHH
Confidence            65322211 11123456679999999988999999999999999999999999865332110000000000  0000011


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      ..+........+..++.++.+++.+||+.+|++|||+.||++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111112222334567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-40  Score=313.00  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=202.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      .|+..+.||+|+||.||+|.+..+.      ..||+|.+...........+.+|+.++++++||||+++++++..+...+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTK------EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW   78 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCC------eEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceE
Confidence            3556678999999999999875543      3499999876544455567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +||||+++++|.+++...   .+++..+..++.+++.|+.|||..+  ++|+||+|+||++++++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          79 IIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccC
Confidence            999999999999887542   5889999999999999999999977  99999999999999999999999999876543


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      ...  ......|+..|+|||++.+..++.++|+||||+++|||++|+.||....+....                 ..+.
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~~~~  214 (277)
T cd06642         154 TQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-----------------FLIP  214 (277)
T ss_pred             cch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-----------------hhhh
Confidence            221  122356889999999999989999999999999999999999998754321110                 0011


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...........+..+.+++.+||+.+|++|||+.+++.+
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         215 KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            111112223456778999999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.1e-40  Score=308.79  Aligned_cols=252  Identities=27%  Similarity=0.385  Sum_probs=200.3

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  193 (429)
                      |++.+.||+|+||.||+|.+..+.      ..+++|.+... .......+.+|+++++.++||||+++++++..++..++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~------~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~   79 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETG------VLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   79 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCC------eEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence            566788999999999999765543      34888888654 34456678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCC
Q 014189          194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  273 (429)
Q Consensus       194 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  273 (429)
                      ||||+++|+|..++.... .++++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||++......
T Consensus        80 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          80 LIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            999999999988776532 36899999999999999999999977  999999999999999999999999998765332


Q ss_pred             CCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          274 DKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       274 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .  .......|+..|+|||++.     +..++.++|||||||++|||++|.+||........  ...    .       .
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~----~-------~  221 (282)
T cd06643         157 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK----I-------A  221 (282)
T ss_pred             c--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH----H-------h
Confidence            1  1123357899999999984     44578899999999999999999999976543211  000    0       0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      ....+.  ...+...+..+.+++.+||+.+|++|||+.+++++-
T Consensus       222 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         222 KSEPPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             hcCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            000111  112234567899999999999999999999999773

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.8e-40  Score=304.18  Aligned_cols=257  Identities=30%  Similarity=0.468  Sum_probs=205.9

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  193 (429)
                      +++.+.||.|+||.||+|.+.....  .....+|+|.............+..|+.++..++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG--EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC--CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            3567899999999999998765431  22355999999776554466788899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCC
Q 014189          194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  273 (429)
Q Consensus       194 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  273 (429)
                      +|||+++++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999987654333899999999999999999999977  999999999999999999999999999876543


Q ss_pred             CCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       274 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      .... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........   ....              .
T Consensus       157 ~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~--------------~  218 (258)
T smart00219      157 DYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYL--------------K  218 (258)
T ss_pred             cccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH--------------h
Confidence            2211 112347789999999988889999999999999999998 7888875432111   0000              0


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      .......+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      219 KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0001112233567899999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=346.70  Aligned_cols=258  Identities=22%  Similarity=0.303  Sum_probs=201.1

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      .....+|.+.+.||+|+||.||+|.+....      ..+|+|++.... .......|..|+.+++.++|||||+++++|.
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg------~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~   82 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQ------EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL   82 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCC------eEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            345578999999999999999999876543      448999886542 3344567889999999999999999999885


Q ss_pred             e--CCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeCCCCCCcEEEcCC-
Q 014189          187 E--DEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAE-----KPVIYRDFKTSNILLDTD-  256 (429)
Q Consensus       187 ~--~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~ivH~Dlkp~NIll~~~-  256 (429)
                      .  ...+||||||+++|+|.++|...  ....+++..++.|+.||+.||+|||..+     ++||||||||+||||+.+ 
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            4  45789999999999999988643  2246999999999999999999999854     459999999999999643 


Q ss_pred             ----------------CcEEEeccCCCcCCCCCCCccccccccCCccccccccccc--CCCCcccchhhHHHHHHHHHhC
Q 014189          257 ----------------YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTG  318 (429)
Q Consensus       257 ----------------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltG  318 (429)
                                      +.+||+|||++.......   ......||+.|+|||++.+  ..++.++|||||||+||||++|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                            348999999998654322   2234579999999999864  4589999999999999999999


Q ss_pred             CCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          319 RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       319 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..||........     ... .+.      ..  +.+.   ....+..+.+|+..||..+|.+|||+.+++.+
T Consensus       240 k~PF~~~~~~~q-----li~-~lk------~~--p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        240 KTPFHKANNFSQ-----LIS-ELK------RG--PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCCCCcCCcHHH-----HHH-HHh------cC--CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            999975442211     100 000      00  1110   11245778999999999999999999999854

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-39  Score=304.84  Aligned_cols=256  Identities=21%  Similarity=0.325  Sum_probs=192.5

Q ss_pred             eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEec
Q 014189          119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM  198 (429)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  198 (429)
                      .||+|+||.||+|.......    ...+++|.............|.+|+.+++.++||||+++++.+......++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTG----VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCC----cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            59999999999996543321    23467787766555556678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCc
Q 014189          199 ARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  276 (429)
Q Consensus       199 ~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  276 (429)
                      ++|+|.+++....  ....++.....++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||++.........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            9999999987542  234667778899999999999999977  999999999999999999999999998643222111


Q ss_pred             cccccccCCccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          277 HVSTRIMGTYGYAAPEYIMT-------GHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       277 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .......++..|+|||++..       ..++.++||||||+++|||++ |..||........      .......  ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~--~~~  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVIKD--QQV  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhh--ccc
Confidence            12234578899999998753       245789999999999999997 5668865443211      1111111  111


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      ...++.+    ....+..+.+++..|| .+|++||++++|++.|.
T Consensus       228 ~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1222222    2234567888999999 67999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.8e-40  Score=310.76  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=204.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||.|+||.||+|....++      ..|++|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~------~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATG------QEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCC------cEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            46899999999999999999765543      349999886543 23346678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++|+||+++++|..++...   .+++.++..++.+++.|++|||+.+  ++|+||||+||+++.++.+||+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            9999999999999988543   5899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......       .      ..  
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-------~------~~--  229 (296)
T cd06655         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------I------AT--  229 (296)
T ss_pred             cccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------H------Hh--
Confidence            3221  12335789999999999988899999999999999999999999987654221110       0      00  


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ........+...+..+.+++.+||..||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            0000111233456778899999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.2e-40  Score=309.50  Aligned_cols=268  Identities=22%  Similarity=0.243  Sum_probs=199.4

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|++.+.||+|+||.||+|.+..+.      ..||+|.+..... ......+.+|+.+++.++||||+++++++..++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTG------QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCC------cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            4788899999999999999876543      3499998865422 22335677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      ++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++...
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            99999997 68888876433 246899999999999999999999977  999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh-HHHhHhhH-------H
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWALPL-------L  341 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~-~~~~~~~~-------~  341 (429)
                      ....  .......+++.|+|||.+.+ ..++.++||||||+++|+|+||++||.......... ........       .
T Consensus       152 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         152 GIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             CCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence            3321  12233467899999998875 457899999999999999999999998654321110 00000000       0


Q ss_pred             HhhhhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          342 KEKKKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .........++....   .......+.++.+++.+||..||++|||+++++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000000000000   00112356788899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-40  Score=309.06  Aligned_cols=247  Identities=25%  Similarity=0.380  Sum_probs=193.9

Q ss_pred             eeecCCCcEEEEEEEEcccccc-CcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      +.||+|+||.||+|........ ......+++|..... .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            3699999999999987544322 234455888887543 23344578889999999999999999999999899999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc--------EEEeccCCCc
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN--------AKLSDFGLAK  268 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfgla~  268 (429)
                      |+++|+|.+++..... .+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.        ++++|||++.
T Consensus        80 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999999876543 5899999999999999999999977  999999999999987765        6999999887


Q ss_pred             CCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCC-CCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR-KSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ....      .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...........       ...   
T Consensus       157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~---  220 (258)
T cd05078         157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YED---  220 (258)
T ss_pred             ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHc---
Confidence            5432      123467889999999986 45899999999999999999995 56554332211100       000   


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                               ....+.....++.+++.+||+.||++|||++++++.|+
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ---------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     01122234467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-39  Score=308.66  Aligned_cols=253  Identities=26%  Similarity=0.369  Sum_probs=201.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +.|++.+.||.|+||.||+|.+..+..      .+++|..... .......+.+|+.+++.++||||+++++++..++..
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~------~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGA------LAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL   84 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCc------eEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence            568899999999999999997765433      4899998754 344566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++++|..++.... ..+++..+..++.|++.+|+|||.++  ++||||||+||+++.++.+||+|||++....
T Consensus        85 ~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          85 WIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             EEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999999999988775443 36899999999999999999999977  9999999999999999999999999987543


Q ss_pred             CCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ...  .......++..|+|||++.     ...++.++|||||||++|||++|..||........  .    ..       
T Consensus       162 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~-------  226 (292)
T cd06644         162 KTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L----LK-------  226 (292)
T ss_pred             ccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--H----HH-------
Confidence            221  1123356889999999985     34578899999999999999999999976543211  0    00       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ......+.  ...+...+.++.+++.+||..+|++||++++++++
T Consensus       227 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         227 IAKSEPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             HhcCCCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00000111  11123456678999999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.1e-40  Score=316.75  Aligned_cols=266  Identities=18%  Similarity=0.211  Sum_probs=196.3

Q ss_pred             cceeecCC--CcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          116 QDRVLGGG--GFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       116 ~~~~lG~G--~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +.++||+|  +|++||++....+++      .||+|.+..... ......+.+|+.+++.++||||+++++++..++..+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGE------YVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCc------EEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            45789999  789999998766544      499999876533 333455667999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++++||+.+.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999999999987654456899999999999999999999977  99999999999999999999999986543321


Q ss_pred             CCC-c----cccccccCCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH---
Q 014189          273 GDK-S----HVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK---  342 (429)
Q Consensus       273 ~~~-~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~---  342 (429)
                      ... .    .......++..|+|||++.+  ..++.++|||||||++|||++|+.||........  ..........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  231 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLL  231 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccc
Confidence            110 0    01112356788999999976  4689999999999999999999999975432111  0000000000   


Q ss_pred             h-----hhhh-----hhhcCC-----------------CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 E-----KKKL-----LNIIDP-----------------RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~-----~~~~-----~~~~~~-----------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +     ....     ....+.                 ..........+..+.+|+.+||+.||++|||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0     0000     000000                 00001112345688999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.9e-40  Score=303.55  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=204.3

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|+..+.||+|+||.||+|....+      +..+|+|.+.... .......+.+|+.+++.++||||+++++.+..++..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKAD------QKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCC------CcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            578889999999999999987654      3449999886542 334556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-CcEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~  270 (429)
                      ++||||+++++|.+++.......+++..+..++.+++.+|+|||+++  ++|+||+|+||+++++ +.+||+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999999999999997765556899999999999999999999977  9999999999999865 45899999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .....   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+....      ...          .
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~----------~  213 (256)
T cd08220         153 SSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLK----------I  213 (256)
T ss_pred             CCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHH----------H
Confidence            43221   2235688999999999988899999999999999999999999976543211      000          0


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .. ......+...+..+.+++.+||..+|++|||++|++.+
T Consensus       214 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         214 MS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             Hh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            00 00111233456788999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.6e-40  Score=304.93  Aligned_cols=247  Identities=24%  Similarity=0.374  Sum_probs=191.5

Q ss_pred             eeecCCCcEEEEEEEEccccc------cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          118 RVLGGGGFGCVYKGFISEDLR------EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +.||+|+||.||+|++.....      .......|++|.+.... ......|.+|+.+++.++||||+++++++..+...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            368999999999998643221      11234458889876543 33445678899999999999999999999998899


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc-------EEEecc
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-------AKLSDF  264 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~-------~kl~Df  264 (429)
                      ++||||+++|+|..++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            99999999999988876543 35899999999999999999999977  999999999999987664       899999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEIL-TGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      |++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..||...........         
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---------  221 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---------  221 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---------
Confidence            998754321      2245788999999887 567899999999999999998 58888865432111000         


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                           .   .....  ........+.+|+.+||+.||++||++.+|+..|+
T Consensus       222 -----~---~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 -----Y---EGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -----H---hcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                 0   00000  11123457889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.5e-40  Score=304.21  Aligned_cols=251  Identities=27%  Similarity=0.391  Sum_probs=204.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..+++|.+....   ....+.+|++++++++||||+++++++......
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~------~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   73 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETG------QVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDL   73 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCC------cEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence            57888999999999999999876543      348999886542   256788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++++||+++++|.+++.... ..+++..+..++.|++.||.|||..+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        74 ~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             EEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            99999999999999886543 46899999999999999999999977  9999999999999999999999999988765


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...........             .....
T Consensus       151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~  215 (256)
T cd06612         151 DTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------IPNKP  215 (256)
T ss_pred             cCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------hccCC
Confidence            4321  12335688999999999988999999999999999999999999986543211100             00000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+  ....+...+..+.+++.+||+.||++|||+.+++.+
T Consensus       216 ~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         216 PP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            00  111123455788999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.5e-40  Score=307.76  Aligned_cols=254  Identities=24%  Similarity=0.330  Sum_probs=200.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|.+.+.||+|+||.||+|.+..+.      ..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~   81 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTG------ELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL   81 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCC------cEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence            46777889999999999999776543      349999887553 23345677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++++|.+++....  .+++.++..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             EEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            99999999999999886543  6899999999999999999999987  9999999999999999999999999987553


Q ss_pred             CCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...  .......|+..|+|||++.   ...++.++|+|||||++|+|++|..||....+......       ..    ..
T Consensus       158 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-------~~----~~  224 (267)
T cd06645         158 ATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MT----KS  224 (267)
T ss_pred             Ccc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-------hh----cc
Confidence            221  1123457899999999874   45688999999999999999999999865443211000       00    00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....+...  .....+..+.+++.+||..+|++|||+++++++
T Consensus       225 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         225 NFQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00111110  011245678899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-40  Score=310.03  Aligned_cols=253  Identities=27%  Similarity=0.387  Sum_probs=202.2

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|++.+.||+|+||.||+|.+....      ..+|+|.+...........+.+|+.++++++||||+++++++...+..+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTG------VTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY   75 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCC------cEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence            6788899999999999999876443      3499998876544455577889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          193 LIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +||||+++++|..++.... ...+++..+..++.+++.||.|||. .+  ++|+||||+||+++.++.+||+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9999999999988876531 2368999999999999999999996 36  999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCcccccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTG------HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ....    .....|+..|+|||.+.+.      .++.++|+|||||++|+|++|..||..........            
T Consensus       154 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~------------  217 (286)
T cd06622         154 VASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA------------  217 (286)
T ss_pred             cCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH------------
Confidence            3221    2234688899999998644      35889999999999999999999997543211100            


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       .+..+.+. .....+...+.++.+++.+||+.+|++||++++++.+
T Consensus       218 -~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         218 -QLSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -HHHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence             01111111 1122334567888999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.1e-40  Score=304.13  Aligned_cols=251  Identities=25%  Similarity=0.440  Sum_probs=200.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|.+..+       ..+|+|.+.....  ....|.+|++++++++|||++++++++......
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~-------~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEK-------RKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPI   74 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCC-------CeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence            4688889999999999999976432       2389998765422  335688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++.... ..+++..+..++.+++.+++|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          75 CLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            99999999999999886543 35889999999999999999999977  9999999999999999999999999987653


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .... .......++..|+|||.+.+..++.++||||||+++|||++ |..||........   ..       .   +.. 
T Consensus       152 ~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~-------~---~~~-  216 (256)
T cd05112         152 DDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---VE-------T---INA-  216 (256)
T ss_pred             cCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---HH-------H---HhC-
Confidence            3211 11122345678999999998899999999999999999998 9999975442210   00       0   000 


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                         ......+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus       217 ---~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         217 ---GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence               001111222457899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=302.83  Aligned_cols=255  Identities=25%  Similarity=0.318  Sum_probs=204.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..+++|++...... ....+.+|+.++++++||||+++++++......
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   75 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATG------ELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL   75 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCC------CEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEE
Confidence            57889999999999999999875543      34899998765332 556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++|||+++++|.+++.... ..+++..+..++.|++.||+|||.++  ++|+||+|+||+++.++.+||+|||++....
T Consensus        76 ~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          76 WIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             EEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhh
Confidence            99999999999999886542 36899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTG---HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...  .......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||............      .     ..
T Consensus       153 ~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~------~-----~~  219 (262)
T cd06613         153 ATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI------S-----KS  219 (262)
T ss_pred             hhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-----hc
Confidence            321  112335788899999999776   8899999999999999999999999765532211000      0     00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ......  .......+..+.+++.+||..+|.+|||+++|+.+
T Consensus       220 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         220 NFPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cCCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000011  11123456789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.6e-40  Score=308.98  Aligned_cols=258  Identities=28%  Similarity=0.325  Sum_probs=202.4

Q ss_pred             HHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeE
Q 014189          106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGY  184 (429)
Q Consensus       106 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  184 (429)
                      ++....+.|++.+.||+|+||.||+|.+....      ..+|+|+.....  .....+..|+.++.++ +||||++++++
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~   81 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTG------QLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGA   81 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcCCC------cEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence            33445678999999999999999999876543      349999886542  3345677899999988 69999999999


Q ss_pred             EEe------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc
Q 014189          185 CCE------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN  258 (429)
Q Consensus       185 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~  258 (429)
                      +..      ....+++|||+++|+|.+++.......+++..+..++.|++.||.|||+.+  ++|+||+|+||++++++.
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~  159 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCC
Confidence            853      467899999999999999887655556888989999999999999999977  999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH
Q 014189          259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL  333 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~  333 (429)
                      ++|+|||++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|..||....+......
T Consensus       160 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~  237 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL  237 (282)
T ss_pred             EEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence            99999999876532211  123356899999999886     34688899999999999999999999975443211100


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                   ......   ........+..+.+++.+||..||.+|||+.|++++
T Consensus       238 -------------~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         238 -------------IPRNPP---PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -------------HhhCCC---CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                         000001   111122456789999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-40  Score=320.48  Aligned_cols=266  Identities=21%  Similarity=0.308  Sum_probs=197.2

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .+.++|++.+.||+|+||.||+|.+..+.      ..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLR------QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCC------CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence            45678999999999999999999865543      349999987542 22334567789999999999999999998753


Q ss_pred             C------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          188 D------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       188 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                      .      ...|+++|++ +++|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl  159 (343)
T cd07878          86 ATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRI  159 (343)
T ss_pred             cccccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEE
Confidence            3      4568999988 67888776432   5899999999999999999999987  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-HHhHh-
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWAL-  338 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~~~~~-  338 (429)
                      +|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....... ..... 
T Consensus       160 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07878         160 LDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT  234 (343)
T ss_pred             cCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999999865432     233578999999999876 5789999999999999999999999976543221100 00000 


Q ss_pred             ---hHHHh--hhhhhhhcC--CCCCCC----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          339 ---PLLKE--KKKLLNIID--PRLEGD----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       339 ---~~~~~--~~~~~~~~~--~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         .....  .........  +.....    ........+.+|+.+||..||++|||+.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00000  000000000  000000    001123457899999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.9e-40  Score=304.95  Aligned_cols=252  Identities=23%  Similarity=0.383  Sum_probs=201.5

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh--------hhHHHHHHHHHHHhccCCCceeeeeeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--------QGHREWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      +|.+...||+|+||.||+|.+..+.      ..+|+|.+......        .....+.+|+.++++++||||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSG------ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS   74 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCC------cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            4677889999999999999865443      34899987654221        123457789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                      +.+.+..+++|||+++++|.+++....  .+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          75 SLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEeccc
Confidence            999999999999999999999986543  6888999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCC----ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          265 GLAKDGPEGDK----SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       265 gla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      |+++.......    ........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........  .       
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~-------  221 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--I-------  221 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--H-------
Confidence            99886642111    1111234688999999999988899999999999999999999999986432111  0       


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                             ..... ......+...+..+.+++.+||+.||.+||++.+++++
T Consensus       222 -------~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         222 -------FKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -------HHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                   00000 11122233456788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.2e-39  Score=304.18  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=197.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .+|+..+.||+|+||.||+|.+..+.      ..+++|.+....    .......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTG------RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCC------cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            47889999999999999999766543      348999876432    22334567889999999999999999998875


Q ss_pred             --CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          188 --DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       188 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                        ....+++|||+++++|.+++....  .+++.....++.|++.||+|||+.+  ++|+||+|+||+++.++.+||+|||
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCC
Confidence              367889999999999999986543  5888999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCC-ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          266 LAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       266 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      +++....... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.........             
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-------------  218 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-------------  218 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-------------
Confidence            9876532111 11112356889999999999888999999999999999999999999754321110             


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ............+......+.+++ +||..+|++||+++||+.+
T Consensus       219 ---~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         219 ---FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ---HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence               001100111222334455667777 7888999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=326.62  Aligned_cols=256  Identities=26%  Similarity=0.394  Sum_probs=218.3

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +..+.+.||+|.||.|++|.|+....   .-..||||.++.+.......+|++|+.+|.+|+|||+++|||+..+ ....
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psg---k~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSG---KHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCC---cEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            34456889999999999999876433   2456999999988766677899999999999999999999999987 6778


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +|||+++.|+|.+.|+......|.......++.|||.||.||.+.+  +|||||..+|+|+.....|||+||||.+-+..
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            9999999999999998855567888889999999999999999966  99999999999999999999999999998876


Q ss_pred             CCCcccccc-ccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          273 GDKSHVSTR-IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       273 ~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ++..+.... ..-...|+|||.++...++.++|||+|||++|||+| |..||-+.....                 +.+.
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------------IL~~  327 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------------ILKN  327 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------------HHHh
Confidence            655443322 334678999999999999999999999999999999 778998876532                 2334


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +|..-+...+..|+.++.+++..||..+|.+||||..|.+.
T Consensus       328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            45555566788999999999999999999999999999744

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.5e-40  Score=307.89  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=190.7

Q ss_pred             eecCCCcEEEEEEEEcccc------------------ccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceee
Q 014189          119 VLGGGGFGCVYKGFISEDL------------------REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK  180 (429)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~~~------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  180 (429)
                      .||+|+||.||+|.+..+.                  ........|++|++.... ......|.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            5899999999999764321                  122334568999886542 233456888999999999999999


Q ss_pred             eeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC---
Q 014189          181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---  257 (429)
Q Consensus       181 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~---  257 (429)
                      +++++.+....++||||+++|+|..++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++..+   
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence            999999999999999999999999888653 336889999999999999999999876  99999999999997654   


Q ss_pred             ----cEEEeccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHH-hCCCCCCCCChhhhh
Q 014189          258 ----NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEIL-TGRKSLDKSRPAREQ  331 (429)
Q Consensus       258 ----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tG~~p~~~~~~~~~~  331 (429)
                          .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||.........
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                3899999987653221      12357788999998875 56899999999999999984 799999765432211


Q ss_pred             hHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          332 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      ..       ....            ...+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus       232 ~~-------~~~~------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 RF-------YEKK------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH-------HHhc------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            10       0000            0111122356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.2e-40  Score=303.28  Aligned_cols=252  Identities=22%  Similarity=0.309  Sum_probs=205.2

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|++.+.||+|+||.||++....+.+      .+++|.+.... ......++.+|+.++++++||||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGK------QYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCC------EEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            47889999999999999998765433      49999876432 334456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++++|.+++.......+++.+++.++.|++.|+.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            99999999999999887655556889999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  ......|++.|+|||++.+..++.++|+||||+++++|++|+.||...+....      ...          +.
T Consensus       153 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~----------~~  214 (256)
T cd08218         153 STVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLK----------II  214 (256)
T ss_pred             cchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHH----------Hh
Confidence            3221  12234688999999999988899999999999999999999999975432211      100          00


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .. .....+...+..+.+++.+||+.+|++||++.+|+++
T Consensus       215 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         215 RG-SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cC-CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            00 0112233556789999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.2e-40  Score=311.19  Aligned_cols=251  Identities=22%  Similarity=0.340  Sum_probs=203.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|....+..      .||+|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQ------EVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCC------EEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            579999999999999999998655433      499998875432 3345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++++|.+++...   .+++.++..++.|++.||.|||+.+  ++|+||||+|||++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             EEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            9999999999999988543   5788999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...++......               ...
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---------------~~~  229 (297)
T cd06656         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---------------IAT  229 (297)
T ss_pred             CCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---------------ecc
Confidence            3221  12335688999999999998899999999999999999999999975443211000               000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ........+...+..+.+++.+||..+|++||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000111233456678899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=314.21  Aligned_cols=265  Identities=26%  Similarity=0.362  Sum_probs=213.1

Q ss_pred             cChHHHHHHhc-CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCce
Q 014189          102 FTYDELRIITA-NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNL  178 (429)
Q Consensus       102 ~~~~~~~~~~~-~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni  178 (429)
                      +.+-+++..+. .|+.-++||+||||.||-+....+++.      +|.|.+.+..  ........++|-.+|.+++.+.|
T Consensus       174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKM------YAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~Fi  247 (591)
T KOG0986|consen  174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKM------YACKKLDKKRIKKRKGETMALNEKQILEKVSSPFI  247 (591)
T ss_pred             HHHHHhhhccccceeeeEEEecccccceeEEEEecchhh------HHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcE
Confidence            33444444443 488899999999999999876665544      8888765532  22334456789999999999999


Q ss_pred             eeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc
Q 014189          179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN  258 (429)
Q Consensus       179 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~  258 (429)
                      |.+-.+|++.+.+++|+..|+||+|.-+|...+...+++..+.-++.+|+.||++||...  ||+|||||+|||+|+.|+
T Consensus       248 VslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~Gh  325 (591)
T KOG0986|consen  248 VSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGH  325 (591)
T ss_pred             EEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCC
Confidence            999999999999999999999999999999888888999999999999999999999977  999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      ++|+|+|||..++.+..   ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||.........   +-+.
T Consensus       326 vRISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvd  399 (591)
T KOG0986|consen  326 VRISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVD  399 (591)
T ss_pred             eEeeccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHH
Confidence            99999999998876543   23348999999999999999999999999999999999999999754322110   0000


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                               ..+.  .....++...+.++.+|....|++||++|..     +++|.+|
T Consensus       400 ---------rr~~--~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  400 ---------RRTL--EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             ---------HHHh--cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence                     0011  0122345677889999999999999999964     4466654

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.6e-40  Score=304.48  Aligned_cols=253  Identities=28%  Similarity=0.388  Sum_probs=200.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-----hhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-----YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      +|+..+.||+|+||.||+|....       +..+|+|.+.....     ......+.+|+++++.++|+||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~-------~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQ-------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcC-------CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence            47788999999999999996532       23489998764321     2233567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+..+++|||+++++|.+++.+..  ++++..+..++.|++.||+|||+.+  ++|+||+|+||++++++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhh
Confidence            999999999999999999986653  5889999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCC----CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          268 KDGPEGD----KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       268 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      .......    .........|+..|+|||++.+..++.++||||||+++|+|++|..||...+.......       ...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-------~~~  222 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-------IGA  222 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-------hhh
Confidence            7543211    11112335689999999999998899999999999999999999999976543211000       000


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          ..    ......+...+..+.+++.+||..+|++||++.+++.+
T Consensus       223 ----~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         223 ----HR----GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ----cc----CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                00    00112233456778999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.1e-39  Score=302.23  Aligned_cols=253  Identities=25%  Similarity=0.324  Sum_probs=199.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .+|++.+.||+|+||.||+|.+.++..      .|++|.+....    .......+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~------~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGR------ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCc------EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            578899999999999999998765543      49999875322    12334577889999999999999999998875


Q ss_pred             C--CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          188 D--EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       188 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                      .  ..++++|||+++|+|.+++....  .+++.....++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCc
Confidence            3  56789999999999999887553  5788889999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          266 LAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       266 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ++......... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.........             
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-------------  218 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-------------  218 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-------------
Confidence            98765321111 1122356899999999998888999999999999999999999999754321110             


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ............+...+..+.+++.+|+. +|++||++++|+++
T Consensus       219 ---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         219 ---FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence               01111111222344566788899999995 99999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-41  Score=322.02  Aligned_cols=243  Identities=23%  Similarity=0.287  Sum_probs=188.5

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc---CCCceeeeeeEEEeCCeEEEE
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL---SHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv  194 (429)
                      ||+|+||.||+|.+..+.      ..||+|++....  .......+..|..++...   +||||+++++++.+.+..|+|
T Consensus         1 lG~G~~g~Vy~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTR------RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEECCCC------CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence            799999999999876543      349999986432  112233455677777655   699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          75 TDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            99999999998886543  6899999999999999999999977  9999999999999999999999999987643322


Q ss_pred             CccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  353 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (429)
                      .  .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||........      ... +.       ....
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~~~-i~-------~~~~  214 (330)
T cd05586         151 K--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------YRN-IA-------FGKV  214 (330)
T ss_pred             C--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------HHH-HH-------cCCC
Confidence            1  23346799999999998754 589999999999999999999999976542211      000 00       0000


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCC----CHHHHHHh
Q 014189          354 RLEGDYPVKGVHKAAMLAYHCLNHNPKARP----LMRDIVDS  391 (429)
Q Consensus       354 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~evl~~  391 (429)
                      .+.   ....+..+.+++.+||+.||.+||    ++.+++++
T Consensus       215 ~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         215 RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            110   112466788999999999999998    57777765

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-39  Score=304.92  Aligned_cols=257  Identities=24%  Similarity=0.372  Sum_probs=200.5

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC---------hhhHHHHHHHHHHHhccCCCceeeeee
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---------YQGHREWLAEVIFLGHLSHPNLVKLIG  183 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~l~~  183 (429)
                      +|...+.||+|+||.||+|....++      ..+|+|.+.....         ....+.+..|+.+++.++||||+++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   75 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTG------EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG   75 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCC------ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            4777899999999999999865543      3499998753211         112345778999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          184 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                      ++...+..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEee
Confidence            999999999999999999999998765  36899999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      ||++................|+..|+|||.+....  ++.++|+||||+++|+|++|..||........  ...    . 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~----~-  224 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFK----L-  224 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHH----h-
Confidence            99987654322222223456899999999987654  89999999999999999999999965432111  000    0 


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                           .................+..+.+++.+||..+|++|||+++|+.+
T Consensus       225 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         225 -----GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -----hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                 000011111111223456789999999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.5e-39  Score=303.76  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=200.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .++++.....||+|+||.||+|.+..+.      ..|++|.+.... ......+.+|+.+++.++|+||+++++++..++
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQ------VRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG   78 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCC------cEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence            3455666679999999999999865543      349999876553 345567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC-CCcEEEeccCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPL--PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGL  266 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl  266 (429)
                      ..++|+||+++++|.+++..... .+  ++..+..++.|++.||+|||+.+  |+||||||+||+++. ++.++|+|||+
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          79 FFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             EEEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchh
Confidence            99999999999999999875432 34  78888999999999999999977  999999999999986 67899999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      +........  ......|+..|+|||++.+.  .++.++||||||+++|+|++|..||.........   .+...     
T Consensus       156 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~-----  225 (268)
T cd06624         156 SKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVG-----  225 (268)
T ss_pred             heecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhh-----
Confidence            876543221  12234688999999998754  3789999999999999999999999754321110   00000     


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ..     ......+.....++.+++.+||+.+|++|||+.+++.+
T Consensus       226 --~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         226 --MF-----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --hh-----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence              00     01112233456788999999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-40  Score=307.43  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=203.4

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||.|+||.||+|.+..+      +..+|+|..... .......|..|+.++++++||||+++++.+..+..
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~------~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKET------GLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK   76 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCC------CcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence            35688889999999999999987543      344999998754 34455678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhh
Confidence            999999999999999886543 36899999999999999999999977  999999999999999999999999998764


Q ss_pred             CCCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      .....  ......|++.|+|||.+.     ...++.++|+||||+++|||++|+.||...+....  .    ..      
T Consensus       154 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~----~~------  219 (280)
T cd06611         154 KSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--L----LK------  219 (280)
T ss_pred             ccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--H----HH------
Confidence            33221  123356899999999975     34577899999999999999999999976543211  0    00      


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       ......+.  ...+...+..+.+++.+||+.+|.+||++++++++
T Consensus       220 -~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         220 -ILKSEPPT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -HhcCCCCC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             00000011  11123456788999999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-39  Score=306.22  Aligned_cols=268  Identities=24%  Similarity=0.308  Sum_probs=201.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|+..+.||+|+||.||+|.+..++      ..||+|.+..... ......+.+|+.+++.++|||++++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETG------QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCC------cEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            36888999999999999999876543      3499998764322 2233557789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++++|..++....  .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceec
Confidence            999999999988877654432  5899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-HHhHhhHHHhhhhh-
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKKL-  347 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~-  347 (429)
                      .....  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||........... .............. 
T Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            54321  1223467889999999876 5688999999999999999999999986654322111 10000000000000 


Q ss_pred             ------hhhcCCCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 ------LNIIDPRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ------~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            .....+......     ....+..+.+|+.+||+.+|++|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                  000000000000     01235778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-41  Score=323.52  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=204.8

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      -+||+|+||+||-|++.++.      ..+|||-+.... .+..+-+..|+.+-++++|.|||+++|.+.+++++-|.||-
T Consensus       581 vVLGKGTYG~VYA~RD~~tq------vrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq  653 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQ------VRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ  653 (1226)
T ss_pred             EEeecCceeEEEeeccccce------eEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence            47999999999999776654      449999887653 34556678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-CCCcEEEeccCCCcCCCCCC
Q 014189          198 MARGSVENNLFSKVLLPL--PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~  274 (429)
                      ++||+|.++|..+=+ ++  ++.+.-.+.+||++||.|||.+.  |||||||-+|||++ -.|.+||+|||.+++...-.
T Consensus       654 VPGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  654 VPGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             CCCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            999999999976532 55  77888889999999999999987  99999999999996 47899999999998865432


Q ss_pred             CccccccccCCcccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                        ..+.++.||..|||||++..+  .|..++|||||||++.||.||++||-.......               .+.+.--
T Consensus       731 --P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMFkVGm  793 (1226)
T KOG4279|consen  731 --PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMFKVGM  793 (1226)
T ss_pred             --ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhhhhcc
Confidence              345668899999999999754  689999999999999999999999975432211               1111111


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      -..+.+.|.+.+.++..++++|+..||.+||++++++.-
T Consensus       794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            233556678889999999999999999999999999853

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.4e-40  Score=303.01  Aligned_cols=247  Identities=27%  Similarity=0.442  Sum_probs=198.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||.||+|...        +..+|+|......   ....+.+|+.+++.++||||+++++++..+ ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~--------~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   73 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYT--------GQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GL   73 (254)
T ss_pred             HHceeeeeeccCCCCceEecccC--------CCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-Cc
Confidence            46888999999999999998532        2348999886542   335688999999999999999999998754 46


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++|||+++|+|.+++.......+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||++....
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            99999999999999997665556899999999999999999999977  9999999999999999999999999987643


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ..     ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||..........       ..         
T Consensus       152 ~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~---------  210 (254)
T cd05083         152 MG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE-------CV---------  210 (254)
T ss_pred             cc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH-------HH---------
Confidence            21     112334678999999998899999999999999999998 999997654321100       00         


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                       ........+...+..+.+++.+||+.+|++||++++++..|+.
T Consensus       211 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         211 -EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             0111111223456788899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.2e-39  Score=305.02  Aligned_cols=260  Identities=27%  Similarity=0.420  Sum_probs=201.0

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC---
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE---  189 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  189 (429)
                      |.+.+.||+|+||.||+|.+....   ..+..+|+|++.... .......+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSED---GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccC---CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            566789999999999999865432   224569999887543 3345567889999999999999999999886432   


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          190 ---HRVLIYEFMARGSVENNLFSKV----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       190 ---~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                         ..++++||+.+|+|.+++....    ...+++.....++.|++.||+|||+.+  |+||||||+||+++.++.+||+
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEEC
Confidence               3478899999999988875321    224788999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      |||+++...............+++.|++||.+....++.++||||||+++|||++ |+.||.......   ...+..   
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---  229 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---  229 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---
Confidence            9999986543322212223445678999999998889999999999999999999 888987554321   111100   


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                       ..      .    ....+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       230 -~~------~----~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 -KG------N----RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -cC------C----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             00      0    0111234567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.7e-40  Score=306.37  Aligned_cols=254  Identities=26%  Similarity=0.363  Sum_probs=204.8

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|+..+.||.|+||.||+|.+..+.      ..+++|.+...........+.+|+++++.++||||+++++++...+..+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTG------KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDIS   75 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCC------cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEE
Confidence            5777889999999999999876543      3499999877655556677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++||+++++|.+++.... ..+++.....++.|++.+|+|||+ .+  ++|+||||+||+++.++.++|+|||.+....
T Consensus        76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999999999999887653 478999999999999999999998 77  9999999999999999999999999987653


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ...    .....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ..+..          ....
T Consensus       153 ~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~----------~~~~  217 (265)
T cd06605         153 NSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELL----------QYIV  217 (265)
T ss_pred             HHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHH----------HHHh
Confidence            221    11267889999999999999999999999999999999999999755321110 11111          0111


Q ss_pred             CCCCCCCCChH-HHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVK-GVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .... ...+.. .+..+.+++.+||..||++|||+.+++.+
T Consensus       218 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         218 NEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             cCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            1110 111122 56779999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=321.35  Aligned_cols=247  Identities=29%  Similarity=0.405  Sum_probs=202.8

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC--CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      |.-++-||.|+||.||.|++..+.+      .||||.+...  .+.....++++|+.+|++++|||++.+.|||..+...
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~e------vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta  101 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA  101 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccc------eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence            4445679999999999997665543      4999997643  3555667889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      |||||||- |+-.+.+.-. .+++-+..+..|+.+.+.||+|||+++  .||||||..|||+++.|.|||+|||.|-...
T Consensus       102 WLVMEYCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  102 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHHHHHHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcC
Confidence            99999995 5777776544 347888999999999999999999988  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      +      ..+++|||.|||||++.   .+.|+-++||||||++..||...++|+..++....  +           .-+.
T Consensus       178 P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--L-----------YHIA  238 (948)
T KOG0577|consen  178 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L-----------YHIA  238 (948)
T ss_pred             c------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--H-----------HHHH
Confidence            3      34589999999999986   57899999999999999999999999876653211  0           0112


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      +.-.|.+.   ..+-+..+..++..||++-|.+|||.++++.|-
T Consensus       239 QNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  239 QNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             hcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence            22233332   335678899999999999999999999998763

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=307.40  Aligned_cols=269  Identities=25%  Similarity=0.329  Sum_probs=202.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||.||+|.+.++.      ..|++|.+.... .......+.+|++++++++|+||+++++++..++.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATG------EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCC------cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            36888999999999999999876553      349999886542 23334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .+++|||++++.+..+....  ..+++..+..++.+++.||+|||..+  ++|+||+|+||+++.++.+||+|||++...
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          75 LYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            99999999987666544332  35899999999999999999999977  999999999999999999999999998876


Q ss_pred             CCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh-hHHHhh----
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL-PLLKEK----  344 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~----  344 (429)
                      ..... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||................ ......    
T Consensus       151 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         151 RARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             CCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence            54332 122345788999999999887 88999999999999999999999998654322111100000 000000    


Q ss_pred             ---hhhh--hhcCCC----CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 ---KKLL--NIIDPR----LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ---~~~~--~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ....  ...+..    .....+..++.++.+|+.+||..+|++|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence               0000  000000    0001122347889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7e-40  Score=313.70  Aligned_cols=265  Identities=22%  Similarity=0.300  Sum_probs=187.7

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--CCeEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DEHRVLI  194 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  194 (429)
                      .++||+|+||.||+|...+.    .....+|+|.+.....   ...+.+|+.++++++||||+++++++..  +...+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~----~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG----KDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccC----CCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            36899999999999986532    1234599998865432   2346689999999999999999998854  4578899


Q ss_pred             EEecCCCChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE----cCCCcEEEec
Q 014189          195 YEFMARGSVENNLFSK-------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSD  263 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll----~~~~~~kl~D  263 (429)
                      |||+. ++|.+++...       ....+++..+..++.|++.||+|||+.+  |+||||||+|||+    +.++.+||+|
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            99996 5787776422       1235889999999999999999999977  9999999999999    4667899999


Q ss_pred             cCCCcCCCCCCCc-cccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhh------hHHH
Q 014189          264 FGLAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ------NLAD  335 (429)
Q Consensus       264 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~------~~~~  335 (429)
                      ||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||.........      ....
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  235 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  235 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence            9999865432211 12234678999999999876 45899999999999999999999999754321100      0000


Q ss_pred             hHhhHH----Hhhh----------hhhhhcCCCCCCC---------CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 WALPLL----KEKK----------KLLNIIDPRLEGD---------YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 ~~~~~~----~~~~----------~~~~~~~~~~~~~---------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ......    ...+          .............         ........+.+|+.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000000    0000          0000000000000         001123468899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.5e-39  Score=303.90  Aligned_cols=249  Identities=25%  Similarity=0.372  Sum_probs=203.0

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      -|+..+.||+|+||.||+|.+..+.      ..+|+|.............+.+|+.++++++||||+++++++..++..+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   78 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQ------KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   78 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCC------cEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence            4677789999999999999765543      3499998876544455567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +||||+++|+|.+++...   .+++..+..++.+++.++.|||..+  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          79 IIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            999999999999888543   5889999999999999999999977  99999999999999999999999999876543


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      ...  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||..........      .           +.
T Consensus       154 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~-----------~~  214 (277)
T cd06641         154 TQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF------L-----------IP  214 (277)
T ss_pred             chh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH------H-----------Hh
Confidence            221  1233568899999999988889999999999999999999999997543221100      0           00


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...........+..+.+++.+||..+|++||++.+++.+
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         215 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            000111223456778899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-39  Score=354.86  Aligned_cols=263  Identities=31%  Similarity=0.496  Sum_probs=205.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ...|...++||+|+||.||+|.+..+.      ..||+|.+.......     ..|++++++++|||||+++++|.+.+.
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~-----~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNG------MQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCC------cEEEEEEccCCcccc-----HHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            345777889999999999999875443      349999886542211     246888999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .++||||+++|+|.+++.     .++|..+..++.|++.||+|||.. .++|+||||||+||+++.++..++. ||....
T Consensus       758 ~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            999999999999999984     388999999999999999999954 3459999999999999999988876 665543


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ...      .....||+.|+|||++.+..++.++|||||||++|||+||+.||+..... ......|...... ......
T Consensus       832 ~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~  903 (968)
T PLN00113        832 LCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYS-DCHLDM  903 (968)
T ss_pred             ccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcC-ccchhh
Confidence            221      12236889999999999999999999999999999999999999643221 2233444433221 122344


Q ss_pred             hcCCCCCCC--CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          350 IIDPRLEGD--YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       350 ~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      .+|+.+...  .+.....++.+++.+||+.||++||||+|+++.|+.+...
T Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            455555332  2345667889999999999999999999999999887554

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-39  Score=306.39  Aligned_cols=253  Identities=26%  Similarity=0.329  Sum_probs=195.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHH-HhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF-LGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||.||+|.+..++      ..||+|.+...........+..|+.+ ++.++||||+++++++..++.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTG------TIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCC------cEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence            46888999999999999999876553      34999998765433344556667665 566689999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          191 RVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+++|||++ |+|.+++...  ....+++..+..++.|++.||+|||++ +  ++||||||+||+++.++.+||+|||++
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999996 6887777542  234689999999999999999999985 6  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCccccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      .......   ..+...|+..|+|||.+.+    ..++.++|+||||+++|+|++|+.||........ ...    .    
T Consensus       152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~----~----  219 (283)
T cd06617         152 GYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLK----Q----  219 (283)
T ss_pred             ccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHH----H----
Confidence            8654321   1233568899999998864    4568899999999999999999999974322111 000    0    


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ......+.+   .....+..+.+++.+||..+|++||++++++++
T Consensus       220 ---~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         220 ---VVEEPSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ---HHhcCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000011111   112346788999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-39  Score=302.58  Aligned_cols=245  Identities=27%  Similarity=0.414  Sum_probs=192.9

Q ss_pred             eeecCCCcEEEEEEEEcccccc----CcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLRE----GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  193 (429)
                      +.||+|+||.||+|.+......    ......+++|........  ...|.+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            4689999999999988765321    222345778876654322  5778899999999999999999999988 77899


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-------cEEEeccCC
Q 014189          194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-------NAKLSDFGL  266 (429)
Q Consensus       194 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfgl  266 (429)
                      ||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+  ++||||||+|||++.++       .+||+|||+
T Consensus        78 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            9999999999998876543 6889999999999999999999977  99999999999999888       799999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccC--CCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      +.....      .....++..|+|||++.+.  .++.++||||||+++|||++ |..||...........   .    . 
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~---~----~-  220 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF---Y----Q-  220 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH---H----h-
Confidence            886543      1224567789999999876  78999999999999999999 5777765532111000   0    0 


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                              ..   ...+......+.+++.+||..+|++|||+.++++.|+
T Consensus       221 --------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 --------DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --------cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    00   0011111267889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-39  Score=307.28  Aligned_cols=262  Identities=27%  Similarity=0.344  Sum_probs=202.0

Q ss_pred             hHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeee
Q 014189          104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLI  182 (429)
Q Consensus       104 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  182 (429)
                      ++.+....++|++.+.||+|+||.||+|.+..+.      ..+|+|+......  ....+.+|+.+++.+ +||||++++
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~------~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~   81 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNG------SKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFY   81 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCC------ceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeee
Confidence            3445556789999999999999999999876543      3489998764322  234577899999999 699999999


Q ss_pred             eEEE-----eCCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC
Q 014189          183 GYCC-----EDEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT  255 (429)
Q Consensus       183 ~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~  255 (429)
                      +++.     .++..++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.+  ++||||||+||+++.
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~  159 (286)
T cd06638          82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTT  159 (286)
T ss_pred             eeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECC
Confidence            9874     345789999999999999887532  2346888999999999999999999977  999999999999999


Q ss_pred             CCcEEEeccCCCcCCCCCCCccccccccCCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh
Q 014189          256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  330 (429)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~  330 (429)
                      ++.+||+|||+++.......  ......|++.|+|||++..     ..++.++|||||||++|||++|+.||........
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~  237 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA  237 (286)
T ss_pred             CCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence            99999999999876543221  1233568999999999853     4578999999999999999999999976543211


Q ss_pred             hhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          331 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      .  ..           ......+..  ..+...+..+.+|+.+||+.||++|||+.|+++++
T Consensus       238 ~--~~-----------~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         238 L--FK-----------IPRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             H--hh-----------ccccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            0  00           000000000  11222356789999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=305.25  Aligned_cols=247  Identities=26%  Similarity=0.362  Sum_probs=207.7

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  193 (429)
                      |.+.++||+|+||.||+|.++..+.      .+|+|.+.-+   .+.++..+|+.+++++..|++|+++|.|.....+++
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~------v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGH------VLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCc------EEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            5667899999999999998877654      4999988754   356678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCC
Q 014189          194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  273 (429)
Q Consensus       194 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  273 (429)
                      |||||..|+..+.+..+ ++++.+.+...++...+.||+|||...  -+|||||..|||++.+|.+||+|||.|..+.+.
T Consensus       106 VMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             ehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            99999999999977654 458999999999999999999999866  799999999999999999999999999876542


Q ss_pred             CCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC-
Q 014189          274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID-  352 (429)
Q Consensus       274 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  352 (429)
                      .  ....+..||+.|||||++..-.|+.++||||||++..||..|++||....+....                 -++. 
T Consensus       183 M--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-----------------FMIPT  243 (502)
T KOG0574|consen  183 M--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-----------------FMIPT  243 (502)
T ss_pred             H--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-----------------EeccC
Confidence            2  2234578999999999999999999999999999999999999999865542211                 1111 


Q ss_pred             -CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 -PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 -~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       |.-....|..-+.++.+++.+||.++|++|-|+-++++|
T Consensus       244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence             111112244568899999999999999999999998876

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=305.28  Aligned_cols=282  Identities=27%  Similarity=0.433  Sum_probs=209.1

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhc--cCCCceeeeeeEEEeCC-
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH--LSHPNLVKLIGYCCEDE-  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~-  189 (429)
                      ..++.++||+|.||.||+|.+.+        ..||||++.    .+..+.|.+|.+|.+.  ++|+||++++++-.... 
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~--------~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDN--------RLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             chhhHHHhhcCccceeehhhccC--------ceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            34455789999999999997765        349999985    4566778888888764  57999999999876544 


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceeCCCCCCcEEEcCCCcE
Q 014189          190 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-------EKPVIYRDFKTSNILLDTDYNA  259 (429)
Q Consensus       190 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-------~~~ivH~Dlkp~NIll~~~~~~  259 (429)
                         .++||++|.+.|+|.++|..+   .++|....+|+..+++||+|||..       .++|+|||||++||||.+|++.
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence               889999999999999999877   599999999999999999999973       2579999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCcccccccccccC-CCC-----cccchhhHHHHHHHHHhCCCCCC-CCChhhhhh
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLT-----PRSDVYSFGVVLLEILTGRKSLD-KSRPAREQN  332 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DvwslG~il~elltG~~p~~-~~~~~~~~~  332 (429)
                      .|+|||||..+..+.........+||.+|||||++.+. ++.     .+.||||+|.+||||++....+. +.-+..+..
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            99999999988766555555568999999999999753 222     46899999999999998654432 111111111


Q ss_pred             HH---------HhHhhHHHhhhhhhhhcCCCCCCCCCh-HHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCC
Q 014189          333 LA---------DWALPLLKEKKKLLNIIDPRLEGDYPV-KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA  402 (429)
Q Consensus       333 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  402 (429)
                      +.         +-.+..+     +.+-..|.+...+.. ....-+.+.+..||..||+-|.|+.=+-+++..+..+.+. 
T Consensus       436 fe~evG~hPt~e~mq~~V-----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~-  509 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELV-----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED-  509 (534)
T ss_pred             hhHHhcCCCCHHHHHHHH-----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc-
Confidence            11         1111111     111112222222111 3466788999999999999999999888888777666555 


Q ss_pred             CCCCccccccCCC
Q 014189          403 PTPKNFVTVVTPE  415 (429)
Q Consensus       403 ~~p~~~~~~~~~~  415 (429)
                      +.++.....++|.
T Consensus       510 ~~~~s~~~~~~~~  522 (534)
T KOG3653|consen  510 SSGESSSSLVTPV  522 (534)
T ss_pred             cCCccccccCCCC
Confidence            4454444444444

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=306.94  Aligned_cols=268  Identities=22%  Similarity=0.280  Sum_probs=198.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||+|....+.      ..||+|.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTG------QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTL   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCC------cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence            57889999999999999999865443      349999987543333334567899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+. ++|.+++..... .+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccC
Confidence            99999997 489988865543 6889999999999999999999977  9999999999999999999999999987543


Q ss_pred             CCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhh-hHHHhHhh-HHHhh----
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ-NLADWALP-LLKEK----  344 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~-~~~~~~~~-~~~~~----  344 (429)
                      ....  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......... ........ .....    
T Consensus       155 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         155 VPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             CCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence            2111  1222457889999999875 56899999999999999999999999755422111 00000000 00000    


Q ss_pred             hhhhhhcCCCCC--------CCC-ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLE--------GDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~--------~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ............        ... .......+.+++.+||+.+|++|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            000000000000        000 00112678899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.6e-39  Score=300.85  Aligned_cols=252  Identities=23%  Similarity=0.298  Sum_probs=203.1

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--CC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DE  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  189 (429)
                      +|++.+.||.|+||.||+|.+..+.      ..+|+|.+.... .......+..|+.+++.++||||+++++++..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDG------KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCC------CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            4788899999999999999766543      348999886543 34445678899999999999999999998753  45


Q ss_pred             eEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          190 HRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLH-----EAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH-----~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      ..+++|||+++++|.+++...  ...++++..++.++.+++.||+|||     +.+  ++|+||+|+||++++++.+||+
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEe
Confidence            689999999999999988653  2346899999999999999999999     655  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      |||++........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...   ....      
T Consensus       153 d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~------  221 (265)
T cd08217         153 DFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK------  221 (265)
T ss_pred             cccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH------
Confidence            9999987654321  1233568999999999998889999999999999999999999998654211   1100      


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                              +........+...+..+.+++.+||+.+|++|||+++|+++
T Consensus       222 --------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         222 --------IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --------HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                    00111122334566789999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.8e-39  Score=303.54  Aligned_cols=269  Identities=24%  Similarity=0.296  Sum_probs=199.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      +++|.+.+.||+|+||.||+|....++.      .+++|.+...........+.+|+.+++.++|+||+++++++..++.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQ------LVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCc------EEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            4689999999999999999998765533      3999998765433333456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+|||++.++.+||+|||+++..
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEecccccccc
Confidence            999999996 67777765443 35788888999999999999999977  999999999999999999999999998764


Q ss_pred             CCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh---hHHH---h
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL---PLLK---E  343 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~---~~~~---~  343 (429)
                      .....  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......+.....|..   +.-.   .
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         154 SIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence            33211  1233467899999999875 457899999999999999999999998655422211111100   0000   0


Q ss_pred             hhhhhhhcCCCCCCCCC---------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 KKKLLNIIDPRLEGDYP---------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~---------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...+............+         ...+..+.+++.+|+..||++|||+.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            00000000000000000         0124678899999999999999999999865

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.6e-39  Score=303.07  Aligned_cols=258  Identities=26%  Similarity=0.333  Sum_probs=202.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--CC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  189 (429)
                      ++|...+.||.|++|.||+|.+..+      +..+|+|.+...........+.+|++++++++||||++++++|..  .+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNT------GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCC------CeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence            3678889999999999999987654      344999998765454556778899999999999999999998864  34


Q ss_pred             eEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          190 HRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+++||||+++++|.+++..  .....+++.....++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccc
Confidence            78999999999999887753  22345888999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChh--hhhhHHHhHhhHHHhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA--REQNLADWALPLLKEKK  345 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~  345 (429)
                      .......    .....++..|+|||.+.+..++.++||||||+++|+|++|..||......  .......+..       
T Consensus       153 ~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  221 (287)
T cd06621         153 GELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-------  221 (287)
T ss_pred             ccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-------
Confidence            7643321    12346788999999999999999999999999999999999999865321  1111111111       


Q ss_pred             hhhhhcCCCCCCCCC--hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRLEGDYP--VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ....+.+.....  ...+..+.+++.+||..+|++|||+.|++.+
T Consensus       222 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         222 ---NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ---cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence               000111111111  1346778999999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.1e-40  Score=308.03  Aligned_cols=268  Identities=24%  Similarity=0.306  Sum_probs=200.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..+|+|.+...... .....+.+|+++++.++||||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETG------QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCC------CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            36888999999999999999876543      34999987654322 234567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++++|..+.....  .+++..+..++.|++.||+|||+.+  ++|+||+|+||++++++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            999999999988887664432  4899999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhh-hHHHhHhhHHHh-----
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ-NLADWALPLLKE-----  343 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~-----  343 (429)
                      .....  ......++..|+|||++.+ ..++.++||||||+++|||++|++||......... ....+.......     
T Consensus       151 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         151 AAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             cCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            43321  2233568899999999875 45788999999999999999999999755432111 111100000000     


Q ss_pred             --hhhhhhhcCCCCCC-----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 --KKKLLNIIDPRLEG-----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 --~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .........+....     ......+..+.+++.+||..+|++||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence              00000000000000     0012346779999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-39  Score=305.24  Aligned_cols=265  Identities=23%  Similarity=0.277  Sum_probs=202.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|++.+.||+|+||.||+|.+..++      ..|++|.+..... ......+.+|+.++++++||||+++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETG------ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCC------ceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            4788899999999999999876543      3499999876532 33446788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+ +++|.+++.... .++++..+..++.|++.+|+|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            9999999 999999886544 46999999999999999999999977  9999999999999999999999999988765


Q ss_pred             CCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH----hhh-
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK----EKK-  345 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~----~~~-  345 (429)
                      .... .......|+..|+|||.+.+. .++.++||||||+++|||++|.+||..........   .......    ..+ 
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  226 (286)
T cd07832         151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA---IVFRTLGTPNEETWP  226 (286)
T ss_pred             CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH---HHHHHcCCCChHHHh
Confidence            4322 112335789999999998754 46899999999999999999988887554321110   0000000    000 


Q ss_pred             h------hhhhcCCCCC----CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 K------LLNIIDPRLE----GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~------~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .      ...+..+...    .....+.+..+.+++.+||+.+|++|||+++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0      0000000000    00112345789999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-39  Score=299.03  Aligned_cols=250  Identities=26%  Similarity=0.411  Sum_probs=201.4

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +|+..+.||+|+||.||+|....+..      .+++|.+....    .......+.+|+.+++.++|+||+++++++...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGD------FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE   74 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCc------EEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence            46777899999999999998764433      39999876432    123456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ...+++|||+++++|.+++....  .+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.+||+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccce
Confidence            99999999999999999986553  5889999999999999999999987  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccCCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ......   ......|+..|++||.+.... ++.++|+||||+++|+|++|..||........  ..    .       .
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~----~-------~  214 (258)
T cd06632         151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VF----K-------I  214 (258)
T ss_pred             eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HH----H-------H
Confidence            654322   123456899999999988766 89999999999999999999999976542111  00    0       0


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...   ......+...+..+.+++.+||..+|++||++.+++.+
T Consensus       215 ~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         215 GRS---KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             Hhc---ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            000   00112233456788999999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.2e-39  Score=305.22  Aligned_cols=247  Identities=26%  Similarity=0.355  Sum_probs=202.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||++.+..+.      ..+|+|.+....  .......+.+|++++++++||||+++++++...+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSG------KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            46889999999999999999876543      349999886532  2234456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.+||+|||++..
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            9999999999999999987653  6889999999999999999999977  99999999999999999999999999887


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ....     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||........   .             ..
T Consensus       151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-------------~~  209 (290)
T cd05580         151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---Y-------------EK  209 (290)
T ss_pred             cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---H-------------HH
Confidence            5443     2335789999999999888899999999999999999999999976542110   0             00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      +...  ....+...+..+.+++.+||..||.+||     +++|++++
T Consensus       210 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         210 ILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            0110  1112334467889999999999999999     78888865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-39  Score=307.73  Aligned_cols=255  Identities=27%  Similarity=0.340  Sum_probs=197.8

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  191 (429)
                      +|...+.||+|+||.||++.+..+.      ..+|+|.+...........+.+|+.++.++. ||||+++++++..++..
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~   78 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSG------TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC   78 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCC------CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence            4555678999999999999876543      4499999876544455667889999999996 99999999999988999


Q ss_pred             EEEEEecCCCChhhh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          192 VLIYEFMARGSVENN---LFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      +++|||+.. ++.++   +.......+++..+..++.+++.||+|||+. +  ++||||||+||+++.++.+||+|||++
T Consensus        79 ~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          79 WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             EEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchh
Confidence            999999864 55443   3333345789999999999999999999973 6  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCcccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTG---HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ........   .....|+..|+|||++.+.   .++.++||||||+++|+|++|+.||........     ...      
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~------  221 (288)
T cd06616         156 GQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD-----QLT------  221 (288)
T ss_pred             HHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH-----HHh------
Confidence            76543221   2234688999999998866   689999999999999999999999975431110     000      


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       .......+.+....+...+..+.+|+.+||+.+|++|||+++|+.+
T Consensus       222 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         222 -QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -hhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0001111222222233467789999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-41  Score=299.87  Aligned_cols=243  Identities=25%  Similarity=0.316  Sum_probs=202.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      -++|..+++||+|+||.|-+++-+      .++..+|+|+++++..  ......-+.|-++|...+||.+..+...|+..
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEK------at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREK------ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ  240 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeec------ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence            367999999999999999998544      4456699999987642  22334456799999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +++|+||||..||.|.-+|.+..  .+++....-+-..|+.||.|||+.+  ||+||||.+|.|+|.+|++||+|||+.+
T Consensus       241 drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccch
Confidence            99999999999999998886654  5888888888999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .....  ...+.++||||.|+|||++....|..++|+|.+||++|||++|+.||...+...                 +.
T Consensus       317 E~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-----------------LF  377 (516)
T KOG0690|consen  317 EEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-----------------LF  377 (516)
T ss_pred             hcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-----------------HH
Confidence            65432  234567999999999999999999999999999999999999999998654321                 11


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP  383 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  383 (429)
                      +++- .-...+|...+.++..|+...|.+||.+|.
T Consensus       378 eLIl-~ed~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  378 ELIL-MEDLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             HHHH-hhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            1110 001234667788899999999999999996

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=302.35  Aligned_cols=250  Identities=26%  Similarity=0.373  Sum_probs=201.2

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC---CCceeeeeeEEEeCC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYCCEDE  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  189 (429)
                      .|+..+.||+|+||.||+|.+..+.      ..+++|.+...........+.+|+.+++.++   |||++++++++....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTG------RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCC------cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence            4777889999999999999876543      3499999876544455567888999999986   999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++++|.+++...   .+++..+..++.+++.||.|||..+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            999999999999999987543   6899999999999999999999977  99999999999999999999999999887


Q ss_pred             CCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......  ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||..........             ...
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------------~~~  215 (277)
T cd06917         151 LNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------------LIP  215 (277)
T ss_pred             cCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------------ccc
Confidence            654321  1233578999999999875 457899999999999999999999997654221100             000


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....+.+.   ....+..+.+++.+||+.||++||++.+++.+
T Consensus       216 ~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         216 KSKPPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             cCCCCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            00111111   11256788999999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.1e-39  Score=300.55  Aligned_cols=256  Identities=24%  Similarity=0.414  Sum_probs=202.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-----hhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-----YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      +|+..+.||+|+||.||+|....+.      ..+|+|.+.....     ......+.+|+.++++++|+||+++++++.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~------~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTG------TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCC------cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            4778899999999999999765543      3499998864321     1234678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-cEEEeccCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGL  266 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl  266 (429)
                      .+..++||||+++++|.+++....  ++++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++ .+||+|||+
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccc
Confidence            999999999999999999886543  6889999999999999999999977  99999999999998776 599999999


Q ss_pred             CcCCCCCCC--ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          267 AKDGPEGDK--SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       267 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      +........  ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........           
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----------  219 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-----------  219 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-----------
Confidence            876543211  1112235688999999999888899999999999999999999999975432111000           


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .............+...+..+.+++.+||..+|++|||+.+++++
T Consensus       220 --~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         220 --IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             --HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence              001111111223344567889999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5e-39  Score=299.06  Aligned_cols=254  Identities=26%  Similarity=0.354  Sum_probs=207.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|++|.||+|.+..+.      ..+++|.+...........+.+|+..+.+++|+||+++++++...+..
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~------~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTG------KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCC------cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence            36888899999999999999876543      349999987765445567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      ++||||+++++|.+++...  .++++..+..++.|++.|++|||+ .+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceec
Confidence            9999999999999998765  368999999999999999999998 88  999999999999999999999999998865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ......  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.............             .+
T Consensus       151 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------------~~  215 (264)
T cd06623         151 ENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-------------AI  215 (264)
T ss_pred             ccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH-------------HH
Confidence            433221  123568899999999998899999999999999999999999997654211111110             11


Q ss_pred             cCCCCCCCCChH-HHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 IDPRLEGDYPVK-GVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .. ......+.. .+..+.+++.+||..+|++|||+.+++++
T Consensus       216 ~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         216 CD-GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             hc-CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11 111112223 56789999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.6e-39  Score=304.20  Aligned_cols=260  Identities=29%  Similarity=0.357  Sum_probs=201.3

Q ss_pred             HHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeee
Q 014189          105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIG  183 (429)
Q Consensus       105 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  183 (429)
                      .++..+.++|.+.+.||+|+||.||+|....+.      ..+|+|.+.....  ....+.+|+.++.++ +|||++++++
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~------~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~   86 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDG------SLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYG   86 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCC------CEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence            344455788999999999999999999876543      3489998865422  234567899999988 7999999999


Q ss_pred             EEEeC-----CeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          184 YCCED-----EHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       184 ~~~~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      ++...     +..++||||+++|+|.+++...  ....+++..++.++.|++.||+|||..+  ++|+||||+||+++.+
T Consensus        87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~  164 (291)
T cd06639          87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC
Confidence            98753     3689999999999999987532  2346899999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhh
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-----HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ  331 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~  331 (429)
                      +.+||+|||++........  ......|+..|+|||.+...     .++.++|||||||++|||++|+.||........ 
T Consensus       165 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-  241 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-  241 (291)
T ss_pred             CCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-
Confidence            9999999999886543221  12235688999999998643     368999999999999999999999976543211 


Q ss_pred             hHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          332 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       ...           ......+.+  ..+......+.+++.+||+.+|++||++.+++++
T Consensus       242 -~~~-----------~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 -LFK-----------IPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -HHH-----------HhcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             100           000001111  1122345678999999999999999999999976

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-39  Score=306.77  Aligned_cols=265  Identities=23%  Similarity=0.290  Sum_probs=197.1

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|++.+.||+|+||.||+|.+..++.      .+++|.+..... ......+.+|+.++++++||||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~------~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHE------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCc------EEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            47888999999999999998765433      489998865422 22234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++|+||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.+||+|||+++...
T Consensus        75 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             EEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            99999997 57888776543 36899999999999999999999977  9999999999999999999999999988654


Q ss_pred             CCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH----Hhhh-
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL----KEKK-  345 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~----~~~~-  345 (429)
                      ....  ......++..|+|||.+.+. .++.++|||||||++|+|+||..|+........ .+. ......    ...+ 
T Consensus       151 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~~  226 (284)
T cd07839         151 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLK-RIFRLLGTPTEESWP  226 (284)
T ss_pred             CCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHH-HHHHHhCCCChHHhH
Confidence            3221  12234678999999998764 479999999999999999999988654332211 000 000000    0000 


Q ss_pred             hhhhhcCCC----CC-----CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPR----LE-----GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~----~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ......+..    ..     .......+.++.+++.+||+.||.+|||+++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000000000    00     00112346788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-39  Score=309.42  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=187.4

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE--eCCeEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC--EDEHRVLIY  195 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~  195 (429)
                      .+||+|+||.||+|...+..    ....+|+|.+.....   ...+.+|+.+++.++||||+++++++.  .+...++||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~----~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGK----DEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             eEeccCCCeeEEEEEecCCC----ccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            68999999999999865422    234599998865422   235678999999999999999999885  356789999


Q ss_pred             EecCCCChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE----cCCCcEEEecc
Q 014189          196 EFMARGSVENNLFSK-------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDF  264 (429)
Q Consensus       196 e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll----~~~~~~kl~Df  264 (429)
                      ||+++ +|.+++...       ....+++..+..++.|++.||.|||+.+  |+||||||+|||+    +.++.+||+||
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            99964 777766421       1235888999999999999999999977  9999999999999    56778999999


Q ss_pred             CCCcCCCCCCCc-cccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh-------hhHHH
Q 014189          265 GLAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE-------QNLAD  335 (429)
Q Consensus       265 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~-------~~~~~  335 (429)
                      |+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||++||........       ..+..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            999865432211 11234578999999999876 4589999999999999999999999975432110       00000


Q ss_pred             hHhhH---HHhhh----------hhhhhcC-C-----CC---CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 WALPL---LKEKK----------KLLNIID-P-----RL---EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 ~~~~~---~~~~~----------~~~~~~~-~-----~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....   ....+          ....... .     .+   ...........+.+|+.+||..||.+|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            00000   00000          0000000 0     00   000011224568889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.9e-39  Score=300.37  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=201.0

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC---------CChhhHHHHHHHHHHHhc-cCCCceeeee
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD---------NSYQGHREWLAEVIFLGH-LSHPNLVKLI  182 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~E~~~l~~-l~h~niv~l~  182 (429)
                      +|++.+.||+|+||.||+|.+..+     .+..+|+|.+...         .......++..|+.++.+ ++||||++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~-----~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~   75 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN-----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY   75 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC-----CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence            477888999999999999987652     1234899986532         122344567788888865 7999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcE
Q 014189          183 GYCCEDEHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNA  259 (429)
Q Consensus       183 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~  259 (429)
                      +++..++..+++|||+++++|.+++..  .....+++..++.++.|++.+|.|||. .+  ++|+||+|+||+++.++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcE
Confidence            999999999999999999999988743  223468999999999999999999995 45  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      +|+|||++.......   ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.........        
T Consensus       154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~--------  222 (269)
T cd08528         154 TITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA--------  222 (269)
T ss_pred             EEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH--------
Confidence            999999998754432   233467899999999999888999999999999999999999999754322110        


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                              ..+.............+..+.+++.+||+.||++||++.|+..+++
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 --------TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --------HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                    0000111111111134577899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=301.51  Aligned_cols=255  Identities=29%  Similarity=0.369  Sum_probs=200.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      .+++|++.+.||+|+||.||+|.+..+.      ..+++|++.....  ....+.+|+.+++++ +|+||+++++++...
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTG------QLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKK   75 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCC------cEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence            3578999999999999999999875543      3489998876532  345688999999999 699999999999754


Q ss_pred             C------eEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEE
Q 014189          189 E------HRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  260 (429)
Q Consensus       189 ~------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  260 (429)
                      .      ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~  153 (275)
T cd06608          76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVK  153 (275)
T ss_pred             CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEE
Confidence            4      4899999999999999886533  456899999999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccCCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~  335 (429)
                      |+|||++.......  .......|+..|+|||++..     ..++.++||||||+++|+|++|..||........  .. 
T Consensus       154 l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~-  228 (275)
T cd06608         154 LVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF-  228 (275)
T ss_pred             ECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH-
Confidence            99999987643321  11233568999999998753     3478899999999999999999999975432111  00 


Q ss_pred             hHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         .       ......+  ....+...+..+.+++.+||..||++|||+.+++++
T Consensus       229 ---~-------~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         229 ---K-------IPRNPPP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ---H-------hhccCCC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence               0       0000011  111122356789999999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.2e-39  Score=304.08  Aligned_cols=266  Identities=24%  Similarity=0.300  Sum_probs=200.2

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|+..+.||.|+||.||+|.+..++      ..+|+|.+..... ......+.+|++++++++||||+++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTG------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCC------CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            5788899999999999999876543      3499998865432 22335678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+. ++|.+++.......+++..+..++.|++.||+|||..+  ++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999996 68988887665567899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh----------H
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP----------L  340 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~----------~  340 (429)
                      ....  ......++..|+|||.+.+.. ++.++||||||+++|+|+||+.||........  .......          .
T Consensus       152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  227 (284)
T cd07860         152 VPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPG  227 (284)
T ss_pred             cCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhh
Confidence            3221  122345788999999887644 68899999999999999999999976543211  1110000          0


Q ss_pred             HHhhhhhhhhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..........+......   ......+..+.+++.+||+.||++|||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            00000000000000000   0011245678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.4e-39  Score=304.97  Aligned_cols=256  Identities=22%  Similarity=0.275  Sum_probs=198.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||++.+....      ..|++|.+.....  ......+.+|+++++.++||||+++++.+..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~------~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETR------QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCC------cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence            36888999999999999999876553      3499998875432  233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++....  .+++..+..++.+++.||+|||+.+  ++||||||+||+++.++.+||+|||+++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            9999999999999999986543  6899999999999999999999977  99999999999999999999999999874


Q ss_pred             CCCCCC-------------ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh
Q 014189          270 GPEGDK-------------SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       270 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~  336 (429)
                      ......             ........|+..|+|||.+.+..++.++|+||||+++|||++|..||.......      .
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~  224 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------L  224 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H
Confidence            211100             001112467889999999998889999999999999999999999997543211      0


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      .....     ......+.    .....+..+.+++.+||+.+|++||++.++.+.|
T Consensus       225 ~~~~~-----~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         225 FGQVI-----SDDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             HHHHH-----hcccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence            00000     00001111    1113567789999999999999999865444444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=320.11  Aligned_cols=252  Identities=26%  Similarity=0.407  Sum_probs=203.5

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      .|.++.-||-|+||.||+|..+++      +...|.|++... +....++|+-||+||..+.||+||++++.|..++.++
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket------~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKET------KLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccc------hhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            345556799999999999976644      333567777654 5667788999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      |+.|||.||-....+..-. .+|++.++..+++|++.||.|||+.+  |||||||..|||++.+|.++|+|||.+.....
T Consensus       106 iliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchh
Confidence            9999999998887765543 47999999999999999999999977  99999999999999999999999998764322


Q ss_pred             CCCccccccccCCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                        ......++.|||.|||||+..+     .+|+.++||||||++|.||..+.+|....++...      .+.       +
T Consensus       183 --t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------llK-------i  247 (1187)
T KOG0579|consen  183 --TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLK-------I  247 (1187)
T ss_pred             --HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH------HHH-------H
Confidence              1223456899999999999864     5799999999999999999999999876654321      111       1


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..--.|.+.  .|..-+..+.+++..||.+||..||++.++++|
T Consensus       248 aKSePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  248 AKSEPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             hhcCCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            111122221  133456788999999999999999999999976

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-38  Score=296.79  Aligned_cols=255  Identities=27%  Similarity=0.378  Sum_probs=202.4

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|.+.+.||+|+||.||+|....+.      ..+++|.+..... ......+..|+.+++.++|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTG------ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCC------cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            4788899999999999999865543      3499999876533 24567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++|+||+++++|.+++....  .+++..+..++.+++.||.|||+.+  ++|+||+|+||++++++.+||+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            99999999999999887643  5788899999999999999999977  9999999999999999999999999988764


Q ss_pred             CCCCccc--cccccCCcccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          272 EGDKSHV--STRIMGTYGYAAPEYIMTGH---LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       272 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      .......  .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||...........       .     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~-------~-----  218 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-------H-----  218 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH-------H-----
Confidence            4322111  11356889999999998766   89999999999999999999999975532111000       0     


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ......+.+  ......+..+.+++.+||+.+|++|||+++++.+
T Consensus       219 ~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         219 VGAGHKPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HhcCCCCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000001111  1112346778899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-38  Score=299.69  Aligned_cols=264  Identities=22%  Similarity=0.264  Sum_probs=195.4

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeC--Ce
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED--EH  190 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~  190 (429)
                      |++.+.||+|+||.||+|....+.      ..+|+|.+.............+|+.++.++. |+|++++++++.+.  +.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~------~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTG------KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCC------cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence            567889999999999999865543      3499998876433333334557899999885 99999999999877  88


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||++ |+|.+.+.... ..+++..+..++.|++.||+|||..+  ++|+||+|+||+++. +.+||+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          75 LALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             EEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            999999997 58888776543 36899999999999999999999977  999999999999999 99999999999865


Q ss_pred             CCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh----hHHHhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL----PLLKEKK  345 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~----~~~~~~~  345 (429)
                      .....   .....++..|+|||.+.. ..++.++|||||||++|||++|..||...+............    ..+....
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            43221   123467899999997654 567899999999999999999999998765432111100000    0000000


Q ss_pred             hhhhhcCCCCCCC-------CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRLEGD-------YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ......+......       .....+..+.+++.+||+.+|++|||+++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000000000000       012346889999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.9e-39  Score=307.04  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=199.2

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      .|.....||+|+||.||++....+.      ..||+|.+... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~------~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTG------KQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCC------CEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            3444567999999999999765443      34999988654 2344566889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +||||+++++|.+++...   .+++..+..++.|++.||+|||+++  ++||||||+||+++.++.++|+|||++.....
T Consensus        96 lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658          96 VVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             EEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            999999999999987543   5889999999999999999999977  99999999999999999999999999875433


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|||++|..||..........             .......
T Consensus       171 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------------~~~~~~~  235 (292)
T cd06658         171 EVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------------RIRDNLP  235 (292)
T ss_pred             ccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHhcCC
Confidence            221  1233568999999999998889999999999999999999999997654321110             0111111


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +.+..  ....+..+.+++.+||..||++|||+++++++
T Consensus       236 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         236 PRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             Ccccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11111  11345678899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.2e-39  Score=297.84  Aligned_cols=252  Identities=21%  Similarity=0.343  Sum_probs=202.9

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|.+.+.||+|+||.||+|....++.      .+|+|.+.... .......+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSE------HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCc------eEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            47888999999999999998766543      38999886532 223445677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc-EEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~  270 (429)
                      ++|+||+++++|.+++.......+++..+..++.+++.||.|||+.+  ++|+||||+||++++++. +||+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999999999999987665556899999999999999999999977  999999999999998864 699999998765


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .....  ......|++.|+|||.+.+..++.++|+||||+++|||++|..||.......      +...          .
T Consensus       153 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~----------~  214 (257)
T cd08225         153 NDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLK----------I  214 (257)
T ss_pred             cCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHH----------H
Confidence            43221  1223468999999999988889999999999999999999999997543211      1111          0


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..... .......+..+.+++.+||..+|++|||+.+++++
T Consensus       215 ~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         215 CQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             hcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11111 11223445679999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.9e-39  Score=300.00  Aligned_cols=250  Identities=25%  Similarity=0.328  Sum_probs=204.0

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      +|++.+.||.|+||.||+|.+..+..      .+|+|.+....  .......+.+|++++++++||||+++++++.+...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKK------MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCc------EEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            58889999999999999998765433      49999987542  22345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++|+||+.+++|.+++...  .++++..+..++.|++.||.|||.++  ++|+||+|+||++++++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            99999999999999998665  36899999999999999999999977  999999999999999999999999998865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ....   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........+.    .          .
T Consensus       151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~----------~  213 (258)
T cd05578         151 TPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----A----------K  213 (258)
T ss_pred             CCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----H----------H
Confidence            4432   123356889999999999888999999999999999999999999866532111110    0          0


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM--RDIVD  390 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl~  390 (429)
                      ... .....+...+..+.+++.+||..||.+||++  +|+++
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         214 QET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             hcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            000 1122233456889999999999999999999  77664

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.2e-38  Score=302.44  Aligned_cols=267  Identities=24%  Similarity=0.280  Sum_probs=200.4

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh----hhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY----QGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +|++.+.||+|+||.||+|.+..++      ..|++|.+......    .....+..|+.+++.++|+||+++++++.+.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETG------RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCC------cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence            4778899999999999999876543      34999998764322    2234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+ +|+|.+++.... ..+++..+..++.|++.||+|||+++  ++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeee
Confidence            9999999999 899999986654 36899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-HHhHhhHHHhhh-
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKK-  345 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~-  345 (429)
                      .......  ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||........... ............ 
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         151 SFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            6644321  1223456888999998865 4678999999999999999999888875543221100 000000000000 


Q ss_pred             ---hhhhhcCCCCCCC-----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 ---KLLNIIDPRLEGD-----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ---~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         .+...........     .....+..+.+++.+||..+|++|||+.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence               0000000000000     112346788999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=287.04  Aligned_cols=254  Identities=28%  Similarity=0.398  Sum_probs=204.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  190 (429)
                      ++.+.+..||.|+.|.||++....++      ...|||.+....+.+..+.++..+.++.+.+ .|.||+.+|+|..+..
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~------~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTG------HIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccc------eEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            34555678999999999999877654      3499999988877777788888888887775 8999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++-||.|.  .-.+.|..+...++++..+-++...++.||.||.. .++|+|||+||+|||+|+.|++|+||||++..+
T Consensus       166 V~IcMelMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  166 VFICMELMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             HHHHHHHHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeeccccccee
Confidence            999999983  44444544555679999999999999999999985 234999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      .+..   ..+...|-+.|||||.+.   ...|+.++||||||++++||.||+.||...+...+  ..          ..+
T Consensus       243 vdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~l----------tkv  307 (391)
T KOG0983|consen  243 VDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VL----------TKV  307 (391)
T ss_pred             eccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HH----------HHH
Confidence            5532   345578999999999996   45799999999999999999999999987653221  00          111


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+...|.+...  ..++..+.+++..||++|+.+||...+++++
T Consensus       308 ln~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  308 LNEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             HhcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            22222333332  2378899999999999999999999999987

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7e-39  Score=309.34  Aligned_cols=273  Identities=23%  Similarity=0.294  Sum_probs=200.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC--
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  188 (429)
                      +++|++.+.||+|+||.||+|.+..++      ..||+|.+...........+.+|+.++++++||||+++++++...  
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTG------VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF   77 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCC------CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence            568999999999999999999876543      349999986543344556678899999999999999999887543  


Q ss_pred             ---CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          189 ---EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       189 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                         ...++++||+. ++|...+...   .+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          78 ESFNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             cccceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECccc
Confidence               35799999996 4787766433   5899999999999999999999987  9999999999999999999999999


Q ss_pred             CCcCCCCCCCc-cccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          266 LAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       266 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ++......... .......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+............... .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-~  230 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-S  230 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-C
Confidence            98765432211 11223578999999998754 568999999999999999999999997654322111000000000 0


Q ss_pred             hhhhhhhcC-----------CCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--ccccc
Q 014189          344 KKKLLNIID-----------PRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQ  396 (429)
Q Consensus       344 ~~~~~~~~~-----------~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~  396 (429)
                      ......+.+           ......   .....+..+.+++.+||+.+|++|||+.+++++  |+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            000000000           000000   011235678999999999999999999999998  55443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.6e-38  Score=301.51  Aligned_cols=249  Identities=28%  Similarity=0.366  Sum_probs=197.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..|...+.||+|+||.||+|....++      ..||+|.+....  .......+.+|+++++.++||||+++++++...+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~   88 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTN------EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH   88 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCC------cEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence            45888899999999999999876543      349999876432  3334467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~  164 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASL  164 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCccee
Confidence            9999999997 57777665433 36899999999999999999999977  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ....      ....|+..|+|||++.   ...++.++||||||+++|||+||..||...+.......             
T Consensus       165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-------------  225 (307)
T cd06607         165 VSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------------  225 (307)
T ss_pred             cCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-------------
Confidence            4322      2346888999999884   45688999999999999999999999976543211000             


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      ......+   ...+...+..+.+++.+||..+|++||++.+++.+.
T Consensus       226 ~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         226 IAQNDSP---TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             HhcCCCC---CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            0000001   111223566799999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-38  Score=301.56  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=202.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|.+.+.||+|+||.||+|....+.      ..+++|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATG------QEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCC------CEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            57889999999999999999765443      339999886442 23346678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++|+||+++|+|.+++...   .+++..+..++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            9999999999999988653   4788999999999999999999977  9999999999999999999999999887654


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  ......|++.|+|||.+.+..++.++|+||||+++|++++|+.||...+.......      ..         .
T Consensus       167 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~---------~  229 (293)
T cd06647         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IA---------T  229 (293)
T ss_pred             cccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hh---------c
Confidence            3221  12335688999999999888899999999999999999999999976543211000      00         0


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ........+...+..+.+++.+||..+|++||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000111122345678899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.7e-38  Score=306.83  Aligned_cols=277  Identities=26%  Similarity=0.349  Sum_probs=202.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      +.++|++.+.||+|+||.||+|.+..++      ..+|+|.+.... .......+.+|+.+++++ +||||+++++++..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~   78 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTK------EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA   78 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCC------eEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence            4567889999999999999999875443      348999875431 223345567899999999 99999999999864


Q ss_pred             C--CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          188 D--EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       188 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                      .  ...++||||++ ++|.+++...   .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          79 ENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             CCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeecc
Confidence            3  46899999997 5898887654   6888999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCc---cccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh--
Q 014189          266 LAKDGPEGDKS---HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--  339 (429)
Q Consensus       266 la~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--  339 (429)
                      ++.........   .......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            98865433211   12234568999999998764 5678999999999999999999999976543322111000000  


Q ss_pred             ------HHH--hhhhhhhhc-CCCC--CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCC
Q 014189          340 ------LLK--EKKKLLNII-DPRL--EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       340 ------~~~--~~~~~~~~~-~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                            .+.  ......... ....  ........+..+.+++.+||+.||++|||+.+++.+  +..+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                  000  000000000 0000  000111246789999999999999999999999987  4444443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-38  Score=298.61  Aligned_cols=247  Identities=26%  Similarity=0.367  Sum_probs=195.8

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      ||+|+||+||+|....+++      .+|+|.+....  .......+.+|+++++.++||||+++++.+...+..|+||||
T Consensus         1 lg~g~~g~vy~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVKATGK------MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEcCCCc------EEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEec
Confidence            6999999999997665433      49999886532  222345567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++++|.+++.......+++..+..++.|++.||.|||..+  ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---  149 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---  149 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---
Confidence            99999999997665557899999999999999999999977  9999999999999999999999999987654321   


Q ss_pred             ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCC
Q 014189          278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  357 (429)
Q Consensus       278 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (429)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........       +.     .....  ...
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~-----~~~~~--~~~  215 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------LK-----RRTLE--MAV  215 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------HH-----hcccc--ccc
Confidence            12234678899999999888899999999999999999999999976543111000       00     00000  111


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          358 DYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       358 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      ..+...+..+.+++.+||+.+|++||     ++.+++.+
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            22334577889999999999999999     66667764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.5e-38  Score=295.85  Aligned_cols=245  Identities=26%  Similarity=0.332  Sum_probs=198.6

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      ||.|+||.||+|.+..+      +..+++|++.....  ......+.+|+.+++.++||||+++++++.++...+++|||
T Consensus         1 lg~g~~~~v~~~~~~~~------~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKSK------NRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECCC------CcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence            69999999999987653      34499999875432  23446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++++|.+++....  .+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---  147 (262)
T cd05572          75 CLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---  147 (262)
T ss_pred             CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence            99999999987653  5889999999999999999999977  9999999999999999999999999998765432   


Q ss_pred             ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCC
Q 014189          278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  357 (429)
Q Consensus       278 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (429)
                      ......|+..|++||.+.+..++.++|+||||+++|+|++|..||........    ..          ...+.......
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~----------~~~~~~~~~~~  213 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EI----------YNDILKGNGKL  213 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HH----------HHHHhccCCCC
Confidence            12235688999999999888899999999999999999999999986542110    00          11111111122


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          358 DYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       358 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                      ..+...+..+.+++.+||+.+|++||+     ++|++++
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            334444778999999999999999999     7888764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-40  Score=290.60  Aligned_cols=254  Identities=22%  Similarity=0.245  Sum_probs=203.2

Q ss_pred             HHhcCCccc-eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEE
Q 014189          109 IITANFRQD-RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  186 (429)
Q Consensus       109 ~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  186 (429)
                      .++++|.+. ++||-|-.|.|-.+.++.+++.      +|+|++....      ...+|+++--.. .|||||.++++|.
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ek------fALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVye  125 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEK------FALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYE  125 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhh------hHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhh
Confidence            356677664 6899999999999988777655      9999886542      233677765444 5999999999885


Q ss_pred             e----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCcE
Q 014189          187 E----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNA  259 (429)
Q Consensus       187 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~~  259 (429)
                      +    ...+.+|||.|+||.|.+.+..++...+++.++..|+.||+.|+.|||+.+  |.||||||+|+|...   |..+
T Consensus       126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~l  203 (400)
T KOG0604|consen  126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPL  203 (400)
T ss_pred             hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcce
Confidence            3    457789999999999999999999889999999999999999999999988  999999999999964   4569


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      ||+|||+|+.....   ....+.+-|+.|.|||++....|+...|+||+||++|-|++|.+||.......-       .+
T Consensus       204 KLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-------sp  273 (400)
T KOG0604|consen  204 KLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------SP  273 (400)
T ss_pred             EecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------Ch
Confidence            99999999976532   224457899999999999999999999999999999999999999976543110       00


Q ss_pred             HHHhhhhhhhhcCC--CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          340 LLKEKKKLLNIIDP--RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       340 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      -++     .++...  ....+-....+....++++.+|..+|.+|.|+++++++
T Consensus       274 gMk-----~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  274 GMK-----RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             hHH-----hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            011     111111  11222234678899999999999999999999999987

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.8e-39  Score=302.95  Aligned_cols=249  Identities=23%  Similarity=0.310  Sum_probs=198.2

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  193 (429)
                      |.....||+|+||.||+|....+.      ..||+|.+.... ......+.+|+.++..++||||+++++++..++..++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~------~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i   95 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSG------RQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV   95 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCC------CEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence            334457999999999999765443      349999986542 2334567889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCC
Q 014189          194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  273 (429)
Q Consensus       194 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  273 (429)
                      +|||+++++|..++...   .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++......
T Consensus        96 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          96 LMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             EEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            99999999999877542   5889999999999999999999977  999999999999999999999999998754432


Q ss_pred             CCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCC
Q 014189          274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  353 (429)
Q Consensus       274 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (429)
                      ..  ......|+..|+|||++.+..++.++||||||+++|||++|+.||...........       +.      .....
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-------~~------~~~~~  235 (297)
T cd06659         171 VP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-------LR------DSPPP  235 (297)
T ss_pred             cc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------Hh------ccCCC
Confidence            21  12335789999999999988999999999999999999999999975543211100       00      00000


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          354 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       354 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ........+..+.+++.+||+.+|++||++++++++
T Consensus       236 --~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         236 --KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             --CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              011122345678899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-40  Score=317.42  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=198.0

Q ss_pred             ccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe--EE
Q 014189          115 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH--RV  192 (429)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~  192 (429)
                      +...+||+|+|-+||+|.+..++-+   -.--.+|+-.........+.|..|+.+|+.|+||||++++++|.+...  +.
T Consensus        43 k~~evLGrGafKtVYka~De~~giE---VAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIE---VAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchh---hHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence            4457899999999999987655432   111234554445566777889999999999999999999999986554  77


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC-CCcEEEeccCCCcCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDGP  271 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~  271 (429)
                      +|.|.|..|+|..|+.+..  ..+......|+.||+.||.|||++.+||||||||-+||+|+. -|.|||+|+|||....
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            8999999999999997765  577788999999999999999999999999999999999975 5889999999998764


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ...    .....|||.|||||+.. ..|++.+||||||.+++||+|+..||.......     +.+.++...       +
T Consensus       198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-----QIYKKV~SG-------i  260 (632)
T KOG0584|consen  198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-----QIYKKVTSG-------I  260 (632)
T ss_pred             ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-----HHHHHHHcC-------C
Confidence            422    23378999999999776 889999999999999999999999998654322     222221111       1


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .|   ..+..--..++.++|.+||.. .++|||+.|+|++
T Consensus       261 KP---~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  261 KP---AALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CH---HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            00   001111135788999999999 9999999999976

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=299.09  Aligned_cols=267  Identities=21%  Similarity=0.253  Sum_probs=199.8

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      |++.+.||.|++|.||+|.+..++      ..|++|++...... .....+.+|+.+++.++|||++++++++.+.+..+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTG------EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCC------CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            567789999999999999876543      34999988654322 23356778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      ++|||++ ++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            9999995 68999887655456899999999999999999999977  99999999999999999999999999976533


Q ss_pred             CCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhh-hHHHhHhhHHHhh------
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ-NLADWALPLLKEK------  344 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~------  344 (429)
                      ...  ......++..|+|||++.+. .++.++|+||||+++|+|++|+.||......... ....+........      
T Consensus       152 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         152 PVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             Ccc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence            211  12234568899999988754 5789999999999999999999999765432211 1111000000000      


Q ss_pred             -hhhhhhcCCC---CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 -KKLLNIIDPR---LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 -~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       ......+...   .........+..+.+++.+||+.+|++|||++|++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             0000000000   0001122345788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.3e-38  Score=298.65  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=200.0

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|...+.||+|++|.||+|....+.      ..+++|.+... .......+.+|+.+++.++||||+++++++...+..+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~   92 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTG------RQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELW   92 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCC------CEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEE
Confidence            3555689999999999999765443      34999987644 2334456789999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +++||+++++|.+++..   ..+++..+..++.|++.||+|||+++  ++||||+|+||+++.++.++|+|||++.....
T Consensus        93 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          93 VVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             EEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            99999999999998866   25889999999999999999999987  99999999999999999999999998875443


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...++....      ..       ......
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~-------~~~~~~  232 (285)
T cd06648         168 EVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KR-------IRDNLP  232 (285)
T ss_pred             CCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HH-------HHhcCC
Confidence            211  123356899999999999888999999999999999999999999765432111      00       001111


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +...  .+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       233 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         233 PKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            1111  122356789999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-38  Score=298.48  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=205.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|+..+.||+|+||.||+|.+....      ..+++|++.....  ....+.+|+++++.++|+|++++++++....
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   88 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATG------KEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGD   88 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCC------cEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC
Confidence            3456888899999999999999876433      3499999876533  4567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++++||+++++|.+++.... ..+++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          89 ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            9999999999999999987654 36899999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ......  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+.....  ..          ...
T Consensus       166 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~----------~~~  231 (286)
T cd06614         166 LTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LI----------TTK  231 (286)
T ss_pred             hccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HH----------Hhc
Confidence            543221  1233467889999999998889999999999999999999999997654321110  00          000


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...   ....+...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       232 ~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         232 GIP---PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CCC---CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            000   011112256788999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.5e-38  Score=297.87  Aligned_cols=268  Identities=23%  Similarity=0.288  Sum_probs=200.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|+..+.||.|++|.||+|.+..++      ..||+|.+...........+.+|+.++++++||||+++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTG------EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCC------eEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEE
Confidence            5888899999999999999876543      3499999876544444556778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          193 LIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +||||+++ +|.+++.... ...+++..+..++.|++.||+|||+.+  ++|+||||+||++++++.++|+|||++....
T Consensus        75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            99999985 8888876543 246899999999999999999999977  9999999999999999999999999987543


Q ss_pred             CCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh-HHHhHhhHHHhhh-hhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWALPLLKEKK-KLL  348 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~-~~~  348 (429)
                      ....  ......++..|++||.+.+ ..++.++||||||+++|+|++|..||...+...... ............. .+.
T Consensus       152 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         152 IPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             CCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            3211  1223467889999998865 457899999999999999999999998655322111 0000000000000 000


Q ss_pred             h--hcCCCCCC-------CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 N--IIDPRLEG-------DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~--~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .  ........       ......+..+.+++.+||+.||.+||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0  00000000       0011335678899999999999999999999865

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.3e-38  Score=307.87  Aligned_cols=267  Identities=20%  Similarity=0.283  Sum_probs=199.6

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .+..+|+..+.||+|+||.||+|.+..+.+      .||+|.+.... .......+.+|+.++++++||||+++++++..
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQ------NVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCC------EEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            355789999999999999999998765543      49999986532 23344567789999999999999999998864


Q ss_pred             C------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          188 D------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       188 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                      .      ...|+||||+. ++|.+.+...    ++...+..++.|++.||+|||+.+  ++||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL  159 (353)
T cd07850          87 QKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  159 (353)
T ss_pred             CCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEE
Confidence            3      35799999996 5788777532    788889999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-H------
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-A------  334 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~------  334 (429)
                      +|||+++......   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....... .      
T Consensus       160 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  236 (353)
T cd07850         160 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP  236 (353)
T ss_pred             ccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999998654321   12335688999999999999999999999999999999999999976553221100 0      


Q ss_pred             --HhHh-------hHHHhhh-----hhhhhcCCCC----CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 --DWAL-------PLLKEKK-----KLLNIIDPRL----EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 --~~~~-------~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .+..       .......     .....+....    ....+...+..+.+++.+||+.||++|||+.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000       0000000     0000000000    000012346678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=293.26  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=200.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC----CChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD----NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .+|++.+.||+|+||.||+|.+..+.      ..+++|.+...    ........+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTG------RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCC------CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            47889999999999999999876543      34999987532    123344678899999999999999999999875


Q ss_pred             C--CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          188 D--EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       188 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                      .  ..+++++||+++++|.+++....  .+++.....++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccc
Confidence            3  46889999999999999887543  5788899999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCC-ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          266 LAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       266 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      +++....... ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||........              
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------  217 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--------------  217 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--------------
Confidence            9986532111 1112235689999999999988899999999999999999999999975432110              


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .............+...+..+.+++.+||. +|..||++.+++.+
T Consensus       218 --~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         218 --IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             --HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence              111111111223345567889999999999 57999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-38  Score=298.70  Aligned_cols=244  Identities=24%  Similarity=0.322  Sum_probs=189.0

Q ss_pred             eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHh---ccCCCceeeeeeEEEeCCeEEE
Q 014189          119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLG---HLSHPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~l  193 (429)
                      +||+|+||.||++....+.      ..+|+|.+.....  ......+.+|..++.   ..+||||+.+++++...+..++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTG------KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEECCCC------cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence            4899999999999865543      3499998865422  122233444544433   3479999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCC
Q 014189          194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  273 (429)
Q Consensus       194 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  273 (429)
                      ||||+++|+|.+++..+.  .+++..+..++.|++.||+|||+.+  ++|+||||+|||+++++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          75 ILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            999999999998886553  6899999999999999999999977  999999999999999999999999998754332


Q ss_pred             CCccccccccCCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          274 DKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       274 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      .    .....||..|+|||.+. +..++.++|||||||++|+|++|..||.............           ..    
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-----------~~----  211 (279)
T cd05633         151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----------MT----  211 (279)
T ss_pred             C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-----------Hh----
Confidence            1    22346899999999986 4568999999999999999999999997543221111000           00    


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      .......+...+.++.+++.+||..||++||     |+++++++
T Consensus       212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         212 LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            0111223345667889999999999999999     69999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.3e-38  Score=300.72  Aligned_cols=255  Identities=27%  Similarity=0.377  Sum_probs=201.1

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .|...+.||+|+||.||+|.+..+.      ..+|+|.+....  .......+.+|+.+++.++|||++++++++..+..
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~------~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTN------EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT   99 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCC------cEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence            3667789999999999999876543      349999886532  23344578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+. |+|.+.+... ..++++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.+||+|||++...
T Consensus       100 ~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         100 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             EEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            999999997 5777776543 336899999999999999999999977  999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ..      .....|+..|+|||.+.   .+.++.++|||||||++|||++|..||.........                
T Consensus       176 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~----------------  233 (317)
T cd06635         176 SP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------------  233 (317)
T ss_pred             CC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH----------------
Confidence            32      12346889999999974   456899999999999999999999998754322110                


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                      ..+.............+..+.+++.+||+.+|.+||++.+++.++..+...+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         234 YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            0000001111112245667899999999999999999999999876655543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-39  Score=324.03  Aligned_cols=277  Identities=19%  Similarity=0.224  Sum_probs=192.0

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcC---------cee----EEEEEecCCCChhhHHHHHHHHHHHhccCC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQ---------PVP----VAVKVHDGDNSYQGHREWLAEVIFLGHLSH  175 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~---------~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h  175 (429)
                      .+..+|++.+.||+|+||.||+|.+.........         +..    ++.|...  ........+.+|+.+|++++|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK--AGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh--cchHHHHHHHHHHHHHHhCCC
Confidence            4567899999999999999999875432211000         000    1111111  122344567899999999999


Q ss_pred             CceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEE
Q 014189          176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV---LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  252 (429)
Q Consensus       176 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIl  252 (429)
                      |||+++++++...+..|+|++++. ++|.+++....   ...........++.|++.||+|||+++  |+||||||+|||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NIL  299 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIF  299 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence            999999999999999999999995 57777765432   112335667789999999999999977  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCCCChhhhh
Q 014189          253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK-SLDKSRPAREQ  331 (429)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~-p~~~~~~~~~~  331 (429)
                      ++.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|.. |+.........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999987644322 12234679999999999999999999999999999999999886 44433222222


Q ss_pred             hHHHhHhhHH--H-----hhhhhhhhcCCCCC----CCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          332 NLADWALPLL--K-----EKKKLLNIIDPRLE----GDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       332 ~~~~~~~~~~--~-----~~~~~~~~~~~~~~----~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+........  .     ....+...++....    ...+     ...+..+.+++.+||+.||++|||+.|++.+
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            2211111000  0     00001111110000    0000     1123467788999999999999999999976

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-39  Score=311.67  Aligned_cols=250  Identities=24%  Similarity=0.310  Sum_probs=211.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ....|.+...||+|.|+.|.+|++..+..+      ||+|++.+..-. ...+.+.+|+++|..++|||||+++.+....
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~------VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~  127 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTE------VAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE  127 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCce------EEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence            456799999999999999999987766444      999999886533 3335578999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ..+|+||||+.+|.+.+++....+  ..+..+..++.|+..+++|||+.+  |||||||++||||+.+.++||+|||++.
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFST  203 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccce
Confidence            999999999999999999987763  555888899999999999999977  9999999999999999999999999999


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      .+..+   ....+.+|++.|.|||++.+..| .+.+|+||+|++||.|+.|..||++....                   
T Consensus       204 ~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------  261 (596)
T KOG0586|consen  204 FFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------  261 (596)
T ss_pred             eeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------
Confidence            87643   33556899999999999999887 58999999999999999999999965421                   


Q ss_pred             hhhcCCCCCCC--CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          348 LNIIDPRLEGD--YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       348 ~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                       .+-++.+.+.  .+.-.+.++.+++.++|-.+|.+|++++++.++-
T Consensus       262 -~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  262 -ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             -cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence             1112222222  2334467788999999999999999999998774

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=334.69  Aligned_cols=259  Identities=23%  Similarity=0.244  Sum_probs=211.6

Q ss_pred             HHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeee
Q 014189          106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIG  183 (429)
Q Consensus       106 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~  183 (429)
                      +++.-.++|.+.++||+|+||.|.+++++.+.+      .+|+|++.+-.  .......|..|..+|..-+.+-|+.++-
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~------VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy  142 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEK------VYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY  142 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeecccc------chhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence            445556789999999999999999998877654      49999987621  1234457889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          184 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                      +|+++.++|+|||||+||+|..++....  .+|+..+.-++..++.||.-||+.|  +|||||||+|||||..|++||+|
T Consensus       143 AFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  143 AFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             HhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeecc
Confidence            9999999999999999999999887665  6999999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccc----c-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM----T-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      ||.+-..... ....+...+|||.|++||++.    + +.|++.+|+||+||++|||+.|..||...      .+..-+ 
T Consensus       219 FGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY-  290 (1317)
T KOG0612|consen  219 FGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETY-  290 (1317)
T ss_pred             chhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHH-
Confidence            9988766532 334456689999999999996    3 67999999999999999999999999743      222222 


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCC--hHHHHHHHHHHHHhhccCCCCCCC---HHHHHHhc
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYP--VKGVHKAAMLAYHCLNHNPKARPL---MRDIVDSL  392 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~L  392 (429)
                               .++++-.-...+|  .+.+.++.+||.+.+. +|+.|..   ++++-.|-
T Consensus       291 ---------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  291 ---------GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             ---------HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence                     2222221122333  3578899999988776 8888888   99998873

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.3e-38  Score=290.67  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=206.8

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeC--C
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--E  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  189 (429)
                      +|+..+.||+|++|.||+|.+..+.      ..+++|....... ......+.+|+.++++++||||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTG------ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCC------cEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            4777899999999999999876543      3499998876532 24456788999999999999999999999888  8


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++++||+++++|.+++....  .+++..+..++.+++.+|+|||+.+  ++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            9999999999999999987654  7899999999999999999999977  99999999999999999999999999887


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ..............++..|+|||.+.+..++.++||||||+++|+|++|..||.........               ...
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~  215 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA---------------LYK  215 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---------------HHh
Confidence            65433211123457889999999999888999999999999999999999999865511100               011


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..........+...+..+.+++.+|+..+|++||++.+++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            111111222344457889999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.7e-38  Score=300.71  Aligned_cols=268  Identities=21%  Similarity=0.253  Sum_probs=199.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCceeeeeeEEEeC--
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  188 (429)
                      ++|++.+.||.|+||.||+|.+..+.      ..+++|.+...... .....+.+|+.++++++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTG------EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCC------cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            46888899999999999999876543      34899988654322 2233567899999999999999999998877  


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ...|+||||++ ++|.+++..... .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++.
T Consensus        79 ~~~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          79 DKIYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             CcEEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCcee
Confidence            89999999997 589888765442 6899999999999999999999977  9999999999999999999999999988


Q ss_pred             CCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH-HhHhhHHHhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWALPLLKEKKK  346 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~  346 (429)
                      .......  ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||............ ..........+.
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         155 EYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            7654321  12335678899999998754 4689999999999999999999999865532211100 000000000000


Q ss_pred             ------------hhhhcCCCCCCCCChH-HHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 ------------LLNIIDPRLEGDYPVK-GVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ------------~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                  ........+...++.. .+..+.+++.+||+.+|++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                        0000000111112222 46778999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.6e-38  Score=288.83  Aligned_cols=251  Identities=28%  Similarity=0.408  Sum_probs=204.3

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|+..+.||+|++|.||++.+..+.      ..+++|+...... .....+.+|+.+++.++|+|++++++++......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTG------KEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCC------cEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            4778899999999999999876543      3499999876543 45567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +++||+++++|.+++.... ..+++..+..++.+++.+|.|||..+  ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        74 l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          74 IVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             EEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            9999999999999886653 46899999999999999999999977  99999999999999999999999999887654


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      ...   .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+........             .....
T Consensus       151 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~  214 (253)
T cd05122         151 TKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-------------ATNGP  214 (253)
T ss_pred             ccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------------HhcCC
Confidence            321   23457889999999999888999999999999999999999999865432111100             00000


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +.+  ......+..+.+++.+||+.||++|||+.+++++
T Consensus       215 ~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         215 PGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            001  1111235779999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.4e-38  Score=291.25  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=206.1

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|.+.+.||.|+||.||++.+..+      +..+++|.+..... ......+.+|+++++.++|||++++.+.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSD------GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCC------CcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            578889999999999999987653      33499999876432 24556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          192 VLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ++|+||+++++|.+++....  ...+++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceee
Confidence            99999999999999887643  357999999999999999999999977  99999999999999999999999999886


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .....  .......|++.|+|||.+.+..++.++|+||+|+++++|++|..||........      ...          
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~----------  214 (258)
T cd08215         153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------ALK----------  214 (258)
T ss_pred             cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH------HHH----------
Confidence            54432  123345789999999999988899999999999999999999999976542210      000          


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ... ......+...+..+.+++.+||..+|++|||+.+++++
T Consensus       215 ~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         215 ILK-GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             Hhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000 00112233556788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.4e-38  Score=293.08  Aligned_cols=250  Identities=24%  Similarity=0.316  Sum_probs=204.3

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|++.+.||+|+||.||++.+..+.      ..+++|.+.... .......+.+|+.+++.++|+||+++++++......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDN------QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCC------CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            4788899999999999999765543      348999886543 334456778899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          192 VLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ++||||+++++|.+++...  ....+++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.+||+|||++..
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhh
Confidence            9999999999999988652  2246899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ....    ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||...+......                 
T Consensus       153 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~-----------------  211 (256)
T cd08530         153 LKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY-----------------  211 (256)
T ss_pred             hccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----------------
Confidence            6543    1223568899999999999899999999999999999999999998655321100                 


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..........+...+.++.+++.+||..+|++|||+.+++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         212 KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000011112233566789999999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.7e-38  Score=298.43  Aligned_cols=269  Identities=20%  Similarity=0.252  Sum_probs=198.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|++|.||+|.+..++      ..+|+|.+..... ......+.+|++++++++||||+++++++.....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTN------ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCC------cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            46889999999999999999876543      3499998765432 2334567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC-CCcEEEeccCCCcC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKD  269 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~  269 (429)
                      .++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||+|+||+++. ++.+||+|||++..
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            999999996 58888876555445788888999999999999999977  999999999999985 56799999999976


Q ss_pred             CCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-HHhHhhHHHhhh--
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKK--  345 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~--  345 (429)
                      .....  .......+++.|+|||.+.+ ..++.++||||||+++|+|+||..||........... ...........+  
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        153 FGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             cCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            53321  11233467899999998876 4578999999999999999999999986543221110 000000000000  


Q ss_pred             --hhhhhcC--CCCCC----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 --KLLNIID--PRLEG----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 --~~~~~~~--~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .+.....  +....    ......+..+.+++.+||+.+|++||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0000000  00000    0112345678999999999999999999999975

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.8e-38  Score=299.28  Aligned_cols=269  Identities=21%  Similarity=0.233  Sum_probs=196.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccC-CCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+..+.+      .||+|........ .....+.+|+.+++.+. ||||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~------~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCc------EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            368889999999999999998765543      4999987654322 23356778999999995 699999999987666


Q ss_pred             e-----EEEEEEecCCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC-CCcEE
Q 014189          190 H-----RVLIYEFMARGSVENNLFSKV---LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAK  260 (429)
Q Consensus       190 ~-----~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~-~~~~k  260 (429)
                      .     .|+||||+++ +|.+++....   ...+++..+..++.|++.||.|||+.+  ++||||+|+||+++. ++.+|
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEE
Confidence            5     8999999985 7888876432   246899999999999999999999977  999999999999998 89999


Q ss_pred             EeccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh-HHHhHh
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWAL  338 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~-~~~~~~  338 (429)
                      |+|||++........  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ......
T Consensus       152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  229 (295)
T cd07837         152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG  229 (295)
T ss_pred             EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999876533211  1122357889999998865 457999999999999999999999997654322110 000000


Q ss_pred             hHHHhhh-hhhhhcC----CCC----CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          339 PLLKEKK-KLLNIID----PRL----EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       339 ~~~~~~~-~~~~~~~----~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ......+ ......+    +..    ........+..+.+++.+||..||.+|||+.|++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000000 0000000    000    000012356778999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-38  Score=305.28  Aligned_cols=275  Identities=23%  Similarity=0.295  Sum_probs=202.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  188 (429)
                      ..+|.+.+.||+|+||.||+|.+..+.      ..||+|.+.... .......+.+|+.+++.++||||+++++++... 
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETN------EKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCC------CeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            467999999999999999999865543      449999876532 222345567899999999999999999987643 


Q ss_pred             ----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          189 ----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       189 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                          ...++||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          78 REAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             ccccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcC
Confidence                35799999996 6888887654  36899999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH-hHhhHHH
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD-WALPLLK  342 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~-~~~~~~~  342 (429)
                      |++.......  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+......... .......
T Consensus       153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  230 (337)
T cd07858         153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE  230 (337)
T ss_pred             ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9998654322  11233568899999998865 568999999999999999999999997654321111100 0000000


Q ss_pred             hh------hhhhhh---cCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCC
Q 014189          343 EK------KKLLNI---IDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       343 ~~------~~~~~~---~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                      ..      ....+.   ......   .......+..+.+++.+||+.+|++|||+++++++  |+.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            00      000000   000000   01122456788999999999999999999999998  6655444

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.7e-38  Score=303.26  Aligned_cols=264  Identities=21%  Similarity=0.265  Sum_probs=194.8

Q ss_pred             eeecCC--CcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGG--GFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G--~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      ..||+|  +||+||+|.+...+      ..||+|+..... .....+.+.+|+.+++.++||||++++++|..++..++|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTG------TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCC------cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            346666  99999999875543      349999987543 333446778899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+.+|+|.+++.......+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.++++||+.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            99999999999887655556899999999999999999999977  9999999999999999999999998654322111


Q ss_pred             C-cc----ccccccCCcccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh--------
Q 014189          275 K-SH----VSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--------  339 (429)
Q Consensus       275 ~-~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--------  339 (429)
                      . ..    ......++..|+|||++.+.  .++.++|||||||++|||++|..||.........  ......        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~  233 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccc
Confidence            0 00    01112356679999999763  5789999999999999999999999765432211  000000        


Q ss_pred             -HHHhhh----------------------hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          340 -LLKEKK----------------------KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       340 -~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       ......                      ......+..+....+..++..+.+|+.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             000000                      0000011111222233567889999999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.4e-38  Score=296.49  Aligned_cols=263  Identities=16%  Similarity=0.182  Sum_probs=187.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhH----------HHHHHHHHHHhccCCCcee
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH----------REWLAEVIFLGHLSHPNLV  179 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~niv  179 (429)
                      ...+|.+.++||+|+||.||+|.+.++..   ....+++|+..........          .....+...+..+.|+|++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHC---INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcc---cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            34679999999999999999998765421   1223677764433211110          1122344455677899999


Q ss_pred             eeeeEEEeCC----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC
Q 014189          180 KLIGYCCEDE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT  255 (429)
Q Consensus       180 ~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~  255 (429)
                      ++++++....    ..++++|++. .++.+.+...  ...++..+..++.|++.||+|||+.+  ++||||||+|||++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~  161 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDG  161 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC
Confidence            9999765443    3467788774 3566555433  24678888999999999999999977  999999999999999


Q ss_pred             CCcEEEeccCCCcCCCCCCCc-----cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh
Q 014189          256 DYNAKLSDFGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  330 (429)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~  330 (429)
                      ++.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            999999999999865422111     112235699999999999999999999999999999999999999986532211


Q ss_pred             h-hH--HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          331 Q-NL--ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       331 ~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      . ..  .++.          .++.....   .....+..+.+++..|+..+|++||+++++++.|+
T Consensus       242 ~~~~~~~~~~----------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDFI----------KRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHHH----------HHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1 00  0111          11111111   11234577899999999999999999999998763

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=300.46  Aligned_cols=272  Identities=22%  Similarity=0.287  Sum_probs=197.2

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC--
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  188 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  188 (429)
                      .|++.+.||+|+||.||+|.....    ..+..+|+|.+....  .......+.+|+.+++.++||||+++++++...  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC
Confidence            477889999999999999987652    123459999987632  122234567899999999999999999999887  


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC----CCcEEE
Q 014189          189 EHRVLIYEFMARGSVENNLFSKV---LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT----DYNAKL  261 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~----~~~~kl  261 (429)
                      ...++||||+++ +|.+.+....   ...+++..+..++.|++.||+|||+.+  ++||||||+||+++.    ++.+||
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          77 KSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             ceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEE
Confidence            889999999975 6766664322   236889999999999999999999977  999999999999999    999999


Q ss_pred             eccCCCcCCCCCCC-ccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhh-------hhh
Q 014189          262 SDFGLAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR-------EQN  332 (429)
Q Consensus       262 ~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~-------~~~  332 (429)
                      +|||++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|++||.......       ...
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            99999886543222 112233568899999998876 458999999999999999999999997554322       001


Q ss_pred             HHHhHhhH----------HHhhhhhhhhcCCCCCCCCC-----------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          333 LADWALPL----------LKEKKKLLNIIDPRLEGDYP-----------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       333 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +......+          ...........+.......+           ...+..+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            11000000          00000000000000000111           0334678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.9e-38  Score=299.83  Aligned_cols=269  Identities=25%  Similarity=0.260  Sum_probs=197.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCceeeeeeEEEeC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  188 (429)
                      .++|++.+.||+|+||.||+|.+..++      ..||+|.+...... .....+.+|+.++++++|+||+++++++... 
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSG------EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH   79 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCC------cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence            357999999999999999999876543      34999988654322 2223456799999999999999999998754 


Q ss_pred             -CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          189 -EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       189 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                       +..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          80 LDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             CCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcccee
Confidence             56899999996 47888776532 46899999999999999999999988  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH-HhHhhHHHhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWALPLLKEKK  345 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~  345 (429)
                      ........  ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||...+........ ..........+
T Consensus       156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         156 RTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             eecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            87643221  1222346788999999875 56899999999999999999999999866543221111 00000000000


Q ss_pred             hhhhhcCC----CCCCC-------CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDP----RLEGD-------YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~----~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ........    .+...       .....+..+.+++.+||+.||++|||+++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000000    00000       001235678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=293.06  Aligned_cols=266  Identities=25%  Similarity=0.320  Sum_probs=199.3

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  192 (429)
                      |++.+.||+|+||.||+|......+      .|++|.+.............+|+..+++++ ||||+++++++..++..+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGE------LVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCc------EEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence            5677899999999999998765433      499998865533233334557999999998 999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +||||+ +|+|.+++.......+++..+..++.|++.+|.|||+++  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            999999 789999887665456899999999999999999999977  99999999999999999999999999886543


Q ss_pred             CCCccccccccCCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh-HHHhHhhH----HHhhhh
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWALPL----LKEKKK  346 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~-~~~~~~~~----~~~~~~  346 (429)
                      ...   .....++..|+|||++. +..++.++|+||||++++||++|++||.......... ...+....    +.+...
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         152 RPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            221   22356888999999885 4567999999999999999999999997654322111 00000000    000000


Q ss_pred             hhhhcCCCCCCC-------CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGD-------YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....+..+...       .....+..+.+++.+||+.+|++|||++|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000111010000       011124678999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.2e-38  Score=298.04  Aligned_cols=271  Identities=24%  Similarity=0.280  Sum_probs=196.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .++|++.+.||+|+||.||+|....+.      ..||+|.+..... ......+.+|+.++++++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTK------QIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCC------cEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            357999999999999999999866543      4499998765422 222334568999999999999999999886543


Q ss_pred             --------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          190 --------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       190 --------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                              ..++||||+. ++|.+.+.... ..+++.++..++.|++.||+|||+++  ++|+||||+||+++.++.+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             ccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEE
Confidence                    4599999996 47887775443 36899999999999999999999987  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCc--cccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          262 SDFGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      +|||++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|..||................
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999765432211  112234678899999988764 47889999999999999999999998665433222211110


Q ss_pred             hHHHhh----hhhhhhcCC-CCCCCC---------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          339 PLLKEK----KKLLNIIDP-RLEGDY---------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       339 ~~~~~~----~~~~~~~~~-~~~~~~---------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ......    .......+. ......         .......+.+|+.+||..||.+|||+++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000000    000000000 000000         00124567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.6e-38  Score=295.99  Aligned_cols=252  Identities=27%  Similarity=0.359  Sum_probs=195.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..+|+|.+...........+..|+.++.+.. ||||+++++++.....
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTG------HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCC------eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            56888899999999999999876543      3499999876544445556677887777775 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+++|||+. ++|.+.+.... ..+++..+..++.+++.||+|||+ .+  ++||||+|+||++++++.+||+|||++..
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchh
Confidence            999999985 46776654433 378999999999999999999997 46  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCcccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGH----LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ......   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.......+ .+            
T Consensus       165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~------------  228 (296)
T cd06618         165 LVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VL------------  228 (296)
T ss_pred             ccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HH------------
Confidence            543221   22345788999999987553    88999999999999999999999975322110 00            


Q ss_pred             hhhhhcCCCC-CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRL-EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ........ .......++.++.+++.+||..||++||++++++.+
T Consensus       229 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         229 --TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             --HHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              00111100 001111356778999999999999999999999977

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.8e-38  Score=304.00  Aligned_cols=270  Identities=21%  Similarity=0.302  Sum_probs=201.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  187 (429)
                      ..+|++.+.||+|+||.||+|....++.      .||+|.+.... .......+.+|+.++++++||||+++++++..  
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~------~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   77 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGK------KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG   77 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCC------EEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence            4689999999999999999998765543      49999887543 22344567789999999999999999998753  


Q ss_pred             --CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          188 --DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       188 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                        ....++||||+. |+|.+++....  .+++..+..++.|++.||+|||..+  ++||||||+||+++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          78 ADFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             CCCceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccc
Confidence              357899999995 68888876543  5899999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCc--cccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH--
Q 014189          266 LAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL--  340 (429)
Q Consensus       266 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~--  340 (429)
                      ++.........  .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..............  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~  232 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS  232 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence            98765432211  11233578999999999865 56899999999999999999999999766543221111100000  


Q ss_pred             ---HH--hhhhhhhh---cCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 ---LK--EKKKLLNI---IDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ---~~--~~~~~~~~---~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ..  ......+.   ........   .....+..+.+++.+||+.+|++|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               00  00000000   11000000   112346789999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=286.11  Aligned_cols=250  Identities=29%  Similarity=0.458  Sum_probs=204.4

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|++.+.||+|++|.||+|.+....      ..+++|....... ......+.+|++++++++|||++++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETG------DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCC------cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            4778899999999999999765543      3499999876532 24456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +++|||+++++|.+++...  ..+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            9999999999999988665  36899999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      .....  .....++..|+|||.+.+..++.++||||||+++|+|++|..||........  ..           ....  
T Consensus       151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~-----------~~~~--  213 (254)
T cd06627         151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LF-----------RIVQ--  213 (254)
T ss_pred             CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HH-----------HHhc--
Confidence            43321  2335789999999999888899999999999999999999999975442111  00           0000  


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ......+...+..+.+++.+||..+|++|||+.+++.+
T Consensus       214 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         214 --DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             --cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence              01112233456788999999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3e-39  Score=287.26  Aligned_cols=276  Identities=23%  Similarity=0.298  Sum_probs=199.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhh-HHHHHHHHHHHhccCCCceeeeeeEEEe-CC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNLVKLIGYCCE-DE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  189 (429)
                      ..|+....||+|+||.||+|.-+++...  ....+|+|.++....... .....+|+.+++.++|||++.+..+|.+ +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k--r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK--RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcc--cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            4688899999999999999965443221  133589998876532222 2334589999999999999999998876 78


Q ss_pred             eEEEEEEecCCCChhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC----CcEEEe
Q 014189          190 HRVLIYEFMARGSVENNLFSK---VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD----YNAKLS  262 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~----~~~kl~  262 (429)
                      ..++++||.+. +|...++.+   ....++...+..|+.||+.|++|||++-  |+||||||.|||+..+    |.|||+
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEee
Confidence            89999999986 788777533   2346889999999999999999999988  9999999999999877    899999


Q ss_pred             ccCCCcCCCCCCCcc-ccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh------HH
Q 014189          263 DFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN------LA  334 (429)
Q Consensus       263 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~------~~  334 (429)
                      |||+++.+.+.-... .....+-|.+|+|||.+.|. .|+.+.|||+.|||+.||+|-.+.|..........      -.
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999876543322 23446779999999999875 68999999999999999999988886543221110      00


Q ss_pred             HhHhhHH--------------HhhhhhhhhcCCCCCCCC--------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          335 DWALPLL--------------KEKKKLLNIIDPRLEGDY--------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       335 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      +.+..++              .+......-+........        ...-+....+|+.++|.+||-+|.|+++.+++.
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            0010000              000000000000000000        001123488999999999999999999999874

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=291.43  Aligned_cols=272  Identities=24%  Similarity=0.305  Sum_probs=226.9

Q ss_pred             hHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeee
Q 014189          104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG  183 (429)
Q Consensus       104 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  183 (429)
                      ..++..-..+++..-++-+|+||.||.|+|.+.. .....+.|.+|.++...+..+...++.|.-.+....|||+..+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEd-t~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREED-TYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccC-CcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            3455556677888889999999999999887542 223344578899888888888889999999999999999999999


Q ss_pred             EEEe-CCeEEEEEEecCCCChhhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          184 YCCE-DEHRVLIYEFMARGSVENNLFS------KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       184 ~~~~-~~~~~lv~e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      ++.+ ....+.+|.++.-|+|..+|..      ...+.++..+...++.|++.|++|||+++  +||.||..+|.+||+.
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh
Confidence            8864 4567889999999999999962      22345777888999999999999999988  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHH
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~  335 (429)
                      ..+||+|=.+++.....+..........+..||+||.+....|+.++|||||||+||||+| |+.|+-..++.+.     
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-----  507 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-----  507 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence            9999999999998877776666666677889999999999999999999999999999998 8899987766432     


Q ss_pred             hHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                                  ...+....+...|.+|+.+++.++.-||+.+|++||+++++..-|..+
T Consensus       508 ------------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  508 ------------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ------------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                        122222333445778999999999999999999999999999888654

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-37  Score=292.03  Aligned_cols=244  Identities=24%  Similarity=0.334  Sum_probs=188.8

Q ss_pred             eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh--hhHHHHHHHHH---HHhccCCCceeeeeeEEEeCCeEEE
Q 014189          119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--QGHREWLAEVI---FLGHLSHPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~l  193 (429)
                      .||+|+||.||+|....+.      ..||+|.+......  .....+..|..   .++...||||+++++++...+..++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTG------KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEecCC------CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence            4899999999999765543      34999988654211  12222334443   3444579999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCC
Q 014189          194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  273 (429)
Q Consensus       194 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  273 (429)
                      ||||+++|+|..++....  .+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++......
T Consensus        75 v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          75 ILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            999999999998886543  6899999999999999999999977  999999999999999999999999998765332


Q ss_pred             CCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          274 DKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       274 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      .    .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||............           ....   
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-----------~~~~---  212 (278)
T cd05606         151 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------RMTL---  212 (278)
T ss_pred             C----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-----------HHhh---
Confidence            1    2235789999999998754 6899999999999999999999999765322111100           0000   


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                       ......+...+..+.+++.+||..+|.+||     ++.+++++
T Consensus       213 -~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         213 -TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence             011122334567899999999999999999     99999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=293.32  Aligned_cols=267  Identities=24%  Similarity=0.290  Sum_probs=198.8

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC--Ce
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--EH  190 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  190 (429)
                      |++.+.||.|+||.||+|.+..+.      ..+|+|.+.... .......+.+|+.+++.++|||++++++++...  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTG------ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCC------eEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            567889999999999999876543      349999987653 233345678899999999999999999999887  89


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++ +|.+++.... ..+++..+..++.|++.||+|||..+  ++|+||+|+||++++++.+||+|||++...
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          75 IYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             EEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            9999999974 8888876543 36899999999999999999999977  999999999999999999999999999866


Q ss_pred             CCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH-HhHhhHHHhhh-hh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWALPLLKEKK-KL  347 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~-~~  347 (429)
                      ..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............ ..........+ ..
T Consensus       151 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         151 TKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             cCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence            54321 11223457889999998765 46799999999999999999999999866542211110 00000000000 00


Q ss_pred             hh-----hcCC------CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LN-----IIDP------RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~-----~~~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..     ...+      .+.......++..+.+++.+||..+|++||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00     0000      00000011136788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=288.08  Aligned_cols=244  Identities=24%  Similarity=0.277  Sum_probs=188.2

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHH-hccCCCceeeeeeEEEeCCeEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFL-GHLSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.||+|+||.||+|......      ..||+|.+.....  ......+..|..++ ...+|+|++++++++..++..++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTG------DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCC------CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence            57999999999999875543      3499999865421  12223344555544 455899999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||+|+||++++++.++|+|||++.....  
T Consensus        76 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  149 (260)
T cd05611          76 MEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--  149 (260)
T ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence            99999999999886543  6889999999999999999999977  99999999999999999999999999875432  


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                          .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.........      .... .     .  ...
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~-----~--~~~  211 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF------DNIL-S-----R--RIN  211 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-h-----c--ccC
Confidence                22356889999999998888999999999999999999999999765432110      0000 0     0  000


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH---HHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR---DIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~---evl~~  391 (429)
                      ........++..+.+++.+||+.+|++||++.   |++.+
T Consensus       212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            11111224567899999999999999999665   55443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=295.31  Aligned_cols=246  Identities=26%  Similarity=0.340  Sum_probs=201.3

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh--hHHHHHHHHHHHhcc-CCCceeeeeeEE
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ--GHREWLAEVIFLGHL-SHPNLVKLIGYC  185 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~  185 (429)
                      +-..+|..+.+||+|+||.|.+|.-+.+      ...+|||+++++...+  +.+--+.|-++|... +-|.++.++.+|
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgt------dELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF  419 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGT------DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF  419 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCc------chhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence            3456899999999999999999854433      3459999998764221  222334677788766 467899999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          186 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       186 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                      ++-+.+|+||||+.||+|.-+++.-+  .+.+..+.-++..||.||-+||+.+  ||+||||.+|||+|.+|++||+|||
T Consensus       420 QTmDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFG  495 (683)
T KOG0696|consen  420 QTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFG  495 (683)
T ss_pred             hhhhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecc
Confidence            99999999999999999998887655  5778888999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      +.+.--...  ..+.+++|||.|+|||++...+|+..+|+|||||+||||+.|++||++.+....               
T Consensus       496 mcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---------------  558 (683)
T KOG0696|consen  496 MCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---------------  558 (683)
T ss_pred             cccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---------------
Confidence            998644332  345679999999999999999999999999999999999999999998764321               


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL  384 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs  384 (429)
                       +..+.+..  -.+|...+.++.++....|.+.|.+|..
T Consensus       559 -F~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  559 -FQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -HHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence             12222222  2346677899999999999999999953

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-39  Score=312.47  Aligned_cols=203  Identities=33%  Similarity=0.462  Sum_probs=175.1

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC----
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE----  189 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  189 (429)
                      +...+.||+|+||.||+|+++.+++.      ||||.++........+.+.+|+++|++++|+|||+++++-++..    
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~------vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRL------VAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccc------hhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            44557899999999999987766554      99999988766677788899999999999999999999765433    


Q ss_pred             --eEEEEEEecCCCChhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC--CC--cEEEe
Q 014189          190 --HRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--DY--NAKLS  262 (429)
Q Consensus       190 --~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~--~~--~~kl~  262 (429)
                        ...+|||||.+|||...|.+ .+...|++.+.+.+..+++.||.|||.++  |+||||||.||++-.  +|  ..||+
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeee
Confidence              56899999999999999965 33456999999999999999999999988  999999999999843  23  37999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCh
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP  327 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltG~~p~~~~~~  327 (429)
                      |||.|+..+++.   ...+..||..|++||+.. .+.|+..+|.|||||++|+++||..||.....
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            999999887644   456789999999999998 48899999999999999999999999976543

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-38  Score=301.57  Aligned_cols=275  Identities=24%  Similarity=0.308  Sum_probs=205.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC--
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  189 (429)
                      +|++.+.||.|+||.||+|......      ..+++|.+..... ......+.+|+.+++.++||||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTG------RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCC------cEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            5788899999999999999865543      3499998876432 334467889999999999999999999987765  


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          190 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       190 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                         ..|++|||++ ++|.+++....  ++++..+..++.+++.||+|||+.+  ++|+||||+|||++.++.++|+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCc
Confidence               7899999997 57888876543  7999999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCc-cccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH--
Q 014189          267 AKDGPEGDKS-HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK--  342 (429)
Q Consensus       267 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~--  342 (429)
                      +......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....................  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            9876543210 112335678999999999887 889999999999999999999999987654321111000000000  


Q ss_pred             -----hhhhhhhhcC---CCC---CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCC
Q 014189          343 -----EKKKLLNIID---PRL---EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       343 -----~~~~~~~~~~---~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                           ........+.   ...   ........+..+.+++.+||+.+|++|||+++++.+  |+.++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                 0000000000   000   000112346778999999999999999999999987  5655554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=293.31  Aligned_cols=266  Identities=23%  Similarity=0.268  Sum_probs=200.8

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      |+..+.||.|++|.||+|.+..++      ..+++|.+...... .....+.+|+.++++++|+||+++++++..++..+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTG------EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCC------cEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            566789999999999999865443      34899988764322 33456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +||||+++ +|.+++.... ..+++..+..++.+++.||.|||..+  ++|+||||+||+++.++.++|+|||.+.....
T Consensus        75 ~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            99999975 8888776643 46899999999999999999999977  99999999999999999999999999876654


Q ss_pred             CCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH-h-HhhHHHhhhhhhh
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD-W-ALPLLKEKKKLLN  349 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~  349 (429)
                      ..  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+......... . ..+..........
T Consensus       151 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         151 PV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             Cc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            32  112235678899999998876 78999999999999999999999997665432211100 0 0000000000000


Q ss_pred             --------hcCCC--CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 --------IIDPR--LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 --------~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                              .....  .........+.++.+++.+||+.||.+||++++++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                    00000  0001122456789999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.4e-37  Score=294.24  Aligned_cols=246  Identities=23%  Similarity=0.330  Sum_probs=196.9

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      ..+||+|+||.||+|....++.      .||+|.+... .......+.+|+.+++.++|+||+++++++...+..+++||
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~------~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGK------LVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCe------EEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence            3579999999999998765433      4999987543 33445668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCc
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  276 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  276 (429)
                      |+++++|.+++...   .+++.....++.|++.+++|||+.+  ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        98 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-  171 (292)
T cd06657          98 FLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  171 (292)
T ss_pred             cCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence            99999999877433   5789999999999999999999977  99999999999999999999999999876543221 


Q ss_pred             cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCC
Q 014189          277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  356 (429)
Q Consensus       277 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (429)
                       ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........       .      .....+.+.
T Consensus       172 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-------~------~~~~~~~~~  237 (292)
T cd06657         172 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-------I------RDNLPPKLK  237 (292)
T ss_pred             -cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------H------HhhCCcccC
Confidence             12335688999999999888899999999999999999999999976543211110       0      011111110


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          357 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       357 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .....+..+.+++.+||..+|.+||++.+++.+
T Consensus       238 --~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         238 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             --CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence              112345678899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.3e-37  Score=293.27  Aligned_cols=246  Identities=28%  Similarity=0.389  Sum_probs=194.5

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      |...+.||+|+||.||+|....++      ..+++|.+....  .......+.+|+.+++.++|||++++++++.+....
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~------~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTN------EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCC------cEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            666788999999999999865543      349999886532  223345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      |+||||+. |+|.+.+.... .++++..+..++.|++.+|.|||+.+  ++|+||+|+||+++.++.+||+|||++....
T Consensus        97 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            99999996 57777775443 36899999999999999999999977  9999999999999999999999999986432


Q ss_pred             CCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .      .....|+..|+|||++.   ...++.++||||||+++|+|++|..||...+.......      .       .
T Consensus       173 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~------~-------~  233 (313)
T cd06633         173 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------I-------A  233 (313)
T ss_pred             C------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH------H-------H
Confidence            2      22357889999999984   45688999999999999999999999976543211100      0       0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....+   .......+..+.+++.+||+.+|.+||++.+++.+
T Consensus       234 ~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         234 QNDSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             hcCCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00001   11112334568899999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-37  Score=289.69  Aligned_cols=245  Identities=26%  Similarity=0.339  Sum_probs=194.7

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      ||.|+||.||+|.+..++      ..+++|.+.....  ......+.+|++++++++||||+++++.+......|++|||
T Consensus         1 lg~g~~~~vy~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTG------DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECCCC------CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEec
Confidence            689999999999876543      3499999875432  23456678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC--
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK--  275 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~--  275 (429)
                      +++++|.+++.+..  .+++..+..++.|++.||+|||..+  ++|+||+|+||++++++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          75 LPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            99999999887654  6899999999999999999999977  99999999999999999999999999876543211  


Q ss_pred             ----ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          276 ----SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       276 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                          ........++..|+|||.+....++.++||||||+++|+|++|..||.........      .          ...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~----------~~~  214 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------Q----------NIL  214 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------H----------HHh
Confidence                11223356888999999998888999999999999999999999999765432110      0          000


Q ss_pred             CCCCCCCCChH--HHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          352 DPRLEGDYPVK--GVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       352 ~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      ....  ..+..  .+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus       215 ~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         215 NGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             cCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            0011  11112  367889999999999999999994444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-37  Score=290.77  Aligned_cols=264  Identities=23%  Similarity=0.281  Sum_probs=196.2

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhcc---CCCceeeeeeEEEeCC
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHL---SHPNLVKLIGYCCEDE  189 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~  189 (429)
                      |++.+.||+|+||.||+|.+..+      +..+|+|.+...... .....+.+|+.++.++   +||||+++++++...+
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNT------GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCC------CCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            56788999999999999987653      334999998754322 2234455787777655   5999999999998777


Q ss_pred             e-----EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          190 H-----RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       190 ~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                      .     .+++|||+. ++|.+++.......+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.+||+||
T Consensus        75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEecc
Confidence            6     899999997 48988887654446899999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH---
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL---  341 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~---  341 (429)
                      |++........   .....++..|+|||.+.+..++.++|+|||||++|||++|.+||........  ...+.....   
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~  226 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPS  226 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCC
Confidence            99877643321   1234578899999999999999999999999999999999999986543221  111110000   


Q ss_pred             Hhhhhhh-----hhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          342 KEKKKLL-----NIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       342 ~~~~~~~-----~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .......     ........   .......+..+.+++.+||+.||++||++++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0000000     00000000   01112345778899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.3e-37  Score=287.99  Aligned_cols=248  Identities=22%  Similarity=0.207  Sum_probs=191.9

Q ss_pred             HHHhcCCccceee--cCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeE
Q 014189          108 RIITANFRQDRVL--GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGY  184 (429)
Q Consensus       108 ~~~~~~y~~~~~l--G~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  184 (429)
                      ....++|.+.+.+  |+|+||.||++....+.      ..+|+|.........      .|+.....+ +||||++++++
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~   77 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQ------KLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYS   77 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCC------cEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEE
Confidence            3445667776666  99999999999766543      348999876542211      122222222 69999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-cEEEec
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSD  263 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~D  263 (429)
                      +...+..++||||+++|+|.+++....  ++++..+..++.|++.||.|||+.+  ++||||||+||+++.++ .++|+|
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         78 VTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             EecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEec
Confidence            999999999999999999999987654  7999999999999999999999977  99999999999999998 999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ||++......      ....|+..|+|||++.+..++.++||||||+++|||++|..||....... .....+..     
T Consensus       154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-----  221 (267)
T PHA03390        154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK-----  221 (267)
T ss_pred             CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH-----
Confidence            9998764321      22468899999999999899999999999999999999999998443211 11111110     


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-HHHHHHh
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-MRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~  391 (429)
                            ....  ........+..+.+++.+||+.+|.+||+ +++++++
T Consensus       222 ------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        222 ------RQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ------hhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                  0010  11122346778999999999999999995 6999865

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-37  Score=299.41  Aligned_cols=271  Identities=21%  Similarity=0.310  Sum_probs=198.5

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|...+.||+|+||.||+|.+..++      ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~   86 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTG------EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSA   86 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCC------cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence            3578999999999999999999875543      349999886532 222335677899999999999999999998654


Q ss_pred             ------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 ------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                            ...++|+||+.. +|..++    ...+++..+..++.|++.||+|||+++  ++||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~  159 (342)
T cd07879          87 VSGDEFQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKIL  159 (342)
T ss_pred             ccCCCCceEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEe
Confidence                  346899999964 666554    225889999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh--
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--  339 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--  339 (429)
                      |||+++.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.............  
T Consensus       160 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (342)
T cd07879         160 DFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  234 (342)
T ss_pred             eCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998864321     123467889999999876 4689999999999999999999999986543221111000000  


Q ss_pred             --HHHh---hhhhhhhcC--CCC-CCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCC
Q 014189          340 --LLKE---KKKLLNIID--PRL-EGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       340 --~~~~---~~~~~~~~~--~~~-~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                        .+..   .........  +.. ....   ....+..+.+++.+||+.||++||++++++.+  ++.++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence              0000   000000000  000 0000   11245678899999999999999999999977  6666554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1e-37  Score=292.72  Aligned_cols=252  Identities=24%  Similarity=0.333  Sum_probs=204.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  188 (429)
                      ++|.+.+.||+|+||.||+|....+      +..+++|+.....  .......+.+|..++++++ ||||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~------~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKET------NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCC------CCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            3688899999999999999987654      3449999987532  2334466788999999998 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||.|||+++  ++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCcccc
Confidence            99999999999999999987654  6999999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCc------------------cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh
Q 014189          269 DGPEGDKS------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  330 (429)
Q Consensus       269 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~  330 (429)
                      ........                  .......|+..|+|||...+..++.++|+||||++++++++|..||........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            65432210                  112235678999999999888899999999999999999999999986542110


Q ss_pred             hhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH----HHHHHh
Q 014189          331 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM----RDIVDS  391 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~~  391 (429)
                        .              .....  .....+...+..+.+++.+||+.+|++|||+    ++++++
T Consensus       231 --~--------------~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         231 --F--------------QKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             --H--------------HHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence              0              00000  1112233446778999999999999999999    888765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.5e-37  Score=293.87  Aligned_cols=252  Identities=27%  Similarity=0.355  Sum_probs=197.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC--CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .|...+.||+|+||.||+|.+..+.      ..+++|.+...  ........+.+|+++++.++|+|++++++++.....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   89 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNS------EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCC------cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence            3666688999999999999876543      34899987642  233444568889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+. |+|.+.+.... .++++..+..++.+++.|+.|||+.+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceee
Confidence            999999996 67877765443 35889999999999999999999977  999999999999999999999999998764


Q ss_pred             CCCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ..      .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||..........               
T Consensus       166 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---------------  224 (308)
T cd06634         166 AP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---------------  224 (308)
T ss_pred             cC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH---------------
Confidence            32      12346889999999975   3567889999999999999999999986543211100               


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                       ...............+..+.+|+.+||..+|++||++++++.+-.-..
T Consensus       225 -~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         225 -HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             -HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence             000000111112245677899999999999999999999998854444

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=281.62  Aligned_cols=274  Identities=21%  Similarity=0.271  Sum_probs=208.5

Q ss_pred             CCccccChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-C
Q 014189           97 NPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-H  175 (429)
Q Consensus        97 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h  175 (429)
                      +....-.++++-.+++     +.||+|+|+.|--++...+..+      +|||++.+.. .-......+|++++.+++ |
T Consensus        68 ~ss~~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~E------YAVKiidKq~-gHsR~RvfREVe~f~~Cqgh  135 (463)
T KOG0607|consen   68 TSSLSGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKE------YAVKIIDKQP-GHSRSRVFREVETFYQCQGH  135 (463)
T ss_pred             cccccchHHHHHHhHH-----HHhcCccceeeeeeeeeccchh------hhhhhhhcCC-chHHHHHHHHHHHHHHhcCC
Confidence            4444556777777765     7899999999998876665444      9999998873 334556678999999996 9


Q ss_pred             CceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC
Q 014189          176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT  255 (429)
Q Consensus       176 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~  255 (429)
                      +||+.++++|++++.+|||||-|.||+|..+++.+.  .+++.++..+..+|+.||.|||..|  |.||||||+|||...
T Consensus       136 ~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~  211 (463)
T KOG0607|consen  136 KNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCES  211 (463)
T ss_pred             ccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecC
Confidence            999999999999999999999999999999997765  6899999999999999999999977  999999999999965


Q ss_pred             CCc---EEEeccCCCcCCCCCC-----CccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCC
Q 014189          256 DYN---AKLSDFGLAKDGPEGD-----KSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSL  322 (429)
Q Consensus       256 ~~~---~kl~Dfgla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~  322 (429)
                      -..   +|||||.|.--.....     ......+.+|+..|||||+..     ...|+.++|.||||+|||-||+|.+||
T Consensus       212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF  291 (463)
T KOG0607|consen  212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF  291 (463)
T ss_pred             CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence            544   8999998864322111     111223478999999999874     346899999999999999999999999


Q ss_pred             CCCChhhh----hhHHHhHhhHHHhhhhhhhhcCCCCCC--CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          323 DKSRPARE----QNLADWALPLLKEKKKLLNIIDPRLEG--DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       323 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+.-...-    -..-...++     .-+..+.+.....  .-...++.+..+++...|..++.+|.++.+++++
T Consensus       292 vG~Cg~dCGWdrGe~Cr~CQ~-----~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  292 VGHCGADCGWDRGEVCRVCQN-----KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             cCccCCcCCccCCCccHHHHH-----HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            86533110    000011111     1112222222211  1123578899999999999999999999999985

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-40  Score=336.38  Aligned_cols=256  Identities=27%  Similarity=0.352  Sum_probs=204.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ++-++....+||.|.||.||-|.+.++++      ..|+|-+..... ......+.+|..++..++|||+|+++|+-.+.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGe------llAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGE------LLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccc------hhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH
Confidence            33467778899999999999998776644      388887664332 33345567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..+|.||||.+|+|.+.+....  ..++.....+..|++.|++|||+++  ||||||||+||+++.+|.+|++|||.|.
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeeccccee
Confidence            99999999999999999885443  3556666677889999999999988  9999999999999999999999999998


Q ss_pred             CCCCCCC--ccccccccCCcccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          269 DGPEGDK--SHVSTRIMGTYGYAAPEYIMTG---HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       269 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      .......  ........||+.|||||++.+.   ....+.|||||||++.||+||+.||...+......+.         
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~--------- 1453 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH--------- 1453 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH---------
Confidence            7654321  1122347899999999999753   4567899999999999999999999866543221111         


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                             +-..-....|...+.+-.+++.+||..||+.|.++.|++++
T Consensus      1454 -------V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 -------VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -------HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                   11111233455678899999999999999999999999876

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.8e-37  Score=293.41  Aligned_cols=271  Identities=25%  Similarity=0.281  Sum_probs=199.0

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ...++|++.+.||+|+||.||+|.+..++      ..||+|.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~   77 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTG------ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTD   77 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCC------cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence            34578999999999999999999876543      3489999865432 2233456789999999999999999998876


Q ss_pred             CC----------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC
Q 014189          188 DE----------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       188 ~~----------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      ..          .+++|+||+++ +|...+... ...+++..+..++.|++.||+|||..+  |+|+||||+||++++++
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~  153 (302)
T cd07864          78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKG  153 (302)
T ss_pred             cchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCC
Confidence            54          78999999976 677766554 336899999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh
Q 014189          258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~  336 (429)
                      .+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|++||..............
T Consensus       154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~  232 (302)
T cd07864         154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR  232 (302)
T ss_pred             cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999999999986544321 11122356788999998865 4578999999999999999999999986543221111100


Q ss_pred             H-hhHHHhh-hhhhhh-----cCC------CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          337 A-LPLLKEK-KKLLNI-----IDP------RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       337 ~-~~~~~~~-~~~~~~-----~~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      . ....... ....+.     .+.      .... .....+..+.+++.+||+.+|++|||+++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0 0000000 000000     000      0000 011246788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.6e-37  Score=294.48  Aligned_cols=264  Identities=20%  Similarity=0.240  Sum_probs=194.1

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC-CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEE
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.+.+|.|+++.||++.  .      .+..+|+|++... ........+.+|+.+++.++||||+++++++...+..+++
T Consensus         6 i~~~~~~~~~v~~~~~~--~------~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   77 (314)
T cd08216           6 IGKCFEDLMIVHLAKHK--P------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV   77 (314)
T ss_pred             hhHhhcCCceEEEEEec--C------CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEE
Confidence            33445555565555543  2      2345999998765 3445567788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |||+++|+|.+++.......+++.....++.|++.||+|||+++  |+||||||+||+++.++.+||+|||.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~  155 (314)
T cd08216          78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG  155 (314)
T ss_pred             EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccc
Confidence            99999999999997655556899999999999999999999977  9999999999999999999999999886543211


Q ss_pred             C-----ccccccccCCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh----HHHh
Q 014189          275 K-----SHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP----LLKE  343 (429)
Q Consensus       275 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~----~~~~  343 (429)
                      .     ........++..|+|||++.+  ..++.++|+|||||++|||++|..||.........  .+....    .+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~  233 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCcccccc
Confidence            1     111123457889999999875  45889999999999999999999999865432211  000000    0000


Q ss_pred             ------hhhhhh----hcCCC----CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 ------KKKLLN----IIDPR----LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ------~~~~~~----~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            ......    ..++.    .........+.++.+|+.+||..||++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                  000000    00000    0111123446788999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.9e-37  Score=297.95  Aligned_cols=269  Identities=22%  Similarity=0.250  Sum_probs=195.6

Q ss_pred             cCCc-cceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh-------------hHHHHHHHHHHHhccCCCc
Q 014189          112 ANFR-QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-------------GHREWLAEVIFLGHLSHPN  177 (429)
Q Consensus       112 ~~y~-~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~n  177 (429)
                      ++|. +.+.||.|+||.||+|.+....      ..||+|.+.......             ....+.+|+.+++.++|||
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   81 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTG------KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN   81 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCC------CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence            4554 3577999999999999866543      349999876542211             0124678999999999999


Q ss_pred             eeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC
Q 014189          178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       178 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      |+++++++...+..++||||+. |+|.+++....  .+++.....++.|++.||+|||+.+  ++|+||+|+||+++.++
T Consensus        82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKG  156 (335)
T ss_pred             eeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCC
Confidence            9999999999999999999996 68998886543  5889999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCC------------CccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 014189          258 NAKLSDFGLAKDGPEGD------------KSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDK  324 (429)
Q Consensus       258 ~~kl~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~  324 (429)
                      .++|+|||++.......            .........+++.|+|||.+.+. .++.++|||||||++|+|++|..||..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999987654110            00111224568899999998764 468999999999999999999999986


Q ss_pred             CChhhhhhHH-HhHhhHHHhhhh----hh--hhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          325 SRPAREQNLA-DWALPLLKEKKK----LL--NIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       325 ~~~~~~~~~~-~~~~~~~~~~~~----~~--~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+........ ..........+.    ..  .........   ......+..+.+++.+||+.+|++|||++|++.+
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            6543211100 000000000000    00  000000000   0012335678899999999999999999999986

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-37  Score=297.93  Aligned_cols=267  Identities=22%  Similarity=0.293  Sum_probs=198.3

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      ..+.++|++.+.||+|+||.||+|....++      ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTG------AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCC------cEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence            345678999999999999999999866543      349999886432 2333456779999999999999999999987


Q ss_pred             eCC------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEE
Q 014189          187 EDE------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  260 (429)
Q Consensus       187 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  260 (429)
                      ...      ..++||||+ +++|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          85 PDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             CCccccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEE
Confidence            543      458999999 67888777542   5899999999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh-HH----
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LA----  334 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~-~~----  334 (429)
                      |+|||++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ..    
T Consensus       159 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~  233 (343)
T cd07880         159 ILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG  233 (343)
T ss_pred             EeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999865332     123467889999999876 458899999999999999999999998654321100 00    


Q ss_pred             ----HhHhhHHHh-hhhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 ----DWALPLLKE-KKKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 ----~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          .+....... .......+.....   .......+..+.+++.+||+.||++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                000000000 0000000000000   00112345678899999999999999999999965

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.7e-37  Score=295.73  Aligned_cols=270  Identities=21%  Similarity=0.321  Sum_probs=199.8

Q ss_pred             HHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeee
Q 014189          105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIG  183 (429)
Q Consensus       105 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~  183 (429)
                      .++..++++|.+.+.||+|+||.||+|....+      +..||+|.+.... .......+.+|+.++++++||||+++++
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~   83 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKT------GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD   83 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCC------CeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence            34566778999999999999999999976544      3449999887542 2233456778999999999999999999


Q ss_pred             EEEeC------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC
Q 014189          184 YCCED------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       184 ~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      ++...      ...+++++++ +++|.+++...   .+++..+..++.|++.||+|||+.+  ++||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~  157 (345)
T cd07877          84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             eeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCC
Confidence            88543      3467888887 77898876543   5899999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH-H
Q 014189          258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-D  335 (429)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~-~  335 (429)
                      .+||+|||++......     .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||............ .
T Consensus       158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999998864321     223568899999998876 56889999999999999999999999765432211100 0


Q ss_pred             h-------HhhHHHh--hhhhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 W-------ALPLLKE--KKKLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 ~-------~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .       ....+..  .......++......   .....+..+.+++.+||+.||.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0       0000000  000000000000000   011235678999999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.9e-37  Score=286.96  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=194.9

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC----CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD----NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +|.+.+.||+|+||.||++.+......      +++|+....    ........+..|+.+++.++||||+++++++.+.
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAE------ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCc------ceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence            478889999999999999976544222      444444321    1222334566799999999999999999999988


Q ss_pred             CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          189 EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      ...++||||+++++|.+++..  .....+++..++.++.|++.||.|||+.+  ++|+||+|+||+++. +.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCc
Confidence            999999999999999988864  23346899999999999999999999977  999999999999975 5699999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      +........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||........      ..        
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~--------  215 (260)
T cd08222         152 SRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV------VL--------  215 (260)
T ss_pred             eeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HH--------
Confidence            876543221  22335688999999999888899999999999999999999999964432110      00        


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .... ......+...+..+.+++.+||..+|++||++.+++++
T Consensus       216 --~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         216 --RIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             --HHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence              0000 01112234556789999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.1e-37  Score=289.54  Aligned_cols=257  Identities=26%  Similarity=0.321  Sum_probs=198.4

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      +|++.+.||+|+||.||+|.......   .+..||+|++....   .......+.+|+.++.++ +|+||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~---~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHD---SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCC---CCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            47888999999999999997643211   24559999986532   122335677899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ...++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  ++||||+|+|||++.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999999987653  6888999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ....... .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.......  ........       
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~-------  223 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRR-------  223 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHH-------
Confidence            6543221 122335689999999998753  47889999999999999999999996432110  01111000       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                         ....  ....+...+..+.+++.+||+.||++||     ++++++.+
T Consensus       224 ---~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         224 ---ILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ---hhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence               0000  1122334567889999999999999997     77887765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1e-36  Score=293.19  Aligned_cols=272  Identities=24%  Similarity=0.296  Sum_probs=201.4

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .++++|++.+.||+|+||.||+|....+++      .+|+|.+.... .......+.+|+.+++.++||||+++.+++..
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   80 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQ------NVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS   80 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCC------EEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence            467889999999999999999998665543      49999876532 22334567789999999999999999999865


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          188 -DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       188 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                       ....++++||+ +++|..++...   ++++.....++.|++.||.|||+.+  ++|+||+|+||++++++.++|+|||+
T Consensus        81 ~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          81 PLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             CCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCcccc
Confidence             56789999998 56888777533   5788888899999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-HH--------h
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-AD--------W  336 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~~--------~  336 (429)
                      +......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... .+        +
T Consensus       155 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  229 (328)
T cd07856         155 ARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV  229 (328)
T ss_pred             ccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            8754321     123467889999998765 5789999999999999999999999976654221111 00        0


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCC
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                      ....... ....-..........+     ...+..+.+++.+||+.+|++|||+++++.+  ++..+..
T Consensus       230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         230 INTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence            0000000 0000000000011111     1245789999999999999999999999987  4444433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=318.71  Aligned_cols=270  Identities=28%  Similarity=0.422  Sum_probs=219.5

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEcccccc-CcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGY  184 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  184 (429)
                      ++....+..+.+.||+|.||.|++|....-... ......||||.........+...+..|+++|+.+ .|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            444455666778999999999999976543332 2236679999998877777788899999999998 59999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKV------------L--LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  250 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~N  250 (429)
                      |..++..++|+||+..|+|.++|....            .  ..++....+.+++|||.|++||++..  +|||||..+|
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRN  448 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARN  448 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhh
Confidence            999999999999999999999997654            0  13888999999999999999999865  9999999999


Q ss_pred             EEEcCCCcEEEeccCCCcCCCCCCCcccccccc--CCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCh
Q 014189          251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM--GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRP  327 (429)
Q Consensus       251 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~  327 (429)
                      ||+..+..+||+|||+|+........... ...  -+..|||||.+....|+.++||||||++|||++| |..||.+...
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            99999999999999999976554333211 122  2456999999999999999999999999999999 8889976332


Q ss_pred             hhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          328 AREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      ..+                +.+.+....+...|..++.++.+++..||+.+|++||++.++.+.|+..
T Consensus       528 ~~~----------------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 TEE----------------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHH----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            111                1112223334455677889999999999999999999999999999884

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.3e-37  Score=289.68  Aligned_cols=260  Identities=25%  Similarity=0.302  Sum_probs=199.8

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      +|++.+.||+|+||.||++.......   .+..+|+|.+....   .......+.+|+.++.++ +||||+++++.+..+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHD---AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecccc---CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            47788999999999999997543221   24559999886432   122345677899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ...++||||+++|+|.+++....  .+++..+..++.|++.+|.|||+.+  ++|+||+|+||+++.++.++|+|||+++
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999999999886543  6889999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccCCcccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ....... .......|+..|+|||.+.+..  ++.++|+||||+++|||++|..||.......  ........       
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~-------  223 (288)
T cd05583         154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRR-------  223 (288)
T ss_pred             ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHH-------
Confidence            6543221 1122356899999999987655  7889999999999999999999996432110  00010000       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                         ....  ....+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       224 ---~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         224 ---ILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ---HHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence               0000  112233456678899999999999999998877665544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.4e-37  Score=294.72  Aligned_cols=270  Identities=23%  Similarity=0.265  Sum_probs=194.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe---
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE---  187 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  187 (429)
                      +|++.+.||+|+||.||+|......    .+..+|+|.+.... .......+.+|+.+++++ +||||+++++.+..   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS----EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC----cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            4788899999999999999876441    13449999876532 222345677899999999 59999999987542   


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          188 -DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       188 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                       ....++++||+. ++|.+++...  ..+++..+..++.|++.||.|||..+  ++||||||+||+++.++.+||+|||+
T Consensus        77 ~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          77 NFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence             245788999986 6898888644  36899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCc--cccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-H--------
Q 014189          267 AKDGPEGDKS--HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-A--------  334 (429)
Q Consensus       267 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~--------  334 (429)
                      ++........  .......||..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+....... .        
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9865432211  11223578999999998765 5689999999999999999999999986553211100 0        


Q ss_pred             HhHhhHHHhh-hhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 DWALPLLKEK-KKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 ~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+........ ............   .......+..+.+++.+||+.||++|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000000 000000000000   00111235678999999999999999999999866

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3e-37  Score=294.31  Aligned_cols=271  Identities=25%  Similarity=0.278  Sum_probs=195.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  188 (429)
                      .++|++.+.||+|+||.||+|.+..+..      .+++|.+..... ......+.+|+++++.++||||+++++++... 
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGR------VVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCc------EEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            4689999999999999999998765533      389998764322 22234566899999999999999999987543 


Q ss_pred             -------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          189 -------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       189 -------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                             ...++||||+.+ +|...+... ...+++..+..++.|++.||+|||+.+  ++|+||||+||++++++.++|
T Consensus        81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             ccccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEE
Confidence                   346999999964 677766543 336999999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCcc---------ccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhh
Q 014189          262 SDFGLAKDGPEGDKSH---------VSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ  331 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~  331 (429)
                      +|||+++.........         ..+...|++.|+|||.+.+ ..++.++||||||+++|||++|++||.........
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999987654322111         1123467889999998865 45899999999999999999999999865543221


Q ss_pred             hHHHh-HhhHHHhh----hhhhhhcCCCCCCCCC-------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          332 NLADW-ALPLLKEK----KKLLNIIDPRLEGDYP-------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       332 ~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..... ........    ..+....+.......+       ......+.+++.+||+.||++|||+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            11100 00000000    0000000000000011       1233678899999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=288.67  Aligned_cols=270  Identities=23%  Similarity=0.312  Sum_probs=207.6

Q ss_pred             HHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCC--Cc----ee
Q 014189          106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH--PN----LV  179 (429)
Q Consensus       106 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv  179 (429)
                      ....++++|.+...+|+|+||.|-.+++...      +..||+|+++.-..  -.+..+-|+++|.++.+  |+    +|
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~------~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv  154 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRET------KEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCV  154 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCC------CceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence            3345578999999999999999999987655      34599999875422  22334569999999942  32    78


Q ss_pred             eeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC----
Q 014189          180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT----  255 (429)
Q Consensus       180 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~----  255 (429)
                      .+.++|...++.|||+|.+ |-|+.+++..+.-.+++...+..+++|++.+++|||+.+  ++|.||||+|||+.+    
T Consensus       155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceE
Confidence            8889999999999999999 459999999888889999999999999999999999987  999999999999832    


Q ss_pred             ----------------CCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCC
Q 014189          256 ----------------DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR  319 (429)
Q Consensus       256 ----------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~  319 (429)
                                      +..++|+|||.|+......     +..+.|..|+|||++.+-.++..+||||+||||+|+.||.
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence                            3458999999998643322     3467899999999999999999999999999999999999


Q ss_pred             CCCCCCChhhhhhHHHhHhhHHHhh----hhhhhhcCC-CCC---------------CC--------CChHHHHHHHHHH
Q 014189          320 KSLDKSRPAREQNLADWALPLLKEK----KKLLNIIDP-RLE---------------GD--------YPVKGVHKAAMLA  371 (429)
Q Consensus       320 ~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~~---------------~~--------~~~~~~~~l~~l~  371 (429)
                      ..|...+..+...+.+.++..+...    ....+.+.. .+.               ..        ........+++|+
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            9998776554433333332221111    000111100 000               00        1124566899999


Q ss_pred             HHhhccCCCCCCCHHHHHHh
Q 014189          372 YHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       372 ~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+||..||.+|+|+.|++.+
T Consensus       387 ~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHccCccccccHHHHhcC
Confidence            99999999999999999976

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.3e-37  Score=298.36  Aligned_cols=268  Identities=24%  Similarity=0.306  Sum_probs=195.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC--
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  188 (429)
                      ..+|.+.+.||.|+||.||+|....++      ..||+|.+..... .....+.+|+++++.++||||+++++++...  
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~------~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCD------KRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCC------cEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            468999999999999999999876543      3499998865533 3446677899999999999999999776543  


Q ss_pred             ------------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-C
Q 014189          189 ------------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-T  255 (429)
Q Consensus       189 ------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-~  255 (429)
                                  ...++||||++ ++|.+++...   .+++..+..++.|++.||.|||+.+  ++||||||+||+++ +
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~  150 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTE  150 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCC
Confidence                        35789999997 5888777532   5889999999999999999999987  99999999999997 4


Q ss_pred             CCcEEEeccCCCcCCCCCCCc-cccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH
Q 014189          256 DYNAKLSDFGLAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL  333 (429)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~  333 (429)
                      ++.+||+|||++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+......
T Consensus       151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~  230 (342)
T cd07854         151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL  230 (342)
T ss_pred             CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            567899999998764322111 11122467889999998754 5688999999999999999999999987654332211


Q ss_pred             HHhHhhH--HHhhhhhhhhcC-----CCCCCC-----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          334 ADWALPL--LKEKKKLLNIID-----PRLEGD-----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       334 ~~~~~~~--~~~~~~~~~~~~-----~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....+.  ............     ......     .....+.++.+++.+||+.||++|||+.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            1100000  000000000000     000000     011345678899999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1e-37  Score=319.60  Aligned_cols=257  Identities=28%  Similarity=0.385  Sum_probs=194.4

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ....++|+.+++||+||||.||+++++-++..      +|||.+.-..+........+|+.+|++|+|||||+++..+.+
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~------YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE  548 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGRE------YAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE  548 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchh------hhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence            34567889999999999999999987666544      999999876666666778899999999999999998753210


Q ss_pred             --------------------------------------------------------------------------------
Q 014189          188 --------------------------------------------------------------------------------  187 (429)
Q Consensus       188 --------------------------------------------------------------------------------  187 (429)
                                                                                                      
T Consensus       549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~  628 (1351)
T KOG1035|consen  549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR  628 (1351)
T ss_pred             cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------------C--------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHH
Q 014189          188 -------------------------------D--------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA  228 (429)
Q Consensus       188 -------------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~  228 (429)
                                                     +        ..+||-||||+..+|.+.+.++.... .....+.++.+|+
T Consensus       629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREIL  707 (1351)
T ss_pred             ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHH
Confidence                                           0        23577889998877776665543211 3567789999999


Q ss_pred             HHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC----------------CCCCccccccccCCccccccc
Q 014189          229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP----------------EGDKSHVSTRIMGTYGYAAPE  292 (429)
Q Consensus       229 ~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE  292 (429)
                      .||+|+|+.+  ||||||||.||++|+++.|||+|||+|....                .+......+..+||.-|+|||
T Consensus       708 EGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE  785 (1351)
T KOG1035|consen  708 EGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE  785 (1351)
T ss_pred             HHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence            9999999977  9999999999999999999999999998621                011111345689999999999


Q ss_pred             ccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCC--CChHHHHHH
Q 014189          293 YIMTG---HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGD--YPVKGVHKA  367 (429)
Q Consensus       293 ~~~~~---~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  367 (429)
                      ++.+.   .|+.|+|+||||+||+||+.   ||...-               +.-..+.++.++.+...  +.......-
T Consensus       786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---------------ERa~iL~~LR~g~iP~~~~f~~~~~~~e  847 (1351)
T KOG1035|consen  786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM---------------ERASILTNLRKGSIPEPADFFDPEHPEE  847 (1351)
T ss_pred             HhcccccccccchhhhHHHHHHHHHHhc---cCCchH---------------HHHHHHHhcccCCCCCCcccccccchHH
Confidence            99754   49999999999999999986   565321               11112223333333222  233444556


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHh
Q 014189          368 AMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       368 ~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..++.++++.||++|||+.|+|+.
T Consensus       848 ~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  848 ASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHHHhcCCCccCCCHHHHhhc
Confidence            779999999999999999999975

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-37  Score=287.13  Aligned_cols=266  Identities=25%  Similarity=0.324  Sum_probs=199.2

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      |+..+.||+|+||.||+|....+.      ..+++|.+.... .......+..|+.+++.++|+||+++++++...+..+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTG------EIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCC------cEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            556788999999999999876543      349999987653 2233456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      +||||++ ++|.+++.... ..+++..+..++.+++.||+|||..+  ++|+||+|+||++++++.++|+|||++.....
T Consensus        75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            9999997 58999887653 36899999999999999999999977  99999999999999999999999999886543


Q ss_pred             CCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh-HHHhHhhHHHhhhh-hhh
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWALPLLKEKKK-LLN  349 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~  349 (429)
                      ...  ......++..|+|||.+.+. .++.++||||||+++|||++|..||.......... ............+. ...
T Consensus       151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         151 PLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             Ccc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            221  12234567889999998766 88999999999999999999999997654321110 00000000000000 000


Q ss_pred             h--cCCCCC---C----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 I--IDPRLE---G----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~--~~~~~~---~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .  .+....   .    ......+..+.+++.+||..||++||++++++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0  000000   0    0011235679999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=301.83  Aligned_cols=242  Identities=25%  Similarity=0.267  Sum_probs=197.8

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      .+..|.+...+|.|+|+.|-.+.+..+...      .++|++.+.....     .+|+.++... +||||+++++.+.+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~------~~vkii~~~~~~~-----~~e~~~~~~~~~h~niv~~~~v~~~~  388 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQE------PAVKIISKRADDN-----QDEIPISLLVRDHPNIVKSHDVYEDG  388 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccc------hhheecccccccc-----ccccchhhhhcCCCcceeecceecCC
Confidence            345688888899999999999987666544      8999987652211     1467666555 699999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE-cCCCcEEEeccCCC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNAKLSDFGLA  267 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla  267 (429)
                      .+.|+|||++.||-|.+.+....   .....+..|+++++.++.|||.++  +|||||||+|||+ ++.++++|+|||.+
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a  463 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFW  463 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechh
Confidence            99999999999999988887654   333777889999999999999977  9999999999999 69999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      +.....     ..+.+-|..|.|||++....|++++||||||++||+||+|+.||.......  .             ..
T Consensus       464 ~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--e-------------i~  523 (612)
T KOG0603|consen  464 SELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--E-------------IH  523 (612)
T ss_pred             hhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--H-------------HH
Confidence            886653     233567899999999999999999999999999999999999997654320  0             01


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..+    ..+.+....+..+.+|+.+||+.||.+||++.++..+
T Consensus       524 ~~i----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  524 TRI----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             Hhh----cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            111    1223335678899999999999999999999999877

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=286.80  Aligned_cols=271  Identities=26%  Similarity=0.389  Sum_probs=202.0

Q ss_pred             HHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHh--ccCCCceeeeee
Q 014189          106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG--HLSHPNLVKLIG  183 (429)
Q Consensus       106 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~  183 (429)
                      ..+.+..+..+.+.||+|.||.||+|.+.+.        .||||++...    ++..|.+|.+|.+  .|+|+||+.+++
T Consensus       205 VQRTiarqI~L~e~IGkGRyGEVwrG~wrGe--------~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIa  272 (513)
T KOG2052|consen  205 VQRTIARQIVLQEIIGKGRFGEVWRGRWRGE--------DVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIA  272 (513)
T ss_pred             hHHhhhheeEEEEEecCccccceeeccccCC--------ceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhh
Confidence            3456678899999999999999999988653        3999999754    3455667777775  459999999998


Q ss_pred             EEEeC----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----C-CCceeCCCCCCcEEE
Q 014189          184 YCCED----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-----E-KPVIYRDFKTSNILL  253 (429)
Q Consensus       184 ~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~-~~ivH~Dlkp~NIll  253 (429)
                      .-..+    ..++||.+|.+.|||+++|.+.   .++....++++..+|.||++||..     | +.|.|||||+.|||+
T Consensus       273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV  349 (513)
T KOG2052|consen  273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV  349 (513)
T ss_pred             ccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence            75432    3679999999999999999774   688899999999999999999963     3 459999999999999


Q ss_pred             cCCCcEEEeccCCCcCCCCCCC--ccccccccCCcccccccccccCC----C--CcccchhhHHHHHHHHHh-----C--
Q 014189          254 DTDYNAKLSDFGLAKDGPEGDK--SHVSTRIMGTYGYAAPEYIMTGH----L--TPRSDVYSFGVVLLEILT-----G--  318 (429)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslG~il~ellt-----G--  318 (429)
                      ..++...|+|+|||........  .......+||.+|||||++...-    +  -..+||||||.++||+..     |  
T Consensus       350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~  429 (513)
T KOG2052|consen  350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV  429 (513)
T ss_pred             ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence            9999999999999987654321  12234468999999999986421    1  246899999999999975     2  


Q ss_pred             ---CCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCC-ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          319 ---RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       319 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                         +.||...-+... ++.+ ..+     -...+-+.|.+...+ ..+....+.+++..||..||.-|.|+=.|.+.|.+
T Consensus       430 eey~~Pyyd~Vp~DP-s~ee-Mrk-----VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  430 EEYQLPYYDVVPSDP-SFEE-MRK-----VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             hhhcCCcccCCCCCC-CHHH-Hhc-----ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence               246654322110 0000 000     011111222222222 34678889999999999999999999999999887


Q ss_pred             ccCC
Q 014189          395 LQVL  398 (429)
Q Consensus       395 ~~~~  398 (429)
                      +...
T Consensus       503 l~~~  506 (513)
T KOG2052|consen  503 LSNS  506 (513)
T ss_pred             HhcC
Confidence            7654

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-37  Score=296.54  Aligned_cols=266  Identities=22%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .+.++|++.+.||+|+||.||+|.+..+.      ..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTG------RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCC------cEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            34678999999999999999999876543      349999876532 22334567789999999999999999998865


Q ss_pred             CCe------EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          188 DEH------RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       188 ~~~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                      .+.      .++|+||+ +++|.+++...   .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL  159 (343)
T cd07851          86 ASSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKI  159 (343)
T ss_pred             cccccccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEE
Confidence            554      89999999 56898887642   5899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-HH----
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-AD----  335 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~~----  335 (429)
                      +|||++......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... .+    
T Consensus       160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~  234 (343)
T cd07851         160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT  234 (343)
T ss_pred             cccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence            999999865432     223467889999999865 4678999999999999999999999976543221110 00    


Q ss_pred             ----hHhhHHHhh-hhhhhhcCCCCCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 ----WALPLLKEK-KKLLNIIDPRLEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 ----~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          +........ ..............+   ....+..+.+++.+||+.+|++|||+.+|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                000000000 000000000000000   11236789999999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=279.41  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=201.9

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhc-cCCCceeeeeeEEEe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGH-LSHPNLVKLIGYCCE  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  187 (429)
                      ..+|.++++||+|+|+.|.++.++.+.      +.+|+|+++++-  ..+...=...|-.+..+ -+||.+|.++.+|++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~------qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTD------QIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccc------eeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            467999999999999999999776654      449999887642  22222222345555544 479999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      +..+++|.||++||+|.-++.++.  .+|++.+.-+...|+.||.|||+.|  ||+||||.+|||+|..|++||+|+|+.
T Consensus       323 esrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchh
Confidence            999999999999999988776654  6999999999999999999999987  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC-hhhhhhHHHhHhhHHHhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR-PAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~  346 (429)
                      +.....  ...+++++|||.|.|||++++..|...+|+|+|||+++||+.|+.||+... ...+.+..++..+++.+++.
T Consensus       399 ke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi  476 (593)
T KOG0695|consen  399 KEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI  476 (593)
T ss_pred             hcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence            875432  234677999999999999999999999999999999999999999998543 23344555665555544321


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP  383 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  383 (429)
                                 ..|...+..+..++...|++||.+|.
T Consensus       477 -----------riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 -----------RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -----------cccceeehhhHHHHHHhhcCCcHHhc
Confidence                       12345566778899999999999985

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=278.08  Aligned_cols=242  Identities=28%  Similarity=0.329  Sum_probs=196.0

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEe
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  197 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  197 (429)
                      ||+|+||.||++.+...      +..+++|.+.....  ......+..|+.+++.++||||+++++.+..+...++||||
T Consensus         1 lg~G~~~~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKDT------GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECCC------CcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence            69999999999987553      33499998876432  22455788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcc
Q 014189          198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  277 (429)
Q Consensus       198 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  277 (429)
                      +++++|.+++....  .+++.....++.|++.|+.|||..+  ++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~  148 (250)
T cd05123          75 APGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--S  148 (250)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCC--C
Confidence            99999999987654  5899999999999999999999977  9999999999999999999999999987654321  1


Q ss_pred             ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCC
Q 014189          278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  357 (429)
Q Consensus       278 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (429)
                      ......++..|++||.+.+..++.++|+||||+++|+|++|..||...+...   .   .          ..+..  ...
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~---~----------~~~~~--~~~  210 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---I---Y----------EKILK--DPL  210 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H---H----------HHHhc--CCC
Confidence            2334578899999999998889999999999999999999999997654311   0   0          00111  111


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCCCH---HHHHHh
Q 014189          358 DYPVKGVHKAAMLAYHCLNHNPKARPLM---RDIVDS  391 (429)
Q Consensus       358 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~---~evl~~  391 (429)
                      ..+...+..+.+++.+||..||++||++   ++++++
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            2333446788999999999999999999   666654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=293.94  Aligned_cols=247  Identities=26%  Similarity=0.316  Sum_probs=202.9

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  195 (429)
                      .++||.|.||+||-|++..++++      ||||++.+.. .......+.+|+.||..++||.||.+...|++.+..++||
T Consensus       569 devLGSGQFG~VYgg~hRktGrd------VAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRD------VAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HhhccCCcceeeecceecccCce------eeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            38999999999999988777665      9999998754 3344466789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC---CcEEEeccCCCcCCCC
Q 014189          196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSDFGLAKDGPE  272 (429)
Q Consensus       196 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~  272 (429)
                      |-+. |+..+.+.......+++..-.-+..||+.||.|||..+  |+|+||||+|||+.+.   -.+||||||+|+....
T Consensus       643 EKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  643 EKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            9995 56666666655567998888889999999999999877  9999999999999755   3599999999998765


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  352 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (429)
                      .   ....+.+||+.|+|||+++.+.|+...|+||.|||+|--++|..||.......++     +       + -..+  
T Consensus       720 k---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ-----I-------Q-NAaF--  781 (888)
T KOG4236|consen  720 K---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ-----I-------Q-NAAF--  781 (888)
T ss_pred             h---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH-----h-------h-cccc--
Confidence            3   2355689999999999999999999999999999999999999999855432110     0       0 0011  


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       ........+.+..+.+||...|+..-.+|.|....+.+
T Consensus       782 -MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  782 -MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             -ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence             11222345778899999999999999999999887765

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.1e-36  Score=312.46  Aligned_cols=147  Identities=27%  Similarity=0.319  Sum_probs=129.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|.+.+.||+|+||.||+|.+....      ..||+|++....  .......+..|+.++..++||||+++++++...+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~------~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNS------KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCC------cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            57999999999999999999876543      349999987542  2333466788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ..|+||||+.+|+|.+++....  .+++..++.++.|++.||+|||..+  |+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999999886543  5788999999999999999999977  9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=286.43  Aligned_cols=263  Identities=25%  Similarity=0.397  Sum_probs=205.7

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhH------HHHHHHHHHHhccCCCceeeee
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH------REWLAEVIFLGHLSHPNLVKLI  182 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~h~niv~l~  182 (429)
                      .+.++|-++.+||+|||+.||+|++....      .+||+|+..-...+.+.      +...+|..|-+.|.||.||+++
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~Eq------RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY  533 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQ------RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY  533 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchh------heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence            34557888999999999999999865543      45999997654333322      2345799999999999999999


Q ss_pred             eEEE-eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCc
Q 014189          183 GYCC-EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYN  258 (429)
Q Consensus       183 ~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~  258 (429)
                      ++|. +.+.+|-|+|||+|.+|.-+|..+.  .+++.++..|+.||+.||.||....++|||-||||.|||+-.   .|.
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence            9997 5567889999999999998887654  588999999999999999999988899999999999999954   478


Q ss_pred             EEEeccCCCcCCCCCCCc-----cccccccCCcccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCChhh
Q 014189          259 AKLSDFGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTG----HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR  329 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltG~~p~~~~~~~~  329 (429)
                      +||+||||++.+......     ..++...||.+|++||.+.-+    .++.++||||.|||+|.++.|+.||.......
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ  691 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ  691 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence            999999999987654322     234457899999999998643    46889999999999999999999998654321


Q ss_pred             hhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          330 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        +.       +.+ ..+.+  -..+..+..+..+.++.++|.+||++.-++|....++...
T Consensus       692 --dI-------Lqe-NTIlk--AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  692 --DI-------LQE-NTILK--ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             --HH-------Hhh-hchhc--ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence              11       111 11111  1112223334578889999999999999999999988754

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-37  Score=252.11  Aligned_cols=267  Identities=23%  Similarity=0.279  Sum_probs=201.3

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh-hHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +|...++||+|+||+||+|+..++.+      .||+|.++-+...+ .-...++|+-+|+.++|.|||++++....+..+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~e------ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHE------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccc------eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            35556789999999999997666543      49999987654333 335567899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      .+|+|||.. +|..+..+.+ ..+....+..++.|+++||.|+|+++  +.||||||.|.|++.+|++|++|||+++.+.
T Consensus        77 tlvfe~cdq-dlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   77 TLVFEFCDQ-DLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             EEeHHHhhH-HHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            999999964 7887765544 46888999999999999999999988  9999999999999999999999999999765


Q ss_pred             CCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHh-hh-hh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKE-KK-KL  347 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~-~~-~~  347 (429)
                      -.-  ...+..+-|.+|++|+++.+. .|+...|+||-||++.|+.. |++.|.+.+-..+....-|.+....+ .| .+
T Consensus       153 ipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  153 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             Cce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence            322  223345679999999999875 58999999999999999986 77777766544332222222221111 11 12


Q ss_pred             hhhcCCCCCCCCC---------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYP---------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~---------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..+-|-....-++         +.....-++|+.+.|.-+|..|.+++..+++
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            2222211111111         1223455789999999999999999998876

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=277.07  Aligned_cols=253  Identities=28%  Similarity=0.305  Sum_probs=198.0

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEE
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  194 (429)
                      -+..||.|+||+|++-.++..+      ...|||.++..+.....++++.|.+...+- +.||||+++|++..++..|+-
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg------~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSG------KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccC------cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            3467999999999997766554      449999999887777888899998886555 699999999999999999999


Q ss_pred             EEecCCCChhhhh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          195 YEFMARGSVENNL---FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       195 ~e~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ||+|. -||..+.   +......+++...-.|....+.||.||-.. ..|||||+||+|||++..|.+||||||++..+.
T Consensus       142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            99995 3554333   333344689999999999999999999863 239999999999999999999999999987654


Q ss_pred             CCCCccccccccCCcccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .   ....+.-.|-..|||||.+.  +..|+.++||||||++|||+.||+.||.+++...++    .        ..+..
T Consensus       220 ~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq----l--------~~Vv~  284 (361)
T KOG1006|consen  220 D---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ----L--------CQVVI  284 (361)
T ss_pred             H---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH----H--------HHHHc
Confidence            3   23345568899999999996  346999999999999999999999999877642211    1        11111


Q ss_pred             hcCCCCCCCCC-hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYP-VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      --.|.+..... .+.+..+..++.-||.+|-++||.+.+++++
T Consensus       285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            11222222222 3467889999999999999999999998864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7.4e-36  Score=273.84  Aligned_cols=225  Identities=21%  Similarity=0.232  Sum_probs=179.0

Q ss_pred             CCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEecCCCC
Q 014189          123 GGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGS  202 (429)
Q Consensus       123 G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  202 (429)
                      |.||.||++.+..+.+      .+|+|.+....      .+..|...+....||||+++++++.+.+..++||||+++|+
T Consensus         4 g~~~~v~~~~~~~~~~------~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMDTRTQQ------TFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEEccCCc------EEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCC
Confidence            8999999998766544      49999987642      12234455555679999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccc
Q 014189          203 VENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI  282 (429)
Q Consensus       203 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  282 (429)
                      |.+++....  .+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++++|||.+......     ....
T Consensus        72 L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~  142 (237)
T cd05576          72 LWSHISKFL--NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGE  142 (237)
T ss_pred             HHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccC
Confidence            999886653  5899999999999999999999977  999999999999999999999999987654332     1234


Q ss_pred             cCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChH
Q 014189          283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVK  362 (429)
Q Consensus       283 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (429)
                      .++..|+|||.+.+..++.++|+||+|+++|||++|..|+.......                      ........+..
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~~~~~~~~~~  200 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------NTHTTLNIPEW  200 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------ccccccCCccc
Confidence            56778999999988889999999999999999999998875321100                      00001112334


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 014189          363 GVHKAAMLAYHCLNHNPKARPLM-----RDIVD  390 (429)
Q Consensus       363 ~~~~l~~l~~~cl~~dP~~RPs~-----~evl~  390 (429)
                      .+..+.+++.+||+.||++||++     +++++
T Consensus       201 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  233 (237)
T cd05576         201 VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKS  233 (237)
T ss_pred             CCHHHHHHHHHHccCCHHHhcCCCccchHHHHc
Confidence            56778999999999999999996     55554

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=296.26  Aligned_cols=256  Identities=27%  Similarity=0.340  Sum_probs=207.4

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEE-
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC-  186 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  186 (429)
                      ..++-|++.+.||.|.+|.||+++...+.      +..|+|+...+...+  ++...|.++|+.. .|||++.++|+|. 
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~------~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTG------QLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecC------ceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            34567899999999999999999766543      348888887664433  3445788999877 5999999999985 


Q ss_pred             ----eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          187 ----EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       187 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                          .++.+|||||||.+||..+++....+..+.|.....|++.++.|+.+||.+.  ++|||||-.|||++.++.|||.
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEe
Confidence                3679999999999999999997766778999999999999999999999877  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~  337 (429)
                      |||.+.......  ....+..||+.|||||++..     ..|+..+|+||||++..||.-|.+|+-...+....      
T Consensus       166 DFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------  237 (953)
T KOG0587|consen  166 DFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------  237 (953)
T ss_pred             eeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------
Confidence            999988765422  22445789999999999974     34788999999999999999999999876543211      


Q ss_pred             hhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                               +.....|......+..-+.++.++|..||.+|-+.||++.++++|
T Consensus       238 ---------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  238 ---------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                     111112222233345668899999999999999999999998865

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=289.25  Aligned_cols=252  Identities=25%  Similarity=0.327  Sum_probs=208.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .++..+.-||-|+||.|=++.......      .+|+|++++..  ...+.+....|.++|..++.|.||+++-.|.++.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~------~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKA------TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccch------HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            355666779999999999886554322      37888877643  3344556778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      +.|+.||-|-||.|...|.++.  .+......-++..+++|++|||+++  ||+|||||+|.+++.+|-+||.|||+|+.
T Consensus       494 yvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHH
Confidence            9999999999999999887665  5777888889999999999999977  99999999999999999999999999998


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ...+.+   +-++||||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++..-.++.             ..
T Consensus       570 i~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-------------Lk  633 (732)
T KOG0614|consen  570 IGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-------------LK  633 (732)
T ss_pred             hccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------------Hh
Confidence            876654   34589999999999999999999999999999999999999999988764221111             11


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHhc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDSL  392 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L  392 (429)
                      -+|   .-.+|......+.+|+++....+|.+|..     +.||.+|-
T Consensus       634 Gid---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  634 GID---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             hhh---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence            111   12345567788999999999999999986     67777774

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-35  Score=285.00  Aligned_cols=245  Identities=23%  Similarity=0.293  Sum_probs=190.5

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      -|..++-||-|+||.|.++.-.++      ...+|+|.+++...  .........|..||..-..+-||+|+-.|++++.
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT------~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn  703 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDT------RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN  703 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecch------hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence            477788999999999999864444      23489998876532  2233456689999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +|+||||++||++..+|.+.+  -|++..+..++..+..|+++.|..|  .|||||||+|||||.+|++||+||||..-+
T Consensus       704 LYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccc
Confidence            999999999999999998775  5888888899999999999999977  999999999999999999999999997521


Q ss_pred             ---------CCCCCc-------------------------------cccccccCCcccccccccccCCCCcccchhhHHH
Q 014189          271 ---------PEGDKS-------------------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV  310 (429)
Q Consensus       271 ---------~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  310 (429)
                               ..++..                               ......+||+.|+|||++....|+..+|+||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence                     110000                               0012368999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCChhhhh-hHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC
Q 014189          311 VLLEILTGRKSLDKSRPAREQ-NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP  383 (429)
Q Consensus       311 il~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  383 (429)
                      |||||+.|++||....+..-+ .+..|           ...+    ....-.+.+.++.++|.++. .+++.|.
T Consensus       860 il~em~~g~~pf~~~tp~~tq~kv~nw-----------~~~l----~~~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQYKVINW-----------RNFL----HIPYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcceeeeeeh-----------hhcc----ccccccccCHHHHHHHHHHh-cChhhhh
Confidence            999999999999866554321 11111           1112    12222355677777886653 4677775

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9.5e-35  Score=296.00  Aligned_cols=268  Identities=19%  Similarity=0.227  Sum_probs=171.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeE-----
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGY-----  184 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-----  184 (429)
                      ..++|.+.+.||+|+||.||+|++..+..  ..+..||+|.+.....   .+.+..|  .+....+.++..+...     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~--~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS--KKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc--ccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            34689999999999999999998876521  2234599998764321   1112222  1222223333332221     


Q ss_pred             -EEeCCeEEEEEEecCCCChhhhhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 014189          185 -CCEDEHRVLIYEFMARGSVENNLFSKVLL------------------PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  245 (429)
Q Consensus       185 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~D  245 (429)
                       .......++||||+++++|.+++......                  ......+..++.|++.||+|||+.+  |+|||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRD  280 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRD  280 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCc
Confidence             24566889999999999999988654210                  0112345679999999999999977  99999


Q ss_pred             CCCCcEEEcC-CCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccC----------------------CCCcc
Q 014189          246 FKTSNILLDT-DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG----------------------HLTPR  302 (429)
Q Consensus       246 lkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~  302 (429)
                      |||+|||+++ ++.+||+|||+++...... ........||+.|+|||.+...                      .++.+
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            9999999986 5899999999998654322 2223456889999999966422                      24456


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCC----C--ChHHHHHHHHHHHHhhc
Q 014189          303 SDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGD----Y--PVKGVHKAAMLAYHCLN  376 (429)
Q Consensus       303 ~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~l~~l~~~cl~  376 (429)
                      +|||||||+||||+++..+++.........+....    ...........+.....    +  .........+|+.+||+
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRND----YDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcC----CcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            79999999999999977665422111000000000    00000111111110000    0  00112345689999999


Q ss_pred             cCCCCCCCHHHHHHh
Q 014189          377 HNPKARPLMRDIVDS  391 (429)
Q Consensus       377 ~dP~~RPs~~evl~~  391 (429)
                      .||++|||++++++|
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999987

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-36  Score=263.19  Aligned_cols=274  Identities=24%  Similarity=0.306  Sum_probs=198.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEe---
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  187 (429)
                      +.|.-..+||+|.||.||+|...++.+.      ||+|++--++. ...-...++|+.+|..++|+|++.++..|..   
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kk------valkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKK------VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccch------hHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            4566667899999999999976655443      78776543221 1122345689999999999999999987742   


Q ss_pred             -----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          188 -----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       188 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                           ...+|+||++|+. +|...|... ...++..++..++.++..||.|+|.+.  |+|||+||+|+||+.+|.+||+
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEee
Confidence                 3458999999976 788777544 236888999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCc--cccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh
Q 014189          263 DFGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       263 Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      |||+++.+...+..  ...+..+-|.+|++||.+.| ..|+++.|||.-|||+.||+||.+.+.+........+..-...
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            99999876543321  11234566999999999986 4799999999999999999999999987765444333221110


Q ss_pred             -HHHhh------hhhhhhc--CCCCCCCC--------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          340 -LLKEK------KKLLNII--DPRLEGDY--------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       340 -~~~~~------~~~~~~~--~~~~~~~~--------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                       ..++-      -.+-+-+  .|...+.+        +..-..+..+|+.++|..||.+|+++.+++++--..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence             00000      0011111  11001110        011134788999999999999999999999885333

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.9e-34  Score=260.17  Aligned_cols=240  Identities=30%  Similarity=0.385  Sum_probs=193.2

Q ss_pred             CcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEecCCCCh
Q 014189          124 GFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV  203 (429)
Q Consensus       124 ~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  203 (429)
                      +||.||+|.+..+.      ..+++|+............+.+|+..+++++|+||+++++++......+++|||+++++|
T Consensus         1 ~~g~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKKTG------KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECCCC------cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            58999999876543      349999987654433267888999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcccccccc
Q 014189          204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM  283 (429)
Q Consensus       204 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  283 (429)
                      .+++....  .+++..+..++.+++.++.|||..+  ++|+||+|+||+++.++.++|+|||.+.......   ......
T Consensus        75 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~  147 (244)
T smart00220       75 FDLLKKRG--RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV  147 (244)
T ss_pred             HHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence            99886654  3888999999999999999999987  9999999999999999999999999998765432   233456


Q ss_pred             CCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCCh-H
Q 014189          284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPV-K  362 (429)
Q Consensus       284 gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  362 (429)
                      ++..|++||.+.+..++.++||||||+++++|++|..||........  ..+             ............. .
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~-------------~~~~~~~~~~~~~~~  212 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFK-------------KIGKPKPPFPPPEWK  212 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHH-------------HHhccCCCCcccccc
Confidence            88999999999988899999999999999999999999976321110  000             0000111000011 1


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          363 GVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       363 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+.++.+++.+|+..+|++||++.+++++
T Consensus       213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      213 ISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             CCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            56789999999999999999999999973

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.6e-33  Score=278.89  Aligned_cols=272  Identities=18%  Similarity=0.241  Sum_probs=184.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccc----------cCcCceeEEEEEecCCCChhhHHH--------------HHHH
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLR----------EGLQPVPVAVKVHDGDNSYQGHRE--------------WLAE  166 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----------~~~~~~~vavK~~~~~~~~~~~~~--------------~~~E  166 (429)
                      .++|.+.++||+|+||.||+|.......          ....+..||||.+..... ....+              +..|
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHHH
Confidence            5689999999999999999997533221          112345699999865421 12222              3346


Q ss_pred             HHHHhccCCCce-----eeeeeEEEe--------CCeEEEEEEecCCCChhhhhhcCCC---------------------
Q 014189          167 VIFLGHLSHPNL-----VKLIGYCCE--------DEHRVLIYEFMARGSVENNLFSKVL---------------------  212 (429)
Q Consensus       167 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  212 (429)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     667777643        3568999999999999998864311                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccc
Q 014189          213 -LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP  291 (429)
Q Consensus       213 -~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP  291 (429)
                       ..+++..+..++.|++.+|.|||..+  |+||||||+|||++.++.+||+|||++......... ......+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence             12467788899999999999999977  999999999999999999999999999765432211 11123458899999


Q ss_pred             cccccCC--------------------C--CcccchhhHHHHHHHHHhCCC-CCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          292 EYIMTGH--------------------L--TPRSDVYSFGVVLLEILTGRK-SLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       292 E~~~~~~--------------------~--~~~~DvwslG~il~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      |.+....                    |  ..+.||||+||++|+|++|.. |+....... .....+.. .. ..+  .
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~-~~~~~~~~-~~-~~~--r  454 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN-TELRQYDN-DL-NRW--R  454 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh-hHHhhccc-hH-HHH--H
Confidence            9885422                    1  134799999999999999886 665322111 00000000 00 000  0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCC---CCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP---KARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~~  391 (429)
                      ...............+....+|+.+||..+|   .+|+|++|+++|
T Consensus       455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0111111111223457789999999999876   689999999987

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=257.77  Aligned_cols=132  Identities=24%  Similarity=0.365  Sum_probs=111.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-----C---Cceeeeee
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-----H---PNLVKLIG  183 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~  183 (429)
                      .+|.+.++||+|.|++||+|++....      ..||+|+.+.....  .+..+.||.+|++++     |   .+||+|++
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~------r~VAlKVvKSAqhY--tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNK------RYVALKVVKSAQHY--TEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCC------eEEEEEEEehhhHH--HHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            68999999999999999999876653      45999999865322  234568999999884     3   36999999


Q ss_pred             EEE----eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE
Q 014189          184 YCC----EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL  253 (429)
Q Consensus       184 ~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll  253 (429)
                      .|.    +..+.|||+|++ |.+|..+|....-+.++...+.+|++|++.||.|||.. -+|||.||||+|||+
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL  221 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence            996    456999999999 66899999888778899999999999999999999974 249999999999999

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-34  Score=238.80  Aligned_cols=209  Identities=26%  Similarity=0.296  Sum_probs=170.7

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEE
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  186 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  186 (429)
                      .+..++...+..||+|++|.|-+-++..      .+...|+|.+...-..+.....++|+.+..+. .+|.+|.++|.+.
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~  115 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQ------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF  115 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeecc------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence            3344555556789999999987765443      45669999998877777778888999987665 6999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          187 EDEHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                      ..+..++.||.|. .||..+...  ..+...++...-+|+..++.||.|||+. ..++|||+||+|||++.+|++|+|||
T Consensus       116 regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  116 REGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             ccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEccc
Confidence            9999999999995 466554422  2345789999999999999999999984 23999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccCCccccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCCh
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRP  327 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltG~~p~~~~~~  327 (429)
                      |++-.+.++   ...+...|-..|||||.+..    ..|+.++||||||+++.||.+++.||+.+..
T Consensus       194 GIsG~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  194 GISGYLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             ccceeehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            999876543   22333578889999999863    4799999999999999999999999987653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-33  Score=246.68  Aligned_cols=267  Identities=23%  Similarity=0.341  Sum_probs=199.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC-CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC---
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED---  188 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  188 (429)
                      +.+..+.||-|+||.||.+++..+++.      |+.|.+..- .+....+.+.+|+.+|..++|.|++..+++.+-.   
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrr------valkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKR------VALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccc------hhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            344568999999999999887666554      888876542 2344456778999999999999999998876533   


Q ss_pred             --CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          189 --EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       189 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                        +.+|++.|+|. .+|+..+.+-  ..++...+.-+.+||++||.|||+.+  |.||||||.|.|++.|..+||||||+
T Consensus       128 fFqEiYV~TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  128 FFQELYVLTELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHHHHHHHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEeccccc
Confidence              24578888884 4777766543  36777888889999999999999988  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH-----
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL-----  340 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-----  340 (429)
                      ++..+..+..+ .+..+-|..|+|||+++|. .|+.+.||||.|||+.||+..+..|...++..+.++....+..     
T Consensus       203 ARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  203 ARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA  281 (449)
T ss_pred             ccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence            99765544333 3445678999999999975 6899999999999999999998899887776665543322211     


Q ss_pred             ---HHhhhhhhhhcCCCCCCC---------CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          341 ---LKEKKKLLNIIDPRLEGD---------YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       341 ---~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                         -.++.+ ..++......+         .+.....+..+++.+++..||+.|.+..+.+.++
T Consensus       282 Mr~ACEGAk-~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  282 MKYACEGAK-NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHhhhhH-HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence               011111 11111111111         1123345677888999999999999999998875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=272.54  Aligned_cols=246  Identities=28%  Similarity=0.374  Sum_probs=184.9

Q ss_pred             CccceeecCCCcEE-EEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeE
Q 014189          114 FRQDRVLGGGGFGC-VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       114 y~~~~~lG~G~fg~-Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  191 (429)
                      |.-.+++|.|+-|+ ||+|...+        +.||||.+-.+    ......+|+..|+.- +|||||++++.-.+++..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~--------R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~  578 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEG--------REVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL  578 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCC--------ceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence            44457899999875 79997654        34999987644    222335799999888 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---C--CcEEEecc
Q 014189          192 VLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---D--YNAKLSDF  264 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Df  264 (429)
                      ||..|.|. .+|.+++...  ..........+.+..|++.||++||+.+  ||||||||.||||+.   +  ..++|+||
T Consensus       579 YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  579 YIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             EEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccc
Confidence            99999995 6999999764  1111111344778899999999999988  999999999999976   3  46899999


Q ss_pred             CCCcCCCCCCCcc-ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCChhhhhhHHHhHhhHHH
Q 014189          265 GLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG-RKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       265 gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      |+++....+.... ......||-+|+|||++....-+.++||+||||++|+.++| ..||...-..+. +.       +.
T Consensus       656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NI-------l~  727 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NI-------LT  727 (903)
T ss_pred             ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hh-------hc
Confidence            9999887654322 23446799999999999998889999999999999999996 789975432111 00       11


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....+..+       ....++  ++.+||.+|++.+|..||++.+|+.|
T Consensus       728 ~~~~L~~L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  728 GNYTLVHL-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             Cccceeee-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            11111110       011122  78999999999999999999999965

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=261.44  Aligned_cols=196  Identities=24%  Similarity=0.352  Sum_probs=168.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHH---------HHHHHHHhccC---CCcee
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW---------LAEVIFLGHLS---HPNLV  179 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~~E~~~l~~l~---h~niv  179 (429)
                      .+|...+.+|+|+||.|++|+++.....      |++|.+.++...  ...|         -.|+.||..++   |+||+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~e------VViK~I~KeRIL--~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl  632 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYE------VVIKMIFKERIL--VDTWVRDRKLGTVPSEIQILATLNKHSHENIL  632 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceE------EEeeehhhhhhh--hhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence            4689999999999999999998877544      999998775321  1122         24999999998   99999


Q ss_pred             eeeeEEEeCCeEEEEEEec-CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc
Q 014189          180 KLIGYCCEDEHRVLIYEFM-ARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN  258 (429)
Q Consensus       180 ~l~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~  258 (429)
                      +++++|++++++||+||-. ++-+|.+++..+.  .+.+.++..|++|++.|+++||+.+  |||||||-+||.++.+|-
T Consensus       633 KlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  633 KLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             hhhheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCe
Confidence            9999999999999999986 4557888887665  5889999999999999999999988  999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 014189          259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLD  323 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~  323 (429)
                      +||+|||.|.....+.    ...++||..|.|||++.|..| ...-|||++|++||.++....||.
T Consensus       709 ~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999987654432    345789999999999999888 567899999999999999888875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.7e-32  Score=257.49  Aligned_cols=273  Identities=22%  Similarity=0.205  Sum_probs=202.9

Q ss_pred             hHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC------CCc
Q 014189          104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS------HPN  177 (429)
Q Consensus       104 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~n  177 (429)
                      +.-.+.+..+|.+....|+|-|++|-+|.+....      ..||||++...  ..-...=+.|+++|++|+      --|
T Consensus       424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~------~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARG------QEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             EehhhhhcceeEEEeccccceeeeeeeccccCCC------CeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhH
Confidence            3344556678888999999999999999765443      35999999865  223344457999999996      248


Q ss_pred             eeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       178 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      +++++-.|...+++|||+|-+. -+|.+.|..-+ ...|....+..++.|+..||..|-..+  |+|.||||+|||++++
T Consensus       496 clrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccC
Confidence            9999999999999999999884 58888885432 345778889999999999999999878  9999999999999987


Q ss_pred             C-cEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 014189          257 Y-NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       257 ~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~  335 (429)
                      . .+||||||.|-......-    +...-+..|.|||++.|..|+...|+||.||+||||.||+..|.+........+..
T Consensus       573 k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             cceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence            5 479999999987654332    22334568999999999999999999999999999999999998776543322211


Q ss_pred             h-----HhhHHHhhhhhhhhcC--------------------------C------CCCC--CCC---hHHHHHHHHHHHH
Q 014189          336 W-----ALPLLKEKKKLLNIID--------------------------P------RLEG--DYP---VKGVHKAAMLAYH  373 (429)
Q Consensus       336 ~-----~~~~~~~~~~~~~~~~--------------------------~------~~~~--~~~---~~~~~~l~~l~~~  373 (429)
                      -     ...++....-..+-+|                          |      .+..  ..+   ......+.+|+.+
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            1     1111111110011111                          1      0000  012   2345678999999


Q ss_pred             hhccCCCCCCCHHHHHHh
Q 014189          374 CLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       374 cl~~dP~~RPs~~evl~~  391 (429)
                      ||..||++|.|..+.|.|
T Consensus       729 ml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALKH  746 (752)
T ss_pred             HhccChhhcCCHHHHhcC
Confidence            999999999999999976

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.5e-30  Score=230.85  Aligned_cols=213  Identities=34%  Similarity=0.533  Sum_probs=182.0

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEecC
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA  199 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  199 (429)
                      ||+|++|.||++....+.      ..+++|+............+.+|+..++.+.|++++++++++......+++||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKKTG------KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecCCC------cEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence            689999999999876533      34899998876443245678899999999999999999999999899999999999


Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC-CCcEEEeccCCCcCCCCCCCccc
Q 014189          200 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDGPEGDKSHV  278 (429)
Q Consensus       200 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~  278 (429)
                      +++|.+++.... ..+++..+..++.+++.++++||..+  ++|+||+|.||+++. ++.++|+|||.+........  .
T Consensus        75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (215)
T cd00180          75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--L  149 (215)
T ss_pred             CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--h
Confidence            999999887553 35889999999999999999999977  999999999999999 89999999999886544321  1


Q ss_pred             cccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCC
Q 014189          279 STRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  357 (429)
Q Consensus       279 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (429)
                      .....+...|++||.+... .++.+.|+|++|+++++|                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            2335678899999999877 889999999999999999                                          


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          358 DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       358 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                             ..+.+++.+|++.+|++||++.++++++
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                   2456789999999999999999999764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.1e-31  Score=229.79  Aligned_cols=261  Identities=16%  Similarity=0.257  Sum_probs=193.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED-  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-  188 (429)
                      .++|++.+++|+|.|+.||.|....+.+.      ++||+++.-    ......+|+.||..+. ||||+++++...+. 
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK------~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~  106 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEK------CVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE  106 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCce------EEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence            35799999999999999999976555443      899998653    4456778999999997 99999999998754 


Q ss_pred             -CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-CcEEEeccCC
Q 014189          189 -EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGL  266 (429)
Q Consensus       189 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl  266 (429)
                       ....+|+||+++.+......     .++.-.....+.+++.||.|+|+.|  |.|||+||.|+++|.. -.++|+|+|+
T Consensus       107 SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGL  179 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGL  179 (338)
T ss_pred             ccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecch
Confidence             46679999999887665432     4666677889999999999999977  9999999999999865 5699999999


Q ss_pred             CcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-----------H
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-----------A  334 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-----------~  334 (429)
                      |..+-.+....   ..+.+..|--||.+.. ..|+...|+|||||+|..|+..+.||.......++-+           .
T Consensus       180 AEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~  256 (338)
T KOG0668|consen  180 AEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY  256 (338)
T ss_pred             HhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence            98876554332   2356778899999875 5689999999999999999999999876654433211           1


Q ss_pred             HhHhhH-HHhhhhhhhhcCCCCCCCC--------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 DWALPL-LKEKKKLLNIIDPRLEGDY--------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 ~~~~~~-~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+..+. +..+.....++....+..+        ..-.+.++.+|+.+.|.+|..+|||++|...|
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            111110 0001111111111111111        11235789999999999999999999999876

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=239.23  Aligned_cols=264  Identities=21%  Similarity=0.278  Sum_probs=190.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  187 (429)
                      ..+|.-++.+|.|.- .|--+.+      ......||+|...... .........+|..++..++|+||++++.+|.-  
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D------~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFD------QVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecch------hhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            356777788999888 5555543      2334558888765431 22233445679999999999999999999853  


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          188 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       188 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                          -...|+|||+|. ++|.+.+.-    .++-.....|++|++.|+.|||+.+  |+||||||+||++..++.+||.|
T Consensus        89 ~l~~~~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             cHHHHHhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeecc
Confidence                246799999995 588887762    3566778899999999999999988  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh-----------
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-----------  332 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~-----------  332 (429)
                      ||+|+.....   ...+..+.|..|+|||++.+..|.+.+||||+||++.||++|...|.+.+...+-.           
T Consensus       162 fg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  162 FGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             chhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence            9999864332   34556788999999999998889999999999999999999999888654322111           


Q ss_pred             -----HHHhHhhHHHhhh-----hhhhhc-CCCCCC--CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          333 -----LADWALPLLKEKK-----KLLNII-DPRLEG--DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       333 -----~~~~~~~~~~~~~-----~~~~~~-~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                           +..-+..+.....     ...+.+ |.....  +.+......+.+++.+||-.||++|.|++++|.|
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                 1000000110000     001111 111111  1111234568899999999999999999999988

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=232.88  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=187.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeee-EEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIG-YCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~  187 (429)
                      +.+.|.+.+.||+|.||.+-++.+....      ..+++|.+...  .....+|.+|...--.| .|.||+.-++ .|++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~------t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSK------TRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCc------eEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            4467899999999999999999776553      44999998765  44667899998776666 4899998765 5788


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc--CCCcEEEeccC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD--TDYNAKLSDFG  265 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg  265 (429)
                      .+.+++++||++.|+|.+.+...   .+.+.....++.|++.|+.|+|+.+  +||||||.+||||-  +...+||||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             CceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecc
Confidence            88999999999999999887654   4778888999999999999999977  99999999999994  33469999999


Q ss_pred             CCcCCCCCCCccccccccCCccccccccccc---C--CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---G--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      +.+.....     ......+..|.+||....   +  ...+.+|+|.||+++|.++||..||... ...+.....|..-.
T Consensus       169 ~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~  242 (378)
T KOG1345|consen  169 LTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWL  242 (378)
T ss_pred             cccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHh
Confidence            98864321     122345678999998753   2  2467899999999999999999999833 23334444443221


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD  387 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e  387 (429)
                      ....        +.+... -...+..+.++..+-|..+|++|--..+
T Consensus       243 ~rk~--------~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~  280 (378)
T KOG1345|consen  243 KRKN--------PALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWT  280 (378)
T ss_pred             cccC--------ccCchh-hcccCHHHHHHHHHhcCCcccccchhHH
Confidence            1111        111111 1134677888999999999999944433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=259.25  Aligned_cols=253  Identities=24%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|.+..++|.|+||.|||++++...      ...|+|+++-.. .....-...|+-+++..+|||||.+++.|...+.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~------elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSG------ELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccC------chhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            467999999999999999999766543      347888876542 2233334478999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +++.||||.+|+|.+..+.  ..++++-+....++....|++|||+.+  -+|||||-.|||+++.|.+|++|||.+..+
T Consensus        87 lwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             cEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhh
Confidence            9999999999999986654  448999999999999999999999977  789999999999999999999999998765


Q ss_pred             CCCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ...  ......+.||+.|||||+-.   .+.|...+|||++|+...|+-.-++|.....+.....+       +.     
T Consensus       163 tat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------mT-----  228 (829)
T KOG0576|consen  163 TAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------MT-----  228 (829)
T ss_pred             hhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------hh-----
Confidence            432  22345589999999999864   67899999999999999999888877654433221111       00     


Q ss_pred             hhhcC-CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014189          348 LNIID-PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD  390 (429)
Q Consensus       348 ~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  390 (429)
                      ...++ +.+.  -+..-+..+.+|++.||.++|++|||++.++.
T Consensus       229 kS~~qpp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  229 KSGFQPPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccCCCCCccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11111 1111  12234667889999999999999999998775

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.9e-29  Score=227.20  Aligned_cols=201  Identities=31%  Similarity=0.391  Sum_probs=171.4

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  193 (429)
                      |.+.+.||.|++|.||+|.+..+.      ..+++|.............+.+|++.++.++|+|++++++++......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTG------ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCC------cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEE
Confidence            566789999999999999876533      34999998865433355678899999999999999999999999899999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCC
Q 014189          194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  273 (429)
Q Consensus       194 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  273 (429)
                      ++||+++++|.+++..... .+++.....++.+++.++.+||..+  ++|+||+|.||+++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999999999999876542 2789999999999999999999977  999999999999999999999999998876543


Q ss_pred             CCccccccccCCccccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 014189          274 DKSHVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEILTGRKSLDK  324 (429)
Q Consensus       274 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltG~~p~~~  324 (429)
                      ... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       152 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 LAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            211 12345678899999998 667788899999999999999999999975

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=9.9e-30  Score=235.79  Aligned_cols=272  Identities=25%  Similarity=0.291  Sum_probs=195.6

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYC  185 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  185 (429)
                      ...+...|...++||+|+|++||++++...   ......||+|.+.......   ...+|+++|..+. +.||+++.+++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~---~~~~~~valk~i~~ts~p~---ri~~El~~L~~~gG~~ni~~~~~~~  104 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ---DTKRRYVALKAIYRTSSPS---RILNELEMLYRLGGSDNIIKLNGCF  104 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh---ccccceEeeeecccccCch---HHHHHHHHHHHhccchhhhcchhhh
Confidence            344556789999999999999999987652   2235569999987654333   3568999999985 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-CcEEEecc
Q 014189          186 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDF  264 (429)
Q Consensus       186 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  264 (429)
                      ..++...+|+||++...-.+++.     .++...+..+++.+..||.++|..|  ||||||||.|+|.+.. +.-.|.||
T Consensus       105 rnnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  105 RNNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             ccCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEec
Confidence            99999999999999988777664     3567788899999999999999988  9999999999999854 56789999


Q ss_pred             CCCcCCCCCC--------------C------------------c----------cccccccCCccccccccccc-CCCCc
Q 014189          265 GLAKDGPEGD--------------K------------------S----------HVSTRIMGTYGYAAPEYIMT-GHLTP  301 (429)
Q Consensus       265 gla~~~~~~~--------------~------------------~----------~~~~~~~gt~~y~aPE~~~~-~~~~~  301 (429)
                      |+|.......              .                  .          .......||++|+|||++.. ...+.
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9987211000              0                  0          00112579999999999874 56789


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCCChhhhhh-----------HHHhH---hh--HHH--------h----hhhh-hhhcC
Q 014189          302 RSDVYSFGVVLLEILTGRKSLDKSRPAREQN-----------LADWA---LP--LLK--------E----KKKL-LNIID  352 (429)
Q Consensus       302 ~~DvwslG~il~elltG~~p~~~~~~~~~~~-----------~~~~~---~~--~~~--------~----~~~~-~~~~~  352 (429)
                      ++||||.|||++.+++++.||.........-           +...+   ..  .+.        +    ...+ .+.+.
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            9999999999999999999997543221100           00000   00  000        0    0000 00000


Q ss_pred             C-C---C-CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          353 P-R---L-EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       353 ~-~---~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      + .   . ........+..+.+|+.+||..||.+|.|+++.|+|
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0 0   0 001112235588999999999999999999999987

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.6e-29  Score=268.14  Aligned_cols=197  Identities=19%  Similarity=0.227  Sum_probs=140.8

Q ss_pred             ccCC-CceeeeeeEE-------EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 014189          172 HLSH-PNLVKLIGYC-------CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIY  243 (429)
Q Consensus       172 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH  243 (429)
                      .++| +||++++++|       .....+++++||+ +++|.+++... ...+++..++.++.|++.||+|||+.+  |+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG--IVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence            3455 5788888877       2334677889988 56999999654 346999999999999999999999977  999


Q ss_pred             CCCCCCcEEEcC-------------------CCcEEEeccCCCcCCCCCCC--------------ccccccccCCccccc
Q 014189          244 RDFKTSNILLDT-------------------DYNAKLSDFGLAKDGPEGDK--------------SHVSTRIMGTYGYAA  290 (429)
Q Consensus       244 ~Dlkp~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y~a  290 (429)
                      |||||+||||+.                   ++.+|++|||+++.......              ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999954                   44566666676654211000              000112468999999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHH
Q 014189          291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAML  370 (429)
Q Consensus       291 PE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  370 (429)
                      ||++.+..|+.++|||||||+||||++|.+|+......    ....          .....++..     .........+
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~----------~~~~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSL----------RHRVLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHH----------HHhhcChhh-----hhcCHHHHHH
Confidence            99999999999999999999999999998876532110    0000          001111110     1112345678


Q ss_pred             HHHhhccCCCCCCCHHHHHHh
Q 014189          371 AYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       371 ~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +.+||+.+|.+|||+.|++++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            899999999999999999976

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.6e-27  Score=206.77  Aligned_cols=167  Identities=23%  Similarity=0.199  Sum_probs=125.9

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccc
Q 014189          201 GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST  280 (429)
Q Consensus       201 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (429)
                      |+|.+++.... .++++..+..++.|++.||+|||+.+        ||+|||++.++.+|+  ||++......       
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-------
Confidence            68999887543 36999999999999999999999855        999999999999999  9998765331       


Q ss_pred             cccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCC
Q 014189          281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP  360 (429)
Q Consensus       281 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (429)
                      ...||+.|+|||++.+..|+.++|||||||++|||+||+.||........ .+..+.    ..   ... .++. ....+
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~----~~---~~~-~~~~-~~~~~  132 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILL----NG---MPA-DDPR-DRSNL  132 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHH----HH---hcc-CCcc-ccccH
Confidence            12689999999999999999999999999999999999999965432111 111110    00   000 0000 00111


Q ss_pred             hHHHH--HHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          361 VKGVH--KAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       361 ~~~~~--~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      .....  .+.+++.+||..+|++|||+.++++++..+
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            22333  689999999999999999999999987554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.6e-25  Score=211.18  Aligned_cols=264  Identities=18%  Similarity=0.189  Sum_probs=196.4

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCC----CceeeeeeEE-Ee
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH----PNLVKLIGYC-CE  187 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~  187 (429)
                      +|.+.+.||+|+||.||+|......     ...+|+|+.......... .+..|..++..+..    +++..+++.. ..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~-----~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~   92 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK-----NKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRST   92 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC-----CeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence            8999999999999999999866543     234888887654322221 45568888888862    5888999888 57


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-----CcEEEe
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-----YNAKLS  262 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-----~~~kl~  262 (429)
                      ....|+||+.+ |.+|.++........++..+.+.|+.|++.+|.++|+.|  ++||||||+|+++...     ..+.|.
T Consensus        93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence            77889999988 679998775555567999999999999999999999988  9999999999999865     359999


Q ss_pred             ccCCCc--CCCCCCCc---cc---cccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhh-hH
Q 014189          263 DFGLAK--DGPEGDKS---HV---STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ-NL  333 (429)
Q Consensus       263 Dfgla~--~~~~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~-~~  333 (429)
                      |||+++  ........   ..   ...+.||..|.++....+...+.+.|+||++.++.|++.|..||......... .+
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence            999999  43222111   11   12356999999999999999999999999999999999999999765432221 11


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                      ....         .......     .....+..+..+...+-..+..++|....+...|.......
T Consensus       250 ~~~~---------~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  250 EKDP---------RKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHHh---------hhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            1000         0000110     11223455666666666789999999999998876655443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.2e-25  Score=215.21  Aligned_cols=179  Identities=18%  Similarity=0.147  Sum_probs=133.7

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCceee-ee
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVK-LI  182 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~-l~  182 (429)
                      ..+.++|.+.+.||+|+||+||+|.+....     +..+|+|++....    .......|.+|+++|++++|+|+++ ++
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDP-----GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCC-----CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            456688999999999999999999865421     2337999865331    2233456889999999999999985 44


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCC-CCCcEEEcCCCcEEE
Q 014189          183 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF-KTSNILLDTDYNAKL  261 (429)
Q Consensus       183 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dl-kp~NIll~~~~~~kl  261 (429)
                      +    .+..|+||||++|++|.. +. .    ..   ...++.+++.+|.|||+.+  |+|||| ||+|||++.++.+||
T Consensus        89 ~----~~~~~LVmE~~~G~~L~~-~~-~----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         89 A----TGKDGLVRGWTEGVPLHL-AR-P----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             E----cCCcEEEEEccCCCCHHH-hC-c----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEE
Confidence            3    245799999999999863 21 1    11   1467889999999999977  999999 999999999999999


Q ss_pred             eccCCCcCCCCCCCccc------cccccCCcccccccccccC------CCCcccchh
Q 014189          262 SDFGLAKDGPEGDKSHV------STRIMGTYGYAAPEYIMTG------HLTPRSDVY  306 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~Dvw  306 (429)
                      +|||+|+..........      .....++..|+|||.+...      ..+...|-|
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99999987654321111      1346788999999998632      233446766

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-27  Score=206.34  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=197.4

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC-CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEE
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  194 (429)
                      +.-+|.+...|..|+|++.++.        +++|++.-. ......++|..|.-.|+.+.||||+.+++.|...-.+.++
T Consensus       194 l~tkl~e~hsgelwrgrwqgnd--------ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQGND--------IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             hhhhhccCCCcccccccccCcc--------hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            3457889999999999886542        667776543 2344456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe--ccCCCcCCCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS--DFGLAKDGPE  272 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~--Dfgla~~~~~  272 (429)
                      ..||+.|+|++.|+.......+..++.+++.++++|++|||+..+-|.---|.+..+++|++.+.+|+  |--++..   
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq---  342 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---  342 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---
Confidence            99999999999999887767788899999999999999999987645556799999999999988765  3222211   


Q ss_pred             CCCccccccccCCcccccccccccCCCC---cccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLT---PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                            .....-.+.||+||.+...+-+   .++|+|||++++|||.|...||....+.+-             +   .+
T Consensus       343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------------g---mk  400 (448)
T KOG0195|consen  343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------------G---MK  400 (448)
T ss_pred             ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------------h---hh
Confidence                  1112346899999999866543   578999999999999999999987654221             0   11


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      +--..++...|+..+..+.+|+.-|+..||.+||.+..|+-.||+++
T Consensus       401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            22234455667778889999999999999999999999999998764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.2e-23  Score=200.49  Aligned_cols=261  Identities=31%  Similarity=0.406  Sum_probs=196.7

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh--hHHHHHHHHHHHhccCCC-ceeeeeeEEEeCCe
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEH  190 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~  190 (429)
                      |.+.+.||.|+||.||++.+.         ..+++|.+.......  ....|.+|+.+++.+.|+ +|+++.+.+.....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence            667789999999999999765         338889887654433  467788999999999988 79999999987777


Q ss_pred             EEEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-cEEEeccCCCc
Q 014189          191 RVLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLAK  268 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~  268 (429)
                      .+++++++.++++.+.+..... ..+.......++.+++.++.|+|..+  ++|||+||+||+++..+ .++++|||++.
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            8999999999999966544321 25888899999999999999999988  99999999999999998 79999999998


Q ss_pred             CCCCCCCcc----ccccccCCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCChh-hhhhHHHhHhhH
Q 014189          269 DGPEGDKSH----VSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA-REQNLADWALPL  340 (429)
Q Consensus       269 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltG~~p~~~~~~~-~~~~~~~~~~~~  340 (429)
                      .........    ......||..|++||.+.+   ..++...|+||+|++++++++|..||...... .......    .
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~----~  226 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK----I  226 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH----H
Confidence            554432211    2355789999999999987   57899999999999999999999997655421 0000000    0


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +....  ...................+.+++..|+..+|..|.+..+....
T Consensus       227 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         227 ILELP--TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHhcC--CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000  00000000000001223578899999999999999999887765

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.9e-24  Score=194.84  Aligned_cols=261  Identities=18%  Similarity=0.228  Sum_probs=191.5

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  187 (429)
                      ++.-+|+++++||+|+||..+.|+.-      .+..+||||.-.......   ++..|.+..+.|. .+.|...+-+-.+
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl------~nne~VAIKfEPrkS~AP---QLrdEYr~YKlL~g~~GIP~vYYFGqe   95 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNL------YNNEPVAIKFEPRKSEAP---QLRDEYRTYKLLGGTEGIPQVYYFGQE   95 (449)
T ss_pred             EecccceeccccccCcceeeeccccc------ccCceEEEEeccccCCcc---hHHHHHHHHHHHcCCCCCCceeeeccc
Confidence            34568999999999999999998543      345669999876543222   3446888888775 6899988888888


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-----CcEEEe
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-----YNAKLS  262 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-----~~~kl~  262 (429)
                      ..+-.||+|++ |-||.+++.-. +..|+..++..+|.|++.-++|+|.++  +|+|||||+|+||..-     ..+.|+
T Consensus        96 G~~NiLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~Ihii  171 (449)
T KOG1165|consen   96 GKYNILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHII  171 (449)
T ss_pred             cchhhhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEE
Confidence            88889999999 66888865443 457999999999999999999999988  9999999999999643     348999


Q ss_pred             ccCCCcCCCCCCCc-----cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH
Q 014189          263 DFGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       263 Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~  337 (429)
                      |||+|+.+.+....     ....+..||..||+-....+.+.+.+.|+-|||-++++.|-|..||.+......       
T Consensus       172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-------  244 (449)
T KOG1165|consen  172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-------  244 (449)
T ss_pred             eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-------
Confidence            99999987654321     123357899999999999999999999999999999999999999987543211       


Q ss_pred             hhHHHhhhhhhhhcCCCCCCCCC---hHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          338 LPLLKEKKKLLNIIDPRLEGDYP---VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                            +....++-+........   ...+.++..-+.-.-..+-++-|..+-+...+..+
T Consensus       245 ------K~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  245 ------KEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             ------HHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                  11122222222211111   12344555555555566677777766555444333

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=7.4e-26  Score=230.30  Aligned_cols=261  Identities=21%  Similarity=0.262  Sum_probs=187.1

Q ss_pred             ccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhH-HHHHHHHHHHhccCCCceeeeeeEEEeCCeEEE
Q 014189          115 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  193 (429)
                      ...+++|.|++|.|+........+... ...++++ .......... ..+..|+.+-..++|||++..+..+.+....+-
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~-~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFP-EKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccch-hhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence            456789999999777765443332211 1112222 1122222222 225678888889999999888877776666666


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCC
Q 014189          194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  273 (429)
Q Consensus       194 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  273 (429)
                      +||||++ +|..++....  .+....+-.++.|++.|+.|+|+.|  |.|||+|++|++++.+|.+||+|||.+..+...
T Consensus       399 ~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            6999999 9999887652  4777888899999999999999988  999999999999999999999999998765543


Q ss_pred             CCc--cccccccCCcccccccccccCCCCc-ccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          274 DKS--HVSTRIMGTYGYAAPEYIMTGHLTP-RSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       274 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ...  ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||.............       ....-.+.
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~~~~~~~  546 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NYSDQRNI  546 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------cccccccc
Confidence            333  5566789999999999999999976 5899999999999999999997654332211000       00000000


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .  .-........+.....++.++|+.||.+|.|+++|++.
T Consensus       547 ~--~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  547 F--EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             c--cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            0  00001112456778889999999999999999999863

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.2e-24  Score=186.35  Aligned_cols=257  Identities=20%  Similarity=0.234  Sum_probs=191.2

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCC-CceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~  187 (429)
                      +...+|.+.++||.|+||.+|.|.....+++      ||||+-.......   .+.-|..+...+++ ..|..+..+..+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~------VAiK~Es~~a~hp---qL~yEskvY~iL~~g~GiP~i~~y~~e   82 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEE------VAIKLESSKAKHP---QLLYESKVYRILQGGVGIPHIRHYGTE   82 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCce------EEEEeecccCCCc---chhHHHHHHHHhccCCCCchhhhhccc
Confidence            4557899999999999999999988776655      9999977654333   34468888888875 677888888888


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC---CcEEEecc
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSDF  264 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df  264 (429)
                      ..+-.+|||++ |-+|.+++.-. ...++..+++.++-|++.-++|+|.++  .|||||||+|.|..-+   ..+.++||
T Consensus        83 ~~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDF  158 (341)
T KOG1163|consen   83 KDYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDF  158 (341)
T ss_pred             cccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEec
Confidence            88999999999 66888766443 336899999999999999999999977  9999999999999654   45899999


Q ss_pred             CCCcCCCCCCC-----ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh
Q 014189          265 GLAKDGPEGDK-----SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       265 gla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      |+|+.+.+...     ........||..|.+-....+...+.+.|+-|+|.+|.++.-|..||.+......+..-+.+. 
T Consensus       159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~-  237 (341)
T KOG1163|consen  159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS-  237 (341)
T ss_pred             cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH-
Confidence            99987654321     112334789999999988888888999999999999999999999999876544332222111 


Q ss_pred             HHHhhhhhhhhcCCCCCCCCC---hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          340 LLKEKKKLLNIIDPRLEGDYP---VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                  .........   ...+.++...+.-|-..--++-|...-+-+.
T Consensus       238 ------------EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrql  280 (341)
T KOG1163|consen  238 ------------EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQL  280 (341)
T ss_pred             ------------HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence                        111111000   0124555666667777767777766544443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=8.1e-23  Score=182.25  Aligned_cols=175  Identities=10%  Similarity=0.095  Sum_probs=132.2

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh--hHHH------HHHHHHHHhccCCCcee
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ--GHRE------WLAEVIFLGHLSHPNLV  179 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~------~~~E~~~l~~l~h~niv  179 (429)
                      ..+.++|+..++||.|+||.||++.. . .      ..+|+|++.......  ....      +.+|+..+.+++||+|.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~-~------~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~   98 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-D-Y------GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA   98 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-C-C------CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence            35678899999999999999998633 2 1      239999997653222  2122      56899999999999999


Q ss_pred             eeeeEEEeC--------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcE
Q 014189          180 KLIGYCCED--------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  251 (429)
Q Consensus       180 ~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NI  251 (429)
                      .+.+++...        +..+++|||++|.+|.+..      .++.    ....+++.++..+|..+  ++|||++|+||
T Consensus        99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Ni  166 (232)
T PRK10359         99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHG--MVSGDPHKGNF  166 (232)
T ss_pred             cceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcC--CccCCCChHHE
Confidence            998886533        3578999999999998763      1222    34568899999999988  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh
Q 014189          252 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT  317 (429)
Q Consensus       252 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt  317 (429)
                      +++.+| ++|+|||...........   .           .++....|+.++|+||||+++..+..
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~---d-----------~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAK---D-----------RIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhH---H-----------HHHHHhHhcccccccceeEeehHHHH
Confidence            999998 999999988765321110   0           13445567789999999999876543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.3e-23  Score=214.49  Aligned_cols=254  Identities=23%  Similarity=0.254  Sum_probs=185.0

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHH---HHHHHHhccCCCceeeeeeEEEeCC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL---AEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      +|...+.||.+.|=.|.+|++.++.        |+||++-+.........|.   .|++ ...++|||.+++.-+-..+.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~--------vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL--------VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce--------EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH
Confidence            5666789999999999999765542        8999987655444444444   4444 45568999999988888888


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|||-+|+.+ +|++++..+.  -+...+..-|+.|++.||.-+|..+  |+|||||.+||||+.-.-+.|+||..-+.
T Consensus        95 AAylvRqyvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   95 AAYLVRQYVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCC
Confidence            88999999965 8999886553  3667788899999999999999988  99999999999999999999999987654


Q ss_pred             C--CCCCC---ccccccccCCcccccccccccC-----------CCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhh
Q 014189          270 G--PEGDK---SHVSTRIMGTYGYAAPEYIMTG-----------HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQN  332 (429)
Q Consensus       270 ~--~~~~~---~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~  332 (429)
                      .  +.+++   .....+...-.+|.|||.+...           ..+++.||||+||++.||++ |++||....-     
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-----  244 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-----  244 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----
Confidence            3  22221   1222233445689999988531           25788999999999999987 7888873211     


Q ss_pred             HHHhHhh-HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          333 LADWALP-LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       333 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                       ..+-.. ......-+.++-|            ..++.++..|++.||+.|.|+++.|+.-.++.++
T Consensus       245 -~aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP  298 (1431)
T KOG1240|consen  245 -LAYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFP  298 (1431)
T ss_pred             -HhHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhccccH
Confidence             110000 0000111222222            2467899999999999999999999987666554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-23  Score=205.00  Aligned_cols=230  Identities=29%  Similarity=0.335  Sum_probs=178.8

Q ss_pred             eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh-hHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeEEEEEE
Q 014189          119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      ++|+|+||.|+++.-..   ....+..+|+|+..+..... .......|..++..++ ||.+|+++..++.+...+++++
T Consensus         1 vlg~g~~gkvfLvrk~~---g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAG---GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhc---cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            37999999999863211   12234447777765542111 1113446888888887 9999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCc
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  276 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  276 (429)
                      |..+|+|..++....  .+.+.........++.+++++|..+  ++|||+|++||+++.+|++++.|||+++..-.... 
T Consensus        78 ~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             hcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            999999988776554  4666666777788899999999988  99999999999999999999999999987544322 


Q ss_pred             cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCC
Q 014189          277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  356 (429)
Q Consensus       277 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (429)
                           .|||..|||||++.  .....+|+||||++++||+||..||...       .             +..+.  ...
T Consensus       153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-------~-------------~~~Il--~~~  203 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-------T-------------MKRIL--KAE  203 (612)
T ss_pred             -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-------H-------------HHHHh--hhc
Confidence                 28999999999998  5688999999999999999999999750       0             11111  112


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCH
Q 014189          357 GDYPVKGVHKAAMLAYHCLNHNPKARPLM  385 (429)
Q Consensus       357 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  385 (429)
                      ...|...+..+.+++..++..+|..|.-.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            34566778889999999999999999755

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=5.1e-22  Score=174.92  Aligned_cols=140  Identities=15%  Similarity=0.139  Sum_probs=104.6

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hh-------H-----------------HHHHHHHHHHh
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QG-------H-----------------REWLAEVIFLG  171 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~-------~-----------------~~~~~E~~~l~  171 (429)
                      ...||+|+||.||+|.+. +      +..||+|+++..... ..       .                 .....|+..+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~------g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05147           2 NGCISTGKEANVYHATTA-N------GEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK   74 (190)
T ss_pred             CCccccccceEEEEEECC-C------CCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence            467999999999999764 2      345999998754211 00       0                 11234999999


Q ss_pred             ccCCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeCCCCCCc
Q 014189          172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL-HEAEKPVIYRDFKTSN  250 (429)
Q Consensus       172 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~ivH~Dlkp~N  250 (429)
                      ++.++++.....+.. . ..++||||++++++.......  .+++......++.|++.+|.++ |..+  |+||||||+|
T Consensus        75 ~l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~N  148 (190)
T cd05147          75 RLVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYN  148 (190)
T ss_pred             HHHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHH
Confidence            998777643332222 2 238999999988776543322  3688899999999999999999 6877  9999999999


Q ss_pred             EEEcCCCcEEEeccCCCcCC
Q 014189          251 ILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       251 Ill~~~~~~kl~Dfgla~~~  270 (429)
                      ||++ ++.++|+|||+|...
T Consensus       149 Ili~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEE-CCcEEEEEccccccC
Confidence            9998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=6.9e-21  Score=168.24  Aligned_cols=142  Identities=18%  Similarity=0.112  Sum_probs=108.3

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh-------------------------hHHHHHHHHHHHh
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-------------------------GHREWLAEVIFLG  171 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------~~~~~~~E~~~l~  171 (429)
                      .+.||+|+||.||+|.+. +      +..||+|+++......                         ....+..|...+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~------g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05145           2 NGCISTGKEANVYHARTG-D------GEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK   74 (190)
T ss_pred             CceeecCCCcEEEEEEcC-C------CCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence            468999999999999764 2      3459999987652110                         0112347899999


Q ss_pred             ccCCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCc
Q 014189          172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSN  250 (429)
Q Consensus       172 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~N  250 (429)
                      ++.|+++.....+....  .++||||++|+++.......  ..++......++.+++.++.++|. .+  |+||||||+|
T Consensus        75 ~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~N  148 (190)
T cd05145          75 RLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYN  148 (190)
T ss_pred             HHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhh
Confidence            99999875444433332  48999999988654432222  257788889999999999999998 88  9999999999


Q ss_pred             EEEcCCCcEEEeccCCCcCCCC
Q 014189          251 ILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       251 Ill~~~~~~kl~Dfgla~~~~~  272 (429)
                      ||++ ++.++|+|||++.....
T Consensus       149 Ill~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEEE-CCCEEEEEcccceecCC
Confidence            9999 88999999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=2.5e-21  Score=177.82  Aligned_cols=234  Identities=22%  Similarity=0.288  Sum_probs=149.5

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecC--CCChhhHHHHHHHHHHHhccCC-----------Cce-
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG--DNSYQGHREWLAEVIFLGHLSH-----------PNL-  178 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h-----------~ni-  178 (429)
                      .+...+.||.|+|+.||.+++.++++      .+|+|+...  .......+.+.+|......+.+           .-+ 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~------~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~   86 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGE------EFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV   86 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTE------EEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred             EEEEccccccCCceEEEEEEEccCCc------eEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence            35566899999999999998776644      499998643  3334455667766655544332           111 


Q ss_pred             ----eeeee---EEEeC---C-----eEEEEEEecCCCChhhhhh---cCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014189          179 ----VKLIG---YCCED---E-----HRVLIYEFMARGSVENNLF---SKV--LLPLPWSIRMKIAFGAAKGLAFLHEAE  238 (429)
Q Consensus       179 ----v~l~~---~~~~~---~-----~~~lv~e~~~~g~L~~~l~---~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~  238 (429)
                          +++.+   ++...   .     ..+++|+-+ .++|.+.+.   ...  ...+....++.+..|+++.+++||..|
T Consensus        87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G  165 (288)
T PF14531_consen   87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG  165 (288)
T ss_dssp             -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence                11110   12111   1     236788877 468877653   221  123445666778899999999999988


Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCccccccccccc--------CCCCcccchhhHHH
Q 014189          239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--------GHLTPRSDVYSFGV  310 (429)
Q Consensus       239 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~  310 (429)
                        ++|+||+|+|++++.+|.++|+||+.......    .... ...+..|.+||....        -.++.+.|.|+||+
T Consensus       166 --lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  166 --LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             --EEEST-SGGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             --eEecccceeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence              99999999999999999999999988765332    1111 345678999997743        25788999999999


Q ss_pred             HHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCC
Q 014189          311 VLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR  382 (429)
Q Consensus       311 il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  382 (429)
                      ++|.|++|..||+...+......                     .-..+. +.+..+..|+..+|+.||.+|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999986643211100                     112334 678889999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.6e-20  Score=164.09  Aligned_cols=185  Identities=17%  Similarity=0.108  Sum_probs=132.8

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh---hhHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeE
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY---QGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  191 (429)
                      ....|++|+||+||.+...        +..++.+.+....-.   .....|.+|+++|+++. |+++++++++    +..
T Consensus         6 ~~~~l~~~~f~~v~~~~~~--------~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~   73 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGG--------ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGR   73 (218)
T ss_pred             cceeecCCCcceEEEeecC--------CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence            3478999999999976321        223555555443221   11124678999999995 5889999886    346


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCC-CCCcEEEcCCCcEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF-KTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +++|||+.|.+|...+..        . ...++.+++.+|.++|.++  |+|||| ||+|||++.++.++|+|||++...
T Consensus        74 ~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             EEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            999999999888654311        1 1356788999999999988  999999 799999999999999999999865


Q ss_pred             CCCCCc--c-c--------cccccCCcccccccccccC-CCC-cccchhhHHHHHHHHHhCCCCCC
Q 014189          271 PEGDKS--H-V--------STRIMGTYGYAAPEYIMTG-HLT-PRSDVYSFGVVLLEILTGRKSLD  323 (429)
Q Consensus       271 ~~~~~~--~-~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~elltG~~p~~  323 (429)
                      ......  . .        ......++.|++|+..... ..+ ...++++-|.-+|.++|+..++-
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            432210  0 0        1112367788888765432 333 56788899999999999988754

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=9.2e-21  Score=184.83  Aligned_cols=220  Identities=27%  Similarity=0.392  Sum_probs=163.3

Q ss_pred             HhccCCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCC
Q 014189          170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS  249 (429)
Q Consensus       170 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~  249 (429)
                      |+.+.|.|+.+++|.+.++...+.|.+||.-|+|.+.+... ...+++.....+.++++.||+|+|..... .|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~-~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIG-YHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcce-eeeeeccc
Confidence            45688999999999999999999999999999999998764 34688999999999999999999985522 89999999


Q ss_pred             cEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCC-------CCcccchhhHHHHHHHHHhCCCCC
Q 014189          250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-------LTPRSDVYSFGVVLLEILTGRKSL  322 (429)
Q Consensus       250 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~elltG~~p~  322 (429)
                      |.++|....+||+|||+.................-..-|.|||.+++..       .+.+.|+||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987664211111111223456799999998641       467799999999999999999999


Q ss_pred             CCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          323 DKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      +........  .+.+.....   .-...+.|.+...  .+...++..++..||..+|++||++++|-..++.+...
T Consensus       159 ~~~~~~~~~--~eii~~~~~---~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  159 DLRNLVEDP--DEIILRVKK---GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccCCh--HHHHHHHHh---cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            864432221  111111111   0011111211111  13344788999999999999999999999888776543

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=6.5e-20  Score=163.08  Aligned_cols=137  Identities=18%  Similarity=0.164  Sum_probs=103.7

Q ss_pred             ccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-----CCCceeeeeeEEEeCC
Q 014189          115 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-----SHPNLVKLIGYCCEDE  189 (429)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~  189 (429)
                      .-.+.||+|+||.||.  +..+.      . .+||++.... ......+.+|+.+++.+     .||||+++++++.++.
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~------~-k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~   74 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDA------Q-RCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC   74 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCc------C-eEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC
Confidence            3457899999999995  43321      1 4688876542 22445688999999999     5799999999998763


Q ss_pred             ---eEE-EEEEe--cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceeCCCCCCcEEEcC----CCc
Q 014189          190 ---HRV-LIYEF--MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL-AFLHEAEKPVIYRDFKTSNILLDT----DYN  258 (429)
Q Consensus       190 ---~~~-lv~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~~lH~~~~~ivH~Dlkp~NIll~~----~~~  258 (429)
                         ..+ +|+||  +.+|+|.+++...   .+++.  ..++.+++.++ +|||+++  |+||||||+|||++.    ++.
T Consensus        75 g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         75 GTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             CCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCc
Confidence               433 78999  5579999999653   35544  35577777777 9999988  999999999999974    347


Q ss_pred             EEEeccCCCc
Q 014189          259 AKLSDFGLAK  268 (429)
Q Consensus       259 ~kl~Dfgla~  268 (429)
                      ++|+||+.+.
T Consensus       148 ~~LiDg~G~~  157 (210)
T PRK10345        148 PVVCDNIGES  157 (210)
T ss_pred             EEEEECCCCc
Confidence            9999955443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=2.4e-20  Score=172.18  Aligned_cols=197  Identities=19%  Similarity=0.234  Sum_probs=138.6

Q ss_pred             CCCceeeeeeEEEe---------------------------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHH
Q 014189          174 SHPNLVKLIGYCCE---------------------------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG  226 (429)
Q Consensus       174 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~  226 (429)
                      +|||||++.++|.+                           ...+|+||...+. +|..++..+.   .+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence            49999999887632                           3467899988864 8999987664   455566778899


Q ss_pred             HHHHHHHHHhCCCCceeCCCCCCcEEEc--CCC--cEEEeccCCCcCCCCCC--Cc--cccccccCCcccccccccccCC
Q 014189          227 AAKGLAFLHEAEKPVIYRDFKTSNILLD--TDY--NAKLSDFGLAKDGPEGD--KS--HVSTRIMGTYGYAAPEYIMTGH  298 (429)
Q Consensus       227 i~~~l~~lH~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfgla~~~~~~~--~~--~~~~~~~gt~~y~aPE~~~~~~  298 (429)
                      +++|+.|||.++  |.|||+|++|||+.  +|+  .+.|+|||++--...-.  ..  .-.-..-|...-||||+....+
T Consensus       350 lLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  350 LLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999988  99999999999983  333  47999999864322100  00  0111245788899999986321


Q ss_pred             ------CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHH
Q 014189          299 ------LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAY  372 (429)
Q Consensus       299 ------~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  372 (429)
                            --.++|.|+.|.+.||+++...||.+.... ..+...           ..+---    ...+..++..+.+|+.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----------Yqe~qL----Palp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----------YQESQL----PALPSRVPPVARQLVF  491 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----------hhhhhC----CCCcccCChHHHHHHH
Confidence                  125899999999999999999999863211 111110           111111    1234456778889999


Q ss_pred             HhhccCCCCCCCHHHHHHhc
Q 014189          373 HCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       373 ~cl~~dP~~RPs~~evl~~L  392 (429)
                      ..|+.||++|+|..-..+.|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999987555544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=4.9e-20  Score=191.69  Aligned_cols=194  Identities=20%  Similarity=0.203  Sum_probs=156.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC---CCceeeeeeEEEeC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYCCED  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  188 (429)
                      ..|.+.+.||+|+||.||+|...+       +..||+|+-+..+.++.+.    -.+++.+|+   -+.|..+..++.-.
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-------~~~~alK~e~P~~~WEfYI----~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-------GKLVALKVEKPPNPWEFYI----CLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-------CcEEEEEeecCCCceeeee----hHHHHHhhchhhhcchHHHHHHHccC
Confidence            458888999999999999997655       3449999988776554332    223344444   34566666666777


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-------CCCcEEE
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-------TDYNAKL  261 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-------~~~~~kl  261 (429)
                      +.-++|+||.+.|+|.+++.  ..+..+|...+.++.|++..++.||..+  |||+||||+|.||.       .+..++|
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             CcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEE
Confidence            77899999999999999886  4457899999999999999999999988  99999999999993       2445899


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK  320 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~  320 (429)
                      +|||.+-.+..-.........++|-.+-++|+..|..++...|.|.|+.+++-||.|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999875543333333455789999999999999999999999999999999999974

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=2.9e-20  Score=190.05  Aligned_cols=211  Identities=25%  Similarity=0.365  Sum_probs=144.7

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ...+|..++.|..|+||.||.+.++..      .+.+|+|+-+.. -      .++-  ++.....|.+|          
T Consensus        81 ~e~df~~IklisngAygavylvrh~~t------rqrfa~kiNkq~-l------ilRn--ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKET------RQRFAMKINKQN-L------ILRN--ILTFAGNPFVV----------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeecccc------ccchhhcccccc-h------hhhc--cccccCCccee----------
Confidence            346899999999999999999976654      334787543221 0      0010  22222334333          


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                                 |+-...+..-.  +++...        +.+++|||+-+  |+|||+||+|.+|+.-|++|++|||+++.
T Consensus       136 -----------gDc~tllk~~g--~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIG--PLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             -----------chhhhhcccCC--CCcchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhh
Confidence                       44444443322  344332        67899999866  99999999999999999999999999875


Q ss_pred             CCCCCCc------------c-ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh
Q 014189          270 GPEGDKS------------H-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       270 ~~~~~~~------------~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~  336 (429)
                      .......            . .....+||+.|+|||++....|...+|+|++|+|+||.+.|..||.+..+.+..     
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf-----  267 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-----  267 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH-----
Confidence            3221110            0 112368999999999999999999999999999999999999999876543221     


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP  383 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  383 (429)
                       .+++.+....         .+.......++.+++.++|+.+|..|-
T Consensus       268 -g~visd~i~w---------pE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  268 -GQVISDDIEW---------PEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             -hhhhhhhccc---------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence             1111111000         011223467899999999999999995

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3.6e-18  Score=153.59  Aligned_cols=135  Identities=18%  Similarity=0.221  Sum_probs=109.9

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--h-----hhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--Y-----QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      +.||+|++|.||+|.+.+        ..+++|+......  .     .....+.+|+.++..+.|+++.....++...+.
T Consensus         2 ~~l~~G~~~~vy~~~~~~--------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLG--------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN   73 (211)
T ss_pred             cccccCceEEEEEEeeCC--------CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC
Confidence            579999999999997622        2388887654321  1     112356789999999999998877777777778


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+++|||++|++|.+.+....     . .+..++.+++.+|.++|..+  ++|+|++|.|||++ ++.++|+|||++..
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            899999999999999875432     1 77899999999999999977  99999999999999 78899999998875

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=2.2e-18  Score=156.95  Aligned_cols=144  Identities=15%  Similarity=0.098  Sum_probs=107.0

Q ss_pred             CCccceeecCCCcEEEEEEE-EccccccCcCceeEEEEEecCCCCh-----------------------hhHHHHHHHHH
Q 014189          113 NFRQDRVLGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSY-----------------------QGHREWLAEVI  168 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~-~~~~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~E~~  168 (429)
                      .|.+.+.||+|+||.||+|. +..+      +..||+|++......                       .....+..|+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~------g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGS------GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCC------CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            48888999999999999997 3332      345999998754210                       01123557999


Q ss_pred             HHhccCCCc--eeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCC
Q 014189          169 FLGHLSHPN--LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF  246 (429)
Q Consensus       169 ~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dl  246 (429)
                      .+.++.+.+  +.+++++   . ..++||||+++++|.......  ..+.......++.|++.++++||.++ +++|+||
T Consensus       103 ~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Di  175 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDL  175 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCC
Confidence            999997532  3344432   2 348999999998887654332  24556667899999999999999844 2999999


Q ss_pred             CCCcEEEcCCCcEEEeccCCCcCC
Q 014189          247 KTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       247 kp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      ||+||+++ ++.++|+|||.+...
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999 889999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=8.6e-20  Score=174.93  Aligned_cols=176  Identities=22%  Similarity=0.341  Sum_probs=129.5

Q ss_pred             CeEEEEEEecCCCChhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          189 EHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .++|+.|++|..++|.+||.+ ......++...+.++.|++.++.|   .+  .+|+|+||.||++..+..+||+|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence            367899999999999999964 334457888899999999999999   34  999999999999999999999999998


Q ss_pred             cCCCCCC----CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          268 KDGPEGD----KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       268 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      .......    .....+...||..||+||.+.+..|+.++||||||++|+|+++   +|....               ..
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~---------------er  465 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQF---------------ER  465 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHH---------------HH
Confidence            7654433    1112345789999999999999999999999999999999998   222110               00


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI  388 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev  388 (429)
                      -..+..+.|..+...+..+ -..-..|+.+++...|.+||++.+.
T Consensus       466 ~~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  466 IATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             HHhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence            1111222222221111111 1233568999999999999955443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=5.3e-18  Score=173.26  Aligned_cols=138  Identities=20%  Similarity=0.225  Sum_probs=109.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEec-CC-C-----ChhhHHHHHHHHHHHhccCCCceeeeeeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD-GD-N-----SYQGHREWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~-~~-~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      ..|...+.||+|+||.||+|.+....        +++|... +. .     .......+.+|++++..++|++++....+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~  404 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD--------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY  404 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc--------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence            44567789999999999998765432        3333321 11 1     11223567899999999999999888777


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                      +......++||||+++++|.+++.          ....++.+++.+|.+||+.+  ++||||||+|||+ .++.++|+||
T Consensus       405 ~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDF  471 (535)
T PRK09605        405 DVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDF  471 (535)
T ss_pred             EEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeC
Confidence            777777899999999999998774          34678999999999999977  9999999999999 6788999999


Q ss_pred             CCCcCC
Q 014189          265 GLAKDG  270 (429)
Q Consensus       265 gla~~~  270 (429)
                      |+++..
T Consensus       472 Gla~~~  477 (535)
T PRK09605        472 GLGKYS  477 (535)
T ss_pred             cccccC
Confidence            998763

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=6.9e-18  Score=150.30  Aligned_cols=131  Identities=18%  Similarity=0.254  Sum_probs=103.1

Q ss_pred             eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--C-----hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--S-----YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .||+|+||.||+|.+.+        ..+++|......  .     ......+.+|++++..+.|+++.....++......
T Consensus         1 ~ig~G~~~~vy~~~~~~--------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLG--------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK   72 (199)
T ss_pred             CCCCCceEEEEEeecCC--------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC
Confidence            38999999999997432        238888855421  1     11224567899999999988765555555566677


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ++||||++|++|.+.+....         ..++.+++.+|.++|..+  ++|+|++|+||+++ ++.++++|||++..
T Consensus        73 ~lv~e~~~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEGN---------DELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEEECCccHHHHHhhcH---------HHHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999999998774431         178899999999999977  99999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.2e-17  Score=148.75  Aligned_cols=139  Identities=17%  Similarity=0.099  Sum_probs=105.0

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh---------------------hhHHHHHHHHHHHh
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY---------------------QGHREWLAEVIFLG  171 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~  171 (429)
                      .|.+.+.||+|+||.||+|...+       +..||+|++......                     .....+..|+.++.
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPD-------GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCC-------CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            47788999999999999997642       334999987653210                     01123567888898


Q ss_pred             ccCCCc--eeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCC
Q 014189          172 HLSHPN--LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS  249 (429)
Q Consensus       172 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~  249 (429)
                      .+.|++  +...++    ....++||||++|++|......        .....++.+++.++.++|..+  ++|+||||+
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~  154 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEF  154 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcc
Confidence            888774  344443    2345899999999988764321        234678889999999999977  999999999


Q ss_pred             cEEEcCCCcEEEeccCCCcCCCC
Q 014189          250 NILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       250 NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      ||++++++.++|+|||++.....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=8.8e-19  Score=178.69  Aligned_cols=260  Identities=25%  Similarity=0.257  Sum_probs=189.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  189 (429)
                      ..|.+.+.||+|+|+.|-......+.     ...+|.|.+.... ..........|..+-..+. |+|++.+++...+.+
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~-----~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDP-----ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCC-----cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc
Confidence            35667778999999999876543322     2336666554432 2222223334766767776 999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeCCCCCCcEEEcCCC-cEEEeccCCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH-EAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLA  267 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla  267 (429)
                      ..+++++|..+|++.+.+........+...+...+.|+..++.|+| ..+  +.|+||||+|.+++..+ .++++|||+|
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhh
Confidence            9999999999999998873222223455566788899999999999 766  99999999999999999 9999999999


Q ss_pred             cCCCC-CCCccccccccC-CcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          268 KDGPE-GDKSHVSTRIMG-TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       268 ~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ..+.. ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|++....... ....|...    .
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~----~  247 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSN----K  247 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeeccc----c
Confidence            88776 444444555788 9999999999885 446789999999999999999999986543221 11111100    0


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                              ................+++.+++..+|+.|.+.+++...
T Consensus       248 --------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  248 --------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             --------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                    000111223455677888999999999999999987643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=8.5e-16  Score=129.82  Aligned_cols=134  Identities=22%  Similarity=0.198  Sum_probs=110.5

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCC--CceeeeeeEEEeCCeEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH--PNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  194 (429)
                      .+.||.|.++.||++...+        ..+++|.......   ...+..|+.++..++|  .+++++++++...+..+++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~--------~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v   71 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD--------EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL   71 (155)
T ss_pred             ceecccccccceEEEEecC--------CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence            4789999999999997643        2389998866533   4567789999999976  5889999888877889999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       195 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      |||++++.+...         +......++.+++.+++++|... .+++|+|++|+||+++.++.+++.|||.+...
T Consensus        72 ~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          72 MEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            999998876643         44566788999999999999742 35999999999999999999999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=4.4e-16  Score=137.22  Aligned_cols=138  Identities=22%  Similarity=0.217  Sum_probs=94.6

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHH----------------------HHHHHHHhcc
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREW----------------------LAEVIFLGHL  173 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~----------------------~~E~~~l~~l  173 (429)
                      .+.||+|+||.||+|.+.+       +..||+|++...... .....+                      ..|...+..+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~-------~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   74 (187)
T cd05119           2 GGPIGTGKEADVYLALDGD-------GEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL   74 (187)
T ss_pred             CcccccccceeEEEEECCC-------CCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH
Confidence            4679999999999997542       345999987754211 111111                      2455556555


Q ss_pred             CCCc--eeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCc
Q 014189          174 SHPN--LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSN  250 (429)
Q Consensus       174 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~N  250 (429)
                      .+..  +.+.+++    ...++||||++++++.........  .. .....++.+++.++.++|. .+  ++|+||||+|
T Consensus        75 ~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~N  145 (187)
T cd05119          75 YEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYN  145 (187)
T ss_pred             HHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhh
Confidence            4332  3444432    235899999999654322111110  11 5567899999999999998 77  9999999999


Q ss_pred             EEEcCCCcEEEeccCCCcCCC
Q 014189          251 ILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       251 Ill~~~~~~kl~Dfgla~~~~  271 (429)
                      |+++ ++.++|+|||.+....
T Consensus       146 ili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         146 ILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             EEEE-CCcEEEEECccccccc
Confidence            9999 8999999999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=3.2e-15  Score=136.49  Aligned_cols=136  Identities=22%  Similarity=0.180  Sum_probs=100.5

Q ss_pred             eeec-CCCcEEEEEEEEccccccCcCceeEEEEEecCCC------------ChhhHHHHHHHHHHHhccCCCce--eeee
Q 014189          118 RVLG-GGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN------------SYQGHREWLAEVIFLGHLSHPNL--VKLI  182 (429)
Q Consensus       118 ~~lG-~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~  182 (429)
                      ..|| .|+.|+||++...+        ..+++|......            .......+.+|++++.++.|++|  +..+
T Consensus        37 ~~lg~~~g~gtv~~v~~~~--------~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl  108 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPG--------VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPI  108 (239)
T ss_pred             ceeecCCCCccEEEEEeCC--------ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeE
Confidence            5687 88888998876542        227888764321            01223456789999999998775  6667


Q ss_pred             eEEEeC-C---eEEEEEEecCC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC
Q 014189          183 GYCCED-E---HRVLIYEFMAR-GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       183 ~~~~~~-~---~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      ++.... .   ..++|||+++| .+|.+++...   +++..    .+.+++.++.+||..+  |+|+||||+|||++.++
T Consensus       109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~  179 (239)
T PRK01723        109 AARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCC
Confidence            664432 2   22599999997 6888877542   34443    3568899999999988  99999999999999999


Q ss_pred             cEEEeccCCCcCC
Q 014189          258 NAKLSDFGLAKDG  270 (429)
Q Consensus       258 ~~kl~Dfgla~~~  270 (429)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999988753

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.9e-14  Score=130.44  Aligned_cols=203  Identities=23%  Similarity=0.311  Sum_probs=139.8

Q ss_pred             HhccCCCceeeeeeEEEeC-----CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 014189          170 LGHLSHPNLVKLIGYCCED-----EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVI  242 (429)
Q Consensus       170 l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~iv  242 (429)
                      |-++.|.|||+++.|+.+.     ....++.|||..|+|..+|.+  .....+....-.+|+-||..||.|||+..++|+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            4456699999999998643     356789999999999999964  233456777778999999999999999999999


Q ss_pred             eCCCCCCcEEEcCCCcEEEeccCCCcCCCC--CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 014189          243 YRDFKTSNILLDTDYNAKLSDFGLAKDGPE--GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK  320 (429)
Q Consensus       243 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~  320 (429)
                      |+++..+.|++..+|-+|++--.-......  ...........+.++|.+||.-..-..+.++|||+||....||..|..
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence            999999999999999999863211110000  000001122456789999998777777889999999999999988875


Q ss_pred             CCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          321 SLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       321 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      --........  ...       ..........-.+.           +.++.+|++-.|..||+|++++-|.
T Consensus       281 q~tnseS~~~--~ee-------~ia~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  281 QSTNSESKVE--VEE-------NIANVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             ccCCCcceee--hhh-------hhhhheeeccCccc-----------cCcCcccccCCCCCCcchhhhhcCc
Confidence            3221111100  000       00001111111111           2366799999999999999988664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=2.5e-14  Score=140.08  Aligned_cols=253  Identities=24%  Similarity=0.277  Sum_probs=179.5

Q ss_pred             CCccceeecC--CCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccC-CCceeeeeeEEEeC
Q 014189          113 NFRQDRVLGG--GGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED  188 (429)
Q Consensus       113 ~y~~~~~lG~--G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  188 (429)
                      .|...+.+|.  |.+|.||.+....    ......+|+|.-...-. ......-++|+....+++ |+|.++.+..+...
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTN----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hcccccccccCCCCCceeecccCCc----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence            4666788999  9999999986522    12234478876333211 122222335666666774 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceeCCCCCCcEEEcCC-CcEEEec
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK----GLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSD  263 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~D  263 (429)
                      +.+++-+|++. .+|..+.+.... -++....+....+...    |+.++|+.+  ++|-|+||.||+...+ ...+++|
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCC
Confidence            99999999995 688887765543 3667777788888888    999999977  9999999999999999 8899999


Q ss_pred             cCCCcCCCCCCCcc---ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          264 FGLAKDGPEGDKSH---VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       264 fgla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      ||+...+..+....   ...+..|...|++||... +.++...|+|++|.++.+..+|..+.......      .|..  
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~--  337 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ--  337 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc--
Confidence            99998776654221   122346888999999664 56789999999999999999988765433110      0100  


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            +.+.   .+..++-...+.++..++.++++.+|-.|++.+.+..+
T Consensus       338 ------~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  338 ------LRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ------cccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                  0000   01111111224555668899999999999999987653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=2.6e-13  Score=134.47  Aligned_cols=142  Identities=19%  Similarity=0.115  Sum_probs=96.1

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhH-------------------------------------
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-------------------------------------  160 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------  160 (429)
                      +.||.|++|.||+|++.++       ..||||+.+.+......                                     
T Consensus       123 ~plasaSigQVh~A~l~~G-------~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~  195 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDG-------KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR  195 (437)
T ss_pred             cceeeeehhheEEEEecCC-------CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence            6799999999999987643       34999998765211100                                     


Q ss_pred             --HHHHHHHHHHhcc----CCCceeeeeeEEE-eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHH-HHH
Q 014189          161 --REWLAEVIFLGHL----SHPNLVKLIGYCC-EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK-GLA  232 (429)
Q Consensus       161 --~~~~~E~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~l~  232 (429)
                        -+|.+|...+.++    +|.+-+.+-..+. ..+..++||||++|++|.+....... ...   ...++..++. .+.
T Consensus       196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~  271 (437)
T TIGR01982       196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLN  271 (437)
T ss_pred             HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHH
Confidence              1233455444444    2333333333332 23456999999999999886643211 122   3445555555 467


Q ss_pred             HHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       233 ~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      .+|..+  ++|+|++|.||+++.++.++++|||++.....
T Consensus       272 ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       272 QVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            888877  99999999999999999999999999887643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=1.6e-12  Score=112.39  Aligned_cols=130  Identities=22%  Similarity=0.110  Sum_probs=93.3

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCcee-eeeeEEEeCCeEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV-KLIGYCCEDEHRVLIY  195 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~  195 (429)
                      .+.|+.|.++.||++...        +..+++|+......  ....+..|+.++..+.+.+++ +++.+.  ....++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--------~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--------NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC--------CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEE
Confidence            367899999999998653        22399998765432  122456788899888655544 444443  23457999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK---PVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       196 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ||++|.++...   .    .   ....++.+++.+|+.||..+.   .++|+|++|.||+++ ++.++++|||.+..
T Consensus        71 e~i~G~~l~~~---~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          71 EFIEGSELLTE---D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EecCCCccccc---c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99999887643   0    1   113456789999999998651   259999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.36  E-value=8.1e-13  Score=132.62  Aligned_cols=144  Identities=16%  Similarity=0.086  Sum_probs=90.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh-----------------------------h----
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-----------------------------G----  159 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------------~----  159 (429)
                      .|+. +.||+|++|.||+|++.++++      .||||+.+.+....                             .    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~------~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~  193 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGR------EVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF  193 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCC------EEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence            4665 789999999999999876433      39999997652110                             0    


Q ss_pred             H------HHHHHHHHHHhccC----CCceeeeeeEEEe-CCeEEEEEEecCCCChhhhh--hcCCC--CCCCHHHHHHHH
Q 014189          160 H------REWLAEVIFLGHLS----HPNLVKLIGYCCE-DEHRVLIYEFMARGSVENNL--FSKVL--LPLPWSIRMKIA  224 (429)
Q Consensus       160 ~------~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~--~~l~~~~~~~i~  224 (429)
                      .      -+|.+|..-+.++.    +.+.+.+-.++.+ ....+|||||++|+.+.+.-  ...+.  ..+....+..++
T Consensus       194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~  273 (537)
T PRK04750        194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF  273 (537)
T ss_pred             HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence            0      11333443333332    3344444444432 44568999999999997642  22210  012222222222


Q ss_pred             HHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC----cEEEeccCCCcCCCC
Q 014189          225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAKLSDFGLAKDGPE  272 (429)
Q Consensus       225 ~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~~  272 (429)
                             .-+...|  ++|+|++|.||+++.++    .+++.|||++...+.
T Consensus       274 -------~Qif~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 -------TQVFRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------HHHHhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   2334456  99999999999999988    999999999887654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.36  E-value=1.3e-11  Score=108.09  Aligned_cols=145  Identities=14%  Similarity=0.131  Sum_probs=97.7

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-----------h----------hhHHHHH----HHHHHHhc
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-----------Y----------QGHREWL----AEVIFLGH  172 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-----------~----------~~~~~~~----~E~~~l~~  172 (429)
                      ..||.|--+.||.|...++......+..+|+|+.+....           .          .....+.    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            579999999999996432110111234599998754210           0          0111222    79999988


Q ss_pred             cCC--CceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeCCCCCC
Q 014189          173 LSH--PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL-HEAEKPVIYRDFKTS  249 (429)
Q Consensus       173 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~ivH~Dlkp~  249 (429)
                      +..  -++...+++    ..-++||||+.++.+.......  ..++......+..+++.+|..+ |..+  +||+||++.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence            853  456666654    3458999999765443221111  1344556677888999999988 8877  999999999


Q ss_pred             cEEEcCCCcEEEeccCCCcCCC
Q 014189          250 NILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       250 NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      |||++ ++.+.|+|||.+....
T Consensus       155 NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeCC
Confidence            99997 4679999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.32  E-value=3.8e-11  Score=119.20  Aligned_cols=163  Identities=18%  Similarity=0.185  Sum_probs=117.7

Q ss_pred             ceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHH
Q 014189          143 PVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK  222 (429)
Q Consensus       143 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~  222 (429)
                      +.+|.|...+.... .......+-+..|+.++||||+++++.++.++.+|+|+|-+  -.|..++....     ......
T Consensus        37 ~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~~  108 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVCL  108 (690)
T ss_pred             CCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHHH
Confidence            33466666655443 33344556788899999999999999999999999999998  45666665433     455566


Q ss_pred             HHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcc
Q 014189          223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPR  302 (429)
Q Consensus       223 i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  302 (429)
                      .+.||+.||.|||.. ..++|++|..+.|++++.|..||++|-++........  ......--..|..|+.+....  -.
T Consensus       109 Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s  183 (690)
T KOG1243|consen  109 GLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WS  183 (690)
T ss_pred             HHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cc
Confidence            788999999999853 2399999999999999999999999988765432221  001111122355666443221  34


Q ss_pred             cchhhHHHHHHHHHhC
Q 014189          303 SDVYSFGVVLLEILTG  318 (429)
Q Consensus       303 ~DvwslG~il~elltG  318 (429)
                      .|.|-|||+++|++.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            6999999999999999

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.31  E-value=8.8e-13  Score=135.96  Aligned_cols=250  Identities=20%  Similarity=0.213  Sum_probs=170.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .+.+.+.+.+-.|+++.++.+.=....      -..++|+......  ....+....+-.++-...+|-+++...-+...
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sg------h~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSG------HTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccc------cccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC
Confidence            355677778889999999876322222      1133333322110  01111222333333334456666665555667


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ...+++++|..+++|...|+...  +.+..........+..+++|||...  +.|+|++|.|.|...+++.+++|||+..
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccc
Confidence            78899999999999999887654  3444444555666778999999865  8999999999999999999999998432


Q ss_pred             CCCCC--------C---------------------CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCC
Q 014189          269 DGPEG--------D---------------------KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR  319 (429)
Q Consensus       269 ~~~~~--------~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~  319 (429)
                      .....        .                     .........||+.|.+||.+.+......+|+|++|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            21100        0                     001122367899999999999999999999999999999999999


Q ss_pred             CCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCC-CCChHHHHHHHHHHHHhhccCCCCCCCHH
Q 014189          320 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG-DYPVKGVHKAAMLAYHCLNHNPKARPLMR  386 (429)
Q Consensus       320 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  386 (429)
                      +||....+..                .+.++....... ..+...+..+.+++...+..+|.+|..+.
T Consensus      1033 pp~na~tpq~----------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQ----------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhh----------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9998665421                122333222211 22345678889999999999999998876

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=3.9e-12  Score=124.86  Aligned_cols=255  Identities=20%  Similarity=0.137  Sum_probs=176.2

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccC-CCceeeeeeEE
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLS-HPNLVKLIGYC  185 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~  185 (429)
                      .....+|.....||.|.|+.|+.....     ......+++|........ .....-+.|+.+...+. |.++++....+
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r-----~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W  335 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKR-----PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW  335 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeec-----CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence            344567889999999999999986522     122344777766544221 12222245777776664 88999988888


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-CcEEEecc
Q 014189          186 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDF  264 (429)
Q Consensus       186 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  264 (429)
                      ......|+--||++++++...+.  ....+....++.+..+++.++.++|+..  .+|+|+||+||++..+ +..+++||
T Consensus       336 ~~~r~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  336 SQLRQGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             cccccccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccc
Confidence            87788889999999998876552  2224566777889999999999999866  9999999999999886 78899999


Q ss_pred             CCCcCCCCCCCccccccccCCcccc--cccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYA--APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      |....+....     ....+..+++  ++.......+..+.|++|||..+.+.++|...-.....               
T Consensus       412 ~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------------  471 (524)
T KOG0601|consen  412 GCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------------  471 (524)
T ss_pred             ccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---------------
Confidence            9886532211     1122334444  44445567788999999999999999998764332211               


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                          ...+....+ ...+ .....+..++..++..++..||.+.++..+.+..+.
T Consensus       472 ----~~~i~~~~~-p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  472 ----SLTIRSGDT-PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ----ceeeecccc-cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                011111100 1111 223677788889999999999999998877665543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1.6e-10  Score=104.32  Aligned_cols=142  Identities=18%  Similarity=0.196  Sum_probs=104.8

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCC--CceeeeeeEEEeC---CeEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH--PNLVKLIGYCCED---EHRV  192 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~  192 (429)
                      +.||.|.++.||++...+       +..+++|+............+..|..++..+.+  .++.+++.+....   +..+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecC-------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            678999999999987543       234899987654322234467789999999875  3456677776553   3568


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-----------------------------------  237 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----------------------------------  237 (429)
                      +||||++|+++.+.+..   ..++......++.+++..|..||+.                                   
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999999888765432   2466667777788888888888742                                   


Q ss_pred             -------------------CCCceeCCCCCCcEEEcC--CCcEEEeccCCCcC
Q 014189          238 -------------------EKPVIYRDFKTSNILLDT--DYNAKLSDFGLAKD  269 (429)
Q Consensus       238 -------------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~  269 (429)
                                         ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               123699999999999998  66789999998765

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.18  E-value=3.5e-10  Score=95.38  Aligned_cols=144  Identities=20%  Similarity=0.162  Sum_probs=99.9

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEEEEec-CCCCh------hhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD-GDNSY------QGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~-~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ...+|-+|+-+.|+++.+...        ...||... +....      -....-.+|.++|.++.--.|.--.-++.+.
T Consensus        11 ~l~likQGAEArv~~~~~~Ge--------~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGE--------AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT   82 (229)
T ss_pred             cceeeeccceeeEeeeccCCc--------eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec
Confidence            457899999999999876543        24555432 22211      1223456799999888644443333344555


Q ss_pred             CeEEEEEEecCC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc---EEEecc
Q 014189          189 EHRVLIYEFMAR-GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---AKLSDF  264 (429)
Q Consensus       189 ~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df  264 (429)
                      ..-.|+|||++| .++.+++................+..+-+.+.-||.++  |+|+||..+||++..++.   +.++||
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEee
Confidence            556899999976 36777776554333333333678888999999999988  999999999999976654   589999


Q ss_pred             CCCcC
Q 014189          265 GLAKD  269 (429)
Q Consensus       265 gla~~  269 (429)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99764

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=3.2e-10  Score=96.05  Aligned_cols=132  Identities=19%  Similarity=0.237  Sum_probs=94.2

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecC-CCChhh------HHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG-DNSYQG------HREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ..+++|+-+.+|.+.+.+        ..+++|.... ......      ...-.+|..++.++.--.|..-.=+..+.+.
T Consensus         2 ~~i~~GAEa~i~~~~~~g--------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG--------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN   73 (204)
T ss_pred             chhhCCcceeEEeeeccC--------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC
Confidence            357899999999985432        1256665332 221111      1234579999988864444333334456677


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+|||++|..|.+.+...         ...++..+-..+.-||.++  |+|+||.++||++..+. +.++||||+..
T Consensus        74 ~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            78999999998888888654         1456667777788899988  99999999999998765 99999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.07  E-value=3.1e-09  Score=102.72  Aligned_cols=169  Identities=20%  Similarity=0.245  Sum_probs=123.7

Q ss_pred             cEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE----eCCeEEEEEEecCC
Q 014189          125 FGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC----EDEHRVLIYEFMAR  200 (429)
Q Consensus       125 fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~  200 (429)
                      -.+.|+++...++.      .+++|++..+.. .....-..-+++.+++.|+|+|++..+|.    .+..+++||+|.++
T Consensus       289 ~~Ttyk~~s~~DG~------~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~  361 (655)
T KOG3741|consen  289 SITTYKATSNVDGN------AYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS  361 (655)
T ss_pred             cceeEeeeeccCCc------eeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence            35789997765544      388888854321 11111224577889999999999999886    34578999999886


Q ss_pred             -CChhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          201 -GSVENNLFSKV-------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       201 -g~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                       ++|.+..+...             +...++...+.++.|+..||.++|+.|  +..+-|.|.+||++.+..++|+..|.
T Consensus       362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i  439 (655)
T KOG3741|consen  362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGI  439 (655)
T ss_pred             CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccc
Confidence             45766554321             234678899999999999999999988  88899999999999999999998887


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS  321 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p  321 (429)
                      ......+..                |-+.+   -.+-|.=.||.+++.|.||..-
T Consensus       440 ~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  440 MDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             eeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            665433220                11111   3467899999999999999653

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.01  E-value=9.2e-09  Score=95.12  Aligned_cols=106  Identities=17%  Similarity=0.086  Sum_probs=80.4

Q ss_pred             HHHHHHHHHhccCCCce--eeeeeEEEe-----CCeEEEEEEecCCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 014189          162 EWLAEVIFLGHLSHPNL--VKLIGYCCE-----DEHRVLIYEFMARG-SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF  233 (429)
Q Consensus       162 ~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~  233 (429)
                      .+.+|...+.++..-+|  +..+++...     ...-++|+|++++. +|.+++......+.+...+..++.+++..+.-
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            36688888888853333  344555543     23468999999876 78887754323345667778999999999999


Q ss_pred             HHhCCCCceeCCCCCCcEEEcC-------CCcEEEeccCCCcC
Q 014189          234 LHEAEKPVIYRDFKTSNILLDT-------DYNAKLSDFGLAKD  269 (429)
Q Consensus       234 lH~~~~~ivH~Dlkp~NIll~~-------~~~~kl~Dfgla~~  269 (429)
                      ||.+|  |+|+|++++|||++.       ++.+.++||+.+..
T Consensus       154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99988  999999999999975       46799999998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.94  E-value=3.7e-08  Score=93.21  Aligned_cols=261  Identities=16%  Similarity=0.174  Sum_probs=155.3

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeE-----E-Ee-
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGY-----C-CE-  187 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-----~-~~-  187 (429)
                      ..+.||+|+-+.+|-.-.   ..+      .+.|+......... .   ..+..|... .||-+-.=+.+     + -+ 
T Consensus        15 ~gr~LgqGgea~ly~l~e---~~d------~VAKIYh~Pppa~~-a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~   81 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE---VRD------QVAKIYHAPPPAAQ-A---QKVAELAATPDAPLLNYRVAWPQATLHGGRR   81 (637)
T ss_pred             CCccccCCccceeeecch---hhc------hhheeecCCCchHH-H---HHHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence            347899999999995311   111      34577665432222 1   233445544 46643321111     1 11 


Q ss_pred             CCeEEEEEEecCCCC-hhhhhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          188 DEHRVLIYEFMARGS-VENNLF----SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~-L~~~l~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      ....-+.|..+.+.. +..++.    ++......|...+..+..++.+.+-||.+|  .+-+|+.++|+|+.+++.+.|.
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LV  159 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLV  159 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEE
Confidence            223567788876642 222221    122234689999999999999999999988  8889999999999999999998


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCCCChhhh--hhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTG-RKSLDKSRPARE--QNLA  334 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG-~~p~~~~~~~~~--~~~~  334 (429)
                      |=..-....+   .....-.+|...|.+||...     +-.-+...|.|.||+++++++.| +.||.+......  ....
T Consensus       160 dsDsfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E  236 (637)
T COG4248         160 DSDSFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE  236 (637)
T ss_pred             cccceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence            7544333211   11223357899999999865     33457789999999999999876 889985421110  0010


Q ss_pred             Hh-HhhHHHhhhhhhhhcCCCCCCCCCh-HHHHHHHHHHHHhhccC--CCCCCCHHHHHHhcccc
Q 014189          335 DW-ALPLLKEKKKLLNIIDPRLEGDYPV-KGVHKAAMLAYHCLNHN--PKARPLMRDIVDSLEPL  395 (429)
Q Consensus       335 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~d--P~~RPs~~evl~~L~~~  395 (429)
                      .. ....+........-.. .-....+- -.+..+..|..+|+...  +.-|||++-++..|..+
T Consensus       237 ~~Ia~g~f~ya~~~~~g~~-p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         237 TDIAHGRFAYASDQRRGLK-PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hhhhcceeeechhccCCCC-CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            00 0000000000000000 00111222 24567888889999754  56899999888777554

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.89  E-value=1.5e-08  Score=88.50  Aligned_cols=98  Identities=22%  Similarity=0.244  Sum_probs=62.0

Q ss_pred             HHHHHHHHhccCCC--ceeeeeeEEEeCCeEEEEEEecC--CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhC
Q 014189          163 WLAEVIFLGHLSHP--NLVKLIGYCCEDEHRVLIYEFMA--RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF-LHEA  237 (429)
Q Consensus       163 ~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~-lH~~  237 (429)
                      ..+|.+.|.++..-  ++.+.+++.    .-++||||++  |..+.. +....   ++......++.+++..+.. +|..
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~-l~~~~---~~~~~~~~~~~~il~~~~~~~~~~  126 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPR-LKDVD---LSPEEPKELLEEILEEIIKMLHKA  126 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGC-HHHCG---GGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhh-HHhcc---ccchhHHHHHHHHHHHHHHHHHhc
Confidence            45799999999755  456665442    2379999998  544433 33221   1122345666677775544 5787


Q ss_pred             CCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       238 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      +  |+|+||.+.|||++++ .+.|+|||.+....
T Consensus       127 g--ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  127 G--IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             T--EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             C--ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            7  9999999999999988 89999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.80  E-value=6e-08  Score=87.29  Aligned_cols=137  Identities=18%  Similarity=0.086  Sum_probs=92.8

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh---------------------hhHHHHHHHHHHHhc
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY---------------------QGHREWLAEVIFLGH  172 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~  172 (429)
                      ..++..||-|--|.||.|...++       ..+|+|..+.....                     .......+|.++|.+
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g-------~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~  165 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKG-------RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR  165 (304)
T ss_pred             HhhccccccCccceEEEEECCCC-------CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence            56678999999999999976543       33999987644211                     112234568999988


Q ss_pred             cCCC--ceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 014189          173 LSHP--NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  250 (429)
Q Consensus       173 l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~N  250 (429)
                      |.-.  .+.+.+++    +.-.+||||++|-.|...-       +.....-.++..++.-+.-+-..|  |||+|+++-|
T Consensus       166 L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefN  232 (304)
T COG0478         166 LYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFN  232 (304)
T ss_pred             hhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchhe
Confidence            8643  56655553    4458999999886554321       112223334444444444444556  9999999999


Q ss_pred             EEEcCCCcEEEeccCCCcCC
Q 014189          251 ILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       251 Ill~~~~~~kl~Dfgla~~~  270 (429)
                      |+++++|.+.++||-.+...
T Consensus       233 IlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EEEecCCCEEEEeCcccccC
Confidence            99999999999999766543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.76  E-value=3.5e-09  Score=105.80  Aligned_cols=150  Identities=21%  Similarity=0.309  Sum_probs=103.3

Q ss_pred             HHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCc-------cccccccCCcccccccccccCC
Q 014189          226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS-------HVSTRIMGTYGYAAPEYIMTGH  298 (429)
Q Consensus       226 ~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~  298 (429)
                      +++.|+.|+|.+- ++||++|.|++|.++.++..||+.|+.+.........       ....-..-...|.|||++.+..
T Consensus       107 ~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            4458999999753 4999999999999999999999999987644331110       0111123456899999999988


Q ss_pred             CCcccchhhHHHHHHHHH-hCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhcc
Q 014189          299 LTPRSDVYSFGVVLLEIL-TGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNH  377 (429)
Q Consensus       299 ~~~~~DvwslG~il~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  377 (429)
                      .+.++|+||+|+++|.+. .|+.-+..........              .....+..-......+.+.++.+=+.+++..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHhcC
Confidence            899999999999999999 4554444332111000              0111111111223356678888889999999


Q ss_pred             CCCCCCCHHHHHH
Q 014189          378 NPKARPLMRDIVD  390 (429)
Q Consensus       378 dP~~RPs~~evl~  390 (429)
                      ++..||++..+..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999998776654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.71  E-value=2.8e-07  Score=82.31  Aligned_cols=106  Identities=24%  Similarity=0.153  Sum_probs=81.4

Q ss_pred             HHHHHHHHHHhccCCC--ceeeeeeEEEeC----CeEEEEEEecCCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 014189          161 REWLAEVIFLGHLSHP--NLVKLIGYCCED----EHRVLIYEFMARG-SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF  233 (429)
Q Consensus       161 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~  233 (429)
                      ....+|...+..+..-  .....+++....    ...++|+|++++. +|.+++.....  .+......++.+++..++-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            3456788877777533  345556665542    2448999999874 78888765332  5556678899999999999


Q ss_pred             HHhCCCCceeCCCCCCcEEEcCCC---cEEEeccCCCcCC
Q 014189          234 LHEAEKPVIYRDFKTSNILLDTDY---NAKLSDFGLAKDG  270 (429)
Q Consensus       234 lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~  270 (429)
                      ||..+  |+|+|+++.|||++.++   .+.++||+.++..
T Consensus       134 lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99988  99999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.62  E-value=8.3e-07  Score=78.10  Aligned_cols=139  Identities=17%  Similarity=0.115  Sum_probs=99.2

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCC--CC---hhhHHHHHHHHHHHhccCCC--ceeeeeeEEE-e----
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NS---YQGHREWLAEVIFLGHLSHP--NLVKLIGYCC-E----  187 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~---~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~----  187 (429)
                      -|+||.+.|++....+.        .+-+|.-...  .+   .-....|.+|+..|.++..-  .+.+.. ++. .    
T Consensus        26 ~~rgG~SgV~r~~~~g~--------~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~   96 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK--------KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG   96 (216)
T ss_pred             cCCCCcceEEEEEeCCc--------EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC
Confidence            36789999998644322        2666654311  01   22556788999999988632  244444 332 1    


Q ss_pred             CCeEEEEEEecCC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc--EEEecc
Q 014189          188 DEHRVLIYEFMAR-GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN--AKLSDF  264 (429)
Q Consensus       188 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~--~kl~Df  264 (429)
                      ...-+||+|-++| -+|.+++......+.+...+..+..+++..++-||..+  +.|+|+.+.||+++.++.  ++++||
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEh
Confidence            1245799997753 47888876655446677888899999999999999988  999999999999986677  999999


Q ss_pred             CCCcC
Q 014189          265 GLAKD  269 (429)
Q Consensus       265 gla~~  269 (429)
                      .-++.
T Consensus       175 Ek~r~  179 (216)
T PRK09902        175 EKSRR  179 (216)
T ss_pred             hccch
Confidence            86654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.4e-06  Score=87.48  Aligned_cols=142  Identities=18%  Similarity=0.114  Sum_probs=89.8

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh-----------------------------h---------
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-----------------------------G---------  159 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------------~---------  159 (429)
                      +.|+.++-|.||+|+++++       ..||||+.+.+-...                             .         
T Consensus       131 ~PiAsASIaQVH~A~L~sG-------~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         131 EPIASASIAQVHRAVLKSG-------EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             CchhhhhHhhheeEEecCC-------CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            6799999999999998873       339999987653211                             0         


Q ss_pred             -HHHHHHHHHHHhccC----CCceeeeeeEEE-eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHH-HH
Q 014189          160 -HREWLAEVIFLGHLS----HPNLVKLIGYCC-EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG-LA  232 (429)
Q Consensus       160 -~~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~-l~  232 (429)
                       +-++.+|..-+.++.    ...-+.+=.+|+ -.+.-.|+|||++|-.+.+...-.. ..++...   ++..++.+ +.
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~  279 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLR  279 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHH
Confidence             011233444444332    222233333443 3456689999999988887642222 2344322   23222222 12


Q ss_pred             HHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       233 ~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      .+-.+|  .+|.|..|.||+++.+|.+.+.|||+......
T Consensus       280 q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         280 QLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            222246  99999999999999999999999999887654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.41  E-value=6.6e-08  Score=95.93  Aligned_cols=185  Identities=17%  Similarity=0.112  Sum_probs=130.0

Q ss_pred             ccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCc-eeeeeeEEEeCCeEEE
Q 014189          115 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDEHRVL  193 (429)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l  193 (429)
                      ...+-+++|+++.++|.+....      .. ...+++...      ....-++++|.+++||| .+..++-++.+...++
T Consensus       245 ~~fh~fvK~altknpKkRptae------kl-L~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAE------KL-LQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChh------hh-eeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            3345578999999998643221      11 224444332      22335888999999999 7777777778888999


Q ss_pred             EEEecCCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          194 IYEFMARG-SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       194 v~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      .++++.+| +-..... .....+..-+...+...-.++++++|+..  =+|+|    ||+..+ +..+.+||+....+..
T Consensus       312 ~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             hhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCc
Confidence            99999877 2211110 00012333344556666678999999854  48898    777766 6789999999877655


Q ss_pred             CCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 014189          273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD  323 (429)
Q Consensus       273 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~  323 (429)
                      ..   ..+...+|+.++|||+.....+..+.|+|++|+--.+|.-|-+|-.
T Consensus       384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            33   3455789999999999999999999999999987778877777654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.38  E-value=9.1e-06  Score=73.58  Aligned_cols=138  Identities=16%  Similarity=0.094  Sum_probs=82.7

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCc--eeeeeeEEEeCCeEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN--LVKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~  195 (429)
                      ..||+|..+.||+..   + .      .+++|+.......   ....+|.++++.+..-.  +.+.+++....+...+||
T Consensus         7 ~~i~~G~t~~~y~~~---~-~------~~VlR~~~~~~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~   73 (226)
T TIGR02172         7 TQTGEGGNGESYTHK---T-G------KWMLKLYNPGFDK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIY   73 (226)
T ss_pred             eeecCCCCcceeEec---C-C------CEEEEeCCCCCCH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeee
Confidence            579999999999841   1 1      2778887654322   23467999998886333  466677777777788999


Q ss_pred             EecCCCC-hhhh---------------------hhcCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHh--CCC
Q 014189          196 EFMARGS-VENN---------------------LFSKVLLPLPWSIRMK-IAF----------GAAK-GLAFLHE--AEK  239 (429)
Q Consensus       196 e~~~~g~-L~~~---------------------l~~~~~~~l~~~~~~~-i~~----------~i~~-~l~~lH~--~~~  239 (429)
                      |+++|.+ +...                     ++.......+...... +..          .+.. ...+|..  ...
T Consensus        74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            9999864 1111                     1111000111111100 000          0111 1223322  223


Q ss_pred             CceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       240 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .++|+|+.|.||++++++ +.|+||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            478999999999999988 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.32  E-value=2.3e-05  Score=69.38  Aligned_cols=139  Identities=13%  Similarity=0.053  Sum_probs=87.3

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHH---------HHHHHHhccC---CC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL---------AEVIFLGHLS---HP  176 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------~E~~~l~~l~---h~  176 (429)
                      ....+|...+++-......|.+-...        +..+++|..+..... ..+.|.         +.+..+.++.   --
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~--------~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~   98 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID--------GKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFT   98 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC--------CcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence            45677888888888777777664322        223888887654322 222221         2333333332   22


Q ss_pred             ceeeeeeEEE-----eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcE
Q 014189          177 NLVKLIGYCC-----EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  251 (429)
Q Consensus       177 niv~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NI  251 (429)
                      .+..++.+..     -....+++|||++|..|.+...      ++.    .++..++.++.-+|.+|  ++|+|+.|.|+
T Consensus        99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNF  166 (229)
T PF06176_consen   99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNF  166 (229)
T ss_pred             ccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcE
Confidence            2333333222     2234568999999987766431      222    24456677889999988  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcC
Q 014189          252 LLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       252 ll~~~~~~kl~Dfgla~~  269 (429)
                      +++.++ +++.||+..+.
T Consensus       167 lv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  167 LVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             EEECCc-EEEEECccccc
Confidence            998655 99999986553

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.30  E-value=1.7e-05  Score=70.95  Aligned_cols=154  Identities=19%  Similarity=0.134  Sum_probs=94.7

Q ss_pred             cChHHHHHHhcCCcccee---ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh--------------------
Q 014189          102 FTYDELRIITANFRQDRV---LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ--------------------  158 (429)
Q Consensus       102 ~~~~~~~~~~~~y~~~~~---lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------  158 (429)
                      .+...+..+.+...+...   |++|--+.||+|...+       +..+|+|+.......-                    
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~-------~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~r  107 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGD-------GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNR  107 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCC-------CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCH
Confidence            444555666666655555   5566677899986422       3449999976542110                    


Q ss_pred             --hHHHH-HHHHHHHhccC--CCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 014189          159 --GHREW-LAEVIFLGHLS--HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF  233 (429)
Q Consensus       159 --~~~~~-~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~  233 (429)
                        ....| .+|+.-|.++.  +-.+.+-+++..    -.|||||+....+-.-  .-...++.......+..++++.+.-
T Consensus       108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP--~LkDv~~e~~e~~~~~~~~v~~~~~  181 (268)
T COG1718         108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAP--RLKDVPLELEEAEGLYEDVVEYMRR  181 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCC--CcccCCcCchhHHHHHHHHHHHHHH
Confidence              00011 24666666653  333444444442    2799999955411110  0111123333566777788888877


Q ss_pred             HHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          234 LHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       234 lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      |-. .+  +||+||+.=|||+. ++.+.|+|||-|....
T Consensus       182 l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         182 LYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHhcC--cccccchhhheEEE-CCeEEEEECccccccC
Confidence            776 66  99999999999999 8899999999887654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.28  E-value=1.4e-05  Score=73.26  Aligned_cols=139  Identities=18%  Similarity=0.091  Sum_probs=81.5

Q ss_pred             eecCCCc-EEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeEEEEEE
Q 014189          119 VLGGGGF-GCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       119 ~lG~G~f-g~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      .|-.|.. ..||+....+        ..+.+|+.....    .....+|+.+++.+. +--+.+++++....+..++|||
T Consensus         5 ~~~~g~~~~~v~~~~~~~--------~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   72 (244)
T cd05150           5 RVTEGQSGATVYRLDGKN--------PGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTS   72 (244)
T ss_pred             ecCCCCCcCeEEEEcCCC--------CcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEE
Confidence            4555555 7889874321        127888875542    223457888888774 4345577777766667899999


Q ss_pred             ecCCCChhhhh-------------------hcCC--CCCCCH--HHHHHHHH--------------------HHHHHHHH
Q 014189          197 FMARGSVENNL-------------------FSKV--LLPLPW--SIRMKIAF--------------------GAAKGLAF  233 (429)
Q Consensus       197 ~~~~g~L~~~l-------------------~~~~--~~~l~~--~~~~~i~~--------------------~i~~~l~~  233 (429)
                      +++|.+|....                   +...  ..++..  ........                    .+...+..
T Consensus        73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T cd05150          73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE  152 (244)
T ss_pred             eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence            99988776432                   1110  001110  00000000                    01111222


Q ss_pred             HHh-----CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          234 LHE-----AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       234 lH~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      |-.     ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            211     113489999999999999988889999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.21  E-value=1.9e-05  Score=83.92  Aligned_cols=194  Identities=20%  Similarity=0.235  Sum_probs=135.3

Q ss_pred             HHHHHHhccCCCceeeeeeEEEeCCeE----EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 014189          165 AEVIFLGHLSHPNLVKLIGYCCEDEHR----VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP  240 (429)
Q Consensus       165 ~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~  240 (429)
                      -|.+.+.+..|+|++.++.+-.++...    .+..+++..-++...+....  ..+..+.+.+..++..|+.|+|++.  
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~--  306 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLS--  306 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhc--
Confidence            467778888999999999887544322    24457888888888776554  5778888899999999999999875  


Q ss_pred             ceeCCCCCC---cEEEcCCCcEEEe--ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcc--cchhhHHHHHH
Q 014189          241 VIYRDFKTS---NILLDTDYNAKLS--DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPR--SDVYSFGVVLL  313 (429)
Q Consensus       241 ivH~Dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwslG~il~  313 (429)
                      ..|.-+..+   +.-.+..+.+.++  ||+.+.........   ....-+..+.++|......++.+  .|+|.+|..+.
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            555544444   4555666777777  99988876553322   22334556788888776665544  79999999999


Q ss_pred             HHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          314 EILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       314 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      .+..|..+-.....                   ...+++-        .......+...+|+..++++|++..+++.+.
T Consensus       384 ~~~~~~~i~~~~~~-------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  384 QLSQGEDISEKSAV-------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhcCcccccccc-------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            99988765432211                   0111110        1111466778899999999999999999763

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.21  E-value=4.7e-05  Score=67.09  Aligned_cols=129  Identities=19%  Similarity=0.256  Sum_probs=86.6

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC---------------ChhhHHHHHHHHHHHhccC------C
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---------------SYQGHREWLAEVIFLGHLS------H  175 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~E~~~l~~l~------h  175 (429)
                      ...||+|+.-.||.  +.++..       .+||+.....               ......++.+|+.-...+.      +
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~-------~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~   76 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPN-------LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW   76 (199)
T ss_pred             CcccccCCCceEEE--CCCCCC-------eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence            46799999999996  333222       7889887664               1112344555655555444      8


Q ss_pred             CceeeeeeEEEeCCeEEEEEEecCCC------ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCC
Q 014189          176 PNLVKLIGYCCEDEHRVLIYEFMARG------SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS  249 (429)
Q Consensus       176 ~niv~l~~~~~~~~~~~lv~e~~~~g------~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~  249 (429)
                      .+|.+++|+.+++...-+|+|.+.+.      +|.+++...   .++. .....   +-+-..||-.+.  |+.+|++|.
T Consensus        77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~---L~~f~~~l~~~~--Iv~~dl~~~  147 (199)
T PF10707_consen   77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQA---LDEFKRYLLDHH--IVIRDLNPH  147 (199)
T ss_pred             cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHH---HHHHHHHHHHcC--CeecCCCcc
Confidence            89999999999999999999987532      366666433   2444 22333   334446677766  999999999


Q ss_pred             cEEEcCCC----cEEEec
Q 014189          250 NILLDTDY----NAKLSD  263 (429)
Q Consensus       250 NIll~~~~----~~kl~D  263 (429)
                      ||++....    .+.|+|
T Consensus       148 NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cEEEEecCCCceEEEEEe
Confidence            99996432    467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.17  E-value=4e-05  Score=82.68  Aligned_cols=150  Identities=15%  Similarity=0.152  Sum_probs=89.8

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCce--eeeeeEEEeC---Ce
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNL--VKLIGYCCED---EH  190 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~  190 (429)
                      .+.|+.|.+..+|+.....+..    ...+++|+............+.+|+.+|+.+. |+++  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~----~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGS----VKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCc----ceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            4678999999999876543211    12366776554322223345778999999985 6654  7777777654   46


Q ss_pred             EEEEEEecCCCChhhh-----------------------hhcCCC---------CCCCH--HHHHHHHH-----------
Q 014189          191 RVLIYEFMARGSVENN-----------------------LFSKVL---------LPLPW--SIRMKIAF-----------  225 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~-----------------------l~~~~~---------~~l~~--~~~~~i~~-----------  225 (429)
                      .|+||||++|..+.+.                       |+.-..         .+..+  .+...+..           
T Consensus       119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~  198 (822)
T PLN02876        119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP  198 (822)
T ss_pred             ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence            7899999987653210                       111100         01111  11111111           


Q ss_pred             ----HHHHHHHHHHhCC---------CCceeCCCCCCcEEEcCC-Cc-EEEeccCCCcCC
Q 014189          226 ----GAAKGLAFLHEAE---------KPVIYRDFKTSNILLDTD-YN-AKLSDFGLAKDG  270 (429)
Q Consensus       226 ----~i~~~l~~lH~~~---------~~ivH~Dlkp~NIll~~~-~~-~kl~Dfgla~~~  270 (429)
                          .+...+.+|..+-         ..+||+|+++.|||++.+ +. +-|.||.++...
T Consensus       199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence                1233456665422         239999999999999853 33 579999988754

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.16  E-value=2.6e-05  Score=70.72  Aligned_cols=141  Identities=18%  Similarity=0.178  Sum_probs=80.5

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCC--ceeeeeeEEE---eCCeE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP--NLVKLIGYCC---EDEHR  191 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~---~~~~~  191 (429)
                      ++.|+.|..+.||+....++        .+++|.....   ........|..+++.+...  .+.+++.+..   .....
T Consensus         2 i~~l~~G~~n~~~~v~~~~~--------~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~   70 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDG--------RYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFP   70 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTS--------EEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEE
T ss_pred             CccCCCCCeeeEEEEEECCc--------EEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccc
Confidence            36899999999999865542        2899987643   3445566788888887532  3456665442   33457


Q ss_pred             EEEEEecCCCChhh----------------hh---hcC--CCCCCCHHH---------HHHH------------HHHHHH
Q 014189          192 VLIYEFMARGSVEN----------------NL---FSK--VLLPLPWSI---------RMKI------------AFGAAK  229 (429)
Q Consensus       192 ~lv~e~~~~g~L~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~i~~  229 (429)
                      +++|++++|..+..                .+   +..  ...++....         ....            ...+..
T Consensus        71 ~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (239)
T PF01636_consen   71 YLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEE  150 (239)
T ss_dssp             EEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             eEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHH
Confidence            89999999887776                11   111  111111100         0000            011222


Q ss_pred             -HHHHHHh-----CCCCceeCCCCCCcEEEc-CCCcEEEeccCCCc
Q 014189          230 -GLAFLHE-----AEKPVIYRDFKTSNILLD-TDYNAKLSDFGLAK  268 (429)
Q Consensus       230 -~l~~lH~-----~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~  268 (429)
                       .+..++.     ....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  151 RLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence             2333332     224499999999999999 66666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.10  E-value=1.4e-05  Score=70.06  Aligned_cols=101  Identities=25%  Similarity=0.295  Sum_probs=79.1

Q ss_pred             HHHHHHhccCC-CceeeeeeEEEeCCeEEEEEEecCCCChhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCc
Q 014189          165 AEVIFLGHLSH-PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLHEAE-KPV  241 (429)
Q Consensus       165 ~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~~i  241 (429)
                      .|.-+++.+++ +++++++|+|-.    +++.||.+.+++...... ......+|..+.+||.++++.+.+++... ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58888888876 699999999933    679999987766432100 01124789999999999999999998632 127


Q ss_pred             eeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          242 IYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       242 vH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .-.|++++|+-+++++.+|++|...+..
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcch
Confidence            7789999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.94  E-value=8.1e-05  Score=74.70  Aligned_cols=143  Identities=15%  Similarity=0.072  Sum_probs=85.3

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh------------------------------------hHH
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ------------------------------------GHR  161 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------------~~~  161 (429)
                      +.||.-+.|.||+|+.++       +..||||+-+.+-...                                    .+-
T Consensus       167 ~piaaASlaQVhrA~L~~-------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL  239 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL  239 (538)
T ss_pred             chhhhcchhheEEEEecC-------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence            679999999999999877       3349999977652211                                    011


Q ss_pred             HHHHHHHH----HhccCCCc---eeeeeeEEEe-CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 014189          162 EWLAEVIF----LGHLSHPN---LVKLIGYCCE-DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF  233 (429)
Q Consensus       162 ~~~~E~~~----l~~l~h~n---iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~  233 (429)
                      +|.+|.+=    .+.+.|-+   -|.+=.++++ .....|+||||+|..+.+.-.-... .++......-+.+... -.-
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~-~qI  317 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL-EQI  317 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH-HHH
Confidence            23333322    22333444   1223333332 3466899999999887664321111 2333332222222211 112


Q ss_pred             HHhCCCCceeCCCCCCcEEEcC----CCcEEEeccCCCcCCCC
Q 014189          234 LHEAEKPVIYRDFKTSNILLDT----DYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       234 lH~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla~~~~~  272 (429)
                      ++ +|  .+|+|-.|.||++..    ++.+.+.|||+......
T Consensus       318 f~-~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FK-TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             Hh-cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            22 35  999999999999984    67899999999876544

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.93  E-value=0.00017  Score=63.19  Aligned_cols=126  Identities=25%  Similarity=0.332  Sum_probs=87.8

Q ss_pred             cCCccceeecCCCc-EEEEEEEEccccccCcCceeEEEEEecC---CCC----------h-------hhHHHHHHHHHHH
Q 014189          112 ANFRQDRVLGGGGF-GCVYKGFISEDLREGLQPVPVAVKVHDG---DNS----------Y-------QGHREWLAEVIFL  170 (429)
Q Consensus       112 ~~y~~~~~lG~G~f-g~Vy~~~~~~~~~~~~~~~~vavK~~~~---~~~----------~-------~~~~~~~~E~~~l  170 (429)
                      .+++.++.||.|.- |.||++.+.+.        .+|+|+...   ...          .       .....|..|.+..
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~--------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAf  108 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGR--------IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAF  108 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCe--------EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhh
Confidence            68889999999999 99999876543        499999221   100          0       1123577888888


Q ss_pred             hccC---CCce--eeeeeEEEeC------------------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHH
Q 014189          171 GHLS---HPNL--VKLIGYCCED------------------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA  227 (429)
Q Consensus       171 ~~l~---h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i  227 (429)
                      .+|+   +.++  |+.+||..-.                  -...||.||++...           .+.    ..-+.++
T Consensus       109 gRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~  173 (207)
T PF13095_consen  109 GRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQM  173 (207)
T ss_pred             HHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHH
Confidence            7775   4566  8999987322                  12357888876543           122    2334566


Q ss_pred             HHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       228 ~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+-+..+|..+  |+-+|+++.|..   +  -||+|||.+
T Consensus       174 ~~dl~~~~k~g--I~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILHKLG--IVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHCC--eeeccCcccccc---C--CEEEecccC
Confidence            67788899988  999999999987   2  388999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.90  E-value=0.00014  Score=66.39  Aligned_cols=30  Identities=20%  Similarity=0.236  Sum_probs=25.7

Q ss_pred             CceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       240 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .++|+|+.+.||+++.+...-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            389999999999998776667999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.90  E-value=0.00011  Score=62.33  Aligned_cols=128  Identities=16%  Similarity=0.150  Sum_probs=83.3

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      .+.||+|++|.||+|.+...        .+|+|+-+.+..   ...+..|.++|..++-.++-+=+-.+.   .-++.||
T Consensus        27 ~~~L~KG~~s~Vyl~~~~~~--------~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me   92 (201)
T COG2112          27 EKELAKGTTSVVYLGEWRGG--------EVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRME   92 (201)
T ss_pred             hhhhhcccccEEEEeeccCc--------eEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhh
Confidence            46799999999999976543        489998876643   345668999999887666543222222   2245599


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC-CCcEEEcCCCcEEEeccCCCcC
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFK-TSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlk-p~NIll~~~~~~kl~Dfgla~~  269 (429)
                      |+.|-.|.++....     +-..    ...+++.-.-|-..|  |-|+.|. |...++..++.+.|+||..|..
T Consensus        93 ~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            99988887654321     1122    223334433344445  8888886 4445555555899999998873

>PRK10593 hypothetical protein; Provisional

Probab=97.82  E-value=0.00049  Score=65.10  Aligned_cols=76  Identities=13%  Similarity=0.060  Sum_probs=52.9

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCC---CceeeeeeEEEe---CCe
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH---PNLVKLIGYCCE---DEH  190 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~  190 (429)
                      .+.||.|..+.||+....++        .+.+|..+...   ....|..|.+.|+.+.-   -.+.++++++..   .+.
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~--------~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG--------NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             eeecCCccceeEEEEEcCCC--------CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            46799999999998643222        16777754311   22356789999988853   357788887753   366


Q ss_pred             EEEEEEecCCCCh
Q 014189          191 RVLIYEFMARGSV  203 (429)
Q Consensus       191 ~~lv~e~~~~g~L  203 (429)
                      .++|||+++++++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            8999999998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.79  E-value=0.00043  Score=63.06  Aligned_cols=76  Identities=24%  Similarity=0.173  Sum_probs=45.2

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCc-eeeeeeEEEeCCeEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  195 (429)
                      .+.|..|-...+|+....++     ....+++|+.......  .....+|+.+++.+.... ..++++.+.  +  .++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~-----~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~   71 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKED-----NQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIY   71 (235)
T ss_pred             EEEcCCcccceEEEEEcCCC-----CCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEE
Confidence            35788888899998754320     0123788876543221  112236888888875333 344444332  2  4799


Q ss_pred             EecCCCCh
Q 014189          196 EFMARGSV  203 (429)
Q Consensus       196 e~~~~g~L  203 (429)
                      ||++|.++
T Consensus        72 e~i~G~~l   79 (235)
T cd05157          72 EFIPGRTL   79 (235)
T ss_pred             EeeCCCcC
Confidence            99998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.66  E-value=0.0044  Score=60.62  Aligned_cols=77  Identities=21%  Similarity=0.115  Sum_probs=50.3

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC-----CC-hhhHHHHHHHHHHHhccC---CCceeeeeeEEEeC
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-----NS-YQGHREWLAEVIFLGHLS---HPNLVKLIGYCCED  188 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~-----~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  188 (429)
                      +.||.|.+..||++...++.      ..++||.-...     .. ......+..|.+.|..+.   -.++.+++.+  +.
T Consensus        32 ~elggGn~N~VyrV~~~~g~------~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~  103 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGG------KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE  103 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCC------eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC
Confidence            57999999999999765432      23889974311     11 123445667888887763   2356666665  34


Q ss_pred             CeEEEEEEecCCCC
Q 014189          189 EHRVLIYEFMARGS  202 (429)
Q Consensus       189 ~~~~lv~e~~~~g~  202 (429)
                      +..++||||+++..
T Consensus       104 ~~~~lVME~L~~~~  117 (401)
T PRK09550        104 ELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCEEEEecCCCcc
Confidence            55789999998643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.60  E-value=0.001  Score=62.91  Aligned_cols=141  Identities=19%  Similarity=0.136  Sum_probs=80.8

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCC--ceeeeee------EEEeC
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP--NLVKLIG------YCCED  188 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~  188 (429)
                      .+.|..|....+|+....++        .+++|+.... .   ......|+.++..+.+.  .+.+++.      +....
T Consensus        19 i~~i~~G~~n~~y~v~~~~~--------~~vLr~~~~~-~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~   86 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG--------RYVLTLFEKV-S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA   86 (296)
T ss_pred             eecccCccccceEEEEeCCC--------cEEEEEcCCC-C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence            45677888889998743221        2888887642 1   22344577777777432  2344433      12334


Q ss_pred             CeEEEEEEecCCCChhh--------------hhhcC--C-C------CCCCHHHHH----------HHHHHHHHHHHHHH
Q 014189          189 EHRVLIYEFMARGSVEN--------------NLFSK--V-L------LPLPWSIRM----------KIAFGAAKGLAFLH  235 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~--------------~l~~~--~-~------~~l~~~~~~----------~i~~~i~~~l~~lH  235 (429)
                      +..+++++|++|..+..              .++..  . .      ....|....          .....+..++.++.
T Consensus        87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  166 (296)
T cd05153          87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD  166 (296)
T ss_pred             CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence            56789999999876532              01110  0 0      011221110          01111233444444


Q ss_pred             h-----CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          236 E-----AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       236 ~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .     ....++|+|+.|.|||+++++.+.|.||+.+..
T Consensus       167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3     113499999999999999987789999987764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.56  E-value=0.0035  Score=59.96  Aligned_cols=31  Identities=29%  Similarity=0.383  Sum_probs=26.5

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       239 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+++|+|+.|.||+++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3599999999999999776668999998764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.47  E-value=0.0018  Score=61.47  Aligned_cols=81  Identities=23%  Similarity=0.254  Sum_probs=46.9

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-eeeeeEEEeCCeEEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  196 (429)
                      +.|..|-...+|+....+.......+..+++|+......  ......+|..++..+....+ .++++++. +   .+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhh
Confidence            566667777999876433211112234488898665422  22234468888887753333 34555543 2   35899


Q ss_pred             ecCCCChh
Q 014189          197 FMARGSVE  204 (429)
Q Consensus       197 ~~~~g~L~  204 (429)
                      |++|..+.
T Consensus        78 ~i~G~~l~   85 (302)
T cd05156          78 FIPSRTLT   85 (302)
T ss_pred             eeCCCcCC
Confidence            99887764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.39  E-value=0.0046  Score=58.83  Aligned_cols=142  Identities=18%  Similarity=0.126  Sum_probs=78.2

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCC--ceeeeeeE------EEeC
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP--NLVKLIGY------CCED  188 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~  188 (429)
                      .+.++.|....+|+....++        .+++|+........   ....|.+++..|...  .+.+++..      ....
T Consensus        27 i~~~~~G~~n~~y~v~t~~~--------~~vLK~~~~~~~~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG--------RYILTLYEKRVKAE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             ccccCCccccceEEEEeCCC--------cEEEEEecCCCCHH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            45677777789998743211        27788775532222   233466666666321  23333331      1234


Q ss_pred             CeEEEEEEecCCCChhh--------------hhhcCCC---CC-------CCHHHHH------------HHHHHHHHHHH
Q 014189          189 EHRVLIYEFMARGSVEN--------------NLFSKVL---LP-------LPWSIRM------------KIAFGAAKGLA  232 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~--------------~l~~~~~---~~-------l~~~~~~------------~i~~~i~~~l~  232 (429)
                      +..+++++|++|..+..              .++....   .+       -.|....            .....+...++
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            56789999998865421              1111000   00       1111100            00112233455


Q ss_pred             HHHh-----CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          233 FLHE-----AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       233 ~lH~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ++..     ....++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            5532     124599999999999999988778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.38  E-value=0.0013  Score=60.68  Aligned_cols=136  Identities=18%  Similarity=0.123  Sum_probs=73.7

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-eeeeeEEEeCCeEEEEEEec
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIYEFM  198 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~  198 (429)
                      +..|-.+.+|+....        +..+++|+........ .....+|..+++.+....+ .+++...  .  -++||||+
T Consensus         4 ~~~G~tn~~y~~~~~--------~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i   70 (256)
T TIGR02721         4 LSGGLTNRSWRIEHP--------GISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWL   70 (256)
T ss_pred             CCCcCcCCeEEEEeC--------CccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEec
Confidence            456778889987521        1237788754432111 0124578888888864333 3333332  2  26899999


Q ss_pred             CCCChhhh-----------------hhcCC--CCCCCHHHH-HHHHHH---------HHHHHHHHHhC------CCCcee
Q 014189          199 ARGSVENN-----------------LFSKV--LLPLPWSIR-MKIAFG---------AAKGLAFLHEA------EKPVIY  243 (429)
Q Consensus       199 ~~g~L~~~-----------------l~~~~--~~~l~~~~~-~~i~~~---------i~~~l~~lH~~------~~~ivH  243 (429)
                      +|..+...                 ++...  ..+++.... .....+         +...+..+-..      ...++|
T Consensus        71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H  150 (256)
T TIGR02721        71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH  150 (256)
T ss_pred             cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence            98765421                 12111  111222111 111111         11112222111      124899


Q ss_pred             CCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          244 RDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       244 ~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      +|+.|.||++++++ +.|+||..+..
T Consensus       151 ~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       151 MDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCCcCcEEEeCCC-CEEEeccccCc
Confidence            99999999999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.20  E-value=0.00069  Score=63.08  Aligned_cols=148  Identities=17%  Similarity=0.163  Sum_probs=94.4

Q ss_pred             cChHHHHHHhcC---CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-------------------Ch--
Q 014189          102 FTYDELRIITAN---FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-------------------SY--  157 (429)
Q Consensus       102 ~~~~~~~~~~~~---y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-------------------~~--  157 (429)
                      +.|-.++....+   +.+++.||-|.-+.+|.+....+       .+.++|+.+-..                   ++  
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G-------~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWly  151 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEG-------NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLY  151 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCC-------CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhh
Confidence            444444444443   67789999999999999865432       336677643221                   11  


Q ss_pred             hhHHHHHHHHHHHhccC-CC-ceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014189          158 QGHREWLAEVIFLGHLS-HP-NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH  235 (429)
Q Consensus       158 ~~~~~~~~E~~~l~~l~-h~-niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH  235 (429)
                      -..-...+|+..|+.|. |- -+.+.+++    +..++|||++.|-.|...-+-..        .-.+...+..-+.-|.
T Consensus       152 LSRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d--------~~~ly~~lm~~Iv~la  219 (465)
T KOG2268|consen  152 LSRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVED--------PPTLYDDLMGLIVRLA  219 (465)
T ss_pred             hHHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecCC--------hHHHHHHHHHHHHHHH
Confidence            11122346888888874 32 23344443    35589999998877664322111        1233444445556677


Q ss_pred             hCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       236 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .+|  +||+|..-=||++++++.++++||--....
T Consensus       220 ~~G--lIHgDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  220 NHG--LIHGDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             HcC--ceecccchheeEEecCCCEEEeechHhhcc
Confidence            777  999999999999999999999999754433

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.18  E-value=5.7e-05  Score=82.32  Aligned_cols=159  Identities=15%  Similarity=-0.022  Sum_probs=113.2

Q ss_pred             HHHHHHHHhccCCCceeeeeeEEE--eCCeEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 014189          163 WLAEVIFLGHLSHPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEA-  237 (429)
Q Consensus       163 ~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~-  237 (429)
                      .+.|...++...|+++.....-..  +....+.+++|+.+|.+.+.+....  ..++...-+.....+...+..-+|+. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            345666666678998877655443  3456688999999999999886532  22233333333333334555555542 


Q ss_pred             --CCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHH
Q 014189          238 --EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI  315 (429)
Q Consensus       238 --~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el  315 (429)
                        +...+|+++|+-|.+|..+..+|++++|+.+...+.  ........+++.|++|++...-.++.++|+|+.|+-+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              355799999999999999999999999999832221  1223346788899999998888899999999999999999


Q ss_pred             HhCCCCCC
Q 014189          316 LTGRKSLD  323 (429)
Q Consensus       316 ltG~~p~~  323 (429)
                      -.|..+|-
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            88877663

>PLN02236 choline kinase

Probab=96.72  E-value=0.024  Score=54.79  Aligned_cols=144  Identities=15%  Similarity=0.087  Sum_probs=79.6

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-eeeeeEEEeCCeEEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  196 (429)
                      +.|-.|-.-.+|++.......  .....+++|+......  ....-.+|..++..+..-++ .++++.+.. +   .|.+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~--~~~~~~v~Ri~g~~t~--~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~e  113 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEG--NLGRKVLVRIYGEGVE--LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEE  113 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCC--CCCCeEEEEEccCCCC--eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEE
Confidence            456567788999976533211  1224488888765432  11222468888888754333 345565533 2   5899


Q ss_pred             ecCCCChhhh-----------------hhcCC--C-C-CCCHHHHHHHHHH-----------------HHHHHHHH----
Q 014189          197 FMARGSVENN-----------------LFSKV--L-L-PLPWSIRMKIAFG-----------------AAKGLAFL----  234 (429)
Q Consensus       197 ~~~~g~L~~~-----------------l~~~~--~-~-~l~~~~~~~i~~~-----------------i~~~l~~l----  234 (429)
                      |+++.+|...                 +|...  . . ...+.....+..+                 +...+..|    
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            9987776421                 11111  0 0 1112222222211                 11112222    


Q ss_pred             Hh--CCCCceeCCCCCCcEEEcC-CCcEEEeccCCCcC
Q 014189          235 HE--AEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKD  269 (429)
Q Consensus       235 H~--~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~  269 (429)
                      ..  ....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            21  1134899999999999986 47899999988764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.57  E-value=0.0065  Score=60.07  Aligned_cols=165  Identities=22%  Similarity=0.285  Sum_probs=89.9

Q ss_pred             HHHHHHHHHHhccCCCceeeeeeEEEe-CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 014189          161 REWLAEVIFLGHLSHPNLVKLIGYCCE-DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK  239 (429)
Q Consensus       161 ~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~  239 (429)
                      ...+....+++.+.|+|...++++... .....+|||++ +.||.+.+..+....         .    .++    .++ 
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~---------~----s~~----~~~-   87 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKD---------E----SLL----AHG-   87 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccch---------h----hhc----ccc-
Confidence            345567788899999999999888753 34578899999 468888876553111         0    011    112 


Q ss_pred             CceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCC
Q 014189          240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR  319 (429)
Q Consensus       240 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~  319 (429)
                       +.|-.+            .+++| -++...         ....                .+|+||||+|.++.++.-|.
T Consensus        88 -~~~~~~------------~~~td-~~~t~~---------~~~~----------------~pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   88 -VLHLNI------------IYITD-HFLTKY---------PSPI----------------GPKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             -cceehh------------hhccc-cccccC---------CCCC----------------CcchhhhhHHHHHHHHHHhh
Confidence             332221            23333 111100         0011                14999999999999999987


Q ss_pred             CCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014189          320 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV  389 (429)
Q Consensus       320 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  389 (429)
                      .-+......+.   ....+.+...+.....+..   ......++.....++..+|+-..|..||...++.
T Consensus       129 ~l~~~~~~s~~---l~~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  129 SLEAELTESEY---LEILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHHHHH---HHHHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            65543322111   1111111111111000000   0011224556778899999999999988655443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.37  E-value=0.063  Score=50.17  Aligned_cols=31  Identities=32%  Similarity=0.458  Sum_probs=25.7

Q ss_pred             CceeCCCCCCcEEEcCCCc-EEEeccCCCcCC
Q 014189          240 PVIYRDFKTSNILLDTDYN-AKLSDFGLAKDG  270 (429)
Q Consensus       240 ~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~  270 (429)
                      .++|+|+.|.|||++.++. .-|.||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            3899999999999997555 569999987653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.31  E-value=0.053  Score=52.14  Aligned_cols=143  Identities=17%  Similarity=0.223  Sum_probs=77.5

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-eeeeeEEEeCCeEEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  196 (429)
                      +.|..|-...+|+....+...   ....+++++......  ......+|..+++.+..-++ .++++++. .+   +|.+
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~---~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~   90 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENG---NEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS   90 (330)
T ss_pred             EEeCCcccceEEEEEecCCCC---CCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence            456557778899876443211   122488888765432  12223468888888865444 35555553 22   5899


Q ss_pred             ecCCCChhh-----------------hhhcCCC---C-CCCHHHHHHHHHHH----------------------HHHHH-
Q 014189          197 FMARGSVEN-----------------NLFSKVL---L-PLPWSIRMKIAFGA----------------------AKGLA-  232 (429)
Q Consensus       197 ~~~~g~L~~-----------------~l~~~~~---~-~l~~~~~~~i~~~i----------------------~~~l~-  232 (429)
                      |+++.+|..                 .+|....   . +-.|.....+..++                      ..-+. 
T Consensus        91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  170 (330)
T PLN02421         91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE  170 (330)
T ss_pred             hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence            997766521                 0111110   0 11122222222111                      11111 


Q ss_pred             ---HHHhCC--CCceeCCCCCCcEEEcC-CCcEEEeccCCCcC
Q 014189          233 ---FLHEAE--KPVIYRDFKTSNILLDT-DYNAKLSDFGLAKD  269 (429)
Q Consensus       233 ---~lH~~~--~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~  269 (429)
                         ++...+  .-.+|.|+.+.|||+++ ++.++++||..|..
T Consensus       171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence               121112  12689999999999975 57899999998764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.21  E-value=0.074  Score=50.81  Aligned_cols=144  Identities=15%  Similarity=0.126  Sum_probs=85.8

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC------------------------ChhhHHHH-HHHHHHH
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN------------------------SYQGHREW-LAEVIFL  170 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~-~~E~~~l  170 (429)
                      +...|..|--+.||.|+-.++.       .+|||+.+..-                        +..-..-| ..|++=|
T Consensus       148 inGCiSTGKEANVYHat~~dG~-------~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL  220 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGS-------EFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL  220 (520)
T ss_pred             cccccccCccceeEeeecCCCc-------eEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence            3467888999999998654432       28999865320                        00111111 2466667


Q ss_pred             hccCCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCc
Q 014189          171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  250 (429)
Q Consensus       171 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~N  250 (429)
                      .+++...|.--.-+.. . .-.|||+|+....-..-.  -....++...+..+-.+++.-+.-|.... ++||.||+-=|
T Consensus       221 kRl~~aGIP~PePIlL-k-~hVLVM~FlGrdgw~aPk--LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c-~LVHADLSEfN  295 (520)
T KOG2270|consen  221 KRLNNAGIPCPEPILL-K-NHVLVMEFLGRDGWAAPK--LKDASLSTSKARELYQQCVRIMRRLYQKC-RLVHADLSEFN  295 (520)
T ss_pred             HHHHhcCCCCCCceee-e-cceEeeeeccCCCCcCcc--cccccCChHHHHHHHHHHHHHHHHHHHHh-ceeccchhhhh
Confidence            7776544322111111 1 236899999532211100  11224666666677777777777666432 39999999999


Q ss_pred             EEEcCCCcEEEeccCCCcCCCC
Q 014189          251 ILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       251 Ill~~~~~~kl~Dfgla~~~~~  272 (429)
                      +|+. +|.+.|+|-+-+.....
T Consensus       296 ~Lyh-dG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  296 LLYH-DGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             heEE-CCEEEEEEccccccCCC
Confidence            9995 56799999988776443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.11  E-value=0.092  Score=50.54  Aligned_cols=32  Identities=22%  Similarity=0.367  Sum_probs=26.2

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       239 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ..++|+|+.+.||++++++ ++++||..+...+
T Consensus       192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~G~  223 (370)
T TIGR01767       192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFYGP  223 (370)
T ss_pred             ceeeeccCCcccEEEcCCC-CEEEcCcccccCc
Confidence            3489999999999997765 7899998776543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.10  E-value=0.12  Score=48.97  Aligned_cols=33  Identities=21%  Similarity=0.424  Sum_probs=29.5

Q ss_pred             CceeCCCCCCcEEEcCCCcEEEeccCCCcCCCC
Q 014189          240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  272 (429)
Q Consensus       240 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  272 (429)
                      .++|+|+.+.|++++.++-+=|.||+++.....
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            489999999999999999999999999987543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.10  E-value=0.1  Score=49.58  Aligned_cols=30  Identities=23%  Similarity=0.325  Sum_probs=25.6

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       239 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            45899999999999988 6689999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.92  E-value=0.19  Score=48.98  Aligned_cols=76  Identities=14%  Similarity=0.144  Sum_probs=44.3

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEec----CCCC-hhhHHHHHHHHHHHhccC--CCc-eeeeeeEEEeC
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD----GDNS-YQGHREWLAEVIFLGHLS--HPN-LVKLIGYCCED  188 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~----~~~~-~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~  188 (429)
                      .+.||-|.-.-||++.+..+.      ..|+||.-.    ...+ .....+..-|.+.|+...  -|. +.+++.  .+.
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~------~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKN------ISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDS  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCC------ceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECc
Confidence            367899999999999763211      227888522    1111 222334445777777663  353 444443  234


Q ss_pred             CeEEEEEEecCC
Q 014189          189 EHRVLIYEFMAR  200 (429)
Q Consensus       189 ~~~~lv~e~~~~  200 (429)
                      +...+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            455788998854

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.88  E-value=0.055  Score=47.98  Aligned_cols=102  Identities=16%  Similarity=0.065  Sum_probs=64.9

Q ss_pred             EEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHH
Q 014189          146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF  225 (429)
Q Consensus       146 vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~  225 (429)
                      ..+|.++.-.......-|.++.+++++++  .|+++..-  +.-.+-+|.|+|-.-.           ..+   .-.|..
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i~~---~N~i~a  149 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------INF---SNFITA  149 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------cch---hHHHHH
Confidence            34454443322223345678888888774  46666621  2334458899884321           011   111222


Q ss_pred             HHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       226 ~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      + +.+|.-.|+.....+|+|-.|+||+-|..|.+||.|-+.
T Consensus       150 g-i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  150 G-IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             h-HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            2 356788897666799999999999999999999999774

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.77  E-value=0.024  Score=50.58  Aligned_cols=28  Identities=36%  Similarity=0.493  Sum_probs=20.2

Q ss_pred             ceeCCCCCCcEEE-cCCCcEEEeccCCCc
Q 014189          241 VIYRDFKTSNILL-DTDYNAKLSDFGLAK  268 (429)
Q Consensus       241 ivH~Dlkp~NIll-~~~~~~kl~Dfgla~  268 (429)
                      +.|+|+.|.|||+ +.++.++++||..+.
T Consensus       145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  145 FCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             EeeccCccccEEeccCCCeEEEecHHHHh
Confidence            7899999999999 889999999998765

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.77  E-value=0.03  Score=52.50  Aligned_cols=73  Identities=25%  Similarity=0.287  Sum_probs=43.8

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC---CCceeeeeeEEEeCCeEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  193 (429)
                      .+.++.|....+|+..  .+      +..+.+|+-...    ....|..|.+-|+.|.   --.+.+.+++....+.-+|
T Consensus        22 ~~~v~GG~i~~a~~~~--~~------~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL   89 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TD------GGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL   89 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TT------S-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred             eEecCCCChhheEEEE--CC------CccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence            4678989999999865  21      223888987622    2235667888887773   3457788888877777799


Q ss_pred             EEEecCCC
Q 014189          194 IYEFMARG  201 (429)
Q Consensus       194 v~e~~~~g  201 (429)
                      ||||++.+
T Consensus        90 lle~l~~~   97 (288)
T PF03881_consen   90 LLEFLEMG   97 (288)
T ss_dssp             EEE-----
T ss_pred             EEEeecCC
Confidence            99999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.72  E-value=0.17  Score=47.67  Aligned_cols=79  Identities=16%  Similarity=0.145  Sum_probs=46.9

Q ss_pred             cCCCcEEEEEEEEcc--ccccCcCceeEEEEEecCCCCh----hhHHHHHHHHHHHhccC---------C----Cceeee
Q 014189          121 GGGGFGCVYKGFISE--DLREGLQPVPVAVKVHDGDNSY----QGHREWLAEVIFLGHLS---------H----PNLVKL  181 (429)
Q Consensus       121 G~G~fg~Vy~~~~~~--~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~---------h----~niv~l  181 (429)
                      |.|-.|.+|++....  ..........+.||........    .....|.+|+.+.+.+-         +    ....++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            678889999987755  2233445667899987632211    12244667777766541         1    123445


Q ss_pred             eeEEEeCCeEEEEEEecC
Q 014189          182 IGYCCEDEHRVLIYEFMA  199 (429)
Q Consensus       182 ~~~~~~~~~~~lv~e~~~  199 (429)
                      +....+....+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            554444446789998764

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.62  E-value=0.17  Score=48.10  Aligned_cols=30  Identities=17%  Similarity=0.176  Sum_probs=27.5

Q ss_pred             CceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       240 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      +++|+|+.+.|+|++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            599999999999999999999999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.60  E-value=0.047  Score=52.04  Aligned_cols=104  Identities=16%  Similarity=0.171  Sum_probs=68.8

Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      ..+.|++|++. |++|.. +     ..-.+.+...++.+.+..++-+.. ..+.=|||+.-.||||+ +|++-|+||-++
T Consensus       298 ~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence            34567778876 444432 1     134678889999988877776664 34578999999999999 999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhH
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSF  308 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  308 (429)
                      +....++.  +..     ...--|-.+.|.. +.+-|||-+
T Consensus       369 Rl~~~q~~--isy-----~rldhp~lF~G~d-d~QFeIYrl  401 (488)
T COG5072         369 RLSYSQGI--ISY-----NRLDHPDLFNGVD-DYQFEIYRL  401 (488)
T ss_pred             ecccCCce--eec-----cccCchhhhcCcc-ceeeeHHHH
Confidence            95433221  111     1222344444333 667778764

>PTZ00384 choline kinase; Provisional

Probab=95.55  E-value=0.24  Score=48.50  Aligned_cols=82  Identities=15%  Similarity=0.117  Sum_probs=46.3

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-eeeeeEEEeCCeEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  195 (429)
                      .+.|..|-...+|++...+..........|.+......  .....+-.+|+.+++.+...++ .++++.+..    ++++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~--~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY--NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC--CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            35666688889999865433211111122444443221  1111222368889988865544 455666642    5899


Q ss_pred             EecCCCChh
Q 014189          196 EFMARGSVE  204 (429)
Q Consensus       196 e~~~~g~L~  204 (429)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999987764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.07  E-value=0.25  Score=44.21  Aligned_cols=55  Identities=22%  Similarity=0.305  Sum_probs=40.4

Q ss_pred             EEEEEecCCCChhhHHHHHHHHHHHhccCC---CceeeeeeEEEeCCeEEEEEEecCCCChh
Q 014189          146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSH---PNLVKLIGYCCEDEHRVLIYEFMARGSVE  204 (429)
Q Consensus       146 vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~~g~L~  204 (429)
                      +-+|+-.    ......|..|+.-|..|.-   -++.+++.+-...++.|+||||++-|.+.
T Consensus        42 ~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          42 FFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             eEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            7777643    2344667788887777753   45667777778889999999999987664

>PRK06148 hypothetical protein; Provisional

Probab=94.97  E-value=0.44  Score=52.92  Aligned_cols=31  Identities=42%  Similarity=0.476  Sum_probs=26.0

Q ss_pred             CCceeCCCCCCcEEEcCCC--cEE-EeccCCCcC
Q 014189          239 KPVIYRDFKTSNILLDTDY--NAK-LSDFGLAKD  269 (429)
Q Consensus       239 ~~ivH~Dlkp~NIll~~~~--~~k-l~Dfgla~~  269 (429)
                      +.+||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4599999999999999875  554 999998764

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.47  E-value=1.6  Score=42.93  Aligned_cols=74  Identities=11%  Similarity=0.054  Sum_probs=45.1

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC---h---hhHHHHHHHHHHHhccC---CCceeeeeeEEEe
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---Y---QGHREWLAEVIFLGHLS---HPNLVKLIGYCCE  187 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  187 (429)
                      .+.||.|....||+.....  +      .++||.-.....   .   -....-..|.+.|+.+.   ..++.+++.++. 
T Consensus        37 ~~eiggGn~N~VyrV~~~~--~------svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSS--G------SFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcCC--c------cEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            4678999999999975421  1      278887541110   0   01122223566665553   246777888776 


Q ss_pred             CCeEEEEEEecCC
Q 014189          188 DEHRVLIYEFMAR  200 (429)
Q Consensus       188 ~~~~~lv~e~~~~  200 (429)
                       +.-+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             445788999976

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.18  E-value=1.2  Score=42.60  Aligned_cols=138  Identities=20%  Similarity=0.245  Sum_probs=76.2

Q ss_pred             ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC---CCc---eeeeeeEE--EeCC--
Q 014189          120 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPN---LVKLIGYC--CEDE--  189 (429)
Q Consensus       120 lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~n---iv~l~~~~--~~~~--  189 (429)
                      |.+ .-..||+....++.        +++|+.......   .+...|...|..+.   .+=   +..+-|-.  .-.+  
T Consensus        34 l~s-~eN~~f~~~~~~g~--------~iLki~~~~~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~  101 (331)
T COG2334          34 LNS-EENSNFRVQTEDGR--------YILKIYRPGWTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGP  101 (331)
T ss_pred             ccc-ccCceEEEEecCCC--------eEEEEecCCCCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCc
Confidence            444 45568886543321        589998876222   23334666776663   221   22222211  1233  


Q ss_pred             eEEEEEEecCCCChhh-h--------------hhc--CCC--------CCCCHHH-------------HHHHHHHHHHHH
Q 014189          190 HRVLIYEFMARGSVEN-N--------------LFS--KVL--------LPLPWSI-------------RMKIAFGAAKGL  231 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~-~--------------l~~--~~~--------~~l~~~~-------------~~~i~~~i~~~l  231 (429)
                      ..+-+++|++|..+.. .              ++.  +..        ....|..             ......++...+
T Consensus       102 r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~  181 (331)
T COG2334         102 RPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAAL  181 (331)
T ss_pred             eeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHH
Confidence            7788999999987762 1              110  000        0122320             011223334444


Q ss_pred             HHHHhCC------CC--ceeCCCCCCcEEEcCCCc-EEEeccCCCcC
Q 014189          232 AFLHEAE------KP--VIYRDFKTSNILLDTDYN-AKLSDFGLAKD  269 (429)
Q Consensus       232 ~~lH~~~------~~--ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~  269 (429)
                      ..+...-      -+  +||+|+.|.||+++.+.. +.+.||+-+..
T Consensus       182 ~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         182 DRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             HHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            4444321      12  899999999999999885 89999997754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=93.74  E-value=0.018  Score=56.89  Aligned_cols=75  Identities=27%  Similarity=0.347  Sum_probs=60.7

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      .....++|.....+|.|+||+|+.+..+.+..      .+|||.+.-.+........++|..-+.++.|+++++++..|.
T Consensus        44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~------~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~  117 (516)
T KOG1033|consen   44 TSREANDFEPGQCLGRGGFGVVFSAQNKADEN------KYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWY  117 (516)
T ss_pred             hhhhhccccccccccccCccccCCccccccch------hhHHHHhcccchhhhhhhhhccccchhhhcccchhhheecee
Confidence            34556789999999999999999986655432      288998887766667777788999999999999999988775


Q ss_pred             e
Q 014189          187 E  187 (429)
Q Consensus       187 ~  187 (429)
                      .
T Consensus       118 ~  118 (516)
T KOG1033|consen  118 E  118 (516)
T ss_pred             c
Confidence            4

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	429
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-43
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-42
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-42
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-31
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-07
3soa_A	444	Full-Length Human Camkii Length = 444		1e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 107/285 (37%), Positives = 160/285 (56%), Gaps = 13/285 (4%)
Query: 111 TANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 170
           T NF    ++       VYKG     LR+G +   VA+K    ++S QG  E+  E+  L
Sbjct: 38  TNNFDHKFLIGHGVFGKVYKGV----LRDGAK---VALKRRTPESS-QGIEEFETEIETL 89
Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL--LPLPWSIRMKIAFGAA 228
               HP+LV LIG+C E    +LIY++M  G+++ +L+   L  + + W  R++I  GAA
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           +GL +LH   + +I+RD K+ NILLD ++  K++DFG++K G E D++H+   + GT GY
Sbjct: 150 RGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXX 348
             PEY + G LT +SDVYSFGVVL E+L  R ++ +S P    NLA+WA           
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-VESHNNGQLE 266
Query: 349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            I+DP L      + + K    A  CL  + + RP M D++  LE
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 106/285 (37%), Positives = 159/285 (55%), Gaps = 13/285 (4%)
Query: 111 TANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 170
           T NF    ++       VYKG     LR+G +   VA+K    ++S QG  E+  E+  L
Sbjct: 38  TNNFDHKFLIGHGVFGKVYKGV----LRDGAK---VALKRRTPESS-QGIEEFETEIETL 89
Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL--LPLPWSIRMKIAFGAA 228
               HP+LV LIG+C E    +LIY++M  G+++ +L+   L  + + W  R++I  GAA
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           +GL +LH   + +I+RD K+ NILLD ++  K++DFG++K G E  ++H+   + GT GY
Sbjct: 150 RGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXX 348
             PEY + G LT +SDVYSFGVVL E+L  R ++ +S P    NLA+WA           
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-VESHNNGQLE 266
Query: 349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            I+DP L      + + K    A  CL  + + RP M D++  LE
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 162/300 (54%), Gaps = 14/300 (4%)
Query: 99  LIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ 158
           L  F+  EL++ + NF    +L       VYKG +++          VAVK    +    
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-------TLVAVKRLKEERXQG 77
Query: 159 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLLPLP 216
           G  ++  EV  +    H NL++L G+C     R+L+Y +MA GSV + L  +     PL 
Sbjct: 78  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 137
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKP-VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
           W  R +IA G+A+GLA+LH+   P +I+RD K +NILLD ++ A + DFGLAK     D 
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD- 196
Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN--L 333
            HV   + GT G+ APEY+ TG  + ++DV+ +GV+LLE++TG+++ D +R A + +  L
Sbjct: 197 XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 334 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            DW             ++D  L+G+Y  + V +   +A  C   +P  RP M ++V  LE
Sbjct: 257 LDWVKGLLKEKKLEA-LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 14/300 (4%)
Query: 99  LIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ 158
           L  F+  EL++ + NF    +L       VYKG +++          VAVK    + +  
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADG-------XLVAVKRLKEERTQG 69
Query: 159 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLLPLP 216
           G  ++  EV  +    H NL++L G+C     R+L+Y +MA GSV + L  +     PL 
Sbjct: 70  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKP-VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
           W  R +IA G+A+GLA+LH+   P +I+RD K +NILLD ++ A + DFGLAK     D 
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD- 188
Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN--L 333
            HV   + G  G+ APEY+ TG  + ++DV+ +GV+LLE++TG+++ D +R A + +  L
Sbjct: 189 XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 334 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            DW             ++D  L+G+Y  + V +   +A  C   +P  RP M ++V  LE
Sbjct: 249 LDWVKGLLKEKKLEA-LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/302 (31%), Positives = 160/302 (52%), Gaps = 18/302 (5%)
Query: 101 AFTYDELRIITANFRQDRV------LXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGD 154
           +F++ EL+ +T NF +  +      +       VYKG+++ +    ++ +   V +    
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI---- 68
Query: 155 NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLL 213
            + +  +++  E+  +    H NLV+L+G+  + +   L+Y +M  GS+ + L       
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
           PL W +R KIA GAA G+ FLHE     I+RD K++NILLD  + AK+SDFGLA+   + 
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 333
            ++ + +RI+GT  Y APE  + G +TP+SD+YSFGVVLLEI+TG  ++D+ R    Q L
Sbjct: 187 AQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLL 243
Query: 334 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            D             + ID ++  D     V     +A  CL+     RP ++ +   L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 394 PL 395
            +
Sbjct: 303 EM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/302 (31%), Positives = 159/302 (52%), Gaps = 18/302 (5%)
Query: 101 AFTYDELRIITANFRQDRV------LXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGD 154
           +F++ EL+ +T NF +  +      +       VYKG+++ +    ++ +   V +    
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI---- 68
Query: 155 NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLL 213
            + +  +++  E+  +    H NLV+L+G+  + +   L+Y +M  GS+ + L       
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
           PL W +R KIA GAA G+ FLHE     I+RD K++NILLD  + AK+SDFGLA+   + 
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 333
            ++ +  RI+GT  Y APE  + G +TP+SD+YSFGVVLLEI+TG  ++D+ R    Q L
Sbjct: 187 AQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLL 243
Query: 334 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            D             + ID ++  D     V     +A  CL+     RP ++ +   L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 394 PL 395
            +
Sbjct: 303 EM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 96/302 (31%), Positives = 158/302 (52%), Gaps = 18/302 (5%)
Query: 101 AFTYDELRIITANFRQDRV------LXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGD 154
           +F++ EL+ +T NF +  +      +       VYKG+++ +    ++ +   V +    
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI---- 62
Query: 155 NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLL 213
            + +  +++  E+  +    H NLV+L+G+  + +   L+Y +M  GS+ + L       
Sbjct: 63  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 122
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
           PL W +R KIA GAA G+ FLHE     I+RD K++NILLD  + AK+SDFGLA+   + 
Sbjct: 123 PLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 333
            +  +  RI+GT  Y APE  + G +TP+SD+YSFGVVLLEI+TG  ++D+ R    Q L
Sbjct: 181 AQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLL 237
Query: 334 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            D             + ID ++  D     V     +A  CL+     RP ++ +   L+
Sbjct: 238 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296
Query: 394 PL 395
            +
Sbjct: 297 EM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 153/300 (51%), Gaps = 18/300 (6%)
Query: 101 AFTYDELRIITANFRQDRVLXXXXXX------CVYKGFISEDLREGLQPVPVAVKVHDGD 154
           +F++ EL+ +T NF +  +              VYKG+++ +    ++ +   V +    
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI---- 59
Query: 155 NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLL 213
            + +  +++  E+       H NLV+L+G+  + +   L+Y +   GS+ + L       
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP 119
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
           PL W  R KIA GAA G+ FLHE     I+RD K++NILLD  + AK+SDFGLA+   + 
Sbjct: 120 PLSWHXRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 333
            +    +RI+GT  Y APE  + G +TP+SD+YSFGVVLLEI+TG  ++D+ R    Q L
Sbjct: 178 AQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLL 234
Query: 334 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
            D             + ID +   D     V     +A  CL+     RP ++ +   L+
Sbjct: 235 LDIKEEIEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 117/252 (46%), Gaps = 20/252 (7%)
Query: 146 VAVKV-HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+  + D   +   E+L EV  +  L HPN+V  +G   +  +  ++ E+++RGS+ 
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 205 NNLF-SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
             L  S     L    R+ +A+  AKG+ +LH    P+++RD K+ N+L+D  Y  K+ D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCD 182
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
           FGL++   +      S    GT  + APE +       +SDVYSFGV+L E+ T ++   
Sbjct: 183 FGLSR--LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
              PA+                        RLE   P     + A +   C  + P  RP
Sbjct: 241 NLNPAQ--------------VVAAVGFKCKRLE--IPRNLNPQVAAIIEGCWTNEPWKRP 284
Query: 384 LMRDIVDSLEPL 395
               I+D L PL
Sbjct: 285 SFATIMDLLRPL 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 117/252 (46%), Gaps = 20/252 (7%)
Query: 146 VAVKV-HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+  + D   +   E+L EV  +  L HPN+V  +G   +  +  ++ E+++RGS+ 
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 205 NNLF-SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
             L  S     L    R+ +A+  AKG+ +LH    P+++R+ K+ N+L+D  Y  K+ D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
           FGL++   +      S    GT  + APE +       +SDVYSFGV+L E+ T ++   
Sbjct: 183 FGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
              PA+                        RLE   P     + A +   C  + P  RP
Sbjct: 241 NLNPAQ--------------VVAAVGFKCKRLE--IPRNLNPQVAAIIEGCWTNEPWKRP 284
Query: 384 LMRDIVDSLEPL 395
               I+D L PL
Sbjct: 285 SFATIMDLLRPL 296

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 103/203 (50%), Gaps = 27/203 (13%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLIGYCC 186
           VY+ F   D       V V    HD D       E +  E      L HPN++ L G C 
Sbjct: 23  VYRAFWIGD------EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76
Query: 187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH-EAEKPVIYRD 245
           ++ +  L+ EF ARG   N + S   +P    I +  A   A+G+ +LH EA  P+I+RD
Sbjct: 77  KEPNLCLVMEF-ARGGPLNRVLSGKRIPP--DILVNWAVQIARGMNYLHDEAIVPIIHRD 133
Query: 246 FKTSNILL-----DTDYN---AKLSDFGLAKDGPEGDKSHVSTRI--MGTYGYAAPEYIM 295
            K+SNIL+     + D +    K++DFGLA++       H +T++   G Y + APE I 
Sbjct: 134 LKSSNILILQKVENGDLSNKILKITDFGLAREW------HRTTKMSAAGAYAWMAPEVIR 187
Query: 296 TGHLTPRSDVYSFGVVLLEILTG 318
               +  SDV+S+GV+L E+LTG
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTG 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 34/288 (11%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VYKG +      G + VPVA+K      + +   ++L E   +G  SH N+++L G   +
Sbjct: 60  VYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117
Query: 188 DEHRVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIY 243
            +  ++I E+M  G+++  L  K     +L L   +R     G A G+ +L  A    ++
Sbjct: 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR-----GIAAGMKYL--ANMNYVH 170
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
           RD    NIL++++   K+SDFGL++   D PE   +    +I     + APE I     T
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTAPEAISYRKFT 228
Query: 301 PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYP 360
             SDV+SFG+V+ E++T        RP  E +                  I+       P
Sbjct: 229 SASDVWSFGIVMWEVMT-----YGERPYWELS-----------NHEVMKAINDGFRLPTP 272
Query: 361 VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNF 408
           +        L   C       RP   DIV  L+ L   PD   T  +F
Sbjct: 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 43  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 99
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 100 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 154
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 214
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 215 KSDVWSFGVLLWELMT 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 46  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 102
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 103 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 157
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 158 RDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 217
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 218 KSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 45  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 101
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 102 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 156
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 217 KSDVWSFGVLLWELMT 232

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 92/171 (53%), Gaps = 15/171 (8%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 220
           +E+  EV  + +L+HPN+VKL G        V+  EF+  G + + L  K   P+ WS++
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVK 124
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYN----AKLSDFGLAKDGPEGDK 275
           +++    A G+ ++     P+++RD ++ NI L + D N    AK++DFGL++       
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QS 179
Query: 276 SHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDK 324
            H  + ++G + + APE I       T ++D YSF ++L  ILTG    D+
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 104 CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 160
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 161 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 215
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 276 KSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 50  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 106
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 107 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 161
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 162 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 221
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 222 KSDVWSFGVLLWELMT 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 46  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 102
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 103 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 157
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 158 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 217
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 218 KSDVWSFGVLLWELMT 233

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 45  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 101
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 102 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 156
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 217 KSDVWSFGVLLWELMT 232

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 91/171 (53%), Gaps = 15/171 (8%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 220
           +E+  EV  + +L+HPN+VKL G        V+  EF+  G + + L  K   P+ WS++
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVK 124
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYN----AKLSDFGLAKDGPEGDK 275
           +++    A G+ ++     P+++RD ++ NI L + D N    AK++DFG ++       
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QS 179
Query: 276 SHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDK 324
            H  + ++G + + APE I       T ++D YSF ++L  ILTG    D+
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 91/171 (53%), Gaps = 15/171 (8%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 220
           +E+  EV  + +L+HPN+VKL G        V+  EF+  G + + L  K   P+ WS++
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVK 124
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYN----AKLSDFGLAKDGPEGDK 275
           +++    A G+ ++     P+++RD ++ NI L + D N    AK++DF L++       
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QS 179
Query: 276 SHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDK 324
            H  + ++G + + APE I       T ++D YSF ++L  ILTG    D+
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 44  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 100
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 101 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 155
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 156 RDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTT 215
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 216 KSDVWSFGVLLWELMT 231

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           G + VPVA+K      + +  R++L+E   +G   HPN+++L G        +++ E+M 
Sbjct: 74  GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133
Query: 200 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
            GS++  L +      ++ L   +R     G   G+ +L  ++   ++RD    N+L+D+
Sbjct: 134 NGSLDTFLRTHDGQFTIMQLVGMLR-----GVGAGMRYL--SDLGYVHRDLAARNVLVDS 186
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D P+   +    +I     + APE I     +  SDV+SFGVV+
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVM 244
Query: 313 LEILT 317
            E+L 
Sbjct: 245 WEVLA 249

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 96/185 (51%), Gaps = 16/185 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           G + VPVA+K      + +  R++L+E   +G   HPN+++L G        +++ E+M 
Sbjct: 74  GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133
Query: 200 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
            GS++  L +      ++ L   +R     G   G+ +L  ++   ++RD    N+L+D+
Sbjct: 134 NGSLDTFLRTHDGQFTIMQLVGMLR-----GVGAGMRYL--SDLGYVHRDLAARNVLVDS 186
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D P  D ++ +T       + APE I     +  SDV+SFGVV+
Sbjct: 187 NLVCKVSDFGLSRVLEDDP--DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244
Query: 313 LEILT 317
            E+L 
Sbjct: 245 WEVLA 249

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 129/304 (42%), Gaps = 41/304 (13%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 61
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+  +   ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 122 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-------GRKSLDKSRPAR 329
               + +    + +PE +  G  T  SDV+SFGVVL EI T       G  +    R   
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 239
Query: 330 EQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
           E  L D             N  D  LE             L   C  +NPK RP   +I+
Sbjct: 240 EGGLLD----------KPDNCPDMLLE-------------LMRMCWQYNPKMRPSFLEII 276
Query: 390 DSLE 393
            S++
Sbjct: 277 SSIK 280

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 90/178 (50%), Gaps = 16/178 (8%)
Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW 217
           +  R +L EV  +  L HPN++K IG   +D+    I E++  G++   +   +    PW
Sbjct: 49  ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR-GIIKSMDSQYPW 107
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA------KDGP 271
           S R+  A   A G+A+LH     +I+RD  + N L+  + N  ++DFGLA      K  P
Sbjct: 108 SQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 272 EGDKS------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
           EG +S           ++G   + APE I       + DV+SFG+VL EI+ GR + D
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 92/181 (50%), Gaps = 18/181 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K   G  + +  RE+L+E   +G   HPN+++L G        +++ EFM  G++++
Sbjct: 47  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 106
Query: 206 NL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
            L      F+ + L       + +  G A G+ +L  AE   ++RD    NIL++++   
Sbjct: 107 FLRLNDGQFTVIQL-------VGMLRGIASGMRYL--AEMSYVHRDLAARNILVNSNLVC 157
Query: 260 KLSDFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 316
           K+SDFGL++   E       T  +G      + APE I     T  SD +S+G+V+ E++
Sbjct: 158 KVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217
Query: 317 T 317
           +
Sbjct: 218 S 218

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 45  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 101
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 102 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 156
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 217 KSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 64  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 120
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 121 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 175
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 176 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 235
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 236 KSDVWSFGVLLWELMT 251

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 42  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 98
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 99  RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 153
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 213
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 214 KSDVWSFGVLLWELMT 229

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 37  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 93
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 94  RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 148
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 149 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 208
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 209 KSDVWSFGVLLWELMT 224

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 44  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 100
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 101 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 155
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 156 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 215
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 216 KSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 45  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 101
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 102 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 156
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 217 KSDVWSFGVLLWELMT 232

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 63  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 119
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 120 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 174
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 175 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 234
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 235 KSDVWSFGVLLWELMT 250

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 92/181 (50%), Gaps = 18/181 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K   G  + +  RE+L+E   +G   HPN+++L G        +++ EFM  G++++
Sbjct: 45  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 104
Query: 206 NL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
            L      F+ + L       + +  G A G+ +L  AE   ++RD    NIL++++   
Sbjct: 105 FLRLNDGQFTVIQL-------VGMLRGIASGMRYL--AEMSYVHRDLAARNILVNSNLVC 155
Query: 260 KLSDFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 316
           K+SDFGL++   E       T  +G      + APE I     T  SD +S+G+V+ E++
Sbjct: 156 KVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 215
Query: 317 T 317
           +
Sbjct: 216 S 216

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 40  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 97  RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 151
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 212 KSDVWSFGVLLWELMT 227

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 27/297 (9%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 70
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 131 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
               + +    + +PE +  G  T  SDV+SFGVVL EI T               LA+ 
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQ 233
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                        +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 234 PYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 43  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 99
Query: 187 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 243
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 100 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 154
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 214
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+SFGV+L E++T
Sbjct: 215 KSDVWSFGVLLWELMT 230

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 132/304 (43%), Gaps = 33/304 (10%)
Query: 101 AFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 160
            F  DE  +        R L       VY+G +++ + +      VA+K  +   S +  
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 63
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVL 212
            E+L E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL
Sbjct: 64  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 213 LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE 272
            P   S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN 332
            D      + +    + +PE +  G  T  SDV+SFGVVL EI T        +P   Q 
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQPY--QG 234
Query: 333 LADWAXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
           L++              ++   +EG   D P         L   C  +NPK RP   +I+
Sbjct: 235 LSN------------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 282
Query: 390 DSLE 393
            S++
Sbjct: 283 SSIK 286

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 31/306 (10%)
Query: 98  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 157
           P   F  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASL 61
Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 215
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 119
Query: 216 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 267
                 P +++  I   A  A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 327
           +D  E D      + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 178 RDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 227
Query: 328 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 387
                LA+              ++D     D P     +   L   C   NPK RP   +
Sbjct: 228 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 388 IVDSLE 393
           IV+ L+
Sbjct: 282 IVNLLK 287

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 133/300 (44%), Gaps = 33/300 (11%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 76
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+  +   ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 137 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
               + +    + +PE +  G  T  SDV+SFGVVL EI T  +     +P   Q L++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPY--QGLSN- 246
Query: 337 AXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                        ++   +EG   D P         L   C  +NPK RP   +I+ S++
Sbjct: 247 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 27/297 (9%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 76
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+  +   ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 137 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
               + +    + +PE +  G  T  SDV+SFGVVL EI T               LA+ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQ 239
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                        +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 240 PYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 27/297 (9%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 63
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+  +   ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 124 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
               + +    + +PE +  G  T  SDV+SFGVVL EI T               LA+ 
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQ 226
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                        +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 227 PYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 121/235 (51%), Gaps = 25/235 (10%)
Query: 106 ELRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREW 163
           +LRI+     ++ +VL       VYKG     + EG    +PVA+K+ +     + + E+
Sbjct: 31  QLRILKETELKRVKVLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEF 87
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLP 216
           + E + +  + HP+LV+L+G C     + L+ + M  G +       ++N+ S++L  L 
Sbjct: 88  MDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLL--LN 144
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
           W +++      AKG+ +L   E+ +++RD    N+L+ +  + K++DFGLA+     +K 
Sbjct: 145 WCVQI------AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
           + +        + A E I     T +SDV+S+GV + E++T G K  D   P RE
Sbjct: 197 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 250

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 121/235 (51%), Gaps = 25/235 (10%)
Query: 106 ELRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREW 163
           +LRI+     ++ +VL       VYKG     + EG    +PVA+K+ +     + + E+
Sbjct: 8   QLRILKETELKRVKVLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEF 64
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLP 216
           + E + +  + HP+LV+L+G C     + L+ + M  G +       ++N+ S++L  L 
Sbjct: 65  MDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLL--LN 121
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
           W +++      AKG+ +L   E+ +++RD    N+L+ +  + K++DFGLA+     +K 
Sbjct: 122 WCVQI------AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 173
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
           + +        + A E I     T +SDV+S+GV + E++T G K  D   P RE
Sbjct: 174 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 227

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 27/297 (9%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 69
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 130 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
               + +    + +PE +  G  T  SDV+SFGVVL EI T               LA+ 
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQ 232
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                        +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 233 PYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 27/297 (9%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 70
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 131 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
               + +    + +PE +  G  T  SDV+SFGVVL EI T               LA+ 
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQ 233
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                        +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 234 PYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 33/300 (11%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 66
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 127 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
               + +    + +PE +  G  T  SDV+SFGVVL EI T        +P   Q L++ 
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQPY--QGLSN- 236
Query: 337 AXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                        ++   +EG   D P         L   C  +NPK RP   +I+ S++
Sbjct: 237 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 33/300 (11%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 69
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 130 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
               + +    + +PE +  G  T  SDV+SFGVVL EI T        +P   Q L++ 
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQPY--QGLSN- 239
Query: 337 AXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                        ++   +EG   D P         L   C  +NPK RP   +I+ S++
Sbjct: 240 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 128/304 (42%), Gaps = 41/304 (13%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 63
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+  +   ++RD    N  +  D+  K+ DFG+ +D  E D  
Sbjct: 124 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-------GRKSLDKSRPAR 329
               + +    + +PE +  G  T  SDV+SFGVVL EI T       G  +    R   
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 241
Query: 330 EQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
           E  L D             N  D  LE             L   C  +NPK RP   +I+
Sbjct: 242 EGGLLD----------KPDNCPDMLLE-------------LMRMCWQYNPKMRPSFLEII 278
Query: 390 DSLE 393
            S++
Sbjct: 279 SSIK 282

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 128/303 (42%), Gaps = 31/303 (10%)
Query: 101 AFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 160
            F  DE  +        R L       VY+G  + D+ +G     VAVK  +   S +  
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASLRER 61
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL----- 215
            E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P      
Sbjct: 62  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAENNP 119
Query: 216 ---PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 270
              P +++  I   A  A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ +D 
Sbjct: 120 GRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 177
Query: 271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE 330
            E D      + +    + APE +  G  T  SD++SFGVVL EI +             
Sbjct: 178 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------------- 224
Query: 331 QNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
             LA+              ++D     D P     +   L   C   NPK RP   +IV+
Sbjct: 225 --LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 281
Query: 391 SLE 393
            L+
Sbjct: 282 LLK 284

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 27/297 (9%)
Query: 105 DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 98
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 159 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
               + +    + +PE +  G  T  SDV+SFGVVL EI T               LA+ 
Sbjct: 217 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQ 261
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                        +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 262 PYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGLA+   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLARVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 313 LEILT 317
            E+++
Sbjct: 241 WEVMS 245

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           G + V VA+K      + +  R++L E   +G   HPN+V L G     +  +++ EFM 
Sbjct: 68  GKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFME 127
Query: 200 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
            G+++  L        ++ L   +R     G A G+ +L  A+   ++RD    NIL+++
Sbjct: 128 NGALDAFLRKHDGQFTVIQLVGMLR-----GIAAGMRYL--ADMGYVHRDLAARNILVNS 180
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + APE I     T  SDV+S+G+V+
Sbjct: 181 NLVCKVSDFGLSRVIEDDPEAVYTTTGGKI--PVRWTAPEAIQYRKFTSASDVWSYGIVM 238
Query: 313 LEILT 317
            E+++
Sbjct: 239 WEVMS 243

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 97/187 (51%), Gaps = 20/187 (10%)
Query: 140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           G + +PVA+K      + +  R++L E   +G   HPN++ L G   + +  +++ E+M 
Sbjct: 47  GKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 106
Query: 200 RGSVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL 253
            GS++  L      F+ + L       + +  G + G+ +L  ++   ++RD    NIL+
Sbjct: 107 NGSLDTFLKKNDGQFTVIQL-------VGMLRGISAGMKYL--SDMGYVHRDLAARNILI 157
Query: 254 DTDYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +++   K+SDFGL++   D PE   +    +I     + APE I     T  SDV+S+G+
Sbjct: 158 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAFRKFTSASDVWSYGI 215
Query: 311 VLLEILT 317
           V+ E+++
Sbjct: 216 VMWEVVS 222

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 14/185 (7%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D S    +++  E   L +L H ++VK  G C E +  ++++E+M  G +
Sbjct: 44  ILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 102
Query: 204 ENNLFSK----VLLP-------LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 252
              L +     VL+        L  S  + IA   A G+ +L  A +  ++RD  T N L
Sbjct: 103 NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCL 160
Query: 253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +  +   K+ DFG+++D    D   V    M    +  PE IM    T  SDV+S GVVL
Sbjct: 161 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 220
Query: 313 LEILT 317
            EI T
Sbjct: 221 WEIFT 225

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           G + + VA+K      + +  R++L+E   +G   HPN++ L G   +    ++I EFM 
Sbjct: 58  GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 117
Query: 200 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
            GS+++ L        ++ L   +R     G A G+ +L  A+   ++RD    NIL+++
Sbjct: 118 NGSLDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL--ADMNYVHRDLAARNILVNS 170
Query: 256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   +       T  +G      + APE I     T  SDV+S+G+V+
Sbjct: 171 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 230
Query: 313 LEILT 317
            E+++
Sbjct: 231 WEVMS 235

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 31/306 (10%)
Query: 98  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 157
           P   F  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASL 61
Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 215
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 119
Query: 216 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 267
                 P +++  I   A  A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 327
           +D  E D      + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 178 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 227
Query: 328 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 387
                LA+              ++D     D P     +   L   C   NPK RP   +
Sbjct: 228 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 388 IVDSLE 393
           IV+ L+
Sbjct: 282 IVNLLK 287

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 205 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 250
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 123 EYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 180
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 311 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 370
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 241 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 284
Query: 371 AYHCLNHNPKARPLMRDIVDSLEPLQVL 398
              C +  P  RP  + +V+ L+ +  L
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 43  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 102
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 103 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 153
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 154 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 211
Query: 313 LEILT 317
            E+++
Sbjct: 212 WEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 60  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 119
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 120 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 170
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 171 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 228
Query: 313 LEILT 317
            E+++
Sbjct: 229 WEVMS 233

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGFVHRDLAARNILINS 182
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 313 LEILT 317
            E+++
Sbjct: 241 WEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 70  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 129
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 130 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 180
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 181 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 238
Query: 313 LEILT 317
            E+++
Sbjct: 239 WEVMS 243

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 110/241 (45%), Gaps = 31/241 (12%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW--- 217
           + ++ E+  L  ++HPN+VKL G C       L+ E+   GS+ N L      PLP+   
Sbjct: 47  KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAE--PLPYYTA 102
Query: 218 SIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK 275
           +  M      ++G+A+LH  + K +I+RD K  N+LL       K+ DFG A D     +
Sbjct: 103 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQ 158
Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK-SRPAREQNLA 334
           +H++    G+  + APE     + + + DV+S+G++L E++T RK  D+   PA      
Sbjct: 159 THMTNN-KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---I 214
Query: 335 DWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 394
            WA           N+  P                L   C + +P  RP M +IV  +  
Sbjct: 215 MWAVHNGTRPPLIKNLPKP-------------IESLMTRCWSKDPSQRPSMEEIVKIMTH 261
Query: 395 L 395
           L
Sbjct: 262 L 262

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 31/241 (12%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW--- 217
           + ++ E+  L  ++HPN+VKL G C       L+ E+   GS+ N L      PLP+   
Sbjct: 46  KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAE--PLPYYTA 101
Query: 218 SIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK 275
           +  M      ++G+A+LH  + K +I+RD K  N+LL       K+ DFG A D     +
Sbjct: 102 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQ 157
Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK-SRPAREQNLA 334
           +H+ T   G+  + APE     + + + DV+S+G++L E++T RK  D+   PA      
Sbjct: 158 THM-TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---I 213
Query: 335 DWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 394
            WA           N+  P                L   C + +P  RP M +IV  +  
Sbjct: 214 MWAVHNGTRPPLIKNLPKP-------------IESLMTRCWSKDPSQRPSMEEIVKIMTH 260
Query: 395 L 395
           L
Sbjct: 261 L 261

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 313 LEILT 317
            E+++
Sbjct: 241 WEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 313 LEILT 317
            E+++
Sbjct: 241 WEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 313 LEILT 317
            E+++
Sbjct: 241 WEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 313 LEILT 317
            E+++
Sbjct: 241 WEVMS 245

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 205 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 250
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 169
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 170 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 229
Query: 311 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 370
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 230 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 273
Query: 371 AYHCLNHNPKARPLMRDIVDSLEPLQVL 398
              C +  P  RP  + +V+ L+ +  L
Sbjct: 274 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 301

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 96/185 (51%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL +   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 313 LEILT 317
            E+++
Sbjct: 241 WEVMS 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 115
Query: 205 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 250
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 173
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 174 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 233
Query: 311 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 370
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 234 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 277
Query: 371 AYHCLNHNPKARPLMRDIVDSLEPLQVL 398
              C +  P  RP  + +V+ L+ +  L
Sbjct: 278 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 305

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 114
Query: 205 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 250
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 172
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 173 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 232
Query: 311 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 370
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 233 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 276
Query: 371 AYHCLNHNPKARPLMRDIVDSLEPLQVL 398
              C +  P  RP  + +V+ L+ +  L
Sbjct: 277 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 304

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 205 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 250
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 180
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 311 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 370
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 241 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 284
Query: 371 AYHCLNHNPKARPLMRDIVDSLEPLQVL 398
              C +  P  RP  + +V+ L+ +  L
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 205 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 250
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 180
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 311 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 370
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 241 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 284
Query: 371 AYHCLNHNPKARPLMRDIVDSLEPLQVL 398
              C +  P  RP  + +V+ L+ +  L
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 128/306 (41%), Gaps = 31/306 (10%)
Query: 98  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 157
           P   +  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 3   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASL 61
Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 215
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 119
Query: 216 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 267
                 P +++  I   A  A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 327
           +D  E D      + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 178 RDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 227
Query: 328 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 387
                LA+              ++D     D P     +   L   C   NP  RP   +
Sbjct: 228 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPNMRPTFLE 281
Query: 388 IVDSLE 393
           IV+ L+
Sbjct: 282 IVNLLK 287

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 96/185 (51%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENG 131
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGAVHRDLAARNILINS 182
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 313 LEILT 317
            E+++
Sbjct: 241 WEVMS 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 205 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 250
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 221
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 281
Query: 311 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 370
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 282 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 325
Query: 371 AYHCLNHNPKARPLMRDIVDSLEPLQVL 398
              C +  P  RP  + +V+ L+ +  L
Sbjct: 326 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 353

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           G + + VA+K      + +  R++L+E   +G   HPN++ L G   + +  ++I E+M 
Sbjct: 54  GKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYME 113
Query: 200 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
            GS++  L        ++ L   +R     G   G+ +L  ++   ++RD    NIL+++
Sbjct: 114 NGSLDAFLRKNDGRFTVIQLVGMLR-----GIGSGMKYL--SDMSAVHRDLAARNILVNS 166
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFG+++   D PE   +    +I     + APE I     T  SDV+S+G+V+
Sbjct: 167 NLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVM 224
Query: 313 LEILT 317
            E+++
Sbjct: 225 WEVMS 229

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 96/185 (51%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E M  G
Sbjct: 43  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENG 102
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 103 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 153
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 154 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 211
Query: 313 LEILT 317
            E+++
Sbjct: 212 WEVMS 216

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVE 204
           VAVK    D + Q    +LAE   +  L H NLV+L+G   E++  + ++ E+MA+GS+ 
Sbjct: 219 VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           + L S+    L     +K +    + + +L       ++RD    N+L+  D  AK+SDF
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDF 333
Query: 265 GLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
           GL K+         ST+  G     + APE +     + +SDV+SFG++L EI + GR
Sbjct: 334 GLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVE 204
           VAVK    D + Q    +LAE   +  L H NLV+L+G   E++  + ++ E+MA+GS+ 
Sbjct: 32  VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           + L S+    L     +K +    + + +L       ++RD    N+L+  D  AK+SDF
Sbjct: 89  DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDF 146
Query: 265 GLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
           GL K+         ST+  G     + APE +     + +SDV+SFG++L EI + GR
Sbjct: 147 GLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 90/175 (51%), Gaps = 15/175 (8%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVE 204
           VAVK    D + Q    +LAE   +  L H NLV+L+G   E++  + ++ E+MA+GS+ 
Sbjct: 47  VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           + L S+    L     +K +    + + +L       ++RD    N+L+  D  AK+SDF
Sbjct: 104 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDF 161
Query: 265 GLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           GL K+         ST+  G     + APE +     + +SDV+SFG++L EI +
Sbjct: 162 GLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           G + + VA+K      + +  R++L+E   +G   HPN++ L G   + +  ++I E+M 
Sbjct: 39  GKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYME 98
Query: 200 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
            GS++  L        ++ L   +R     G   G+ +L  ++   ++RD    NIL+++
Sbjct: 99  NGSLDAFLRKNDGRFTVIQLVGMLR-----GIGSGMKYL--SDMSYVHRDLAARNILVNS 151
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFG+++   D PE   +    +I     + APE I     T  SDV+S+G+V+
Sbjct: 152 NLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVM 209
Query: 313 LEILT 317
            E+++
Sbjct: 210 WEVMS 214

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 90/175 (51%), Gaps = 15/175 (8%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVE 204
           VAVK    D + Q    +LAE   +  L H NLV+L+G   E++  + ++ E+MA+GS+ 
Sbjct: 38  VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 94
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           + L S+    L     +K +    + + +L       ++RD    N+L+  D  AK+SDF
Sbjct: 95  DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDF 152
Query: 265 GLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           GL K+         ST+  G     + APE +     + +SDV+SFG++L EI +
Sbjct: 153 GLTKEAS-------STQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+  RG V   L  + L             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYIT 120
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 224
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 225 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           G + + VA+K      + +  R++L+E   +G   HPN++ L G   + +  ++I E+M 
Sbjct: 33  GKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYME 92
Query: 200 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
            GS++  L        ++ L   +R     G   G+ +L  ++   ++RD    NIL+++
Sbjct: 93  NGSLDAFLRKNDGRFTVIQLVGMLR-----GIGSGMKYL--SDMSYVHRDLAARNILVNS 145
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFG+++   D PE   +    +I     + APE I     T  SDV+S+G+V+
Sbjct: 146 NLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVM 203
Query: 313 LEILT 317
            E+++
Sbjct: 204 WEVMS 208

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 124/286 (43%), Gaps = 31/286 (10%)
Query: 118 RVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           R L       VY+G  + D+ +G     VAVK  +   S +   E+L E   +   +  +
Sbjct: 22  RELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 80
Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL--------PWSIRMKIAFGA-- 227
           +V+L+G   + +  +++ E MA G +++ L S  L P         P +++  I   A  
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ +D  E D      + +    
Sbjct: 139 ADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXX 347
           + APE +  G  T  SD++SFGVVL EI +               LA+            
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 241
Query: 348 XNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
             ++D     D P     +   L   C   NPK RP   +IV+ L+
Sbjct: 242 KFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 33/268 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 205 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 250
             L ++    L +                 +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 165
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 311 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 370
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 226 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 269
Query: 371 AYHCLNHNPKARPLMRDIVDSLEPLQVL 398
              C +  P  RP  + +V+ L+ +  L
Sbjct: 270 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 24/219 (10%)
Query: 108 RIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 167
           R++T +   DRV+       VY G   E + +    +  A+K        Q    +L E 
Sbjct: 20  RVVTHS---DRVIGKGHFGVVYHG---EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREG 73
Query: 168 IFLGHLSHPNLVKLIGYCCEDE---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
           + +  L+HPN++ LIG     E   H +L Y  M  G +   + S    P   +++  I+
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPY--MCHGDLLQFIRSPQRNP---TVKDLIS 128
Query: 225 FG--AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD----KSHV 278
           FG   A+G+ +L  AE+  ++RD    N +LD  +  K++DFGLA+D  + +    + H 
Sbjct: 129 FGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             R+     + A E + T   T +SDV+SFGV+L E+LT
Sbjct: 187 HARL--PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK    + S    +++  E   L  L H ++V+  G C E    ++++E+M  G +  
Sbjct: 51  VAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 109
Query: 206 NLFS-----KVLL--------PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 252
            L S     K+L         PL     + +A   A G+ +L  A    ++RD  T N L
Sbjct: 110 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCL 167
Query: 253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +      K+ DFG+++D    D   V  R M    +  PE I+    T  SDV+SFGVVL
Sbjct: 168 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 227
Query: 313 LEILT 317
            EI T
Sbjct: 228 WEIFT 232

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 87/188 (46%), Gaps = 21/188 (11%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK    D +    +++  E   L +L H ++VK  G C + +  ++++E+M  G +  
Sbjct: 48  VAVKALK-DPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-- 104
Query: 206 NLFSKVLLP----------------LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
           N F +   P                L  S  + IA   A G+ +L  A +  ++RD  T 
Sbjct: 105 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATR 162
Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           N L+  +   K+ DFG+++D    D   V    M    +  PE IM    T  SDV+SFG
Sbjct: 163 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 222
Query: 310 VVLLEILT 317
           V+L EI T
Sbjct: 223 VILWEIFT 230

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 96/185 (51%), Gaps = 20/185 (10%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENG 131
Query: 202 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 256 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 313 LEILT 317
            E+++
Sbjct: 241 WEVMS 245

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK    + S    +++  E   L  L H ++V+  G C E    ++++E+M  G +  
Sbjct: 45  VAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 103
Query: 206 NLFS-----KVLL--------PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 252
            L S     K+L         PL     + +A   A G+ +L  A    ++RD  T N L
Sbjct: 104 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCL 161
Query: 253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +      K+ DFG+++D    D   V  R M    +  PE I+    T  SDV+SFGVVL
Sbjct: 162 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 221
Query: 313 LEILT 317
            EI T
Sbjct: 222 WEIFT 226

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/182 (34%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV---LIYEFMARGS 202
           VAVK    D   Q    W  E+  L  L H +++K  G CCED       L+ E++  GS
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKG-CCEDAGAASLQLVMEYVPLGS 121
Query: 203 VENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD 256
           + + L       +++LL          A    +G+A+LH   +  I+RD    N+LLD D
Sbjct: 122 LRDYLPRHSIGLAQLLL---------FAQQICEGMAYLHA--QHYIHRDLAARNVLLDND 170
Query: 257 YNAKLSDFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
              K+ DFGLAK  PEG + + V         + APE +        SDV+SFGV L E+
Sbjct: 171 RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
Query: 316 LT 317
           LT
Sbjct: 231 LT 232

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 113/251 (45%), Gaps = 24/251 (9%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L++EFM  G + 
Sbjct: 34  VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 91  DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--SVIHRDLAARNCLVGENQVIKVSDF 147
Query: 265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 324
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 148 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 206
Query: 325 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 384
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 207 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPEDRPA 250
Query: 385 MRDIVDSLEPL 395
              ++  L  +
Sbjct: 251 FSRLLRQLAAI 261

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 93/185 (50%), Gaps = 14/185 (7%)
Query: 140 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           G + + VA+K      + +  R++L+E   +G   HPN++ L G   +    ++I EFM 
Sbjct: 32  GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 91
Query: 200 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
            GS+++ L        ++ L   +R     G A G+ +L  A+   ++R     NIL+++
Sbjct: 92  NGSLDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL--ADMNYVHRALAARNILVNS 144
Query: 256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +   K+SDFGL++   +       T  +G      + APE I     T  SDV+S+G+V+
Sbjct: 145 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 204
Query: 313 LEILT 317
            E+++
Sbjct: 205 WEVMS 209

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 24/248 (9%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L++EFM  G + 
Sbjct: 32  VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 89  DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDF 145
Query: 265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 324
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 146 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204
Query: 325 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 384
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 205 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPEDRPA 248
Query: 385 MRDIVDSL 392
              ++  L
Sbjct: 249 FSRLLRQL 256

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 31/306 (10%)
Query: 98  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 157
           P   F  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASL 61
Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 215
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 119
Query: 216 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 267
                 P +++  I   A  A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 327
           +D  E        + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 178 RDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 227
Query: 328 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 387
                LA+              ++D     D P     +   L   C   NPK RP   +
Sbjct: 228 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 388 IVDSLE 393
           IV+ L+
Sbjct: 282 IVNLLK 287

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 94/184 (51%), Gaps = 29/184 (15%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK +  G  S Q    +L E   +  L H  LV+L     ++E   +I EFMA+GS+ 
Sbjct: 39  VAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLL 95
Query: 205 NNLFS----KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 260
           + L S    KVLLP       +IA    +G+A++    K  I+RD + +N+L+      K
Sbjct: 96  DFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIER--KNYIHRDLRAANVLVSESLMCK 149
Query: 261 LSDFGLAK-------DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
           ++DFGLA+          EG K  +         + APE I  G  T +S+V+SFG++L 
Sbjct: 150 IADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAINFGCFTIKSNVWSFGILLY 201
Query: 314 EILT 317
           EI+T
Sbjct: 202 EIVT 205

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 19/156 (12%)
Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           ++F+G+ + P L  +  +C   E   L +   A    E     K L+         IA  
Sbjct: 83  LLFMGYSTKPQLAIVTQWC---EGSSLYHHLHAS---ETKFEMKKLI--------DIARQ 128
Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
            A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   ++ G+ 
Sbjct: 129 TARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 287 GYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
            + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 93/184 (50%), Gaps = 29/184 (15%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK +  G  S Q    +L E   +  L H  LV+L      +E   +I E+MA+GS+ 
Sbjct: 40  VAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLL 96
Query: 205 NNLFS----KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 260
           + L S    KVLLP       +IA    +G+A++    K  I+RD + +N+L+      K
Sbjct: 97  DFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIER--KNYIHRDLRAANVLVSESLMCK 150
Query: 261 LSDFGLAK-------DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
           ++DFGLA+          EG K  +         + APE I  G  T +SDV+SFG++L 
Sbjct: 151 IADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAINFGCFTIKSDVWSFGILLY 202
Query: 314 EILT 317
           EI+T
Sbjct: 203 EIVT 206

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 24/248 (9%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L++EFM  G + 
Sbjct: 37  VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 94  DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDF 150
Query: 265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 324
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 151 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 209
Query: 325 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 384
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 210 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWRERPEDRPA 253
Query: 385 MRDIVDSL 392
              ++  L
Sbjct: 254 FSRLLRQL 261

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 62  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 120
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 121 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 178
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 179 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 24/248 (9%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L++EFM  G + 
Sbjct: 34  VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 91  DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDF 147
Query: 265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 324
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 148 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 206
Query: 325 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 384
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 207 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPEDRPA 250
Query: 385 MRDIVDSL 392
              ++  L
Sbjct: 251 FSRLLRQL 258

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK    + S    +++  E   L  L H ++V+  G C E    ++++E+M  G +  
Sbjct: 74  VAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 132
Query: 206 NLFS-----KVLL--------PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 252
            L S     K+L         PL     + +A   A G+ +L  A    ++RD  T N L
Sbjct: 133 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCL 190
Query: 253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           +      K+ DFG+++D    D   V  R M    +  PE I+    T  SDV+SFGVVL
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
Query: 313 LEILT 317
            EI T
Sbjct: 251 WEIFT 255

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 33/268 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 205 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 250
             L ++    L +                 +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 180
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 311 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 370
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 241 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 284
Query: 371 AYHCLNHNPKARPLMRDIVDSLEPLQVL 398
              C +  P  RP  + +V+ L+ +  L
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 19/156 (12%)
Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           ++F+G+ + P L  +  +C   E   L +   A    E     K L+         IA  
Sbjct: 83  LLFMGYSTAPQLAIVTQWC---EGSSLYHHLHAS---ETKFEMKKLI--------DIARQ 128
Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
            A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   ++ G+ 
Sbjct: 129 TARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 287 GYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
            + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 64  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 122
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 123 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 180
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 181 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 62  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 120
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 121 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 178
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 179 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 119/239 (49%), Gaps = 23/239 (9%)
Query: 85  EEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKG-FISEDLREGLQP 143
           E +E L     AN ++A  + E        R+ +VL       V+KG +I E   E ++ 
Sbjct: 9   ESIEPLDPSEKANKVLARIFKE-----TELRKLKVLGSGVFGTVHKGVWIPEG--ESIK- 60
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           +PV +KV +  +  Q  +     ++ +G L H ++V+L+G C     + L+ +++  GS+
Sbjct: 61  IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSL 119
Query: 204 ENNL--FSKVLLP---LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN 258
            +++      L P   L W +++      AKG+ +L E    +++R+    N+LL +   
Sbjct: 120 LDHVRQHRGALGPQLLLNWGVQI------AKGMYYLEE--HGMVHRNLAARNVLLKSPSQ 171
Query: 259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            +++DFG+A   P  DK  + +       + A E I  G  T +SDV+S+GV + E++T
Sbjct: 172 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 61  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 119
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 120 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 177
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 178 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 8/188 (4%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           + + VA+KV           E + E   +  L +P +V+LIG  C+ E  +L+ E    G
Sbjct: 36  KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGG 94
Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
            +   L  K    +P S   ++    + G+ +L E  K  ++RD    N+LL   + AK+
Sbjct: 95  PLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKI 151
Query: 262 SDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-G 318
           SDFGL+K     D S+ + R  G +   + APE I     + RSDV+S+GV + E L+ G
Sbjct: 152 SDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 210
Query: 319 RKSLDKSR 326
           +K   K +
Sbjct: 211 QKPYKKMK 218

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 119/258 (46%), Gaps = 36/258 (13%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK + +G  S     E+  E   +  LSHP LVK  G C ++    ++ E+++ G + 
Sbjct: 35  VAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91
Query: 205 NNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS 262
           N L S  K L P   S  +++ +   +G+AFL   +   I+RD    N L+D D   K+S
Sbjct: 92  NYLRSHGKGLEP---SQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVS 146
Query: 263 DFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-G 318
           DFG+ +     D  +VS+  +GT     ++APE       + +SDV++FG+++ E+ + G
Sbjct: 147 DFGMTRYVL--DDQYVSS--VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202
Query: 319 RKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHN 378
           +   D    +                     +  P L  D           + Y C +  
Sbjct: 203 KMPYDLYTNSE----------VVLKVSQGHRLYRPHLASD-------TIYQIMYSCWHEL 245
Query: 379 PKARPLMRDIVDSLEPLQ 396
           P+ RP  + ++ S+EPL+
Sbjct: 246 PEKRPTFQQLLSSIEPLR 263

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 65  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 123
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 124 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 181
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 182 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 66  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 124
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 125 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 182
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 183 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 115 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKF 172
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 173 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 84/158 (53%), Gaps = 15/158 (9%)
Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           +LAE   +  L H  LVKL     + E   +I EFMA+GS+ + L S      P    + 
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 282
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
            +   A+G+AF+ +  +  I+RD + +NIL+      K++DFGLA+ G +          
Sbjct: 283 FSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVGAKF--------- 331
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
                + APE I  G  T +SDV+SFG++L+EI+T GR
Sbjct: 332 --PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 115 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 172
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 173 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR---VLIYEFMARGS 202
           VAVK    D   Q    W  E+  L  L H +++K  G CCED+      L+ E++  GS
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKG-CCEDQGEKSLQLVMEYVPLGS 104
Query: 203 VENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD 256
           + + L       +++LL          A    +G+A+LH      I+R+    N+LLD D
Sbjct: 105 LRDYLPRHSIGLAQLLL---------FAQQICEGMAYLHSQH--YIHRNLAARNVLLDND 153
Query: 257 YNAKLSDFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
              K+ DFGLAK  PEG + + V         + APE +        SDV+SFGV L E+
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213
Query: 316 LT 317
           LT
Sbjct: 214 LT 215

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 57  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 115
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 116 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 173
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 174 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 58  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 116
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 117 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 174
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 175 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 115 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 172
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 173 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 88/182 (48%), Gaps = 22/182 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR---VLIYEFMARGS 202
           VAVK    D   Q    W  E+  L  L H +++K  G CCED+      L+ E++  GS
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKG-CCEDQGEKSLQLVMEYVPLGS 104
Query: 203 VENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD 256
           + + L       +++LL          A    +G+A+LH   +  I+R+    N+LLD D
Sbjct: 105 LRDYLPRHSIGLAQLLL---------FAQQICEGMAYLHA--QHYIHRNLAARNVLLDND 153
Query: 257 YNAKLSDFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
              K+ DFGLAK  PEG + + V         + APE +        SDV+SFGV L E+
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213
Query: 316 LT 317
           LT
Sbjct: 214 LT 215

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 141
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 142 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 195
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 245
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 246 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 115 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 173 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 87/165 (52%), Gaps = 19/165 (11%)
Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           +LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + 
Sbjct: 50  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 108
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 275
           +A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K
Sbjct: 109 MAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
             +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 167 FPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 20/231 (8%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           +++ E   +  LSHP LV+L G C E     L++EFM  G + + L ++  L    ++ +
Sbjct: 68  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-L 126
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
            +     +G+A+L EA   VI+RD    N L+  +   K+SDFG+ +   + D+   ST 
Sbjct: 127 GMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTG 183
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXX 341
                 +A+PE       + +SDV+SFGV++ E+ +  K   ++R   E           
Sbjct: 184 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VV 234
Query: 342 XXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 392
                   +  PRL   +  +       +  HC    P+ RP    ++  L
Sbjct: 235 EDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPEDRPAFSRLLRQL 278

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 87/183 (47%), Gaps = 11/183 (6%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS 202
           + VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 203 VENNLFSKVLLPL------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLD 254
           + N L  K    L      P  +R  + F +  A+G+AFL  A K  I+RD    N+LL 
Sbjct: 137 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLT 194
Query: 255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 314
             + AK+ DFGLA+D        V         + APE I     T +SDV+S+G++L E
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 315 ILT 317
           I +
Sbjct: 255 IFS 257

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 121/252 (48%), Gaps = 34/252 (13%)
Query: 82  SNPEEVED----LRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDL 137
           S+PEE++D    L+RD   N LIA    ++ +   NF   R         VY+      +
Sbjct: 320 SDPEELKDKKLFLKRD---NLLIA----DIELGCGNFGSVR-------QGVYR------M 359
Query: 138 REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           R+  + + VA+KV           E + E   +  L +P +V+LIG  C+ E  +L+ E 
Sbjct: 360 RK--KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEM 416
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
              G +   L  K    +P S   ++    + G+ +L E  K  ++R+    N+LL   +
Sbjct: 417 AGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRH 473
Query: 258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
            AK+SDFGL+K     D S+ + R  G +   + APE I     + RSDV+S+GV + E 
Sbjct: 474 YAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 532
Query: 316 LT-GRKSLDKSR 326
           L+ G+K   K +
Sbjct: 533 LSYGQKPYKKMK 544

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 87/183 (47%), Gaps = 11/183 (6%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS 202
           + VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G 
Sbjct: 69  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 203 VENNLFSKVLLPL------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLD 254
           + N L  K    L      P  +R  + F +  A+G+AFL  A K  I+RD    N+LL 
Sbjct: 129 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLT 186
Query: 255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 314
             + AK+ DFGLA+D        V         + APE I     T +SDV+S+G++L E
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 315 ILT 317
           I +
Sbjct: 247 IFS 249

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 85/164 (51%), Gaps = 19/164 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           LAE   +  L H  LVKL     + E   +I EFMA+GS+ + L S      P    +  
Sbjct: 58  LAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 116
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 276
           +   A+G+AF+ +  +  I+RD + +NIL+      K++DFGLA+          EG K 
Sbjct: 117 SAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 174
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
            +         + APE I  G  T +SDV+SFG++L+EI+T GR
Sbjct: 175 PIK--------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 116/275 (42%), Gaps = 42/275 (15%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+   + S    R+ L+E   L  ++HP+++KL G C +D   +LI E+   GS+  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 206 NLF-SKVLLP---------------------LPWSIRMKIAFGAAKGLAFLHEAEKPVIY 243
            L  S+ + P                     L     +  A+  ++G+ +L  AE  +++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMSLVH 173
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 303
           RD    NIL+      K+SDFGL++D  E D     ++      + A E +     T +S
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 304 DVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVK 362
           DV+SFGV+L EI+T G        P R  NL                    R+E   P  
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK---------------TGHRME--RPDN 276
Query: 363 GVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV 397
              +   L   C    P  RP+  DI   LE + V
Sbjct: 277 CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 132
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 133 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 186
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 236
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 237 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 273

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 116/275 (42%), Gaps = 42/275 (15%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+   + S    R+ L+E   L  ++HP+++KL G C +D   +LI E+   GS+  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 206 NLF-SKVLLP---------------------LPWSIRMKIAFGAAKGLAFLHEAEKPVIY 243
            L  S+ + P                     L     +  A+  ++G+ +L  AE  +++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVH 173
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 303
           RD    NIL+      K+SDFGL++D  E D     ++      + A E +     T +S
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 304 DVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVK 362
           DV+SFGV+L EI+T G        P R  NL                    R+E   P  
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK---------------TGHRME--RPDN 276
Query: 363 GVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV 397
              +   L   C    P  RP+  DI   LE + V
Sbjct: 277 CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+  RG V   L  + L             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYIT 120
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGT 174
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 224
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 225 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 86/165 (52%), Gaps = 19/165 (11%)
Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           +LAE   +  L H  LVKL     + E   +I EFMA+GS+ + L S      P    + 
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 275
            +   A+G+AF+ +  +  I+RD + +NIL+      K++DFGLA+          EG K
Sbjct: 289 FSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 346
Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
             +         + APE I  G  T +SDV+SFG++L+EI+T GR
Sbjct: 347 FPIK--------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGT 169
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 74  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 131
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   ++ G+
Sbjct: 132 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 286 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 116/275 (42%), Gaps = 42/275 (15%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+   + S    R+ L+E   L  ++HP+++KL G C +D   +LI E+   GS+  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 206 NLF-SKVLLP---------------------LPWSIRMKIAFGAAKGLAFLHEAEKPVIY 243
            L  S+ + P                     L     +  A+  ++G+ +L  AE  +++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVH 173
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 303
           RD    NIL+      K+SDFGL++D  E D     ++      + A E +     T +S
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 304 DVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVK 362
           DV+SFGV+L EI+T G        P R  NL                    R+E   P  
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK---------------TGHRME--RPDN 276
Query: 363 GVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV 397
              +   L   C    P  RP+  DI   LE + V
Sbjct: 277 CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 84/163 (51%), Gaps = 19/163 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSI 219
           EV  L    H N++  +GY  + +   ++ ++    S+ ++L      F  + L      
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL------ 106
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
            + IA   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH  
Sbjct: 107 -IDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 163
Query: 280 TRIMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
            ++ G+  + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 172
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 169
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 139
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   ++ G+
Sbjct: 140 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 286 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 120
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 224
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 225 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           ++F+G+ + P L  +  +C   E   L +   A    E     K L+         IA  
Sbjct: 71  LLFMGYSTKPQLAIVTQWC---EGSSLYHHLHAS---ETKFEMKKLI--------DIARQ 116
Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
            A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ G+ 
Sbjct: 117 TARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 287 GYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
            + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 111/248 (44%), Gaps = 24/248 (9%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L+ EFM  G + 
Sbjct: 35  VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 92  DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDF 148
Query: 265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 324
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 149 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 207
Query: 325 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 384
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 208 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWRERPEDRPA 251
Query: 385 MRDIVDSL 392
              ++  L
Sbjct: 252 FSRLLRQL 259

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 31/306 (10%)
Query: 98  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 157
           P   +  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 3   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASL 61
Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 215
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 119
Query: 216 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 267
                 P +++  I   A  A G+A+L+   K  ++R+    N ++  D+  K+ DFG+ 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMT 177
Query: 268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 327
           +D  E D      + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 178 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 227
Query: 328 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 387
                LA+              ++D     D P     +   L   C   NP  RP   +
Sbjct: 228 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPNMRPTFLE 281
Query: 388 IVDSLE 393
           IV+ L+
Sbjct: 282 IVNLLK 287

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 116
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   ++ +S    GT
Sbjct: 117 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GT 170
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 220
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 221 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 53  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 112
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 113 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 170
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 171 TARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 230
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 231 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 274
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 275 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 306

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-- 203
           VAVK+   + S     ++  E   +    +PN+VKL+G C   +   L++E+MA G +  
Sbjct: 80  VAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
Query: 204 --------------ENNLFSKVLL------PLPWSIRMKIAFGAAKGLAFLHEAEKPVIY 243
                          ++L ++  +      PL  + ++ IA   A G+A+L  +E+  ++
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVH 197
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 303
           RD  T N L+  +   K++DFGL+++    D             +  PE I     T  S
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES 257
Query: 304 DVYSFGVVLLEILT 317
           DV+++GVVL EI +
Sbjct: 258 DVWAYGVVLWEIFS 271

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 31/306 (10%)
Query: 98  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 157
           P   +  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 4   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASL 62
Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 215
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 63  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 120
Query: 216 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 267
                 P +++  I   A  A G+A+L+   K  ++R+    N ++  D+  K+ DFG+ 
Sbjct: 121 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMT 178
Query: 268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 327
           +D  E D      + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 179 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 228
Query: 328 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 387
                LA+              ++D     D P     +   L   C   NP  RP   +
Sbjct: 229 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPNMRPTFLE 282
Query: 388 IVDSLE 393
           IV+ L+
Sbjct: 283 IVNLLK 288

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 122
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 58  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 117
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 118 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 175
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 176 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 235
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 236 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 279
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 280 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 311

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 116
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 117 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGT 170
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 220
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 221 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 122
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGT 169
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 55  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 114
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 115 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 172
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 173 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 232
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 233 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 276
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 277 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 308

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 13  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 69
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 126
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 127 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 178
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 179 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 231

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 16  LRILKETEFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 72
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 129
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 130 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 234

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 10  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 66
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 123
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 124 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 175
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 176 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 228

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 19  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 75
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 76  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 132
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 133 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 184
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 185 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 237

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 10  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 66
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLN--W 123
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 124 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 175
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 176 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 228

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 120
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGT 174
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 224
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 225 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 16  LRILKETEFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 72
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 129
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 130 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 234

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 124
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 125 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 176
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 229

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 114
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 115 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 168
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 218
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 219 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 255

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGT 169
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 68
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 125
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 126 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 230

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 112 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 171
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 229
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 289
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 290 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 333
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 334 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 122
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 15  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 71
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 72  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 128
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 129 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 180
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 181 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 233

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 19/165 (11%)
Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           +LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + 
Sbjct: 51  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 109
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 275
           +A   A+G+AF+ E  +  I+R+ + +NIL+    + K++DFGLA+          EG K
Sbjct: 110 MAAQIAEGMAFIEE--RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
             +         + APE I  G  T +SDV+SFG++L EI+T GR
Sbjct: 168 FPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLN--W 122
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASK 125
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 124
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 125 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 176
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 229

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 172
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 122
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 68
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 125
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 126 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 230

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 120
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 224
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP +R++++
Sbjct: 225 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 34  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 90
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 91  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 147
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 148 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 199
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 200 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 252

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +  L+H N+V+ IG   +
Sbjct: 47  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQ 105
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 106 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 163
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 164 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 223
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 224 TSKTDTWSFGVLLWEIFS 241

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 119
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 120 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 173
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 223
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 224 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 260

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 68
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 125
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 126 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 230

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGT 169
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 112
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 113 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 166
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 167 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 216
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 217 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 253

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 16  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 72
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 129
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 130 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 234

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 68
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 125
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 126 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 230

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 141
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 142 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGT 195
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 245
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 246 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 3   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 59
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 116
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 117 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 221

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDS-XQEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +  L+H N+V+ IG   +
Sbjct: 61  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQ 119
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 120 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 177
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 178 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 237
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 238 TSKTDTWSFGVLLWEIFS 255

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 201 GSVENNLFSKV-----------LLP---LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++             +P   + +   +   +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASK 125
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 10/151 (6%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
           L  ++HP +VKL  Y  + E ++ LI +F+  G +   L  +V+          + F  A
Sbjct: 80  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-----TEEDVKFYLA 133
Query: 229 K-GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           +  LA  H     +IYRD K  NILLD + + KL+DFGL+K+  + +K   S    GT  
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           Y APE +     T  +D +SFGV++ E+LTG
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 117
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K+++FG +   P   +    T + GT
Sbjct: 118 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGT 171
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 221
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 222 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 383 PLMRDI 388
             + DI
Sbjct: 254 ITIPDI 259

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 7/157 (4%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 81  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 138
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ G+
Sbjct: 139 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 286 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSI 219
           EV  L    H N++  +GY  + +   ++ ++    S+ ++L      F  + L      
Sbjct: 56  EVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL------ 108
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
            + IA   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH  
Sbjct: 109 -IDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 165
Query: 280 TRIMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
            ++ G+  + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 166 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 7/157 (4%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 139
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ G+
Sbjct: 140 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 286 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSI 219
           EV  L    H N++  +GY  + +   ++ ++    S+ ++L      F  + L      
Sbjct: 59  EVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL------ 111
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
            + IA   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH  
Sbjct: 112 -IDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 280 TRIMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
            ++ G+  + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSI 219
           EV  L    H N++  +GY  + +   ++ ++    S+ ++L      F  + L      
Sbjct: 59  EVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL------ 111
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
            + IA   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH  
Sbjct: 112 -IDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 280 TRIMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
            ++ G+  + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 84/160 (52%), Gaps = 16/160 (10%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSI 219
           R+ L EV      +HP +VKL  Y  + E ++ LI +F+  G +   L  +V+       
Sbjct: 78  RDILVEV------NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT----- 125
Query: 220 RMKIAFGAAK-GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
              + F  A+  LA  H     +IYRD K  NILLD + + KL+DFGL+K+  + +K   
Sbjct: 126 EEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 185
Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           S    GT  Y APE +     T  +D +SFGV++ E+LTG
Sbjct: 186 S--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   +++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 84/160 (52%), Gaps = 16/160 (10%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSI 219
           R+ L EV      +HP +VKL  Y  + E ++ LI +F+  G +   L  +V+       
Sbjct: 77  RDILVEV------NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT----- 124
Query: 220 RMKIAFGAAK-GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
              + F  A+  LA  H     +IYRD K  NILLD + + KL+DFGL+K+  + +K   
Sbjct: 125 EEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184
Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           S    GT  Y APE +     T  +D +SFGV++ E+LTG
Sbjct: 185 S--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 33  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 92
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 93  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 148
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 207
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 208 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 251
Query: 383 PLMRDI 388
             + DI
Sbjct: 252 ITIPDI 257

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSI 219
           EV  L    H N++  +GY  + +   ++ ++    S+ ++L      F  + L      
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL------ 106
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
            + IA   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH  
Sbjct: 107 -IDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 280 TRIMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
            ++ G+  + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 204 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 177
Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 310 VVLLEILT 317
           V+L EI +
Sbjct: 238 VLLWEIFS 245

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 117
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 118 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 171
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 221
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 222 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 383 PLMRDI 388
             + DI
Sbjct: 254 ITIPDI 259

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/102 (39%), Positives = 59/102 (57%), Gaps = 5/102 (4%)
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           + IA   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   
Sbjct: 107 IDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 281 RIMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 319
           ++ G+  + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 46  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 162
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 163 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 222
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 223 TSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 46  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 105 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 162
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 163 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 222
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 223 TSKTDTWSFGVLLWEIFS 240

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 89/187 (47%), Gaps = 15/187 (8%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS 202
           + VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 203 VENNLF--SKVLLPLP--------WSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSN 250
           + N L   S+VL   P         S R  + F +  A+G+AFL  A K  I+RD    N
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARN 194
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +LL   + AK+ DFGLA+D        V         + APE I     T +SDV+S+G+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 311 VLLEILT 317
           +L EI +
Sbjct: 255 LLWEIFS 261

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 383 PLMRDI 388
             + DI
Sbjct: 254 ITIPDI 259

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 73  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 131
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 132 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 189
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 190 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 249
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 250 TSKTDTWSFGVLLWEIFS 267

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 63  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 121
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 122 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 179
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 180 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 239
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 240 TSKTDTWSFGVLLWEIFS 257

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K+++FG +   P   +    T + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGT 172
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 383 PLMRDI 388
             + DI
Sbjct: 254 ITIPDI 259

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   ++     + GT
Sbjct: 116 ELANALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA----ALCGT 169
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G+       P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK-------PPFEANTYQDTYKRIS--- 219
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 47  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 105
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 106 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 163
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 164 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 223
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 224 TSKTDTWSFGVLLWEIFS 241

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 116
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 117 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----TLCGT 170
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 220
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 221 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   ++     + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA----ALCGT 172
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 204 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 168
Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 169 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 310 VVLLEILT 317
           V+L EI +
Sbjct: 229 VLLWEIFS 236

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFG 150
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 383 PLMRDI 388
             + DI
Sbjct: 254 ITIPDI 259

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFG 150
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 383 PLMRDI 388
             + DI
Sbjct: 254 ITIPDI 259

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFG 150
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 383 PLMRDI 388
             + DI
Sbjct: 254 ITIPDI 259

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFG 150
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 383 PLMRDI 388
             + DI
Sbjct: 254 ITIPDI 259

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 323
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 324 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 382
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 383 PLMRDI 388
             + DI
Sbjct: 253 ITIPDI 258

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   ++     + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA----ALCGT 169
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 6   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 62
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 63  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 119
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      A+G+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 120 CVQI------AEGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 171
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 172 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 224

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 204 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 168
Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 169 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 310 VVLLEILT 317
           V+L EI +
Sbjct: 229 VLLWEIFS 236

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 117/239 (48%), Gaps = 35/239 (14%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           LRI+     R+ +VL       VYKG    D  E ++ +PVA+KV   + S + ++E L 
Sbjct: 11  LRILKETELRKVKVLGSGAFGTVYKGIWIPD-GENVK-IPVAIKVLRENTSPKANKEILD 68
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPWS 218
           E   +  +  P + +L+G C     + L+ + M  G +          L S+ LL   W 
Sbjct: 69  EAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLN--WC 125
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----DGPE-- 272
           +++      AKG+++L +    +++RD    N+L+ +  + K++DFGLA+    D  E  
Sbjct: 126 MQI------AKGMSYLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 177
Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            D   V  + M      A E I+    T +SDV+S+GV + E++T G K  D   PARE
Sbjct: 178 ADGGKVPIKWM------ALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE 229

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 89/187 (47%), Gaps = 15/187 (8%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS 202
           + VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 203 VENNLF--SKVLLPLPW--------SIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSN 250
           + N L   S+VL   P         S R  + F +  A+G+AFL  A K  I+RD    N
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARN 194
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +LL   + AK+ DFGLA+D        V         + APE I     T +SDV+S+G+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 311 VLLEILT 317
           +L EI +
Sbjct: 255 LLWEIFS 261

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 53  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 111
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 112 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 169
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 170 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 229
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 230 TSKTDTWSFGVLLWEIFS 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 38  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 96
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 97  SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 154
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 155 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 214
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 215 TSKTDTWSFGVLLWEIFS 232

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 47  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 105
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 106 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 163
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 164 HRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 223
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 224 TSKTDTWSFGVLLWEIFS 241

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 61  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 119
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 120 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 177
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 178 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 237
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 238 TSKTDTWSFGVLLWEIFS 255

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 204 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 177
Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 310 VVLLEILT 317
           V+L EI +
Sbjct: 238 VLLWEIFS 245

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 64  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 122
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 123 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 180
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 181 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF 240
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 241 TSKTDTWSFGVLLWEIFS 258

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 172
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 80/157 (50%), Gaps = 10/157 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           E+  L +L H N+VK  G C ED      LI EF+  GS++  L  K    +    ++K 
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKY 131
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST--- 280
           A    KG+ +L    +  ++RD    N+L+++++  K+ DFGL K   E DK   +    
Sbjct: 132 AVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDD 188
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           R    + Y APE +M       SDV+SFGV L E+LT
Sbjct: 189 RDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 87  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 203
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 204 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF 263
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 264 TSKTDTWSFGVLLWEIFS 281

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 84/150 (56%), Gaps = 8/150 (5%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
           L  ++HP +VKL  Y  + E ++ LI +F+  G +   L SK ++     ++  +A   A
Sbjct: 84  LADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELA 140
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
            GL  LH     +IYRD K  NILLD + + KL+DFGL+K+  + +K   S    GT  Y
Sbjct: 141 LGLDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEY 196
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            APE +     +  +D +S+GV++ E+LTG
Sbjct: 197 MAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 88/187 (47%), Gaps = 17/187 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 204 ENNLFSKVLLPLPWSIRMKI-------------AFGAAKGLAFLHEAEKPVIYRDFKTSN 250
              L SK    +P+     +             +F  AKG+ FL  A +  I+RD    N
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARN 178
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           ILL      K+ DFGLA+D  +               + APE I     T +SDV+SFGV
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 311 VLLEILT 317
           +L EI +
Sbjct: 239 LLWEIFS 245

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 80/157 (50%), Gaps = 10/157 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           E+  L +L H N+VK  G C ED      LI EF+  GS++  L  K    +    ++K 
Sbjct: 61  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKY 119
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST--- 280
           A    KG+ +L    +  ++RD    N+L+++++  K+ DFGL K   E DK   +    
Sbjct: 120 AVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDD 176
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           R    + Y APE +M       SDV+SFGV L E+LT
Sbjct: 177 RDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 61  VYEGQVS-GMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 119
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 242
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 120 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 177
Query: 243 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 178 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 237
Query: 300 TPRSDVYSFGVVLLEILT 317
           T ++D +SFGV+L EI +
Sbjct: 238 TSKTDTWSFGVLLWEIFS 255

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 15/156 (9%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E + L  ++HP ++++ G   + +   +I +++  G + + L      P P +      F
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-----KF 110
Query: 226 GAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
            AA+    L +LH   K +IYRD K  NILLD + + K++DFG AK  P+     V+  +
Sbjct: 111 YAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXL 163
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            GT  Y APE + T       D +SFG+++ E+L G
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 88/186 (47%), Gaps = 16/186 (8%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 204 ENNLFSKVLLPLPWSIR------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 251
              L SK    +P+               +  +F  AKG+ FL  A +  I+RD    NI
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNI 179
Query: 252 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV 311
           LL      K+ DFGLA+D  +               + APE I     T +SDV+SFGV+
Sbjct: 180 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 312 LLEILT 317
           L EI +
Sbjct: 240 LWEIFS 245

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 13  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 69
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 126
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 127 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 178
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 179 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 231

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 86/182 (47%), Gaps = 22/182 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR---VLIYEFMARGS 202
           VAVK        Q    W  E+  L  L H ++VK  G CCED+      L+ E++  GS
Sbjct: 41  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKG-CCEDQGEKSVQLVMEYVPLGS 99
Query: 203 VENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD 256
           + + L       +++LL          A    +G+A+LH   +  I+R     N+LLD D
Sbjct: 100 LRDYLPRHCVGLAQLLL---------FAQQICEGMAYLHA--QHYIHRALAARNVLLDND 148
Query: 257 YNAKLSDFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
              K+ DFGLAK  PEG + + V         + APE +        SDV+SFGV L E+
Sbjct: 149 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208
Query: 316 LT 317
           LT
Sbjct: 209 LT 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 169
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 117/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I  + ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASK 125
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 124
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 125 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 176
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 229

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 112
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  +
Sbjct: 113 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEV 168
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 169 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 204 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 177
Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 310 VVLLEILT 317
           V+L EI +
Sbjct: 238 VLLWEIFS 245

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGT 172
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 345
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 346 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 115/227 (50%), Gaps = 24/227 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+       S + ++E L
Sbjct: 43  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIMELREATSPKANKEIL 99
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 156
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 157 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 208
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLD 323
            +        + A E I+    T +SDV+S+GV + E++T G K  D
Sbjct: 209 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 88/184 (47%), Gaps = 14/184 (7%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 204 ENNLFSKVLLPLPWSIRMK----------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILL 253
              L SK    +P+    K           +F  AKG+ FL  A +  I+RD    NILL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKXIHRDLAARNILL 177
Query: 254 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
                 K+ DFGLA+D  +               + APE I     T +SDV+SFGV+L 
Sbjct: 178 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 314 EILT 317
           EI +
Sbjct: 238 EIFS 241

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 124
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 125 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 176
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 229

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 86/182 (47%), Gaps = 22/182 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR---VLIYEFMARGS 202
           VAVK        Q    W  E+  L  L H ++VK  G CCED+      L+ E++  GS
Sbjct: 40  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKG-CCEDQGEKSVQLVMEYVPLGS 98
Query: 203 VENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD 256
           + + L       +++LL          A    +G+A+LH   +  I+R     N+LLD D
Sbjct: 99  LRDYLPRHCVGLAQLLL---------FAQQICEGMAYLHA--QHYIHRALAARNVLLDND 147
Query: 257 YNAKLSDFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
              K+ DFGLAK  PEG + + V         + APE +        SDV+SFGV L E+
Sbjct: 148 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207
Query: 316 LT 317
           LT
Sbjct: 208 LT 209

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 171
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 122
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 174
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 172
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 171
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 172
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---G 230
            HP L  +       E+   + E++  G +  ++ S     L      +  F AA+   G
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILG 131
Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L FLH   K ++YRD K  NILLD D + K++DFG+ K+   GD    +    GT  Y A
Sbjct: 132 LQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYIA 187
Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           PE ++        D +SFGV+L E+L G+
Sbjct: 188 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 11  NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 124 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 179
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 88/184 (47%), Gaps = 14/184 (7%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 204 ENNLFSKVLLPLPWSIRMK----------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILL 253
              L SK    +P+    K           +F  AKG+ FL  A +  I+RD    NILL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNILL 177
Query: 254 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
                 K+ DFGLA+D  +               + APE I     T +SDV+SFGV+L 
Sbjct: 178 SEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 314 EILT 317
           EI +
Sbjct: 238 EIFS 241

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 11  NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 124 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 179
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 124
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 125 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 176
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 229

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 108
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  +
Sbjct: 109 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEV 164
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 107
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  +
Sbjct: 108 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEV 163
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 117/272 (43%), Gaps = 33/272 (12%)
Query: 142 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 200
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I  + ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASK 125
Query: 201 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 246
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 307 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 366
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 367 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 398
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 204 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 168
Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 169 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 310 VVLLEILT 317
           V+L EI +
Sbjct: 229 VLLWEIFS 236

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 107 LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 164
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 16  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 72
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 217
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 129
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 130 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 181
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 330
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 234

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 204 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 214
Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 274
Query: 310 VVLLEILT 317
           V+L EI +
Sbjct: 275 VLLWEIFS 282

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 108
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  +
Sbjct: 109 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEV 164
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 118 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 173
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 112 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 169
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 170 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 224
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---GL 231
           HP L  +       E+   + E++  G +  ++ S     L      +  F AA+   GL
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILGL 131
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            FLH   K ++YRD K  NILLD D + K++DFG+ K+   GD    +    GT  Y AP
Sbjct: 132 QFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAP 187
Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           E ++        D +SFGV+L E+L G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 18/212 (8%)
Query: 112 ANFRQDRVLXXXXXXCVYKG-FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 170
              R+ +VL       V+KG +I E   E ++ +PV +KV +  +  Q  +     ++ +
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEG--ESIK-IPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLP---LPWSIRMKIAF 225
           G L H ++V+L+G C     + L+ +++  GS+ +++      L P   L W +++    
Sbjct: 70  GSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI---- 124
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             AKG+ +L E    +++R+    N+LL +    +++DFG+A   P  DK  + +     
Sbjct: 125 --AKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             + A E I  G  T +SDV+S+GV + E++T
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 204 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 168
Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 169 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 310 VVLLEILT 317
           V+L EI +
Sbjct: 229 VLLWEIFS 236

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 7/158 (4%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILG 117
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           K++    +GLA+L E  + +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 118 KVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 172
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y APE +   H + +SD++S G+ L+E+  GR
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G + 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 205 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 250
           N L  K    L +S                +  +   A+G+AFL  A K  I+RD    N
Sbjct: 139 NFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARN 196
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +LL   + AK+ DFGLA+D        V         + APE I     T +SDV+S+G+
Sbjct: 197 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 256
Query: 311 VLLEILT 317
           +L EI +
Sbjct: 257 LLWEIFS 263

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 12/184 (6%)
Query: 144 VPVAVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR-----VLIYEF 197
           + VAVK    DNS Q    E+L+E   +   SHPN+++L+G C E   +     ++I  F
Sbjct: 63  LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPF 122
Query: 198 MARGSVENNLFSKVLLP----LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL 253
           M  G +   L    L      +P    +K     A G+ +L  + +  ++RD    N +L
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCML 180
Query: 254 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
             D    ++DFGL+K    GD             + A E +     T +SDV++FGV + 
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240
Query: 314 EILT 317
           EI T
Sbjct: 241 EIAT 244

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 134
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 135 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 189
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF++   +++ + +  L  +P  +     F   +GL
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF++   +++ + +  L  +P  +     F   +GL
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G + 
Sbjct: 64  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 123
Query: 205 NNLFSKVLLPL-------------------PWSIRMKIAFGA--AKGLAFLHEAEKPVIY 243
           N L  K    L                   P  +R  + F +  A+G+AFL  A K  I+
Sbjct: 124 NFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIH 181
Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 303
           RD    N+LL   + AK+ DFGLA+D        V         + APE I     T +S
Sbjct: 182 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 241
Query: 304 DVYSFGVVLLEILT 317
           DV+S+G++L EI +
Sbjct: 242 DVWSYGILLWEIFS 255

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 7/158 (4%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 53  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 110
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++  G   D+  ++  
Sbjct: 111 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANE 165
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 166 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           +F H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 117 SFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 172
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 106/257 (41%), Gaps = 31/257 (12%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 37  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 94
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 95  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 152
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSL 322
           FGL++    GD             + APE +     + +SDV++FGV+L EI T G    
Sbjct: 153 FGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211
Query: 323 DKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY----PVKGVHKAAMLAYHCLNHN 378
               P++   L                     LE DY    P     K   L   C   N
Sbjct: 212 PGIDPSQVYEL---------------------LEKDYRMERPEGCPEKVYELMRACWQWN 250
Query: 379 PKARPLMRDIVDSLEPL 395
           P  RP   +I  + E +
Sbjct: 251 PSDRPSFAEIHQAFETM 267

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 104/248 (41%), Gaps = 10/248 (4%)
Query: 147 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 203
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI EF+  GS+
Sbjct: 44  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSL 103
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
              L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 104 REYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 160
Query: 264 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 321
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 161 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 219
Query: 322 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 381
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 220 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 278
Query: 382 RPLMRDIV 389
           RP  RD+ 
Sbjct: 279 RPSFRDLA 286

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  +++ + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 37  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 94
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 95  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 152
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 153 FGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 40  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 97
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 98  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 155
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 156 FGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 39/219 (17%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVH--DGDNSYQGHREWLAEVIFLGHLSHPNLVKLI-- 182
           CV+K  +  D         VAVK+       S+Q  RE    +     + H NL++ I  
Sbjct: 30  CVWKAQLMNDF--------VAVKIFPLQDKQSWQSERE----IFSTPGMKHENLLQFIAA 77
Query: 183 ---GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE--- 236
              G   E E   LI  F  +GS+ + L   ++    W+    +A   ++GL++LHE   
Sbjct: 78  EKRGSNLEVE-LWLITAFHDKGSLTDYLKGNII---TWNELCHVAETMSRGLSYLHEDVP 133
Query: 237 -----AEKPVI-YRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
                  KP I +RDFK+ N+LL +D  A L+DFGLA     G     +   +GT  Y A
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMA 193
Query: 291 PEYIMTGHLT------PRSDVYSFGVVLLEILTGRKSLD 323
           PE ++ G +        R D+Y+ G+VL E+++  K+ D
Sbjct: 194 PE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF++   ++  + +  L  +P  +     F   +GL
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 110
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 111 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 108
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 109 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 165
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 107
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 108 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 164
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 108
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 109 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 165
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 111
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 112 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 110
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 111 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF++   ++  + +  L  +P  +     F   +GL
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 118 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 110
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 111 LFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 107
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 108 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 164
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 44  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 102 LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 160 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 96
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 44  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 102 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 160 FGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 109
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 110 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 69  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 126
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 127 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 181
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 111
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 112 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 109
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 110 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 8   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 121 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 176
Query: 292 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           E ++   + +   D++S G +  E++T R
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 96
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 109
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 110 LFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 147 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 203
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 40  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 99
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 100 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 156
Query: 264 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 321
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 157 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 215
Query: 322 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 381
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 216 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 274
Query: 382 RPLMRDI 388
           RP  RD+
Sbjct: 275 RPSFRDL 281

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 147 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 203
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 45  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 104
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 105 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 161
Query: 264 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 321
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 162 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 220
Query: 322 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 381
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 221 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 279
Query: 382 RPLMRDI 388
           RP  RD+
Sbjct: 280 RPSFRDL 286

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 9/232 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 54  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 112
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 113 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 169
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 170 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 228
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
                        ++        P     +  M+   C N+N   RP  RD+
Sbjct: 229 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 280

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 9/233 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 61  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 119
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 120 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 176
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 177 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 235
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 236 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 288

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 9/233 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 114
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 115 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFF 171
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 230
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 44  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 101
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 102 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 160 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 9/233 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 62  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 120
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 121 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 177
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 178 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 236
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 237 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 289

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 9/233 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 117
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 118 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 174
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 233
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 234 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 37  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 94
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 95  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 152
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 153 FGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 147 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 203
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 41  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 101 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 157
Query: 264 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 321
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 158 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216
Query: 322 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 381
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 217 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 275
Query: 382 RPLMRDI 388
           RP  RD+
Sbjct: 276 RPSFRDL 282

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 90/188 (47%), Gaps = 18/188 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 203
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 204 ENNLFSKVLLPLPW------------SIRMKI--AFGAAKGLAFLHEAEKPVIYRDFKTS 249
              L SK    +P+            ++   I  +F  AKG+ FL  A +  I+RD    
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 179
Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 180 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 239
Query: 310 VVLLEILT 317
           V+L EI +
Sbjct: 240 VLLWEIFS 247

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 9/233 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 114
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 115 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 171
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 230
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 44  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 102 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 160 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 52  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 109
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 110 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 167
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 168 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 9/233 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 63  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 121
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 122 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 178
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 179 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 237
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 238 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 290

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           E+L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L       +   + +
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
            +A   +  + +L   +K  I+RD    N L+  ++  K++DFGL++    GD       
Sbjct: 120 YMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAG 176
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE +     + +SDV++FGV+L EI T
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 9/233 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 87  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 145
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 146 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 202
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 261
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 262 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 40  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 97
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 98  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 155
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 156 FGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 41  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 99  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 156
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 157 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 3/156 (1%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           ++L E   L   SHPN+V+LIG C + +   ++ E +  G     L ++    L     +
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLL 216
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           ++   AA G+ +L    K  I+RD    N L+      K+SDFG++++  +G  +     
Sbjct: 217 QMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGL 274
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE +  G  +  SDV+SFG++L E  +
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 43  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 101 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 158
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 159 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K+ D + +     +   E+  L     P + K  G   +D    +I E++  GS  +
Sbjct: 55  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 114
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            L      PL  +    I     KGL +LH  +K  I+RD K +N+LL      KL+DFG
Sbjct: 115 LLEPG---PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFG 169
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G     + 
Sbjct: 170 VA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227
Query: 326 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARP 383
            P +   L                   P LEG+Y  P+K   +A      CLN  P  RP
Sbjct: 228 HPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVEA------CLNKEPSFRP 268
Query: 384 LMRDIV 389
             ++++
Sbjct: 269 TAKELL 274

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           E+L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L       +   + +
Sbjct: 57  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 116
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
            +A   +  + +L   +K  I+RD    N L+  ++  K++DFGL++    GD       
Sbjct: 117 YMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAG 173
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE +     + +SDV++FGV+L EI T
Sbjct: 174 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K+ D + +     +   E+  L     P + K  G   +D    +I E++  GS  +
Sbjct: 50  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 109
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            L      PL  +    I     KGL +LH  +K  I+RD K +N+LL      KL+DFG
Sbjct: 110 LLEPG---PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFG 164
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G     + 
Sbjct: 165 VA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
Query: 326 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARP 383
            P +   L                   P LEG+Y  P+K   +A      CLN  P  RP
Sbjct: 223 HPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVEA------CLNKEPSFRP 263
Query: 384 LMRDIV 389
             ++++
Sbjct: 264 TAKELL 269

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 41  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 99  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 156
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 157 FGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 9/232 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 132
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 133 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 189
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 248
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
                        ++        P     +  M+   C N+N   RP  RD+
Sbjct: 249 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 92/190 (48%), Gaps = 24/190 (12%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGY----CCEDEHRVLIYEFMARG 201
           VAVK+    +      E+  EV  L  + H N+++ IG        D    LI  F  +G
Sbjct: 50  VAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107
Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-------AEKPVI-YRDFKTSNILL 253
           S+ + L + V+    W+    IA   A+GLA+LHE         KP I +RD K+ N+LL
Sbjct: 108 SLSDFLKANVV---SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164
Query: 254 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT------PRSDVYS 307
             +  A ++DFGLA     G  +  +   +GT  Y APE ++ G +        R D+Y+
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYA 223
Query: 308 FGVVLLEILT 317
            G+VL E+ +
Sbjct: 224 MGLVLWELAS 233

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K+ D + +     +   E+  L     P + K  G   +D    +I E++  GS  +
Sbjct: 35  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 94
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            L      PL  +    I     KGL +LH  +K  I+RD K +N+LL      KL+DFG
Sbjct: 95  LLEPG---PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G     + 
Sbjct: 150 VA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207
Query: 326 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARP 383
            P +   L                   P LEG+Y  P+K   +A      CLN  P  RP
Sbjct: 208 HPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVEA------CLNKEPSFRP 248
Query: 384 LMRDIV 389
             ++++
Sbjct: 249 TAKELL 254

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 9/233 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 57  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 115
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+R+  T NIL++ +   K+ DFGL K  P+ DK + 
Sbjct: 116 KLLQYTSQICKGMEYL--GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYY 172
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 173 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 231
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 232 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 284

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K+ D + +     +   E+  L     P + K  G   +D    +I E++  GS  +
Sbjct: 35  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 94
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            L      PL  +    I     KGL +LH  +K  I+RD K +N+LL      KL+DFG
Sbjct: 95  LLEPG---PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFG 149
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G     + 
Sbjct: 150 VA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207
Query: 326 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARP 383
            P +   L                   P LEG+Y  P+K   +A      CLN  P  RP
Sbjct: 208 HPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVEA------CLNKEPSFRP 248
Query: 384 LMRDIV 389
             ++++
Sbjct: 249 TAKELL 254

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 9/232 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 132
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 133 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 189
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 248
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
                        ++        P     +  M+   C N+N   RP  RD+
Sbjct: 249 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN--NLFSKVLLPLPWS 218
           +E + E+  +     P++VK  G   ++    ++ E+   GSV +   L +K L     +
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA 128
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             ++      KGL +LH   K  I+RD K  NILL+T+ +AKL+DFG+A  G   D    
Sbjct: 129 TILQ---STLKGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAK 181
Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
              ++GT  + APE I        +D++S G+  +E+  G+       P R
Sbjct: 182 RNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 99/233 (42%), Gaps = 9/233 (3%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 218
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L +         
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIK 118
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
           + ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 119 L-LQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 174
Query: 279 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 233
Query: 337 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 234 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 3/156 (1%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           ++L E   L   SHPN+V+LIG C + +   ++ E +  G     L ++    L     +
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLL 216
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           ++   AA G+ +L    K  I+RD    N L+      K+SDFG++++  +G  +     
Sbjct: 217 QMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE +  G  +  SDV+SFG++L E  +
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 7/156 (4%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV  L    H N++  +GY  +D +  ++ ++    S+  +L  +      + + + IA 
Sbjct: 82  EVAVLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIAR 139
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A+G+ +LH   K +I+RD K++NI L      K+ DFGLA        S    +  G+
Sbjct: 140 QTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGS 197
Query: 286 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTG 318
             + APE I      P   +SDVYS+G+VL E++TG
Sbjct: 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           V  A KV D   S +   +++ E+  L    HPN+VKL+     + +  ++ EF A G+V
Sbjct: 63  VLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 121
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
           +  +  ++  PL  S    +       L +LH+    +I+RD K  NIL   D + KL+D
Sbjct: 122 DAVML-ELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLAD 178
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTP---RSDVYSFGVVLLEI 315
           FG++       +   S   +GT  + APE +M  T    P   ++DV+S G+ L+E+
Sbjct: 179 FGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++E + +  ++  + +  L  +P  +    
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSY 107
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  +
Sbjct: 108 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEV 163
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           V  A KV D   S +   +++ E+  L    HPN+VKL+     + +  ++ EF A G+V
Sbjct: 63  VLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 121
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
           +  +  ++  PL  S    +       L +LH+    +I+RD K  NIL   D + KL+D
Sbjct: 122 DAVML-ELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLAD 178
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTP---RSDVYSFGVVLLEI 315
           FG++       +   S   +GT  + APE +M  T    P   ++DV+S G+ L+E+
Sbjct: 179 FGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 138 REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R  L    VAVK+ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 250
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 310 VVLLEILTGRKSLDKSRPAREQNLAD 335
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 138 REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R  L    VAVK+ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 250
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 310 VVLLEILTGRKSLDKSRPAREQNLAD 335
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 5/147 (3%)
Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            LSH N+V +I    ED+   L+ E++   ++   + S      P S+   I F      
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILD 122
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
              H  +  +++RD K  NIL+D++   K+ DFG+AK   E   +  +  ++GT  Y +P
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSP 181
Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTG 318
           E          +D+YS G+VL E+L G
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 215
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 132
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 133 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 181
Query: 276 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 215
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 132
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 133 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 181
Query: 276 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           E+L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L       +   + +
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
            +A   +  + +L   +K  I+R+    N L+  ++  K++DFGL++    GD       
Sbjct: 322 YMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAG 378
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE +     + +SDV++FGV+L EI T
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 215
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 130
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 131 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 179
Query: 276 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 180 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 215
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 122
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 123 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 171
Query: 276 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 215
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 474
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 475 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 523
Query: 276 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 117/261 (44%), Gaps = 47/261 (18%)
Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFSKVLLPLP----WSIRMK 222
           +F    +HP LV L   C + E R+  + E++  G +  ++  +  LP      +S  + 
Sbjct: 73  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 131
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTR 281
           +A      L +LHE  + +IYRD K  N+LLD++ + KL+D+G+ K+G   GD    ++ 
Sbjct: 132 LA------LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSX 180
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWAXX 339
             GT  Y APE +         D ++ GV++ E++ GR   D   S    +QN  D+   
Sbjct: 181 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 240
Query: 340 XXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PL 384
                     I++ ++    P     KAA +    LN +PK R               P 
Sbjct: 241 V---------ILEKQIR--IPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPF 289
Query: 385 MRDI-VDSLEPLQVLPDEAPT 404
            R++  D +E  QV+P   P 
Sbjct: 290 FRNVDWDMMEQKQVVPPFKPN 310

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 138 REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R  L    VAVK+ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 35  RHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVME 94
Query: 197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 250
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 95  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KYIVHRDLKAEN 144
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 145 LLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 310 VVLLEILTGRKSLDKSRPAREQNLAD 335
           V+L  +++G      S P   QNL +
Sbjct: 202 VILYTLVSG------SLPFDGQNLKE 221

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 215
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 116
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 117 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 165
Query: 276 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 166 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 138 REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R  L    VAVK+ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 250
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
           +LLD D N K++DFG + +   G+K        G   YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 310 VVLLEILTGRKSLDKSRPAREQNLAD 335
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           E+L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L       +   + +
Sbjct: 301 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 360
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
            +A   +  + +L   +K  I+R+    N L+  ++  K++DFGL++    GD       
Sbjct: 361 YMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAG 417
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE +     + +SDV++FGV+L EI T
Sbjct: 418 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 215
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 475
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 476 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 524
Query: 276 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 525 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 215
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 112
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 113 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 161
Query: 276 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 215
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 110
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 111 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 159
Query: 276 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 160 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 117/261 (44%), Gaps = 47/261 (18%)
Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFSKVLLPLP----WSIRMK 222
           +F    +HP LV L   C + E R+  + E++  G +  ++  +  LP      +S  + 
Sbjct: 105 VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTR 281
           +A      L +LHE  + +IYRD K  N+LLD++ + KL+D+G+ K+G   GD    ++ 
Sbjct: 164 LA------LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTST 212
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWAXX 339
             GT  Y APE +         D ++ GV++ E++ GR   D   S    +QN  D+   
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272
Query: 340 XXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PL 384
                     I++ ++    P     KAA +    LN +PK R               P 
Sbjct: 273 V---------ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321
Query: 385 MRDI-VDSLEPLQVLPDEAPT 404
            R++  D +E  QV+P   P 
Sbjct: 322 FRNVDWDMMEQKQVVPPFKPN 342

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 11/177 (6%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 203
           V  A KV D   S +   +++ E+  L    HPN+VKL+     + +  ++ EF A G+V
Sbjct: 63  VLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 121
Query: 204 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
           +  +  ++  PL  S    +       L +LH+    +I+RD K  NIL   D + KL+D
Sbjct: 122 DAVML-ELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLAD 178
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTP---RSDVYSFGVVLLEI 315
           FG++       +       +GT  + APE +M  T    P   ++DV+S G+ L+E+
Sbjct: 179 FGVSAKNTRXIQRR--DXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 117 DRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           +R+L       VY+G  +    E +    VAVK    D +     ++++E + + +L HP
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 69
Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGS----VENNLFS-KVLLPLPWSIRMKIAFGAAKGL 231
           ++VKLIG   E+E   +I E    G     +E N  S KVL  + +S+++       K +
Sbjct: 70  HIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI------CKAM 122
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS-TRIMGTYGYAA 290
           A+L       ++RD    NIL+ +    KL DFGL++   + D    S TR+     + +
Sbjct: 123 AYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMS 178
Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 321
           PE I     T  SDV+ F V + EIL+  K 
Sbjct: 179 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 209

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 117 DRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           +R+L       VY+G  +    E +    VAVK    D +     ++++E + + +L HP
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 85
Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGS----VENNLFS-KVLLPLPWSIRMKIAFGAAKGL 231
           ++VKLIG   E+E   +I E    G     +E N  S KVL  + +S+++       K +
Sbjct: 86  HIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI------CKAM 138
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS-TRIMGTYGYAA 290
           A+L       ++RD    NIL+ +    KL DFGL++   + D    S TR+     + +
Sbjct: 139 AYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMS 194
Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILT 317
           PE I     T  SDV+ F V + EIL+
Sbjct: 195 PESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 112/251 (44%), Gaps = 39/251 (15%)
Query: 174 SHPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           +HP LV L   C + E R+  + E++  G +  ++  +  LP   +      + A   LA
Sbjct: 64  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR----FYSAEISLA 118
Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTRIMGTYGYAAP 291
             +  E+ +IYRD K  N+LLD++ + KL+D+G+ K+G   GD    ++   GT  Y AP
Sbjct: 119 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGTPNYIAP 175
Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWAXXXXXXXXXXXN 349
           E +         D ++ GV++ E++ GR   D   S    +QN  D+             
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------- 226
Query: 350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PLMRDI-VDSLE 393
           I++ ++    P     KAA +    LN +PK R               P  R++  D +E
Sbjct: 227 ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 284
Query: 394 PLQVLPDEAPT 404
             QV+P   P 
Sbjct: 285 QKQVVPPFKPN 295

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 138 REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R  L    VAV++ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 250
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 310 VVLLEILTGRKSLDKSRPAREQNLAD 335
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 84/196 (42%), Gaps = 24/196 (12%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 202
           + VAVK+             ++E+  +  L SH N+V L+G C       LI+E+   G 
Sbjct: 76  IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135
Query: 203 VENNLFSKV---------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPV 241
           + N L SK                      L  L +   +  A+  AKG+ FL    K  
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSC 193
Query: 242 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           ++RD    N+L+      K+ DFGLA+D        V         + APE +  G  T 
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 302 RSDVYSFGVVLLEILT 317
           +SDV+S+G++L EI +
Sbjct: 254 KSDVWSYGILLWEIFS 269

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 138 REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R  L    VAV++ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 250
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 310 VVLLEILTGRKSLDKSRPAREQNLAD 335
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 117 DRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           +R+L       VY+G  +    E +    VAVK    D +     ++++E + + +L HP
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGS----VENNLFS-KVLLPLPWSIRMKIAFGAAKGL 231
           ++VKLIG   E+E   +I E    G     +E N  S KVL  + +S+++       K +
Sbjct: 74  HIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI------CKAM 126
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS-TRIMGTYGYAA 290
           A+L       ++RD    NIL+ +    KL DFGL++   + D    S TR+     + +
Sbjct: 127 AYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMS 182
Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILT 317
           PE I     T  SDV+ F V + EIL+
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 112/251 (44%), Gaps = 39/251 (15%)
Query: 174 SHPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           +HP LV L   C + E R+  + E++  G +  ++  +  LP   +      + A   LA
Sbjct: 68  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR----FYSAEISLA 122
Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTRIMGTYGYAAP 291
             +  E+ +IYRD K  N+LLD++ + KL+D+G+ K+G   GD    ++   GT  Y AP
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGTPNYIAP 179
Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWAXXXXXXXXXXXN 349
           E +         D ++ GV++ E++ GR   D   S    +QN  D+             
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------- 230
Query: 350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PLMRDI-VDSLE 393
           I++ ++    P     KAA +    LN +PK R               P  R++  D +E
Sbjct: 231 ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 288
Query: 394 PLQVLPDEAPT 404
             QV+P   P 
Sbjct: 289 QKQVVPPFKPN 299

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 138 REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R  L    VAVK+ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 27  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 86
Query: 197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 250
           + + G V + L +       W   MK     AK       + + H+  K +++RD K  N
Sbjct: 87  YASGGEVFDYLVAH-----GW---MKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 136
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 137 LLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 193
Query: 310 VVLLEILTGRKSLDKSRPAREQNLAD 335
           V+L  +++G      S P   QNL +
Sbjct: 194 VILYTLVSG------SLPFDGQNLKE 213

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VYKG +      G Q   VA+K            E+  E +    L HPN+V L+G   +
Sbjct: 42  VYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100
Query: 188 DEHRVLIYEFMARG----------------SVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
           D+   +I+ + + G                S +++   K  L  P  + +     A  G+
Sbjct: 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA--GM 158
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            +L  +   V+++D  T N+L+    N K+SD GL ++    D   +    +    + AP
Sbjct: 159 EYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216
Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILT 317
           E IM G  +  SD++S+GVVL E+ +
Sbjct: 217 EAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 215
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 116
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 117 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 165
Query: 276 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           +    +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 166 NXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 31/200 (15%)
Query: 138 REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCEDEHRVLIY- 195
           ++GL+ +  A+K      S   HR++  E+  L  L H PN++ L+G C   EHR  +Y 
Sbjct: 38  KDGLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYL 93
Query: 196 --EFMARGSVENNLF-SKVLLPLP-----------WSIRMKIAFGA--AKGLAFLHEAEK 239
             E+   G++ + L  S+VL   P            S +  + F A  A+G+ +L  ++K
Sbjct: 94  AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQK 151
Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTG 297
             I+RD    NIL+  +Y AK++DFGL++    G + +V  + MG     + A E +   
Sbjct: 152 QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYS 206
Query: 298 HLTPRSDVYSFGVVLLEILT 317
             T  SDV+S+GV+L EI++
Sbjct: 207 VYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 31/200 (15%)
Query: 138 REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCEDEHRVLIY- 195
           ++GL+ +  A+K      S   HR++  E+  L  L H PN++ L+G C   EHR  +Y 
Sbjct: 48  KDGLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYL 103
Query: 196 --EFMARGSVENNLF-SKVLLPLP-----------WSIRMKIAFGA--AKGLAFLHEAEK 239
             E+   G++ + L  S+VL   P            S +  + F A  A+G+ +L  ++K
Sbjct: 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQK 161
Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTG 297
             I+RD    NIL+  +Y AK++DFGL++    G + +V  + MG     + A E +   
Sbjct: 162 QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYS 216
Query: 298 HLTPRSDVYSFGVVLLEILT 317
             T  SDV+S+GV+L EI++
Sbjct: 217 VYTTNSDVWSYGVLLWEIVS 236

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E+   ++I E+M++GS+ + L  ++   L LP  + M
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 120 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQG 174
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           + E+  L  L+HPN+VKL+     +    L++E + +  ++  + +  L  +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSY 111
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+      +++    + 
Sbjct: 112 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           VYKG +      G Q   VA+K            E+  E +    L HPN+V L+G   +
Sbjct: 25  VYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 83
Query: 188 DEHRVLIYEFMARG----------------SVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
           D+   +I+ + + G                S +++   K  L  P  + +     A  G+
Sbjct: 84  DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA--GM 141
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            +L  +   V+++D  T N+L+    N K+SD GL ++    D   +    +    + AP
Sbjct: 142 EYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 199
Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILT 317
           E IM G  +  SD++S+GVVL E+ +
Sbjct: 200 EAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 164 LAEVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           + E++ +    +PN+V  L  Y   DE  V + E++A GS+ + +    +     +    
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA---A 120
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTR 281
           +     + L FLH  +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + 
Sbjct: 121 VCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSE 175
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
           ++GT  + APE +      P+ D++S G++ +E++ G        P R
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYIT 119
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL ++   K++DFG +   P   +    T + GT
Sbjct: 120 ELANALSYCH--SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGT 173
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             Y  PE I       + D++S GV+  E L G
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 138 REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R  L    VA+K+ D    +    ++   EV  +  L+HPN+VKL      ++   LI E
Sbjct: 32  RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 91
Query: 197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 250
           + + G V + L +          RMK     +K       + + H+  K +++RD K  N
Sbjct: 92  YASGGEVFDYLVAHG--------RMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAEN 141
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
           +LLD D N K++DFG + +   G K        G+  YAAPE      +  P  DV+S G
Sbjct: 142 LLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 198
Query: 310 VVLLEILTGRKSLDKSRPAREQNLAD 335
           V+L  +++G      S P   QNL +
Sbjct: 199 VILYTLVSG------SLPFDGQNLKE 218

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 164 LAEVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           + E++ +    +PN+V  L  Y   DE  V + E++A GS+ + +    +     +    
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA---A 120
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTR 281
           +     + L FLH  +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + 
Sbjct: 121 VCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RST 175
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
           ++GT  + APE +      P+ D++S G++ +E++ G        P R
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E+   ++I E+M++GS+ + L  ++   L LP  + M
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 120 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQG 174
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 111 TANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 170
           ++ F+Q   L       VYKG            V VA+K    D+        + E+  +
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGL------NKTTGVYVALKEVKLDSEEGTPSTAIREISLM 57
Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA----FG 226
             L H N+V+L      +    L++EFM    ++  + S+ +   P  + + +     + 
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
             +GLAF HE +  +++RD K  N+L++     KL DFGLA+    G   +  +  + T 
Sbjct: 117 LLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLAR--AFGIPVNTFSSEVVTL 172
Query: 287 GYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            Y AP+ +M       S D++S G +L E++TG+
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 102/246 (41%), Gaps = 28/246 (11%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K+ D + +     +   E+  L     P + +  G   +     +I E++  GS  +
Sbjct: 47  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD 106
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            L      PL  +    I     KGL +LH   K  I+RD K +N+LL    + KL+DFG
Sbjct: 107 LLKPG---PLEETYIATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFG 161
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G       
Sbjct: 162 VA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219
Query: 326 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARP 383
            P R   L                   P LEG +  P K   +A      CLN +P+ RP
Sbjct: 220 HPMRVLFLIPKNSP-------------PTLEGQHSKPFKEFVEA------CLNKDPRFRP 260
Query: 384 LMRDIV 389
             ++++
Sbjct: 261 TAKELL 266

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 164 LAEVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           + E++ +    +PN+V  L  Y   DE  V + E++A GS+ + +    +     +    
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA---A 120
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTR 281
           +     + L FLH  +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + 
Sbjct: 121 VCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSX 175
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
           ++GT  + APE +      P+ D++S G++ +E++ G        P R
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 138 REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R  L    VA+K+ D    +    ++   EV  +  L+HPN+VKL      ++   LI E
Sbjct: 35  RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94
Query: 197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 250
           + + G V + L +          RMK     +K       + + H+  K +++RD K  N
Sbjct: 95  YASGGEVFDYLVAHG--------RMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAEN 144
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
           +LLD D N K++DFG + +   G K        G   YAAPE      +  P  DV+S G
Sbjct: 145 LLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 310 VVLLEILTGRKSLDKSRPAREQNLAD 335
           V+L  +++G      S P   QNL +
Sbjct: 202 VILYTLVSG------SLPFDGQNLKE 221

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 164 LAEVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           + E++ +    +PN+V  L  Y   DE  V + E++A GS+ + +    +     +    
Sbjct: 66  INEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA---A 121
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTR 281
           +     + L FLH  +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + 
Sbjct: 122 VCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSX 176
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
           ++GT  + APE +      P+ D++S G++ +E++ G        P R
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 224

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + M
Sbjct: 51  LQEAQVMKKLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 109
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 110 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQG 164
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 165 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 16/229 (6%)
Query: 113 NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH--REWLAEVIFL 170
           +F+   +L       VY+   +E +  GL+   VA+K+ D    Y+    +    EV   
Sbjct: 12  DFKVGNLLGKGSFAGVYR---AESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
             L HP++++L  Y  +  +  L+ E    G +   L ++V  P   +           G
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITG 124
Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           + +LH     +++RD   SN+LL  + N K++DFGLA       + H +  + GT  Y +
Sbjct: 125 MLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYIS 180
Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN---LADW 336
           PE          SDV+S G +   +L GR   D        N   LAD+
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + M
Sbjct: 52  LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 110
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 111 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQG 165
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 166 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + M
Sbjct: 50  LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 108
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 109 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQG 163
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 164 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + M
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 120 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQG 174
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   +  L H  LV+L     E E   ++ E+M +GS+ + L       L     + +
Sbjct: 52  LEEAQIMKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM 110
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           A   A G+A++       I+RD +++NIL+      K++DFGLA+   E ++        
Sbjct: 111 AAQVAAGMAYIERMN--YIHRDLRSANILVGNGLICKIADFGLARL-IEDNEXTARQGAK 167
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 319
               + APE  + G  T +SDV+SFG++L E++T GR
Sbjct: 168 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           E+L E   +  + HPNLV+L+G C  +    ++ E+M  G++ + L       +   + +
Sbjct: 74  EFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLL 133
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
            +A   +  + +L   +K  I+RD    N L+  ++  K++DFGL++    GD       
Sbjct: 134 YMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHVVKVADFGLSRL-MTGDTYTAHAG 190
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE +     + +SDV++FGV+L EI T
Sbjct: 191 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + M
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 120 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQG 174
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + M
Sbjct: 54  LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 112
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 113 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQG 167
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 168 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 31/200 (15%)
Query: 138 REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCEDEHRVLIY- 195
           ++GL+ +  A+K      S   HR++  E+  L  L H PN++ L+G C   EHR  +Y 
Sbjct: 45  KDGLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYL 100
Query: 196 --EFMARGSVENNLF-SKVLLPLP-----------WSIRMKIAFGA--AKGLAFLHEAEK 239
             E+   G++ + L  S+VL   P            S +  + F A  A+G+ +L  ++K
Sbjct: 101 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQK 158
Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTG 297
             I+R+    NIL+  +Y AK++DFGL++    G + +V  + MG     + A E +   
Sbjct: 159 QFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYS 213
Query: 298 HLTPRSDVYSFGVVLLEILT 317
             T  SDV+S+GV+L EI++
Sbjct: 214 VYTTNSDVWSYGVLLWEIVS 233

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 132 FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR 191
           + + D+R   + V +    + G  S +  ++ + EV FL  L HPN ++  G C   EH 
Sbjct: 32  YFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHT 89
Query: 192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 251
             +      GS  ++L      PL       +  GA +GLA+LH     +I+RD K  NI
Sbjct: 90  AWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNI 146
Query: 252 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSF 308
           LL      KL DFG A      +        +GT  + APE I+    G    + DV+S 
Sbjct: 147 LLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 309 GVVLLEI 315
           G+  +E+
Sbjct: 201 GITCIEL 207

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 220
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEG 273
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+          +G
Sbjct: 285 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            K  +         + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 341 AKFPIK--------WTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 220
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + 
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEG 273
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+          +G
Sbjct: 368 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            K  +         + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 424 AKFPIK--------WTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 220
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEG 273
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+          +G
Sbjct: 285 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            K  +         + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 341 AKFPIK--------WTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 132 FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR 191
           + + D+R   + V +    + G  S +  ++ + EV FL  L HPN ++  G C   EH 
Sbjct: 71  YFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHT 128
Query: 192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 251
             +      GS  ++L      PL       +  GA +GLA+LH     +I+RD K  NI
Sbjct: 129 AWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNI 185
Query: 252 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSF 308
           LL      KL DFG A      +        +GT  + APE I+    G    + DV+S 
Sbjct: 186 LLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239
Query: 309 GVVLLEI 315
           G+  +E+
Sbjct: 240 GITCIEL 246

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/110 (43%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
           +P  I  KI     K L  L E  K +I+RD K SNILLD   N KL DFG++  G   D
Sbjct: 122 IPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVD 178
Query: 275 KSHVSTRIMGTYGYAAPEYI-----MTGHLTPRSDVYSFGVVLLEILTGR 319
            S   TR  G   Y APE I       G+   RSDV+S G+ L E+ TGR
Sbjct: 179 -SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGR 226

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 220
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEG 273
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+          +G
Sbjct: 285 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            K  +         + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 341 AKFPIK--------WTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 7/158 (4%)
Query: 160 HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           +R  L E+  L  LSHPN++ L+       +  L+++FM    +E  +    L+  P  I
Sbjct: 56  NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHI 114
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
           +  +     +GL +LH+    +++RD K +N+LLD +   KL+DFGLAK     ++++  
Sbjct: 115 KAYMLM-TLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH 171
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEIL 316
             +  T  Y APE +    +     D+++ G +L E+L
Sbjct: 172 QVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 164 LAEVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           + E++ +    +PN+V  L  Y   DE  V + E++A GS+ + +    +     +    
Sbjct: 66  INEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA---A 121
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTR 281
           +     + L FLH  +  VI+R+ K+ NILL  D + KL+DFG  A+  PE  K    + 
Sbjct: 122 VCRECLQALEFLHSNQ--VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RST 176
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
           ++GT  + APE +      P+ D++S G++ +E++ G        P R
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 224

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYIT 119
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L++ H   K VI+RD K  N+LL ++   K++DFG +   P   +      + GT
Sbjct: 120 ELANALSYCH--SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD----TLCGT 173
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             Y  PE I       + D++S GV+  E L G
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  + H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + M
Sbjct: 61  LQEAQVMKKIRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 120 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQG 174
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF-MARGSVENNLFSKVLLPLPWSIRMKIA 224
           E++ L H+ H N++ L+            Y+F +    ++ +L   + L         + 
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV 132
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
           +   KGL ++H A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR   
Sbjct: 133 YQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 187
Query: 285 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 331
              Y APE I++  H     D++S G ++ E+LTG K+L K +   +Q
Sbjct: 188 --WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ 232

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 220
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + 
Sbjct: 227 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 285
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGL   G   + +  + 
Sbjct: 286 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL---GRLIEDNEYTA 338
Query: 281 RIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           R    +   + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 339 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + M
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD   +NIL+  +   K++DFGLA+   E ++      
Sbjct: 120 --AAQIASGMAYVERMN--YVHRDLAAANILVGENLVCKVADFGLARL-IEDNEYTARQG 174
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 138 REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R  L    VAVK+ D    +    ++   EV     L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXE 93
Query: 197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 250
           + + G V + L +          R K     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RXKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
           +LLD D N K++DFG + +   G+K        G   YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 310 VVLLEILTGRKSLDKSRPAREQNLAD 335
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 18/178 (10%)
Query: 146 VAVKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VAVK+ D     Q  RE L  EV+ +    H N+V++       E   ++ EF+  G++ 
Sbjct: 73  VAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL- 129
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
            ++ S+V L         +     + LA+LH   + VI+RD K+ +ILL  D   KLSDF
Sbjct: 130 TDIVSQVRLNEEQI--ATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDF 185
Query: 265 G----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           G    ++KD P+         ++GT  + APE I         D++S G++++E++ G
Sbjct: 186 GFCAQISKDVPK------RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 17  CIGEGQFG-DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNL----FSKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
           LIG   E+   + I E    G + + L    FS  L  L     +  A+  +  LA+L  
Sbjct: 76  LIGVITENPVWI-IMELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLSTALAYLE- 128
Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT 296
             K  ++RD    N+L+ ++   KL DFGL++   +      S   +    + APE I  
Sbjct: 129 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESINF 186
Query: 297 GHLTPRSDVYSFGVVLLEIL 316
              T  SDV+ FGV + EIL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 131 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M++G + + L  ++   L LP  + M
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDM 119
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 120 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQG 174
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 131 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 22/163 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M +GS+ + L  +    L LP  + M
Sbjct: 58  LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM 116
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGD 274
                 A G+A++       ++RD + +NIL+  +   K++DFGLA+          +G 
Sbjct: 117 SAQI--ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGA 172
Query: 275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           K  +         + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 173 KFPIK--------WTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 131 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M +GS+ + L  +    L LP  + M
Sbjct: 58  LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM 116
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
                 A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 117 SAQI--ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQG 171
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 172 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 56/106 (52%), Gaps = 3/106 (2%)
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 272
           P+     +++   A + L F H+    +I+RD K +NIL+      K+ DFG+A+     
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANILISATNAVKVVDFGIARAIADS 169
Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG
Sbjct: 170 GNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--- 220
           + E+  L  L HPN+V LI     +    L++EFM +         KVL      ++   
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD------LKKVLDENKTGLQDSQ 120
Query: 221 MKI-AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
           +KI  +   +G+A  H+    +++RD K  N+L+++D   KL+DFGLA+      +S+  
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-- 176
Query: 280 TRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           T  + T  Y AP+ +M +   +   D++S G +  E++TG+
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRM 221
           L E   +  L H  LV+L     E E   ++ E+M++G + + L  ++   L LP  + M
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDM 119
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++      
Sbjct: 120 --AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQG 174
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 19/191 (9%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 202
           + VAVK+             ++E+  L +L +H N+V L+G C      ++I E+   G 
Sbjct: 70  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 129
Query: 203 VENNLFSK----------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 246
           + N L  K                  L L     +  ++  AKG+AFL  A K  I+RD 
Sbjct: 130 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 187
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              NILL      K+ DFGLA+D        V         + APE I     T  SDV+
Sbjct: 188 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 247
Query: 307 SFGVVLLEILT 317
           S+G+ L E+ +
Sbjct: 248 SYGIFLWELFS 258

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 56/93 (60%), Gaps = 4/93 (4%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIMGTYG 287
           +GL ++H A   V++RD K SN+L++T  + K+ DFGLA+   PE D +   T  + T  
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 288 YAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
           Y APE ++      +S D++S G +L E+L+ R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 131 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--- 220
           + E+  L  L HPN+V LI     +    L++EFM +         KVL      ++   
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD------LKKVLDENKTGLQDSQ 120
Query: 221 MKI-AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
           +KI  +   +G+A  H+    +++RD K  N+L+++D   KL+DFGLA+      +S+  
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-- 176
Query: 280 TRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           T  + T  Y AP+ +M +   +   D++S G +  E++TG+
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 24/154 (15%)
Query: 174 SHPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA---FGAA 228
           +HP L +L  +CC    +    + EF+  G +        +  +  S R   A   F AA
Sbjct: 82  NHPFLTQL--FCCFQTPDRLFFVMEFVNGGDL--------MFHIQKSRRFDEARARFYAA 131
Query: 229 K---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-G 284
           +    L FLH+  K +IYRD K  N+LLD + + KL+DFG+ K   EG  + V+T    G
Sbjct: 132 EIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCG 186
Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  Y APE +      P  D ++ GV+L E+L G
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 151 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 16/160 (10%)
Query: 166 EVIFLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 220
           E+  L HL H N++ L+         ED   V +   +    + N + S+ L        
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF- 135
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
             + +   +GL ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V+T
Sbjct: 136 --LVYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVAT 191
Query: 281 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           R      Y APE ++   H     D++S G ++ E+L G+
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 11/160 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+ +L  L HP+++KL          V++ E+ A G + + +  K  +      R     
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A      H+    +++RD K  N+LLD + N K++DFGL+    +G+    S    G+
Sbjct: 118 ICAIEYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GS 170
Query: 286 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSLD 323
             YAAPE ++ G L   P  DV+S G+VL  +L GR   D
Sbjct: 171 PNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 133 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 129 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 129 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 136 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 137 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 128 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 19/191 (9%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 202
           + VAVK+             ++E+  L +L +H N+V L+G C      ++I E+   G 
Sbjct: 72  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 131
Query: 203 VENNLFSK----------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 246
           + N L  K                  L L     +  ++  AKG+AFL  A K  I+RD 
Sbjct: 132 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 189
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              NILL      K+ DFGLA+D        V         + APE I     T  SDV+
Sbjct: 190 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 249
Query: 307 SFGVVLLEILT 317
           S+G+ L E+ +
Sbjct: 250 SYGIFLWELFS 260

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 133 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 139 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 131 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF-MARGSVENNLFSKVLLPLPWSIRMKIA 224
           E++ L H+ H N++ L+            Y+F +    ++ +L   + +         + 
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLV 150
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
           +   KGL ++H A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR   
Sbjct: 151 YQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 205
Query: 285 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 331
              Y APE I++  H     D++S G ++ E+LTG K+L K +   +Q
Sbjct: 206 --WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ 250

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 133 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 397 CIGEGQFG-DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 456 LIGVITENPVWI-IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE--SKR 511
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 301 PRSDVYSFGVVLLEIL 316
             SDV+ FGV + EIL
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 5/135 (3%)
Query: 192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 251
            L+   M  G ++ +++       P +  +  A     GL  LH     ++YRD K  NI
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENI 317
Query: 252 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV 311
           LLD   + ++SD GLA   PEG    +  R+ GT GY APE +     T   D ++ G +
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCL 374
Query: 312 LLEILTGRKSLDKSR 326
           L E++ G+    + +
Sbjct: 375 LYEMIAGQSPFQQRK 389

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 151 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 19/191 (9%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 202
           + VAVK+             ++E+  L +L +H N+V L+G C      ++I E+   G 
Sbjct: 77  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 136
Query: 203 VENNLFSK----------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 246
           + N L  K                  L L     +  ++  AKG+AFL  A K  I+RD 
Sbjct: 137 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 194
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              NILL      K+ DFGLA+D        V         + APE I     T  SDV+
Sbjct: 195 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 307 SFGVVLLEILT 317
           S+G+ L E+ +
Sbjct: 255 SYGIFLWELFS 265

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 56/97 (57%), Gaps = 5/97 (5%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH +EK V+YRD K  N++LD D + K++DFGL K+G + D + + T  
Sbjct: 256 YGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-F 312
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 313 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 19/191 (9%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 202
           + VAVK+             ++E+  L +L +H N+V L+G C      ++I E+   G 
Sbjct: 54  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 203 VENNLFSK----------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 246
           + N L  K                  L L     +  ++  AKG+AFL  A K  I+RD 
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 171
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              NILL      K+ DFGLA+D        V         + APE I     T  SDV+
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 307 SFGVVLLEILT 317
           S+G+ L E+ +
Sbjct: 232 SYGIFLWELFS 242

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 56/97 (57%), Gaps = 5/97 (5%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH +EK V+YRD K  N++LD D + K++DFGL K+G + D + + T  
Sbjct: 253 YGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-F 309
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 5/134 (3%)
Query: 193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 252
           L+   M  G ++ +++       P +  +  A     GL  LH     ++YRD K  NIL
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENIL 318
Query: 253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           LD   + ++SD GLA   PEG    +  R+ GT GY APE +     T   D ++ G +L
Sbjct: 319 LDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLL 375
Query: 313 LEILTGRKSLDKSR 326
            E++ G+    + +
Sbjct: 376 YEMIAGQSPFQQRK 389

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 17/170 (10%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
           AE   L  + HP +V LI          LI E+++ G     LF ++     +       
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE----LFMQLEREGIFMEDTACF 125
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           + A   +A  H  +K +IYRD K  NI+L+   + KL+DFGL K+   +G  +H      
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FC 182
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG---------RKSLDK 324
           GT  Y APE +M        D +S G ++ ++LTG         +K++DK
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 3/106 (2%)
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 272
           P+     +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+     
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 14  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 73  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 128
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 301 PRSDVYSFGVVLLEIL 316
             SDV+ FGV + EIL
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 3/106 (2%)
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 272
           P+     +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+     
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-IMGTYGY 288
           GL FLH+  + +IYRD K  N++LD++ + K++DFG+ K   E     V+TR   GT  Y
Sbjct: 132 GLFFLHK--RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCGTPDY 186
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
            APE I         D +++GV+L E+L G+   D
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 3/106 (2%)
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 272
           P+     +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+     
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 3/106 (2%)
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 272
           P+     +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+     
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 17  CIGEGQFG-DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 76  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 131
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 301 PRSDVYSFGVVLLEIL 316
             SDV+ FGV + EIL
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 19  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 78  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 133
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 301 PRSDVYSFGVVLLEIL 316
             SDV+ FGV + EIL
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 17  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 76  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 131
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 301 PRSDVYSFGVVLLEIL 316
             SDV+ FGV + EIL
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 3/106 (2%)
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 272
           P+     +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+     
Sbjct: 129 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 186
Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG
Sbjct: 187 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
           AE   L  + HP +V LI          LI E+++ G     LF ++     +       
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE----LFMQLEREGIFMEDTACF 125
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
           + A   +A  H  +K +IYRD K  NI+L+   + KL+DFGL K+        V+    G
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHXFCG 183
Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG---------RKSLDK 324
           T  Y APE +M        D +S G ++ ++LTG         +K++DK
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 20  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 79  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 134
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 301 PRSDVYSFGVVLLEIL 316
             SDV+ FGV + EIL
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 45  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 104 LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 159
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 301 PRSDVYSFGVVLLEIL 316
             SDV+ FGV + EIL
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH 235
           P +V+  G    +    +  E M  G+    L  ++  P+P  I  K+     K L +L 
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM 295
           E +  VI+RD K SNILLD     KL DFG++    + DK+    R  G   Y APE I 
Sbjct: 142 E-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-DKA--KDRSAGCAAYMAPERID 197
Query: 296 TGHLTP-----RSDVYSFGVVLLEILTGR 319
               T      R+DV+S G+ L+E+ TG+
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 12/173 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+ +L  L HP+++KL       +  +++ E+       N LF  ++     S +    F
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEARRF 108
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
                 A  +     +++RD K  N+LLD   N K++DFGL+    +G+    S    G+
Sbjct: 109 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 165
Query: 286 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSL-DKSRPAREQNLAD 335
             YAAPE +++G L   P  DV+S GV+L  +L  R    D+S P   +N+++
Sbjct: 166 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 217

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 22  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 81  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 136
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 301 PRSDVYSFGVVLLEIL 316
             SDV+ FGV + EIL
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 135 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 191
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 12/173 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+ +L  L HP+++KL       +  +++ E+       N LF  ++     S +    F
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEARRF 112
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
                 A  +     +++RD K  N+LLD   N K++DFGL+    +G+    S    G+
Sbjct: 113 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 169
Query: 286 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSL-DKSRPAREQNLAD 335
             YAAPE +++G L   P  DV+S GV+L  +L  R    D+S P   +N+++
Sbjct: 170 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 135 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 191
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 137 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR- 193
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 137 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR- 193
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+  L    HP+++KL           ++ E+++ G + + +     L    S R+    
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
               G+ + H     V++RD K  N+LLD   NAK++DFGL+    +G+    S    G+
Sbjct: 126 --LSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GS 178
Query: 286 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSLD 323
             YAAPE +++G L   P  D++S GV+L  +L G    D
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 12/173 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+ +L  L HP+++KL       +  +++ E+       N LF  ++     S +    F
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEARRF 118
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
                 A  +     +++RD K  N+LLD   N K++DFGL+    +G+    S    G+
Sbjct: 119 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 175
Query: 286 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSL-DKSRPAREQNLAD 335
             YAAPE +++G L   P  DV+S GV+L  +L  R    D+S P   +N+++
Sbjct: 176 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 227

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 17  CIGEGQFG-DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNL----FSKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
           LIG   E+   + I E    G + + L    FS  L  L     +  A+  +  LA+L  
Sbjct: 76  LIGVITENPVWI-IMELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLSTALAYLE- 128
Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT 296
             K  ++RD    N+L+      KL DFGL++   E    + +++      + APE I  
Sbjct: 129 -SKRFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 297 GHLTPRSDVYSFGVVLLEIL 316
              T  SDV+ FGV + EIL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 137 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR- 193
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 141 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 197
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 127 CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 397 CIGEGQFG-DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 456 LIGVITENPVWI-IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE--SKR 511
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 300
            ++RD    N+L+      KL DFGL++   E    + +++      + APE I     T
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 301 PRSDVYSFGVVLLEIL 316
             SDV+ FGV + EIL
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 12/173 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+ +L  L HP+++KL       +  +++ E+       N LF  ++     S +    F
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEARRF 117
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
                 A  +     +++RD K  N+LLD   N K++DFGL+    +G+    S    G+
Sbjct: 118 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 174
Query: 286 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSL-DKSRPAREQNLAD 335
             YAAPE +++G L   P  DV+S GV+L  +L  R    D+S P   +N+++
Sbjct: 175 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 226

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L EV  L  L HPN++KL  +  +  +  L+ E    G + + + S+       + R  I
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--I 131
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 280
                 G+ ++H  +  +++RD K  N+LL++   D N ++ DFGL+      + S    
Sbjct: 132 IRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMK 186
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 136 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR- 192
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 164 LAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           L EV  L  +S HPN+++L      +    L+++ M +G + + L  KV L    +   K
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--RK 128
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           I     + +  LH+    +++RD K  NILLD D N KL+DFG +     G+K      +
Sbjct: 129 IMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EV 183
Query: 283 MGTYGYAAPEYIMTGH------LTPRSDVYSFGVVLLEILTG 318
            GT  Y APE I               D++S GV++  +L G
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 164 LAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           L EV  L  +S HPN+++L      +    L+++ M +G + + L  KV L    +   K
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--RK 115
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           I     + +  LH+    +++RD K  NILLD D N KL+DFG +     G+K      +
Sbjct: 116 IMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EV 170
Query: 283 MGTYGYAAPEYIMTGH------LTPRSDVYSFGVVLLEILTG 318
            GT  Y APE I               D++S GV++  +L G
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L EV  L  L HPN++KL  +  +  +  L+ E    G + + + S+       + R  I
Sbjct: 80  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--I 137
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 280
                 G+ ++H+ +  +++RD K  N+LL++   D N ++ DFGL+      + S    
Sbjct: 138 IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMK 192
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 193 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 135 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 191
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 132 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR- 188
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 166 EVIFLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 220
           E+  L HL H N++ L+         ED   V +   +    + N +  + L        
Sbjct: 69  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF- 127
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
             + +   +GL ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V+T
Sbjct: 128 --LVYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVAT 183
Query: 281 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           R      Y APE ++   H     D++S G ++ E+L G+
Sbjct: 184 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 135 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 191
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 129 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 185
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 137 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 193
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 132 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 188
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 132 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 188
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 140 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 196
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 197 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +      +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 283
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +      +
Sbjct: 136 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 136 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 192
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 136 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 192
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 132 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 188
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 16/160 (10%)
Query: 166 EVIFLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 220
           E+  L H+ H N++ L+         E+ + V +   +    + N + S+ L        
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF- 129
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
             + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGL +   +    +V+T
Sbjct: 130 --LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVAT 185
Query: 281 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 141 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 197
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 136 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 192
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 166 EVIFLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 220
           E+  L HL H N++ L+         ED   V +   +    + N +  + L        
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF- 135
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
             + +   +GL ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V+T
Sbjct: 136 --LVYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVAT 191
Query: 281 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           R      Y APE ++   H     D++S G ++ E+L G+
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 126 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 182
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 127 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 183
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 184 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 126 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 182
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 142 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 198
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 199 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 142 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 198
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 199 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 127 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 183
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 184 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 164 LAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           L EV  L  +S HPN+++L      +    L+++ M +G + + L  KV L    +   K
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--RK 128
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           I     + +  LH+    +++RD K  NILLD D N KL+DFG +     G+K      +
Sbjct: 129 IMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SV 183
Query: 283 MGTYGYAAPEYIMTGH------LTPRSDVYSFGVVLLEILTG 318
            GT  Y APE I               D++S GV++  +L G
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L EV  L  L HPN++KL  +  +  +  L+ E    G + + + S+       + R  I
Sbjct: 97  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--I 154
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 280
                 G+ ++H  +  +++RD K  N+LL++   D N ++ DFGL+      + S    
Sbjct: 155 IRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMK 209
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 210 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 142 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 198
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 199 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 153 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 209
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 210 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 150 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 206
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 207 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 97/244 (39%), Gaps = 24/244 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K+ D + +     +   E+  L       + K  G   +     +I E++  GS  +
Sbjct: 51  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALD 110
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
            L +        +  +K      KGL +LH  +K  I+RD K +N+LL    + KL+DFG
Sbjct: 111 LLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFG 165
Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G       
Sbjct: 166 VA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223
Query: 326 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM 385
            P R   L                   P L GD+              CLN +P  RP  
Sbjct: 224 HPMRVLFLIPKNNP-------------PTLVGDF----TKSFKEFIDACLNKDPSFRPTA 266
Query: 386 RDIV 389
           ++++
Sbjct: 267 KELL 270

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 83/195 (42%), Gaps = 15/195 (7%)
Query: 130 KGFISEDLREGLQPVPVA-VKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYC 185
           K F + DL+ G + V +  V+V  G+         + EV  L HL    HPN+V+L   C
Sbjct: 26  KVFKARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLETFEHPNVVRLFDVC 83
Query: 186 C---EDEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAEKPV 241
                D    L   F            KV  P +P      + F   +GL FLH     V
Sbjct: 84  TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--V 141
Query: 242 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           ++RD K  NIL+ +    KL+DFGLA+           T ++ T  Y APE ++      
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 302 RSDVYSFGVVLLEIL 316
             D++S G +  E+ 
Sbjct: 199 PVDLWSVGCIFAEMF 213

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 128 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 184
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 153 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR- 209
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 210 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L EV  L  L HPN++KL  +  +  +  L+ E    G + + + S+       + R  I
Sbjct: 98  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--I 155
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 280
                 G+ ++H  +  +++RD K  N+LL++   D N ++ DFGL+      + S    
Sbjct: 156 IRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMK 210
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 211 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 149 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 205
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 206 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 149 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 205
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 206 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 112 ANFRQDRVLXXXXXXCVYKGFISEDLREG--LQPVPVAVK---VHDGDNSYQGHREWLAE 166
           ANFR ++ +         +G  SE  R    L  VPVA+K   + D  ++ +   + + E
Sbjct: 32  ANFRIEKKIG--------RGQFSEVYRAACLLDGVPVALKKVQIFDLMDA-KARADCIKE 82
Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKIA 224
           +  L  L+HPN++K      ED    ++ E    G +   +  F K    +P     K  
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
                 L  +H   + V++RD K +N+ +      KL D GL +      K+  +  ++G
Sbjct: 143 VQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 198
Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           T  Y +PE I       +SD++S G +L E+
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 126 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 182
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 150 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 206
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 207 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 104/253 (41%), Gaps = 38/253 (15%)
Query: 154 DNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DEHRVLIYEFMARGSVENNLFSKV 211
           D S +  R++  E   L   SHPN++ ++G C      H  LI  +M  GS+ N L    
Sbjct: 45  DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT 104
Query: 212 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS--DFGLAKD 269
              +  S  +K A   A+G+AFLH  E  +      + ++++D D  A++S  D   +  
Sbjct: 105 NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164
Query: 270 GPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPR--SDVYSFGVVLLEILTGRKSLDKSR 326
            P           M    + APE +      T R  +D++SF V+L E++T         
Sbjct: 165 SPGR---------MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT--------- 206
Query: 327 PAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPV--KGVH-KAAMLAYHCLNHNPKARP 383
             RE   AD +                 LEG  P    G+    + L   C+N +P  RP
Sbjct: 207 --REVPFADLSNMEIGMKVA--------LEGLRPTIPPGISPHVSKLMKICMNEDPAKRP 256
Query: 384 LMRDIVDSLEPLQ 396
               IV  LE +Q
Sbjct: 257 KFDMIVPILEKMQ 269

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 159 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 215
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 216 ----WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL 234
           HP+++ LI          L+++ M +G + + L  KV L    +    I     + ++FL
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET--RSIMRSLLEAVSFL 216
Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI 294
           H     +++RD K  NILLD +   +LSDFG +     G+K      + GT GY APE +
Sbjct: 217 HANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEIL 271
Query: 295 MTGH------LTPRSDVYSFGVVLLEILTG 318
                          D+++ GV+L  +L G
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 83/195 (42%), Gaps = 15/195 (7%)
Query: 130 KGFISEDLREGLQPVPVA-VKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYC 185
           K F + DL+ G + V +  V+V  G+         + EV  L HL    HPN+V+L   C
Sbjct: 26  KVFKARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLETFEHPNVVRLFDVC 83
Query: 186 C---EDEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAEKPV 241
                D    L   F            KV  P +P      + F   +GL FLH     V
Sbjct: 84  TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--V 141
Query: 242 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           ++RD K  NIL+ +    KL+DFGLA+           T ++ T  Y APE ++      
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 302 RSDVYSFGVVLLEIL 316
             D++S G +  E+ 
Sbjct: 199 PVDLWSVGCIFAEMF 213

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR- 220
           +++ E+  L    HP +VKL+G    D    ++ EF   G+V+      ++L L   +  
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD-----AIMLELDRGLTE 116
Query: 221 ---MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
                +     + L FLH   K +I+RD K  N+L+  + + +L+DFG++    +  +  
Sbjct: 117 PQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 278 VSTRIMGTYGYAAPEYIM--TGHLTP---RSDVYSFGVVLLEI 315
            S   +GT  + APE +M  T   TP   ++D++S G+ L+E+
Sbjct: 175 DS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CV KG   E  R       VAVK+    +     RE   E+     L H N++  I    
Sbjct: 15  CVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIASDM 72
Query: 187 EDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------E 236
              +      LI  +   GS+ + L  + L P    + +++A  AA GLA LH      +
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHVSTR-IMGTYGYAAPEYI 294
            +  + +RDFK+ N+L+ ++    ++D GLA    +G D   +     +GT  Y APE +
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 295 MTGHLT------PRSDVYSFGVVLLEI 315
                T        +D+++FG+VL EI
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR- 220
           +++ E+  L    HP +VKL+G    D    ++ EF   G+V+      ++L L   +  
Sbjct: 54  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD-----AIMLELDRGLTE 108
Query: 221 ---MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
                +     + L FLH   K +I+RD K  N+L+  + + +L+DFG++    +  +  
Sbjct: 109 PQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 166
Query: 278 VSTRIMGTYGYAAPEYIM--TGHLTP---RSDVYSFGVVLLEI 315
            S   +GT  + APE +M  T   TP   ++D++S G+ L+E+
Sbjct: 167 DS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH +EK V+YRD K  N++LD D + K++DFGL K   EG K   + + 
Sbjct: 115 YGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKX 170
Query: 283 M-GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 171 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH +EK V+YRD K  N++LD D + K++DFGL K+G +   +      
Sbjct: 113 YGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXF 169
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 170 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 83/195 (42%), Gaps = 15/195 (7%)
Query: 130 KGFISEDLREGLQPVPVA-VKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYC 185
           K F + DL+ G + V +  V+V  G+         + EV  L HL    HPN+V+L   C
Sbjct: 26  KVFKARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLETFEHPNVVRLFDVC 83
Query: 186 C---EDEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAEKPV 241
                D    L   F            KV  P +P      + F   +GL FLH     V
Sbjct: 84  TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--V 141
Query: 242 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 301
           ++RD K  NIL+ +    KL+DFGLA+           T ++ T  Y APE ++      
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 302 RSDVYSFGVVLLEIL 316
             D++S G +  E+ 
Sbjct: 199 PVDLWSVGCIFAEMF 213

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH +EK V+YRD K  N++LD D + K++DFGL K+G +   +      
Sbjct: 114 YGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXF 170
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 10/159 (6%)
Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           E++ E   + +LSH  LV+L G C +     +I E+MA G + N L  ++         +
Sbjct: 50  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLL 108
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           ++     + + +L    K  ++RD    N L++     K+SDFGL++     D  + S+R
Sbjct: 109 EMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSR 164
Query: 282 IMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             G+     ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 165 --GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 81/191 (42%), Gaps = 19/191 (9%)
Query: 144 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 202
           + VAVK+             ++E+  L +L +H N+V L+G C      ++I E+   G 
Sbjct: 77  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 136
Query: 203 VENNLFSK----------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 246
           + N L  K                  L L     +  ++  AKG+AFL  A K  I+RD 
Sbjct: 137 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 194
Query: 247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 306
              NILL      K+ DFGLA+         V         + APE I     T  SDV+
Sbjct: 195 AARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 307 SFGVVLLEILT 317
           S+G+ L E+ +
Sbjct: 255 SYGIFLWELFS 265

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ D+GLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L EV  L  L HPN+ KL  +  +  +  L+ E    G + + + S+       + R  I
Sbjct: 74  LREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--I 131
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 280
                 G+ + H  +  +++RD K  N+LL++   D N ++ DFGL+      + S    
Sbjct: 132 IRQVLSGITYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKXK 186
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 148 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 205
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 179 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 237
Query: 206 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 238 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 286
Query: 260 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 287 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 340
Query: 316 LTG 318
           + G
Sbjct: 341 VDG 343

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR 
Sbjct: 126 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR- 182
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-IMGTY 286
           A GL FL    K +IYRD K  N++LD++ + K++DFG+ K   E     V+T+   GT 
Sbjct: 452 AIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTP 506
Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            Y APE I         D ++FGV+L E+L G+
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 7/177 (3%)
Query: 144 VPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           V VAVK    D   Q     +++ EV  +  L H NL++L G       + ++ E    G
Sbjct: 41  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 99
Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
           S+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    K+
Sbjct: 100 SLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKI 156
Query: 262 SDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            DFGL +  P+ D  +V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 157 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 51  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 108 NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 164
Query: 265 GLAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           GL++   + ++ S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 165 GLSRYVLDDEETSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKI 223
           E+  L  + HPN+V L        H  LI + ++ G     LF +++    ++ R   ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG----ELFDRIVEKGFYTERDASRL 121
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNIL---LDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F     + +LH+    +++RD K  N+L   LD D    +SDFGL+K     D   V +
Sbjct: 122 IFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              GT GY APE +     +   D +S GV+   +L G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR 
Sbjct: 150 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR- 206
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 207 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 148 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 205
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 57  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 115
Query: 206 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 116 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 164
Query: 260 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 165 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 218
Query: 316 LTG 318
           + G
Sbjct: 219 VDG 221

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKI 223
           E+  L  + HPN+V L        H  LI + ++ G     LF +++    ++ R   ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG----ELFDRIVEKGFYTERDASRL 121
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNIL---LDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F     + +LH+    +++RD K  N+L   LD D    +SDFGL+K     D   V +
Sbjct: 122 IFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              GT GY APE +     +   D +S GV+   +L G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKI 223
           E+  L  + HPN+V L        H  LI + ++ G     LF +++    ++ R   ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG----ELFDRIVEKGFYTERDASRL 121
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNIL---LDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F     + +LH+    +++RD K  N+L   LD D    +SDFGL+K     D   V +
Sbjct: 122 IFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              GT GY APE +     +   D +S GV+   +L G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 148 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 205
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 59  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 117
Query: 206 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 118 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 166
Query: 260 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 167 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 220
Query: 316 LTG 318
           + G
Sbjct: 221 VDG 223

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 7/177 (3%)
Query: 144 VPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           V VAVK    D   Q     +++ EV  +  L H NL++L G       + ++ E    G
Sbjct: 37  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 95
Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
           S+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    K+
Sbjct: 96  SLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKI 152
Query: 262 SDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            DFGL +  P+ D  +V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKI 223
           E+  L  + HPN+V L        H  LI + ++ G     LF +++    ++ R   ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG----ELFDRIVEKGFYTERDASRL 121
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNIL---LDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F     + +LH+    +++RD K  N+L   LD D    +SDFGL+K     D   V +
Sbjct: 122 IFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              GT GY APE +     +   D +S GV+   +L G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 31  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 88  NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 144
Query: 265 GLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           GL++   + +  S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 145 GLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 35  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 91
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 92  NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 148
Query: 265 GLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           GL++   + +  S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 149 GLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
           + A   L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +G
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VG 352
Query: 285 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 318
           T+GY APE +  G      +D +S G +L ++L G
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
           + A   L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +G
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VG 352
Query: 285 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 318
           T+GY APE +  G      +D +S G +L ++L G
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 7/179 (3%)
Query: 142 QPVPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           + V VAVK    D   Q     +++ EV  +  L H NL++L G       + ++ E   
Sbjct: 39  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAP 97
Query: 200 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
            GS+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    
Sbjct: 98  LGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLV 154
Query: 260 KLSDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           K+ DFGL +  P+ D  +V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 155 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 7/177 (3%)
Query: 144 VPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           V VAVK    D   Q     +++ EV  +  L H NL++L G       + ++ E    G
Sbjct: 47  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 105
Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
           S+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    K+
Sbjct: 106 SLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKI 162
Query: 262 SDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            DFGL +  P+ D  +V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTY 286
           A GL FL    K +IYRD K  N++LD++ + K++DFG+ K   E     V+T+   GT 
Sbjct: 131 AIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTP 185
Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            Y APE I         D ++FGV+L E+L G+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 7/179 (3%)
Query: 142 QPVPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
           + V VAVK    D   Q     +++ EV  +  L H NL++L G       + ++ E   
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAP 93
Query: 200 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
            GS+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLV 150
Query: 260 KLSDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           K+ DFGL +  P+ D  +V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
           + A   L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +G
Sbjct: 296 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VG 351
Query: 285 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 318
           T+GY APE +  G      +D +S G +L ++L G
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           GL  LH+  + +IYRD K  N+LLD D N ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE ++        D ++ GV L E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
           + A   L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +G
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VG 352
Query: 285 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 318
           T+GY APE +  G      +D +S G +L ++L G
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           GL  LH+  + +IYRD K  N+LLD D N ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE ++        D ++ GV L E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 36  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 92
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 93  NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 149
Query: 265 GLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           GL++   + +  S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 150 GLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           GL  LH+  + +IYRD K  N+LLD D N ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE ++        D ++ GV L E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           GL  LH+  + +IYRD K  N+LLD D N ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE ++        D ++ GV L E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 51  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 108 NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 164
Query: 265 GLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           GL++   + +  S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 165 GLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 148 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 205
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 106
Query: 206 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 107 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 155
Query: 260 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 156 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 316 LTG 318
           + G
Sbjct: 210 VDG 212

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 148 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 205
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 102 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 160
Query: 206 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 161 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 209
Query: 260 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 210 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 263
Query: 316 LTG 318
           + G
Sbjct: 264 VDG 266

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 148 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 205
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 52  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 110
Query: 206 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 111 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 159
Query: 260 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 160 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 213
Query: 316 LTG 318
           + G
Sbjct: 214 VDG 216

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 13/185 (7%)
Query: 144 VPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR------VLIYE 196
           V VAVK+   D  +     E+L E   +    HP++ KL+G       +      ++I  
Sbjct: 52  VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111
Query: 197 FMARGSVENNLFSKVL----LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 252
           FM  G +   L +  +      LP    ++     A G+ +L  + +  I+RD    N +
Sbjct: 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCM 169
Query: 253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           L  D    ++DFGL++    GD             + A E +     T  SDV++FGV +
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229
Query: 313 LEILT 317
            EI+T
Sbjct: 230 WEIMT 234

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 146 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 204
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 42  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 98
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 99  NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 155
Query: 265 GLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           GL++   + +  S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 156 GLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 23/176 (13%)
Query: 152 DGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV 211
           D  N  + H E   E+  L  L HPN++KL     + ++  L+ EF   G     LF ++
Sbjct: 82  DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQI 137
Query: 212 LLPLPWS--IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSDFGL 266
           +    +       I      G+ +LH+    +++RD K  NILL+      N K+ DFGL
Sbjct: 138 INRHKFDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGL 195
Query: 267 ----AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
               +KD    D+       +GT  Y APE ++      + DV+S GV++  +L G
Sbjct: 196 SSFFSKDYKLRDR-------LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 7/177 (3%)
Query: 144 VPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           V VAVK    D   Q     +++ EV  +  L H NL++L G       + ++ E    G
Sbjct: 37  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 95
Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
           S+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    K+
Sbjct: 96  SLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKI 152
Query: 262 SDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            DFGL +  P+ D   V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 153 GDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 7/177 (3%)
Query: 144 VPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 201
           V VAVK    D   Q     +++ EV  +  L H NL++L G       + ++ E    G
Sbjct: 47  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 105
Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
           S+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    K+
Sbjct: 106 SLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKI 162
Query: 262 SDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            DFGL +  P+ D   V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 163 GDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+  FGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 229
           +  L HP  VKL  +C +D+ ++    +      +N    K +  +         F  A+
Sbjct: 91  MSRLDHPFFVKLY-FCFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 145
Query: 230 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 146 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKL------IGYCCEDEHRVLIYEFMA 199
           VA+K    + S +    W  E+  +  L+HPN+V        +     ++  +L  E+  
Sbjct: 43  VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCE 102
Query: 200 RGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
            G +    N F          IR  ++   +  L +LHE    +I+RD K  NI+L    
Sbjct: 103 GGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHENR--IIHRDLKPENIVLQPGP 159
Query: 258 NA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 314
                K+ D G AK   E D+  + T  +GT  Y APE +     T   D +SFG +  E
Sbjct: 160 QRLIHKIIDLGYAK---ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFE 216
Query: 315 ILTG 318
            +TG
Sbjct: 217 CITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKL------IGYCCEDEHRVLIYEFMA 199
           VA+K    + S +    W  E+  +  L+HPN+V        +     ++  +L  E+  
Sbjct: 42  VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCE 101
Query: 200 RGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
            G +    N F          IR  ++   +  L +LHE    +I+RD K  NI+L    
Sbjct: 102 GGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHENR--IIHRDLKPENIVLQPGP 158
Query: 258 NA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 314
                K+ D G AK   E D+  + T  +GT  Y APE +     T   D +SFG +  E
Sbjct: 159 QRLIHKIIDLGYAK---ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFE 215
Query: 315 ILTG 318
            +TG
Sbjct: 216 CITG 219

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 15/160 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--M 221
           L EV  L  L HPN++KL     +     ++ E    G     LF +++    +S     
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA 124
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHV 278
           +I      G+ ++H  +  +++RD K  NILL++   D + K+ DFGL+    +  K  +
Sbjct: 125 RIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--M 180
Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             RI GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 50/85 (58%), Gaps = 6/85 (7%)
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL- 299
           V++RD K  N+LLD   NAK++DFGL+    +G+    S    G+  YAAPE +++G L 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLY 187
Query: 300 -TPRSDVYSFGVVLLEILTGRKSLD 323
             P  D++S GV+L  +L G    D
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 14/195 (7%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K  + +       E L E+  +    HPN+V         +   L+ + ++ GSV +
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 206 NLFSKVLLP------LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
            +   V         L  S    I     +GL +LH+  +  I+RD K  NILL  D + 
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSV 155
Query: 260 KLSDFGLA---KDGPEGDKSHVSTRIMGTYGYAAPEYI--MTGHLTPRSDVYSFGVVLLE 314
           +++DFG++     G +  ++ V    +GT  + APE +  + G+   ++D++SFG+  +E
Sbjct: 156 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIE 214
Query: 315 ILTGRKSLDKSRPAR 329
           + TG     K  P +
Sbjct: 215 LATGAAPYHKYPPMK 229

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 14/195 (7%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 205
           VA+K  + +       E L E+  +    HPN+V         +   L+ + ++ GSV +
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 206 NLFSKVLLP------LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
            +   V         L  S    I     +GL +LH+  +  I+RD K  NILL  D + 
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSV 160
Query: 260 KLSDFGLA---KDGPEGDKSHVSTRIMGTYGYAAPEYI--MTGHLTPRSDVYSFGVVLLE 314
           +++DFG++     G +  ++ V    +GT  + APE +  + G+   ++D++SFG+  +E
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIE 219
Query: 315 ILTGRKSLDKSRPAR 329
           + TG     K  P +
Sbjct: 220 LATGAAPYHKYPPMK 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 15/160 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--M 221
           L EV  L  L HPN++KL     +     ++ E    G     LF +++    +S     
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAA 124
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHV 278
           +I      G+ ++H+    +++RD K  NILL++   D + K+ DFGL+    +  K  +
Sbjct: 125 RIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--M 180
Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             RI GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 15/160 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--M 221
           L EV  L  L HPN++KL     +     ++ E    G     LF +++    +S     
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAA 124
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHV 278
           +I      G+ ++H+    +++RD K  NILL++   D + K+ DFGL+    +  K  +
Sbjct: 125 RIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--M 180
Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             RI GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DF LA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH   + V+YRD K  N++LD D + K++DFGL K+G   D + + T  
Sbjct: 113 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-F 168
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH   + V+YRD K  N++LD D + K++DFGL K+G   D + + T  
Sbjct: 110 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-F 165
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/234 (21%), Positives = 97/234 (41%), Gaps = 39/234 (16%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLLP----LPWSI 219
           EV  L ++ HPN+V+      E+    ++ ++   G +   + ++  VL      L W +
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
           ++         LA  H  ++ +++RD K+ NI L  D   +L DFG+A+         ++
Sbjct: 133 QI--------CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR--VLNSTVELA 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXX 339
              +GT  Y +PE         +SD+++ G VL E+ T + + +                
Sbjct: 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-------------- 228
Query: 340 XXXXXXXXXNIIDPRLEGDYPVKGVHKA---AMLAYHCLNHNPKARPLMRDIVD 390
                    N++   + G +P   +H +     L       NP+ RP +  I++
Sbjct: 229 ------SMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH   + V+YRD K  N++LD D + K++DFGL K+G   D + + T  
Sbjct: 110 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-F 165
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR- 186
Query: 283 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 9/157 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN-NLFSKVLLPLPWSIRMK 222
           + E+  L  L H NLV L+  C + +   L++EF+    +++  LF      L + +  K
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQK 128
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
             F    G+ F H     +I+RD K  NIL+      KL DFG A+         V    
Sbjct: 129 YLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDE 184
Query: 283 MGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTG 318
           + T  Y APE ++      ++ DV++ G ++ E+  G
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 21/163 (12%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS----- 218
           L EV  L  L HPN++KL  +  +  +  L+ E    G     LF +++L   +S     
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGG----ELFDEIILRQKFSEVDAA 107
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 275
           + MK       G  +LH  +  +++RD K  N+LL++   D   K+ DFGL+     G K
Sbjct: 108 VIMKQVLS---GTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK 162
Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             +  R +GT  Y APE ++      + DV+S GV+L  +L G
Sbjct: 163 --MKER-LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+    HL HPN++++  Y  + +   L+ EF  RG +   L          S       
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 124
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-G 284
             A  L + H  E+ VI+RD K  N+L+      K++DFG +   P      +  R M G
Sbjct: 125 --ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCG 175
Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
           T  Y  PE I       + D++  GV+  E L G    D
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+    HL H N+V+ +G   E+    +  E +  GS+   L SK   PL  +    I F
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDN-EQTIGF 126
Query: 226 GAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVST 280
              +   GL +LH+ +  +++RD K  N+L++T Y+   K+SDFG +K       +  + 
Sbjct: 127 YTKQILEGLKYLHDNQ--IVHRDIKGDNVLINT-YSGVLKISDFGTSKR--LAGINPCTE 181
Query: 281 RIMGTYGYAAPEYIMTGHLTPR-----SDVYSFGVVLLEILTGR 319
              GT  Y APE I  G   PR     +D++S G  ++E+ TG+
Sbjct: 182 TFTGTLQYMAPEIIDKG---PRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+    HL HPN++++  Y  + +   L+ EF  RG +   L          S       
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 123
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-G 284
             A  L + H  E+ VI+RD K  N+L+      K++DFG +   P      +  R M G
Sbjct: 124 --ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCG 174
Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
           T  Y  PE I       + D++  GV+  E L G    D
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS----- 218
           L EV  L  L HPN++KL  +  +  +  L+ E    G     LF +++L   +S     
Sbjct: 69  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGG----ELFDEIILRQKFSEVDAA 124
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 275
           + MK       G  +LH+    +++RD K  N+LL++   D   K+ DFGL+     G K
Sbjct: 125 VIMKQVLS---GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK 179
Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
                  +GT  Y APE ++      + DV+S GV+L  +L G
Sbjct: 180 ---MKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 59/121 (48%), Gaps = 5/121 (4%)
Query: 196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           EF  +G++E  +  +    L   + +++     KG+ ++H   K +I+RD K SNI L  
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFLVD 171
Query: 256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
               K+ DFGL        K    TR  GT  Y +PE I +       D+Y+ G++L E+
Sbjct: 172 TKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 316 L 316
           L
Sbjct: 229 L 229

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 146 VAVKV--HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG--YCCEDEHRVLIYEFMARG 201
           VAVK   H G +     R++  E+  L  L    +VK  G  Y    +   L+ E++  G
Sbjct: 42  VAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
            + + L  +    L  S  +  +    KG+ +L    +  ++RD    NIL++++ + K+
Sbjct: 99  CLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKI 155
Query: 262 SDFGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           +DFGLAK  P  DK +   R  G     + APE +     + +SDV+SFGVVL E+ T
Sbjct: 156 ADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 134 SEDLREGLQPVPVAVKVHDG-DNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHR 191
           S D R G   V    K+ D   NS    R +  E++ L  LS H N+V L+     D  R
Sbjct: 28  SIDRRTG--EVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNLLNVLRADNDR 84
Query: 192 --VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS 249
              L++++M    +   + + +L P+    +  + +   K + +LH     +++RD K S
Sbjct: 85  DVYLVFDYM-ETDLHAVIRANILEPVH---KQYVVYQLIKVIKYLHSG--GLLHRDMKPS 138
Query: 250 NILLDTDYNAKLSDFGLAK-----------------DGPEG--DKSHVSTRIMGTYGYAA 290
           NILL+ + + K++DFGL++                 +  E   D   + T  + T  Y A
Sbjct: 139 NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRA 198
Query: 291 PEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           PE ++ +   T   D++S G +L EIL G+
Sbjct: 199 PEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 50/85 (58%), Gaps = 6/85 (7%)
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL- 299
           V++RD K  N+LLD   NAK++DFGL+    +G+    S    G+  YAAPE +++G L 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPE-VISGRLY 187
Query: 300 -TPRSDVYSFGVVLLEILTGRKSLD 323
             P  D++S GV+L  +L G    D
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 30/183 (16%)
Query: 148 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLIG-YCCEDEHRVLIYEFMARGSVEN 205
           V V   D   Q  RE L  EV+ +    H N+V +   Y   DE  V++ EF+  G++ +
Sbjct: 73  VAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVM-EFLEGGALTD 131
Query: 206 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
                    +    RM       +     + L++LH   + VI+RD K+ +ILL +D   
Sbjct: 132 ---------IVTHTRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRI 180
Query: 260 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           KLSDFG    ++K+ P+         ++GT  + APE I         D++S G++++E+
Sbjct: 181 KLSDFGFCAQVSKEVPK------RKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 234
Query: 316 LTG 318
           + G
Sbjct: 235 IDG 237

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 93  DSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVK--- 149
           ++A   LIA    EL  + + +   R +       V  G  SE        +PVA+K   
Sbjct: 7   EAAMRDLIA----ELHAMQSPYTVQRFISSGSYGAVCAGVDSEG-------IPVAIKRVF 55
Query: 150 --VHDG------DNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE----HRVLIYEF 197
             V DG       +S+   R  L E+  L H  HPN++ L       E    H++ +   
Sbjct: 56  NTVSDGRTVNILSDSFLCKR-VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE 114
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           + R  +   +  + ++  P  I+    +    GL  LHEA   V++RD    NILL  + 
Sbjct: 115 LMRTDLAQVIHDQRIVISPQHIQY-FMYHILLGLHVLHEA--GVVHRDLHPGNILLADNN 171
Query: 258 NAKLSDFGLAK-DGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEI 315
           +  + DF LA+ D  + +K+H  T       Y APE +M     T   D++S G V+ E+
Sbjct: 172 DITICDFNLAREDTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 316 LTGRKSL 322
              RK+L
Sbjct: 228 F-NRKAL 233

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLXGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 146 VAVKV--HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG--YCCEDEHRVLIYEFMARG 201
           VAVK   H G +     R++  E+  L  L    +VK  G  Y    +   L+ E++  G
Sbjct: 55  VAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
            + + L  +    L  S  +  +    KG+ +L    +  ++RD    NIL++++ + K+
Sbjct: 112 CLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKI 168
Query: 262 SDFGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           +DFGLAK  P  DK +   R  G     + APE +     + +SDV+SFGVVL E+ T
Sbjct: 169 ADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 146 VAVKV--HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG--YCCEDEHRVLIYEFMARG 201
           VAVK   H G +     R++  E+  L  L    +VK  G  Y    +   L+ E++  G
Sbjct: 43  VAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 99
Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
            + + L  +    L  S  +  +    KG+ +L    +  ++RD    NIL++++ + K+
Sbjct: 100 CLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKI 156
Query: 262 SDFGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           +DFGLAK  P  DK +   R  G     + APE +     + +SDV+SFGVVL E+ T
Sbjct: 157 ADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH   + V+YRD K  N++LD D + K++DFGL K+G     +      
Sbjct: 110 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+    HL H N+V+ +G   E+    +  E +  GS+   L SK   PL  +    I F
Sbjct: 55  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDN-EQTIGF 112
Query: 226 GAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVST 280
              +   GL +LH+ +  +++RD K  N+L++T Y+   K+SDFG +K       +  + 
Sbjct: 113 YTKQILEGLKYLHDNQ--IVHRDIKGDNVLINT-YSGVLKISDFGTSKR--LAGINPCTE 167
Query: 281 RIMGTYGYAAPEYIMTGHLTPR-----SDVYSFGVVLLEILTGR 319
              GT  Y APE I  G   PR     +D++S G  ++E+ TG+
Sbjct: 168 TFTGTLQYMAPEIIDKG---PRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH   + V+YRD K  N++LD D + K++DFGL K+G     +      
Sbjct: 115 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 170
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 93  DSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVK--- 149
           ++A   LIA    EL  + + +   R +       V  G  SE        +PVA+K   
Sbjct: 7   EAAMRDLIA----ELHAMQSPYTVQRFISSGSYGAVCAGVDSEG-------IPVAIKRVF 55
Query: 150 --VHDG------DNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE----HRVLIYEF 197
             V DG       +S+   R  L E+  L H  HPN++ L       E    H++ +   
Sbjct: 56  NTVSDGRTVNILSDSFLCKR-VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE 114
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           + R  +   +  + ++  P  I+    +    GL  LHEA   V++RD    NILL  + 
Sbjct: 115 LMRTDLAQVIHDQRIVISPQHIQY-FMYHILLGLHVLHEA--GVVHRDLHPGNILLADNN 171
Query: 258 NAKLSDFGLAK-DGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEI 315
           +  + DF LA+ D  + +K+H  T       Y APE +M     T   D++S G V+ E+
Sbjct: 172 DITICDFNLAREDTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 316 LTGRKSL 322
              RK+L
Sbjct: 228 F-NRKAL 233

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           LA  H  +  +IYRD K  NILLD++ +  L+DFGL+K+    D++  +    GT  Y A
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMA 228
Query: 291 PEYIM---TGHLTPRSDVYSFGVVLLEILTG 318
           P+ +    +GH     D +S GV++ E+LTG
Sbjct: 229 PDIVRGGDSGH-DKAVDWWSLGVLMYELLTG 258

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLVGIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S GV++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 12/164 (7%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP---WSIRM 221
            E+     L +P++V   G+  +D+   ++ E   R S+      +  +  P   + +R 
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
            I     +G+ +LH     VI+RD K  N+ L+ D + K+ DFGLA    E D     T 
Sbjct: 151 TI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATK-IEFDGERKKT- 201
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
           + GT  Y APE +     +   D++S G +L  +L G+   + S
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH   + V+YRD K  N++LD D + K++DFGL K+G     +      
Sbjct: 110 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCE--DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           E+  L  L HPN+VKL+    +  ++H  +++E + +G V   +    L PL        
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARFY 142
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
                KG+ +LH  +  +I+RD K SN+L+  D + K++DFG++ +    D   + +  +
Sbjct: 143 FQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTV 198
Query: 284 GTYGYAAPEY------IMTGHLTPRSDVYSFGVVLLEILTGR 319
           GT  + APE       I +G      DV++ GV L   + G+
Sbjct: 199 GTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQ 237

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 225 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           +GA     L +LH   + V+YRD K  N++LD D + K++DFGL K+G     +      
Sbjct: 110 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAF 225
           +   + P +V+L     +D++  ++ E+M  G + N L S   +P  W    +  + +A 
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLAL 187
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
            A   +  +H        RD K  N+LLD   + KL+DFG      E    H  T + GT
Sbjct: 188 DAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GT 238
Query: 286 YGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTG 318
             Y +PE + +    G+     D +S GV L E+L G
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLVGIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S GV++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 20/162 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHR------VLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E+  L H+ H N++ L+     DE         L+  FM  G+    L     L      
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG---ED 128
Query: 220 RMK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
           R++ + +   KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+         V
Sbjct: 129 RIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXV 186
Query: 279 STRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
            TR      Y APE I+     T   D++S G ++ E++TG+
Sbjct: 187 VTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           +F  AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  +           
Sbjct: 204 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 261
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
               + APE I     T +SDV+SFGV+L EI +
Sbjct: 262 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           +F  AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  +           
Sbjct: 197 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 254
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
               + APE I     T +SDV+SFGV+L EI +
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           +F  AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  +           
Sbjct: 199 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
               + APE I     T +SDV+SFGV+L EI +
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTY 286
           +GL ++H A+  VI+RD K SN+L++ +   K+ DFG+A+       +  +  T  + T 
Sbjct: 170 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 287 GYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRK 320
            Y APE +++ H  T   D++S G +  E+L  R+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 120
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 121 MSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 175
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           +F  AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  +           
Sbjct: 206 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 263
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
               + APE I     T +SDV+SFGV+L EI +
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLXGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 7/160 (4%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E+  L  L H N+V+L      D+   L++EF  +       F      L   I    
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSF 106
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   KGL F H   + V++RD K  N+L++ +   KL+DFGLA+    G      +  +
Sbjct: 107 LFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLADFGLAR--AFGIPVRCYSAEV 162
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSL 322
            T  Y  P+ +    L   S D++S G +  E+    + L
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 229
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE 140
Query: 230 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            Y +PE +     +  SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP---WSIRM 221
            E+     L +P++V   G+  +D+   ++ E   R S+      +  +  P   + +R 
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVST 280
            I     +G+ +LH     VI+RD K  N+ L+ D + K+ DFGLA K   +G++     
Sbjct: 151 TI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX-- 201
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
            + GT  Y APE +     +   D++S G +L  +L G+   + S
Sbjct: 202 -LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTY 286
           +GL ++H A+  VI+RD K SN+L++ +   K+ DFG+A+       +  +  T  + T 
Sbjct: 169 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 287 GYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRK 320
            Y APE +++ H  T   D++S G +  E+L  R+
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP---WSIRM 221
            E+     L +P++V   G+  +D+   ++ E   R S+      +  +  P   + +R 
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVST 280
            I     +G+ +LH     VI+RD K  N+ L+ D + K+ DFGLA K   +G++     
Sbjct: 151 TI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KK 200
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
            + GT  Y APE +     +   D++S G +L  +L G+   + S
Sbjct: 201 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP---WSIRM 221
            E+     L +P++V   G+  +D+   ++ E   R S+      +  +  P   + +R 
Sbjct: 75  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 134
Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVST 280
            I     +G+ +LH     VI+RD K  N+ L+ D + K+ DFGLA K   +G++     
Sbjct: 135 TI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KK 184
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
            + GT  Y APE +     +   D++S G +L  +L G+   + S
Sbjct: 185 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 229
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 63  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 117
Query: 230 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 118 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 122 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT-- 285
            KG+ +L    +  ++RD    NIL++++ + K++DFGLAK  P  DK     R  G   
Sbjct: 121 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDXXVVREPGQSP 177
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             + APE +     + +SDV+SFGVVL E+ T
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           A  L +LH     ++YRD K  NILLD+  +  L+DFGL K+  E + +  ++   GT  
Sbjct: 149 ASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPE 204
Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           Y APE +         D +  G VL E+L G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 119 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 18/161 (11%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E+  L  LSHPN++KL           L+ E +  G     LF +++    +S R   A
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERD--A 150
Query: 225 FGAAK----GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSH 277
             A K     +A+LHE    +++RD K  N+L  T   D   K++DFGL+K     +   
Sbjct: 151 ADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQV 205
Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +   + GT GY APE +      P  D++S G++   +L G
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 138 REGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           R+ +  V  A+K+      S   + + L EV  L  L HPN++KL  +  +  +  L+ E
Sbjct: 57  RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116
Query: 197 FMARGSVENNLFSKVLL-PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
               G + + +  ++    +  ++ +K       G+ +LH  +  +++RD K  N+LL++
Sbjct: 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYLH--KHNIVHRDLKPENLLLES 171
Query: 256 ---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
              D   K+ DFGL+      ++  +  R +GT  Y APE ++      + DV+S GV+L
Sbjct: 172 KEKDALIKIVDFGLS--AVFENQKKMKER-LGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
Query: 313 LEILTG 318
             +L G
Sbjct: 228 FILLAG 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 126 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 72  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 126
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 127 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 181
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 182 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 128
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 129 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 183
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK- 222
           L E+  L H  H N++ +      D        ++ +  ++ +L   +   +     ++ 
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---------DGPEG 273
             +   + +  LH +   VI+RD K SN+L++++ + K+ DFGLA+           P G
Sbjct: 117 FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLDKSRPAREQN 332
            +S + T  + T  Y APE ++T     R+ DV+S G +L E+   R+ +   R  R Q 
Sbjct: 175 QQSGM-TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQL 232
Query: 333 L 333
           L
Sbjct: 233 L 233

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ L  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIHMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       + + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 165
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 166 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 220
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 121
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 122 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 176
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 165
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 166 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 220
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 128
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 129 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 183
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 121
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 122 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 176
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 12/109 (11%)
Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL--AKDGPEGDK 275
           S+ + I    A+ + FLH   K +++RD K SNI    D   K+ DFGL  A D  E ++
Sbjct: 118 SVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 276 SHVS--------TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 316
           + ++        T  +GT  Y +PE I     + + D++S G++L E+L
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD---G 270
           P+     +  +F  A+G+ FL  + +  I+RD    NILL  +   K+ DFGLA+D    
Sbjct: 195 PITMEDLISYSFQVARGMEFL--SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           P+  +    TR+     + APE I     + +SDV+S+GV+L EI +
Sbjct: 253 PDYVRKG-DTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK- 222
           L E+  L H  H N++ +      D        ++ +  ++ +L   +   +     ++ 
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---------DGPEG 273
             +   + +  LH +   VI+RD K SN+L++++ + K+ DFGLA+           P G
Sbjct: 117 FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLDKSRPAREQN 332
            +S + T  + T  Y APE ++T     R+ DV+S G +L E+   R+ +   R  R Q 
Sbjct: 175 QQSGM-TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQL 232
Query: 333 L 333
           L
Sbjct: 233 L 233

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 120
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 121 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 288
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++  V   + GT  Y
Sbjct: 153 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 207
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 288
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++  V   + GT  Y
Sbjct: 151 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 205
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 206 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y 
Sbjct: 147 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +PE +        SD+++ G ++ +++ G
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ L  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 71  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIHMELDHER 125
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       + + 
Sbjct: 126 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---ASTNFMM 180
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 181 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 17/102 (16%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-------------GDK 275
           + L+++H   + +I+RD K  NI +D   N K+ DFGLAK+                G  
Sbjct: 127 EALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 276 SHVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEIL 316
            ++++ I GT  Y A E +  TGH   + D+YS G++  E++
Sbjct: 185 DNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL- 231
           L HPN+V+L     E+ H  LI++ +  G +  ++ ++      +      +    + L 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILE 132
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           A LH  +  V++RD K  N+LL +       KL+DFGLA +  EG++        GT GY
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQ-QAWFGFAGTPGY 190
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            +PE +         D+++ GV+L  +L G
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 17/102 (16%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-------------GDK 275
           + L+++H   + +I+RD K  NI +D   N K+ DFGLAK+                G  
Sbjct: 127 EALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 276 SHVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEIL 316
            ++++ I GT  Y A E +  TGH   + D+YS G++  E++
Sbjct: 185 DNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 288
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++  V   + GT  Y
Sbjct: 127 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 181
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLVGIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 35/204 (17%)
Query: 128 VYKGFISEDLREGLQPVPVA-VKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLI---- 182
           VYKG  +E        V VA  ++ D   +    + +  E   L  L HPN+V+      
Sbjct: 42  VYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWE 95
Query: 183 ----GYCCEDEHRVLIYEFMARGSVENNL----FSKVLLPLPWSIRMKIAFGAAKGLAFL 234
               G  C     VL+ E    G+++  L      K+ +   W  ++       KGL FL
Sbjct: 96  STVKGKKC----IVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQFL 145
Query: 235 HEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 293
           H    P+I+RD K  NI +     + K+ D GLA       ++  +  ++GT  + APE 
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFXAPEX 201
Query: 294 IMTGHLTPRSDVYSFGVVLLEILT 317
               +     DVY+FG   LE  T
Sbjct: 202 YEEKY-DESVDVYAFGXCXLEXAT 224

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 128
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 129 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 183
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 23/207 (11%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CV KG   E  R   Q   VAVK+    +     RE   E+     L H N++  I    
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 187 EDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------E 236
              H      LI  +   GS+ + L    L  L     ++I    A GLA LH      +
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTR-IMGTYGYAAPEYI 294
            +  + +RD K+ NIL+  +    ++D GLA       ++  V     +GT  Y APE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 295 MTGHLT------PRSDVYSFGVVLLEI 315
                        R D+++FG+VL E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 23/207 (11%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CV KG   E  R   Q   VAVK+    +     RE   E+     L H N++  I    
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 187 EDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------E 236
              H      LI  +   GS+ + L    L  L     ++I    A GLA LH      +
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTR-IMGTYGYAAPEYI 294
            +  + +RD K+ NIL+  +    ++D GLA       ++  V     +GT  Y APE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 295 MTGHLT------PRSDVYSFGVVLLEI 315
                        R D+++FG+VL E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+    G    ++
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMT 183
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             ++  Y Y APE I+        D++S G ++ E++ G
Sbjct: 184 PEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 7/160 (4%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E+  L  L H N+V+L      D+   L++EF  +       F      L   I    
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSF 106
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            F   KGL F H   + V++RD K  N+L++ +   KL++FGLA+    G      +  +
Sbjct: 107 LFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLAR--AFGIPVRCYSAEV 162
Query: 284 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSL 322
            T  Y  P+ +    L   S D++S G +  E+    + L
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 50/221 (22%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE--VIFLGHLSHPNLVKLIGY 184
            VYKG + E         PVAVKV     S+   + ++ E  +  +  + H N+ + I  
Sbjct: 28  AVYKGSLDER--------PVAVKVF----SFANRQNFINEKNIYRVPLMEHDNIARFI-- 73
Query: 185 CCEDEH--------RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH- 235
              DE          +L+ E+   GS+   L    L    W    ++A    +GLA+LH 
Sbjct: 74  -VGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 236 -----EAEKPVI-YRDFKTSNILLDTDYNAKLSDFGLA------KDGPEGDKSHVSTRIM 283
                +  KP I +RD  + N+L+  D    +SDFGL+      +    G++ + +   +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 284 GTYGYAAPEYIMTGHLTPRS--------DVYSFGVVLLEIL 316
           GT  Y APE ++ G +  R         D+Y+ G++  EI 
Sbjct: 190 GTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 11/158 (6%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E+  L  L HPNLV L+          L++E+     +      +    +P  +   I
Sbjct: 50  LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHE--LDRYQRGVPEHLVKSI 107
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSHVSTR 281
            +   + + F H+     I+RD K  NIL+      KL DFG A+   GP    S     
Sbjct: 108 TWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGP----SDYYDD 161
Query: 282 IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 318
            + T  Y +PE ++      P  DV++ G V  E+L+G
Sbjct: 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 23/207 (11%)
Query: 127 CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           CV KG   E  R   Q   VAVK+    +     RE   E+     L H N++  I    
Sbjct: 44  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 101
Query: 187 EDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------E 236
              H      LI  +   GS+ + L    L  L     ++I    A GLA LH      +
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTR-IMGTYGYAAPEYI 294
            +  + +RD K+ NIL+  +    ++D GLA       ++  V     +GT  Y APE +
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 295 MTGHLT------PRSDVYSFGVVLLEI 315
                        R D+++FG+VL E+
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL---LPLPWSIRMK 222
           E+  +  L HP LV L     +D   V+IYEFM+ G     LF KV      +     ++
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVE 153
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVST 280
                 KGL  +HE     ++ D K  NI+  T  +   KL DFGL           V+T
Sbjct: 154 YMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 211
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              GT  +AAPE      +   +D++S GV+   +L+G
Sbjct: 212 ---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 8/153 (5%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+    HL HPN+++L  Y  +     LI E+  RG +   L          +    I  
Sbjct: 73  EIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRT--ATIME 130
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A  L + H   K VI+RD K  N+LL      K++DFG +   P   +      + GT
Sbjct: 131 ELADALMYCH--GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK----TMCGT 184
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             Y  PE I       + D++  GV+  E+L G
Sbjct: 185 LDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK- 222
           L E+  L H  H N++ +      D        ++ +  ++ +L   +   +     ++ 
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---------DGPEG 273
             +   + +  LH +   VI+RD K SN+L++++ + K+ DFGLA+           P G
Sbjct: 117 FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLDKSRPAREQN 332
            +S +    + T  Y APE ++T     R+ DV+S G +L E+   R+ +   R  R Q 
Sbjct: 175 QQSGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQL 232
Query: 333 L 333
           L
Sbjct: 233 L 233

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 89/195 (45%), Gaps = 22/195 (11%)
Query: 133 ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV 192
           + E+   GL+ V   +K  + D S     +  AE+  L  L HPN++K+     ED H +
Sbjct: 40  LVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE-VFEDYHNM 95
Query: 193 LIYEFMARGS------VENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 246
            I      G       V      K L     +  MK    A   LA+ H   + V+++D 
Sbjct: 96  YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFH--SQHVVHKDL 150
Query: 247 KTSNILL-DTDYNA--KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 303
           K  NIL  DT  ++  K+ DFGLA+     +    ST   GT  Y APE +    +T + 
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPE-VFKRDVTFKC 206
Query: 304 DVYSFGVVLLEILTG 318
           D++S GVV+  +LTG
Sbjct: 207 DIWSAGVVMYFLLTG 221

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL---LPLPWSIRMK 222
           E+  +  L HP LV L     +D   V+IYEFM+ G     LF KV      +     ++
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVE 259
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVST 280
                 KGL  +HE     ++ D K  NI+  T  +   KL DFGL           V+T
Sbjct: 260 YMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              GT  +AAPE      +   +D++S GV+   +L+G
Sbjct: 318 ---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 57/121 (47%), Gaps = 5/121 (4%)
Query: 196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           EF  +G++E  +  +    L   + +++     KG+ ++H   K +I RD K SNI L  
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVD 157
Query: 256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
               K+ DFGL        K     R  GT  Y +PE I +       D+Y+ G++L E+
Sbjct: 158 TKQVKIGDFGLVTSLKNDGK---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214
Query: 316 L 316
           L
Sbjct: 215 L 215

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 129
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 130 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 184
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              + T  Y APE I+        D++S G ++ E++ G
Sbjct: 185 VPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 67  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 121
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 122 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 176
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 288
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++      + GT  Y
Sbjct: 129 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNY 183
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAF 225
           +   + P +V+L     +D +  ++ E+M  G + N L S   +P  W    +  + +A 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLAL 181
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
            A   + F+H        RD K  N+LLD   + KL+DFG      +       T + GT
Sbjct: 182 DAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 232
Query: 286 YGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTG 318
             Y +PE + +    G+     D +S GV L E+L G
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 4/96 (4%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA    E D     T + GT  Y 
Sbjct: 133 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKT-LCGTPNYI 188
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
           APE +     +   DV+S G ++  +L G+   + S
Sbjct: 189 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 288
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++      + GT  Y
Sbjct: 129 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNY 183
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 78  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 132
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 133 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 187
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 188 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 245

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+    G    + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMME 183
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
             ++  Y Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 184 PEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAF 225
           +   + P +V+L     +D +  ++ E+M  G + N L S   +P  W    +  + +A 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLAL 186
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
            A   + F+H        RD K  N+LLD   + KL+DFG      +       T + GT
Sbjct: 187 DAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 237
Query: 286 YGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTG 318
             Y +PE + +    G+     D +S GV L E+L G
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 9/159 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLF--SKVLLPLPWSI 219
           ++EV  L  L HPN+V+      +  +  L  + E+   G + + +   +K    L    
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 220 RMKIAFGAAKGLAFLH---EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            +++       L   H   +    V++RD K +N+ LD   N KL DFGLA+     D S
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTS 171
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
              T  +GT  Y +PE +       +SD++S G +L E+
Sbjct: 172 FAKT-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAF 225
           +   + P +V+L     +D +  ++ E+M  G + N L S   +P  W    +  + +A 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLAL 186
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
            A   + F+H        RD K  N+LLD   + KL+DFG      +       T + GT
Sbjct: 187 DAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 237
Query: 286 YGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTG 318
             Y +PE + +    G+     D +S GV L E+L G
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL- 231
           L HPN+V+L     E+ H  LI++ +  G +  ++ ++      +      +    + L 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILE 121
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           A LH  +  V++R+ K  N+LL +       KL+DFGLA +  EG++        GT GY
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQ-AWFGFAGTPGY 179
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            +PE +         D+++ GV+L  +L G
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM----------ARGSVENNLFSKVLL 213
           + E+  L  L H N+VKL       +  VL++E +            G +E+      LL
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
            L              G+A+ H+  + V++RD K  N+L++ +   K++DFGLA+    G
Sbjct: 108 QL------------LNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLAR--AFG 151
Query: 274 DKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 318
                 T  + T  Y AP+ +M +   +   D++S G +  E++ G
Sbjct: 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 69
Query: 188 DE----HRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------ 235
           D        L+ ++   GS+ +  N ++  +  +     +K+A   A GLA LH      
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 124
Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY 293
           + +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE 
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 294 ----IMTGHLTP--RSDVYSFGVVLLEI 315
               I   H     R+D+Y+ G+V  EI
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 68
Query: 188 DE----HRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------ 235
           D        L+ ++   GS+ +  N ++  +  +     +K+A   A GLA LH      
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 123
Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY 293
           + +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 294 ----IMTGHLTP--RSDVYSFGVVLLEI 315
               I   H     R+D+Y+ G+V  EI
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM----------ARGSVENNLFSKVLL 213
           + E+  L  L H N+VKL       +  VL++E +            G +E+      LL
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
            L              G+A+ H+  + V++RD K  N+L++ +   K++DFGLA+    G
Sbjct: 108 QL------------LNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLAR--AFG 151
Query: 274 DKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 318
                 T  + T  Y AP+ +M +   +   D++S G +  E++ G
Sbjct: 152 IPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM----------ARGSVENNLFSKVLL 213
           + E+  L  L H N+VKL       +  VL++E +            G +E+      LL
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
            L              G+A+ H+  + V++RD K  N+L++ +   K++DFGLA+    G
Sbjct: 108 QL------------LNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLAR--AFG 151
Query: 274 DKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 318
                 T  + T  Y AP+ +M +   +   D++S G +  E++ G
Sbjct: 152 IPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 166 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 127
Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+    G    + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMME 183
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 331
             ++  Y Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 184 PEVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 12/106 (11%)
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL--AKDGPEGDKSHV 278
           + I    A+ + FLH   K +++RD K SNI    D   K+ DFGL  A D  E +++ +
Sbjct: 167 LHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 279 S--------TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 316
           +           +GT  Y +PE I   + + + D++S G++L E+L
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 243 YRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPR 302
           +RD K  NIL+  D  A L DFG+A    +   + +   + GT  Y APE     H T R
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 303 SDVYSFGVVLLEILTG 318
           +D+Y+   VL E LTG
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 107
Query: 188 DE----HRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------ 235
           D        L+ ++   GS+ +  N ++  +  +     +K+A   A GLA LH      
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 162
Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY 293
           + +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 294 ----IMTGHLTP--RSDVYSFGVVLLEI 315
               I   H     R+D+Y+ G+V  EI
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 99/251 (39%), Gaps = 34/251 (13%)
Query: 154 DNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DEHRVLIYEFMARGSVENNLFSKV 211
           D S +  R++  E   L   SHPN++ ++G C      H  LI  +   GS+ N L    
Sbjct: 45  DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGT 104
Query: 212 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 271
              +  S  +K A   A+G AFLH  E  +      + ++ +D D  A++S   +     
Sbjct: 105 NFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQ 164
Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPR--SDVYSFGVVLLEILTGRKSLDKSRPA 328
              + +          + APE +      T R  +D +SF V+L E++T           
Sbjct: 165 SPGRXYAP-------AWVAPEALQKKPEDTNRRSADXWSFAVLLWELVT----------- 206
Query: 329 REQNLADWAXXXXXXXXXXXNIIDPRLEGDYPV--KGVH-KAAMLAYHCLNHNPKARPLM 385
           RE   AD +                 LEG  P    G+    + L   C N +P  RP  
Sbjct: 207 REVPFADLSNXEIGXKVA--------LEGLRPTIPPGISPHVSKLXKICXNEDPAKRPKF 258
Query: 386 RDIVDSLEPLQ 396
             IV  LE  Q
Sbjct: 259 DXIVPILEKXQ 269

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 131 GFISEDLREGLQP----VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 186
           GF   DL EGL          +  H+  +  +  RE     +F    +HPN+++L+ YC 
Sbjct: 41  GFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF----NHPNILRLVAYCL 96
Query: 187 ED---EHRV-LIYEFMARGSVENNL--FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
            +   +H   L+  F  RG++ N +         L     + +  G  +GL  +H   K 
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKG 154
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDG---PEGDKSHVSTRIMG----TYGYAAPE- 292
             +RD K +NILL  +    L D G         EG +  ++ +       T  Y APE 
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 293 YIMTGH--LTPRSDVYSFGVVLLEILTGRKSLD 323
           + +  H  +  R+DV+S G VL  ++ G    D
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK-VLLPLPWSIRMKIA 224
           E+  L  + H N+V L        H  L+ + ++ G + + +  + V      S+ ++  
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV 115
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYNAKL--SDFGLAKDGPEGDKSHVSTR 281
             A K   +LHE    +++RD K  N+L L  + N+K+  +DFGL+K    G    + + 
Sbjct: 116 LSAVK---YLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMST 166
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             GT GY APE +     +   D +S GV+   +L G
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 74
Query: 188 DE----HRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------ 235
           D        L+ ++   GS+ +  N ++  +  +     +K+A   A GLA LH      
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 129
Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY 293
           + +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE 
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 294 ----IMTGHLTP--RSDVYSFGVVLLEI 315
               I   H     R+D+Y+ G+V  EI
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 71
Query: 188 DE----HRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------ 235
           D        L+ ++   GS+ +  N ++  +  +     +K+A   A GLA LH      
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 126
Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY 293
           + +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE 
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 294 ----IMTGHLTP--RSDVYSFGVVLLEI 315
               I   H     R+D+Y+ G+V  EI
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 128 VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 187
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 94
Query: 188 DE----HRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------ 235
           D        L+ ++   GS+ +  N ++  +  +     +K+A   A GLA LH      
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 149
Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY 293
           + +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE 
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 294 ----IMTGHLTP--RSDVYSFGVVLLEI 315
               I   H     R+D+Y+ G+V  EI
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 17/102 (16%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-------------GDK 275
           + L+++H   + +I+R+ K  NI +D   N K+ DFGLAK+                G  
Sbjct: 127 EALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 276 SHVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEIL 316
            ++++ I GT  Y A E +  TGH   + D YS G++  E +
Sbjct: 185 DNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 9/159 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLF--SKVLLPLPWSI 219
           ++EV  L  L HPN+V+      +  +  L  + E+   G + + +   +K    L    
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 220 RMKIAFGAAKGLAFLH---EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            +++       L   H   +    V++RD K +N+ LD   N KL DFGLA+       +
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDT 170
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
             +   +GT  Y +PE +       +SD++S G +L E+
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 25/166 (15%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMAR---------GSVENNLFSKVLLP 214
           + EV  L  L H N+V L      ++   L++E++ +         G++ N    K+ L 
Sbjct: 48  IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL- 106
Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
                     F   +GLA+ H   + V++RD K  N+L++     KL+DFGLA+      
Sbjct: 107 ----------FQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154
Query: 275 KSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           K++ +  +  T  Y  P+ ++ +   + + D++  G +  E+ TGR
Sbjct: 155 KTYDNEVV--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 9/159 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLF--SKVLLPLPWSI 219
           ++EV  L  L HPN+V+      +  +  L  + E+   G + + +   +K    L    
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 220 RMKIAFGAAKGLAFLH---EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            +++       L   H   +    V++RD K +N+ LD   N KL DFGLA+        
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDE 170
Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
             +   +GT  Y +PE +       +SD++S G +L E+
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 68/157 (43%), Gaps = 10/157 (6%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL---FSKVLLP-LPWSIRMKIAF 225
           L    HPN+V+L+  C        I   +    V+ +L     K   P LP      +  
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
              +GL FLH     +++RD K  NIL+ +    KL+DFGLA+           T ++ T
Sbjct: 128 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVVVT 182
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 322
             Y APE ++        D++S G +  E+   RK L
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 170 LGHLSHPNLVKLIGY--CCEDEHRVLIYEFMARGSVEN-------NLFSKVLLPLPWSIR 220
           L  L HPN+V+L  Y     +  R  IY  +    V +       N + + + P P  I+
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFGLAK--DGPEGDKSH 277
           +   F   + +  LH     V +RD K  N+L++  D   KL DFG AK     E + ++
Sbjct: 133 V-FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 278 VSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 318
           + +R      Y APE I    H T   D++S G +  E++ G
Sbjct: 192 ICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E+M  G    ++FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG----DMFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     K++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E+M  G    ++FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG----DMFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     K++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 10/163 (6%)
Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 220
           R    E+  +  L HP LV L     ++E   ++ + +  G +  +L   V      +++
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-TVK 118
Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           +   F     +A  +   + +I+RD K  NILLD   +  ++DF +A   P   ++ ++T
Sbjct: 119 L---FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT 173
Query: 281 RIMGTYGYAAPEYIMTGHLTPRS---DVYSFGVVLLEILTGRK 320
            + GT  Y APE   +      S   D +S GV   E+L GR+
Sbjct: 174 -MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVV----GNKRLKEA 114
Query: 225 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 275
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 115 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 170
Query: 276 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 318
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 171 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVV----GNKRLKEA 114
Query: 225 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 275
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 115 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 170
Query: 276 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 318
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 171 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 63  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVV----GNKRLKEA 113
Query: 225 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 275
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 114 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 169
Query: 276 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 318
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 170 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVV----GNKRLKEA 114
Query: 225 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 275
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 115 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 170
Query: 276 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 318
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 171 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E++    LS P +V L G   E     +  E +  GS+      K +  LP    +    
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ--LIKQMGCLPEDRALYYLG 173
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFG----LAKDGPEGDKSHVST 280
            A +GL +LH   + +++ D K  N+LL +D + A L DFG    L  DG  G       
Sbjct: 174 QALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL-GKSLLTGD 230
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            I GT  + APE +M      + D++S   ++L +L G
Sbjct: 231 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E++    L+ P +V L G   E     +  E +  GS+   +  +  LP     R     
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRALYYL 191
Query: 226 GAA-KGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFG----LAKDGPEGDKSHVS 279
           G A +GL +LH   + +++ D K  N+LL +D  +A L DFG    L  DG  G      
Sbjct: 192 GQALEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGKSLLTG 248
Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             I GT  + APE ++      + DV+S   ++L +L G
Sbjct: 249 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E++    LS P +V L G   E     +  E +  GS+      K +  LP    +    
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ--LIKQMGCLPEDRALYYLG 157
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFG----LAKDGPEGDKSHVST 280
            A +GL +LH   + +++ D K  N+LL +D + A L DFG    L  DG  G       
Sbjct: 158 QALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL-GKSLLTGD 214
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            I GT  + APE +M      + D++S   ++L +L G
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E++    LS P +V L G   E     +  E +  GS+      K +  LP    +    
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ--LIKQMGCLPEDRALYYLG 171
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFG----LAKDGPEGDKSHVST 280
            A +GL +LH   + +++ D K  N+LL +D + A L DFG    L  DG  G       
Sbjct: 172 QALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL-GKSLLTGD 228
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            I GT  + APE +M      + D++S   ++L +L G
Sbjct: 229 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 70  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVV----GNKRLKEA 120
Query: 225 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 275
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 121 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 176
Query: 276 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 318
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 177 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E+  L  L+HP ++K+  +   +++ +++ E M  G     LF KV+     + R+K A
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGE----LFDKVV----GNKRLKEA 239
Query: 225 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 275
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 240 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 295
Query: 276 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 318
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 296 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP------LPWSIRMKIAFG 226
           L HPN+V+L     E+    L+++ +  G +  ++ ++              I   IA+ 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIM 283
            + G          +++R+ K  N+LL +       KL+DFGLA +  + +  H      
Sbjct: 122 HSNG----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 168
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E+  L  L+HP ++K+  +   +++ +++ E M  G     LF KV+     + R+K A
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGE----LFDKVV----GNKRLKEA 253
Query: 225 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 275
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 254 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 309
Query: 276 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 318
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 310 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYC---------CEDEHRVLIYEFMARGSVENNLFSKVLLP 214
           L E+  L  L H N+V LI  C         C+     L+++F         L S VL+ 
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLA--GLLSNVLVK 121
Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD---GP 271
              S   ++      GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+      
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILT 317
               +    R++ T  Y  PE ++      P  D++  G ++ E+ T
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP------LPWSIRMKIAFG 226
           L HPN+V+L     E+    L+++ +  G +  ++ ++              I   IA+ 
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIM 283
            + G          +++R+ K  N+LL +       KL+DFGLA +  + +  H      
Sbjct: 121 HSNG----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 167
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 168 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP------LPWSIRMKIAFG 226
           L HPN+V+L     E+    L+++ +  G +  ++ ++              I   IA+ 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIM 283
            + G          +++R+ K  N+LL +       KL+DFGLA +  + +  H      
Sbjct: 122 HSNG----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 168
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E++    L+ P +V L G   E     +  E +  GS+   +  +  LP     R     
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRALYYL 172
Query: 226 GAA-KGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFG---------LAKDGPEGD 274
           G A +GL +LH   + +++ D K  N+LL +D  +A L DFG         L KD   GD
Sbjct: 173 GQALEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230
Query: 275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
                  I GT  + APE ++      + DV+S   ++L +L G
Sbjct: 231 Y------IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 5/149 (3%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           L HP++V+L+     D    +++EFM    +   +  +      +S  +   +      A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
             +  +  +I+RD K  N+LL +  N+   KL DFG+A     G+   V+   +GT  + 
Sbjct: 143 LRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGTPHFM 200
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           APE +         DV+  GV+L  +L+G
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 14/157 (8%)
Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKIAF 225
           I L +  HPN++ L     + ++  ++ E M  G     L  K+L    +S R    + F
Sbjct: 68  ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLF 123
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYN---AKLSDFGLAKDGPEGDKSHVSTR 281
              K + +LH   + V++RD K SNIL +D   N    ++ DFG AK     +   + T 
Sbjct: 124 TITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAENGLLMTP 180
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              T  + APE +         D++S GV+L  +LTG
Sbjct: 181 CY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYC---------CEDEHRVLIYEFMARGSVENNLFSKVLLP 214
           L E+  L  L H N+V LI  C         C+     L+++F         L S VL+ 
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLA--GLLSNVLVK 121
Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
              S   ++      GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+      
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 275 KSH---VSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILT 317
            S       R++ T  Y  PE ++      P  D++  G ++ E+ T
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 165
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            + A   L F +     +IYRD K  N+L+D     +++DFG AK          +  + 
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLC 220
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 66/150 (44%), Gaps = 11/150 (7%)
Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
            HPN+VKL     +  H  L+ E +  G     LF ++     +S             A 
Sbjct: 64  GHPNIVKLHEVFHDQLHTFLVMELLNGGE----LFERIKKKKHFSETEASYIMRKLVSAV 119
Query: 234 LHEAEKPVIYRDFKTSNILLDTDYN----AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            H  +  V++RD K  N+L  TD N     K+ DFG A+  P  D   + T    T  YA
Sbjct: 120 SHMHDVGVVHRDLKPENLLF-TDENDNLEIKIIDFGFARLKPP-DNQPLKTPCF-TLHYA 176
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           APE +         D++S GV+L  +L+G+
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYC---------CEDEHRVLIYEFMARGSVENNLFSKVLLP 214
           L E+  L  L H N+V LI  C         C+     L+++F         L S VL+ 
Sbjct: 64  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLA--GLLSNVLVK 120
Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
              S   ++      GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+      
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 275 KSH---VSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILT 317
            S       R++ T  Y  PE ++      P  D++  G ++ E+ T
Sbjct: 179 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 145
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL---FSKVLLP-LPWSIRMKIAF 225
           L    HPN+V+L+  C        I   +    V+ +L     K   P LP      +  
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
              +GL FLH     +++RD K  NIL+ +    KL+DFGLA+             ++ T
Sbjct: 120 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVT 174
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 322
             Y APE ++        D++S G +  E+   RK L
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYC---------CEDEHRVLIYEFMARGSVENNLFSKVLLP 214
           L E+  L  L H N+V LI  C         C+     L+++F         L S VL+ 
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCK-ASIYLVFDFCEHDLA--GLLSNVLVK 121
Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
              S   ++      GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+      
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 275 KSH---VSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILT 317
            S       R++ T  Y  PE ++      P  D++  G ++ E+ T
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 12/157 (7%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK-VLLPLPWSIRMKIA 224
           E+  L  + H N+V L        H  L+ + ++ G + + +  K        S  ++  
Sbjct: 70  EIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQV 129
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   + +LH     +++RD K  N+L    D +    +SDFGL+K   +GD   V + 
Sbjct: 130 LDA---VYYLHRM--GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMST 181
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             GT GY APE +     +   D +S GV+   +L G
Sbjct: 182 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP------WSIRMKIAFG 226
           L HPN+V+L     E+    L+++ +  G +  ++ ++              I   IA+ 
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIM 283
            + G          +++R+ K  N+LL +       KL+DFGLA +  + +  H      
Sbjct: 145 HSNG----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 191
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
           +P  I  KIA    K L  LH ++  VI+RD K SN+L++     K+ DFG++  G   D
Sbjct: 150 IPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVD 206
Query: 275 KSHVSTRIMGTYGYAAPEYI-----MTGHLTPRSDVYSFGVVLLEILTGR 319
            S   T   G   Y APE I       G+ + +SD++S G+ ++E+   R
Sbjct: 207 -SVAKTIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILR 254

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 76  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 131
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 132 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK--------RVKGRTW 183
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 184 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL---FSKVLLP-LPWSIRMKIAF 225
           L    HPN+V+L+  C        I   +    V+ +L     K   P LP      +  
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
              +GL FLH     +++RD K  NIL+ +    KL+DFGLA+             ++ T
Sbjct: 120 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVT 174
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 322
             Y APE ++        D++S G +  E+   RK L
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 13/149 (8%)
Query: 188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFK 247
           D+   L+ EF   GSV + + +     L       I     +GL+ LH+ +  VI+RD K
Sbjct: 99  DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIK 156
Query: 248 TSNILLDTDYNAKLSDFGLAK--DGPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLT 300
             N+LL  +   KL DFG++   D   G ++      +GT  + APE I           
Sbjct: 157 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----TFIGTPYWMAPEVIACDENPDATYD 212
Query: 301 PRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
            +SD++S G+  +E+  G   L    P R
Sbjct: 213 FKSDLWSLGITAIEMAEGAPPLCDMHPMR 241

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHA----- 143
Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 281 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 9/123 (7%)
Query: 154 DNSYQGHREWLAEVIFLGHLS-HPNLVKL-----IGYCCEDEHR---VLIYEFMARGSVE 204
            N  + +R  + EV F+  LS HPN+V+      IG    D  +   +L+ E      VE
Sbjct: 63  SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE 122
Query: 205 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 264
                +   PL     +KI +   + +  +H  + P+I+RD K  N+LL      KL DF
Sbjct: 123 FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 265 GLA 267
           G A
Sbjct: 183 GSA 185

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA----- 138
Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 139 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 188
Query: 281 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 189 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL---FSKVLLP-LPWSIRMKIAF 225
           L    HPN+V+L+  C        I   +    V+ +L     K   P LP      +  
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
              +GL FLH     +++RD K  NIL+ +    KL+DFGLA+             ++ T
Sbjct: 120 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVT 174
Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 322
             Y APE ++        D++S G +  E+   RK L
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA----- 143
Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 281 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA----- 143
Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 281 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA----- 143
Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 281 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL- 231
           L H N+V+L     E+    L+++ +  G +  ++ ++      +      +    + L 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILE 114
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           A LH  +  V++RD K  N+LL +       KL+DFGLA +  +GD+        GT GY
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQGDQQ-AWFGFAGTPGY 172
Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            +PE +         D+++ GV+L  +L G
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ ++  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+++D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     K++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA----- 164
Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 165 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 214
Query: 281 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 215 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E+   G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+++D     K++DFGLAK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK--IAF 225
           I L +  HPN++ L     + +H  L+ E M  G     L  K+L    +S R    +  
Sbjct: 73  ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGG----ELLDKILRQKFFSEREASFVLH 128
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYN---AKLSDFGLAKDGPEGDKSHVSTR 281
              K + +LH   + V++RD K SNIL +D   N    ++ DFG AK     +   + T 
Sbjct: 129 TIGKTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTP 185
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              T  + APE +         D++S G++L  +L G
Sbjct: 186 CY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK--IAF 225
           I L +  HPN++ L     + +H  L+ E M  G     L  K+L    +S R    +  
Sbjct: 73  ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGG----ELLDKILRQKFFSEREASFVLH 128
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYN---AKLSDFGLAKDGPEGDKSHVSTR 281
              K + +LH   + V++RD K SNIL +D   N    ++ DFG AK     +   + T 
Sbjct: 129 TIGKTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTP 185
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              T  + APE +         D++S G++L  +L G
Sbjct: 186 CY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 80/191 (41%), Gaps = 40/191 (20%)
Query: 175 HPNLVKLIGYCCEDEHRVL-----IYEFMARGSVENNLFSKVLLPL-----PWSIRMKIA 224
           HPN+++   YC E   R L     +     +  VE+   S   L L     P S+  +IA
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------------DYNAKLSDFGLAKDGP 271
                G+A LH  +  +I+RD K  NIL+ T             +    +SDFGL K   
Sbjct: 126 ----SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 272 EGDKSHVST--RIMGTYGYAAPEYIMTGH-------LTPRSDVYSFGVVLLEILTGRKSL 322
            G  S  +      GT G+ APE +   +       LT   D++S G V   IL+  K  
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 323 DKSRPAREQNL 333
              + +RE N+
Sbjct: 240 FGDKYSRESNI 250

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 89/234 (38%), Gaps = 43/234 (18%)
Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
            HP +++L+ +    E  +L+ E   R     +LF  +    P        F      A 
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 234 LHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFG---LAKDGPEGDKSHVSTRIMGTYGYA 289
            H   + V++RD K  NIL+D     AKL DFG   L  D P  D         GT  Y+
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-------GTRVYS 205
Query: 290 APEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXX 347
            PE+I     H  P + V+S G++L +++ G    ++ +   E  L              
Sbjct: 206 PPEWISRHQYHALP-ATVWSLGILLYDMVCGDIPFERDQEILEAEL-------------- 250
Query: 348 XNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE 401
                      +P         L   CL   P +RP + +I+  L+P    P E
Sbjct: 251 ----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL--LDPWMQTPAE 292

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 57/113 (50%), Gaps = 16/113 (14%)
Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-------- 266
           +P  I  KIA    K L  LH ++  VI+RD K SN+L++     K+ DFG+        
Sbjct: 106 IPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164
Query: 267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           AKD   G K +++   +       PE    G+ + +SD++S G+ ++E+   R
Sbjct: 165 AKDIDAGCKPYMAPERIN------PELNQKGY-SVKSDIWSLGITMIELAILR 210

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +   +       G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEA--TEFLKQILNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPAFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 55/128 (42%), Gaps = 36/128 (28%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD------------- 269
           I +    G  F+HE+   +I+RD K +N LL+ D + K+ DFGLA+              
Sbjct: 136 ILYNLLLGEKFIHES--GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193
Query: 270 ---------GPEGDK------SHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLL 313
                    GP          SHV TR      Y APE I+   + T   D++S G +  
Sbjct: 194 EEKEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTNSIDIWSTGCIFA 248
Query: 314 EILTGRKS 321
           E+L   KS
Sbjct: 249 ELLNMMKS 256

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL---LPLPWSIRMK 222
           E+  +  L HP L+ L     +    VLI EF++ G     LF ++      +  +  + 
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYKMSEAEVIN 153
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVST 280
               A +GL  +H  E  +++ D K  NI+ +T    + K+ DFGLA      +   V+T
Sbjct: 154 YMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
               T  +AAPE +    +   +D+++ GV+   +L+G
Sbjct: 212 ---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 13/185 (7%)
Query: 140 GLQPVPVAVKVHDGDNSYQG--HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GL+     +K      S +G    E   EV  L  + HPN++ L          VLI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI-LLDTD 256
           ++ G + + L  K  L    +           G+ +LH   K + + D K  NI LLD +
Sbjct: 97  VSGGELFDFLAQKESLSEEEA--TSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKN 152
Query: 257 Y---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
               + KL DFGLA +  +G +      I GT  + APE +    L   +D++S GV+  
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 314 EILTG 318
            +L+G
Sbjct: 210 ILLSG 214

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 166 EVIFLGHLSHPNLVKL-IGYCCEDEHRVLIYEFMARGSVENNLF------SKVLLPLPWS 218
           E+  +  L H N+V+L   +    E + ++Y  +    V   ++      S+    LP  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSH 277
                 +   + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ + 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN- 179
Query: 278 VSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             + I   Y Y APE I      T   DV+S G VL E+L G+
Sbjct: 180 -VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 31/193 (16%)
Query: 131 GFISEDLREGLQPVPVAVK--VHDGDNSYQGH----REWLAEVIFLGHLSHPNLVKLIGY 184
           G+I   L   +   PV +K  VH GD   Q      R++LAEV+      HP++V++  +
Sbjct: 94  GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV------HPSIVQIFNF 147
Query: 185 C-CEDEH----RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
               D H      ++ E++   S++ +   K  LP+  +I   +    A  L++LH    
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPA--LSYLHSIG- 202
Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 299
            ++Y D K  NI+L T+   KL D G         + +    + GT G+ APE + TG  
Sbjct: 203 -LVYNDLKPENIML-TEEQLKLIDLGAVS------RINSFGYLYGTPGFQAPEIVRTGP- 253
Query: 300 TPRSDVYSFGVVL 312
           T  +D+Y+ G  L
Sbjct: 254 TVATDIYTVGRTL 266

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 137
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 138 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 189
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 285
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 285
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y AP  I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 13/89 (14%)
Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYGYA 289
           +LH  +  +IYRD K  N+L+D     K++DFG AK         V  R   + GT  Y 
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYL 206
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           APE I++       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 285
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 161 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 215
Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 216 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 285
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 167 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 221
Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 222 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 145
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 145
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            + A   L F +     +IYRD K  N+L+D     +++DFG AK      K    T + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWT-LC 200
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 285
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 285
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 146 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 200
Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 201 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 55/125 (44%), Gaps = 33/125 (26%)
Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD------------- 269
           I +    G  F+HE+   +I+RD K +N LL+ D + K+ DFGLA+              
Sbjct: 134 ILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 270 ------GPEGDK------SHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEIL 316
                 GP          SHV TR      Y APE I+   + T   D++S G +  E+L
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 317 TGRKS 321
              +S
Sbjct: 247 NMLQS 251

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 285
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 169 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 223
Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 224 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 145
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 145
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 145
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 75  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 130
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            + A   L F +     +IYRD K  N+L+D     +++DFG AK      K    T + 
Sbjct: 131 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWT-LC 185
Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 186 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E+   G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+++D     +++DFGLAK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 285
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 171 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 225
Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 226 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 285
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 212 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 266
Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 267 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E+   G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHAR 145
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+++D     K++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 197
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 285
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 138 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 192
Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 193 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E+   G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+++D     K++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 165
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 217
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 17/130 (13%)
Query: 193 LIYEFMARGSVENNLFSKVLLPL--------PWSIRMKIAFGAAKGLAFLHEAEKPVIYR 244
           +IYE+M   S+    F +    L        P  +   I        +++H  EK + +R
Sbjct: 120 IIYEYMENDSILK--FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHR 176
Query: 245 DFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPR 302
           D K SNIL+D +   KLSDFG ++     DK    +R  GTY +  PE+    + +   +
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESE--YMVDKKIKGSR--GTYEFMPPEFFSNESSYNGAK 232
Query: 303 SDVYSFGVVL 312
            D++S G+ L
Sbjct: 233 VDIWSLGICL 242

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKIAF 225
           I L +  HPN++ L     + ++  ++ E    G     L  K+L    +S R    + F
Sbjct: 68  ILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGG----ELLDKILRQKFFSEREASAVLF 123
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYN---AKLSDFGLAKDGPEGDKSHVSTR 281
              K + +LH   + V++RD K SNIL +D   N    ++ DFG AK     +   + T 
Sbjct: 124 TITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAENGLLXTP 180
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              T  + APE +         D++S GV+L   LTG
Sbjct: 181 CY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +   +       G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEA--TEFLKQILNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 134 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 188
Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 187
Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 21/143 (14%)
Query: 187 EDEHRVLIYEFMARGSVENNLFSKVLLPLP------WSIRMKIAFGAAKGLAFLHEAEKP 240
           +D +  L+ ++   G +   L SK    LP      +   M IA  +   L ++H     
Sbjct: 145 DDNNLYLVMDYYVGGDLLT-LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH----- 198
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---- 296
              RD K  NIL+D + + +L+DFG      E D +  S+  +GT  Y +PE +      
Sbjct: 199 ---RDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 297 -GHLTPRSDVYSFGVVLLEILTG 318
            G   P  D +S GV + E+L G
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYG 277

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 152 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 206
Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 141 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 195
Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 187
Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 145 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 199
Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 77/187 (41%), Gaps = 36/187 (19%)
Query: 175 HPNLVKLIGYCCEDEHRVL-----IYEFMARGSVENNLFSKVLLPL-----PWSIRMKIA 224
           HPN+++   YC E   R L     +     +  VE+   S   L L     P S+  +IA
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------------DYNAKLSDFGLAKDGP 271
                G+A LH  +  +I+RD K  NIL+ T             +    +SDFGL K   
Sbjct: 144 ----SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 272 EGDKSHVST--RIMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR 326
            G            GT G+ APE +       LT   D++S G V   IL+  K     +
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 257
Query: 327 PAREQNL 333
            +RE N+
Sbjct: 258 YSRESNI 264

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 13/89 (14%)
Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYGYA 289
           +LH  +  +IYRD K  N+++D     K++DFG AK         V  R   + GT  Y 
Sbjct: 156 YLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYL 205
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           APE I++       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 187
Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 77/187 (41%), Gaps = 36/187 (19%)
Query: 175 HPNLVKLIGYCCEDEHRVL-----IYEFMARGSVENNLFSKVLLPL-----PWSIRMKIA 224
           HPN+++   YC E   R L     +     +  VE+   S   L L     P S+  +IA
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------------DYNAKLSDFGLAKDGP 271
                G+A LH  +  +I+RD K  NIL+ T             +    +SDFGL K   
Sbjct: 144 ----SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 272 EGDKSHVST--RIMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR 326
            G            GT G+ APE +       LT   D++S G V   IL+  K     +
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 257
Query: 327 PAREQNL 333
            +RE N+
Sbjct: 258 YSRESNI 264

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 145 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 199
Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 137 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 191
Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 167 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 221
Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 13/89 (14%)
Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYGYA 289
           +LH  +  +IYRD K  N+++D     K++DFG AK         V  R   + GT  Y 
Sbjct: 157 YLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYL 206
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           APE I++       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 13/89 (14%)
Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYGYA 289
           +LH  +  +IYRD K  N+++D     K++DFG AK         V  R   + GT  Y 
Sbjct: 157 YLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYL 206
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           APE I++       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 47/290 (16%)
Query: 128 VYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREWLAEVIF-----LGHLSHPNLVKL 181
           ++KG   E    G L    V +KV D     + HR + +E  F     +  LSH +LV  
Sbjct: 24  IFKGVRREVGDYGQLHETEVLLKVLD-----KAHRNY-SESFFEAASMMSKLSHKHLVLN 77
Query: 182 IGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 240
            G C   +  +L+ EF+  GS++  L  +K  + + W  ++++A   A  + FL   E  
Sbjct: 78  YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE--ENT 133
Query: 241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR--IMGTYGYAAPEYIMT-G 297
           +I+ +    NILL  + + K  +    K    G    V  +  +     +  PE I    
Sbjct: 134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPK 193
Query: 298 HLTPRSDVYSFGVVLLEILTGR----KSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDP 353
           +L   +D +SFG  L EI +G      +LD  R  + Q   D                  
Sbjct: 194 NLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQFYED------------------ 233
Query: 354 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAP 403
                 P     + A L  +C+++ P  RP  R I+  L  L   PD  P
Sbjct: 234 --RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL-FTPDLVP 280

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 66/133 (49%), Gaps = 16/133 (12%)
Query: 192 VLIYEFMARGSVENNLFSKVLLPLPWSIR----MKIAFGAAKGLAFLHEAEKPVIYRDFK 247
           +LI E+ A G +    FS  L  L   +     +++     +G+ +LH+    +++ D K
Sbjct: 105 ILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLK 158
Query: 248 TSNILLDTDY---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSD 304
             NILL + Y   + K+ DFG+++      +      IMGT  Y APE +    +T  +D
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EIMGTPEYLAPEILNYDPITTATD 215
Query: 305 VYSFGVVLLEILT 317
           +++ G++   +LT
Sbjct: 216 MWNIGIIAYMLLT 228

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 13/89 (14%)
Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYGYA 289
           +LH  +  +IYRD K  N+++D     K++DFG AK         V  R   + GT  Y 
Sbjct: 157 YLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYL 206
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           APE I++       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 35  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 95  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 149
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 150 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206
Query: 313 LEILTG 318
             +L+G
Sbjct: 207 YILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 35  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 95  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 149
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 150 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206
Query: 313 LEILTG 318
             +L+G
Sbjct: 207 YILLSG 212

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT    APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 22/152 (14%)
Query: 179 VKLIGYCCEDE-HRVLIYEFMARGSVENNLFSKVLLPLPWSI------RMKIAFGAAKGL 231
           +  + Y  +DE H  L+ ++   G +   L SK    LP  +       M +A  +   L
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 194
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            ++H        RD K  N+LLD + + +L+DFG      + D +  S+  +GT  Y +P
Sbjct: 195 HYVH--------RDIKPDNVLLDVNGHIRLADFGSCLKMND-DGTVQSSVAVGTPDYISP 245
Query: 292 EYIMT-----GHLTPRSDVYSFGVVLLEILTG 318
           E +       G   P  D +S GV + E+L G
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G + ++L        P +     
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA----- 136
Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 137 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 186
Query: 281 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 187 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 13/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV  L  + HPN++ L          VLI E ++ G + + L  K  L    + +     
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 124
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-----KLSDFGLAKDGPEGDKSHVST 280
               G+ +LH   K + + D K  NI+L  D N      KL DFG+A     G++     
Sbjct: 125 --LDGVHYLHS--KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKIEAGNEF---K 176
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA----- 143
Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 281 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA----- 143
Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 281 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E++  G + ++L        P +     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA----- 144
Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 145 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 194
Query: 281 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 22/152 (14%)
Query: 179 VKLIGYCCEDE-HRVLIYEFMARGSVENNLFSKVLLPLPWSI------RMKIAFGAAKGL 231
           +  + Y  +DE H  L+ ++   G +   L SK    LP  +       M +A  +   L
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 210
Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            ++H        RD K  N+LLD + + +L+DFG      + D +  S+  +GT  Y +P
Sbjct: 211 HYVH--------RDIKPDNVLLDVNGHIRLADFGSCLKMND-DGTVQSSVAVGTPDYISP 261
Query: 292 EYIMT-----GHLTPRSDVYSFGVVLLEILTG 318
           E +       G   P  D +S GV + E+L G
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   L  ++ P LVKL     ++ +  ++ E+   G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHAR 144
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
            + A   L F +     +IYRD K  N+++D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 282 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 119/291 (40%), Gaps = 49/291 (16%)
Query: 128 VYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREWLAEVIF-----LGHLSHPNLVKL 181
           ++KG   E    G L    V +KV D     + HR + +E  F     +  LSH +LV  
Sbjct: 24  IFKGVRREVGDYGQLHETEVLLKVLD-----KAHRNY-SESFFEAASMMSKLSHKHLVLN 77
Query: 182 IGYC-CEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
            G C C DE+ +L+ EF+  GS++  L  +K  + + W  ++++A   A  + FL   E 
Sbjct: 78  YGVCFCGDEN-ILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLE--EN 132
Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR--IMGTYGYAAPEYIMT- 296
            +I+ +    NILL  + + K  +    K    G    V  +  +     +  PE I   
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENP 192
Query: 297 GHLTPRSDVYSFGVVLLEILTG----RKSLDKSRPAREQNLADWAXXXXXXXXXXXNIID 352
            +L   +D +SFG  L EI +G      +LD  R  + Q   D                 
Sbjct: 193 KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQFYED----------------- 233
Query: 353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAP 403
                  P     + A L  +C+++ P  RP  R I+  L  L   PD  P
Sbjct: 234 ---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL-FTPDLVP 280

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 13/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV  L  + HPN++ L          VLI E ++ G + + L  K  L    + +     
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-----KLSDFGLAKDGPEGDKSHVST 280
               G+ +LH   K + + D K  NI+L  D N      KL DFG+A     G++     
Sbjct: 118 --LDGVHYLHS--KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKIEAGNEF---K 169
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR-MKIA 224
           E+  +  L HPN+++L     ++    L+ E    G +   +  K +     + R MK  
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   +A+ H+    V +RD K  N L  T   D   KL DFGLA     G    + T+
Sbjct: 116 LSA---VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTK 168
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           + GT  Y +P+ ++ G   P  D +S GV++  +L G
Sbjct: 169 V-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR-MKIA 224
           E+  +  L HPN+++L     ++    L+ E    G +   +  K +     + R MK  
Sbjct: 73  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 132
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   +A+ H+    V +RD K  N L  T   D   KL DFGLA     G    + T+
Sbjct: 133 LSA---VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTK 185
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           + GT  Y +P+ ++ G   P  D +S GV++  +L G
Sbjct: 186 V-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 27/180 (15%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV+      H N+V  +G C    H  +I   + +G    ++     + L  +   +IA 
Sbjct: 79  EVMAYRQTRHENVVLFMGACMSPPHLAIITS-LCKGRTLYSVVRDAKIVLDVNKTRQIAQ 137
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL------AKDGPEGDKSHVS 279
              KG+ +LH   K ++++D K+ N+  D      ++DFGL       + G   DK  + 
Sbjct: 138 EIVKGMGYLH--AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 280 TRIMGTYGYAAPEYIMTGHLTP-----------RSDVYSFGVVLLEILTGRKSLDKSRPA 328
               G   + APE I    L+P            SDV++ G +  E L  R+   K++PA
Sbjct: 195 N---GWLCHLAPEIIR--QLSPDTEEDKLPFSKHSDVFALGTIWYE-LHAREWPFKTQPA 248

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 140 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGEL 95
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 258 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 313 LEILTG 318
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+I    L HPN+V+         H  ++ E+ + G     LF ++     +S      F
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFF 120
Query: 226 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVSTR 281
                 G+++ H  +  V +RD K  N LLD       K++DFG +K      +   +  
Sbjct: 121 FQQLISGVSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA-- 176
Query: 282 IMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTG 318
            +GT  Y APE ++      + +DV+S GV L  +L G
Sbjct: 177 -VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 13/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           EV  L  + HPN++ L          VLI E ++ G + + L  K  L    + +     
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-----KLSDFGLAKDGPEGDKSHVST 280
               G+ +LH   K + + D K  NI+L  D N      KL DFG+A     G++     
Sbjct: 139 --LDGVHYLHS--KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKIEAGNEF---K 190
Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 191 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 25/157 (15%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           L HPN+V+L     E+    L+++ +  G +  ++ ++              +  A    
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY------------YSEADASH 134
Query: 233 FLHEA--------EKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTR 281
            +H+         +  +++RD K  N+LL +       KL+DFGLA +  +G++      
Sbjct: 135 CIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQGEQ-QAWFG 192
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             GT GY +PE +         D+++ GV+L  +L G
Sbjct: 193 FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+I    L HPN+V+         H  ++ E+ + G     LF ++     +S      F
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFF 120
Query: 226 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVSTR 281
                 G+++ H  +  V +RD K  N LLD       K+ DFG +K      +   +  
Sbjct: 121 FQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 176
Query: 282 IMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTG 318
            +GT  Y APE ++      + +DV+S GV L  +L G
Sbjct: 177 -VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+I    L HPN+V+         H  ++ E+ + G     LF ++     +S      F
Sbjct: 64  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFF 119
Query: 226 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVSTR 281
                 G+++ H  +  V +RD K  N LLD       K+ DFG +K      +   +  
Sbjct: 120 FQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 175
Query: 282 IMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTG 318
            +GT  Y APE ++      + +DV+S GV L  +L G
Sbjct: 176 -VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 35/146 (23%)
Query: 193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------EAEKPVIYRDF 246
           LI ++   GS+ + L S  L        +K+A+ +  GL  LH      + +  + +RD 
Sbjct: 112 LITDYHENGSLYDYLKSTTLDA---KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168
Query: 247 KTSNILLDTDYNAKLSDFGLA----KDGPEGDKSHVSTRIMGTYGYAAPE---------- 292
           K+ NIL+  +    ++D GLA     D  E D    +TR+ GT  Y  PE          
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP-NTRV-GTKRYMPPEVLDESLNRNH 226
Query: 293 ---YIMTGHLTPRSDVYSFGVVLLEI 315
              YIM       +D+YSFG++L E+
Sbjct: 227 FQSYIM-------ADMYSFGLILWEV 245

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 38/75 (50%), Gaps = 4/75 (5%)
Query: 239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG- 297
           K +I+RD K  NI++  D+  KL DFG A     G   +      GT  Y APE +M   
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPEVLMGNP 205
Query: 298 HLTPRSDVYSFGVVL 312
           +  P  +++S GV L
Sbjct: 206 YRGPELEMWSLGVTL 220

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 40/191 (20%)
Query: 175 HPNLVKLIGYCCEDEHRVL-----IYEFMARGSVENNLFSKVLLPL-----PWSIRMKIA 224
           HPN+++   YC E   R L     +     +  VE+   S   L L     P S+  +IA
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------------DYNAKLSDFGLAKDGP 271
                G+A LH  +  +I+RD K  NIL+ T             +    +SDFGL K   
Sbjct: 126 ----SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 272 EGDKSHVST--RIMGTYGYAAPEYIMTGH-------LTPRSDVYSFGVVLLEILTGRKSL 322
            G            GT G+ APE +   +       LT   D++S G V   IL+  K  
Sbjct: 180 SGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 323 DKSRPAREQNL 333
              + +RE N+
Sbjct: 240 FGDKYSRESNI 250

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 156 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 215
           S + H++   E      L HPN+V+L     E+    L+++ +  G +  ++ ++     
Sbjct: 43  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR----- 97
Query: 216 PWSIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGP 271
            +      +    + L  ++      +++RD K  N+LL +       KL+DFGLA +  
Sbjct: 98  EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-V 156
Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +GD+        GT GY +PE +         D+++ GV+L  +L G
Sbjct: 157 QGDQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 156 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 215
           S + H++   E      L HPN+V+L     E+    L+++ +  G +  ++ ++     
Sbjct: 43  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR----- 97
Query: 216 PWSIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGP 271
            +      +    + L  ++      +++RD K  N+LL +       KL+DFGLA +  
Sbjct: 98  EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-V 156
Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +GD+        GT GY +PE +         D+++ GV+L  +L G
Sbjct: 157 QGDQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E+I    L HPN+V+         H  +I E+ + G     L+ ++     +S      F
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG----ELYERICNAGRFSEDEARFF 121
Query: 226 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVSTR 281
                 G+++ H  +  + +RD K  N LLD       K+ DFG +K      +   +  
Sbjct: 122 FQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 177
Query: 282 IMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTG 318
            +GT  Y APE ++      + +DV+S GV L  +L G
Sbjct: 178 -VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 16/113 (14%)
Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-------- 266
           +P  I  KIA    K L  LH ++  VI+RD K SN+L++     K  DFG+        
Sbjct: 133 IPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDV 191
Query: 267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           AKD   G K + +   +       PE    G+ + +SD++S G+  +E+   R
Sbjct: 192 AKDIDAGCKPYXAPERIN------PELNQKGY-SVKSDIWSLGITXIELAILR 237

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 32/183 (17%)
Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E+  L  L+H ++VK++      +      E      + ++ F K+     +   + I
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKF-DELYVVLEIADSDFKKLFRTPVYLTELHI 158
Query: 224 A---FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKS-- 276
               +    G+ ++H A   +++RD K +N L++ D + K+ DFGLA+  D PE   S  
Sbjct: 159 KTLLYNLLVGVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 277 ------------------HVSTRIMG---TYGYAAPEYI-MTGHLTPRSDVYSFGVVLLE 314
                             ++  ++ G   T  Y APE I +  + T   DV+S G +  E
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 315 ILT 317
           +L 
Sbjct: 277 LLN 279

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 155 NSYQGHREWLAEVIFLGHLSHP------NLVKLIGYCCEDEHRVLIYEFMARGSVE---N 205
           N  + HR+   E+  L HL         N++ ++       H  + +E ++    E    
Sbjct: 132 NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK 191
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSD 263
           N F    LPL   +R K A    + L  LH+    +I+ D K  NILL     +  K+ D
Sbjct: 192 NKFQGFSLPL---VR-KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVID 245
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           FG +      +   V T I   + Y APE I+        D++S G +L E+LTG
Sbjct: 246 FGSSCY----EHQRVYTXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 67/149 (44%), Gaps = 5/149 (3%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           L HP++V+L+     D    +++EFM    +   +  +      +S  +   +      A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
             +  +  +I+RD K   +LL +  N+   KL  FG+A     G+   V+   +GT  + 
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFM 200
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           APE +         DV+  GV+L  +L+G
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 155 NSYQGHREWLAEVIFLGHLSHP------NLVKLIGYCCEDEHRVLIYEFMARGSVE---N 205
           N  + HR+   E+  L HL         N++ ++       H  + +E ++    E    
Sbjct: 132 NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK 191
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSD 263
           N F    LPL   +R K A    + L  LH+    +I+ D K  NILL     +  K+ D
Sbjct: 192 NKFQGFSLPL---VR-KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVID 245
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           FG +      +   V T I   + Y APE I+        D++S G +L E+LTG
Sbjct: 246 FGSSCY----EHQRVYTXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF--SKVLLPLPWSIRMKI 223
           E+  +  L H NL++L          VL+ E++  G + + +   S  L  L   + MK 
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK- 194
Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYNA-KLSDFGLAKDGPEGDKSHVSTR 281
                +G+  +H+    +++ D K  NIL ++ D    K+ DFGLA+     +K  V+  
Sbjct: 195 --QICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN-- 248
Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             GT  + APE +    ++  +D++S GV+   +L+G
Sbjct: 249 -FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 39/182 (21%)
Query: 165 AEVIFLGHL--SHPN----LVKLIGYCCEDEHRVLIYEFMARGS---VENNLFSKVLLPL 215
           +E+  L HL  + PN     V+++ +     H  +++E +   +   ++ N F    LP 
Sbjct: 60  SEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF----LPF 115
Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDY----------------- 257
                 K+A+   K + FLH  +  + + D K  NIL + +DY                 
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 258 -NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 316
            + K+ DFG A    E   + VSTR      Y APE I+    +   DV+S G +L+E  
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTR-----HYRAPEVILALGWSQPCDVWSIGCILIEYY 228
Query: 317 TG 318
            G
Sbjct: 229 LG 230

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 26/171 (15%)
Query: 166 EVIFLGHLSHPNLVKL--IGYCCEDEHRVLIYEF----------MARGSVENNLFSKVLL 213
           E+  L  L HPN++ L  +     D    L++++            R S  N    K  +
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPV 123
Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAKLSDFGLAK- 268
            LP  +   + +    G+ +LH     V++RD K +NIL+  +       K++D G A+ 
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 269 -DGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT 317
            + P    + +   ++ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 182 FNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 67/149 (44%), Gaps = 5/149 (3%)
Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           L HP++V+L+     D    +++EFM    +   +  +      +S  +   +      A
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
             +  +  +I+RD K   +LL +  N+   KL  FG+A     G+   V+   +GT  + 
Sbjct: 145 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFM 202
Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           APE +         DV+  GV+L  +L+G
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 22/94 (23%)
Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL--------AKDGPEGDKSHVSTRI 282
           LA  H   + +++ D K +NI L      KL DFGL        A +  EGD  +++  +
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 283 M-GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           + G+YG AA             DV+S G+ +LE+
Sbjct: 228 LQGSYGTAA-------------DVFSLGLTILEV 248

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 13/185 (7%)
Query: 140 GLQPVPVAVKVHDGDNSYQG--HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GL+     +K      S +G    E   EV  L  + H N++ L          VLI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI-LLDTD 256
           ++ G + + L  K  L    +           G+ +LH   K + + D K  NI LLD +
Sbjct: 97  VSGGELFDFLAQKESLSEEEA--TSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKN 152
Query: 257 Y---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
               + KL DFGLA +  +G +      I GT  + APE +    L   +D++S GV+  
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 314 EILTG 318
            +L+G
Sbjct: 210 ILLSG 214

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 193 LIYEFMARGSVENNLFSKVLL-PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 251
           L++E M  GS+ +++  +     L  S+ ++     A  L FLH   K + +RD K  NI
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLH--NKGIAHRDLKPENI 142
Query: 252 LLDTDYN---AKLSDFGLAKD-GPEGDKSHVSTRIM----GTYGYAAPEYI-----MTGH 298
           L +        K+ DFGL       GD S +ST  +    G+  Y APE +         
Sbjct: 143 LCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 299 LTPRSDVYSFGVVLLEILTG 318
              R D++S GV+L  +L+G
Sbjct: 203 YDKRCDLWSLGVILYILLSG 222

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 13/185 (7%)
Query: 140 GLQPVPVAVKVHDGDNSYQG--HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GL+     +K      S +G    E   EV  L  + H N++ L          VLI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI-LLDTD 256
           ++ G + + L  K  L    +           G+ +LH   K + + D K  NI LLD +
Sbjct: 97  VSGGELFDFLAQKESLSEEEA--TSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKN 152
Query: 257 Y---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
               + KL DFGLA +  +G +      I GT  + APE +    L   +D++S GV+  
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 314 EILTG 318
            +L+G
Sbjct: 210 ILLSG 214

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 25/186 (13%)
Query: 146 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--------VLIY-- 195
           VA+K    D  ++     +  ++      HPN+V L  +   +  +        VL Y  
Sbjct: 67  VAIKKVLQDKRFKNRELQIMRIV-----KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
Query: 196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 255
           E + R S     ++K+   +P  +     +   + LA++H     + +RD K  N+LLD 
Sbjct: 122 ETVYRASRH---YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDP 176
Query: 256 DYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLL 313
                KL DFG AK    G+ +   + I   Y Y APE I    + T   D++S G V+ 
Sbjct: 177 PSGVLKLIDFGSAKILIAGEPN--VSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMA 233
Query: 314 EILTGR 319
           E++ G+
Sbjct: 234 ELMQGQ 239

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 13/185 (7%)
Query: 140 GLQPVPVAVKVHDGDNSYQG--HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GL+     +K      S +G    E   EV  L  + H N++ L          VLI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI-LLDTD 256
           ++ G + + L  K  L    +           G+ +LH   K + + D K  NI LLD +
Sbjct: 97  VSGGELFDFLAQKESLSEEEA--TSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKN 152
Query: 257 Y---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
               + KL DFGLA +  +G +      I GT  + APE +    L   +D++S GV+  
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 314 EILTG 318
            +L+G
Sbjct: 210 ILLSG 214

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 74/175 (42%), Gaps = 22/175 (12%)
Query: 155 NSYQGHREWLAEVIFLGHLSHP------NLVKLIGYCCEDEHRVLIYEFMARGSVE---N 205
           N  + HR+   E+  L HL         N++ ++       H  + +E ++    E    
Sbjct: 132 NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK 191
Query: 206 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSD 263
           N F    LPL   +R K A    + L  LH+    +I+ D K  NILL     +  K+ D
Sbjct: 192 NKFQGFSLPL---VR-KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVID 245
Query: 264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           FG +    +     + +R      Y APE I+        D++S G +L E+LTG
Sbjct: 246 FGSSCYEHQRVYXXIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 13/185 (7%)
Query: 140 GLQPVPVAVKVHDGDNSYQG--HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 197
           GL+     +K      S +G    E   EV  L  + H N++ L          VLI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 198 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI-LLDTD 256
           ++ G + + L  K  L    +           G+ +LH   K + + D K  NI LLD +
Sbjct: 97  VSGGELFDFLAQKESLSEEEA--TSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKN 152
Query: 257 Y---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 313
               + KL DFGLA +  +G +      I GT  + APE +    L   +D++S GV+  
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 314 EILTG 318
            +L+G
Sbjct: 210 ILLSG 214

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	429
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-170
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-145
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-82
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-65
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-60
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-49
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-34
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-33
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-32
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-28
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-04
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-19
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-18
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  512 bits (1320), Expect = 0.0
 Identities = 107/320 (33%), Positives = 172/320 (53%), Gaps = 24/320 (7%)

Query: 88  EDLRRDSAANPLIAFTYDELRIITANFRQDR------VLGGGGFGCVYKGFISEDLREGL 141
           E+   + +     +F++ EL+ +T NF +         +G GGFG VYKG+++       
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT----- 55

Query: 142 QPVPVAVK---VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM 198
               VAVK         + +  +++  E+  +    H NLV+L+G+  + +   L+Y +M
Sbjct: 56  ---TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 199 ARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 257
             GS+ + L       PL W +R KIA GAA G+ FLHE     I+RD K++NILLD  +
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAF 170

Query: 258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            AK+SDFGLA+   +  ++ +++RI+GT  Y APE  + G +TP+SD+YSFGVVLLEI+T
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIIT 229

Query: 318 GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNH 377
           G  ++D+ R    Q L D    +  E+K + + ID ++  D     V     +A  CL+ 
Sbjct: 230 GLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHE 286

Query: 378 NPKARPLMRDIVDSLEPLQV 397
               RP ++ +   L+ +  
Sbjct: 287 KKNKRPDIKKVQQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  480 bits (1237), Expect = e-170
 Identities = 116/303 (38%), Positives = 170/303 (56%), Gaps = 13/303 (4%)

Query: 102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 161
               +L   T NF    ++G G FG VYKG     LR+G     VA+K      S QG  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGV----LRDG---AKVALKRRT-PESSQGIE 80

Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL--LPLPWSI 219
           E+  E+  L    HP+LV LIG+C E    +LIY++M  G+++ +L+   L  + + W  
Sbjct: 81  EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
           R++I  GAA+GL +LH   + +I+RD K+ NILLD ++  K++DFG++K G E D++H+S
Sbjct: 141 RLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP 339
           T + GT GY  PEY + G LT +SDVYSFGVVL E+L  R ++ +S P    NLA+WA+ 
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258

Query: 340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP 399
                 +L  I+DP L      + + K    A  CL  + + RP M D++  LE    L 
Sbjct: 259 SH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

Query: 400 DEA 402
           +  
Sbjct: 318 ESV 320

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  414 bits (1067), Expect = e-145
 Identities = 118/297 (39%), Positives = 176/297 (59%), Gaps = 14/297 (4%)

Query: 102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 161
           F+  EL++ + NF    +LG GGFG VYKG     L +G     VAVK    + +  G  
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGR----LADGTL---VAVKRLKEERTQGGEL 72

Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSI 219
           ++  EV  +    H NL++L G+C     R+L+Y +MA GSV + L  +     PL W  
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132

Query: 220 RMKIAFGAAKGLAFLHEAEKP-VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
           R +IA G+A+GLA+LH+   P +I+RD K +NILLD ++ A + DFGLAK     D +HV
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THV 191

Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ--NLADW 336
           +T + GT G+ APEY+ TG  + ++DV+ +GV+LLE++TG+++ D +R A +    L DW
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
              LLKE KKL  ++D  L+G+Y  + V +   +A  C   +P  RP M ++V  LE
Sbjct: 252 VKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  253 bits (649), Expect = 6e-82
 Identities = 77/323 (23%), Positives = 130/323 (40%), Gaps = 39/323 (12%)

Query: 102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 161
              + L   +   +   V   G FGCV+K  +  +         VAVK+       Q  +
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE--------YVAVKIF----PIQDKQ 61

Query: 162 EWLAE--VIFLGHLSHPNLVKLIGYCCEDEHRV----LIYEFMARGSVENNLFSKVLLPL 215
            W  E  V  L  + H N+++ IG             LI  F  +GS+ + L +     +
Sbjct: 62  SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VV 118

Query: 216 PWSIRMKIAFGAAKGLAFLHE-------AEKP-VIYRDFKTSNILLDTDYNAKLSDFGLA 267
            W+    IA   A+GLA+LHE         KP + +RD K+ N+LL  +  A ++DFGLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

Query: 268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-----TPRSDVYSFGVVLLEILTGRKSL 322
                G  +  +   +GT  Y APE +            R D+Y+ G+VL E+ +   + 
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 323 DKSRPAREQNLAD--WALPLLKEKKKL--LNIIDPRLEGDY-PVKGVHKAAMLAYHCLNH 377
           D           +     P L++ +++       P L   +    G+         C +H
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298

Query: 378 NPKARPLMRDIVDSLEPLQVLPD 400
           + +AR     + + +  +Q L +
Sbjct: 299 DAEARLSAGCVGERITQMQRLTN 321

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  210 bits (536), Expect = 7e-65
 Identities = 66/341 (19%), Positives = 127/341 (37%), Gaps = 50/341 (14%)

Query: 100 IAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG 159
           +     E  +   N +   ++G G +G VYKG     L E     PVAVKV     S+  
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKG----SLDER----PVAVKV----FSFAN 48

Query: 160 HREWLAE--VIFLGHLSHPNLVKLIGYCCEDE-----HRVLIYEFMARGSVENNLFSKVL 212
            + ++ E  +  +  + H N+ + I              +L+ E+   GS+   L     
Sbjct: 49  RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-- 106

Query: 213 LPLPWSIRMKIAFGAAKGLAFLHE-------AEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
               W    ++A    +GLA+LH         +  + +RD  + N+L+  D    +SDFG
Sbjct: 107 -TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165

Query: 266 LAK------DGPEGDKSHVSTRIMGTYGYAAPEYIM-------TGHLTPRSDVYSFGVVL 312
           L+           G++ + +   +GT  Y APE +              + D+Y+ G++ 
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 313 LEILTGRKSLDKSRPAREQNLA----DWALPLLKEKKKL--LNIIDPRLEGDYPVKGVHK 366
            EI      L       E  +A        P  ++ + L       P+    +    +  
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285

Query: 367 AAM--LAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP 405
            ++      C + + +AR   +   + +  L ++ +   + 
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (503), Expect = 3e-60
 Identities = 84/333 (25%), Positives = 143/333 (42%), Gaps = 35/333 (10%)

Query: 74  KKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFI 133
           K  +   P +  ++           +     D++ I   +      +G G FG V++   
Sbjct: 2   KHHHHHHPMSDYDIPTTENLYFQGAM---DGDDMDIPWCDLNIKEKIGAGSFGTVHRAE- 57

Query: 134 SEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV 192
                       VAVK+  + D   +   E+L EV  +  L HPN+V  +G   +  +  
Sbjct: 58  -------WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110

Query: 193 LIYEFMARGSVENNLFSK-VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 251
           ++ E+++RGS+   L        L    R+ +A+  AKG+ +LH    P+++R+ K+ N+
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170

Query: 252 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV 311
           L+D  Y  K+ DFGL++       S  S    GT  + APE +       +SDVYSFGV+
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228

Query: 312 LLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKA-AML 370
           L E+ T ++      P    N A     +  + K+L          + P + ++   A +
Sbjct: 229 LWELATLQQ------PWGNLNPAQVVAAVGFKCKRL----------EIP-RNLNPQVAAI 271

Query: 371 AYHCLNHNPKARPLMRDIVDSLEPLQ--VLPDE 401
              C  + P  RP    I+D L PL    +P  
Sbjct: 272 IEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (489), Expect = 3e-58
 Identities = 80/332 (24%), Positives = 134/332 (40%), Gaps = 48/332 (14%)

Query: 104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW 163
           Y E+ +       + V+G G FG V K           +   VA+K  + ++     + +
Sbjct: 7   YKEIEV-------EEVVGRGAFGVVCKAK--------WRAKDVAIKQIESESE---RKAF 48

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMK 222
           + E+  L  ++HPN+VKL G C       L+ E+   GS+ N L   + L     +  M 
Sbjct: 49  IVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106

Query: 223 IAFGAAKGLAFLH-EAEKPVIYRDFKTSNILLDTDYN-AKLSDFGLAKDGPEGDKSHVST 280
                ++G+A+LH    K +I+RD K  N+LL       K+ DFG A D          T
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMT 161

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 340
              G+  + APE     + + + DV+S+G++L E++T RK      P  E     + +  
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK------PFDEIGGPAFRIMW 215

Query: 341 LKEKKKLLNIIDPRLEGDYPVKGVHKA-AMLAYHCLNHNPKARPLMRDIVDSLEPLQVL- 398
                    +I          K + K    L   C + +P  RP M +IV  +  L    
Sbjct: 216 AVHNGTRPPLI----------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

Query: 399 --PDEAPTPKNFVTVVTPEEPKAEIQTKDSQC 428
              DE        ++   E+ + E     ++ 
Sbjct: 266 PGADEPLQYPCQHSLPPGEDGRVEPYVDFAEF 297

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  188 bits (481), Expect = 2e-57
 Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 50/302 (16%)

Query: 104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHRE 162
           + +L            L     G ++KG          Q   + VKV    D S +  R+
Sbjct: 9   FKQLNF-------LTKLNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRD 53

Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCE--DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 220
           +  E   L   SHPN++ ++G C      H  LI  +M  GS+ N L       +  S  
Sbjct: 54  FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA 113

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           +K A   A+G+AFLH  E  +      + ++++D D  A++S   +         S  S 
Sbjct: 114 VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSP 166

Query: 281 RIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 337
             M    + APE +           +D++SF V+L E++T         P  + +  +  
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV------PFADLSNMEIG 220

Query: 338 LPLLKEKKKLLNI---IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 394
           + +  E  +   I   I P +            + L   C+N +P  RP    IV  LE 
Sbjct: 221 MKVALEGLR-PTIPPGISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEK 267

Query: 395 LQ 396
           +Q
Sbjct: 268 MQ 269

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  184 bits (469), Expect = 2e-55
 Identities = 77/309 (24%), Positives = 133/309 (43%), Gaps = 56/309 (18%)

Query: 104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSY 157
            +E+         ++ +G GGFG V+KG + +          VA+K              
Sbjct: 18  DNEIEY-------EKQIGKGGFGLVHKGRLVK------DKSVVAIKSLILGDSEGETEMI 64

Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW 217
           +  +E+  EV  + +L+HPN+VKL G         ++ EF+  G + + L  K   P+ W
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-PIKW 121

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-----DYNAKLSDFGLAKDGPE 272
           S+++++    A G+ ++     P+++RD ++ NI L +        AK++DFGL++    
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177

Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSLDKSRPARE 330
               H  + ++G + + APE I       T ++D YSF ++L  ILTG        P  E
Sbjct: 178 -QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDE 230

Query: 331 QNLADWALPLLKEKKKL-LNI---IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR 386
            +        +  ++ L   I     PRL              +   C + +PK RP   
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFS 278

Query: 387 DIVDSLEPL 395
            IV  L  L
Sbjct: 279 YIVKELSEL 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  182 bits (463), Expect = 3e-54
 Identities = 75/304 (24%), Positives = 119/304 (39%), Gaps = 40/304 (13%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
            VLG G FG   K       RE      + +K     +     R +L EV  +  L HPN
Sbjct: 16  EVLGKGCFGQAIKV----THRE--TGEVMVMKELIRFDEET-QRTFLKEVKVMRCLEHPN 68

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
           ++K IG   +D+    I E++  G++   + S      PWS R+  A   A G+A+LH  
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHS- 126

Query: 238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAK------------DGPEGDKSHVSTRIMGT 285
              +I+RD  + N L+  + N  ++DFGLA+               +         ++G 
Sbjct: 127 -MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 345
             + APE I       + DV+SFG+VL EI+  R + D     R  +        L  + 
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDYLPRTMDFG------LNVRG 238

Query: 346 KLLNIIDPRLEGDYPVKGVHKA-AMLAYHCLNHNPKARPLMRDIVDSLEPLQV-LPDEAP 403
            L                   +   +   C + +P+ RP    +   LE L++ L    P
Sbjct: 239 FL------DRY---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289

Query: 404 TPKN 407
               
Sbjct: 290 LGPQ 293

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  181 bits (462), Expect = 4e-54
 Identities = 62/341 (18%), Positives = 114/341 (33%), Gaps = 42/341 (12%)

Query: 81  PSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREG 140
           P     +   R         +    E  I         ++G G FG VY G    +    
Sbjct: 2   PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---- 57

Query: 141 LQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 199
                VA+++     ++    + +  EV+      H N+V  +G C    H  +I     
Sbjct: 58  -----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112

Query: 200 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 259
             ++ + +     + L  +   +IA    KG+ +LH   K ++++D K+ N+  D +   
Sbjct: 113 GRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKV 168

Query: 260 KLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTG---------HLTPRSDVYS 307
            ++DFGL         G +        G   + APE I              +  SDV++
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228

Query: 308 FGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKA 367
            G +  E+           P + Q     A+          N+    +  +         
Sbjct: 229 LGTIWYELHAREW------PFKTQPAE--AIIWQMGTGMKPNLSQIGMGKEI-------- 272

Query: 368 AMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNF 408
           + +   C     + RP    ++D LE L         P +F
Sbjct: 273 SDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF 313

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  177 bits (452), Expect = 3e-53
 Identities = 87/305 (28%), Positives = 133/305 (43%), Gaps = 52/305 (17%)

Query: 104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV---HDGDNSYQGH 160
           + EL +       + ++G GGFG VY+ F             VAVK       ++  Q  
Sbjct: 6   FAELTL-------EEIIGIGGFGKVYRAF--------WIGDEVAVKAARHDPDEDISQTI 50

Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 220
                E      L HPN++ L G C ++ +  L+ EF   G +   L  K    +P  I 
Sbjct: 51  ENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDIL 107

Query: 221 MKIAFGAAKGLAFLH-EAEKPVIYRDFKTSNILLD--------TDYNAKLSDFGLAKDGP 271
           +  A   A+G+ +LH EA  P+I+RD K+SNIL+         ++   K++DFGLA+   
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--- 164

Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 331
           E  ++   +   G Y + APE I     +  SDV+S+GV+L E+LTG        P R  
Sbjct: 165 EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------PFRGI 217

Query: 332 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKA-AMLAYHCLNHNPKARPLMRDIVD 390
           +    A  +   K          L    P     +  A L   C N +P +RP   +I+D
Sbjct: 218 DGLAVAYGVAMNKL--------ALP--IP-STCPEPFAKLMEDCWNPDPHSRPSFTNILD 266

Query: 391 SLEPL 395
            L  +
Sbjct: 267 QLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  177 bits (452), Expect = 5e-53
 Identities = 77/298 (25%), Positives = 125/298 (41%), Gaps = 29/298 (9%)

Query: 103 TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHR 161
             D+  I        + +G G FG VYKG    D         VAVK+ +    + Q  +
Sbjct: 15  AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQ 65

Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 221
            +  EV  L    H N++  +G         ++ ++    S+ ++L +           +
Sbjct: 66  AFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLI 123

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
            IA   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   +
Sbjct: 124 DIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181

Query: 282 IMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 338
           + G+  + APE I      P   +SDVY+FG+VL E++TG+       P    N  D  +
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQII 235

Query: 339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
            ++       ++   R      +K +    M    CL      RP    I+  +E L 
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRL----MAE--CLKKKRDERPSFPRILAEIEELA 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  172 bits (437), Expect = 1e-50
 Identities = 69/314 (21%), Positives = 113/314 (35%), Gaps = 43/314 (13%)

Query: 108 RIITANFRQDRVLGGGGFGCVYKG-FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE 166
           R +  +      +G G +G V++G +  E+         VAVK+    +     RE   E
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQGEN---------VAVKIFSSRDEKSWFRE--TE 52

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           +     L H N++  I       H      LI  +   GS+ + L       L     ++
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLR 109

Query: 223 IAFGAAKGLAFLHEAEK------PVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGD 274
           I    A GLA LH           + +RD K+ NIL+  +    ++D GLA         
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169

Query: 275 KSHVSTRIMGTYGYAAPE------YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA 328
               +   +GT  Y APE       +       R D+++FG+VL E+     S       
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229

Query: 329 R----EQNLADWALPLLKE---KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 381
           +    +    D +   +++     +    I  R   D  +  + K   L   C   NP A
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK---LMKECWYQNPSA 286

Query: 382 RPLMRDIVDSLEPL 395
           R     I  +L  +
Sbjct: 287 RLTALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  172 bits (437), Expect = 3e-50
 Identities = 67/320 (20%), Positives = 112/320 (35%), Gaps = 53/320 (16%)

Query: 108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 167
           R I    +  + +G G +G V+ G      R       VAVKV          RE   E+
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMG----KWRG----EKVAVKVFFTTEEASWFRE--TEI 82

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
                + H N++  I    +         LI ++   GS+ + L S     L     +K+
Sbjct: 83  YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKL 139

Query: 224 AFGAAKGLAFLHE------AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDK 275
           A+ +  GL  LH        +  + +RD K+ NIL+  +    ++D GLA        + 
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTP-------RSDVYSFGVVLLEILTGRKSLDKSRPA 328
                  +GT  Y  PE ++   L          +D+YSFG++L E+          R  
Sbjct: 200 DIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR--------RCV 250

Query: 329 REQNLADWALPLLKEKKKLLNIID-----------PRLEGDYPVKGVHKA-AMLAYHCLN 376
               + ++ LP         +  D           P     +      +    L   C  
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310

Query: 377 HNPKARPLMRDIVDSLEPLQ 396
           HNP +R     +  +L  + 
Sbjct: 311 HNPASRLTALRVKKTLAKMS 330

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  170 bits (433), Expect = 1e-49
 Identities = 81/357 (22%), Positives = 129/357 (36%), Gaps = 49/357 (13%)

Query: 66  DESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGF 125
           D S       E + L     ++      S    L        R I         +G G F
Sbjct: 2   DPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLL------VQRTIARTIVLQESIGKGRF 55

Query: 126 GCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC 185
           G V++G      R       VAVK+          RE  AE+     L H N++  I   
Sbjct: 56  GEVWRG----KWRG----EEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 105

Query: 186 CEDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE----- 236
            +D        L+ ++   GS+ + L       +     +K+A   A GLA LH      
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 237 AEKPVI-YRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY 293
             KP I +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE- 221

Query: 294 IMTGHLTP-------RSDVYSFGVVLLEILTGRKSLDKSR----PAREQNLADWALPLLK 342
           ++   +         R+D+Y+ G+V  EI               P  +   +D ++  ++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281

Query: 343 E---KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
           +   ++KL   I  R +    ++ + K   +   C   N  AR     I  +L  L 
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAK---IMRECWYANGAARLTALRIKKTLSQLS 335

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (376), Expect = 6e-41
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 11/218 (5%)

Query: 101 AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 160
           A   D+  +   +      +G G FG V+ G +            VAVK           
Sbjct: 103 AVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR------ADNTLVAVKSCRETLPPDLK 156

Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSI 219
            ++L E   L   SHPN+V+LIG C + +   ++ E +  G     L +    L +   +
Sbjct: 157 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLL 216

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
           +M     AA G+ +L    K  I+RD    N L+      K+SDFG++++  +G  +   
Sbjct: 217 QM--VGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                   + APE +  G  +  SDV+SFG++L E  +
Sbjct: 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  138 bits (350), Expect = 8e-38
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 23/214 (10%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           R LG G FG VY+G +++ + +      VA+K  +   S +   E+L E   +   +  +
Sbjct: 31  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNL--------FSKVLLPLPWSIRMKIAFGAAK 229
           +V+L+G   + +  ++I E M RG +++ L         + VL P   S  +++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRI----M 283
           G+A+L       ++RD    N ++  D+  K+ DFG+ +D  E D  +      +    M
Sbjct: 150 GMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 +PE +  G  T  SDV+SFGVVL EI T
Sbjct: 208 ------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  136 bits (344), Expect = 8e-37
 Identities = 78/348 (22%), Positives = 134/348 (38%), Gaps = 55/348 (15%)

Query: 78  SKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDL 137
           S L     +   L+     NP          I   +      LG G FG V+      +L
Sbjct: 7   SSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLA-ECHNL 65

Query: 138 REGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
                 + VAVK + +   S    +++  E   L  L H ++V+  G C E    ++++E
Sbjct: 66  LPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123

Query: 197 FMARGS-----------VENNLFSKVLLPLPWSIR--MKIAFGAAKGLAFLHEAEKPVIY 243
           +M  G             +     + + P P  +   + +A   A G+ +L  A    ++
Sbjct: 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVH 181

Query: 244 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRI----MGTYGYAAPEYIMTG 297
           RD  T N L+      K+ DFG+++D    D  +    T +    M       PE I+  
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM------PPESILYR 235

Query: 298 HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE 356
             T  SDV+SFGVVL EI T G+      +P  + +  + A+  + + ++L         
Sbjct: 236 KFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTE-AIDCITQGREL--------- 279

Query: 357 GDYPV---KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE 401
            + P      V+    +   C    P+ R  ++D+   L+ L   P  
Sbjct: 280 -ERPRACPPEVYA---IMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (341), Expect = 1e-36
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 27/216 (12%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 176
           ++LG G FG V +G + +   E    + VAVK +   ++S +   E+L+E   +   SHP
Sbjct: 40  KILGEGEFGSVMEGNLKQ---EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 177 NLVKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLLPLPWSIRMK----IAFGA 227
           N+++L+G C E   +      +I  FM  G +   L    L   P  I ++         
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRI--- 282
           A G+ +L  + +  ++RD    N +L  D    ++DFGL+K    GD  +     ++   
Sbjct: 157 ALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 283 -MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            +      A E +     T +SDV++FGV + EI T
Sbjct: 215 WI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  135 bits (342), Expect = 1e-36
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 10/217 (4%)

Query: 107 LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           LRI+    F++ +VLG G FG VYKG    +  +    +PVA+K      S + ++E L 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILD 66

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIA 224
           E   +  + +P++ +L+G  C      LI + M  G + + +   K  +   + +     
Sbjct: 67  EAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--C 123

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
              AKG+ +L   ++ +++RD    N+L+ T  + K++DFGLAK     +K + +     
Sbjct: 124 VQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
              + A E I+    T +SDV+S+GV + E++T G K
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (338), Expect = 2e-36
 Identities = 67/290 (23%), Positives = 108/290 (37%), Gaps = 62/290 (21%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGH 172
            + D  +G G F  VYKG    D       V VA   + D   +    + +  E   L  
Sbjct: 28  LKFDIEIGRGSFKTVYKGL---DTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKG 81

Query: 173 LSHPNLVKLIGYC---CEDEHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
           L HPN+V+         + +  +++  E M  G+++   + K    +   +         
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT--YLKRFKVMKIKVLRSWCRQIL 139

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           KGL FLH    P+I+RD K  NI +     + K+ D GLA       ++  +  ++GT  
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPE 195

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG--------------RKSLDKSRPAREQNL 333
           + APE     +     DVY+FG+ +LE+ T               R+     +PA    +
Sbjct: 196 FMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254

Query: 334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
           A    P +KE      II+                     C+  N   R 
Sbjct: 255 AI---PEVKE------IIE--------------------GCIRQNKDERY 275

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  134 bits (340), Expect = 2e-36
 Identities = 82/327 (25%), Positives = 123/327 (37%), Gaps = 35/327 (10%)

Query: 93  DSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD 152
             A   L     D         ++ R LG G FG V       D         VAVK   
Sbjct: 12  HGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCY--DPTNDGTGEMVAVKALK 69

Query: 153 GDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV--LIYEFMARGSVENNLFSK 210
            D   Q    W  E+  L  L H +++K  G C +       L+ E++  GS+ + L  +
Sbjct: 70  ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PR 128

Query: 211 VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 270
             + L   +    A    +G+A+LH   +  I+RD    N+LLD D   K+ DFGLAK  
Sbjct: 129 HSIGLAQLLLF--AQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184

Query: 271 PEGD---KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSL 322
           PEG    +                  APE +        SDV+SFGV L E+LT    S 
Sbjct: 185 PEGHEYYRVREDGDSPVFWY------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238

Query: 323 DKSRPAREQNLADWALPLLKEKKKLLNIIDP--RLE--GDYPVKGVHKAAMLAYHCLNHN 378
                  E          +     L  +++   RL      P + V+    L  +C    
Sbjct: 239 SPPTKFLELIGIAQGQMTVLR---LTELLERGERLPRPDKCPAE-VY---HLMKNCWETE 291

Query: 379 PKARPLMRDIVDSLEPL-QVLPDEAPT 404
              RP   +++  L+ + +    +AP+
Sbjct: 292 ASFRPTFENLIPILKTVHEKYQGQAPS 318

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  133 bits (338), Expect = 4e-36
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 28/217 (12%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 176
           R+LG G FG V +  + +   E    V VAVK +     +     E+L E   +    HP
Sbjct: 29  RMLGKGEFGSVREAQLKQ---EDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 177 NLVKLIGYCCEDEHRV------LIYEFMARGSVENNLFSKVLLPLPWSIRMK----IAFG 226
           ++ KL+G       +       +I  FM  G +   L +  +   P+++ ++        
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRI-- 282
            A G+ +L  + +  I+RD    N +L  D    ++DFGL++    GD  +   ++++  
Sbjct: 146 IACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 283 --MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             +      A E +     T  SDV++FGV + EI+T
Sbjct: 204 KWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  132 bits (335), Expect = 7e-36
 Identities = 73/294 (24%), Positives = 110/294 (37%), Gaps = 36/294 (12%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           R LG G FG V       D         VAVK    ++      +   E+  L +L H N
Sbjct: 27  RDLGEGHFGKVELCRY--DPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 178 LVKLIGYCCEDEHRV--LIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFL 234
           +VK  G C ED      LI EF+  GS++  L   K  + L   ++   A    KG+ +L
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY--AVQICKGMDYL 142

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI----MGTYG 287
               +  ++RD    N+L+++++  K+ DFGL K                          
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY---- 196

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK 346
             APE +M       SDV+SFGV L E+LT             +          +     
Sbjct: 197 --APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR--- 251

Query: 347 LLNIIDP--RLEGDYPV---KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
           L+N +    RL    P      V+    L   C    P  R   +++++  E L
Sbjct: 252 LVNTLKEGKRLPC--PPNCPDEVY---QLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  131 bits (333), Expect = 1e-35
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 24/214 (11%)

Query: 116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLS 174
           +D+ LG G FG V KG+     +       VAVK+  +  N      E LAE   +  L 
Sbjct: 21  EDKELGSGNFGTVKKGY----YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 76

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL 234
           +P +V++IG  CE E  +L+ E    G +   L     +     I +      + G+ +L
Sbjct: 77  NPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL--VHQVSMGMKYL 133

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI----MGTYG 287
              E   ++RD    N+LL T + AK+SDFGL+K     +   K+    +          
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---- 187

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
             APE I     + +SDV+SFGV++ E  + G+K
Sbjct: 188 --APECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (340), Expect = 2e-35
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 19/227 (8%)

Query: 92  RDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVH 151
            +        F      +     +  + +G G FG V  G          +   VAVK  
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCI 224

Query: 152 DGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSK 210
             D +    + +LAE   +  L H NLV+L+G   E++  + ++ E+MA+GS+ + L S+
Sbjct: 225 KNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 281

Query: 211 VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 270
               L     +K +    + + +L       ++RD    N+L+  D  AK+SDFGL K+ 
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339

Query: 271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                +  + ++     + APE +     + +SDV+SFG++L EI +
Sbjct: 340 ---SSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  132 bits (333), Expect = 3e-35
 Identities = 80/316 (25%), Positives = 123/316 (38%), Gaps = 41/316 (12%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           R LG G FG VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N
Sbjct: 36  RGLGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNL-----FSKVLLPLPWSIRMKIAFGAAKGLA 232
           +V+ IG   +   R ++ E MA G +++ L            L     + +A   A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 233 FLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGD--KSHVSTRI----M 283
           +L   E   I+RD    N LL        AK+ DFG+A+D       +      +    M
Sbjct: 155 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLK 342
                  PE  M G  T ++D +SFGV+L EI + G        P   ++  +  L  + 
Sbjct: 213 ------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQE-VLEFVT 259

Query: 343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA 402
              ++          D P         +   C  H P+ RP    I++ +E     PD  
Sbjct: 260 SGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309

Query: 403 PTPKNFVTVVTPEEPK 418
            T          EE +
Sbjct: 310 NTALPIEYGPLVEEEE 325

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (333), Expect = 5e-35
 Identities = 79/314 (25%), Positives = 123/314 (39%), Gaps = 41/314 (13%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
           R LG G FG VY+G     +     P+ VAVK      S Q   ++L E + +   +H N
Sbjct: 77  RGLGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFS---KVLLPLPWSIR--MKIAFGAAKGLA 232
           +V+ IG   +   R ++ E MA G +++ L     +   P   ++   + +A   A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 233 FLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGD--KSHVSTRI----M 283
           +L   E   I+RD    N LL        AK+ DFG+A+D       +      +    M
Sbjct: 196 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLK 342
                  PE  M G  T ++D +SFGV+L EI + G        P   ++  +  L  + 
Sbjct: 254 ------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQE-VLEFVT 300

Query: 343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA 402
              ++          D P         +   C  H P+ RP    I++ +E     PD  
Sbjct: 301 SGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350

Query: 403 PTPKNFVTVVTPEE 416
            T          EE
Sbjct: 351 NTALPIEYGPLVEE 364

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (328), Expect = 7e-35
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 35/217 (16%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           + V+G G FGCVY G +   L    + +  AVK  +         ++L E I +   SHP
Sbjct: 30  NEVIGRGHFGCVYHGTL---LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86

Query: 177 NLVKLIGYCCEDEHRVL-IYEFMARGSV-------ENNLFSKVLLPLPWSIRMKIAFGAA 228
           N++ L+G C   E   L +  +M  G +        +N   K L+              A
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--------GFGLQVA 138

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD----KSHVSTRI-- 282
           KG+ +L  A K  ++RD    N +LD  +  K++DFGLA+D  + +     +    ++  
Sbjct: 139 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196

Query: 283 --MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             M      A E + T   T +SDV+SFGV+L E++T
Sbjct: 197 KWM------ALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  129 bits (326), Expect = 9e-35
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 28/225 (12%)

Query: 102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 161
           F      +     +  + +G G FG V  G          +   VAVK    D +    +
Sbjct: 11  FYRSGWALNMKELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCIKNDAT---AQ 59

Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI-YEFMARGSVENNLFSKVLLPLPWSIR 220
            +LAE   +  L H NLV+L+G   E++  + I  E+MA+GS+ + L S+    L     
Sbjct: 60  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 119

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           +K +    + + +L       ++RD    N+L+  D  AK+SDFGL K+      +  + 
Sbjct: 120 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTG 174

Query: 281 RI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
           ++           APE +     + +SDV+SFG++L EI + GR 
Sbjct: 175 KLPVKWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  130 bits (330), Expect = 9e-35
 Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 21/233 (9%)

Query: 97  NPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS 156
           +P  A       I  +   + +V+G G FG VYKG +      G + VPVA+K      +
Sbjct: 29  DPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYT 86

Query: 157 YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPL 215
            +   ++L E   +G  SH N+++L G   + +  ++I E+M  G+++  L        +
Sbjct: 87  EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV 146

Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA---KDGPE 272
              + M    G A G+ +L  A    ++RD    NIL++++   K+SDFGL+   +D PE
Sbjct: 147 LQLVGM--LRGIAAGMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202

Query: 273 GDKSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
              +    +I           APE I     T  SDV+SFG+V+ E++T G +
Sbjct: 203 ATYTTSGGKIPIRWT------APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  130 bits (329), Expect = 1e-34
 Identities = 66/265 (24%), Positives = 120/265 (45%), Gaps = 18/265 (6%)

Query: 59  HCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDR 118
           H   S   E+   + K    +  + P   E+        P  A       I  +    ++
Sbjct: 4   HHHHSSGRENLYFQGKLPEPQFYAEPHTYEE--------PGRAGRSFTREIEASRIHIEK 55

Query: 119 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           ++G G  G V  G +      G + VPVA+K      + +  R++L+E   +G   HPN+
Sbjct: 56  IIGSGDSGEVCYGRL---RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 179 VKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLHEA 237
           ++L G        +++ E+M  GS++  L +      +   + M    G   G+ +L  +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM--LRGVGAGMRYL--S 168

Query: 238 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDKSHVSTRIMGTYGYAAPEYIMT 296
           +   ++RD    N+L+D++   K+SDFGL++    + D ++ +T       + APE I  
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 297 GHLTPRSDVYSFGVVLLEILT-GRK 320
              +  SDV+SFGVV+ E+L  G +
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  133 bits (337), Expect = 1e-34
 Identities = 75/305 (24%), Positives = 129/305 (42%), Gaps = 27/305 (8%)

Query: 91  RRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV 150
           +R+      ++  YD+  +   +      LGGG +G VY+G   +        + VAVK 
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKT 252

Query: 151 HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK 210
              D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L   
Sbjct: 253 LKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310

Query: 211 VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 270
               +   + + +A   +  + +L   +K  I+R+    N L+  ++  K++DFGL++  
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL- 367

Query: 271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE 330
             GD             + APE +     + +SDV++FGV+L EI T         P   
Sbjct: 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM-----SPYPG 422

Query: 331 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
            +L+     LL++  ++      R     P     K   L   C   NP  RP   +I  
Sbjct: 423 IDLSQ-VYELLEKDYRM-----ER-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471

Query: 391 SLEPL 395
           + E +
Sbjct: 472 AFETM 476

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (329), Expect = 1e-34
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 10/217 (4%)

Query: 107 LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           LRI+    F++ +VLG G FG VYKG    +  +    +PVA+K      S + ++E L 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILD 66

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIA 224
           E   +  + +P++ +L+G  C      LI + M  G + + +   K  +   + +     
Sbjct: 67  EAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--C 123

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
              AKG+ +L   ++ +++RD    N+L+ T  + K++DFGLAK     +K + +     
Sbjct: 124 VQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
              + A E I+    T +SDV+S+GV + E++T G K
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  130 bits (328), Expect = 1e-34
 Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 9/206 (4%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
            +VLG G FG V+KG    +       +PV +KV +  +  Q  +     ++ +G L H 
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESI--KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAAKGLAFLH 235
           ++V+L+G  C      L+ +++  GS+ +++   +  L     +        AKG+ +L 
Sbjct: 76  HIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW--GVQIAKGMYYL- 131

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM 295
             E  +++R+    N+LL +    +++DFG+A   P  DK  + +       + A E I 
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 296 TGHLTPRSDVYSFGVVLLEILT-GRK 320
            G  T +SDV+S+GV + E++T G +
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAE 216

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (325), Expect = 2e-34
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 29/220 (13%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
             LG   FG VYKG        G Q   VA+K            E+  E +    L HPN
Sbjct: 15  EELGEDRFGKVYKG-HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGS----------VENNLFSKVLLPLPWSIRMK----I 223
           +V L+G   +D+   +I+ + + G             +   +     +  ++       +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTR 281
               A G+ +L  +   V+++D  T N+L+    N K+SD GL ++    D  K   ++ 
Sbjct: 134 VAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 282 I----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           +    M      APE IM G  +  SD++S+GVVL E+ +
Sbjct: 192 LPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (325), Expect = 2e-34
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)

Query: 115 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS 174
             DRV+G G FG VY G   +   +    +  A+K        Q    +L E + +  L+
Sbjct: 24  HSDRVIGKGHFGVVYHGEYID---QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 175 HPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLA 232
           HPN++ LIG     E     +  +M  G +   + S +    +   I        A+G+ 
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGME 138

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD----KSHVSTRI----MG 284
           +L  AE+  ++RD    N +LD  +  K++DFGLA+D  + +    + H   R+      
Sbjct: 139 YL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT- 195

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                A E + T   T +SDV+SFGV+L E+LT
Sbjct: 196 -----ALESLQTYRFTTKSDVWSFGVLLWELLT 223

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  129 bits (326), Expect = 4e-34
 Identities = 65/269 (24%), Positives = 112/269 (41%), Gaps = 44/269 (16%)

Query: 77  YSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISED 136
             +L  NP         +     + +  + +  +       R +G G FG V++   +  
Sbjct: 19  LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYV-------RDIGEGAFGRVFQA-RAPG 70

Query: 137 LREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 196
           L        VAVK+   + S     ++  E   +    +PN+VKL+G C   +   L++E
Sbjct: 71  LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130

Query: 197 FMARGS------------------VENNLFSKVLLPLPWSIRMK----IAFGAAKGLAFL 234
           +MA G                    + +  ++V  P P  +       IA   A G+A+L
Sbjct: 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRI----MGTYGY 288
             +E+  ++RD  T N L+  +   K++DFGL+++    D  K+  +  I    M     
Sbjct: 191 --SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM----- 243

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
             PE I     T  SDV+++GVVL EI +
Sbjct: 244 -PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (337), Expect = 4e-34
 Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 23/295 (7%)

Query: 29  ILDIPFLFCKLMKKTEMKKVQSFFQFQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVE 88
           + D+   +C+L+       +    +    +         +  +  +     +    +  E
Sbjct: 310 MADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAE 369

Query: 89  DLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAV 148
            +  +         +  +  I        R +G G FG V++G     +      + VA+
Sbjct: 370 IIDEED---TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQG---IYMSPENPAMAVAI 423

Query: 149 KVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF 208
           K      S     ++L E + +    HP++VKLIG    +    +I E    G + + L 
Sbjct: 424 KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ 482

Query: 209 S-KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 267
             K  L L   I    A+  +  LA+L    K  ++RD    N+L+ ++   KL DFGL+
Sbjct: 483 VRKFSLDLASLILY--AYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538

Query: 268 KDGPEGD-----KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           +   +       K  +  + M      APE I     T  SDV+ FGV + EIL 
Sbjct: 539 RYMEDSTYYKASKGKLPIKWM------APESINFRRFTSASDVWMFGVCMWEILM 587

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  129 bits (327), Expect = 4e-34
 Identities = 83/372 (22%), Positives = 148/372 (39%), Gaps = 53/372 (14%)

Query: 46  KKVQSFFQFQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYD 105
           K++    Q    +    S    +P  +     S     P        +   +P   F  D
Sbjct: 22  KRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRD 81

Query: 106 ELRIITANFRQDRVLGGGGFGCVYKGFISE-DLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           +L +        + LG G FG V        D  +  + V VAVK+   D + +   + +
Sbjct: 82  KLTLG-------KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 134

Query: 165 AEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS--------------VENNLFS 209
           +E+  +  +  H N++ L+G C +D    +I E+ ++G+                 ++  
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194

Query: 210 KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 269
                + +   +   +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252

Query: 270 GPEGD--KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 323
               D  K   + R+    M      APE +     T +SDV+SFGV++ EI T   S  
Sbjct: 253 INNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

Query: 324 KSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
              P  E         LLKE  ++          D P    ++  M+   C +  P  RP
Sbjct: 307 PGIPVEE------LFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRP 350

Query: 384 LMRDIVDSLEPL 395
             + +V+ L+ +
Sbjct: 351 TFKQLVEDLDRI 362

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  131 bits (331), Expect = 4e-34
 Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 29/305 (9%)

Query: 96  ANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN 155
                    D   I   + R +  LG G FG V+ G  +           VA+K      
Sbjct: 168 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGT 220

Query: 156 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 215
                  +L E   +  L H  LV+L      +E   ++ E+M++GS+ + L  +    L
Sbjct: 221 M--SPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYL 277

Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
                + +A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++
Sbjct: 278 RLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNE 334

Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 335
                       + APE  + G  T +SDV+SFG++L E+ T  +      P       +
Sbjct: 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-----VPYPGMVNRE 389

Query: 336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
             L  ++   ++     P      P + +H    L   C    P+ RP    +   LE  
Sbjct: 390 -VLDQVERGYRM-----PCPPE-CP-ESLHD---LMCQCWRKEPEERPTFEYLQAFLEDY 438

Query: 396 QVLPD 400
               +
Sbjct: 439 FTSTE 443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  129 bits (325), Expect = 4e-34
 Identities = 76/311 (24%), Positives = 116/311 (37%), Gaps = 51/311 (16%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLGHLSH 175
             LG G FG V       D         VAVK   H G +     R++  E+  L  L  
Sbjct: 29  SQLGKGNFGSVELCRY--DPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILKALHS 83

Query: 176 PNLVKLIGYCCEDEHRV--LIYEFMARGSV-------ENNLFSKVLLPLPWSIRMKIAFG 226
             +VK  G       +   L+ E++  G +          L +  LL          +  
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL--------LYSSQ 135

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI- 282
             KG+ +L    +  ++RD    NIL++++ + K++DFGLAK  P            +  
Sbjct: 136 ICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 283 ---MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAL 338
                     APE +     + +SDV+SFGVVL E+ T   KS   S         +  +
Sbjct: 194 IFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247

Query: 339 PLLKEKKKLLNIIDP--RLE--GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 394
           P L     LL +++   RL      P + VH    L   C   +P+ RP    +   L+ 
Sbjct: 248 PALSR---LLELLEEGQRLPAPPACPAE-VH---ELMKLCWAPSPQDRPSFSALGPQLDM 300

Query: 395 LQVLPDEAPTP 405
           L        T 
Sbjct: 301 LWSGSRGCETH 311

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  131 bits (331), Expect = 5e-34
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 15/221 (6%)

Query: 98  PLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 157
           P   +  D   I   + + ++ LG G FG V+            +   VAVK     +  
Sbjct: 174 PQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMA-------TYNKHTKVAVKTMKPGSMS 226

Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW 217
                +LAE   +  L H  LVKL       E   +I EFMA+GS+ + L S      P 
Sbjct: 227 V--EAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 283

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KS 276
              +  +   A+G+AF+   ++  I+RD + +NIL+      K++DFGLA+   + +  +
Sbjct: 284 PKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341

Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
               +      + APE I  G  T +SDV+SFG++L+EI+T
Sbjct: 342 REGAKFP--IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  127 bits (321), Expect = 6e-34
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 25/223 (11%)

Query: 101 AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 160
              Y    I   +    + LG G FG V  G              VA+K+    +  +  
Sbjct: 13  GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGSMSE-- 63

Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSI 219
            E++ E   + +LSH  LV+L G C +     +I E+MA G + N L   +        +
Sbjct: 64  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 123

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHV 278
            M       + + +L    K  ++RD    N L++     K+SDFGL++   + +  S V
Sbjct: 124 EM--CKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179

Query: 279 STRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            ++             PE +M    + +SD+++FGV++ EI +
Sbjct: 180 GSKFPVRWS------PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  129 bits (326), Expect = 6e-34
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 31/215 (14%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           + V+G G FGCVY G + ++  +    +  AVK  +         ++L E I +   SHP
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGK---KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 150

Query: 177 NLVKLIGYCCEDEHRVL-IYEFMARGSV-------ENNLFSKVLLPLPWSIRMKIAFGAA 228
           N++ L+G C   E   L +  +M  G +        +N   K L+              A
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--------GFGLQVA 202

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG---- 284
           KG+ FL  A K  ++RD    N +LD  +  K++DFGLA+D  + +   V  +       
Sbjct: 203 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260

Query: 285 --TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                  A E + T   T +SDV+SFGV+L E++T
Sbjct: 261 KWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  126 bits (319), Expect = 9e-34
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLSHP 176
           + +G G FG V+ G+        L    VA+K   +G  S +   +++ E   +  LSHP
Sbjct: 14  QEIGSGQFGLVHLGYW-------LNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHP 63

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLH 235
            LV+L G C E     L+ EFM  G + + L + + L      + M       +G+A+L 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRI----MGTYGYAA 290
             E  VI+RD    N L+  +   K+SDFG+ +   +    S   T+            +
Sbjct: 121 -EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------S 173

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
           PE       + +SDV+SFGV++ E+ + G+ 
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (319), Expect = 1e-33
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 24/213 (11%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           D  LG G FG V +G      R   + + VA+KV           E + E   +  L +P
Sbjct: 15  DIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAAKGLAFLH 235
            +V+LIG  C+ E  +L+ E    G +   L   +  +P+     +      + G+ +L 
Sbjct: 71  YIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVSMGMKYL- 126

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI----MGTYGY 288
             EK  ++RD    N+LL   + AK+SDFGL+K     D    +  + +           
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----- 180

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
            APE I     + RSDV+S+GV + E L+ G+K
Sbjct: 181 -APECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (320), Expect = 2e-33
 Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 37/233 (15%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           N    + LG G FG V K      L+       VAVK+   + S    R+ L+E   L  
Sbjct: 24  NLVLGKTLGEGEFGKVVKATA-FHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGS------------------VENNLFSKVLLP 214
           ++HP+++KL G C +D   +LI E+   GS                    +   S +  P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 215 LPWSIRMK----IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 270
              ++ M      A+  ++G+ +L  AE  +++RD    NIL+      K+SDFGL++D 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200

Query: 271 PEGD--KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            E D        RI    M      A E +     T +SDV+SFGV+L EI+T
Sbjct: 201 YEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  125 bits (317), Expect = 3e-33
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 32/221 (14%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 176
           R LG G FG V+      +L      + VAVK + D   +    +++  E   L +L H 
Sbjct: 21  RELGEGAFGKVFLA-ECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHE 77

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGS----------VENNLFSKVLLPLPWSIRMK---- 222
           ++VK  G C + +  ++++E+M  G               L           + +     
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVST 280
           IA   A G+ +L  A +  ++RD  T N L+  +   K+ DFG+++D    D  +    T
Sbjct: 138 IASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 281 RI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            +    M       PE IM    T  SDV+SFGV+L EI T
Sbjct: 196 MLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  125 bits (316), Expect = 3e-33
 Identities = 75/308 (24%), Positives = 116/308 (37%), Gaps = 53/308 (17%)

Query: 113 NFRQDRVLGGGGFGCVYKG-FISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFL 170
           +   +  LG G F  ++KG          L    V +KV      +Y     +      +
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMM 66

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAK 229
             LSH +LV   G C   +  +L+ EF+  GS++  L   K  + + W + +  A   A 
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAA 124

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYN--------AKLSDFGLAKDGPEGDKSHVSTR 281
            + FL   E  +I+ +    NILL  + +         KLSD G++      D       
Sbjct: 125 AMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182

Query: 282 IMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALP 339
            +       PE I    +L   +D +SFG  L EI + G K      P          L 
Sbjct: 183 WV------PPECIENPKNLNLATDKWSFGTTLWEICSGGDK------P----------LS 220

Query: 340 LLKEKKKLLNIID----PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
            L  ++KL    D    P  +    +      A L  +C+++ P  RP  R I+  L  L
Sbjct: 221 ALDSQRKLQFYEDRHQLPAPKAA-EL------ANLINNCMDYEPDHRPSFRAIIRDLNSL 273

Query: 396 QVLPDEAP 403
              PD  P
Sbjct: 274 FT-PDLVP 280

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (328), Expect = 4e-33
 Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 28/277 (10%)

Query: 53  QFQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITA 112
           Q +  +   +    E     +  +   +P +    E    D               ++ A
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
               D  LG G FG V +G      R   + + VA+KV           E + E   +  
Sbjct: 341 ----DIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 392

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGL 231
           L +P +V+LIG  C+ E  +L+ E    G +   L   +  +P+     +      + G+
Sbjct: 393 LDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVSMGM 449

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI----MG 284
            +L   EK  ++R+    N+LL   + AK+SDFGL+K     D    +  + +       
Sbjct: 450 KYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY- 506

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
                APE I     + RSDV+S+GV + E L+ G+K
Sbjct: 507 -----APECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  127 bits (320), Expect = 4e-33
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 22/213 (10%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
           D+V+G G FG V  G +        + + VA+K      + +  R++L E   +G   HP
Sbjct: 50  DKVVGAGEFGEVCSGRLKLP---SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLH 235
           N+++L G   + +  +++ E+M  GS+++ L        +   + M    G A G+ +L 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--LRGIASGMKYL- 163

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA---KDGPEGDKSHVSTRI----MGTYGY 288
            ++   ++RD    NIL++++   K+SDFGL    +D PE   +    +I          
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----- 217

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
            +PE I     T  SDV+S+G+VL E+++ G +
Sbjct: 218 -SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  126 bits (318), Expect = 4e-33
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISE-DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
                + LG G FG V        D  +  + V VAVK+   D + +   + ++E+  + 
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95

Query: 172 HL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS--------------VENNLFSKVLLPLP 216
            +  H N++ L+G C +D    +I E+ ++G+                 ++       + 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-- 274
           +   +   +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D  
Sbjct: 156 FKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213

Query: 275 KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           K   + R+    M      APE +     T +SDV+SFGV++ EI T
Sbjct: 214 KKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  124 bits (314), Expect = 5e-33
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 21/227 (9%)

Query: 101 AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 160
           +    +  I   +   +R+LG G FG VY+G          + + VAVK    D +    
Sbjct: 1   SMGGPQYGIAREDVVLNRILGEGFFGEVYEGVY---TNHKGEKINVAVKTCKKDCTLDNK 57

Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSI 219
            ++++E + + +L HP++VKLIG   E+E   +I E    G + + L   K  L +   +
Sbjct: 58  EKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLV 116

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHV 278
               +    K +A+L       ++RD    NIL+ +    KL DFGL++   + D     
Sbjct: 117 LY--SLQICKAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 172

Query: 279 STRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
            TR+    M      +PE I     T  SDV+ F V + EIL+ G++
Sbjct: 173 VTRLPIKWM------SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  125 bits (315), Expect = 5e-33
 Identities = 75/296 (25%), Positives = 118/296 (39%), Gaps = 38/296 (12%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLGHLSH 175
           + LG G FG V       D  +      VAVK   H  +      R++  E+  L  L H
Sbjct: 16  QQLGKGNFGSVEMCRY--DPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQH 70

Query: 176 PNLVKLIGYCCEDEHRV--LIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLA 232
            N+VK  G C     R   LI E++  GS+ + L   K  +     ++        KG+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TSQICKGME 128

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI----MGT 285
           +L    K  I+RD  T NIL++ +   K+ DFGL K  P+     K              
Sbjct: 129 YLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-- 184

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 345
               APE +     +  SDV+SFGVVL E+ T  +          + + +     +    
Sbjct: 185 ----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-VF 239

Query: 346 KLLNIIDP--RLEGDYPV---KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
            L+ ++    RL    P      ++   M+   C N+N   RP  RD+   ++ ++
Sbjct: 240 HLIELLKNNGRLPR--PDGCPDEIY---MIMTECWNNNVNQRPSFRDLALRVDQIR 290

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  124 bits (313), Expect = 7e-33
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 21/229 (9%)

Query: 99  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ 158
            +  +  +  I        R +G G FG V++G     +      + VA+K      S  
Sbjct: 2   AMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDS 58

Query: 159 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPW 217
              ++L E + +    HP++VKLIG    +    +I E    G + + L   K  L L  
Sbjct: 59  VREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLAS 117

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KS 276
            I    A+  +  LA+L    K  ++RD    N+L+ ++   KL DFGL++   +     
Sbjct: 118 LILY--AYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173

Query: 277 HVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
               ++    M      APE I     T  SDV+ FGV + EIL  G K
Sbjct: 174 ASKGKLPIKWM------APESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  124 bits (314), Expect = 7e-33
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 23/220 (10%)

Query: 104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHRE 162
           YD+  +   +      LGGG +G VY+G   +        + VAVK + +     +   E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE---E 55

Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
           +L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L       +   + + 
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTR 281
           +A   +  + +L   +K  I+RD    N L+  ++  K++DFGL++        +H   +
Sbjct: 116 MATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173

Query: 282 I----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                       APE +     + +SDV++FGV+L EI T
Sbjct: 174 FPIKWT------APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  124 bits (313), Expect = 7e-33
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 17/202 (8%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 176
             LG G FG V+ G+ +           VAVK +  G  S      +LAE   +  L H 
Sbjct: 19  ERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQ 68

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
            LV+L       E   +I E+M  GS+ + L +   + L  +  + +A   A+G+AF+  
Sbjct: 69  RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125

Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIM 295
            E+  I+RD + +NIL+    + K++DFGLA+   + +  +    +      + APE I 
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAIN 183

Query: 296 TGHLTPRSDVYSFGVVLLEILT 317
            G  T +SDV+SFG++L EI+T
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  125 bits (315), Expect = 8e-33
 Identities = 75/294 (25%), Positives = 118/294 (40%), Gaps = 36/294 (12%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLGHLSH 175
           + LG G FG V       D  +      VAVK   H  +      R++  E+  L  L H
Sbjct: 47  QQLGKGNFGSVEMCRY--DPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQH 101

Query: 176 PNLVKLIGYCCEDEHRV--LIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLA 232
            N+VK  G C     R   LI E++  GS+ + L   K  +     ++        KG+ 
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TSQICKGME 159

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI----MGT 285
           +L    K  I+RD  T NIL++ +   K+ DFGL K  P+     K              
Sbjct: 160 YL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-- 215

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 345
               APE +     +  SDV+SFGVVL E+ T  +          + + +     +    
Sbjct: 216 ----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-VF 270

Query: 346 KLLNIIDP--RLE--GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
            L+ ++    RL      P + ++   M+   C N+N   RP  RD+   ++ +
Sbjct: 271 HLIELLKNNGRLPRPDGCPDE-IY---MIMTECWNNNVNQRPSFRDLALRVDQI 320

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  125 bits (316), Expect = 8e-33
 Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 28/224 (12%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           N +  + LG G FG V +   +  L +    + VAVK+             ++E+  + H
Sbjct: 47  NLQFGKTLGAGAFGKVVEA-TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 173 L-SHPNLVKLIGYCCEDEHRVLIYEFMARGS------------VENNLFSKVLLPLPWSI 219
           L  H N+V L+G C      ++I E+   G               +  F+          
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSH 277
            +  +   A+G+AFL  A K  I+RD    N+LL   + AK+ DFGLA+D          
Sbjct: 166 LLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223

Query: 278 VSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
            + R+    M      APE I     T +SDV+S+G++L EI +
Sbjct: 224 GNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  124 bits (313), Expect = 1e-32
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 17/215 (7%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 170
           + R    LG G FG V +G          + V VAVK    D  +  +   +++ EV  +
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAK 229
             L H NL++L G         ++ E    GS+ + L   +    L    R   A   A+
Sbjct: 76  HSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAE 132

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT---Y 286
           G+ +L    K  I+RD    N+LL T    K+ DFGL +  P+ D  +V          +
Sbjct: 133 GMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPF 188

Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
            + APE + T   +  SD + FGV L E+ T G++
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  124 bits (314), Expect = 1e-32
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 32/228 (14%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
                + LG G FG V +      L +    + VAVK+             ++E+  L +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATA-YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 173 L-SHPNLVKLIGYCCEDEHRVLIYEFMARGS------------VENNLFSKVLLPLPWSI 219
           L +H N+V L+G C      ++I E+   G             + +     ++     ++
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 220 RMK----IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD- 274
            ++     ++  AKG+AFL  A K  I+RD    NILL      K+ DFGLA+D      
Sbjct: 143 DLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 275 -KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                + R+    M      APE I     T  SDV+S+G+ L E+ +
Sbjct: 201 YVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  128 bits (323), Expect = 1e-32
 Identities = 68/306 (22%), Positives = 121/306 (39%), Gaps = 31/306 (10%)

Query: 96  ANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN 155
                    D   I   + R +  LG G FG V+ G  +           VA+K      
Sbjct: 251 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGT 303

Query: 156 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 215
                  +L E   +  L H  LV+L      +E   ++ E+M++GS+ + L  +    L
Sbjct: 304 MS--PEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYL 360

Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD- 274
                + +A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   + + 
Sbjct: 361 RLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418

Query: 275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA 334
            +    +      + APE  + G  T +SDV+SFG++L E+ T  +      P       
Sbjct: 419 TARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-----VPYPGMVNR 471

Query: 335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 394
           +  L  ++   ++     P      P + +H    L   C    P+ RP    +   LE 
Sbjct: 472 E-VLDQVERGYRM-----PCPPE-CP-ESLHD---LMCQCWRKEPEERPTFEYLQAFLED 520

Query: 395 LQVLPD 400
                +
Sbjct: 521 YFTSTE 526

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  123 bits (310), Expect = 1e-32
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 28/211 (13%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 176
           + LG G FG V  G              VAVK + +G  S     E+  E   +  LSHP
Sbjct: 14  KELGSGQFGVVKLGKWKG-------QYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHP 63

Query: 177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLH 235
            LVK  G C ++    ++ E+++ G + N L S    L     + M   +   +G+AFL 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL- 120

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRI----MGTYGYAA 290
                 I+RD    N L+D D   K+SDFG+ +   +    S V T+            A
Sbjct: 121 -ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS------A 173

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 320
           PE       + +SDV++FG+++ E+ + G+ 
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (313), Expect = 2e-32
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 32/220 (14%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SH 175
             V+G G FG V K  I +D       +  A+K      S   HR++  E+  L  L  H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLR----MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85

Query: 176 PNLVKLIGYCCEDEHRVLIYEFMARGS----------VENNLFSKVLLPLPWSIRMK--- 222
           PN++ L+G C    +  L  E+   G+          +E +    +      ++  +   
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 223 -IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
             A   A+G+ +L  ++K  I+RD    NIL+  +Y AK++DFGL++      K     R
Sbjct: 146 HFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MGR 202

Query: 282 I----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           +    M      A E +     T  SDV+S+GV+L EI++
Sbjct: 203 LPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  125 bits (315), Expect = 2e-32
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)

Query: 117 DRVLGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-S 174
            + LG G FG V     I  D  +  +   VAVK+   D + +   + ++E+  +  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGS----------VENNLFSKVLLPLPWSIRMK-- 222
           H N++ L+G C +D    +I E+ ++G+                          +  K  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 223 --IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHV 278
              A+  A+G+ +L  A K  I+RD    N+L+  D   K++DFGLA+D    D  K   
Sbjct: 194 VSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 279 STRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
           + R+    M      APE +     T +SDV+SFGV+L EI T
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  121 bits (307), Expect = 1e-31
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 31/227 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
             +  + LG G FG V +   +  + +      VAVK+     ++  HR  ++E+  L H
Sbjct: 28  RLKLGKPLGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 173 L-SHPNLVKLIGYCC-EDEHRVLIYEFMARGS------------VENNLFSKVLLPLPWS 218
           +  H N+V L+G C       ++I EF   G+            V   +  + L     +
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 219 IRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-- 274
           +   I +    AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  +    
Sbjct: 147 LEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204

Query: 275 KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                 R+    M      APE I     T +SDV+SFGV+L EI +
Sbjct: 205 VRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (303), Expect = 4e-31
 Identities = 59/217 (27%), Positives = 87/217 (40%), Gaps = 27/217 (12%)

Query: 112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV----HDGDNSYQG--HREWLA 165
             +R  R++G GG G VY+    ED     +   VA+K+       D  ++    RE  A
Sbjct: 34  GPYRLRRLVGRGGMGDVYEA---EDTV---RERIVALKLMSETLSSDPVFRTRMQRE--A 85

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL---PLPWSIRMK 222
                G L  P++V +  +   D    +         +     + +L    PL     + 
Sbjct: 86  RTA--GRLQEPHVVPIHDFGEIDGQLYVDMRL-----INGVDLAAMLRRQGPLAPPRAVA 138

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           I       L   H A     +RD K  NIL+  D  A L DFG+A    +   + +    
Sbjct: 139 IVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-T 195

Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           +GT  Y APE     H T R+D+Y+   VL E LTG 
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (313), Expect = 5e-31
 Identities = 60/319 (18%), Positives = 104/319 (32%), Gaps = 64/319 (20%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLG 171
           +     +  GG G +Y      D    +   PV +K   H GD   Q     +AE  FL 
Sbjct: 82  YEVKGCIAHGGLGWIYLA---LDRN--VNGRPVVLKGLVHSGDAEAQ--AMAMAERQFLA 134

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMA----RGSVENNLFSKVLLPLPWSIRMKIAFGA 227
            + HP++V++  +    +       ++      G    +L       LP +  +      
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ---SLKRSKGQKLPVAEAIAYLLEI 191

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----DGPEGDKSHVSTRIM 283
              L++LH     ++Y D K  NI+L  +   KL D G        G           + 
Sbjct: 192 LPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----------LY 238

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 343
           GT G+ APE I+    T  +D+Y+ G  L  +               + +          
Sbjct: 239 GTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDL------PTRNGRYVDGLPED---- 287

Query: 344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSLEPLQVL 398
                   DP L+            +L    ++ +P+ R      +   +   L  +   
Sbjct: 288 --------DPVLKTYDSY-----GRLLR-RAIDPDPRQRFTTAEEMSAQLTGVLREVVAQ 333

Query: 399 PDEAPTPKNFVTVVTPEEP 417
               P P    T+ +P   
Sbjct: 334 DTGVPRPGL-STIFSPSRS 351

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  119 bits (300), Expect = 2e-30
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 39/230 (16%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHL-S 174
            +VLG G FG V        + +    + VAVK + +  +S +     ++E+  +  L S
Sbjct: 50  GKVLGSGAFGKVMNATA-YGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMTQLGS 107

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGS---------------------VENNLFSKVLL 213
           H N+V L+G C       LI+E+   G                       +     + L 
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
            L +   +  A+  AKG+ FL    K  ++RD    N+L+      K+ DFGLA+D    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 274 D--KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                  + R+    M      APE +  G  T +SDV+S+G++L EI +
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  115 bits (291), Expect = 1e-29
 Identities = 64/305 (20%), Positives = 115/305 (37%), Gaps = 56/305 (18%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           +F   + LG GGFG V++    ++  +       A+K     N      + + EV  L  
Sbjct: 6   DFEPIQCLGRGGFGVVFEA---KNKVDDCN---YAIKRIRLPNRELAREKVMREVKALAK 59

Query: 173 LSHPNLVKLIGYCCEDE---------HRVLIY---EFMARGSVENNLFS-KVLLPLPWSI 219
           L HP +V+      E            +V +Y   +   + ++++ +     +     S+
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----------D 269
            + I    A+ + FLH   K +++RD K SNI    D   K+ DFGL             
Sbjct: 120 CLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
                     T  +GT  Y +PE I     + + D++S G++L E+L          P  
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFS 228

Query: 330 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHK---AAMLAYHCLNHNPKARPLMR 386
            Q           E+ + L  +       +P     K     ++    L+ +P  RP   
Sbjct: 229 TQM----------ERVRTLTDV---RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI 275

Query: 387 DIVDS 391
           +I+++
Sbjct: 276 NIIEN 280

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  115 bits (291), Expect = 1e-29
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 27/221 (12%)

Query: 108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV----HDGDNSYQG--HR 161
           +II   ++    LGGGG   VY     ED    +    VA+K                 R
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLA---EDTILNI---KVAIKAIFIPPREKEETLKRFER 60

Query: 162 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL---PLPWS 218
           E          LSH N+V +I    ED+   L+ E+     +E    S+ +    PL   
Sbjct: 61  EVHN----SSQLSHQNIVSMIDVDEEDDCYYLVMEY-----IEGPTLSEYIESHGPLSVD 111

Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 278
             +        G+   H+    +++RD K  NIL+D++   K+ DFG+AK   E   +  
Sbjct: 112 TAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169

Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           +  ++GT  Y +PE          +D+YS G+VL E+L G 
Sbjct: 170 NH-VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  115 bits (290), Expect = 2e-29
 Identities = 71/337 (21%), Positives = 109/337 (32%), Gaps = 40/337 (11%)

Query: 57  ISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITA---N 113
           + H            +     S     P  V    R  A+  L +  YD  R  +    +
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVS--FRGEASETLQSPGYDPSRPESFFQQS 58

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGH 172
           F++   LG G +G V+K    ED R        AVK         +     LAEV     
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRL------YAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 173 L-SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
           +  HP  V+L     E     L  E     S++ +        LP +            L
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC-EAWGASLPEAQVWGYLRDTLLAL 170

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           A LH   + +++ D K +NI L      KL DFGL  +        V     G   Y AP
Sbjct: 171 AHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAP 225

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 351
           E +   +    +DV+S G+ +LE+    +               W    L++       +
Sbjct: 226 ELLQGSY-GTAADVFSLGLTILEVACNMELPH--------GGEGW--QQLRQG-----YL 269

Query: 352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
            P            +   +    L  +PK R     +
Sbjct: 270 PPEFTAGLS----SELRSVLVMMLEPDPKLRATAEAL 302

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  115 bits (291), Expect = 3e-29
 Identities = 59/262 (22%), Positives = 95/262 (36%), Gaps = 22/262 (8%)

Query: 63  SPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGG 122
                +   K     S          +          +     E R           +G 
Sbjct: 9   QAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGR 68

Query: 123 GGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLI 182
           G FG V++     D + G Q    AVK    +           E++    LS P +V L 
Sbjct: 69  GSFGEVHRMK---DKQTGFQ---CAVKKVRLEVFRV------EELVACAGLSSPRIVPLY 116

Query: 183 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVI 242
           G   E     +  E +  GS+   +  K +  LP    +     A +GL +LH   + ++
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLH--TRRIL 172

Query: 243 YRDFKTSNILLDTD-YNAKLSDFGLAK--DGPEGDKSHVSTRIM-GTYGYAAPEYIM-TG 297
           + D K  N+LL +D   A L DFG A         KS ++   + GT  + APE +M   
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 298 HLTPRSDVYSFGVVLLEILTGR 319
               + D++S   ++L +L G 
Sbjct: 233 C-DAKVDIWSSCCMMLHMLNGC 253

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  114 bits (287), Expect = 4e-29
 Identities = 65/294 (22%), Positives = 112/294 (38%), Gaps = 58/294 (19%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 170
           +F++  ++G GGFG V+K    +   +G       +K   ++ + + +       EV  L
Sbjct: 12  DFKEIELIGSGGFGQVFKA---KHRIDGKT---YVIKRVKYNNEKAER-------EVKAL 58

Query: 171 GHLSHPNLVKLIGYCCEDEHRV----------------LIYEFMARGSVENNLFSKVLLP 214
             L H N+V   G     ++                  +  EF  +G++E  +  +    
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 274
           L   + +++     KG+ ++H   K +I RD K SNI L      K+ DFGL        
Sbjct: 119 LDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLK 173

Query: 275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA 334
                TR  GT  Y +PE I +       D+Y+ G++L E+L           A E +  
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD------TAFETS-- 225

Query: 335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
                     K   ++ D  +   +      K   L    L+  P+ RP   +I
Sbjct: 226 ----------KFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  114 bits (288), Expect = 4e-29
 Identities = 58/300 (19%), Positives = 112/300 (37%), Gaps = 50/300 (16%)

Query: 107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA- 165
           + +    +   + +G GG   V++   +E  +        A+K  + + +     +    
Sbjct: 23  MSVKGRIYSILKQIGSGGSSKVFQVL-NEKKQI------YAIKYVNLEEADNQTLDSYRN 75

Query: 166 EVIFLGHLSHPNL--VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           E+ +L  L   +   ++L  Y   D++  ++ E      + + L  K  +          
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWER--KSY 132

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
                + +  +H+    +++ D K +N L+      KL DFG+A        S V    +
Sbjct: 133 WKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189

Query: 284 GTYGYAAPEYIM-----------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN 332
           GT  Y  PE I               ++P+SDV+S G +L  +  G+             
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------- 236

Query: 333 LADWALP---LLKEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMRDI 388
                 P   ++ +  KL  IIDP  E ++P     K    +   CL  +PK R  + ++
Sbjct: 237 -----TPFQQIINQISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (290), Expect = 8e-29
 Identities = 56/391 (14%), Positives = 109/391 (27%), Gaps = 84/391 (21%)

Query: 70  SEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDEL---RIITANFRQDRVLGGGGFG 126
                   +         + L   S  N    F  +     R  T    +  VLG     
Sbjct: 35  RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRT--LVRGTVLGQEDPY 92

Query: 127 CVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAEVIFLGH-------- 172
              +     D   G       V V         +   Q   E L   +  G         
Sbjct: 93  AYLEA---TDQETG---ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146

Query: 173 ----------LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--------- 213
                     +  P   K+I    ++    ++  F     +++NL +   +         
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206

Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
            L    R+++     + LA LH     +++   +  +I+LD      L+ F       +G
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDG 262

Query: 274 DKSHVSTRIMGTYGYAAPEYIM----------TGHLTPRSDVYSFGVVLLEILTGRKSLD 323
             +          G+A PE                +T   D ++ G+ +  I        
Sbjct: 263 ASAVSPI----GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD---- 314

Query: 324 KSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
              P  +      +  + +  K +     P+     PV+       L    L +  + R 
Sbjct: 315 --LPNTDDAALGGSEWIFRSCKNI-----PQ-----PVRA------LLEGFLRYPKEDRL 356

Query: 384 LMRDIVDSLEPLQVLPDEAPTPKNFVTVVTP 414
           L    +++ E  Q+  + +     + T   P
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQTDGEP 387

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (286), Expect = 8e-29
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 31/220 (14%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV----HDGDNSYQG--HREWLAEV 167
           +    +LG GG   V+      DLR+      VAVKV       D S+     RE     
Sbjct: 14  YELGEILGFGGMSEVHLA---RDLRDHR---DVAVKVLRADLARDPSFYLRFRREAQN-- 65

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIY----EFMARGSVENNLFSKVLL---PLPWSIR 220
                L+HP +V +      +     +     E+     V+      ++    P+     
Sbjct: 66  --AAALNHPAIVAVYDTGEAETPAGPLPYIVMEY-----VDGVTLRDIVHTEGPMTPKRA 118

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
           +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+   +   S   T
Sbjct: 119 IEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 281 -RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             ++GT  Y +PE      +  RSDVYS G VL E+LTG 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  113 bits (285), Expect = 8e-29
 Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 55/306 (17%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           +F +  VLG G FG V K     +  +       A+K              L+EV+ L  
Sbjct: 7   DFEEIAVLGQGAFGQVVKA---RNALDSRY---YAIKKIRHTEEKL--STILSEVMLLAS 58

Query: 173 LSHPNLVKLIGYCCEDEHRVL----------IY---EFMARGSVENNLFSKVLLPLPWSI 219
           L+H  +V+      E  + V           ++   E+   G++ + + S+ L       
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----------- 268
             ++     + L+++H   + +I+RD K  NI +D   N K+ DFGLAK           
Sbjct: 119 W-RLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 269 --DGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKS 325
                 G   ++++ I GT  Y A E +  TGH   + D+YS G++  E++         
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------- 227

Query: 326 RPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM 385
             +      +    +LK+ + +     P  + +           +    ++H+P  RP  
Sbjct: 228 -FSTGMERVN----ILKKLRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHDPNKRPGA 278

Query: 386 RDIVDS 391
           R +++S
Sbjct: 279 RTLLNS 284

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  115 bits (289), Expect = 9e-29
 Identities = 65/349 (18%), Positives = 127/349 (36%), Gaps = 51/349 (14%)

Query: 59  HCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDE-LRIITANFRQD 117
           H         P     KE +      + ++     +  +   + + +E + +    +   
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD-GDNSYQGHREWLAEVIFLGHLSHP 176
           + +G GG   V++   +E  +        A+K  +  +   Q    +  E+ +L  L   
Sbjct: 62  KQIGSGGSSKVFQVL-NEKKQI------YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 177 NL--VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL 234
           +   ++L  Y   D++  ++ E      + + L  K    +    R        + +  +
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTI 171

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI 294
           H+    +++ D K +N L+  D   KL DFG+A        S V    +G   Y  PE I
Sbjct: 172 HQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 295 M-----------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP---L 340
                          ++P+SDV+S G +L  +  G+                   P   +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------------TPFQQI 270

Query: 341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMRDI 388
           + +  KL  IIDP  E ++P     K    +   CL  +PK R  + ++
Sbjct: 271 INQISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  113 bits (285), Expect = 1e-28
 Identities = 66/310 (21%), Positives = 107/310 (34%), Gaps = 41/310 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           ++   + LG GGF  V      E L +G      A+K     +  Q   E   E      
Sbjct: 30  HYLFIQKLGEGGFSYVDLV---EGLHDGHF---YALKRILC-HEQQDREEAQREADMHRL 82

Query: 173 LSHPNLVKLIGYCCEDE---HRVLIY-EFMARGSVENNL--FSKVLLPLPWSIRMKIAFG 226
            +HPN+++L+ YC  +    H   +   F  RG++ N +         L     + +  G
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM--- 283
             +GL  +H   K   +RD K +NILL  +    L D G         +       +   
Sbjct: 143 ICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 284 ----GTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
                T  Y APE         +  R+DV+S G VL  ++ G        P         
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE------GPYDMVFQKGD 254

Query: 337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
           ++        + N +       +          L    +  +P  RP +  ++  LE LQ
Sbjct: 255 SV-----ALAVQNQLSIPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

Query: 397 -VLPDEAPTP 405
              P +  T 
Sbjct: 306 PPAPGQHTTQ 315

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  113 bits (284), Expect = 3e-28
 Identities = 39/357 (10%), Positives = 78/357 (21%), Gaps = 58/357 (16%)

Query: 69  PSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCV 128
                      L      VE +                L       +    L  G    V
Sbjct: 19  EELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVV 78

Query: 129 YKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC- 185
           +      D+         A+KV     +NS                L   +  +      
Sbjct: 79  FLV---RDVERL---EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132

Query: 186 -------------------------CEDEHRVLIYEFMARGSVEN-NLFSKVLL---PLP 216
                                        + +L+    +       +    V +      
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192

Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
                 +     +  A L    K +++  F   N+ +  D    L D         G + 
Sbjct: 193 ILALHILTAQLIRLAANLQS--KGLVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRG 248

Query: 277 HVSTRIMGTYGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA 334
             S+       YA  E++       T   + +  G+ +  +           P  +    
Sbjct: 249 PASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG--- 302

Query: 335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMRDIVD 390
                    K+  L +             +      L    LN + + R L  + ++
Sbjct: 303 -------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  113 bits (283), Expect = 4e-28
 Identities = 68/308 (22%), Positives = 122/308 (39%), Gaps = 31/308 (10%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           F +   LG G  G V+K         G   + +A K+   +       + + E+  L   
Sbjct: 35  FEKISELGAGNGGVVFKVS---HKPSG---LVMARKLIHLEIKPAIRNQIIRELQVLHEC 88

Query: 174 SHPNLVKLIGYCCEDEHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           + P +V   G     +  + I  E M  GS++     K    +P  I  K++    KGL 
Sbjct: 89  NSPYIVGFYG-AFYSDGEISICMEHMDGGSLDQ--VLKKAGRIPEQILGKVSIAVIKGLT 145

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 292
           +L E  K +++RD K SNIL+++    KL DFG++    +   S  ++ + GT  Y +PE
Sbjct: 146 YLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPE 200

Query: 293 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 352
            +   H + +SD++S G+ L+E+  GR  +        + +    +     +        
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260

Query: 353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP--KNFVT 410
            R    + +      A+              L+  IV+   P   LP    +   ++FV 
Sbjct: 261 GRPLNKFGMDSRPPMAIF------------ELLDYIVNEPPPK--LPSGVFSLEFQDFVN 306

Query: 411 VVTPEEPK 418
               + P 
Sbjct: 307 KCLIKNPA 314

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  111 bits (280), Expect = 9e-28
 Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 50/294 (17%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLG 171
            +   + +G GG   V++   +E  +        A+K  + + +     +    E+ +L 
Sbjct: 10  IYSILKQIGSGGSSKVFQVL-NEKKQI------YAIKYVNLEEADNQTLDSYRNEIAYLN 62

Query: 172 HLSHPNL--VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 229
            L   +   ++L  Y   D++  ++ E      + + L  K  +      R        +
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLE 119

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            +  +H+    +++ D K +N L+      KL DFG+A        S V    +GT  Y 
Sbjct: 120 AVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 290 APEYIM-----------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 338
            PE I               ++P+SDV+S G +L  +  G+                   
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------------T 218

Query: 339 P---LLKEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMRDI 388
           P   ++ +  KL  IIDP  E ++P     K    +   CL  +PK R  + ++
Sbjct: 219 PFQQIINQISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  109 bits (275), Expect = 2e-27
 Identities = 64/285 (22%), Positives = 114/285 (40%), Gaps = 38/285 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 170
           NFR ++ +G G F  VY+      L +G+    VA+K          +   + + E+  L
Sbjct: 33  NFRIEKKIGRGQFSEVYRAA---CLLDGVP---VALKKVQIFDLMDAKARADCIKEIDLL 86

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIY-EFMARGSVENNL--FSKVLLPLPWSIRMKIAFGA 227
             L+HPN++K       +++ + I  E    G +   +  F K    +P     K     
Sbjct: 87  KQLNHPNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
              L  +H   + V++RD K +N+ +      KL D GL +       +   + + GT  
Sbjct: 146 CSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPY 201

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 347
           Y +PE I       +SD++S G +L E+   +                   P   +K  L
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS------------------PFYGDKMNL 243

Query: 348 LNIIDPRLEGDY-PVKGVH---KAAMLAYHCLNHNPKARPLMRDI 388
            ++     + DY P+   H   +   L   C+N +P+ RP +  +
Sbjct: 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  110 bits (277), Expect = 3e-27
 Identities = 43/228 (18%), Positives = 81/228 (35%), Gaps = 31/228 (13%)

Query: 113 NFRQDRVLGGGGFGCVY----KGFI--------SEDLREGLQPVPVAVKVHDGDNSYQGH 160
           ++R  R L  G F  +                 S   ++         K+          
Sbjct: 32  DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91

Query: 161 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSI 219
            E    +  +  + +   +   G    +   V +IYE+M   S+        +L   ++ 
Sbjct: 92  NE----LQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146

Query: 220 RM------KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
            +       I        +++H  EK + +RD K SNIL+D +   KLSDFG ++   + 
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

Query: 274 DKSHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGR 319
               +     GTY +  PE+      +   + D++S G+ L  +    
Sbjct: 206 ---KIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  109 bits (274), Expect = 3e-27
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 25/216 (11%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK---VHDGDNSYQGHREWLAEVIF 169
                 VLG G +G VY G    DL      V +A+K     D   S   H E    +  
Sbjct: 23  ENGDRVVLGKGTYGIVYAGR---DLSNQ---VRIAIKEIPERDSRYSQPLHEE----IAL 72

Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIY-EFMARGSVENNLFSKV-LLPLPWSIRMKIAFGA 227
             HL H N+V+ +G    +   + I+ E +  GS+   L SK   L              
Sbjct: 73  HKHLKHKNIVQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
            +GL +LH  +  +++RD K  N+L++T     K+SDFG +K     +    +    GT 
Sbjct: 132 LEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTL 187

Query: 287 GYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGR 319
            Y APE I     G+    +D++S G  ++E+ TG+
Sbjct: 188 QYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGK 222

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (276), Expect = 4e-27
 Identities = 48/371 (12%), Positives = 100/371 (26%), Gaps = 90/371 (24%)

Query: 75  KEYSKLPSNPEEVEDLRRDSAANPLI---------AFTYD-ELRIITANFRQDRVLGGGG 124
           + ++++P            SAA+ L+          F  + EL        +  VLG   
Sbjct: 26  ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 85

Query: 125 FGCVYKGFISEDLREGLQPVPVAVKV---------------------------HDGDNSY 157
                +    E            V V                                  
Sbjct: 86  PYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--HRVLIYEFMA--RGSVENNLFSKVLL 213
           + H  ++     +       ++++     +     R  +Y  M     +    L S    
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 214 --PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 271
              L    R+++     + LA LH     +++   +  +I+LD      L+ F       
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254

Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMT-----------GHLTPRSDVYSFGVVLLEILTGRK 320
              +         + G+  PE                 +T   D ++ G+V+  I     
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD- 310

Query: 321 SLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPK 380
                 P  +      +  + +  K +     P+     PV+       L    L +  +
Sbjct: 311 -----LPITKDAALGGSEWIFRSCKNI-----PQ-----PVR------ALLEGFLRYPKE 349

Query: 381 ARPLMRDIVDS 391
            R L    +++
Sbjct: 350 DRLLPLQAMET 360

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  109 bits (274), Expect = 6e-27
 Identities = 48/267 (17%), Positives = 85/267 (31%), Gaps = 23/267 (8%)

Query: 106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           E ++ +       +LG G F  VY+     DL +        +KV    N ++ +     
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEA-TQGDLNDAKNKQKFVLKVQKPANPWEFYIG-TQ 116

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL---PLPWSIRMK 222
            +  L        +K           VL+ E  + G++ N +          +P  + + 
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-----------DTDYNAKLSDFGLAKDGP 271
            A      +  +H+ E  +I+ D K  N +L           D      L D G + D  
Sbjct: 177 FAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR---KSLDKSRPA 328
              K  + T    T G+   E +       + D +     +  +L G       +     
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294

Query: 329 REQNLAD-WALPLLKE-KKKLLNIIDP 353
            E        L +  E    +LNI D 
Sbjct: 295 PEGLFRRLPHLDMWNEFFHVMLNIPDC 321

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  109 bits (273), Expect = 1e-26
 Identities = 59/323 (18%), Positives = 114/323 (35%), Gaps = 33/323 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 171
            + + + +G G FG        +   +G Q     +K ++    S +   E   EV  L 
Sbjct: 25  KYVRLQKIGEGSFGKAILV---KSTEDGRQ---YVIKEINISRMSSKEREESRREVAVLA 78

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
           ++ HPN+V+      E+    ++ ++   G +   + ++  +       +         L
Sbjct: 79  NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
             +H+  + +++RD K+ NI L  D   +L DFG+A+             I GT  Y +P
Sbjct: 139 KHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSP 194

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 351
           E         +SD+++ G VL E+ T +            ++      L+    K+++  
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLK------HAFEAGSM----KNLV---LKIISGS 241

Query: 352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSLEPLQVLPDEAPTPK 406
            P +   Y     +    L       NP+ RP     L +  +       + P       
Sbjct: 242 FPPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEF 297

Query: 407 NFVTVVTPEEPKAEIQTKDSQCN 429
              T           +   S  N
Sbjct: 298 CLKTFSKFGSQPIPAKRPASGQN 320

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  105 bits (263), Expect = 6e-26
 Identities = 61/284 (21%), Positives = 104/284 (36%), Gaps = 33/284 (11%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 171
           ++     +G G +G   K        +G     +  K +  G  +    +  ++EV  L 
Sbjct: 7   DYEVLYTIGTGSYGRCQKI---RRKSDGKI---LVWKELDYGSMTEAEKQMLVSEVNLLR 60

Query: 172 HLSHPNLVKLIG-YCCEDEHRVLIY-EFMARGSVENNL--FSKVLLPLPWSIRMKIAFGA 227
            L HPN+V+            + I  E+   G + + +   +K    L     +++    
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 228 AKGLAFLHE---AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
              L   H        V++RD K +N+ LD   N KL DFGLA+     D S   T + G
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-G 178

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 344
           T  Y +PE +       +SD++S G +L E+           P    +  + A       
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELA------- 225

Query: 345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
            K+      R+   Y      +   +    LN     RP + +I
Sbjct: 226 GKIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEI 265

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  104 bits (261), Expect = 1e-25
 Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE--WLAEVIFL 170
           +F   R LG G FG VY   ++ + +       +A+KV       +   E     EV   
Sbjct: 10  DFEIGRPLGKGKFGNVY---LAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQ 63

Query: 171 GHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGA 227
            HL HPN+++L GY   D  RV LI E+   G+    ++ ++                  
Sbjct: 64  SHLRHPNILRLYGYF-HDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITEL 118

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           A  L++ H   K VI+RD K  N+LL +    K++DFG +   P    S   T + GT  
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLD 172

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           Y  PE I       + D++S GV+  E L G+
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  104 bits (261), Expect = 4e-25
 Identities = 71/289 (24%), Positives = 106/289 (36%), Gaps = 35/289 (12%)

Query: 105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
                   + +    +G G +G V K         G     +AVK        +  ++ L
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMV---HKPSG---QIMAVKRIRSTVDEKEQKQLL 68

Query: 165 AEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE--NNLFSKVLLPLPWSIRM 221
            ++  +   S  P +V+  G    +    +  E M+    +    ++S +   +P  I  
Sbjct: 69  MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           KI     K L  L E  K +I+RD K SNILLD   N KL DFG++    +   S   TR
Sbjct: 129 KITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTR 184

Query: 282 IMGTYGYAAPEYIMTGHLTP----RSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 337
             G   Y APE I           RSDV+S G+ L E+ TGR    K     +Q      
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------ 238

Query: 338 LPLLKEKKKLLNIID---PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
                    L  ++    P+L      +           CL  +   RP
Sbjct: 239 ---------LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  104 bits (261), Expect = 4e-25
 Identities = 66/314 (21%), Positives = 118/314 (37%), Gaps = 51/314 (16%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
             R  RVL  GGF  VY+    +D+  G +    A+K    +   + +R  + EV F+  
Sbjct: 29  RLRVRRVLAEGGFAFVYEA---QDVGSGRE---YALKRLLSNEE-EKNRAIIQEVCFMKK 81

Query: 173 LS-HPNLVKLIGYCCEDEHR-------VLIYEFMARGSVENNLFSKVLL-PLPWSIRMKI 223
           LS HPN+V+        +          L+   + +G +   L       PL     +KI
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA---KDGPEGDKSHVST 280
            +   + +  +H  + P+I+RD K  N+LL      KL DFG A      P+   S    
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201

Query: 281 RIM-------GTYGYAAPEYI-MTGHL--TPRSDVYSFGVVLLEILTGRKSLDKSRPARE 330
            ++        T  Y  PE I +  +     + D+++ G +L  +   +   +     R 
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261

Query: 331 QNLADWALP-LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
            N   +++P    +     ++I                       L  NP+ R  + ++V
Sbjct: 262 VN-GKYSIPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVV 300

Query: 390 DSLEPLQVLPDEAP 403
             L+ +    +  P
Sbjct: 301 HQLQEIAAARNVNP 314

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  101 bits (254), Expect = 2e-24
 Identities = 75/270 (27%), Positives = 115/270 (42%), Gaps = 30/270 (11%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           F +   +G G FG V+KG    D R       VA+K+ D + +     +   E+  L   
Sbjct: 24  FTKLEKIGKGSFGEVFKGI---DNRTQ---KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
             P + K  G   +D    +I E++  GS  + L      PL  +    I     KGL +
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDY 134

Query: 234 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 293
           LH  +K  I+RD K +N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 135 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 190

Query: 294 IMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP 353
           I       ++D++S G+  +E+  G     +  P +        L L+ +         P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNP------P 237

Query: 354 RLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
            LEG+Y  K + +   +   CLN  P  RP
Sbjct: 238 TLEGNYS-KPLKE--FVEA-CLNKEPSFRP 263

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  100 bits (252), Expect = 3e-24
 Identities = 52/220 (23%), Positives = 83/220 (37%), Gaps = 18/220 (8%)

Query: 107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE 166
           + +   +      LG G +G V K      +  G     +AVK      + Q  +  L +
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMR---HVPSG---QIMAVKRIRATVNSQEQKRLLMD 55

Query: 167 V-IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKI 223
           + I +  +  P  V   G    +    +  E M   S++            +P  I  KI
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           A    K L  LH     VI+RD K SN+L++     K+ DFG++                
Sbjct: 115 AVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDA 170

Query: 284 GTYGYAAPEYIMTGHLTP----RSDVYSFGVVLLEILTGR 319
           G   Y APE I           +SD++S G+ ++E+   R
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (253), Expect = 3e-24
 Identities = 66/279 (23%), Positives = 105/279 (37%), Gaps = 38/279 (13%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
                 +G G  G V+K       + G     +AVK      + + ++  L ++  +   
Sbjct: 27  LENLGEMGSGTCGQVWKMR---FRKTG---HVIAVKQMRRSGNKEENKRILMDLDVVLKS 80

Query: 174 S-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
              P +V+  G    +    +  E M   + +  L  ++  P+P  I  K+     K L 
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALY 138

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 292
           +L E    VI+RD K SNILLD     KL DFG++             R  G   Y APE
Sbjct: 139 YLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPE 194

Query: 293 YIMTGHL-----TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 347
            I            R+DV+S G+ L+E+ TG+      +   E                L
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV---------------L 239

Query: 348 LNIID---PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
             ++    P L G     G  + + +   CL  + + RP
Sbjct: 240 TKVLQEEPPLLPGHMGFSGDFQ-SFVKD-CLTKDHRKRP 276

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (252), Expect = 3e-24
 Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 40/288 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           ++    V+G G    V   +      +      VA+K  + +       E L E+  +  
Sbjct: 16  DYELQEVIGSGATAVVQAAY---CAPKK---EKVAIKRINLEKCQTSMDELLKEIQAMSQ 69

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK---IAF---G 226
             HPN+V         +   L+ + ++ GSV + +   V      S  +    IA     
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG----LAKDGPEGDKSHVSTRI 282
             +GL +LH+  +  I+RD K  NILL  D + +++DFG    LA  G         T +
Sbjct: 130 VLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 283 MGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL 341
            GT  + APE +        ++D++SFG+  +E+ TG     K  P +        L L 
Sbjct: 188 -GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLT 239

Query: 342 KEKKKLLNIIDPRLEGDYPVKGVHKA------AMLAYHCLNHNPKARP 383
            +         P LE     K + K        M++  CL  +P+ RP
Sbjct: 240 LQNDP------PSLETGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRP 280

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  100 bits (251), Expect = 3e-24
 Identities = 58/212 (27%), Positives = 85/212 (40%), Gaps = 22/212 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE--WLAEVIFL 170
           +F   R LG G FG VY        RE      +A+KV       +   E     E+   
Sbjct: 15  DFDIGRPLGKGKFGNVYLA------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 68

Query: 171 GHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGA 227
            HL HPN++++  Y   D  R+ L+ EF  RG     L+ ++                  
Sbjct: 69  SHLRHPNILRMYNYF-HDRKRIYLMLEFAPRGE----LYKELQKHGRFDEQRSATFMEEL 123

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           A  L + HE  + VI+RD K  N+L+      K++DFG +   P   +        GT  
Sbjct: 124 ADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLD 177

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           Y  PE I       + D++  GV+  E L G 
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  100 bits (252), Expect = 4e-24
 Identities = 54/226 (23%), Positives = 85/226 (37%), Gaps = 26/226 (11%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
                +    +LG G    V++G      R        A+KV +  +  +     + E  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRG------RHKKTGDLFAIKVFNNISFLRPVDVQMREFE 59

Query: 169 FLGHLSHPNLVKLIGY--CCEDEHRVLIYEFMARGSVENNLFSK-VLLPLPWSIRMKIAF 225
            L  L+H N+VKL          H+VLI EF   GS+   L        LP S  + +  
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
               G+  L   E  +++R+ K  NI+     D     KL+DFG A++  + ++    + 
Sbjct: 120 DVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SL 175

Query: 282 IMGTYGYAAPEYIMTGHL--------TPRSDVYSFGVVLLEILTGR 319
             GT  Y  P+      L            D++S GV      TG 
Sbjct: 176 Y-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  102 bits (256), Expect = 5e-24
 Identities = 67/309 (21%), Positives = 110/309 (35%), Gaps = 54/309 (17%)

Query: 108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 167
           + +      +++LG G  G V      +   +G    PVAVK    D       E    +
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVF----QGSFQG---RPVAVKRMLIDFCDIALME----I 59

Query: 168 IFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS-----VENNLFSKVLLPLPWSIRM 221
             L     HPN+++       D    +  E     +        N+  + L        +
Sbjct: 60  KLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPI 118

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------------DYNAKLSDFGLAK 268
            +    A G+A LH     +I+RD K  NIL+ T             +    +SDFGL K
Sbjct: 119 SLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176

Query: 269 DGPEGDKSHVSTR--IMGTYGYAAPEYIM-------TGHLTPRSDVYSFGVVLLEILTGR 319
               G  S  +      GT G+ APE +           LT   D++S G V   IL+  
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 320 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP 379
           K     + +RE N       +++    L       ++  +    + +A  L    ++H+P
Sbjct: 237 KHPFGDKYSRESN-------IIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDP 284

Query: 380 KARPLMRDI 388
             RP    +
Sbjct: 285 LKRPTAMKV 293

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =   99 bits (250), Expect = 5e-24
 Identities = 69/288 (23%), Positives = 107/288 (37%), Gaps = 48/288 (16%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 166
            + + R LG GGF   ++     D          A K+             +   E    
Sbjct: 16  RYVRGRFLGKGGFAKCFEI---SDADTKEV---FAGKIVPKSLLLKPHQREKMSME---- 65

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           +     L+H ++V   G+  ED   V ++ E   R S+      +  L  P +       
Sbjct: 66  ISIHRSLAHQHVVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY--YLR 122

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
               G  +LH     VI+RD K  N+ L+ D   K+ DFGLA    E D       + GT
Sbjct: 123 QIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKV-LCGT 178

Query: 286 YGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 344
             Y APE +   GH +   DV+S G ++  +L G+       P     L           
Sbjct: 179 PNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKP------PFETSCL----------- 220

Query: 345 KKLLNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
           K+    I    + +Y  P      AA L    L  +P ARP + ++++
Sbjct: 221 KETYLRI---KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 99.5 bits (249), Expect = 6e-24
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 27/216 (12%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 166
           +F+   +LG G F  VY+    E +  GL+   VA+K+      +      +   E    
Sbjct: 12  DFKVGNLLGKGSFAGVYRA---ESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNE---- 61

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           V     L HP++++L  Y  ED + V L+ E    G +   L ++V  P   +       
Sbjct: 62  VKIHCQLKHPSILELYNYF-EDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMH 119

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMG 284
               G+ +LH     +++RD   SN+LL  + N K++DFGLA +     +K +  T + G
Sbjct: 120 QIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--T-LCG 174

Query: 285 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           T  Y +PE    + H    SDV+S G +   +L GR
Sbjct: 175 TPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  100 bits (251), Expect = 8e-24
 Identities = 75/338 (22%), Positives = 120/338 (35%), Gaps = 59/338 (17%)

Query: 64  PKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGG 123
           P    P +      +   +             A  +     D        + + R LG G
Sbjct: 2   PAPADPGKAGVPGVAAPGAP-------AAAPPAKEIPEVLVDPRSR--RRYVRGRFLGKG 52

Query: 124 GFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAEVIFLGHLSHPN 177
           GF   ++     D          A K+             +   E    +     L+H +
Sbjct: 53  GFAKCFEI---SDADTKEV---FAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQH 102

Query: 178 LVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 236
           +V   G+  ED   V ++ E   R S+      +  L  P + R         G  +LH 
Sbjct: 103 VVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-R-YYLRQIVLGCQYLHR 159

Query: 237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGYAAPEYIM 295
               VI+RD K  N+ L+ D   K+ DFGLA K   +G++  V   + GT  Y APE + 
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLS 214

Query: 296 -TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR 354
             GH +   DV+S G ++  +L G+       P     L           K+    I   
Sbjct: 215 KKGH-SFEVDVWSIGCIMYTLLVGKP------PFETSCL-----------KETYLRI--- 253

Query: 355 LEGDY--PVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
            + +Y  P      AA L    L  +P ARP + ++++
Sbjct: 254 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (256), Expect = 1e-23
 Identities = 62/304 (20%), Positives = 111/304 (36%), Gaps = 49/304 (16%)

Query: 37  CKLMKKTEMKKVQSFFQFQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAA 96
                + + +   SF   ++++  +    D       +   + L   P   ++       
Sbjct: 111 RAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAP--FQEFLDSLYF 168

Query: 97  NPLIAFTYDELRIITAN-FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN 155
              + + + E + +  + F   RVLG GGFG V+                 A ++     
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF-----------------ACQMKATGK 211

Query: 156 SY------------QGHREW-LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARG 201
            Y            +   +  + E   L  +    +V L  Y  E +  + L+   M  G
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGG 270

Query: 202 SVENNLFSKVLLPLPWSIRMKIA---FGAAK---GLAFLHEAEKPVIYRDFKTSNILLDT 255
               ++   +      +   +     F  A+   GL  LH+  + +IYRD K  N+LLD 
Sbjct: 271 ----DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDD 324

Query: 256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           D N ++SD GLA +   G          GT G+ APE ++        D ++ GV L E+
Sbjct: 325 DGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

Query: 316 LTGR 319
           +  R
Sbjct: 383 IAAR 386

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 50/299 (16%), Positives = 98/299 (32%), Gaps = 66/299 (22%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-WLAEVIFLG 171
            F +   +G G FG V+K        +G      A+K      +     +  L EV    
Sbjct: 12  EFHELEKIGSGEFGSVFKCV---KRLDGCI---YAIKRSKKPLAGSVDEQNALREVYAHA 65

Query: 172 HLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKIAFGAA 228
            L  H ++V+      ED+H ++  E+   GS+ + +    +++     +    +     
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTD-------------------YNAKLSDFGLAKD 269
           +GL ++H     +++ D K SNI +                         K+ D G    
Sbjct: 126 RGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182

Query: 270 GPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 327
                 S       G   + A E +     HL P++D+++  + ++              
Sbjct: 183 ----RISSPQVEE-GDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAE-------- 228

Query: 328 AREQNLADWALPLLKEKKKLLNIID---PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
                      PL +   +   I     PR+      +       L    ++ +P+ RP
Sbjct: 229 -----------PLPRNGDQWHEIRQGRLPRIPQVLSQEFTE----LLKVMIHPDPERRP 272

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (256), Expect = 1e-23
 Identities = 75/310 (24%), Positives = 120/310 (38%), Gaps = 60/310 (19%)

Query: 37  CKLMKKTEMKKVQSFFQFQSISHCKESPKDESPSEKAKKEYSKLPS---NPEEVEDLRRD 93
            +         +      Q +++C +  + + P +   +E ++L     +     D    
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLE-QGPCKDLFQELTRLTHEYLSVAPFADYLDS 164

Query: 94  SAANPLIAFTYDELRIITAN-FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD 152
              N  + + + E + +T N FRQ RVLG GGFG V                  A +V  
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVC-----------------ACQVRA 207

Query: 153 GDNSY------------QGHREW-LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFM 198
               Y            +      L E   L  ++   +V L  Y  E +  + L+   M
Sbjct: 208 TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLM 266

Query: 199 ARGSVENNLF------SKVLLPLPWSIRMKIAFGAAK---GLAFLHEAEKPVIYRDFKTS 249
             G    +L        +   P   ++     F AA+   GL  LH   + ++YRD K  
Sbjct: 267 NGG----DLKFHIYHMGQAGFPEARAV-----FYAAEICCGLEDLHR--ERIVYRDLKPE 315

Query: 250 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 309
           NILLD   + ++SD GLA   PEG       R+ GT GY APE +     T   D ++ G
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALG 372

Query: 310 VVLLEILTGR 319
            +L E++ G+
Sbjct: 373 CLLYEMIAGQ 382

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  101 bits (253), Expect = 1e-23
 Identities = 64/284 (22%), Positives = 104/284 (36%), Gaps = 45/284 (15%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           +F    VLG G  G +        + +      VAVK    +      RE    V  L  
Sbjct: 25  SFCPKDVLGHGAEGTIVY----RGMFDNR---DVAVKRILPECFSFADRE----VQLLRE 73

Query: 173 LS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
              HPN+++      + + + +  E  A  +++  +  K    L       +      GL
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGL 131

Query: 232 AFLHEAEKPVIYRDFKTSNILL-----DTDYNAKLSDFGLAKDGPEGDKS-HVSTRIMGT 285
           A LH     +++RD K  NIL+          A +SDFGL K    G  S    + + GT
Sbjct: 132 AHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

Query: 286 YGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK 342
            G+ APE +      + T   D++S G V   +++                     P  K
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----------------HPFGK 232

Query: 343 EKKKLLNII--DPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARP 383
             ++  NI+     L+  +P K     A  L    +  +P+ RP
Sbjct: 233 SLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP 276

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  100 bits (250), Expect = 2e-23
 Identities = 55/230 (23%), Positives = 86/230 (37%), Gaps = 34/230 (14%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
                +    +LG G    V++G      + G      A+KV +  +  +     + E  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRG---RHKKTGDL---FAIKVFNNISFLRPVDVQMREFE 59

Query: 169 FLGHLSHPNLVKLIGY--CCEDEHRVLIYEFMARGSVENNLFSKV-----LLPLPWSIRM 221
            L  L+H N+VKL          H+VLI EF   GS    L++ +        LP S  +
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS----LYTVLEEPSNAYGLPESEFL 115

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDFGLAKDGPEGDKSH 277
            +      G+  L   E  +++R+ K  NI+     D     KL+DFG A++    D   
Sbjct: 116 IVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQ 171

Query: 278 VSTRIMGTYGYAAPEYIMTGHL--------TPRSDVYSFGVVLLEILTGR 319
             +   GT  Y  P+      L            D++S GV      TG 
Sbjct: 172 FVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  102 bits (254), Expect = 2e-23
 Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 29/221 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
            +     LG GGFG V +               VA+K    + S +    W  E+  +  
Sbjct: 15  PWEMKERLGTGGFGYVLRW------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68

Query: 173 LSHPNLVKLI------GYCCEDEHRVLIYEFMARGSVENNLFSKVLLP-----LPWSIRM 221
           L+HPN+V              ++  +L  E+   G     L   +        L      
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGD----LRKYLNQFENCCGLKEGPIR 124

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHV 278
            +    +  L +LHE    +I+RD K  NI+L         K+ D G AK+  +G+    
Sbjct: 125 TLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT- 181

Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
              + GT  Y APE +     T   D +SFG +  E +TG 
Sbjct: 182 -EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.8 bits (249), Expect = 6e-23
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 35/228 (15%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----------HDGDNSYQ 158
           I  ++ + R LG G +G V      ++     +    A+KV            D + + +
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLC---KEKNGHSE---KAIKVIKKSQFDKGRYSDDNKNIE 87

Query: 159 GHREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLP 216
              E +  E+  L  L HPN++KL     ED+    L+ EF   G     LF +++    
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDV-FEDKKYFYLVTEFYEGG----ELFEQIINRHK 142

Query: 217 WSIRM--KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGP 271
           +       I      G+ +LH  +  +++RD K  NILL+      N K+ DFGL+    
Sbjct: 143 FDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           +  K       +GT  Y APE ++      + DV+S GV++  +L G 
Sbjct: 201 KDYKLR---DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 99.8 bits (249), Expect = 6e-23
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 24/217 (11%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVI 168
           ++  +++ + LG G +G V       D    ++    A+K+    +        L  EV 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLC---RDKVTHVE---RAIKIIRKTSVSTSSNSKLLEEVA 88

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM--KIAF 225
            L  L HPN++KL  +  ED+    L+ E    G     LF +++  + ++      I  
Sbjct: 89  VLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIK 143

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRI 282
               G+ +LH  +  +++RD K  N+LL++   D   K+ DFGL+       K       
Sbjct: 144 QVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ER 198

Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           +GT  Y APE ++      + DV+S GV+L  +L G 
Sbjct: 199 LGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 97.1 bits (242), Expect = 5e-22
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEV 167
            +  ++  RVLG G FG V      +D   G +    AVKV               L EV
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILC---KDKITGQE---CAVKVISKRQVKQKTDKESLLREV 77

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM--KIA 224
             L  L HPN++KL  +  ED+    L+ E    G     LF +++    +S     +I 
Sbjct: 78  QLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARII 132

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTR 281
                G+ ++H  +  +++RD K  N+LL++   D N ++ DFGL+       K      
Sbjct: 133 RQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---D 187

Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            +GT  Y APE ++ G    + DV+S GV+L  +L+G 
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 94.9 bits (236), Expect = 6e-22
 Identities = 46/259 (17%), Positives = 95/259 (36%), Gaps = 46/259 (17%)

Query: 151 HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK 210
               +S         ++  +   S  N V  +       +  +  +   + ++++ +  +
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155

Query: 211 VLLPLP-----WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 265
             L          I ++IA    + + FLH   K +++RD K SNI    D   K+ DFG
Sbjct: 156 CSLEDREHGVCLHIFIQIA----EAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFG 209

Query: 266 LAKD----------GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 315
           L                       T  +GT  Y +PE I   + + + D++S G++L E+
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

Query: 316 LTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP---VKGVHKAAMLAY 372
           L                   ++     E+ +++  +       +P    +   +  M+  
Sbjct: 270 L-------------------YSFSTQMERVRIITDVR---NLKFPLLFTQKYPQEHMMVQ 307

Query: 373 HCLNHNPKARPLMRDIVDS 391
             L+ +P  RP   DI+++
Sbjct: 308 DMLSPSPTERPEATDIIEN 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 19/78 (24%), Positives = 29/78 (37%), Gaps = 6/78 (7%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           +F   + +G GGFG V++     D          A+K     N      + + EV  L  
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCN------YAIKRIRLPNRELAREKVMREVKALAK 60

Query: 173 LSHPNLVKLIGYCCEDEH 190
           L HP +V+      E   
Sbjct: 61  LEHPGIVRYFNAWLETPP 78

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 96.3 bits (240), Expect = 9e-22
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 30/220 (13%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVI 168
               +    +LG G FG V K    +D     +    AVKV +  ++       +  EV 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKC---KDRITQQE---YAVKVINKASAKNKDTSTILREVE 73

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR-----MK 222
            L  L HPN++KL     ED     ++ E    G     LF +++    +S       +K
Sbjct: 74  LLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVS 279
             F     + ++H  +  +++RD K  NILL++   D + K+ DFGL+    +  K    
Sbjct: 129 QVFSG---ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-- 181

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
              +GT  Y APE ++ G    + DV+S GV+L  +L+G 
Sbjct: 182 -DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 41/207 (19%), Positives = 70/207 (33%), Gaps = 16/207 (7%)

Query: 121 GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLV 179
           G      V           G     V V+  + +        +L  E+      +HPN+V
Sbjct: 36  GFEDLMTVNLAR---YKPTGEY---VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 180 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 239
                   D    ++  FMA GS ++ + +  +  +       I  G  K L ++H    
Sbjct: 90  PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH--M 147

Query: 240 PVIYRDFKTSNILLDTDYNAKLSDFG-LAKDGPEGDKSHVSTRIM----GTYGYAAPEYI 294
             ++R  K S+IL+  D    LS           G +  V             + +PE +
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207

Query: 295 MTGHL--TPRSDVYSFGVVLLEILTGR 319
                    +SD+YS G+   E+  G 
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGH 234

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 75/331 (22%), Positives = 124/331 (37%), Gaps = 53/331 (16%)

Query: 59  HCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRD-SAANPLIAFTYDELRIITANFRQD 117
           H   S   +  +E    +   + ++ +    LR      +P                   
Sbjct: 4   HHHHSSGVDLGTENLYFQSGVV-THEQFKAALRMVVDQGDP------------RLLLDSY 50

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
             +G G  G V       +   G Q   VAVK+ D     Q       EV+ +    H N
Sbjct: 51  VKIGEGSTGIVCLAR---EKHSGRQ---VAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFN 103

Query: 178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF---GAAKGLAFL 234
           +V++       E   ++ EF+  G++  ++ S+V L         IA       + LA+L
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQ-----IATVCEAVLQALAYL 157

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYAAPEY 293
           H   + VI+RD K+ +ILL  D   KLSDFG  A+   +  K    + + GT  + APE 
Sbjct: 158 HA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEV 212

Query: 294 IMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKKLLNIID 352
           I         D++S G++++E++ G        P +      D   P LK   K+  ++ 
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLR 272

Query: 353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
             LE                  L  +P+ R 
Sbjct: 273 DFLE----------------RMLVRDPQERA 287

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.3 bits (237), Expect = 3e-21
 Identities = 72/310 (23%), Positives = 114/310 (36%), Gaps = 65/310 (20%)

Query: 41  KKTEMKKVQSFFQFQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 100
              E+      F   +I H +     +       + Y +     E  ++LR D     + 
Sbjct: 113 IMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIE-----EICQNLRGDVFQKFIE 167

Query: 101 AFTYDEL----------RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV 150
           +  +              +   +F   R++G GGFG VY                   + 
Sbjct: 168 SDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVY-----------------GCRK 210

Query: 151 HDGDNSY-------------QGHREWLAEVIFLGHLS---HPNLVKLIGYCCEDEHRV-L 193
            D    Y             QG    L E I L  +S    P +V +  Y      ++  
Sbjct: 211 ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSF 269

Query: 194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---GLAFLHEAEKPVIYRDFKTSN 250
           I + M  G +  +L    +        M+  F AA+   GL  +H   + V+YRD K +N
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSEA---DMR--FYAAEIILGLEHMHN--RFVVYRDLKPAN 322

Query: 251 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS-DVYSFG 309
           ILLD   + ++SD GLA D  +         + GT+GY APE +  G     S D +S G
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVLQKGVAYDSSADWFSLG 378

Query: 310 VVLLEILTGR 319
            +L ++L G 
Sbjct: 379 CMLFKLLRGH 388

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 92.8 bits (231), Expect = 9e-21
 Identities = 68/274 (24%), Positives = 109/274 (39%), Gaps = 42/274 (15%)

Query: 64  PKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFT-YDELRIITANFRQDRVLGG 122
           P+  S +E  K           +V   +  S    ++A       R    ++   +V+G 
Sbjct: 5   PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64

Query: 123 GGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKL 181
           G FG VY+  + +          VA+K V       Q  R    E+  +  L H N+V+L
Sbjct: 65  GSFGVVYQAKLCDSGEL------VAIKKVL------QDKRFKNRELQIMRKLDHCNIVRL 112

Query: 182 IGYCCEDEHRV------LIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAK 229
             +      +       L+ +++        +      +S+    LP        +   +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGTY 286
            LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    Y
Sbjct: 168 SLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y 221

Query: 287 GYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 319
            Y APE I      T   DV+S G VL E+L G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 39/275 (14%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           + +   +G G  G VY      D+  G +   VA++  +           + E++ +   
Sbjct: 22  YTRFEKIGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQ-PKKELIINEILVMREN 74

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF---GAAKG 230
            +PN+V  +      +   ++ E++A GS+  ++ ++  +         IA       + 
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQ-----IAAVCRECLQA 128

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYA 289
           L FLH     VI+RD K+ NILL  D + KL+DFG  A+  PE  K    T + GT  + 
Sbjct: 129 LEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWM 183

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKKLL 348
           APE +      P+ D++S G++ +E++ G        P R   L A    P L+  +KL 
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243

Query: 349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
            I    L                  CL  + + R 
Sbjct: 244 AIFRDFLN----------------RCLEMDVEKRG 262

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 16/209 (7%)

Query: 111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 170
              F     LG G +G VYK         G     VA+K    ++  Q   E + E+  +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAI---HKETGQI---VAIKQVPVESDLQ---EIIKEISIM 78

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
                P++VK  G   ++    ++ E+   GSV +++       L       I     KG
Sbjct: 79  QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV-SDIIRLRNKTLTEDEIATILQSTLKG 137

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYA 289
           L +LH      I+RD K  NILL+T+ +AKL+DFG+  +      K +  T I GT  + 
Sbjct: 138 LEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN--TVI-GTPFWM 192

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           APE I        +D++S G+  +E+  G
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEG 221

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 53/270 (19%), Positives = 95/270 (35%), Gaps = 39/270 (14%)

Query: 61  KESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 120
                      + K +  K+    +  ED+ +     P+          +   +     L
Sbjct: 4   SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGS----VYDYYDILEEL 59

Query: 121 GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 180
           G G FG V++     +   G        K  +             E+  +  L HP L+ 
Sbjct: 60  GSGAFGVVHRC---VEKATGRV---FVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLIN 112

Query: 181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG---AAK-------G 230
           L     +    VLI EF++ G  E  LF ++                            G
Sbjct: 113 LHDAFEDKYEMVLILEFLSGG--E--LFDRI-------AAEDYKMSEAEVINYMRQACEG 161

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVSTRIMGTYGY 288
           L  +HE    +++ D K  NI+ +T   +  K+ DFGLA    + +   +      T  +
Sbjct: 162 LKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEF 216

Query: 289 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           AAPE +    +   +D+++ GV+   +L+G
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD--GDNSYQGHREWLAEVIFLG 171
           +     LG G FG VYK     +   G      A KV +   +   +   +++ E+  L 
Sbjct: 21  WEIVGELGDGAFGKVYKAK---NKETGAL---AAAKVIETKSEEELE---DYIVEIEILA 71

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
              HP +VKL+G    D    ++ EF   G+V + +  ++   L       +     + L
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYAA 290
            FLH   K +I+RD K  N+L+  + + +L+DFG+ AK+     K    + I GT  + A
Sbjct: 131 NFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD--SFI-GTPYWMA 185

Query: 291 PEYIMTGHLT-----PRSDVYSFGVVLLEILTG 318
           PE +M   +       ++D++S G+ L+E+   
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
           I   F   R LG G FG V+     E+   GL+     +K  + D S     +  AE+  
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLV---EERSSGLE---RVIKTINKDRSQVPMEQIEAEIEV 73

Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR-------- 220
           L  L HPN++K+     ED H + ++ E    G  E  L  +++                
Sbjct: 74  LKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAE 128

Query: 221 -MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKS 276
            MK    A   LA+ H   + V+++D K  NIL          K+ DFGLA+     +  
Sbjct: 129 LMKQMMNA---LAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH- 182

Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             ST   GT  Y APE +    +T + D++S GVV+  +LTG
Sbjct: 183 --STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 39/229 (17%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVI 168
               F+ +R+ G G FG V  G              VA+K V   D  ++ +RE L  + 
Sbjct: 21  EMDRFQVERMAGQGTFGTVQLGKEKSTGM------SVAIKKVIQ-DPRFR-NRE-LQIMQ 71

Query: 169 FLGHLSHPNLVKLIGY-------CCEDEHRVLIYEFMARGSVENNL------FSKVLLPL 215
            L  L HPN+V+L  Y          D +  ++ E++      + L      + +  +  
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAP 126

Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFGLAKDGPEGD 274
           P  +     F   + +  LH     V +RD K  N+L++  D   KL DFG AK     +
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 275 K--SHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGR 319
              +++ +R    Y Y APE ++ G  H T   D++S G +  E++ G 
Sbjct: 187 PNVAYICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 49/224 (21%), Positives = 82/224 (36%), Gaps = 36/224 (16%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-------HDGDNSYQGHREWLA 165
            +    +LG G +G V +   SE L         AVK+          +      +E   
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCR------RAVKILKKKKLRRIPNGEANVKKE--- 56

Query: 166 EVIFLGHLSHPNLVKL--IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
            +  L  L H N+++L  + Y  E +   ++ E+   G  E  +   V        R  +
Sbjct: 57  -IQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP-----EKRFPV 108

Query: 224 AFGAAK------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
                       GL +LH   + ++++D K  N+LL T    K+S  G+A+         
Sbjct: 109 CQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166

Query: 278 VSTRIMGTYGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGR 319
                 G+  +  PE           + D++S GV L  I TG 
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 30/219 (13%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-AEVI 168
               +    +LG G FG V K    +D     +    AVKV +  ++       +  EV 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKC---KDRITQQE---YAVKVINKASAKNKDTSTILREVE 73

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR-----MK 222
            L  L HPN++KL     ED     ++ E    G  E  LF +++    +S       +K
Sbjct: 74  LLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGG--E--LFDEIIKRKRFSEHDAARIIK 128

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVS 279
             F     + ++H  +  +++RD K  NILL++   D + K+ DFGL+    +       
Sbjct: 129 QVFSG---ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KM 180

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
              +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 181 KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 54/278 (19%), Positives = 90/278 (32%), Gaps = 58/278 (20%)

Query: 91  RRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV 150
              S+    + F    L  +   +     +G G +G V       + +        A+K+
Sbjct: 5   HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVA---IENQTRAI---RAIKI 58

Query: 151 HD----GDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGS--- 202
            +       + +       EV  +  L HPN+ +L     EDE  + L+ E    G    
Sbjct: 59  MNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLD 117

Query: 203 --VENNLFSKVLLPLPWSIRMKIAFG--------------------------AAK----- 229
                   S     +                                      +      
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177

Query: 230 --GLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAK--DGPEGDKSHVSTRIM 283
              L +LH   + + +RD K  N L  T+ +   KL DFGL+K        + +  T   
Sbjct: 178 FSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235

Query: 284 GTYGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGR 319
           GT  + APE + T +    P+ D +S GV+L  +L G 
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 61/259 (23%), Positives = 107/259 (41%), Gaps = 42/259 (16%)

Query: 78  SKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDL 137
           S  P N  ++  L   +    ++A            +   +V+G G FG V++  + E  
Sbjct: 6   SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 138 REGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV---- 192
                   VA+K V       Q  R    E+  +  + HPN+V L  +   +  +     
Sbjct: 66  E-------VAIKKVL------QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112

Query: 193 --LIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYR 244
             L+ E++        +      ++K+   +P  +     +   + LA++H     + +R
Sbjct: 113 LNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHR 165

Query: 245 DFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGTYGYAAPEYIMTG-HLT 300
           D K  N+LLD      KL DFG AK    G+   S++ +R    Y Y APE I    + T
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELIFGATNYT 220

Query: 301 PRSDVYSFGVVLLEILTGR 319
              D++S G V+ E++ G+
Sbjct: 221 TNIDIWSTGCVMAELMQGQ 239

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 88.0 bits (218), Expect = 6e-19
 Identities = 65/291 (22%), Positives = 96/291 (32%), Gaps = 39/291 (13%)

Query: 44  EMKKVQSFFQFQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFT 103
           E K  QS     +        + +        E  K+      V     +   +    + 
Sbjct: 85  ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144

Query: 104 YDELRIITANFRQ----DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG 159
              + I   +          LG G FG V++     +   G      A K     +    
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV---TERATGNN---FAAKFVMTPHE-SD 197

Query: 160 HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 219
                 E+  +  L HP LV L     +D   V+IYEFM+ G     LF KV        
Sbjct: 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKV-------A 246

Query: 220 RMKIAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT--DYNAKLSDFGLA 267
                     A +       GL  +H  E   ++ D K  NI+  T      KL DFGL 
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304

Query: 268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
                     V     GT  +AAPE      +   +D++S GV+   +L+G
Sbjct: 305 AHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 57/275 (20%), Positives = 95/275 (34%), Gaps = 49/275 (17%)

Query: 63  SPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGG 122
                  +    +      + P+  E+L   S         +   +     +    V+G 
Sbjct: 45  RDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGR 104

Query: 123 GGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLA-EVIFLGHLS- 174
           G    V +         G +    AVK+             +  RE    E   L  ++ 
Sbjct: 105 GVSSVVRRC---VHRATGHE---FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158

Query: 175 HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG---AAK- 229
           HP+++ LI    E    + L+++ M +G  E  LF          +  K+A         
Sbjct: 159 HPHIITLIDS-YESSSFMFLVFDLMRKG--E--LFDY--------LTEKVALSEKETRSI 205

Query: 230 ------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
                  ++FLH     +++RD K  NILLD +   +LSDFG +     G        + 
Sbjct: 206 MRSLLEAVSFLH--ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELC 260

Query: 284 GTYGYAAPE------YIMTGHLTPRSDVYSFGVVL 312
           GT GY APE                 D+++ GV+L
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 59/282 (20%), Positives = 103/282 (36%), Gaps = 41/282 (14%)

Query: 55  QSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANF 114
            S      S  +E+    +  + ++      +           P   F +  +       
Sbjct: 26  NSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAV 85

Query: 115 RQD------RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
                     +LGGG FG V+K    E+   GL+   +A K+       +   E   E+ 
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKC---EETATGLK---LAAKIIKTRGM-KDKEEVKNEIS 138

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG-- 226
            +  L H NL++L          VL+ E++  G  E  LF ++       I         
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG--E--LFDRI-------IDESYNLTEL 187

Query: 227 -AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT--DYNAKLSDFGLAKDGPEGDKS 276
                      G+  +H  +  +++ D K  NIL         K+ DFGLA+     +K 
Sbjct: 188 DTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245

Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            V     GT  + APE +    ++  +D++S GV+   +L+G
Sbjct: 246 KV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 72/274 (26%), Positives = 110/274 (40%), Gaps = 37/274 (13%)

Query: 56  SISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFR 115
           S  H       + P+ +       +   P               + F  D  ++    F 
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKL----FS 57

Query: 116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD--GDNSYQGHREWLAEVIFLGHL 173
             R +G G FG VY      D+R       VA+K     G  S +  ++ + EV FL  L
Sbjct: 58  DLREIGHGSFGAVYFAR---DVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR-MKIAF---GAAK 229
            HPN ++  G    +    L+ E+   GS      S +L      ++ ++IA    GA +
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCL-GSA-----SDLLEVHKKPLQEVEIAAVTHGALQ 165

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR--IMGTYG 287
           GLA+LH     +I+RD K  NILL      KL DFG A        S ++     +GT  
Sbjct: 166 GLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPY 215

Query: 288 YAAPEYIMT---GHLTPRSDVYSFGVVLLEILTG 318
           + APE I+    G    + DV+S G+  +E+   
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 83.2 bits (206), Expect = 7e-18
 Identities = 74/288 (25%), Positives = 108/288 (37%), Gaps = 52/288 (18%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           F    ++G G +G VYKG     ++ G      A+KV D         E   E+  L   
Sbjct: 26  FELVELVGNGTYGQVYKGR---HVKTG---QLAAIKVMDVTG--DEEEEIKQEINMLKKY 77

Query: 174 S-HPNLVKLIG------YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF- 225
           S H N+    G          D+   L+ EF   GSV + + +     L       IA+ 
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYI 134

Query: 226 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 281
                +GL+ LH+ +   I+RD K  N+LL  +   KL DFG++             R  
Sbjct: 135 CREILRGLSHLHQHKV--IHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRN 187

Query: 282 -IMGTYGYAAPEYIMTGHLT-----PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 335
             +GT  + APE I            +SD++S G+  +E+  G   L    P R      
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ 241

Query: 336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
            AL L+           PRL+     K       +   CL  N   RP
Sbjct: 242 -ALFLIPRNPA------PRLKSKKWSKKFQS--FIES-CLVKNHSQRP 279

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 58/228 (25%), Positives = 86/228 (37%), Gaps = 42/228 (18%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD-----GDNSYQGHREWL 164
           +   +     LG G F  V K     +   GL+    A K                 E  
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKC---REKSTGLE---YAAKFIKKRQSRASRRGVCREEIE 63

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            EV  L  + HPN++ L          VLI E ++ G  E  LF          +  K +
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGG--E--LFDF--------LAQKES 111

Query: 225 F---GAAK-------GLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDFGLAKDG 270
                A         G+ +LH   K + + D K  NI+L        + KL DFGLA + 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            +G +      I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 170 EDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 27/216 (12%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD----GDNSYQGHREWLA 165
               +    V+G G F  V +     +   G Q    AVK+ D      +      +   
Sbjct: 22  FEDVYELCEVIGKGPFSVVRRC---INRETGQQ---FAVKIVDVAKFTSSPGLSTEDLKR 75

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR---- 220
           E      L HP++V+L+      +  + +++EFM    +   +  +      +S      
Sbjct: 76  EASICHMLKHPHIVELLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134

Query: 221 -MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKS 276
            M+    A   L + H  +  +I+RD K   +LL +       KL  FG+A    E    
Sbjct: 135 YMRQILEA---LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL- 188

Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
            V+   +GT  + APE +         DV+  GV+L
Sbjct: 189 -VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 82.3 bits (204), Expect = 9e-18
 Identities = 56/229 (24%), Positives = 83/229 (36%), Gaps = 50/229 (21%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-------HDGDNSYQGHRE 162
              N+    +LG G    V +           +    AVK+              Q  RE
Sbjct: 15  FYENYEPKEILGRGVSSVVRRC---IHKPTCKE---YAVKIIDVTGGGSFSAEEVQELRE 68

Query: 163 WLA-EVIFLGHLS-HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSI 219
               EV  L  +S HPN+++L     E      L+++ M +G  E  LF          +
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKG--E--LFDY--------L 115

Query: 220 RMKIAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 269
             K+        K        +  LH  +  +++RD K  NILLD D N KL+DFG +  
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 270 GPEGDKSHVSTRIMGTYGYAAPE------YIMTGHLTPRSDVYSFGVVL 312
              G        + GT  Y APE                 D++S GV++
Sbjct: 174 LDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 28/213 (13%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVI 168
            T  ++    LG G F  V +      +  G +    A  + +         + L  E  
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRC---VKVLAGQE---YAAMIINTKKLSARDHQKLEREAR 62

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR-----MK 222
               L HPN+V+L      +E    LI++ +  G  E  LF  ++    +S       ++
Sbjct: 63  ICRLLKHPNIVRLHDS-ISEEGHHYLIFDLVTGG--E--LFEDIVAREYYSEADASHCIQ 117

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVS 279
               A   +   H  +  V++R+ K  N+LL +       KL+DFGLA +     +    
Sbjct: 118 QILEA---VLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AW 170

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
               GT GY +PE +         D+++ GV+L
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 30/218 (13%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
           I   +  +  +G G +G V            ++    A K        +    +  E+  
Sbjct: 7   INQYYTLENTIGRGSWGEVKIA---VQKGTRIR---RAAKKIPKYFV-EDVDRFKQEIEI 59

Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR-----MKI 223
           +  L HPN+++L     ED   + L+ E    G  E  LF +V+    +        MK 
Sbjct: 60  MKSLDHPNIIRLYET-FEDNTDIYLVMELCTGG--E--LFERVVHKRVFRESDAARIMKD 114

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 280
              A   +A+ H  +  V +RD K  N L  T   D   KL DFGLA     G    +  
Sbjct: 115 VLSA---VAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMR 166

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
             +GT  Y +P+ ++ G   P  D +S GV++  +L G
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 55/244 (22%), Positives = 92/244 (37%), Gaps = 51/244 (20%)

Query: 102 FTYDELRIITANFRQD----RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------- 150
            T D+  +     R +    + LG G  G V   F   + +   +   VA+++       
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF---ERKTCKK---VAIRIISKRKFA 174

Query: 151 HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK 210
                          E+  L  L+HP ++K+  +  + E   ++ E M  G  E  LF K
Sbjct: 175 IGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK 229

Query: 211 VLLPLPWSIRMKIAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DY 257
                   +                     + +LH  E  +I+RD K  N+LL +   D 
Sbjct: 230 --------VVGNKRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDC 279

Query: 258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL---TPRSDVYSFGVVLLE 314
             K++DFG +K   E     +   + GT  Y APE +++          D +S GV+L  
Sbjct: 280 LIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 336

Query: 315 ILTG 318
            L+G
Sbjct: 337 CLSG 340

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 54/231 (23%), Positives = 82/231 (35%), Gaps = 48/231 (20%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWL 164
           +  ++     LG G F  V K         G +    A K                 E  
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKC---RQKGTGKE---YAAKFIKKRRLSSSRRGVSREEIE 56

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGS-----VENNLFS--------KV 211
            EV  L  + HPN++ L          VLI E ++ G       E    +        K 
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ 116

Query: 212 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDFGLA 267
           +L                G+ +LH   K + + D K  NI+L      +   KL DFG+A
Sbjct: 117 IL---------------DGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

Query: 268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
                G++      I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 160 HKIEAGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 33/219 (15%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD----GDNSYQGHREWLAEVI 168
           ++   + LG G +G V       +         VAVK+ D     D      +E    + 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA---VNRVTEEA---VAVKIVDMKRAVDCPENIKKE----IC 57

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
               L+H N+VK  G+  E   + L  E+ + G  E  LF ++       I M     A 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGG--E--LFDRIEP----DIGMPEP-DAQ 108

Query: 229 K-------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
           +       G+ +LH     + +RD K  N+LLD   N K+SDFGLA      ++  +  +
Sbjct: 109 RFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 282 IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           + GT  Y APE +          DV+S G+VL  +L G 
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 29/220 (13%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 167
           +   ++  + +G G  G V     + D         VA+K +     N     R    E+
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCA---AYDAVLDRN---VAIKKLSRPFQNQTHAKRA-YREL 112

Query: 168 IFLGHLSHPNLVKLI-----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + +  ++H N++ L+         E+   V L+ E M     + NL   + + L      
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMS 167

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS--HVS 279
            + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+          +V 
Sbjct: 168 YLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           TR      Y APE I+        D++S G ++ E++  +
Sbjct: 226 TRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 57/228 (25%), Positives = 85/228 (37%), Gaps = 42/228 (18%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWL 164
           +   +     LG G F  V K     +   GL+    A K                 E  
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKC---REKSTGLE---YAAKFIKKRQSRASRRGVSREEIE 63

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            EV  L  + H N++ L          VLI E ++ G  E  LF          +  K +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--E--LFDF--------LAQKES 111

Query: 225 F---GAAK-------GLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDFGLAKDG 270
                A         G+ +LH   K + + D K  NI+L        + KL DFGLA + 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            +G +      I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 170 EDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 82.8 bits (204), Expect = 3e-17
 Identities = 70/309 (22%), Positives = 125/309 (40%), Gaps = 42/309 (13%)

Query: 31  DIPFLFCKLMKKTEMKKVQSFFQFQSISHCKE-------SPKDESPSEKAKKEYSKLPSN 83
              F+       +E++K      F+ +S  +         P+    +E+ ++++ +    
Sbjct: 253 RNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIG 312

Query: 84  PEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCV----YKGFISEDLRE 139
                   + +          +  R+   +F    VLG G FG V     KG  +++L  
Sbjct: 313 QGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG--TDEL-- 368

Query: 140 GLQPVPVAVKVHDGDNSYQGHR-EW-LAE-VIFLGHLSHPNLVKLIGYCC--EDEHRVLI 194
                  AVK+   D   Q    E  + E  +       P L +L  + C    +    +
Sbjct: 369 ------YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL--HSCFQTMDRLYFV 420

Query: 195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---GLAFLHEAEKPVIYRDFKTSNI 251
            E++  G +  ++        P ++     F AA+   GL FL    K +IYRD K  N+
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPHAV-----FYAAEIAIGLFFLQS--KGIIYRDLKLDNV 473

Query: 252 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTYGYAAPEYIMTGHLTPRSDVYSFGV 310
           +LD++ + K++DFG+ K+         +T+   GT  Y APE I         D ++FGV
Sbjct: 474 MLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 530

Query: 311 VLLEILTGR 319
           +L E+L G+
Sbjct: 531 LLYEMLAGQ 539

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 80.7 bits (200), Expect = 4e-17
 Identities = 41/221 (18%), Positives = 77/221 (34%), Gaps = 36/221 (16%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
           +   +     LG G FG V++     +            K                E+  
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRC---VETSSKKT---YMAKFVKV--KGTDQVLVKKEISI 54

Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--- 226
           L    H N++ L       E  V+I+EF++    +  +F ++                  
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGL--D--IFERI-------NTSAFELNERE 103

Query: 227 AAK-------GLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSH 277
                      L FLH     + + D +  NI+  T  ++  K+ +FG A+    GD   
Sbjct: 104 IVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161

Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           +   +     Y APE      ++  +D++S G ++  +L+G
Sbjct: 162 L---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 42/307 (13%), Positives = 84/307 (27%), Gaps = 62/307 (20%)

Query: 108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLA 165
           RI    +R     GG      ++     D         VA+      G       +E L+
Sbjct: 27  RIANGRYRLLIFHGGVPPLQFWQA---LDTALD---RQVALTFVDPQGVLPDDVLQETLS 80

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
             + L  +  P + +++         +++ E++  GS++  +      P+     ++   
Sbjct: 81  RTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQE-VADTSPSPVG---AIRAMQ 136

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             A      H A   V       S + +  D +  L+                       
Sbjct: 137 SLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 345
                          P+ D+   G  L  +L  R       P  E  +     P  ++  
Sbjct: 175 --TMPDA-------NPQDDIRGIGASLYALLVNR------WPLPEAGVRSGLAPAERDTA 219

Query: 346 KLLNIIDPRLEGDYPVKGVHKA-AMLAYHCLNHNPKARP------LMRDIVDSLEPLQVL 398
                I+P          +    + +A   +  +   R       LM+      +  +VL
Sbjct: 220 G--QPIEPADIDR----DIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVL 273

Query: 399 PDEAPTP 405
                 P
Sbjct: 274 GPIDEAP 280

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 80.3 bits (199), Expect = 5e-17
 Identities = 51/217 (23%), Positives = 82/217 (37%), Gaps = 40/217 (18%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
           I   F    VLG G F  V+     +    G      A+K     +          E+  
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLV---KQRLTGKL---FALKCIK-KSPAFRDSSLENEIAV 59

Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF--- 225
           L  + H N+V L     E      L+ + ++ G  E  LF +        I  +  +   
Sbjct: 60  LKKIKHENIVTLEDIY-ESTTHYYLVMQLVSGG--E--LFDR--------ILERGVYTEK 106

Query: 226 GAAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 275
            A+         + +LHE    +++RD K  N+L  T   +    ++DFGL+K    G  
Sbjct: 107 DASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162

Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
             + +   GT GY APE +     +   D +S GV+ 
Sbjct: 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 31/221 (14%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 167
           +   ++  + +G G  G V   +   D         VA+K +     N     R    E+
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAY---DAILERN---VAIKKLSRPFQNQTHAKRA-YREL 75

Query: 168 IFLGHLSHPNLVKLI-----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + +  ++H N++ L+         E+   V ++ E M     + NL   + + L    RM
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMEL-DHERM 129

Query: 222 K-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS--HV 278
             + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+          +V
Sbjct: 130 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187

Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            TR      Y APE I+        D++S G ++ E++ G 
Sbjct: 188 VTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 79.5 bits (197), Expect = 7e-17
 Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 39/218 (17%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVI 168
            + N+     LG G F  V +         GL+    A K+ +         + L  E  
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRC---VHKTTGLE---FAAKIINTKKLSARDFQKLEREAR 57

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG- 226
               L HPN+V+L     ++E    L+++ +  G  E  LF          I  +  +  
Sbjct: 58  ICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGG--E--LFED--------IVAREFYSE 104

Query: 227 --AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGD 274
             A+         +A+ H     +++R+ K  N+LL +       KL+DFGLA +  +  
Sbjct: 105 ADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161

Query: 275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
                    GT GY +PE +     +   D+++ GV+L
Sbjct: 162 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 39/218 (17%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVI 168
            + N+     LG G F  V +         GL+    A K+ +    S +  ++   E  
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRC---VHKTTGLE---FAAKIINTKKLSARDFQKLEREAR 80

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG- 226
               L HPN+V+L     ++E    L+++ +  G  E  LF          I  +  +  
Sbjct: 81  ICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGG--E--LFED--------IVAREFYSE 127

Query: 227 --AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGD 274
             A+         +A+ H     +++R+ K  N+LL +       KL+DFGLA +  +  
Sbjct: 128 ADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184

Query: 275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
                    GT GY +PE +     +   D+++ GV+L
Sbjct: 185 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.1 bits (198), Expect = 8e-17
 Identities = 53/244 (21%), Positives = 85/244 (34%), Gaps = 33/244 (13%)

Query: 90  LRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK 149
           L     A  L      E       +     LG G FG V+         +  +   V VK
Sbjct: 3   LEEPPKAVELEGLAACEGEYS-QKYSTMSPLGSGAFGFVWTA------VDKEKNKEVVVK 55

Query: 150 V-------HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGS 202
                    D         +   E+  L  + H N++K++          L+ E    G 
Sbjct: 56  FIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGL 115

Query: 203 VENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSNILLDTD 256
              +LF+ +        R+     +         + +L    K +I+RD K  NI++  D
Sbjct: 116 ---DLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAED 166

Query: 257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEI 315
           +  KL DFG A     G   +      GT  Y APE +M   +  P  +++S GV L  +
Sbjct: 167 FTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223

Query: 316 LTGR 319
           +   
Sbjct: 224 VFEE 227

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 57/232 (24%), Positives = 85/232 (36%), Gaps = 50/232 (21%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWL 164
           +   +     LG G F  V K     +   GLQ    A K                 +  
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKC---REKSTGLQ---YAAKFIKKRRTKSSRRGVSREDIE 62

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
            EV  L  + HPN++ L     E++  V LI E +A G  E  LF  +            
Sbjct: 63  REVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGG--E--LFDFL-----------A 106

Query: 224 AFG------AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT----DYNAKLSDFGL 266
                    A +       G+ +LH     + + D K  NI+L          K+ DFGL
Sbjct: 107 EKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

Query: 267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
           A     G++      I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 165 AHKIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 41/223 (18%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD----GDNSYQGHREWLAEVI 168
           ++   + LG G +G V       +         VAVK+ D     D      +E    + 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA---VNRVTEEA---VAVKIVDMKRAVDCPENIKKE----IC 57

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK------ 222
               L+H N+VK  G+  E   + L  E+ + G  E  LF ++       I M       
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGG--E--LFDRIEP----DIGMPEPDAQR 109

Query: 223 -----IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
                +A     G+ +LH     + +RD K  N+LLD   N K+SDFGLA      ++  
Sbjct: 110 FFHQLMA-----GVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 278 VSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           +  ++ GT  Y APE +          DV+S G+VL  +L G 
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 24/212 (11%)

Query: 116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLGHLS 174
             + LG G F  V +         G +    A K        Q  R  +  E+  L    
Sbjct: 33  TSKELGRGKFAVVRQC---ISKSTGQE---YAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 175 H-PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---- 229
             P ++ L          +LI E+ A G  E  +FS  L  L   +         K    
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
           G+ +LH+    +++ D K  NILL +     + K+ DFG+++      +      IMGT 
Sbjct: 143 GVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTP 197

Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            Y APE +    +T  +D+++ G++   +LT 
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 73/282 (25%), Positives = 113/282 (40%), Gaps = 41/282 (14%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLG 171
           N+R  + +G G F  V         R  L    VA+K+ D         + L  EV  + 
Sbjct: 16  NYRLLKTIGKGNFAKVKLA------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGAAK 229
            L+HPN+VKL      ++   LI E+ + G     +F  ++    +              
Sbjct: 70  ILNHPNIVKLFEVIETEKTLYLIMEYASGG----EVFDYLVAHGRMKEKEARSKFRQIVS 125

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
            + + H+  K +++RD K  N+LLD D N K++DFG + +   G K        G   YA
Sbjct: 126 AVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYA 180

Query: 290 APEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL 348
           APE      +  P  DV+S GV+L  +++G        P   QN     L  L+E+    
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQN-----LKELRER---- 225

Query: 349 NIIDPRLEGDYPV-KGVHK-AAMLAYHCLNHNPKARPLMRDI 388
            +    L G Y +   +      L    L  NP  R  +  I
Sbjct: 226 -V----LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 28/168 (16%)

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
             E   +  L HP  VKL  +  +D+ ++     +   G     L           IR  
Sbjct: 78  TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGE----LL--------KYIRKI 124

Query: 223 IAF--GAAK--------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE 272
            +F     +         L +LH   K +I+RD K  NILL+ D + +++DFG AK    
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 182

Query: 273 GDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 319
             K   +   +GT  Y +PE +         SD+++ G ++ +++ G 
Sbjct: 183 ESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 60/269 (22%), Positives = 96/269 (35%), Gaps = 48/269 (17%)

Query: 59  HCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDR 118
           H   S  D        +  S + ++          ++  P           ++  F  + 
Sbjct: 5   HHHSSGVDLGTENLYFQSMSSVTASAAP-----GTASLVPDYWIDGSNRDALSDFFEVES 59

Query: 119 VLGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
            LG G    VY+           L+ +   V                 E+  L  LSHPN
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT----------EIGVLLRLSHPN 109

Query: 178 LVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG---AAK---- 229
           ++KL     E    + L+ E +  G     LF +        I  K  +    AA     
Sbjct: 110 IIKLKEI-FETPTEISLVLELVTGGE----LFDR--------IVEKGYYSERDAADAVKQ 156

Query: 230 ---GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
               +A+LH  E  +++RD K  N+L  T   D   K++DFGL+K         +   + 
Sbjct: 157 ILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVC 211

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
           GT GY APE +      P  D++S G++ 
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 71/303 (23%), Positives = 119/303 (39%), Gaps = 36/303 (11%)

Query: 37  CKLMKKTEMKK-------VQSFFQFQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVED 89
           C+LMK    +        +Q     +   H +   + E  +   +     L        D
Sbjct: 60  CQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMD 119

Query: 90  LRRDSAANPL------IAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP 143
            R  S ++        ++    + R+    F   ++LG G FG V         +E    
Sbjct: 120 FRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILV------KEKATG 173

Query: 144 VPVAVKVHDGDNSYQGHR-EW-LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMAR 200
              A+K+   +           L E   L +  HP L  L  Y  +   R+  + E+   
Sbjct: 174 RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANG 232

Query: 201 GSVENNLFSKVLLPLPWSIRMKIAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDY 257
           G +  +L  + +       R +  F  A+    L +LH +EK V+YRD K  N++LD D 
Sbjct: 233 GELFFHLSRERVFSED---RAR--FYGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDG 286

Query: 258 NAKLSDFGLAKDGPEGDKSHVSTRIM-GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 316
           + K++DFGL K+G +      + +   GT  Y APE +         D +  GVV+ E++
Sbjct: 287 HIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343

Query: 317 TGR 319
            GR
Sbjct: 344 CGR 346

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 65/276 (23%), Positives = 105/276 (38%), Gaps = 30/276 (10%)

Query: 57  ISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQ 116
           ++H     ++E  S       S      +  E L            T    ++   NF  
Sbjct: 1   MAHHHHHHEEEGGSSGGAAGTS--ADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFEL 58

Query: 117 DRVLGGGGFGCVY--KGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREW-LAE-VIFL 170
            +VLG G +G V+  +     D  +       A+KV             E    E  +  
Sbjct: 59  LKVLGTGAYGKVFLVRKISGHDTGK-----LYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 171 GHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 229
                P LV L  Y  + E ++ LI +++  G +  +L  +                  +
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-----QIYVGE 167

Query: 230 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
               L  LH+    +IYRD K  NILLD++ +  L+DFGL+K+    +         GT 
Sbjct: 168 IVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTI 224

Query: 287 GYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGR 319
            Y AP+ +    +GH     D +S GV++ E+LTG 
Sbjct: 225 EYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGA 259

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 59/233 (25%), Positives = 85/233 (36%), Gaps = 52/233 (22%)

Query: 110 ITANFRQD-----RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
            +  F         VLG G    V       +L    +    AVK+ +            
Sbjct: 6   FSGRFEDVYQLQEDVLGEGAHARVQTC---INLITSQE---YAVKIIE-KQPGHIRSRVF 58

Query: 165 AEVIFLGHLS-HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
            EV  L     H N+++LI +  E+E R  L++E M  GS    + S         I  +
Sbjct: 59  REVEMLYQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGS----ILSH--------IHKR 105

Query: 223 IAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKD 269
             F    A+         L FLH   K + +RD K  NIL +        K+ DF L   
Sbjct: 106 RHFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163

Query: 270 -GPEGDKSHVSTRIM----GTYGYAAPEYIMTGHLTPRS-----DVYSFGVVL 312
               GD S +ST  +    G+  Y APE +              D++S GV+L
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 47/232 (20%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-------HDGDNSYQGHRE 162
           +   +   + LG G  G V   F   + +   +   VA+K+                   
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAF---ERKTCKK---VAIKIISKRKFAIGSAREADPALN 61

Query: 163 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
              E+  L  L+HP ++K+  +  + E   ++ E M  G  E  LF K        +   
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG--E--LFDK--------VVGN 108

Query: 223 IAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKD 269
                             + +LHE    +I+RD K  N+LL +   D   K++DFG +K 
Sbjct: 109 KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166

Query: 270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHL---TPRSDVYSFGVVLLEILTG 318
             E     + T   GT  Y APE +++          D +S GV+L   L+G
Sbjct: 167 LGETSL--MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 44/239 (18%)

Query: 104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHR- 161
             EL  + + +   R +  G +G V  G  SE +        VA+K V +  +  +    
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIP-------VAIKRVFNTVSDGRTVNI 66

Query: 162 ---EWLA-----EVIFLGHLSHPNLVKL----IGYCCEDEHRV-LIYEFMARGSVENNLF 208
               +L      E+  L H  HPN++ L    + +     H++ L+ E M       +L 
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDL- 120

Query: 209 SKVL----LPLPWSIRMK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 263
           ++V+    + +     ++   +    GL  LHEA   V++RD    NILL  + +  + D
Sbjct: 121 AQVIHDQRIVIS-PQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICD 177

Query: 264 FGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 319
           F LA++         +V+ R      Y APE +M     T   D++S G V+ E+   +
Sbjct: 178 FNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 22/214 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHREWLAEVIFLG 171
            F   +VLG G FG V   F+ + +         A+KV                E   L 
Sbjct: 25  QFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81

Query: 172 HLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 229
            ++HP +VKL  Y  + E ++ LI +F+  G +   L  +V+            F  A+ 
Sbjct: 82  EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-----KFYLAEL 135

Query: 230 --GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTY 286
              L  LH     +IYRD K  NILLD + + KL+DFGL+K+  + +K         GT 
Sbjct: 136 ALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTV 190

Query: 287 GYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            Y APE +   GH T  +D +SFGV++ E+LTG 
Sbjct: 191 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 18/156 (11%)

Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
           L +  HP L  L  Y  +   R+  + E+   G +  +L  + +       R +  F  A
Sbjct: 59  LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RAR--FYGA 112

Query: 229 K---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-G 284
           +    L +LH   + V+YRD K  N++LD D + K++DFGL K+G        + +   G
Sbjct: 113 EIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCG 167

Query: 285 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           T  Y APE +    +     D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 20/164 (12%)

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
             E+  +  L HP LV L  Y  +DE  + ++ + +  G +  +L   V         +K
Sbjct: 63  FKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVK 118

Query: 223 IAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
                 +    L +L    + +I+RD K  NILLD   +  ++DF +A   P   +    
Sbjct: 119 --LFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---I 171

Query: 280 TRIMGTYGYAAPEYIM----TGHLTPRSDVYSFGVVLLEILTGR 319
           T + GT  Y APE        G+ +   D +S GV   E+L GR
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGR 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 77.2 bits (191), Expect = 7e-16
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 24/216 (11%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW---LAEVIF 169
            F   RVLG GG+G V   F    +         A+KV       +  ++     AE   
Sbjct: 18  CFELLRVLGKGGYGKV---FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74

Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
           L  + HP +V LI Y  +   ++ LI E+++ G +   L  + +     +      F  A
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-----CFYLA 128

Query: 229 K---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-G 284
           +    L  LH+  K +IYRD K  NI+L+   + KL+DFGL K+          T    G
Sbjct: 129 EISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VTHTFCG 183

Query: 285 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           T  Y APE +M +GH     D +S G ++ ++LTG 
Sbjct: 184 TIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 167
           +   +     +G G +G V       D R G +   VA+K +     +     R    E+
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAI---DKRSGEK---VAIKKLSRPFQSEIFAKRA-YREL 74

Query: 168 IFLGHLSHPNLVKLI-----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM 221
           + L H+ H N++ L+          + +   L+  FM     + +L   + L        
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQ 129

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
            + +   KGL ++H A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR
Sbjct: 130 YLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187

Query: 282 IMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 319
                 Y APE I++  H     D++S G ++ E+LTG+
Sbjct: 188 W-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 36/220 (16%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 166
           ++     LG G FG V  G   E    G +   VAVK+         D   +  RE    
Sbjct: 12  HYVLGDTLGVGTFGKVKIG---EHQLTGHK---VAVKILNRQKIRSLDVVGKIKRE---- 61

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           +  L    HP+++KL           ++ E+++ G     LF  +        R++    
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE----LFDYICK----HGRVEEMEA 113

Query: 227 AAK------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
                     + + H     V++RD K  N+LLD   NAK++DFGL+    +G+    S 
Sbjct: 114 RRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 171

Query: 281 RIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
              G+  YAAPE I    +  P  D++S GV+L  +L G 
Sbjct: 172 ---GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 63/300 (21%), Positives = 106/300 (35%), Gaps = 74/300 (24%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL-- 170
            +R   +LG GGFG V+ G     L + L    VA+KV   +          +    L  
Sbjct: 32  EYRLGPLLGKGGFGTVFAG---HRLTDRL---QVAIKVIPRNRVLGWSPLSDSVTCPLEV 85

Query: 171 -------GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
                      HP +++L+ +    E  +L+ E         +LF  +        +  +
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITE------KGPL 136

Query: 224 AFGAAK--------GLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLA---KDGP 271
             G ++         +   H   + V++RD K  NIL+D      KL DFG      D P
Sbjct: 137 GEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP 194

Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLT-PRSDVYSFGVVLLEILTGRKSLDKSRPARE 330
                       GT  Y+ PE+I         + V+S G++L +++ G            
Sbjct: 195 ----YTDFD---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD----------- 236

Query: 331 QNLADWALPLLKEKKKLLNIIDPRLEGDYPV-KGVHKAAM-LAYHCLNHNPKARPLMRDI 388
                  +P  ++++         LE +      V      L   CL   P +RP + +I
Sbjct: 237 -------IPFERDQEI--------LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 39/110 (35%), Positives = 52/110 (47%), Gaps = 14/110 (12%)

Query: 214 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 273
            L     +  +F  AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  + 
Sbjct: 189 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246

Query: 274 D--KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 317
                    R+    M      APE I     T +SDV+SFGV+L EI +
Sbjct: 247 PDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 3/100 (3%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
             +  + LG G FG V +      + +      VAVK+     ++  HR  ++E+  L H
Sbjct: 23  RLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 173 L-SHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSK 210
           +  H N+V L+G C +    + +I EF   G++   L SK
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 50/221 (22%), Positives = 80/221 (36%), Gaps = 46/221 (20%)

Query: 111 TANFRQD----RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE 166
           +  F         +G G +    +          ++    AVK+ D  +      E    
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRC---IHKATNME---FAVKIID-KSKRDPTEE---I 66

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
            I L +  HPN++ L     +D   V ++ E M  G     L  K        I  +  F
Sbjct: 67  EILLRYGQHPNIITLKDV-YDDGKYVYVVTELMKGGE----LLDK--------ILRQKFF 113

Query: 226 G---AAK-------GLAFLHEAEKPVIYRDFKTSNILL-DTDYNA---KLSDFGLAKDGP 271
               A+         + +LH   + V++RD K SNIL  D   N    ++ DFG AK   
Sbjct: 114 SEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171

Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
             +   +      T  + APE +         D++S GV+L
Sbjct: 172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 34/222 (15%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-----EV 167
            ++   +LG GGFG VY G     + + L   PVA+K  + D                EV
Sbjct: 44  QYQVGPLLGSGGFGSVYSG---IRVSDNL---PVAIKHVEKDRISDWGELPNGTRVPMEV 97

Query: 168 IFLGHLSH--PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PLPWSIRMKI 223
           + L  +S     +++L+ +    +  VLI E       +  LF  +     L   +    
Sbjct: 98  VLLKKVSSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSF 154

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLA---KDGPEGDKSHVS 279
            +   + +   H     V++RD K  NIL+D +    KL DFG     KD          
Sbjct: 155 FWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDF 208

Query: 280 TRIMGTYGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGR 319
               GT  Y+ PE+I   H      + V+S G++L +++ G 
Sbjct: 209 D---GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 16/157 (10%)

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           +      HP L  +     + +  +  + E++  G +  ++ S     L  +      F 
Sbjct: 70  VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-----TFY 123

Query: 227 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           AA+   GL FLH   K ++YRD K  NILLD D + K++DFG+ K+   GD     T   
Sbjct: 124 AAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTF 178

Query: 284 -GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE ++        D +SFGV+L E+L G+
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 18/162 (11%)

Query: 166 EVIFLGHLSHPNLVKLIGYC-CEDEHRVLIY---EFMARGSVENNLFSKVLL-PLPWSIR 220
           E+  L  L HPN+VKL      +D +   +Y   E + +G     +     L PL     
Sbjct: 86  EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGP----VMEVPTLKPLSEDQA 139

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
                   KG+ +LH   + +I+RD K SN+L+  D + K++DFG++ +  +G  + +S 
Sbjct: 140 RFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSDALLSN 196

Query: 281 RIMGTYGYAAPEYIMTGHLT---PRSDVYSFGVVLLEILTGR 319
            + GT  + APE +            DV++ GV L   + G+
Sbjct: 197 TV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 18/158 (11%)

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           + L ++ HP LV L  +  +   ++  + +++  G +  +L  +     P +      F 
Sbjct: 91  VLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-----RFY 144

Query: 227 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           AA+    L +LH     ++YRD K  NILLD+  +  L+DFGL K+  E +    +T   
Sbjct: 145 AAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTF 199

Query: 284 -GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +    +     D +  G VL E+L G 
Sbjct: 200 CGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 67/279 (24%), Positives = 116/279 (41%), Gaps = 42/279 (15%)

Query: 54  FQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITAN 113
                H      D   +E    + +      EE E +    +     +           +
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ-------D 53

Query: 114 FRQDRVLGGGGFGCVY----KGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHREW-LAE- 166
           F   RV+G G +  V     K   ++ +         A++V   +        +W   E 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKK--TDRI--------YAMRVVKKELVNDDEDIDWVQTEK 103

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
            +F    +HP LV L   C + E R+  + E++  G +  ++  +  LP   +      F
Sbjct: 104 HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-----RF 157

Query: 226 GAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
            +A+    L +LHE  + +IYRD K  N+LLD++ + KL+D+G+ K+G        +T  
Sbjct: 158 YSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTST 212

Query: 283 M-GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
             GT  Y APE I+ G     S D ++ GV++ E++ GR
Sbjct: 213 FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 167
           + A +R  + +G G +G V       D R G +   VA+K ++    +     R    E+
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAV---DGRTGAK---VAIKKLYRPFQSELFAKRA-YREL 75

Query: 168 IFLGHLSHPNLVKLI-----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWS-IR 220
             L H+ H N++ L+         +D     L+  FM       +L  K++        R
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDL-GKLMKHEKLGEDR 129

Query: 221 MK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
           ++ + +   KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+        +V 
Sbjct: 130 IQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187

Query: 280 TRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 319
           TR      Y APE I+     T   D++S G ++ E++TG+
Sbjct: 188 TRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG--DNSYQGHREWLAEV 167
           +   ++    +G G +G V   F ++          VAVK       +     R    E+
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLR------VAVKKLSRPFQSIIHAKRT-YREL 79

Query: 168 IFLGHLSHPNLVKLI-----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWS-IR 220
             L H+ H N++ L+         E+ + V L+   M       +L + ++     +   
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADL-NNIVKCQKLTDDH 133

Query: 221 MK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 279
           ++ + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+
Sbjct: 134 VQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA 191

Query: 280 TRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 319
           TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 TRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.6 bits (184), Expect = 6e-15
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 18/158 (11%)

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           +F    +HP LV L   C + E R+  + E++  G +  ++  +  LP   +      F 
Sbjct: 62  VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-----RFY 115

Query: 227 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           +A+    L +LHE  + +IYRD K  N+LLD++ + KL+D+G+ K+G        +T   
Sbjct: 116 SAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 170

Query: 284 -GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 319
            GT  Y APE I+ G     S D ++ GV++ E++ GR
Sbjct: 171 CGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.1 bits (183), Expect = 6e-15
 Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 40/222 (18%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 166
            + +   +G G +G V+K     +   G     VA+K                    L E
Sbjct: 4   KYEKIGKIGEGSYGVVFKC---RNRDTG---QIVAIKKFLESEDDPVIKKIA-----LRE 52

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRM 221
           +  L  L HPNLV L+          L++E+      ++ +     L      +P  +  
Sbjct: 53  IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC-----DHTV--LHELDRYQRGVPEHLVK 105

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSH-V 278
            I +   + + F H+     I+RD K  NIL+      KL DFG A+   GP       V
Sbjct: 106 SITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163

Query: 279 STRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           +TR      Y +PE ++      P  DV++ G V  E+L+G 
Sbjct: 164 ATR-----WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 42/218 (19%)

Query: 116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS- 174
           +D+ LG G F    K       +        AVK+          +E    +  L     
Sbjct: 15  KDKPLGEGSFSICRKC---VHKKSNQA---FAVKIISKRMEANTQKE----ITALKLCEG 64

Query: 175 HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG---AAK- 229
           HPN+VKL      D+    L+ E +  G     LF +        I+ K  F    A+  
Sbjct: 65  HPNIVKLHEV-FHDQLHTFLVMELLNGGE----LFER--------IKKKKHFSETEASYI 111

Query: 230 ------GLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFGLAKDGPEGDKSHVST 280
                  ++ +H  +  V++RD K  N+L    + +   K+ DFG A+  P  ++  + T
Sbjct: 112 MRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKT 168

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
               T  YAAPE +         D++S GV+L  +L+G
Sbjct: 169 PC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 18/158 (11%)

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           I     +HP L +L   C +   R+  + EF+  G +  ++          +      F 
Sbjct: 76  ILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-----RFY 129

Query: 227 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           AA+    L FLH+  K +IYRD K  N+LLD + + KL+DFG+ K+G        +T   
Sbjct: 130 AAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATF 184

Query: 284 -GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE +    +  P  D ++ GV+L E+L G 
Sbjct: 185 CGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 18/158 (11%)

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           +       P L +L   C +   R+  + E++  G +  ++        P +      F 
Sbjct: 73  VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-----VFY 126

Query: 227 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           AA+   GL FL    K +IYRD K  N++LD++ + K++DFG+ K+         +T+  
Sbjct: 127 AAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTF 181

Query: 284 -GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            GT  Y APE I    +     D ++FGV+L E+L G+
Sbjct: 182 CGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 39/227 (17%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVI 168
           +   +     +G G +G V   +   D    ++   VA+K +   ++     R  L E+ 
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAY---DNLNKVR---VAIKKISPFEHQTYCQRT-LREIK 77

Query: 169 FLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK- 222
            L    H N++ +          + +   ++ + M     E +L  K+       ++ + 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDL-YKL-------LKTQH 124

Query: 223 --------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-DGPEG 273
                     +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ 
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

Query: 274 DKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 319
           D +   T  + T  Y APE ++     T   D++S G +L E+L+ R
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 59/252 (23%), Positives = 102/252 (40%), Gaps = 32/252 (12%)

Query: 78  SKLPSNPEEVEDLRRDSAANPLIAFTYDELRIIT-ANFRQDRVLGGGGFGCVYKGFISED 136
           +K  S  E V++    +  + L  +            F + + LG G FG V        
Sbjct: 6   AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML------ 59

Query: 137 LREGLQPVPVAVKV----HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV 192
           ++        A+K+             H   L E   L  ++ P LVKL  +  +D   +
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHT--LNEKRILQAVNFPFLVKLE-FSFKDNSNL 116

Query: 193 -LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---GLAFLHEAEKPVIYRDFKT 248
            ++ E++A G + ++L        P +      F AA+      +LH     +IYRD K 
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLTFEYLHS--LDLIYRDLKP 169

Query: 249 SNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYS 307
            N+L+D     +++DFG AK       +     + GT    APE I++ G+     D ++
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY-NKAVDWWA 223

Query: 308 FGVVLLEILTGR 319
            GV++ E+  G 
Sbjct: 224 LGVLIYEMAAGY 235

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREW-----LAE 166
            +    ++G G +G V K     +   G     VA+K   + D+      +      + E
Sbjct: 26  KYENLGLVGEGSYGMVMKC---RNKDTG---RIVAIKKFLESDD-----DKMVKKIAMRE 74

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRM 221
           +  L  L H NLV L+  C + +   L++EF+     ++ +     L      L + +  
Sbjct: 75  IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-----DHTI--LDDLELFPNGLDYQVVQ 127

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSH-V 278
           K  F    G+ F H     +I+RD K  NIL+      KL DFG A+    P       V
Sbjct: 128 KYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV 185

Query: 279 STRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           +TR      Y APE ++         DV++ G ++ E+  G 
Sbjct: 186 ATR-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 36/220 (16%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 166
           ++     LG G FG V  G   +    G +   VAVK+         D   +  RE    
Sbjct: 17  HYILGDTLGVGTFGKVKVG---KHELTGHK---VAVKILNRQKIRSLDVVGKIRRE---- 66

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           +  L    HP+++KL           ++ E+++ G  E  LF  +      + R+     
Sbjct: 67  IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG--E--LFDYICK----NGRLDEKES 118

Query: 227 AAK------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
                    G+ + H     V++RD K  N+LLD   NAK++DFGL+    +G+    S 
Sbjct: 119 RRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176

Query: 281 RIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
              G+  YAAPE I    +  P  D++S GV+L  +L G 
Sbjct: 177 ---GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 37/220 (16%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 166
            +     LG G FG V         +   +   VA+K          D   +  RE    
Sbjct: 10  PYIIRETLGEGSFGKVKLA---THYKTQQK---VALKFISRQLLKKSDMHMRVERE---- 59

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           + +L  L HP+++KL          V++ E+         LF  ++       RM    G
Sbjct: 60  ISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-----AGGELFDYIV----EKKRMTEDEG 110

Query: 227 AAK------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
                     + + H     +++RD K  N+LLD + N K++DFGL+    +G+    S 
Sbjct: 111 RRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168

Query: 281 RIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
              G+  YAAPE I    +  P  DV+S G+VL  +L GR
Sbjct: 169 ---GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 52/258 (20%), Positives = 94/258 (36%), Gaps = 71/258 (27%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
            +  +   + LG G FG V + F  E  +        A+K    D  Y+       E+  
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGK------RFALKKVLQDPRYK-----NRELDI 53

Query: 170 LGHLSHPNLVKLIGYCCEDEHRV------------------------------------- 192
           +  L H N++KL+ Y                                             
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 193 -LIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD 245
            +I E++      + L      F +    +P ++     +   + + F+H     + +RD
Sbjct: 114 NVIMEYV-----PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRD 166

Query: 246 FKTSNILLD-TDYNAKLSDFGLAKDGPEGDK--SHVSTRIMGTYGYAAPEYIMTG-HLTP 301
            K  N+L++  D   KL DFG AK     +   +++ +R    + Y APE ++     TP
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTP 221

Query: 302 RSDVYSFGVVLLEILTGR 319
             D++S G V  E++ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 60/291 (20%), Positives = 102/291 (35%), Gaps = 54/291 (18%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH--REWLAEVIFL 170
            +   + +G G FG         D         VAVK  +   +   +  RE    +I  
Sbjct: 21  RYDFVKDIGSGNFGVARLM---RDKLTKEL---VAVKYIERGAAIDENVQRE----IINH 70

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 229
             L HPN+V+         H  +I E+ + G     L+ ++      + R          
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGG----ELYERICN----AGRFSEDEARFFF 122

Query: 230 -----GLAFLHEAEKPVIYRDFKTSNILLDTDY--NAKLSDFGLAKDGPEGDKSHVSTRI 282
                G+++ H     + +RD K  N LLD       K+ DFG +K      +   +   
Sbjct: 123 QQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-- 178

Query: 283 MGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL 341
            GT  Y APE ++   +    +DV+S GV L  +L G        P  +           
Sbjct: 179 -GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAY------PFEDPEEP------- 224

Query: 342 KEKKKLLNIIDPRLEGDYPV-KGVH---KAAMLAYHCLNHNPKARPLMRDI 388
           ++ +K +  I   L   Y +   +    +   L       +P  R  + +I
Sbjct: 225 RDYRKTIQRI---LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 32/227 (14%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG-DNSYQGHREWLAEVI 168
           I+++F+   +LG G +G V           G     VA+K  +  D      R  L E+ 
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSAT---HKPTGEI---VAIKKIEPFDKPLFALRT-LREIK 61

Query: 169 FLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS-IRMK 222
            L H  H N++ +                +I E M     + +L  +V+     S   ++
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDL-HRVISTQMLSDDHIQ 115

Query: 223 -IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA----KDGPEGDKSH 277
              +   + +  LH +   VI+RD K SN+L++++ + K+ DFGLA    +   +  +  
Sbjct: 116 YFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 278 VSTRIMGTY----GYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGR 319
                M  +     Y APE ++T    +   DV+S G +L E+   R
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 55/271 (20%)

Query: 62  ESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLG 121
             P                P  P++       S          D+ ++        +VLG
Sbjct: 18  APPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT------SQVLG 71

Query: 122 GGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLS-HPNLV 179
            G  G V + F   + R   +    A+K+  D   + +       EV      S  P++V
Sbjct: 72  LGINGKVLQIF---NKRTQEK---FALKMLQDCPKARR-------EVELHWRASQCPHIV 118

Query: 180 KLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG---AA--- 228
           +++    E+ +       ++ E +  G     LFS++        R   AF    A+   
Sbjct: 119 RIVDVY-ENLYAGRKCLLIVMECLDGGE----LFSRIQD------RGDQAFTEREASEIM 167

Query: 229 ----KGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA--KLSDFGLAKDGPEGDKSHVSTR 281
               + + +LH     + +RD K  N+L      NA  KL+DFG AK+    +   ++T 
Sbjct: 168 KSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTP 223

Query: 282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 312
              T  Y APE +         D++S GV++
Sbjct: 224 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.1 bits (175), Expect = 7e-14
 Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 34/229 (14%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
           + + +   + LG GG G V+      D     +   VA+K     +        L E+  
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAV---DNDCDKR---VAIKKIVLTDPQSVKHA-LREIKI 61

Query: 170 LGHLSHPNLVKLI-------------GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPL 215
           +  L H N+VK+                   + + V ++ E+M     E +L + VL   
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDL-ANVLEQG 115

Query: 216 PWS-IRMK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAK-DGP 271
           P      +   +   +GL ++H A   V++RD K +N+ ++T D   K+ DFGLA+   P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 272 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 319
                   +  + T  Y +P  +++  + T   D+++ G +  E+LTG+
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 71.1 bits (175), Expect = 8e-14
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 30/219 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWLAEV 167
            F+Q   LG G +  VYKG            V VA+K       +G  S       + E+
Sbjct: 6   QFKQLEKLGNGTYATVYKG------LNKTTGVYVALKEVKLDSEEGTPSTA-----IREI 54

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA---RGSVENNLFSKVLLPLPWSIRMKIA 224
             +  L H N+V+L      +    L++EFM    +  +++         L  ++     
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSH-VSTR 281
           +   +GLAF HE    +++RD K  N+L++     KL DFGLA     P    S  V T 
Sbjct: 115 WQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172

Query: 282 IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
                 Y AP+ +M +   +   D++S G +L E++TG+
Sbjct: 173 -----WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 70.6 bits (174), Expect = 8e-14
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 30/220 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
            + +   +G G +G V+K    ++         VA+K    D+  +G     L E+  L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKA---KNRETH---EIVALKRVRLDDDDEGVPSSALREICLLK 56

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRMKIAFG 226
            L H N+V+L      D+   L++EF      + +L  K         L   I     F 
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFC-----DQDL--KKYFDSCNGDLDPEIVKSFLFQ 109

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSH-VSTRIM 283
             KGL F H   + V++RD K  N+L++ +   KL++FGLA+    P    S  V T   
Sbjct: 110 LLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL-- 165

Query: 284 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSL 322
               Y  P+ +      +   D++S G +  E+    + L
Sbjct: 166 ---WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 120 LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 178
           +G G +G VYK    +D ++       A+K +     S    RE    +  L  L HPN+
Sbjct: 29  VGRGTYGHVYKA-KRKDGKDD---KDYALKQIEGTGISMSACRE----IALLRELKHPNV 80

Query: 179 VKLIGYCCEDEHR--VLIYEFMAR------GSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
           + L         R   L++++              +  +K  + LP  +   + +    G
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNA----KLSDFGLAK--DGPEGDKSHVSTRIMG 284
           + +LH     V++RD K +NIL+  +       K++D G A+  + P    + +   ++ 
Sbjct: 141 IHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197

Query: 285 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           T+ Y APE ++   H T   D+++ G +  E+LT  
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 27/165 (16%)

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFS----KVLLPLPWS 218
             E + L  ++HP ++++     +D  ++ +I +++  G     LFS        P P  
Sbjct: 54  NDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGE----LFSLLRKSQRFPNP-- 106

Query: 219 IRMKIAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
              K  F AA+    L +LH   K +IYRD K  NILLD + + K++DFG AK  P+   
Sbjct: 107 -VAK--FYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161

Query: 276 SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 319
           +     + GT  Y APE + T  +     D +SFG+++ E+L G 
Sbjct: 162 T-----LCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGY 200

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 55/233 (23%)

Query: 111 TANFRQD-----RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWL 164
                 D     +VLG G  G V + F     R G +    A+K+ +D   + Q      
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECF---HRRTGQK---CALKLLYDSPKARQ------ 70

Query: 165 AEVIFLGHLS-HPNLVKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLLPLPWS 218
            EV      S  P++V ++    E+ H       +I E M  G     LFS++       
Sbjct: 71  -EVDHHWQASGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGE----LFSRIQE----- 119

Query: 219 IRMKIAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILL-DTDYNA--KLSDFG 265
            R   AF    AA+        + FLH     + +RD K  N+L    + +A  KL+DFG
Sbjct: 120 -RGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176

Query: 266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            AK+  +     + T    T  Y APE +         D++S GV++  +L G
Sbjct: 177 FAKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 39/221 (17%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWLAEV 167
            + +   LG G +  VYKG      +  L    VA+K       +G          + EV
Sbjct: 3   TYIKLDKLGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTA-----IREV 51

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRMK 222
             L  L H N+V L      ++   L++E++     + +L  K  L      +       
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-----DKDL--KQYLDDCGNIINMHNVKL 104

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSH-VS 279
             F   +GLA+ H   + V++RD K  N+L++     KL+DFGLA  K  P     + V 
Sbjct: 105 FLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV 162

Query: 280 TRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           T       Y  P+ ++ +   + + D++  G +  E+ TGR
Sbjct: 163 TL-----WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 65/320 (20%), Positives = 114/320 (35%), Gaps = 79/320 (24%)

Query: 58  SHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQD 117
           SH   + +  +   +     S+      +     + +A+ P     +     I   +   
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQ----IPDRYEIR 58

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEVIFLGHLSH 175
            ++G G +G V + +   D  E      VA+K +    ++     R  L E+  L  L+H
Sbjct: 59  HLIGTGSYGHVCEAY---DKLEKRV---VAIKKILRVFEDLIDCKRI-LREIAILNRLNH 111

Query: 176 PNLVKL----IGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA-- 228
            ++VK+    I    E    + ++ E       +++   K+        R  +       
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDF-KKL-------FRTPVYLTELHI 158

Query: 229 --------KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKS-- 276
                    G+ ++H A   +++RD K +N L++ D + K+ DFGLA+  D PE   S  
Sbjct: 159 KTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216

Query: 277 --------------------------HVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFG 309
                                     HV TR      Y APE I+     T   DV+S G
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRW-----YRAPELILLQENYTEAIDVWSIG 271

Query: 310 VVLLEILTGRKSLDKSRPAR 329
            +  E+L   K        R
Sbjct: 272 CIFAELLNMIKENVAYHADR 291

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 24/167 (14%)

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFS---KVLLPLPWSI 219
             E   +   + P +V+L  Y  +D+  + ++ E+M  G    +L +      +P  W+ 
Sbjct: 117 WEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGG----DLVNLMSNYDVPEKWA- 170

Query: 220 RMKIAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
                F  A+    L  +H      I+RD K  N+LLD   + KL+DFG      +    
Sbjct: 171 ----RFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224

Query: 277 HVSTRIMGTYGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTGR 319
              T + GT  Y +PE + +    G+     D +S GV L E+L G 
Sbjct: 225 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 38/165 (23%), Positives = 69/165 (41%), Gaps = 29/165 (17%)

Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFS-----KVLLPLPWSIRMKI 223
           L +     +  L  Y  +D++ + L+ ++   G    +L +     +  LP   +     
Sbjct: 128 LVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGG----DLLTLLSKFEDRLPEEMA----- 177

Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F  A+    +  +H+     ++RD K  NIL+D + + +L+DFG      E      S 
Sbjct: 178 RFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235

Query: 281 RIMGTYGYAAPEYIMT------GHLTPRSDVYSFGVVLLEILTGR 319
             +GT  Y +PE +         +  P  D +S GV + E+L G 
Sbjct: 236 -AVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGE 278

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 35/166 (21%), Positives = 63/166 (37%), Gaps = 29/166 (17%)

Query: 170 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFS-----KVLLPLPWSIRMKI 223
           L +     + +L  +  +DE+ + L+ E+   G    +L +        +P   +     
Sbjct: 115 LVNGDRRWITQLH-FAFQDENYLYLVMEYYVGG----DLLTLLSKFGERIPAEMA----- 164

Query: 224 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F  A+    +  +H      ++RD K  NILLD   + +L+DFG               
Sbjct: 165 RFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVY-------SFGVVLLEILTGR 319
            + GT  Y +PE +      P +  Y       + GV   E+  G+
Sbjct: 223 AV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 69.1 bits (170), Expect = 4e-13
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 43/225 (19%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVA---VKVHDGDNSYQG-HREWLAEVI 168
            + +   LG G F  VYK     D         VA   +K+     +  G +R  L E+ 
Sbjct: 11  RYEKLDFLGEGQFATVYKA---RDKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
            L  LSHPN++ L+       +  L+++FM     E +L  +V++         +    +
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFM-----ETDL--EVIIK-----DNSLVLTPS 112

Query: 229 ----------KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKS 276
                     +GL +LH+    +++RD K +N+LLD +   KL+DFGLAK    P    +
Sbjct: 113 HIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170

Query: 277 H-VSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           H V TR      Y APE +          D+++ G +L E+L   
Sbjct: 171 HQVVTR-----WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 45/230 (19%), Positives = 93/230 (40%), Gaps = 34/230 (14%)

Query: 104 YDELRI---ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 160
           Y+   +      +++  R LG G +  V++     +  +      V VK+          
Sbjct: 25  YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK------VVVKILKPVK----K 74

Query: 161 REWLAEVIFLGHLS-HPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPW 217
           ++   E+  L +L   PN++ L     +   R   L++E      V N  F ++   L  
Sbjct: 75  KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLTD 129

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK- 275
                  +   K L + H     +++RD K  N+++D ++   +L D+GLA+    G + 
Sbjct: 130 YDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187

Query: 276 -SHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSL 322
              V++R    Y +  PE ++          D++S G +L  ++  ++  
Sbjct: 188 NVRVASR----Y-FKGPE-LLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 53/259 (20%), Positives = 97/259 (37%), Gaps = 60/259 (23%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 167
           +  N+    ++G G +G VY  +   D         VA+K V+   ++     R  L E+
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAY---DKNTEKN---VAIKKVNRMFEDLIDCKRI-LREI 76

Query: 168 IFLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 222
             L  L    +++L          + +   ++ E       +++L  K+        +  
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDL-KKL-------FKTP 123

Query: 223 IAFGAA----------KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA----- 267
           I                G  F+HE+   +I+RD K +N LL+ D + K+ DFGLA     
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181

Query: 268 -----------KDGPEGDKSHVSTRIMGTY----GYAAPEYIMTGHL-TPRSDVYSFGVV 311
                      ++   G  +    + + ++     Y APE I+     T   D++S G +
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241

Query: 312 LLEILTGRKSLDKSRPARE 330
             E+L   +S       R 
Sbjct: 242 FAELLNMLQSHINDPTNRF 260

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 35/219 (15%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 166
            +++   +G G +G VYK    +D +  +    VA+K        +G  S    RE    
Sbjct: 22  KYQKLEKVGEGTYGVVYKA---KDSQGRI----VALKRIRLDAEDEGIPS-TAIRE---- 69

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRM 221
           +  L  L HPN+V LI     +    L++EFM     E +L  K +L      L  S   
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-----EKDL--KKVLDENKTGLQDSQIK 122

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 281
              +   +G+A  H+    +++RD K  N+L+++D   KL+DFGLA+    G      T 
Sbjct: 123 IYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTH 178

Query: 282 IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            + T  Y AP+ +M +   +   D++S G +  E++TG+
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 42/175 (24%), Positives = 73/175 (41%), Gaps = 35/175 (20%)

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRV--------LIYEFMARGSVENNLFSKVLLPLPW 217
           E+  L  L H N+V LI  C               L+++F      E++L    LL    
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL--AGLLS--- 115

Query: 218 SIRMKIAFGAA----------KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 267
              + + F  +           GL ++H     +++RD K +N+L+  D   KL+DFGLA
Sbjct: 116 --NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLA 171

Query: 268 K--DGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
           +     +  + +  T  + T  Y  PE ++      P  D++  G ++ E+ T  
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 38/223 (17%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 166
            +R+   LG G +G VYK     D         VA+K        +G          + E
Sbjct: 35  RYRRITKLGEGTYGEVYKA---IDTVTNET---VAIKRIRLEHEEEGVPGTA-----IRE 83

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL----PLPWSIRMK 222
           V  L  L H N+++L      +    LI+E+      EN+L  K  +     +   +   
Sbjct: 84  VSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDL--KKYMDKNPDVSMRVIKS 136

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-----KLSDFGLAKDGPEGDKSH 277
             +    G+ F H   +  ++RD K  N+LL     +     K+ DFGLA+    G    
Sbjct: 137 FLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--AFGIPIR 192

Query: 278 VSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
             T  + T  Y  PE ++ + H +   D++S   +  E+L   
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 66.8 bits (164), Expect = 1e-12
 Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 41/222 (18%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 166
            +     +G G +G VYK       +        A+K        +G  S       + E
Sbjct: 3   KYHGLEKIGEGTYGVVYKA------QNNYGET-FALKKIRLEKEDEGIPSTT-----IRE 50

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRM 221
           +  L  L H N+VKL       +  VL++E +     + +L  K LL      L      
Sbjct: 51  ISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-----DQDL--KKLLDVCEGGLESVTAK 103

Query: 222 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSH-V 278
                   G+A+ H+  + V++RD K  N+L++ +   K++DFGLA+    P    +H +
Sbjct: 104 SFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161

Query: 279 STRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 319
            T       Y AP+ +M +   +   D++S G +  E++ G 
Sbjct: 162 VTL-----WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 32/225 (14%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEV 167
            +   FR  R +G G FG +Y G    +++   +   VA+K+ +    + Q   E     
Sbjct: 4   RVGNKFRLGRKIGSGSFGEIYLG---TNIQTNEE---VAIKLENVKTKHPQLLYES---- 53

Query: 168 IFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
                L     +  +  +  E ++ VL+ + +   S+E +LF+     L     + +A  
Sbjct: 54  KIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQ 111

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK---LSDFGLAKD-GPEGDKSHVSTR- 281
               + F+H   K  ++RD K  N L+     A    + DFGLAK         H+  R 
Sbjct: 112 MINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169

Query: 282 ---IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 319
              + GT  YA+    +  HL    + R D+ S G VL+  L G 
Sbjct: 170 NKNLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 56/244 (22%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 167
           +   +   + LG G +G V+K     D R G     VAVK + D   NS    R    E+
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSI---DRRTGEV---VAVKKIFDAFQNSTDAQRT-FREI 59

Query: 168 IFLGHLS-HPNLVKL--IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK-- 222
           + L  LS H N+V L  +     D    L++++M     E +L   V       IR    
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDL-HAV-------IRANIL 106

Query: 223 -------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-------- 267
                  + +   K + +LH     +++RD K SNILL+ + + K++DFGL+        
Sbjct: 107 EPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164

Query: 268 -------KDGPEGDKSHVSTRIMGTY----GYAAPEYIMTGHL-TPRSDVYSFGVVLLEI 315
                        +       I+  Y     Y APE ++     T   D++S G +L EI
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

Query: 316 LTGR 319
           L G+
Sbjct: 225 LCGK 228

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 51/231 (22%), Positives = 93/231 (40%), Gaps = 40/231 (17%)

Query: 108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAE 166
            ++  +++  R +G G FG +++G    +L    Q   VA+K      ++ Q   E+   
Sbjct: 6   NVVGVHYKVGRRIGEGSFGVIFEG---TNLLNNQQ---VAIKFEPRRSDAPQLRDEYRTY 59

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM--KIA 224
            +  G      +  +  +  E  H VL+ + +   S+E +L         +S++     A
Sbjct: 60  KLLAG---CTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDL--CGRKFSVKTVAMAA 112

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK-----LSDFGLAK---DGPEGDKS 276
                 +  +H  EK ++YRD K  N L+    +       + DFG+ K   D     K 
Sbjct: 113 KQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQ 168

Query: 277 HVSTR----IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 319
           H+  R    + GT  Y +    +  HL    + R D+ + G V +  L G 
Sbjct: 169 HIPYREKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 52/230 (22%), Positives = 92/230 (40%), Gaps = 40/230 (17%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEV 167
           ++  NFR  + +G G FG +  G   ++L        VA+K+      + Q H E+    
Sbjct: 6   MVGPNFRVGKKIGCGNFGELRLG---KNLYTNEY---VAIKLEPMKSRAPQLHLEYRFYK 59

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM--KIAF 225
                     + ++  +    ++  ++ E +   S+E +LF        +S++    IA 
Sbjct: 60  QLGS---GDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDL--CDRTFSLKTVLMIAI 112

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK-----LSDFGLAK---DGPEGDKSH 277
                + ++H   K +IYRD K  N L+    N       + DF LAK   D     K H
Sbjct: 113 QLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKH 168

Query: 278 VSTR----IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 319
           +  R    + GT  Y +    +  HL    + R D+ + G + +  L G 
Sbjct: 169 IPYREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 45/226 (19%), Positives = 91/226 (40%), Gaps = 42/226 (18%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS--- 174
           R LG G F  V+    ++D+        VA+K+  GD  Y        E+  L  ++   
Sbjct: 25  RKLGWGHFSTVWL---AKDMVNN---THVAMKIVRGDKVY--TEAAEDEIKLLQRVNDAD 76

Query: 175 --------HPNLVKLIGY----CCEDEHRVLIYEFMA---RGSVENNLFSKVLLPLPWSI 219
                     +++KL+ +         H V+++E +       ++      + L     +
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY---V 133

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD------TDYNAKLSDFGLAKDGPEG 273
           + +I+     GL ++H     +I+ D K  N+L++           K++D G A    E 
Sbjct: 134 K-QISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191

Query: 274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             + + TR      Y +PE ++       +D++S   ++ E++TG 
Sbjct: 192 YTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 62.6 bits (153), Expect = 5e-11
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 42/227 (18%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-----RE--WLA 165
            +     +G G +G V+K     DL+ G + V  A+K        +G      RE   L 
Sbjct: 12  QYECVAEIGEGAYGKVFKA---RDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 166 EVIFLGHLSHPNLVKLI----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLL------P 214
               L    HPN+V+L         + E ++ L++E +     + +L     L       
Sbjct: 67  H---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----DQDL--TTYLDKVPEPG 116

Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEG 273
           +P      + F   +GL FLH     V++RD K  NIL+ +    KL+DFGLA+    + 
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174

Query: 274 DKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             +  V T       Y APE ++        D++S G +  E+   +
Sbjct: 175 ALTSVVVTL-----WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 62.2 bits (152), Expect = 5e-11
 Identities = 57/227 (25%), Positives = 89/227 (39%), Gaps = 40/227 (17%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW----LAEVI 168
            +     +G G +G VYK     D   G     VA+K     N   G        + EV 
Sbjct: 10  RYEPVAEIGVGAYGTVYKA---RDPHSGHF---VALKSVRVPNGGGGGGGLPISTVREVA 63

Query: 169 FLGHLS---HPNLVKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLL------P 214
            L  L    HPN+V+L+  C            L++E +     + +L  +  L       
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDL--RTYLDKAPPPG 116

Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEG 273
           LP      +     +GL FLH     +++RD K  NIL+ +    KL+DFGLA+    + 
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174

Query: 274 DKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             +  V T       Y APE ++        D++S G +  E+   +
Sbjct: 175 ALTPVVVTL-----WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 32/226 (14%)

Query: 108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAE 166
             +   +R  R +G G FG +Y G       E      VA+K+      +   H E    
Sbjct: 5   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEE------VAIKLECVKTKHPQLHIES--- 55

Query: 167 VIFLGHLSH-PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
                 +     +  +     E ++ V++ E +   S+E +LF+           + +A 
Sbjct: 56  -KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTVLLLAD 112

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK---LSDFGLAKD-GPEGDKSHVSTR 281
                + ++H   K  I+RD K  N L+          + DFGLAK         H+  R
Sbjct: 113 QMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170

Query: 282 ----IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 319
               + GT  YA+    +  HL    + R D+ S G VL+    G 
Sbjct: 171 ENKNLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 34/225 (15%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
                +  D ++G G FG V K +   D  E      VA+K+     ++    +   EV 
Sbjct: 51  KWMDRYEIDSLIGKGSFGQVVKAY---DRVEQ---EWVAIKIIKNKKAF--LNQAQIEVR 102

Query: 169 FLGHLSHP------NLVKLIGYCCEDEHRVLIYEFMARGSVENNLF------SKVLLPLP 216
            L  ++         +V L  +     H  L++E +       NL+      +   + L 
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-----SYNLYDLLRNTNFRGVSLN 157

Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGD 274
              R K A      L FL   E  +I+ D K  NILL     +  K+ DFG +    +  
Sbjct: 158 -LTR-KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215

Query: 275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
             ++ +R      Y +PE ++        D++S G +L+E+ TG 
Sbjct: 216 YQYIQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 56/305 (18%), Positives = 95/305 (31%), Gaps = 79/305 (25%)

Query: 76  EYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISE 135
           E   L S+ +E ED          +    D   +    +   R LG G F  V+    S 
Sbjct: 4   EEEILGSDDDEQEDPNDYCKGGYHLVKIGD---LFNGRYHVIRKLGWGHFSTVWL---SW 57

Query: 136 DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-----SHPN---LVKLIGY--- 184
           D++       VA+KV      Y        E+  L  +     + PN   +V+L+     
Sbjct: 58  DIQGKKF---VAMKVVKSAEHYTETALD--EIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112

Query: 185 -CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIY 243
                 H  +++E +    +   +       LP     KI     +GL +LH  +  +I+
Sbjct: 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH-TKCRIIH 170

Query: 244 RDFKTSNILLDTD----------------------------------------------- 256
            D K  NILL  +                                               
Sbjct: 171 TDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNA 230

Query: 257 --YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 314
                K++D G A    +     + TR      Y + E ++       +D++S   +  E
Sbjct: 231 EKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFE 285

Query: 315 ILTGR 319
           + TG 
Sbjct: 286 LATGD 290

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 50/238 (21%), Positives = 89/238 (37%), Gaps = 38/238 (15%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFI--SEDLREGLQPVPVAVKVHDGDNS--------YQ 158
           +  A ++    +G GGFGC+Y   +  SE +          VKV   DN         YQ
Sbjct: 32  MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAP---CVVKVEPSDNGPLFTELKFYQ 88

Query: 159 --GHREWLAEVIFLGHLSHPNLVKLIGY----CCEDEHRVLIYEFMARGSVENNLFSKVL 212
                E + + I    L +  + K  G          +R +I +      ++  ++    
Sbjct: 89  RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEANA 146

Query: 213 LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK--LSDFGLAKD- 269
                   ++++      L ++H  E   ++ D K SN+LL+     +  L D+GLA   
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

Query: 270 GPEGDKSHVSTR----IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 319
            PEG     +        GT  + +    +  H     + R D+   G  +++ LTG 
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 42/236 (17%), Positives = 86/236 (36%), Gaps = 42/236 (17%)

Query: 113 NFRQDRVLGGGGFGCVYKGF--ISEDLREGLQPVPVAVKV-------HDGDNSYQ--GHR 161
            ++          G +Y+     +     G Q    ++K+        +  N +Q     
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102

Query: 162 EWLAEVIFLGHLSHPNLVKLIGY-CCEDEHRVLIYEFMARGSVEN--NLFSKVLLPLPWS 218
             + +   L       +   +G+   +D++R L+   + R S+++  ++  K +L    S
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSER-S 160

Query: 219 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK--LSDFGLAK---DGPEG 273
           +   +A      L FLH  E   ++ +    NI +D +  ++  L+ +G A         
Sbjct: 161 VLQ-VACRLLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP---- 213

Query: 274 DKSHVSTR------IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 319
              HV+          G   + +    M  H     + RSD+ S G  +L+ L G 
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 40/227 (17%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
            +   +   +V+G G FG V K +   D +       VA+K+   +  +  HR+   E+ 
Sbjct: 94  HVAYRYEVLKVIGKGSFGQVVKAY---DHKVH---QHVALKMVRNEKRF--HRQAAEEIR 145

Query: 169 FLGHLSH------PNLVKLIGYCCEDEHRVLI--------YEFMARGSVENNLFSKVLLP 214
            L HL         N++ ++       H  +         YE +     + N F    LP
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELI-----KKNKFQGFSLP 200

Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA-KLSDFGLAKDGPE 272
           L   +R K A    + L  LH+    +I+ D K  NILL     +  K+ DFG +    +
Sbjct: 201 L---VR-KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254

Query: 273 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
              +++ +R      Y APE I+        D++S G +L E+LTG 
Sbjct: 255 RVYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 49/275 (17%), Positives = 93/275 (33%), Gaps = 52/275 (18%)

Query: 77  YSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISED 136
           +    S+  ++        + P       +  +    +   + +G GGFG +Y       
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMPFPEGKVLDD-MEGNQWVLGKKIGSGGFGLIYLA---FP 58

Query: 137 LREGLQPVPVAVKVHDGDNS--------YQ--GHREWLAEVIFLGHLSHPNLVKLIGY-- 184
             +  +     VKV   +N         YQ    ++ + + I    L +  +    G   
Sbjct: 59  TNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118

Query: 185 --CCEDEHRVLIYEFMARGSVE-----NNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLH 235
                  +R ++ E +    ++     N  F K  VL          +       L ++H
Sbjct: 119 TEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQ---------LGIRMLDVLEYIH 168

Query: 236 EAEKPVIYRDFKTSNILLDTDYNAK--LSDFGLAKD-GPEGDKSHVSTR----IMGTYGY 288
             E   ++ D K +N+LL      +  L+D+GL+    P G+             GT  +
Sbjct: 169 --ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEF 226

Query: 289 AAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 319
            +    +  H     + RSDV   G  +L  L G+
Sbjct: 227 TS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 46/172 (26%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLS- 174
            +VLG G  G V +     + R   +    A+K+  D   + +       EV      S 
Sbjct: 23  SQVLGLGINGKVLQI---FNKRTQEK---FALKMLQDCPKARR-------EVELHWRASQ 69

Query: 175 HPNLVKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--- 226
            P++V+++    E+ +       ++ E +  G  E  LFS++        R   AF    
Sbjct: 70  CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSRIQD------RGDQAFTERE 118

Query: 227 AA-------KGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA--KLSDFGLAK 268
           A+       + + +LH     + +RD K  N+L      NA  KL+DFG AK
Sbjct: 119 ASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 2e-06
 Identities = 50/323 (15%), Positives = 89/323 (27%), Gaps = 110/323 (34%)

Query: 29  ILD-------I-PFLF-CKLMKKTEMKKVQSFFQFQSISHCKESP------KDESPSEKA 73
           +L           F   CK++  T  K+V  F    + +H            DE  S   
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308

Query: 74  KK---EYSKLPS-----NP-------EEVED--LRRD-------SAANPLIAFT------ 103
           K        LP      NP       E + D     D            +I  +      
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP 368

Query: 104 ------YDELRIITANFRQD-----RVLGGGGFGCVY---------KGFISEDLREGL-- 141
                 +D L +    F         +L       +             +++  +  L  
Sbjct: 369 AEYRKMFDRLSV----FPPSAHIPTILL------SLIWFDVIKSDVMVVVNKLHKYSLVE 418

Query: 142 -QPVPVAVKVHDGDNSYQGHREWLAEVIFLGH---LSHPNLVKLIGYCCEDEHRVL---- 193
            QP    + +       +   E    +    H   + H N+ K   +  +D         
Sbjct: 419 KQPKESTISIPSIYLELKVKLENEYAL----HRSIVDHYNIPK--TFDSDDLIPPYLDQY 472

Query: 194 IYEFMAR--GSVEN----NLFSKVLLPLPWSIRMKI-----AFGAAKG-LAFLHEAEKPV 241
            Y  +     ++E+     LF  V L   + +  KI     A+ A+   L  L + +   
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVFLDFRF-LEQKIRHDSTAWNASGSILNTLQQLKF-- 529

Query: 242 IYRDFKTSNILLDTDYNAKLSDF 264
            Y+ +   N   D  Y   ++  
Sbjct: 530 -YKPYICDN---DPKYERLVNAI 548

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 4e-06
 Identities = 74/458 (16%), Positives = 140/458 (30%), Gaps = 140/458 (30%)

Query: 46  KKVQSFFQ--FQSISHCKESPKDESPSEKAKKEYSKLPSNPEEVEDLRR------DSAAN 97
           K + S F+  F     CK+   D   S  +K+E   +  + + V    R           
Sbjct: 19  KDILSVFEDAFVDNFDCKDVQ-DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEE 77

Query: 98  PLIAFTYDELRI--------ITANFRQ------------DRVLGGGGFGCVYKGFIS--- 134
            +  F  + LRI        I    RQ            DR+          K  +S   
Sbjct: 78  MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV--FAKYNVSRLQ 135

Query: 135 --EDLREGL---QPVPVAVKVHDGDNSYQGHREWLA-EVIFLGHLSHPNLVKL------- 181
               LR+ L   +P    V +  G     G + W+A +V     LS+    K+       
Sbjct: 136 PYLKLRQALLELRPAK-NVLID-GVLGS-G-KTWVALDVC----LSYKVQCKMDFKIFWL 187

Query: 182 -IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL------PWSIRMKIAFGAAKGLAFL 234
            +  C   E    + E +        L  ++            +I+++I    A+    L
Sbjct: 188 NLKNCNSPE---TVLEML------QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAK-LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 293
                    + ++   ++L    NAK  + F L        K  ++TR            
Sbjct: 239 KS-------KPYENCLLVLLNVQNAKAWNAFNL------SCKILLTTRFKQ--------- 276

Query: 294 IMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA------LPLLKEKKKL 347
            +T  L+  +  +         LT  +            L  +       LP  +E    
Sbjct: 277 -VTDFLSAATTTHISLDHHSMTLTPDEVKSL--------LLKYLDCRPQDLP--REVLT- 324

Query: 348 LNIIDPRLEGDYPVKGVHKAAMLA--------YHCLNHNPKARPLMRDIVDSLEP----- 394
               +PR      +  +  A  +         +  +N +     ++   ++ LEP     
Sbjct: 325 ---TNPRR-----LSII--AESIRDGLATWDNWKHVNCDKLTT-IIESSLNVLEPAEYRK 373

Query: 395 ----LQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQC 428
               L V P  A  P   ++++  +  K+++    ++ 
Sbjct: 374 MFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL 411

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 52/244 (21%), Positives = 83/244 (34%), Gaps = 58/244 (23%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
            +   +     LG G FG V +       +       VA+K+      Y        E+ 
Sbjct: 16  WLQERYEIVGNLGEGTFGKVVECLDHARGKS-----QVALKIIRNVGKY--REAARLEIN 68

Query: 169 FLGHLSHP------NLVKLIGYCCEDEHRVL--------IYEFMARGSVENNLFSKVLLP 214
            L  +           V +  +     H  +         +EF+     + N F     P
Sbjct: 69  VLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL-----KENNFQ----P 119

Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA-------------- 259
            P      +A+     L FLHE +  + + D K  NIL  ++++                
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177

Query: 260 ----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLE 314
               +++DFG A    E   + V+TR      Y  PE I+  G   P  DV+S G +L E
Sbjct: 178 NTSIRVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQP-CDVWSIGCILFE 231

Query: 315 ILTG 318
              G
Sbjct: 232 YYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 62/244 (25%), Positives = 95/244 (38%), Gaps = 58/244 (23%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
           +++A +     LG G FG V +     D + G +   VAVK+    + Y       +E+ 
Sbjct: 11  VLSARYEIVDTLGEGAFGKVVECI---DHKAGGR--HVAVKIVKNVDRY--CEAARSEIQ 63

Query: 169 FLGHLSHP------NLVKLIGYCCEDEHRVL--------IYEFMARGSVENNLFSKVLLP 214
            L HL+          V+++ +     H  +         Y+F+     + N F     P
Sbjct: 64  VLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFI-----KENGFL----P 114

Query: 215 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA-------------- 259
                  K+A+   K + FLH  +  + + D K  NIL   +DY                
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172

Query: 260 ----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLE 314
               K+ DFG A    E   + VSTR      Y APE I+  G   P  DV+S G +L+E
Sbjct: 173 NPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQP-CDVWSIGCILIE 226

Query: 315 ILTG 318
              G
Sbjct: 227 YYLG 230

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 45.6 bits (107), Expect = 1e-05
 Identities = 40/256 (15%), Positives = 70/256 (27%), Gaps = 70/256 (27%)

Query: 111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-------HDGDNSYQGHREW 163
           T   ++   +G G FG V++              PVA+K+           +  +   E 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIADHT--------PVAIKIIAIEGPDLVNGSHQKTFEEI 70

Query: 164 LAEVIFLGHL---------SHPNLVKLIGYCC---------------------------- 186
           L E+I    L              + L    C                            
Sbjct: 71  LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130

Query: 187 --EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYR 244
             +D+   ++ EF   G     + +K+      +    I       LA    + +   +R
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLS---SLATAKSILHQLTASLAVAEASLR-FEHR 186

Query: 245 DFKTSNILLDTDYNAKLSDFGLAKD------GPEGDKSHVSTRIMGTYG------YAAPE 292
           D    N+LL      KL      K       G +      +   +   G       +  E
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDE 246

Query: 293 YIMTGHLTPRSDVYSF 308
            + TG    + D+Y  
Sbjct: 247 DLFTGDGDYQFDIYRL 262

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.8 bits (104), Expect = 6e-05
 Identities = 59/249 (23%), Positives = 83/249 (33%), Gaps = 64/249 (25%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
           ++   F   R +G G FG V        +         AVKV      Y   R    E  
Sbjct: 32  LLNNAFLVIRKMGDGTFGRVLLCQ---HIDNKKY---YAVKVVRNIKKY--TRSAKIEAD 83

Query: 169 FLGHLSH-----PNLVKLIGYCCEDEHRVL--------IYEFMARGSVENNLFSKVLLPL 215
            L  + +      N+VK  G     +H  L        +YE +       N ++      
Sbjct: 84  ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEII-----TRNNYN----GF 134

Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA--------------- 259
                        K L +L +    + + D K  NILL D  +                 
Sbjct: 135 HIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192

Query: 260 ---------KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 309
                    KL DFG A    +   S ++TR      Y APE I+  G     SD++SFG
Sbjct: 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDVS-SDMWSFG 246

Query: 310 VVLLEILTG 318
            VL E+ TG
Sbjct: 247 CVLAELYTG 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	429
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.19
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.72
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.5
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.47
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.38
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.38
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.13
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.05
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.8
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.39
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.38
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.37
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.36
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.32
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.19
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.08
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.06
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.94
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.8
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.76
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.4
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.38
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.61
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.42
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.03
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.23
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.97

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-60  Score=449.82  Aligned_cols=266  Identities=26%  Similarity=0.373  Sum_probs=218.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +++++.+.||+|+||+||+|.+.... ....+..||||++.........++|.+|+.++++++|||||+++|+|.+++.+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~-~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPA-PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCc-cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            45677899999999999999875421 22335669999998765556677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      +||||||++|+|.++|..+.              ...++|..++.|+.|+|.||+|||+++  ||||||||+||||++++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCCC
Confidence            99999999999999996532              235899999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHh
Q 014189          258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~  336 (429)
                      .+||+|||+|+.....+.........||+.|||||++.++.|+.++|||||||++|||+| |..||.......   +...
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999987654433334455789999999999999999999999999999999999 899998765321   1111


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                          +          ......+.+..++..+.+|+.+||+.||++||||.||+++|+.+..
T Consensus       260 ----i----------~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          260 ----I----------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             ----H----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             ----H----------HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence                1          1111223456778899999999999999999999999999987643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.6e-60  Score=449.62  Aligned_cols=266  Identities=27%  Similarity=0.400  Sum_probs=212.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|.+.+.||+|+||.||+|.+.... ....+..||||++... .....++|.+|+++|++++|||||+++++|.+.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLL-PEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSC-C---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcc-cCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            56888899999999999999875421 1223566999999765 455667899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc
Q 014189          192 VLIYEFMARGSVENNLFSKV-------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN  258 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~  258 (429)
                      |||||||++|+|.+++....             ..+++|.+++.|+.|++.||+|||+.+  ||||||||+||||++++.
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCCc
Confidence            99999999999999997542             246999999999999999999999977  999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhH
Q 014189          259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~  337 (429)
                      +||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||........   ..  
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~--  271 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---ID--  271 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HH--
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HH--
Confidence            99999999997655444444456789999999999999999999999999999999999 9999987653221   11  


Q ss_pred             hhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                        .+..          ......+..++.++.+|+.+||+.||++||||+||+++|+.+...
T Consensus       272 --~i~~----------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 --CITQ----------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             --HHHH----------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --HHHc----------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence              0111          112234556778899999999999999999999999999988654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-59  Score=441.46  Aligned_cols=264  Identities=27%  Similarity=0.397  Sum_probs=209.7

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC-CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ..+++.+.+.||+|+||+||+|.+..+         ||||+++.. ......+.|.+|+.+|++++|||||++++++.+ 
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~~---------vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-  103 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHGD---------VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-  103 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSSE---------EEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECCc---------EEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence            346788899999999999999976432         899998754 345566789999999999999999999998864 


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +.++||||||++|+|.++|.... .++++.+++.|+.|+|.||+|||+++  ||||||||+||||++++.+||+|||+|+
T Consensus       104 ~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~  180 (307)
T 3omv_A          104 DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLAT  180 (307)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred             CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCce
Confidence            56899999999999999997654 36999999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ..............+||+.|||||++.+   +.|+.++|||||||+||||+||+.||...+......      ..+.   
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~------~~~~---  251 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII------FMVG---  251 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHH---
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH------HHHh---
Confidence            7654433334456789999999999964   468999999999999999999999998655322110      0010   


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                        .....+.+ ...+..++..+.+|+.+||+.||++||||.||+++|+.++..
T Consensus       252 --~~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          252 --RGYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             --TTCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             --cCCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence              11112211 223456778899999999999999999999999999888643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.8e-60  Score=447.01  Aligned_cols=265  Identities=27%  Similarity=0.387  Sum_probs=217.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|.+.+.||+|+||.||+|.+.... ....+..||||+++.. .....++|.+|+++|++++|||||+++++|.+++.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC-----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcc-cCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            57888999999999999999875421 1223567999999765 455677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEE
Q 014189          192 VLIYEFMARGSVENNLFSKV-----------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  260 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  260 (429)
                      +||||||++|+|.++|....           ...++|.+++.++.|++.||+|||+++  ||||||||+|||+++++.+|
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcEE
Confidence            99999999999999997542           346999999999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhh
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      |+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||........   ..    
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~----  241 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE----  241 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HH----
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----
Confidence            999999986544333333344679999999999999999999999999999999999 9999987653211   11    


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      .+..          ......+..++.++.+|+.+||+.||++|||+++|+..|+.+..
T Consensus       242 ~i~~----------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          242 CITQ----------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHc----------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            0111          11123455677889999999999999999999999999987653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.3e-59  Score=445.37  Aligned_cols=253  Identities=21%  Similarity=0.306  Sum_probs=208.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++++.||+|+||.||+|++..+++      .||||++.... .....+.|.+|+.+|++++|||||++++++.+++.
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGR------QYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCC------EEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCC------EEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            589999999999999999998766543      49999997653 44456778999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +|||||||+||+|.+++..+....+++..+..++.|++.||+|||+++  ||||||||+||||+.+|.+||+|||+|+..
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceee
Confidence            999999999999999998776667899999999999999999999987  999999999999999999999999999875


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ...  ....+..+||+.|||||++.+..|+.++|||||||++|||+||+.||...+....      .....         
T Consensus       176 ~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~---------  238 (350)
T 4b9d_A          176 NST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------VLKII---------  238 (350)
T ss_dssp             CHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHH---------
T ss_pred             cCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHH---------
Confidence            432  1223457899999999999999999999999999999999999999987653211      11111         


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       .... ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       239 -~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          239 -SGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -HTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -cCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             1010 12234567889999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-58  Score=445.00  Aligned_cols=277  Identities=28%  Similarity=0.350  Sum_probs=228.3

Q ss_pred             cChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCC-Cceee
Q 014189          102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVK  180 (429)
Q Consensus       102 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~  180 (429)
                      +..+++++..++|++.+.||+|+||.||+|.+.... .......||||.+.........+.|.+|+.+|.++.| ||||+
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~-~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID-KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSS-STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCC-cccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            445566677789999999999999999999876543 2334566999999887667777889999999999965 99999


Q ss_pred             eeeEEEeC-CeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 014189          181 LIGYCCED-EHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  245 (429)
Q Consensus       181 l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~D  245 (429)
                      ++++|.+. +.+++|||||++|+|.++|....              ...+++..+..++.|+|.||+|||+++  |||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRD  210 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  210 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCc
Confidence            99999764 57899999999999999997532              235899999999999999999999977  99999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 014189          246 FKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDK  324 (429)
Q Consensus       246 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~  324 (429)
                      |||+|||+++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999997765444344455789999999999999999999999999999999998 9999986


Q ss_pred             CChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          325 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      ......      ....+..          ......+..++.++.+|+.+||+.||++|||+.||+++|+.+..
T Consensus       291 ~~~~~~------~~~~i~~----------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          291 VKIDEE------FCRRLKE----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CCCSHH------HHHHHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHH------HHHHHHc----------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            543211      1111111          11223445667889999999999999999999999999988653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.6e-59  Score=435.91  Aligned_cols=250  Identities=22%  Similarity=0.284  Sum_probs=211.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||+||+|++..+++      .||+|++.+..  .......+.+|+++|++++|||||+++++|++++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~------~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSR------EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCC------EEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            579999999999999999998776544      49999987532  1223467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+|||||||+||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+.
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            9999999999999999997654  6999999999999999999999987  99999999999999999999999999997


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ...........+.+||+.|||||++.+..|+.++|||||||++|||+||+.||...+....      ...          
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~----------  245 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI------FAK----------  245 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH----------
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH----------
Confidence            7554443445568999999999999999999999999999999999999999986553211      011          


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV  389 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  389 (429)
                      +....  ..++...+.++.+|+.+||+.||++|||++|++
T Consensus       246 i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          246 IIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            11101  123445677899999999999999999999863

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.5e-58  Score=427.24  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=202.2

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe----C
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE----D  188 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~  188 (429)
                      |++.+.||+|+||.||+|.+..+.      ..||+|.+.... .......|.+|+.+|++++|||||+++++|.+    +
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETT------VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCC------eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            366788999999999999876654      349999986543 34456779999999999999999999999865    3


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-CCCcEEEeccCCC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFGLA  267 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla  267 (429)
                      +.+|||||||+||+|.+++....  .+++..+..++.|++.||+|||+++++||||||||+||||+ .++.+||+|||+|
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            56899999999999999997654  69999999999999999999999777799999999999998 4899999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      +....    ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||........  +.             
T Consensus       180 ~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~-------------  239 (290)
T 3fpq_A          180 TLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY-------------  239 (290)
T ss_dssp             GGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH-------------
T ss_pred             EeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HH-------------
Confidence            86432    12345789999999998865 699999999999999999999999976543211  00             


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..+.........+...+.++.+|+.+||+.||++|||++|+++|
T Consensus       240 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00111111111222345678999999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-57  Score=434.10  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=210.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ..|++.+.||+|+||.||+|++..+++      .||||++.... ....+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~------~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  146 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGK------LVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL  146 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCC------EEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            569999999999999999998776543      49999986542 22334577999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      |||||||+||+|.+++...   .+++..+..++.|++.||+|||+++  ||||||||+||||+.+|.+||+|||+|+...
T Consensus       147 ~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          147 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             EEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            9999999999999988753   5999999999999999999999988  9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ...  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+......       .      +....
T Consensus       222 ~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-------~------i~~~~  286 (346)
T 4fih_A          222 KEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------M------IRDNL  286 (346)
T ss_dssp             SSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------H------HHHSS
T ss_pred             CCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------H------HHcCC
Confidence            432  22456799999999999999999999999999999999999999998654322110       0      11111


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+.  ...+...+.++.+|+.+||+.||++|||++|+++|
T Consensus       287 ~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          287 PPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111  12234567889999999999999999999999987

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-57  Score=432.56  Aligned_cols=256  Identities=22%  Similarity=0.215  Sum_probs=208.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ..|++.++||+|+||.||+|++..++      ..||||+++....      +.+|+.+|+.++|||||++++++.+++.+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g------~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTG------FQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCC------CEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46888899999999999999876654      3499999976532      13699999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-cEEEeccCCCcCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLAKDG  270 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~  270 (429)
                      |||||||+||+|.+++....  .+++..+..++.|++.||+|||+++  ||||||||+||||+.+| .+||+|||+|+..
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            99999999999999997654  6999999999999999999999977  99999999999999988 6999999999876


Q ss_pred             CCCCCc---cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          271 PEGDKS---HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       271 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ......   ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.........      ......... 
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~~~-  274 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEPPP-  274 (336)
T ss_dssp             ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSCCG-
T ss_pred             cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCCCC-
Confidence            543211   1223468999999999999999999999999999999999999999765432110      011111000 


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                              ....+..++..+.+|+.+||+.||++|||+.|++++|......
T Consensus       275 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          275 --------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             --------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence                    0123445678899999999999999999999999998765443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.9e-56  Score=414.55  Aligned_cols=248  Identities=24%  Similarity=0.331  Sum_probs=194.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||+||+|.+..++      ..||+|++.+..  .......+.+|+.+|++++|||||++++++.+++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTG------QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTC------CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCC------CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            68999999999999999999876543      449999987643  2233467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+|+||||+ +|+|.+++..+.  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCee
Confidence            999999999 689999987654  6999999999999999999999988  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .....   ...+.+||+.|||||++.+..| +.++|||||||++|||+||+.||...+....      .....       
T Consensus       162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~------~~~i~-------  225 (275)
T 3hyh_A          162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL------FKNIS-------  225 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-------
T ss_pred             cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-------
Confidence            54322   2345789999999999998876 5899999999999999999999986543211      11100       


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ...  ...+...+.++.+|+.+||+.||++|||++|+++|
T Consensus       226 ---~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          226 ---NGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ---HTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ---cCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               000  12234567789999999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.9e-56  Score=435.34  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=210.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ..|++.+.||+|+||.||+|.+..+++      .||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~------~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  223 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGK------LVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL  223 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCC------EEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence            469999999999999999998776544      499999876532 2345578999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      |||||||+||+|.+++...   .+++..+..++.|++.||+|||+++  ||||||||+||||+.+|.+||+|||+|+...
T Consensus       224 ~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          224 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            9999999999999988654   5999999999999999999999988  9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ...  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||..........       .      +....
T Consensus       299 ~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-------~------i~~~~  363 (423)
T 4fie_A          299 KEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------M------IRDNL  363 (423)
T ss_dssp             SSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------H------HHHSC
T ss_pred             CCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------H------HHcCC
Confidence            432  22455799999999999999999999999999999999999999998655322110       0      11111


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+.+  ......+.++.+|+.+||..||++|||++|+++|
T Consensus       364 ~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          364 PPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111  1233567889999999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.3e-57  Score=423.97  Aligned_cols=253  Identities=27%  Similarity=0.317  Sum_probs=202.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||+||+|....+   ..++..||+|++.... .......+.+|+.+|++++|||||++++++.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISG---SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSS---TTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccC---CCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            5799999999999999999976432   2234569999987542 12223457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +|+|||||+||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||+|+..
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999999997654  6999999999999999999999988  999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ....  ....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.....      .          .+
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~------~----------~i  238 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM------T----------MI  238 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------H----------HH
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH------H----------HH
Confidence            4322  2234578999999999999999999999999999999999999999876532211      0          11


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                      ...  ....+...+.++.+|+.+||+.||++|||     ++|+++|
T Consensus       239 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          239 LKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             HcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            111  11234456788999999999999999998     4788875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-55  Score=417.74  Aligned_cols=273  Identities=23%  Similarity=0.299  Sum_probs=200.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC--
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  189 (429)
                      .+|.+.+.||+|+||+||+|.+.        +..||||++....  .....+..|+..+.+++|||||++++++.+++  
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--------g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~   72 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--------TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence            46888899999999999999864        2349999986532  22222335666667889999999999998654  


Q ss_pred             --eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceeCCCCCCcEEEcCCCcEEE
Q 014189          190 --HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA------EKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       190 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                        .+|||||||++|+|.+++...   +++|..+..++.|++.||+|||++      .++||||||||+||||+.++++||
T Consensus        73 ~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           73 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence              679999999999999999765   589999999999999999999986      235999999999999999999999


Q ss_pred             eccCCCcCCCCCCCc--cccccccCCcccccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCChhh----
Q 014189          262 SDFGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMTG------HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR----  329 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltG~~p~~~~~~~~----  329 (429)
                      +|||+|+........  ......+||+.|||||++.+.      .|+.++|||||||+||||+||.+||.......    
T Consensus       150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            999999865443221  122346899999999999754      47889999999999999999988775332110    


Q ss_pred             hhhHHHhHhhHHHhhhhhhhhcCCCCCCCC-ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          330 EQNLADWALPLLKEKKKLLNIIDPRLEGDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      ...........+. ........++.+.... ..+++..+.+|+.+||+.||++||||.||++.|+.+...
T Consensus       230 ~~~~~~~~~~~~~-~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          230 DLVPSDPSVEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTSCSSCCHHHHH-HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hcccccchHHHHH-HHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0000000000000 0011111222222111 234667899999999999999999999999999887654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.7e-55  Score=410.47  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=191.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC--
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  189 (429)
                      ++|++.+.||+|+||.||+|++..++      ..||+|++.........+.+.+|+.+|++++|||||+++++|.+.+  
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDD------CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTC------CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCC------CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            46999999999999999999876654      3499999876666666678999999999999999999999987544  


Q ss_pred             ----------eEEEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc
Q 014189          190 ----------HRVLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN  258 (429)
Q Consensus       190 ----------~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~  258 (429)
                                .+|+|||||++|+|.+++..+.. ...++..++.++.|++.||+|||+++  |+||||||+|||++.++.
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~  156 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDV  156 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCc
Confidence                      37999999999999999976543 23567778899999999999999987  999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCcc----------ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChh
Q 014189          259 AKLSDFGLAKDGPEGDKSH----------VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA  328 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~  328 (429)
                      +||+|||+|+.........          ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||..... 
T Consensus       157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-  232 (299)
T 4g31_A          157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-  232 (299)
T ss_dssp             EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred             EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-
Confidence            9999999998765432111          1234689999999999999999999999999999999997   7753211 


Q ss_pred             hhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          329 REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       ....             +..+..... .......+..+.+|+.+||+.||++|||+.|++++
T Consensus       233 -~~~~-------------~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          233 -RVRT-------------LTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             -HHHH-------------HHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHH-------------HHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             0000             001111000 00112334567889999999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-52  Score=408.58  Aligned_cols=270  Identities=21%  Similarity=0.284  Sum_probs=206.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  187 (429)
                      .++|++.+.||+|+||.||+|.+..+++      .||||++.... .......+++|+.+|+.++|||||++++++..  
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~------~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQ------QVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCC------EEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            4679999999999999999998766543      49999997653 33445678899999999999999999998753  


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          188 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       188 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                          .+.+|||||||+ |+|.+++....  ++++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEee
Confidence                367899999996 67999886543  7999999999999999999999988  99999999999999999999999


Q ss_pred             cCCCcCCCCCC--CccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          264 FGLAKDGPEGD--KSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       264 fgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      ||+|+......  ........+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..............
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~  281 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT  281 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998764321  12234457999999999998875 5699999999999999999999999876644322111100000


Q ss_pred             HH----------hhhhhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LK----------EKKKLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~----------~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..          ........+.+.....   .....+.++.+|+.+||..||++|||++|+++|
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00          0000000011110000   011346788999999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.5e-51  Score=398.14  Aligned_cols=270  Identities=21%  Similarity=0.237  Sum_probs=201.5

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      .+.++|++.+.||+|+||+||+|+++..   ..++..||+|.+.....   ...+.+|+++|+.+ +|||||+++++|.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~---~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQ---VGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBT---TSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEccc---CCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            4567899999999999999999976422   12345699999876532   34567899999988 69999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-CcEEEeccCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGL  266 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl  266 (429)
                      .+++|+||||+++|+|.+++.     .+++.++..++.|++.||+|||+++  |+||||||+|||++.+ +.+||+|||+
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            999999999999999999883     4899999999999999999999988  9999999999999877 7999999999


Q ss_pred             CcCCCCCCCc--------------------------cccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCC
Q 014189          267 AKDGPEGDKS--------------------------HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR  319 (429)
Q Consensus       267 a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~  319 (429)
                      |+........                          ...+..+||+.|+|||++.+. .|+.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            9754332110                          112345899999999999875 5899999999999999999999


Q ss_pred             CCCCCCChhhhh-hHHHhHhhH---HHhh------------------hhhh---hhcC---CC---------CCCCCChH
Q 014189          320 KSLDKSRPAREQ-NLADWALPL---LKEK------------------KKLL---NIID---PR---------LEGDYPVK  362 (429)
Q Consensus       320 ~p~~~~~~~~~~-~~~~~~~~~---~~~~------------------~~~~---~~~~---~~---------~~~~~~~~  362 (429)
                      .||......... .........   ....                  ....   ...+   +.         ........
T Consensus       245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            999655432111 000000000   0000                  0000   0000   00         00111224


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          363 GVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       363 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+.++.+|+.+||+.||++|||++|+++|
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            56788999999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.5e-51  Score=416.21  Aligned_cols=251  Identities=22%  Similarity=0.283  Sum_probs=202.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-----ChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-----SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      ++|++.++||+|+||.||+|.+..++      ..||+|++.+..     ..........++.+++.++|||||+++++|.
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg------~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTG------KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCC------CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            57999999999999999999876654      449999986431     1111222234466777889999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      +.+.+|||||||+||+|.++|....  .+++..+..++.|++.||+|||+++  ||||||||+||||+.+|++||+|||+
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccce
Confidence            9999999999999999999997654  6999999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      |+......    ..+.+||+.|||||++.. ..|+.++|||||||++|||++|.+||..........+.           
T Consensus       339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~-----------  403 (689)
T 3v5w_A          339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------  403 (689)
T ss_dssp             CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH-----------
T ss_pred             eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-----------
Confidence            98765432    345799999999999974 57999999999999999999999999753321111110           


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                        ..+...  ...++...+.++.+|+.+||+.||++|++     ++||++|
T Consensus       404 --~~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          404 --RMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             --HHHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             --HhhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence              011111  11234556788999999999999999998     6888876

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.4e-51  Score=415.74  Aligned_cols=254  Identities=22%  Similarity=0.259  Sum_probs=211.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+++      .||+|++.... ......+.+|+.+|+.++|||||+++++|.+++.
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~------~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGN------NFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCC------EEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            4689999999999999999998776544      49999987653 4455678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC--CcEEEeccCCCc
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAK  268 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~  268 (429)
                      +|||||||+||+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.+  +.+||+|||+|+
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~  305 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA  305 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred             EEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeecccee
Confidence            999999999999999986543 36999999999999999999999988  9999999999999854  899999999999


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......   .....+||+.|||||++.+..|+.++|||||||++|||++|..||...+.......      ..       
T Consensus       306 ~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~------i~-------  369 (573)
T 3uto_A          306 HLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN------VK-------  369 (573)
T ss_dssp             ECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------HH-------
T ss_pred             EccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH------HH-------
Confidence            865432   23457899999999999999999999999999999999999999987654221100      00       


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       ..+...........+.++.+|+.+||+.||++|||+.|+++|
T Consensus       370 -~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          370 -SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -TTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             001111112223457889999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-49  Score=380.46  Aligned_cols=284  Identities=39%  Similarity=0.683  Sum_probs=234.1

Q ss_pred             HHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeE
Q 014189          105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       105 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      .++...+++|++.+.||+|+||.||+|.+.+       +..||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~  103 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-------GAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGF  103 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTT-------CCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECC-------CCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3344567899999999999999999998542       3349999887653 3456678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      +.+.+..++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEEC
T ss_pred             EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEe
Confidence            999999999999999999999986543  235899999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      |||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||....+........|..... 
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-  260 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-  260 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-
Confidence            9999986543333333344678999999999999999999999999999999999999998765544444444433221 


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                      ....+...+++.+....+...+..+.+++.+||+.||++|||+.|++++|+.+....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            223344555666666667788999999999999999999999999999998876553

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.5e-48  Score=380.14  Aligned_cols=268  Identities=24%  Similarity=0.387  Sum_probs=221.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccc-cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+....+ ....+..||+|++...........+.+|+.+++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            4679999999999999999998754222 22345679999998776666677899999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVL--------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  254 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~  254 (429)
                      +.+|+||||+++|+|.+++.....              ..+++..++.++.|++.||+|||+++  |+||||||+|||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~  237 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT  237 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEEC
Confidence            999999999999999999976431              35889999999999999999999987  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 014189          255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNL  333 (429)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~  333 (429)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.........  
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~--  315 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--  315 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--
Confidence            999999999999986654333233344567899999999999999999999999999999999 99999865432110  


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                                     ..+........+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       316 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          316 ---------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             ---------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                           0011111223344567889999999999999999999999999988754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6e-49  Score=376.35  Aligned_cols=288  Identities=40%  Similarity=0.691  Sum_probs=233.7

Q ss_pred             CccccChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCc
Q 014189           98 PLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN  177 (429)
Q Consensus        98 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n  177 (429)
                      ....+++.++....++|++.+.||+|+||.||+|.+.+       +..||+|++...........+.+|+.+++.++|||
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~   88 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-------GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN   88 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-------SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTT
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC-------CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCC
Confidence            44568889999999999999999999999999996432       34599999876544434446889999999999999


Q ss_pred             eeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeCCCCCCcEE
Q 014189          178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEA---EKPVIYRDFKTSNIL  252 (429)
Q Consensus       178 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~~~ivH~Dlkp~NIl  252 (429)
                      |+++++++...+..++||||+++|+|.+++....  ..++++..+..++.|++.||+|||+.   +  |+||||||+|||
T Consensus        89 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil  166 (326)
T 3uim_A           89 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANIL  166 (326)
T ss_dssp             BCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEE
T ss_pred             ccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEE
Confidence            9999999999999999999999999999997653  33599999999999999999999997   6  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChh--hh
Q 014189          253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA--RE  330 (429)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~--~~  330 (429)
                      ++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......  ..
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  245 (326)
T 3uim_A          167 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD  245 (326)
T ss_dssp             ECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred             ECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence            99999999999999987644322 2334467999999999999999999999999999999999999999632111  11


Q ss_pred             hhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          331 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .....|...... ........+..+....+...+..+.+++.+||+.||++|||+.||+++|++..
T Consensus       246 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          246 VMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             SBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            222333322221 23344555666666677788999999999999999999999999999998743

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.4e-48  Score=370.43  Aligned_cols=268  Identities=24%  Similarity=0.410  Sum_probs=218.9

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+..   ....||+|++...........|.+|+.++++++||||+++++++.+.+.
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ---RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTS---CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCC---CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            4679999999999999999998765432   2456999999877666777889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            999999999999999986543 36999999999999999999999987  999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||..........                
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----------------  265 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS----------------  265 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH----------------
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH----------------
Confidence            543221 12223456888999999999999999999999999999999 999997654321110                


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE  401 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  401 (429)
                       .+........+..++..+.+|+.+||..||++|||+.+|++.|+.+...++.
T Consensus       266 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          266 -SVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             -HHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence             0011112233445678899999999999999999999999999998765443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.5e-48  Score=366.61  Aligned_cols=265  Identities=28%  Similarity=0.424  Sum_probs=208.5

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ....+|++.+.||+|+||.||+|.+.        +..||+|++.... .......|.+|+.++++++||||+++++++.+
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH--------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC--------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            44568999999999999999999753        2349999987654 34455678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      .+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+.+|+||||||+|||++.++.+||+|||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            9999999999999999999976432 238999999999999999999999766699999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ++......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........             
T Consensus       186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~-------------  250 (309)
T 3p86_A          186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA-------------  250 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-------------
T ss_pred             Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------
Confidence            98643321  123346799999999999999999999999999999999999999987654221110             


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                         ..........+...+..+.+|+.+||+.||++|||++++++.|+.+....
T Consensus       251 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          251 ---VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ---HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ---HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence               00001112334456778999999999999999999999999999887663

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=376.13  Aligned_cols=276  Identities=25%  Similarity=0.373  Sum_probs=226.8

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccc-cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEE
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  186 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  186 (429)
                      ...++|.+.+.||+|+||.||+|.+....+ .......||+|++...........+.+|+++++++ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            345789999999999999999998754332 22345669999998876677778899999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEE
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  252 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIl  252 (429)
                      ..+..++||||+++|+|.+++....              ...+++..+..++.|++.||+|||+.+  |+||||||+|||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl  223 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL  223 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEE
Confidence            9999999999999999999997654              235899999999999999999999987  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhh
Q 014189          253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQ  331 (429)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~  331 (429)
                      ++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987654433333444678899999999999999999999999999999999 99999865432110


Q ss_pred             hHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCC
Q 014189          332 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAP  403 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  403 (429)
                                       ..+........+..++..+.+|+.+||+.||++|||+++|+++|+++........
T Consensus       304 -----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          304 -----------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             -----------------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             -----------------HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence                             0011111222334567789999999999999999999999999999876544333

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.2e-48  Score=376.22  Aligned_cols=276  Identities=28%  Similarity=0.352  Sum_probs=223.4

Q ss_pred             cChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceee
Q 014189          102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVK  180 (429)
Q Consensus       102 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  180 (429)
                      +....+....++|++.+.||+|+||.||+|.+... .....+..||+|++...........+.+|+.++.++ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccc-cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            45556666778999999999999999999986442 123445679999998776666777899999999999 7999999


Q ss_pred             eeeEEEeCC-eEEEEEEecCCCChhhhhhcCCC-----------------------------------------------
Q 014189          181 LIGYCCEDE-HRVLIYEFMARGSVENNLFSKVL-----------------------------------------------  212 (429)
Q Consensus       181 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  212 (429)
                      +++++.+.+ ..++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998754 48999999999999999976432                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC
Q 014189          213 -----------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  275 (429)
Q Consensus       213 -----------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  275 (429)
                                       ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             12889999999999999999999987  99999999999999999999999999987654433


Q ss_pred             ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       276 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                      ........||+.|+|||++.+..++.++||||||+++|||+| |..||.........      .....      .    .
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~------~----~  312 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLK------E----G  312 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHH------H----T
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHH------c----C
Confidence            333445678999999999999999999999999999999998 99999765432110      00010      0    1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .....+...+..+.+++.+||+.||++|||++|++++|+.+.
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            112223445678999999999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.4e-47  Score=360.66  Aligned_cols=252  Identities=21%  Similarity=0.338  Sum_probs=209.4

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ..+|++.+.||+|+||.||+|.+..+      +..||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   91 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVAT------GQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTT------CCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCC------CcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence            46899999999999999999976554      3449999986542 2234567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            99999999999999998765   5899999999999999999999987  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|..||...........      .       ...
T Consensus       167 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~-------~~~  231 (297)
T 3fxz_A          167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------I-------ATN  231 (297)
T ss_dssp             CSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------H-------HHH
T ss_pred             CCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------H-------HhC
Confidence            54322  23446899999999999999999999999999999999999999986654321110      0       000


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .  ......+...+..+.+|+.+||+.||++|||++|++++
T Consensus       232 ~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          232 G--TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             C--SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             C--CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0  11112244567889999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-49  Score=381.86  Aligned_cols=270  Identities=28%  Similarity=0.377  Sum_probs=217.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+.... ....+..||+|++...........+.+|+.++++++||||+++++++.+...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMP-NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCC-CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            467999999999999999999865421 2234566999999876667777789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC---cEEEe
Q 014189          191 RVLIYEFMARGSVENNLFSKV-----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---NAKLS  262 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~  262 (429)
                      .++||||+++|+|.+++....     ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++   .+||+
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999997543     235899999999999999999999987  99999999999999555   59999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.........          
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~----------  296 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL----------  296 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------
Confidence            9999874322222222334578999999999999999999999999999999998 99999876532111          


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCC
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  400 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  400 (429)
                             ..+........+..++..+.+|+.+||+.||++|||+.+|+++|+.+...++
T Consensus       297 -------~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          297 -------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             -------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             -------HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence                   0000111122234566789999999999999999999999999998877654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-47  Score=366.00  Aligned_cols=250  Identities=25%  Similarity=0.351  Sum_probs=209.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .++|++.+.||+|+||.||+|.+..++      ..||+|++.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTG------REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            468999999999999999999876553      349999986543 3445567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            9999999999999999997654  5899999999999999999999987  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT-PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .....   .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+......      ...       
T Consensus       164 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~i~-------  227 (328)
T 3fe3_A          164 FTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE------RVL-------  227 (328)
T ss_dssp             GSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-------
T ss_pred             cCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHH-------
Confidence            54432   23457899999999999988775 89999999999999999999998765322110      000       


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ..  ....+...+..+.+|+.+||..||.+|||++|++++
T Consensus       228 ---~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          228 ---RG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---HC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---hC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               00  012233456788999999999999999999999987

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-47  Score=365.85  Aligned_cols=257  Identities=26%  Similarity=0.347  Sum_probs=207.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++...........+.+|+.+++.++||||+++++++.+.+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTE------EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCC------cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            468999999999999999999876543      34999998765444445668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeecccee
Confidence            999999999999999886543  5899999999999999999999987  999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+             
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~-------------  221 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-------------  221 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH-------------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH-------------
Confidence            43333333445789999999999987775 7899999999999999999999986543211 11111             


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                       .............+..+.+|+.+||+.||++|||++|++++-
T Consensus       222 -~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          222 -KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             -HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             -hcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence             011111111234567889999999999999999999999873

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=364.21  Aligned_cols=263  Identities=27%  Similarity=0.375  Sum_probs=212.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|.+.+.||+|+||.||+|.+..+.      ..||+|.+... .......|.+|+.++++++||||+++++++.+++.
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~------~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETG------EVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTC------CEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCC------cEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence            367899999999999999999876553      34999988654 45566789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             eEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            999999999999999997643 36999999999999999999999987  999999999999999999999999999865


Q ss_pred             CCCCCcc------------ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          271 PEGDKSH------------VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       271 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      .......            ......||+.|+|||++.+..++.++||||||+++|||++|..|+............ .  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-~--  235 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-N--  235 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-C--
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-h--
Confidence            4322111            112467999999999999999999999999999999999999998754332111000 0  


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                              .....+.    ..+..++..+.+++.+||+.||++|||+.++++.|+.++..
T Consensus       236 --------~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          236 --------VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             --------HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                    0000000    11223455688999999999999999999999999988653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.3e-48  Score=379.93  Aligned_cols=263  Identities=24%  Similarity=0.371  Sum_probs=215.3

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ...++|.+.+.||+|+||.||+|.+..+.      ..||+|++...........|.+|+.++++++||||+++++++...
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADN------TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTC------CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCC------eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            34568999999999999999999876543      349999988665555566788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            99999999999999999987543 35899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ...............+++.|+|||.+.+..++.++|||||||++|||+| |..||.........                
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~----------------  325 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR----------------  325 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH----------------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------
Confidence            6443211111112345778999999999999999999999999999998 99999876532211                


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                       ..+........+..++..+.+|+.+||+.||++|||++++++.|+.++.
T Consensus       326 -~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          326 -EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             -HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence             1111111223344567789999999999999999999999999987653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.3e-48  Score=368.06  Aligned_cols=273  Identities=26%  Similarity=0.334  Sum_probs=208.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  189 (429)
                      .++|++.++||+|+||.||+|.+.+        ..||+|++...  ......+..|+.++++++||||+++++++.... 
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLLN--------EYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEETT--------EEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhheecccCceEEEEEEECC--------CEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            4689999999999999999997642        34999998654  233345567899999999999999999998744 


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceeCCCCCCcEEEcCC
Q 014189          190 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA----------EKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       190 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----------~~~ivH~Dlkp~NIll~~~  256 (429)
                         .+++||||+++|+|.+++...   .+++..+..++.|++.||+|||+.          +  |+||||||+|||++.+
T Consensus        93 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           93 VDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT
T ss_pred             CCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC
Confidence               479999999999999999764   489999999999999999999987          6  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhh
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ  331 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~  331 (429)
                      +.+||+|||+++...............||+.|+|||++.+     ..++.++|||||||++|||+||+.||.........
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            9999999999976554333333344689999999999986     35677899999999999999999999765432211


Q ss_pred             hHHHhHhhH--HHh--hhhhhhhcCCCCCCC-CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          332 NLADWALPL--LKE--KKKLLNIIDPRLEGD-YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       332 ~~~~~~~~~--~~~--~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      .........  ...  .........+.+... .....+..+.+|+.+||+.||++|||+.++++.|+.++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            111110000  000  000011111111111 1224567799999999999999999999999999887643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.4e-47  Score=362.92  Aligned_cols=267  Identities=29%  Similarity=0.401  Sum_probs=220.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ...+|.+.+.||+|+||.||+|.+.... ....+..||+|++...........+.+|+.+++.++||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLK-GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGG-GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccC-cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            3568999999999999999999875432 123346699999987766667788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVL----------------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFK  247 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlk  247 (429)
                      ..++||||+++|+|.+++.....                      ..+++..+..++.|++.||+|||+++  |+|||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dik  177 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLA  177 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccccc
Confidence            99999999999999999976432                      24889999999999999999999987  9999999


Q ss_pred             CCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 014189          248 TSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSR  326 (429)
Q Consensus       248 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~  326 (429)
                      |+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654333223334567889999999999999999999999999999999 999998655


Q ss_pred             hhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          327 PAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      ......                 .+........+...+..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       258 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          258 PERLFN-----------------LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             GGGHHH-----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHH-----------------HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            321110                 00011112234456788999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.2e-48  Score=369.28  Aligned_cols=264  Identities=25%  Similarity=0.399  Sum_probs=208.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+.+.  ....||+|.+...........|.+|+.++++++||||+++++++.+.. 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCce--EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            35799999999999999999987654332  234478998876655566678999999999999999999999998755 


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            789999999999999997654 36999999999999999999999987  999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .............||+.|+|||++.+..++.++|||||||++|||+| |+.||.........                 .
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----------------~  230 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------------S  230 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----------------H
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-----------------H
Confidence            44333333344567889999999999999999999999999999999 99999865432211                 1


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      .+........+..++..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            111111223344567789999999999999999999999999987654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.5e-46  Score=355.06  Aligned_cols=286  Identities=36%  Similarity=0.626  Sum_probs=228.1

Q ss_pred             CccccChHHHHHHhcCCccc------eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC---ChhhHHHHHHHHH
Q 014189           98 PLIAFTYDELRIITANFRQD------RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVI  168 (429)
Q Consensus        98 ~~~~~~~~~~~~~~~~y~~~------~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~  168 (429)
                      +...|++.++..++++|...      +.||+|+||.||+|.+.        +..||+|++....   .......+.+|+.
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~E~~   82 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--------NTTVAVKKLAAMVDITTEELKQQFDQEIK   82 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--------SCEEEEEEECCCTTSCTTTHHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--------CceEEEEEEecccCcchHHHHHHHHHHHH
Confidence            34568889999999988776      89999999999999752        2349999986532   2344567889999


Q ss_pred             HHhccCCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 014189          169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK-VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFK  247 (429)
Q Consensus       169 ~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlk  247 (429)
                      +++.++||||+++++++.+.+..++||||+++|+|.+++... ...++++..+..++.|++.||+|||+.+  ++|||||
T Consensus        83 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlk  160 (307)
T 2nru_A           83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIK  160 (307)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCC
T ss_pred             HHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCC
Confidence            999999999999999999999999999999999999988643 2346999999999999999999999987  9999999


Q ss_pred             CCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCh
Q 014189          248 TSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP  327 (429)
Q Consensus       248 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~  327 (429)
                      |+|||++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||.....
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            9999999999999999999987654333333344679999999998865 589999999999999999999999986543


Q ss_pred             hhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          328 AREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      ...  ...+..........+...+++.+ ...+...+..+.+++.+||+.||++|||+++++++|+.+..
T Consensus       240 ~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          240 PQL--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SSB--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hHH--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            211  11111111111222333444433 23456778899999999999999999999999999988754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.9e-47  Score=366.31  Aligned_cols=253  Identities=23%  Similarity=0.283  Sum_probs=208.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-----hhHHHHHHHHHHHhccCCCceeeeeeE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      +.++|++.+.||+|+||.||+|.+..++      ..||+|++......     .....+.+|+.+|+.++||||++++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~------~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTG------LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCC------CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            4578999999999999999999876543      34999998764322     134678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC----cEE
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAK  260 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~----~~k  260 (429)
                      +.+.+..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEE
Confidence            999999999999999999999996543  6999999999999999999999987  99999999999998877    799


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      |+|||++.......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.........         
T Consensus       160 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~---------  227 (361)
T 2yab_A          160 LIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---------  227 (361)
T ss_dssp             ECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---------
T ss_pred             EEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---------
Confidence            99999998765432   234468999999999999999999999999999999999999999865432111         


Q ss_pred             HHhhhhhhhhcCCCC--CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRL--EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                             ..+.....  ........+..+.+|+.+||..||++|||+.|++++
T Consensus       228 -------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          228 -------ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             -------HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------HHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                   00110000  000112346788999999999999999999999976

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-47  Score=366.12  Aligned_cols=271  Identities=26%  Similarity=0.349  Sum_probs=219.3

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ....++|++.+.||+|+||.||+|.+.... ....+..||+|++...........|.+|+.++++++||||+++++++.+
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSS-TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcC-CCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            344578999999999999999999876421 1123456999999877666667789999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKV----------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  245 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~D  245 (429)
                      .+..++||||+++|+|.+++....                      ...+++..++.++.|++.||+|||+++  |+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~D  199 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRD  199 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence            999999999999999999997642                      146899999999999999999999987  99999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 014189          246 FKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDK  324 (429)
Q Consensus       246 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~  324 (429)
                      |||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999875433222222334578999999999999999999999999999999999 9999986


Q ss_pred             CChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          325 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      .......                ..+.+.. ....+..++..+.+|+.+||+.||++|||+.+++++|+.+...
T Consensus       280 ~~~~~~~----------------~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          280 MAHEEVI----------------YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             SCHHHHH----------------HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CChHHHH----------------HHHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            5432110                0001111 1123345667899999999999999999999999999988764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-46  Score=361.71  Aligned_cols=250  Identities=24%  Similarity=0.299  Sum_probs=207.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+..++      ..||+|++....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~   78 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATG------RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCC------CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence            57999999999999999999876543      449999986531  1223456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            9999999999999999887643  6899999999999999999999987  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .....  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.....      ....        
T Consensus       155 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~--------  218 (337)
T 1o6l_A          155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELIL--------  218 (337)
T ss_dssp             SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH--------
T ss_pred             cccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH------HHHH--------
Confidence            43322  1234578999999999999999999999999999999999999999865432110      0000        


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                        ...  ...+...+.++.+|+.+||+.||++||     +++|+++|
T Consensus       219 --~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          219 --MEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --HCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --cCC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence              001  123345677899999999999999999     89999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-47  Score=367.50  Aligned_cols=263  Identities=24%  Similarity=0.406  Sum_probs=209.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||+|.+..+...  ....||+|.+...........+.+|+.+++.++||||+++++++. .+..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGES--IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCS--CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCce--EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            5799999999999999999987654322  234488888865544444455678999999999999999999886 4568


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999987652 36888999999999999999999987  9999999999999999999999999998776


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ............||..|+|||++.+..++.++||||||+++|+|++ |..||...........                 
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-----------------  229 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-----------------  229 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-----------------
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-----------------
Confidence            5444334455678889999999999999999999999999999999 9999986543221111                 


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      +........+..++..+.+++.+||..||++|||+++++++|+.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          230 LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             HHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            00011112233345567889999999999999999999999988754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.7e-47  Score=370.73  Aligned_cols=265  Identities=24%  Similarity=0.398  Sum_probs=205.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ..+|++.+.||+|+||.||+|.+....   ..+..||+|++...........|.+|+.++++++||||+++++++.+.+.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPS---KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTT---SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCC---CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            457999999999999999999765321   22455999999876666667789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999999997543 46999999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........                 
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~-----------------  260 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-----------------  260 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH-----------------
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------
Confidence            543211 11122345788999999999999999999999999999998 99999765432110                 


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      ..+........+..++..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            00111111222345678899999999999999999999999999887543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-46  Score=354.57  Aligned_cols=266  Identities=23%  Similarity=0.330  Sum_probs=211.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC--CChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++...  ........|.+|+.++++++||||+++++++.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILN------IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTC------SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCC------CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            4568999999999999999999866543      34999987543  234455778899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+..++||||+++|+|.+++....  ++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            999999999999999999997654  6899999999999999999999987  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........      ....      
T Consensus       159 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~------  225 (294)
T 4eqm_A          159 KALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHI------  225 (294)
T ss_dssp             TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHH------
T ss_pred             cccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHh------
Confidence            87644321 1233467999999999999999999999999999999999999999876532210      0000      


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-CHHHHHHhcccccCCC
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-LMRDIVDSLEPLQVLP  399 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~  399 (429)
                      .. ..+......+...+..+.+++.+||+.||++|| +++++.+.|+.+....
T Consensus       226 ~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          226 QD-SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             SS-CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             hc-cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            00 000001112234567899999999999999999 9999999998876653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5e-47  Score=360.59  Aligned_cols=270  Identities=26%  Similarity=0.358  Sum_probs=220.4

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      ...++|++.+.||+|+||.||+|.+... .....+..||+|++...........+.+|+.+++++ +||||+++++++..
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGL-IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeec-cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            3456899999999999999999986432 122335669999998776666677899999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcE
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVL----------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  251 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NI  251 (429)
                      .+..++||||+++|+|.+++.....                ..+++..+..++.|++.||+|||+++  ++||||||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Ni  176 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI  176 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceE
Confidence            9999999999999999999976542                24899999999999999999999987  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhh
Q 014189          252 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE  330 (429)
Q Consensus       252 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~  330 (429)
                      |++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||........
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            999999999999999987665443333344567889999999999999999999999999999999 9999976543211


Q ss_pred             hhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          331 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                        ..    ....      .    ......+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       257 --~~----~~~~------~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          257 --FY----KMIK------E----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             --HH----HHHH------H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HH----HHhc------c----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence              00    0010      1    11112233456789999999999999999999999999987654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-47  Score=366.12  Aligned_cols=272  Identities=25%  Similarity=0.369  Sum_probs=215.5

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      ...++|++.+.||+|+||.||+|.+.... ....+..||+|++...........+.+|+.+++++ +||||+++++++..
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGIS-KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCS-SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccc-cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34578999999999999999999874321 12235569999998654445557788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVL---------------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF  246 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dl  246 (429)
                      .+..++||||+++|+|.+++.....                     ..+++..+..++.|++.||+|||+++  |+||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Di  198 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDL  198 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTC
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCC
Confidence            9999999999999999999976532                     24789999999999999999999987  999999


Q ss_pred             CCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 014189          247 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKS  325 (429)
Q Consensus       247 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~  325 (429)
                      ||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999986654333333344567889999999999999999999999999999998 99999765


Q ss_pred             ChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          326 RPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                      .....  .              ...+........+...+..+.+|+.+||..||.+|||+.+++++|+.+....
T Consensus       279 ~~~~~--~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          279 PVDAN--F--------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCSHH--H--------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CcHHH--H--------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            43211  0              0111111122234456778999999999999999999999999998876553

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=363.10  Aligned_cols=265  Identities=25%  Similarity=0.391  Sum_probs=209.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ..+|++.+.||+|+||.||+|.+..+.+.  ....|++|.+...........+.+|+.++++++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCS--CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCce--EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            36799999999999999999987655432  233478888876655566778899999999999999999999998765 


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++|+||+.+|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            789999999999999997654 36899999999999999999999987  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .............||+.|+|||++.+..++.++|||||||++|||++ |..||.........                 .
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-----------------~  230 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------------S  230 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----------------H
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----------------H
Confidence            54333333334567889999999999999999999999999999999 99999866532211                 1


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      .+........+..++..+.+++.+||..||++|||++|+++.|+.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            1111112223445677899999999999999999999999999887653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=370.21  Aligned_cols=257  Identities=21%  Similarity=0.250  Sum_probs=209.4

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .+.++|++.+.||+|+||.||+|.+..++      ..+|+|++..... ......+.+|+.+++.++||||+++++++.+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~------~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   81 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAG------QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE   81 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTT------EEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCC------cEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence            35678999999999999999999876554      4499999876543 3445678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc---CCCcEEEecc
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD---TDYNAKLSDF  264 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~---~~~~~kl~Df  264 (429)
                      .+..|+||||+++|+|.+.+....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++   .++.+||+||
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccC
Confidence            999999999999999999997764  6999999999999999999999987  99999999999998   5688999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      |++........  ......||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.....      .....  
T Consensus       158 G~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~--  227 (444)
T 3soa_A          158 GLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY------QQIKA--  227 (444)
T ss_dssp             SSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHH--
T ss_pred             ceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH------HHHHh--
Confidence            99987654322  234468999999999999999999999999999999999999999765432111      00000  


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          .  ............+..+.+|+.+||+.||++|||+.|++++
T Consensus       228 ----~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          228 ----G--AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ----T--CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----C--CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                0  0011111123457789999999999999999999999987

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.2e-46  Score=361.79  Aligned_cols=256  Identities=21%  Similarity=0.290  Sum_probs=209.4

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .+.++|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   99 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTG------LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   99 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCC------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            34578999999999999999999876553      349999987653 34455678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC---cEEEecc
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---NAKLSDF  264 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~Df  264 (429)
                      .+..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++   .+||+||
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A          100 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeec
Confidence            999999999999999999886553  6899999999999999999999987  99999999999998654   5999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      |++.......   ......||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.....      .... . 
T Consensus       176 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------~~i~-~-  244 (362)
T 2bdw_A          176 GLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY------AQIK-A-  244 (362)
T ss_dssp             TTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-H-
T ss_pred             CcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-h-
Confidence            9998765432   223468999999999999999999999999999999999999999865432110      0000 0 


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          .  ............+..+.+|+.+||+.||++|||+.+++++
T Consensus       245 ----~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          245 ----G--AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----T--CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----C--CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0  0001111123457789999999999999999999999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=358.12  Aligned_cols=255  Identities=23%  Similarity=0.297  Sum_probs=207.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-----hhHHHHHHHHHHHhccCCCceeeeeeE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++......     .....+.+|+.+++.++||||++++++
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   82 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTG------LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   82 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTC------CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCC------cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            3467999999999999999999876543      34999998754321     235678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC----cEE
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAK  260 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~----~~k  260 (429)
                      +.+.+..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++    .+|
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           83 YENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEE
Confidence            99999999999999999999998654  36999999999999999999999987  99999999999999888    799


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      |+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........      .
T Consensus       159 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------~  229 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN------V  229 (326)
T ss_dssp             ECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------H
T ss_pred             EEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH------H
Confidence            999999987643321   2346799999999999999999999999999999999999999976543211100      0


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..        .............+..+.+|+.+||..||++|||++|++++
T Consensus       230 ~~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          230 SA--------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HH--------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             Hh--------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00        00000000112345778999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-46  Score=352.31  Aligned_cols=262  Identities=24%  Similarity=0.352  Sum_probs=203.5

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||.||+|.+..+..   ....||+|.............+.+|+.++++++||||+++++++. ++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence            34689999999999999999998754322   245699999887666666778999999999999999999999984 56


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccccc
Confidence            7899999999999999997653 36899999999999999999999987  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.........   .             
T Consensus       166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~-------------  228 (281)
T 1mp8_A          166 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G-------------  228 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H-------------
T ss_pred             cCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---H-------------
Confidence            644321 12233457889999999999999999999999999999997 99999865432110   0             


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .+.. ......+..++..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       229 ~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          229 RIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0000 0111234456788999999999999999999999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.5e-46  Score=366.39  Aligned_cols=258  Identities=25%  Similarity=0.353  Sum_probs=205.4

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      .++|++.++||+|+||.||+|.+..+.      ..||+|++.+..  .......+..|..++.++ +||||+++++++.+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~------~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~  124 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTD------RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT  124 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence            467999999999999999999876653      449999987542  222334567899999877 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+.+|+||||+++|+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla  200 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC  200 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeeccee
Confidence            999999999999999999987653  6999999999999999999999987  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh--hhHHHhHhhHHHhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE--QNLADWALPLLKEKK  345 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~  345 (429)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........  .........      
T Consensus       201 ~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~------  272 (396)
T 4dc2_A          201 KEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ------  272 (396)
T ss_dssp             BCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH------
T ss_pred             eecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH------
Confidence            8643222  224557899999999999999999999999999999999999999975432111  111111111      


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH------HHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM------RDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~  391 (429)
                         .+...  ....+...+..+.+|+.+||+.||++||++      +||++|
T Consensus       273 ---~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          273 ---VILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             ---HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             ---HHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence               11111  112344567889999999999999999985      688776

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7e-47  Score=361.53  Aligned_cols=275  Identities=26%  Similarity=0.383  Sum_probs=199.3

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ...++|++.+.||+|+||.||+|.+..+..   ....||+|++.... .......+.+|+.++++++||||+++++++..
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDG---SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCC---cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            345689999999999999999998665432   12359999987643 33456778999999999999999999999987


Q ss_pred             CCeE------EEEEEecCCCChhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC
Q 014189          188 DEHR------VLIYEFMARGSVENNLFSKV----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       188 ~~~~------~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      ....      ++||||+++|+|.+++....    ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTS
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCC
Confidence            6655      99999999999999885432    225899999999999999999999987  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHh
Q 014189          258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~  336 (429)
                      .+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |..||..........    
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----  250 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN----  250 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH----
Confidence            999999999987654433333334567889999999999999999999999999999999 999998655322110    


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCCCC
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP  405 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p  405 (429)
                                  .+.. ......+...+..+.+|+.+||+.||++|||+.++++.|+.+..-+...+..
T Consensus       251 ------------~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          251 ------------YLIG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             ------------HHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             ------------HHhc-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence                        0000 1112234456678999999999999999999999999999887665444433

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-46  Score=350.19  Aligned_cols=257  Identities=25%  Similarity=0.407  Sum_probs=211.4

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+       ..||+|++.....  ....+.+|+.++++++||||+++++++.+.+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   79 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-------EEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hhhceeeheecCCCccEEEEEEecCC-------CeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence            46799999999999999999987542       2399999986533  33568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           80 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccc
Confidence            999999999999999986543 36899999999999999999999987  999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........             ...
T Consensus       157 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~-------------~~~  222 (269)
T 4hcu_A          157 LDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------------IST  222 (269)
T ss_dssp             CCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------------HHT
T ss_pred             cccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-------------Hhc
Confidence            4321 112233567888999999999999999999999999999999 9999986553211000             000


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                          ......+...+..+.+++.+||+.||++|||+++++++|+.+..
T Consensus       223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          223 ----GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                11122233456789999999999999999999999999988754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=364.07  Aligned_cols=251  Identities=27%  Similarity=0.346  Sum_probs=203.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|..++..+ +||||+++++++.+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~   95 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETG------DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT   95 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCC------CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe
Confidence            478999999999999999999876553      349999987532  222345677899999988 69999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+..|+||||+++|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccce
Confidence            999999999999999999987654  6899999999999999999999987  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.....                
T Consensus       172 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~----------------  233 (353)
T 3txo_A          172 KEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF----------------  233 (353)
T ss_dssp             BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------
T ss_pred             eecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH----------------
Confidence            8643322  2234578999999999999999999999999999999999999999876532110                


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH------HHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM------RDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~  391 (429)
                      ..+....  ..++...+..+.+|+.+||+.||++||++      +++++|
T Consensus       234 ~~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          234 EAILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             HHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            0111111  12234456789999999999999999998      788875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-46  Score=358.15  Aligned_cols=254  Identities=18%  Similarity=0.212  Sum_probs=208.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..+|+|.+...  ......+.+|+.+++.++||||+++++++.+.+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   74 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSK------KTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESME   74 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCC------cEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence            3468999999999999999999876553      44999998754  234456789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC--CCcEEEeccCCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--DYNAKLSDFGLA  267 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla  267 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.  ++.+||+|||++
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a  151 (321)
T 1tki_A           75 ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             EEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence            9999999999999999986543 36899999999999999999999987  999999999999997  789999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      .......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........      .......   
T Consensus       152 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~~---  219 (321)
T 1tki_A          152 RQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII------ENIMNAE---  219 (321)
T ss_dssp             EECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTC---
T ss_pred             eECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHHcCC---
Confidence            8765432   233467999999999999988999999999999999999999999865532111      0000000   


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         .  ..........+.++.+|+.+||..||++|||+.|++++
T Consensus       220 ---~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          220 ---Y--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ---C--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---C--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               0  00000012346789999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.1e-47  Score=362.93  Aligned_cols=274  Identities=27%  Similarity=0.403  Sum_probs=220.9

Q ss_pred             HHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeE
Q 014189          105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       105 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      +++....++|++.+.||+|+||.||+|.+.... ....+..||+|.+...........+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVV-KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEE-TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCcc-CCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            344556678999999999999999999875321 1123456999999877666667789999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKV--------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      +.+.+..++||||+++|+|.+++....        ..++++..+..++.|++.||+|||+++  |+||||||+|||++.+
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED  174 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence            999999999999999999999986421        235789999999999999999999987  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHH
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~  335 (429)
                      +.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||..........   
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---  251 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR---  251 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH---
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH---
Confidence            9999999999986543222222333567899999999999999999999999999999999 889998654321110   


Q ss_pred             hHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                                   .+.... ....+..++..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus       252 -------------~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          252 -------------FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             -------------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             -------------HHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                         000101 1122345677899999999999999999999999999887553

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-45  Score=352.52  Aligned_cols=250  Identities=24%  Similarity=0.316  Sum_probs=206.4

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEE
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  193 (429)
                      |...+.||+|+||.||+|.+..++      ..||||++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  119 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSG------RQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV  119 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCC------cEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence            677789999999999999876543      349999987653 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCC
Q 014189          194 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  273 (429)
Q Consensus       194 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  273 (429)
                      ||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++......
T Consensus       120 v~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          120 LMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             EECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence            99999999999988643   5899999999999999999999977  999999999999999999999999999865442


Q ss_pred             CCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCC
Q 014189          274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  353 (429)
Q Consensus       274 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (429)
                      ..  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........             .+.....+
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~-------------~~~~~~~~  259 (321)
T 2c30_A          195 VP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-------------RLRDSPPP  259 (321)
T ss_dssp             SC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------HHHHSSCC
T ss_pred             cc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHhcCCCC
Confidence            21  2344689999999999999999999999999999999999999998654321100             01111111


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          354 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       354 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      .+  ......+..+.+++.+||+.||++|||+++++++-
T Consensus       260 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          260 KL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             CC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             Cc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            11  11234567899999999999999999999999873

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-46  Score=359.61  Aligned_cols=269  Identities=25%  Similarity=0.397  Sum_probs=219.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccc-cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+....+ ....+..||+|++...........+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            4689999999999999999998754322 22345669999998776666777899999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVL--------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  254 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~  254 (429)
                      +..++||||+++|+|.+++.....              ..+++..++.++.|++.||+|||+.+  |+||||||+|||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT  191 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEc
Confidence            999999999999999999976432              24889999999999999999999987  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 014189          255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNL  333 (429)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~  333 (429)
                      .++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||.........  
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--  269 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--  269 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH--
Confidence            999999999999987654332222334567889999999999899999999999999999999 99999865432110  


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                       .    .+.      ..    .....+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       270 -~----~~~------~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          270 -K----LLK------EG----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             -H----HHH------HT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -H----HHh------cC----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             0    010      00    11122345667899999999999999999999999999988654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-46  Score=379.70  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=219.9

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      +.....+|++.+.||+|+||.||+|.+....      ..||+|++.....  ....|.+|+.+|++++||||+++++++.
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~  286 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCT  286 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGT------EEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCC------eEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            3445567999999999999999999876543      4499999876532  4567899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      ..+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus       287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccc
Confidence            9999999999999999999998766667999999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ++...... ........+|..|+|||++.+..++.++|||||||++|||+| |..||.........              
T Consensus       365 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~--------------  429 (495)
T 1opk_A          365 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--------------  429 (495)
T ss_dssp             EECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--------------
T ss_pred             ceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH--------------
Confidence            98764322 122233456789999999999999999999999999999999 99999876532110              


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                         +.+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       430 ---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          430 ---ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             ---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             ---HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence               11111222334456678899999999999999999999999999987543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.5e-46  Score=348.09  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=211.9

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+       ..||+|++.....  ....+.+|+.++.+++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQ-------YDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP   77 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeeeccCCCceEEEEEecCc-------eeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence            46799999999999999999976542       2399999876532  34568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             eEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceec
Confidence            999999999999999987643 35899999999999999999999987  999999999999999999999999999866


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........             ...
T Consensus       155 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------------~~~  220 (268)
T 3sxs_A          155 LDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-------------VSQ  220 (268)
T ss_dssp             CTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------------HHT
T ss_pred             chhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-------------HHc
Confidence            54322 22233557788999999999899999999999999999999 9999986653221100             000


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                          ......+...+..+.+++.+||+.||++|||+.+++++|+.++..
T Consensus       221 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          221 ----GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ----CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                011112233467789999999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.1e-46  Score=355.81  Aligned_cols=264  Identities=18%  Similarity=0.171  Sum_probs=208.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||.||+|.+..+      +..||+|++......   ..+.+|+.+++++ +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYT------NEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTT------TEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCC------CcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            356899999999999999999986554      345999998755332   2467899999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc-----EEEec
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-----AKLSD  263 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~-----~kl~D  263 (429)
                      +..++||||+ +|+|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.     +||+|
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~D  153 (330)
T 2izr_A           78 KYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIID  153 (330)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred             CccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEE
Confidence            9999999999 99999998765 346999999999999999999999987  999999999999999887     99999


Q ss_pred             cCCCcCCCCCCCcc-----ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          264 FGLAKDGPEGDKSH-----VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       264 fgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      ||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus       154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~  233 (330)
T 2izr_A          154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG  233 (330)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred             cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence            99998654332211     1235689999999999999999999999999999999999999998754322211111110


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                         ......   ....+    ....+ ++.+++..||+.||.+||++.+|++.|+.+..
T Consensus       234 ---~~~~~~---~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          234 ---DTKRAT---PIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             ---HHHHHS---CHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---hhhccC---CHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence               000000   00000    01134 89999999999999999999999999976644

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.3e-47  Score=379.23  Aligned_cols=265  Identities=28%  Similarity=0.396  Sum_probs=216.2

Q ss_pred             hHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeee
Q 014189          104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG  183 (429)
Q Consensus       104 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  183 (429)
                      .+.+.+..++|++.+.||+|+||.||+|.+...       ..||||++....  ...+.|.+|+.+|++++||||+++++
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~-------~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~  250 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH-------TKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHA  250 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTT-------EEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCc-------cEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEE
Confidence            344455667899999999999999999987542       349999998653  34578999999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          184 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                      ++. .+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       251 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             EEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECS
T ss_pred             EEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEee
Confidence            986 567899999999999999997654446889999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      ||+++...... ........+|..|+|||++....++.++|||||||++|||+| |+.||..........       .+.
T Consensus       328 FG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~-------~i~  399 (454)
T 1qcf_A          328 FGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-------ALE  399 (454)
T ss_dssp             TTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-------HHH
T ss_pred             CCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHH
Confidence            99998754321 111223456889999999999999999999999999999999 999998665322110       010


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                            .    ......+..++..+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus       400 ------~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          400 ------R----GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ------H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ------c----CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                  0    111223445678899999999999999999999999999988654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-46  Score=354.02  Aligned_cols=274  Identities=21%  Similarity=0.235  Sum_probs=213.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  189 (429)
                      ..+|++.+.||+|+||.||+|.+..+.      ..||+|++...........+.+|+.++++++||||+++++++...+ 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTG------DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCC------cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            467999999999999999999876543      3499999876544455677889999999999999999999998655 


Q ss_pred             -eEEEEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE----cCCCcEEEec
Q 014189          190 -HRVLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSD  263 (429)
Q Consensus       190 -~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll----~~~~~~kl~D  263 (429)
                       ..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEcc
Confidence             7899999999999999997543 234899999999999999999999987  9999999999999    8888899999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~  335 (429)
                      ||+++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||.........  ..
T Consensus       160 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~  234 (319)
T 4euu_A          160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE  234 (319)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HH
T ss_pred             CCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HH
Confidence            999987654322   23467999999999986        578899999999999999999999999754432211  11


Q ss_pred             hHhhHHHhhh-h----hhhh------c--CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          336 WALPLLKEKK-K----LLNI------I--DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       336 ~~~~~~~~~~-~----~~~~------~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      .......... .    ....      .  ........+...+..+.+++.+||+.||++|||++|++++...-.-
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            1111111100 0    0000      0  0011123345678899999999999999999999999999765443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-46  Score=351.17  Aligned_cols=252  Identities=24%  Similarity=0.323  Sum_probs=198.9

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-------------------------hhHHHHHH
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-------------------------QGHREWLA  165 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~  165 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++......                         .....+.+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDN------TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ   85 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTT------EEEEEEEEECC-------------------------------CHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCC------cEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence            468999999999999999999876543      44999998754311                         12346789


Q ss_pred             HHHHHhccCCCceeeeeeEEEe--CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 014189          166 EVIFLGHLSHPNLVKLIGYCCE--DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIY  243 (429)
Q Consensus       166 E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH  243 (429)
                      |+.++++++||||+++++++.+  .+..++||||+++|+|.+++..   .++++..+..++.|++.||+|||+++  |+|
T Consensus        86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH  160 (298)
T 2zv2_A           86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK--IIH  160 (298)
T ss_dssp             HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence            9999999999999999999986  5789999999999999876532   36999999999999999999999987  999


Q ss_pred             CCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCC---CCcccchhhHHHHHHHHHhCCC
Q 014189          244 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH---LTPRSDVYSFGVVLLEILTGRK  320 (429)
Q Consensus       244 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltG~~  320 (429)
                      |||||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            99999999999999999999999987644321  234468999999999998655   4788999999999999999999


Q ss_pred             CCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          321 SLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       321 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ||........      ... +         .............+..+.+|+.+||+.||++|||+.|++++
T Consensus       239 pf~~~~~~~~------~~~-~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          239 PFMDERIMCL------HSK-I---------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSCCSSHHHH------HHH-H---------HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCccHHHH------HHH-H---------hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            9986543211      000 0         00111111123456789999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-46  Score=358.28  Aligned_cols=277  Identities=27%  Similarity=0.353  Sum_probs=222.2

Q ss_pred             cChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceee
Q 014189          102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVK  180 (429)
Q Consensus       102 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  180 (429)
                      +....+....++|++.+.||+|+||.||+|.+... .....+..||+|++...........+.+|+.++.++ +||||++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecC-CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            44455556678899999999999999999976432 123345679999998776666677899999999999 6999999


Q ss_pred             eeeEEEeCC-eEEEEEEecCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 014189          181 LIGYCCEDE-HRVLIYEFMARGSVENNLFSKVL--------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  245 (429)
Q Consensus       181 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~D  245 (429)
                      +++++...+ ..++||||+++|+|.+++.....              ..+++..+..++.|++.||+|||+.+  |+|||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~d  173 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  173 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--ccccc
Confidence            999987654 58999999999999999976542              12789999999999999999999987  99999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 014189          246 FKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDK  324 (429)
Q Consensus       246 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~  324 (429)
                      |||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+| |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654433333344678899999999999999999999999999999998 9999976


Q ss_pred             CChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          325 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      ......  ..    ....      ..    .....+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       254 ~~~~~~--~~----~~~~------~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          254 VKIDEE--FC----RRLK------EG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCCSHH--HH----HHHH------HT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHH--HH----HHhc------cC----ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            543211  00    0010      00    1112233456789999999999999999999999999987653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=364.21  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=206.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.+|+.++||||+++++++.+.
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~------~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTK------KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            367999999999999999999876554      349999986432  122345678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..|+||||+.+|+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceee
Confidence            99999999999999999987643  6999999999999999999999988  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ......   .....+||+.|+|||++.+   ..|+.++|||||||++|||++|+.||...............        
T Consensus       164 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--------  232 (384)
T 4fr4_A          164 MLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--------  232 (384)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--------
T ss_pred             eccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--------
Confidence            764432   2345789999999999974   46899999999999999999999999755432211111100        


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-HHHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-MRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~  391 (429)
                        ..     .....+...+..+.+|+.+||+.||++||+ +++++++
T Consensus       233 --~~-----~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          233 --ET-----TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             --HH-----CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             --hh-----cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence              00     011234456788999999999999999998 7777764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4e-46  Score=346.72  Aligned_cols=256  Identities=25%  Similarity=0.316  Sum_probs=211.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  188 (429)
                      .++|++.+.||+|+||.||+|.+.        +..||+|++.... .......|.+|+.++++++||||+++++++.+. 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            357999999999999999999864        2349999987653 445557789999999999999999999999876 


Q ss_pred             -CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          189 -EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       189 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                       +..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+.+++||||||+|||++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             7889999999999999999877666799999999999999999999987666999999999999999999999999887


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCc---ccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      .....       ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||.........             
T Consensus       161 ~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------------  220 (271)
T 3kmu_A          161 FSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-------------  220 (271)
T ss_dssp             CTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-------------
T ss_pred             eeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-------------
Confidence            54322       2357899999999998765544   799999999999999999999865532210             


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                         ............+...+..+.+++.+||+.||++|||++++++.|+.++.
T Consensus       221 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          221 ---MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---HHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence               01111112223344567889999999999999999999999999988754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-46  Score=355.11  Aligned_cols=280  Identities=24%  Similarity=0.317  Sum_probs=211.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--C
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--D  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  188 (429)
                      ..+|++.+.||+|+||.||+|.+...  ....+..||+|++... .......+.+|+.++++++||||+++++++..  .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPL--QDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTT--CSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecc--cCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            46799999999999999999975321  2233566999998765 44556778899999999999999999999864  3


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ...++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            56899999999999999997653 25899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ........ .......+|..|+|||.+.+..++.++||||||+++|||+||..|+.................... ....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  241 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-VFHL  241 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH-HHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh-HHHH
Confidence            76543221 122334578889999999999999999999999999999999999864321110000000000000 0011


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      ...+........+..++..+.+|+.+||+.||++|||++|+++.|+.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            11122222333455677889999999999999999999999999988754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-45  Score=347.16  Aligned_cols=257  Identities=29%  Similarity=0.521  Sum_probs=207.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhH------HHHHHHHHHHhccCCCceeeeeeE
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH------REWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++.........      ..+.+|+.++++++||||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDK------SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTC------CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hccceehhccccCCceeEEEEEEcCCc------eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            468999999999999999999876553      34999998654322111      578899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc-----E
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-----A  259 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~-----~  259 (429)
                      +.+..  ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++.+|+||||||+|||++.++.     +
T Consensus        92 ~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           92 MHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             ETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             ecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence            87655  69999999999999887653 3699999999999999999999997666999999999999988876     9


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCcccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~  337 (429)
                      ||+|||+++....     ......||+.|+|||++.  ...++.++||||||+++|||++|+.||...........    
T Consensus       169 kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----  239 (287)
T 4f0f_A          169 KVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----  239 (287)
T ss_dssp             EECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH----
T ss_pred             EeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH----
Confidence            9999999985432     233467999999999984  45678999999999999999999999986543221100    


Q ss_pred             hhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                                ............+..++..+.+++.+||+.||++|||++++++.|+++
T Consensus       240 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 ----------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ----------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ----------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                      001111222233456678899999999999999999999999999764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-46  Score=356.64  Aligned_cols=267  Identities=27%  Similarity=0.429  Sum_probs=210.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ..+|++.+.||+|+||.||+|.+..+.  ......||+|++...........+.+|+.++++++||||+++++++...+.
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSS--GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCC--CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            457888999999999999999876432  123456999999876666667789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            999999999999999987653 36899999999999999999999987  999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||........   ..             
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~-------------  261 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MK-------------  261 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH-------------
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---HH-------------
Confidence            443211 11223456889999999999999999999999999999999 9999976543211   00             


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                      .+.+ ......+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       262 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          262 AIND-GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             HHHT-TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHHC-CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            0000 1112223456778999999999999999999999999998875543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.9e-47  Score=374.19  Aligned_cols=265  Identities=20%  Similarity=0.223  Sum_probs=210.5

Q ss_pred             hHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeee
Q 014189          104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKL  181 (429)
Q Consensus       104 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l  181 (429)
                      +.++....++|++.++||+|+||.||+|.+..+.      ..||+|++.....  ......+.+|+.++..++||||+++
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l  139 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD------KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL  139 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCE
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCC------cEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            3445556788999999999999999999876653      4499999864211  1112237789999999999999999


Q ss_pred             eeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          182 IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       182 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                      +++|.+.+.+|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||
T Consensus       140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL  216 (437)
T 4aw2_A          140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRL  216 (437)
T ss_dssp             EEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEE
Confidence            999999999999999999999999997642 36999999999999999999999987  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~  336 (429)
                      +|||+++....... ......+||+.|+|||++.     ...|+.++|||||||++|||++|+.||...+......    
T Consensus       217 ~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~----  291 (437)
T 4aw2_A          217 ADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG----  291 (437)
T ss_dssp             CCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----
T ss_pred             cchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH----
Confidence            99999976544322 2234468999999999997     5678999999999999999999999998765332111    


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHh
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDS  391 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  391 (429)
                        ..+....   ...-+    ......+..+.+|+.+||..+|++  ||+++|+++|
T Consensus       292 --~i~~~~~---~~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          292 --KIMNHKE---RFQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             --HHHTHHH---HCCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             --hhhhccc---cccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence              1111000   00001    111235778999999999998888  9999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.1e-47  Score=363.04  Aligned_cols=269  Identities=26%  Similarity=0.343  Sum_probs=218.0

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      ...++|++.+.||+|+||.||+|.+..... ......||+|.+...........+.+|+.+++.+ +||||+++++++.+
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSS-SCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCc-ccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            345789999999999999999998765432 2234469999998776666677899999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKV------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT  255 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~  255 (429)
                      .+..++||||+++|+|.+++....            ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEG
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECC
Confidence            999999999999999999986431            235899999999999999999999987  999999999999999


Q ss_pred             CCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHH
Q 014189          256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLA  334 (429)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~  334 (429)
                      ++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||+| |..||.........   
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---  276 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF---  276 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH---
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH---
Confidence            99999999999986544333223334567889999999999999999999999999999999 99999765432110   


Q ss_pred             HhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                         .....      .    ......+...+..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus       277 ---~~~~~------~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          277 ---YKLVK------D----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             ---HHHHH------H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHh------c----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence               00011      0    1111223345678899999999999999999999999997654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1e-46  Score=354.28  Aligned_cols=263  Identities=25%  Similarity=0.391  Sum_probs=219.2

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      +....++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .....+.+|+.++++++||||+++++++.
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   79 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCT   79 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGT------EEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCC------EEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            3345678999999999999999999876543      449999987653  34567889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      +.+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCcc
Confidence            9999999999999999999998776677999999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      +........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........              
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~--------------  222 (288)
T 3kfa_A          158 SRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--------------  222 (288)
T ss_dssp             GGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--------------
T ss_pred             ceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--------------
Confidence            987654322 22334567889999999999999999999999999999999 99999865532111              


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                         ..+........+..++..+.+|+.+||..||++|||+.++++.|+.+..
T Consensus       223 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          223 ---ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence               1111111223344567889999999999999999999999999977643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-45  Score=355.96  Aligned_cols=257  Identities=26%  Similarity=0.357  Sum_probs=206.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|..++.++ +||||+++++++.+.
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTD------RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   82 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCC------CEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence            57999999999999999999876543      449999987542  334456678899999887 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCK  158 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccc
Confidence            99999999999999999987643  6899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh--hhHHHhHhhHHHhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE--QNLADWALPLLKEKKK  346 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~  346 (429)
                      ......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........  .........       
T Consensus       159 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------  229 (345)
T 3a8x_A          159 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------  229 (345)
T ss_dssp             CSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH-------
T ss_pred             cccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH-------
Confidence            643222  223457899999999999999999999999999999999999999975322111  001111111       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH------HHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM------RDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~  391 (429)
                        .+....  ...+...+..+.+|+.+||+.||++||++      +|+++|
T Consensus       230 --~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          230 --VILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             --HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             --HHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence              111111  12344567789999999999999999995      688766

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-46  Score=354.51  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=206.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|....++      ..||+|++....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   79 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNG------RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   79 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence            57999999999999999999876543      449999986532  1123456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCccee
Confidence            9999999999999999997654  6899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+....      .          ..
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~----------~~  214 (318)
T 1fot_A          156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------Y----------EK  214 (318)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H----------HH
T ss_pred             cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------H----------HH
Confidence            5431     2346899999999999999999999999999999999999999986543211      0          01


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      +....  ..++...+.++.+++.+||..||++||     +++++++|
T Consensus       215 i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          215 ILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            11111  122345567899999999999999999     89999976

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-45  Score=359.99  Aligned_cols=255  Identities=20%  Similarity=0.274  Sum_probs=209.3

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..+|+|++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~------~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATG------RVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY  121 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCC------CEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence            3468999999999999999999876553      349999987653 344557889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC--CCcEEEeccCCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--DYNAKLSDFGLA  267 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla  267 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.  ++.+||+|||++
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a  198 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLA  198 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccc
Confidence            9999999999999999886543 36899999999999999999999987  999999999999974  477999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|..||..........      ....     
T Consensus       199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~------~i~~-----  264 (387)
T 1kob_A          199 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------NVKR-----  264 (387)
T ss_dssp             EECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHH-----
T ss_pred             eecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHH------HHHh-----
Confidence            8765432   2234579999999999999999999999999999999999999998755321110      0000     


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         .............+..+.+|+.+||+.||++|||+.|++++
T Consensus       265 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          265 ---CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ---CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence               01111112223457789999999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=355.90  Aligned_cols=305  Identities=19%  Similarity=0.236  Sum_probs=211.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..||+|++...........+.+|+.+++.++||||+++++++...+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTD------NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCC------cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE
Confidence            47999999999999999999876543      349999987654332223455799999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            99999997 58988887653 36899999999999999999999987  9999999999999999999999999998654


Q ss_pred             CCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH-H-------H
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL-L-------K  342 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-~-------~  342 (429)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................. .       .
T Consensus       152 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          152 IPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence            322  12334578999999999876 56899999999999999999999999876543321111100000 0       0


Q ss_pred             hhhhhhhhcCCCCCCC----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCCCCCCCCCCccccccCCCC
Q 014189          343 EKKKLLNIIDPRLEGD----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVLPDEAPTPKNFVTVVTPEE  416 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~p~~~~~~~~~~~  416 (429)
                      ..........+.....    .....+..+.+|+.+||+.||++|||++|++++  |..+.......+.+......-.-+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  309 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQL  309 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCCC
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHHh
Confidence            0000000000000000    012345778999999999999999999999986  5555555445555544555555556


Q ss_pred             CCcccccccccC
Q 014189          417 PKAEIQTKDSQC  428 (429)
Q Consensus       417 ~~~~~~~~~~~~  428 (429)
                      +|+..-.+++++
T Consensus       310 q~~~~~~~~~~~  321 (324)
T 3mtl_A          310 QKEASLRSAHHH  321 (324)
T ss_dssp             CC----------
T ss_pred             hhhhhhhhhhhc
Confidence            666655555543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.7e-46  Score=359.42  Aligned_cols=253  Identities=26%  Similarity=0.353  Sum_probs=206.5

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEE
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  185 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  185 (429)
                      ...++|++.+.||+|+||.||+|.+..++      ..||+|++....  .......+..|..++..+ +||||+++++++
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~   87 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTN------QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   87 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTT------EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence            34578999999999999999999876543      459999987531  112345567899999877 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          186 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       186 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                      .+.+..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        88 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           88 QTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeECh
Confidence            99999999999999999999997643  5899999999999999999999987  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      +++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...+.....      .....   
T Consensus       164 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~~---  232 (345)
T 1xjd_A          164 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------HSIRM---  232 (345)
T ss_dssp             TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH---
T ss_pred             hhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH------HHHHh---
Confidence            9986433221  234578999999999999999999999999999999999999999865532110      00000   


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHH-HHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR-DIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~  391 (429)
                           ..    ...+...+..+.+|+.+||..||++||++. ++++|
T Consensus       233 -----~~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          233 -----DN----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             -----CC----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -----CC----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                 01    122334567899999999999999999998 77754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.2e-45  Score=347.42  Aligned_cols=264  Identities=27%  Similarity=0.439  Sum_probs=200.0

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      +..++|++.+.||+|+||.||+|.+...         +|+|++.... .......|.+|+.++++++||||+++++++ .
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~~---------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~   90 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T   90 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSSE---------EEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcCc---------eEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence            3457899999999999999999975432         8999987553 445567789999999999999999999965 4


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      ....++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             CCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceec
Confidence            566899999999999999886543 46999999999999999999999987  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ................||+.|+|||++.   +..++.++||||||+++|+|++|+.||........  ..    ..... 
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~-  240 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--II----EMVGR-  240 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HH----HHHHH-
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HH----HHhcc-
Confidence            8654433223334467999999999987   66789999999999999999999999986543221  10    00100 


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                          ....+. .......++..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus       241 ----~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          241 ----GSLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ----TSCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----cccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                111111 111233567889999999999999999999999999988753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.1e-45  Score=357.44  Aligned_cols=257  Identities=22%  Similarity=0.282  Sum_probs=204.8

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCceeeeeeEE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVKLIGYC  185 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  185 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++....    .......+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETG------QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCC------CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4567999999999999999999876554      349999985321    112356788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc---EE
Q 014189          186 CEDEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---AK  260 (429)
Q Consensus       186 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~---~k  260 (429)
                      .+.+..|+||||+++|+|.+++...  ....+++..+..++.|++.||+|||+++  |+||||||+|||++.++.   +|
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEE
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEE
Confidence            9999999999999999998887543  2335899999999999999999999987  999999999999987655   99


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      |+|||++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||......    ..   ...
T Consensus       174 l~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~---~~i  244 (351)
T 3c0i_A          174 LGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LF---EGI  244 (351)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HH---HHH
T ss_pred             EecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HH---HHH
Confidence            99999998765432  2234468999999999999999999999999999999999999999864211    10   000


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....      .  ..........+..+.+|+.+||..||++|||+.+++++
T Consensus       245 ~~~~------~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          245 IKGK------Y--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HHTC------C--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HcCC------C--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000      0  00000011346788999999999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.4e-46  Score=355.18  Aligned_cols=255  Identities=22%  Similarity=0.335  Sum_probs=200.4

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||.||+|.+..++      ..||+|++...........+.+|+.++++++||||+++++++.+..
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   77 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDD------CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP   77 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTC------CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCC------cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence            3467999999999999999999876543      3499999986655556678999999999999999999999986543


Q ss_pred             ---------------------------------------------------------eEEEEEEecCCCChhhhhhcCCC
Q 014189          190 ---------------------------------------------------------HRVLIYEFMARGSVENNLFSKVL  212 (429)
Q Consensus       190 ---------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~  212 (429)
                                                                               ..++||||+++|+|.+++.....
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  157 (332)
T 3qd2_B           78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS  157 (332)
T ss_dssp             SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred             cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence                                                                     38999999999999999976543


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCc----------ccccc
Q 014189          213 -LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS----------HVSTR  281 (429)
Q Consensus       213 -~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~  281 (429)
                       ...++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++........          .....
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence             23567778999999999999999987  999999999999999999999999999876543211          12234


Q ss_pred             ccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCCh
Q 014189          282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPV  361 (429)
Q Consensus       282 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (429)
                      ..||+.|+|||++.+..++.++||||||+++|||++|..|+...     ....             ....... ......
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~-------------~~~~~~~-~~~~~~  296 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRII-------------TDVRNLK-FPLLFT  296 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHH-------------HHHHTTC-CCHHHH
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHH-------------HHhhccC-CCcccc
Confidence            57999999999999999999999999999999999987664210     0000             0000000 000112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          362 KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       362 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..+..+.+|+.+||+.||++|||++|++++
T Consensus       297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          297 QKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             cCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            345677899999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.5e-46  Score=370.82  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=210.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||.||+|.+.+        ..||||++....   ....|.+|+.+|++++||||+++++++.+..
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~~--------~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  259 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK  259 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT--------EEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEecC--------CeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence            34678999999999999999997642        349999998653   3457889999999999999999999987665


Q ss_pred             -eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          190 -HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       190 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                       ..++||||+++|+|.+++.......+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence             7899999999999999998765556899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      .....     .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||.........   .            
T Consensus       338 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~------------  397 (450)
T 1k9a_A          338 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P------------  397 (450)
T ss_dssp             ECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---H------------
T ss_pred             ccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H------------
Confidence            54321     122367889999999999999999999999999999999 99999865432110   0            


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                        .+........+..++..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus       398 --~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          398 --RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             --HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence              0011112234456778899999999999999999999999999887643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.5e-46  Score=357.98  Aligned_cols=252  Identities=25%  Similarity=0.307  Sum_probs=207.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  186 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  186 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+..|..++..+ +||||+++++++.
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTD------ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEE------EEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            3468999999999999999999876553      349999987532  112345677899999988 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      +.+..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            9999999999999999999997643  5899999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....      ..        
T Consensus       168 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~--------  231 (353)
T 2i0e_A          168 CKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQ--------  231 (353)
T ss_dssp             CBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH--------
T ss_pred             ccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH------HH--------
Confidence            98643222  123457899999999999999999999999999999999999999986543211      11        


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                        .+....  ..++...+.++.+|+.+||..||++||+     ++++++|
T Consensus       232 --~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          232 --SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              111111  1234456788999999999999999995     5888876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-45  Score=345.94  Aligned_cols=278  Identities=16%  Similarity=0.151  Sum_probs=218.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      ..++|++.+.||+|+||.||+|.+..+      +..||+|++......   ..+.+|+.++..+ +|+|++++++++...
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   78 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLN------NQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEG   78 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTT------TEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCC------CcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence            456899999999999999999986554      345999998754322   3466899999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc-----EEEec
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-----AKLSD  263 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~-----~kl~D  263 (429)
                      ...++||||+ +|+|.+++.... .++++..+..++.|++.||+|||+++  |+||||||+|||++.++.     +||+|
T Consensus        79 ~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           79 LHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             ceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence            9999999999 999999997653 35999999999999999999999977  999999999999988776     99999


Q ss_pred             cCCCcCCCCCCCc-----cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          264 FGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       264 fgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      ||+++........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||................
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            9999865443221     12344679999999999999999999999999999999999999998754322211111111


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCCCCCcccc
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVT  410 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~~  410 (429)
                      .... .......         ...++..+.+++.+||+.||++|||+++|++.|+.+..........+.+|.
T Consensus       235 ~~~~-~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  296 (298)
T 1csn_A          235 EKKQ-STPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  296 (298)
T ss_dssp             HHHH-HSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             hhcc-CccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence            0000 0000000         113457889999999999999999999999999988766555555555554

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.2e-45  Score=346.18  Aligned_cols=267  Identities=23%  Similarity=0.271  Sum_probs=203.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||+||+|.+..+.      ..||+|++.... .......+.+|+.++++++||||+++++++.+++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETH------EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCC------ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            47999999999999999999876553      349999987543 33344678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           76 LTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999975 6666665433 36999999999999999999999987  999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH---HHhhh-
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL---LKEKK-  345 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~---~~~~~-  345 (429)
                      ....  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ .+.......   ....+ 
T Consensus       152 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             CSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCT
T ss_pred             CCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhh
Confidence            4322  2234467899999999998765 89999999999999999998888644332211 111000000   00000 


Q ss_pred             hhhhhcC---------CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIID---------PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~---------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ......+         ...........+..+.+|+.+||+.||++|||++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000000         000111123457788999999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.5e-46  Score=352.98  Aligned_cols=269  Identities=24%  Similarity=0.334  Sum_probs=193.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+      +..||+|++...........+.+|+.++++++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTT------GVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK   77 (317)
T ss_dssp             ---------------CEEEEEECSSS------CCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCC------CcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe
Confidence            35799999999999999999976554      345999998765444444677899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          191 RVLIYEFMARGSVENNLFSKV----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      .++||||++ |+|.+++....    ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCcc
Confidence            999999998 69998885431    235899999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh-----H
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-----L  340 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~-----~  340 (429)
                      ++.......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................     .
T Consensus       155 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          155 ARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             CEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred             ceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence            986543221  2234578999999999976 4689999999999999999999999987654322111100000     0


Q ss_pred             HHhhhhhhhhcCCCCCC------------CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEG------------DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~------------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +........ ..+....            ......+..+.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          233 WPSVTKLPK-YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CGGGGGCTT-CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhhh-cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            000000000 0000000            0111345689999999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.2e-46  Score=358.57  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=204.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|.+.+.||+|+||.||+|.+..+.      ..||+|++.....  ......+.+|+.+++.++||||+++++++.+.
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   81 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQ------QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP   81 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCC------CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            368999999999999999999876553      3499999864311  11234677999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+ +|+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           82 TDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             SEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             CEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccce
Confidence            9999999999 689999887654  6899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......                 +
T Consensus       157 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------------~  216 (336)
T 3h4j_B          157 IMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------------L  216 (336)
T ss_dssp             TTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------------C
T ss_pred             eccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------------H
Confidence            765432   2344689999999999998776 789999999999999999999997543211                 0


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...+.. .....+...+..+.+|+.+||+.||.+|||++|++++
T Consensus       217 ~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          217 FKKVNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             BCCCCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            011110 1112344567789999999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-45  Score=362.50  Aligned_cols=279  Identities=19%  Similarity=0.224  Sum_probs=209.4

Q ss_pred             hcCCccceeecCC--CcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          111 TANFRQDRVLGGG--GFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G--~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .++|++.+.||+|  +||.||+|.+..++      ..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTG------EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTC------CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCC------CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            4679999999999  99999999876543      449999987543 33445677889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999999999999998776567999999999999999999999987  999999999999999999999999987


Q ss_pred             cCCCCCCC-----ccccccccCCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-HHhHhh
Q 014189          268 KDGPEGDK-----SHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALP  339 (429)
Q Consensus       268 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~~~~~~  339 (429)
                      ........     ........||+.|+|||++.+  ..|+.++|||||||++|||++|+.||........... ......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            64322110     111223578999999999987  6799999999999999999999999976543221100 000000


Q ss_pred             -HHHh----hh-------------hhhhhc---C------CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh-
Q 014189          340 -LLKE----KK-------------KLLNII---D------PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS-  391 (429)
Q Consensus       340 -~~~~----~~-------------~~~~~~---~------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~-  391 (429)
                       ....    ..             ......   .      .......+...+..+.+|+.+||+.||++|||++|++++ 
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp  335 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  335 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence             0000    00             000000   0      000011223456789999999999999999999999987 


Q ss_pred             -cccccC
Q 014189          392 -LEPLQV  397 (429)
Q Consensus       392 -L~~~~~  397 (429)
                       |..+..
T Consensus       336 ~f~~~~~  342 (389)
T 3gni_B          336 FFKQIKR  342 (389)
T ss_dssp             GGGGC--
T ss_pred             HHHHHhh
Confidence             555543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.8e-46  Score=358.08  Aligned_cols=248  Identities=23%  Similarity=0.280  Sum_probs=207.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+..++      ..||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  113 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESG------NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN  113 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCC------CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            367999999999999999999876543      349999986532  122345678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccce
Confidence            99999999999999999997653  5899999999999999999999988  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+....      ..          
T Consensus       190 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~----------  248 (350)
T 1rdq_E          190 RVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YE----------  248 (350)
T ss_dssp             ECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH----------
T ss_pred             eccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH------HH----------
Confidence            65432     2346899999999999999999999999999999999999999986543211      00          


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                      .+....  ...+...+..+.+|+.+||+.||++||+     +++|++|
T Consensus       249 ~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          249 KIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            111111  1233456778999999999999999998     8999876

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-45  Score=343.40  Aligned_cols=257  Identities=26%  Similarity=0.353  Sum_probs=209.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..||+|++...........+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTE------EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCC------cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence            3468999999999999999999876543      3499999875544455677889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            999999999999999988654  36899999999999999999999987  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ..............||+.|+|||.+.+..+ +.++||||||+++|+|++|..||........ ....+.           
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-----------  222 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-----------  222 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH-----------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh-----------
Confidence            543322222345679999999999987765 7899999999999999999999986543211 111110           


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ............+..+.+|+.+||+.||++|||++|++++
T Consensus       223 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          223 ---EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ---TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence               0000111123456788999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.1e-46  Score=371.81  Aligned_cols=262  Identities=25%  Similarity=0.361  Sum_probs=209.8

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      +....++|++.+.||+|+||.||+|.+..+       ..||+|++.....  ..+.|.+|+.+|++++||||+++++++.
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~  249 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS  249 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTT-------EEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCC-------ceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            344557799999999999999999987643       2399999886532  3467899999999999999999999987


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      + +..++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus       250 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCcc
Confidence            6 67899999999999999997544446899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ++....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||..........             
T Consensus       327 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-------------  392 (452)
T 1fmk_A          327 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------------  392 (452)
T ss_dssp             TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------------
T ss_pred             ceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-------------
Confidence            987643221 12233457889999999999999999999999999999999 999998665321100             


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                          .+........+..++..+.+|+.+||+.||++|||++++++.|+.+...
T Consensus       393 ----~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          393 ----QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ----HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ----HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                0011112233456678899999999999999999999999999988655

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-46  Score=370.46  Aligned_cols=260  Identities=21%  Similarity=0.229  Sum_probs=208.2

Q ss_pred             HHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeee
Q 014189          106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIG  183 (429)
Q Consensus       106 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~  183 (429)
                      ++....++|++.+.||+|+||.||+|.+..+.      ..||+|++.....  ......+.+|+.+++.++||||+++++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~------~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~  136 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR------KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY  136 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCC------cEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            34445678999999999999999999876653      3499999864210  111234678999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          184 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                      ++.+.+.+|+||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       137 ~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~D  211 (410)
T 3v8s_A          137 AFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLAD  211 (410)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEec
Confidence            999999999999999999999988754   5899999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH----LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      ||+++...... .......+||+.|+|||++.+..    |+.++|||||||++|||++|+.||...+.....      ..
T Consensus       212 FG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~  284 (410)
T 3v8s_A          212 FGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SK  284 (410)
T ss_dssp             CTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HH
T ss_pred             cceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH------HH
Confidence            99998764432 12234578999999999998665    889999999999999999999999865532211      11


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHh
Q 014189          340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDS  391 (429)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  391 (429)
                      .......        +........+..+.+|+.+||..+|.+  ||+++||++|
T Consensus       285 i~~~~~~--------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          285 IMNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHTHHHH--------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HHhcccc--------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            1110000        011112245678999999999999998  9999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.4e-46  Score=359.85  Aligned_cols=291  Identities=19%  Similarity=0.201  Sum_probs=214.9

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhh----------HHHHHHHHHHHhccCCCcee
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG----------HREWLAEVIFLGHLSHPNLV  179 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv  179 (429)
                      ..++|++.+.||+|+||.||+|.+..+.. ...+..||+|++........          ...+..|+..++.++||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSES-VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSC-CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccc-cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            34589999999999999999998765422 22345699999876532110          01234566677888999999


Q ss_pred             eeeeEEEeC----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-
Q 014189          180 KLIGYCCED----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-  254 (429)
Q Consensus       180 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-  254 (429)
                      ++++++...    ...++||||+ +|+|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~  187 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY  187 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence            999998764    4589999999 99999998764 346999999999999999999999987  99999999999999 


Q ss_pred             -CCCcEEEeccCCCcCCCCCCCc-----cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChh
Q 014189          255 -TDYNAKLSDFGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA  328 (429)
Q Consensus       255 -~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~  328 (429)
                       .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999765432111     1123356999999999999999999999999999999999999999853322


Q ss_pred             hhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCCCCCcc
Q 014189          329 REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNF  408 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~  408 (429)
                      ..  .......  ........++++.+.   ...++.++.+++..||..||++||++++|++.|+.+............+
T Consensus       268 ~~--~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d  340 (364)
T 3op5_A          268 PK--YVRDSKI--RYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD  340 (364)
T ss_dssp             HH--HHHHHHH--HHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred             HH--HHHHHHH--HhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence            11  1111110  001112222222211   1234578899999999999999999999999998876655555555556


Q ss_pred             cccc
Q 014189          409 VTVV  412 (429)
Q Consensus       409 ~~~~  412 (429)
                      |...
T Consensus       341 w~~~  344 (364)
T 3op5_A          341 LSVV  344 (364)
T ss_dssp             C---
T ss_pred             eEec
Confidence            6443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=355.03  Aligned_cols=254  Identities=23%  Similarity=0.331  Sum_probs=201.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCC--CceeeeeeEEEe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSH--PNLVKLIGYCCE  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~  187 (429)
                      ..+|++.+.||+|+||.||+|.+..       +..||+|++.... .......+.+|+.++.+++|  |||+++++++..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTT-------SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCC-------CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            4569999999999999999997532       3449999987543 34455778899999999976  999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+..++||| +.+|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++ ++.+||+|||++
T Consensus        81 ~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           81 DQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             CCEEEEEEe-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccc
Confidence            999999999 56789999997754  6899999999999999999999987  99999999999997 678999999999


Q ss_pred             cCCCCCCCccccccccCCccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~  336 (429)
                      +...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......       
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------  227 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------  227 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-------
Confidence            87654433333445689999999999865           678999999999999999999999997543211       


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                              ..+...+++......+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus       228 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          228 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             --------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                    112223333333444555567889999999999999999999999873

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=347.29  Aligned_cols=263  Identities=25%  Similarity=0.380  Sum_probs=211.1

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE-
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR-  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-  191 (429)
                      .|...++||+|+||.||+|.+..+..   ....+|+|.+...........+.+|+.++++++||||+++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ---NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS---CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCC---ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            46677999999999999998755432   24459999998776667778899999999999999999999999866655 


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+++...
T Consensus        99 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999998764 346899999999999999999999987  9999999999999999999999999998654


Q ss_pred             CCCC--ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          272 EGDK--SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS-LDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       272 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ....  ........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |........   .              
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~---~--------------  238 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL---T--------------  238 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH---H--------------
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH---H--------------
Confidence            3221  1122345788999999999999999999999999999999995554 544332211   0              


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      ..+........+...+..+.+++.+||+.||++|||++++++.|+.+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            00001111222344567899999999999999999999999999887554

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1e-45  Score=358.88  Aligned_cols=276  Identities=23%  Similarity=0.273  Sum_probs=213.4

Q ss_pred             cccChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-----
Q 014189          100 IAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-----  174 (429)
Q Consensus       100 ~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----  174 (429)
                      ..+++.+...+.++|++.+.||+|+||.||+|.+..+.      ..||+|++...  ......+..|+.+++.+.     
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~   94 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNK------KYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDIN   94 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTT
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCC------eEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCC
Confidence            34555556677889999999999999999999876543      34999998743  344556778999999886     


Q ss_pred             CCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc
Q 014189          175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  254 (429)
Q Consensus       175 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~  254 (429)
                      ||||+++++++...+..++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++
T Consensus        95 h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~  171 (360)
T 3llt_A           95 NNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLD  171 (360)
T ss_dssp             GGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES
T ss_pred             CCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEc
Confidence            999999999999999999999999 899999998776667999999999999999999999987  99999999999997


Q ss_pred             C-------------------------CCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHH
Q 014189          255 T-------------------------DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG  309 (429)
Q Consensus       255 ~-------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  309 (429)
                      .                         ++.+||+|||++......     .....||+.|+|||++.+..++.++||||||
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  246 (360)
T 3llt_A          172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG  246 (360)
T ss_dssp             CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred             cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence            6                         789999999999864332     2346799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh-------hhhhhcC-CCCCCCCC--------------------h
Q 014189          310 VVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK-------KLLNIID-PRLEGDYP--------------------V  361 (429)
Q Consensus       310 ~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~~~~--------------------~  361 (429)
                      |++|+|++|+.||.......................       ......+ ......++                    .
T Consensus       247 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  326 (360)
T 3llt_A          247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI  326 (360)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred             HHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence            999999999999987654332221111100000000       0000000 00000000                    0


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          362 KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       362 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....+.+|+.+||+.||++|||++|++++
T Consensus       327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          327 IKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             chHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            112567899999999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-45  Score=358.13  Aligned_cols=254  Identities=21%  Similarity=0.281  Sum_probs=195.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++.....  ....+.+|+.+++.++||||+++++++.+.+.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   90 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTK------ELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   90 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTC------CEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCC------cEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence            468999999999999999999876543      3499999876432  23457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc--EEEeccCCCc
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN--AKLSDFGLAK  268 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~  268 (429)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.  +||+|||+++
T Consensus        91 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           91 LAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             EEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            999999999999999986644  5899999999999999999999987  999999999999987776  9999999997


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ......   ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........  ....          .
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~----------~  231 (361)
T 3uc3_A          167 SSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKT----------I  231 (361)
T ss_dssp             -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHH----------H
T ss_pred             cccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHH----------H
Confidence            533221   2234679999999999988887655 8999999999999999999986442211  1000          1


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..+.............+..+.+|+.+||+.||++|||++|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          232 QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            11111111111222456788999999999999999999999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.4e-46  Score=347.65  Aligned_cols=257  Identities=22%  Similarity=0.370  Sum_probs=208.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||.||+|.+..+       ..||+|++.....  ....+.+|+.++.+++||||+++++++.+.+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTT-------EEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCC-------CeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            456899999999999999999976542       3399999986533  3356889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             CeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccc
Confidence            9999999999999999986532 35999999999999999999999987  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ..... ........+|+.|+|||++.+..++.++||||||+++|+|+| |+.||...........             ..
T Consensus       170 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-------------~~  235 (283)
T 3gen_A          170 VLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------------IA  235 (283)
T ss_dssp             BCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------------HH
T ss_pred             ccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-------------Hh
Confidence            54321 111223457888999999999999999999999999999998 9999987653221100             01


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .    ......+...+..+.+++.+||+.||++|||+++++++|+.+.
T Consensus       236 ~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          236 Q----GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             T----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c----ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            1    1112223345678999999999999999999999999998764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-45  Score=352.65  Aligned_cols=278  Identities=27%  Similarity=0.354  Sum_probs=218.2

Q ss_pred             cCC-ccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--C
Q 014189          112 ANF-RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--D  188 (429)
Q Consensus       112 ~~y-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  188 (429)
                      .+| ++.+.||+|+||.||++.+...  ....+..||+|++...........+.+|+.++++++||||+++++++.+  .
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPT--NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSC--C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccC--CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            344 8999999999999999865432  2234667999999887666677789999999999999999999999987  4


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ...++||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccc
Confidence            6789999999999999999765   4899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ........ .......||..|+|||++.+..++.++||||||+++|+|++|..||........ ....+..... ....+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~  260 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQM-TVLRL  260 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHH-HHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccch-hHHHH
Confidence            76543321 123345688899999999999999999999999999999999999875322110 0000000000 01112


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      ...+........+..++..+.+|+.+||+.||++|||++++++.|+.+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            222333333444556778999999999999999999999999999887543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-45  Score=342.93  Aligned_cols=254  Identities=31%  Similarity=0.505  Sum_probs=197.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC---hhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .++|++.+.||+|+||.||+|.+.+        ..||+|++.....   ......+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIG--------DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK   77 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETT--------EEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcC--------CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            3579999999999999999998642        3499999875432   2334678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeCCCCCCcEEEcC--------CCc
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK-PVIYRDFKTSNILLDT--------DYN  258 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivH~Dlkp~NIll~~--------~~~  258 (429)
                      .+..++||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+. +++||||||+|||++.        ++.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             CCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence            99999999999999999988533   68999999999999999999999763 3889999999999986        778


Q ss_pred             EEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      +||+|||++.......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........       
T Consensus       155 ~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------  223 (271)
T 3dtc_A          155 LKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-------  223 (271)
T ss_dssp             EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-------
T ss_pred             eEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------
Confidence            9999999998654322    22457999999999999999999999999999999999999999865532110       


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                               ............+..++..+.+++.+||+.||++|||+.|++++|+.+
T Consensus       224 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          224 ---------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---------HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                     011111222233455678899999999999999999999999999764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-45  Score=359.84  Aligned_cols=278  Identities=23%  Similarity=0.309  Sum_probs=199.8

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC-CChhhHHHHHHHHHHHhccC-CCceeeeeeEEE
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCC  186 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  186 (429)
                      .+.++|++.+.||+|+||.||+|.+..++      ..||+|++... ........+.+|+.++..+. ||||+++++++.
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~   79 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTG------EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR   79 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTC------CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCC------CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence            45679999999999999999999876654      34999988654 24455567789999999997 999999999997


Q ss_pred             eCC--eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          187 EDE--HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       187 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                      ..+  ..|+||||++ |+|...+...   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DF  153 (388)
T 3oz6_A           80 ADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADF  153 (388)
T ss_dssp             CTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCC
Confidence            544  7899999997 5899888764   5899999999999999999999988  999999999999999999999999


Q ss_pred             CCCcCCCCCC-------------------CccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 014189          265 GLAKDGPEGD-------------------KSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDK  324 (429)
Q Consensus       265 gla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~  324 (429)
                      |+++......                   .....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||..
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            9997643211                   1112334689999999999986 6799999999999999999999999987


Q ss_pred             CChhhhhhHHHhHh-----------------hHHHhhhhhhhhcCCCCCCC------------CChHHHHHHHHHHHHhh
Q 014189          325 SRPAREQNLADWAL-----------------PLLKEKKKLLNIIDPRLEGD------------YPVKGVHKAAMLAYHCL  375 (429)
Q Consensus       325 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~l~~~cl  375 (429)
                      .+............                 .....-..............            .....+..+.+|+.+||
T Consensus       234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L  313 (388)
T 3oz6_A          234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL  313 (388)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence            66433211110000                 00000000000000000000            01134568999999999


Q ss_pred             ccCCCCCCCHHHHHHh--cccccCC
Q 014189          376 NHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       376 ~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                      +.||++|||++|+++|  |..+...
T Consensus       314 ~~dP~~R~t~~e~l~Hp~~~~~~~~  338 (388)
T 3oz6_A          314 QFNPNKRISANDALKHPFVSIFHNP  338 (388)
T ss_dssp             CSSGGGSCCHHHHTTSTTTTTTCCG
T ss_pred             ccCcccCCCHHHHhCCHHHHHhcCC
Confidence            9999999999999998  5555444

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.9e-45  Score=349.89  Aligned_cols=269  Identities=23%  Similarity=0.274  Sum_probs=202.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||.||+|.+..       +..||+|++..... ......+.+|+.++++++||||+++++++.++
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-------GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-------SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-------CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            45789999999999999999998643       33499999875432 22346678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           92 RCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             SCEEEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCce
Confidence            999999999985 7888776543 35899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh-HhhH----HH
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW-ALPL----LK  342 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~-~~~~----~~  342 (429)
                      .......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............. ....    +.
T Consensus       168 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          168 AFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             ETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             ecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            7543221  2334578999999999876 5689999999999999999999999986654322111000 0000    00


Q ss_pred             hhhhhhhhcCCCC--CCC-----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKKLLNIIDPRL--EGD-----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~~~~~~~~~~--~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....+........  ...     .....+.++.+|+.+||+.||++|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0000000000000  000     112345688999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.3e-46  Score=358.77  Aligned_cols=271  Identities=28%  Similarity=0.380  Sum_probs=212.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||.||+|.+.... ....+..||+|++...........+.+|+.++++++||||+++++++.+.+
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMP-NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCC-CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            3468999999999999999999754321 123355699999987666667778999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCcEEE
Q 014189          190 HRVLIYEFMARGSVENNLFSKVL-----LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKL  261 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl  261 (429)
                      ..++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.   +..+||
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999976532     34889999999999999999999987  999999999999994   456999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhH
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      +|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||.........   ..    
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~----  257 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EF----  257 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HH----
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH---HH----
Confidence            99999875432222222234568999999999999999999999999999999998 99999865432110   00    


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCC
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  400 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  400 (429)
                      +.          .......+..++..+.+++.+||+.||++|||+.+++++|+.+...++
T Consensus       258 ~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          258 VT----------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             HH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             Hh----------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence            00          011112234556789999999999999999999999999998876544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.5e-46  Score=348.99  Aligned_cols=264  Identities=25%  Similarity=0.348  Sum_probs=207.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEcccccc-CcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .++|.+.+.||+|+||.||+|.+..+... ......||+|++... .......+.+|+.++++++||||+++++++.+.+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            46799999999999999999987665421 222355999998654 3345567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc--------EEE
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN--------AKL  261 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~--------~kl  261 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999999997653 24899999999999999999999987  999999999999998887        999


Q ss_pred             eccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCC-CCCCCChhhhhhHHHhHhh
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRK-SLDKSRPAREQNLADWALP  339 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~-p~~~~~~~~~~~~~~~~~~  339 (429)
                      +|||++.....      .....||+.|+|||++.+ ..++.++||||||+++|||++|.. ||...........      
T Consensus       163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~------  230 (289)
T 4fvq_A          163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF------  230 (289)
T ss_dssp             CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH------
T ss_pred             ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH------
Confidence            99999875432      123468899999999987 779999999999999999999554 5544332211100      


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCC
Q 014189          340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAP  403 (429)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  403 (429)
                       ...        .    ...+...+..+.+|+.+||+.||++|||+++++++|+.+....+.++
T Consensus       231 -~~~--------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~  281 (289)
T 4fvq_A          231 -YED--------R----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR  281 (289)
T ss_dssp             -HHT--------T----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred             -hhc--------c----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence             000        0    11122234568889999999999999999999999999988755543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=346.30  Aligned_cols=263  Identities=25%  Similarity=0.365  Sum_probs=213.4

Q ss_pred             cCCccce-eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDR-VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|.+.+ .||+|+||.||+|.+....    .+..||+|++...........+.+|+.+++.++||||+++++++ ..+.
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCC----CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            5666666 9999999999999764321    24559999998776666778899999999999999999999999 5567


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeee
Confidence            89999999999999998654 346999999999999999999999987  999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.........   ..    +      .
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~----i------~  227 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AF----I------E  227 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HH----H------H
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---HH----H------h
Confidence            443221 11223457899999999998899999999999999999999 99999865532111   00    0      0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                      .    ......+..++..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus       228 ~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          228 Q----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             T----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             c----CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            0    1112334466788999999999999999999999999998876543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.4e-45  Score=345.61  Aligned_cols=262  Identities=26%  Similarity=0.360  Sum_probs=210.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+....   ..+..||+|.+...........+.+|+.+++.++||||+++++++.+ +.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHK---GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTT---CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCC---CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence            468999999999999999999865432   22456999999877666667889999999999999999999999875 45


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  ++||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            689999999999999987543 35899999999999999999999987  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..........       ...      .
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-------~~~------~  229 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-------VLE------K  229 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-------HHH------H
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-------HHh------c
Confidence            54321 12233567889999999999999999999999999999998 999997554321110       000      0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                          ......+..++..+.+++.+||..||++|||+.+++++|+.+..
T Consensus       230 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          230 ----GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                00112233456789999999999999999999999999987643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.2e-46  Score=351.39  Aligned_cols=278  Identities=25%  Similarity=0.326  Sum_probs=212.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC--C
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--E  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  189 (429)
                      ..|++.+.||+|+||.||+|.+...  ....+..||+|++...........+.+|+.+++.++||||+++++++...  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPE--GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTT--SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccc--cCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            4688999999999999999985332  22345679999998665555667788999999999999999999999876  6


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccccccc
Confidence            7899999999999999986543 35899999999999999999999987  99999999999999999999999999987


Q ss_pred             CCCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ....... .......||..|+|||++.+..++.++||||||+++|+|++|..|+.................  .......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~  253 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ--MTVTRLV  253 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG--GHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc--cCHHHHH
Confidence            6543321 223345788899999999999999999999999999999999998653211100000000000  0001111


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      ..+........+...+..+.+|+.+||+.||++|||++++++.|+.+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            122222233345567788999999999999999999999999998753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.8e-45  Score=358.60  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=201.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccC--CCceeeeeeEEEeC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLS--HPNLVKLIGYCCED  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  188 (429)
                      .+|++.+.||+|+||.||+|.+..       +..||+|++.... .......+.+|+.+|++++  ||||+++++++...
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~  128 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  128 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-------CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence            469999999999999999997543       3349999987543 4455677899999999996  59999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..|+||| +.+|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++ ++.+||+|||+++
T Consensus       129 ~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          129 QYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             SEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             CEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            99999999 56889999997654  6889999999999999999999977  99999999999995 5889999999998


Q ss_pred             CCCCCCCccccccccCCccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMT-----------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~  337 (429)
                      ..............+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......        
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------  274 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------  274 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--------
Confidence            7654333333445689999999999875           468999999999999999999999997543211        


Q ss_pred             hhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                             ..+..++++......+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       275 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          275 -------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             -------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                   11122233333333344446788999999999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-45  Score=347.63  Aligned_cols=263  Identities=25%  Similarity=0.407  Sum_probs=208.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE-eCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC-EDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~  190 (429)
                      .+|++.+.||+|+||.||+|.+..+..   ....+|+|.+...........+.+|+.++++++||||+++++++. .++.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCC---ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            468889999999999999998654322   245589999987766677788999999999999999999999864 5668


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+++..
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             eEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccc
Confidence            899999999999999996543 46899999999999999999999987  999999999999999999999999999866


Q ss_pred             CCCCC--ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          271 PEGDK--SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       271 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      .....  ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........             .
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-------------~  245 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------------L  245 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-------------H
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-------------H
Confidence            44221  112234567889999999999999999999999999999999 5566665432211000             0


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      ..    ......+...+..+.+++.+||+.||++|||++++++.|+.+..
T Consensus       246 ~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          246 LQ----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             HT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hc----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            00    01112233456789999999999999999999999999988654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=354.69  Aligned_cols=252  Identities=24%  Similarity=0.294  Sum_probs=193.1

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .+.++|++.+.||+|+||.||+|.+..+.      ..||+|++....   ....+.+|+.++++++||||+++++++.+.
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  120 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQ------KPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETP  120 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCC------cEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence            35678999999999999999999876543      349999987643   334577899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCcEEEeccC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFG  265 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  265 (429)
                      +..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.   ++.+||+|||
T Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          121 TEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCc
Confidence            99999999999999999986543  6899999999999999999999987  999999999999975   8899999999


Q ss_pred             CCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      +++......   ......||+.|+|||++.+..++.++|||||||++|||++|..||........  ..           
T Consensus       197 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~-----------  260 (349)
T 2w4o_A          197 LSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF-----------  260 (349)
T ss_dssp             -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH-----------
T ss_pred             cccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH-----------
Confidence            998654321   23346799999999999999999999999999999999999999976543211  00           


Q ss_pred             hhhhhcCC--CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDP--RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ..+...  ..........+..+.+|+.+||+.||++|||+.|++++
T Consensus       261 --~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          261 --RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             --HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              011111  11112223567789999999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=348.50  Aligned_cols=249  Identities=23%  Similarity=0.215  Sum_probs=197.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      ..++|++.++||+|+||+||+|.+..+.      ..||+|++.... .......+..|+..+.++ +||||+++++++.+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDG------RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTS------CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCC------eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            3467999999999999999999876543      349999876543 334445566677666655 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+..++||||+ +|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLL  204 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred             CCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceee
Confidence            99999999999 679998886653 36999999999999999999999987  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      .......   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+......     .             
T Consensus       205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~-------------  262 (311)
T 3p1a_A          205 VELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-----Q-------------  262 (311)
T ss_dssp             EECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----H-------------
T ss_pred             eecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----H-------------
Confidence            8754322   2334679999999998876 7999999999999999999997766432110     0             


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       .+.........+...+..+.+|+.+||+.||++|||++|++++
T Consensus       263 -~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          263 -QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             -HHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -HHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence             0001111111122346789999999999999999999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=346.75  Aligned_cols=271  Identities=24%  Similarity=0.286  Sum_probs=201.5

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC----ChhhHHHHHHHHHHHhcc---CCCceeee
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHL---SHPNLVKL  181 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l---~h~niv~l  181 (429)
                      ...++|++.+.||+|+||.||+|.+..+      +..||+|++....    .......+.+|+.+++.+   +||||+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHS------GHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTT------CCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCC------CcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            4567999999999999999999976554      3459999986322    111123455677777666   49999999


Q ss_pred             eeEEEeCC-----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          182 IGYCCEDE-----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       182 ~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      ++++....     ..++||||+. |+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~  156 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG  156 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT
T ss_pred             eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC
Confidence            99998755     5799999997 69999998776666999999999999999999999988  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~  336 (429)
                      +.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus       157 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          157 GTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             SCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             CCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999998764322   23446899999999999999999999999999999999999999987654322111000


Q ss_pred             HhhHH-Hhhhh----h-hhhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          337 ALPLL-KEKKK----L-LNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       337 ~~~~~-~~~~~----~-~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..... ...+.    . ...+.+....   ......+..+.+|+.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            00000 00000    0 0000000000   0012356788999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=359.61  Aligned_cols=263  Identities=25%  Similarity=0.403  Sum_probs=201.8

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE-eCCeE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC-EDEHR  191 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~  191 (429)
                      .|++.+.||+|+||.||+|.+....   .....||+|.+...........|.+|+.++++++||||+++++++. .++..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETT---TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCC---CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            4778899999999999999875432   1234589999876655666788999999999999999999999875 45688


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccc
Confidence            99999999999999986543 35889999999999999999999987  9999999999999999999999999998654


Q ss_pred             CCCCc--cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          272 EGDKS--HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       272 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .....  .......+|+.|+|||++.+..++.++||||||+++|||++ |.+||........   ...    ..      
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~----~~------  310 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY----LL------  310 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHH----HH------
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHH----HH------
Confidence            32211  11233567889999999999999999999999999999999 6778875443211   000    00      


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      .    ......+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       311 ~----~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          311 Q----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             c----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            0    001122345567899999999999999999999999999887544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.7e-45  Score=344.71  Aligned_cols=268  Identities=22%  Similarity=0.281  Sum_probs=202.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||.||+|.+..++      ..||+|++..... ......+.+|+.++++++||||+++++++...+.
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTG------QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR   76 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCC------cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe
Confidence            67999999999999999999876543      3499998866543 3345667899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence            999999999999988776543  6899999999999999999999987  999999999999999999999999999875


Q ss_pred             CCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh-h-------HH
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL-P-------LL  341 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~-~-------~~  341 (429)
                      .....  ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||................ .       ..
T Consensus       153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          153 TGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             C--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence            43221  2334679999999999976 678999999999999999999999998776543222111100 0       00


Q ss_pred             HhhhhhhhhcCCCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          342 KEKKKLLNIIDPRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...........+......     ....+..+.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000000000000000     02356678999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.1e-46  Score=348.03  Aligned_cols=262  Identities=27%  Similarity=0.383  Sum_probs=212.0

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      +....++|++.+.||+|+||.||+|.+...       ..||+|.+.....  ....+.+|+++++.++||||+++++++.
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCC-------cEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence            344557899999999999999999986532       3499999876532  3467889999999999999999999986


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                       .+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  ++||||||+|||++.++.+||+|||+
T Consensus        79 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~  155 (279)
T 1qpc_A           79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGL  155 (279)
T ss_dssp             -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             -CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcc
Confidence             456899999999999999986543336899999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      +........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.........   .    .+    
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~----~~----  223 (279)
T 1qpc_A          156 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---Q----NL----  223 (279)
T ss_dssp             CEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H----HH----
T ss_pred             cccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH---H----HH----
Confidence            987654321 12233567889999999998899999999999999999999 99999865432110   0    00    


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                        ..    ......+...+..+.+++.+||..||++|||+.++++.|+.+...
T Consensus       224 --~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          224 --ER----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             --HT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --hc----ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence              00    111222345567899999999999999999999999999887554

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.5e-45  Score=367.92  Aligned_cols=251  Identities=25%  Similarity=0.310  Sum_probs=199.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC--CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++...  ........+.+|+.+++.++||||+++++++.+.
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~  220 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATG------RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH  220 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCC------CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence            467999999999999999999876553      44999998643  1233445677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      +..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+ .+  |+||||||+|||++.++.+||+|||++
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a  296 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLC  296 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCc
Confidence            99999999999999999887654  68999999999999999999997 77  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.......      ..      
T Consensus       297 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~------  362 (446)
T 4ejn_A          297 KEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------IL------  362 (446)
T ss_dssp             CTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH------
T ss_pred             eeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH------HH------
Confidence            8643322  223457899999999999999999999999999999999999999986553211100      00      


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                          ..  ....+...+..+.+|+.+||+.||++||     |++|+++|
T Consensus       363 ----~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          363 ----ME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ----HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----hC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                00  0122345567899999999999999999     99999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.8e-45  Score=351.18  Aligned_cols=261  Identities=26%  Similarity=0.358  Sum_probs=209.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||.||+|.+..+..    ...+|+|.+...........+.+|+.+++++ +||||+++++++.+.+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTE----EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCc----ccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            679999999999999999998765432    1236999887655555566788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      .++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC
Confidence            999999999999999987543              246899999999999999999999987  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHH
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~  335 (429)
                      +.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.........    
T Consensus       179 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~----  251 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY----  251 (327)
T ss_dssp             GCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----
T ss_pred             CeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH----
Confidence            999999999987533211   1223467889999999999899999999999999999998 99999866532110    


Q ss_pred             hHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                                   ..+........+...+..+.+|+.+||+.||++|||+++++++|+.+...
T Consensus       252 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          252 -------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             -------------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -------------HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                         00111112223445678899999999999999999999999999887654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9e-45  Score=340.35  Aligned_cols=255  Identities=21%  Similarity=0.301  Sum_probs=208.5

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.++++++||||+++++++.+.
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTG------LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCC------ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence            4578999999999999999999876553      349999986543 444556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc---EEEeccC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---AKLSDFG  265 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg  265 (429)
                      +..++||||+++|+|.+.+....  .+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.   +||+|||
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            99999999999999998887653  6899999999999999999999987  999999999999987665   9999999


Q ss_pred             CCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........       ...  
T Consensus       154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-------~~~--  221 (284)
T 3kk8_A          154 LAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ-------IKA--  221 (284)
T ss_dssp             TCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHH--
T ss_pred             eeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH-------HHh--
Confidence            997654432   22346799999999999999999999999999999999999999976553221100       000  


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ..  ...........+..+.+|+.+||+.||++|||++|++++
T Consensus       222 ---~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          222 ---GA--YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ---TC--CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ---cc--ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence               00  011111123456789999999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-46  Score=364.61  Aligned_cols=264  Identities=20%  Similarity=0.191  Sum_probs=208.0

Q ss_pred             hHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeee
Q 014189          104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKL  181 (429)
Q Consensus       104 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l  181 (429)
                      +.+.....++|++.+.||+|+||.||+|.+..++      ..||+|++.+..  .......+.+|..++..++||||+++
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~------~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l  126 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG------QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL  126 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            3444455688999999999999999999876543      449999986431  11122347789999999999999999


Q ss_pred             eeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          182 IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       182 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                      ++++.+.+.+|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++++||
T Consensus       127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEE
Confidence            999999999999999999999999997643 26899999999999999999999987  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  334 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~  334 (429)
                      +|||+++....... ......+||+.|+|||++.       +..|+.++|||||||++|||++|+.||...+.....   
T Consensus       204 ~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---  279 (412)
T 2vd5_A          204 ADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY---  279 (412)
T ss_dssp             CCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---
T ss_pred             eechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH---
Confidence            99999987644322 2233468999999999997       357899999999999999999999999876532211   


Q ss_pred             HhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCC---CCHHHHHHh
Q 014189          335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---PLMRDIVDS  391 (429)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~~  391 (429)
                         ........   ....+    ..+...+.++.+|+.+||. +|.+|   |+++|+++|
T Consensus       280 ---~~i~~~~~---~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          280 ---GKIVHYKE---HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ---HHHHTHHH---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ---HHHHhccc---CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence               01110000   00001    1123456789999999999 99998   699999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.5e-45  Score=347.44  Aligned_cols=267  Identities=26%  Similarity=0.391  Sum_probs=203.7

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ...++|.+.+.||+|+||.||+|.+....   ..+..||+|++.... .......+.+|+.++++++||||+++++++.+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQED---GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTT---SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccC---CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            34568999999999999999999765432   234569999987553 34455778899999999999999999999976


Q ss_pred             CC-----eEEEEEEecCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc
Q 014189          188 DE-----HRVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN  258 (429)
Q Consensus       188 ~~-----~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~  258 (429)
                      .+     ..++||||+++|+|.+++...    ....+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSC
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCc
Confidence            54     359999999999999988532    3346999999999999999999999977  999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhH
Q 014189          259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWA  337 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~  337 (429)
                      +||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........     
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-----  260 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD-----  260 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-----
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH-----
Confidence            99999999987654332222334567889999999999999999999999999999999 889997654321100     


Q ss_pred             hhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                                 .+.. ......+..++..+.+++.+||..||++|||+.+++++|+.+..
T Consensus       261 -----------~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          261 -----------YLLH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             -----------HHHT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------HHHc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       0000 11122334566789999999999999999999999999988654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=346.67  Aligned_cols=257  Identities=28%  Similarity=0.425  Sum_probs=200.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||.||+|.+..        ..||+|.+...   .....|.+|+.++++++||||+++++++.  +..
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~   74 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRA--------KDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPV   74 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETT--------EEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTT
T ss_pred             hHeeeeeEeecCCCceEEEEEECC--------eeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCc
Confidence            578899999999999999997642        34999998643   34567889999999999999999999886  347


Q ss_pred             EEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC-CCceeCCCCCCcEEEcCCCc-EEEeccCCCc
Q 014189          192 VLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYN-AKLSDFGLAK  268 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~  268 (429)
                      ++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            899999999999999976542 24788999999999999999999832 34999999999999998887 7999999997


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........  +         ...
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~---------~~~  218 (307)
T 2eva_A          155 DIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--W---------AVH  218 (307)
T ss_dssp             ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH--H---------HHH
T ss_pred             ccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH--H---------HHh
Confidence            64321     2234699999999999999999999999999999999999999975432211000  0         001


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE  401 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  401 (429)
                      ..    .........+..+.+++.+||+.||++|||++++++.|+.+......
T Consensus       219 ~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          219 NG----TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             TT----CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             cC----CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            11    11122334567889999999999999999999999999887654433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.1e-45  Score=359.48  Aligned_cols=255  Identities=18%  Similarity=0.216  Sum_probs=194.2

Q ss_pred             hcCCccc-eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHh-ccCCCceeeeeeEEEe-
Q 014189          111 TANFRQD-RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG-HLSHPNLVKLIGYCCE-  187 (429)
Q Consensus       111 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~-  187 (429)
                      .++|.+. ++||+|+||.||+|.+..++      ..||+|++...      ..+.+|+.++. ..+||||+++++++.. 
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~------~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQ------EKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCC------CEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            4567766 78999999999999876554      34999998642      24557888874 4589999999999875 


Q ss_pred             ---CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCcEEE
Q 014189          188 ---DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKL  261 (429)
Q Consensus       188 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl  261 (429)
                         .+.+|+||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.   ++.+||
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEE
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEE
Confidence               567899999999999999998766567999999999999999999999987  999999999999998   789999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      +|||+++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........   ....+
T Consensus       206 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i  279 (400)
T 1nxk_A          206 TDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRI  279 (400)
T ss_dssp             CCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHH
T ss_pred             EecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHH
Confidence            9999998654322   23456899999999999999999999999999999999999999976543211000   00000


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      ..    .   ............+.++.+|+.+||+.||++|||+.|++++-
T Consensus       280 ~~----~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          280 RM----G---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             HH----T---CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             Hc----C---cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            00    0   00111111234677899999999999999999999999873

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-45  Score=342.69  Aligned_cols=255  Identities=25%  Similarity=0.294  Sum_probs=201.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      +.++|.+.+.||+|+||.||+|.+..+.      ..+|+|++...........+.+|+.++++++||||+++++++.+.+
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   93 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSG------LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH   93 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCC------ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence            3467999999999999999999876543      3499999876554455677889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE---cCCCcEEEecc
Q 014189          190 HRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDF  264 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df  264 (429)
                      ..++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.+  |+||||||+|||+   +.++.+||+||
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEee
Confidence            999999999999999988542  2346999999999999999999999987  9999999999999   55688999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      |++.......   ......||+.|+|||++. ..++.++||||||+++|||++|+.||............          
T Consensus       172 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~----------  237 (285)
T 3is5_A          172 GLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA----------  237 (285)
T ss_dssp             CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------
T ss_pred             ecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh----------
Confidence            9998654322   233467999999999875 56899999999999999999999999876532211100          


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          ....+.... .....+..+.+|+.+||+.||++|||++|++++
T Consensus       238 ----~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          238 ----TYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ----HHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ----ccCCccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                001111100 011245678899999999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.7e-45  Score=348.71  Aligned_cols=255  Identities=22%  Similarity=0.271  Sum_probs=207.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-----hhHHHHHHHHHHHhccCCCceeeeeeE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      +.++|++.+.||+|+||.||+|.+..++      ..||+|++......     .....+.+|+.++++++||||++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTG------LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV   83 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCC------eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            4567999999999999999999876543      34999998754322     135678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC----cEE
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAK  260 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~----~~k  260 (429)
                      +.+.+..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           84 YENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEE
Confidence            999999999999999999999997543  6899999999999999999999987  99999999999999888    799


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      |+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........      .
T Consensus       160 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------i  230 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN------I  230 (321)
T ss_dssp             ECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------H
T ss_pred             EccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH------H
Confidence            999999987654321   2346799999999999999999999999999999999999999986543211100      0


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                             .. .............+..+.+|+.+||..||++|||++|++++
T Consensus       231 -------~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          231 -------TS-VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             -------HT-TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             -------Hh-cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   00 00000000112345678999999999999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.5e-45  Score=348.29  Aligned_cols=254  Identities=26%  Similarity=0.311  Sum_probs=198.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC---ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .++|++.+.||+|+||.||+|.....   ...+..||+|++....   .......+.+|+.+++.++||||+++++++..
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTG---ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSS---TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEecc---CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            46899999999999999999976422   1234569999987653   12334557789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999999987643  5889999999999999999999987  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      +......  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||.........      .....     
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~-----  235 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------DKILK-----  235 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHH-----
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHh-----
Confidence            7643322  1234468999999999999999999999999999999999999999865532110      01110     


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                           .  ....+...+..+.+|+.+||..||++||     +++++++|
T Consensus       236 -----~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          236 -----C--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -----T--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -----C--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                 0  1122345567899999999999999999     78899876

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5e-45  Score=343.12  Aligned_cols=267  Identities=20%  Similarity=0.243  Sum_probs=199.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||.||+|.+..       +..||+|++...... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNY-------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETT-------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCC-------CCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            478999999999999999997632       234999998765322 223567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            9999999975 8988886543 36899999999999999999999987  999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH-hhHHHhhh-hh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA-LPLLKEKK-KL  347 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~~-~~  347 (429)
                      ....  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... .......+ ..
T Consensus       151 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          151 GIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             Cccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh
Confidence            3221  11234578999999999976 45899999999999999999999999876543221110000 00000000 00


Q ss_pred             h--hhcCCCCCC-------CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 L--NIIDPRLEG-------DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~--~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .  ...++....       ......+..+.+|+.+||+.||++|||++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0  001111100       1112356788999999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.2e-45  Score=373.13  Aligned_cols=255  Identities=26%  Similarity=0.375  Sum_probs=210.4

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+..++      ..||+|++....  .......+.+|+.+|+.++||||+++++++.+.
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg------~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATG------KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            456999999999999999999876543      449999986431  122345678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +.+|+||||++||+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccce
Confidence            99999999999999999998766556999999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh-hhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE-QNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  347 (429)
                      ......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ..+...    .      
T Consensus       335 ~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~----i------  401 (576)
T 2acx_A          335 HVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL----V------  401 (576)
T ss_dssp             ECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH----H------
T ss_pred             ecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH----h------
Confidence            765432   23346899999999999999999999999999999999999999986542111 011000    0      


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      . ..    ...++...+..+.+|+.+||+.||++||     +++|+++|
T Consensus       402 ~-~~----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          402 K-EV----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             H-HC----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             h-cc----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            0 00    1123345678899999999999999999     78999977

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-45  Score=352.44  Aligned_cols=281  Identities=23%  Similarity=0.260  Sum_probs=215.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE--eCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC--EDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+...  ....+..||+|++... .......+.+|+.++++++||||+++++++.  +..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPL--GDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTT--SSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccC--CCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            5799999999999999999975321  2233566999998765 3455567889999999999999999999886  456


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccccee
Confidence            7899999999999999987543 25899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||............ ... .......+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~-~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CER-DVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-ccc-ccccHHHHH
Confidence            6543321 1223356888999999999999999999999999999999999998743321100000 000 000001112


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  400 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  400 (429)
                      ..+........+..++..+.+|+.+||+.||++|||+++++++|+.+.....
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            2222233334455678889999999999999999999999999998876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.3e-45  Score=351.89  Aligned_cols=254  Identities=21%  Similarity=0.291  Sum_probs=203.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++......     +.+|++++.++ +||||+++++++.+.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~   88 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATN------MEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDG   88 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence            4568999999999999999999876553      44999999765322     23688888887 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC----CcEEEecc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD----YNAKLSDF  264 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~----~~~kl~Df  264 (429)
                      +..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||+..+    +.+||+||
T Consensus        89 ~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Df  164 (342)
T 2qr7_A           89 KYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDF  164 (342)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence            99999999999999999987654  6899999999999999999999987  9999999999998543    35999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      |+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..........+..   . +.. 
T Consensus       165 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~-i~~-  237 (342)
T 2qr7_A          165 GFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---R-IGS-  237 (342)
T ss_dssp             TTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---H-HHH-
T ss_pred             CCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---H-Hcc-
Confidence            99986543322  2345689999999999998889999999999999999999999997543211111111   0 000 


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            .............+..+.+|+.+||..||++|||+.+++++
T Consensus       238 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          238 ------GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             ------CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ------CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  01111222234567889999999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=354.53  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=198.2

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      .+.||+|+||.||+|.+..++      ..||+|++... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E  166 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATG------LKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME  166 (373)
T ss_dssp             EEECC-----CEEEEEETTTC------CEEEEEEEECC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEecCcCEEEEEEEEcCCC------cEEEEEEEccc-ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            578999999999999876543      34999998865 33456778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE--cCCCcEEEeccCCCcCCCCCC
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL--DTDYNAKLSDFGLAKDGPEGD  274 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~  274 (429)
                      |+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||+  +.++.+||+|||+++......
T Consensus       167 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          167 YVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             CCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             CCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            999999999887543 35899999999999999999999987  9999999999999  677899999999998765432


Q ss_pred             CccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          275 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       275 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                      .   .....||+.|+|||++.+..++.++|||||||++|||++|..||.........      .......      .  .
T Consensus       244 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~~------~--~  306 (373)
T 2x4f_A          244 K---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL------NNILACR------W--D  306 (373)
T ss_dssp             B---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTC------C--C
T ss_pred             c---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcc------C--C
Confidence            2   23457999999999999999999999999999999999999999876532211      0001000      0  0


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .........+..+.+|+.+||+.||++|||++|++++
T Consensus       307 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0111112456789999999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.4e-45  Score=351.60  Aligned_cols=250  Identities=27%  Similarity=0.358  Sum_probs=203.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..|+..+.||+|+||.||+|.+..+      +..||+|++....  .......+.+|+.++++++||||+++++++...+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRN------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH  127 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeeEEccCCCEEEEEEEEccC------CeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            4588999999999999999986554      3459999987543  2334467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+. |+|.+.+.... .++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             eEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            9999999997 68888775432 36899999999999999999999987  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ...      .....||+.|+|||++.   ...++.++|||||||++|||++|+.||.........      ...      
T Consensus       204 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~------  265 (348)
T 1u5q_A          204 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHI------  265 (348)
T ss_dssp             SSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHH------
T ss_pred             cCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHH------
Confidence            543      22357999999999985   567899999999999999999999999765432110      000      


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                       .....+.   ..+...+..+.+|+.+||+.||++|||+++++++..
T Consensus       266 -~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          266 -AQNESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             -HHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             -HhcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence             1111111   112345677899999999999999999999998743

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.8e-45  Score=346.55  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=198.8

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhc--cCCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH--LSHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~  187 (429)
                      +.++|++.+.||+|+||.||+|.+.        +..||+|++...    ....+..|.+++..  ++||||+++++++..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~   73 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ--------GENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMT   73 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET--------TEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC--------CEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence            4578999999999999999999763        334999998643    33445566666665  789999999998754


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeCCCCCCcEEEcC
Q 014189          188 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH--------EAEKPVIYRDFKTSNILLDT  255 (429)
Q Consensus       188 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~ivH~Dlkp~NIll~~  255 (429)
                          ....++||||+++|+|.+++...   .+++..+..++.|++.||+|||        +.+  |+||||||+|||++.
T Consensus        74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~  148 (301)
T 3q4u_A           74 SRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKK  148 (301)
T ss_dssp             EETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECT
T ss_pred             ccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcC
Confidence                34689999999999999999543   6999999999999999999999        756  999999999999999


Q ss_pred             CCcEEEeccCCCcCCCCCCCcc--ccccccCCcccccccccccC------CCCcccchhhHHHHHHHHHhC---------
Q 014189          256 DYNAKLSDFGLAKDGPEGDKSH--VSTRIMGTYGYAAPEYIMTG------HLTPRSDVYSFGVVLLEILTG---------  318 (429)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltG---------  318 (429)
                      ++.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|         
T Consensus       149 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~  228 (301)
T 3q4u_A          149 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED  228 (301)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence            9999999999997544322211  12235799999999999876      556799999999999999999         


Q ss_pred             -CCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCC-CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          319 -RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG-DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       319 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                       ..||......... ... .....     ......+.... ..+...+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus       229 ~~~pf~~~~~~~~~-~~~-~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          229 YKPPFYDVVPNDPS-FED-MRKVV-----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCTTTTTSCSSCC-HHH-HHHHH-----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccccCCCCcc-hhh-hhHHH-----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence             7787644321110 000 00000     00111111111 11235678899999999999999999999999999765

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.4e-45  Score=348.77  Aligned_cols=262  Identities=19%  Similarity=0.241  Sum_probs=209.8

Q ss_pred             HHHHHHhcCCccc-eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccC-CCceeee
Q 014189          105 DELRIITANFRQD-RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLS-HPNLVKL  181 (429)
Q Consensus       105 ~~~~~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l  181 (429)
                      .....+.+.|.+. +.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.++..+. ||||+++
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~   94 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTG------QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL   94 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCC------CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            3445667788887 89999999999999876553      349999987643 2334567889999999995 7999999


Q ss_pred             eeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCc
Q 014189          182 IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYN  258 (429)
Q Consensus       182 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~  258 (429)
                      ++++.+.+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.   ++.
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCC
T ss_pred             EEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCc
Confidence            999999999999999999999999987665667999999999999999999999987  999999999999998   789


Q ss_pred             EEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      +||+|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........     
T Consensus       173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-----  244 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-----  244 (327)
T ss_dssp             EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----
T ss_pred             EEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-----
Confidence            9999999998764322   12346799999999999999999999999999999999999999987653221100     


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                              .. ..............+..+.+|+.+||+.||++|||+++++++
T Consensus       245 --------i~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          245 --------IS-QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             --------HH-HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             --------HH-hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                    00 011111222233567789999999999999999999999987

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-45  Score=356.88  Aligned_cols=251  Identities=25%  Similarity=0.309  Sum_probs=196.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHH-HhccCCCceeeeeeEEEe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIF-LGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~  187 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+..|..+ ++.++||||+++++++.+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEE------VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTC------CEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCC------CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            467999999999999999999876543      449999987543  12233456677776 567899999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+.+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a  186 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLC  186 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccc
Confidence            999999999999999999987643  5889999999999999999999987  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+....      .          
T Consensus       187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~----------  248 (373)
T 2r5t_A          187 KENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------Y----------  248 (373)
T ss_dssp             GGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH------H----------
T ss_pred             cccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------H----------
Confidence            8633221  123457899999999999999999999999999999999999999986543211      0          


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHH----HHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR----DIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~----evl~~  391 (429)
                      ..+....  ...+...+..+.+|+.+||+.||.+||++.    ++++|
T Consensus       249 ~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          249 DNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             HHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             HHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence            0111111  122335567899999999999999999974    55544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2e-45  Score=349.73  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=199.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      +.++|++.+.||+|+||.||+|.+..+      +..||+|++....  .......+.+|+.++++++||||+++++++..
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   83 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRD------HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   83 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCC------CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence            457899999999999999999987554      3459999997653  33445678899999999999999999999875


Q ss_pred             CC----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          188 DE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       188 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                      ..    ..|+||||+++|+|.+++....  ++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~D  159 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMD  159 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEee
Confidence            54    3499999999999999987653  6899999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          264 FGLAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       264 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      ||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........      .....
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~  233 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVR  233 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhc
Confidence            9999865443221 1223457999999999999999999999999999999999999999876542210      00000


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHH-HhcccccC
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV-DSLEPLQV  397 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl-~~L~~~~~  397 (429)
                      ..        ...........+..+.+|+.+||+.||++||+..+++ ..|.++..
T Consensus       234 ~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          234 ED--------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             CC--------CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CC--------CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            00        0000000123467889999999999999999766655 44555433

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.5e-45  Score=363.96  Aligned_cols=250  Identities=26%  Similarity=0.339  Sum_probs=207.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|.+.+.||+|+||.||+|.+..++      ..||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g------~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~   88 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTG------HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP   88 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTC------CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            368999999999999999999876543      349999986432  112345688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchh
Confidence            99999999999999999986543  6999999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........      .          
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~----------  225 (476)
T 2y94_A          165 MMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL------F----------  225 (476)
T ss_dssp             ECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH------H----------
T ss_pred             hccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH------H----------
Confidence            765432   2344689999999999998766 7899999999999999999999986543211      0          


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..+.+..  ...+...+..+.+|+.+||..||++|||++|++++
T Consensus       226 ~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          226 KKICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            1111111  11233456788999999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4e-45  Score=352.46  Aligned_cols=261  Identities=23%  Similarity=0.266  Sum_probs=202.9

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCceeeee
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVKLI  182 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~  182 (429)
                      +..+.++|++.+.||+|+||.||+|.+..+.      ..||+|++....    .......+.+|+.++++++||||++++
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   94 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTR------AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY   94 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCC------ceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence            3456788999999999999999999876543      349999986431    234556788999999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCC--------------------------------------CCCCCHHHHHHHH
Q 014189          183 GYCCEDEHRVLIYEFMARGSVENNLFSKV--------------------------------------LLPLPWSIRMKIA  224 (429)
Q Consensus       183 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~  224 (429)
                      +++.+.+..++||||+++|+|.+++....                                      ...+++..+..++
T Consensus        95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  174 (345)
T 3hko_A           95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM  174 (345)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred             hhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence            99999999999999999999999884210                                      1123567788899


Q ss_pred             HHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC--cEEEeccCCCcCCCCCC--CccccccccCCccccccccccc--CC
Q 014189          225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY--NAKLSDFGLAKDGPEGD--KSHVSTRIMGTYGYAAPEYIMT--GH  298 (429)
Q Consensus       225 ~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~  298 (429)
                      .|++.||+|||+.+  |+||||||+|||++.++  .+||+|||++.......  .........||+.|+|||++.+  ..
T Consensus       175 ~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          175 RQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            99999999999987  99999999999998777  89999999997543211  1112344679999999999975  67


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCC--CCCCChHHHHHHHHHHHHhhc
Q 014189          299 LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL--EGDYPVKGVHKAAMLAYHCLN  376 (429)
Q Consensus       299 ~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~  376 (429)
                      ++.++||||||+++|||++|+.||.........                ..+.....  ........+..+.+|+.+||+
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  316 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI----------------SQVLNKKLCFENPNYNVLSPLARDLLSNLLN  316 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHCCCCTTSGGGGGSCHHHHHHHHHHSC
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH----------------HHHHhcccccCCcccccCCHHHHHHHHHHcC
Confidence            899999999999999999999999876543211                01111111  111112356789999999999


Q ss_pred             cCCCCCCCHHHHHHh
Q 014189          377 HNPKARPLMRDIVDS  391 (429)
Q Consensus       377 ~dP~~RPs~~evl~~  391 (429)
                      .||.+|||+.+++++
T Consensus       317 ~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          317 RNVDERFDAMRALQH  331 (345)
T ss_dssp             SCTTTSCCHHHHHHS
T ss_pred             CChhHCCCHHHHhcC
Confidence            999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-45  Score=340.08  Aligned_cols=257  Identities=25%  Similarity=0.402  Sum_probs=210.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+       ..||+|++.....  ....+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeEecCCCceeEEEEEecCC-------CeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            46799999999999999999987532       3499999986543  33578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             eEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccccccc
Confidence            999999999999999997653 36899999999999999999999987  999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..........      .       ...
T Consensus       155 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~-------i~~  220 (267)
T 3t9t_A          155 LDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE------D-------IST  220 (267)
T ss_dssp             CCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------H-------HHT
T ss_pred             cccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH------H-------Hhc
Confidence            4321 111233567889999999998999999999999999999999 899998654321100      0       000


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                          ......+...+..+.+++.+||+.||++|||+++++++|+.+..
T Consensus       221 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          221 ----GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                11112233456788999999999999999999999999987754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.3e-45  Score=353.91  Aligned_cols=267  Identities=23%  Similarity=0.299  Sum_probs=209.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++...........+.+|+.+++.++||||+++++++...+.
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSG------LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCC------cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            467999999999999999999876543      44999999877666667788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .++||||+++|+|.+++....  .+++..+..++.+++.||+|||+. +  |+||||||+|||++.++.+||+|||++..
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            999999999999999997654  589999999999999999999984 7  99999999999999999999999999864


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh---------H
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP---------L  340 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~---------~  340 (429)
                      ....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................         .
T Consensus       182 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          182 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             HHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             cccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence            3221    12345799999999999999999999999999999999999999987654322111000000         0


Q ss_pred             H-----------------HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 L-----------------KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .                 ........+.............+..+.+|+.+||+.||++|||++|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            0                 00000000111111111122356789999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=346.51  Aligned_cols=275  Identities=23%  Similarity=0.354  Sum_probs=205.1

Q ss_pred             ChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc--CCCceee
Q 014189          103 TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL--SHPNLVK  180 (429)
Q Consensus       103 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~  180 (429)
                      .......+.++|++.+.||+|+||.||+|.+.        +..||+|++...    ....+..|.+++..+  +||||++
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~   95 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--------GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILG   95 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCC
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC--------CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeee
Confidence            33444566789999999999999999999764        334999998643    233444566666554  8999999


Q ss_pred             eeeEEEeC----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceeCCCCCCc
Q 014189          181 LIGYCCED----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA------EKPVIYRDFKTSN  250 (429)
Q Consensus       181 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivH~Dlkp~N  250 (429)
                      +++++...    ...++||||+++|+|.+++...   .+++..+..++.|++.||+|||+.      .++|+||||||+|
T Consensus        96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~N  172 (337)
T 3mdy_A           96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN  172 (337)
T ss_dssp             EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGG
T ss_pred             EEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHH
Confidence            99999877    7899999999999999999665   589999999999999999999987      1139999999999


Q ss_pred             EEEcCCCcEEEeccCCCcCCCCCCCcc--ccccccCCcccccccccccCCCCcc------cchhhHHHHHHHHHhC----
Q 014189          251 ILLDTDYNAKLSDFGLAKDGPEGDKSH--VSTRIMGTYGYAAPEYIMTGHLTPR------SDVYSFGVVLLEILTG----  318 (429)
Q Consensus       251 Ill~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltG----  318 (429)
                      ||++.++.+||+|||+++.........  ......||+.|+|||++.+..++..      +|||||||++|||++|    
T Consensus       173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            999999999999999997654332211  1224579999999999987766665      9999999999999999    


Q ss_pred             ------CCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCC-ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          319 ------RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       319 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            ..||......... ...     ... ........+...... ...++..+.+|+.+||+.||++|||+.+++++
T Consensus       253 ~~~~~~~~p~~~~~~~~~~-~~~-----~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPS-YED-----MRE-IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCC-HHH-----HHH-HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccccccccHhhhcCCCCc-hhh-----hHH-HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                  5666543221100 000     000 000111111111111 23678889999999999999999999999999


Q ss_pred             cccccCCC
Q 014189          392 LEPLQVLP  399 (429)
Q Consensus       392 L~~~~~~~  399 (429)
                      |+.+....
T Consensus       326 L~~l~~~~  333 (337)
T 3mdy_A          326 LAKMSESQ  333 (337)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHhhc
Confidence            99887654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.6e-45  Score=351.11  Aligned_cols=249  Identities=23%  Similarity=0.286  Sum_probs=180.2

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeEEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      +.||+|+||.||+|.+..+.      ..||+|++...    ....+.+|+.++..+. ||||+++++++.+....|+|||
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSN------QAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTC------CEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CccccCCCeEEEEEEECCCC------CEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            78999999999999876553      34999998643    3456678999999997 9999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC---cEEEeccCCCcCCCCC
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---NAKLSDFGLAKDGPEG  273 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~  273 (429)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++   .+||+|||+++.....
T Consensus        87 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           87 LLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            999999999997754  6999999999999999999999987  99999999999998766   8999999999865433


Q ss_pred             CCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCC
Q 014189          274 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  353 (429)
Q Consensus       274 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (429)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..............         ....+...
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---------~~~~i~~~  231 (325)
T 3kn6_A          163 NQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE---------IMKKIKKG  231 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH---------HHHHHTTT
T ss_pred             CC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH---------HHHHHHcC
Confidence            22  23446789999999999999999999999999999999999999986543211000000         01111111


Q ss_pred             CCC--CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          354 RLE--GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       354 ~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...  .......+..+.+|+.+||+.||++|||+++++++
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            111  11112357789999999999999999999999876

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.1e-45  Score=364.43  Aligned_cols=275  Identities=21%  Similarity=0.291  Sum_probs=191.3

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  187 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.+|+.++||||+++++++.. 
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEK------RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCC------cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            3478999999999999999999876553      349999986543 34455778899999999999999999999843 


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          188 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       188 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                          ...+|+||||+ +|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~D  199 (458)
T 3rp9_A          125 DVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCD  199 (458)
T ss_dssp             CTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECC
T ss_pred             CcccCceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecc
Confidence                35789999998 478998886543  6999999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCc-------------------------cccccccCCccccccccc-ccCCCCcccchhhHHHHHHHHHh
Q 014189          264 FGLAKDGPEGDKS-------------------------HVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEILT  317 (429)
Q Consensus       264 fgla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt  317 (429)
                      ||+++........                         ...+..+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus       200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            9999876432110                         122346789999999986 46679999999999999999999


Q ss_pred             -----------CCCCCCCCChhhh-----------------hhHHHhHhhHHH-------------hhhhhhhhcCCCCC
Q 014189          318 -----------GRKSLDKSRPARE-----------------QNLADWALPLLK-------------EKKKLLNIIDPRLE  356 (429)
Q Consensus       318 -----------G~~p~~~~~~~~~-----------------~~~~~~~~~~~~-------------~~~~~~~~~~~~~~  356 (429)
                                 |+++|.+......                 .+....+...+.             ........+.....
T Consensus       280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  359 (458)
T 3rp9_A          280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG  359 (458)
T ss_dssp             TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred             hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence                       6666654331100                 000000000000             00000111111100


Q ss_pred             C---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccc
Q 014189          357 G---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPL  395 (429)
Q Consensus       357 ~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~  395 (429)
                      .   ......+..+.+|+.+||..||++|||++|+++|  |..+
T Consensus       360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            0   0112346789999999999999999999999997  4444

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.7e-45  Score=341.92  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=207.6

Q ss_pred             hcCCccce-eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDR-VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ..+|.+.+ .||+|+||.||+|.+...    ..+..||+|++..... ......+.+|+.+++.++||||+++++++ ..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECS----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             chhhhhccCccccccCeeeEeeeecCC----CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            35788888 999999999999965322    1245599999876532 33356788999999999999999999999 56


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            77899999999999999997653  5899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCcc-ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          269 DGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       269 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..........       .+     
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~-----  233 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-------ML-----  233 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HH-----
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HH-----
Confidence            765433211 1222456789999999998889999999999999999999 999998765321100       00     


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                           ........+..++..+.+++.+||+.||++|||+.++++.|+.+-.
T Consensus       234 -----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          234 -----EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             -----HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 0111122344567889999999999999999999999999987643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9e-45  Score=375.23  Aligned_cols=261  Identities=26%  Similarity=0.367  Sum_probs=207.7

Q ss_pred             cCCccce-eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDR-VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++.+.+ .||+|+||.||+|.+....    .+..||||++...........|.+|+.+|++++|||||++++++.. +.
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSS----CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCC----CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            3444444 7999999999999875321    2345999999876555567889999999999999999999999976 56


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            89999999999999998654 346999999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCcc-ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........                 
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-----------------  549 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-----------------  549 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-----------------
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----------------
Confidence            5432211 1122346789999999999999999999999999999998 99999876542211                 


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      ..+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       550 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          550 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            0011111223445677889999999999999999999999999987643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.3e-45  Score=344.77  Aligned_cols=269  Identities=22%  Similarity=0.295  Sum_probs=202.4

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC--CChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+..++      ..||+|++...  ........+.+|+.++++++||||+++++++...
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDG------VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED  104 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTC------CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCC------ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            357999999999999999999875543      44999998753  2344567788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          189 EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      +..++||||+++|+|.+++..  .....+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            999999999999999998864  22346899999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      +.......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||........    .....       
T Consensus       183 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-------  249 (310)
T 2wqm_A          183 GRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCKK-------  249 (310)
T ss_dssp             ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----HHHHH-------
T ss_pred             eeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----HHHHH-------
Confidence            88654322  122345789999999999999999999999999999999999999975432110    00000       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCC
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAP  403 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  403 (429)
                      ...   ...........+..+.+|+.+||..||++|||+.++++.|++++.....++
T Consensus       250 ~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          250 IEQ---CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             HHT---TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             hhc---ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence            000   011111123456789999999999999999999999999999877644443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=348.05  Aligned_cols=271  Identities=18%  Similarity=0.226  Sum_probs=201.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh----------hHHHHHHHHHHHhccCCCceee
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ----------GHREWLAEVIFLGHLSHPNLVK  180 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~  180 (429)
                      .++|++.+.||+|+||.||+|.+.....   ....+|+|+........          ....+.+|+..++.++||||++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE---KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCG---GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCC---ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            4679999999999999999998765211   23459999987654321          1123567888999999999999


Q ss_pred             eeeEEEe----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          181 LIGYCCE----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       181 l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      +++++..    ....++||||+ +++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence            9999987    77899999999 999999987654  6999999999999999999999987  9999999999999988


Q ss_pred             C--cEEEeccCCCcCCCCCCC-----ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhh
Q 014189          257 Y--NAKLSDFGLAKDGPEGDK-----SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR  329 (429)
Q Consensus       257 ~--~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~  329 (429)
                      +  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  999999999976532211     111244689999999999999999999999999999999999999996422111


Q ss_pred             hhhHHHhHhhHHHhh-hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          330 EQNLADWALPLLKEK-KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      .. ............ ........       ....+..+.+++.+||..||++|||+++|++.|+.+..
T Consensus       268 ~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 VA-VQTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HH-HHHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HH-HHHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            10 000000000000 00000000       11345689999999999999999999999999988654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.5e-45  Score=339.82  Aligned_cols=249  Identities=28%  Similarity=0.419  Sum_probs=203.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.++++++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSK------FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCC------cEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            467999999999999999999876553      349999986432  112245678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccc
Confidence            99999999999999999987653  5899999999999999999999977  9999999999999999999999999986


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......    .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...........             ..
T Consensus       158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~  220 (279)
T 3fdn_A          158 HAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-------------IS  220 (279)
T ss_dssp             CC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------------HH
T ss_pred             cCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH-------------HH
Confidence            543322    2346799999999999999999999999999999999999999986543211100             00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      . .    ....+...+..+.+|+.+||+.||++|||++|++++
T Consensus       221 ~-~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          221 R-V----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             H-T----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             h-C----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0 0    112233456788999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=374.05  Aligned_cols=262  Identities=25%  Similarity=0.360  Sum_probs=214.1

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      +.+..++|++.+.||+|+||.||+|.+..+       ..||||++.....  ..+.|.+|+.+|++++||||+++++++.
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~  332 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS  332 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTT-------EEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCC-------ceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            344567799999999999999999987643       2399999986532  3467899999999999999999999987


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      + +..++||||+++|+|.+++.......+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus       333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEccccc
Confidence            6 67899999999999999997544446899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ++...... ........+|..|+|||++.+..++.++|||||||++|||++ |+.||..........       .+    
T Consensus       410 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~-------~i----  477 (535)
T 2h8h_A          410 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QV----  477 (535)
T ss_dssp             TTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH-------HH----
T ss_pred             ceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HH----
Confidence            98754321 111223457889999999999999999999999999999999 999998654321100       00    


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                            ........+..++..+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus       478 ------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          478 ------ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                  01112223446678899999999999999999999999999987654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=351.09  Aligned_cols=245  Identities=22%  Similarity=0.301  Sum_probs=204.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-------hhHHHHHHHHHHHhccCCCceeeee
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-------QGHREWLAEVIFLGHLSHPNLVKLI  182 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~  182 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..||+|++......       .....+.+|+.++++++||||++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~   95 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKN------KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL   95 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTT------EEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCC------cEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4568999999999999999999876553      44999998765311       1223466799999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          183 GYCCEDEHRVLIYEFMARG-SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       183 ~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                      +++.+.+..++||||+.+| +|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A           96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             EEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEE
Confidence            9999999999999999777 9999886654  6999999999999999999999987  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      +|||++........   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......            
T Consensus       172 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------  236 (335)
T 3dls_A          172 IDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------  236 (335)
T ss_dssp             CCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------
T ss_pred             eecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------
Confidence            99999987654322   234679999999999998776 88999999999999999999999742210            


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                ....  ...+...+..+.+|+.+||+.||++|||+++++++
T Consensus       237 ----------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ----------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      0000  11122356789999999999999999999999997

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-44  Score=361.55  Aligned_cols=266  Identities=21%  Similarity=0.261  Sum_probs=197.8

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLD------RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTT------EEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCC------CEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            3578999999999999999999876553      449999987542 344456788999999999999999999999654


Q ss_pred             ------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 ------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                            ...|+||||++++ |.+.+..    .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus       134 ~~~~~~~~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~  206 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  206 (464)
T ss_dssp             CSTTTCCEEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEEC
T ss_pred             CccccCCeEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEE
Confidence                  4679999999764 6665532    4889999999999999999999987  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh---
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP---  339 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~---  339 (429)
                      |||+++......   ..+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.............   
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~  283 (464)
T 3ttj_A          207 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  283 (464)
T ss_dssp             CCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998754321   23456899999999999999999999999999999999999999987664322111000000   


Q ss_pred             --HHHh-hhhhhhhcCCC---------------CCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          340 --LLKE-KKKLLNIIDPR---------------LEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       340 --~~~~-~~~~~~~~~~~---------------~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .+.. .......+...               +....   ....+..+.+|+.+||..||++|||++|+++|
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0000 00001111100               00000   01126789999999999999999999999987

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-44  Score=337.73  Aligned_cols=249  Identities=22%  Similarity=0.287  Sum_probs=204.7

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..+|+|.+.... ......+.+|+.++++++||||+++++++.+.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTR------IRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT   79 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCC------cEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            4567999999999999999999876553      348999886542 234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE---cCCCcEEEeccCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFGL  266 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgl  266 (429)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||+|||+.+  ++||||||+|||+   +.++.+||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~  155 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGL  155 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             eEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence            9999999999999999887653  5899999999999999999999987  9999999999999   8889999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      +.......   ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........      ..     
T Consensus       156 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~-----  220 (277)
T 3f3z_A          156 AARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK------IR-----  220 (277)
T ss_dssp             CEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-----
T ss_pred             ceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH------HH-----
Confidence            98654432   23346799999999988654 89999999999999999999999987553221100      00     


Q ss_pred             hhhhcCCCCCCCCCh----HHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPV----KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                           ...  ...+.    ..+..+.+|+.+||+.||++|||+.+++++
T Consensus       221 -----~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          221 -----EGT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             -----HCC--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -----hCC--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000  01111    346789999999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.8e-44  Score=341.74  Aligned_cols=252  Identities=25%  Similarity=0.367  Sum_probs=210.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ...|++.+.||+|+||.||+|.+..+.      ..||+|++...........+.+|+.+++.++||||+++++++...+.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQ------KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCC------cEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            356999999999999999999875543      34999999776555566788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++++|.+++...   ++++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.+||+|||++...
T Consensus        95 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceec
Confidence            99999999999999988643   6899999999999999999999987  999999999999999999999999999765


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ....  .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........       .      ...
T Consensus       170 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~------~~~  234 (303)
T 3a7i_A          170 TDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-------I------PKN  234 (303)
T ss_dssp             BTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------H------HHS
T ss_pred             Cccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------h------hcC
Confidence            4322  122346799999999999999999999999999999999999999986543221100       0      011


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      ..    ...+...+..+.+|+.+||+.||++|||+.+++++.
T Consensus       235 ~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          235 NP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CC----CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             CC----CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            11    122334567799999999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.3e-44  Score=337.73  Aligned_cols=252  Identities=24%  Similarity=0.373  Sum_probs=201.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe---
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  187 (429)
                      ..|++.+.||+|+||.||+|.+..+.      ..||+|.+.... .......+.+|+.+++.++||||+++++++..   
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~------~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETT------VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCc------eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            34788899999999999999876543      449999886542 34456778899999999999999999999865   


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-CCCcEEEeccC
Q 014189          188 -DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFG  265 (429)
Q Consensus       188 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg  265 (429)
                       ....++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+.+++||||||+|||++ .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence             456899999999999999997643  68999999999999999999998766699999999999998 88999999999


Q ss_pred             CCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ++......    ......||+.|+|||++. +.++.++||||||+++|+|++|+.||..........             
T Consensus       178 ~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-------------  239 (290)
T 1t4h_A          178 LATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-------------  239 (290)
T ss_dssp             GGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-------------
T ss_pred             Cccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-------------
Confidence            99764332    223467999999999886 458999999999999999999999997654322110             


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ............+...+..+.+|+.+||+.||++|||++|++++
T Consensus       240 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          240 --RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --HHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              00001011111122334678999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.6e-44  Score=338.15  Aligned_cols=278  Identities=18%  Similarity=0.186  Sum_probs=214.9

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEE-EeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC-CED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~  188 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++......   ..+.+|+.+++.++|++++..+.++ ...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAG------EEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTT------EEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCC------cEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence            4578999999999999999999865543      45999998765332   3477899999999988766665555 667


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE---cCCCcEEEeccC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFG  265 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg  265 (429)
                      +..++||||+ +|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||+   +.++.+||+|||
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           78 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             CceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            8889999999 899999987443 36999999999999999999999987  9999999999999   488999999999


Q ss_pred             CCcCCCCCCCc-----cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh-
Q 014189          266 LAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-  339 (429)
Q Consensus       266 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~-  339 (429)
                      ++.........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||................. 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence            99865543221     112346799999999999999999999999999999999999999986543221111111100 


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCCCCCccccc
Q 014189          340 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTV  411 (429)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~~~  411 (429)
                      ....  .. ..        .....+..+.+++.+||+.||++|||++++++.|+.+......+..-+.+|..
T Consensus       234 ~~~~--~~-~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~  294 (296)
T 3uzp_A          234 KMST--PI-EV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  294 (296)
T ss_dssp             HHHS--CH-HH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred             ccCC--ch-HH--------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence            0000  00 00        01234577899999999999999999999999999987766665555566654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.2e-45  Score=346.16  Aligned_cols=265  Identities=23%  Similarity=0.267  Sum_probs=205.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe---
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  187 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++... .......+.+|+.+++.++||||+++++++..   
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDG------HFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERG  100 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTC------CEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCC------cEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence            467999999999999999999875543      45999988654 34556778899999999999999999999862   


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          188 -DEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       188 -~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                       ....++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEec
Confidence             34789999999999999988652  3346999999999999999999999987  999999999999999999999999


Q ss_pred             CCCcCCCCCCCcc-------ccccccCCcccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 014189          265 GLAKDGPEGDKSH-------VSTRIMGTYGYAAPEYIMTGH---LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  334 (429)
Q Consensus       265 gla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~  334 (429)
                      |++..........       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||........ ...
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~  257 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVA  257 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhh
Confidence            9987643211100       012245799999999987554   78999999999999999999999953111000 000


Q ss_pred             HhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                                    ...............+..+.+++.+||+.||.+|||+++++++|+.++...
T Consensus       258 --------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          258 --------------LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             --------------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             --------------HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence                          000001111223345678999999999999999999999999999887553

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.2e-45  Score=342.32  Aligned_cols=254  Identities=26%  Similarity=0.356  Sum_probs=207.0

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  187 (429)
                      .+..+|++.+.||+|+||.||+|.+..+.      ..||+|.+....     ..+.+|+.++++++||||+++++++.. 
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDG------KTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGF   76 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTC------CEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCC------eEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence            45678999999999999999999876543      349999987653     235689999999999999999998854 


Q ss_pred             ---------------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEE
Q 014189          188 ---------------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  252 (429)
Q Consensus       188 ---------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIl  252 (429)
                                     ....++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+  |+|+||||+|||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil  154 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIF  154 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEE
Confidence                           456899999999999999997665557999999999999999999999987  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh
Q 014189          253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN  332 (429)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~  332 (429)
                      ++.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..|+....     .
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~  226 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----K  226 (284)
T ss_dssp             EEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----H
T ss_pred             EcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----H
Confidence            99999999999999987654321   234579999999999999999999999999999999999998864210     0


Q ss_pred             HHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCC
Q 014189          333 LADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  400 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  400 (429)
                         ..          ..+....    .+...+..+.+++.+||+.||++|||+.|++++|+.++..+.
T Consensus       227 ---~~----------~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          227 ---FF----------TDLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             ---HH----------HHHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ---HH----------HHhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence               00          0111111    122345678899999999999999999999999988876644

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=354.05  Aligned_cols=286  Identities=18%  Similarity=0.205  Sum_probs=216.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEcccccc--CcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceee--------
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLRE--GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK--------  180 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------  180 (429)
                      .++|++.+.||+|+||.||+|.+..+...  ...+..||+|++...      ..+.+|+.++++++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            36799999999999999999987653210  012445999998754      24668999999999999988        


Q ss_pred             -------eeeEEEe-CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEE
Q 014189          181 -------LIGYCCE-DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  252 (429)
Q Consensus       181 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIl  252 (429)
                             +++++.. ++..++||||+ +|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl  191 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIF  191 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEE
Confidence                   5677765 77899999999 999999998764457999999999999999999999987  999999999999


Q ss_pred             EcCCC--cEEEeccCCCcCCCCCCCc-----cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 014189          253 LDTDY--NAKLSDFGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS  325 (429)
Q Consensus       253 l~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~  325 (429)
                      ++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  8999999999865432211     1123358999999999999999999999999999999999999999865


Q ss_pred             ChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCCCC
Q 014189          326 RPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP  405 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p  405 (429)
                      ..... ..........   .....+.+..   ......+..+.+|+.+||..||++|||++++++.|+.+..........
T Consensus       272 ~~~~~-~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~  344 (352)
T 2jii_A          272 LPNTE-DIMKQKQKFV---DKPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD  344 (352)
T ss_dssp             TTCHH-HHHHHHHHHH---HSCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             CcCHH-HHHHHHHhcc---CChhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence            42211 1111111000   0001111100   001234678999999999999999999999999999988776666666


Q ss_pred             Ccccccc
Q 014189          406 KNFVTVV  412 (429)
Q Consensus       406 ~~~~~~~  412 (429)
                      +.+|+.+
T Consensus       345 ~~dw~~~  351 (352)
T 2jii_A          345 PIGLPMV  351 (352)
T ss_dssp             CCCCCC-
T ss_pred             cccCcCC
Confidence            6666543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.1e-44  Score=338.49  Aligned_cols=278  Identities=18%  Similarity=0.170  Sum_probs=209.3

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEE-Ee
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC-CE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~  187 (429)
                      .+.++|++.+.||+|+||.||+|.+..+.      ..||+|+.......   ..+.+|+.+++.++|++++..+..+ ..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAG------EEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTT------EEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCC------ceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence            35678999999999999999999865543      34999987654322   2466899999999988777666555 67


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE---cCCCcEEEecc
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDF  264 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df  264 (429)
                      .+..++||||+ +|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||+   +.++.+||+||
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Df  152 (296)
T 4hgt_A           77 GDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred             CCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecC
Confidence            78889999999 899999987543 36999999999999999999999987  9999999999999   78999999999


Q ss_pred             CCCcCCCCCCCc-----cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH-h
Q 014189          265 GLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA-L  338 (429)
Q Consensus       265 gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~-~  338 (429)
                      |+++........     .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||............... .
T Consensus       153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 4hgt_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence            999865443221     1223467999999999999999999999999999999999999999865432211111110 0


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCCCCCcccc
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVT  410 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~~  410 (429)
                      .....  ....         .....+..+.+++.+||+.||++|||++++++.|+.+.........-+.+|.
T Consensus       233 ~~~~~--~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 4hgt_A          233 KKMST--PIEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             HHHHS--CHHH---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred             ccccc--hhhh---------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence            00000  0000         0112356889999999999999999999999999988776555544444454

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-44  Score=337.61  Aligned_cols=255  Identities=23%  Similarity=0.294  Sum_probs=203.9

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-----hhHHHHHHHHHHHhccCCCceeeeeeE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++......     .....+.+|+.++++++||||++++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTG------KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI   76 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCC------CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence            3467999999999999999999876543      34999988654221     235678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC----cEE
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAK  260 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~----~~k  260 (429)
                      +.+.+..++||||+++++|.+++....  .+++..+..++.|++.||+|||+.+  ++||||||+||+++.++    .+|
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           77 FENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEE
T ss_pred             ecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceE
Confidence            999999999999999999999987543  6899999999999999999999987  99999999999999887    899


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      |+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........       
T Consensus       153 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------  222 (283)
T 3bhy_A          153 LIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN-------  222 (283)
T ss_dssp             ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------
T ss_pred             EEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH-------
Confidence            999999986543221   2345799999999999999999999999999999999999999987553211100       


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +      .. .............+..+.+++.+||..||++|||+.+++++
T Consensus       223 ~------~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          223 I------SA-VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             H------HT-TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             h------Hh-cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            0      00 00000000112345678999999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5e-44  Score=343.71  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=208.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ..+|.+.+.||+|+||.||+|.+..+.      ..+|+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTK------EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN  113 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            467999999999999999999876553      349999986542  344556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCce
Confidence            99999999999999999886543  6899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........      ......     
T Consensus       190 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~-----  256 (335)
T 2owb_A          190 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKKN-----  256 (335)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHT-----
T ss_pred             ecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHhcC-----
Confidence            6543221  233467999999999999999999999999999999999999999865432110      000000     


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         .    ...+...+..+.+|+.+||+.||++|||++|++++
T Consensus       257 ---~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 ---E----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---C----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               0    11233456778899999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-44  Score=358.08  Aligned_cols=257  Identities=23%  Similarity=0.330  Sum_probs=193.9

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-------ChhhHHHHHHHHHHHhccCCCceee
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-------SYQGHREWLAEVIFLGHLSHPNLVK  180 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~  180 (429)
                      ..+.++|.+.+.||+|+||.||+|.+..+.+      .||+|++....       .......+.+|+.+|++++||||++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  204 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCK------KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK  204 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCc------EEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence            3457899999999999999999998766543      49999986431       1122234778999999999999999


Q ss_pred             eeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC---
Q 014189          181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---  257 (429)
Q Consensus       181 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~---  257 (429)
                      +++++. .+..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++   
T Consensus       205 l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~  279 (419)
T 3i6u_A          205 IKNFFD-AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDC  279 (419)
T ss_dssp             CCEEEE-SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSC
T ss_pred             EEEEEe-cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcc
Confidence            999985 456799999999999999886543  6999999999999999999999987  99999999999997544   


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccCCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 014189          258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  334 (429)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~  334 (429)
                      .+||+|||+++......   .....+||+.|+|||++.+   ..|+.++|||||||++|+|++|..||........  +.
T Consensus       280 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~  354 (419)
T 3i6u_A          280 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK  354 (419)
T ss_dssp             CEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH
T ss_pred             eEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH
Confidence            59999999998764322   2345689999999999863   6788999999999999999999999976432211  00


Q ss_pred             HhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..    +...     ..  ..........+..+.+|+.+||+.||++|||++|++++
T Consensus       355 ~~----i~~~-----~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          355 DQ----ITSG-----KY--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HH----HHTT-----CC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HH----HhcC-----CC--CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00    0000     00  00000012346789999999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.9e-44  Score=338.39  Aligned_cols=253  Identities=21%  Similarity=0.294  Sum_probs=205.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      +.++|.+.+.||+|+||.||+|.+..++      ..||+|++.... ......+.+|+.++++++||||+++++++.+.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTG------KLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTT   79 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCC------CEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence            4568999999999999999999876543      349999987653 223456789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE---cCCCcEEEeccCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFGL  266 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgl  266 (429)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  ++||||||+||++   +.++.+||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            9999999999999999886543  6899999999999999999999987  9999999999999   7889999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      +......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||.........   .   . +..   
T Consensus       156 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~---~-i~~---  221 (304)
T 2jam_A          156 SKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF---E---K-IKE---  221 (304)
T ss_dssp             TCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H---H-HHH---
T ss_pred             ceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---H---H-HHc---
Confidence            9764332    123357999999999999999999999999999999999999999765432110   0   0 000   


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .  ............+..+.+++.+||..||++|||+++++++
T Consensus       222 --~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          222 --G--YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             --C--CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             --C--CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              0  0011112233556789999999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-44  Score=348.17  Aligned_cols=272  Identities=22%  Similarity=0.287  Sum_probs=202.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||.||+|.+..++      ..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTG------AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTC------CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCC------CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            3568999999999999999999876553      349999986543 344456788999999999999999999999765


Q ss_pred             ------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 ------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                            ..+|+||||+ +++|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~  170 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKIL  170 (367)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred             CccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEE
Confidence                  3469999999 78999988763   5899999999999999999999988  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh--
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--  339 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--  339 (429)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.............  
T Consensus       171 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~  245 (367)
T 1cm8_A          171 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  245 (367)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999875432     234678999999999987 6899999999999999999999999987654322111000000  


Q ss_pred             ---HHH-----hhhhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCC
Q 014189          340 ---LLK-----EKKKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       340 ---~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                         ...     ........+.....   .......+..+.+|+.+||..||++|||++|+++|  +..+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence               000     00000001110000   01123456789999999999999999999999987  5555443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.7e-44  Score=365.63  Aligned_cols=256  Identities=23%  Similarity=0.322  Sum_probs=207.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|.+.++||+|+||.||+|.+..++      ..||+|++.....  ......+.+|+.++++++||||+++++++.+.+
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg------~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  258 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATG------KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT  258 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCC------cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence            57999999999999999999876543      4499999865321  123456789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+|+||||++||+|.+++....  ...+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||++
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeeccee
Confidence            9999999999999999987643  346999999999999999999999987  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      +.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........  .......        
T Consensus       337 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~--------  404 (543)
T 3c4z_A          337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQR--------  404 (543)
T ss_dssp             EECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHH--------
T ss_pred             eeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHH--------
Confidence            87654322  23346899999999999999999999999999999999999999986532110  0011111        


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~  391 (429)
                        +...  ...++...+..+.+|+.+||+.||++||++     ++|++|
T Consensus       405 --i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          405 --VLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             --HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             --Hhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence              1111  112344567889999999999999999975     677765

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.7e-45  Score=348.48  Aligned_cols=265  Identities=23%  Similarity=0.308  Sum_probs=192.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEE--
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCC--  186 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--  186 (429)
                      ...+|++.+.||+|+||.||+|.+..+.      ..||+|++... .......+.+|+.++.++. ||||+++++++.  
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSG------REYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTC------CEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCC------cEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            3457999999999999999999876543      34999988654 3455667889999999996 999999999984  


Q ss_pred             ------eCCeEEEEEEecCCCChhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcE
Q 014189          187 ------EDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  259 (429)
Q Consensus       187 ------~~~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~  259 (429)
                            .....++||||+. |+|.+++.. ....++++..+..++.|++.||+|||+.+.+|+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                  3445899999996 789888864 22346999999999999999999999866669999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCcc----------ccccccCCccccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 014189          260 KLSDFGLAKDGPEGDKSH----------VSTRIMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR  326 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltG~~p~~~~~  326 (429)
                      ||+|||+++.........          ......||+.|+|||++   .+..++.++||||||+++|+|++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998765432211          11135689999999998   56778999999999999999999999997533


Q ss_pred             hhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCC
Q 014189          327 PAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA  402 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  402 (429)
                      ...                    +.............+..+.+|+.+||+.||++|||+.|++++|+.+.......
T Consensus       258 ~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          258 KLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence            210                    11111111112233455788999999999999999999999999887654433

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.3e-44  Score=336.89  Aligned_cols=255  Identities=22%  Similarity=0.260  Sum_probs=202.7

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC---ChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++....   .......+.+|+.+++.++||||+++++++.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETL------CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY   76 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTC------CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCC------cEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            3478999999999999999999865543      349999986532   1234567889999999999999999999984


Q ss_pred             --eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          187 --EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       187 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                        +.+..++||||+++| |.+++.......+++..+..++.|++.||+|||+++  ++||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~df  153 (305)
T 2wtk_C           77 NEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISAL  153 (305)
T ss_dssp             CC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecc
Confidence              456889999999876 777777655667999999999999999999999987  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      |++................||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.........      .. +.
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~-i~  226 (305)
T 2wtk_C          154 GVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF------EN-IG  226 (305)
T ss_dssp             TTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HH-HH
T ss_pred             ccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH------HH-Hh
Confidence            9998765433333334567999999999998644  478999999999999999999999865432110      00 00


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            .   .  ....+..++..+.+++.+||+.||++|||+++++++
T Consensus       227 ------~---~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          227 ------K---G--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ------H---C--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------c---C--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  0   0  012233456788999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6e-45  Score=358.09  Aligned_cols=275  Identities=21%  Similarity=0.229  Sum_probs=213.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  189 (429)
                      ..+|++.++||+|+||.||+|.+..+.      ..||+|++...........+.+|++++++++||||+++++++...+ 
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTG------DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCC------cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence            457999999999999999999876543      3499999976544445667889999999999999999999998655 


Q ss_pred             -eEEEEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE----cCCCcEEEec
Q 014189          190 -HRVLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSD  263 (429)
Q Consensus       190 -~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll----~~~~~~kl~D  263 (429)
                       ..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEec
Confidence             7899999999999999986543 234899999999999999999999987  9999999999999    7888899999


Q ss_pred             cCCCcCCCCCCCccccccccCCccccccccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~  335 (429)
                      ||+++......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.........  ..
T Consensus       160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~  234 (396)
T 4eut_A          160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE  234 (396)
T ss_dssp             GGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HH
T ss_pred             CCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HH
Confidence            99998764422   2334679999999999875        56788999999999999999999999754322110  01


Q ss_pred             hHhhHHHhhhh-----hhhh------c--CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          336 WALPLLKEKKK-----LLNI------I--DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       336 ~~~~~~~~~~~-----~~~~------~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      ...........     +...      .  +.......+......+.+++.+||+.||++|||+.++++.++.+...
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11111110000     0000      0  00111223456788899999999999999999999999998777554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-44  Score=343.42  Aligned_cols=267  Identities=22%  Similarity=0.257  Sum_probs=198.4

Q ss_pred             hcCCccc-eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          111 TANFRQD-RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      .+.|++. +.||+|+||.||+|.+..+      +..||+|++.... ......+.+|+.++.++ +||||+++++++.+.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLIT------SQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSS------CCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCC------CcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            4678874 7899999999999976544      3449999987653 33456788999999885 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc---EEEeccC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---AKLSDFG  265 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg  265 (429)
                      +..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.   +||+|||
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            99999999999999999997653  6899999999999999999999987  999999999999998876   9999999


Q ss_pred             CCcCCCCCCC-----ccccccccCCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 014189          266 LAKDGPEGDK-----SHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       266 la~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~  335 (429)
                      ++........     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||.............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            9876532211     111223569999999999875     568999999999999999999999997654221000000


Q ss_pred             hHhhHHHhhhhhhhhcCCCCCCCCC----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 WALPLLKEKKKLLNIIDPRLEGDYP----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .... .........+.....  ..+    ...+..+.+|+.+||+.||++|||+.|++++
T Consensus       240 ~~~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          240 EACP-ACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             -CCH-HHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccch-hHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000 000000001111111  111    1346789999999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.4e-44  Score=355.84  Aligned_cols=278  Identities=22%  Similarity=0.300  Sum_probs=202.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.+|+.++||||+++++++...
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTE------KNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTT------EEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCC------cEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            4578999999999999999999876553      449999987542 344557788999999999999999999999765


Q ss_pred             -----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          189 -----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       189 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                           ...|+||||++ |+|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~D  172 (432)
T 3n9x_A           98 DLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCD  172 (432)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEcc
Confidence                 57899999996 5999988654  36999999999999999999999988  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCc--------------------cccccccCCccccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCC
Q 014189          264 FGLAKDGPEGDKS--------------------HVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEILTGRKSL  322 (429)
Q Consensus       264 fgla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltG~~p~  322 (429)
                      ||+++........                    ...+..+||+.|+|||++ ....|+.++|||||||++|||++|..||
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            9999876432211                    123457899999999986 5667999999999999999999854443


Q ss_pred             -----------CCCChhh--------------hhhHHHhHhhHHH-------------hhhhhhhhcCCCCCCC---CCh
Q 014189          323 -----------DKSRPAR--------------EQNLADWALPLLK-------------EKKKLLNIIDPRLEGD---YPV  361 (429)
Q Consensus       323 -----------~~~~~~~--------------~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~---~~~  361 (429)
                                 .+.+...              ..+....+...+.             ................   ...
T Consensus       253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (432)
T 3n9x_A          253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP  332 (432)
T ss_dssp             CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred             ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence                       3222100              0000000000000             0000000011000000   012


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCC
Q 014189          362 KGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       362 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                      ..+..+.+|+.+||+.||++|||++|++++  |..+...
T Consensus       333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            356789999999999999999999999987  5555443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.7e-44  Score=340.69  Aligned_cols=264  Identities=23%  Similarity=0.243  Sum_probs=201.9

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.++++++||||+++++++..+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRE------RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTT------EEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCC------eEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            478999999999999999999876543      449999987542  233446788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             CeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            99999999999999999987653  6899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......   ..    ....      
T Consensus       183 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~----~~~~------  248 (309)
T 2h34_A          183 ATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MG----AHIN------  248 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HH----HHHH------
T ss_pred             ccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HH----HHhc------
Confidence            6544321 12234579999999999999999999999999999999999999998653221   00    0000      


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-CHHHHHHhcccccCCCC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-LMRDIVDSLEPLQVLPD  400 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~  400 (429)
                      ....  .....+...+..+.+++.+||+.||++|| |++++++.|+.+.....
T Consensus       249 ~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          249 QAIP--RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             SCCC--CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             cCCC--CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            0000  01112334566789999999999999999 99999999988765543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-44  Score=346.55  Aligned_cols=269  Identities=23%  Similarity=0.349  Sum_probs=203.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .++|++.+.||+|+||.||+|.+..++      ..||+|++.... .......+.+|+.++++++||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTG------RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTC------CEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCC------ceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            357999999999999999999876543      349999886543 3334556789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            9999999999998888765443  5899999999999999999999987  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhH--------hhH
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA--------LPL  340 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~  340 (429)
                      .....  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...............        ...
T Consensus       174 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          174 LAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            54322  123346799999999999875 7899999999999999999999999876543221111000        000


Q ss_pred             HHhhhhhhhhcCCCCCCCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +...........+......+     ...+..+.+|+.+||+.||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            01111111111111111111     2356789999999999999999999999976

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.8e-44  Score=362.54  Aligned_cols=252  Identities=24%  Similarity=0.294  Sum_probs=203.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh------------hhHHHHHHHHHHHhccCCCc
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY------------QGHREWLAEVIFLGHLSHPN  177 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~n  177 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++......            .....+.+|+.++++++|||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  107 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGH------SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN  107 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTC------CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCC------cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence            4678999999999999999999876553      34999998764321            23467889999999999999


Q ss_pred             eeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC
Q 014189          178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       178 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      |+++++++.+.+..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKN  183 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTT
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCC
Confidence            9999999999999999999999999999887653  6999999999999999999999987  99999999999998876


Q ss_pred             ---cEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 014189          258 ---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  334 (429)
Q Consensus       258 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~  334 (429)
                         .+||+|||++.......   ......||+.|+|||++. ..|+.++|||||||++|+|++|..||........... 
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-  258 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK-  258 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred             CCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence               69999999998765432   234467999999999887 4699999999999999999999999987654221110 


Q ss_pred             HhHhhHHHhhhhhhhhcCCCCCCC--CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 DWALPLLKEKKKLLNIIDPRLEGD--YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            +.         .......  .....+..+.+|+.+||+.||.+|||++|++++
T Consensus       259 ------i~---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          259 ------VE---------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             ------HH---------HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------HH---------cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                  00         0000000  012346789999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.1e-45  Score=340.16  Aligned_cols=252  Identities=26%  Similarity=0.392  Sum_probs=200.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC-C
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-E  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~  189 (429)
                      .++|++.+.||+|+||.||+|.+.        +..||+|++....   ....+.+|+.++++++||||+++++++.+. +
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--------CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            467999999999999999999764        2349999987643   345688999999999999999999987544 5


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++..
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE  166 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccc
Confidence            7899999999999999997654334889999999999999999999987  99999999999999999999999999886


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ....     .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........   .              
T Consensus       167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~--------------  224 (278)
T 1byg_A          167 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V--------------  224 (278)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H--------------
T ss_pred             cccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H--------------
Confidence            4432     123467889999999999999999999999999999998 9999976543211   0              


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      ..+........+...+..+.+++.+||+.||++|||+.++++.|+.++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          225 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            0011111223344567889999999999999999999999999988754

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.7e-44  Score=361.79  Aligned_cols=254  Identities=23%  Similarity=0.298  Sum_probs=204.4

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.++++++||||+++++++.+.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQ------QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTC------CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCC------CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence            4568999999999999999999876543      349999985421 122346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc---CCCcEEEeccC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD---TDYNAKLSDFG  265 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg  265 (429)
                      +..++||||+.+|+|.+.+....  .+++..+..++.|++.||.|||+++  |+||||||+|||++   .++.+||+|||
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECC
Confidence            99999999999999999887653  6899999999999999999999987  99999999999995   45679999999


Q ss_pred             CCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      +++......   ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||..........      . +..  
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~-i~~--  236 (486)
T 3mwu_A          170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK------R-VET--  236 (486)
T ss_dssp             CTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HHH--
T ss_pred             cCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHh--
Confidence            998654432   2334679999999999875 59999999999999999999999998765322110      0 000  


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         .  ............+..+.+|+.+||+.||++|||+.+++++
T Consensus       237 ---~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          237 ---G--KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ---T--CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ---C--CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               0  0001111123457789999999999999999999999987

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-44  Score=346.20  Aligned_cols=270  Identities=20%  Similarity=0.250  Sum_probs=195.2

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ...++|++.+.||+|+||.||+|.+..+.      ..||+|++...... .....+.+|+.++++++||||+++++++.+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTN------ETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTT------EEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCC------ceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            34568999999999999999999876553      45999998765322 234567789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE-----cCCCcEEEe
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-----DTDYNAKLS  262 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll-----~~~~~~kl~  262 (429)
                      .+..++||||++ |+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||+     +.++.+||+
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             CCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEEC
Confidence            999999999997 59999887654  5899999999999999999999987  9999999999999     455569999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      |||+++......  .......||+.|+|||++.+. .++.++|||||||++|||++|..||...................
T Consensus       180 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          180 DFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            999997653321  122345789999999999874 58999999999999999999999998765432211100000000


Q ss_pred             H-hhh----hhhhhcC--CCCCCC-----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          342 K-EKK----KLLNIID--PRLEGD-----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       342 ~-~~~----~~~~~~~--~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      . ..+    .......  +.....     .+...+..+.+|+.+||+.||++|||++|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            0 000    0000000  000000     011245788999999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.7e-44  Score=361.69  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=200.9

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  108 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTH------VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK  108 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTC------CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCC------cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            4567999999999999999999876543      349999987643 223346688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC---CcEEEeccC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSDFG  265 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg  265 (429)
                      +..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.+   +.+||+|||
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            99999999999999999887653  6899999999999999999999987  9999999999999764   459999999


Q ss_pred             CCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ++.......   ......||+.|+|||++. ..|+.++|||||||++|+|++|..||..........      .....  
T Consensus       185 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i~~~--  252 (494)
T 3lij_A          185 LSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR------KVEKG--  252 (494)
T ss_dssp             TCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHT--
T ss_pred             CCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhC--
Confidence            998765432   234467999999999886 569999999999999999999999998765422110      00000  


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            ............+..+.+|+.+||+.||++|||+++++++
T Consensus       253 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          253 ------KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             ------CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ------CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                  0000111112456789999999999999999999999976

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=336.32  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=184.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..||+|++.....  ......+.+|+.++++++||||+++++++.+.+
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTG------LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             ccceeeeeecCCCceEEEEEEEccCC------ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            57999999999999999999875543      3499999864321  122356889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++++|.+++.... .++++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++..
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            9999999999999999887543 46899999999999999999999987  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ......  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........                ...
T Consensus       162 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~  223 (278)
T 3cok_A          162 LKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNK  223 (278)
T ss_dssp             CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------
T ss_pred             ccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHH
Confidence            543221  12345789999999999999999999999999999999999999976542110                001


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....  ...+...+..+.+++.+||+.||++|||+++++++
T Consensus       224 ~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          224 VVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             Hhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            11111  12233456788999999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.9e-44  Score=335.46  Aligned_cols=251  Identities=23%  Similarity=0.322  Sum_probs=208.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|.+.+.||+|+||.||+|.+..+.      ..+|+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTK------EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCC------ceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            467999999999999999999876553      349999986542  344556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCce
Confidence            99999999999999999886543  6899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .......  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........      .          
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~----------  225 (294)
T 2rku_A          164 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------L----------  225 (294)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H----------
T ss_pred             ecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H----------
Confidence            6543221  223467999999999999999999999999999999999999999865432110      0          


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+....  ...+...+..+.+++.+||+.||++|||++|++++
T Consensus       226 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          226 RIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000000  11233456788999999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-43  Score=351.45  Aligned_cols=266  Identities=22%  Similarity=0.271  Sum_probs=206.4

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc------CCCceeeeee
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL------SHPNLVKLIG  183 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~  183 (429)
                      +..+|++.+.||+|+||.||+|.+..+.      ..||+|++...  ......+.+|+.+++.+      +|+||+++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~------~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVH------QHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTT------EEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCC------cEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            4567999999999999999999876543      44999999754  33445677888888776      5789999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc--EEE
Q 014189          184 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN--AKL  261 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~--~kl  261 (429)
                      ++...+..++||||+. |+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.  +||
T Consensus       167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL  243 (429)
T 3kvw_A          167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKV  243 (429)
T ss_dssp             EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEE
T ss_pred             ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEE
Confidence            9999999999999996 69999998776667999999999999999999999977  999999999999999987  999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh---
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL---  338 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~---  338 (429)
                      +|||++......     .....||+.|+|||++.+..|+.++|||||||++|||++|.+||...+............   
T Consensus       244 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p  318 (429)
T 3kvw_A          244 IDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP  318 (429)
T ss_dssp             CCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999999764322     234679999999999999999999999999999999999999998766433211110000   


Q ss_pred             --hHHHhhhhhhhhcCCCCC--------------------------------CC----CChHHHHHHHHHHHHhhccCCC
Q 014189          339 --PLLKEKKKLLNIIDPRLE--------------------------------GD----YPVKGVHKAAMLAYHCLNHNPK  380 (429)
Q Consensus       339 --~~~~~~~~~~~~~~~~~~--------------------------------~~----~~~~~~~~l~~l~~~cl~~dP~  380 (429)
                        ............++....                                ..    .+...+..+.+|+.+||+.||+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~  398 (429)
T 3kvw_A          319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA  398 (429)
T ss_dssp             CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence              000000111111111000                                00    0011256789999999999999


Q ss_pred             CCCCHHHHHHh
Q 014189          381 ARPLMRDIVDS  391 (429)
Q Consensus       381 ~RPs~~evl~~  391 (429)
                      +|||++|++++
T Consensus       399 ~Rpta~e~L~H  409 (429)
T 3kvw_A          399 VRMTPGQALRH  409 (429)
T ss_dssp             TSCCHHHHHTS
T ss_pred             hCCCHHHHhCC
Confidence            99999999987

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2e-44  Score=363.66  Aligned_cols=254  Identities=26%  Similarity=0.334  Sum_probs=207.9

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.++++++||||+++++++.+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITG------QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCC------CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            4568999999999999999999876543      349999986543  23455678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE---cCCCcEEEecc
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDF  264 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df  264 (429)
                      .+..++||||+.+|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            999999999999999999887654  6899999999999999999999987  9999999999999   56789999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      |++.......   ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||...........       +.. 
T Consensus       174 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------i~~-  241 (484)
T 3nyv_A          174 GLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK-------VEK-  241 (484)
T ss_dssp             THHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHH-
T ss_pred             eeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHc-
Confidence            9998654432   2334679999999999876 699999999999999999999999987654321100       000 


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          .  ............+..+.+|+.+||+.||++|||+.|+++|
T Consensus       242 ----~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          242 ----G--KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ----C--CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----C--CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                0  0001111123467889999999999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.8e-45  Score=339.87  Aligned_cols=261  Identities=21%  Similarity=0.262  Sum_probs=207.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  187 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|.+.... .......+.+|+.++++++||||+++++++..  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDG------KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCC------cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            467999999999999999999876543      349999987653 34456778899999999999999999998854  


Q ss_pred             CCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCceeCCCCCCcEEEcCCCcEEEe
Q 014189          188 DEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAE---KPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      ....++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.+   .+++||||||+|||++.++.+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            67899999999999999998643  2345899999999999999999999855   349999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      |||++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||........   ..   . +.
T Consensus       159 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~-i~  229 (279)
T 2w5a_A          159 DFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG---K-IR  229 (279)
T ss_dssp             CCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---H-HH
T ss_pred             cCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HH---H-Hh
Confidence            999987654321  122345789999999999999999999999999999999999999987653211   00   0 00


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                            ...    ....+...+..+.+++.+||+.||++|||+.|+++++....
T Consensus       230 ------~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          230 ------EGK----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             ------HTC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             ------hcc----cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                  000    11223355678999999999999999999999999875443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.1e-44  Score=336.78  Aligned_cols=248  Identities=18%  Similarity=0.247  Sum_probs=201.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+..+..+ +||||+++++++.+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~   82 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDG------CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE   82 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCC------ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            4578999999999999999999876543      349999987643 334556788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC---------
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---------  256 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~---------  256 (429)
                      .+..++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+++  |+||||||+|||++.+         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-----------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccc
Confidence            999999999999999999996532  246899999999999999999999987  9999999999999844         


Q ss_pred             ----------CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 014189          257 ----------YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKS  325 (429)
Q Consensus       257 ----------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~  325 (429)
                                ..+||+|||++......      ....||+.|+|||++.+. .++.++||||||+++|+|++|.+|+...
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             cccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                      47999999999875432      124589999999999865 6678999999999999999999876533


Q ss_pred             ChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          326 RPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....                .....    .....+...+..+.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~----------------~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          235 DQWH----------------EIRQG----RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHH----------------HHHTT----CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             hHHH----------------HHHcC----CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            2100                00110    1112234556789999999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=345.73  Aligned_cols=257  Identities=28%  Similarity=0.348  Sum_probs=200.6

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  185 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  185 (429)
                      +....++|++.+.||+|+||.||+|.+..+.      ..||+|++.....  ....+.+|+.+++++ +||||+++++++
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTG------QLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCC------CeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            3345678999999999999999999876543      3499999875432  335678999999999 799999999999


Q ss_pred             Ee------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcE
Q 014189          186 CE------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  259 (429)
Q Consensus       186 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~  259 (429)
                      ..      .+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+|+||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCE
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCE
Confidence            76      568899999999999999998765557999999999999999999999987  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  334 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~  334 (429)
                      ||+|||++........  ......||+.|+|||++.     +..++.++|||||||++|+|++|..||........... 
T Consensus       169 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-  245 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-  245 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-
T ss_pred             EEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-
Confidence            9999999986543211  123457999999999987     56789999999999999999999999976553221100 


Q ss_pred             HhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                  ......+.   ......+..+.+|+.+||..||++|||+++++++
T Consensus       246 ------------~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          246 ------------IPRNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ------------HHHSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ------------hhcCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                        00101111   1123446788999999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.2e-44  Score=335.38  Aligned_cols=249  Identities=24%  Similarity=0.362  Sum_probs=206.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNK------FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR   86 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCC------cEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence            367999999999999999999876543      449999986431  112245678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccc
Confidence            99999999999999999987654  5899999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.........                .
T Consensus       163 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------------~  222 (284)
T 2vgo_A          163 HAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH----------------R  222 (284)
T ss_dssp             ECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------H
T ss_pred             cCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH----------------H
Confidence            654321    23467999999999999999999999999999999999999999865432110                0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+...  ....+...+..+.+++.+||+.||++|||+++++++
T Consensus       223 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          223 RIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             HHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             HHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            01111  112234456788999999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.1e-44  Score=336.75  Aligned_cols=255  Identities=24%  Similarity=0.259  Sum_probs=189.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHH-HHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW-LAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ..++|++.+.||+|+||.||+|.+..++      ..||+|++...........+ .++...++.++||||+++++++.+.
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   78 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSG------QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE   78 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCC------eEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence            3468999999999999999999876543      44999999876444444444 4455557888999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          189 EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                      +..++||||++ |+|.+++..  .....+++..+..++.|++.||+|||+. +  ++||||||+|||++.++.+||+|||
T Consensus        79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecC
Confidence            99999999997 588777653  2334799999999999999999999996 7  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccCCccccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYI----MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      ++........   .....||+.|+|||++    .+..++.++||||||+++|+|++|+.||......... .        
T Consensus       156 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~--------  223 (290)
T 3fme_A          156 ISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-L--------  223 (290)
T ss_dssp             -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-H--------
T ss_pred             Cccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-H--------
Confidence            9986544321   2335799999999996    5667899999999999999999999999864322110 0        


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            ................+..+.+++.+||+.||++|||+.|++++
T Consensus       224 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          224 ------KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             ------HHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ------HHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                  01111111111223456789999999999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.3e-44  Score=373.55  Aligned_cols=252  Identities=25%  Similarity=0.314  Sum_probs=208.7

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  186 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  186 (429)
                      ..++|++.++||+|+||.||+|.+..+.      ..||+|++....  .......+..|..++..+ +||||+++++++.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~------~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~  412 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTD------ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ  412 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSC------CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCC------cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence            3468999999999999999999876653      349999987531  122335577899999988 6999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      +.+.+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGl  488 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGM  488 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTT
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecce
Confidence            9999999999999999999997654  6899999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ++......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+....                
T Consensus       489 a~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~----------------  550 (674)
T 3pfq_A          489 CKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----------------  550 (674)
T ss_dssp             CEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------
T ss_pred             eeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH----------------
Confidence            98643322  224457899999999999999999999999999999999999999987653211                


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~  391 (429)
                      ...+....  ..++...+.++.+|+.+||+.||++||++     +||++|
T Consensus       551 ~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          551 FQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             HHHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             HHHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            11111111  22345667889999999999999999998     888865

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.9e-44  Score=339.14  Aligned_cols=265  Identities=25%  Similarity=0.343  Sum_probs=202.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|.+.....   ....||+|++....  .......+.+|+.++++++||||+++++++...
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCC---ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            3579999999999999999998643221   23458999887542  234557788999999999999999999999876


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      . .++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++  ++|+||||+|||++.++.+||+|||++.
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             C-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccc
Confidence            5 789999999999999987542 35899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCcc-ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          269 DGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       269 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ......... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||.........               
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---------------  234 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---------------  234 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---------------
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---------------
Confidence            765433221 2233567889999999998889999999999999999999 99999866532110               


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                       ..+.........+...+..+.+++.+||..||++|||+.++++.|+.++..
T Consensus       235 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          235 -HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             -HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             -HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence             011111111223345678899999999999999999999999999877643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-43  Score=344.89  Aligned_cols=258  Identities=23%  Similarity=0.321  Sum_probs=207.3

Q ss_pred             HHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-------hhhHHHHHHHHHHHhcc-CCC
Q 014189          105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-------YQGHREWLAEVIFLGHL-SHP  176 (429)
Q Consensus       105 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l-~h~  176 (429)
                      .....+.++|++.+.||+|+||.||+|.+..++      ..||||++.....       ......+.+|+.+++++ +||
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g------~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp  160 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG------HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP  160 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCC------cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            344556678999999999999999999876543      3499999875431       11234577899999999 799


Q ss_pred             ceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          177 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       177 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      ||+++++++...+..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||||+|||++.+
T Consensus       161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN  236 (365)
T ss_dssp             TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT
T ss_pred             CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence            99999999999999999999999999999987543  6899999999999999999999987  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  330 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~  330 (429)
                      +.+||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||........
T Consensus       237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  313 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM  313 (365)
T ss_dssp             CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999999987654322   334689999999999863      3588999999999999999999999976543211


Q ss_pred             hhHHHhHhhHHHhhhhhhhhcCCCCCCCC--ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          331 QNLADWALPLLKEKKKLLNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...       +..         .......  ....+..+.+|+.+||+.||++|||+++++++
T Consensus       314 ~~~-------i~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          314 LRM-------IME---------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHH-------HHH---------TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHH-------HHh---------CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            100       000         0000000  01345678999999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=341.21  Aligned_cols=271  Identities=24%  Similarity=0.264  Sum_probs=198.7

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh----hHHHHHHHHHHHhccCCCceeeeeeEE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ----GHREWLAEVIFLGHLSHPNLVKLIGYC  185 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~  185 (429)
                      ..++|++.+.||+|+||.||+|.+..++      ..||+|++.......    ....+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTN------QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF   81 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCC------SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCC------cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            4578999999999999999999876543      349999987542211    124577899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          186 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       186 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                      .+.+..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           82 GHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             CCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             eeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecc
Confidence            999999999999986 8888776543 36888899999999999999999988  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH-HhHhhHHHh
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWALPLLKE  343 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~  343 (429)
                      +++......  .......||+.|+|||++.+. .++.++|||||||++|||++|.+||............ .........
T Consensus       158 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          158 LAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE  235 (346)
T ss_dssp             GGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence            998764322  123446799999999999764 5899999999999999999999999876543211100 000000000


Q ss_pred             hh----hhhhhcCCCCCCCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHhc
Q 014189          344 KK----KLLNIIDPRLEGDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  392 (429)
Q Consensus       344 ~~----~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  392 (429)
                      .+    ..............+     ...+..+.+|+.+||+.||++|||++|++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            00    000000000000001     23457899999999999999999999999873

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-44  Score=342.64  Aligned_cols=267  Identities=23%  Similarity=0.332  Sum_probs=188.5

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ...++|++.+.||+|+||.||+|.+..+.      ..||+|.+...........+.+|+.++++++||||+++++++...
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   85 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKK------EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK   85 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCC------cEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence            44578999999999999999999765443      349999987654444556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 EHRVLIYEFMARGSVENNLFS------KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      +..++||||+++|+|.+++..      .....+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEEC
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEE
Confidence            999999999999999998863      12346899999999999999999999987  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCC---ccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          263 DFGLAKDGPEGDK---SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       263 Dfgla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      |||++........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........     
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----  238 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----  238 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----
Confidence            9999876543211   112234579999999999876 5689999999999999999999999987653321100     


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       .....  .................+..+.+|+.+||+.||++|||+.+++++
T Consensus       239 -~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          239 -TLQND--PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             -HHTSS--CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -HhccC--CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             00000  000000000111223456788999999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.4e-44  Score=346.59  Aligned_cols=258  Identities=17%  Similarity=0.157  Sum_probs=203.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC---CCceeeeeeEEE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYCC  186 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  186 (429)
                      ..++|.+.+.||+|+||.||+|.+... .....+..||+|++....    ..++..|+.++..++   |+||+++++++.
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDL-NDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCC-cccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            346799999999999999999965332 123345569999997652    335667777777776   999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC--------
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSK---VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--------  255 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~--------  255 (429)
                      ..+..++||||+++|+|.+++...   ....+++..++.++.|++.||+|||+.+  |+||||||+|||++.        
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC---
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCcccc
Confidence            999999999999999999999642   2346999999999999999999999977  999999999999998        


Q ss_pred             ---CCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh
Q 014189          256 ---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN  332 (429)
Q Consensus       256 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~  332 (429)
                         ++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||++|||+||+.||.......   
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence               89999999999975432222333455789999999999999999999999999999999999999986432110   


Q ss_pred             HHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCC-CCHHHHHHhccccc
Q 014189          333 LADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR-PLMRDIVDSLEPLQ  396 (429)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~~~~  396 (429)
                                  ..    ........   .....+.+++..||+.+|.+| |+++++.+.|+.+.
T Consensus       293 ------------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          293 ------------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             ------------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             ------------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence                        00    01111111   225567889999999999998 57888888777654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-43  Score=338.42  Aligned_cols=260  Identities=17%  Similarity=0.240  Sum_probs=201.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEe--C
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCE--D  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~  188 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..||+|++...    ....+.+|+.++++++ ||||+++++++.+  .
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~  105 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNN------EKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVS  105 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CceEEEEEecccCCeEEEEEEECCCC------cEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence            67999999999999999999876553      34999998754    2356789999999997 9999999999987  6


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-cEEEeccCCC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLA  267 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla  267 (429)
                      ...++||||+++++|.+++.     .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++ .+||+|||++
T Consensus       106 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          106 RTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             CCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence            78899999999999998874     3888999999999999999999987  99999999999999776 8999999999


Q ss_pred             cCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH--HhHh-----h
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA--DWAL-----P  339 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~--~~~~-----~  339 (429)
                      +.......   .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||............  ....     .
T Consensus       179 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~  255 (330)
T 3nsz_A          179 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  255 (330)
T ss_dssp             EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             eEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence            86544322   234578999999999987 67899999999999999999999999654432211100  0000     0


Q ss_pred             HHHhh-----hhhhhhcC--------CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          340 LLKEK-----KKLLNIID--------PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       340 ~~~~~-----~~~~~~~~--------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....     ........        ...........+..+.+|+.+||+.||++|||++|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00000     00000000        001111222357889999999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.9e-44  Score=345.89  Aligned_cols=269  Identities=22%  Similarity=0.274  Sum_probs=206.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC--
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  188 (429)
                      ..+|++.+.||+|+||.||+|.+..+      +..||+|++...........+.+|+.++++++||||+++++++...  
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLN------KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCC------CeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            46899999999999999999986554      3459999998765566667889999999999999999999999654  


Q ss_pred             ---CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          189 ---EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       189 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                         ...++||||++ |+|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCc
Confidence               46899999997 5899888654   5899999999999999999999987  9999999999999999999999999


Q ss_pred             CCcCCCCCCC-ccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH-hHhhHHH
Q 014189          266 LAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD-WALPLLK  342 (429)
Q Consensus       266 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~-~~~~~~~  342 (429)
                      ++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............. .......
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9986543221 111234689999999998764 558999999999999999999999998765433211110 0000000


Q ss_pred             hhh------hhhhhc-CCCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          343 EKK------KLLNII-DPRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       343 ~~~------~~~~~~-~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +..      ...... ........     ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000      000000 00000011     12346788999999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.9e-45  Score=346.11  Aligned_cols=275  Identities=20%  Similarity=0.304  Sum_probs=202.5

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYC  185 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  185 (429)
                      +....++|++.+.||+|+||.||+|.+...         +|+|++.... .......+.+|+.++++++||||+++++++
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~---------~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHGE---------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC   98 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESSS---------EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcCe---------EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            344457899999999999999999976432         8999987542 222334566899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          186 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       186 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                      .+.+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+  ++||||||+|||++ ++.+||+|||
T Consensus        99 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B           99 MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             ECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCS
T ss_pred             ecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecC
Confidence            99999999999999999999986543 36889999999999999999999987  99999999999998 6799999999


Q ss_pred             CCcCCCCCC---CccccccccCCccccccccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH
Q 014189          266 LAKDGPEGD---KSHVSTRIMGTYGYAAPEYIMT---------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL  333 (429)
Q Consensus       266 la~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~  333 (429)
                      ++.......   .........||+.|+|||++.+         ..++.++||||||+++|||++|+.||.......... 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-  253 (319)
T 2y4i_B          175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-  253 (319)
T ss_dssp             CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH-
T ss_pred             CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence            987543211   1112233568999999999874         457899999999999999999999998655321100 


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCCCCCcccc
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVT  410 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~~  410 (429)
                                  .......+..   .....+..+.+++.+||..||++|||+.++++.|+.+.......+.|..+|.
T Consensus       254 ------------~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~  315 (319)
T 2y4i_B          254 ------------QMGTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK  315 (319)
T ss_dssp             ------------HHHTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred             ------------HhccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence                        0011111111   1123456788999999999999999999999999999888777666665553

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.4e-44  Score=371.10  Aligned_cols=252  Identities=26%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      +.||+|+||.||+|.+...    ..+..||||++.... ......+|.+|+.+|++++|||||++++++.. +..++|||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS----SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCC----CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence            4799999999999965432    123459999987642 23445789999999999999999999999864 56889999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC-
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK-  275 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-  275 (429)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++....... 
T Consensus       450 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          450 MAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             ccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            999999999997653  6899999999999999999999987  99999999999999999999999999986644322 


Q ss_pred             ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       276 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                      ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||........                 ...+...
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-----------------~~~i~~~  588 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----------------TAMLEKG  588 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HHHHHTT
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHcC
Confidence            112233457889999999999999999999999999999998 9999987654221                 1111111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      .....+..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            22234456778899999999999999999999999999764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.6e-43  Score=340.86  Aligned_cols=270  Identities=22%  Similarity=0.260  Sum_probs=201.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEe---
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  187 (429)
                      ++|++.+.||+|+||.||+|.+..++      ..||+|++..... ......+.+|+.+++.++||||+++++++..   
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTG------QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTC------CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCC------CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            67999999999999999999876543      3499999865432 2234567789999999999999999999976   


Q ss_pred             -----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          188 -----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       188 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                           .+..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             ------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEc
Confidence                 4568999999975 7777776543 36999999999999999999999987  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCC--ccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh
Q 014189          263 DFGLAKDGPEGDK--SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       263 Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      |||+++.......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999986543221  122344678999999999876 5689999999999999999999999987654332211111000


Q ss_pred             HHHh-h------hhhhhhcCCCCCCCCCh-------HHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          340 LLKE-K------KKLLNIIDPRLEGDYPV-------KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       340 ~~~~-~------~~~~~~~~~~~~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .... .      .................       ..+..+.+|+.+||+.||++|||++|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            0000 0      00000000000000000       014568899999999999999999999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=343.18  Aligned_cols=279  Identities=24%  Similarity=0.320  Sum_probs=212.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  189 (429)
                      ..+|++.+.||+|+||.||+|.+...  ....+..||+|++... .......+.+|+.++++++||||+++++++...+ 
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPL--QDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTT--SSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccc--cCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            45799999999999999999975321  1223566999998765 3445567889999999999999999999986543 


Q ss_pred             -eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          190 -HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       190 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                       ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchh
Confidence             7899999999999999997653 35899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+................... ....+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  272 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVFHL  272 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH-HHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh-hHHHH
Confidence            76543221 11223467888999999999899999999999999999999999886421110000000000000 00011


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      ...+........+..++..+.+++.+||+.||++|||+.++++.|+.++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1112112222334566788999999999999999999999999998765

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7e-44  Score=349.00  Aligned_cols=266  Identities=23%  Similarity=0.307  Sum_probs=197.7

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  187 (429)
                      ....+|++.+.||+|+||.||+|.+..++      ..||+|++..+....     .+|+.+++.++||||+++++++.. 
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~------~~vAiK~~~~~~~~~-----~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESG------KRFALKKVLQDPRYK-----NRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTC------CEEEEEEEECCTTSC-----CHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCC------CEEEEEEEecCcchH-----HHHHHHHHHcCCCCccchhheeeec
Confidence            45678999999999999999999876554      349999987653222     269999999999999999999843 


Q ss_pred             -------------------------------------CCeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHH
Q 014189          188 -------------------------------------DEHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAA  228 (429)
Q Consensus       188 -------------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~  228 (429)
                                                           ....++||||++ |+|.+.+..  .....+++..+..++.|++
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                 334889999998 587777653  2334799999999999999


Q ss_pred             HHHHHHHhCCCCceeCCCCCCcEEEc-CCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccC-CCCcccchh
Q 014189          229 KGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVY  306 (429)
Q Consensus       229 ~~l~~lH~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw  306 (429)
                      .||+|||+.+  |+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||
T Consensus       152 ~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          152 RAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            9999999977  99999999999998 689999999999986544322   2345789999999998865 589999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChhhhhhHH-HhHhhHHHh-----hhhhhhhcCCCCC-----CCCChHHHHHHHHHHHHhh
Q 014189          307 SFGVVLLEILTGRKSLDKSRPAREQNLA-DWALPLLKE-----KKKLLNIIDPRLE-----GDYPVKGVHKAAMLAYHCL  375 (429)
Q Consensus       307 slG~il~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl  375 (429)
                      ||||++|||++|+.||............ ........+     ........-+...     ...+...+..+.+|+.+||
T Consensus       227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            9999999999999999876543221110 000000000     0000000000000     0122345678999999999


Q ss_pred             ccCCCCCCCHHHHHHh
Q 014189          376 NHNPKARPLMRDIVDS  391 (429)
Q Consensus       376 ~~dP~~RPs~~evl~~  391 (429)
                      +.||++|||+.|+++|
T Consensus       307 ~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          307 RYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CSSGGGSCCHHHHHTS
T ss_pred             cCChhhCCCHHHHhcC
Confidence            9999999999999976

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=333.24  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=200.2

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEE
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  192 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  192 (429)
                      +|....+||+|+||.||+|.+..+.      ..||+|.+.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQ------VRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTC------CEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCC------eEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            3445569999999999999876543      449999987653 334567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC-CCcEEEeccCCCcCC
Q 014189          193 LIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDG  270 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~  270 (429)
                      +||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+  ++|+||||+||+++. ++.+||+|||++...
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            9999999999999997653 335678899999999999999999987  999999999999987 899999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      .....  ......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||...........        ..  . .
T Consensus       174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------~~--~-~  240 (295)
T 2clq_A          174 AGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--------KV--G-M  240 (295)
T ss_dssp             CC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--------HH--H-H
T ss_pred             CCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--------hh--c-c
Confidence            43221  223467999999999997653  89999999999999999999999975432211000        00  0 0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .    ......+...+..+.+++.+||+.||++|||+.+++++
T Consensus       241 ~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          241 F----KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             H----CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             c----cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0    11122344567789999999999999999999999976

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.1e-44  Score=370.01  Aligned_cols=264  Identities=24%  Similarity=0.362  Sum_probs=212.5

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ....++|++.+.||+|+||.||+|.+.....   ....||+|.............|.+|+.++++++||||+++++++. 
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPEN---PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSS---CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCC---ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            3445779999999999999999998764322   245699999887666666678999999999999999999999985 


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      ++..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCC
Confidence            466899999999999999997653 35899999999999999999999987  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      +....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||........   ...    +.    
T Consensus       539 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~----i~----  606 (656)
T 2j0j_A          539 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR----IE----  606 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----HH----
T ss_pred             eecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HH----
Confidence            87654322 12233567889999999999999999999999999999997 9999986653221   000    00    


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                        .    ......+..++..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus       607 --~----~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          607 --N----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             --H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --c----CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              0    0112234456788999999999999999999999999998764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.9e-44  Score=346.35  Aligned_cols=271  Identities=22%  Similarity=0.320  Sum_probs=189.7

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||.||+|.+..++      ..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTG------LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTT------EEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCC------CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            3578999999999999999999876543      459999987542 344556788999999999999999999998653


Q ss_pred             ------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 ------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                            ...|+||||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEe
Confidence                  5679999999 6899888764   36999999999999999999999987  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH-
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL-  340 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-  340 (429)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.............. 
T Consensus       175 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  249 (367)
T 2fst_X          175 DFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  249 (367)
T ss_dssp             C--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             ecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999865432     234679999999999987 67999999999999999999999999876643221111000000 


Q ss_pred             ----H---H-h-hhhhhhhcCCCCCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccC
Q 014189          341 ----L---K-E-KKKLLNIIDPRLEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQV  397 (429)
Q Consensus       341 ----~---~-~-~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~  397 (429)
                          +   . . .......+...-...+   ....+..+.+|+.+||..||++|||++|++++  |..+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                0   0 0 0000000000000000   11235678999999999999999999999987  444433

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=334.63  Aligned_cols=254  Identities=25%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ...++|++.+.||+|+||.||+|.+..++      ..||+|.+....   ....+.+|+.+++.++||||+++++++...
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   96 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETG------QIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKN   96 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTC------CEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCC------CEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            34568999999999999999999876543      349999987643   235678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.+||+|||++.
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccch
Confidence            9999999999999999988643 236899999999999999999999987  9999999999999999999999999997


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......  .......||+.|+|||.+.+..++.++||||||+++|+|++|..||...........             ..
T Consensus       174 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~  238 (314)
T 3com_A          174 QLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-------------IP  238 (314)
T ss_dssp             ECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HH
T ss_pred             hhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------Hh
Confidence            654321  122346799999999999999999999999999999999999999986553221100             00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....+  ....+...+..+.+|+.+||..||++|||+.+++++
T Consensus       239 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          239 TNPPP--TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             HSCCC--CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cCCCc--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11111  111233456789999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8e-44  Score=349.63  Aligned_cols=266  Identities=19%  Similarity=0.240  Sum_probs=205.3

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC--------CCceeee
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS--------HPNLVKL  181 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l  181 (429)
                      +.++|++.+.||+|+||.||+|.+..+      +..||+|++...  ......+.+|+.+++.++        |+||+++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQG------KKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCC------CeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            457899999999999999999987654      345999999754  344567889999999885        7889999


Q ss_pred             eeEEE----eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEcCC
Q 014189          182 IGYCC----EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       182 ~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~~~  256 (429)
                      ++++.    .....++||||+ +|+|.+.+.......+++..+..++.|++.||+|||++ +  |+||||||+|||++.+
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~  183 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN  183 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCC
T ss_pred             ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEecc
Confidence            99987    456889999999 67787777766556799999999999999999999997 7  9999999999999977


Q ss_pred             C-------------------------------------------------cEEEeccCCCcCCCCCCCccccccccCCcc
Q 014189          257 Y-------------------------------------------------NAKLSDFGLAKDGPEGDKSHVSTRIMGTYG  287 (429)
Q Consensus       257 ~-------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  287 (429)
                      +                                                 .+||+|||++......     .....||+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~  258 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQ  258 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGG
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCc
Confidence            5                                                 7999999999865432     234579999


Q ss_pred             cccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh---hhHHHhHhhHHH--------hhhhhhhhcCCC--
Q 014189          288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE---QNLADWALPLLK--------EKKKLLNIIDPR--  354 (429)
Q Consensus       288 y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~---~~~~~~~~~~~~--------~~~~~~~~~~~~--  354 (429)
                      |+|||++.+..++.++|||||||++|||++|+.||........   ............        ........+...  
T Consensus       259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  338 (397)
T 1wak_A          259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD  338 (397)
T ss_dssp             GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred             ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence            9999999999999999999999999999999999986543211   111110000000        000000000000  


Q ss_pred             ---C--------------CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          355 ---L--------------EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       355 ---~--------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         +              ....+...+..+.+|+.+||+.||++|||++|++++
T Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence               0              012345677889999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-43  Score=342.59  Aligned_cols=270  Identities=22%  Similarity=0.267  Sum_probs=204.5

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC-
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  188 (429)
                      +.++|++.+.||+|+||.||+|.+..++      ..||+|++...........+.+|+.+++.++||||+++++++... 
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTG------EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCC------cEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            4578999999999999999999876543      459999997665666667788999999999999999999988654 


Q ss_pred             ----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          189 ----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       189 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                          ...++||||+. |+|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCC
T ss_pred             cCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEec
Confidence                67899999997 6899888763   5899999999999999999999987  999999999999999999999999


Q ss_pred             CCCcCCCCCCCcc--------ccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 014189          265 GLAKDGPEGDKSH--------VSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       265 gla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~  335 (429)
                      |++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.........
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  236 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF  236 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9998654322110        1223578999999998764 778999999999999999999999998765432211100


Q ss_pred             hHhhHHH--------hhhhhhhhc---CCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 WALPLLK--------EKKKLLNII---DPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 ~~~~~~~--------~~~~~~~~~---~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      -......        .........   ......   ......+..+.+|+.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000        000000000   000000   0012456788999999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-43  Score=340.24  Aligned_cols=273  Identities=24%  Similarity=0.345  Sum_probs=209.4

Q ss_pred             cChHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhc--cCCCcee
Q 014189          102 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH--LSHPNLV  179 (429)
Q Consensus       102 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv  179 (429)
                      ........+.++|++.+.||+|+||.||+|.+.        +..||+|++...    ....+.+|.+++..  ++||||+
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~   99 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENIL   99 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEEc--------CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEE
Confidence            444455667789999999999999999999763        344999998643    34567788888877  7899999


Q ss_pred             eeeeEEEeCC----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeCCCC
Q 014189          180 KLIGYCCEDE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH--------EAEKPVIYRDFK  247 (429)
Q Consensus       180 ~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~ivH~Dlk  247 (429)
                      ++++++....    ..++||||+++|+|.+++...   .+++..+..++.|++.||+|||        +.+  |+|||||
T Consensus       100 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlk  174 (342)
T 1b6c_B          100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLK  174 (342)
T ss_dssp             CEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCS
T ss_pred             EEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCC
Confidence            9999998775    889999999999999999764   5899999999999999999999        656  9999999


Q ss_pred             CCcEEEcCCCcEEEeccCCCcCCCCCCCcc--ccccccCCcccccccccccC------CCCcccchhhHHHHHHHHHhC-
Q 014189          248 TSNILLDTDYNAKLSDFGLAKDGPEGDKSH--VSTRIMGTYGYAAPEYIMTG------HLTPRSDVYSFGVVLLEILTG-  318 (429)
Q Consensus       248 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltG-  318 (429)
                      |+|||++.++.+||+|||++..........  ......||+.|+|||++.+.      .++.++||||||+++|||++| 
T Consensus       175 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~  254 (342)
T 1b6c_B          175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC  254 (342)
T ss_dssp             GGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             HHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhcc
Confidence            999999999999999999997654332111  12345799999999999865      344789999999999999999 


Q ss_pred             ---------CCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCC-CChHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014189          319 ---------RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGD-YPVKGVHKAAMLAYHCLNHNPKARPLMRDI  388 (429)
Q Consensus       319 ---------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev  388 (429)
                               ..||........ ....+...      .......+.+... ....+...+.+|+.+||+.||++|||+++|
T Consensus       255 ~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          255 SIGGIHEDYQLPYYDLVPSDP-SVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             CBTTBCCCCCCTTTTTSCSSC-CHHHHHHH------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CcCCcccccccCccccCcCcc-cHHHHHHH------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence                     677765432110 00000000      0011111111111 123567889999999999999999999999


Q ss_pred             HHhcccccCC
Q 014189          389 VDSLEPLQVL  398 (429)
Q Consensus       389 l~~L~~~~~~  398 (429)
                      +++|+.+...
T Consensus       328 ~~~L~~i~~~  337 (342)
T 1b6c_B          328 KKTLSQLSQQ  337 (342)
T ss_dssp             HHHHHHHHHT
T ss_pred             HHHHHHHHHH
Confidence            9999887544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-43  Score=329.90  Aligned_cols=251  Identities=25%  Similarity=0.324  Sum_probs=197.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTG------HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST   82 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCC------ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            3468999999999999999999876543      349999986432  11234567899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+..++||||+++++|.+++....  .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccc
Confidence            999999999999999999987653  5899999999999999999999987  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      .......   ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.........      .. ..    
T Consensus       159 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~-~~----  224 (276)
T 2h6d_A          159 NMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF------KK-IR----  224 (276)
T ss_dssp             GCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH-HH----
T ss_pred             cccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH------HH-hh----
Confidence            8764432   1234578999999999987765 68999999999999999999999865432110      00 00    


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ..     ....+...+..+.+++.+||+.||++|||+++++++
T Consensus       225 --~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          225 --GG-----VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --HC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --cC-----cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              00     011233456778999999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.8e-43  Score=329.84  Aligned_cols=255  Identities=25%  Similarity=0.320  Sum_probs=206.4

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--------hhhHHHHHHHHHHHhccC-CCceee
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--------YQGHREWLAEVIFLGHLS-HPNLVK  180 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~  180 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..||+|++.....        ......+.+|+.+++++. ||||++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTC------KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   88 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcC------ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence            4578999999999999999999876543      3499999875431        123456789999999995 999999


Q ss_pred             eeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEE
Q 014189          181 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  260 (429)
Q Consensus       181 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  260 (429)
                      +++++...+..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.+|
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEE
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEE
Confidence            9999999999999999999999999997643  6899999999999999999999987  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  334 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~  334 (429)
                      |+|||++........   .....||+.|+|||++.      ...++.++||||||+++|+|++|..||..........  
T Consensus       165 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--  239 (298)
T 1phk_A          165 LTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR--  239 (298)
T ss_dssp             ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--
T ss_pred             EecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH--
Confidence            999999987644322   23467999999999985      4568899999999999999999999997654321100  


Q ss_pred             HhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          ....      .  ............+..+.+++.+||+.||++|||+.+++++
T Consensus       240 ----~~~~------~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          240 ----MIMS------G--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             ----HHHH------T--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ----HHhc------C--CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence                0000      0  0011111123567789999999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.4e-43  Score=336.08  Aligned_cols=267  Identities=22%  Similarity=0.290  Sum_probs=207.8

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCc------eeeeee
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN------LVKLIG  183 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~  183 (429)
                      +.++|++.+.||+|+||.||+|.+...     .+..||+|++...  ......+.+|+.+++.++|+|      ++++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKA-----GGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCC-----CCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            457899999999999999999976321     2345999998753  344567788999998887654      999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC--------
Q 014189          184 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--------  255 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~--------  255 (429)
                      ++...+..++||||+ +++|.+++......++++..+..++.|++.||+|||+++  |+||||||+|||++.        
T Consensus        85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred             ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccC
Confidence            999999999999999 889999998776667999999999999999999999987  999999999999987        


Q ss_pred             -----------CCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 014189          256 -----------DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK  324 (429)
Q Consensus       256 -----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~  324 (429)
                                 ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                       678999999999864332     2346799999999999999999999999999999999999999987


Q ss_pred             CChhhhhhHHHhHhhHHHh----hh---------------------hhhhhcCCCC-CCCCChHHHHHHHHHHHHhhccC
Q 014189          325 SRPAREQNLADWALPLLKE----KK---------------------KLLNIIDPRL-EGDYPVKGVHKAAMLAYHCLNHN  378 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~----~~---------------------~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~d  378 (429)
                      .+.................    ..                     .......+.. ........+..+.+|+.+||+.|
T Consensus       237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            6643322111111000000    00                     0000000000 01123356788999999999999


Q ss_pred             CCCCCCHHHHHHh
Q 014189          379 PKARPLMRDIVDS  391 (429)
Q Consensus       379 P~~RPs~~evl~~  391 (429)
                      |++|||+.|++++
T Consensus       317 P~~Rpt~~ell~h  329 (339)
T 1z57_A          317 PAKRITLREALKH  329 (339)
T ss_dssp             TTTSCCHHHHTTS
T ss_pred             cccccCHHHHhcC
Confidence            9999999999976

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.9e-43  Score=341.55  Aligned_cols=265  Identities=19%  Similarity=0.248  Sum_probs=194.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILE------RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCC------ceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            468999999999999999999876543      449999987643 3445567889999999999999999999997654


Q ss_pred             ------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          190 ------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       190 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                            ..++||||+++ +|.+.+..    .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEE
Confidence                  78999999974 78877742    4889999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH---------
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA---------  334 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~---------  334 (429)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+........         
T Consensus       171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998654321   233467999999999999999999999999999999999999999876543211100         


Q ss_pred             HhHhh-------HHHhhh-----hhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 DWALP-------LLKEKK-----KLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 ~~~~~-------~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .+...       ......     .....+.......   .....+..+.+|+.+||..||++|||++|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            00000       000000     0000000000000   011236789999999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-44  Score=347.01  Aligned_cols=260  Identities=26%  Similarity=0.305  Sum_probs=204.0

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEE
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  186 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  186 (429)
                      .++|++.+.||+|+||.||+|.....   ...+..||+|++....   .......+.+|+.+++++ +||||+++++++.
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISG---HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSS---TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEccc---CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            36899999999999999999987432   1234569999986432   112233456799999999 6999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      ..+..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCC
Confidence            9999999999999999999997654  6899999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ++...... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........  .........   
T Consensus       206 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~---  279 (355)
T 1vzo_A          206 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRIL---  279 (355)
T ss_dssp             EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHH---
T ss_pred             CeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHh---
Confidence            98654322 122334679999999999985  3578999999999999999999999975432111  011110000   


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHhc
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSL  392 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L  392 (429)
                          . .    ....+...+..+.+|+.+||..||++||     |+++++++.
T Consensus       280 ----~-~----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          280 ----K-S----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ----H-C----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ----c-c----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                0 0    1123445667889999999999999999     999999885

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-43  Score=339.04  Aligned_cols=256  Identities=23%  Similarity=0.326  Sum_probs=197.9

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-------hhhHHHHHHHHHHHhccCCCceeee
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-------YQGHREWLAEVIFLGHLSHPNLVKL  181 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l  181 (429)
                      .+.++|++.+.||+|+||.||+|.+..+.      ..||+|++.....       ......+.+|+.++++++||||+++
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   80 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTC------KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI   80 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCC------cEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence            34578999999999999999999876543      3499999875421       1223457789999999999999999


Q ss_pred             eeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc---
Q 014189          182 IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---  258 (429)
Q Consensus       182 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~---  258 (429)
                      ++++..+. .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.   
T Consensus        81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~  155 (322)
T 2ycf_A           81 KNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCL  155 (322)
T ss_dssp             EEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCC
T ss_pred             eeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCe
Confidence            99987655 89999999999999988654  36899999999999999999999987  999999999999987665   


Q ss_pred             EEEeccCCCcCCCCCCCccccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 014189          259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  335 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~  335 (429)
                      +||+|||++......   .......||+.|+|||++.   ...++.++|||||||++|+|++|..||........  +..
T Consensus       156 ~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~  230 (322)
T 2ycf_A          156 IKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD  230 (322)
T ss_dssp             EEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH
T ss_pred             EEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH
Confidence            999999999875432   1223457999999999974   56789999999999999999999999975432211  100


Q ss_pred             hHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .    +...     ..  ..........+..+.+|+.+||..||++|||+.+++++
T Consensus       231 ~----~~~~-----~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          231 Q----ITSG-----KY--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             H----HHHT-----CC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             H----HHhC-----cc--ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            0    0000     00  00000012346788999999999999999999999965

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=344.96  Aligned_cols=271  Identities=22%  Similarity=0.371  Sum_probs=195.9

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHH--HhccCCCceeeeeeEEEe-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF--LGHLSHPNLVKLIGYCCE-  187 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-  187 (429)
                      .++|++.+.||+|+||.||+|.+.        +..||+|++...    ....+..|.++  +..++||||+++++.+.. 
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD--------ERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET--------TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC--------CeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence            468999999999999999999653        245999998643    22334444444  456899999999986542 


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceeCCCCCCcEEEc
Q 014189          188 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA---------EKPVIYRDFKTSNILLD  254 (429)
Q Consensus       188 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---------~~~ivH~Dlkp~NIll~  254 (429)
                          ...+++||||+++|+|.+++...   ..++..+..++.|++.||+|||+.         +  |+||||||+|||++
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~  154 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK  154 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc
Confidence                33678999999999999999765   358899999999999999999987         6  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCC------ccccccccCCccccccccccc-------CCCCcccchhhHHHHHHHHHhCCCC
Q 014189          255 TDYNAKLSDFGLAKDGPEGDK------SHVSTRIMGTYGYAAPEYIMT-------GHLTPRSDVYSFGVVLLEILTGRKS  321 (429)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltG~~p  321 (429)
                      .++.+||+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..|
T Consensus       155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence            999999999999986543211      112234579999999999986       4567899999999999999999877


Q ss_pred             CCCCChhhhh--hHHHhH--hhHHHhhh--hhhhhcCCCCCCCC--ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          322 LDKSRPAREQ--NLADWA--LPLLKEKK--KLLNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       322 ~~~~~~~~~~--~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      |.........  ......  .+......  .......+.+....  ....+..+.+|+.+||+.||++|||++|+++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            6433221110  000000  00000000  00011111111111  2346778999999999999999999999999998


Q ss_pred             cccCC
Q 014189          394 PLQVL  398 (429)
Q Consensus       394 ~~~~~  398 (429)
                      .+...
T Consensus       315 ~ll~~  319 (336)
T 3g2f_A          315 ELMMI  319 (336)
T ss_dssp             HHHHC
T ss_pred             HHHHH
Confidence            87543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.7e-43  Score=347.43  Aligned_cols=271  Identities=22%  Similarity=0.313  Sum_probs=198.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  189 (429)
                      ..+|++.+.||+|+||.||+|.+..+..       +|+|.+.......     .+|+.+++.++||||+++++++...+ 
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-------~aikk~~~~~~~~-----~~E~~il~~l~h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-------VAIKKVLQDKRFK-----NRELQIMRIVKHPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-------EEEEEEECCTTSC-----CHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-------EEEEEEecCcchH-----HHHHHHHHhCCCCCcceEEEEEEecCC
Confidence            4579999999999999999998765432       7777775543221     26999999999999999999986543 


Q ss_pred             -----eEEEEEEecCCCChhhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-CCCcEEEe
Q 014189          190 -----HRVLIYEFMARGSVENNLF-SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLS  262 (429)
Q Consensus       190 -----~~~lv~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-~~~~~kl~  262 (429)
                           ..++||||++++.+..... ......+++..+..++.|++.||+|||+.+  |+||||||+|||++ .++.+||+
T Consensus       107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEEC
T ss_pred             CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEe
Confidence                 3789999998754433221 122346999999999999999999999987  99999999999999 79999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH-HHhHhhH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPL  340 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~-~~~~~~~  340 (429)
                      |||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||...+....... .......
T Consensus       185 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          185 DFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             CCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999987644322   2346789999999998764 589999999999999999999999987654322111 0000000


Q ss_pred             HHhh--hhhhhhcCCCCCC--------CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCC
Q 014189          341 LKEK--KKLLNIIDPRLEG--------DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       341 ~~~~--~~~~~~~~~~~~~--------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                      ..+.  .............        .++...+.++.+|+.+||+.||++|||+.|+++|  +..+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            0000  0000011111100        0122356789999999999999999999999987  5665544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.7e-43  Score=345.54  Aligned_cols=261  Identities=25%  Similarity=0.348  Sum_probs=194.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC---
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED---  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  188 (429)
                      .+|++.+.||+|+||.||+|.+..+.      ..||||++......     +.+|+++|+.++||||++++++|...   
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~------~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~  122 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSG------ELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEK  122 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCC------cEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence            46999999999999999999876543      34999998754321     23699999999999999999988532   


Q ss_pred             ---CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-CcEEEe
Q 014189          189 ---EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLS  262 (429)
Q Consensus       189 ---~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~  262 (429)
                         ..+++||||+++ +|.+.+..  .....+++..+..++.|++.||+|||+++  |+||||||+|||++.+ +.+||+
T Consensus       123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEEC
T ss_pred             CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEec
Confidence               246799999975 56655532  23347999999999999999999999977  9999999999999965 678999


Q ss_pred             ccCCCcCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      |||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||........  +.......-
T Consensus       200 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg  274 (420)
T 1j1b_A          200 DFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLG  274 (420)
T ss_dssp             CCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHC
T ss_pred             cchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhC
Confidence            9999987544322   2346789999999999764 799999999999999999999999987654322  111110000


Q ss_pred             H-hhhhhhhhc-------CCCCCCC-----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          342 K-EKKKLLNII-------DPRLEGD-----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       342 ~-~~~~~~~~~-------~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      . ....+....       .+.+...     ++...+.++.+|+.+||..||++|||+.|+++|
T Consensus       275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            0 000000100       0011000     122446789999999999999999999999976

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.7e-43  Score=351.55  Aligned_cols=263  Identities=19%  Similarity=0.229  Sum_probs=205.5

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCC-CceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~  188 (429)
                      +.++|++.++||+|+||.||+|.+..+.      ..||||++.......   .+..|+++++.++| +++..+..++...
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~------~~vAvK~~~~~~~~~---~~~~E~~il~~L~~~~~i~~i~~~~~~~   75 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN------EEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNVRWFGVEG   75 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTC------CEEEEEEEETTCSSC---CHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCC------cEEEEEEeccccccH---HHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence            3578999999999999999999876543      349999987553322   36689999999986 5666666677788


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE---cCCCcEEEeccC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFG  265 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg  265 (429)
                      +..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+||||   +.++.+||+|||
T Consensus        76 ~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           76 DYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             CEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCC
Confidence            8999999999 899999987543 36999999999999999999999987  9999999999999   688999999999


Q ss_pred             CCcCCCCCCCc-----cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          266 LAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       266 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      +++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (483)
T 3sv0_A          152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (483)
T ss_dssp             TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred             cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence            99876543221     1123568999999999999999999999999999999999999999875542221111111100


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      .. ......+         ...++.++.+|+..||+.+|++||++.+|++.|+.+
T Consensus       232 ~~-~~~~~~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          232 KV-ATSIEAL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HH-HSCHHHH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cc-cccHHHH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            00 0000000         012356889999999999999999999999998776

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.5e-43  Score=333.09  Aligned_cols=256  Identities=22%  Similarity=0.325  Sum_probs=200.7

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccC--CCceeeeeeE
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLS--HPNLVKLIGY  184 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~niv~l~~~  184 (429)
                      .....+|++.+.||+|+||.||+|.+..       +..||+|++.... .......+.+|+.++.+++  ||||++++++
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTT-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcCC-------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            3445779999999999999999997643       3449999987543 4455677889999999997  5999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                      +...+..++||| +.+++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||+++ +.+||+||
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Df  170 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDF  170 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeec
Confidence            999999999999 56889999997654  6899999999999999999999987  999999999999964 89999999


Q ss_pred             CCCcCCCCCCCccccccccCCccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhH
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL  333 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~  333 (429)
                      |++................||+.|+|||++.+           ..++.++||||||+++|+|++|+.||........   
T Consensus       171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---  247 (313)
T 3cek_A          171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---  247 (313)
T ss_dssp             SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---
T ss_pred             cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---
Confidence            99987654333223344679999999999875           4788999999999999999999999975432211   


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                  .+....++......+...+..+.+++.+||+.||++|||+.|++++
T Consensus       248 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          248 ------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                        1122223333333344456789999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-43  Score=335.72  Aligned_cols=255  Identities=25%  Similarity=0.355  Sum_probs=200.3

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETG------ALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTC------CEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCC------cEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence            3468999999999999999999876543      34999998755 3344567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+  ++||||||+|||++.++.+||+|||++..
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            9999999999999999886532 35899999999999999999999987  99999999999999999999999998753


Q ss_pred             CCCCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  344 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ....  ........||+.|+|||++.     +..++.++||||||+++|+|++|..||.........      ....   
T Consensus       167 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~---  235 (302)
T 2j7t_A          167 NLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIA---  235 (302)
T ss_dssp             HHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHH---
T ss_pred             cccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHh---
Confidence            2110  01122357899999999984     667899999999999999999999999866532110      0000   


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          ....+  ....+...+..+.+++.+||+.||++|||+.+++++
T Consensus       236 ----~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          236 ----KSDPP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ----HSCCC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ----ccCCc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                00000  111234556789999999999999999999999976

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-43  Score=343.78  Aligned_cols=274  Identities=23%  Similarity=0.302  Sum_probs=200.1

Q ss_pred             hHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC----------hhhHHHHHHHHHHHhcc
Q 014189          104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS----------YQGHREWLAEVIFLGHL  173 (429)
Q Consensus       104 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~E~~~l~~l  173 (429)
                      ..++..+.++|++.+.||+|+||.||+|.+..       +..||+|++.....          ......+.+|+.+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   86 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF   86 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCC-------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC
Confidence            45677888999999999999999999997543       34599998854321          12236788999999999


Q ss_pred             CCCceeeeeeEEEe-----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCC
Q 014189          174 SHPNLVKLIGYCCE-----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKT  248 (429)
Q Consensus       174 ~h~niv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp  248 (429)
                      +||||+++++++..     ....++||||++ |+|.+.+... ...+++..+..++.|++.||+|||+.+  |+||||||
T Consensus        87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp  162 (362)
T 3pg1_A           87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHP  162 (362)
T ss_dssp             CCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred             CCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCCh
Confidence            99999999999854     336899999997 6888888654 346999999999999999999999987  99999999


Q ss_pred             CcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCh
Q 014189          249 SNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRP  327 (429)
Q Consensus       249 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~  327 (429)
                      +|||++.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             GGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             HHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999997543322   2334678999999999887 6789999999999999999999999987654


Q ss_pred             hhhhhH-HHhHhhH-HH-----hhhhhhhhcCCCCCC---C----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          328 AREQNL-ADWALPL-LK-----EKKKLLNIIDPRLEG---D----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       328 ~~~~~~-~~~~~~~-~~-----~~~~~~~~~~~~~~~---~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...... ....... ..     ........+......   .    .....+..+.+|+.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            322111 0000000 00     000001111111100   0    112345678999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-44  Score=353.09  Aligned_cols=244  Identities=16%  Similarity=0.121  Sum_probs=189.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCC--CChhhHHHHHHHH---HHHhccCCCceeeee---
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEV---IFLGHLSHPNLVKLI---  182 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~---~~l~~l~h~niv~l~---  182 (429)
                      .++|++.+.||+|+||.||+|.+..++      ..||+|++...  ........+.+|+   .+++.++||||++++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETG------ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCC------CEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCC------cEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            467999999999999999999865443      34999998643  2334556788999   455566799999998   


Q ss_pred             ----eEEEeCC-----------------eEEEEEEecCCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHh
Q 014189          183 ----GYCCEDE-----------------HRVLIYEFMARGSVENNLFSKVL-----LPLPWSIRMKIAFGAAKGLAFLHE  236 (429)
Q Consensus       183 ----~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~  236 (429)
                          +++...+                 ..|+||||+ +|+|.+++.....     ..+++..+..++.|++.||+|||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence                6665543                 278999999 6899999975321     124458888999999999999999


Q ss_pred             CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccC-----------CCCcccch
Q 014189          237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-----------HLTPRSDV  305 (429)
Q Consensus       237 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv  305 (429)
                      ++  |+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||
T Consensus       225 ~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          225 YG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             TT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             CC--eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            87  99999999999999999999999999986322     2344678 999999999887           89999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH
Q 014189          306 YSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM  385 (429)
Q Consensus       306 wslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  385 (429)
                      |||||++|||++|+.||........                ...+..      .....+..+.+|+.+||+.||++|||+
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGG----------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CC----------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccc----------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            9999999999999999975432110                011111      012345778999999999999999999


Q ss_pred             HHHHHh
Q 014189          386 RDIVDS  391 (429)
Q Consensus       386 ~evl~~  391 (429)
                      .+++++
T Consensus       355 ~e~l~h  360 (377)
T 3byv_A          355 LQAMET  360 (377)
T ss_dssp             HHHHTS
T ss_pred             HHHhhC
Confidence            999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.4e-44  Score=348.34  Aligned_cols=257  Identities=12%  Similarity=0.048  Sum_probs=184.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhcc--CCCceeeee----
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHL--SHPNLVKLI----  182 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l--~h~niv~l~----  182 (429)
                      ..+|++.+.||+|+||.||+|.+..+.      ..||+|++.....  ......+.+|+.++..+  +||||++++    
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~  134 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERL------EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL  134 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBC
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCC------ceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence            345899999999999999999876553      4599999987642  33445667775444444  699988754    


Q ss_pred             ---eEEEeC-----------------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHh
Q 014189          183 ---GYCCED-----------------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIR------MKIAFGAAKGLAFLHE  236 (429)
Q Consensus       183 ---~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~i~~~l~~lH~  236 (429)
                         +++...                 ...|+||||++ |+|.+++..... .+++..+      ..++.|++.||+|||+
T Consensus       135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~  212 (371)
T 3q60_A          135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQS  212 (371)
T ss_dssp             CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence               444433                 34799999998 899999976422 3455555      7888999999999999


Q ss_pred             CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCccccccccccc--CCCCcccchhhHHHHHHH
Q 014189          237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLE  314 (429)
Q Consensus       237 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~e  314 (429)
                      ++  |+||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++||
T Consensus       213 ~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e  285 (371)
T 3q60_A          213 KG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR  285 (371)
T ss_dssp             TT--EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred             CC--CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence            87  999999999999999999999999999865321     113567799999999987  789999999999999999


Q ss_pred             HHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          315 ILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       315 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      |++|+.||............         ....................+..+.+|+.+||+.||++|||+.+++++
T Consensus       286 lltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          286 VWCLFLPFGLVTPGIKGSWK---------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHHSSCSTTBCCTTCTTCCC---------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HHhCCCCCCCcCcccccchh---------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99999999866432111000         000001111111122223567889999999999999999999999865

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-42  Score=339.05  Aligned_cols=207  Identities=23%  Similarity=0.285  Sum_probs=176.1

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CC-----ceeee
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HP-----NLVKL  181 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l  181 (429)
                      ..+.++|++.+.||+|+||.||+|.+..+.      ..||+|++...  ......+..|+.++..++ |+     +|+++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~  121 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQ------EWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL  121 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTT------EEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCC------cEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence            345678999999999999999999876543      44999999753  334556778888888875 55     49999


Q ss_pred             eeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc--CCCcE
Q 014189          182 IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD--TDYNA  259 (429)
Q Consensus       182 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~--~~~~~  259 (429)
                      ++++...+..++||||++ |+|.+++.......+++..+..++.|++.||.|||++..+|+||||||+|||++  .++.+
T Consensus       122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcE
Confidence            999999999999999996 599999987765679999999999999999999997555699999999999994  57889


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChh
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA  328 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~  328 (429)
                      ||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus       201 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999875432     23467999999999999999999999999999999999999999876543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.8e-43  Score=339.99  Aligned_cols=265  Identities=20%  Similarity=0.254  Sum_probs=201.4

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-----------CCcee
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-----------HPNLV  179 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv  179 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++...  ......+.+|+.++++++           ||||+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~   89 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNN------THVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL   89 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCC------cEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence            368999999999999999999875543      45999998753  334566788999998886           89999


Q ss_pred             eeeeEEEeCC----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEc
Q 014189          180 KLIGYCCEDE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLD  254 (429)
Q Consensus       180 ~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~  254 (429)
                      ++++++...+    ..++||||+ +++|.+++.......+++..+..++.|++.||+|||++ +  |+||||||+|||++
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~  166 (373)
T 1q8y_A           90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLME  166 (373)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEE
T ss_pred             HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEe
Confidence            9999997654    789999999 88999999876666799999999999999999999997 7  99999999999994


Q ss_pred             ------CCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChh
Q 014189          255 ------TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA  328 (429)
Q Consensus       255 ------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~  328 (429)
                            ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence                  4458999999999865432     23357999999999999999999999999999999999999999865422


Q ss_pred             hh----hhHHHhHh-------hHHHhhhhhhhhcCCC-------------------CCCCCChHHHHHHHHHHHHhhccC
Q 014189          329 RE----QNLADWAL-------PLLKEKKKLLNIIDPR-------------------LEGDYPVKGVHKAAMLAYHCLNHN  378 (429)
Q Consensus       329 ~~----~~~~~~~~-------~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~l~~l~~~cl~~d  378 (429)
                      ..    ..+.....       ............++..                   .....+...+..+.+|+.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence            11    01100000       0000000000000000                   011234567889999999999999


Q ss_pred             CCCCCCHHHHHHh
Q 014189          379 PKARPLMRDIVDS  391 (429)
Q Consensus       379 P~~RPs~~evl~~  391 (429)
                      |++|||++|++++
T Consensus       322 P~~Rpt~~ell~h  334 (373)
T 1q8y_A          322 PRKRADAGGLVNH  334 (373)
T ss_dssp             TTTCBCHHHHHTC
T ss_pred             ccccCCHHHHhhC
Confidence            9999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.8e-43  Score=335.60  Aligned_cols=257  Identities=26%  Similarity=0.325  Sum_probs=183.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHH-HHhccCCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI-FLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .++|++.+.||+|+||.||+|.+..++      ..||+|++...........+..|+. +++.++||||+++++++...+
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSG------QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTT------EEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCC------CEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence            368999999999999999999876543      4499999987655555566666766 677789999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEcCCCcEEEeccC
Q 014189          190 HRVLIYEFMARGSVENNLFS---KVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFG  265 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  265 (429)
                      ..++||||+++ +|.+++..   .....+++..+..++.|++.||.|||+. +  |+||||||+|||++.++.+||+|||
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCC
Confidence            99999999985 77776642   2345789999999999999999999997 7  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccCCccccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH
Q 014189          266 LAKDGPEGDKSHVSTRIMGTYGYAAPEYI----MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       266 la~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      +++......   ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||.........     .    
T Consensus       172 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~----  239 (327)
T 3aln_A          172 ISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----L----  239 (327)
T ss_dssp             SSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------
T ss_pred             Cceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----H----
Confidence            998764322   12334799999999998    4667899999999999999999999999764321100     0    


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         ........+.+........+..+.+|+.+||+.||++|||+.+++++
T Consensus       240 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          240 ---TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             ---CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ---HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence               00001111112222223467789999999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-43  Score=340.49  Aligned_cols=262  Identities=19%  Similarity=0.216  Sum_probs=204.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh----------------hhHHHHHHHHHHHhccC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY----------------QGHREWLAEVIFLGHLS  174 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~E~~~l~~l~  174 (429)
                      .++|++.+.||+|+||.||+|.+  +      +..||+|++......                .....+.+|+.++++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--D------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--T------TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--C------CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            46899999999999999999986  2      345999998643111                11267889999999999


Q ss_pred             CCceeeeeeEEEeCCeEEEEEEecCCCChhhh------hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCC
Q 014189          175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENN------LFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFK  247 (429)
Q Consensus       175 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlk  247 (429)
                      ||||+++++++.+.+..++||||+++|+|.++      +.......+++..+..++.|++.||+|||+ .+  ++|||||
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~  179 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVK  179 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCC
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCC
Confidence            99999999999999999999999999999998      655445679999999999999999999998 78  9999999


Q ss_pred             CCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCCC
Q 014189          248 TSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTP-RSDVYSFGVVLLEILTGRKSLDKS  325 (429)
Q Consensus       248 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltG~~p~~~~  325 (429)
                      |+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++||||||+++|||++|..||...
T Consensus       180 p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          180 PSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999865432    23446799999999999877 6766 999999999999999999999865


Q ss_pred             ChhhhhhHHHhHhhHHHhhhhhhh----hcCCC---CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          326 RPAREQNLADWALPLLKEKKKLLN----IIDPR---LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....  .....   .........    ...+.   .........+..+.+|+.+||+.||++|||++|++++
T Consensus       256 ~~~~~--~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          256 ISLVE--LFNNI---RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             SCSHH--HHHHH---TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CcHHH--HHHHH---hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            53111  10000   000000000    00000   0000113456789999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.9e-42  Score=335.64  Aligned_cols=280  Identities=23%  Similarity=0.276  Sum_probs=194.1

Q ss_pred             HHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEE
Q 014189          106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC  185 (429)
Q Consensus       106 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  185 (429)
                      ......++|++.+.||+|+||.||+|.+..+.      ..||+|++.....  ....+.+++..+..++||||+++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~   88 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTG------MSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYF   88 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTC------CEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCC------CEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence            34456689999999999999999999876543      3499998865432  223455788888999999999999999


Q ss_pred             EeCCe-------EEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC-
Q 014189          186 CEDEH-------RVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-  255 (429)
Q Consensus       186 ~~~~~-------~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~-  255 (429)
                      ...+.       .++||||+++ +|...+..  .....+++..+..++.|++.||.|||.+..+|+||||||+|||++. 
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT
T ss_pred             hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC
Confidence            75433       7899999986 55544432  2344689999999999999999999933344999999999999997 


Q ss_pred             CCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 014189          256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  334 (429)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~  334 (429)
                      ++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||............
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence            89999999999987654322   2346789999999998765 4899999999999999999999999876543221111


Q ss_pred             HhHhhHHHhhhhhhhhcCCCC----------------CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--ccccc
Q 014189          335 DWALPLLKEKKKLLNIIDPRL----------------EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQ  396 (429)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~  396 (429)
                        ...............++..                ........+..+.+|+.+||+.||++|||+.|++++  |..+.
T Consensus       245 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          245 --VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             --HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             --HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence              0000000000000000000                011122357889999999999999999999999987  55554


Q ss_pred             CCC
Q 014189          397 VLP  399 (429)
Q Consensus       397 ~~~  399 (429)
                      ...
T Consensus       323 ~~~  325 (360)
T 3e3p_A          323 DPA  325 (360)
T ss_dssp             CTT
T ss_pred             Ccc
Confidence            443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-42  Score=328.40  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=195.5

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  187 (429)
                      ..++|++.+.||+|+||.||+|.+..+.      ..||+|++...  ......+.+|+.++++++||||+++++++.+  
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDS------RYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERR   75 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCC------eEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence            4568999999999999999999876543      34999998643  3455678899999999999999999998865  


Q ss_pred             -----------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          188 -----------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       188 -----------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                                 .+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  ++||||||+|||++.+
T Consensus        76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~  152 (303)
T 1zy4_A           76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES  152 (303)
T ss_dssp             CCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT
T ss_pred             chhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCC
Confidence                       457899999999999999997643 35788999999999999999999987  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCC------------ccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 014189          257 YNAKLSDFGLAKDGPEGDK------------SHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLD  323 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~  323 (429)
                      +.+||+|||++........            ........||+.|+|||++.+. .++.++||||||+++|+|++   ||.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence            9999999999986543210            1112345799999999999864 78999999999999999998   444


Q ss_pred             CCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          324 KSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....  ....   ...       + ...........+...+..+.+++.+||+.||++|||+++++++
T Consensus       230 ~~~~--~~~~---~~~-------~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          230 TGME--RVNI---LKK-------L-RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             SHHH--HHHH---HHH-------H-HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             Cchh--HHHH---HHh-------c-cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            2111  1011   000       0 0111122233445566788999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.3e-43  Score=344.34  Aligned_cols=270  Identities=22%  Similarity=0.303  Sum_probs=183.4

Q ss_pred             hcCCcc-ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--
Q 014189          111 TANFRQ-DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  187 (429)
Q Consensus       111 ~~~y~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  187 (429)
                      .+.|.+ .++||+|+||.||+|.+.+..    .+..||+|++......   ..+.+|+.+|++++||||+++++++..  
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGK----DDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSS----CCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCC----CCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            345665 468999999999999865321    2345999998764322   356789999999999999999999954  


Q ss_pred             CCeEEEEEEecCCCChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE----cCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSK-------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTD  256 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll----~~~  256 (429)
                      ....++||||++ |+|.+++...       ....+++..+..++.|++.||+|||+.+  |+||||||+|||+    +.+
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTT
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCC
Confidence            678999999997 5787777421       2235899999999999999999999988  9999999999999    778


Q ss_pred             CcEEEeccCCCcCCCCCCC-ccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh----
Q 014189          257 YNAKLSDFGLAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE----  330 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~----  330 (429)
                      +.+||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........    
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            9999999999987643211 122334689999999999987 4589999999999999999999999976543210    


Q ss_pred             ---hhHHHhHhhHHH--------------hhhhhhhhcCCCCCCCC---------ChHHHHHHHHHHHHhhccCCCCCCC
Q 014189          331 ---QNLADWALPLLK--------------EKKKLLNIIDPRLEGDY---------PVKGVHKAAMLAYHCLNHNPKARPL  384 (429)
Q Consensus       331 ---~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~---------~~~~~~~l~~l~~~cl~~dP~~RPs  384 (429)
                         ..+.. ....+.              ........+........         ....+..+.+|+.+||..||++|||
T Consensus       249 ~~~~~l~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          249 YHHDQLDR-IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCHHHHHH-HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             chHHHHHH-HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence               00000 000000              00000000000000000         0012457889999999999999999


Q ss_pred             HHHHHHh
Q 014189          385 MRDIVDS  391 (429)
Q Consensus       385 ~~evl~~  391 (429)
                      ++|+++|
T Consensus       328 a~e~L~h  334 (405)
T 3rgf_A          328 SEQAMQD  334 (405)
T ss_dssp             HHHHHTS
T ss_pred             HHHHhcC
Confidence            9999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.7e-42  Score=337.72  Aligned_cols=264  Identities=22%  Similarity=0.296  Sum_probs=199.8

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|.+.+.||+|+||.||+|.+..++      ..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  113 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSG------EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA  113 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCC------CEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence            4578999999999999999999876543      449999987643 334456788999999999999999999999876


Q ss_pred             CeE------EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 EHR------VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 ~~~------~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      +..      ++||||+. |+|.+.+.    ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEEC
T ss_pred             CCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEE
Confidence            654      99999997 68887763    24899999999999999999999987  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh---
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL---  338 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~---  338 (429)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+............   
T Consensus       187 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  261 (371)
T 4exu_A          187 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  261 (371)
T ss_dssp             STTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999865332     234678999999999987 789999999999999999999999998765432211100000   


Q ss_pred             ------hHH-HhhhhhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          339 ------PLL-KEKKKLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       339 ------~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            ... .........+.......   .....+..+.+|+.+||+.||++|||++|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                  000 00000000111100000   012346789999999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.2e-43  Score=332.27  Aligned_cols=269  Identities=22%  Similarity=0.306  Sum_probs=196.5

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE---
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC---  186 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---  186 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++... .......+.+|+.++++++||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCD------KRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG   81 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTT------EEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCC------eEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence            3578999999999999999999876543      34999998765 3455677889999999999999999999873   


Q ss_pred             -----------eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-
Q 014189          187 -----------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-  254 (429)
Q Consensus       187 -----------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-  254 (429)
                                 +....++||||++ |+|.+++..   .++++..+..++.|++.||+|||+.+  |+||||||+|||++ 
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~  155 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINT  155 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEET
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcC
Confidence                       4468899999997 699998854   36899999999999999999999987  99999999999997 


Q ss_pred             CCCcEEEeccCCCcCCCCCCC-ccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhh
Q 014189          255 TDYNAKLSDFGLAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN  332 (429)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~  332 (429)
                      +++.+||+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||..........
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  235 (320)
T 2i6l_A          156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ  235 (320)
T ss_dssp             TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            567999999999987543211 111233567999999998875 678999999999999999999999998766432211


Q ss_pred             HHHhHhhH--HHhhhhhhh--------hc-CCCC-CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          333 LADWALPL--LKEKKKLLN--------II-DPRL-EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       333 ~~~~~~~~--~~~~~~~~~--------~~-~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ........  ......+..        .. .+.. ........+..+.+|+.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            11000000  000000000        00 0000 000112356789999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.4e-42  Score=332.82  Aligned_cols=267  Identities=20%  Similarity=0.235  Sum_probs=205.9

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCc------eeeeee
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN------LVKLIG  183 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~  183 (429)
                      +.++|++.+.||+|+||.||+|.+..+.     +..||+|++...  ......+.+|+.+++.++|++      ++.+++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTT-----TEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCC-----ceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            4578999999999999999999875442     245999998753  344567788999999887665      899999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEE----------
Q 014189          184 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----------  253 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll----------  253 (429)
                      ++...+..++||||+ +|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||+          
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccc
Confidence            999999999999999 678888887766567999999999999999999999977  9999999999999          


Q ss_pred             ---------cCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 014189          254 ---------DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK  324 (429)
Q Consensus       254 ---------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~  324 (429)
                               +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                     66789999999999864332     2346799999999999999999999999999999999999999987


Q ss_pred             CChhhhhhHHHhHhh-----HHHhhh--------------------hhhhhcCCC-CCCCCChHHHHHHHHHHHHhhccC
Q 014189          325 SRPAREQNLADWALP-----LLKEKK--------------------KLLNIIDPR-LEGDYPVKGVHKAAMLAYHCLNHN  378 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~-----~~~~~~--------------------~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~d  378 (429)
                      ...............     ......                    .......+. .........+..+.+|+.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            654322111111000     000000                    000000000 000112345678999999999999


Q ss_pred             CCCCCCHHHHHHh
Q 014189          379 PKARPLMRDIVDS  391 (429)
Q Consensus       379 P~~RPs~~evl~~  391 (429)
                      |++|||+.|++++
T Consensus       322 P~~Rpt~~e~l~h  334 (355)
T 2eu9_A          322 PAQRITLAEALLH  334 (355)
T ss_dssp             TTTSCCHHHHTTS
T ss_pred             hhhCcCHHHHhcC
Confidence            9999999999976

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1e-42  Score=332.90  Aligned_cols=271  Identities=23%  Similarity=0.291  Sum_probs=202.8

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhcc---CCCceeeeeeEE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHL---SHPNLVKLIGYC  185 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~  185 (429)
                      ..++|++.+.||+|+||.||+|.+...     .+..||+|++..... ......+.+|+.+++.+   +||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCC-----CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            457899999999999999999987421     134599998764321 11122455677777666   899999999998


Q ss_pred             E-----eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEE
Q 014189          186 C-----EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  260 (429)
Q Consensus       186 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  260 (429)
                      .     .....++||||++ |+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEE
Confidence            7     5567899999997 69999998766566999999999999999999999987  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH-HhHhh
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWALP  339 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~-~~~~~  339 (429)
                      |+|||++......   .......||+.|+|||++.+..++.++||||||+++|+|++|+.||............ .....
T Consensus       161 l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          161 LADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  237 (326)
T ss_dssp             ECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9999999865432   1234467999999999999999999999999999999999999999876543221110 00000


Q ss_pred             HHHhhhh----hh-hhcCC---CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          340 LLKEKKK----LL-NIIDP---RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       340 ~~~~~~~----~~-~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....+.    .. ..+..   ..........+..+.+|+.+||..||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000000    00 00000   00011123456788999999999999999999999976

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.4e-42  Score=330.52  Aligned_cols=263  Identities=22%  Similarity=0.296  Sum_probs=199.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .++|.+.+.||+|+||.||+|.+..++      ..||+|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSG------EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCC------CEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            468999999999999999999876543      449999987643 3344567889999999999999999999998665


Q ss_pred             e------EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          190 H------RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       190 ~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                      .      .++||||+. |+|.+++.    ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECS
T ss_pred             ccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEee
Confidence            3      499999997 58887663    24899999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH-------
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD-------  335 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~-------  335 (429)
                      ||+++.....     .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.........       
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999864322     234578999999999887 678999999999999999999999998765432111100       


Q ss_pred             --hHhhHHHh-hhhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 --WALPLLKE-KKKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 --~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        +....... .......+.....   .......+..+.+|+.+||+.||++|||+++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              00000000 0000001111101   11223557889999999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-42  Score=334.55  Aligned_cols=255  Identities=19%  Similarity=0.219  Sum_probs=176.5

Q ss_pred             HhcCCccce-eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-
Q 014189          110 ITANFRQDR-VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-  187 (429)
Q Consensus       110 ~~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  187 (429)
                      +.++|.+.+ +||+|+||.||+|.+..+.      ..||+|++...  .....   .....++.+.||||+++++++.. 
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~--~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~   94 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTG------QKCALKLLYDS--PKARQ---EVDHHWQASGGPHIVCILDVYENM   94 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEESS--HHHHH---HHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCC------CEEEEEEecCc--HHHHH---HHHHHHHhcCCCChHHHHHHHhhc
Confidence            457899854 6999999999999876553      34999998653  22222   22233566789999999999876 


Q ss_pred             ---CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCcEEE
Q 014189          188 ---DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKL  261 (429)
Q Consensus       188 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl  261 (429)
                         ....++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.   ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEE
T ss_pred             cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEE
Confidence               456899999999999999998776667999999999999999999999987  999999999999986   455999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      +|||++......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........   ..   
T Consensus       173 ~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~---  242 (336)
T 3fhr_A          173 TDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MK---  242 (336)
T ss_dssp             CCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             eccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HH---
Confidence            999999865432    12346789999999999988999999999999999999999999975432211000   00   


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       .   .................+..+.+|+.+||+.||++|||++|++++
T Consensus       243 -~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          243 -R---RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -H---hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0   000000111111223567789999999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-42  Score=325.83  Aligned_cols=256  Identities=23%  Similarity=0.290  Sum_probs=204.3

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      ..+.++|++.+.||+|+||.||+|.+..+.      ..||+|++.... .......+.+|+.++++++||||+++++++.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~------~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQ------QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCC------cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            345678999999999999999999876543      349999986532 2334567889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC---CcEEEec
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSD  263 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~---~~~kl~D  263 (429)
                      ..+..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+   +.+||+|
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEec
Confidence            9999999999999999999886543  5899999999999999999999987  9999999999999764   4699999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ||++........   .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.........      .. +..
T Consensus       168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~-~~~  236 (287)
T 2wei_A          168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL------KR-VET  236 (287)
T ss_dssp             TTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH-HHH
T ss_pred             cCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHc
Confidence            999986543221   223468999999998875 4899999999999999999999999876532110      00 000


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .     ..  ..........+..+.+++.+||..||++|||+.+++++
T Consensus       237 ~-----~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          237 G-----KY--AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             C-----CC--CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             C-----CC--CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            0     00  00001112456789999999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.1e-42  Score=325.39  Aligned_cols=254  Identities=25%  Similarity=0.342  Sum_probs=181.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHH-HHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW-LAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|++...........+ ..+..+++.++||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTG------HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTC------CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccceeeecCCeeEEEEEEecCC------eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            467999999999999999999876543      34999999876544444444 44455678889999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      ..++||||+ ++.+.. +.......+++..+..++.|++.||+|||+. +  ++|+||||+|||++.++.+||+|||++.
T Consensus        98 ~~~lv~e~~-~~~~~~-l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEK-LKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             EEEEEECCC-SEEHHH-HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             cEEEEEecc-CCcHHH-HHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            999999999 444444 4333234689999999999999999999984 7  9999999999999999999999999997


Q ss_pred             CCCCCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ......   ......||+.|+|||++.     ...++.++||||||+++|+|++|+.||........  .   .....  
T Consensus       174 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~---~~~~~--  243 (318)
T 2dyl_A          174 RLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--V---LTKVL--  243 (318)
T ss_dssp             ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H---HHHHH--
T ss_pred             hccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--H---HHHHh--
Confidence            654322   123457999999999994     56789999999999999999999999986432211  0   00000  


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                           ....+.+  ......+..+.+++.+||+.||.+|||+++++++
T Consensus       244 -----~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          244 -----QEEPPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -----HSCCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -----ccCCCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                 0011111  1112356789999999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=329.74  Aligned_cols=247  Identities=26%  Similarity=0.397  Sum_probs=192.8

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-----hhHHHHHHHHHHHhcc----CCCc
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHL----SHPN  177 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~n  177 (429)
                      .....++|++.+.||+|+||.||+|.+..+.      ..||+|++......     .....+.+|+.++.++    +|||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~   99 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDR------LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG   99 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTC------CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCC------eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence            3456688999999999999999999765543      44999998754321     1223355789999888    8999


Q ss_pred             eeeeeeEEEeCCeEEEEEEe-cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-C
Q 014189          178 LVKLIGYCCEDEHRVLIYEF-MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-T  255 (429)
Q Consensus       178 iv~l~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-~  255 (429)
                      |+++++++...+..++|||| +.+++|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+||+++ .
T Consensus       100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A          100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLR  175 (312)
T ss_dssp             BCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETT
T ss_pred             eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCC
Confidence            99999999999999999999 78999999997643  6899999999999999999999987  99999999999999 8


Q ss_pred             CCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 014189          256 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  334 (429)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~  334 (429)
                      ++.+||+|||++.......    .....||..|+|||++.+..+ +.++||||||+++|+|++|+.||......      
T Consensus       176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------  245 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------  245 (312)
T ss_dssp             TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------
T ss_pred             CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------
Confidence            8999999999998764422    234679999999999987766 45899999999999999999999742110      


Q ss_pred             HhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          335 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            ..      .      ....+...+..+.+++.+||+.||++|||++|++++
T Consensus       246 ------~~------~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 ------LE------A------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ------HH------T------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------hh------h------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  00      0      011233456788999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.1e-43  Score=333.15  Aligned_cols=247  Identities=23%  Similarity=0.377  Sum_probs=200.5

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-----hhHHHHHHHHHHHhccC--CCcee
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLS--HPNLV  179 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv  179 (429)
                      .....++|++.+.||+|+||.||+|.+..+.      ..||+|++......     .....+.+|+.++++++  ||||+
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDN------LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTT------EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCC------cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence            3456678999999999999999999876543      45999998654211     11234557999999996  59999


Q ss_pred             eeeeEEEeCCeEEEEEEecCC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-CCC
Q 014189          180 KLIGYCCEDEHRVLIYEFMAR-GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDY  257 (429)
Q Consensus       180 ~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-~~~  257 (429)
                      ++++++...+..++|||++.+ ++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++ +++
T Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~  187 (320)
T 3a99_A          112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRG  187 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTT
T ss_pred             EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCC
Confidence            999999999999999999976 89999987643  6899999999999999999999987  99999999999999 789


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh
Q 014189          258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~  336 (429)
                      .+||+|||++.......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......        
T Consensus       188 ~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------  255 (320)
T 3a99_A          188 ELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------  255 (320)
T ss_dssp             EEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------
T ss_pred             CEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------
Confidence            99999999998764322    234679999999999987765 78899999999999999999999742110        


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          ..      .      ....+...+..+.+|+.+||+.||++|||+++++++
T Consensus       256 ----~~------~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          256 ----IR------G------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ----HH------C------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----hc------c------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00      0      001123456788999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.2e-41  Score=335.34  Aligned_cols=252  Identities=26%  Similarity=0.314  Sum_probs=186.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  190 (429)
                      +.|...+.||+|+||+||.+...       .+..||||++..+    ....+.+|+.+++++ +||||+++++++.+.+.
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~-------~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF-------QGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES-------SSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             heeeccCeEeeCCCeEEEEEEEE-------CCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            45666789999999999865322       2445999998643    234567899999876 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC---------
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPL-----PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---------  256 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l-----~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~---------  256 (429)
                      .++||||++ |+|.+++........     ++..++.++.|++.||+|||+.+  |+||||||+|||++.+         
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccccc
Confidence            999999995 699999976542211     23345789999999999999987  9999999999999754         


Q ss_pred             ----CcEEEeccCCCcCCCCCCCcc--ccccccCCccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCC
Q 014189          257 ----YNAKLSDFGLAKDGPEGDKSH--VSTRIMGTYGYAAPEYIMT-------GHLTPRSDVYSFGVVLLEILT-GRKSL  322 (429)
Q Consensus       257 ----~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-G~~p~  322 (429)
                          +.+||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                489999999998765432211  1234679999999999975       678999999999999999999 99999


Q ss_pred             CCCChhhhhhHHHhHhhHHHhhhhhhhhcC-CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          323 DKSRPAREQNLADWALPLLKEKKKLLNIID-PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ........ ..       .      ..... +..........+.++.+|+.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~-~i-------~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          241 GDKYSRES-NI-------I------RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             CSTTTHHH-HH-------H------HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCchhhHH-HH-------h------cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            75432211 00       0      01111 111112234667899999999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.4e-42  Score=350.82  Aligned_cols=262  Identities=23%  Similarity=0.302  Sum_probs=201.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe----
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE----  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  187 (429)
                      ++|++.+.||+|+||.||+|.+..+      +..||+|++...........+.+|+.++++++||||+++++++..    
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~t------g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDT------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTT------TCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCC------CcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            6899999999999999999976544      344999998876666677789999999999999999999998755    


Q ss_pred             --CCeEEEEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCc---EEE
Q 014189          188 --DEHRVLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---AKL  261 (429)
Q Consensus       188 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~---~kl  261 (429)
                        .+..++||||+++|+|.+++.... ...+++..+..++.+++.||+|||+.+  |+||||||+|||++.++.   +||
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEE
Confidence              677899999999999999997643 235888999999999999999999987  999999999999997765   999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      +|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......     .|.....
T Consensus       166 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~  237 (676)
T 3qa8_A          166 IDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVR  237 (676)
T ss_dssp             CSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC
T ss_pred             ccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhh
Confidence            9999998765432   2344689999999999999999999999999999999999999997643221     1111000


Q ss_pred             Hhhh---hhhhhcCC------C--CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014189          342 KEKK---KLLNIIDP------R--LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV  389 (429)
Q Consensus       342 ~~~~---~~~~~~~~------~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  389 (429)
                      ....   ........      .  .........+..+.+++.+||..||++|||+++++
T Consensus       238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            0000   00000000      0  11223445788999999999999999999998743

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.4e-40  Score=310.88  Aligned_cols=236  Identities=13%  Similarity=0.099  Sum_probs=186.0

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      +.++|++.+.||+|+||.||+|.+..+.      ..||+|++.....  ......|.+|+.++.+++||||+++++++.+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  102 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALD------RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT  102 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTT------EEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCC------ceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence            4568999999999999999999876543      4499999986543  3445778999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+..|+||||+++++|.+++...    .....+..++.|++.||+|||+++  |+||||||+|||++.++.+||+++|  
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~--  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA--  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--
T ss_pred             CCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--
Confidence            99999999999999999998432    344567889999999999999987  9999999999999999999998543  


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                                          |++       .++.++|||||||++|||+||+.||...........             .
T Consensus       175 --------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------------~  214 (286)
T 3uqc_A          175 --------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------------A  214 (286)
T ss_dssp             --------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-------------C
T ss_pred             --------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-------------H
Confidence                                223       368899999999999999999999986543210000             0


Q ss_pred             hhhcCCCCC--CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCC
Q 014189          348 LNIIDPRLE--GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  400 (429)
Q Consensus       348 ~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  400 (429)
                      .........  .......+..+.+|+.+||+.||++| |+.|+++.|+.+.....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          215 ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            000000000  00112456779999999999999999 99999999998776543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=329.65  Aligned_cols=250  Identities=24%  Similarity=0.281  Sum_probs=184.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  190 (429)
                      .+|...++||+|+||+||.....       .+..||||++......    .+.+|+.+|+.+ +||||+++++++.+.+.
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~-------~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~   92 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMF-------DNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQF   92 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEES-------SSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred             EEEecCCeeecCcCEEEEEEEEe-------CCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence            46889999999999996543221       2344999998764322    244799999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC-----CCcEEEeccC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-----DYNAKLSDFG  265 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg  265 (429)
                      .|+||||++ |+|.+++..... .+.+..+..++.|++.||+|||+++  |+||||||+|||++.     ...+||+|||
T Consensus        93 ~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           93 QYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             EEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            999999996 699999876543 3444556789999999999999987  999999999999953     2358899999


Q ss_pred             CCcCCCCCCCc-cccccccCCcccccccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhH
Q 014189          266 LAKDGPEGDKS-HVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       266 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      +++........ .......||+.|+|||++.   ...++.++|||||||++|||++ |..||..........        
T Consensus       169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--------  240 (432)
T 3p23_A          169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--------  240 (432)
T ss_dssp             EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--------
T ss_pred             ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--------
Confidence            99876543211 2234467999999999997   4567889999999999999999 899996543211100        


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            ........ ........+..+.+|+.+||+.||++|||++++++|
T Consensus       241 ------~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          241 ------LLGACSLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ------HTTCCCCT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ------HhccCCcc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                  00000000 011123456778999999999999999999999965

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-40  Score=349.33  Aligned_cols=244  Identities=21%  Similarity=0.359  Sum_probs=195.2

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      .+.++|++.+.||+|+||.||+|.+...     .+..||+|++...........+.+|+.++++++||||+++++++...
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNV-----NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT  151 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGG-----TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCC-----CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence            3457899999999999999999987542     13459999987665556667889999999999999999999999876


Q ss_pred             Ce-----EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          189 EH-----RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       189 ~~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                      +.     .|+||||+++++|.+++..    .+++..++.++.|++.||+|||+++  |+||||||+|||++.+ .+||+|
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEe
Confidence            65     7999999999999886643    6899999999999999999999987  9999999999999986 899999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ||+++.....      ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.......              
T Consensus       225 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------  283 (681)
T 2pzi_A          225 LGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------  283 (681)
T ss_dssp             CTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------
T ss_pred             cccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------------
Confidence            9999875432      345799999999998765 4899999999999999999998876421100              


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-HHHHHHhcccc
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-MRDIVDSLEPL  395 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L~~~  395 (429)
                             +.   ........+..+.+|+.+||+.||++||+ ++++...|..+
T Consensus       284 -------~~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          284 -------LP---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -------CC---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------cc---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                   00   00001123467889999999999999995 56666666544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-39  Score=307.37  Aligned_cols=230  Identities=19%  Similarity=0.273  Sum_probs=181.3

Q ss_pred             HhcCCccc-eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHH-hccCCCceeeeeeEEEe
Q 014189          110 ITANFRQD-RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL-GHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~  187 (429)
                      +.++|.+. +.||+|+||.||+|.+..+.      ..||+|++...      ..+.+|+.++ +..+||||+++++++..
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQ------EKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCC------cEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            34567776 78999999999999876543      34999998642      2455788887 55689999999999986


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCcEE
Q 014189          188 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAK  260 (429)
Q Consensus       188 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~~k  260 (429)
                          ....++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.   ++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEE
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEE
Confidence                678899999999999999998876667999999999999999999999987  999999999999998   78899


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      |+|||++....                        +..++.++|||||||++|||++|+.||..........        
T Consensus       161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--------  208 (299)
T 3m2w_A          161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--------  208 (299)
T ss_dssp             ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--------
T ss_pred             Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--------
Confidence            99999986432                        2346889999999999999999999997543211000        


Q ss_pred             HHhhhhhhhhcCCCCCCCCC----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYP----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          .....+...  ....+    ...+..+.+|+.+||+.||++|||+.|++++
T Consensus       209 ----~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          209 ----GMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             ----CSCCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                000000000  00111    2356789999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.6e-40  Score=323.37  Aligned_cols=244  Identities=17%  Similarity=0.128  Sum_probs=181.1

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccCC-Cceee-------
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSH-PNLVK-------  180 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~-------  180 (429)
                      ..+|...++||+|+||.||+|.+..+++      .||||++.....  ....+.|.+|+.++..++| +|...       
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~------~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~  150 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  150 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCC------ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence            3457888999999999999998765543      499999874322  2235678899999999977 22111       


Q ss_pred             --------------eeeEEEe-----CCeEEEEEEecCCCChhhhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 014189          181 --------------LIGYCCE-----DEHRVLIYEFMARGSVENNLF-----SKVLLPLPWSIRMKIAFGAAKGLAFLHE  236 (429)
Q Consensus       181 --------------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~  236 (429)
                                    +..++..     ....+++|+++ +|+|.+++.     ......+++..++.++.|++.||+|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  229 (413)
T 3dzo_A          151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  229 (413)
T ss_dssp             CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                          1111111     22456777766 689998884     2333457888999999999999999999


Q ss_pred             CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCccccccccc----------ccCCCCcccchh
Q 014189          237 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI----------MTGHLTPRSDVY  306 (429)
Q Consensus       237 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvw  306 (429)
                      .+  |+||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++|||
T Consensus       230 ~~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          230 YG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             TT--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             CC--cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence            87  999999999999999999999999998864321     344678 999999999          555688999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHH
Q 014189          307 SFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR  386 (429)
Q Consensus       307 slG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  386 (429)
                      ||||++|||++|+.||........                ...++..      ....+..+.+|+.+||+.||++|||+.
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~~----------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALGG----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhh----------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHH
Confidence            999999999999999976532110                0111110      113357799999999999999999987


Q ss_pred             HHHHh
Q 014189          387 DIVDS  391 (429)
Q Consensus       387 evl~~  391 (429)
                      +++++
T Consensus       360 ~~l~~  364 (413)
T 3dzo_A          360 QAMET  364 (413)
T ss_dssp             HHTTS
T ss_pred             HHHhC
Confidence            77654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-39  Score=313.27  Aligned_cols=244  Identities=17%  Similarity=0.172  Sum_probs=183.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-------ChhhHHHHHHHHHHHhccC---------
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-------SYQGHREWLAEVIFLGHLS---------  174 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---------  174 (429)
                      .++|++.+.||+|+||.||+|++.        +..||+|++....       .......+.+|+.+++.++         
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~   90 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIAD--------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR   90 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEET--------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSB
T ss_pred             cccchheeeecccCceEEEEEEeC--------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccccc
Confidence            467899999999999999999762        2459999987543       2223466788999988885         


Q ss_pred             CCceeeeeeEE-----------------Ee-------------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHH
Q 014189          175 HPNLVKLIGYC-----------------CE-------------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA  224 (429)
Q Consensus       175 h~niv~l~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~  224 (429)
                      ||||+++.+++                 .+             .+..|+||||+++|++.+.+..   ..+++..+..++
T Consensus        91 h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~  167 (336)
T 2vuw_A           91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSIL  167 (336)
T ss_dssp             CCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHH
T ss_pred             CCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHH
Confidence            66666666653                 22             6889999999999987777744   358999999999


Q ss_pred             HHHHHHHHHHH-hCCCCceeCCCCCCcEEEcCCC--------------------cEEEeccCCCcCCCCCCCcccccccc
Q 014189          225 FGAAKGLAFLH-EAEKPVIYRDFKTSNILLDTDY--------------------NAKLSDFGLAKDGPEGDKSHVSTRIM  283 (429)
Q Consensus       225 ~~i~~~l~~lH-~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~  283 (429)
                      .|++.||+||| +.+  |+||||||+|||++.++                    .+||+|||+|+....       ....
T Consensus       168 ~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~  238 (336)
T 2vuw_A          168 HQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVV  238 (336)
T ss_dssp             HHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEE
T ss_pred             HHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEE
Confidence            99999999999 877  99999999999999887                    899999999986532       1347


Q ss_pred             CCcccccccccccCCCCcccchhhHHHH-HHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh-hcCCCCCCCCCh
Q 014189          284 GTYGYAAPEYIMTGHLTPRSDVYSFGVV-LLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN-IIDPRLEGDYPV  361 (429)
Q Consensus       284 gt~~y~aPE~~~~~~~~~~~DvwslG~i-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  361 (429)
                      ||+.|+|||++.+.. +.++||||||++ .+++++|..||...         .|......  ..... ............
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~--~~~~~~~~~~~~~~~~~~  306 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTD--KMLKQMTFKTKCNTPAMK  306 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHH--HHHHTCCCSSCCCSHHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHH--hhhhhhccCcccchhhhh
Confidence            999999999998766 899999998777 77788999888421         01000000  00000 011111111233


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHH-Hh
Q 014189          362 KGVHKAAMLAYHCLNHNPKARPLMRDIV-DS  391 (429)
Q Consensus       362 ~~~~~l~~l~~~cl~~dP~~RPs~~evl-~~  391 (429)
                      ..+.++.+|+.+||+.|     |++|++ +|
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            57889999999999976     999999 65

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=5.9e-33  Score=283.72  Aligned_cols=169  Identities=17%  Similarity=0.105  Sum_probs=126.5

Q ss_pred             ceeEEEEEecCCC---------ChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCC
Q 014189          143 PVPVAVKVHDGDN---------SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL  212 (429)
Q Consensus       143 ~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~  212 (429)
                      +..+++|++....         .....++|.+|+++|+++ .|+||+++++++++++..||||||++||+|.+.|.... 
T Consensus       259 g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-  337 (569)
T 4azs_A          259 GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-  337 (569)
T ss_dssp             CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-
T ss_pred             cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-
Confidence            4459999987642         123446789999999999 69999999999999999999999999999999997654 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCccccccc
Q 014189          213 LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE  292 (429)
Q Consensus       213 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE  292 (429)
                       +++..   .|+.||+.||+|+|++|  ||||||||+|||++.+|.+||+|||+|+.......  ...+.+||+.|+|||
T Consensus       338 -~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE  409 (569)
T 4azs_A          338 -EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNE  409 (569)
T ss_dssp             -CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHH
T ss_pred             -CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHH
Confidence             56653   58899999999999988  99999999999999999999999999987654322  234578999999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCC
Q 014189          293 YIMTGHLTPRSDVYSFGVVLLEILTGRKS  321 (429)
Q Consensus       293 ~~~~~~~~~~~DvwslG~il~elltG~~p  321 (429)
                      ++.+ .+..++|+||+|+++++|.+|..+
T Consensus       410 ~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          410 LFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HC------------------CCCCTTHHH
T ss_pred             HhCC-CCCCcccccccccchhhhccccch
Confidence            9875 467789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=3.7e-29  Score=254.28  Aligned_cols=187  Identities=14%  Similarity=0.175  Sum_probs=144.0

Q ss_pred             ccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--h-----hhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          115 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--Y-----QGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      ...++||+|+||.||+|....        ..+++|.......  .     ...+.|.+|++++++++||||+++..++..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  410 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLD--------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD  410 (540)
T ss_dssp             ---------CCEEEEEEECSS--------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECC--------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence            345789999999999994332        2378887654321  1     123457899999999999999976666667


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      .+..|+||||+++|+|.+++..          +..++.|++.||+|||+++  |+||||||+|||++.  .+||+|||++
T Consensus       411 ~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          411 LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccC
Confidence            7788999999999999999865          4689999999999999987  999999999999999  9999999999


Q ss_pred             cCCCCCCCcc-----ccccccCCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 014189          268 KDGPEGDKSH-----VSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLD  323 (429)
Q Consensus       268 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltG~~p~~  323 (429)
                      +.........     ......||+.|+|||++..  ..|+...|+||..+-..+.+.++.+|.
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9765422111     1235789999999999986  678889999999998888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.6e-24  Score=202.40  Aligned_cols=147  Identities=14%  Similarity=0.090  Sum_probs=115.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-----------------hhHHHHHHHHHHHhccC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----------------QGHREWLAEVIFLGHLS  174 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~  174 (429)
                      ..|.+.+.||+|+||.||+|.+ .+      +..||+|++......                 .....+.+|+.++++++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~------g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EK------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TT------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEecCEeccCCCceEEEEEe-CC------CCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            4577779999999999999987 32      344999998653211                 13456889999999998


Q ss_pred             CCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc
Q 014189          175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  254 (429)
Q Consensus       175 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~  254 (429)
                        | +++.+++.. +..++||||++||+|.+ +..        .....++.|++.||.|||+.+  |+||||||+|||++
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS  227 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE
Confidence              5 666666544 45699999999999988 421        123579999999999999988  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCccccccccCCccccccccccc
Q 014189          255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT  296 (429)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  296 (429)
                       ++.+||+|||+++.               +..++|||++..
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence             99999999999863               334788998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=2.3e-20  Score=171.90  Aligned_cols=138  Identities=20%  Similarity=0.091  Sum_probs=103.2

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCcee--EEEEEecCCCCh-----------------------hhHHHHHHHHH
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVP--VAVKVHDGDNSY-----------------------QGHREWLAEVI  168 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~  168 (429)
                      |.+.+.||+|+||.||+|.+..+      +..  ||+|+++.....                       .....+.+|+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~------g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFD------GKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEET------TEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCC------CcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            67889999999999999976322      345  999987543211                       11235778999


Q ss_pred             HHhccCCCce--eeeeeEEEeCCeEEEEEEecCC-C----ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCC
Q 014189          169 FLGHLSHPNL--VKLIGYCCEDEHRVLIYEFMAR-G----SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH-EAEKP  240 (429)
Q Consensus       169 ~l~~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~~  240 (429)
                      +|.++.|+++  ..++++    +..++||||+.+ |    +|.+....     .++..+..++.|++.+|.||| ..+  
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g--  191 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE--  191 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC--
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC--
Confidence            9999988764  333332    356899999942 4    56655432     223456789999999999999 877  


Q ss_pred             ceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          241 VIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       241 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      |+||||||+|||++.  .++|+|||+|...
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=4.4e-18  Score=163.34  Aligned_cols=138  Identities=12%  Similarity=0.111  Sum_probs=95.5

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-------------hhhHHHH--------HHHHHHHhc
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-------------YQGHREW--------LAEVIFLGH  172 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~--------~~E~~~l~~  172 (429)
                      |++.+.||+|+||.||+|....       +..||||+++....             ......+        .+|...|.+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~-------G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEK-------GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTT-------CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEECCC-------CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            8999999999999999997543       34599999764210             0011111        245556666


Q ss_pred             cCCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEE
Q 014189          173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  252 (429)
Q Consensus       173 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIl  252 (429)
                      +.+.++. ....+... ..+|||||++|++|.....      .  .....++.|++.+|.+||.++  ||||||||.|||
T Consensus       170 L~~~gv~-vp~p~~~~-~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NIL  237 (397)
T 4gyi_A          170 LYEEGFP-VPEPIAQS-RHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHG--LIHGDFNEFNIL  237 (397)
T ss_dssp             HHHTTCS-CCCEEEEE-TTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEE
T ss_pred             HHhcCCC-CCeeeecc-CceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEE
Confidence            6433322 11111111 2379999999988865432      1  123567899999999999988  999999999999


Q ss_pred             EcCCC----------cEEEeccCCCcCC
Q 014189          253 LDTDY----------NAKLSDFGLAKDG  270 (429)
Q Consensus       253 l~~~~----------~~kl~Dfgla~~~  270 (429)
                      +++++          .+.|+||+-+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98877          3899999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.35  E-value=3.5e-12  Score=117.16  Aligned_cols=144  Identities=15%  Similarity=0.075  Sum_probs=108.9

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  187 (429)
                      .....|++...+|.|+.+.||++...        +..+++|+...... .....+.+|+.+++.+. +.++.++++++..
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--------~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~   81 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE--------NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS--------SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC--------CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence            34467888889999999999998532        12389999864211 11224668999999885 6778899999998


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE-----------------------------  238 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----------------------------  238 (429)
                      .+..|+||||++|.+|.+.+...       .....++.+++.+|+.||...                             
T Consensus        82 ~~~~~lv~e~i~G~~l~~~~~~~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T 3tm0_A           82 DGWSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHCCTT-------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred             CCceEEEEEecCCeehhhccCCc-------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence            89999999999999988753211       123467889999999999810                             


Q ss_pred             ----------------------------CCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          239 ----------------------------KPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       239 ----------------------------~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                                                  ..++|+|++|.|||++++..+.|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                        238999999999999876667799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.19  E-value=6.3e-11  Score=108.29  Aligned_cols=135  Identities=15%  Similarity=0.061  Sum_probs=94.7

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCc--eeeeeeEEEeCCe
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN--LVKLIGYCCEDEH  190 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~  190 (429)
                      ++.+..+.+.|..+.||++...+       +..+++|+.....    ...+..|+.+++.+.+.+  +.+++++....+.
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~-------g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~   89 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQG-------RPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR   89 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTT-------SCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred             CCceEecccCCCCceEEEEecCC-------CCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence            44443333466679999985322       2238999876541    134567899998886444  4568888888788


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE--------------------------------  238 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--------------------------------  238 (429)
                      .++||||++|.+|.  ...     ..   ...++.+++..|+.||...                                
T Consensus        90 ~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           90 DWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             EEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             CEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            99999999998874  211     11   2356677778888888632                                


Q ss_pred             ------------------------CCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          239 ------------------------KPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       239 ------------------------~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                                              ..++|+|++|.|||++.++.+.|+|||.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                    128999999999999887667799999865

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.19  E-value=7.8e-11  Score=113.37  Aligned_cols=142  Identities=13%  Similarity=0.177  Sum_probs=103.3

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEEEEec--CCCChhhHHHHHHHHHHHhccC--CCceeeeeeEEEeC---
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD--GDNSYQGHREWLAEVIFLGHLS--HPNLVKLIGYCCED---  188 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---  188 (429)
                      ..+.|+.|.++.||+....+        ..+++|+..  ..........+.+|+.+++.+.  +..+.+++.++.+.   
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~--------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~  113 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG--------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI  113 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS--------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred             eEEEcCCcccceEEEEEECC--------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence            35789999999999986432        237888765  3322222345668999999887  45678888888766   


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-------------------------------  237 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-------------------------------  237 (429)
                      +..|+||||++|..+.+..    ...++...+..++.+++..|+.||..                               
T Consensus       114 g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             SSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            4579999999988775422    12467788889999999999999973                               


Q ss_pred             -------------------------CCCceeCCCCCCcEEEcCCCc--EEEeccCCCcC
Q 014189          238 -------------------------EKPVIYRDFKTSNILLDTDYN--AKLSDFGLAKD  269 (429)
Q Consensus       238 -------------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~  269 (429)
                                               ...++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     134899999999999997753  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=2.2e-10  Score=107.64  Aligned_cols=182  Identities=18%  Similarity=0.183  Sum_probs=118.4

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCc--eeeeeeEEEeCC---e
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPN--LVKLIGYCCEDE---H  190 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~  190 (429)
                      .+.++.|....||+..           ..+++|+....   .....+.+|..+|+.+. +..  +.+++......+   .
T Consensus        25 i~~~~~G~~n~v~~v~-----------~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~   90 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----------RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQM   90 (304)
T ss_dssp             CCEEEECSSEEEEEST-----------TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSC
T ss_pred             eEecCCCCcceEEEEC-----------CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCc
Confidence            3568999999999852           12888886532   34456778999998874 332  334444433332   3


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE--------------------------------  238 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--------------------------------  238 (429)
                      .|+||++++|.+|......    .++..++..++.+++..++.||...                                
T Consensus        91 ~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (304)
T 3sg8_A           91 SFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK  166 (304)
T ss_dssp             SCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred             ceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence            4789999999888654332    3666777788888888888888511                                


Q ss_pred             ------------------------CCceeCCCCCCcEEEcC--CCcEEEeccCCCcCCCCCCCccccccccCCccc---c
Q 014189          239 ------------------------KPVIYRDFKTSNILLDT--DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY---A  289 (429)
Q Consensus       239 ------------------------~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y---~  289 (429)
                                              ..++|+|++|.||+++.  +..+.|+||+.+........      ......+   .
T Consensus       167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~  240 (304)
T 3sg8_A          167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEY  240 (304)
T ss_dssp             HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSC
T ss_pred             cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhcccc
Confidence                                    23799999999999998  56688999998865322100      0000011   1


Q ss_pred             ccccccc-----CCC---------CcccchhhHHHHHHHHHhCCCCC
Q 014189          290 APEYIMT-----GHL---------TPRSDVYSFGVVLLEILTGRKSL  322 (429)
Q Consensus       290 aPE~~~~-----~~~---------~~~~DvwslG~il~elltG~~p~  322 (429)
                      .|+....     +..         ..-.+.|++|.++|.+.+|..+|
T Consensus       241 ~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          241 GMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            2221110     000         12258999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.50  E-value=2.1e-06  Score=80.33  Aligned_cols=135  Identities=19%  Similarity=0.136  Sum_probs=91.0

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCC---ceeeeeeEEE-eCCeEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP---NLVKLIGYCC-EDEHRV  192 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~  192 (429)
                      .+.++.|....||+.    + .      .+++|+-.   .......+..|..+|+.+.+.   .+.+.+.+.. ..+..+
T Consensus        24 v~~l~~G~~n~v~~v----g-~------~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~   89 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----N-G------DWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPF   89 (306)
T ss_dssp             EEEEEECSSEEEEEE----T-T------TEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEE
T ss_pred             eeecCCCcceeEEEE----C-C------EEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceE
Confidence            467889999999986    1 1      27888853   233445678999999998642   3556666664 455678


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 014189          193 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE----------------------------------  238 (429)
Q Consensus       193 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~----------------------------------  238 (429)
                      +|||+++|.++......    .++......++.+++..|+.||+..                                  
T Consensus        90 ~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~  165 (306)
T 3tdw_A           90 VGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD  165 (306)
T ss_dssp             EEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred             EEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence            99999999888653211    1334444455555555555555321                                  


Q ss_pred             ------------------------CCceeCCCCCCcEEEcC---CCc-EEEeccCCCcC
Q 014189          239 ------------------------KPVIYRDFKTSNILLDT---DYN-AKLSDFGLAKD  269 (429)
Q Consensus       239 ------------------------~~ivH~Dlkp~NIll~~---~~~-~kl~Dfgla~~  269 (429)
                                              ..++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                    23699999999999997   455 58999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.47  E-value=2.7e-06  Score=77.82  Aligned_cols=135  Identities=17%  Similarity=0.100  Sum_probs=89.7

Q ss_pred             eecCCCcE-EEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeEEEEEE
Q 014189          119 VLGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       119 ~lG~G~fg-~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      .+..|..| .||+.....+.      ..+++|+-...    ....+..|...|+.+. +--+.++++++.+.+..++|||
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~------~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme  100 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNA------PELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT  100 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTC------CCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             EccCCCcCCeEEEEEecCCC------eEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence            45555544 68986543332      23888886532    3445678999998875 3346778888888999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE--------------------------------------  238 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------  238 (429)
                      +++|.++.+......      .....+..+++..|+-||...                                      
T Consensus       101 ~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A          101 AIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             CCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             eeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            999987765442211      112234444444455555310                                      


Q ss_pred             ------------------CCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          239 ------------------KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       239 ------------------~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                                        ..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              1278999999999999887778999987653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=3.3e-06  Score=80.72  Aligned_cols=88  Identities=2%  Similarity=-0.130  Sum_probs=52.2

Q ss_pred             ceee-cCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC--hhhHHHHHHHHHHHhccC-C--CceeeeeeEEEeC--
Q 014189          117 DRVL-GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLS-H--PNLVKLIGYCCED--  188 (429)
Q Consensus       117 ~~~l-G~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  188 (429)
                      .+.| +.|....+|+............+..+++|+......  ......+.+|..+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3677 888899999875430000000022378887654320  001123557888888774 3  3466777777654  


Q ss_pred             -CeEEEEEEecCCCChh
Q 014189          189 -EHRVLIYEFMARGSVE  204 (429)
Q Consensus       189 -~~~~lv~e~~~~g~L~  204 (429)
                       +..++||||++|.++.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.13  E-value=7.1e-06  Score=79.64  Aligned_cols=77  Identities=14%  Similarity=0.090  Sum_probs=46.9

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC------hhhHHHHHHHHHHHhccCC--Cc-eeeeeeEEEe
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS------YQGHREWLAEVIFLGHLSH--PN-LVKLIGYCCE  187 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~  187 (429)
                      .+.||.|.++.||++....+      +..+++|.......      ......+..|.++++.+..  +. +.+++.+  +
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~------~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEH------DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEECCCCceEEEEEEEECCC------CcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence            46899999999999865432      22388997653211      0112345678888887742  43 3345543  3


Q ss_pred             CCeEEEEEEecCCC
Q 014189          188 DEHRVLIYEFMARG  201 (429)
Q Consensus       188 ~~~~~lv~e~~~~g  201 (429)
                      .+..++|||++++.
T Consensus       107 ~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTTEEEECCCTTS
T ss_pred             CCccEEEEEeCCCc
Confidence            44568999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.05  E-value=5e-05  Score=71.72  Aligned_cols=31  Identities=19%  Similarity=0.200  Sum_probs=27.4

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       239 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            4599999999999998888999999997653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.80  E-value=0.00015  Score=67.82  Aligned_cols=75  Identities=19%  Similarity=0.146  Sum_probs=56.8

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC---CCceeeeeeEEEeCCeEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYCCEDEHRVL  193 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  193 (429)
                      .+.|+.|....+|+....        +..+++|+....    ....+..|...|+.+.   ...+.+++++....+..++
T Consensus        41 ~~~l~gG~~n~~y~v~~~--------~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~l  108 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--------VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFL  108 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--------SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEE
T ss_pred             eEEeCCccceeeeEEEEC--------CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEE
Confidence            467999999999997532        123788886532    2456778988888874   3567888888887888999


Q ss_pred             EEEecCCCCh
Q 014189          194 IYEFMARGSV  203 (429)
Q Consensus       194 v~e~~~~g~L  203 (429)
                      ||||+++..+
T Consensus       109 vme~l~G~~~  118 (312)
T 3jr1_A          109 LLEALNKSKN  118 (312)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeccCCCC
Confidence            9999998765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.39  E-value=0.0011  Score=57.51  Aligned_cols=98  Identities=14%  Similarity=0.075  Sum_probs=63.0

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCcccccc
Q 014189          202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR  281 (429)
Q Consensus       202 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (429)
                      +|.+.|... +.++++.+++.++.|.+.+|.-+-.... -..+=+.|..|++..+|.|.+.+ +.+.             
T Consensus        34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc-------------
Confidence            677777654 3489999999999999998866521111 11233457999999999998764 1111             


Q ss_pred             ccCCcccccccccccCCCCcccchhhHHHHHHHHHh
Q 014189          282 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT  317 (429)
Q Consensus       282 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt  317 (429)
                       .....+.|||... ...+.+.=|||||+++|.-+-
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence             1123466888763 345678899999999998876

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.38  E-value=0.002  Score=60.16  Aligned_cols=153  Identities=14%  Similarity=0.142  Sum_probs=80.5

Q ss_pred             HHHHHHhcCCcc-----ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCc--
Q 014189          105 DELRIITANFRQ-----DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN--  177 (429)
Q Consensus       105 ~~~~~~~~~y~~-----~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--  177 (429)
                      +++..+...|.+     .+.|+.|....+|+....++        .+++|+.......   ..+..|..++..+....  
T Consensus        10 ~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g--------~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~   78 (322)
T 2ppq_A           10 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--------PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLS   78 (322)
T ss_dssp             HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--------CEEEEEECC---C---CHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc--------cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCC
Confidence            344444444543     35677888899999754321        2889988753111   12335666666653211  


Q ss_pred             eeeeee------EEEeCCeEEEEEEecCCCChhh--------------hhhcC--C-CCC----C---CHHHHHH-----
Q 014189          178 LVKLIG------YCCEDEHRVLIYEFMARGSVEN--------------NLFSK--V-LLP----L---PWSIRMK-----  222 (429)
Q Consensus       178 iv~l~~------~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~--~-~~~----l---~~~~~~~-----  222 (429)
                      +.+++.      +....+..+++|+|++|..+..              .++..  . ..+    .   .|.....     
T Consensus        79 vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~  158 (322)
T 2ppq_A           79 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER  158 (322)
T ss_dssp             CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred             CCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHH
Confidence            223332      1123466789999998865421              11211  0 001    1   1222110     


Q ss_pred             -------HHHHHHHHHHHHHhC-----CCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          223 -------IAFGAAKGLAFLHEA-----EKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       223 -------i~~~i~~~l~~lH~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                             +...+...++.++..     ...++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       159 ~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          159 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                   001134445555531     1348999999999999987666899998765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.37  E-value=0.0011  Score=61.39  Aligned_cols=71  Identities=7%  Similarity=0.111  Sum_probs=42.7

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-eeeeeEEEeCCeEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  195 (429)
                      .+.|+.|....+|+.      .      .+++|+........  ....+|..+++.+....+ .+++++.  .+.-++++
T Consensus        23 i~~l~gG~tN~~~~~------~------~~vlR~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~   86 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------G------DLCLRIPGKGTEEY--INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVT   86 (301)
T ss_dssp             CEEEESCSSEEEEEE------T------TEEEEEECC----C--CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEE
T ss_pred             eeEcCCcccccccee------e------eEEEECCCCCccce--eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEE
Confidence            578999999999997      1      18889876532111  112357777766642222 4555443  33347899


Q ss_pred             Eec-CCCCh
Q 014189          196 EFM-ARGSV  203 (429)
Q Consensus       196 e~~-~~g~L  203 (429)
                      ||+ ++.++
T Consensus        87 e~i~~g~~l   95 (301)
T 3dxq_A           87 RYIAGAQTM   95 (301)
T ss_dssp             ECCTTCEEC
T ss_pred             eecCCCccC
Confidence            999 65544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.36  E-value=0.00089  Score=65.27  Aligned_cols=77  Identities=16%  Similarity=0.212  Sum_probs=47.1

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccC--CcccccccccccC---CCCcccchhhHHHHHH
Q 014189          239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG--TYGYAAPEYIMTG---HLTPRSDVYSFGVVLL  313 (429)
Q Consensus       239 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~il~  313 (429)
                      ..++|+|++|.|||++.++ +.|+||+.+......-.  ... ..+  ...|++|+.....   .-....++.++...+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            4599999999999999877 99999998875432110  000 010  2346666654311   1122344557777778


Q ss_pred             HHHhCC
Q 014189          314 EILTGR  319 (429)
Q Consensus       314 elltG~  319 (429)
                      +.+++.
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.32  E-value=0.00055  Score=63.01  Aligned_cols=79  Identities=18%  Similarity=0.220  Sum_probs=51.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCC---ceeeeeeEEEeCC
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP---NLVKLIGYCCEDE  189 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~  189 (429)
                      ...-.+.+|.|..+.||+....++       ..+.+|+...... .....|..|...|+.+.-.   -+.+++++  .  
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG-------~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--   83 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADG-------TPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--   83 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTS-------CEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--
T ss_pred             CeEEEEecCCCCCeEEEEEEECCC-------CEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--
Confidence            345567899999999999876553       2389998654422 2223466898888887422   23444443  2  


Q ss_pred             eEEEEEEecCCCCh
Q 014189          190 HRVLIYEFMARGSV  203 (429)
Q Consensus       190 ~~~lv~e~~~~g~L  203 (429)
                      .-++||||++++..
T Consensus        84 ~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 DRTLAMEWVDERPP   97 (288)
T ss_dssp             TTEEEEECCCCCCC
T ss_pred             CceEEEEeecccCC
Confidence            23789999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.19  E-value=0.0012  Score=64.55  Aligned_cols=80  Identities=20%  Similarity=0.214  Sum_probs=48.4

Q ss_pred             ceeecCCCcEEEEEEEEcccccc-CcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-eeeeeEEEeCCeEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLI  194 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv  194 (429)
                      .+.|+.|....||++...+.... ...+..+++|+......   ...+..|..+++.+...++ .++++.+.  +  .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence            46788888999999865421100 01123488898744211   1344578888887753333 56666553  2  389


Q ss_pred             EEecCCCCh
Q 014189          195 YEFMARGSV  203 (429)
Q Consensus       195 ~e~~~~g~L  203 (429)
                      +||++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999986444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.08  E-value=0.0022  Score=61.42  Aligned_cols=146  Identities=15%  Similarity=0.173  Sum_probs=80.0

Q ss_pred             eeecCCCcEEEEEEEEccccc-cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  195 (429)
                      +.|..|-...+|++...+... .......+++++....  ........+|..+++.+. +.-..++++++.+    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            567778888999986542110 0112244888885332  122344557888888774 3223566666543    2899


Q ss_pred             EecCCCChhhh-----------------hhcCC---CCCCC--HHHHHHHHHHHHH-------------------HHHH-
Q 014189          196 EFMARGSVENN-----------------LFSKV---LLPLP--WSIRMKIAFGAAK-------------------GLAF-  233 (429)
Q Consensus       196 e~~~~g~L~~~-----------------l~~~~---~~~l~--~~~~~~i~~~i~~-------------------~l~~-  233 (429)
                      ||++|.+|...                 |+...   ..+..  +.+...+..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665311                 11111   11122  3444444433321                   2233 


Q ss_pred             ---HHhCC--CCceeCCCCCCcEEEcCC----CcEEEeccCCCcC
Q 014189          234 ---LHEAE--KPVIYRDFKTSNILLDTD----YNAKLSDFGLAKD  269 (429)
Q Consensus       234 ---lH~~~--~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~  269 (429)
                         |...+  ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               32222  248999999999999876    7899999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.06  E-value=0.0046  Score=60.83  Aligned_cols=75  Identities=15%  Similarity=0.050  Sum_probs=45.5

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-eeeeeEEEeCCeEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  195 (429)
                      .+.|+.|-...+|+....+.      +..+++|+........  .....|..+++.+...++ .++++++.  +  .+||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~------~~~~vLRi~g~~~~~~--idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~  180 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSK------QAKYLIRLYGPKTDEI--INREREKKISCILYNKNIAKKIYVFFT--N--GRIE  180 (458)
T ss_dssp             EEEECC--CEEEEEEEETTT------TEEEEEEEECC-CCSC--SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEE
T ss_pred             EEEcCCCeEeEEEEEEECCC------CceEEEEECCCChhhh--cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEE
Confidence            46788888899999865431      1338888875432111  111368888888865444 46677663  2  2599


Q ss_pred             EecCCCCh
Q 014189          196 EFMARGSV  203 (429)
Q Consensus       196 e~~~~g~L  203 (429)
                      ||++|.+|
T Consensus       181 e~I~G~~l  188 (458)
T 2qg7_A          181 EFMDGYAL  188 (458)
T ss_dssp             ECCCSEEC
T ss_pred             EeeCCccC
Confidence            99987554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.94  E-value=0.0021  Score=60.42  Aligned_cols=32  Identities=31%  Similarity=0.379  Sum_probs=27.5

Q ss_pred             CCceeCCCCCCcEEEcCC----CcEEEeccCCCcCC
Q 014189          239 KPVIYRDFKTSNILLDTD----YNAKLSDFGLAKDG  270 (429)
Q Consensus       239 ~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~~  270 (429)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            358999999999999875    67999999988754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.80  E-value=0.016  Score=53.98  Aligned_cols=140  Identities=14%  Similarity=0.092  Sum_probs=76.1

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCC--ceeeeeeE-----EEeCCe
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP--NLVKLIGY-----CCEDEH  190 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~  190 (429)
                      ..|+ |....||+....+       +..+++|+......  ....+..|..++..+...  .+++++..     ....+.
T Consensus        32 ~~l~-g~~n~~y~v~~~~-------g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~  101 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDED-------RRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGF  101 (328)
T ss_dssp             EEEC-CSSSEEEEECCTT-------CCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTE
T ss_pred             Eeec-CcccceEEEEcCC-------CCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCE
Confidence            4677 8888999864322       12388999864321  223455677777766421  23334332     223566


Q ss_pred             EEEEEEecCCCChhh--------------hhhc--C--C---CCCCCHHHH----HHH---------------HHHHHHH
Q 014189          191 RVLIYEFMARGSVEN--------------NLFS--K--V---LLPLPWSIR----MKI---------------AFGAAKG  230 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~--------------~l~~--~--~---~~~l~~~~~----~~i---------------~~~i~~~  230 (429)
                      .+++|++++|..+..              .++.  .  .   .....+...    ..+               ...+...
T Consensus       102 ~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  181 (328)
T 1zyl_A          102 YFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDEL  181 (328)
T ss_dssp             EEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHH
T ss_pred             EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHH
Confidence            788999998754320              0111  0  0   011222111    000               0111122


Q ss_pred             HHHHHh-----CCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          231 LAFLHE-----AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       231 l~~lH~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ++.+..     ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       182 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          182 IAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            233322     123478999999999999 4 899999988764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.76  E-value=0.0034  Score=59.93  Aligned_cols=81  Identities=10%  Similarity=0.030  Sum_probs=42.8

Q ss_pred             ceeecCCCcEEEEEEEEccccc--cCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCc-eeeeeeEEEeCCeEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLR--EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDEHRVL  193 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l  193 (429)
                      .+.|+.|....+|+....+...  .......+++|+......  .......|..+++.+...+ ..++++..  .+  ++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence            3567888888999986543110  000123488888654321  1112246777777774323 34566544  22  68


Q ss_pred             EEEecCCCCh
Q 014189          194 IYEFMARGSV  203 (429)
Q Consensus       194 v~e~~~~g~L  203 (429)
                      ||||++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.40  E-value=0.021  Score=53.73  Aligned_cols=30  Identities=13%  Similarity=0.186  Sum_probs=26.9

Q ss_pred             CceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          240 PVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       240 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            489999999999999888899999987664

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.61  E-value=0.12  Score=50.07  Aligned_cols=81  Identities=14%  Similarity=0.041  Sum_probs=45.7

Q ss_pred             ceeecCCCcEEEEEEEEcccccc-CcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLI  194 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  194 (429)
                      .+.|..|-...+|+......... ......+++++.......  .....+|..+++.+. +.-..++++.+  .+  ++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence            36677788889999865421110 011234888886543211  111236777777774 22234555533  22  689


Q ss_pred             EEecCCCCh
Q 014189          195 YEFMARGSV  203 (429)
Q Consensus       195 ~e~~~~g~L  203 (429)
                      |||++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.42  E-value=0.61  Score=44.70  Aligned_cols=29  Identities=28%  Similarity=0.318  Sum_probs=24.6

Q ss_pred             ceeCCCCCCcEEE------cCCCcEEEeccCCCcC
Q 014189          241 VIYRDFKTSNILL------DTDYNAKLSDFGLAKD  269 (429)
Q Consensus       241 ivH~Dlkp~NIll------~~~~~~kl~Dfgla~~  269 (429)
                      ++|+|+.+.|||+      +++..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5699999999999      4567799999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.03  E-value=0.87  Score=39.32  Aligned_cols=117  Identities=6%  Similarity=0.008  Sum_probs=76.9

Q ss_pred             cCCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEE
Q 014189          173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  252 (429)
Q Consensus       173 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIl  252 (429)
                      ..||+++.. .+-.+++.+.+.++.-+.  ...+-.   -..++...++.++..++....++++    -+|--|.|+|++
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~  111 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELF  111 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEE
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEE
Confidence            358888876 455666666666655432  222221   1246778889999998887655542    478899999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 014189          253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD  323 (429)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~  323 (429)
                      ++.++.+++.-.|+-...++                   .     .++...=+-.+=|++..+++|+..|+
T Consensus       112 f~~~~~p~i~~RGik~~l~P-------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVVDP-------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTBSC-------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCCCC-------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999998876443221                   1     01111122357788889999988775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.23  E-value=0.075  Score=52.24  Aligned_cols=62  Identities=11%  Similarity=0.121  Sum_probs=16.6

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEE------EEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAV------KVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vav------K~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      +.+.||   ||.||+|.+...      ...||+      |...... .......|.+|..++..++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKK------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhccccccc------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            445676   999999987542      123677      6655432 2334456888999999999999999988764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.97  E-value=2.2  Score=36.97  Aligned_cols=114  Identities=8%  Similarity=0.079  Sum_probs=73.8

Q ss_pred             CCCceeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceeCCCCCCcEE
Q 014189          174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA-FLHEAEKPVIYRDFKTSNIL  252 (429)
Q Consensus       174 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~-~lH~~~~~ivH~Dlkp~NIl  252 (429)
                      .||++  --.+-.+++.+.+.++.-+++.-...+.     .++...++.++..++.... +++  .  -+|--|.|+|++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEE
Confidence            57877  2333466777777777654443333331     4677888888887776554 333  2  678899999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccch-hhHHHHHHHHHhCCCCCC
Q 014189          253 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDV-YSFGVVLLEILTGRKSLD  323 (429)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-wslG~il~elltG~~p~~  323 (429)
                      ++.++.+++.-.|+-..+                   +|.-+     + ..|. -.+=|++..++.++..|+
T Consensus       117 f~~~~~p~i~hRGi~~~l-------------------pP~e~-----~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESL-------------------PPDEW-----D-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETTTB-------------------SSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCcccC-------------------CCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999988864332                   22211     1 1122 256778888888877664

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	429
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-69
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-64
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-63
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-61
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-59
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-57
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-54
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 3e-69
 Identities = 79/296 (26%), Positives = 123/296 (41%), Gaps = 29/296 (9%)

Query: 105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREW 163
           D+  I        + +G G FG VYKG    D         VAVK+ +    + Q  + +
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAF 51

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
             EV  L    H N++  +GY        ++ ++    S+ ++L             + I
Sbjct: 52  KNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDI 109

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           A   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ 
Sbjct: 110 ARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167

Query: 284 GTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 340
           G+  + APE I        + +SDVY+FG+VL E++TG+       P    N  D  + +
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFM 221

Query: 341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
           +         + P L              L   CL      RPL   I+ S+E L 
Sbjct: 222 VGR-----GYLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (528), Expect = 1e-64
 Identities = 71/312 (22%), Positives = 131/312 (41%), Gaps = 34/312 (10%)

Query: 102 FTYDELRIITANF---------RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD 152
           FT+++       F         + ++V+G G FG V  G        G + + VA+K   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSG---HLKLPGKREIFVAIKTLK 63

Query: 153 GDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL 212
              + +  R++L+E   +G   HPN++ L G   +    ++I EFM  GS++ +   +  
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQND 122

Query: 213 LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE 272
                   + +  G A G+ +L   +   ++RD    NIL++++   K+SDFGL++   +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 273 GDKSHVSTR---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 329
                  T          + APE I     T  SDV+S+G+V+ E+++  +     RP  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYW 235

Query: 330 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 389
           +    D           ++N I+       P+        L   C   +   RP    IV
Sbjct: 236 DMTNQD-----------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 390 DSLEPLQVLPDE 401
           ++L+ +   P+ 
Sbjct: 285 NTLDKMIRNPNS 296

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 2e-63
 Identities = 73/301 (24%), Positives = 128/301 (42%), Gaps = 22/301 (7%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
           I  +   + +V+G G FG VYKG +      G + VPVA+K      + +   ++L E  
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
            +G  SH N+++L G   + +  ++I E+M  G+  +    +          + +  G A
Sbjct: 62  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHVSTRIMGTYG 287
            G+ +L       ++RD    NIL++++   K+SDFGL++   +  + ++ ++       
Sbjct: 121 AGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 347
           + APE I     T  SDV+SFG+V+ E++T  +         E                +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------V 222

Query: 348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKN 407
           +  I+       P+        L   C       RP   DIV  L+ L   PD   T  +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282

Query: 408 F 408
           F
Sbjct: 283 F 283

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 8e-62
 Identities = 74/315 (23%), Positives = 116/315 (36%), Gaps = 41/315 (13%)

Query: 102 FTYDELRIITA-NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 160
           + YD        N    +VLG G FG V         + G   + VAVK+          
Sbjct: 26  YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTG-VSIQVAVKMLKEKADSSER 84

Query: 161 REWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------- 210
              ++E+  +  L SH N+V L+G C       LI+E+   G + N L SK         
Sbjct: 85  EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144

Query: 211 ------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN 258
                        L  L +   +  A+  AKG+ FL    K  ++RD    N+L+     
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKV 202

Query: 259 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 318
            K+ DFGLA+D        V         + APE +  G  T +SDV+S+G++L EI + 
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262

Query: 319 RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHN 378
             +     P                      +I    + D P     +  ++   C   +
Sbjct: 263 GVNPYPGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 307

Query: 379 PKARPLMRDIVDSLE 393
            + RP   ++   L 
Sbjct: 308 SRKRPSFPNLTSFLG 322

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (504), Expect = 2e-61
 Identities = 71/292 (24%), Positives = 119/292 (40%), Gaps = 27/292 (9%)

Query: 104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW 163
           YD+  +   +      LGGG +G VY+G   +          VAVK    D       E+
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT------VAVKTLKEDT--MEVEEF 60

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
           L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L       +   + + +
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
           A   +  + +L   +K  I+RD    N L+  ++  K++DFGL++    GD         
Sbjct: 121 ATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 177

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 343
               + APE +     + +SDV++FGV+L EI T   S        +             
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------- 224

Query: 344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
              +  +++     + P     K   L   C   NP  RP   +I  + E +
Sbjct: 225 ---VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-61
 Identities = 70/310 (22%), Positives = 130/310 (41%), Gaps = 23/310 (7%)

Query: 107 LRIITAN-FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           LRI+    F++ +VLG G FG VYKG    +  +    +PVA+K      S + ++E L 
Sbjct: 3   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILD 60

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E   +  + +P++ +L+   C      LI + M  G + + +       +     +    
Sbjct: 61  EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCV 118

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K + +      
Sbjct: 119 QIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 286 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 345
             + A E I+    T +SDV+S+GV + E++T         PA E               
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------- 221

Query: 346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP 405
            + +I++       P        M+   C   +  +RP  R+++     +   P      
Sbjct: 222 -ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280

Query: 406 KNFVTVVTPE 415
           +    +  P 
Sbjct: 281 QGDERMHLPS 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 1e-60
 Identities = 80/316 (25%), Positives = 129/316 (40%), Gaps = 37/316 (11%)

Query: 83  NPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQ 142
           NPE V+ ++        +      L +   +F  + V+G G FGCVY G     L    +
Sbjct: 10  NPELVQAVQH-------VVIGPSSLIV---HF--NEVIGRGHFGCVYHG---TLLDNDGK 54

Query: 143 PVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARG 201
            +  AVK  +         ++L E I +   SHPN++ L+G C   E    ++  +M  G
Sbjct: 55  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114

Query: 202 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
            + N               +      AKG+ FL    K  ++RD    N +LD  +  K+
Sbjct: 115 DLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKV 171

Query: 262 SDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 319
           +DFGLA+D    E D  H  T       + A E + T   T +SDV+SFGV+L E++T  
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231

Query: 320 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP 379
                  P  + N  D  + LL+ ++ L            P         +   C +   
Sbjct: 232 A-----PPYPDVNTFDITVYLLQGRRLLQ-----------PEYCPDPLYEVMLKCWHPKA 275

Query: 380 KARPLMRDIVDSLEPL 395
           + RP   ++V  +  +
Sbjct: 276 EMRPSFSELVSRISAI 291

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-60
 Identities = 72/291 (24%), Positives = 119/291 (40%), Gaps = 29/291 (9%)

Query: 105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +     +    LG G FG V+ G+ +           VAVK     +       +L
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQGS--MSPDAFL 56

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
           AE   +  L H  LV+L       E   +I E+M  GS+ + L +   + L  +  + +A
Sbjct: 57  AEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
              A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+   + ++         
Sbjct: 116 AQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKF 172

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 344
              + APE I  G  T +SDV+SFG++L EI+T  +         E              
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------------- 218

Query: 345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
             ++  ++       P     +   L   C    P+ RP    +   LE  
Sbjct: 219 --VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 6e-60
 Identities = 63/308 (20%), Positives = 114/308 (37%), Gaps = 39/308 (12%)

Query: 107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE 166
           + +   +F +   LG G  G V+K               +A K+   +       + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLV------MARKLIHLEIKPAIRNQIIRE 54

Query: 167 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
           +  L   + P +V   G    D    +  E M  GS++  L       +P  I  K++  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIA 112

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
             KGL +L E +  +++RD K SNIL+++    KL DFG++    +     ++   +GT 
Sbjct: 113 VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 167

Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK----------------------SLDK 324
            Y +PE +   H + +SD++S G+ L+E+  GR                       +   
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 325 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHK----AAMLAYHCLNHNPK 380
            RP              +    +  ++D  +    P                 CL  NP 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 381 ARPLMRDI 388
            R  ++ +
Sbjct: 288 ERADLKQL 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-59
 Identities = 61/281 (21%), Positives = 108/281 (38%), Gaps = 29/281 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           +    + LG G FG V  G              VA+K+           E++ E   + +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIK--EGSMSEDEFIEEAKVMMN 55

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           LSH  LV+L G C +     +I E+MA G + N L             +++     + + 
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAME 114

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 292
           +L    K  ++RD    N L++     K+SDFGL++   + D+   S        ++ PE
Sbjct: 115 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPE 171

Query: 293 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 352
            +M    + +SD+++FGV++ EI +  K   +     E                    I 
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIA 215

Query: 353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
             L    P     K   + Y C +     RP  + ++ ++ 
Sbjct: 216 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-59
 Identities = 68/284 (23%), Positives = 119/284 (41%), Gaps = 29/284 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
                + +G G FG V+ G+     +       VA+K            +++ E   +  
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDK-------VAIKTIR--EGAMSEEDFIEEAEVMMK 56

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           LSHP LV+L G C E     L++EFM  G + + L ++  L       + +     +G+A
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMA 115

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 292
           +L E    VI+RD    N L+  +   K+SDFG+ +   + D+   ST       +A+PE
Sbjct: 116 YLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE 172

Query: 293 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 352
                  + +SDV+SFGV++ E+ +  K   ++R   E         ++++      +  
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYK 223

Query: 353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
           PRL              +  HC    P+ RP    ++  L  + 
Sbjct: 224 PRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 3e-59
 Identities = 68/302 (22%), Positives = 112/302 (37%), Gaps = 37/302 (12%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 177
             +G G FG V++G    +         VAVK+          RE  AE+     L H N
Sbjct: 9   ESIGKGRFGEVWRGKWRGE--------EVAVKIFSSREERSWFRE--AEIYQTVMLRHEN 58

Query: 178 LVKLIGYCCEDE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
           ++  I    +D        L+ ++   GS+ + L       +     +K+A   A GLA 
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAH 115

Query: 234 LHE------AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSHVSTRIMGT 285
           LH        +  + +RD K+ NIL+  +    ++D GLA   D             +GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 286 YGYAAPEYIMT------GHLTPRSDVYSFGVVLLEILTGRK----SLDKSRPAREQNLAD 335
             Y APE +             R+D+Y+ G+V  EI           D   P  +   +D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 336 WALPLLKEKKKLLNIIDPRLEGDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 394
            ++  ++ K      + P +   +   + +   A +   C   N  AR     I  +L  
Sbjct: 236 PSVEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

Query: 395 LQ 396
           L 
Sbjct: 295 LS 296

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 6e-59
 Identities = 69/308 (22%), Positives = 119/308 (38%), Gaps = 29/308 (9%)

Query: 98  PLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 157
                  D   I   + R +  LG G FG V+ G  +   R       VA+K        
Sbjct: 3   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-------VAIKTLK--PGT 53

Query: 158 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW 217
                +L E   +  L H  LV+L     E+    ++ E+M++GS+ + L  +    L  
Sbjct: 54  MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRL 112

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
              + +A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   + ++  
Sbjct: 113 PQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYT 169

Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 337
                     + APE  + G  T +SDV+SFG++L E+ T  +        RE       
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------- 222

Query: 338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV 397
                    +L+ ++       P +       L   C    P+ RP    +   LE    
Sbjct: 223 ---------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

Query: 398 LPDEAPTP 405
             +    P
Sbjct: 274 STEPQYQP 281

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 9e-59
 Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 35/285 (12%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
             +  + +G G FG V  G          +   VAVK    D + Q    +LAE   +  
Sbjct: 8   ELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCIKNDATAQ---AFLAEASVMTQ 56

Query: 173 LSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
           L H NLV+L+G   E++  + ++ E+MA+GS+ + L S+    L     +K +    + +
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            +L       ++RD    N+L+  D  AK+SDFGL K+      S           + AP
Sbjct: 117 EYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAP 169

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 351
           E +     + +SDV+SFG++L EI +  +      P ++                ++  +
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRV 213

Query: 352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
           +   + D P         +  +C + +   RP    + + LE ++
Sbjct: 214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-58
 Identities = 72/298 (24%), Positives = 109/298 (36%), Gaps = 35/298 (11%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
                + LG G FG V +      ++     + VAVK+             ++E+  L +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAA-MTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 173 LS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK----------------VLLPL 215
           L  H N+V L+G C      ++I E+   G + N L  K                  L L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 216 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 275
                +  ++  AKG+AFL    K  I+RD    NILL      K+ DFGLA+D      
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 276 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 335
             V         + APE I     T  SDV+S+G+ L E+ +   S     P   +    
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256

Query: 336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                         +I        P     +   +   C + +P  RP  + IV  +E
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-58
 Identities = 70/290 (24%), Positives = 120/290 (41%), Gaps = 26/290 (8%)

Query: 106 ELRIITANFR-QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           +L +   N    D  LG G FG V +G      R   + + VA+KV           E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMM 57

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            E   +  L +P +V+LIG  C+ E  +L+ E    G +   L  K    +P S   ++ 
Sbjct: 58  REAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELL 115

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDKSHVSTRIM 283
              + G+ +L E  K  ++RD    N+LL   + AK+SDFGL+K  G +       +   
Sbjct: 116 HQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 343
               + APE I     + RSDV+S+GV + E L+  +     +P ++    +        
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE-------- 220

Query: 344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
              ++  I+     + P +   +   L   C  +  + RP    +   + 
Sbjct: 221 ---VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (483), Expect = 5e-58
 Identities = 72/314 (22%), Positives = 115/314 (36%), Gaps = 41/314 (13%)

Query: 104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW 163
              L     N    R +G G FG V++      L        VAVK+   + S     ++
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPF-TMVAVKMLKEEASADMQADF 63

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK------------- 210
             E   +    +PN+VKL+G C   +   L++E+MA G +   L S              
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 211 ---------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 261
                       PL  + ++ IA   A G+A+L E  +  ++RD  T N L+  +   K+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKI 181

Query: 262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 321
           +DFGL+++    D             +  PE I     T  SDV+++GVVL EI +    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 322 LDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 381
                   E                +  + D  +    P     +   L   C +  P  
Sbjct: 242 PYYGMAHEEV---------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPAD 285

Query: 382 RPLMRDIVDSLEPL 395
           RP    I   L+ +
Sbjct: 286 RPSFCSIHRILQRM 299

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 7e-58
 Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 26/277 (9%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           ++   + LG G +G V                 VAVK+ D   +         E+     
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEA------VAVKIVDMKRAVDCPENIKKEICINKM 59

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           L+H N+VK  G+  E   + L  E+ + G + + +   +   +P     +       G+ 
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 117

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 292
           +LH     + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 118 YLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 293 YIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 351
            +          DV+S G+VL  +L G    D+   + ++                 +  
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWK 220

Query: 352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
           + +   +   K       L +  L  NP AR  + DI
Sbjct: 221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-57
 Identities = 70/298 (23%), Positives = 118/298 (39%), Gaps = 40/298 (13%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           + +   V+G G FG V K      +++    +  A+K      S   HR++  E+  L  
Sbjct: 11  DIKFQDVIGEGNFGQVLKAR----IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66

Query: 173 LS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--------------PLPW 217
           L  HPN++ L+G C    +  L  E+   G++ + L    +L               L  
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 277
              +  A   A+G+ +L +  K  I+RD    NIL+  +Y AK++DFGL++      K  
Sbjct: 127 QQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 337
           +         + A E +     T  SDV+S+GV+L EI++   +     P      A+  
Sbjct: 185 MGR---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAE-- 234

Query: 338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
                    L   +      + P+    +   L   C    P  RP    I+ SL  +
Sbjct: 235 ---------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-56
 Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 27/281 (9%)

Query: 116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLS 174
           +D+ LG G FG V KG+     +       VAVK+  +  N      E LAE   +  L 
Sbjct: 11  EDKELGSGNFGTVKKGY----YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 66

Query: 175 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL 234
           +P +V++IG  CE E  +L+ E    G +   L       +     +++    + G+ +L
Sbjct: 67  NPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYL 123

Query: 235 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHVSTRIMGTYGYAAPEY 293
            E     ++RD    N+LL T + AK+SDFGL+K      +     T       + APE 
Sbjct: 124 EE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181

Query: 294 IMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP 353
           I     + +SDV+SFGV++ E  +  +     +P R    ++           +  +++ 
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE-----------VTAMLEK 225

Query: 354 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 394
                 P     +   L   C  ++ + RP    +   L  
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-56
 Identities = 72/287 (25%), Positives = 112/287 (39%), Gaps = 25/287 (8%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 170
           + R    LG G FG V +G       +    V VAVK    D  +  +   +++ EV  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKT---VSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
             L H NL++L G       + ++ E    GS+ + L              + A   A+G
Sbjct: 66  HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEG 123

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV-STRIMGTYGYA 289
           + +L    K  I+RD    N+LL T    K+ DFGL +  P+ D  +V        + + 
Sbjct: 124 MGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 349
           APE + T   +  SD + FGV L E+ T  +      P    N +     + KE ++L  
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERL-- 234

Query: 350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
                     P         +   C  H P+ RP    + D L   Q
Sbjct: 235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 2e-55
 Identities = 62/283 (21%), Positives = 106/283 (37%), Gaps = 34/283 (12%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGH 172
            + D  +G G F  VYKG  +E   E      VA     D   +    + +  E   L  
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVE------VAWCELQDRKLTKSERQRFKEEAEMLKG 64

Query: 173 LSHPNLVKLIGYCCE----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
           L HPN+V+            +  VL+ E M  G+++  L       +   +         
Sbjct: 65  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQIL 122

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILL-DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           KGL FLH    P+I+RD K  NI +     + K+ D GLA       ++  +  ++GT  
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPE 178

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 347
           + APE           DVY+FG+ +LE+ T      + + A +                 
Sbjct: 179 FMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------Y 222

Query: 348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
             +        +    + +   +   C+  N   R  ++D+++
Sbjct: 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 4e-54
 Identities = 68/280 (24%), Positives = 107/280 (38%), Gaps = 34/280 (12%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 170
           +F   R LG G FG VY     +          +A+KV             +   EV   
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFI------LALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
            HL HPN+++L GY  +     LI E+   G+V   L                    A  
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANA 118

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L++ H   K VI+RD K  N+LL +    K++DFG +   P   ++ +     GT  Y  
Sbjct: 119 LSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLP 172

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 350
           PE I       + D++S GV+  E L G+       P       +    + + +    + 
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPDF 226

Query: 351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
           +               A  L    L HNP  RP++R++++
Sbjct: 227 VTE------------GARDLISRLLKHNPSQRPMLREVLE 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 6e-54
 Identities = 76/297 (25%), Positives = 131/297 (44%), Gaps = 27/297 (9%)

Query: 105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 164
           DE  +        R LG G FG VY+G     +++  +   VA+K  +   S +   E+L
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFL 71

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF--------SKVLLPLP 216
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L         + VL P  
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 132 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189

Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
               + +    + +PE +  G  T  SDV+SFGVVL EI T  +   +     +      
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----- 244

Query: 337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
                     L  +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 245 ----------LRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 1e-53
 Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 24/283 (8%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
                R +G G FG V++G            + VA+K      S     ++L E + +  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPA---LAVAIKTCKNCTSDSVREKFLQEALTMRQ 64

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
             HP++VKLIG   E+    +I E    G + +         L  +  +  A+  +  LA
Sbjct: 65  FDHPHIVKLIGVITEN-PVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALA 122

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 292
           +L    K  ++RD    N+L+ ++   KL DFGL++   +    + +++      + APE
Sbjct: 123 YLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPE 179

Query: 293 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 352
            I     T  SDV+ FGV + EIL         +P +     D          ++ N   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVI-------GRIENGER 227

Query: 353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
             +  + P         L   C  ++P  RP   ++   L  +
Sbjct: 228 LPMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 5e-53
 Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 33/286 (11%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-WLAEVIFLG 171
           ++     +G G +G   K     D +       +  K  D  +  +  ++  ++EV  L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKI------LVWKELDYGSMTEAEKQMLVSEVNLLR 58

Query: 172 HLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLF--SKVLLPLPWSIRMKIAFGA 227
            L HPN+V+      +  +  L  + E+   G + + +   +K    L     +++    
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 228 AKGLAFLHE---AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
              L   H        V++RD K +N+ LD   N KL DFGLA+       +  +   +G
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVG 176

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 344
           T  Y +PE +       +SD++S G +L E+           P    +  + A       
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELA------- 223

Query: 345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 390
            K+      R+   Y      +   +    LN     RP + +I++
Sbjct: 224 GKIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 6e-53
 Identities = 77/302 (25%), Positives = 120/302 (39%), Gaps = 39/302 (12%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
            +     LG G FG VYK    ++       V  A KV D   S +   +++ E+  L  
Sbjct: 13  FWEIIGELGDGAFGKVYKA---QNKETS---VLAAAKVID-TKSEEELEDYMVEIDILAS 65

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
             HPN+VKL+     + +  ++ EF A G+V+  +      PL  S    +       L 
Sbjct: 66  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALN 124

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 292
           +LH+    +I+RD K  NIL   D + KL+DFG++       +       +GT  + APE
Sbjct: 125 YLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPE 180

Query: 293 YIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 347
            +M           ++DV+S G+ L+E+           P  E N     L + K +   
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKSEPPT 234

Query: 348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI-------VDSLEPLQVLPD 400
           L           P +           CL  N  AR     +       VDS +P++ L  
Sbjct: 235 L---------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIA 285

Query: 401 EA 402
           EA
Sbjct: 286 EA 287

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-52
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 34/299 (11%)

Query: 113 NFRQDRVLGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 171
                + LG G FG V     I  D  +  +   VAVK+   D + +   + ++E+  + 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 172 HLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------------VLLPLP 216
            +  H N++ L+G C +D    +I E+ ++G++   L ++                  L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
               +  A+  A+G+ +L    K  I+RD    N+L+  D   K++DFGLA+D    D  
Sbjct: 134 SKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
             +T       + APE +     T +SDV+SFGV+L EI T   S     P  E      
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------ 245

Query: 337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
                     L  ++      D P    ++  M+   C +  P  RP  + +V+ L+ +
Sbjct: 246 ----------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (441), Expect = 1e-51
 Identities = 75/306 (24%), Positives = 110/306 (35%), Gaps = 42/306 (13%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLG 171
           F   R +G G FG VY      +         VA+K   + G  S +  ++ + EV FL 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L HPN ++  G    +    L+ E+    + +     K   PL       +  GA +GL
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGL 128

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           A+LH     +I+RD K  NILL      KL DFG A           +   +GT  + AP
Sbjct: 129 AYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAP 180

Query: 292 EYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL 348
           E I+    G    + DV+S G+  +E+   +       P    N                
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSAL------YHIAQ 228

Query: 349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI-----VDSLEPLQVLPDEAP 403
           N       G +              CL   P+ RP    +     V    P  V+ D   
Sbjct: 229 NESPALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284

Query: 404 TPKNFV 409
             K+ V
Sbjct: 285 RTKDAV 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-51
 Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 34/299 (11%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
             +  + LG G FG V +   +  + +      VAVK+     ++  HR  ++E+  L H
Sbjct: 14  RLKLGKPLGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 173 LSH-PNLVKLIGYCCEDEHRVLI-YEFMARGSVENNLFSK--------------VLLPLP 216
           + H  N+V L+G C +    +++  EF   G++   L SK                  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 217 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 276
               +  +F  AKG+ FL    +  I+RD    NILL      K+ DFGLA+D  +    
Sbjct: 133 LEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 277 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 336
                      + APE I     T +SDV+SFGV+L EI +   S     P     + + 
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEE 245

Query: 337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
               LKE  ++            P     +       C +  P  RP   ++V+ L  L
Sbjct: 246 FCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-48
 Identities = 64/286 (22%), Positives = 101/286 (35%), Gaps = 30/286 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 170
           +F+  ++LG G F  V         RE       A+K+                 E   +
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYVTRERDVM 62

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
             L HP  VKL     +DE       +   G +   +          +            
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSA 120

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y +
Sbjct: 121 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 350
           PE +        SD+++ G ++ +++ G        P R  N          E      I
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGN----------EYLIFQKI 222

Query: 351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 396
           I  +LE D+P K   KA  L    L  +   R    ++        
Sbjct: 223 I--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-48
 Identities = 55/276 (19%), Positives = 105/276 (38%), Gaps = 29/276 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
            + +   +G G  G VY        +E      VA++  +           + E++ +  
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQE------VAIRQMNLQQQ-PKKELIINEILVMRE 73

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
             +PN+V  +      +   ++ E++A GS+ + +       +       +     + L 
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALE 130

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 292
           FLH     VI+RD K+ NILL  D + KL+DFG         +    + ++GT  + APE
Sbjct: 131 FLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPE 186

Query: 293 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 352
            +      P+ D++S G++ +E++ G        P R                  L   +
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---------------LIATN 231

Query: 353 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
              E   P K           CL+ + + R   +++
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  154 bits (390), Expect = 1e-44
 Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 32/295 (10%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEV 167
           ++  +    +LG GG   V+      DLR       VAVKV   D       +  +  E 
Sbjct: 5   LSDRYELGEILGFGGMSEVHLA---RDLRLH---RDVAVKVLRADLARDPSFYLRFRREA 58

Query: 168 IFLGHLSHPNLVKLIGYCCEDEHR----VLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
                L+HP +V +      +        ++ E++   ++ + + ++   P+     +++
Sbjct: 59  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEV 116

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDKSHVSTRI 282
              A + L F H+    +I+RD K +NI++      K+ DFG+A+     G+    +  +
Sbjct: 117 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK 342
           +GT  Y +PE      +  RSDVYS G VL E+LTG        P    +    A   ++
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVR 228

Query: 343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-MRDIVDSLEPLQ 396
           E     +     L  D           +    L  NP+ R     ++   L  + 
Sbjct: 229 EDPIPPSARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 59/278 (21%), Positives = 97/278 (34%), Gaps = 29/278 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
           ++     LG G FG V++                A K     +          E+  +  
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNN------FAAKFVMTPHE-SDKETVRKEIQTMSV 79

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           L HP LV L     +D   V+IYEFM+ G +   +  +    +     ++      KGL 
Sbjct: 80  LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLC 138

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYN--AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
            +H  E   ++ D K  NI+  T  +   KL DFGL           V+T   GT  +AA
Sbjct: 139 HMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAA 193

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 350
           PE      +   +D++S GV+   +L+G        P   +N  +    +      + + 
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMDDS 247

Query: 351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
               +  D                L  +P  R  +   
Sbjct: 248 AFSGISED--------GKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 52/281 (18%), Positives = 102/281 (36%), Gaps = 29/281 (10%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
           +   +     LG G FG V++       R          K  +             E+  
Sbjct: 27  VYDYYDILEELGSGAFGVVHRCVEKATGRV------FVAKFINTPYP-LDKYTVKNEISI 79

Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 229
           +  L HP L+ L     +    VLI EF++ G + + + ++    +  +  +     A +
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACE 138

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
           GL  +HE    +++ D K  NI+ +T   +  K+ DFGLA      +          T  
Sbjct: 139 GLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAE 193

Query: 288 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 347
           +AAPE +    +   +D+++ GV+   +L+G        P   ++  +    + +   + 
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEF 247

Query: 348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
                  +  +        A     + L   P+ R  + D 
Sbjct: 248 DEDAFSSVSPE--------AKDFIKNLLQKEPRKRLTVHDA 280

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (377), Expect = 2e-42
 Identities = 65/288 (22%), Positives = 105/288 (36%), Gaps = 30/288 (10%)

Query: 104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW 163
           + +   I   +    VLG G F  V      ED R       VA+K              
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILA---EDKRTQ---KLVAIKCIAKKALEGKEGSM 54

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
             E+  L  + HPN+V L        H  LI + ++ G + + +  K           ++
Sbjct: 55  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 112

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFGLAKDGPEGDKSHVST 280
            F     + +LH  +  +++RD K  N+L    D D    +SDFGL+K     D   V +
Sbjct: 113 IFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 167

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 340
              GT GY APE +     +   D +S GV+   +L G        P  ++N A     +
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQI 221

Query: 341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
           LK + +  +     +           A     H +  +P+ R      
Sbjct: 222 LKAEYEFDSPYWDDISDS--------AKDFIRHLMEKDPEKRFTCEQA 261

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 3e-42
 Identities = 58/296 (19%), Positives = 103/296 (34%), Gaps = 31/296 (10%)

Query: 106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 165
           ELR+    +R  R +G G FG +Y G    D+  G +   VA+K+         H +   
Sbjct: 2   ELRV-GNRYRLGRKIGSGSFGDIYLG---TDIAAGEE---VAIKLECVKTK---HPQLHI 51

Query: 166 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 225
           E      +     +  I +C  +    ++   +   S+E+ LF+           + +A 
Sbjct: 52  ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLAD 110

Query: 226 GAAKGLAFLHEAEKPVIYRDFKTSNIL---LDTDYNAKLSDFGLAKDGPEGD-----KSH 277
                + ++H   K  I+RD K  N L           + DFGLAK   +          
Sbjct: 111 QMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168

Query: 278 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 337
            +  + GT  YA+    +    + R D+ S G VL+    G       + A ++      
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK---- 224

Query: 338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 393
               +  +K ++     L   YP     + A     C +     +P    +     
Sbjct: 225 --YERISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 3e-42
 Identities = 78/334 (23%), Positives = 121/334 (36%), Gaps = 50/334 (14%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 170
           +F   ++LG G FG V+     +  +        A+K    D           + E   L
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQF------FAIKALKKDVVLMDDDVECTMVEKRVL 56

Query: 171 GH-LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 229
                HP L  +       E+   + E++  G +  ++ S        S     A     
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIIL 114

Query: 230 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           GL FLH   K ++YRD K  NILLD D + K++DFG+ K+   GD         GT  Y 
Sbjct: 115 GLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYI 170

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 349
           APE ++        D +SFGV+L E+L G+       P   Q+  +    +  +      
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFYPR 224

Query: 350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR----------PLMRDIV-DSLEPLQVL 398
            ++              A  L        P+ R          PL R+I  + LE  ++ 
Sbjct: 225 WLEKE------------AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID 272

Query: 399 PDEAPTPK------NFVTVVTPEEPKAEIQTKDS 426
           P   P  K      NF      E+P+     +  
Sbjct: 273 PPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRAL 306

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 63/291 (21%), Positives = 103/291 (35%), Gaps = 42/291 (14%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--------HDGDNSYQGHREWL 164
           N+    +LG G    V +       +E       AVK+           +   +     L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKE------YAVKIIDVTGGGSFSAEEVQELREATL 57

Query: 165 AEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
            EV  L  +S HPN+++L      +    L+++ M +G + + L  KV   L      KI
Sbjct: 58  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKI 115

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
                + +  LH+    +++RD K  NILLD D N KL+DFG +    + D       + 
Sbjct: 116 MRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVC 170

Query: 284 GTYGYAAPEYIMTGHL------TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 337
           GT  Y APE I               D++S GV++  +L G        P   +      
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLML 224

Query: 338 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
             ++    +  +                    L    L   P+ R    + 
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (373), Expect = 3e-41
 Identities = 61/277 (22%), Positives = 100/277 (36%), Gaps = 35/277 (12%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVI-- 168
           +F   R++G GGFG VY    ++  +        A+K          QG    L E I  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKM------YAMKCLDKKRIKMKQGETLALNERIML 58

Query: 169 -FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA 227
             +     P +V +       +    I + M  G +  +L          +     A   
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEI 116

Query: 228 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 287
             GL  +H   + V+YRD K +NILLD   + ++SD GLA D  +          +GT+G
Sbjct: 117 ILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHG 170

Query: 288 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK 346
           Y APE +  G      +D +S G +L ++L G     + +   +  +    L        
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------- 223

Query: 347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
               +   L   +      +   L    L  +   R 
Sbjct: 224 ----MAVELPDSFS----PELRSLLEGLLQRDVNRRL 252

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 5e-41
 Identities = 47/278 (16%), Positives = 93/278 (33%), Gaps = 30/278 (10%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 172
            +     LG G FG V++   +   +          K      + Q       E+  L  
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKT------YMAKFVKVKGTDQ--VLVKKEISILNI 57

Query: 173 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
             H N++ L       E  V+I+EF++   +   + +     L     +       + L 
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQ 116

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           FLH     + + D +  NI+  T  ++  K+ +FG A+    GD   +   +     Y A
Sbjct: 117 FLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYA 171

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 350
           PE      ++  +D++S G ++  +L+G        P   +        ++  +      
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTFDEE 225

Query: 351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
               +  +        A       L    K+R    + 
Sbjct: 226 AFKEISIE--------AMDFVDRLLVKERKSRMTASEA 255

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  144 bits (365), Expect = 8e-41
 Identities = 48/297 (16%), Positives = 94/297 (31%), Gaps = 32/297 (10%)

Query: 109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 168
           ++  +++  R +G G FG +++G    +L        VA+K     +     R+      
Sbjct: 2   VVGVHYKVGRRIGEGSFGVIFEG---TNLLNN---QQVAIKFEPRRSDAPQLRDEYRTYK 55

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
            L       +  +  +  E  H VL+ + +  G    +L                A    
Sbjct: 56  LLAG--CTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQML 111

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLD-----TDYNAKLSDFGLAKDGPEGDKS-----HV 278
             +  +HE  K ++YRD K  N L+            + DFG+ K   +           
Sbjct: 112 ARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169

Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 338
              + GT  Y +    +    + R D+ + G V +  L G       + A  +       
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK----- 224

Query: 339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 395
              +  +K  +     L   +P     +     ++  N    A P    +      +
Sbjct: 225 -YERIGEKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-40
 Identities = 61/295 (20%), Positives = 110/295 (37%), Gaps = 24/295 (8%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 169
           +   +     +G G +G V   + + +         VA+K           +  L E+  
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVR------VAIKKISPFEHQTYCQRTLREIKI 59

Query: 170 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-PLPWSIRMKIAFGAA 228
           L    H N++ +           +   ++    +  +L+  +    L         +   
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 119

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDKSHVSTRIMGTYG 287
           +GL ++H     V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  + T  
Sbjct: 120 RGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 288 YAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--PLLKEK 344
           Y APE ++      +S D++S G +L E+L+ R          + N     L  P  ++ 
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 345 KKLLNIIDPRLEGDYPVKGV-----------HKAAMLAYHCLNHNPKARPLMRDI 388
             ++N+         P K              KA  L    L  NP  R  +   
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 9e-40
 Identities = 63/288 (21%), Positives = 100/288 (34%), Gaps = 36/288 (12%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWL 164
           +   +     LG G F  V K     +   GLQ    A K                 +  
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKC---REKSTGLQ---YAAKFIKKRRTKSSRRGVSREDIE 61

Query: 165 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
            EV  L  + HPN++ L          +LI E +A G + + L  K    L      +  
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFL 119

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD----YNAKLSDFGLAKDGPEGDKSHVST 280
                G+ +LH     + + D K  NI+L          K+ DFGLA     G++     
Sbjct: 120 KQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---K 174

Query: 281 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 340
            I GT  + APE +    L   +D++S GV+   +L+G                      
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------------- 221

Query: 341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
            +E    ++ ++   E +Y       A       L  +PK R  ++D 
Sbjct: 222 -QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 9e-40
 Identities = 65/293 (22%), Positives = 107/293 (36%), Gaps = 27/293 (9%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-WLAEVIFLG 171
            +     +G G +G V+K     DL+ G + V  A+K        +G     + EV  L 
Sbjct: 8   QYECVAEIGEGAYGKVFKA---RDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLR 62

Query: 172 HLS---HPNLVKLIGYCC----EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 224
           HL    HPN+V+L   C     + E ++ +        +   L       +P      + 
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122

Query: 225 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 284
           F   +GL FLH     V++RD K  NIL+ +    KL+DFGLA+           T ++ 
Sbjct: 123 FQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVV 177

Query: 285 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 344
           T  Y APE ++        D++S G +  E+   +     S    +       + L  E+
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 345 ---------KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
                    ++  +    +    +          L   CL  NP  R      
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-39
 Identities = 62/288 (21%), Positives = 112/288 (38%), Gaps = 22/288 (7%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 171
           NF++   +G G +G VYK               VA+K    D   +G     + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEV------VALKKIRLDTETEGVPSTAIREISLLK 56

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L+HPN+VKL+     +    L++EF+ +   +  + +  L  +P  +     F   +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDL-KKFMDASALTGIPLPLIKSYLFQLLQGL 115

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +   +  ++  +  A  
Sbjct: 116 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPE 172

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 351
             +   + +   D++S G +  E++T R          +       L    E        
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232

Query: 352 DPRLEGDYPVKGVHK-----------AAMLAYHCLNHNPKARPLMRDI 388
            P  +  +P                    L    L+++P  R   +  
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 62/273 (22%), Positives = 106/273 (38%), Gaps = 35/273 (12%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 170
           +F+  R LG G FG V+      + R        A+KV   +     +       E + L
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRY------YAMKVLKKEIVVRLKQVEHTNDERLML 58

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
             ++HP ++++ G   + +   +I +++  G + + L        P  +    A      
Sbjct: 59  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLA 116

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L +LH   K +IYRD K  NILLD + + K++DFG AK  P+   +       GT  Y A
Sbjct: 117 LEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIA 169

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 350
           PE + T       D +SFG+++ E+L G        P  + N       +L  + +    
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYT------PFYDSNTMKTYEKILNAELRFPPF 223

Query: 351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
            +                 L    +  +   R 
Sbjct: 224 FNE------------DVKDLLSRLITRDLSQRL 244

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 9e-39
 Identities = 71/307 (23%), Positives = 117/307 (38%), Gaps = 31/307 (10%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV----HDGDNSYQGHREWLAEVIFLGHL 173
             LG G F  VYK       +       VA+K     H  +     +R  L E+  L  L
Sbjct: 4   DFLGEGQFATVYKARDKNTNQI------VAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57

Query: 174 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 233
           SHPN++ L+       +  L+++FM   +    +     L L  S          +GL +
Sbjct: 58  SHPNIIGLLDAFGHKSNISLVFDFM--ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 234 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 293
           LH  +  +++RD K +N+LLD +   KL+DFGLAK     ++++  T  + T  Y APE 
Sbjct: 116 LH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPEL 171

Query: 294 IMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN--LADWALPLLKEKKKLLNI 350
           +    +     D+++ G +L E+L     L       +          P  ++   + ++
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 351 IDPRLEGDYPVKGVHK--------AAMLAYHCLNHNPKARPLMRDIVD----SLEPLQVL 398
            D      +P   +H            L       NP AR      +     S  P    
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291

Query: 399 PDEAPTP 405
             + P P
Sbjct: 292 GCQLPRP 298

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 5e-37
 Identities = 59/284 (20%), Positives = 102/284 (35%), Gaps = 46/284 (16%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWLAEVI 168
           ++   +LG GGFG VY G     + +    +PVA+K                     EV+
Sbjct: 6   YQVGPLLGSGGFGSVYSG---IRVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVV 59

Query: 169 FLGHLS--HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 226
            L  +S     +++L+ +    +  VLI E         +  ++    L   +     + 
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQ 118

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGPEGDKSHVSTRIMGT 285
             + +   H     V++RD K  NIL+D +    KL DFG         K  V T   GT
Sbjct: 119 VLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGT 172

Query: 286 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 344
             Y+ PE+I    +    + V+S G++L +++ G        P            +++ +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDE------EIIRGQ 220

Query: 345 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
                 +              +   L   CL   P  RP   +I
Sbjct: 221 VFFRQRVSS------------ECQHLIRWCLALRPSDRPTFEEI 252

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 9e-37
 Identities = 70/326 (21%), Positives = 114/326 (34%), Gaps = 40/326 (12%)

Query: 108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 167
           R    ++   +V+G G FG VY+  + +          VA+K        Q  R    E+
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKVL-----QDKRFKNREL 64

Query: 168 IFLGHLSHPNLVKLIGYCCE------DEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIR 220
             +  L H N+V+L  +         + +  L+ +++          +S+    LP    
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 221 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGPEGDKSHVS 279
               +   + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   
Sbjct: 125 KLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-- 180

Query: 280 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP 339
           + I   Y  A          T   DV+S G VL E+L G+          +       L 
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240

Query: 340 LLKE-----------KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
                          + K   I        +  +   +A  L    L + P AR    + 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

Query: 389 V------DSLEPLQVLPDEAPTPKNF 408
                  +  +P   LP+   TP  F
Sbjct: 301 CAHSFFDELRDPNVKLPNGRDTPALF 326

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  133 bits (334), Expect = 2e-36
 Identities = 54/288 (18%), Positives = 107/288 (37%), Gaps = 24/288 (8%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-WLAEVIFLG 171
            +     +G G +G VYK   +            A+K    +   +G     + E+  L 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGET-------FALKKIRLEKEDEGIPSTTIREISILK 55

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L H N+VKL       +  VL++E + +   +     +    L              G+
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGI 113

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
           A+ H  ++ V++RD K  N+L++ +   K++DFGLA+      + +    I+  +  A  
Sbjct: 114 AYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPD 170

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE----------QNLADWALPLL 341
             + +   +   D++S G +  E++ G         A +           N  +W     
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 342 KEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMRDI 388
             K      +   L  +  +KG+ ++ + L    L  +P  R   +  
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 4e-36
 Identities = 47/279 (16%), Positives = 95/279 (34%), Gaps = 33/279 (11%)

Query: 117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 176
            +VLG G  G V + F      +       A+K+    +  +  RE     +       P
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEK------FALKMLQ--DCPKARRE---VELHWRASQCP 65

Query: 177 NLVKLIGYC----CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 232
           ++V+++          +  +++ E +  G + + +  +           +I     + + 
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 233 FLHEAEKPVIYRDFKTSNILLDTDYN---AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 289
           +LH     + +RD K  N+L  +       KL+DFG AK+    +          T  Y 
Sbjct: 126 YLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYV 180

Query: 290 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 349
           APE +         D++S GV++  +L G        P    +    +  +    +    
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQY 234

Query: 350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
                   +       +  ML  + L   P  R  + + 
Sbjct: 235 EFPNPEWSEVS----EEVKMLIRNLLKTEPTQRMTITEF 269

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-35
 Identities = 62/273 (22%), Positives = 99/273 (36%), Gaps = 32/273 (11%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 170
           +F   ++LG G FG V         R        A+K+   +   +       + E   L
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRY------YAMKILRKEVIIAKDEVAHTVTESRVL 59

Query: 171 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 230
            +  HP L  L       +    + E+   G +  +L  +                    
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSA 117

Query: 231 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 290
           L +LH   + V+YRD K  N++LD D + K++DFGL K+G     +       GT  Y A
Sbjct: 118 LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLA 173

Query: 291 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 350
           PE +         D +  GVV+ E++ GR       P   Q+       +L E+ +    
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFPRT 227

Query: 351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
           + P            +A  L    L  +PK R 
Sbjct: 228 LSP------------EAKSLLAGLLKKDPKQRL 248

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 2e-35
 Identities = 58/289 (20%), Positives = 104/289 (35%), Gaps = 24/289 (8%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 171
            + +   +G G +G V+K    E          VA+K V   D+        L E+  L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEI------VALKRVRLDDDDEGVPSSALREICLLK 56

Query: 172 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 231
            L H N+V+L      D+   L++EF  +   +          L   I     F   KGL
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGL 114

Query: 232 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 291
            F H   + V++RD K  N+L++ +   KL++FGLA+      + + S  ++  +     
Sbjct: 115 GFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPD 171

Query: 292 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 351
                   +   D++S G +  E+    + L       +Q    + L     +++  ++ 
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 352 DPRLEGDYPVKGVHK------------AAMLAYHCLNHNPKARPLMRDI 388
                  YP+                    L  + L  NP  R    + 
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 6e-35
 Identities = 65/302 (21%), Positives = 113/302 (37%), Gaps = 36/302 (11%)

Query: 113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR-EWLAEVIFLG 171
            + +   +G G FG V+K    +  ++      VA+K    +N  +G     L E+  L 
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQK------VALKKVLMENEKEGFPITALREIKILQ 64

Query: 172 HLSHPNLVKLIGYCCEDEHRV--------LIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
            L H N+V LI  C               L+++F         L S VL+    S   ++
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRV 122

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS--TR 281
                 GL ++H     +++RD K +N+L+  D   KL+DFGLA+       S  +  T 
Sbjct: 123 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 282 IMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAR----------- 329
            + T  Y  PE ++      P  D++  G ++ E+ T    +  +               
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 330 --EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMR 386
              +   +     L EK +L+     +++           A+ L    L  +P  R    
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 387 DI 388
           D 
Sbjct: 301 DA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 5e-34
 Identities = 58/315 (18%), Positives = 111/315 (35%), Gaps = 30/315 (9%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVI 168
           + A +R  + +G G +G V          +      VA+K  +    S    +    E+ 
Sbjct: 16  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAK------VAIKKLYRPFQSELFAKRAYRELR 69

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFG 226
            L H+ H N++ L+     DE      +F            K++    L       + + 
Sbjct: 70  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129

Query: 227 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 286
             KGL ++H     +I+RD K  N+ ++ D   K+ DFGLA+       S ++  ++  +
Sbjct: 130 MLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRW 183

Query: 287 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR-------------KSLDKSRPAREQNL 333
             A    +     T   D++S G ++ E++TG+             + +  +     + +
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243

Query: 334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS-- 391
                   K   K L  ++ +            A  L    L  + + R    + +    
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303

Query: 392 LEPLQVLPDEAPTPK 406
            E L    DE    K
Sbjct: 304 FESLHDTEDEPQVQK 318

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (302), Expect = 2e-31
 Identities = 59/309 (19%), Positives = 105/309 (33%), Gaps = 36/309 (11%)

Query: 78  SKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITAN-FRQDRVLGGGGFGCVYKGFISED 136
           +K  S  E V++    +  + L  +          + F + + LG G FG V      E 
Sbjct: 6   AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES 65

Query: 137 LREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI 194
                     A+K+         +     L E   L  ++ P LVKL     ++ +  ++
Sbjct: 66  GNH------YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 195 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD 254
            E++A G + ++L                A        +LH     +IYRD K  N+L+D
Sbjct: 120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLID 175

Query: 255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 314
                +++DFG AK       +     + GT    APE I++       D ++ GV++ E
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 315 ILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHC 374
           +  G        P            ++  K +  +                    L  + 
Sbjct: 231 MAAGY------PPFFADQPIQIYEKIVSGKVRFPSHFSS------------DLKDLLRNL 272

Query: 375 LNHNPKARP 383
           L  +   R 
Sbjct: 273 LQVDLTKRF 281

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (292), Expect = 4e-30
 Identities = 55/313 (17%), Positives = 110/313 (35%), Gaps = 44/313 (14%)

Query: 102 FTYDELRIITAN---FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ 158
           + Y+   +   N   ++  R LG G +  V++     ++    +   V VK+        
Sbjct: 22  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEA---INITNNEK---VVVKILKPVK--- 72

Query: 159 GHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW 217
             ++   E+  L +L   PN++ L     +   R     F     V N  F ++   L  
Sbjct: 73  -KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTD 128

Query: 218 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGPEGDKS 276
                  +   K L + H     +++RD K  N+++D +    +L D+GLA+    G + 
Sbjct: 129 YDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186

Query: 277 HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ---- 331
                 + +  +  PE ++         D++S G +L  ++  ++         +Q    
Sbjct: 187 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243

Query: 332 -------NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHK---------AAMLAYHCL 375
                  +L D+      E     N I  R       + VH          A       L
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303

Query: 376 NHNPKARPLMRDI 388
            ++ ++R   R+ 
Sbjct: 304 RYDHQSRLTAREA 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-30
 Identities = 65/282 (23%), Positives = 102/282 (36%), Gaps = 28/282 (9%)

Query: 108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV---HDGDNSYQGHREWL 164
           ++   NF   +VLG G +G V+          G      A+KV          +      
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTG---KLYAMKVLKKATIVQKAKTTEHTR 76

Query: 165 AEVIFLGHLSH-PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
            E   L H+   P LV L      +    LI +++  G +  +L  +             
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIY 134

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
                  L  LH+    +IYRD K  NILLD++ +  L+DFGL+K+    D++  +    
Sbjct: 135 VGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFC 191

Query: 284 GTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL 341
           GT  Y AP+ +  G        D +S GV++ E+LTG        P       +    + 
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA------SPFTVDGEKNSQAEIS 245

Query: 342 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 383
           +   K        +           A  L    L  +PK R 
Sbjct: 246 RRILKSEPPYPQEMSAL--------AKDLIQRLLMKDPKKRL 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 7e-28
 Identities = 60/310 (19%), Positives = 115/310 (37%), Gaps = 37/310 (11%)

Query: 105 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-W 163
           D    +   ++  + +G G  G V   + +   R       VA+K        Q H +  
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRA 63

Query: 164 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE-FMARGSVENNLFSKVLLPLPWSIRMK 222
             E++ +  ++H N++ L+      +      + ++    ++ NL   + + L       
Sbjct: 64  YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123

Query: 223 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 282
           + +    G+  LH     +I+RD K SNI++ +D   K+ DFGLA+       S + T  
Sbjct: 124 LLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 178

Query: 283 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR----------------KSLDKSR 326
           + T  Y APE I+        D++S G ++ E++  +                + L    
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 327 PAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHK--------AAMLAYHCLNHN 378
           P   + L       ++ + K   +  P+L  D       +        A  L    L  +
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 379 PKARPLMRDI 388
           P  R  + D 
Sbjct: 299 PAKRISVDDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 3e-27
 Identities = 53/298 (17%), Positives = 103/298 (34%), Gaps = 34/298 (11%)

Query: 110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVI 168
           +   ++    +G G +G V   F ++          VAVK       S    +    E+ 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLR------VAVKKLSRPFQSIIHAKRTYRELR 69

Query: 169 FLGHLSHPNLVKLIGYC-----CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 223
            L H+ H N++ L+         E+ + V +   +    + N +  +    L       +
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFL 126

Query: 224 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 283
            +   +GL ++H     +I+RD K SN+ ++ D   K+ DFGLA+         ++  + 
Sbjct: 127 IYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVA 180

Query: 284 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR-------------KSLDKSRPARE 330
             +  A    +   H     D++S G ++ E+LTGR               L        
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240

Query: 331 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 388
           + L   +    +   + L  +      +  +     A  L    L  +   R      
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 96.6 bits (239), Expect = 8e-23
 Identities = 51/320 (15%), Positives = 101/320 (31%), Gaps = 38/320 (11%)

Query: 114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 173
           +   R LG G F  V+     +D+        VA+K+  GD  Y        E+  L  +
Sbjct: 15  YILVRKLGWGHFSTVWLA---KDMVNN---THVAMKIVRGDKVY--TEAAEDEIKLLQRV 66

Query: 174 SHPNLVKLIGYCCEDEHRVLIYE--------------FMARGSVENNLFSKVLLPLPWSI 219
           +  +  K          ++L +                +   ++   +       +P   
Sbjct: 67  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126

Query: 220 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDGPEGDKSHV 278
             +I+     GL ++H     +I+ D K  N+L++  D    L    +A  G        
Sbjct: 127 VKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185

Query: 279 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 338
            T  + T  Y +PE ++       +D++S   ++ E++TG    +           D   
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245

Query: 339 -----------PLLKEKKKLLNIIDPR-LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR 386
                       LL+  K      + R L  +           +       +      + 
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305

Query: 387 DIVDSLEPLQVLPDEAPTPK 406
           D +  +  LQ+ P +     
Sbjct: 306 DFLSPM--LQLDPRKRADAG 323

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.9 bits (178), Expect = 1e-15
 Identities = 24/161 (14%), Positives = 52/161 (32%), Gaps = 24/161 (14%)

Query: 118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---------YQGHREWLAEVI 168
           +++G G    V+    SE   E        VK H   ++           G   +    I
Sbjct: 6   KLMGEGKESAVFNC-YSEKFGE------CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58

Query: 169 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 228
                    L KL G          +Y +     +   + +K L  +      ++     
Sbjct: 59  RSARNEFRALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMIL 113

Query: 229 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 269
           + +A  +   + +++ D    N+L+  +    + DF  + +
Sbjct: 114 EEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	429
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.56
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.83
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.75
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.76
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.52
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.37

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-58  Score=424.66  Aligned_cols=256  Identities=25%  Similarity=0.328  Sum_probs=208.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||+||+|.+..++      ..||+|++.........+.+.+|+.+|++++|||||++++++.+++.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTE------EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   77 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCC------CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence            357999999999999999999876654      34999999776544455678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||+++++.+||+|||+|+..
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheee
Confidence            999999999999999986543  6999999999999999999999987  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .........+..+||+.|+|||++.+..+ +.++|||||||++|||+||+.||......... ..              .
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~--------------~  218 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS--------------D  218 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HH--------------H
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HH--------------H
Confidence            54433334456789999999999988776 67899999999999999999999765432110 00              0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..............+.++.+|+.+||+.||++|||++|++++
T Consensus       219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            011111112223557788999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-57  Score=423.12  Aligned_cols=263  Identities=27%  Similarity=0.413  Sum_probs=207.7

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ..++|++.+.||+|+||+||+|.+..         .||||+++... .....+.|.+|+.+|++++|||||++++++.+ 
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-   75 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-   75 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESSS---------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEECC---------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-
Confidence            35689999999999999999997543         29999987543 34556789999999999999999999998754 


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +.+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  ||||||||+|||++.++.+||+|||+|+
T Consensus        76 ~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          76 PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             SSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             cEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEcccccee
Confidence            56899999999999999997554 36999999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      ...............||+.|+|||++.+   ..|+.++|||||||++|||+||+.||..........      .....  
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~--  224 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGR--  224 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHH--
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhc--
Confidence            7655443344456789999999999874   358999999999999999999999998755332110      00100  


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                         ....+.+ ...+..++..+.+|+.+||+.||++|||++||+++|+.++.
T Consensus       225 ---~~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         225 ---GYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ---TSCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               1111111 12234567889999999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-57  Score=424.41  Aligned_cols=264  Identities=24%  Similarity=0.397  Sum_probs=208.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.++||+|+||+||+|.+..+.+   ....||||.+.........+.|.+|+.+|++++|||||++++++.+++..
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            568888999999999999998765432   24568999988776777778899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++|||||++|+|.+++.... ..+++.++..++.|++.||+|||+++  |+||||||+||||+.++.+||+|||+++...
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEcc
Confidence            99999999999999886543 36999999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccc---cccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          272 EGDKSHV---STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       272 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      .......   .....||+.|+|||.+.+..|+.++|||||||++|||+| |+.||........   ..            
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~------------  244 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---IN------------  244 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH------------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---HH------------
Confidence            4322111   122468999999999999999999999999999999998 8999986653211   10            


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                        .+........+..++..+.+|+.+||+.||++|||+.||++.|+++..-
T Consensus       245 --~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         245 --AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             --HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence              0111122334556778899999999999999999999999999887543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-57  Score=422.67  Aligned_cols=264  Identities=25%  Similarity=0.378  Sum_probs=219.2

Q ss_pred             HHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEE
Q 014189          107 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       107 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      +++..++|++.+.||+|+||+||+|.+..+.      ..||||++..+..  ..++|.+|+.+|++++|||||+++++|.
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~   83 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCT   83 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGT------EEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCC------eEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence            3344578999999999999999999886654      3499999876533  4567899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      +++..++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||+++++.+||+|||+
T Consensus        84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccc
Confidence            9999999999999999999998776678999999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      |+...... ........||+.|+|||++.+..|+.++|||||||++|||++|..|+........                
T Consensus       162 a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~----------------  224 (287)
T d1opja_         162 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------  224 (287)
T ss_dssp             TTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------------
T ss_pred             eeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH----------------
Confidence            98765432 2233445689999999999999999999999999999999997766543322111                


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                      +.+.+........+..++.++.+|+.+||+.||++|||++||++.|+.+..
T Consensus       225 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            111111222334455677889999999999999999999999999987754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=410.22  Aligned_cols=248  Identities=28%  Similarity=0.416  Sum_probs=208.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||.||+|.+..+.      ..||+|++....  .......+.+|+.++++++|||||++++++.+++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSK------FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCC------cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            57999999999999999999876654      349999986432  1223456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+|+.
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeee
Confidence            9999999999999999997654  6999999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .....    .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.....                ..
T Consensus       156 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----------------~~  215 (263)
T d2j4za1         156 APSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY----------------KR  215 (263)
T ss_dssp             CCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HH
T ss_pred             cCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH----------------HH
Confidence            65432    23468999999999999999999999999999999999999999865532110                01


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +...  ....+...+.++.+|+.+||+.||++|||++|+++|
T Consensus       216 i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         216 ISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            1111  112344567889999999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=412.98  Aligned_cols=251  Identities=21%  Similarity=0.329  Sum_probs=209.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|++.+.||+|+||+||+|.+..++      ..||+|++.... ....+.+.+|+.++++++|||||++++++.+++.+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~------~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   92 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATG------QEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTC------CEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCC------CEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEE
Confidence            47999999999999999999876553      349999987542 22346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      |+||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+|+...
T Consensus        93 ~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeec
Confidence            9999999999999887654   5999999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhc
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  351 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
                      ....  .....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||...+......      ...       ...
T Consensus       168 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~-------~~~  232 (293)
T d1yhwa1         168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIA-------TNG  232 (293)
T ss_dssp             STTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHH-------HHC
T ss_pred             cccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHH-------hCC
Confidence            4322  2345689999999999999999999999999999999999999998655322110      000       000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          352 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       352 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ......+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       233 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         233 --TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             --SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             --CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              11122345567889999999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-56  Score=411.52  Aligned_cols=256  Identities=24%  Similarity=0.412  Sum_probs=201.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||+||+|.+.++       ..||||++....  ...++|.+|+.++++++|||||++++++..++..
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   75 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTT-------EEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCC-------CEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence            5789999999999999999987543       239999987643  2346799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||+++++.+||+|||+++...
T Consensus        76 ~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             EEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             EEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheecc
Confidence            99999999999999887653 46899999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG-RKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .... .......||+.|+|||++.+..|+.++|||||||++|||+|| .+||.......   ...    .+.      . 
T Consensus       153 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~----~i~------~-  217 (263)
T d1sm2a_         153 DDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE----DIS------T-  217 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHH----HHH------H-
T ss_pred             CCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHH----HHH------h-
Confidence            4322 223346799999999999999999999999999999999995 55565443211   110    010      1 


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                         ......+..++.++.+|+.+||+.||++|||++||+++|++++.
T Consensus       218 ---~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         218 ---GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence               11122344567789999999999999999999999999988753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=424.51  Aligned_cols=264  Identities=26%  Similarity=0.398  Sum_probs=214.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  189 (429)
                      .++|++.++||+|+||+||+|++....+. .....||+|.+...........|.+|+.+|.++ +|||||++++++.+.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKT-GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSS-SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcc-cceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            46799999999999999999987654332 234569999987665555667789999999998 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVL---------------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKT  248 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp  248 (429)
                      .+++||||+++|+|.+++..+..                     ..+++..++.++.|++.||+|||+.+  ||||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp  192 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAA  192 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCch
Confidence            99999999999999999975431                     35899999999999999999999977  99999999


Q ss_pred             CcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCh
Q 014189          249 SNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRP  327 (429)
Q Consensus       249 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~  327 (429)
                      +|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987655443333445678999999999999999999999999999999998 8999986543


Q ss_pred             hhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcc
Q 014189          328 AREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  393 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  393 (429)
                      ...                +.+++........+..++.++.+|+.+||+.||++|||++||+++|.
T Consensus       273 ~~~----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DAN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHH----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH----------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            211                11111112223345567788999999999999999999999999984

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=413.35  Aligned_cols=255  Identities=21%  Similarity=0.278  Sum_probs=198.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe--C
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--D  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  188 (429)
                      ++|++.+.||+|+||.||+|.+..++      ..||+|++.... .....+.+.+|+++|++++|||||++++++.+  +
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDG------KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCC------CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            67999999999999999999876654      349999987654 44455678899999999999999999999864  4


Q ss_pred             CeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCceeCCCCCCcEEEcCCCcEEEec
Q 014189          189 EHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAE---KPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                      +.+|+||||+++|+|.+++...  ....+++..++.++.|++.||+|||+.+   .+|+||||||+|||++.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            6789999999999999988542  2347999999999999999999999854   3599999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHh
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  343 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ||+++......  .......||+.|+|||++.+..|+.++|||||||++|||+||+.||...+....   .   ..    
T Consensus       158 FG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~---~~----  225 (269)
T d2java1         158 FGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---A---GK----  225 (269)
T ss_dssp             HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H---HH----
T ss_pred             ccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---H---HH----
Confidence            99998765422  223457899999999999999999999999999999999999999986553211   0   00    


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                            +..... ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       226 ------i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         226 ------IREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ------HHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------HHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                  000111 12234567789999999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=424.30  Aligned_cols=268  Identities=23%  Similarity=0.298  Sum_probs=210.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..++|++.+.||+|+||+||+|.+..+      +..||+|++...........+.+|+.+|++++|||||+++++|.+++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~------~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   77 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPS------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   77 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTT------TEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCC------CcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            357899999999999999999987654      34599999987655556678899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      .+|+||||+++|+|.+++.+..  .+++..+..++.|++.||.|||+ ++  |+||||||+|||++.++.+||+|||+|+
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCcc
Confidence            9999999999999999997654  58999999999999999999997 47  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh-HhhHHHh----
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW-ALPLLKE----  343 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~----  343 (429)
                      .....    ..+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.......... .......    
T Consensus       154 ~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (322)
T d1s9ja_         154 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  229 (322)
T ss_dssp             HHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred             ccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence            64321    23456899999999999999999999999999999999999999986553221110000 0000000    


Q ss_pred             ---------------------hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 ---------------------KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                                           ....................+.++.+|+.+||+.||++|||++|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                                 000000000000001112346789999999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=411.16  Aligned_cols=268  Identities=26%  Similarity=0.411  Sum_probs=211.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      +++|+..++||+|+||.||+|.+..+..  .....||||.+..........+|++|+.++++++|||||++++++.+.+.
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            4578889999999999999998765432  23456999999877666667789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+.+|++.+.+.... ..+++..+..++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++..
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhcc
Confidence            999999999999998776553 36999999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCC-ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDK-SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ..... ........||+.|+|||++.++.|+.++|||||||++|||++|..|+........  .              ..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~--------------~~  224 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--V--------------MK  224 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H--------------HH
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--H--------------HH
Confidence            54322 2223345789999999999999999999999999999999996665543322111  1              11


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCC
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  399 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  399 (429)
                      .+........+..++..+.+|+.+||+.||++|||+.||++.|+++...+
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            11112233445567788999999999999999999999999998876653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=409.63  Aligned_cols=259  Identities=26%  Similarity=0.385  Sum_probs=212.1

Q ss_pred             cCCcccee-ecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRV-LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~-lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|.+.+. ||+|+||.||+|.+....    .+..||||++.........+.|.+|+++|++++|||||++++++.. +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCC----CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            46777775 999999999999875432    2456999999877666677889999999999999999999999865 56


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      +|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcc
Confidence            899999999999999875443 36999999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          271 PEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       271 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||........   ..    .+       
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~----~i-------  225 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA----FI-------  225 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HH----HH-------
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HH----HH-------
Confidence            543322 22334578999999999999999999999999999999998 9999986543211   10    01       


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                         ........+..++.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       226 ---~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         226 ---EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ---HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               11112234556778899999999999999999999999988654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=405.46  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=201.3

Q ss_pred             CccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe----C
Q 014189          114 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE----D  188 (429)
Q Consensus       114 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~  188 (429)
                      |++.+.||+|+||+||+|.+..+.      ..||+|.+.... .....+.|.+|+++|++++|||||++++++.+    +
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~------~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETT------VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             EEeeeEEecCcCcEEEEEEECCCC------eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence            366778999999999999876553      349999886543 44456678999999999999999999999865    3


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc-CCCcEEEeccCCC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFGLA  267 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla  267 (429)
                      ..+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++.+|+||||||+|||++ +++.+||+|||+|
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            56899999999999999997654  68999999999999999999999777799999999999996 5889999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      +.....    .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||........  +.             
T Consensus       163 ~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~-------------  222 (270)
T d1t4ha_         163 TLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY-------------  222 (270)
T ss_dssp             GGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH-------------
T ss_pred             eeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HH-------------
Confidence            864332    2345789999999998875 599999999999999999999999976543211  00             


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..+.........+...+.++.+|+.+||+.||++|||++|+++|
T Consensus       223 ~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            01111111111222345678999999999999999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=412.45  Aligned_cols=257  Identities=27%  Similarity=0.394  Sum_probs=209.3

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +..++|++.+.||+|+||.||+|.+.++       ..||||++.....  ..+.|.+|+.++++++|||||++++++.+ 
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-   79 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-   79 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEECCC-------CEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence            3456899999999999999999987532       3499999976532  34679999999999999999999998754 


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..++||||+++|+|.+++......++++..++.++.|++.||+|||+++  |+||||||+||||++++.+||+|||+|+
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceE
Confidence            56799999999999999886655556999999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS-LDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ...... ........||+.|+|||++.++.|+.++|||||||++|||+||..| +.......   ...            
T Consensus       158 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~------------  221 (272)
T d1qpca_         158 LIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ------------  221 (272)
T ss_dssp             ECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH------------
T ss_pred             EccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHH------------
Confidence            765432 2233446799999999999999999999999999999999996554 44333211   100            


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                        .+........+..++.++.+|+.+||+.||++|||+++|++.|+.+
T Consensus       222 --~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         222 --NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             --HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence              0111122233455678899999999999999999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=411.61  Aligned_cols=250  Identities=22%  Similarity=0.281  Sum_probs=205.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||+||+|.+..+++      .||||++....  .......+.+|+++|++++||||+++++++.+++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSR------EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            579999999999999999998766543      49999986432  1223456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||+++++.+||+|||+|+.
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEeccccccee
Confidence            9999999999999999887654  6999999999999999999999987  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .............+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.....                .+
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----------------~~  221 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----------------QK  221 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HH
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH----------------HH
Confidence            75544333445578999999999999999999999999999999999999999876532110                01


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV  389 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  389 (429)
                      +....  ..++...+.++.+|+.+||+.||++|||++|++
T Consensus       222 i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         222 IIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             HHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             HHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            11111  123445677899999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-55  Score=413.54  Aligned_cols=255  Identities=24%  Similarity=0.312  Sum_probs=195.1

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      +.+.|++.+.||+|+||+||+|.+..++      ..||+|++...........+.+|+.+|++++|||||++++++.+++
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQ------KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG   80 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTC------CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCC------CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            3467999999999999999999876553      3499999987654444566789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc---CCCcEEEeccCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD---TDYNAKLSDFGL  266 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgl  266 (429)
                      .+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||+.   +++.+||+|||+
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccce
Confidence            9999999999999999997654  6999999999999999999999977  99999999999994   578999999999


Q ss_pred             CcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      |+......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........   ..   ...    
T Consensus       157 a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~---i~~----  223 (307)
T d1a06a_         157 SKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQ---ILK----  223 (307)
T ss_dssp             -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HH---HHT----
T ss_pred             eEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HH---Hhc----
Confidence            98654322   234468999999999999999999999999999999999999999865432110   00   000    


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          .............+.++.+|+.+||+.||++|||++|+++|
T Consensus       224 ----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         224 ----AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ----TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                01111222334567889999999999999999999999987

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=409.32  Aligned_cols=253  Identities=27%  Similarity=0.384  Sum_probs=207.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      +.|++.+.||+|+||.||+|.+..++      ..||+|++.... ....+.|.+|+++|++++|||||++++++.+++..
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~   84 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETS------VLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL   84 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCC------eEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeE
Confidence            46899999999999999999876654      349999987653 34456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++.... .++++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+...
T Consensus        85 ~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          85 WILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccC
Confidence            99999999999999876543 36999999999999999999999987  9999999999999999999999999997643


Q ss_pred             CCCCccccccccCCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ..  ........||+.|+|||++.     +..|+.++|||||||++|||+||+.||.........      ....     
T Consensus       162 ~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~i~-----  228 (288)
T d2jfla1         162 RT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIA-----  228 (288)
T ss_dssp             HH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHH-----
T ss_pred             CC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HHHH-----
Confidence            21  11233578999999999984     456899999999999999999999999866532210      0000     


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        ....+  ....+...+.++.+|+.+||+.||++|||++|+++|
T Consensus       229 --~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         229 --KSEPP--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             --HSCCC--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --cCCCC--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00001  112234567889999999999999999999999886

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-55  Score=399.80  Aligned_cols=254  Identities=22%  Similarity=0.380  Sum_probs=212.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      ++|++.+.||+|+||+||+|++.+       +..||||+++....  ...+|.+|+.++++++||||++++++|.+++.+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~   74 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   74 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETT-------TEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECC-------CCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence            689999999999999999998753       23499999886533  346799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+  |+||||||+|||+++++.+||+|||+++...
T Consensus        75 ~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          75 FIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             EEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             EEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheecc
Confidence            999999999999998765533 6899999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      .... .......||+.|+|||.+.+..|+.++|||||||++|||+| |+.||.........   .    .+      .  
T Consensus       152 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~---~----~i------~--  215 (258)
T d1k2pa_         152 DDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---E----HI------A--  215 (258)
T ss_dssp             SSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---H----HH------H--
T ss_pred             CCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH---H----HH------H--
Confidence            4332 22334679999999999999999999999999999999998 89999876532111   0    01      1  


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                        .......+..++.++.+|+.+||+.||++|||+++|+++|..+
T Consensus       216 --~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         216 --QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             --hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence              1112233445678899999999999999999999999998653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-55  Score=409.69  Aligned_cols=248  Identities=27%  Similarity=0.353  Sum_probs=204.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ..|+.++.||+|+||.||+|++..++      ..||||++....  .......+.+|+.+|++++|||||++++++.+++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNS------EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTT------EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCC------cEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence            35899999999999999999876654      349999987653  2344567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..|+|||||++|+|..++....  ++++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+.
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccc
Confidence            9999999999999876665543  6999999999999999999999987  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  346 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      ...      .....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.........               
T Consensus       165 ~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~---------------  223 (309)
T d1u5ra_         165 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------------  223 (309)
T ss_dssp             SSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---------------
T ss_pred             cCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH---------------
Confidence            533      234689999999999864   46899999999999999999999999865432110               


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       ..+.........+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       224 -~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         224 -YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence             00110111111223456789999999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=401.80  Aligned_cols=251  Identities=26%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             eeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeEEEEEE
Q 014189          118 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  196 (429)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  196 (429)
                      +.||+|+||+||+|.+...    .....||||++.... .....+.|.+|+.+|++++|||||+++++|.. +..++|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccC----CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence            5799999999999986432    124569999987543 33345679999999999999999999999865 45789999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCCc
Q 014189          197 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  276 (429)
Q Consensus       197 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  276 (429)
                      |+++|+|.+++....  .+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++........
T Consensus        88 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          88 MAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             CCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             cCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            999999999987654  6999999999999999999999977  999999999999999999999999999876543322


Q ss_pred             -cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCCC
Q 014189          277 -HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  354 (429)
Q Consensus       277 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (429)
                       .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||........   .              ..+...
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~--------------~~i~~~  226 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---T--------------AMLEKG  226 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H--------------HHHHTT
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---H--------------HHHHcC
Confidence             22334679999999999999999999999999999999998 8999987653211   1              011111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccc
Q 014189          355 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  394 (429)
Q Consensus       355 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  394 (429)
                      .....+..++.++.+|+.+||+.||++|||+++|++.|+.
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            2233445677889999999999999999999999988764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-53  Score=409.41  Aligned_cols=254  Identities=22%  Similarity=0.256  Sum_probs=210.8

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..++      ..||+|++... .....+.+.+|+.+|++++|||||++++++.+++.
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g------~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATG------NNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTT------EEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCC------CEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            468999999999999999999876553      44999999765 34456678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC--CCcEEEeccCCCc
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--DYNAKLSDFGLAK  268 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~  268 (429)
                      +|+|||||++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.  ++.+||+|||+++
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~  174 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA  174 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhe
Confidence            999999999999999986543 36999999999999999999999988  999999999999964  6789999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.....      .....      
T Consensus       175 ~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~------  239 (350)
T d1koaa2         175 HLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------RNVKS------  239 (350)
T ss_dssp             ECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH------
T ss_pred             eccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH------HHHHh------
Confidence            765432   234578999999999999999999999999999999999999999865432111      00000      


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .............+.++.+|+.+||+.||++|||++|+++|
T Consensus       240 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         240 --CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --TCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              01111111223457789999999999999999999999997

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=403.40  Aligned_cols=261  Identities=24%  Similarity=0.358  Sum_probs=205.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|++..+..   ....||+|.+...........|.+|+.++++++|||||++++++. ++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCc---eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            4679999999999999999998765432   245689999877666667788999999999999999999999986 567


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+|+..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheec
Confidence            899999999999999876553 36899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ..... .......||+.|+|||++.+..|+.++|||||||++|||+| |.+||........   ..             .
T Consensus       159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~-------------~  221 (273)
T d1mp8a_         159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG-------------R  221 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH-------------H
T ss_pred             cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HH-------------H
Confidence            54322 22344678999999999999999999999999999999998 8999987654221   10             0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      +.. ......+..++..+.+|+.+||+.||++|||++||+++|+.+.
T Consensus       222 i~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         222 IEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            001 1112345567788999999999999999999999999998764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-54  Score=407.14  Aligned_cols=269  Identities=26%  Similarity=0.342  Sum_probs=219.1

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      +...++|++.+.||+|+||+||+|++.... ....+..||||++...........|.+|+.+|++++||||+++++++..
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSS-TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCc-cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            334578999999999999999999875421 2233456999999877666667889999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKV----------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  245 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~D  245 (429)
                      .+..+++|||+++|+|.+++....                      ...+++..++.++.|++.||+|||+.+  |||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrD  165 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRD  165 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeE
Confidence            999999999999999999986432                      234889999999999999999999977  99999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCC
Q 014189          246 FKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR-KSLDK  324 (429)
Q Consensus       246 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~-~p~~~  324 (429)
                      |||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..|+.++|||||||++|||++|. +||..
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999999998654433333445578999999999999999999999999999999999986 56766


Q ss_pred             CChhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          325 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .......   .             .+.+.. ....+..++.++.+|+.+||+.||++||||.||++.|++++
T Consensus       246 ~~~~e~~---~-------------~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         246 MAHEEVI---Y-------------YVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             SCHHHHH---H-------------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCHHHHH---H-------------HHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            5432211   0             111111 12334566778999999999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=406.49  Aligned_cols=274  Identities=28%  Similarity=0.335  Sum_probs=211.4

Q ss_pred             hHHHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeee
Q 014189          104 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLI  182 (429)
Q Consensus       104 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  182 (429)
                      .+.+.+..++|++.+.||+|+||.||+|.+.... +...+..||||++...........+.+|..++.++ +|+||+.++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID-KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTT-SSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCC-cccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            3444455578999999999999999999876542 23445679999998776666777888899888877 689999999


Q ss_pred             eEEEeC-CeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCC
Q 014189          183 GYCCED-EHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFK  247 (429)
Q Consensus       183 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlk  247 (429)
                      +++... ..+++|||||++|+|.+++....              ...+++..+..++.|++.||+|||+++  |+|||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlK  161 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA  161 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCC
Confidence            988654 56899999999999999996542              235889999999999999999999977  9999999


Q ss_pred             CCcEEEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCC
Q 014189          248 TSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR-KSLDKSR  326 (429)
Q Consensus       248 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~-~p~~~~~  326 (429)
                      |+|||+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999998765544444445578999999999999999999999999999999999975 5776544


Q ss_pred             hhhhhhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          327 PAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      ....      ....+..          ......+..++.++.+|+.+||+.||++|||++||+++|+++.
T Consensus       242 ~~~~------~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         242 IDEE------FCRRLKE----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             CSHH------HHHHHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH------HHHHHhc----------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            3211      0111111          1112334456778999999999999999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=408.88  Aligned_cols=262  Identities=25%  Similarity=0.404  Sum_probs=209.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+|+++++||+|+||+||+|.+..+++.  ....||+|.+.........+.|.+|+.++++++|||||+++++|.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCE--EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            4699999999999999999987655432  23458999987765666678899999999999999999999999865 56


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      ++++||+.+|+|.+++.... ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+...
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            78899999999999887653 46999999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ............||+.|+|||++.++.|+.++|||||||++|||+| |.+||.........                 ..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-----------------~~  225 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------------SI  225 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-----------------HH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-----------------HH
Confidence            5444333445679999999999999999999999999999999998 78898765432211                 01


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      +........+..++..+.+|+.+||+.||++|||+.||+++|+.+.
T Consensus       226 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            1111122334567788999999999999999999999999997764

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=402.61  Aligned_cols=259  Identities=25%  Similarity=0.363  Sum_probs=205.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|++.++.       .||||++.....  ..+.|.+|+.++++++|||||++++++.+ +.
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~-------~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~   85 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP   85 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTE-------EEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCC-------EEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence            467999999999999999999876542       399999876533  44679999999999999999999999854 56


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++||||+++|+|..++.......++|.+++.++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++..
T Consensus        86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhc
Confidence            789999999999999887655557999999999999999999999987  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  350 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (429)
                      ..... .......||+.|+|||++..+.++.++|||||||++|||+||..|+.......+  ....              
T Consensus       164 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~--------------  226 (285)
T d1fmka3         164 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ--------------  226 (285)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH--------------
T ss_pred             cCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHH--------------
Confidence            54322 233446799999999999999999999999999999999997665543322111  1110              


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          351 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       351 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      +........+..++.++.+|+.+||+.||++|||+++|++.|+.....
T Consensus       227 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         227 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            111122234556678899999999999999999999999999886654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.1e-53  Score=407.57  Aligned_cols=254  Identities=20%  Similarity=0.261  Sum_probs=211.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      .++|++.+.||+|+||.||+|.+..++      ..||+|++.... ......+.+|+.+|++++|||||+++++|.+++.
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~------~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATG------RVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCC------CEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            357999999999999999999876554      349999987653 3445678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc--CCCcEEEeccCCCc
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD--TDYNAKLSDFGLAK  268 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~  268 (429)
                      +|+|||||++|+|.+++.... .++++..+..++.|++.||+|||+++  |+||||||+|||++  .++.+||+|||+|+
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~  177 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLAT  177 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccce
Confidence            999999999999998776543 36999999999999999999999987  99999999999998  67899999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......   ......||+.|+|||++.+..|+.++|||||||++|||+||+.||..........      ...       
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~i~-------  241 (352)
T d1koba_         178 KLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------NVK-------  241 (352)
T ss_dssp             ECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHH-------
T ss_pred             ecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-------
Confidence            765432   2345689999999999999999999999999999999999999998765432110      000       


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                       ..+...........+.++.+|+.+||+.||.+|||++|+++|
T Consensus       242 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         242 -RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             011112222334567889999999999999999999999987

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=400.47  Aligned_cols=255  Identities=23%  Similarity=0.289  Sum_probs=209.3

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-----ChhhHHHHHHHHHHHhccCCCceeeeeeE
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-----SYQGHREWLAEVIFLGHLSHPNLVKLIGY  184 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~  184 (429)
                      +.++|++.+.||+|+||+||+|.+..++      ..||+|++....     .....+.|.+|+.+|++++|||||+++++
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~------~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   81 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTG------LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   81 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCC------CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            3467999999999999999999876554      349999986432     22345778899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC----cEE
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAK  260 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~----~~k  260 (429)
                      +.+++.+|+|||||++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++    .+|
T Consensus        82 ~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          82 YENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceE
Confidence            999999999999999999999987654  6999999999999999999999987  99999999999998877    499


Q ss_pred             EeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          261 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      |+|||+|.......   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.......      .
T Consensus       158 l~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i  228 (293)
T d1jksa_         158 IIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN------V  228 (293)
T ss_dssp             ECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------H
T ss_pred             ecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH------H
Confidence            99999998765432   23446899999999999999999999999999999999999999986553221100      0


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .       . .........+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       229 ~-------~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         229 S-------A-VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             H-------T-TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             H-------h-cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0       0 00000111112456788999999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=402.78  Aligned_cols=250  Identities=24%  Similarity=0.303  Sum_probs=210.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++++.||+|+||.||+|++..++      ..||+|++.+..  .......+.+|+.+|++++||||+++++++.+++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~------~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   78 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATG------RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCC------CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence            57999999999999999999876654      349999987532  1223466789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||+|+.
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccc
Confidence            9999999999999999987654  6899999999999999999999987  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      .....  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.....      ..          
T Consensus       155 ~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~------~~----------  216 (337)
T d1o6la_         155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------EL----------  216 (337)
T ss_dssp             SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH----------
T ss_pred             cccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH------HH----------
Confidence            54322  2234578999999999999999999999999999999999999999876542211      00          


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                      +...  ...++...+.++.+|+.+||+.||++||+     ++|+++|
T Consensus       217 i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         217 ILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HhcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            0000  11234456788999999999999999995     8899886

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=399.00  Aligned_cols=267  Identities=25%  Similarity=0.381  Sum_probs=217.3

Q ss_pred             hcCCccceeecCCCcEEEEEEEEcccccc-CcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  188 (429)
                      .++|++.+.||+|+||.||+|+.....+. ......||||++..+.......++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            46899999999999999999987654332 2345679999998877777778899999999888 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  254 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~  254 (429)
                      +..++||||+++|+|.+++..+.              ...+++.+++.++.|++.||+|||+.+  ||||||||+|||++
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~  169 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT  169 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeec
Confidence            99999999999999999996543              245899999999999999999999987  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 014189          255 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNL  333 (429)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~  333 (429)
                      .++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+||........   
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~---  246 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---  246 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH---
Confidence            999999999999987655444444455789999999999999999999999999999999998 7888876543211   


Q ss_pred             HHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          334 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                      .              ..+........+..++..+.+|+.+||+.||++|||+.||++.|+++.
T Consensus       247 ~--------------~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         247 F--------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             H--------------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--------------HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            0              111112223334456778999999999999999999999999998874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=393.27  Aligned_cols=252  Identities=26%  Similarity=0.395  Sum_probs=202.2

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-CC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-DE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  189 (429)
                      .++|++.+.||+|+||.||+|.+++        ..||||+++.+.   ..+.|.+|++++++++||||+++++++.+ .+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT--------EEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             HHHeEEeEEEecCCCeEEEEEEECC--------eEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            3578889999999999999998743        239999997543   34578899999999999999999999854 56


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+++||||+++|+|.+++..+....+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeeccccccee
Confidence            7899999999999999997654446899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ....     .....+|..|+|||++.+..++.++|||||||++|||+| |++||.......   ...             
T Consensus       153 ~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~-------------  211 (262)
T d1byga_         153 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP-------------  211 (262)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH-------------
T ss_pred             cCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHH-------------
Confidence            5432     233568999999999999999999999999999999998 688887554321   111             


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                       .+........+...+.++.+|+.+||+.||++|||+.+++++|+.+++
T Consensus       212 -~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         212 -RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             -HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence             111122334455667889999999999999999999999999988764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=393.22  Aligned_cols=261  Identities=26%  Similarity=0.355  Sum_probs=203.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      .+|++.+.||+|+||.||+|.+.....   ....||||++....  .....+.|.+|+.+|++++|||||++++++.+ .
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~---~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCC---cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            579999999999999999998654322   24458999987543  33445689999999999999999999999975 4


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+++|+|.+++..+. ..+++..++.++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhh
Confidence            6789999999999998886543 36999999999999999999999977  99999999999999999999999999997


Q ss_pred             CCCCCCcc-ccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhhhhHHHhHhhHHHhhhhh
Q 014189          270 GPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  347 (429)
Q Consensus       270 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (429)
                      ........ ......||..|+|||.+.+..++.++|||||||++|||+| |+.||...+....                .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----------------~  224 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----------------L  224 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------H
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH----------------H
Confidence            65543322 2233568889999999999999999999999999999998 8999986653321                1


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccc
Q 014189          348 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  395 (429)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  395 (429)
                      ..+.........+..++..+.+|+.+||+.||++|||+++|++.|+..
T Consensus       225 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111111222333456678899999999999999999999999988764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=398.74  Aligned_cols=269  Identities=26%  Similarity=0.371  Sum_probs=221.4

Q ss_pred             HHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 014189          109 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  187 (429)
Q Consensus       109 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  187 (429)
                      ...++|++.++||+|+||.||+|++....+ ...+..||||++...........|.+|+.+++++ +|||||++++++.+
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEecccc-CCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            345789999999999999999998754322 2446679999998877777777899999999999 69999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcE
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKV----------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  251 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NI  251 (429)
                      .+..++||||+++|+|.+++....                ...+++..+..++.|++.||+|||+++  ++||||||+||
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NI  176 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI  176 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccccc
Confidence            999999999999999999986542                235889999999999999999999977  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCChhhh
Q 014189          252 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE  330 (429)
Q Consensus       252 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-G~~p~~~~~~~~~  330 (429)
                      |++.++.+|++|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||........
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999998765544444556789999999999999999999999999999999999 5555655433211


Q ss_pred             hhHHHhHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhccccc
Q 014189          331 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  396 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  396 (429)
                                      +.+++........+...+..+.+|+.+||+.||++|||+++|++.|+++.
T Consensus       257 ----------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         257 ----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             ----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence                            01111111222333456788999999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-52  Score=396.94  Aligned_cols=247  Identities=25%  Similarity=0.362  Sum_probs=207.8

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++.+.||+|+||+||+|.+..++      ..||+|++....  .....+.+.+|+.+|++++|||||++++++.+++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g------~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNG------RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCC------CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            57999999999999999999876554      349999986432  1233467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      .+|+||||++||+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.+|.+||+|||+|+.
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceE
Confidence            9999999999999999887665  5788899999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ....     ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+.....                ..
T Consensus       154 ~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----------------~~  212 (316)
T d1fota_         154 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY----------------EK  212 (316)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HH
T ss_pred             eccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH----------------HH
Confidence            6432     33478999999999999999999999999999999999999999876532211                01


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      +...  ....+...+.++.+++.+||..||.+||     |++++++|
T Consensus       213 i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         213 ILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHcC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            1111  1123345667899999999999999996     99999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-53  Score=397.90  Aligned_cols=261  Identities=26%  Similarity=0.344  Sum_probs=210.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.++||+|+||.||+|++..++.    ...||||.+.........+.|.+|+++|+++ +|||||++++++.+++.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTE----EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCe----EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            578899999999999999998865433    2348888887655555667899999999998 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC
Q 014189          191 RVLIYEFMARGSVENNLFSK--------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~  256 (429)
                      +++||||+++|+|.++++..              ....+++..+..++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC
Confidence            99999999999999998654              2356999999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCCCChhhhhhHHH
Q 014189          257 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK-SLDKSRPAREQNLAD  335 (429)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~-p~~~~~~~~~~~~~~  335 (429)
                      +.+||+|||+++......   ......||..|+|||.+.+..|+.++|||||||++|||++|.. ||...+....   . 
T Consensus       164 ~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~-  236 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y-  236 (309)
T ss_dssp             GCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-
T ss_pred             CceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---H-
Confidence            999999999998654322   1233568999999999999999999999999999999999765 6765442211   1 


Q ss_pred             hHhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          336 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                                   ..+........+..++.++.+|+.+||+.||++||||+||+++|+++...
T Consensus       237 -------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         237 -------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             -------------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -------------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                         01111122334456778999999999999999999999999999987653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.9e-52  Score=389.30  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=206.2

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      +.++|++.+.||+|+||.||+|.+..++      ..||+|++....  .......|.+|+.+++.++|||||++++++..
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~   78 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLH------RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   78 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCC------CEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence            3567999999999999999999876554      349999997643  33445678999999999999999999999876


Q ss_pred             CC----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          188 DE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       188 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                      .+    ..|+||||++||+|.+++....  ++++.++..++.|++.||+|||+++  |+||||||+|||++.++.++|+|
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECC
T ss_pred             ccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeeh
Confidence            54    4799999999999999886654  6999999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCC-ccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          264 FGLAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       264 fgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      ||.+........ .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+....      ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~  228 (277)
T d1o6ya_         155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVR  228 (277)
T ss_dssp             CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHH
T ss_pred             hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHh
Confidence            999875543221 1223446899999999999999999999999999999999999999987653221      011111


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-CHHHHHHhcccccC
Q 014189          343 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-LMRDIVDSLEPLQV  397 (429)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~  397 (429)
                      .        ++..........+..+.+|+.+||+.||++|| |++++++.|.+++.
T Consensus       229 ~--------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         229 E--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             C--------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             c--------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            1        11111112234567899999999999999999 89999998887653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=395.83  Aligned_cols=270  Identities=27%  Similarity=0.401  Sum_probs=220.8

Q ss_pred             HHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 014189          108 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  187 (429)
Q Consensus       108 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  187 (429)
                      .+..++|++.+.||+|+||+||+|.+..... ......||||+++..........|.+|+.++++++|||||++++++..
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEET-TEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCccc-CCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3445789999999999999999998754321 122356999999877666677789999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcE
Q 014189          188 DEHRVLIYEFMARGSVENNLFSK--------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  259 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~  259 (429)
                      ++..++||||+++|+|.+++...        ....+++..+..++.|++.||.|||+.+  |+||||||+|||++.++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceE
Confidence            99999999999999999988532        2345789999999999999999999977  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCChhhhhhHHHhHh
Q 014189          260 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR-KSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~-~p~~~~~~~~~~~~~~~~~  338 (429)
                      ||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. +||.........       
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~-------  245 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-------  245 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence            999999998765443333445567999999999999999999999999999999999985 677655432111       


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                               ..+.+.. ....+..++..+.+|+.+||+.||++|||+++|+++|++...
T Consensus       246 ---------~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 ---------RFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ---------HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---------HHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                     1111111 122344567889999999999999999999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.3e-52  Score=383.78  Aligned_cols=253  Identities=25%  Similarity=0.312  Sum_probs=208.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh--------hhHHHHHHHHHHHhccC-CCceeeee
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--------QGHREWLAEVIFLGHLS-HPNLVKLI  182 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-h~niv~l~  182 (429)
                      ++|++.+.||+|+||+||+|++..+.      ..||||++......        .....+.+|+.++++++ ||||++++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~------~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~   76 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTC------KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   76 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCC------CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            68999999999999999999876553      44999998764321        12345789999999997 99999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          183 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       183 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      +++.+++.+|+||||+++|+|.+++..+.  ++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~  152 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLT  152 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEEC
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEc
Confidence            99999999999999999999999997654  6999999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHh
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  336 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~  336 (429)
                      |||+++......   ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||..........    
T Consensus       153 DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~----  225 (277)
T d1phka_         153 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR----  225 (277)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----
T ss_pred             cchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH----
Confidence            999998765432   2344689999999999863      357889999999999999999999998765322110    


Q ss_pred             HhhHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          337 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                        .....        ............+.++.+|+.+||+.||++|||++|+++|
T Consensus       226 --~i~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         226 --MIMSG--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             --HHHHT--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             --HHHhC--------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              00000        1111222234677899999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-52  Score=391.25  Aligned_cols=260  Identities=25%  Similarity=0.410  Sum_probs=209.0

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-CCeEEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-DEHRVLIY  195 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  195 (429)
                      .++||+|+||+||+|++..+..   +...||||.+...........|.+|+++|++++|||||+++|++.+ ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            4789999999999998765432   2456899999876667777889999999999999999999999875 56889999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCCCCCC
Q 014189          196 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  275 (429)
Q Consensus       196 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  275 (429)
                      |||++|+|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||+++++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999999886553 35788999999999999999999977  99999999999999999999999999987654322


Q ss_pred             c--cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhhhcCC
Q 014189          276 S--HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  353 (429)
Q Consensus       276 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (429)
                      .  .......||+.|+|||.+.+..++.++||||||+++|||+||..||.......  +...+.          ..    
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i----------~~----  249 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----------LQ----  249 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----------HT----
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH----------Hc----
Confidence            1  12234578999999999999999999999999999999999888876433211  111110          00    


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCC
Q 014189          354 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  398 (429)
Q Consensus       354 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  398 (429)
                      ......+..++..+.+|+.+||+.||++|||++||+++|+++...
T Consensus       250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            111223445677899999999999999999999999999988653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-52  Score=396.16  Aligned_cols=247  Identities=23%  Similarity=0.287  Sum_probs=207.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  189 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  189 (429)
                      ++|++++.||+|+||.||+|.+..+++      .||+|++....  .......+.+|+.+|+.++|||||++++++.+.+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~------~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGN------HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCC------EEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            579999999999999999998766543      49999986431  1233456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  269 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  269 (429)
                      ..++||||+.+|+|..++....  .+++..+..++.|++.||.|||+++  ||||||||+|||++.++.+||+|||+|+.
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            9999999999999999987654  6899999999999999999999987  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhhh
Q 014189          270 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  349 (429)
Q Consensus       270 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (429)
                      ....     .....||+.|+|||++.+..|+.++|||||||++|||+||+.||...+.....      .          .
T Consensus       191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~----------~  249 (350)
T d1rdqe_         191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY------E----------K  249 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------H----------H
T ss_pred             cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH------H----------H
Confidence            6432     23468999999999999999999999999999999999999999865432110      0          0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          350 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       350 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                      +....  ...+...+.++.+|+.+||+.||.+|+     |++++++|
T Consensus       250 i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         250 IVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            11001  122345677899999999999999994     89999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=394.84  Aligned_cols=252  Identities=19%  Similarity=0.229  Sum_probs=201.3

Q ss_pred             hcCCccce-eecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCceeeeeeEEEe-
Q 014189          111 TANFRQDR-VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE-  187 (429)
Q Consensus       111 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  187 (429)
                      .++|.+.. .||+|+||.||+|.+..+.+      .||||++...      ..+.+|+.++.++ +|||||+++++|.+ 
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~------~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQE------KFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCC------EEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            46898875 69999999999998765543      4999998643      2455799887655 79999999999875 


Q ss_pred             ---CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCcEEE
Q 014189          188 ---DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKL  261 (429)
Q Consensus       188 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl  261 (429)
                         +..+|+|||||+||+|.+++..+....+++.++..++.|++.||+|||+.+  |+||||||+|||++.   ++.+||
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEE
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccc
Confidence               467899999999999999998766667999999999999999999999987  999999999999985   567999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHH
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  341 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~  341 (429)
                      +|||+|+.......   ....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||..........         
T Consensus       156 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---------  223 (335)
T d2ozaa1         156 TDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---------  223 (335)
T ss_dssp             CCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------
T ss_pred             cccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---------
Confidence            99999987654332   344689999999999999999999999999999999999999997543221100         


Q ss_pred             HhhhhhhhhcCCCCCCC--CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          342 KEKKKLLNIIDPRLEGD--YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       342 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                         .....+........  .....+.++.+|+.+||+.||++|||++|+++|
T Consensus       224 ---~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         224 ---GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               00011111111111  113467889999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-52  Score=392.68  Aligned_cols=250  Identities=27%  Similarity=0.375  Sum_probs=205.9

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHHHHHHHHh-ccCCCceeeeeeEEEeC
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLG-HLSHPNLVKLIGYCCED  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~  188 (429)
                      ++|++.+.||+|+||+||+|++..++      ..||||++....  .......+..|..++. .++|||||++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~------~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTN------QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTT------EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCC------CEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            57999999999999999999877654      449999986431  1223455667777765 68999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      +..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhh
Confidence            99999999999999999997654  6899999999999999999999987  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......  ...+...||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+......      . +.      
T Consensus       152 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~-i~------  216 (320)
T d1xjda_         152 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH------S-IR------  216 (320)
T ss_dssp             CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HH------
T ss_pred             hccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH------H-HH------
Confidence            755432  22345689999999999999999999999999999999999999998765432110      0 00      


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHH-HHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR-DIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~  391 (429)
                       ...    ...+...+.++.+|+.+||..||++|||++ ++++|
T Consensus       217 -~~~----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         217 -MDN----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             -HCC----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -cCC----CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence             011    123345678899999999999999999996 78754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-51  Score=396.89  Aligned_cols=251  Identities=24%  Similarity=0.316  Sum_probs=202.3

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC--ChhhHHHHH---HHHHHHhccCCCceeeeeeEEE
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWL---AEVIFLGHLSHPNLVKLIGYCC  186 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~  186 (429)
                      ++|++.+.||+|+||.||+|++..+++      .||+|++....  .......+.   .|+.+++.++|||||++++++.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~------~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~   77 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGK------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH   77 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCC------EEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence            579999999999999999998766543      49999986421  111122233   4577788889999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          187 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       187 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                      +.+.+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeece
Confidence            9999999999999999999997654  6889999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          267 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       267 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      |+......    ....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||...........            
T Consensus       154 a~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------------  217 (364)
T d1omwa3         154 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI------------  217 (364)
T ss_dssp             CEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH------------
T ss_pred             eeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH------------
Confidence            98765432    334689999999999974 5689999999999999999999999986543211111            


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  391 (429)
                       ......  .....+...+.++.+|+.+||+.||++|||     ++|+++|
T Consensus       218 -~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         218 -DRMTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             -HHHSSS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             -HHhccc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence             001111  112234456788999999999999999999     6899876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-52  Score=391.82  Aligned_cols=253  Identities=18%  Similarity=0.216  Sum_probs=207.4

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      -++|++.+.||+|+||+||+|.+..+++      .||+|++....  .....+.+|+++|+.++|||||++++++.+++.
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~------~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   75 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKK------TYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCc------EEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            4679999999999999999998776543      49999997653  334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC--CcEEEeccCCCc
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAK  268 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~  268 (429)
                      +|+|||||+||+|.+++.... ..+++.++..++.|++.||+|||+++  |+||||||+|||++.+  +.+||+|||+++
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhh
Confidence            999999999999999986543 36899999999999999999999977  9999999999999854  479999999998


Q ss_pred             CCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhhhhh
Q 014189          269 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  348 (429)
Q Consensus       269 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (429)
                      ......   ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||...+.....      .......    
T Consensus       153 ~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~------~~i~~~~----  219 (321)
T d1tkia_         153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII------ENIMNAE----  219 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTC----
T ss_pred             ccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC----
Confidence            764432   234467999999999999999999999999999999999999999876532110      0001000    


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          349 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                          ...........+.++.+|+.+||..||++|||++|+++|
T Consensus       220 ----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         220 ----YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                000000112346788999999999999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-51  Score=382.86  Aligned_cols=269  Identities=24%  Similarity=0.309  Sum_probs=203.0

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||+||+|.+..++      ..||+|++..... ......+.+|+++|++++|||||++++++.+++.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTG------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCC------CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            58999999999999999999876554      3499999865432 2234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .|+||||+.+ ++..++.......+++..+..++.|++.||+|||+.+  ||||||||+|||++.++.+||+|||+|+..
T Consensus        76 ~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          76 LYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             eeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceec
Confidence            9999999975 5555565555567999999999999999999999977  999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHH-hHhhHHHhh-hhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD-WALPLLKEK-KKL  347 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~-~~~~~~~~~-~~~  347 (429)
                      ....  .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+......... ......... ...
T Consensus       153 ~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         153 GVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             CCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence            4322  2234468999999999987655 5889999999999999999999998765432111000 000000000 000


Q ss_pred             hhhcC--CCC----CCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          348 LNIID--PRL----EGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       348 ~~~~~--~~~----~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ....+  ...    ...   .....+.++.+|+.+||..||++|||++|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000  000    000   011345788999999999999999999999997

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=384.11  Aligned_cols=261  Identities=25%  Similarity=0.260  Sum_probs=196.1

Q ss_pred             cceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChh----hHHHHHHHHHHHhccCCCceeeeeeEEEeCCeE
Q 014189          116 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ----GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  191 (429)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  191 (429)
                      .+++||+|+||+||+|.+..++      ..||||++.......    ....+.+|+.+|++++|||||++++++.+++.+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~   75 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTN------QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   75 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCC------SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             cceEeccCcCeEEEEEEECCCC------cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence            3589999999999999876543      449999987543221    124578999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCCC
Q 014189          192 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  271 (429)
Q Consensus       192 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  271 (429)
                      |+||||+.++++......  ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        76 ~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             eehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccC
Confidence            999999998877665533  336888899999999999999999987  9999999999999999999999999998765


Q ss_pred             CCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH----hhh-
Q 014189          272 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK----EKK-  345 (429)
Q Consensus       272 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~----~~~-  345 (429)
                      ....  .....+||+.|+|||++.+ ..|+.++|||||||++|||+||.+||...........   +.....    ... 
T Consensus       152 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~---i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         152 SPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWP  226 (299)
T ss_dssp             SCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSS
T ss_pred             CCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH---HHHhcCCCChhhcc
Confidence            4322  2334689999999999875 4689999999999999999999999987654322111   000000    000 


Q ss_pred             hhhhhcCCCC---CCCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          346 KLLNIIDPRL---EGDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~---~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ..........   ....+     ...+.++.+|+.+||+.||++|||++|+++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            0000000000   00001     1345789999999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-51  Score=383.25  Aligned_cols=271  Identities=24%  Similarity=0.329  Sum_probs=198.7

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHH--HHHHHHhccCCCceeeeeeEEEeC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL--AEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      ..+|.+.+.||+|+||.||+|++.        +..||||++...    ....+.  .|+..+.+++|||||++++++.++
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~--------g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~   69 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKD   69 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--------TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeC
Confidence            356788899999999999999863        234999998643    223333  455555678999999999999765


Q ss_pred             C----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceeCCCCCCcEEEcCCCc
Q 014189          189 E----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA------EKPVIYRDFKTSNILLDTDYN  258 (429)
Q Consensus       189 ~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivH~Dlkp~NIll~~~~~  258 (429)
                      +    .+++||||+++|+|.+++.+.   +++|..++.++.|++.||+|+|+.      .++|+||||||+||||+.++.
T Consensus        70 ~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~  146 (303)
T d1vjya_          70 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             CCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence            4    689999999999999999765   589999999999999999999974      245999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCc--cccccccCCcccccccccccCC------CCcccchhhHHHHHHHHHhCCCCCCCCChhhh
Q 014189          259 AKLSDFGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMTGH------LTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  330 (429)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltG~~p~~~~~~~~~  330 (429)
                      +||+|||+++........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..||........
T Consensus       147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            999999999876443221  1233468999999999987542      67899999999999999999988754322110


Q ss_pred             ----hhHHHhHhhHHHhhhhhhhhcCCCCCCCC-ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccC
Q 014189          331 ----QNLADWALPLLKEKKKLLNIIDPRLEGDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  397 (429)
Q Consensus       331 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  397 (429)
                          ............ .........+.+.... ..+....+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       227 ~~~~~~~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         227 PYYDLVPSDPSVEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTTTSCSSCCHHHHH-HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhcccccchHHHHH-HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence                000000000000 0001111122221111 23456779999999999999999999999999987653

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=379.13  Aligned_cols=243  Identities=24%  Similarity=0.398  Sum_probs=197.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCCh-----hhHHHHHHHHHHHhccC--CCceeeeee
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLS--HPNLVKLIG  183 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~  183 (429)
                      .++|++.+.||+|+||+||+|++..++      ..||||++......     .....+.+|+.+|++++  |||||++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~   76 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDN------LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD   76 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCC------CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence            468999999999999999999876654      34999998643211     11223567999999986  899999999


Q ss_pred             EEEeCCeEEEEEEecCC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCC-CcEEE
Q 014189          184 YCCEDEHRVLIYEFMAR-GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKL  261 (429)
Q Consensus       184 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl  261 (429)
                      ++.+++..++||||+.+ +++.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.+ +.+||
T Consensus        77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          77 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEE
T ss_pred             EEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEE
Confidence            99999999999999976 57777775543  6999999999999999999999977  9999999999999854 79999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  340 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~  340 (429)
                      +|||+|+.....    ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....            .
T Consensus       153 ~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i  216 (273)
T d1xwsa_         153 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------I  216 (273)
T ss_dssp             CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H
T ss_pred             Cccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------H
Confidence            999999865432    2345789999999999987765 6789999999999999999999974211            0


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...            ....+...+.++.+|+.+||+.||++|||++|++++
T Consensus       217 ~~~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         217 IRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             HHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhc------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            000            011233456789999999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-50  Score=376.29  Aligned_cols=274  Identities=23%  Similarity=0.285  Sum_probs=201.4

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhcc---CCCceeeeeeEEE
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHL---SHPNLVKLIGYCC  186 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~  186 (429)
                      .++|++++.||+|+||+||+|.+..+.     +..||||++..... ......+.+|+.+|+.+   +||||++++++|.
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNG-----GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTT-----TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCC-----CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            468999999999999999999875432     34589999864321 11222355677777665   7999999999985


Q ss_pred             e-----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEE
Q 014189          187 E-----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  261 (429)
Q Consensus       187 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  261 (429)
                      .     ....+++|||+++|++.... ......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEE
T ss_pred             ccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeee
Confidence            3     34789999999887665433 334456899999999999999999999987  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhH-
Q 014189          262 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL-  340 (429)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-  340 (429)
                      +|||+++.....   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.............. 
T Consensus       158 ~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         158 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            999998865432   2345578999999999999999999999999999999999999999876543221111000000 


Q ss_pred             HHhhh----hhh-hhc---CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccc
Q 014189          341 LKEKK----KLL-NII---DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPL  395 (429)
Q Consensus       341 ~~~~~----~~~-~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~  395 (429)
                      .....    ... ...   ............+..+.+|+.+||+.||++|||++|+++|  |+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            00000    000 000   0000011223456788999999999999999999999987  5444

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-49  Score=376.96  Aligned_cols=277  Identities=23%  Similarity=0.294  Sum_probs=201.6

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||+||+|.+..++      ..||||++.... .......+.+|+.+|++++|||||+++++|...
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTG------AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTC------CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCC------CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            3578999999999999999999876553      449999997643 344556788999999999999999999999765


Q ss_pred             C------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          189 E------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       189 ~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                      +      .+|+||||+ +++|...+...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+|++
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred             ccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccc
Confidence            4      579999999 55677665443   5999999999999999999999988  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh--
Q 014189          263 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--  339 (429)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--  339 (429)
                      |||+|+.....     .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.............  
T Consensus       164 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  238 (346)
T d1cm8a_         164 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  238 (346)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence            99999875432     244689999999999876 4578999999999999999999999987654322111100000  


Q ss_pred             ---HH-----HhhhhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCCCCCCC
Q 014189          340 ---LL-----KEKKKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVLPDEAP  403 (429)
Q Consensus       340 ---~~-----~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~  403 (429)
                         ..     ...............   .......+..+.+|+.+||..||++|||++|+++|  |+.+....+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~  315 (346)
T d1cm8a_         239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ  315 (346)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C
T ss_pred             cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccccc
Confidence               00     000000111111100   11123456788999999999999999999999997  666654433333

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.6e-49  Score=369.76  Aligned_cols=266  Identities=21%  Similarity=0.253  Sum_probs=200.4

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++.+.||+|+||+||+|.+..       +..||||++..... ......+.+|+.+|++++|||||++++++..++.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNY-------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETT-------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeCC-------CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            579999999999999999998643       23499999876532 2234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .+++|||+.++.+.......  ..+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|||++...
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceec
Confidence            99999999877666554433  46999999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh-----HHHhh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-----LLKEK  344 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~-----~~~~~  344 (429)
                      ....  .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.............     .....
T Consensus       151 ~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         151 GIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence            4322  123345789999999998754 569999999999999999999999987654322111000000     00000


Q ss_pred             hhhhhhcCCCC-------CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          345 KKLLNIIDPRL-------EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       345 ~~~~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ...... +...       ........+..+.+|+.+||+.||++|||++|+++|
T Consensus       229 ~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         229 TELPKY-DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             GGSTTC-CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhc-ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000 0000       011123356789999999999999999999999975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-49  Score=376.34  Aligned_cols=277  Identities=22%  Similarity=0.261  Sum_probs=205.5

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCC-
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  189 (429)
                      +.+|++++.||+|+||+||+|++..++      ..||||++...........+++|+.+|++++||||+++++++.... 
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNK------VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTC------SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCC------cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            467999999999999999999876554      3499999987666666778899999999999999999999986543 


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 014189          190 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  266 (429)
Q Consensus       190 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  266 (429)
                         ..+++++|+.+|+|.+++...   .+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCc
Confidence               234455667799999998754   5899999999999999999999987  99999999999999999999999999


Q ss_pred             CcCCCCCCCc-cccccccCCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH--
Q 014189          267 AKDGPEGDKS-HVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK--  342 (429)
Q Consensus       267 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~--  342 (429)
                      ++........ ......+||+.|+|||++. +..++.++||||+||++|||++|+.||....................  
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            9865433221 1234467999999999985 45679999999999999999999999987654322211111100000  


Q ss_pred             --------hhhhhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccCC
Q 014189          343 --------EKKKLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  398 (429)
Q Consensus       343 --------~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~  398 (429)
                              ................   .....+.++.+|+.+||+.||++|||++|+++|  |+.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                    0000000000000000   011345678999999999999999999999987  5544443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-48  Score=366.07  Aligned_cols=270  Identities=23%  Similarity=0.256  Sum_probs=196.5

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe---
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  187 (429)
                      ++|++.+.||+|+||+||+|++..++      ..||||++.... .......+.+|+.+|++++||||+++++++..   
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~   83 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTG------QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   83 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCC------CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence            68999999999999999999876554      349999986543 23344667899999999999999999998854   


Q ss_pred             -----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEe
Q 014189          188 -----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  262 (429)
Q Consensus       188 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  262 (429)
                           ++..++||||+.++.+.....  ....+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          84 PYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             -------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEEC
T ss_pred             cccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEee
Confidence                 456899999998876654433  3346899999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCc--cccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhh
Q 014189          263 DFGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  339 (429)
Q Consensus       263 Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~  339 (429)
                      |||+++........  ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.................
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999765532211  122346799999999998765 689999999999999999999999987654332211111100


Q ss_pred             HHHhhh-------hhhhhcCCCCCCCCCh-------HHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          340 LLKEKK-------KLLNIIDPRLEGDYPV-------KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       340 ~~~~~~-------~~~~~~~~~~~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      ......       ................       ..+..+.+|+.+||+.||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            000000       0000000000000000       124567889999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-48  Score=369.39  Aligned_cols=269  Identities=24%  Similarity=0.322  Sum_probs=198.6

Q ss_pred             CCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-----
Q 014189          113 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-----  187 (429)
Q Consensus       113 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  187 (429)
                      +|+..++||+|+||+||+|++..++      ..||||++..+...     +.+|+++|++++||||++++++|..     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSG------ELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCC------CEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence            6888899999999999999876654      34999998765422     2369999999999999999999853     


Q ss_pred             -CCeEEEEEEecCCCChhhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-cEEEecc
Q 014189          188 -DEHRVLIYEFMARGSVENNLF-SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDF  264 (429)
Q Consensus       188 -~~~~~lv~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df  264 (429)
                       ..++++||||+++|.+..... ......+++..+..++.|++.||+|||+++  |+||||||+|||++.++ .+||+||
T Consensus        90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCC
T ss_pred             CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecc
Confidence             235789999998764433322 223447999999999999999999999977  99999999999999775 8999999


Q ss_pred             CCCcCCCCCCCccccccccCCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh-----
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL-----  338 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~-----  338 (429)
                      |+++.......   .....||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||................     
T Consensus       168 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~  244 (350)
T d1q5ka_         168 GSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  244 (350)
T ss_dssp             TTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence            99987654332   334689999999998875 578999999999999999999999998765432211110000     


Q ss_pred             hHHHhh-hhhhhhcCCCC-----CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccC
Q 014189          339 PLLKEK-KKLLNIIDPRL-----EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQV  397 (429)
Q Consensus       339 ~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~  397 (429)
                      ..+... .......-+..     ........+.++.+|+.+||..||++|||++|+++|  |+.+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            000000 00000000000     001122456789999999999999999999999986  555544

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-47  Score=359.66  Aligned_cols=278  Identities=17%  Similarity=0.137  Sum_probs=204.6

Q ss_pred             hcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-eeeeeEEEeCC
Q 014189          111 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDE  189 (429)
Q Consensus       111 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~  189 (429)
                      .++|++.+.||+|+||.||+|++..++      ..||||++......   .++..|+++++.++|+|+ +.+.+++.+.+
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~------~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~   76 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAG------EEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   76 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTT------EEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCC------CEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence            467999999999999999999876553      34999998765332   246689999999987664 55566667888


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC---CCcEEEeccCC
Q 014189          190 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGL  266 (429)
Q Consensus       190 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl  266 (429)
                      ..++||||+ +|+|...+.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.   +..+||+|||+
T Consensus        77 ~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~  152 (299)
T d1ckia_          77 YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  152 (299)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred             EEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCc
Confidence            999999999 456666655433 36999999999999999999999987  999999999999864   55799999999


Q ss_pred             CcCCCCCCCc-----cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH-HhHhhH
Q 014189          267 AKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWALPL  340 (429)
Q Consensus       267 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~-~~~~~~  340 (429)
                      |+........     .......||+.|+|||++.+..++.++|||||||++|||+||+.||............ ......
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ckia_         153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  232 (299)
T ss_dssp             CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred             ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc
Confidence            9876543221     1233468999999999999999999999999999999999999999865533221111 110000


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCCCCCcccccc
Q 014189          341 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVV  412 (429)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~~~~  412 (429)
                      ..  .....         ....++.++.+++.+||+.+|++||++.++.+.|+.+.........-+++|...
T Consensus       233 ~~--~~~~~---------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~  293 (299)
T d1ckia_         233 MS--TPIEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML  293 (299)
T ss_dssp             HH--SCHHH---------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHG
T ss_pred             CC--CChhH---------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhh
Confidence            00  00000         012345778999999999999999999999888876543333333334555444

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.4e-47  Score=355.47  Aligned_cols=278  Identities=17%  Similarity=0.153  Sum_probs=211.4

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCC-CceeeeeeEEEeC
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCED  188 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~  188 (429)
                      +.++|++.+.||+|+||+||+|++..++      ..||+|++.......   .+.+|+++++.+.| +|++.+++++...
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~------~~vAvK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~~   73 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNN------QQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQEG   73 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTT------EEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCC------CEEEEEEEccccCcH---HHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence            3568999999999999999999876553      349999986653322   35578888888865 8999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcC-----CCcEEEec
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-----DYNAKLSD  263 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~-----~~~~kl~D  263 (429)
                      ...++||||+ +|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.     ++.+||+|
T Consensus        74 ~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~D  149 (293)
T d1csna_          74 LHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVD  149 (293)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             CccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcc
Confidence            9999999999 689998886544 36899999999999999999999977  999999999999974     57899999


Q ss_pred             cCCCcCCCCCCCc-----cccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHh
Q 014189          264 FGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  338 (429)
Q Consensus       264 fgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~  338 (429)
                      ||+|+........     .......||+.|+|||++.+..++.++|||||||++|||+||..||................
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~  229 (293)
T d1csna_         150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  229 (293)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence            9999875432211     12334689999999999999999999999999999999999999998654332211111111


Q ss_pred             hHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHhcccccCCCCCCCCCCcccc
Q 014189          339 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVT  410 (429)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~p~~~~~  410 (429)
                      .. .......++         ...++.++.+++..|+..+|++||+++.+.+.|+.+.........-+++|.
T Consensus       230 ~~-~~~~~~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~  291 (293)
T d1csna_         230 EK-KQSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  291 (293)
T ss_dssp             HH-HHHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             hc-cCCCChHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence            00 000001111         112356788999999999999999999998888775443333333344553

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.5e-47  Score=360.40  Aligned_cols=260  Identities=17%  Similarity=0.231  Sum_probs=199.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeEEEe--C
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCE--D  188 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~  188 (429)
                      ++|+++++||+|+||+||+|++..+      +..||+|++....    ...+.+|+.+|+.++ ||||++++++|..  .
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~------~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITN------NEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTT------TEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCC------CCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence            5799999999999999999987654      3459999987542    356778999999995 9999999999974  4


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC-cEEEeccCCC
Q 014189          189 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLA  267 (429)
Q Consensus       189 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla  267 (429)
                      ..+++||||+.+|+|....     ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++ .+||+|||+|
T Consensus       105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a  177 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA  177 (328)
T ss_dssp             CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred             CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccc
Confidence            5789999999999987653     25899999999999999999999988  99999999999998655 6999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH--HhHhhHHHh-
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA--DWALPLLKE-  343 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~--~~~~~~~~~-  343 (429)
                      +.......   .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||............  ......... 
T Consensus       178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~  254 (328)
T d3bqca1         178 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  254 (328)
T ss_dssp             EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             eeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence            87654322   3446799999999998865 5799999999999999999999999866543221110  000000000 


Q ss_pred             ---------hhhhhhhcCCC--------CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          344 ---------KKKLLNIIDPR--------LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       344 ---------~~~~~~~~~~~--------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                               ...........        .........+.++.+|+.+||..||++|||++|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     00000011000        0111123456789999999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=355.01  Aligned_cols=268  Identities=22%  Similarity=0.254  Sum_probs=206.1

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  190 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  190 (429)
                      ++|++++.||+|+||+||+|++..++      ..||||+++... .......+.+|+.+|+.++||||+++++++.+...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETH------EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCC------cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            47999999999999999999876554      349999987554 33445778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCCcCC
Q 014189          191 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  270 (429)
Q Consensus       191 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  270 (429)
                      .++|++++.+++|..++...  ..+++..+..++.|++.||+|||.++  |+||||||+|||++.++.+||+|||.++..
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcc
Confidence            99999999999888776544  36899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCChhhhh-hHH-HhHhhHHHhh-hh
Q 014189          271 PEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ-NLA-DWALPLLKEK-KK  346 (429)
Q Consensus       271 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltG~~p~~~~~~~~~~-~~~-~~~~~~~~~~-~~  346 (429)
                      .....  ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||.......+. ... .......... ..
T Consensus       152 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             cCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence            54322  233356788999999988655 699999999999999999999997654432211 100 0000000000 00


Q ss_pred             hhhhcC---------CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          347 LLNIID---------PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       347 ~~~~~~---------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      .....+         ...........+..+.+|+.+||+.||++|||++|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000         000111223456789999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=363.77  Aligned_cols=258  Identities=26%  Similarity=0.310  Sum_probs=204.2

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC---ChhhHHHHHHHHHHHhccCC-CceeeeeeEEEe
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCE  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~  187 (429)
                      ++|++.+.||+|+||+||+|.....   ..++..||+|++....   .....+.+.+|+++|++++| |||+++++++.+
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISG---HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSS---TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECcc---CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            6799999999999999999976432   2235569999986432   12233456789999999976 899999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEeccCCC
Q 014189          188 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  267 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  267 (429)
                      ....+++|||+.+|+|.+++....  .+++..+..++.|++.||+|+|+.+  |+||||||+|||++.++.+||+|||++
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999999999987665  5778889999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCcccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHHhhh
Q 014189          268 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  345 (429)
Q Consensus       268 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
                      +....... .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........  ...       
T Consensus       177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~-------  246 (322)
T d1vzoa_         177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISR-------  246 (322)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHH-------
T ss_pred             hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHH-------
Confidence            87644322 223446899999999999754  468899999999999999999999976543211100  000       


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHh
Q 014189          346 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  391 (429)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  391 (429)
                         .....  ....+...+.++.+|+.+||..||++||     |++|+++|
T Consensus       247 ---~~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         247 ---RILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ---HHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ---hcccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence               00000  1123446778999999999999999999     48899876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=361.61  Aligned_cols=264  Identities=20%  Similarity=0.245  Sum_probs=192.7

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe---
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  187 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  187 (429)
                      ++|++.++||+|+||+||+|.+..++      ..||||++.... .......+.+|+.+|++++|||||+++++|..   
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLD------RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT   90 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTT------EEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCC------CEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence            67999999999999999999876553      459999997653 33445678899999999999999999999963   


Q ss_pred             ---CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEecc
Q 014189          188 ---DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  264 (429)
Q Consensus       188 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  264 (429)
                         ...+|+||||+.++. .+.+.    ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+|++||
T Consensus        91 ~~~~~~~~iv~Ey~~~~l-~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDANL-CQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             TTTCCEEEEEEECCSEEH-HHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC
T ss_pred             cccCceeEEEEeccchHH-HHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeech
Confidence               368899999997654 44443    25899999999999999999999987  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHH---------H
Q 014189          265 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA---------D  335 (429)
Q Consensus       265 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~---------~  335 (429)
                      |+++......   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+........         +
T Consensus       164 ~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             CC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             hhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence            9988654432   234467999999999999999999999999999999999999999866543221110         0


Q ss_pred             hHhhHHHhhh------------hhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh
Q 014189          336 WALPLLKEKK------------KLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  391 (429)
Q Consensus       336 ~~~~~~~~~~------------~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  391 (429)
                      +.........            .....+.......   .....+..+.+|+.+||..||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000000            0000010000000   112357789999999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-47  Score=362.35  Aligned_cols=272  Identities=22%  Similarity=0.300  Sum_probs=201.4

Q ss_pred             HhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCceeeeeeEEEe-
Q 014189          110 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-  187 (429)
Q Consensus       110 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  187 (429)
                      ++++|++++.||+|+||+||+|++..++      ..||||++.... .......+.+|+.+|++++|||||++++++.. 
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTG------LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   89 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTT------EEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCC------CEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence            3568999999999999999999876553      459999987653 34455678899999999999999999999863 


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCCcEEEec
Q 014189          188 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  263 (429)
Q Consensus       188 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  263 (429)
                          ....+++++|+.+|+|.+++..+   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+|++|
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~d  164 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILD  164 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccc
Confidence                23446677888899999988543   5999999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccCCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCChhhhhhHHHhHhhHHH
Q 014189          264 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  342 (429)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~  342 (429)
                      ||++.....     ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+................
T Consensus       165 fg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~  239 (348)
T d2gfsa1         165 FGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  239 (348)
T ss_dssp             C----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999876432     23446799999999987765 468999999999999999999999987654322111100000000


Q ss_pred             -h------hhhhhhhcCCCCC-CCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHh--cccccC
Q 014189          343 -E------KKKLLNIIDPRLE-GDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQV  397 (429)
Q Consensus       343 -~------~~~~~~~~~~~~~-~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~  397 (429)
                       +      ............. ...     ....+..+.+|+.+||..||++|||++|+++|  |..+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence             0      0000000000000 000     12346778999999999999999999999986  444433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.2e-41  Score=323.79  Aligned_cols=265  Identities=19%  Similarity=0.226  Sum_probs=191.6

Q ss_pred             cCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-----------CCceee
Q 014189          112 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-----------HPNLVK  180 (429)
Q Consensus       112 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~  180 (429)
                      ++|+++++||+|+||+||+|++..++      ..||||+++.+  ......+.+|+.+++.++           |+||++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g------~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~   84 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNN------THVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   84 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence            35999999999999999999876553      44999999765  233456778998888775           578999


Q ss_pred             eeeEEEe--CCeEEEEEEecCCCChh-hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeCCCCCCcEEEcCC
Q 014189          181 LIGYCCE--DEHRVLIYEFMARGSVE-NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTD  256 (429)
Q Consensus       181 l~~~~~~--~~~~~lv~e~~~~g~L~-~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~Dlkp~NIll~~~  256 (429)
                      +++++..  ....+++|+++..+... ..........+++..+..++.|++.||+|||+ .+  |+||||||+|||++.+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred             EEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeecc
Confidence            9988754  45667777776555433 33344455578999999999999999999997 66  9999999999999876


Q ss_pred             Cc------EEEeccCCCcCCCCCCCccccccccCCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCChhhh
Q 014189          257 YN------AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  330 (429)
Q Consensus       257 ~~------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltG~~p~~~~~~~~~  330 (429)
                      +.      ++++|||.+......     ....+||+.|+|||++.+..|+.++||||+||++++|++|+.||........
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~  237 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  237 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence            54      999999998764322     2346799999999999999999999999999999999999999975433211


Q ss_pred             hhHHHhHhhH-----------HHhhhhhhhhcCC-----CC--------------CCCCChHHHHHHHHHHHHhhccCCC
Q 014189          331 QNLADWALPL-----------LKEKKKLLNIIDP-----RL--------------EGDYPVKGVHKAAMLAYHCLNHNPK  380 (429)
Q Consensus       331 ~~~~~~~~~~-----------~~~~~~~~~~~~~-----~~--------------~~~~~~~~~~~l~~l~~~cl~~dP~  380 (429)
                      ..........           ...........+.     .+              ........+.++.+|+.+||..||.
T Consensus       238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  317 (362)
T d1q8ya_         238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  317 (362)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence            1100000000           0000000111110     00              1122345678899999999999999


Q ss_pred             CCCCHHHHHHh
Q 014189          381 ARPLMRDIVDS  391 (429)
Q Consensus       381 ~RPs~~evl~~  391 (429)
                      +|||++|+++|
T Consensus       318 ~Rpta~e~L~H  328 (362)
T d1q8ya_         318 KRADAGGLVNH  328 (362)
T ss_dssp             TCBCHHHHHTC
T ss_pred             HCcCHHHHhcC
Confidence            99999999987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=5.2e-25  Score=191.60  Aligned_cols=164  Identities=13%  Similarity=0.088  Sum_probs=116.2

Q ss_pred             ccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCC-----------------hhhHHHHHHHHHHHhccCCCc
Q 014189          115 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-----------------YQGHREWLAEVIFLGHLSHPN  177 (429)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~E~~~l~~l~h~n  177 (429)
                      .+.++||+|+||+||+|.+.+       +..||||+++....                 .........|...+.++.|++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~-------g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   75 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEK-------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA   75 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETT-------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred             hhCCEeeeCcceEEEEEECCC-------CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence            467899999999999997643       23499998754211                 011223456888999999999


Q ss_pred             eeeeeeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeCCCCCCcEEEcCCC
Q 014189          178 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  257 (429)
Q Consensus       178 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~Dlkp~NIll~~~~  257 (429)
                      ++..+++..    .+++|||++++.+..         ++......++.|++.+++|||+++  |+||||||+|||+++++
T Consensus        76 v~~~~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~~  140 (191)
T d1zara2          76 VPKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEEG  140 (191)
T ss_dssp             SCCEEEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETTE
T ss_pred             cceEEEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCCC
Confidence            998876532    279999998765543         223335678999999999999987  99999999999999655


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccCCcccccc--cc---cccCCCCcccchhhHHHH
Q 014189          258 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP--EY---IMTGHLTPRSDVYSFGVV  311 (429)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP--E~---~~~~~~~~~~DvwslG~i  311 (429)
                       ++|+|||+|.........          .|...  +.   .....|+.++|+||+.--
T Consensus       141 -~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         141 -IWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             -EEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             -EEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence             899999999765432211          11111  00   123568889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.56  E-value=3.5e-07  Score=81.25  Aligned_cols=147  Identities=16%  Similarity=0.102  Sum_probs=94.2

Q ss_pred             HHHHHhcCCccceeecCCCcEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccC-CCceeeeeeE
Q 014189          106 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGY  184 (429)
Q Consensus       106 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~  184 (429)
                      +++.....|+..+..+.++.+.||+....+        ..+++|+...... .....+.+|...+..+. +--+.+++++
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~--------~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~   78 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGEN--------ENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHF   78 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECSS--------CEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeCC--------CeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEE
Confidence            455556677777766656667899864222        1267887654321 11223456888877664 4346677888


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 014189          185 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE--------------------------  238 (429)
Q Consensus       185 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--------------------------  238 (429)
                      ...++..++||++++|.++.+......    .   ...++.+++..++.||+..                          
T Consensus        79 ~~~~~~~~lv~~~l~G~~~~~~~~~~~----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T d1j7la_          79 ERHDGWSNLLMSEADGVLCSEEYEDEQ----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEETTEEEEEEECCSSEEHHHHTTTCS----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EecCCceEEEEEecccccccccccccc----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence            888899999999999988765432111    1   1223344444444454310                          


Q ss_pred             -------------------------------CCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          239 -------------------------------KPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       239 -------------------------------~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                                                     ..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                           127899999999999987777799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.83  E-value=2.7e-05  Score=68.14  Aligned_cols=75  Identities=13%  Similarity=0.001  Sum_probs=49.0

Q ss_pred             eecCCC-cEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCC--CceeeeeeEEEeCCeEEEEE
Q 014189          119 VLGGGG-FGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH--PNLVKLIGYCCEDEHRVLIY  195 (429)
Q Consensus       119 ~lG~G~-fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~  195 (429)
                      .+..|. -+.||+......       ..+++|........    .+..|...++.+..  -.+.+++++..+.+..++||
T Consensus        17 ~~~~G~s~~~v~r~~~~~~-------~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~   85 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGR-------PVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   85 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTS-------CCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             EcCCcccCCeEEEEEeCCC-------CEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence            445554 368898754332       23788887654321    24467777776642  33567788888888899999


Q ss_pred             EecCCCChh
Q 014189          196 EFMARGSVE  204 (429)
Q Consensus       196 e~~~~g~L~  204 (429)
                      ++++|.++.
T Consensus        86 ~~i~G~~~~   94 (255)
T d1nd4a_          86 GEVPGQDLL   94 (255)
T ss_dssp             ECCSSEETT
T ss_pred             Eeeeccccc
Confidence            999887653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.75  E-value=5.7e-05  Score=70.80  Aligned_cols=79  Identities=15%  Similarity=0.107  Sum_probs=45.2

Q ss_pred             ceeecCCCcEEEEEEEEccccccCcCceeEEEEEecC------CCChhhHHHHHHHHHHHhccC-C-C-ceeeeeeEEEe
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG------DNSYQGHREWLAEVIFLGHLS-H-P-NLVKLIGYCCE  187 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~  187 (429)
                      .+.||.|....||+....++.      ..+++|.-..      +.-.........|.+.|+.+. + | .+.+++.+  +
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~------~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHD------RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEEeCCCceEeEEEEEeCCCC------eEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c
Confidence            356899999999998654433      2388886432      111111222345777777663 2 2 34555543  4


Q ss_pred             CCeEEEEEEecCCCCh
Q 014189          188 DEHRVLIYEFMARGSV  203 (429)
Q Consensus       188 ~~~~~lv~e~~~~g~L  203 (429)
                      .+..++|||++++..+
T Consensus       103 ~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         103 TEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTTEEEECCCTTSEE
T ss_pred             CCCCEEEEeccCCccc
Confidence            4556899999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.76  E-value=0.0044  Score=57.42  Aligned_cols=80  Identities=20%  Similarity=0.199  Sum_probs=49.8

Q ss_pred             ceeecCCCcEEEEEEEEccccccC-cCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-eeeeeEEEeCCeEEEE
Q 014189          117 DRVLGGGGFGCVYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLI  194 (429)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv  194 (429)
                      .+.|+.|-.-.+|++...+..... .....|++++......   .....+|..+++.+.-.++ .++++++.+    .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            367888888999998765542211 1233466776653222   2234478888888753344 467777643    689


Q ss_pred             EEecCCCCh
Q 014189          195 YEFMARGSV  203 (429)
Q Consensus       195 ~e~~~~g~L  203 (429)
                      +||++|.+|
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.52  E-value=0.005  Score=55.41  Aligned_cols=69  Identities=13%  Similarity=0.042  Sum_probs=42.0

Q ss_pred             cEEEEEEEEccccccCcCceeEEEEEecCCCChhhHHHHHHHHHHHhccCCCce-----eeee--eEEEeCCeEEEEEEe
Q 014189          125 FGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-----VKLI--GYCCEDEHRVLIYEF  197 (429)
Q Consensus       125 fg~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~--~~~~~~~~~~lv~e~  197 (429)
                      --.||++...++       ..+++|+.+....  ...++..|...+..|....+     +..-  ..+...+..+.++++
T Consensus        35 EN~vy~v~~~dg-------~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~  105 (325)
T d1zyla1          35 ENRVYQFQDEDR-------RRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  105 (325)
T ss_dssp             SSEEEEECCTTC-------CCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             cceeEEEEcCCC-------CEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEee
Confidence            357999865443       3389999876532  23445568877776642221     1111  233556778899999


Q ss_pred             cCCCC
Q 014189          198 MARGS  202 (429)
Q Consensus       198 ~~~g~  202 (429)
                      ++|..
T Consensus       106 ~~G~~  110 (325)
T d1zyla1         106 VGGRQ  110 (325)
T ss_dssp             CCCEE
T ss_pred             cCCcC
Confidence            98644

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.37  E-value=0.017  Score=51.29  Aligned_cols=30  Identities=30%  Similarity=0.255  Sum_probs=26.6

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCCc
Q 014189          239 KPVIYRDFKTSNILLDTDYNAKLSDFGLAK  268 (429)
Q Consensus       239 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  268 (429)
                      .++||+|+.++||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            359999999999999998877899999765